data_2lme_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lme _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.708 0.29 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -38.15 88.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.268 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -68.37 -42.96 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.17 -44.94 95.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.42 . . . . 0.0 111.137 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD22 ' CD2' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -66.03 -44.19 85.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.526 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.21 -34.17 77.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.011 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -72.77 -37.12 67.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -68.15 -44.02 76.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.734 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.682 ' HG ' HD21 ' C' ' 25' ' ' LEU . 3.9 mt -60.81 -44.92 96.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' OG1' ' A' ' 30' ' ' THR . 49.3 t0 -63.03 -33.85 76.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 11.8 tttt -71.19 -35.89 71.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.54 ' CD1' ' HB3' ' C' ' 28' ' ' LEU . 0.5 OUTLIER -66.42 -52.36 47.33 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HA ' HD23 ' B' ' 28' ' ' LEU . 46.9 t0 -55.56 -39.3 70.46 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.977 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.3 m -61.33 -49.72 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.862 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.623 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 85.0 mmt-85 -58.11 -32.02 67.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 18.9 t -77.3 -36.48 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.162 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.783 ' HB3' ' HG ' ' A' ' 66' ' ' SER . 59.1 m-20 -64.1 -52.8 57.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.94 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.636 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 13.3 pttt -77.22 -37.16 53.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA3' ' HH ' ' C' ' 63' ' ' TYR . . . -61.97 -40.18 98.55 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.433 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.621 HD21 ' CB ' ' B' ' 39' ' ' SER . 0.2 OUTLIER -72.86 -37.38 67.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.91 91.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -50.29 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.632 ' CB ' HD21 ' C' ' 36' ' ' LEU . 96.5 p -52.82 -49.37 65.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.2 73.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -50.53 -42.65 55.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -71.83 -42.51 66.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -75.81 -3.1 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.53 55.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.096 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -97.77 177.13 5.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.816 177.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -169.1 1.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.633 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 33.1 mt-30 63.9 116.38 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.277 9.9 Cg_endo -74.46 95.04 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.587 2.191 . . . . 0.0 112.593 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 87.4 m-85 68.83 -173.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 148.9 90.12 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.207 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -87.78 -14.74 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 123.152 0.581 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.37 48.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.279 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.99 -172.89 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 110.622 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.48 148.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.571 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.689 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.47 44.12 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 111.656 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.475 ' O ' HG13 ' B' ' 103' ' ' ILE . 1.1 t80 -97.48 124.13 41.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.25 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.456 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.2 p -116.5 127.95 55.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.73 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -159.85 154.87 24.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.45 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.53 165.99 29.61 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.518 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 69' ' ' LEU . 13.6 m -112.08 163.68 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.4 179.65 27.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.56 144.82 11.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.552 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.446 ' HH ' ' HA3' ' B' ' 35' ' ' GLY . 75.1 t80 -136.92 129.48 30.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.314 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 65.72 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -152.25 34.96 0.52 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.158 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.783 ' HG ' ' HB3' ' A' ' 33' ' ' ASP . 2.2 m -130.92 168.01 18.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -140.78 144.35 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.113 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.92 156.18 43.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HA ' HG12 ' A' ' 60' ' ' VAL . 6.7 tp -113.19 125.35 54.24 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.778 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB3' ' HB1' ' A' ' 88' ' ' ALA . . . -119.55 151.14 39.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.706 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.73 HG13 ' HB3' ' A' ' 58' ' ' ALA . 18.4 tt -145.2 164.24 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.438 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 179.58 175.56 46.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.44 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.74 147.69 11.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.92 163.3 30.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.232 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.437 ' H ' HD11 ' A' ' 83' ' ' LEU . 20.6 t80 -108.5 120.72 43.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.496 ' CB ' ' HA3' ' A' ' 50' ' ' GLY . 6.6 mmm180 -96.72 92.38 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.723 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.2 p -96.79 131.83 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.6 m120 64.67 -177.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.078 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.3 24.25 11.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.495 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.059 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 82' ' ' ALA . 7.8 p -109.3 153.67 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.403 ' H ' HG22 ' A' ' 81' ' ' VAL . . . -156.28 173.51 16.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 111.259 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.437 HD11 ' H ' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -163.22 140.32 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.611 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.633 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -140.48 134.27 30.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.188 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.95 133.97 14.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.438 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -160.0 170.54 36.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.546 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 71' ' ' ILE . 9.7 p -117.44 147.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.136 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 70' ' ' ALA . . . -119.39 134.57 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.328 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.18 110.85 22.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.733 ' HB1' ' HB3' ' A' ' 94' ' ' ASP . . . -118.91 136.9 53.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.631 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.536 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 50.63 -111.95 1.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.318 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.39 -53.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.689 0.28 . . . . 0.0 111.307 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.508 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -106.37 26.83 9.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.145 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.733 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -116.85 81.82 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.59 139.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.707 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.417 ' HG2' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -135.36 158.53 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.723 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -134.16 133.5 41.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.468 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.73 161.09 17.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.747 0.308 . . . . 0.0 111.393 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.45 0.18 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.724 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.57 ' HB2' HD11 ' C' ' 45' ' ' LEU . 13.8 p -126.02 178.76 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.426 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -144.44 137.77 27.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.863 0.363 . . . . 0.0 111.121 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.568 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 69.9 m-80 -103.29 148.79 25.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.352 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.476 HG13 ' O ' ' C' ' 56' ' ' PHE . 7.4 pt -152.75 146.66 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.686 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 90.0 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.681 0.277 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -38.11 88.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 mtt85 -68.26 -43.03 78.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.15 -44.94 95.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.471 ' CD2' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.98 -44.24 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.627 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.2 -34.08 76.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.078 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.85 -37.09 67.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mtt180 -68.06 -44.02 77.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.675 ' HG ' HD21 ' A' ' 25' ' ' LEU . 3.9 mt -60.91 -44.9 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.59 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.414 ' O ' ' OG1' ' B' ' 30' ' ' THR . 49.3 t0 -63.04 -33.84 76.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.869 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 11.8 tttt -71.16 -35.88 71.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.221 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.539 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -66.34 -52.41 47.31 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.456 ' HA ' HD23 ' C' ' 28' ' ' LEU . 46.8 t0 -55.54 -39.37 70.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.951 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.492 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 13.8 m -61.3 -49.74 75.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.87 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.625 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 85.0 mmt-85 -58.09 -31.97 67.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 18.8 t -77.35 -36.54 23.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.775 ' HB3' ' HG ' ' B' ' 66' ' ' SER . 59.3 m-20 -64.05 -52.81 57.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.654 ' HD2' ' HB2' ' B' ' 94' ' ' ASP . 13.3 pttt -77.27 -37.09 53.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.791 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.446 ' HA3' ' HH ' ' A' ' 63' ' ' TYR . . . -62.02 -40.18 98.56 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.419 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.629 HD21 ' CB ' ' C' ' 39' ' ' SER . 0.2 OUTLIER -72.84 -37.42 67.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.0 91.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.471 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.98 -50.28 50.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.719 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.621 ' CB ' HD21 ' A' ' 36' ' ' LEU . 96.4 p -52.82 -49.34 65.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.11 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.401 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.618 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . . . -50.54 -42.67 55.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.928 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -71.86 -42.43 66.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.92 -3.09 33.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.83 0.35 55.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.178 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -97.69 177.11 5.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.871 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.11 1.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.716 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.63 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 33.1 mt-30 63.97 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.977 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.277 9.8 Cg_endo -74.51 95.08 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.601 2.201 . . . . 0.0 112.508 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 87.4 m-85 68.84 -173.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 148.95 90.13 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.209 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -87.79 -14.77 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.141 0.576 . . . . 0.0 112.425 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.73 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.39 48.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.315 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.86 -172.9 4.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.605 0.241 . . . . 0.0 110.587 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 1.133 HG13 ' O ' ' C' ' 105' ' ' TRP . 4.6 p -103.37 148.77 7.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.607 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.672 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.5 44.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.928 0.395 . . . . 0.0 111.667 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.484 ' O ' HG13 ' C' ' 103' ' ' ILE . 1.1 t80 -97.5 124.12 41.61 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.277 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.448 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.0 p -116.51 127.89 54.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.941 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.709 ' HB3' HG13 ' B' ' 71' ' ' ILE . . . -159.83 154.75 24.63 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.452 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.62 166.04 29.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.544 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' B' ' 69' ' ' LEU . 13.8 m -112.06 163.69 8.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.347 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.37 179.58 27.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.462 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.54 144.87 11.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.451 ' HH ' ' HA3' ' C' ' 35' ' ' GLY . 75.3 t80 -136.92 129.62 30.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.729 0.299 . . . . 0.0 110.727 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 65.52 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.23 34.84 0.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.775 ' HG ' ' HB3' ' B' ' 33' ' ' ASP . 2.2 m -130.86 168.04 17.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -140.78 144.3 35.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.164 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.88 156.3 43.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.473 ' HA ' HG12 ' B' ' 60' ' ' VAL . 6.8 tp -113.2 125.36 54.25 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.792 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.701 ' HB3' ' HB1' ' B' ' 88' ' ' ALA . . . -119.59 151.15 39.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.699 0.285 . . . . 0.0 111.665 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.709 HG13 ' HB3' ' B' ' 58' ' ' ALA . 18.4 tt -145.19 164.2 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.126 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 179.6 175.52 46.47 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.433 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.74 147.77 11.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.873 0.368 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.91 163.33 30.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.433 ' H ' HD11 ' B' ' 83' ' ' LEU . 20.5 t80 -108.49 120.61 42.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.494 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.49 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.73 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.1 p -96.85 131.91 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.239 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.5 m120 64.6 -177.25 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.925 0.393 . . . . 0.0 111.04 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -116.26 24.21 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.563 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.402 HG22 ' N ' ' B' ' 82' ' ' ALA . 7.8 p -109.24 153.67 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.48 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.402 ' N ' HG22 ' B' ' 81' ' ' VAL . . . -156.33 173.47 16.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.281 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.433 HD11 ' H ' ' B' ' 75' ' ' TYR . 0.4 OUTLIER -163.12 140.39 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.63 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.24 30.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.195 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 134.03 14.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -160.04 170.58 36.18 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' B' ' 71' ' ' ILE . 9.8 p -117.44 147.41 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.85 0.357 . . . . 0.0 111.106 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' B' ' 70' ' ' ALA . . . -119.38 134.61 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.323 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.23 110.84 22.55 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.292 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.72 ' HB1' ' HB3' ' B' ' 94' ' ' ASP . . . -118.8 136.93 53.74 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.636 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.547 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 50.6 -112.05 1.45 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.3 -53.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.691 0.281 . . . . 0.0 111.326 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' SER . . . . . 0.504 ' O ' ' OG ' ' B' ' 93' ' ' SER . 2.2 t -106.35 26.85 9.34 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.198 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.72 ' HB3' ' HB1' ' B' ' 90' ' ' ALA . 0.3 OUTLIER -116.95 81.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.69 139.37 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.41 ' HG2' ' HB2' ' B' ' 88' ' ' ALA . 0.0 OUTLIER -135.38 158.52 44.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.711 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -134.12 133.55 41.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.72 161.05 17.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.51 0.18 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.575 ' HB2' HD11 ' A' ' 45' ' ' LEU . 13.9 p -126.05 178.78 5.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.462 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -144.52 137.76 27.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.002 0.429 . . . . 0.0 111.048 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.571 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 69.8 m-80 -103.2 148.8 25.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.442 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 56' ' ' PHE . 7.4 pt -152.77 146.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.336 . . . . 0.0 110.77 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.689 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 90.1 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.767 0.317 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -38.02 87.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.306 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -68.36 -43.0 78.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.13 -44.95 95.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.467 ' CD2' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -66.07 -44.15 85.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.554 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -34.13 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.77 -37.18 67.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -67.94 -44.13 77.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.772 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.682 HD21 ' HG ' ' A' ' 25' ' ' LEU . 3.9 mt -60.72 -44.99 95.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . 0.415 ' O ' ' OG1' ' C' ' 30' ' ' THR . 49.3 t0 -62.99 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.875 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 11.8 tttt -71.08 -35.9 72.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.313 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.54 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -66.38 -52.35 47.72 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.448 ' HA ' HD23 ' A' ' 28' ' ' LEU . 46.9 t0 -55.59 -39.28 70.5 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.496 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 14.3 m -61.4 -49.71 75.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.813 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.615 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 85.0 mmt-85 -58.05 -32.07 67.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.376 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 36' ' ' LEU . 18.6 t -77.26 -36.51 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.227 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.771 ' HB3' ' HG ' ' C' ' 66' ' ' SER . 59.0 m-20 -64.03 -52.85 57.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.631 ' HD2' ' HB2' ' C' ' 94' ' ' ASP . 13.2 pttt -77.26 -37.15 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.725 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . 0.451 ' HA3' ' HH ' ' B' ' 63' ' ' TYR . . . -62.02 -40.11 98.47 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.632 HD21 ' CB ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -72.85 -37.39 67.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.05 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.369 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.89 -50.38 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.629 ' CB ' HD21 ' B' ' 36' ' ' LEU . 96.6 p -52.71 -49.41 65.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.09 73.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.459 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.613 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . . . -50.56 -42.68 55.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -71.83 -42.46 66.94 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.88 -3.06 33.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.52 55.81 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.12 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -97.8 177.15 5.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.791 177.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.08 1.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.638 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.634 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 33.1 mt-30 63.99 116.4 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.95 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.4 94.97 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.647 2.231 . . . . 0.0 112.582 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 87.6 m-85 68.9 -173.61 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.9 90.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.247 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.8 -14.78 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.129 0.572 . . . . 0.0 112.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.43 48.77 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.274 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -147.01 -172.89 4.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.547 0.213 . . . . 0.0 110.573 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 4.6 p -103.42 148.73 8.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.686 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 7.4 m-80 -134.0 136.48 44.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.662 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . 0.476 ' O ' HG13 ' A' ' 103' ' ' ILE . 1.1 t80 -97.49 124.13 41.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.457 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 44.8 p -116.51 127.93 54.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . 0.731 ' HB3' HG13 ' C' ' 71' ' ' ILE . . . -159.82 154.85 24.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.41 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.52 166.07 29.72 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' C' ' 69' ' ' LEU . 13.7 m -112.12 163.7 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.802 0.334 . . . . 0.0 111.339 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.41 179.58 27.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.476 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.49 144.78 11.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.544 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.45 ' HH ' ' HA3' ' A' ' 35' ' ' GLY . 75.5 t80 -136.91 129.57 30.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.723 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.5 mmm-85 65.58 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.22 34.87 0.52 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.16 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' SER . . . . . 0.771 ' HG ' ' HB3' ' C' ' 33' ' ' ASP . 2.2 m -130.93 168.02 18.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . 0.404 HE21 ' HB3' ' C' ' 67' ' ' GLN . 5.7 mm100 -140.73 144.36 35.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.87 156.27 43.44 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.529 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.482 ' HA ' HG12 ' C' ' 60' ' ' VAL . 6.7 tp -113.23 125.38 54.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.702 ' HB3' ' HB1' ' C' ' 88' ' ' ALA . . . -119.54 151.16 39.08 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.695 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.731 HG13 ' HB3' ' C' ' 58' ' ' ALA . 18.3 tt -145.24 164.27 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.19 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.433 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 179.59 175.54 46.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.75 147.77 11.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.967 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.93 163.32 30.43 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.237 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.431 ' H ' HD11 ' C' ' 83' ' ' LEU . 20.6 t80 -108.5 120.64 43.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 111.137 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.495 ' CB ' ' HA3' ' C' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.32 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.675 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.732 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.2 p -96.73 131.87 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 111.332 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.5 m120 64.58 -177.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 111.093 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.33 24.21 11.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.8 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.419 HG22 ' H ' ' C' ' 82' ' ' ALA . 7.9 p -109.19 153.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.544 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.419 ' H ' HG22 ' C' ' 81' ' ' VAL . . . -156.35 173.47 16.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 111.252 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.431 HD11 ' H ' ' C' ' 75' ' ' TYR . 0.4 OUTLIER -163.08 140.34 7.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.595 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.634 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.27 30.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 133.95 14.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . 0.433 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.95 170.58 36.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.597 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -117.48 147.42 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.936 0.398 . . . . 0.0 111.096 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.702 ' HB1' ' HB3' ' C' ' 70' ' ' ALA . . . -119.35 134.61 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.22 110.89 22.63 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' C' ' 94' ' ' ASP . . . -118.88 136.92 53.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.679 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.564 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 50.61 -112.03 1.45 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.255 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.33 -53.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.257 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' C' ' 93' ' ' SER . 2.2 t -106.32 26.83 9.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.721 ' HB3' ' HB1' ' C' ' 90' ' ' ALA . 0.3 OUTLIER -116.88 81.83 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.93 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.63 139.32 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.737 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.411 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.0 OUTLIER -135.34 158.56 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -134.16 133.53 41.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.419 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -113.67 161.09 17.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.403 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.51 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.752 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.565 ' HB2' HD11 ' B' ' 45' ' ' LEU . 13.8 p -126.05 178.69 5.62 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.413 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.4 137.8 27.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.556 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 69.8 m-80 -103.3 148.86 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.377 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.484 HG13 ' O ' ' B' ' 56' ' ' PHE . 7.4 pt -152.79 146.67 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.784 0.326 . . . . 0.0 110.821 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.672 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 90.1 mt-10 -90.39 131.03 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . 1.133 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.9 t-105 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.635 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' O ' HD21 ' A' ' 21' ' ' LEU . 36.1 ttmt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.793 0.33 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -38.48 83.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -66.77 -45.68 77.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.818 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -40.84 96.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.683 HD23 HD22 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -64.51 -45.27 87.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.51 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.69 -28.39 69.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -74.74 -40.33 61.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -70.87 -41.18 71.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.766 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.643 HD21 ' HG ' ' B' ' 25' ' ' LEU . 7.8 mt -62.05 -49.86 74.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.481 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.24 -48.86 79.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 9.0 tmtt? -55.45 -38.02 68.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.168 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.521 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -63.4 -40.4 97.11 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.6 91.93 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.98 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 m -57.74 -48.08 80.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.81 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.542 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 83.9 mmt-85 -57.28 -33.15 67.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 28' ' ' LEU . 44.4 t -76.77 -37.78 28.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.602 ' HB3' ' HG ' ' A' ' 66' ' ' SER . 48.2 m-20 -61.95 -54.34 43.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.012 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.551 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 2.5 pttt -75.87 -36.17 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.795 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 -45.49 87.98 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.422 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -68.19 -39.59 82.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.845 0.355 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.73 90.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.4 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -52.66 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.703 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.699 ' HB3' HD21 ' C' ' 36' ' ' LEU . 78.3 p -50.9 -56.42 12.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.425 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -54.81 -48.95 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.436 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.685 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -49.39 -42.19 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.93 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.63 -36.07 65.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.062 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' C' ' 40' ' ' ALA . 54.4 m-20 -78.27 -3.17 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.704 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.4 t -84.31 1.38 45.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.18 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.792 ' HB3' HG23 ' A' ' 57' ' ' THR . 0.3 OUTLIER -98.26 174.58 6.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.82 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.34 -3.52 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.142 0.496 . . . . 0.0 111.661 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.536 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 35.8 mt-30 64.27 117.55 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.96 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.278 9.8 Cg_endo -74.46 100.39 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.669 2.246 . . . . 0.0 112.577 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 90.3 m-85 67.61 -167.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.26 81.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.203 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -88.26 -12.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.157 0.583 . . . . 0.0 112.396 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.78 45.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.256 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.56 -168.65 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.585 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.0 p -109.68 145.95 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.496 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.4 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 4.1 m-80 -128.52 135.32 49.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.943 0.402 . . . . 0.0 111.69 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.66 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.792 HG23 ' HB3' ' A' ' 45' ' ' LEU . 22.5 p -111.87 124.66 52.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.006 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.434 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -155.35 149.79 26.1 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.478 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.596 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 173.04 165.56 30.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -111.27 165.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 0.0 111.434 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -177.62 27.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.496 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -160.65 144.42 9.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.537 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.492 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 65.5 t80 -133.54 133.42 42.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.728 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.488 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 3.1 mmm-85 64.5 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.126 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.47 33.28 0.37 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.161 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.602 ' HG ' ' HB3' ' A' ' 33' ' ' ASP . 12.5 m -129.73 168.69 16.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -134.84 140.47 45.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.095 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.32 152.01 48.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.595 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HA ' HG12 ' A' ' 60' ' ' VAL . 4.7 tp -111.16 127.46 55.59 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.745 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.685 ' HB1' ' HB3' ' A' ' 41' ' ' ALA . . . -122.83 151.87 41.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.669 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.441 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.5 tt -147.78 163.72 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.088 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.514 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 175.48 172.65 40.53 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.446 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -162.75 147.24 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.6 161.63 28.69 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.295 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.449 ' H ' HD11 ' A' ' 83' ' ' LEU . 20.5 t80 -106.92 119.26 38.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 111.168 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.68 ' HD2' ' HB3' ' A' ' 82' ' ' ALA . 5.0 mmm180 -95.86 101.02 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.711 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 77' ' ' VAL . 12.6 p -98.62 128.88 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.7 m120 65.23 -175.05 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.82 25.45 10.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.573 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.964 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 82' ' ' ALA . 9.8 p -106.22 151.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.68 ' HB3' ' HD2' ' A' ' 76' ' ' ARG . . . -153.42 169.81 22.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.245 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.449 HD11 ' H ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -162.48 141.23 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.536 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 1.3 ttmp? -141.42 133.46 27.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.27 135.03 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.514 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -159.35 173.86 36.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.581 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 96' ' ' MET . 5.6 p -122.83 144.3 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 70' ' ' ALA . . . -112.92 135.43 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.36 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' OH ' HG11 ' A' ' 87' ' ' VAL . 16.6 m-85 -111.08 111.07 21.91 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.236 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . . . -124.01 135.83 53.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.551 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.91 -113.84 4.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.238 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.83 -58.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.526 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -103.9 28.43 6.68 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.203 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.412 ' CB ' ' HD2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -118.18 82.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.962 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' ' 88' ' ' ALA . 11.5 t -120.76 142.81 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' C' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.15 50.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -128.01 129.41 46.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.429 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.5 159.35 22.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.724 0.297 . . . . 0.0 111.393 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.716 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.737 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.7 p -122.86 178.5 5.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -142.13 146.04 34.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.95 0.405 . . . . 0.0 111.12 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.597 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 70.5 m-80 -112.88 150.73 31.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.326 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 pt -157.24 152.04 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.777 0.323 . . . . 0.0 110.814 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 75.8 mt-10 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.44 ' O ' HD21 ' B' ' 21' ' ' LEU . 36.1 ttmt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -38.46 83.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.297 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -66.81 -45.67 77.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -40.85 96.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.684 HD22 HD23 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -64.37 -45.29 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.75 -28.34 69.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.05 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -74.76 -40.32 61.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -70.9 -41.18 71.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.808 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.643 ' HG ' HD21 ' A' ' 25' ' ' LEU . 7.9 mt -61.96 -49.86 74.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.21 -48.87 79.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 9.0 tmtt? -55.43 -37.93 68.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.292 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.518 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.4 OUTLIER -63.49 -40.3 96.73 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -64.18 -44.62 91.48 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.954 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -57.7 -48.06 80.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.535 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 83.9 mmt-85 -57.18 -33.29 67.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.259 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 28' ' ' LEU . 44.5 t -76.78 -37.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.599 ' HB3' ' HG ' ' B' ' 66' ' ' SER . 48.2 m-20 -62.06 -54.28 43.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.999 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.548 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 2.6 pttt -75.9 -36.03 59.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.41 87.61 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -68.18 -39.65 82.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.75 90.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.414 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -52.7 27.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.746 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.702 ' HB3' HD21 ' A' ' 36' ' ' LEU . 78.3 p -50.88 -56.35 12.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.409 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -54.91 -48.95 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.393 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.682 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . . . -49.43 -42.18 41.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 23.8 tp -73.62 -36.04 65.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.426 ' CB ' ' HB3' ' C' ' 43' ' ' ASN . 54.4 m-20 -78.35 -3.14 41.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.712 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -84.26 1.29 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.089 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.775 ' HB3' HG23 ' B' ' 57' ' ' THR . 0.3 OUTLIER -98.21 174.49 6.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.906 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.31 -3.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 111.686 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.553 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.56 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.276 9.9 Cg_endo -74.43 100.38 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.629 2.219 . . . . 0.0 112.608 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 90.2 m-85 67.69 -167.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.2 81.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.228 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -88.28 -12.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.121 0.569 . . . . 0.0 112.402 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.78 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.332 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.77 2.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.637 0.256 . . . . 0.0 110.6 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.966 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.1 p -109.64 145.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.589 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.401 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 4.1 m-80 -128.47 135.31 49.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.648 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.63 122.65 44.26 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.313 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.775 HG23 ' HB3' ' B' ' 45' ' ' LEU . 22.4 p -112.01 124.65 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.932 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.427 ' HB3' HG13 ' B' ' 71' ' ' ILE . . . -155.3 149.84 26.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.602 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 172.97 165.52 30.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 6.9 m -111.31 165.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.05 -177.63 27.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -160.67 144.4 9.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.485 ' CE2' ' HG3' ' B' ' 64' ' ' ARG . 65.8 t80 -133.53 133.49 42.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 110.776 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.485 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 3.1 mmm-85 64.46 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.43 33.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.599 ' HG ' ' HB3' ' B' ' 33' ' ' ASP . 12.5 m -129.75 168.7 16.14 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -134.71 140.54 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.135 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.99 48.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.572 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 tp -111.18 127.35 55.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' B' ' 41' ' ' ALA . . . -122.76 151.89 41.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.726 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.437 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.4 tt -147.72 163.74 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.12 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.503 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 175.47 172.62 40.5 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.466 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 17.9 p -162.8 147.17 11.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.374 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.63 161.64 28.7 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.265 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.456 ' H ' HD11 ' B' ' 83' ' ' LEU . 20.5 t80 -106.85 119.21 38.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 111.146 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.681 ' HD2' ' HB3' ' B' ' 82' ' ' ALA . 5.0 mmm180 -95.85 101.08 12.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.698 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.436 ' O ' HG13 ' B' ' 77' ' ' VAL . 12.7 p -98.66 128.86 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.269 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.8 m120 65.2 -174.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -114.88 25.5 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.559 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.23 -46.38 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.409 HG22 ' N ' ' B' ' 82' ' ' ALA . 9.8 p -106.27 151.12 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.681 ' HB3' ' HD2' ' B' ' 76' ' ' ARG . . . -153.43 169.8 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.235 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.456 HD11 ' H ' ' B' ' 75' ' ' TYR . 0.6 OUTLIER -162.53 141.22 8.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.553 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.553 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.55 27.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.36 135.1 19.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.503 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -159.39 173.9 36.23 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.562 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.442 HG11 ' OH ' ' B' ' 89' ' ' TYR . 5.6 p -122.87 144.31 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.38 . . . . 0.0 111.148 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' B' ' 70' ' ' ALA . . . -112.85 135.38 53.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.313 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . 0.442 ' OH ' HG11 ' B' ' 87' ' ' VAL . 16.7 m-85 -111.12 111.02 21.81 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.3 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' B' ' 34' ' ' LYS . . . -123.92 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.581 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.548 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.84 -113.87 4.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 -58.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 111.293 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' SER . . . . . 0.526 ' O ' ' OG ' ' B' ' 93' ' ' SER . 2.2 t -103.86 28.36 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.153 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.415 ' CB ' ' HD2' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -118.22 82.86 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.446 HG11 ' O ' ' B' ' 88' ' ' ALA . 11.6 t -120.81 142.8 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.724 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.09 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -127.94 129.35 46.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.48 159.3 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.47 0.35 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.761 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.75 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.8 p -122.8 178.56 4.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -142.22 146.07 34.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.587 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.5 m-80 -112.88 150.7 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.409 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 pt -157.25 152.02 7.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 110.757 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.4 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 75.9 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.446 ' O ' HD21 ' C' ' 21' ' ' LEU . 36.1 ttmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.716 0.293 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.71 -38.51 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.272 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -66.77 -45.71 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -40.79 96.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.684 HD23 HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -64.45 -45.25 88.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.609 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.74 -28.34 69.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -74.78 -40.31 61.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -70.91 -41.13 71.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.819 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.629 ' HG ' HD21 ' B' ' 25' ' ' LEU . 7.9 mt -62.08 -49.72 74.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.656 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.37 -48.81 79.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.758 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 9.0 tmtt? -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.62 0.248 . . . . 0.0 111.286 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.523 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.4 OUTLIER -63.41 -40.42 97.16 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.69 91.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.954 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -57.6 -48.08 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.908 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.524 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 83.8 mmt-85 -57.28 -33.23 67.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.523 HG23 ' O ' ' C' ' 28' ' ' LEU . 44.4 t -76.78 -37.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.615 ' HB3' ' HG ' ' C' ' 66' ' ' SER . 48.4 m-20 -61.92 -54.42 42.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.578 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 2.5 pttt -75.85 -36.08 59.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.798 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.37 88.16 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -68.27 -39.64 82.12 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 111.012 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.8 91.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.68 -52.76 27.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.722 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.702 ' HB3' HD21 ' B' ' 36' ' ' LEU . 78.2 p -50.83 -56.41 12.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.419 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -54.83 -48.97 72.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.418 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.695 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . . . -49.38 -42.12 41.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.73 -35.95 65.13 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.074 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.426 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 54.5 m-20 -78.3 -3.2 41.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' SER . . . . . 0.695 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.4 t -84.23 1.24 45.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.129 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.776 ' HB3' HG23 ' C' ' 57' ' ' THR . 0.3 OUTLIER -98.18 174.53 6.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.901 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.32 -3.55 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.535 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.65 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.948 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.46 100.41 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.696 2.264 . . . . 0.0 112.552 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.414 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 90.3 m-85 67.59 -167.18 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.23 81.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.255 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -88.19 -13.03 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.143 0.577 . . . . 0.0 112.381 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.85 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.72 2.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.603 0.24 . . . . 0.0 110.584 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 p -109.67 145.88 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.509 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 4.1 m-80 -128.44 135.31 49.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.666 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.64 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.223 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.776 HG23 ' HB3' ' C' ' 45' ' ' LEU . 22.5 p -111.9 124.58 52.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.989 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . 0.419 ' HB3' HG13 ' C' ' 71' ' ' ILE . . . -155.26 149.91 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.483 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.594 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 172.98 165.53 30.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' C' ' 69' ' ' LEU . 6.9 m -111.27 165.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.391 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.95 -177.59 27.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.465 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -160.68 144.36 9.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.495 ' CE2' ' HG3' ' C' ' 64' ' ' ARG . 65.5 t80 -133.5 133.45 42.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.729 0.299 . . . . 0.0 110.775 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.495 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm-85 64.45 -81.11 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.023 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 33.29 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' SER . . . . . 0.615 ' HG ' ' HB3' ' C' ' 33' ' ' ASP . 12.5 m -129.78 168.71 16.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.808 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -134.77 140.53 45.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.37 151.93 47.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.56 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.408 ' HA ' HG12 ' C' ' 60' ' ' VAL . 4.7 tp -111.07 127.43 55.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.787 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.695 ' HB1' ' HB3' ' C' ' 41' ' ' ALA . . . -122.8 151.89 41.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.431 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.6 tt -147.83 163.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 0.0 111.116 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.506 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 175.51 172.7 40.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.8 p -162.86 147.25 11.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.39 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.67 161.6 28.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.245 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.459 ' H ' HD11 ' C' ' 83' ' ' LEU . 20.4 t80 -106.88 119.23 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.142 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.687 ' HD2' ' HB3' ' C' ' 82' ' ' ALA . 5.0 mmm180 -95.8 100.95 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.737 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.439 HG13 ' O ' ' C' ' 77' ' ' VAL . 12.7 p -98.55 128.86 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.272 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.8 m120 65.27 -175.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -114.86 25.42 10.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.582 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.37 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.408 HG22 ' N ' ' C' ' 82' ' ' ALA . 9.8 p -106.21 151.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.514 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.687 ' HB3' ' HD2' ' C' ' 76' ' ' ARG . . . -153.45 169.75 22.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.459 HD11 ' H ' ' C' ' 75' ' ' TYR . 0.6 OUTLIER -162.41 141.22 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.535 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.63 27.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.163 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.42 135.06 19.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.104 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . 0.506 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.36 173.89 36.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.587 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.439 HG22 ' O ' ' C' ' 96' ' ' MET . 5.6 p -122.92 144.29 32.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' C' ' 70' ' ' ALA . . . -112.92 135.34 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.311 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . 0.432 ' OH ' HG11 ' C' ' 87' ' ' VAL . 16.6 m-85 -111.04 111.02 21.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.23 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' C' ' 34' ' ' LYS . . . -123.91 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.605 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.578 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.86 -113.85 4.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.298 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.79 -58.1 0.98 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.778 0.323 . . . . 0.0 111.32 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' C' ' 93' ' ' SER . 2.2 t -103.85 28.38 6.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.161 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.414 ' CB ' ' HD2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -118.23 82.82 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . 0.454 HG11 ' O ' ' C' ' 88' ' ' ALA . 11.5 t -120.8 142.81 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.708 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' B' ' 62' ' ' GLY . 0.8 OUTLIER -136.86 153.15 50.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.72 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -128.01 129.42 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.51 159.31 23.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.447 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.29 98.55 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.76 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.6 p -122.92 178.6 4.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -142.18 146.07 34.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 111.128 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.598 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 70.5 m-80 -112.85 150.64 31.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.397 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 pt -157.2 152.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.774 0.321 . . . . 0.0 110.841 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.401 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 75.6 mt-10 -94.95 129.48 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . 0.966 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.8 t-105 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.706 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.749 0.309 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -35.45 75.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.309 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.07 -44.07 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.55 -46.86 81.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.092 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -36.81 84.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.58 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.17 -35.91 82.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.031 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.82 -42.21 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HD2' HD12 ' C' ' 25' ' ' LEU . 28.2 mtt180 -62.71 -38.13 89.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.747 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.464 HD12 ' HD2' ' B' ' 24' ' ' ARG . 12.7 mt -67.35 -53.98 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.95 -47.61 77.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.822 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.88 -44.78 94.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.173 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -58.09 -42.68 86.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -64.65 -40.7 95.9 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.983 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.2 m -61.66 -44.42 96.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.801 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 88.4 mmt-85 -57.07 -37.74 72.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 10.0 t -73.27 -29.53 28.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.153 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.561 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 63.6 m-20 -67.95 -62.73 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.037 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 0.5 OUTLIER -66.53 -44.64 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.771 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.51 ' HA3' ' HH ' ' C' ' 63' ' ' TYR . . . -54.87 -46.17 77.46 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.374 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -68.02 -34.18 76.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.852 0.358 . . . . 0.0 111.147 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -65.31 -45.71 83.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.461 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -54.48 19.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.764 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.509 ' CB ' HD21 ' C' ' 36' ' ' LEU . 47.8 p -49.44 -55.06 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.12 -46.13 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.427 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.638 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -51.87 -39.27 58.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 43.1 tp -80.96 -36.79 30.43 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.01 -3.24 28.04 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.424 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 6.1 t -88.62 -7.52 56.25 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.14 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.773 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.5 OUTLIER -90.72 165.75 13.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.856 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.77 -2.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.14 0.495 . . . . 0.0 111.703 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 40.0 mt-30 67.12 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.907 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 47' ' ' GLN 0.406 9.9 Cg_endo -69.59 99.36 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.673 2.249 . . . . 0.0 112.524 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 60.78 -160.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 149.42 83.44 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.29 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.5 p -90.06 -15.51 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.234 0.614 . . . . 0.0 112.45 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 161.71 48.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.267 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.89 -170.25 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.625 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.85 141.01 25.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.58 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.44 ' OD1' ' HD2' ' A' ' 48' ' ' PRO . 3.2 m-80 -125.37 133.96 52.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.53 45.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.246 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.635 HG23 ' HB3' ' A' ' 45' ' ' LEU . 24.4 p -114.93 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.06 146.87 22.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.461 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.502 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 176.05 163.05 28.03 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.543 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.3 m -105.7 167.15 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.23 27.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.522 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.67 141.31 7.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.542 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.561 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 72.4 t80 -129.39 139.24 51.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.725 0.298 . . . . 0.0 110.786 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.42 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 3.0 mmm180 61.2 -81.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.045 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 t -155.96 35.57 0.34 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.531 ' HG ' ' HB3' ' A' ' 33' ' ' ASP . 7.1 m -133.06 166.85 21.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.39 142.83 47.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.49 44.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.565 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.1 tp -110.93 131.25 55.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.717 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 41' ' ' ALA . . . -126.26 154.3 43.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.728 0.299 . . . . 0.0 111.613 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 87' ' ' VAL . 20.4 tt -147.76 162.9 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.76 0.314 . . . . 0.0 111.126 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.423 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 178.58 169.73 39.7 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.411 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -161.94 142.45 10.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.966 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.15 160.95 27.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.201 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.651 ' H ' HD11 ' A' ' 83' ' ' LEU . 25.5 t80 -106.59 116.2 31.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 111.133 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.53 ' HD2' ' HB3' ' A' ' 82' ' ' ALA . 5.2 mmm180 -93.87 93.22 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 8.7 p -93.88 126.04 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 12.2 m120 68.98 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -120.02 24.94 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.611 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 6.8 t -126.06 -39.4 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.982 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.06 152.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.504 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.655 ' HB2' ' HB2' ' A' ' 102' ' ' ASN . . . -149.05 174.53 12.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.226 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.651 HD11 ' H ' ' A' ' 75' ' ' TYR . 1.4 pp -163.88 143.63 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HE3' HE21 ' A' ' 47' ' ' GLN . 2.2 ttmp? -146.7 128.19 15.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.55 135.64 15.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.404 ' HA3' ' CA ' ' A' ' 72' ' ' GLY . . . -161.34 178.52 37.23 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.546 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 71' ' ' ILE . 6.0 p -118.21 140.54 41.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 111.14 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.587 ' HB3' ' HE1' ' A' ' 96' ' ' MET . . . -112.57 131.68 55.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.79 112.04 24.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.221 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 94' ' ' ASP . . . -124.96 131.24 53.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.616 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.647 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.05 -116.06 6.36 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.92 -61.22 1.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.303 . . . . 0.0 111.327 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.482 ' O ' ' OG ' ' A' ' 93' ' ' SER . 3.1 t -100.21 28.98 4.55 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.195 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.585 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.76 136.09 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.587 ' HE1' ' HB3' ' A' ' 88' ' ' ALA . 1.1 ptp -131.35 150.11 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.647 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -123.06 134.02 54.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.456 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.95 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.72 0.295 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.21 91.68 0.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.811 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.779 ' HB2' HD11 ' C' ' 45' ' ' LEU . 21.8 p -119.9 177.78 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.417 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -139.52 144.42 37.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.968 0.413 . . . . 0.0 111.068 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.655 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 70.0 m-80 -112.95 143.51 44.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.368 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.63 151.17 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.0 110.777 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.611 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 55.5 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.741 0.305 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.276 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -70.03 -44.16 69.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.772 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.45 -46.87 81.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.125 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -36.73 84.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.523 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.24 -35.81 82.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.87 -42.22 63.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.791 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.464 ' HD2' HD12 ' A' ' 25' ' ' LEU . 28.1 mtt180 -62.71 -38.09 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.476 HD12 ' HD2' ' C' ' 24' ' ' ARG . 12.7 mt -67.33 -54.1 23.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.86 -47.73 76.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.79 -44.77 93.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.249 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.453 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -57.95 -42.74 85.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -64.82 -40.59 95.45 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.932 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.0 m -61.62 -44.4 97.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.816 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.487 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 88.4 mmt-85 -57.27 -37.72 72.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 9.8 t -73.21 -29.49 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.56 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 63.6 m-20 -67.97 -62.74 1.27 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.653 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 0.5 OUTLIER -66.56 -44.59 81.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.51 ' HA3' ' HH ' ' A' ' 63' ' ' TYR . . . -54.89 -46.11 77.87 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.391 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.2 OUTLIER -68.08 -34.19 75.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.751 0.31 . . . . 0.0 111.055 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 41' ' ' ALA . . . -65.35 -45.71 83.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.54 -54.46 19.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.791 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.495 ' CB ' HD21 ' A' ' 36' ' ' LEU . 47.5 p -49.47 -55.06 14.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.11 82.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.403 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.655 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . . . -51.87 -39.24 58.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.891 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 42.7 tp -81.05 -36.75 30.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -74.02 -3.17 27.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.433 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 6.1 t -88.65 -7.59 56.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.105 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.5 OUTLIER -90.62 165.74 13.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.882 177.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 8.6 p90 -154.84 -2.91 0.16 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.102 0.477 . . . . 0.0 111.609 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.426 HE21 ' HE3' ' B' ' 84' ' ' LYS . 39.9 mt-30 66.99 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.993 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.437 ' HD2' ' OD1' ' B' ' 55' ' ' ASN 0.405 9.9 Cg_endo -69.6 99.41 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.685 2.257 . . . . 0.0 112.518 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 60.73 -159.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.976 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 149.27 83.48 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.309 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 9.6 p -90.06 -15.5 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.148 0.579 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 161.71 48.47 0.02 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.27 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.83 -170.11 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.579 0.228 . . . . 0.0 110.614 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.935 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.7 p -108.97 141.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.608 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.437 ' OD1' ' HD2' ' B' ' 48' ' ' PRO . 3.2 m-80 -125.34 133.84 52.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 111.702 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.77 124.54 45.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.243 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.652 HG23 ' HB3' ' B' ' 45' ' ' LEU . 24.4 p -114.93 125.48 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.03 146.93 22.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.431 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 175.99 163.0 27.92 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.545 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.432 ' H ' HG21 ' B' ' 60' ' ' VAL . 6.3 m -105.68 167.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 111.36 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.94 -176.23 27.84 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.71 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.58 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.568 ' HA ' ' HB2' ' C' ' 96' ' ' MET . 72.5 t80 -129.35 139.27 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.658 0.266 . . . . 0.0 110.761 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 3.0 mmm180 61.13 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.08 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 63' ' ' TYR . 8.0 t -155.88 35.51 0.35 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.17 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.522 ' HG ' ' HB3' ' B' ' 33' ' ' ASP . 6.9 m -133.15 166.73 21.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -134.29 142.91 47.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.045 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.96 156.47 44.88 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tp -110.97 131.31 55.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' B' ' 41' ' ' ALA . . . -126.15 154.24 43.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.691 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.552 HG23 ' O ' ' B' ' 87' ' ' VAL . 20.4 tt -147.75 162.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.722 0.296 . . . . 0.0 111.186 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.424 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 178.56 169.66 39.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.45 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.47 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.16 160.87 27.88 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.248 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.645 ' H ' HD11 ' B' ' 83' ' ' LEU . 25.3 t80 -106.53 116.19 31.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.162 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.529 ' HD2' ' HB3' ' B' ' 82' ' ' ALA . 5.2 mmm180 -93.83 93.18 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' B' ' 78' ' ' ASN . 8.7 p -93.89 126.06 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.311 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 12.1 m120 69.04 -172.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -120.03 24.9 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' SER . . . . . 0.61 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 6.8 t -126.0 -39.5 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -114.99 152.54 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' B' ' 102' ' ' ASN . . . -149.0 174.61 12.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.286 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.645 HD11 ' H ' ' B' ' 75' ' ' TYR . 1.4 pp -163.84 143.7 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.617 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.426 ' HE3' HE21 ' B' ' 47' ' ' GLN . 2.2 ttmp? -146.77 128.1 14.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.43 135.65 15.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.32 178.5 37.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.603 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.552 ' O ' HG23 ' B' ' 71' ' ' ILE . 6.0 p -118.18 140.58 41.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.905 0.383 . . . . 0.0 111.123 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.576 ' HB3' ' HE1' ' B' ' 96' ' ' MET . . . -112.55 131.7 55.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.355 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.8 111.96 24.84 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.278 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.593 ' HB1' ' HB3' ' B' ' 94' ' ' ASP . . . -124.91 131.29 53.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.612 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.653 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.0 -116.11 6.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.224 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -127.92 -61.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.313 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' SER . . . . . 0.506 ' O ' ' OG ' ' B' ' 93' ' ' SER . 3.0 t -100.27 29.04 4.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.157 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.593 ' HB3' ' HB1' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -118.35 83.08 1.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.8 136.05 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.576 ' HE1' ' HB3' ' B' ' 88' ' ' ALA . 1.1 ptp -131.34 150.14 52.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -123.17 134.01 54.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.375 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.98 24.94 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.389 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.82 0.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.721 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.773 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.7 p -120.0 177.78 4.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.429 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -139.55 144.38 37.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.092 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.662 ' HB2' ' HB2' ' B' ' 82' ' ' ALA . 70.1 m-80 -112.92 143.6 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.353 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.72 151.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.61 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 55.4 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.705 0.288 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.44 -35.48 75.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.249 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.03 -44.13 69.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.798 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -46.91 81.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -36.82 84.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.589 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.11 -35.96 82.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.001 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.81 -42.19 64.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.476 ' HD2' HD12 ' B' ' 25' ' ' LEU . 28.1 mtt180 -62.72 -38.09 89.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.788 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.473 HD12 ' HD2' ' A' ' 24' ' ' ARG . 12.6 mt -67.34 -54.03 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.92 -47.74 76.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.813 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.75 -44.8 93.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.191 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.456 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -58.03 -42.63 85.73 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -64.85 -40.57 95.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.949 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 10.2 m -61.69 -44.39 97.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.789 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.488 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 88.2 mmt-85 -57.2 -37.65 72.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' C' ' 36' ' ' LEU . 9.9 t -73.25 -29.6 28.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.118 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.564 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 63.6 m-20 -67.92 -62.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.023 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.675 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 0.5 OUTLIER -66.51 -44.61 82.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.804 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . 0.498 ' HA3' ' HH ' ' B' ' 63' ' ' TYR . . . -54.86 -46.17 77.38 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.2 OUTLIER -68.07 -34.11 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' C' ' 41' ' ' ALA . . . -65.44 -45.65 82.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -54.48 19.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.504 ' CB ' HD21 ' B' ' 36' ' ' LEU . 47.6 p -49.45 -55.06 14.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.09 82.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.515 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.651 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . . . -51.89 -39.18 58.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' C' ' 70' ' ' ALA . 42.9 tp -81.08 -36.66 30.15 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -74.04 -3.24 28.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' SER . . . . . 0.43 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -88.62 -7.6 56.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.081 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.5 OUTLIER -90.58 165.75 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.924 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 8.6 p90 -154.83 -3.0 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.105 0.479 . . . . 0.0 111.649 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.439 HE21 ' HE3' ' C' ' 84' ' ' LYS . 40.0 mt-30 67.04 122.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.937 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' OD1' ' C' ' 55' ' ' ASN 0.406 9.8 Cg_endo -69.53 99.34 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.632 2.222 . . . . 0.0 112.556 -179.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 60.84 -160.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 149.36 83.55 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.198 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 9.5 p -90.14 -15.52 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.217 0.607 . . . . 0.0 112.393 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 161.73 48.48 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.305 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.88 -170.15 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.675 0.274 . . . . 0.0 110.549 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.94 141.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.613 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.428 ' OD1' ' HD2' ' C' ' 48' ' ' PRO . 3.2 m-80 -125.42 133.92 52.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.015 0.435 . . . . 0.0 111.661 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.46 45.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.204 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.654 HG23 ' HB3' ' C' ' 45' ' ' LEU . 24.3 p -114.9 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.903 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.94 146.92 22.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 175.97 163.05 27.99 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.565 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.426 ' H ' HG21 ' C' ' 60' ' ' VAL . 6.2 m -105.76 167.21 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 111.226 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.04 -176.25 27.96 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.503 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.69 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.568 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.564 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 72.2 t80 -129.35 139.31 51.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.698 0.285 . . . . 0.0 110.729 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm180 61.09 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.094 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' SER . . . . . 0.4 ' N ' ' O ' ' C' ' 63' ' ' TYR . 8.0 t -155.91 35.41 0.35 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' SER . . . . . 0.509 ' HG ' ' HB3' ' C' ' 33' ' ' ASP . 7.0 m -132.99 166.83 21.48 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.36 142.8 47.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.89 156.51 44.93 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tp -110.95 131.22 55.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' C' ' 41' ' ' ALA . . . -126.15 154.31 43.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.704 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.539 HG23 ' O ' ' C' ' 87' ' ' VAL . 20.4 tt -147.73 162.89 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.749 0.309 . . . . 0.0 111.137 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.422 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 178.52 169.67 39.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.431 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.46 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.05 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.12 160.92 27.88 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.246 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.652 ' H ' HD11 ' C' ' 83' ' ' LEU . 25.4 t80 -106.59 116.23 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.166 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.514 ' HD2' ' HB3' ' C' ' 82' ' ' ALA . 5.2 mmm180 -93.85 93.16 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' C' ' 78' ' ' ASN . 8.7 p -93.87 126.11 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.273 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 12.2 m120 68.89 -171.96 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.921 0.391 . . . . 0.0 111.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -119.98 24.87 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.616 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' SER . . . . . 0.606 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 6.8 t -126.06 -39.36 2.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.994 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.01 152.61 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.678 ' HB2' ' HB2' ' C' ' 102' ' ' ASN . . . -149.05 174.63 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.278 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.652 HD11 ' H ' ' C' ' 75' ' ' TYR . 1.4 pp -163.84 143.74 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.439 ' HE3' HE21 ' C' ' 47' ' ' GLN . 2.2 ttmp? -146.82 128.16 14.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.48 135.66 15.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.36 178.57 37.22 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.556 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.539 ' O ' HG23 ' C' ' 71' ' ' ILE . 6.0 p -118.25 140.64 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.872 0.367 . . . . 0.0 111.088 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.564 ' HB3' ' HE1' ' C' ' 96' ' ' MET . . . -112.6 131.65 55.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.323 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -105.77 112.05 24.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.292 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.597 ' HB1' ' HB3' ' C' ' 94' ' ' ASP . . . -125.01 131.23 53.44 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.579 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.675 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.09 -116.15 6.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.235 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.86 -61.25 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.717 0.294 . . . . 0.0 111.299 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' C' ' 93' ' ' SER . 3.1 t -100.19 28.98 4.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.193 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.597 ' HB3' ' HB1' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 t -118.82 136.05 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.0 110.706 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.568 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 1.1 ptp -131.31 150.07 52.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -123.08 133.96 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.365 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -116.96 157.96 24.88 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.705 0.288 . . . . 0.0 111.471 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.72 0.12 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.771 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.779 ' HB2' HD11 ' B' ' 45' ' ' LEU . 21.6 p -119.91 177.82 4.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.432 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -139.58 144.48 37.8 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.028 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.678 ' HB2' ' HB2' ' C' ' 82' ' ' ALA . 70.0 m-80 -112.96 143.57 44.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.332 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.7 151.19 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.866 0.365 . . . . 0.0 110.77 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.606 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 55.5 mt-10 -92.33 128.2 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . 0.935 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.696 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.408 ' O ' ' HD1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -72.49 -34.87 67.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.215 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.6 mtt85 -65.97 -40.06 90.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.85 -44.91 63.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 111.134 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.658 HD23 HD22 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -55.61 -37.96 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.591 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.75 -31.13 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.038 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.07 -39.6 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' CB ' HD12 ' C' ' 25' ' ' LEU . 13.7 mtt180 -72.65 -37.56 67.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.782 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.3 mt -68.96 -42.7 76.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.648 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.22 -38.81 92.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.74 74.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.636 0.255 . . . . 0.0 111.181 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.9 -43.73 94.67 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -59.8 -40.5 88.59 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.951 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.504 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 26.0 m -66.67 -41.38 88.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.804 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.337 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.09 -32.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.224 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.694 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 70.4 m-20 -65.56 -63.89 0.99 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.121 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.71 -34.54 62.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.773 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.45 78.44 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.446 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -72.53 -27.31 62.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 111.073 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.61 55.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.399 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.83 -41.58 78.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.62 ' HB3' HD21 ' C' ' 36' ' ' LEU . 31.5 p -55.84 -58.98 5.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.85 -39.54 71.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.444 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.528 ' HB1' ' C ' ' A' ' 60' ' ' VAL . . . -60.73 -37.44 81.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.968 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 tp -75.16 -37.33 61.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.53 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.5 m-20 -76.45 -5.84 49.14 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.523 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.2 t -79.24 -11.23 59.95 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.125 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.728 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -84.2 177.57 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.874 177.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.5 p90 -169.53 -15.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.144 0.497 . . . . 0.0 111.705 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.735 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 40.8 mt-30 81.17 114.64 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.95 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.46 99.43 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.654 2.236 . . . . 0.0 112.558 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.408 ' HB3' ' H ' ' A' ' 50' ' ' GLY . 81.3 m-85 62.24 -160.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.985 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 144.54 93.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.22 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 7.5 p -88.85 -27.1 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.126 0.57 . . . . 0.0 112.444 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 172.25 34.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.269 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.71 -165.43 1.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 110.605 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -110.27 141.33 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.508 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.539 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 6.7 m-80 -120.05 135.84 54.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.977 0.417 . . . . 0.0 111.669 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -99.85 128.52 45.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.27 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.728 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 42.7 p -117.64 131.44 56.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.79 143.39 9.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.485 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 178.77 165.5 33.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 69' ' ' LEU . 10.9 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.876 0.369 . . . . 0.0 111.345 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.5 -174.91 25.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.415 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.38 144.52 9.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.694 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 87.7 t80 -130.49 127.74 39.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.773 0.321 . . . . 0.0 110.69 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 6.9 mmm-85 66.35 -86.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.15 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.76 30.33 0.99 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.152 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.661 ' HG ' ' HB3' ' A' ' 33' ' ' ASP . 4.7 m -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.48 159.45 41.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.094 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.52 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.543 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.537 ' HA ' HG12 ' A' ' 60' ' ' VAL . 8.0 tp -115.1 137.33 52.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.768 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.677 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.81 158.39 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.119 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.442 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 177.44 173.2 42.72 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.45 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.19 142.86 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.21 156.5 26.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.226 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -105.11 116.1 31.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 111.101 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.49 ' HD2' ' HB3' ' A' ' 82' ' ' ALA . 9.6 mmm180 -95.98 89.11 5.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.752 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.659 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 7.7 p -95.73 123.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.302 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.562 ' OD1' HG22 ' A' ' 77' ' ' VAL . 19.9 m120 64.15 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.147 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -99.74 32.06 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.603 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.481 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 t -131.74 -37.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.413 HG22 ' N ' ' A' ' 82' ' ' ALA . 13.6 p -118.74 148.81 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 76' ' ' ARG . . . -150.69 171.24 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.252 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.07 148.67 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.611 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.735 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -146.35 131.77 18.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.182 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.67 12.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.442 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -157.99 171.16 34.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.619 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.16 139.29 47.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.87 0.367 . . . . 0.0 111.093 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.32 132.22 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.77 121.52 41.83 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 94' ' ' ASP . . . -130.1 124.34 32.53 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.589 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.46 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 61.93 -110.66 3.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.345 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -132.1 -63.34 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -99.05 24.64 7.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.136 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.535 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -116.4 85.14 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.943 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.76 137.55 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.468 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -129.64 158.12 40.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.713 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.496 ' HH ' ' HB1' ' A' ' 99' ' ' ALA . 45.8 t80 -133.84 137.52 45.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.451 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.63 152.26 45.42 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.745 0.307 . . . . 0.0 111.437 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.496 ' HB1' ' HH ' ' A' ' 97' ' ' TYR . . . -158.76 92.82 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.773 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 79.0 p -115.73 -177.57 3.18 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.41 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.45 140.52 22.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.945 0.403 . . . . 0.0 111.088 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.759 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 66.3 m-80 -112.28 144.01 42.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.435 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.1 pt -154.98 135.07 4.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 110.766 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.54 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 66.3 mt-10 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.729 0.3 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . 0.405 ' HD1' ' O ' ' B' ' 18' ' ' PHE . 0.2 OUTLIER -72.47 -34.84 67.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.231 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 18.5 mtt85 -65.97 -40.09 90.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.81 -44.93 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.118 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.653 HD23 HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.49 -38.06 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.83 -31.05 66.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.16 -39.49 78.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.74 -37.57 67.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.732 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.0 -42.75 76.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -64.22 -38.82 92.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.63 74.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.67 0.271 . . . . 0.0 111.25 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -59.92 -43.75 94.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.73 -40.57 88.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.963 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.507 ' O ' ' HG3' ' B' ' 34' ' ' LYS . 25.9 m -66.65 -41.36 88.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.88 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' B' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.256 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.12 -32.54 22.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.213 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.699 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 70.4 m-20 -65.59 -63.88 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' B' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.46 62.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.799 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.87 -49.43 78.65 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.617 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -72.55 -27.34 62.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.84 -52.63 55.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.409 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.83 -41.55 78.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.74 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.616 ' HB3' HD21 ' A' ' 36' ' ' LEU . 31.5 p -55.83 -59.04 5.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.76 -39.55 71.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.469 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.52 ' HB1' ' C ' ' B' ' 60' ' ' VAL . . . -60.76 -37.45 81.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.22 -37.3 61.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.049 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.4 m-20 -76.48 -5.86 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.538 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.2 t -79.23 -11.2 59.96 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.193 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.716 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 0.7 OUTLIER -84.32 177.59 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.806 178.022 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.655 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 12.6 p90 -169.57 -15.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.622 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.723 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 40.8 mt-30 81.24 114.62 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.906 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.405 9.7 Cg_endo -69.55 99.55 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.623 2.215 . . . . 0.0 112.491 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.414 ' HB3' ' H ' ' B' ' 50' ' ' GLY . 81.4 m-85 62.13 -160.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.013 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 144.56 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.222 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 78' ' ' ASN . 7.5 p -88.91 -27.04 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.194 0.597 . . . . 0.0 112.433 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 172.22 34.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.292 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.66 -165.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.681 0.276 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.656 HG13 ' O ' ' C' ' 105' ' ' TRP . 8.9 p -110.39 141.19 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.523 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.538 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 6.7 m-80 -119.99 135.83 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.952 0.406 . . . . 0.0 111.689 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.572 ' HB2' ' HB2' ' C' ' 105' ' ' TRP . 2.2 t80 -99.9 128.57 45.98 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.212 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.716 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 42.6 p -117.62 131.41 56.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.023 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.8 143.35 9.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.455 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 178.83 165.52 33.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.586 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' B' ' 69' ' ' LEU . 11.0 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.338 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.52 -174.93 25.96 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.45 144.39 9.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.699 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 87.5 t80 -130.37 127.79 40.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 6.9 mmm-85 66.32 -86.57 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.185 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.84 30.43 0.97 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.66 ' HG ' ' HB3' ' B' ' 33' ' ' ASP . 4.7 m -128.23 167.92 16.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.792 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.38 159.46 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 165.61 36.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.539 ' HA ' HG12 ' B' ' 60' ' ' VAL . 8.0 tp -115.1 137.32 52.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.54 148.85 50.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.673 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.76 158.33 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 0.0 111.13 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 177.45 173.12 42.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.422 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.17 142.81 19.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.52 26.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.13 116.17 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 111.14 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.49 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 9.6 mmm180 -95.96 89.16 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.661 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.642 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 7.7 p -95.76 123.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 111.243 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.548 ' OD1' HG22 ' B' ' 77' ' ' VAL . 19.9 m120 64.12 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -99.76 32.13 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.552 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' SER . . . . . 0.476 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 9.8 t -131.84 -37.7 1.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 82' ' ' ALA . 13.8 p -118.78 148.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.485 ' HB3' ' HD2' ' B' ' 76' ' ' ARG . . . -150.56 171.24 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.09 148.71 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.608 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.723 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -146.33 131.83 18.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.177 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.58 126.69 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -158.0 171.2 34.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.603 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.18 139.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.861 0.362 . . . . 0.0 111.06 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.36 132.25 54.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -100.72 121.51 41.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.542 ' HB1' ' HB3' ' B' ' 94' ' ' ASP . . . -130.1 124.23 32.26 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.651 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 61.91 -110.66 3.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.292 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -132.06 -63.44 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.268 . . . . 0.0 111.281 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.96 24.66 7.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.211 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.542 ' HB3' ' HB1' ' B' ' 90' ' ' ALA . 0.4 OUTLIER -116.41 85.11 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.84 137.56 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.46 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -129.62 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.683 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . 0.499 ' HH ' ' HB1' ' B' ' 99' ' ' ALA . 45.7 t80 -133.77 137.53 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.452 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.6 152.22 45.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.727 0.298 . . . . 0.0 111.458 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . 0.499 ' HB1' ' HH ' ' B' ' 97' ' ' TYR . . . -158.8 92.8 1.13 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.523 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 79.0 p -115.7 -177.61 3.19 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.41 140.54 23.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 111.139 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.764 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 66.4 m-80 -112.34 143.99 42.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.356 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 4.2 pt -154.98 135.01 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.838 0.351 . . . . 0.0 110.776 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.539 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 66.1 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.714 0.292 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -34.92 68.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.273 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 18.6 mtt85 -65.86 -40.1 91.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.803 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.88 -44.88 63.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.658 HD22 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.54 -38.08 68.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.623 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.67 -31.15 66.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.14 -39.54 78.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -72.68 -37.52 67.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.741 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.401 HD12 ' CB ' ' A' ' 24' ' ' ARG . 21.1 mt -69.02 -42.69 76.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.626 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.23 -38.82 92.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.824 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 3.0 tmtt? -69.56 -42.66 74.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.253 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.93 -43.8 94.73 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.69 -40.53 88.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.0 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' C' ' 34' ' ' LYS . 25.9 m -66.72 -41.28 88.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.902 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' C' ' 27' ' ' LYS . 86.4 mmt-85 -54.89 -38.06 67.1 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.389 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.13 -32.53 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.218 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.715 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 70.4 m-20 -65.51 -63.96 0.97 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.075 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' C' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.47 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.758 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.39 79.18 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.384 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.62 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -72.56 -27.34 62.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.803 0.335 . . . . 0.0 111.066 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.56 55.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -41.48 78.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.617 ' HB3' HD21 ' B' ' 36' ' ' LEU . 31.3 p -55.86 -58.96 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.61 71.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.441 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.52 ' HB1' ' C ' ' C' ' 60' ' ' VAL . . . -60.66 -37.47 81.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.21 -37.4 61.14 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.53 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 75.4 m-20 -76.32 -5.93 49.28 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' SER . . . . . 0.543 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.2 t -79.21 -11.24 59.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.111 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.724 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 0.7 OUTLIER -84.22 177.63 8.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.784 178.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.634 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 12.6 p90 -169.61 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.611 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.723 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 40.9 mt-30 81.13 114.59 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.986 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.42 99.41 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.709 2.272 . . . . 0.0 112.564 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.413 ' HB3' ' H ' ' C' ' 50' ' ' GLY . 81.2 m-85 62.24 -160.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.005 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 144.55 93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.255 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' C' ' 78' ' ' ASN . 7.5 p -88.86 -27.03 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.154 0.582 . . . . 0.0 112.468 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 172.18 34.55 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.269 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.64 -165.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.646 0.26 . . . . 0.0 110.592 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -110.36 141.26 26.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.523 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.54 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 6.8 m-80 -120.01 135.74 54.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.973 0.416 . . . . 0.0 111.73 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -99.75 128.47 45.85 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.724 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.0 p -117.58 131.46 56.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.97 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.84 143.35 9.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.49 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 178.79 165.55 33.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.538 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' C' ' 69' ' ' LEU . 10.9 m -111.8 168.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.838 0.352 . . . . 0.0 111.326 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.46 -174.9 25.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.418 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.4 144.49 9.71 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.715 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 87.6 t80 -130.48 127.78 39.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 110.736 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 6.8 mmm-85 66.3 -86.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -146.84 30.32 0.98 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' SER . . . . . 0.662 ' HG ' ' HB3' ' C' ' 33' ' ' ASP . 4.7 m -128.25 167.95 16.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.825 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -136.45 159.43 41.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.104 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.53 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.527 ' HA ' HG12 ' C' ' 60' ' ' VAL . 8.0 tp -115.07 137.28 52.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.782 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.53 148.87 50.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.699 0.285 . . . . 0.0 111.651 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.82 158.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.435 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 177.41 173.18 42.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.488 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -155.19 142.72 19.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.12 156.5 26.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.234 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.09 116.19 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.133 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.491 ' HD2' ' HB3' ' C' ' 82' ' ' ALA . 9.6 mmm180 -95.96 89.1 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.723 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.646 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 7.7 p -95.74 123.77 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 111.208 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.558 ' OD1' HG22 ' C' ' 77' ' ' VAL . 19.9 m120 64.27 167.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 111.09 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -99.81 32.09 3.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.572 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' SER . . . . . 0.481 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 9.7 t -131.75 -37.75 1.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.991 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.406 HG22 ' N ' ' C' ' 82' ' ' ALA . 13.7 p -118.75 148.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.513 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.491 ' HB3' ' HD2' ' C' ' 76' ' ' ARG . . . -150.71 171.12 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.258 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -162.96 148.77 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.573 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.723 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -146.37 131.8 18.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.75 12.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . 0.435 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -158.12 171.17 35.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.572 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.2 139.27 48.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 111.114 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.31 54.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.78 121.49 41.78 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.271 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' C' ' 94' ' ' ASP . . . -130.1 124.23 32.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.628 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.474 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 61.94 -110.63 3.32 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.274 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.5 m -132.1 -63.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 0.0 111.295 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.99 24.7 7.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.531 ' HB3' ' HB1' ' C' ' 90' ' ' ALA . 0.4 OUTLIER -116.42 85.1 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.947 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.77 137.6 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.457 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.4 OUTLIER -129.6 158.17 40.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . 0.493 ' HH ' ' HB1' ' C' ' 99' ' ' ALA . 45.7 t80 -133.84 137.58 45.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.388 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.72 152.19 45.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.417 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . 0.493 ' HB1' ' HH ' ' C' ' 97' ' ' TYR . . . -158.78 92.83 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 79.0 p -115.73 -177.61 3.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.447 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.38 140.61 23.11 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.08 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.778 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 66.4 m-80 -112.31 143.94 42.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.418 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 4.1 pt -154.96 135.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.538 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 66.4 mt-10 -70.52 131.35 43.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.977 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . 0.656 ' O ' HG13 ' B' ' 54' ' ' VAL . 33.1 t-105 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.664 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.581 ' HE2' ' HB2' ' C' ' 17' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.717 0.294 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.97 -37.86 64.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.208 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.2 -60.4 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.68 65.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.097 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.653 HD21 HD21 ' A' ' 25' ' ' LEU . 2.3 tm? -66.96 -62.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -62.24 -23.76 66.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.52 -49.51 47.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HD3' HD12 ' C' ' 21' ' ' LEU . 69.0 mtp85 -73.33 -42.15 62.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.653 HD21 HD21 ' A' ' 21' ' ' LEU . 3.9 mm? -61.36 -46.08 91.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.559 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.29 -32.97 74.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.787 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.79 83.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.185 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -47.94 81.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -60.98 -32.0 71.57 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.967 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 30' ' ' THR . 6.3 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.85 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -30.72 46.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.381 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 29' ' ' ASP . 30.3 m -83.5 -33.49 9.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.501 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 57.9 m-20 -66.29 -48.69 69.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.608 ' CD ' ' HA3' ' A' ' 91' ' ' GLY . 6.6 ptpt -85.07 -25.69 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.835 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.91 -40.68 63.08 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.393 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -77.11 -25.73 52.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.329 . . . . 0.0 111.034 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.725 ' HB2' ' HB3' ' A' ' 68' ' ' ALA . . . -72.31 -40.93 67.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.444 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.67 ' HB3' ' HE1' ' A' ' 96' ' ' MET . 13.3 t -79.0 -43.01 25.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.414 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.4 OUTLIER -59.73 -56.71 18.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB1' ' HG ' ' B' ' 39' ' ' SER . . . -57.34 -40.88 78.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.395 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.426 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -56.41 -35.13 67.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 26.0 tp -76.26 -42.4 45.85 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.592 ' CB ' ' HB3' ' B' ' 43' ' ' ASN . 35.6 m-20 -70.83 -13.81 62.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -67.26 -21.88 65.69 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.128 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' B' ' 100' ' ' SER . 1.5 mm? -80.07 171.8 14.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.857 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.477 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.3 p90 -158.11 -3.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.628 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 55' ' ' ASN . 7.1 mt-30 71.51 119.79 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.953 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.262 9.8 Cg_endo -75.09 106.7 2.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.65 2.233 . . . . 0.0 112.497 -179.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.19 -177.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.462 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 173.02 51.34 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.245 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 4.9 p -73.32 -3.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.12 0.568 . . . . 0.0 112.519 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.84 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.9 54.33 0.03 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.272 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.82 -165.04 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 55' ' ' ASN . 12.0 p -113.24 145.08 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.5 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.611 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.5 m-80 -126.16 118.43 25.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.65 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -83.66 130.31 34.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.255 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.467 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 75.5 p -114.66 120.9 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.986 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.482 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -152.26 135.29 15.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.488 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -179.72 168.57 39.06 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.488 ' CG1' HD11 ' A' ' 69' ' ' LEU . 13.3 m -116.96 158.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 111.418 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -144.99 -170.89 14.34 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.481 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -165.5 142.67 7.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.577 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 56.1 t80 -134.01 134.7 42.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.684 0.278 . . . . 0.0 110.771 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.71 28.59 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 1.6 m -133.77 142.05 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.3 157.11 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.099 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.725 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . . . -149.48 167.78 25.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.558 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.488 HD11 ' CG1' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -125.97 136.66 53.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.757 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -128.31 142.55 51.1 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 111.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.482 HD12 ' HB1' ' A' ' 58' ' ' ALA . 10.4 tp -139.38 155.07 25.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' THR . . . 168.12 176.91 38.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.384 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -168.04 155.82 8.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.01 28.57 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.207 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -123.48 135.74 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.17 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.544 HH21 ' HB2' ' A' ' 47' ' ' GLN . 12.3 ttm180 -131.17 133.27 45.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.678 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.84 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 13.8 p -122.32 139.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 88.8 m-20 61.19 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 7.8 pt-20 177.81 -26.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.55 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 59.5 p -65.65 -67.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.39 139.19 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.496 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 102' ' ' ASN . . . -142.07 155.35 45.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.241 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.564 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.468 ' HG3' ' HE2' ' C' ' 46' ' ' PHE . 8.2 tmtt? -155.31 130.19 9.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.217 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 175.41 12.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.16 -173.69 37.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.543 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 71' ' ' ILE . 14.7 p -141.89 143.17 27.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 96' ' ' MET . . . -115.17 144.11 44.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.351 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.424 ' HH ' ' HA ' ' A' ' 92' ' ' SER . 16.5 t80 -119.24 119.03 32.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.282 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -127.89 135.29 49.8 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.657 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.608 ' HA3' ' CD ' ' A' ' 34' ' ' LYS . . . 60.52 -111.56 3.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.276 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.424 ' HA ' ' HH ' ' A' ' 89' ' ' TYR . 56.3 m -149.61 10.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 111.312 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -165.09 23.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.156 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 37.0 m-20 -116.3 67.7 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.408 HG11 ' CE1' ' A' ' 97' ' ' TYR . 21.4 t -94.08 139.67 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 110.745 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.67 ' HE1' ' HB3' ' A' ' 38' ' ' SER . 7.1 ptp -134.25 135.53 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.723 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.408 ' CE1' HG11 ' A' ' 95' ' ' VAL . 72.4 m-85 -113.86 118.71 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.409 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.03 152.63 23.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.79 0.328 . . . . 0.0 111.394 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.753 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.469 ' HA ' ' HA3' ' C' ' 59' ' ' GLY . 14.4 m -118.6 169.09 10.09 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.396 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.06 136.01 31.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.986 0.422 . . . . 0.0 111.056 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.67 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 70.8 m-80 -104.31 132.8 50.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.355 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -138.22 114.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.376 . . . . 0.0 110.716 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' C' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.574 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.67 0.271 . . . . 0.0 110.578 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.9 -37.87 64.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.23 -60.37 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.63 65.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.983 0.42 . . . . 0.0 111.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.67 HD21 HD21 ' B' ' 25' ' ' LEU . 2.3 tm? -67.04 -62.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.29 -23.73 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.005 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.56 -49.49 47.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.538 ' HD3' HD12 ' A' ' 21' ' ' LEU . 69.1 mtp85 -73.36 -42.15 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.702 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.67 HD21 HD21 ' B' ' 21' ' ' LEU . 3.9 mm? -61.26 -46.08 91.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.603 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.33 -32.92 74.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.773 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.89 -38.7 83.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.647 0.26 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -47.89 81.59 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.562 ' O ' HG22 ' B' ' 32' ' ' VAL . 0.5 OUTLIER -61.06 -31.95 71.6 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 178.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -30.64 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.312 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.562 HG22 ' O ' ' B' ' 29' ' ' ASP . 29.3 m -83.68 -33.33 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.172 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.494 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 58.3 m-20 -66.35 -48.7 69.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.972 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.598 ' CD ' ' HA3' ' B' ' 91' ' ' GLY . 6.6 ptpt -85.17 -25.58 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.92 -40.8 62.95 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.579 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.5 mt -77.03 -25.71 52.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' B' ' 68' ' ' ALA . . . -72.44 -40.76 66.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.411 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.669 ' HB3' ' HE1' ' B' ' 96' ' ' MET . 13.5 t -79.08 -42.97 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.745 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.406 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 0.4 OUTLIER -59.86 -56.71 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.419 ' HB1' ' HG ' ' C' ' 39' ' ' SER . . . -57.28 -40.88 78.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.441 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.43 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -56.48 -35.08 67.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' B' ' 70' ' ' ALA . 26.1 tp -76.3 -42.23 45.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.124 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.593 ' CB ' ' HB3' ' C' ' 43' ' ' ASN . 35.5 m-20 -70.92 -13.77 62.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 46.5 t -67.3 -21.87 65.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.147 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' C' ' 100' ' ' SER . 1.5 mm? -80.05 171.71 14.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.866 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.48 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.3 p90 -158.09 -3.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.162 0.506 . . . . 0.0 111.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.55 ' HB3' ' HB2' ' B' ' 55' ' ' ASN . 7.1 mt-30 71.5 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.992 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.265 10.0 Cg_endo -74.94 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.708 2.272 . . . . 0.0 112.573 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.18 -177.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 173.02 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.219 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 4.9 p -73.42 -3.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.145 0.578 . . . . 0.0 112.466 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.838 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.97 54.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.25 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.81 -165.07 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.445 HG23 ' N ' ' B' ' 55' ' ' ASN . 12.0 p -113.2 145.12 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.561 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' B' ' 48' ' ' PRO . 5.4 m-80 -126.11 118.32 25.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 111.706 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -83.77 130.36 34.94 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.223 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.461 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 75.9 p -114.67 120.9 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.976 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.492 ' HB1' HD12 ' B' ' 71' ' ' ILE . . . -152.28 135.34 15.7 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.458 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -179.77 168.63 39.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.563 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.489 ' CG1' HD11 ' B' ' 69' ' ' LEU . 13.1 m -117.01 158.43 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.811 0.339 . . . . 0.0 111.332 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -144.99 -170.86 14.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.441 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -165.5 142.69 7.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.529 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.564 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 56.0 t80 -134.13 134.7 42.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.672 0.273 . . . . 0.0 110.744 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 64.34 -93.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.73 28.63 1.27 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 1.6 m -133.79 142.1 47.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.36 157.17 17.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.99 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . 0.727 ' HB3' ' HB2' ' B' ' 37' ' ' ALA . . . -149.57 167.74 25.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.523 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.489 HD11 ' CG1' ' B' ' 60' ' ' VAL . 0.6 OUTLIER -125.95 136.61 53.22 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.796 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -128.21 142.53 51.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.668 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.492 HD12 ' HB1' ' B' ' 58' ' ' ALA . 10.4 tp -139.29 155.16 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.103 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.413 ' N ' HG13 ' B' ' 71' ' ' ILE . . . 168.03 176.8 38.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.427 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -167.95 155.89 8.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.027 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.33 171.93 28.66 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.179 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -123.46 135.73 54.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.543 HH21 ' HB2' ' B' ' 47' ' ' GLN . 12.3 ttm180 -131.14 133.33 45.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.838 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 13.7 p -122.44 139.64 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 88.8 m-20 61.25 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 0.0 111.066 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.638 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 7.8 pt-20 177.87 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.585 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' B' ' 103' ' ' ILE . 59.5 p -65.65 -67.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.991 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.4 139.21 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.501 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' B' ' 102' ' ' ASN . . . -142.03 155.35 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.477 ' HG3' ' HE2' ' A' ' 46' ' ' PHE . 8.2 tmtt? -155.28 130.26 9.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.15 175.42 12.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.14 -173.7 37.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.559 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.424 ' O ' HG23 ' B' ' 71' ' ' ILE . 14.7 p -141.89 143.24 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.891 0.377 . . . . 0.0 111.123 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HG2' ' B' ' 96' ' ' MET . . . -115.23 144.1 44.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.33 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . 0.413 ' HH ' ' HA ' ' B' ' 92' ' ' SER . 16.4 t80 -119.24 119.06 32.96 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -127.91 135.36 49.88 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.649 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.598 ' HA3' ' CD ' ' B' ' 34' ' ' LYS . . . 60.48 -111.58 3.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.281 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' SER . . . . . 0.413 ' HA ' ' HH ' ' B' ' 89' ' ' TYR . 56.8 m -149.62 10.3 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.286 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -165.07 23.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.163 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 37.2 m-20 -116.38 67.68 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.416 HG11 ' CE1' ' B' ' 97' ' ' TYR . 21.4 t -94.11 139.61 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.702 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.669 ' HE1' ' HB3' ' B' ' 38' ' ' SER . 7.0 ptp -134.23 135.52 43.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . 0.416 ' CE1' HG11 ' B' ' 95' ' ' VAL . 72.5 m-85 -113.81 118.75 35.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.98 152.62 23.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.692 0.282 . . . . 0.0 111.427 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.49 90.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.698 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.469 ' HB2' HD13 ' A' ' 45' ' ' LEU . 14.3 m -118.56 169.09 10.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.432 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.02 135.89 31.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.692 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.9 m-80 -104.25 132.82 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.426 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -138.19 114.32 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.581 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.709 0.29 . . . . 0.0 110.531 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -74.0 -37.82 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.2 -60.42 3.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.38 -28.62 65.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.667 HD21 HD21 ' C' ' 25' ' ' LEU . 2.3 tm? -67.01 -62.7 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.566 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.18 -23.79 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.46 -49.56 47.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.53 ' HD3' HD12 ' B' ' 21' ' ' LEU . 69.0 mtp85 -73.4 -42.05 62.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.797 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.667 HD21 HD21 ' C' ' 21' ' ' LEU . 3.9 mm? -61.31 -46.08 91.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.624 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.32 -32.91 74.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.846 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.73 83.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -47.86 81.71 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.56 ' O ' HG22 ' C' ' 32' ' ' VAL . 0.5 OUTLIER -61.05 -31.87 71.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.96 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -73.9 -30.26 62.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.865 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -30.73 45.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.56 HG22 ' O ' ' C' ' 29' ' ' ASP . 30.1 m -83.57 -33.38 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.502 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 57.8 m-20 -66.43 -48.63 69.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.609 ' CD ' ' HA3' ' C' ' 91' ' ' GLY . 6.6 ptpt -85.16 -25.61 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.93 -40.71 62.91 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.404 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.579 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.5 mt -77.03 -25.78 52.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.92 0.391 . . . . 0.0 111.165 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.726 ' HB2' ' HB3' ' C' ' 68' ' ' ALA . . . -72.33 -40.77 67.17 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.548 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.657 ' HB3' ' HE1' ' C' ' 96' ' ' MET . 13.2 t -79.07 -42.87 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.803 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.419 ' HG ' ' HB1' ' B' ' 40' ' ' ALA . 0.4 OUTLIER -59.92 -56.71 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.4 ' HB1' ' HG ' ' A' ' 39' ' ' SER . . . -57.25 -41.01 78.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.418 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.421 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -56.34 -35.11 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.941 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.574 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 26.2 tp -76.22 -42.38 46.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.148 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.593 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 35.4 m-20 -70.84 -13.85 62.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -67.31 -21.88 65.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.09 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 100' ' ' SER . 1.5 mm? -80.06 171.84 14.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.845 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.468 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.3 p90 -158.1 -3.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.193 0.52 . . . . 0.0 111.721 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' C' ' 55' ' ' ASN . 7.1 mt-30 71.58 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.968 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.263 9.9 Cg_endo -75.03 106.7 2.33 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.635 2.224 . . . . 0.0 112.585 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.15 -177.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 173.03 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.168 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 4.9 p -73.43 -3.42 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.091 0.557 . . . . 0.0 112.465 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.823 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.94 54.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 -165.16 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 0.0 110.615 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.444 HG23 ' N ' ' C' ' 55' ' ' ASN . 12.0 p -113.15 145.1 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.61 ' HB3' ' HD2' ' C' ' 48' ' ' PRO . 5.4 m-80 -126.1 118.38 25.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 111.655 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -83.76 130.33 34.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.206 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.456 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 75.2 p -114.63 120.92 41.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.97 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . 0.479 ' HB1' HD12 ' C' ' 71' ' ' ILE . . . -152.32 135.35 15.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.484 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -179.76 168.57 39.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.552 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.49 ' CG1' HD11 ' C' ' 69' ' ' LEU . 13.3 m -116.9 158.41 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.328 . . . . 0.0 111.357 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -145.04 -170.8 14.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.421 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -165.59 142.72 7.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.574 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 56.2 t80 -134.04 134.69 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.636 0.255 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.103 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.75 28.58 1.27 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' C' ' 33' ' ' ASP . 1.6 m -133.8 142.04 47.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.21 157.3 17.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . 0.726 ' HB3' ' HB2' ' C' ' 37' ' ' ALA . . . -149.64 167.75 25.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.49 HD11 ' CG1' ' C' ' 60' ' ' VAL . 0.6 OUTLIER -126.01 136.63 53.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.574 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -128.25 142.55 51.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.654 0.264 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.479 HD12 ' HB1' ' C' ' 58' ' ' ALA . 10.4 tp -139.29 155.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.761 0.315 . . . . 0.0 111.11 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.408 ' N ' HG13 ' C' ' 71' ' ' ILE . . . 168.04 176.83 38.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.448 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -168.01 155.85 8.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.339 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.36 171.99 28.67 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.527 HH21 ' HB2' ' C' ' 47' ' ' GLN . 12.3 ttm180 -131.19 133.27 45.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.677 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.823 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 13.6 p -122.38 139.68 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 89.0 m-20 61.17 -94.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 111.042 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . 0.647 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 7.8 pt-20 177.86 -26.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' C' ' 103' ' ' ILE . 59.2 p -65.69 -67.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.35 139.17 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' C' ' 102' ' ' ASN . . . -142.07 155.34 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.229 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.69 146.42 34.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.48 ' HG3' ' HE2' ' B' ' 46' ' ' PHE . 8.2 tmtt? -155.3 130.24 9.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.163 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.1 175.48 12.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.09 -173.71 37.57 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.536 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' C' ' 71' ' ' ILE . 14.7 p -141.91 143.21 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.078 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.501 ' HB2' ' HG2' ' C' ' 96' ' ' MET . . . -115.2 144.14 44.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.348 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . 0.416 ' HH ' ' HA ' ' C' ' 92' ' ' SER . 16.4 t80 -119.26 119.13 33.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -128.0 135.29 49.7 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.672 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.609 ' HA3' ' CD ' ' C' ' 34' ' ' LYS . . . 60.64 -111.59 3.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.279 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' SER . . . . . 0.416 ' HA ' ' HH ' ' C' ' 89' ' ' TYR . 56.7 m -149.67 10.38 0.73 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.294 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -165.15 23.93 0.05 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 37.0 m-20 -116.37 67.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . 0.411 HG11 ' CE1' ' C' ' 97' ' ' TYR . 21.5 t -94.13 139.72 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.657 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 7.1 ptp -134.22 135.52 43.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . 0.411 ' CE1' HG11 ' C' ' 95' ' ' VAL . 72.5 m-85 -113.87 118.77 35.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.403 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.1 152.61 23.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.715 0.293 . . . . 0.0 111.382 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.477 ' HB2' HD13 ' B' ' 45' ' ' LEU . 14.4 m -118.65 169.12 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.403 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.12 135.94 31.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.042 0.449 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.677 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 70.9 m-80 -104.24 132.8 50.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.435 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' C' ' 80' ' ' SER . 0.1 OUTLIER -138.17 114.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.719 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -115.97 157.96 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.8 m-90 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.706 179.624 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.483 ' O ' HD21 ' A' ' 21' ' ' LEU . 34.6 ttmt . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.733 0.302 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.75 -39.7 80.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.889 0.376 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -66.81 -42.89 85.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.779 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.7 -41.39 96.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.1 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.74 HD23 HD22 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -62.9 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.83 -30.72 71.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.73 -39.11 57.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.76 ' HG ' HD21 ' C' ' 25' ' ' LEU . 8.0 mt -67.25 -50.98 58.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.571 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.78 -50.91 72.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.826 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HE2' ' CZ ' ' A' ' 31' ' ' ARG . 9.5 tmtt? -54.78 -38.26 67.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.279 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -62.39 -42.69 99.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -63.54 -41.7 98.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.997 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.4 m -57.91 -47.12 83.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.764 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.607 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 83.2 mmt-85 -59.45 -35.5 74.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.318 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 28' ' ' LEU . 41.7 t -73.75 -36.5 46.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.99 -55.88 16.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.995 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.607 ' HE3' ' HD3' ' A' ' 31' ' ' ARG . 3.4 pttt -72.35 -36.5 68.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.774 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.13 96.33 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.369 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -70.14 -37.13 75.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.805 0.336 . . . . 0.0 111.08 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.72 99.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.463 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -54.38 14.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.753 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.65 ' HB3' HD21 ' C' ' 36' ' ' LEU . 86.9 p -49.07 -56.21 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -52.49 -52.61 53.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.471 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.699 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -49.16 -41.58 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.8 tp -73.88 -34.89 64.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.09 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.4 m-20 -78.25 -5.12 51.01 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.41 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.5 t -86.13 -0.6 56.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.12 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.802 ' HB3' HG23 ' A' ' 57' ' ' THR . 0.3 OUTLIER -95.97 172.18 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.881 177.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -165.76 -5.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.662 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' A' ' 55' ' ' ASN . 35.1 mt-30 65.83 118.9 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.945 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.395 9.8 Cg_endo -69.89 98.2 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.692 2.261 . . . . 0.0 112.54 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 66.94 -165.0 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 146.16 82.25 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.7 p -88.72 -11.03 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.094 0.558 . . . . 0.0 112.477 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.685 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 158.34 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.296 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.01 -166.7 2.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.558 0.218 . . . . 0.0 110.65 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.5 144.05 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.41 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 4.4 m-80 -131.06 134.83 47.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.652 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.452 ' O ' HG13 ' B' ' 103' ' ' ILE . 1.2 t80 -104.53 121.92 44.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.275 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 45' ' ' LEU . 21.1 p -114.57 124.86 52.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.19 150.81 29.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.41 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.519 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.19 164.01 26.17 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.491 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 69' ' ' LEU . 14.5 m -110.21 166.33 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 111.373 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -174.43 22.35 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.53 143.21 8.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.554 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.613 ' CE2' ' HG3' ' A' ' 64' ' ' ARG . 63.2 t80 -132.51 137.1 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.727 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.613 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 2.9 mmm180 61.52 -80.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 63' ' ' TYR . 12.0 t -156.64 32.27 0.31 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -130.11 167.42 18.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.01 142.15 48.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.137 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.43 47.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.61 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.468 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.2 tp -111.32 128.48 55.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.729 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 41' ' ' ALA . . . -122.95 152.09 41.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.708 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.404 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.7 tt -147.54 162.06 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.289 . . . . 0.0 111.183 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.404 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 175.35 169.34 37.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.408 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 p -163.29 147.71 11.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.73 161.85 28.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.245 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.29 119.48 39.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.154 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.608 ' HD2' ' HB3' ' A' ' 82' ' ' ALA . 4.9 mmm180 -96.9 99.21 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.707 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.685 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.0 p -98.23 130.72 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.332 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 8.1 m120 66.27 -170.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.932 0.396 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -120.05 24.53 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.551 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.576 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 5.0 t -129.01 -44.75 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.28 148.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.494 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB3' ' HD2' ' A' ' 76' ' ' ARG . . . -152.07 171.15 18.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 111.205 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.82 143.23 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.606 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.5 23.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.26 135.95 23.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.39 175.04 39.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 96' ' ' MET . 6.3 p -124.08 146.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' HB2' ' HG2' ' A' ' 96' ' ' MET . . . -114.11 134.09 55.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.27 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.86 110.69 22.1 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.259 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 94' ' ' ASP . . . -122.75 132.43 54.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.498 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.84 -113.15 4.04 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.263 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.85 -60.76 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 111.322 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.4 t -101.53 29.77 4.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.221 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.487 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.99 1.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 88' ' ' ALA . 5.0 t -120.4 142.34 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.748 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.547 ' HB2' ' HA ' ' C' ' 63' ' ' TYR . 0.9 OUTLIER -132.57 155.59 48.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -128.48 129.02 45.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.522 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -119.7 160.33 22.74 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.17 99.02 0.12 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.796 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.746 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.2 p -122.67 179.45 4.61 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.43 146.36 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 70.4 m-80 -111.9 150.02 31.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.362 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.46 HG13 ' O ' ' C' ' 56' ' ' PHE . 3.9 pt -156.18 150.99 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.576 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 73.7 mt-10 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.491 ' O ' HD21 ' B' ' 21' ' ' LEU . 34.7 ttmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.75 0.31 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -39.83 80.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -66.76 -42.92 85.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -41.4 96.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.109 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.84 -43.4 98.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.89 -30.69 71.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.78 -39.11 57.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -73.02 -38.36 66.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.813 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.751 HD21 ' HG ' ' C' ' 25' ' ' LEU . 8.0 mt -67.18 -51.03 58.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.61 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.83 -50.89 72.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.799 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.482 ' HE2' ' CZ ' ' B' ' 31' ' ' ARG . 9.5 tmtt? -54.8 -38.27 67.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.277 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.443 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -62.41 -42.63 99.58 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.52 -41.74 98.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.969 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' B' ' 34' ' ' LYS . 4.4 m -57.94 -47.07 83.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.59 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 83.1 mmt-85 -59.37 -35.56 74.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.352 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 28' ' ' LEU . 41.7 t -73.78 -36.56 46.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.201 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.0 -55.86 16.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.955 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.59 ' HE3' ' HD3' ' B' ' 31' ' ' ARG . 3.4 pttt -72.33 -36.58 68.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.744 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.91 -45.05 96.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.382 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -70.12 -37.23 75.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.79 99.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.427 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.56 -54.33 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.666 ' HB3' HD21 ' A' ' 36' ' ' LEU . 86.9 p -49.16 -56.25 9.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.017 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.54 54.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.465 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.675 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . . . -49.23 -41.56 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 tp -73.89 -34.88 64.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.112 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.503 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.1 m-20 -78.13 -5.23 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.419 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -86.05 -0.65 56.1 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.141 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.8 ' HB3' HG23 ' B' ' 57' ' ' THR . 0.3 OUTLIER -95.83 172.21 8.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.894 177.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -165.84 -5.24 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.097 0.475 . . . . 0.0 111.654 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' B' ' 55' ' ' ASN . 35.1 mt-30 65.86 118.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.395 9.7 Cg_endo -69.88 98.36 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.638 2.225 . . . . 0.0 112.552 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 66.75 -164.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 146.15 82.31 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.188 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 8.7 p -88.78 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.144 0.578 . . . . 0.0 112.422 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 158.25 46.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.259 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.1 -166.69 2.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.586 0.231 . . . . 0.0 110.628 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 1.071 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.6 p -109.52 144.12 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.561 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.41 ' HB2' ' OE1' ' B' ' 47' ' ' GLN . 4.4 m-80 -131.12 134.79 46.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.013 0.435 . . . . 0.0 111.61 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.448 ' O ' HG13 ' C' ' 103' ' ' ILE . 1.2 t80 -104.55 121.96 44.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.24 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.8 HG23 ' HB3' ' B' ' 45' ' ' LEU . 21.1 p -114.59 124.86 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.22 150.75 29.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.484 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.523 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.25 164.01 26.22 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.575 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' B' ' 69' ' ' LEU . 14.4 m -110.26 166.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.61 -174.42 22.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.462 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.52 143.15 8.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.613 ' CE2' ' HG3' ' B' ' 64' ' ' ARG . 63.5 t80 -132.48 137.0 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.291 . . . . 0.0 110.765 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.613 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 2.9 mmm180 61.54 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.029 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 63' ' ' TYR . 12.2 t -156.69 32.3 0.31 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.158 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -130.17 167.46 18.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.802 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.02 142.15 48.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.62 155.49 47.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.529 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.459 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.1 tp -111.33 128.44 55.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.724 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' B' ' 41' ' ' ALA . . . -123.0 152.17 41.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.406 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.7 tt -147.56 162.0 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.751 0.31 . . . . 0.0 111.073 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.406 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 175.38 169.35 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.47 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -163.25 147.71 11.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.76 161.89 28.97 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.255 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.34 119.51 39.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.161 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.601 ' HD2' ' HB3' ' B' ' 82' ' ' ALA . 5.0 mmm180 -96.96 99.15 10.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.667 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.9 p -98.08 130.71 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.328 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 8.1 m120 66.17 -170.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.899 0.381 . . . . 0.0 111.154 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.0 24.59 10.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.598 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' SER . . . . . 0.575 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 5.0 t -129.07 -44.72 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.963 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.33 148.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.601 ' HB3' ' HD2' ' B' ' 76' ' ' ARG . . . -152.01 171.22 18.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.224 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.26 9.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.43 23.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.17 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.27 135.96 23.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.38 175.04 39.69 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 96' ' ' MET . 6.3 p -124.1 146.53 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.473 ' HB2' ' HG2' ' B' ' 96' ' ' MET . . . -114.09 134.09 55.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.89 110.74 22.15 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 94' ' ' ASP . . . -122.78 132.45 54.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.574 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.495 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.95 -113.28 4.21 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.259 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.87 -60.67 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.343 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' B' ' 93' ' ' SER . 2.3 t -101.6 29.75 4.69 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.258 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.504 ' HB3' ' HB1' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -119.72 82.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.988 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.458 HG11 ' O ' ' B' ' 88' ' ' ALA . 5.1 t -120.47 142.35 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.017 0.437 . . . . 0.0 110.703 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.527 ' HB2' ' HA ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -132.49 155.63 48.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -128.5 128.93 45.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.492 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.6 160.27 22.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.688 0.28 . . . . 0.0 111.476 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.18 99.04 0.12 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.738 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.726 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.3 p -122.67 179.47 4.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.452 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -140.43 146.26 38.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.4 m-80 -111.82 150.0 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.374 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 56' ' ' PHE . 4.0 pt -156.1 150.97 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.761 0.315 . . . . 0.0 110.825 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.575 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 73.7 mt-10 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.489 ' O ' HD21 ' C' ' 21' ' ' LEU . 34.6 ttmt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.758 0.313 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -39.88 80.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.202 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 49.7 mtt85 -66.7 -42.88 85.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.68 -41.41 96.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.74 HD22 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.87 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -75.76 -39.15 57.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.76 HD21 ' HG ' ' A' ' 25' ' ' LEU . 8.0 mt -67.2 -51.02 58.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -58.77 -50.85 72.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.487 ' HE2' ' CZ ' ' C' ' 31' ' ' ARG . 9.5 tmtt? -54.91 -38.21 67.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.254 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.437 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -62.33 -42.72 99.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.48 -41.77 98.57 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.989 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.481 ' O ' ' CG ' ' C' ' 34' ' ' LYS . 4.4 m -57.89 -46.99 84.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.861 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.589 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 83.2 mmt-85 -59.48 -35.54 74.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.291 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.437 HG23 ' O ' ' C' ' 28' ' ' LEU . 42.0 t -73.8 -36.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.164 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.89 -55.88 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.073 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.589 ' HE3' ' HD3' ' C' ' 31' ' ' ARG . 3.3 pttt -72.39 -36.56 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.732 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.78 -45.18 96.27 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.375 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -70.07 -37.13 75.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.84 0.352 . . . . 0.0 111.149 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.82 99.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.428 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -54.39 14.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.776 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.653 ' HB3' HD21 ' B' ' 36' ' ' LEU . 87.0 p -49.09 -56.18 9.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.073 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -52.55 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.395 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.688 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . . . -49.29 -41.4 37.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.923 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 30.6 tp -74.0 -34.87 64.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.113 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 75.3 m-20 -78.18 -5.13 50.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' SER . . . . . 0.406 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.5 t -86.09 -0.63 56.09 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.156 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.781 ' HB3' HG23 ' C' ' 57' ' ' THR . 0.3 OUTLIER -95.95 172.18 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.892 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -165.76 -5.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.133 0.492 . . . . 0.0 111.66 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.411 ' HG3' HG21 ' C' ' 57' ' ' THR . 35.1 mt-30 65.75 118.93 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.944 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.396 9.8 Cg_endo -69.91 98.23 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.641 2.227 . . . . 0.0 112.565 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 66.96 -164.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 146.17 82.24 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.254 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 8.8 p -88.77 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.391 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.682 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 158.26 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.273 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -142.93 -166.67 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.657 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.54 144.04 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.511 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -131.1 134.83 46.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.067 0.46 . . . . 0.0 111.624 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . 0.46 ' O ' HG13 ' A' ' 103' ' ' ILE . 1.2 t80 -104.62 122.01 44.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.179 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.781 HG23 ' HB3' ' C' ' 45' ' ' LEU . 21.0 p -114.59 124.85 52.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.95 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.2 150.76 29.35 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.23 164.03 26.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' C' ' 69' ' ' LEU . 14.4 m -110.28 166.4 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.62 -174.4 22.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.48 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 143.1 8.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.573 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.608 ' CE2' ' HG3' ' C' ' 64' ' ' ARG . 62.9 t80 -132.45 137.06 47.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.608 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 2.9 mmm180 61.59 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.045 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' SER . . . . . 0.406 ' N ' ' O ' ' C' ' 63' ' ' TYR . 12.1 t -156.68 32.33 0.31 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -130.19 167.5 18.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.05 142.17 48.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.5 47.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.569 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.46 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.1 tp -111.33 128.35 55.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' C' ' 41' ' ' ALA . . . -122.97 152.11 41.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.726 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.411 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.7 tt -147.47 162.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.179 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.411 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 175.3 169.32 36.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.438 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 36.2 p -163.24 147.69 11.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.7 161.91 28.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.273 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.3 119.44 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 111.144 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.605 ' HD2' ' HB3' ' C' ' 82' ' ' ALA . 4.9 mmm180 -96.85 99.16 10.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.772 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.682 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.0 p -98.19 130.62 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.321 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 8.1 m120 66.37 -171.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -120.03 24.56 10.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.561 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' SER . . . . . 0.577 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 5.0 t -129.0 -44.74 1.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.987 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.2 148.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.552 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.605 ' HB3' ' HD2' ' C' ' 76' ' ' ARG . . . -152.02 171.21 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.234 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.22 9.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.52 23.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.145 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 135.91 23.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.02 39.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.609 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.478 HG22 ' O ' ' C' ' 96' ' ' MET . 6.3 p -124.02 146.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.89 0.376 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.463 ' O ' HG11 ' C' ' 95' ' ' VAL . . . -114.03 134.02 55.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.423 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -108.85 110.78 22.21 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.252 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' C' ' 94' ' ' ASP . . . -122.77 132.41 54.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.59 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.515 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.97 -113.18 4.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.209 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.92 -60.73 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' C' ' 93' ' ' SER . 2.3 t -101.59 29.79 4.67 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.486 ' HB3' ' HB1' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . 0.463 HG11 ' O ' ' C' ' 88' ' ' ALA . 5.1 t -120.35 142.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.552 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 0.9 OUTLIER -132.55 155.63 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.687 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -128.5 129.03 45.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.403 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.69 160.29 22.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.666 0.27 . . . . 0.0 111.504 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.2 99.03 0.12 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.728 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.1 p -122.79 179.49 4.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.435 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -140.47 146.28 38.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' C' ' 82' ' ' ALA . 70.4 m-80 -111.77 150.02 30.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.369 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 56' ' ' PHE . 3.9 pt -156.18 150.96 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.577 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 73.8 mt-10 -96.32 130.55 43.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . 1.071 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.6 t-105 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.728 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.73 0.3 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.29 -26.56 62.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.321 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -66.23 -53.73 33.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.742 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.82 -26.96 61.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.94 0.4 . . . . 0.0 111.188 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.545 ' HA ' HD22 ' A' ' 21' ' ' LEU . 3.0 tm? -62.89 -59.99 4.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.556 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -74.71 -47.76 29.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -74.87 -37.58 62.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.76 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 25' ' ' LEU . 2.8 mm? -63.77 -52.67 59.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -57.0 -42.48 80.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -63.45 -31.68 72.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.276 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.488 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -61.3 -45.88 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -66.73 -31.47 72.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.964 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.37 -35.9 71.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.81 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.628 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -71.96 -39.61 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 29' ' ' ASP . 32.8 m -75.85 -30.88 21.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.575 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 26.2 m-20 -68.38 -45.46 72.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.7 ptpt -75.51 -40.61 56.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.31 99.05 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.383 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.484 HD21 ' HG ' ' B' ' 36' ' ' LEU . 0.6 OUTLIER -74.37 -27.05 60.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.673 ' HB3' ' HA2' ' A' ' 62' ' ' GLY . . . -70.08 -41.48 74.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.512 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 8.2 t -82.98 -38.95 21.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.781 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.49 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 3.2 t -57.99 -55.78 30.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -60.74 -33.6 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.433 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.13 76.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 64.7 tp -81.06 -35.79 31.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.079 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.69 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 84.2 m-20 -75.3 -14.38 60.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.85 -22.31 65.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.171 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.721 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.3 mm? -74.32 165.83 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.875 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.557 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 2.5 p90 -157.06 -3.3 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 111.663 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.491 ' HG2' HG22 ' A' ' 57' ' ' THR . 9.1 mt-30 65.43 125.04 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.912 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -88.49 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.673 2.249 . . . . 0.0 112.589 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 11.5 m-30 66.93 -177.51 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.53 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.279 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -79.96 -12.51 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.168 0.587 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.34 52.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.266 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -163.95 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 55' ' ' ASN . 7.6 p -116.57 141.72 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.526 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.49 ' N ' HG23 ' A' ' 54' ' ' VAL . 14.5 m-80 -120.93 114.17 21.16 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.698 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.72 130.46 35.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.262 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.721 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 36.9 p -109.47 126.69 53.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.6 129.75 7.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.406 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' B' ' 100' ' ' SER . . . -174.25 165.18 36.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.558 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.44 160.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.339 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.24 17.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.489 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.673 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -170.15 137.88 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.552 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.575 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 17.8 t80 -123.87 135.0 53.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.708 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 1.7 mmm180 68.54 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.074 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.65 23.51 1.12 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.139 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.0 m -128.86 141.74 51.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.91 27.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -145.92 173.83 11.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.564 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.88 143.29 49.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.776 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.657 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -130.75 135.39 47.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.707 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.504 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.504 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 174.02 -178.49 45.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.446 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.31 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.85 28.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.283 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.66 134.49 50.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.165 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.66 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 15.8 ttm180 -122.46 126.22 47.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.733 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.42 137.99 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 29.8 m-20 60.93 -96.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 111.083 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.36 -19.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.594 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.0 p -73.19 -62.13 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.014 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.69 146.34 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.515 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.66 ' HB2' ' HG3' ' A' ' 76' ' ' ARG . . . -147.39 156.16 42.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.265 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.19 147.2 29.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.553 ' HG3' ' HE2' ' C' ' 46' ' ' PHE . 10.9 tmtt? -150.49 138.83 20.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.155 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.069 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 164.0 -176.0 40.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.529 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 71' ' ' ILE . 12.4 p -142.98 137.68 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.89 144.55 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -117.91 114.55 23.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -120.19 130.81 54.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.599 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.49 -115.84 8.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.242 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.59 7.26 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.343 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 24.74 0.27 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.204 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.438 ' CG ' ' HD2' ' A' ' 34' ' ' LYS . 18.3 m-20 -127.51 80.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.9 t -112.32 139.18 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 110.684 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.525 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 6.8 ptp -133.23 141.31 47.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -112.52 126.01 54.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.475 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.71 152.11 26.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 111.402 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.54 87.24 0.39 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.791 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.613 ' HB3' ' HA3' ' C' ' 59' ' ' GLY . 11.3 m -118.25 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.441 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.412 ' O ' HD11 ' C' ' 45' ' ' LEU . 27.9 p90 -132.4 147.62 52.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.922 0.392 . . . . 0.0 111.136 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.533 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 49.1 m-80 -111.77 130.55 55.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.34 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.02 115.99 22.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.453 ' CG ' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.717 0.294 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.35 -26.49 62.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -66.27 -53.68 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -72.84 -26.99 61.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.505 ' HA ' HD22 ' B' ' 21' ' ' LEU . 3.0 tm? -62.8 -60.03 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.637 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.83 -17.84 64.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.68 -47.77 29.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -74.93 -37.54 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.759 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.505 HD23 ' N ' ' B' ' 25' ' ' LEU . 2.8 mm? -63.73 -52.68 59.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.96 -42.58 80.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.492 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 0.9 OUTLIER -63.38 -31.77 73.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.238 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.492 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -61.28 -45.88 92.67 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.479 ' O ' HG22 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -66.69 -31.5 72.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -71.34 -35.93 71.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.637 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.0 OUTLIER -71.89 -39.74 69.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.479 HG22 ' O ' ' B' ' 29' ' ' ASP . 32.8 m -75.76 -30.92 21.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.572 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 26.1 m-20 -68.4 -45.34 72.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.016 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.7 ptpt -75.52 -40.62 56.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.806 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.3 99.16 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.32 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.484 ' HG ' HD21 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.36 -27.03 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.668 ' HB3' ' HA2' ' B' ' 62' ' ' GLY . . . -70.02 -41.56 74.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.49 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 8.2 t -82.96 -38.93 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.494 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.2 t -58.08 -55.8 30.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.491 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -60.74 -33.58 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.363 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -34.11 76.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' B' ' 70' ' ' ALA . 64.7 tp -81.08 -35.78 31.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.69 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 84.1 m-20 -75.29 -14.31 60.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 28.9 t -67.93 -22.36 65.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.088 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.733 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -74.2 165.8 24.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.901 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.564 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 2.5 p90 -157.07 -3.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' B' ' 57' ' ' THR . 9.0 mt-30 65.39 125.02 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.954 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -88.51 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.722 2.282 . . . . 0.0 112.557 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 11.5 m-30 66.88 -177.5 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.6 57.49 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.314 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -79.92 -12.53 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.162 0.585 . . . . 0.0 112.459 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.3 52.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.213 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -164.0 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.644 0.259 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.489 HG23 ' N ' ' B' ' 55' ' ' ASN . 7.6 p -116.52 141.71 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.552 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.489 ' N ' HG23 ' B' ' 54' ' ' VAL . 14.5 m-80 -120.9 114.27 21.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.968 0.414 . . . . 0.0 111.701 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -82.83 130.43 35.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.299 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.733 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.2 p -109.41 126.7 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.023 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.77 7.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.461 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.613 ' HA3' ' HB3' ' C' ' 100' ' ' SER . . . -174.24 165.15 36.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.563 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.41 160.79 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.18 16.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.467 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . 0.668 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -170.13 137.84 4.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.617 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.572 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 17.8 t80 -123.8 135.08 53.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 1.7 mmm180 68.44 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.58 23.46 1.13 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.67 51.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.53 151.9 27.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 111.093 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -145.89 173.94 11.69 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.563 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.97 143.27 49.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.764 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -130.75 135.43 47.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.687 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.507 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.76 0.314 . . . . 0.0 111.098 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.507 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 173.96 -178.49 45.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.446 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.49 146.4 5.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.965 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.64 162.76 28.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.279 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.63 134.55 50.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.644 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 15.9 ttm180 -122.47 126.31 47.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.56 138.06 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 29.6 m-20 60.88 -96.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 111.086 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.4 -19.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.9 p -73.18 -62.2 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 m -91.58 146.39 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.564 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.644 ' HB2' ' HG3' ' B' ' 76' ' ' ARG . . . -147.47 156.11 42.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.268 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.14 147.19 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.617 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.557 ' HG3' ' HE2' ' A' ' 46' ' ' PHE . 11.0 tmtt? -150.48 138.87 20.44 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.47 173.29 14.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 164.0 -175.95 40.07 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.565 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.453 ' O ' HG23 ' B' ' 71' ' ' ILE . 12.3 p -142.99 137.71 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.89 144.52 36.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.321 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -117.99 114.56 23.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.228 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -120.21 130.76 54.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.605 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.57 -115.86 8.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.326 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.6 7.24 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 111.36 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.89 24.72 0.27 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.213 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.441 ' CG ' ' HD2' ' B' ' 34' ' ' LYS . 18.2 m-20 -127.51 80.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.42 139.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.06 0.457 . . . . 0.0 110.633 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.511 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 6.8 ptp -133.18 141.28 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.678 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.51 126.03 54.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.437 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.62 152.09 26.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 111.493 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.53 87.27 0.4 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.843 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.614 ' HB3' ' HA3' ' A' ' 59' ' ' GLY . 11.3 m -118.24 166.22 12.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.396 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.411 ' O ' HD11 ' A' ' 45' ' ' LEU . 27.9 p90 -132.37 147.61 52.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.939 0.399 . . . . 0.0 111.065 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.538 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 49.3 m-80 -111.71 130.62 55.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.412 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.99 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.448 ' CG ' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.66 0.267 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.4 -26.46 62.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.243 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 47.7 mtt-85 -66.29 -53.68 33.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.8 -26.97 61.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.186 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.474 ' HA ' HD22 ' C' ' 21' ' ' LEU . 3.0 tm? -62.92 -60.0 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.53 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -65.8 -17.85 64.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.67 -47.74 30.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 54.5 mtp85 -74.95 -37.51 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.785 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.499 HD23 ' N ' ' C' ' 25' ' ' LEU . 2.8 mm? -63.87 -52.57 59.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -57.05 -42.49 80.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.484 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 0.9 OUTLIER -63.51 -31.71 72.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.609 0.242 . . . . 0.0 111.215 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.484 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -61.25 -45.97 92.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.48 ' O ' HG22 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -66.65 -31.51 72.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.975 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.35 -35.79 71.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.873 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.643 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -72.05 -39.62 68.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.282 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.48 HG22 ' O ' ' C' ' 29' ' ' ASP . 32.8 m -75.83 -30.84 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.587 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 26.1 m-20 -68.45 -45.35 72.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.7 ptpt -75.58 -40.62 56.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.14 99.11 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.395 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.481 HD21 ' HG ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.47 -27.08 60.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.833 0.349 . . . . 0.0 111.043 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.674 ' HB3' ' HA2' ' C' ' 62' ' ' GLY . . . -70.04 -41.49 74.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.493 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 8.2 t -83.08 -38.82 21.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.486 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 3.2 t -58.02 -55.85 29.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.488 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -60.75 -33.52 73.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.447 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.06 76.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.946 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.637 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 64.8 tp -81.14 -35.75 31.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.686 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 84.2 m-20 -75.33 -14.33 60.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.82 -22.37 65.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.158 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.722 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -74.27 165.83 24.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.862 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.553 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 2.5 p90 -157.1 -3.24 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.126 0.488 . . . . 0.0 111.654 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.5 ' HG2' HG22 ' C' ' 57' ' ' THR . 9.0 mt-30 65.42 124.97 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.988 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -88.45 109.26 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.643 2.229 . . . . 0.0 112.591 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 11.5 m-30 66.8 -177.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.944 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.5 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.258 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -79.84 -12.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.195 0.598 . . . . 0.0 112.466 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.45 52.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.265 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.96 -164.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.615 0.245 . . . . 0.0 110.573 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.497 HG23 ' N ' ' C' ' 55' ' ' ASN . 7.6 p -116.54 141.69 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.56 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.497 ' N ' HG23 ' C' ' 54' ' ' VAL . 14.6 m-80 -120.94 114.19 21.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.65 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -82.67 130.45 35.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.3 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.722 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 37.1 p -109.41 126.7 53.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.987 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.71 7.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.395 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.613 ' HA3' ' HB3' ' A' ' 100' ' ' SER . . . -174.23 165.23 36.72 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.512 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.43 160.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.46 -168.24 16.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.478 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . 0.674 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -170.17 137.86 4.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.587 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 17.9 t80 -123.8 135.14 53.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 110.702 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 1.7 mmm180 68.39 -89.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.6 23.45 1.13 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.77 51.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.807 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.83 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.09 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -145.83 173.93 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.578 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.97 143.25 49.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -130.74 135.38 47.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.65 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.506 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.0 tp -134.1 159.31 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.706 0.288 . . . . 0.0 111.203 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.506 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 174.05 -178.47 45.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.434 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.4 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.995 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.68 162.78 28.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.262 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -126.66 134.57 50.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.365 . . . . 0.0 111.148 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.65 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 15.8 ttm180 -122.44 126.21 47.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.778 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.48 137.97 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 29.8 m-20 60.99 -96.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.063 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.39 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.612 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 8.1 p -73.14 -62.18 1.56 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.66 146.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.65 ' HB2' ' HG3' ' C' ' 76' ' ' ARG . . . -147.42 156.16 42.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.15 147.21 29.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.591 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.564 ' HG3' ' HE2' ' B' ' 46' ' ' PHE . 10.9 tmtt? -150.53 138.85 20.36 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.34 14.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.95 -175.85 40.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.597 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.454 ' O ' HG23 ' C' ' 71' ' ' ILE . 12.4 p -143.01 137.71 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.95 144.53 36.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.357 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -117.87 114.61 23.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.261 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -120.12 130.8 54.8 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -115.76 7.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -146.67 7.22 0.96 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.29 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.92 24.8 0.27 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.235 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.435 ' CG ' ' HD2' ' C' ' 34' ' ' LYS . 18.5 m-20 -127.62 80.84 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 65.1 t -112.34 139.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.67 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.509 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 6.8 ptp -133.25 141.34 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.733 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.59 125.97 54.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.55 152.06 25.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.504 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.52 87.19 0.39 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.815 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.613 ' HB3' ' HA3' ' B' ' 59' ' ' GLY . 11.1 m -118.26 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.408 ' O ' HD11 ' B' ' 45' ' ' LEU . 27.6 p90 -132.43 147.56 52.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.912 0.386 . . . . 0.0 111.058 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.535 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 49.4 m-80 -111.71 130.57 55.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.97 22.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.458 ' CG ' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -118.71 158.79 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.688 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.622 ' HB2' ' HE2' ' B' ' 17' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.631 0.253 . . . . 0.0 110.525 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -35.02 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 111.26 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.19 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.423 HE22 ' HG ' ' C' ' 21' ' ' LEU . 1.7 pp0? -60.44 -28.38 68.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.541 HD12 ' HD3' ' B' ' 24' ' ' ARG . 2.2 tm? -64.99 -59.43 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.81 -23.08 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.05 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.01 -55.18 15.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.533 ' HD3' HD12 ' C' ' 21' ' ' LEU . 69.5 mtp85 -70.34 -38.21 74.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.779 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.476 HD21 HD21 ' A' ' 21' ' ' LEU . 3.7 mm? -63.75 -48.28 77.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.04 -31.73 73.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 2.1 ttpp -65.34 -42.59 92.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.692 0.282 . . . . 0.0 111.288 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -63.35 -43.93 96.31 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -57.17 -30.01 64.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.925 178.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.6 m -79.71 -29.67 40.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.792 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 -26.64 46.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.32 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 29' ' ' ASP . 33.1 m -82.62 -28.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.219 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.632 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 76.1 m-20 -75.95 -45.07 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.984 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 5.2 ptpt -84.1 -29.1 27.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.74 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 39' ' ' SER . . . -68.65 -42.42 80.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.422 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.447 ' HA ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -80.58 -25.59 38.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.105 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 33' ' ' ASP . . . -75.19 -41.38 58.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.49 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.74 ' HB3' ' HE1' ' A' ' 96' ' ' MET . 10.4 t -77.47 -42.58 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.758 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -62.39 -50.87 69.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.467 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.95 78.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 39.4 tp -76.34 -42.59 44.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -71.65 -7.87 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.77 -23.84 63.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.147 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.566 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.7 mm? -82.19 165.82 20.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.862 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.7 p90 -153.28 -3.85 0.2 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.636 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.922 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.762 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -79.65 113.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.613 2.209 . . . . 0.0 112.487 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.449 ' HH ' ' HB ' ' B' ' 51' ' ' VAL . 6.2 m-30 56.43 173.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.016 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 52.98 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.23 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 7.6 p -72.57 -3.83 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.162 0.585 . . . . 0.0 112.45 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 145.57 52.56 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.341 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -169.6 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 110.615 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 55' ' ' ASN . 12.4 p -109.56 142.66 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.573 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.463 ' N ' HG23 ' A' ' 54' ' ' VAL . 23.9 m-80 -122.88 119.0 29.21 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.451 ' HE2' ' HB1' ' A' ' 58' ' ' ALA . 34.6 t80 -87.25 133.85 33.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.242 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.432 ' HB ' ' CB ' ' A' ' 45' ' ' LEU . 81.8 p -115.35 120.03 38.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.451 ' HB1' ' HE2' ' A' ' 56' ' ' PHE . . . -150.65 135.4 17.39 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.425 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.51 169.03 39.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.534 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 69' ' ' LEU . 15.6 m -120.57 154.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.26 -172.83 13.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.437 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -166.0 140.2 6.22 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.632 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 31.9 t80 -133.25 135.1 44.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.708 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.2 mmm180 66.61 -93.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.125 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 p -145.68 31.16 1.07 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.44 141.02 45.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.33 153.9 22.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.08 170.57 17.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.492 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -119.38 141.15 49.32 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -126.23 140.78 52.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.732 0.301 . . . . 0.0 111.637 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 87' ' ' VAL . 8.3 tp -140.95 151.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.093 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.12 174.72 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.438 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.97 155.05 5.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.23 173.13 29.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.252 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.547 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 44.6 t80 -126.48 135.48 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 11.2 ttm180 -125.14 135.34 52.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.754 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 7.6 p -119.35 137.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.34 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 90.4 m-20 64.13 -94.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 6.2 pt-20 179.11 -23.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.604 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.92 -63.95 1.0 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.536 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -141.27 152.0 44.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.247 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 63.5 tp -134.37 140.28 46.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.426 ' HD3' ' N ' ' A' ' 85' ' ' ALA . 7.3 tmtt? -155.58 126.28 6.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.426 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.72 178.05 10.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.96 36.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 71' ' ' ILE . 7.7 p -143.56 141.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 111.165 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.476 ' HB2' ' SD ' ' A' ' 96' ' ' MET . . . -111.72 139.4 47.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.346 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -114.02 114.39 26.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.173 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.44 135.96 54.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.639 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 57.09 -116.81 8.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.31 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 72.5 m -148.61 16.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.74 0.305 . . . . 0.0 111.316 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.71 20.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.19 68.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.96 139.04 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.73 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.74 ' HE1' ' HB3' ' A' ' 38' ' ' SER . 3.3 ptp -133.26 132.97 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.748 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -110.74 118.59 36.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -107.11 152.68 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.12 0.65 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.773 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.466 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 21.6 m -123.82 176.31 6.37 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.448 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.48 139.44 25.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.922 0.392 . . . . 0.0 111.105 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.748 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 70.6 m-80 -103.2 132.8 49.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.346 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.59 117.39 17.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.802 0.334 . . . . 0.0 110.811 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.622 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.649 0.262 . . . . 0.0 110.53 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.41 -35.16 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.194 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.74 -59.24 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.41 HE22 ' HG ' ' A' ' 21' ' ' LEU . 1.7 pp0? -60.37 -28.45 68.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.173 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.544 HD12 ' HD3' ' C' ' 24' ' ' ARG . 2.1 tm? -64.85 -59.56 4.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.574 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -65.77 -23.0 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.059 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.08 -55.16 15.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.541 ' HD3' HD12 ' A' ' 21' ' ' LEU . 69.5 mtp85 -70.36 -38.19 74.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.462 HD21 HD21 ' B' ' 21' ' ' LEU . 3.7 mm? -63.8 -48.34 77.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.588 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.98 -31.66 72.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.477 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 2.1 ttpp -65.48 -42.61 92.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.199 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.477 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -63.22 -44.02 96.47 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.529 ' O ' HG22 ' B' ' 32' ' ' VAL . 0.9 OUTLIER -57.21 -29.96 64.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.926 178.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 5.6 m -79.75 -29.55 40.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -26.54 46.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.326 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.529 HG22 ' O ' ' B' ' 29' ' ' ASP . 33.2 m -82.71 -28.57 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.142 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.646 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 76.2 m-20 -75.97 -44.99 37.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.988 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.428 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 5.3 ptpt -84.19 -29.04 26.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.715 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' B' ' 39' ' ' SER . . . -68.79 -42.29 79.74 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.419 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' C' ' 36' ' ' LEU . 1.5 mt -80.66 -25.54 38.21 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.752 0.311 . . . . 0.0 111.034 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' B' ' 33' ' ' ASP . . . -75.11 -41.52 58.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.51 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.76 ' HB3' ' HE1' ' B' ' 96' ' ' MET . 10.4 t -77.39 -42.6 35.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.785 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 0.9 OUTLIER -62.38 -50.87 69.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.88 85.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.475 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.04 78.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.451 ' HA ' HD11 ' B' ' 42' ' ' LEU . 39.7 tp -76.33 -42.53 44.65 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.07 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -71.68 -7.87 50.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.4 t -69.73 -23.89 63.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.316 -0.856 . . . . 0.0 113.172 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.568 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.7 mm? -82.18 165.88 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.883 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 7.7 p90 -153.35 -3.8 0.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.109 0.48 . . . . 0.0 111.671 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.443 ' HB3' ' CB ' ' B' ' 55' ' ' ASN . 10.1 mt-30 72.03 117.26 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -79.55 113.53 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.645 2.23 . . . . 0.0 112.506 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.448 ' HH ' ' HB ' ' C' ' 51' ' ' VAL . 6.2 m-30 56.48 173.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.71 53.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.289 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 7.7 p -72.57 -3.9 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.117 0.567 . . . . 0.0 112.465 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 145.58 52.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.248 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -169.58 3.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.611 0.243 . . . . 0.0 110.606 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.468 HG23 ' N ' ' B' ' 55' ' ' ASN . 12.4 p -109.59 142.65 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.538 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.468 ' N ' HG23 ' B' ' 54' ' ' VAL . 24.0 m-80 -122.91 118.97 29.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.93 0.395 . . . . 0.0 111.697 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.439 ' HE2' ' HB1' ' B' ' 58' ' ' ALA . 34.5 t80 -87.17 133.83 33.6 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.245 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.435 ' HB ' ' CB ' ' B' ' 45' ' ' LEU . 81.8 p -115.38 119.95 37.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.949 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.439 ' HB1' ' HE2' ' B' ' 56' ' ' PHE . . . -150.58 135.43 17.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.475 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.49 168.98 39.25 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.539 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' B' ' 69' ' ' LEU . 15.6 m -120.52 154.79 23.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.806 0.336 . . . . 0.0 111.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.33 -172.81 13.38 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.409 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . 0.579 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -166.01 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.502 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.646 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 32.0 t80 -133.21 134.98 44.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.74 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.2 mmm180 66.69 -93.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.087 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.63 31.14 1.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.173 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.47 140.98 45.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.35 153.93 22.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.62 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.579 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -119.5 141.2 49.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -126.25 140.64 52.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.589 HG23 ' O ' ' B' ' 87' ' ' VAL . 8.3 tp -140.9 151.84 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.742 0.306 . . . . 0.0 111.11 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.21 174.65 39.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.396 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.94 155.12 5.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.342 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.21 173.19 29.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.245 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 44.8 t80 -126.55 135.58 51.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 11.2 ttm180 -125.22 135.34 52.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.659 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 7.6 p -119.4 137.4 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 90.2 m-20 64.11 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 6.2 pt-20 179.1 -23.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.589 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 17.5 p -70.8 -63.98 0.99 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.98 143.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.58 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -141.29 152.07 44.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.271 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 63.6 tp -134.32 140.2 46.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.604 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' B' ' 85' ' ' ALA . 7.3 tmtt? -155.6 126.13 6.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.141 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.431 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.59 178.07 10.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.88 36.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.534 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.589 ' O ' HG23 ' B' ' 71' ' ' ILE . 7.7 p -143.66 141.44 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.478 ' HB2' ' SD ' ' B' ' 96' ' ' MET . . . -111.82 139.35 47.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.325 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -113.95 114.37 26.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.205 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.36 136.01 54.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.644 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 57.06 -116.92 8.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.248 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.52 16.64 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.75 20.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.197 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -119.22 68.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.957 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.14 139.06 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.76 ' HE1' ' HB3' ' B' ' 38' ' ' SER . 3.3 ptp -133.31 132.99 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.74 118.63 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.415 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.13 152.66 23.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.685 0.279 . . . . 0.0 111.412 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.98 94.11 0.65 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.463 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 21.8 m -123.81 176.44 6.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.391 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -146.65 139.45 25.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.029 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.762 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.6 m-80 -103.22 132.79 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.362 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.35 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.612 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.666 0.27 . . . . 0.0 110.55 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -34.99 65.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.259 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.18 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . 0.421 HE22 ' HG ' ' B' ' 21' ' ' LEU . 1.7 pp0? -60.44 -28.36 68.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.136 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.533 HD12 ' HD3' ' A' ' 24' ' ' ARG . 2.1 tm? -64.98 -59.44 4.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.631 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -65.86 -22.96 66.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.07 -55.17 15.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.544 ' HD3' HD12 ' B' ' 21' ' ' LEU . 69.6 mtp85 -70.33 -38.16 74.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.476 HD21 HD21 ' C' ' 21' ' ' LEU . 3.7 mm? -63.89 -48.36 76.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.87 -31.74 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.466 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 2.0 ttpp -65.47 -42.51 92.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.466 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -63.28 -44.0 96.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.522 ' O ' HG22 ' C' ' 32' ' ' VAL . 0.9 OUTLIER -57.19 -29.96 64.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.936 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 5.6 m -79.8 -29.55 40.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -26.63 46.49 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.357 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.522 HG22 ' O ' ' C' ' 29' ' ' ASP . 33.2 m -82.55 -28.72 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.642 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 76.2 m-20 -75.88 -45.11 37.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.005 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.409 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 5.3 ptpt -84.08 -29.07 27.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.806 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' C' ' 39' ' ' SER . . . -68.6 -42.39 80.82 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 36' ' ' LEU . 1.5 mt -80.61 -25.63 38.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.801 0.334 . . . . 0.0 111.06 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' C' ' 33' ' ' ASP . . . -75.23 -41.45 57.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.402 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.72 ' HB3' ' HE1' ' C' ' 96' ' ' MET . 10.5 t -77.43 -42.6 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' C' ' 35' ' ' GLY . 0.9 OUTLIER -62.3 -50.92 69.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.86 85.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.92 -37.02 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.94 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 39.6 tp -76.25 -42.65 45.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.035 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -71.66 -7.9 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.71 -23.91 63.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.149 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.553 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.7 mm? -82.26 165.78 20.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.813 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 7.7 p90 -153.26 -3.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.651 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.444 ' HB3' ' CB ' ' C' ' 55' ' ' ASN . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.963 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -79.61 113.5 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.667 2.245 . . . . 0.0 112.514 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.454 ' HH ' ' HB ' ' A' ' 51' ' ' VAL . 6.2 m-30 56.47 173.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.985 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.73 53.02 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.229 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 7.7 p -72.58 -3.85 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 145.6 52.65 0.03 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.22 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.603 0.239 . . . . 0.0 110.655 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.466 HG23 ' N ' ' C' ' 55' ' ' ASN . 12.4 p -109.6 142.62 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.567 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.466 ' N ' HG23 ' C' ' 54' ' ' VAL . 24.0 m-80 -122.91 118.99 29.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.646 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . 0.436 ' HE2' ' HB1' ' C' ' 58' ' ' ALA . 34.4 t80 -87.19 133.77 33.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.282 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.428 ' HB ' ' CB ' ' C' ' 45' ' ' LEU . 81.9 p -115.31 120.01 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.983 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . 0.436 ' HB1' ' HE2' ' C' ' 56' ' ' PHE . . . -150.66 135.38 17.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.473 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.48 168.95 39.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' C' ' 69' ' ' LEU . 15.6 m -120.52 154.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.806 0.336 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.31 -172.88 13.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.466 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -166.0 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.574 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.642 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 32.1 t80 -133.19 134.99 44.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 110.812 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.2 mmm180 66.64 -93.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.133 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.61 31.12 1.08 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.43 141.05 45.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.781 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.39 153.91 22.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.54 17.56 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.539 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -119.43 141.18 49.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.747 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -126.24 140.69 52.34 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.702 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.586 HG23 ' O ' ' C' ' 87' ' ' VAL . 8.3 tp -140.88 151.83 20.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.14 174.72 39.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.468 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.93 155.09 5.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.24 173.15 29.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.269 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 44.6 t80 -126.56 135.54 51.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.342 . . . . 0.0 111.172 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.463 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 11.2 ttm180 -125.17 135.39 52.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.666 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 7.5 p -119.43 137.39 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 90.2 m-20 64.15 -94.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 6.2 pt-20 179.07 -23.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.527 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.99 -63.87 1.02 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -141.28 152.07 44.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.257 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 63.3 tp -134.37 140.22 46.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 7.3 tmtt? -155.6 126.23 6.87 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . 0.43 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.68 177.99 10.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.71 -167.82 36.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.58 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.586 ' O ' HG23 ' C' ' 71' ' ' ILE . 7.7 p -143.74 141.45 25.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.464 ' HB2' ' SD ' ' C' ' 96' ' ' MET . . . -111.73 139.31 47.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.316 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -113.97 114.45 26.2 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.45 135.95 54.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.624 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 57.11 -116.86 8.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.248 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.58 16.5 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 111.252 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.73 20.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.238 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.25 68.68 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 24.9 t -94.99 139.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.738 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.72 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 3.3 ptp -133.28 132.99 42.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.701 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.8 118.64 36.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.433 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -107.05 152.64 23.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.727 0.298 . . . . 0.0 111.432 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.1 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.47 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 21.8 m -123.8 176.37 6.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.432 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.59 139.42 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.988 0.423 . . . . 0.0 111.101 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.765 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 70.6 m-80 -103.21 132.8 49.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.37 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.3 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.781 0.324 . . . . 0.0 110.798 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.77 151.94 36.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.71 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.681 0.276 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.79 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.33 -60.07 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.6 -28.13 69.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.654 HD23 HD23 ' C' ' 21' ' ' LEU . 2.4 tm? -63.37 -54.61 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.536 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.483 ' HA ' ' NH2' ' B' ' 24' ' ' ARG . 30.2 m-20 -65.28 -27.07 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.981 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.49 -57.53 8.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.654 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.0 mtp85 -61.6 -38.55 87.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.818 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.651 ' HG ' ' HE ' ' B' ' 24' ' ' ARG . 3.1 mm? -62.18 -48.64 79.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.531 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.9 -28.94 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.772 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 1.2 ttpp -65.15 -44.01 89.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.642 0.258 . . . . 0.0 111.223 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.486 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -59.58 -41.66 90.74 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.637 ' HA ' HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -61.1 -27.71 68.57 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.939 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 m -75.58 -39.82 57.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HD3' ' NZ ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -73.06 -22.81 60.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.334 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.637 HG21 ' HA ' ' A' ' 29' ' ' ASP . 32.6 m -90.28 -28.65 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.144 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.615 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 65.1 m-20 -73.63 -47.74 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 30' ' ' THR . 7.9 ptpt -80.8 -28.47 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.759 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.92 53.82 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.422 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 1.6 mt -75.0 -32.22 61.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 111.127 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB3' ' HA2' ' A' ' 62' ' ' GLY . . . -71.2 -41.17 70.62 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.447 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.64 ' HB3' ' HE1' ' A' ' 96' ' ' MET . 9.0 t -74.8 -41.52 59.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.802 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -60.01 -53.34 58.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.087 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.489 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -60.22 -34.04 73.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.339 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.818 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.33 -41.45 93.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.25 -42.14 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.071 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' C' ' 40' ' ' ALA . 9.2 m-20 -72.09 -9.87 59.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 t -68.49 -22.68 64.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.189 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.625 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.6 mm? -82.7 159.17 22.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.875 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.16 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.647 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' OE1' ' HA3' ' A' ' 74' ' ' GLY . 13.8 mt-30 70.7 118.04 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.758 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.7 Cg_endo -78.48 114.85 3.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.585 2.19 . . . . 0.0 112.501 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.75 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 167.72 55.85 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.263 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 8.3 p -75.49 -5.5 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.136 0.575 . . . . 0.0 112.479 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.8 49.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.33 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.599 0.238 . . . . 0.0 110.649 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 55' ' ' ASN . 14.6 p -105.86 141.63 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.524 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.432 ' N ' HG23 ' A' ' 54' ' ' VAL . 10.0 m-80 -122.77 117.52 25.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 111.624 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.487 ' HE1' HD12 ' A' ' 71' ' ' ILE . 20.3 t80 -87.72 140.59 29.36 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.281 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.625 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 68.1 p -117.23 118.97 33.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.91 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' B' ' 101' ' ' PHE . . . -144.9 132.39 20.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.476 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.461 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.83 174.93 46.17 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.574 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.22 160.67 23.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.392 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.818 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -140.33 177.55 20.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.438 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -162.39 141.04 6.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.537 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.624 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 39.1 t80 -137.24 134.12 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.271 . . . . 0.0 110.815 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 62.89 -93.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 p -143.26 32.39 1.35 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.1 145.15 47.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.782 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.01 153.55 26.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.097 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.98 164.33 32.37 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.523 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.58 136.16 53.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.71 51.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.638 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.487 HD12 ' HE1' ' A' ' 56' ' ' PHE . 6.6 tp -143.17 153.41 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.101 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.89 -177.72 45.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.95 151.26 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.469 ' HA3' ' OE1' ' A' ' 47' ' ' GLN . . . -150.24 171.67 30.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.227 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.03 136.59 50.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 111.11 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.654 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 7.1 ttm180 -132.25 133.89 44.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.589 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 4.1 p -122.95 143.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.286 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.3 m-20 60.13 -88.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.986 0.422 . . . . 0.0 111.083 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 10.0 pt-20 172.21 -31.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.535 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.42 -58.92 5.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.023 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.97 138.7 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.61 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.654 ' HB2' ' HG3' ' A' ' 76' ' ' ARG . . . -144.79 148.39 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 111.255 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -136.37 140.3 43.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.641 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.483 ' HD3' ' C ' ' A' ' 84' ' ' LYS . 8.9 tmtt? -153.79 130.42 10.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.478 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.34 177.05 11.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.02 -169.93 40.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.553 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 96' ' ' MET . 7.5 p -145.27 141.64 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.28 145.82 35.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.368 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -111.31 118.29 35.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.207 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.626 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.464 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 48.01 -114.3 1.79 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.286 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.15 17.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.18 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 27.7 m-20 -116.34 71.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.78 132.32 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.64 ' HE1' ' HB3' ' A' ' 38' ' ' SER . 2.7 ptp -122.69 126.67 48.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.89 111.17 23.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.436 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.32 152.43 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.322 . . . . 0.0 111.398 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.15 96.71 1.0 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.464 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 57.4 m -119.94 177.64 4.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.387 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' C' ' 58' ' ' ALA . 22.3 p90 -147.29 138.86 24.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.409 . . . . 0.0 111.082 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.741 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 74.5 m-20 -100.78 130.65 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.92 112.06 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.749 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.404 ' HG2' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.647 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.711 0.291 . . . . 0.0 110.531 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.11 -38.81 66.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.222 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.3 -60.11 4.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.758 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.58 -28.15 69.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.653 HD23 HD23 ' A' ' 21' ' ' LEU . 2.4 tm? -63.32 -54.65 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.479 ' HA ' ' NH2' ' C' ' 24' ' ' ARG . 30.5 m-20 -65.39 -26.9 68.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.017 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.58 -57.41 9.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.651 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.0 mtp85 -61.71 -38.52 88.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.661 ' HG ' ' HE ' ' C' ' 24' ' ' ARG . 3.1 mm? -62.2 -48.55 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.92 -29.01 70.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.771 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.469 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 1.3 ttpp -65.17 -43.92 90.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.228 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.469 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -59.61 -41.65 90.84 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.635 ' HA ' HG21 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -61.08 -27.67 68.53 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.988 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 4.1 m -75.73 -39.72 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.841 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.418 ' HD3' ' NZ ' ' B' ' 27' ' ' LYS . 0.6 OUTLIER -73.14 -22.79 60.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.284 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' B' ' 29' ' ' ASP . 32.5 m -90.19 -28.69 4.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.22 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.615 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 65.5 m-20 -73.55 -47.87 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.036 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' B' ' 30' ' ' THR . 7.9 ptpt -80.76 -28.38 36.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.805 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.54 -40.75 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.413 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 1.6 mt -75.11 -32.15 61.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.328 . . . . 0.0 111.105 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.546 ' HB3' ' HA2' ' B' ' 62' ' ' GLY . . . -71.23 -41.14 70.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.413 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.665 ' HB3' ' HE1' ' B' ' 96' ' ' MET . 9.1 t -74.85 -41.62 59.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.93 -53.36 58.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.48 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -60.25 -34.0 73.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.404 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.826 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.4 -41.35 93.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.959 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.419 ' HA ' HD11 ' B' ' 42' ' ' LEU . 38.7 tp -72.25 -42.19 65.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.061 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 40' ' ' ALA . 9.2 m-20 -72.07 -9.89 59.02 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.8 t -68.5 -22.64 64.52 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.181 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.631 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.6 mm? -82.73 159.16 22.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.823 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.18 0.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.649 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' B' ' 46' ' ' PHE . 13.8 mt-30 70.68 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.947 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.35 114.64 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.747 2.298 . . . . 0.0 112.571 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.82 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.59 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 167.72 55.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.316 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 8.3 p -75.59 -5.52 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.105 0.562 . . . . 0.0 112.425 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.82 49.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.209 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -173.12 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.629 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.439 HG23 ' N ' ' B' ' 55' ' ' ASN . 14.5 p -105.9 141.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.516 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.439 ' N ' HG23 ' B' ' 54' ' ' VAL . 10.0 m-80 -122.85 117.47 25.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 111.63 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.473 ' HE1' HD12 ' B' ' 71' ' ' ILE . 20.4 t80 -87.71 140.56 29.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.252 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.631 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 67.9 p -117.21 118.9 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.931 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' C' ' 101' ' ' PHE . . . -144.89 132.39 20.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.82 174.93 46.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.614 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.19 160.68 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.347 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . 0.826 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -140.33 177.59 20.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.518 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -162.39 140.93 6.85 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.603 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.626 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 39.1 t80 -137.17 134.25 36.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.31 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 62.96 -93.45 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.979 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 17.3 p -143.23 32.46 1.35 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.143 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.19 145.17 47.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.03 153.54 26.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.0 164.33 32.42 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.517 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.53 136.14 53.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.793 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.72 51.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.473 HD12 ' HE1' ' B' ' 56' ' ' PHE . 6.6 tp -143.19 153.39 16.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.157 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.9 -177.69 45.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.441 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.92 151.3 4.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.389 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.454 ' HA3' ' OE1' ' B' ' 47' ' ' GLN . . . -150.32 171.61 30.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.203 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.94 136.51 50.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.134 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.658 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 7.1 ttm180 -132.19 133.95 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.607 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 4.1 p -122.96 143.1 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.267 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 96.3 m-20 60.21 -88.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.927 0.394 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 10.0 pt-20 172.25 -31.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.555 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 15.6 p -62.49 -58.89 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.06 138.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.5 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.658 ' HB2' ' HG3' ' B' ' 76' ' ' ARG . . . -144.81 148.43 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.27 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 53.4 tp -136.43 140.32 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.581 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' B' ' 85' ' ' ALA . 8.9 tmtt? -153.75 130.44 10.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.38 177.11 11.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.04 -169.89 40.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.592 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.477 HG21 ' O ' ' B' ' 96' ' ' MET . 7.5 p -145.34 141.65 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.32 145.91 35.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.276 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -111.38 118.28 35.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.289 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' B' ' 94' ' ' ASP . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.581 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' B' ' 34' ' ' LYS . . . 47.97 -114.24 1.75 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 39.1 m -149.57 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.687 0.28 . . . . 0.0 111.275 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.24 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 27.3 m-20 -116.39 71.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 39.1 t -99.83 132.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.675 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.665 ' HE1' ' HB3' ' B' ' 38' ' ' SER . 2.7 ptp -122.72 126.62 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.733 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.92 111.26 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.405 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.38 152.42 24.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.724 0.297 . . . . 0.0 111.459 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.18 96.74 1.0 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.461 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 56.5 m -119.96 177.64 4.91 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.428 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' ALA . 21.9 p90 -147.3 138.79 23.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 111.093 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.758 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 74.5 m-20 -100.77 130.6 46.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.433 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.85 112.05 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.65 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.711 0.291 . . . . 0.0 110.541 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.78 66.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.32 -60.07 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.63 -28.17 69.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.42 . . . . 0.0 111.149 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.654 HD23 HD23 ' A' ' 21' ' ' LEU . 2.4 tm? -63.26 -54.67 33.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.545 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . 0.477 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 30.1 m-20 -65.31 -26.99 68.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.085 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.54 -57.45 9.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.661 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.0 mtp85 -61.65 -38.58 88.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.734 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.654 ' HG ' ' HE ' ' A' ' 24' ' ' ARG . 3.1 mm? -62.14 -48.57 79.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.9 -29.01 70.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.816 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.474 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 1.2 ttpp -65.18 -43.92 90.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.652 0.263 . . . . 0.0 111.249 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.474 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -59.59 -41.67 90.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.61 ' HA ' HG21 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -61.12 -27.71 68.58 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.917 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.461 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 4.1 m -75.59 -39.85 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.411 ' HD3' ' NZ ' ' C' ' 27' ' ' LYS . 0.6 OUTLIER -73.05 -22.71 60.58 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' C' ' 29' ' ' ASP . 32.4 m -90.27 -28.7 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.619 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 65.5 m-20 -73.63 -47.76 37.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.469 ' HD3' ' CA ' ' C' ' 91' ' ' GLY . 7.9 ptpt -80.85 -28.37 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.803 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.45 -40.85 53.63 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.478 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 1.6 mt -74.98 -32.36 61.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 111.07 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.559 ' HB3' ' HA2' ' C' ' 62' ' ' GLY . . . -71.12 -41.21 70.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.44 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.643 ' HB3' ' HE1' ' C' ' 96' ' ' MET . 9.1 t -74.81 -41.57 59.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.746 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.96 -53.28 59.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.169 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.487 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -60.27 -33.95 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.403 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.834 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.44 -41.38 93.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.467 ' HA ' HD11 ' C' ' 42' ' ' LEU . 38.9 tp -72.24 -42.23 65.89 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.073 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' B' ' 40' ' ' ALA . 9.1 m-20 -72.02 -9.84 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.9 t -68.54 -22.68 64.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.158 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.6 mm? -82.68 159.15 22.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.866 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 15.1 p90 -148.5 -2.28 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.619 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.471 ' OE1' ' HA3' ' C' ' 74' ' ' GLY . 13.8 mt-30 70.72 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.936 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.44 114.78 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.679 2.253 . . . . 0.0 112.487 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.76 -176.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.612 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 167.69 55.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.246 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 8.3 p -75.48 -5.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.178 0.591 . . . . 0.0 112.445 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.84 49.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.283 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.644 0.259 . . . . 0.0 110.621 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.438 HG23 ' N ' ' C' ' 55' ' ' ASN . 14.7 p -105.84 141.5 21.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.585 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.438 ' N ' HG23 ' C' ' 54' ' ' VAL . 9.8 m-80 -122.74 117.6 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 111.664 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . 0.462 ' HE1' HD12 ' C' ' 71' ' ' ILE . 20.4 t80 -87.8 140.54 29.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.34 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.628 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 67.7 p -117.15 118.9 33.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.001 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 101' ' ' PHE . . . -144.87 132.39 20.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.81 174.9 46.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.586 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.16 160.72 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 111.399 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . 0.834 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -140.35 177.64 20.54 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.4 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . 0.559 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -162.47 141.04 6.92 Favored Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.619 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 39.0 t80 -137.29 134.26 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.711 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 62.9 -93.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.114 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -143.23 32.37 1.35 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.15 145.14 47.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.05 153.56 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 111.097 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.94 164.3 32.45 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.61 136.2 53.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.96 140.69 51.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.462 HD12 ' HE1' ' C' ' 56' ' ' PHE . 6.6 tp -143.25 153.4 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.768 0.318 . . . . 0.0 111.098 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.94 -177.71 45.29 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.456 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.91 151.32 4.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . 0.471 ' HA3' ' OE1' ' C' ' 47' ' ' GLN . . . -150.26 171.75 30.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -129.12 136.49 50.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.636 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 7.1 ttm180 -132.11 134.09 45.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.682 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.601 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 4.1 p -123.09 143.12 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.274 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 96.3 m-20 60.15 -88.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 111.104 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 10.1 pt-20 172.18 -31.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.47 -58.93 5.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.942 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 32.2 m -94.05 138.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.525 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.636 ' HB2' ' HG3' ' C' ' 76' ' ' ARG . . . -144.9 148.39 33.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.279 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 53.6 tp -136.38 140.37 43.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.491 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 8.9 tmtt? -153.85 130.44 10.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . 0.491 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.37 177.1 11.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.043 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.0 -169.91 40.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.555 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.471 HG21 ' O ' ' C' ' 96' ' ' MET . 7.5 p -145.29 141.69 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.872 0.368 . . . . 0.0 111.099 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.28 145.84 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.339 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.38 118.2 35.17 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.277 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' C' ' 94' ' ' ASP . . . -126.02 140.63 52.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.591 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.469 ' CA ' ' HD3' ' C' ' 34' ' ' LYS . . . 48.02 -114.34 1.81 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.244 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -149.47 16.72 0.91 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.264 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.23 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 27.3 m-20 -116.39 71.01 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.81 132.33 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.006 0.432 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.643 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 2.7 ptp -122.65 126.65 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -105.98 111.28 23.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.408 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.31 152.46 24.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.457 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.2 96.74 0.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.468 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 56.5 m -119.95 177.63 4.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.438 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' B' ' 58' ' ' ALA . 22.1 p90 -147.31 138.83 24.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.757 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 74.5 m-20 -100.79 130.62 46.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.358 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.608 HG21 ' CZ2' ' C' ' 105' ' ' TRP . 0.2 OUTLIER -129.93 112.08 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -117.24 146.87 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . 0.608 ' CZ2' HG21 ' C' ' 103' ' ' ILE . 27.3 m-90 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.705 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.671 0.272 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.82 -32.31 67.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.371 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -64.1 -57.64 8.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.74 -31.18 70.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 25' ' ' LEU . 3.2 tm? -61.98 -59.76 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.12 -18.79 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -74.13 -45.99 45.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -77.02 -37.14 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 21' ' ' LEU . 3.3 mm? -66.42 -52.18 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.63 -42.24 92.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.3 ttpp -66.88 -28.95 68.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.419 HD22 HD13 ' C' ' 25' ' ' LEU . 0.0 OUTLIER -62.28 -48.81 78.27 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.561 ' HA ' HG21 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -64.33 -33.09 75.04 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.925 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -67.93 -38.83 83.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.717 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.83 64.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.561 HG21 ' HA ' ' A' ' 29' ' ' ASP . 32.8 m -74.24 -33.46 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.628 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 16.6 m-20 -69.07 -45.28 70.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.717 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.3 ptpt -75.19 -40.65 59.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.729 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.414 ' HA3' ' OH ' ' C' ' 63' ' ' TYR . . . -57.37 -43.63 93.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.381 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.778 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.03 -24.65 58.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.159 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.814 ' HB3' ' HA2' ' A' ' 62' ' ' GLY . . . -69.21 -41.96 76.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.461 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.597 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 8.5 t -82.81 -39.97 21.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.745 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.5 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 4.0 t -58.11 -54.79 43.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' HB3' HD22 ' B' ' 98' ' ' ASN . . . -61.5 -33.51 73.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.445 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.73 -33.6 76.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.643 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 60.1 tp -82.65 -32.37 28.27 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.678 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 87.6 m-20 -75.84 -16.34 60.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.85 -18.83 64.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.207 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.61 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.7 mm? -77.53 163.87 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.909 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.2 p90 -156.56 0.41 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.632 ' HG2' HG22 ' A' ' 57' ' ' THR . 6.0 mt-30 63.07 125.07 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.965 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -83.95 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.671 2.247 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.468 ' OH ' ' HB ' ' B' ' 51' ' ' VAL . 13.7 m-30 63.7 -175.3 0.16 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.595 ' HA3' ' HD2' ' A' ' 76' ' ' ARG . . . 166.69 55.44 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.237 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -81.44 -10.66 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.159 0.584 . . . . 0.0 112.432 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.67 48.17 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.284 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -150.92 -163.92 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.656 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 74' ' ' GLY . 9.0 p -116.72 142.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.553 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.484 ' CB ' ' HB3' ' A' ' 47' ' ' GLN . 10.4 m-80 -124.82 113.32 17.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.677 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.55 129.64 34.98 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.273 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.632 HG22 ' HG2' ' A' ' 47' ' ' GLN . 37.7 p -109.36 122.09 46.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.992 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.495 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -154.62 133.68 12.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.436 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.46 170.49 43.31 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.531 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 69' ' ' LEU . 2.7 m -121.15 161.41 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.366 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.23 17.96 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.461 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.814 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -172.21 138.73 4.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.628 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 34.0 t80 -120.84 131.85 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.685 0.278 . . . . 0.0 110.738 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.4 mmm180 69.52 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.1 p -143.76 26.22 1.58 Allowed 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.159 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.38 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.33 150.96 28.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -146.55 171.79 14.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.548 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -119.98 142.8 48.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.811 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -132.62 137.19 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.686 0.279 . . . . 0.0 111.636 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.55 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.5 tp -137.65 162.1 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.784 0.326 . . . . 0.0 111.05 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.55 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 171.37 179.9 42.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.397 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.61 148.77 12.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.892 0.377 . . . . 0.0 110.965 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -151.49 166.78 30.77 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.228 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.591 ' CE2' ' HB ' ' A' ' 77' ' ' VAL . 38.8 t80 -131.85 134.49 45.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.156 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.598 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 16.4 ttm180 -125.18 121.56 34.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.611 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 8.6 p -110.88 137.99 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 49.7 m-20 64.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.451 ' HB3' ' CE2' ' C' ' 49' ' ' TYR . 10.5 pt-20 175.42 -20.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.59 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 p -70.85 -66.36 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.032 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 m -90.85 141.34 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.589 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.598 ' HB2' ' HG3' ' A' ' 76' ' ' ARG . . . -149.47 153.82 37.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.172 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 101' ' ' PHE . 25.3 tp -148.82 149.88 32.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.618 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HG3' ' HE2' ' C' ' 46' ' ' PHE . 12.1 tmtt? -149.34 141.67 24.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.162 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.17 176.02 11.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.44 -173.06 41.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.587 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.09 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.853 0.358 . . . . 0.0 111.16 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.25 144.23 39.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.351 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -121.97 113.01 18.99 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.39 -116.13 8.72 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.293 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.87 8.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.322 . . . . 0.0 111.337 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t -155.03 22.62 0.44 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.108 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 10.8 m-20 -127.11 82.86 2.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.87 139.4 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.537 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 6.9 ptp -134.22 141.58 47.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -113.26 124.31 52.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.455 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.51 HD22 ' HB3' ' C' ' 40' ' ' ALA . 17.1 m120 -109.57 148.01 32.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.296 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.7 86.9 0.38 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.592 ' CB ' HD13 ' C' ' 45' ' ' LEU . 4.1 m -115.61 162.34 17.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.471 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.598 ' HB3' HD11 ' A' ' 83' ' ' LEU . 31.8 p90 -130.31 145.64 51.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.976 0.417 . . . . 0.0 111.055 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.574 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 56.0 m-80 -115.34 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.399 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.14 119.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.819 0.343 . . . . 0.0 110.726 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.704 0.288 . . . . 0.0 110.5 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.92 -32.3 67.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -63.99 -57.71 8.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.707 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.83 -31.1 70.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.559 HD21 HD21 ' B' ' 25' ' ' LEU . 3.2 tm? -61.95 -59.81 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.591 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -65.07 -18.78 65.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.18 -46.0 44.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -76.94 -37.14 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.794 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.559 HD21 HD21 ' B' ' 21' ' ' LEU . 3.3 mm? -66.47 -52.16 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.641 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.61 -42.19 92.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' B' ' 27' ' ' LYS . 1.3 ttpp -66.93 -29.02 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.418 HD22 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.2 -48.82 78.3 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.559 ' HA ' HG21 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -64.46 -32.9 74.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 178.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 5.9 m -68.03 -38.81 82.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.858 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.732 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -73.3 -39.85 64.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.246 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' B' ' 29' ' ' ASP . 32.6 m -74.21 -33.41 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.223 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.627 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 16.6 m-20 -69.18 -45.25 70.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.732 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.3 ptpt -75.17 -40.61 59.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.416 ' HA3' ' OH ' ' A' ' 63' ' ' TYR . . . -57.37 -43.62 93.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.78 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.06 -24.65 58.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.812 ' HB3' ' HA2' ' B' ' 62' ' ' GLY . . . -69.18 -42.03 76.39 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.577 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 8.5 t -82.72 -40.01 21.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.741 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.494 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.9 t -58.12 -54.62 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.505 ' HB3' HD22 ' C' ' 98' ' ' ASN . . . -61.66 -33.47 74.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.409 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.69 76.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.67 ' HB2' ' HB3' ' B' ' 70' ' ' ALA . 59.6 tp -82.6 -32.29 28.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.689 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 87.4 m-20 -75.8 -16.37 60.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.99 -18.69 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.148 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.6 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.7 mm? -77.63 163.88 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.846 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.468 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.2 p90 -156.54 0.37 0.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 111.714 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.628 ' HG2' HG22 ' B' ' 57' ' ' THR . 6.1 mt-30 63.15 124.98 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.967 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -83.94 109.92 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.642 2.228 . . . . 0.0 112.605 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' C' ' 51' ' ' VAL . 13.6 m-30 63.71 -175.31 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.934 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.58 ' HA3' ' HD2' ' B' ' 76' ' ' ARG . . . 166.72 55.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.245 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -81.34 -10.67 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.161 0.584 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.63 48.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.268 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.435 ' O ' ' CD1' ' B' ' 75' ' ' TYR . 0.0 OUTLIER -150.89 -163.87 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.601 0.239 . . . . 0.0 110.639 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.566 HG23 ' O ' ' B' ' 74' ' ' GLY . 9.1 p -116.78 142.65 29.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.586 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.489 ' CB ' ' HB3' ' B' ' 47' ' ' GLN . 10.4 m-80 -124.8 113.43 17.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.973 0.416 . . . . 0.0 111.663 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.67 129.7 34.96 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.195 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.628 HG22 ' HG2' ' B' ' 47' ' ' GLN . 37.6 p -109.42 122.07 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.943 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.473 ' HB1' HD12 ' B' ' 71' ' ' ILE . . . -154.61 133.7 12.41 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.368 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.47 170.49 43.32 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' B' ' 69' ' ' LEU . 2.7 m -121.16 161.52 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.773 0.321 . . . . 0.0 111.383 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.23 -167.16 17.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.473 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . 0.812 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -172.23 138.75 4.94 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.627 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 34.1 t80 -120.87 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.695 0.283 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.5 mmm180 69.47 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -143.75 26.18 1.58 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.17 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.4 51.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -110.44 151.06 27.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . 0.577 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -146.66 171.7 14.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.537 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.459 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.8 OUTLIER -120.0 142.75 48.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.808 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.67 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -132.58 137.2 47.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.681 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.556 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.5 tp -137.64 162.07 32.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.738 0.304 . . . . 0.0 111.119 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.556 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 171.34 179.87 42.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.444 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.58 148.73 12.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.566 ' O ' HG23 ' B' ' 54' ' ' VAL . . . -151.41 166.8 30.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.598 ' CE2' ' HB ' ' B' ' 77' ' ' VAL . 38.6 t80 -131.88 134.47 45.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.609 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 16.4 ttm180 -125.19 121.47 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.613 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 8.6 p -110.88 138.04 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.344 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 50.2 m-20 64.3 -97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.46 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 10.4 pt-20 175.44 -20.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.541 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.81 -66.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 m -90.84 141.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' B' ' 76' ' ' ARG . . . -149.42 153.82 37.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 0.0 111.225 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' B' ' 101' ' ' PHE . 25.2 tp -148.79 149.88 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.582 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.484 ' HG3' ' HE2' ' A' ' 46' ' ' PHE . 12.1 tmtt? -149.38 141.72 24.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.18 176.05 11.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.086 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.36 -173.1 41.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.556 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.21 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.347 . . . . 0.0 111.107 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.31 144.16 39.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.366 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.89 113.03 19.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.235 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -119.5 129.97 54.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.608 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.28 -116.04 8.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.31 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.92 8.11 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 111.332 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.1 22.65 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 10.9 m-20 -127.07 82.8 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 99.7 t -108.87 139.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.969 0.414 . . . . 0.0 110.653 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.542 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 6.9 ptp -134.22 141.6 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.693 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -113.28 124.3 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.498 HD22 ' HB3' ' A' ' 40' ' ' ALA . 17.0 m120 -109.54 147.99 32.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 111.42 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.76 86.92 0.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.757 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.603 ' CB ' HD13 ' A' ' 45' ' ' LEU . 4.1 m -115.55 162.33 17.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.399 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.592 ' HB3' HD11 ' B' ' 83' ' ' LEU . 32.3 p90 -130.32 145.59 51.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.418 . . . . 0.0 111.073 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.582 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.0 m-80 -115.31 131.85 56.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.401 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.08 119.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.849 0.356 . . . . 0.0 110.776 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.478 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.98 -32.26 67.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 111.245 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -64.04 -57.72 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.79 -31.04 70.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.222 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.556 HD21 HD21 ' C' ' 25' ' ' LEU . 3.2 tm? -62.06 -59.75 4.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.53 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.11 -18.8 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.948 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.15 -45.97 45.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -76.98 -37.15 55.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.751 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.556 HD21 HD21 ' C' ' 21' ' ' LEU . 3.3 mm? -66.52 -52.13 49.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.646 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -59.59 -42.29 92.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' C' ' 27' ' ' LYS . 1.3 ttpp -66.79 -29.02 68.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.229 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.415 HD22 HD13 ' B' ' 25' ' ' LEU . 0.0 OUTLIER -62.32 -48.72 78.59 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.557 ' HA ' HG21 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -64.4 -32.99 74.83 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.994 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 5.9 m -67.92 -38.94 83.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.813 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.716 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.78 65.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.271 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' C' ' 29' ' ' ASP . 32.7 m -74.16 -33.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.622 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 16.6 m-20 -68.97 -45.3 71.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.716 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.3 ptpt -75.12 -40.71 59.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.777 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . 0.416 ' HA3' ' OH ' ' B' ' 63' ' ' TYR . . . -57.34 -43.57 93.75 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.419 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.78 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -75.13 -24.65 58.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.875 0.369 . . . . 0.0 111.092 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.814 ' HB3' ' HA2' ' C' ' 62' ' ' GLY . . . -69.17 -42.03 76.42 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.429 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.573 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 8.5 t -82.75 -39.93 21.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.502 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 4.0 t -58.11 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.51 ' HB3' HD22 ' A' ' 98' ' ' ASN . . . -61.67 -33.45 73.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.392 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.69 -33.66 76.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 59.9 tp -82.61 -32.29 28.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.689 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 87.4 m-20 -75.79 -16.43 60.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -67.9 -18.74 64.88 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.149 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.7 mm? -77.68 163.89 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.858 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.48 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.2 p90 -156.53 0.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.657 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.625 ' HG2' HG22 ' C' ' 57' ' ' THR . 6.1 mt-30 63.13 125.06 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.926 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -83.92 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.632 2.221 . . . . 0.0 112.629 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.465 ' OH ' ' HB ' ' A' ' 51' ' ' VAL . 13.7 m-30 63.74 -175.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.962 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.594 ' HA3' ' HD2' ' C' ' 76' ' ' ARG . . . 166.76 55.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.208 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -81.4 -10.59 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.157 0.583 . . . . 0.0 112.452 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.54 48.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.297 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -150.88 -163.82 1.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.625 0.25 . . . . 0.0 110.619 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.544 HG23 ' O ' ' C' ' 74' ' ' GLY . 9.1 p -116.89 142.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.578 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.488 ' CB ' ' HB3' ' C' ' 47' ' ' GLN . 10.4 m-80 -124.83 113.4 17.85 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.011 0.434 . . . . 0.0 111.659 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -83.63 129.71 34.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.226 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.625 HG22 ' HG2' ' C' ' 47' ' ' GLN . 37.6 p -109.42 122.06 46.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . 0.477 ' HB1' HD12 ' C' ' 71' ' ' ILE . . . -154.61 133.62 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.44 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.39 170.5 43.35 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.554 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' C' ' 69' ' ' LEU . 2.7 m -121.12 161.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.21 17.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.451 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . 0.814 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -172.18 138.76 4.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.548 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.622 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 34.1 t80 -120.9 131.96 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.757 0.313 . . . . 0.0 110.746 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.5 mmm180 69.34 -92.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.1 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.4 p -143.77 26.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.1 141.42 51.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.42 150.96 28.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -146.58 171.75 14.61 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.548 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.461 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.8 OUTLIER -120.01 142.69 48.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -132.55 137.17 47.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.69 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.544 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.5 tp -137.52 162.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.544 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 171.36 179.86 42.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.59 148.75 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . 0.544 ' O ' HG23 ' C' ' 54' ' ' VAL . . . -151.41 166.81 30.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.15 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.604 ' CE2' ' HB ' ' C' ' 77' ' ' VAL . 39.2 t80 -131.91 134.45 45.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.92 0.391 . . . . 0.0 111.153 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.606 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 16.5 ttm180 -125.16 121.56 34.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.731 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.611 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 8.7 p -110.96 138.06 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.291 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 49.8 m-20 64.4 -97.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.013 0.435 . . . . 0.0 111.12 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . 0.464 ' HB3' ' CE2' ' B' ' 49' ' ' TYR . 10.5 pt-20 175.43 -20.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.62 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.87 -66.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -90.97 141.3 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.485 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.606 ' HB2' ' HG3' ' C' ' 76' ' ' ARG . . . -149.38 153.83 37.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.276 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' C' ' 101' ' ' PHE . 25.3 tp -148.77 149.89 32.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.6 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.468 ' HG3' ' HE2' ' B' ' 46' ' ' PHE . 12.1 tmtt? -149.41 141.74 24.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.27 175.94 11.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.056 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.43 -173.18 41.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.546 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.09 138.2 19.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.102 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.39 144.22 39.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.32 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.99 112.93 18.88 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -119.43 129.98 55.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.4 -116.1 8.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.308 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m -148.95 8.09 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.331 . . . . 0.0 111.285 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.07 22.64 0.43 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 10.8 m-20 -127.1 82.77 2.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.76 139.33 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.769 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.542 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 6.8 ptp -134.17 141.61 47.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.3 124.25 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.495 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.505 HD22 ' HB3' ' B' ' 40' ' ' ALA . 17.1 m120 -109.52 148.08 31.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 111.443 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.74 86.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.764 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.592 ' CB ' HD13 ' B' ' 45' ' ' LEU . 4.1 m -115.53 162.35 17.32 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.594 ' HB3' HD11 ' C' ' 83' ' ' LEU . 32.0 p90 -130.34 145.61 51.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 111.064 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.585 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 55.6 m-80 -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.378 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.06 119.7 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.794 0.331 . . . . 0.0 110.737 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.95 159.82 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.663 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.721 0.296 . . . . 0.0 110.55 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.09 -20.26 64.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 111.211 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 mtt-85 -70.74 -60.28 2.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.795 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.534 HE22 HD12 ' C' ' 21' ' ' LEU . 4.4 pp0? -73.14 -17.37 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.152 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -67.71 -49.81 60.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.557 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -73.53 -28.05 61.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.038 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.05 -51.57 45.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -62.5 -44.76 95.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.755 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.44 -50.37 73.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.18 -39.48 82.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 ttpp -60.46 -34.09 73.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.202 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -41.95 81.27 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.45 -25.02 64.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.3 m -79.63 -41.0 27.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.852 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.658 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.4 mpt_? -68.93 -35.83 77.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.303 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.0 m -77.58 -32.13 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.159 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -66.79 -44.84 80.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 4.2 ptpt -77.76 -31.69 52.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.24 67.84 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.393 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.89 -27.77 60.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.23 -46.37 16.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.407 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.542 ' OG ' ' HB2' ' A' ' 88' ' ' ALA . 48.4 t -67.06 -40.59 87.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.504 ' OG ' ' HB1' ' C' ' 40' ' ' ALA . 37.4 t -67.42 -52.89 34.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HB1' ' OG ' ' B' ' 39' ' ' SER . . . -61.88 -25.82 67.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.494 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -65.96 -38.28 88.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 21.7 tp -79.36 -33.63 42.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -73.68 -13.58 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.493 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 30.5 t -71.54 -19.27 62.19 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.182 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.598 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.0 mm? -80.45 157.83 26.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.856 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 8.1 p90 -146.06 -10.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.699 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.518 ' HG2' HG22 ' A' ' 57' ' ' THR . 5.1 mt-30 73.43 121.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.935 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -77.72 101.1 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HH ' ' H ' ' B' ' 50' ' ' GLY . 18.3 m-30 62.1 -170.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 163.03 60.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.5 p -69.89 -18.81 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.146 0.578 . . . . 0.0 112.459 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.764 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.02 51.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.313 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.16 -157.03 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.56 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 55' ' ' ASN . 2.8 p -120.67 145.13 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.579 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.52 ' N ' HG23 ' A' ' 54' ' ' VAL . 11.5 m-80 -126.83 122.06 33.65 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.979 0.418 . . . . 0.0 111.727 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.411 ' CE2' HD12 ' A' ' 71' ' ' ILE . 22.2 t80 -84.27 124.47 31.26 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.267 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.598 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 72.1 p -107.04 120.61 42.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.007 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.85 137.49 20.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.405 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . 178.14 165.48 33.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.533 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 69' ' ' LEU . 30.2 m -121.13 178.76 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.375 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.99 -179.34 38.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -158.14 134.22 3.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.522 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.648 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 26.1 t80 -124.91 124.19 41.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.74 0.305 . . . . 0.0 110.746 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER 68.67 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 p -146.05 16.89 1.39 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.44 140.89 49.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.43 47.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 172.08 13.19 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.671 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.0 tt -123.47 145.16 49.04 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' A' ' 41' ' ' ALA . . . -132.1 119.52 21.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.411 HD12 ' CE2' ' A' ' 56' ' ' PHE . 8.1 tp -118.67 152.74 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.91 -172.12 44.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.446 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.61 158.11 6.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.25 177.75 22.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.25 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.601 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 35.0 t80 -138.12 132.8 32.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 14.1 ttm180 -126.54 117.25 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.764 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.9 p -106.12 138.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.284 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 78.9 m-20 68.82 -92.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 78' ' ' ASN . 14.8 pt-20 172.92 -24.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.579 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -78.46 -52.21 8.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.01 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.44 137.39 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.469 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -144.55 163.77 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.295 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.1 tp -158.88 154.31 25.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.431 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 10.8 tmtt? -159.59 133.97 7.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.1 18.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.83 -174.57 42.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.628 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 96' ' ' MET . 7.9 p -130.24 139.56 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 111.112 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.542 ' HB2' ' OG ' ' A' ' 38' ' ' SER . . . -113.05 136.51 52.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.293 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.19 51.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.294 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 34' ' ' LYS . . . -131.61 135.72 47.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.591 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.541 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.71 -123.26 29.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.281 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.58 9.58 2.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.791 0.329 . . . . 0.0 111.318 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.48 32.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.201 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -132.32 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.25 150.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.01 0.433 . . . . 0.0 110.724 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.632 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 1.2 ptp -146.52 159.69 43.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.594 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.69 141.06 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.444 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -118.05 145.68 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.764 0.316 . . . . 0.0 111.393 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.48 87.6 1.32 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 16.7 m -121.49 148.99 43.73 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.393 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.705 ' HD2' HD13 ' A' ' 103' ' ' ILE . 1.8 p90 -124.47 142.91 50.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.423 . . . . 0.0 111.05 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.75 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 64.1 m-80 -109.45 126.72 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.705 HD13 ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -129.59 121.1 52.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.592 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.655 0.264 . . . . 0.0 110.529 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.02 -20.32 64.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.227 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 mtt-85 -70.6 -60.4 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.749 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.523 HE22 HD12 ' A' ' 21' ' ' LEU . 4.4 pp0? -73.1 -17.37 61.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.151 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -67.69 -49.86 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -73.44 -28.17 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.993 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.98 -51.54 46.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -62.49 -44.82 95.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.8 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.4 -50.46 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.08 -39.48 82.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.871 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.492 ' O ' ' HD3' ' B' ' 31' ' ' ARG . 12.9 ttpp -60.38 -34.2 73.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.212 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.07 -41.87 81.28 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.925 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 1.3 m -79.52 -40.98 28.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.667 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.4 mpt_? -68.87 -36.0 77.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 18.9 m -77.53 -32.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.207 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 9.9 m-20 -66.73 -44.78 80.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.04 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 4.2 ptpt -77.97 -31.53 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.56 -35.23 67.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.88 -27.78 60.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.31 -46.32 16.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.396 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' B' ' 88' ' ' ALA . 48.5 t -67.09 -40.53 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.785 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.513 ' OG ' ' HB1' ' A' ' 40' ' ' ALA . 37.4 t -67.46 -52.94 33.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.512 ' HB1' ' OG ' ' C' ' 39' ' ' SER . . . -61.82 -25.87 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.43 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.604 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . . . -65.87 -38.41 88.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.607 ' HB2' ' HB3' ' B' ' 70' ' ' ALA . 21.6 tp -79.26 -33.65 43.31 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 57.8 m-20 -73.64 -13.59 61.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.495 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 30.4 t -71.58 -19.27 62.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.135 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.614 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.0 mm? -80.48 157.8 26.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.831 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.433 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 8.1 p90 -146.0 -10.43 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.188 0.518 . . . . 0.0 111.717 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.517 ' HG2' HG22 ' B' ' 57' ' ' THR . 5.1 mt-30 73.51 121.16 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.882 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -77.69 101.14 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.623 2.216 . . . . 0.0 112.54 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.5 ' HH ' ' H ' ' C' ' 50' ' ' GLY . 18.4 m-30 62.03 -170.51 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.946 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.509 ' H ' ' HH ' ' A' ' 49' ' ' TYR . . . 163.03 60.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.288 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.4 p -70.0 -18.86 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.186 0.594 . . . . 0.0 112.454 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.762 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.04 51.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.298 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.05 -156.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.546 0.212 . . . . 0.0 110.671 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.514 HG23 ' N ' ' B' ' 55' ' ' ASN . 2.8 p -120.81 145.15 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.577 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.514 ' N ' HG23 ' B' ' 54' ' ' VAL . 11.5 m-80 -126.84 122.09 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.008 0.433 . . . . 0.0 111.669 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.418 ' CE2' HD12 ' B' ' 71' ' ' ILE . 22.2 t80 -84.34 124.5 31.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.248 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.614 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 73.4 p -107.1 120.64 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.81 137.56 20.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.418 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . 178.1 165.51 33.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' B' ' 69' ' ' LEU . 30.3 m -121.16 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.03 -179.39 38.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.453 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -158.12 134.17 3.77 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.646 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 26.2 t80 -124.91 124.18 41.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.734 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 73.3 p -145.99 16.87 1.4 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.81 49.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.42 47.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.107 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.41 172.11 13.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.49 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.689 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.0 tt -123.52 145.19 49.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.762 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -132.19 119.63 21.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.725 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.418 HD12 ' CE2' ' B' ' 56' ' ' PHE . 8.1 tp -118.72 152.72 20.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.96 -172.18 44.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.405 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.52 158.06 6.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.851 0.358 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.2 177.78 22.61 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.267 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.595 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 34.8 t80 -138.13 132.71 32.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.873 0.368 . . . . 0.0 111.166 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 14.0 ttm180 -126.49 117.27 22.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.762 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.9 p -106.16 138.91 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.011 0.434 . . . . 0.0 111.278 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 78.9 m-20 68.81 -92.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.0 111.14 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 14.8 pt-20 172.97 -24.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.1 p -78.48 -52.21 8.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.44 137.36 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -144.58 163.78 32.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.868 0.365 . . . . 0.0 111.255 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 34.6 tp -158.9 154.32 25.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.428 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 10.8 tmtt? -159.66 133.97 7.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.58 171.06 18.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.87 -174.46 42.83 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.626 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.442 HG21 ' O ' ' B' ' 96' ' ' MET . 7.9 p -130.29 139.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.059 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.551 ' HB2' ' OG ' ' B' ' 38' ' ' SER . . . -113.01 136.48 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.359 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.68 125.2 51.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' B' ' 34' ' ' LYS . . . -131.53 135.69 47.24 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.664 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.556 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.76 -123.37 30.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.342 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.28 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.9 t -165.48 32.84 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.242 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.32 82.3 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.24 150.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.648 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 1.2 ptp -146.56 159.65 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.667 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -127.65 141.17 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.366 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -118.14 145.66 44.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 111.359 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 87.51 1.32 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.74 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 16.7 m -121.42 149.01 43.65 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.4 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.701 ' HD2' HD13 ' B' ' 103' ' ' ILE . 1.9 p90 -124.44 142.88 50.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.957 0.408 . . . . 0.0 111.153 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.773 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 64.1 m-80 -109.4 126.78 53.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.701 HD13 ' HD2' ' B' ' 101' ' ' PHE . 0.9 OUTLIER -129.64 121.11 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.866 0.365 . . . . 0.0 110.756 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.584 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.677 0.275 . . . . 0.0 110.591 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -69.0 -20.27 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.297 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -70.73 -60.33 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . 0.529 HE22 HD12 ' B' ' 21' ' ' LEU . 4.4 pp0? -73.1 -17.4 61.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.177 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 0.8 OUTLIER -67.73 -49.81 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.558 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -73.45 -28.16 61.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.99 -51.52 46.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -62.52 -44.78 95.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.722 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.52 -50.34 73.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.611 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -59.15 -39.48 82.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.806 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' C' ' 31' ' ' ARG . 12.9 ttpp -60.44 -34.16 73.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.204 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -41.98 81.21 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.29 -25.11 64.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.987 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.447 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 1.3 m -79.54 -41.03 28.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.853 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.651 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.4 mpt_? -68.91 -35.87 77.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.28 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 19.0 m -77.58 -32.18 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -66.74 -44.79 80.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.045 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.651 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 4.2 ptpt -77.83 -31.68 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.48 -35.31 68.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mt -74.79 -27.82 60.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.113 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.24 -46.33 16.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.452 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.538 ' OG ' ' HB2' ' C' ' 88' ' ' ALA . 48.5 t -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.756 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.512 ' OG ' ' HB1' ' B' ' 40' ' ' ALA . 37.6 t -67.47 -52.96 33.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.504 ' HB1' ' OG ' ' A' ' 39' ' ' SER . . . -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.475 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . . . -65.86 -38.37 88.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 21.6 tp -79.28 -33.69 43.18 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 57.6 m-20 -73.6 -13.62 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' SER . . . . . 0.488 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 30.4 t -71.63 -19.23 62.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.154 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.588 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.0 mm? -80.51 157.78 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.836 177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.431 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 8.1 p90 -145.98 -10.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.172 0.51 . . . . 0.0 111.703 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.516 ' HG2' HG22 ' C' ' 57' ' ' THR . 5.1 mt-30 73.53 121.12 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.932 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 10.0 Cg_endo -77.66 101.08 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.657 2.238 . . . . 0.0 112.57 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.494 ' HH ' ' H ' ' A' ' 50' ' ' GLY . 18.4 m-30 62.12 -170.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.963 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.5 ' H ' ' HH ' ' B' ' 49' ' ' TYR . . . 163.1 60.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.251 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.4 p -69.92 -18.88 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.258 0.623 . . . . 0.0 112.383 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.742 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.01 51.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.356 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 -157.03 0.76 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.594 0.235 . . . . 0.0 110.591 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.518 HG23 ' N ' ' C' ' 55' ' ' ASN . 2.8 p -120.8 145.18 27.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.518 ' N ' HG23 ' C' ' 54' ' ' VAL . 11.5 m-80 -126.82 121.99 33.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.977 0.418 . . . . 0.0 111.696 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . 0.415 ' CE2' HD12 ' C' ' 71' ' ' ILE . 22.3 t80 -84.23 124.47 31.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.272 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.588 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 72.3 p -106.98 120.63 42.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.999 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.84 137.53 20.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.422 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . 178.05 165.49 32.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' C' ' 69' ' ' LEU . 30.5 m -121.18 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.0 -179.41 38.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.521 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -158.1 134.2 3.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.552 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.632 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 26.1 t80 -124.95 124.23 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.091 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 73.4 p -146.02 16.88 1.39 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.82 49.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.32 145.44 47.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.43 172.08 13.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.496 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.0 tt -123.41 145.23 48.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.79 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' C' ' 41' ' ' ALA . . . -132.23 119.62 21.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.653 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' C' ' 56' ' ' PHE . 8.1 tp -118.67 152.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.188 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.98 -172.17 44.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.57 158.11 6.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.19 177.74 22.63 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.236 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.581 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 34.8 t80 -138.14 132.69 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 14.0 ttm180 -126.49 117.3 22.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.742 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.9 p -106.13 138.83 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 78.8 m-20 68.92 -92.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 111.076 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 14.8 pt-20 172.95 -24.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.593 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -78.49 -52.27 8.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.0 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.37 137.42 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -144.61 163.77 32.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.236 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 34.3 tp -158.87 154.27 25.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.595 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.433 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 10.8 tmtt? -159.58 133.94 7.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.13 18.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.81 -174.47 42.8 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.572 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.441 HG21 ' O ' ' C' ' 96' ' ' MET . 8.0 p -130.27 139.55 51.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.125 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.538 ' HB2' ' OG ' ' C' ' 38' ' ' SER . . . -113.09 136.49 52.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.346 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.21 51.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' C' ' 34' ' ' LYS . . . -131.62 135.72 47.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.603 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.544 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.75 -123.34 30.25 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 33.3 m -138.52 9.61 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.53 32.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.193 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.26 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.27 150.61 11.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.646 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 1.2 ptp -146.59 159.68 43.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.685 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.7 141.14 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -118.08 145.7 44.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.708 0.289 . . . . 0.0 111.415 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.54 1.31 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 16.7 m -121.4 148.98 43.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.449 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.7 ' HD2' HD13 ' C' ' 103' ' ' ILE . 1.8 p90 -124.41 142.87 50.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 111.04 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.771 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 64.0 m-80 -109.43 126.73 53.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.38 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.7 HD13 ' HD2' ' C' ' 101' ' ' PHE . 1.0 OUTLIER -129.62 121.06 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.77 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.96 165.95 19.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.665 179.694 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 2.8 mmpt? . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.699 0.285 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.68 -31.28 70.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.247 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -63.07 -58.69 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.18 83.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.117 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.403 HD23 HD12 ' C' ' 21' ' ' LEU . 12.1 mt -60.0 -47.49 85.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.559 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -66.81 -32.25 73.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.093 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.53 -42.31 95.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.53 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.733 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.62 -33.42 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -73.73 -41.2 62.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -63.02 -42.06 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.285 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' C' ' 29' ' ' ASP . 0.2 OUTLIER -62.9 -50.35 71.22 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.483 ' HB2' HD23 ' B' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.14 61.43 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.912 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.15 -40.65 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.472 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.6 mpt_? -60.87 -32.56 71.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.316 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 6.4 m -80.12 -28.94 12.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.216 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -51.88 61.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 20.3 pttt -74.13 -39.28 63.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.751 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.32 -36.21 92.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.534 HD23 ' HG ' ' B' ' 36' ' ' LEU . 5.9 mt -73.53 -31.16 63.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.068 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.91 -45.29 36.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.457 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.475 ' HB3' ' HE2' ' A' ' 96' ' ' MET . 22.7 t -63.86 -44.89 91.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.8 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.536 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 11.5 t -59.13 -46.47 88.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.631 ' HB1' ' OD1' ' B' ' 98' ' ' ASN . . . -67.26 -29.04 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . . . -65.13 -39.88 93.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.06 -38.9 51.69 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -72.12 -15.94 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 t -66.58 -32.92 74.56 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.15 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' B' ' 100' ' ' SER . 1.0 OUTLIER -64.21 143.66 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.881 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.492 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 35.0 p90 -112.69 -42.53 3.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.11 0.481 . . . . 0.0 111.677 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 33.8 mt-30 70.26 109.43 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.948 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.545 ' HD3' ' ND2' ' B' ' 102' ' ' ASN 0.256 9.8 Cg_endo -75.25 -161.16 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.617 2.211 . . . . 0.0 112.576 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 17.5 m-30 68.16 167.02 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.962 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.4 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.193 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' HA ' ' HG3' ' A' ' 79' ' ' GLU . 9.6 p -88.84 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.198 0.599 . . . . 0.0 112.4 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.39 69.1 0.01 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.261 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -143.79 -178.16 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.619 0.247 . . . . 0.0 110.561 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.498 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 10.1 p -119.02 142.17 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' N ' HG22 ' A' ' 54' ' ' VAL . 1.7 m-80 -125.0 178.08 5.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.62 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -151.48 143.39 23.82 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.531 ' HB ' HD21 ' A' ' 45' ' ' LEU . 30.2 p -117.3 142.08 47.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.953 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -177.5 127.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.463 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -179.34 -165.27 33.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.04 154.61 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.367 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 41' ' ' ALA . . . -134.43 171.72 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.504 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 66' ' ' SER . . . -156.73 141.31 7.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.571 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.409 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 84.4 t80 -135.56 110.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.697 0.284 . . . . 0.0 110.74 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 28.0 mtt180 66.28 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.128 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 37.86 1.33 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.122 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' HA2' ' A' ' 62' ' ' GLY . 32.1 t -134.77 157.68 46.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.67 148.31 40.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.42 173.06 14.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tp -124.75 126.66 46.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.702 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.44 ' HB3' ' HB1' ' A' ' 88' ' ' ALA . . . -117.51 163.32 16.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 57' ' ' THR . 2.3 tt -158.71 176.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.77 34.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.462 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 p -164.13 160.03 20.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.45 176.26 29.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.217 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.498 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 5.0 t80 -143.27 127.0 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 111.159 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.483 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.63 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 7.2 p -83.2 127.41 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.284 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.588 ' OD1' HG21 ' A' ' 77' ' ' VAL . 31.3 m120 61.15 162.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 51' ' ' VAL . 32.5 mt-10 -99.48 39.1 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.569 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.31 -52.21 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.25 169.85 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.53 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.53 165.24 12.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 111.29 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -139.25 168.73 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.564 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 85' ' ' ALA . 2.0 tmtp? -157.73 122.85 4.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -132.6 161.04 34.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.32 158.57 18.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.605 HG11 ' CZ ' ' A' ' 89' ' ' TYR . 7.0 p -124.91 130.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.522 ' HB3' ' HE2' ' A' ' 96' ' ' MET . . . -102.05 115.04 29.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.355 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.605 ' CZ ' HG11 ' A' ' 87' ' ' VAL . 77.9 m-85 -91.7 108.8 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -115.02 124.11 50.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.659 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.05 -85.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.67 -50.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.319 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.0 m -104.35 14.43 30.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.624 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 4.0 t70 -116.43 57.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -95.2 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.747 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 39' ' ' SER . 2.9 ptp -146.77 151.44 37.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -130.34 138.21 50.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.422 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.632 ' OD1' ' HB1' ' C' ' 40' ' ' ALA . 8.3 m-80 -132.56 137.15 47.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 111.404 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.32 95.64 2.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.716 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.572 ' HB3' HD13 ' C' ' 45' ' ' LEU . 29.6 m -125.95 161.5 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 8.6 p90 -127.67 145.48 50.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.027 0.442 . . . . 0.0 111.044 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.543 ' ND2' ' HD3' ' C' ' 48' ' ' PRO . 1.8 p-10 -120.0 153.08 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.86 134.91 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.856 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' C' ' 49' ' ' TYR . 18.2 pm0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.534 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 2.8 mmpt? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.68 0.276 . . . . 0.0 110.566 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -68.66 -31.25 70.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.259 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -63.11 -58.71 6.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.769 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -36.19 83.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.406 HD12 HD23 ' C' ' 21' ' ' LEU . 12.1 mt -60.04 -47.47 85.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.601 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -66.81 -32.26 73.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.836 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.48 34.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.757 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.74 -33.34 72.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.632 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -73.73 -41.24 62.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.802 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -63.02 -42.08 99.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.241 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -62.89 -50.26 71.59 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.491 ' HB2' HD23 ' C' ' 28' ' ' LEU . 0.8 OUTLIER -56.61 -29.16 61.83 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.942 178.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.11 -40.57 37.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.863 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.47 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.6 mpt_? -60.81 -32.68 72.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 6.4 m -80.06 -28.98 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.172 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -51.94 61.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 20.3 pttt -73.96 -39.44 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.717 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.35 -36.15 92.34 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.534 ' HG ' HD23 ' A' ' 36' ' ' LEU . 5.8 mt -73.54 -31.18 63.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.787 0.327 . . . . 0.0 111.045 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.08 -45.17 35.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.379 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.466 ' HB3' ' HE2' ' B' ' 96' ' ' MET . 22.7 t -63.9 -44.87 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.537 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 11.5 t -59.17 -46.46 88.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.619 ' HB1' ' OD1' ' C' ' 98' ' ' ASN . . . -67.2 -29.07 68.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.483 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.442 ' HB3' ' HA3' ' B' ' 61' ' ' GLY . . . -65.11 -39.89 93.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.01 -39.0 51.89 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -72.01 -15.97 62.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.6 -32.96 74.63 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.08 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.573 HD13 ' HB3' ' C' ' 100' ' ' SER . 1.0 OUTLIER -64.29 143.71 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.929 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 34.6 p90 -112.73 -42.48 3.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.467 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' B' ' 46' ' ' PHE . 33.8 mt-30 70.29 109.47 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' ND2' ' C' ' 102' ' ' ASN 0.257 9.8 Cg_endo -75.3 -161.15 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.632 2.222 . . . . 0.0 112.61 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 17.5 m-30 68.16 167.05 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.969 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' B' ' 76' ' ' ARG . . . 178.37 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.201 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.482 ' HA ' ' HG3' ' B' ' 79' ' ' GLU . 9.7 p -88.83 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.187 0.595 . . . . 0.0 112.409 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.34 69.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.317 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -143.79 -178.1 5.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.508 ' HB ' ' CE2' ' B' ' 75' ' ' TYR . 10.1 p -119.08 142.14 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.537 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.483 ' N ' HG22 ' B' ' 54' ' ' VAL . 1.7 m-80 -124.99 178.03 5.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.657 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.583 ' HB2' ' CH2' ' C' ' 105' ' ' TRP . 11.4 t80 -151.42 143.46 23.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.276 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.52 ' HB ' HD21 ' B' ' 45' ' ' LEU . 30.2 p -117.38 142.09 47.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.93 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -177.52 127.81 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.479 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -179.26 -165.17 33.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.08 154.61 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 111.343 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' B' ' 41' ' ' ALA . . . -134.4 171.77 22.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.487 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' B' ' 66' ' ' SER . . . -156.77 141.3 7.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.409 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 84.2 t80 -135.59 110.84 8.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.124 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.65 37.86 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.438 ' O ' ' HA2' ' B' ' 62' ' ' GLY . 32.0 t -134.83 157.62 46.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.64 148.32 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.139 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.03 15.04 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tp -124.67 126.73 46.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.756 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.436 ' HB3' ' HB1' ' B' ' 88' ' ' ALA . . . -117.58 163.37 16.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.623 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.473 HG13 ' O ' ' B' ' 57' ' ' THR . 2.3 tt -158.78 176.04 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.154 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.62 -167.82 34.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.36 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 16.6 p -164.16 160.04 20.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.46 176.37 29.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.158 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 5.0 t80 -143.36 126.9 16.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 111.17 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.47 ' O ' ' HA2' ' B' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.33 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.628 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 7.3 p -83.26 127.44 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.592 ' OD1' HG21 ' B' ' 77' ' ' VAL . 31.3 m120 61.04 162.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.482 ' HG3' ' HA ' ' B' ' 51' ' ' VAL . 32.5 mt-10 -99.47 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.6 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.25 -52.23 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.29 169.83 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.57 165.21 12.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.22 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' B' ' 101' ' ' PHE . 0.6 OUTLIER -139.16 168.75 19.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.54 ' HD3' ' N ' ' B' ' 85' ' ' ALA . 2.0 tmtp? -157.8 122.89 4.43 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.54 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -132.65 161.01 35.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.11 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.63 18.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.633 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.612 HG11 ' CZ ' ' B' ' 89' ' ' TYR . 7.1 p -124.97 130.69 73.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.347 . . . . 0.0 111.149 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.508 ' HB3' ' HE2' ' B' ' 96' ' ' MET . . . -102.03 115.15 29.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.32 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . 0.612 ' CZ ' HG11 ' B' ' 87' ' ' VAL . 77.7 m-85 -91.72 108.82 20.18 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.194 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.626 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . . . -115.12 124.15 50.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.08 -85.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.282 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.61 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.391 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.4 14.33 30.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.164 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.626 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 3.9 t70 -116.31 57.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.958 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' B' ' 89' ' ' TYR . 0.3 OUTLIER -95.26 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.699 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.537 ' SD ' ' HB2' ' B' ' 39' ' ' SER . 2.9 ptp -146.79 151.41 37.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.722 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -130.21 138.21 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.447 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.631 ' OD1' ' HB1' ' A' ' 40' ' ' ALA . 8.3 m-80 -132.58 137.22 47.0 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.781 0.324 . . . . 0.0 111.409 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.46 95.77 2.72 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.684 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.577 ' HB3' HD13 ' A' ' 45' ' ' LEU . 29.3 m -126.0 161.39 27.64 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.396 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 8.6 p90 -127.6 145.54 50.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.969 0.414 . . . . 0.0 111.049 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.545 ' ND2' ' HD3' ' A' ' 48' ' ' PRO . 1.8 p-10 -120.07 152.92 36.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.4 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.79 135.01 61.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.483 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 18.2 pm0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.513 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 2.8 mmpt? . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.692 0.282 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.72 -31.29 70.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -63.04 -58.7 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.79 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -36.21 83.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.406 HD23 HD12 ' B' ' 21' ' ' LEU . 12.1 mt -59.93 -47.48 85.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -66.91 -32.27 73.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.028 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -74.4 -47.53 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.751 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.63 -33.42 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.625 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -73.66 -41.3 62.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -62.98 -42.11 99.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.267 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.491 HD23 ' HB2' ' B' ' 29' ' ' ASP . 0.2 OUTLIER -62.8 -50.35 71.34 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.478 ' HB2' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.18 61.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.961 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 m -78.08 -40.62 37.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.475 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.6 mpt_? -60.84 -32.62 72.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' C' ' 36' ' ' LEU . 6.5 m -80.07 -28.92 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -51.76 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 20.3 pttt -74.08 -39.32 63.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.815 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.13 92.24 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.527 ' HG ' HD23 ' B' ' 36' ' ' LEU . 5.8 mt -73.55 -31.18 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.328 . . . . 0.0 111.085 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.21 35.97 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.429 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.479 ' HB3' ' HE2' ' C' ' 96' ' ' MET . 22.9 t -63.95 -44.88 91.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.736 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.54 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 11.6 t -59.12 -46.46 88.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.632 ' HB1' ' OD1' ' A' ' 98' ' ' ASN . . . -67.31 -29.04 68.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.444 ' HB3' ' HA3' ' C' ' 61' ' ' GLY . . . -65.13 -39.85 93.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.06 -38.92 51.62 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -72.12 -15.99 61.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.59 -32.92 74.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 100' ' ' SER . 1.0 OUTLIER -64.24 143.74 57.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.888 177.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 34.6 p90 -112.78 -42.46 3.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.121 0.486 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' C' ' 46' ' ' PHE . 33.8 mt-30 70.3 109.44 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.958 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.543 ' HD3' ' ND2' ' A' ' 102' ' ' ASN 0.257 9.9 Cg_endo -75.24 -161.2 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.707 2.272 . . . . 0.0 112.633 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.482 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 17.5 m-30 68.1 167.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.4 -3.19 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.194 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.496 ' HA ' ' HG3' ' C' ' 79' ' ' GLU . 9.5 p -88.86 -34.72 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.136 0.574 . . . . 0.0 112.393 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.34 69.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.306 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -143.72 -178.11 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.539 0.209 . . . . 0.0 110.642 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.498 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 10.2 p -119.04 142.12 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.533 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.465 ' N ' HG22 ' C' ' 54' ' ' VAL . 1.7 m-80 -124.94 178.1 5.69 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.695 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -151.46 143.38 23.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.231 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.514 ' HB ' HD21 ' C' ' 45' ' ' LEU . 30.1 p -117.31 142.1 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -177.54 127.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.486 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -179.28 -165.26 33.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.551 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.0 154.7 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 111.368 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' C' ' 41' ' ' ALA . . . -134.46 171.73 22.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.472 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' C' ' 66' ' ' SER . . . -156.79 141.25 7.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.575 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 84.3 t80 -135.5 110.83 9.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.334 . . . . 0.0 110.728 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.79 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.168 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.68 37.82 1.34 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.142 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' SER . . . . . 0.45 ' O ' ' HA2' ' C' ' 62' ' ' GLY . 32.1 t -134.8 157.69 46.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.83 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.76 148.31 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.38 173.03 15.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.602 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 8.3 tp -124.69 126.61 45.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.766 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.422 ' HB3' ' HB1' ' C' ' 88' ' ' ALA . . . -117.52 163.27 16.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.694 0.283 . . . . 0.0 111.683 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.467 HG13 ' O ' ' C' ' 57' ' ' THR . 2.3 tt -158.64 176.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.318 . . . . 0.0 111.105 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.79 34.69 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.466 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.0 p -164.09 160.05 21.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.038 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.47 176.35 29.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.234 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.498 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 5.0 t80 -143.32 126.94 16.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 111.151 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.474 ' O ' ' HA2' ' C' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.736 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.617 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 7.3 p -83.19 127.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.998 0.427 . . . . 0.0 111.291 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.598 ' OD1' HG21 ' C' ' 77' ' ' VAL . 31.3 m120 61.14 162.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.088 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' C' ' 51' ' ' VAL . 32.5 mt-10 -99.49 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 2.6 m -121.33 -52.17 2.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.987 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.2 169.82 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.572 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.5 165.23 12.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' C' ' 101' ' ' PHE . 0.6 OUTLIER -139.19 168.79 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.626 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 2.0 tmtp? -157.85 122.76 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . 0.524 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -132.53 161.04 34.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.66 19.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.552 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.607 HG11 ' CZ ' ' C' ' 89' ' ' TYR . 7.0 p -124.93 130.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.523 ' HB3' ' HE2' ' C' ' 96' ' ' MET . . . -102.0 115.07 29.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.307 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . 0.607 ' CZ ' HG11 ' C' ' 87' ' ' VAL . 77.8 m-85 -91.72 108.73 20.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' C' ' 94' ' ' ASP . . . -114.98 124.14 50.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.6 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -85.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.263 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 82.8 p -166.67 -50.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.309 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.35 14.35 30.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.221 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 4.0 t70 -116.42 57.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' C' ' 89' ' ' TYR . 0.3 OUTLIER -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.696 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.54 ' SD ' ' HB2' ' C' ' 39' ' ' SER . 2.9 ptp -146.78 151.38 37.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.711 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -130.2 138.29 50.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.439 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.619 ' OD1' ' HB1' ' B' ' 40' ' ' ALA . 8.2 m-80 -132.63 137.06 46.88 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.31 95.66 2.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.573 ' HB3' HD13 ' B' ' 45' ' ' LEU . 28.7 m -125.88 161.44 27.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.474 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' C' ' 83' ' ' LEU . 8.6 p90 -127.6 145.51 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.956 0.408 . . . . 0.0 111.085 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.54 ' ND2' ' HD3' ' B' ' 48' ' ' PRO . 1.8 p-10 -120.08 152.98 36.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.387 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.79 135.01 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.49 ' HB2' ' CE2' ' B' ' 49' ' ' TYR . 18.3 pm0 -120.1 132.45 55.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . 0.583 ' CH2' ' HB2' ' B' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.59 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.704 0.288 . . . . 0.0 110.514 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.82 -38.78 70.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.301 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.16 -61.81 1.83 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.27 -30.14 59.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.1 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.623 HD23 HD23 ' C' ' 21' ' ' LEU . 2.6 tm? -64.62 -60.46 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.603 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -65.03 -23.77 67.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -63.91 -54.12 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.3 mtp85 -69.78 -37.94 76.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.792 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HG ' ' HE ' ' B' ' 24' ' ' ARG . 3.6 mm? -63.88 -44.71 92.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.605 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.89 -33.19 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HG2' ' HD3' ' A' ' 31' ' ' ARG . 1.2 ttpp -67.91 -37.66 81.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.212 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -45.48 81.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -60.12 -36.55 77.73 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.859 179.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.86 -30.35 56.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.517 ' HD3' ' HG2' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -78.47 -27.18 46.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.28 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 29' ' ' ASP . 27.3 m -84.61 -32.39 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.21 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.504 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 55.6 m-20 -69.0 -43.91 73.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.989 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 5.0 ptpt -84.46 -30.22 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.0 -41.73 86.82 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.422 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.618 HD21 ' HG ' ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.81 -22.82 42.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.712 ' HB3' ' HA2' ' A' ' 62' ' ' GLY . . . -76.61 -39.77 51.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.419 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.925 ' HB3' ' HE1' ' A' ' 96' ' ' MET . 8.6 t -77.64 -39.86 43.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.745 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.42 ' HG ' ' HB1' ' C' ' 40' ' ' ALA . 0.9 OUTLIER -60.06 -55.46 33.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB3' HD22 ' B' ' 98' ' ' ASN . . . -58.87 -39.16 80.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.374 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.47 71.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.958 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 28.3 tp -76.62 -42.21 43.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.093 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.434 ' HB3' ' CB ' ' C' ' 43' ' ' ASN . 32.4 m-20 -70.63 -9.86 57.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.486 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 41.7 t -69.26 -20.65 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.1 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.3 mm? -83.05 169.93 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.833 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.4 -1.66 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 0.0 111.727 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.58 ' OE1' ' HG2' ' A' ' 84' ' ' LYS . 6.0 mt-30 68.49 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.967 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -78.82 109.16 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.56 2.174 . . . . 0.0 112.527 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 59.57 177.48 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.74 50.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.191 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.7 p -71.58 -1.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.166 0.586 . . . . 0.0 112.407 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 143.63 53.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.254 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 -165.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.572 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 74' ' ' GLY . 9.9 p -114.7 142.17 28.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.534 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 47' ' ' GLN . 12.8 m-80 -122.03 118.73 29.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 111.756 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.52 ' CE2' HD12 ' A' ' 71' ' ' ILE . 30.1 t80 -84.84 131.67 34.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.267 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.492 HG23 ' HB3' ' A' ' 45' ' ' LEU . 40.9 p -113.72 121.2 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.9 136.99 18.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.486 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.15 166.51 33.58 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.555 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.0 m -116.43 158.13 17.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 111.304 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.98 -171.43 13.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.484 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.712 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -168.2 141.48 6.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.615 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.516 ' CE1' ' HE2' ' B' ' 96' ' ' MET . 52.0 t80 -135.81 133.06 37.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 0.0 110.789 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 3.1 mmm180 69.52 -94.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 p -144.67 29.22 1.25 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.408 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 5.1 m -135.9 141.72 44.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.73 157.9 17.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.129 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.72 169.04 20.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.572 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.62 54.58 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.735 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -126.52 139.2 53.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.677 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.52 HD12 ' CE2' ' A' ' 56' ' ' PHE . 10.7 tp -141.07 147.91 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.763 0.316 . . . . 0.0 111.128 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.42 -179.68 42.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.402 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.403 ' HB2' ' HA ' ' A' ' 56' ' ' PHE . 1.2 p -166.76 158.59 13.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.496 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -148.23 171.7 28.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.216 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 39.6 t80 -126.37 138.58 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 0.0 111.113 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.558 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 13.7 ttm180 -131.41 134.7 46.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.581 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.8 p -120.9 140.86 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.318 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.0 m-20 64.79 -94.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.072 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.606 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -73.35 -63.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.27 139.64 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.558 ' HB2' ' HG3' ' A' ' 76' ' ' ARG . . . -138.29 156.15 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.532 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 30.3 tp -136.93 141.75 42.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.621 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.58 ' HG2' ' OE1' ' A' ' 47' ' ' GLN . 7.9 tmtt? -153.39 128.71 9.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.71 175.86 11.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.06 -173.45 34.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.593 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' ILE . 7.7 p -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 111.131 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.6 144.68 41.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.329 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.6 120.48 40.31 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.244 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 34' ' ' LYS . . . -127.8 131.07 49.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.605 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.21 -114.44 5.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.301 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.8 m -150.42 17.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.709 0.29 . . . . 0.0 111.331 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -167.24 19.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.192 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 34.0 m-20 -119.44 67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.31 138.01 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.043 0.449 . . . . 0.0 110.75 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.925 ' HE1' ' HB3' ' A' ' 38' ' ' SER . 4.4 ptp -134.84 134.62 40.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.684 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.81 122.46 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.403 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.517 HD22 ' HB3' ' C' ' 40' ' ' ALA . 15.5 m120 -108.24 150.51 27.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 0.0 111.389 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.47 90.58 0.48 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 19.3 m -118.98 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.465 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.43 135.06 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 111.059 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.718 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 73.9 m-80 -102.17 134.39 45.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.78 115.29 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.774 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.404 ' HB3' ' HA ' ' C' ' 55' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.734 0.302 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.77 -38.87 70.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.275 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.1 -61.83 1.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.24 -30.1 59.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.119 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.614 HD23 HD23 ' A' ' 21' ' ' LEU . 2.6 tm? -64.69 -60.44 3.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.592 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -65.06 -23.73 67.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -63.87 -54.15 39.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.942 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.494 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.4 mtp85 -69.79 -37.97 76.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.747 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.498 ' HG ' ' HE ' ' C' ' 24' ' ' ARG . 3.5 mm? -63.85 -44.67 92.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.661 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.97 -33.15 75.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.522 ' HG2' ' HD3' ' B' ' 31' ' ' ARG . 1.2 ttpp -67.95 -37.59 81.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.227 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.401 ' O ' HG12 ' B' ' 32' ' ' VAL . 0.0 OUTLIER -65.97 -45.52 81.42 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.583 ' O ' HG22 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -60.15 -36.49 77.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.939 178.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.94 -30.27 55.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.522 ' HD3' ' HG2' ' B' ' 27' ' ' LYS . 0.1 OUTLIER -78.42 -27.27 46.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.347 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 29' ' ' ASP . 27.4 m -84.65 -32.3 7.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.206 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.505 ' O ' ' HB1' ' B' ' 37' ' ' ALA . 55.8 m-20 -69.04 -43.9 73.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.989 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.615 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 4.9 ptpt -84.44 -30.24 25.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.765 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.75 87.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.435 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.618 ' HG ' HD21 ' A' ' 36' ' ' LEU . 1.0 OUTLIER -79.88 -22.85 42.37 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.723 ' HB3' ' HA2' ' B' ' 62' ' ' GLY . . . -76.61 -39.75 51.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.465 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.92 ' HB3' ' HE1' ' B' ' 96' ' ' MET . 8.6 t -77.56 -39.96 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.417 ' HG ' ' HB1' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -59.89 -55.56 32.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.515 ' HB3' HD22 ' C' ' 98' ' ' ASN . . . -58.92 -39.09 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.363 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.46 71.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.5 ' HA ' HD11 ' B' ' 42' ' ' LEU . 28.1 tp -76.63 -42.16 43.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.429 ' HB3' ' CB ' ' A' ' 43' ' ' ASN . 32.5 m-20 -70.67 -9.87 58.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.471 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 41.6 t -69.38 -20.51 63.82 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.107 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.52 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.3 mm? -83.09 169.85 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.849 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.29 -1.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.191 0.52 . . . . 0.0 111.665 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.592 ' OE1' ' HG2' ' B' ' 84' ' ' LYS . 6.0 mt-30 68.54 116.95 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.984 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.733 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.69 109.0 2.53 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.723 2.282 . . . . 0.0 112.557 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.81 50.72 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.31 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.8 p -71.5 -1.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.158 0.583 . . . . 0.0 112.412 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 143.65 53.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.265 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.8 -165.26 1.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 110.653 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.497 HG23 ' O ' ' B' ' 74' ' ' GLY . 9.9 p -114.71 142.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.584 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' B' ' 47' ' ' GLN . 12.9 m-80 -122.03 118.76 29.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.703 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.521 ' CE2' HD12 ' B' ' 71' ' ' ILE . 30.2 t80 -84.86 131.63 34.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.226 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.489 HG23 ' HB3' ' B' ' 45' ' ' LEU . 40.9 p -113.72 121.25 43.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.976 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.87 137.02 18.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.447 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.13 166.43 33.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.576 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' B' ' 69' ' ' LEU . 7.0 m -116.32 158.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.816 0.341 . . . . 0.0 111.388 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.5 13.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.41 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . 0.723 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -168.08 141.43 6.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.622 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.524 ' CE1' ' HE2' ' C' ' 96' ' ' MET . 52.1 t80 -135.73 133.17 37.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.739 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 3.1 mmm180 69.5 -94.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 15.2 p -144.67 29.23 1.25 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.138 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 5.1 m -136.0 141.72 44.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.69 157.93 17.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.094 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.76 169.03 20.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.578 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.66 54.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.751 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.684 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' B' ' 56' ' ' PHE . 10.7 tp -140.97 147.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.41 -179.62 42.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' B' ' 56' ' ' PHE . 1.2 p -166.87 158.6 12.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.497 ' O ' HG23 ' B' ' 54' ' ' VAL . . . -148.25 171.69 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.531 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 39.7 t80 -126.3 138.61 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 111.197 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.559 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 13.7 ttm180 -131.44 134.72 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.58 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.8 p -120.98 140.87 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.256 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 97.1 m-20 64.73 -94.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.916 0.389 . . . . 0.0 111.111 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 5.6 pt-20 177.11 -23.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 23.9 p -73.39 -63.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.013 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.3 139.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' B' ' 76' ' ' ARG . . . -138.36 156.1 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.316 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.531 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 30.2 tp -136.91 141.76 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.621 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.592 ' HG2' ' OE1' ' B' ' 47' ' ' GLN . 8.0 tmtt? -153.42 128.68 9.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.148 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.81 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.14 -173.43 34.06 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' B' ' 71' ' ' ILE . 7.7 p -141.56 143.47 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.65 144.7 41.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.373 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -114.61 120.51 40.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.266 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' B' ' 34' ' ' LYS . . . -127.85 130.94 49.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.649 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.615 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.37 -114.43 5.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.287 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -150.51 17.44 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.802 0.334 . . . . 0.0 111.296 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -167.18 18.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.205 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -119.38 67.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.971 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.3 137.99 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 110.655 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.92 ' HE1' ' HB3' ' B' ' 38' ' ' SER . 4.4 ptp -134.86 134.66 40.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.708 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -109.89 122.47 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.433 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.525 HD22 ' HB3' ' A' ' 40' ' ' ALA . 15.6 m120 -108.19 150.37 27.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.718 0.294 . . . . 0.0 111.416 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.36 90.59 0.49 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.774 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 19.3 m -119.01 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.373 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -143.42 135.12 26.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.732 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 73.8 m-80 -102.24 134.27 45.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.392 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.68 115.26 10.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.83 0.347 . . . . 0.0 110.779 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.725 0.298 . . . . 0.0 110.522 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -38.83 69.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.191 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.09 -61.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.35 -30.03 59.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.623 HD23 HD23 ' A' ' 21' ' ' LEU . 2.6 tm? -64.58 -60.55 3.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.02 -23.71 67.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.993 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.03 -54.09 39.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.498 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.3 mtp85 -69.69 -38.06 76.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.75 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.487 ' HG ' ' HE ' ' A' ' 24' ' ' ARG . 3.6 mm? -63.78 -44.8 92.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.566 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.85 -33.19 75.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.853 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.532 ' HG2' ' HD3' ' C' ' 31' ' ' ARG . 1.2 ttpp -67.92 -37.61 81.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.23 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -45.44 81.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.584 ' O ' HG22 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -60.17 -36.49 77.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.908 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.93 -30.36 56.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.532 ' HD3' ' HG2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -78.38 -27.28 46.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.288 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.584 HG22 ' O ' ' C' ' 29' ' ' ASP . 27.3 m -84.55 -32.42 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.249 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.503 ' O ' ' HB1' ' C' ' 37' ' ' ALA . 55.7 m-20 -68.95 -43.96 73.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.614 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 5.0 ptpt -84.42 -30.22 25.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.817 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -41.78 87.16 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.42 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.613 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.79 -22.86 42.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.727 ' HB3' ' HA2' ' C' ' 62' ' ' GLY . . . -76.58 -39.8 51.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.46 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.903 ' HB3' ' HE1' ' C' ' 96' ' ' MET . 8.6 t -77.63 -39.88 43.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.719 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.422 ' HG ' ' HB1' ' B' ' 40' ' ' ALA . 0.9 OUTLIER -59.95 -55.52 33.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.132 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.517 ' HB3' HD22 ' A' ' 98' ' ' ASN . . . -58.88 -39.02 80.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.469 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.4 71.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 28.6 tp -76.62 -42.31 42.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.434 ' CB ' ' HB3' ' A' ' 43' ' ' ASN . 32.1 m-20 -70.59 -9.9 58.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' SER . . . . . 0.487 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 41.7 t -69.22 -20.63 63.96 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.156 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.539 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.4 mm? -83.02 169.85 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.946 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -157.35 -1.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.219 0.533 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.591 ' OE1' ' HG2' ' C' ' 84' ' ' LYS . 6.0 mt-30 68.39 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.718 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.76 109.08 2.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.605 2.203 . . . . 0.0 112.582 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.002 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.77 50.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.235 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.7 p -71.49 -1.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.194 0.598 . . . . 0.0 112.483 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 143.58 53.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.282 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 -165.27 1.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.594 0.235 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.492 HG23 ' O ' ' C' ' 74' ' ' GLY . 9.9 p -114.68 142.17 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.598 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' C' ' 47' ' ' GLN . 12.9 m-80 -122.0 118.73 29.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.71 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . 0.519 ' CE2' HD12 ' C' ' 71' ' ' ILE . 29.9 t80 -84.74 131.68 34.53 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.296 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.486 HG23 ' HB3' ' C' ' 45' ' ' LEU . 40.8 p -113.78 121.21 43.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.91 136.99 18.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.1 166.43 33.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.572 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' C' ' 69' ' ' LEU . 7.0 m -116.33 158.14 16.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 111.371 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.41 13.44 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.465 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . 0.727 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -168.15 141.52 6.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.518 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.521 ' CE1' ' HE2' ' A' ' 96' ' ' MET . 52.2 t80 -135.8 133.04 37.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.276 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.1 mmm180 69.53 -94.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 15.0 p -144.68 29.19 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 5.0 m -135.93 141.69 44.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.68 157.99 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.73 169.07 20.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.565 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.551 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -123.36 138.61 54.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.749 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -126.5 139.2 53.41 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.655 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.519 HD12 ' CE2' ' C' ' 56' ' ' PHE . 10.7 tp -141.03 147.97 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.747 0.308 . . . . 0.0 111.085 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.4 -179.65 42.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' C' ' 56' ' ' PHE . 1.2 p -166.82 158.57 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.997 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . 0.492 ' O ' HG23 ' C' ' 54' ' ' VAL . . . -148.21 171.7 28.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.214 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 39.8 t80 -126.33 138.62 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.18 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 13.7 ttm180 -131.49 134.72 46.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.667 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.562 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.9 p -121.0 140.89 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 97.2 m-20 64.73 -94.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.56 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 23.8 p -73.42 -63.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.28 139.77 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.553 ' HB2' ' HG3' ' C' ' 76' ' ' ARG . . . -138.47 156.08 47.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.267 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.533 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 30.4 tp -136.91 141.69 42.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.591 ' HG2' ' OE1' ' C' ' 47' ' ' GLN . 8.0 tmtt? -153.41 128.69 9.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.91 11.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.051 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.05 -173.44 34.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.616 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' C' ' 71' ' ' ILE . 7.9 p -141.56 143.4 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.65 144.68 41.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -114.59 120.52 40.48 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.186 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' C' ' 34' ' ' LYS . . . -127.86 131.0 49.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.631 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.614 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.37 -114.46 5.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.263 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 62.1 m -150.43 17.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.759 0.314 . . . . 0.0 111.294 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -167.25 19.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.21 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -119.47 67.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.25 137.95 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.903 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 4.4 ptp -134.84 134.74 41.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.86 122.44 47.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.404 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.515 HD22 ' HB3' ' B' ' 40' ' ' ALA . 15.5 m120 -108.26 150.42 27.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.713 0.292 . . . . 0.0 111.447 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.37 90.57 0.49 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 19.3 m -119.01 172.22 7.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.407 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.44 135.18 26.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.733 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 73.9 m-80 -102.27 134.39 45.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.385 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 115.26 10.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 110.789 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.411 ' HB3' ' HA ' ' B' ' 55' ' ' ASN . 0.0 OUTLIER -115.22 157.4 23.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.672 179.665 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.68 0.276 . . . . 0.0 110.466 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.11 -30.5 66.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.19 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -63.26 -64.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.723 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 2.6 pp0? -64.0 -27.65 69.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.199 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 2.3 tm? -63.42 -69.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.541 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.46 -23.37 57.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.018 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.08 -47.99 66.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 47.7 mtp85 -70.87 -40.88 72.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 25' ' ' LEU . 2.3 mm? -57.29 -51.12 70.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.547 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.7 -39.44 84.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.549 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 1.1 ttpp -63.13 -37.12 85.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.207 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.549 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -60.93 -38.21 85.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.672 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -73.37 -30.56 63.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 178.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.47 -34.34 72.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -33.83 62.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 29' ' ' ASP . 33.4 m -78.02 -26.67 14.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.182 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.58 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 40.8 m-20 -71.93 -43.19 65.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.047 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 7.0 ptpt -82.88 -28.84 29.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.829 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.58 74.15 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.446 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.611 HD12 ' CE2' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -74.93 -29.61 61.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 111.158 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.621 ' HB3' ' HA2' ' A' ' 62' ' ' GLY . . . -71.17 -42.4 69.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.451 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.728 ' HB3' ' HE1' ' A' ' 96' ' ' MET . 11.5 t -74.73 -45.61 42.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.659 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.589 ' HG ' ' HB1' ' C' ' 40' ' ' ALA . 1.0 OUTLIER -58.42 -49.26 77.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -66.99 -36.87 83.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.456 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.03 85.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 35.9 tp -74.33 -40.88 61.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.016 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.603 ' ND2' ' HA ' ' C' ' 40' ' ' ALA . 63.5 m-20 -73.16 -9.74 59.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.5 t -69.03 -18.88 64.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.149 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 1.5 mm? -80.55 167.72 19.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.911 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -156.24 -3.39 0.12 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.641 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.5 ' HG2' HG22 ' A' ' 57' ' ' THR . 12.7 mt-30 66.2 122.29 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.998 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -84.02 104.66 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.599 2.199 . . . . 0.0 112.51 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 9.2 m-30 66.78 -179.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.959 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 170.37 55.49 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.236 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.3 p -74.68 -5.62 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.133 0.573 . . . . 0.0 112.451 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.56 56.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.369 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.83 -163.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.644 0.259 . . . . 0.0 110.616 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 55' ' ' ASN . 9.1 p -115.95 138.9 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.494 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' N ' HG23 ' A' ' 54' ' ' VAL . 15.3 m-80 -123.0 115.22 21.53 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 111.666 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.412 ' CE2' HD12 ' A' ' 71' ' ' ILE . 37.5 t80 -81.45 129.97 34.86 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.207 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.622 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.9 p -110.57 126.12 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.656 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -156.12 133.15 10.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.581 ' HA3' ' HB3' ' B' ' 100' ' ' SER . . . -175.25 171.43 44.56 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.57 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.06 159.59 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 111.318 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 -169.88 16.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.444 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -167.03 135.95 3.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.518 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.611 ' CE2' HD12 ' A' ' 36' ' ' LEU . 28.6 t80 -123.89 141.62 51.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 110.744 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HG3' ' OD1' ' A' ' 33' ' ' ASP . 2.5 mmm180 60.55 -95.63 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 p -142.34 24.31 1.95 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.34 142.03 50.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.82 156.37 18.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.14 168.67 22.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.598 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.15 138.26 54.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.796 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -131.99 139.2 48.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.671 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.656 HD12 ' HB1' ' A' ' 58' ' ' ALA . 5.5 tp -137.49 162.4 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.121 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.637 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 169.96 -176.07 43.84 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.404 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.78 3.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.01 27.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.268 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.574 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 54.4 t80 -126.4 130.92 51.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 0.0 111.11 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 10.9 ttm180 -122.32 120.88 35.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.777 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.2 p -108.04 140.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.256 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.598 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 38.7 m-20 62.9 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.077 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 p -72.37 -61.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.992 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.09 142.17 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.571 ' HB2' ' HG3' ' A' ' 76' ' ' ARG . . . -141.19 158.83 43.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.85 147.01 31.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.575 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -158.54 132.46 7.76 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.189 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.25 -179.73 8.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.081 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.407 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . 160.53 -173.1 37.04 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.545 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 71' ' ' ILE . 14.8 p -140.43 138.08 36.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.114 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.2 145.85 40.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.303 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.469 ' HH ' ' HA ' ' A' ' 92' ' ' SER . 34.2 t80 -118.48 115.58 24.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.248 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -123.01 131.14 53.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.669 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.538 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 63.46 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.263 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.469 ' HA ' ' HH ' ' A' ' 89' ' ' TYR . 49.9 m -149.28 9.17 0.74 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.329 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.57 25.18 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.219 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-20 -121.03 71.76 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.517 HG11 ' CE1' ' A' ' 97' ' ' TYR . 86.5 t -101.91 137.35 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.071 0.463 . . . . 0.0 110.695 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.728 ' HE1' ' HB3' ' A' ' 38' ' ' SER . 10.2 ptp -130.32 136.87 49.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.517 ' CE1' HG11 ' A' ' 95' ' ' VAL . 77.4 m-85 -112.33 121.95 46.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.361 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.48 154.96 25.07 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 111.419 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.783 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.602 ' HB3' ' HA3' ' C' ' 59' ' ' GLY . 12.8 m -113.83 168.85 9.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.406 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.72 140.7 47.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.955 0.407 . . . . 0.0 111.108 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.633 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 57.1 m-80 -108.6 132.1 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.3 117.49 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.851 0.357 . . . . 0.0 110.712 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.577 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.6 0.238 . . . . 0.0 110.471 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.18 -30.43 66.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.251 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -63.22 -64.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.629 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 2.6 pp0? -64.05 -27.66 69.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.102 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 2.3 tm? -63.36 -69.21 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.41 -23.39 57.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.009 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.02 -48.12 66.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' B' ' 20' ' ' GLN . 47.8 mtp85 -70.83 -40.87 72.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.802 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.468 HD23 ' N ' ' B' ' 25' ' ' LEU . 2.3 mm? -57.23 -51.11 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.636 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -59.68 -39.53 84.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.766 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.565 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 1.2 ttpp -63.15 -37.05 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.218 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.565 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -60.94 -38.21 85.05 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.672 ' O ' HG22 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -73.38 -30.62 63.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.905 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.41 -34.43 72.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -33.9 62.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.276 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.672 HG22 ' O ' ' B' ' 29' ' ' ASP . 33.3 m -77.95 -26.65 14.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.211 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.589 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 40.5 m-20 -71.96 -43.28 65.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.957 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.547 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 6.9 ptpt -82.88 -28.76 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.1 -38.58 73.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' B' ' 63' ' ' TYR . 0.5 OUTLIER -74.98 -29.63 60.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.765 0.317 . . . . 0.0 111.058 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.636 ' HB3' ' HA2' ' B' ' 62' ' ' GLY . . . -71.24 -42.31 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.459 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.715 ' HB3' ' HE1' ' B' ' 96' ' ' MET . 11.4 t -74.73 -45.57 43.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.75 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.587 ' HG ' ' HB1' ' A' ' 40' ' ' ALA . 1.1 t -58.45 -49.2 78.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.607 ' HB1' ' HG ' ' C' ' 39' ' ' SER . . . -67.08 -36.94 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.386 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.0 85.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' B' ' 70' ' ' ALA . 36.2 tp -74.41 -40.8 61.79 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.605 ' ND2' ' HA ' ' A' ' 40' ' ' ALA . 63.6 m-20 -73.16 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 29.4 t -69.05 -18.85 64.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.125 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.603 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 1.6 mm? -80.59 167.7 19.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.889 177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.24 -3.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.131 0.491 . . . . 0.0 111.649 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.514 ' HG2' HG22 ' B' ' 57' ' ' THR . 12.7 mt-30 66.37 122.19 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.956 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -84.0 104.68 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.572 2.181 . . . . 0.0 112.548 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 9.1 m-30 66.8 -179.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 170.37 55.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.252 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.3 p -74.66 -5.67 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.103 0.561 . . . . 0.0 112.454 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.783 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.64 56.11 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.228 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 -163.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.432 HG23 ' N ' ' B' ' 55' ' ' ASN . 9.1 p -115.94 138.9 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.518 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.432 ' N ' HG23 ' B' ' 54' ' ' VAL . 15.4 m-80 -122.93 115.15 21.44 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 111.669 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.484 ' HB2' ' HZ3' ' C' ' 105' ' ' TRP . 37.6 t80 -81.37 130.01 34.86 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.603 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.8 p -110.57 126.09 54.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.959 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.635 ' HB1' HD12 ' B' ' 71' ' ' ILE . . . -156.15 133.24 10.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.403 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.589 ' HA3' ' HB3' ' C' ' 100' ' ' SER . . . -175.33 171.44 44.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.573 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -126.02 159.52 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.16 -169.81 16.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.454 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . 0.636 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -167.1 135.85 3.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.595 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.615 ' CE2' HD12 ' B' ' 36' ' ' LEU . 28.6 t80 -123.8 141.65 51.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.725 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' OD1' ' B' ' 33' ' ' ASP . 2.5 mmm180 60.49 -95.7 0.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 16.8 p -142.26 24.33 1.96 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.23 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.35 141.98 50.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.78 156.39 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 168.71 22.57 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.13 138.31 54.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.782 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -131.97 139.15 48.56 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.635 HD12 ' HB1' ' B' ' 58' ' ' ALA . 5.5 tp -137.5 162.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 111.113 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.608 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 170.02 -176.0 43.89 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.452 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.8 p -170.02 150.72 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.991 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.09 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.239 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.572 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 54.5 t80 -126.38 130.97 51.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 111.159 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.573 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 11.0 ttm180 -122.47 120.96 35.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.783 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.2 p -108.04 140.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 38.5 m-20 62.9 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 176.0 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.567 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.46 -61.43 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 16.3 m -89.11 142.27 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.573 ' HB2' ' HG3' ' B' ' 76' ' ' ARG . . . -141.21 158.85 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.207 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.9 146.98 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -158.49 132.39 7.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.22 -179.72 8.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.074 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.405 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 160.53 -173.11 37.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.61 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.492 ' O ' HG23 ' B' ' 71' ' ' ILE . 14.9 p -140.44 137.99 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.15 145.96 40.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.294 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . 0.47 ' HH ' ' HA ' ' B' ' 92' ' ' SER . 34.3 t80 -118.59 115.6 24.89 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.221 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -123.01 131.24 53.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.547 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 63.31 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.262 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' SER . . . . . 0.47 ' HA ' ' HH ' ' B' ' 89' ' ' TYR . 50.0 m -149.23 9.17 0.74 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.355 . . . . 0.0 111.343 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.61 25.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.184 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 19.1 m-20 -121.09 71.79 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.527 HG11 ' CE1' ' B' ' 97' ' ' TYR . 87.4 t -101.89 137.36 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 110.657 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.715 ' HE1' ' HB3' ' B' ' 38' ' ' SER . 10.2 ptp -130.36 136.89 49.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.652 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . 0.527 ' CE1' HG11 ' B' ' 95' ' ' VAL . 77.7 m-85 -112.4 121.87 46.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.387 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -112.41 154.91 25.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.482 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.18 88.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.762 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.581 ' HB3' ' HA3' ' A' ' 59' ' ' GLY . 12.7 m -113.7 168.91 9.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.446 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.82 140.63 47.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 111.074 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.642 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 57.2 m-80 -108.59 131.96 54.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.373 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.14 117.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.859 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.733 0.301 . . . . 0.0 110.556 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.98 -30.59 66.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.306 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 43.6 mtt-85 -63.16 -64.09 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.771 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . 0.641 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 2.6 pp0? -64.07 -27.71 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.108 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 2.3 tm? -63.44 -69.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.554 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -58.54 -23.28 57.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.017 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.11 -48.01 66.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.641 ' HG3' ' O ' ' C' ' 20' ' ' GLN . 48.1 mtp85 -70.89 -40.83 71.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.775 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.466 HD13 HD22 ' A' ' 28' ' ' LEU . 2.3 mm? -57.31 -51.1 70.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.67 -39.52 84.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.803 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.559 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 1.2 ttpp -63.12 -37.08 85.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.192 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.559 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -61.01 -38.06 84.75 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.667 ' O ' HG22 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -73.43 -30.68 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.92 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.34 -34.47 72.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.848 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -33.9 62.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.322 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.667 HG22 ' O ' ' C' ' 29' ' ' ASP . 33.4 m -77.94 -26.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.579 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 40.2 m-20 -71.96 -43.21 65.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.552 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 6.9 ptpt -82.84 -28.87 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.799 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.99 -38.6 74.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.475 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.605 HD12 ' CE2' ' C' ' 63' ' ' TYR . 0.5 OUTLIER -74.96 -29.65 60.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.819 0.342 . . . . 0.0 111.067 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.64 ' HB3' ' HA2' ' C' ' 62' ' ' GLY . . . -71.27 -42.26 68.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.429 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.706 ' HB3' ' HE1' ' C' ' 96' ' ' MET . 11.5 t -74.77 -45.54 43.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.607 ' HG ' ' HB1' ' B' ' 40' ' ' ALA . 1.0 OUTLIER -58.5 -49.2 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.083 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.603 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -67.1 -36.81 82.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.428 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.97 85.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.906 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 36.0 tp -74.35 -40.83 61.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.599 ' ND2' ' HA ' ' B' ' 40' ' ' ALA . 63.5 m-20 -73.21 -9.67 58.96 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.2 t -69.16 -18.71 63.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 1.5 mm? -80.65 167.69 19.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.872 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.18 -3.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 111.702 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.516 ' HG2' HG22 ' C' ' 57' ' ' THR . 12.7 mt-30 66.31 122.27 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -84.04 104.71 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.573 2.182 . . . . 0.0 112.528 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 9.2 m-30 66.73 -179.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 170.42 55.56 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.201 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.2 p -74.7 -5.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.197 0.599 . . . . 0.0 112.445 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.763 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.51 56.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.323 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 -163.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.656 0.265 . . . . 0.0 110.597 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.431 HG23 ' N ' ' C' ' 55' ' ' ASN . 9.1 p -115.88 138.83 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.584 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.431 ' N ' HG23 ' C' ' 54' ' ' VAL . 15.4 m-80 -122.98 115.18 21.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.022 0.439 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . 0.421 ' CE2' HD12 ' C' ' 71' ' ' ILE . 37.7 t80 -81.45 129.96 34.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.238 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.622 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 45.7 p -110.56 126.07 54.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . 0.65 ' HB1' HD12 ' C' ' 71' ' ' ILE . . . -156.05 133.21 10.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.45 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' ' 100' ' ' SER . . . -175.31 171.5 44.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.588 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -126.12 159.55 34.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.336 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.19 -169.87 16.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.478 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -167.08 135.96 3.91 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.52 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.605 ' CE2' HD12 ' C' ' 36' ' ' LEU . 28.7 t80 -123.87 141.66 51.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.674 0.273 . . . . 0.0 110.816 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.428 ' HG3' ' OD1' ' C' ' 33' ' ' ASP . 2.5 mmm180 60.44 -95.61 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.097 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -142.32 24.35 1.95 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.164 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.3 141.98 50.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.76 156.43 18.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.23 168.61 22.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.605 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.08 138.32 54.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.787 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -132.0 139.19 48.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.633 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.65 HD12 ' HB1' ' C' ' 58' ' ' ALA . 5.5 tp -137.5 162.46 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.634 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 169.97 -176.09 43.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.477 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.7 3.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.1 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.224 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.573 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 54.6 t80 -126.38 130.94 51.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 111.097 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.559 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 10.9 ttm180 -122.35 120.92 35.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.743 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.763 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.2 p -108.08 140.69 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.292 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 38.6 m-20 62.91 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.556 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.36 -61.56 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.953 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.08 142.26 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.497 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' C' ' 76' ' ' ARG . . . -141.21 158.82 43.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.268 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.88 146.99 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -158.49 132.4 7.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.169 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.23 -179.67 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.53 -173.06 37.04 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.552 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.479 ' O ' HG23 ' C' ' 71' ' ' ILE . 14.8 p -140.4 138.06 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 111.164 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.2 145.94 40.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . 0.469 ' HH ' ' HA ' ' C' ' 92' ' ' SER . 34.1 t80 -118.59 115.62 24.93 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.188 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -123.11 131.13 53.57 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.574 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.552 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 63.45 -112.4 4.94 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.213 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' SER . . . . . 0.469 ' HA ' ' HH ' ' C' ' 89' ' ' TYR . 49.8 m -149.29 9.19 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 111.297 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.62 25.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.573 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 19.4 m-20 -121.0 71.8 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . 0.531 HG11 ' CE1' ' C' ' 97' ' ' TYR . 86.8 t -101.86 137.39 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 0.0 110.663 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.706 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 10.2 ptp -130.35 136.82 49.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . 0.531 ' CE1' HG11 ' C' ' 95' ' ' VAL . 78.0 m-85 -112.33 121.96 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.435 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.45 154.92 25.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.456 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.66 0.15 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.767 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.589 ' HB3' ' HA3' ' B' ' 59' ' ' GLY . 12.6 m -113.71 168.91 9.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.47 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -133.79 140.54 47.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.085 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.631 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 56.9 m-80 -108.49 132.03 54.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.392 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.19 117.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.727 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.65 161.18 20.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . 0.484 ' HZ3' ' HB2' ' B' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.675 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HZ1' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.671 0.272 . . . . 0.0 110.523 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.503 ' HA ' ' HZ1' ' B' ' 17' ' ' LYS . 82.1 t80 -60.94 -31.5 71.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.193 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 32.2 mmt180 -75.58 -30.06 59.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.597 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 29.5 mt-30 -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.11 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.47 -50.28 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 22.8 m-20 -71.98 -19.97 61.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 12.9 t-20 -77.4 -41.22 40.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 3.6 mmp_? -71.58 -46.25 59.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.559 HD11 ' HD3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.67 94.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.73 -28.98 66.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.805 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -75.96 -38.1 57.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.241 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.586 ' O ' HG21 ' A' ' 32' ' ' VAL . 8.0 mt -76.5 -34.8 58.61 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -66.76 -47.21 72.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 9.7 t -71.63 -40.19 69.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 21.2 ttp85 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.348 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.586 HG21 ' O ' ' A' ' 28' ' ' LEU . 28.4 m -76.61 -27.67 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.567 ' OD2' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t70 -64.08 -56.18 16.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.96 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.652 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 23.0 pttt -68.71 -37.63 79.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.826 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.67 -48.2 87.42 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.421 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.673 HD22 ' HB2' ' B' ' 39' ' ' SER . 0.4 OUTLIER -67.48 -31.69 72.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.801 0.334 . . . . 0.0 111.095 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -38.44 90.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.405 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.623 ' HG ' ' HE3' ' A' ' 96' ' ' MET . 78.7 p -79.96 -43.52 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.66 ' HB2' HD22 ' C' ' 36' ' ' LEU . 46.7 t -53.24 -60.95 2.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.7 -30.25 60.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.02 74.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -66.99 -32.91 74.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.123 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 1.4 m-20 -78.75 -13.63 59.71 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -19.08 65.68 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.134 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.792 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.2 mm? -75.55 158.57 32.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.9 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 47.3 p90 -146.47 -31.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.645 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 8.3 tt0 75.64 108.58 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.924 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -90.81 137.26 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.668 2.246 . . . . 0.0 112.576 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 14.5 m-85 67.56 154.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.574 ' CA ' ' HB3' ' A' ' 76' ' ' ARG . . . -173.94 73.06 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.228 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' CD ' ' A' ' 53' ' ' LYS . 11.4 p -95.88 -22.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.157 0.583 . . . . 0.0 112.521 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.765 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.89 48.99 0.02 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.301 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.49 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -143.76 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.576 0.227 . . . . 0.0 110.57 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.41 143.4 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.557 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.475 HD22 ' HB3' ' B' ' 102' ' ' ASN . 1.0 OUTLIER -135.14 116.49 14.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.03 0.443 . . . . 0.0 111.697 179.541 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -80.29 131.03 35.59 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.279 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.792 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 27.7 p -110.53 120.96 44.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.971 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.525 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -143.49 139.9 30.06 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.402 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.01 164.68 33.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.536 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.6 m -118.79 164.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.879 0.371 . . . . 0.0 111.282 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 67' ' ' GLN . . . -139.5 177.5 20.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.48 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.05 155.13 26.3 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.517 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.452 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 1.3 t80 -142.04 122.32 13.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 110.736 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.567 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 24.9 mtt-85 67.63 -93.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.107 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -131.89 9.49 4.55 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.167 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 22.9 t -109.93 173.88 6.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -135.31 -179.27 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.61 158.28 23.11 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.515 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 69' ' ' LEU . 3.9 tp -118.11 134.62 54.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.733 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.71 139.06 30.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.68 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.525 HD11 ' HB1' ' A' ' 58' ' ' ALA . 8.9 tp -138.33 150.55 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.718 0.295 . . . . 0.0 111.09 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.7 -177.26 37.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.2 p -160.23 155.26 24.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.61 30.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.242 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.42 120.58 17.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 111.147 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.574 ' HB3' ' CA ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.695 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.765 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 14.9 p -102.47 130.09 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 58.98 -171.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.97 66.02 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.3 p -160.07 -51.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.53 142.08 36.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.83 153.09 45.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 0.0 111.272 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 130.7 32.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.694 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.494 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -135.02 144.02 47.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.062 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.439 ' HA3' HD13 ' A' ' 42' ' ' LEU . . . 173.42 161.11 23.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.588 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.418 ' O ' HD21 ' A' ' 42' ' ' LEU . 4.3 p -130.39 150.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.79 140.68 52.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CD2' HG21 ' A' ' 95' ' ' VAL . 1.3 t80 -125.23 128.4 48.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.247 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 38' ' ' SER . . . -136.33 151.09 49.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.672 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.652 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 50.21 -99.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.256 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.33 -27.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.727 0.298 . . . . 0.0 111.308 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.5 p -123.75 15.03 9.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.2 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.469 ' CB ' ' HB1' ' A' ' 90' ' ' ALA . 41.6 m-20 -101.52 69.91 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.401 HG21 ' CD2' ' A' ' 89' ' ' TYR . 34.9 t -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.74 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.623 ' HE3' ' HG ' ' A' ' 38' ' ' SER . 1.3 ptp -135.2 139.48 44.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.771 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -117.56 129.91 56.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.454 ' ND2' ' HA3' ' C' ' 61' ' ' GLY . 15.1 m120 -129.27 145.43 51.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.661 0.267 . . . . 0.0 111.441 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.52 7.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.746 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.582 ' CB ' HD22 ' C' ' 45' ' ' LEU . 83.9 p -127.99 164.41 22.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.437 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.28 142.62 35.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.951 0.405 . . . . 0.0 111.096 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.512 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 17.0 m-80 -109.32 134.99 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.366 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.58 126.3 48.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.808 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' C' ' 55' ' ' ASN . 3.8 pt-20 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.503 ' HZ1' ' HA ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.655 0.264 . . . . 0.0 110.553 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . 0.504 ' HA ' ' HZ1' ' C' ' 17' ' ' LYS . 82.3 t80 -60.78 -31.53 70.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 111.296 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 32.4 mmt180 -75.66 -30.02 59.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 29.6 mt-30 -73.12 -37.04 66.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.159 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -50.24 68.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.569 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 22.7 m-20 -72.0 -19.99 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.971 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 13.0 t-20 -77.37 -41.2 41.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 3.6 mmp_? -71.54 -46.29 59.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.762 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.571 HD11 ' HD3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.65 94.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.75 -28.98 66.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.835 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -76.01 -37.99 57.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.251 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.587 ' O ' HG21 ' B' ' 32' ' ' VAL . 8.0 mt -76.62 -34.82 58.33 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -66.58 -47.35 73.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.942 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 9.7 t -71.66 -40.11 69.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.885 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.59 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 21.3 ttp85 -62.73 -38.3 89.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.297 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.587 HG21 ' O ' ' B' ' 28' ' ' LEU . 28.6 m -76.69 -27.68 17.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.178 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.564 ' OD2' ' HD2' ' B' ' 64' ' ' ARG . 10.4 t70 -64.0 -56.17 17.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.004 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.653 ' HD2' ' HA3' ' B' ' 91' ' ' GLY . 23.0 pttt -68.77 -37.56 79.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.06 88.12 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.425 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' C' ' 39' ' ' SER . 0.4 OUTLIER -67.64 -31.62 71.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 111.057 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.52 90.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.418 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.631 ' HG ' ' HE3' ' B' ' 96' ' ' MET . 78.4 p -79.93 -43.58 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.673 ' HB2' HD22 ' A' ' 36' ' ' LEU . 46.7 t -53.19 -60.88 2.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.75 -30.22 60.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.403 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.97 74.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' B' ' 42' ' ' LEU . 0.6 OUTLIER -67.04 -32.96 74.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 1.4 m-20 -78.79 -13.58 59.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.12 65.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.131 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.797 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.2 mm? -75.58 158.63 32.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.894 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.436 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 47.4 p90 -146.52 -30.99 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.169 0.509 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.444 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 8.3 tt0 75.45 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.978 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -90.79 137.16 2.25 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.208 . . . . 0.0 112.613 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 14.4 m-85 67.53 154.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.576 ' CA ' ' HB3' ' B' ' 76' ' ' ARG . . . -173.89 73.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.215 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.495 HG11 ' CD ' ' B' ' 53' ' ' LYS . 11.5 p -96.02 -22.88 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 123.162 0.585 . . . . 0.0 112.446 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.739 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.83 49.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.495 ' CD ' HG11 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.631 0.253 . . . . 0.0 110.546 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.43 143.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.571 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.466 HD22 ' HB3' ' C' ' 102' ' ' ASN . 1.0 OUTLIER -135.18 116.49 14.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 111.663 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -80.32 131.07 35.58 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.215 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.797 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 27.8 p -110.63 120.81 43.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.941 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.529 ' HB1' HD11 ' B' ' 71' ' ' ILE . . . -143.37 139.85 30.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.441 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.02 164.63 33.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.522 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -118.68 164.37 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.879 0.371 . . . . 0.0 111.293 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' B' ' 67' ' ' GLN . . . -139.57 177.47 20.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.482 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.0 155.12 26.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.469 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 1.3 t80 -142.05 122.34 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.564 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 25.1 mtt-85 67.59 -93.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.088 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.41 4.54 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.45 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 22.8 t -109.89 173.91 6.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.811 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.6 OUTLIER -135.32 -179.35 5.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.061 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.56 158.22 23.15 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.552 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' B' ' 69' ' ' LEU . 3.9 tp -118.02 134.64 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.72 139.03 30.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.694 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.529 HD11 ' HB1' ' B' ' 58' ' ' ALA . 8.9 tp -138.29 150.47 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.15 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.406 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -164.59 -177.19 37.02 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.423 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -160.28 155.22 24.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.58 30.06 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.235 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.4 120.52 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 111.108 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.576 ' HB3' ' CA ' ' B' ' 50' ' ' GLY . 0.0 OUTLIER -105.21 107.63 18.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.762 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.739 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 14.9 p -102.52 130.07 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 59.0 -171.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -118.99 66.01 0.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 69.9 p -160.03 -51.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.022 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.53 142.07 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.563 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.85 153.15 45.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.895 0.378 . . . . 0.0 111.245 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.57 130.71 32.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -135.09 143.95 46.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.21 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.496 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -148.28 169.11 20.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' B' ' 42' ' ' LEU . . . 173.37 161.02 22.92 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.553 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.426 ' O ' HD21 ' B' ' 42' ' ' LEU . 4.3 p -130.33 150.16 34.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.74 140.67 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.16 128.35 48.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.268 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 38' ' ' SER . . . -136.32 151.09 49.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.625 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.653 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 50.22 -99.64 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.307 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 25.9 t -152.28 -27.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 15.08 9.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.191 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.463 ' CB ' ' HB1' ' B' ' 90' ' ' ALA . 41.5 m-20 -101.59 69.95 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -113.33 127.94 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.747 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.631 ' HE3' ' HG ' ' B' ' 38' ' ' SER . 1.3 ptp -135.19 139.48 44.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -117.57 129.92 56.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.463 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.444 ' ND2' ' HA3' ' A' ' 61' ' ' GLY . 15.0 m120 -129.29 145.43 51.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.7 0.285 . . . . 0.0 111.419 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.45 7.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.695 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.575 ' CB ' HD22 ' A' ' 45' ' ' LEU . 84.1 p -127.99 164.49 22.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.424 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -140.36 142.54 35.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.508 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 17.1 m-80 -109.3 134.95 51.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.57 126.2 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.796 0.331 . . . . 0.0 110.781 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 3.8 pt-20 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.504 ' HZ1' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.65 0.262 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . 0.497 ' HA ' ' HZ1' ' A' ' 17' ' ' LYS . 82.2 t80 -60.87 -31.5 70.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 32.3 mmt180 -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.735 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . 0.6 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 29.6 mt-30 -73.07 -37.0 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 111.212 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.57 -50.25 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 22.7 m-20 -71.91 -20.06 61.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 12.8 t-20 -77.31 -41.27 41.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' C' ' 20' ' ' GLN . 3.6 mmp_? -71.45 -46.4 60.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.555 HD11 ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -59.83 -43.72 94.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.643 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.79 -28.9 66.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -75.98 -38.08 57.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.661 0.267 . . . . 0.0 111.265 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.593 ' O ' HG21 ' C' ' 32' ' ' VAL . 8.0 mt -76.52 -34.91 58.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.54 -47.32 73.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.003 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 9.7 t -71.62 -40.23 69.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.595 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 21.3 ttp85 -62.58 -38.51 90.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.325 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.593 HG21 ' O ' ' C' ' 28' ' ' LEU . 28.3 m -76.59 -27.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.235 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.558 ' OD2' ' HD2' ' C' ' 64' ' ' ARG . 10.4 t70 -63.98 -56.2 16.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.667 ' HD2' ' HA3' ' C' ' 91' ' ' GLY . 23.1 pttt -68.78 -37.56 79.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.807 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 -48.08 88.01 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.384 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.66 HD22 ' HB2' ' A' ' 39' ' ' SER . 0.4 OUTLIER -67.67 -31.56 71.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.28 -38.44 90.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.482 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.629 ' HG ' ' HE3' ' C' ' 96' ' ' MET . 78.7 p -79.9 -43.59 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.67 ' HB2' HD22 ' B' ' 36' ' ' LEU . 46.7 t -53.15 -60.99 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.66 -30.29 60.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.95 -48.98 74.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' C' ' 42' ' ' LEU . 0.6 OUTLIER -67.01 -32.94 74.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.067 179.33 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.3 m-20 -78.77 -13.6 59.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.07 65.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.144 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.805 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.2 mm? -75.65 158.71 32.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.87 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.448 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 47.5 p90 -146.56 -31.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.194 0.521 . . . . 0.0 111.69 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.461 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 8.3 tt0 75.59 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.979 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -90.85 137.17 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.625 2.217 . . . . 0.0 112.545 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 14.6 m-85 67.59 154.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.58 ' CA ' ' HB3' ' C' ' 76' ' ' ARG . . . -173.95 73.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.253 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.501 HG11 ' CD ' ' C' ' 53' ' ' LYS . 11.4 p -95.87 -22.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.198 0.599 . . . . 0.0 112.453 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.9 48.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.296 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . 0.501 ' CD ' HG11 ' C' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.49 7.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.593 0.235 . . . . 0.0 110.566 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.45 143.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.525 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.472 HD22 ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -135.19 116.45 14.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.006 0.431 . . . . 0.0 111.68 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -80.35 131.09 35.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.269 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.805 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 27.6 p -110.63 120.82 43.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.972 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . 0.53 ' HB1' HD11 ' C' ' 71' ' ' ILE . . . -143.37 139.93 30.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.431 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.05 164.61 33.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.563 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.62 164.38 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.331 . . . . 0.0 111.386 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . 0.529 ' O ' ' HG2' ' C' ' 67' ' ' GLN . . . -139.52 177.46 20.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.496 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.99 155.07 26.22 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 1.3 t80 -141.95 122.31 14.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.76 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.558 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 24.9 mtt-85 67.54 -93.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.104 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.45 4.54 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.19 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' SER . . . . . 0.441 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 22.8 t -109.92 173.93 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.6 OUTLIER -135.33 -179.39 5.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.093 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.55 158.27 23.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.549 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' C' ' 69' ' ' LEU . 3.8 tp -118.08 134.63 54.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.69 138.99 30.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.675 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' C' ' 58' ' ' ALA . 8.9 tp -138.3 150.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.712 0.291 . . . . 0.0 111.162 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.401 ' N ' HG13 ' C' ' 71' ' ' ILE . . . -164.62 -177.25 37.09 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.399 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.2 p -160.3 155.12 24.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.65 163.66 30.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.223 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -136.4 120.45 17.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 111.171 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.58 ' HB3' ' CA ' ' C' ' 50' ' ' GLY . 0.0 OUTLIER -105.18 107.65 18.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.796 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.735 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 14.9 p -102.48 130.07 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.291 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 59.01 -171.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.96 66.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.567 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 69.2 p -160.08 -51.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.044 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.59 141.94 37.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.08 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.294 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.48 130.81 33.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.627 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -135.11 144.03 46.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.179 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . 0.496 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . 0.43 ' HA3' HD13 ' C' ' 42' ' ' LEU . . . 173.47 161.09 23.11 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.589 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.43 ' O ' HD21 ' C' ' 42' ' ' LEU . 4.2 p -130.36 150.12 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.897 0.38 . . . . 0.0 111.074 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.71 140.73 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.356 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . 0.409 ' CD2' HG21 ' C' ' 95' ' ' VAL . 1.3 t80 -125.19 128.41 48.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' C' ' 38' ' ' SER . . . -136.38 151.07 49.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.613 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.667 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 50.21 -99.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.334 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.35 -27.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.753 0.311 . . . . 0.0 111.348 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 14.98 9.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.205 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.461 ' CB ' ' HB1' ' C' ' 90' ' ' ALA . 41.4 m-20 -101.48 69.8 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . 0.409 HG21 ' CD2' ' C' ' 89' ' ' TYR . 34.8 t -113.29 127.98 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.989 0.424 . . . . 0.0 110.742 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.629 ' HE3' ' HG ' ' C' ' 38' ' ' SER . 1.3 ptp -135.2 139.52 44.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.746 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -117.57 129.9 56.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.472 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.455 ' ND2' ' HA3' ' B' ' 61' ' ' GLY . 15.0 m120 -129.25 145.37 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.676 0.275 . . . . 0.0 111.43 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.59 114.49 7.33 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.575 ' CB ' HD22 ' B' ' 45' ' ' LEU . 83.9 p -128.04 164.43 22.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.426 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.31 142.5 35.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.967 0.413 . . . . 0.0 111.114 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.508 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 17.4 m-80 -109.24 135.05 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.56 126.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.776 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' B' ' 55' ' ' ASN . 3.8 pt-20 -104.69 148.58 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 57.7 m95 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.705 179.723 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.709 0.29 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.421 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 92.9 t80 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.182 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.02 -30.18 55.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.744 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.525 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.7 mt-30 -71.14 -33.87 70.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.217 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -48.29 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 15.9 m-20 -70.93 -20.44 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.977 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.79 -42.94 57.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 2.6 mmp_? -70.66 -48.82 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.736 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -72.1 -28.9 63.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.813 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -76.0 -37.16 58.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.259 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.497 HD11 ' HA ' ' C' ' 25' ' ' LEU . 9.5 mt -76.13 -32.75 59.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.483 ' O ' HG21 ' A' ' 32' ' ' VAL . 20.9 t0 -67.38 -48.56 67.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 10.0 t -68.7 -37.92 79.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.854 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.582 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 18.9 ttp85 -63.65 -39.09 93.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 29' ' ' ASP . 30.2 m -75.33 -28.25 20.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 13.8 t70 -62.55 -55.12 30.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.001 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 18.7 pttt -70.78 -40.65 72.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.728 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.28 90.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.422 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.516 HD22 ' SD ' ' B' ' 96' ' ' MET . 0.6 OUTLIER -66.95 -34.78 78.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.805 0.336 . . . . 0.0 111.057 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.6 94.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.398 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.514 ' HG ' ' HE3' ' A' ' 96' ' ' MET . 55.6 p -78.38 -39.28 39.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.737 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.0 t -54.66 -64.66 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -54.48 -31.09 55.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.428 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HB1' ' HB1' ' A' ' 70' ' ' ALA . . . -62.39 -48.52 79.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.544 ' HA ' HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -68.59 -32.72 72.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.3 m-20 -80.26 -15.04 57.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -17.55 64.79 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.156 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.767 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.8 mm? -76.59 156.07 33.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.871 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.18 -30.29 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.569 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 7.9 tt0 72.17 108.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.031 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.9 Cg_endo -91.29 139.43 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.637 2.225 . . . . 0.0 112.535 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.0 m-85 69.1 154.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.0 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.408 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -176.62 75.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.255 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.497 HG11 ' CD ' ' A' ' 53' ' ' LYS . 11.7 p -95.57 -24.92 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.067 0.547 . . . . 0.0 112.464 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.812 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.19 48.33 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.246 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.497 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -145.03 179.69 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.6 0.238 . . . . 0.0 110.643 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 11.4 p -105.18 145.3 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.553 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.569 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 0.9 OUTLIER -135.08 119.62 18.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 111.687 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -83.01 132.28 35.15 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.18 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.767 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 43.6 p -111.04 122.73 48.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.926 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.54 143.59 31.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.465 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.89 37.04 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.596 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.14 163.78 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.767 0.317 . . . . 0.0 111.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.19 177.75 19.79 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.447 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.32 26.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.76 123.82 14.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.438 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 27.2 mtt-85 64.18 -94.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.065 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 p -130.69 6.41 4.73 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.203 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.419 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 30.6 t -104.6 174.34 5.92 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.98 177.08 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.46 153.93 20.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.556 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tp -117.26 132.0 56.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -138.8 136.1 35.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.692 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 tp -136.29 145.44 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.28 155.99 34.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.68 163.46 29.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.216 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.437 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t80 -138.43 120.91 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 111.128 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.408 ' HG3' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -110.39 105.58 14.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.685 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.812 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.6 p -104.58 130.8 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.329 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 59.5 -174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 111.143 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.18 68.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.535 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.2 p -160.03 -50.7 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.036 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.26 143.48 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.578 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 154.52 45.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.265 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.88 132.37 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.57 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.445 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -134.72 139.8 45.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.445 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.07 169.42 19.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.68 162.69 25.97 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.532 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.12 33.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.157 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.06 141.33 48.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -124.23 127.86 48.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.269 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -135.59 148.1 48.93 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.7 -98.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.278 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 -28.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 111.323 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.9 p -121.56 15.34 11.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 38.1 m-20 -103.12 70.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.7 t -110.44 128.27 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.722 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.517 ' SD ' HD22 ' C' ' 36' ' ' LEU . 1.6 ptp -135.58 139.44 43.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.74 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -118.93 128.82 54.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.459 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.26 147.37 51.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.36 116.0 5.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.745 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.581 ' CB ' HD22 ' C' ' 45' ' ' LEU . 94.8 p -127.94 163.14 25.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.383 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -136.57 144.58 44.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 111.012 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.425 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 21.6 m-80 -109.83 131.9 54.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.38 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 pt -131.41 126.74 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.75 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.448 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 3.8 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.764 0.316 . . . . 0.0 110.546 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . 0.431 ' O ' ' OD2' ' B' ' 22' ' ' ASP . 92.7 t80 -65.59 -32.23 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.205 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -77.14 -30.08 54.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.735 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.525 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 mt-30 -71.24 -33.85 70.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.099 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.406 HD22 ' HG3' ' C' ' 24' ' ' ARG . 0.5 OUTLIER -65.15 -48.28 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.5 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 15.7 m-20 -70.87 -20.41 62.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.76 -43.03 56.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 2.6 mmp_? -70.63 -48.8 53.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.746 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -60.41 -41.8 94.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.644 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -72.04 -28.96 63.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -75.9 -37.2 59.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.259 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.484 HD11 ' HA ' ' A' ' 25' ' ' LEU . 9.6 mt -76.17 -32.83 59.26 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.479 ' O ' HG21 ' B' ' 32' ' ' VAL . 20.9 t0 -67.26 -48.64 67.13 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.981 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 10.1 t -68.66 -37.93 80.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.579 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 19.0 ttp85 -63.67 -39.06 93.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.479 HG21 ' O ' ' B' ' 29' ' ' ASP . 30.2 m -75.36 -28.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.182 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.492 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 13.8 t70 -62.61 -55.11 30.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 18.7 pttt -70.7 -40.68 72.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.31 90.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.4 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.518 HD22 ' SD ' ' C' ' 96' ' ' MET . 0.6 OUTLIER -66.88 -34.84 78.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.086 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.54 94.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.522 ' HG ' ' HE3' ' B' ' 96' ' ' MET . 56.0 p -78.48 -39.21 39.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -54.77 -64.6 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.101 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.401 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -54.46 -31.15 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.478 ' HB1' ' HB1' ' B' ' 70' ' ' ALA . . . -62.28 -48.65 78.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' B' ' 42' ' ' LEU . 0.4 OUTLIER -68.51 -32.76 72.95 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 2.3 m-20 -80.24 -15.02 57.93 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -17.56 64.8 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.081 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.762 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.8 mm? -76.5 156.17 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.38 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.613 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.576 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 7.9 tt0 72.22 108.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.929 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.8 Cg_endo -91.34 139.39 2.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.617 2.212 . . . . 0.0 112.516 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.0 m-85 69.1 154.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.58 75.35 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.227 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.498 HG11 ' CD ' ' B' ' 53' ' ' LYS . 11.7 p -95.59 -24.89 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 123.147 0.579 . . . . 0.0 112.467 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.784 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.11 48.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.277 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.498 ' CD ' HG11 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -145.12 179.61 7.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 110.634 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' B' ' 75' ' ' TYR . 11.4 p -105.12 145.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.606 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.576 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 0.9 OUTLIER -135.05 119.66 18.17 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 111.606 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -82.94 132.33 35.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.21 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.762 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 43.6 p -111.08 122.76 48.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.972 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.55 143.54 31.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.403 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.59 167.88 37.01 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.547 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.09 163.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 111.335 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.14 177.77 19.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.464 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.64 155.36 26.68 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.583 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.492 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.83 123.69 14.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.77 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.439 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 27.3 mtt-85 64.24 -94.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.044 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 68.8 p -130.74 6.35 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.136 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.416 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 30.3 t -104.53 174.31 5.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.93 177.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.45 153.91 20.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.538 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' B' ' 69' ' ' LEU . 6.0 tp -117.26 132.04 56.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.478 ' HB1' ' HB1' ' B' ' 41' ' ' ALA . . . -138.84 136.13 35.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.689 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 111.097 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.76 179.96 35.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.45 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.2 155.95 34.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.59 163.45 29.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.239 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.428 ' CD2' ' HB ' ' B' ' 54' ' ' VAL . 13.0 t80 -138.53 120.84 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.32 105.54 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.748 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.784 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.5 p -104.6 130.97 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 59.55 -174.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 111.109 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -118.18 68.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.7 p -160.04 -50.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.18 143.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 154.42 45.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.82 132.49 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.452 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.79 45.42 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.153 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.452 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.06 169.52 19.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.55 162.68 25.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.621 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.08 33.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.131 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.03 141.22 48.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.365 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.26 127.84 48.28 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.243 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -135.5 148.2 49.11 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.675 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.61 -98.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.334 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.14 -28.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.316 . . . . 0.0 111.32 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -121.53 15.29 11.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.161 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 38.1 m-20 -103.14 70.67 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.4 128.27 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.522 ' HE3' ' HG ' ' B' ' 38' ' ' SER . 1.6 ptp -135.63 139.49 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.701 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.01 128.84 54.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.482 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -129.21 147.36 51.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 111.389 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.3 116.01 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.784 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.581 ' CB ' HD22 ' A' ' 45' ' ' LEU . 94.2 p -127.91 163.12 25.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.411 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.5 144.58 44.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.945 0.402 . . . . 0.0 111.088 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.435 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 21.5 m-80 -109.8 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 pt -131.46 126.62 58.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.846 0.355 . . . . 0.0 110.855 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.447 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 3.9 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.622 0.249 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . 0.424 ' O ' ' OD2' ' C' ' 22' ' ' ASP . 92.9 t80 -65.53 -32.35 73.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.247 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.04 -30.15 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.781 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.8 mt-30 -71.17 -33.88 70.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.404 HD22 ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -65.18 -48.27 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 15.8 m-20 -70.84 -20.42 62.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.053 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -74.85 -42.9 57.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' C' ' 20' ' ' GLN . 2.6 mmp_? -70.7 -48.77 52.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.497 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -60.41 -41.71 94.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.676 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -72.19 -28.83 63.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.781 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -75.97 -37.21 58.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.18 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.475 HD11 ' HA ' ' B' ' 25' ' ' LEU . 9.7 mt -76.18 -32.73 59.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.481 ' O ' HG21 ' C' ' 32' ' ' VAL . 21.0 t0 -67.4 -48.49 67.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.945 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 10.1 t -68.75 -37.89 79.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.862 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.559 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 18.9 ttp85 -63.74 -39.02 93.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.325 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.481 HG21 ' O ' ' C' ' 29' ' ' ASP . 29.9 m -75.31 -28.27 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.204 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.497 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 13.8 t70 -62.74 -55.08 29.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.945 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 18.7 pttt -70.64 -40.74 72.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.25 90.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.402 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.517 HD22 ' SD ' ' A' ' 96' ' ' MET . 0.6 OUTLIER -67.02 -34.68 78.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 111.096 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.84 -39.51 94.58 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.4 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.514 ' HG ' ' HE3' ' C' ' 96' ' ' MET . 56.6 p -78.51 -39.27 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 35.9 t -54.7 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.55 -31.12 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.407 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' C' ' 70' ' ' ALA . . . -62.33 -48.5 79.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.511 ' HA ' HD23 ' C' ' 42' ' ' LEU . 0.4 OUTLIER -68.61 -32.64 72.66 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.464 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 2.2 m-20 -80.24 -15.15 57.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -17.59 64.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.144 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.752 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.8 mm? -76.56 156.14 33.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.877 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.27 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.651 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.574 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 7.9 tt0 72.11 108.78 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.019 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.523 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.9 Cg_endo -91.32 139.4 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.617 2.211 . . . . 0.0 112.565 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.1 m-85 69.13 154.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.027 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.57 75.35 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.243 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.495 HG11 ' CD ' ' C' ' 53' ' ' LYS . 11.7 p -95.51 -25.0 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.162 0.585 . . . . 0.0 112.44 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.814 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.17 48.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.316 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . 0.495 ' CD ' HG11 ' C' ' 51' ' ' VAL . 0.6 OUTLIER -145.02 179.69 7.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.595 0.236 . . . . 0.0 110.645 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 11.4 p -105.25 145.32 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.517 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.574 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 0.9 OUTLIER -135.06 119.61 18.09 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.971 0.415 . . . . 0.0 111.679 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -82.94 132.34 35.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.273 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.752 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.1 p -111.12 122.65 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 143.63 31.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.453 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.92 37.09 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 26.1 m -119.17 163.86 16.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 111.39 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.18 177.85 19.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.473 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.7 155.33 26.64 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.556 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.497 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.77 123.75 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.429 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 27.3 mtt-85 64.18 -93.97 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.038 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 68.3 p -130.76 6.39 4.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' SER . . . . . 0.404 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 30.6 t -104.57 174.41 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.08 177.07 7.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.116 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.49 153.91 20.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.58 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' C' ' 69' ' ' LEU . 6.0 tp -117.23 131.96 56.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.795 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' C' ' 41' ' ' ALA . . . -138.73 136.18 35.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.637 0.256 . . . . 0.0 111.664 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -155.3 155.96 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 110.965 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.66 163.42 29.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.262 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.434 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.0 t80 -138.51 120.86 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 105.64 14.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.5 p -104.64 130.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 59.49 -174.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.134 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.16 68.11 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.523 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 41.2 p -160.09 -50.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.986 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 143.51 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.3 154.43 45.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.897 0.38 . . . . 0.0 111.295 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.81 132.5 32.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.77 45.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . 0.449 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.06 169.5 19.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.6 162.75 26.02 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.532 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.22 147.09 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.04 141.33 48.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.329 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.3 127.87 48.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -135.54 148.18 49.03 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.645 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.67 -98.67 0.02 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.322 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.19 -28.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 111.326 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -121.57 15.32 11.13 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 38.2 m-20 -103.14 70.58 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.38 128.24 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 110.709 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.518 ' SD ' HD22 ' B' ' 36' ' ' LEU . 1.6 ptp -135.63 139.54 43.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.696 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.03 128.87 54.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.433 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -129.25 147.36 51.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.366 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.37 115.96 5.88 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.718 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.57 ' CB ' HD22 ' B' ' 45' ' ' LEU . 93.9 p -127.85 163.11 25.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.57 144.51 44.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.008 0.432 . . . . 0.0 111.072 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.429 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 21.4 m-80 -109.69 131.87 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.382 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 pt -131.42 126.68 58.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.441 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 3.9 pt-20 -105.84 152.93 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.989 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 44.6 m95 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.7 179.657 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.595 ' HZ1' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.642 0.258 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.581 ' HA ' ' HZ1' ' B' ' 17' ' ' LYS . 90.3 t80 -63.18 -32.88 74.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.38 -38.27 55.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.767 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.544 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 12.7 mt-30 -67.2 -30.87 70.93 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.191 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.9 -56.08 13.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.589 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.9 -23.99 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -67.16 -39.43 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.561 ' HB3' HD13 ' C' ' 25' ' ' LEU . 5.4 mmp_? -71.82 -48.11 48.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.777 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.581 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.6 OUTLIER -56.4 -52.21 65.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.65 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -64.31 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.772 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -71.76 -36.68 70.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.205 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.567 HD11 ' HA ' ' C' ' 25' ' ' LEU . 3.5 mt -79.17 -33.6 43.85 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.18 96.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.941 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.4 t -76.57 -40.64 49.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.879 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.422 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 21.3 ttp85 -61.68 -40.99 96.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.277 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 28' ' ' LEU . 30.7 m -73.43 -29.04 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.597 ' OD1' ' HB2' ' A' ' 64' ' ' ARG . 17.8 t70 -62.92 -52.58 62.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 26.5 pttt -70.74 -39.55 73.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.738 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.89 97.33 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.427 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' B' ' 39' ' ' SER . 0.5 OUTLIER -66.74 -33.57 75.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 111.077 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -61.99 -43.06 99.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.457 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.449 ' HA ' ' HB1' ' A' ' 68' ' ' ALA . 79.3 p -75.22 -41.04 58.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.742 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.441 ' HB2' HD22 ' C' ' 36' ' ' LEU . 38.2 t -57.55 -62.11 2.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.17 48.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.467 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.441 ' HB1' ' HB1' ' A' ' 70' ' ' ALA . . . -65.84 -48.07 72.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.943 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.48 ' HA ' HD23 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -66.1 -32.83 74.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.9 m-20 -79.77 -12.6 59.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -14.82 63.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.137 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.828 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.5 mm? -76.55 156.81 32.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.888 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.13 -26.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 10.1 tt0 71.58 110.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.927 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -90.03 137.13 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.645 2.23 . . . . 0.0 112.549 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.9 m-85 64.64 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.953 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.34 75.43 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.8 p -95.11 -25.26 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.148 0.579 . . . . 0.0 112.415 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.88 48.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.313 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.456 ' HD3' ' H ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -143.44 -178.0 5.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.591 0.234 . . . . 0.0 110.643 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.504 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 8.2 p -106.17 145.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.587 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.597 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 1.4 t30 -134.88 122.69 22.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -85.76 132.86 34.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.235 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.828 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 33.7 p -113.22 125.22 54.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.016 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.45 139.68 22.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.449 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.41 167.3 38.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.434 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' HD12 ' A' ' 69' ' ' LEU . 22.8 m -120.02 161.55 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.326 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.2 177.45 20.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.404 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.35 156.82 28.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.612 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.4 t80 -143.13 128.28 18.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.597 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 16.2 mtt-85 64.97 -91.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 p -135.63 6.1 3.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.496 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 19.3 t -105.18 168.38 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.4 179.29 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.138 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 38' ' ' SER . . . -164.78 150.54 10.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.571 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.583 HD12 ' CG1' ' A' ' 60' ' ' VAL . 12.5 tp -116.22 127.91 55.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.767 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -132.55 136.23 46.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.729 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 tp -132.81 146.68 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.138 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -163.89 -179.44 38.18 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.407 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -154.65 152.04 29.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.257 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.504 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.5 t80 -132.57 122.03 24.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.228 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.34 101.84 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.74 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.5 p -103.56 136.31 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.37 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.943 0.401 . . . . 0.0 111.112 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.47 61.35 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.573 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.76 -44.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.8 p -122.32 141.35 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.258 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.8 134.86 32.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -139.74 138.16 35.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.38 167.93 23.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.41 163.67 25.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 96' ' ' MET . 3.4 p -128.96 145.44 35.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.897 0.38 . . . . 0.0 111.044 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 70' ' ' ALA . . . -114.49 141.12 48.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.18 130.69 54.69 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.273 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 94' ' ' ASP . . . -139.63 145.25 38.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.596 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.428 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 52.19 -96.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.26 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -155.37 -30.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.731 0.3 . . . . 0.0 111.336 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -121.5 16.56 11.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.194 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.523 ' CB ' ' HB1' ' A' ' 90' ' ' ALA . 41.6 m-20 -104.44 73.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.2 t -114.79 131.96 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.642 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 1.2 ptp -136.27 142.27 43.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.714 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -119.95 128.75 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.483 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -125.99 148.94 49.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.346 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.09 114.52 5.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.709 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.476 ' CB ' HD22 ' C' ' 45' ' ' LEU . 53.7 p -130.43 161.24 31.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.463 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -134.0 142.71 47.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.97 0.414 . . . . 0.0 111.072 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 20.7 m-80 -111.68 128.62 56.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.79 131.49 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.8 0.333 . . . . 0.0 110.796 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.51 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 5.4 pt-20 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.581 ' HZ1' ' HA ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.662 0.267 . . . . 0.0 110.488 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . 0.597 ' HA ' ' HZ1' ' C' ' 17' ' ' LYS . 90.3 t80 -63.12 -32.94 74.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.311 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.4 -38.35 55.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.741 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.548 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 12.7 mt-30 -67.1 -30.88 71.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.973 0.416 . . . . 0.0 111.23 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.88 -56.04 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -69.01 -23.91 64.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -67.17 -39.43 86.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 5.4 mmp_? -71.84 -48.19 47.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.701 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.588 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.6 OUTLIER -56.31 -52.26 65.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -64.29 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.762 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -71.65 -36.83 70.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.603 0.239 . . . . 0.0 111.203 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.581 HD11 ' HA ' ' A' ' 25' ' ' LEU . 3.5 mt -79.08 -33.69 44.31 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.46 -42.16 96.09 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 4.5 t -76.59 -40.7 48.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.422 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 21.2 ttp85 -61.6 -41.05 96.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.474 HG21 ' O ' ' B' ' 28' ' ' LEU . 30.6 m -73.37 -29.11 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.161 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.601 ' OD1' ' HB2' ' B' ' 64' ' ' ARG . 17.8 t70 -62.85 -52.69 62.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HD2' ' HA3' ' B' ' 91' ' ' GLY . 26.5 pttt -70.69 -39.5 73.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.755 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.65 -44.95 97.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.425 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' C' ' 39' ' ' SER . 0.5 OUTLIER -66.73 -33.59 75.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 111.054 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' B' ' 41' ' ' ALA . . . -61.93 -43.09 99.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.424 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.451 ' HA ' ' HB1' ' B' ' 68' ' ' ALA . 79.9 p -75.24 -40.95 58.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.77 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.457 ' HB2' HD22 ' A' ' 36' ' ' LEU . 38.4 t -57.63 -62.11 2.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.18 -30.2 48.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.433 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.429 ' HB1' ' HB1' ' B' ' 70' ' ' ALA . . . -65.86 -48.01 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' B' ' 42' ' ' LEU . 0.7 OUTLIER -66.2 -32.76 74.39 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 2.9 m-20 -79.8 -12.66 59.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -14.94 63.22 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.156 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.818 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.5 mm? -76.46 156.84 32.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.847 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.1 -26.93 0.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.17 0.509 . . . . 0.0 111.683 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 10.1 tt0 71.69 109.87 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.914 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -89.86 137.13 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.709 2.273 . . . . 0.0 112.547 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.9 m-85 64.57 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.957 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.35 75.41 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.242 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 12.7 p -95.04 -25.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.469 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.733 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.88 48.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.45 ' HD3' ' H ' ' B' ' 52' ' ' GLY . 0.4 OUTLIER -143.54 -178.05 5.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.507 ' HB ' ' CE2' ' B' ' 75' ' ' TYR . 8.3 p -106.08 145.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.589 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.597 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 1.4 t30 -134.95 122.61 22.15 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 111.658 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -85.65 132.8 34.09 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.309 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.818 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 33.8 p -113.18 125.27 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.004 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.56 139.64 22.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.439 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.33 38.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.526 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.572 ' CG1' HD12 ' B' ' 69' ' ' LEU . 22.6 m -120.04 161.58 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.786 0.327 . . . . 0.0 111.382 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.23 177.48 20.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.459 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' B' ' 37' ' ' ALA . . . -162.34 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.562 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.48 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.4 t80 -143.13 128.22 18.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.66 0.267 . . . . 0.0 110.801 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.601 ' HB2' ' OD1' ' B' ' 33' ' ' ASP . 16.3 mtt-85 64.95 -91.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.087 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 p -135.64 6.09 3.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.5 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 19.4 t -105.2 168.36 9.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.33 179.36 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' B' ' 38' ' ' SER . . . -164.87 150.48 9.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.539 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.572 HD12 ' CG1' ' B' ' 60' ' ' VAL . 12.3 tp -116.16 127.92 55.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.429 ' HB1' ' HB1' ' B' ' 41' ' ' ALA . . . -132.59 136.22 46.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.67 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 tp -132.81 146.74 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.119 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -163.87 -179.42 38.15 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.41 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 64.5 p -154.7 152.09 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.85 0.357 . . . . 0.0 111.043 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.64 156.91 27.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.25 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.507 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 13.7 t80 -132.59 122.06 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 101.93 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.688 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.733 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.5 p -103.49 136.36 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.3 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.142 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.46 61.27 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.568 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -159.65 -44.84 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.988 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -122.32 141.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 155.72 48.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.258 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.75 134.91 32.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.561 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.438 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.19 35.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.438 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.44 167.9 23.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.073 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.41 163.63 25.71 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 96' ' ' MET . 3.4 p -128.96 145.33 35.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.041 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' B' ' 70' ' ' ALA . . . -114.42 141.1 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.363 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.14 130.65 54.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.262 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.521 ' HB1' ' CB ' ' B' ' 94' ' ' ASP . . . -139.69 145.25 38.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.562 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.424 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 52.25 -96.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.276 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.36 -30.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.339 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -121.51 16.44 11.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.521 ' CB ' ' HB1' ' B' ' 90' ' ' ALA . 41.6 m-20 -104.3 73.52 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 56.3 t -114.74 132.01 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.483 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.2 ptp -136.31 142.27 43.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -120.07 128.77 53.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.37 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.0 148.87 49.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.401 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.06 114.51 5.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.709 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.485 ' CB ' HD22 ' A' ' 45' ' ' LEU . 53.7 p -130.42 161.27 31.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.48 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -134.0 142.65 47.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.111 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.511 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 20.4 m-80 -111.59 128.65 56.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.443 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 110.784 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.506 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 5.4 pt-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.597 ' HZ1' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.688 0.28 . . . . 0.0 110.555 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . 0.595 ' HA ' ' HZ1' ' A' ' 17' ' ' LYS . 90.2 t80 -63.17 -32.98 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.37 -38.28 56.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . 0.542 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 12.7 mt-30 -67.26 -30.78 70.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.95 -56.04 13.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.564 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 -23.98 64.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -67.17 -39.43 86.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' B' ' 25' ' ' LEU . 5.4 mmp_? -71.81 -48.18 48.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.788 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.567 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -56.3 -52.28 65.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -64.23 -28.01 69.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.818 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -71.62 -36.8 70.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.248 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.588 HD11 ' HA ' ' B' ' 25' ' ' LEU . 3.5 mt -79.11 -33.66 44.16 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.14 96.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.921 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 4.5 t -76.55 -40.72 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.864 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.435 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 21.3 ttp85 -61.64 -41.0 96.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.469 HG21 ' O ' ' C' ' 28' ' ' LEU . 30.7 m -73.4 -29.09 26.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.596 ' OD1' ' HB2' ' C' ' 64' ' ' ARG . 17.8 t70 -62.77 -52.65 62.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.027 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 26.5 pttt -70.78 -39.44 73.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.94 97.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.386 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 39' ' ' SER . 0.5 OUTLIER -66.68 -33.71 76.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' C' ' 41' ' ' ALA . . . -61.77 -43.16 99.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.441 ' HA ' ' HB1' ' C' ' 68' ' ' ALA . 79.7 p -75.23 -41.02 58.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.46 ' HB2' HD22 ' B' ' 36' ' ' LEU . 38.0 t -57.51 -62.17 1.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.18 48.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.443 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.437 ' HB1' ' HB1' ' C' ' 70' ' ' ALA . . . -65.81 -48.01 73.14 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' C' ' 42' ' ' LEU . 0.7 OUTLIER -66.18 -32.85 74.53 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.409 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 2.8 m-20 -79.71 -12.66 59.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -14.85 63.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.17 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.809 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.5 mm? -76.49 156.86 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.869 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.15 -26.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.206 0.527 . . . . 0.0 111.706 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.58 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 10.1 tt0 71.5 109.91 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.021 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -89.94 137.19 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.554 2.169 . . . . 0.0 112.59 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.8 m-85 64.6 152.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.39 75.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.228 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.94 -25.27 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.18 0.592 . . . . 0.0 112.509 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.714 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.91 48.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.298 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . 0.447 ' HD3' ' H ' ' C' ' 52' ' ' GLY . 0.4 OUTLIER -143.52 -178.07 5.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.585 0.231 . . . . 0.0 110.608 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.507 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 8.2 p -106.16 145.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.557 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.58 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 1.4 t30 -134.88 122.72 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -85.74 132.89 34.05 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.172 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.809 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 33.5 p -113.29 125.27 54.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.895 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.57 139.67 22.11 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.4 38.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.586 ' CG1' HD12 ' C' ' 69' ' ' LEU . 22.6 m -120.12 161.57 19.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 111.33 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.22 177.47 20.29 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.418 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' C' ' 37' ' ' ALA . . . -162.33 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.4 t80 -143.09 128.29 18.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.686 0.279 . . . . 0.0 110.746 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.596 ' HB2' ' OD1' ' C' ' 33' ' ' ASP . 16.3 mtt-85 64.94 -91.07 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.096 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.0 p -135.59 6.15 3.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.227 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' SER . . . . . 0.495 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 19.4 t -105.26 168.4 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.778 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.41 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' C' ' 38' ' ' SER . . . -164.83 150.47 9.97 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.556 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.586 HD12 ' CG1' ' C' ' 60' ' ' VAL . 12.4 tp -116.17 127.9 55.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.437 ' HB1' ' HB1' ' C' ' 41' ' ' ALA . . . -132.63 136.19 46.34 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 tp -132.74 146.75 32.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.732 0.301 . . . . 0.0 111.134 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -163.9 -179.39 38.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.435 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.4 p -154.71 152.0 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 111.056 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.26 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.507 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.7 t80 -132.64 122.05 24.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 111.128 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 101.83 10.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.714 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.5 p -103.46 136.36 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 63.3 -171.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.391 . . . . 0.0 111.089 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.55 61.35 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.72 -44.77 0.05 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.33 141.37 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.69 155.78 47.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.74 134.85 32.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.539 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.21 35.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.157 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.45 167.86 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.49 163.65 25.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.574 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.407 HG22 ' O ' ' C' ' 96' ' ' MET . 3.5 p -128.87 145.41 35.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.137 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' C' ' 70' ' ' ALA . . . -114.5 141.14 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.347 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 130.69 54.71 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.288 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' C' ' 94' ' ' ASP . . . -139.68 145.21 38.11 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.595 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 52.28 -96.33 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.258 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.38 -30.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.281 . . . . 0.0 111.296 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.6 p -121.42 16.45 11.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.239 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.519 ' CB ' ' HB1' ' C' ' 90' ' ' ALA . 41.5 m-20 -104.39 73.54 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -114.79 132.03 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 0.0 110.636 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.48 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 1.2 ptp -136.33 142.2 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.642 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.96 128.72 53.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -125.95 148.84 49.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.299 . . . . 0.0 111.419 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.05 114.5 5.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.829 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.48 ' CB ' HD22 ' B' ' 45' ' ' LEU . 53.6 p -130.44 161.21 31.89 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.393 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -133.95 142.65 47.78 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.917 0.389 . . . . 0.0 111.113 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 20.9 m-80 -111.6 128.68 56.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.79 131.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.743 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.513 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 5.4 pt-20 -112.63 154.92 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 31.0 m95 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.706 179.669 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.667 0.27 . . . . 0.0 110.57 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 24.9 mmt180 -76.8 -36.88 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.725 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.6 mt-30 -67.5 -32.94 74.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' B' ' 24' ' ' ARG . 1.4 tt -68.6 -55.84 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.558 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.13 -25.46 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 24.6 t-20 -71.76 -42.48 67.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 3.7 mmp_? -69.27 -45.28 70.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.814 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.692 HD13 HD11 ' B' ' 28' ' ' LEU . 1.9 tp -56.29 -49.09 75.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.562 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.79 -32.08 73.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -69.98 -32.89 71.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.26 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.7 HD11 HD13 ' C' ' 25' ' ' LEU . 1.7 mt -81.06 -32.37 34.04 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.69 -40.21 88.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.017 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.3 t -76.73 -39.34 52.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.427 HH22 HG23 ' C' ' 32' ' ' VAL . 43.6 ttp85 -59.46 -41.81 90.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 28' ' ' LEU . 27.2 m -78.29 -23.6 13.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.204 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 18.6 t70 -67.63 -51.54 48.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.446 ' NZ ' ' HA3' ' A' ' 91' ' ' GLY . 32.7 pttt -76.38 -40.28 51.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.93 98.75 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -67.09 -33.9 76.47 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.882 0.372 . . . . 0.0 111.156 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.17 99.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.457 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.491 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 94.4 p -76.29 -37.31 57.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.637 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 33.0 t -63.73 -55.01 26.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.98 -32.1 69.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.564 ' HB1' ' HB1' ' A' ' 70' ' ' ALA . . . -64.88 -46.47 81.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.955 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -66.22 -30.39 70.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.3 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 9.7 m-20 -81.36 -15.71 54.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.46 -15.04 62.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.112 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.715 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.9 mm? -71.39 164.52 25.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.911 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 25.0 p90 -152.55 -32.02 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.148 0.499 . . . . 0.0 111.701 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.522 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 15.3 tt0 73.53 106.71 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.96 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -93.07 136.34 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.628 2.219 . . . . 0.0 112.552 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 10.6 m-85 65.52 151.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 178.62 78.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.235 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.31 -23.28 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.206 0.603 . . . . 0.0 112.411 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 157.5 49.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.278 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.65 -176.73 5.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.605 0.24 . . . . 0.0 110.563 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.22 150.57 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.568 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 2.2 t30 -132.91 124.37 27.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.66 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -87.18 128.17 35.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.319 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.715 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 38.2 p -114.71 123.08 48.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.047 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.29 136.78 18.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.451 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.05 44.35 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.582 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.495 HG12 HD12 ' A' ' 69' ' ' LEU . 16.4 m -126.9 166.98 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.801 0.334 . . . . 0.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA3' HD21 ' B' ' 98' ' ' ASN . . . -141.35 172.32 23.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.44 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.47 152.36 23.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.547 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.3 t80 -142.44 128.68 19.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.686 0.279 . . . . 0.0 110.737 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.36 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 p -140.35 10.07 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.455 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 9.8 t -109.6 167.6 10.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.67 -179.09 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.19 156.46 10.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.526 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 60' ' ' VAL . 7.6 tp -114.58 130.97 56.83 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -129.62 141.43 50.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.682 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 72' ' ' GLY . 7.9 tp -138.14 150.38 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.092 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 71' ' ' ILE . . . -169.28 177.41 42.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.395 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.6 146.4 18.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.25 158.41 27.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.519 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 30.9 t80 -126.3 125.02 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.154 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.487 ' NH2' ' HB2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -113.1 102.71 10.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.586 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.0 p -104.41 138.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 59.88 -167.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -126.59 66.08 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.419 ' HA ' ' HG3' ' A' ' 104' ' ' GLU . 19.9 p -165.4 -46.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.986 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.47 ' HA ' HG21 ' A' ' 103' ' ' ILE . 14.7 p -118.24 139.86 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.49 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.46 45.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.293 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.16 138.91 33.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.638 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.124 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . . . -143.34 169.75 17.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.103 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.04 157.62 14.33 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.507 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 88' ' ' ALA . 1.5 p -124.05 144.89 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 111.079 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.425 ' N ' HG22 ' A' ' 87' ' ' VAL . . . -112.57 142.43 45.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.99 122.89 39.63 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.31 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -137.34 147.3 45.47 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.6 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.446 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 57.03 -94.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.276 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 t -159.4 -33.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 111.357 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.77 13.83 12.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 32.6 m-20 -101.85 72.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.969 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 t -116.08 127.05 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.987 0.423 . . . . 0.0 110.759 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 39' ' ' SER . 1.3 ptp -131.85 140.2 49.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.681 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -121.55 126.69 49.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.428 HD21 ' HA3' ' C' ' 61' ' ' GLY . 17.0 m120 -128.42 141.51 51.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . . . -144.83 117.21 8.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.781 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.49 162.13 27.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.452 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.06 133.52 50.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.103 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 28.7 m-80 -108.38 127.86 54.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.458 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.47 HG21 ' HA ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -131.74 138.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.77 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 80' ' ' SER . 4.6 pt-20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.684 0.278 . . . . 0.0 110.566 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.45 -29.86 70.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.259 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 24.9 mmt180 -76.74 -36.89 56.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.61 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.6 mt-30 -67.46 -32.96 74.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.578 HD22 ' HG3' ' C' ' 24' ' ' ARG . 1.4 tt -68.61 -55.77 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.15 -25.44 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 24.6 t-20 -71.79 -42.54 66.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.61 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 3.7 mmp_? -69.3 -45.25 70.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.709 HD13 HD11 ' C' ' 28' ' ' LEU . 1.9 tp -56.36 -49.06 75.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.582 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.73 -32.08 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.814 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -70.02 -32.9 71.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.237 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.692 HD11 HD13 ' A' ' 25' ' ' LEU . 1.7 mt -81.05 -32.34 34.08 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.7 -40.29 88.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.936 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 4.3 t -76.68 -39.38 52.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.814 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.427 HH22 HG23 ' A' ' 32' ' ' VAL . 43.4 ttp85 -59.31 -41.91 90.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.336 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.547 HG21 ' O ' ' B' ' 28' ' ' LEU . 27.2 m -78.28 -23.63 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.157 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' B' ' 66' ' ' SER . 18.6 t70 -67.6 -51.59 48.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.986 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.448 ' NZ ' ' HA3' ' B' ' 91' ' ' GLY . 32.7 pttt -76.28 -40.41 51.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.792 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.21 -43.92 98.77 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.5 OUTLIER -67.14 -33.87 76.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' B' ' 41' ' ' ALA . . . -62.62 -43.13 99.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.47 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 94.5 p -76.33 -37.33 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.758 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.629 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 32.7 t -63.76 -54.97 27.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.0 69.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.567 ' HB1' ' HB1' ' B' ' 70' ' ' ALA . . . -64.83 -46.59 81.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' B' ' 42' ' ' LEU . 0.6 OUTLIER -66.05 -30.49 71.02 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.555 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 9.7 m-20 -81.39 -15.64 54.59 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -15.11 62.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.073 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.723 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.9 mm? -71.4 164.59 25.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.837 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.414 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 24.9 p90 -152.58 -32.08 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.15 0.5 . . . . 0.0 111.625 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.528 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 15.4 tt0 73.49 106.61 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.0 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.487 ' HB2' ' NH2' ' C' ' 76' ' ' ARG . 9.8 Cg_endo -93.02 136.32 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.668 2.245 . . . . 0.0 112.52 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 10.6 m-85 65.56 151.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 178.57 78.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.264 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.22 -23.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 123.108 0.563 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 157.54 49.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.299 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.31 150.59 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.543 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.528 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 2.2 t30 -132.94 124.34 27.62 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.981 0.42 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -87.21 128.23 35.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.224 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.723 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.7 p -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.965 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.3 136.76 18.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.366 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.07 44.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.572 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.496 HG12 HD12 ' B' ' 69' ' ' LEU . 16.4 m -126.89 166.96 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.377 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . 0.421 ' HA3' HD21 ' C' ' 98' ' ' ASN . . . -141.32 172.34 23.87 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.451 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.51 152.42 23.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.579 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.3 t80 -142.53 128.6 19.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 0.0 110.716 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 63.47 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.083 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 34.8 p -140.37 10.17 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.224 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.458 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 9.8 t -109.63 167.63 10.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.72 -179.13 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.13 156.59 10.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.532 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.496 HD12 HG12 ' B' ' 60' ' ' VAL . 7.6 tp -114.66 130.95 56.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.777 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.567 ' HB1' ' HB1' ' B' ' 41' ' ' ALA . . . -129.66 141.45 50.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.446 HG13 ' N ' ' B' ' 72' ' ' GLY . 7.9 tp -138.16 150.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.77 0.319 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.446 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -169.14 177.43 42.86 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.55 146.51 18.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.31 158.37 27.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.254 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . 0.522 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 30.8 t80 -126.3 125.01 41.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.476 ' NH2' ' HB2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.09 102.68 10.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.663 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.6 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.1 p -104.36 138.3 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.95 -167.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -126.58 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' SER . . . . . 0.416 ' HA ' ' HG3' ' B' ' 104' ' ' GLU . 20.1 p -165.47 -46.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.955 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.487 ' HA ' HG21 ' B' ' 103' ' ' ILE . 14.8 p -118.2 139.88 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.557 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.15 155.48 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.273 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.21 138.86 33.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' B' ' 99' ' ' ALA . . . -143.36 169.78 17.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.082 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.99 157.58 14.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.587 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.427 HG22 ' N ' ' B' ' 88' ' ' ALA . 1.5 p -124.08 144.85 32.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.427 ' N ' HG22 ' B' ' 87' ' ' VAL . . . -112.55 142.46 45.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.323 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.05 122.9 39.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -137.35 147.23 45.38 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.585 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.448 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 57.16 -94.64 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.252 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.1 t -159.37 -33.83 0.06 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.735 0.303 . . . . 0.0 111.312 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -119.75 13.87 12.47 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 32.6 m-20 -101.86 72.2 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -116.02 127.11 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.029 0.442 . . . . 0.0 110.712 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.629 ' SD ' ' HB2' ' B' ' 39' ' ' SER . 1.3 ptp -131.98 140.16 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -121.51 126.6 49.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.406 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.419 HD21 ' HA3' ' A' ' 61' ' ' GLY . 16.9 m120 -128.35 141.46 51.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.487 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . 0.642 ' HB2' ' HB3' ' B' ' 85' ' ' ALA . . . -144.71 117.27 8.61 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.58 162.11 28.03 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.446 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -127.03 133.52 50.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.951 0.405 . . . . 0.0 111.079 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.493 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 28.7 m-80 -108.41 127.78 54.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.365 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.487 HG21 ' HA ' ' B' ' 81' ' ' VAL . 0.7 OUTLIER -131.65 138.13 53.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.795 0.331 . . . . 0.0 110.827 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.423 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 4.6 pt-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.648 0.261 . . . . 0.0 110.524 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.279 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 24.8 mmt180 -76.73 -36.96 56.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . 0.606 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.6 mt-30 -67.48 -32.91 74.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.16 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.567 HD22 ' HG3' ' A' ' 24' ' ' ARG . 1.4 tt -68.54 -55.86 10.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -66.15 -25.5 66.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 24.5 t-20 -71.72 -42.51 67.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' C' ' 20' ' ' GLN . 3.7 mmp_? -69.26 -45.29 70.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.7 HD13 HD11 ' A' ' 28' ' ' LEU . 1.9 tp -56.32 -49.09 75.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.581 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.77 -32.06 73.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.787 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -69.97 -32.96 71.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.253 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.709 HD11 HD13 ' B' ' 25' ' ' LEU . 1.7 mt -81.0 -32.4 34.24 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.76 -40.19 88.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.94 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 4.4 t -76.66 -39.29 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.899 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.429 HH22 HG23 ' B' ' 32' ' ' VAL . 43.5 ttp85 -59.51 -41.83 90.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.289 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.54 HG21 ' O ' ' C' ' 28' ' ' LEU . 27.3 m -78.36 -23.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' C' ' 66' ' ' SER . 18.6 t70 -67.51 -51.53 49.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.062 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' C' ' 30' ' ' THR . 32.6 pttt -76.46 -40.3 50.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.755 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.91 98.78 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.43 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.5 OUTLIER -67.1 -34.01 76.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.24 99.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.475 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 95.1 p -76.27 -37.38 57.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.642 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 33.1 t -63.72 -54.88 28.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.15 -32.03 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' C' ' 70' ' ' ALA . . . -64.86 -46.59 81.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' C' ' 42' ' ' LEU . 0.6 OUTLIER -66.12 -30.37 70.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.072 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 43' ' ' ASN . 9.6 m-20 -81.39 -15.73 54.35 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -14.95 62.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.159 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.73 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.9 mm? -71.52 164.56 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.89 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 24.8 p90 -152.55 -32.03 0.14 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.129 0.49 . . . . 0.0 111.705 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.527 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 15.4 tt0 73.49 106.64 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.974 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -92.93 136.31 1.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.647 2.231 . . . . 0.0 112.546 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 10.7 m-85 65.61 151.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 178.62 78.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.266 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.212 0.605 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 157.55 49.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.321 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.604 0.24 . . . . 0.0 110.579 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.27 150.62 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.613 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.527 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 2.2 t30 -132.99 124.28 27.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 111.686 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -87.15 128.26 35.13 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.223 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.73 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 38.1 p -114.82 123.17 48.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.97 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.31 136.66 18.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.474 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.21 176.99 44.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.554 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . 0.502 HG12 HD12 ' C' ' 69' ' ' LEU . 16.4 m -126.87 166.91 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.315 . . . . 0.0 111.418 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . 0.428 ' HA3' HD21 ' A' ' 98' ' ' ASN . . . -141.25 172.41 23.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.518 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.6 152.33 23.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.587 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.582 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.3 t80 -142.46 128.62 19.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.751 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.41 -86.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.6 p -140.38 10.1 2.29 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' SER . . . . . 0.448 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 9.7 t -109.57 167.67 9.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.76 -179.08 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 111.104 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.23 156.51 10.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.541 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . 0.502 HD12 HG12 ' C' ' 60' ' ' VAL . 7.6 tp -114.62 130.87 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.762 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' C' ' 41' ' ' ALA . . . -129.55 141.49 50.96 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.721 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.465 HG13 ' N ' ' C' ' 72' ' ' GLY . 7.9 tp -138.15 150.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.816 0.341 . . . . 0.0 111.065 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.465 ' N ' HG13 ' C' ' 71' ' ' ILE . . . -169.27 177.42 42.94 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.476 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -158.61 146.47 18.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 110.976 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.26 158.38 27.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.255 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.529 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 30.7 t80 -126.27 125.03 41.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.487 ' NH2' ' HB2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -113.12 102.77 10.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.588 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.0 p -104.48 138.3 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.9 -167.39 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -126.62 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.518 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' SER . . . . . 0.426 ' HA ' ' HG3' ' C' ' 104' ' ' GLU . 20.1 p -165.43 -46.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.009 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.481 ' HA ' HG21 ' C' ' 103' ' ' ILE . 14.8 p -118.2 139.77 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.575 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.48 45.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.302 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.25 138.81 33.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.558 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.414 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -145.43 132.57 20.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.15 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' C' ' 99' ' ' ALA . . . -143.31 169.77 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.08 157.58 14.27 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.564 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . 0.427 HG22 ' N ' ' C' ' 88' ' ' ALA . 1.5 p -124.12 144.85 32.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 111.098 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.427 ' N ' HG22 ' C' ' 87' ' ' VAL . . . -112.46 142.44 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.334 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.08 122.95 39.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -137.3 147.36 45.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.64 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.434 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 56.92 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.331 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.3 t -159.37 -33.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.714 0.292 . . . . 0.0 111.338 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.78 13.85 12.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.162 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 32.5 m-20 -101.91 72.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.03 127.15 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.629 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.642 ' SD ' ' HB2' ' C' ' 39' ' ' SER . 1.3 ptp -131.91 140.13 48.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.684 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -121.45 126.7 49.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.402 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.421 HD21 ' HA3' ' B' ' 61' ' ' GLY . 17.0 m120 -128.4 141.52 51.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.38 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' C' ' 85' ' ' ALA . . . -144.82 117.24 8.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.53 162.19 27.82 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.474 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.12 133.53 50.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.0 111.084 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.484 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 28.5 m-80 -108.4 127.84 54.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.345 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.481 HG21 ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -131.67 138.0 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.821 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.426 ' HG3' ' HA ' ' C' ' 80' ' ' SER . 4.7 pt-20 -112.56 147.02 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 40.0 m95 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 179.675 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.647 ' HZ1' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.609 0.242 . . . . 0.0 110.514 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.652 ' HA ' ' HZ1' ' B' ' 17' ' ' LYS . 74.1 t80 -62.6 -41.13 98.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.245 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 34.5 mmt180 -73.7 -30.43 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -71.66 -34.47 69.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.712 HD11 HD11 ' C' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.61 63.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.633 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.85 -25.51 64.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.041 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 6.2 t-20 -66.43 -37.26 84.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HD3' ' HB2' ' C' ' 25' ' ' LEU . 6.3 mmp_? -71.02 -44.8 65.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.671 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.3 OUTLIER -61.11 -32.66 72.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.608 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -81.78 -28.3 33.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' O ' HG22 ' A' ' 30' ' ' THR . 36.9 tttm -73.16 -43.28 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.67 0.272 . . . . 0.0 111.217 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.681 HD11 ' HA ' ' C' ' 25' ' ' LEU . 11.4 mt -72.05 -29.01 63.73 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.445 ' O ' HG21 ' A' ' 32' ' ' VAL . 25.2 t0 -66.78 -47.41 72.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.961 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.529 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.5 t -71.0 -33.81 70.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.869 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.626 HH21 HD23 ' A' ' 28' ' ' LEU . 45.2 ttp85 -67.71 -40.11 84.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.546 HG23 ' NH2' ' B' ' 31' ' ' ARG . 33.8 m -76.09 -29.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.659 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 7.2 t70 -62.42 -57.25 11.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.053 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 30' ' ' THR . 26.8 pttt -70.26 -44.58 68.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.756 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.3 82.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.439 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -26.32 62.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.819 0.342 . . . . 0.0 111.097 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 68' ' ' ALA . . . -66.69 -37.68 85.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.402 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 52.3 p -82.96 -38.75 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.688 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.456 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 31.0 t -57.39 -57.2 13.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -32.54 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.651 ' HB1' ' HB1' ' A' ' 70' ' ' ALA . . . -62.31 -45.31 93.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -66.14 -32.8 74.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.043 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 1.1 m-20 -82.83 -15.82 50.09 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.64 -17.75 64.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.135 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.749 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.4 mm? -75.41 162.66 28.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.812 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.534 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 45.1 p90 -143.83 -30.46 0.48 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 111.706 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.45 ' CG ' ' HB3' ' A' ' 55' ' ' ASN . 15.8 tt0 72.03 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.983 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.7 Cg_endo -89.13 140.6 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.693 2.262 . . . . 0.0 112.52 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 18.2 m-85 67.01 150.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.477 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -173.94 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.329 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.02 -19.41 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.154 0.582 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 148.44 48.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.294 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.09 4.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.674 0.273 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 55' ' ' ASN . 7.1 p -110.35 137.94 40.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.582 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' B' ' 104' ' ' GLU . 6.5 t30 -125.95 119.7 28.42 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.02 0.438 . . . . 0.0 111.686 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -80.3 128.35 33.44 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.269 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.749 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 16.7 p -114.29 119.86 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.498 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -176.96 166.77 37.69 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.573 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.28 165.12 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.843 0.354 . . . . 0.0 111.316 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.15 176.09 21.2 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.396 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.31 27.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.659 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.72 123.33 14.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.57 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 33.3 mtt-85 65.75 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 p -137.59 12.91 2.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.7 t -109.34 173.15 6.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.35 177.21 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.111 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . . . -163.72 161.19 23.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -119.6 136.24 54.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.713 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.651 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -136.43 137.94 40.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.638 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -138.09 145.77 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 111.135 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -172.55 -175.34 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.452 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.11 158.36 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.776 0.322 . . . . 0.0 111.046 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.48 28.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.294 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -129.31 119.02 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 111.135 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HD3' ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -105.82 104.0 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.739 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.712 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 10.8 p -101.9 126.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 63.86 -171.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -118.25 58.34 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.557 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.051 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.772 ' HA ' HG21 ' A' ' 103' ' ' ILE . 6.3 p -112.33 143.45 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.513 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.488 ' HB1' ' HD3' ' A' ' 76' ' ' ARG . . . -146.64 151.78 37.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.36 132.61 35.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.578 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.17 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.64 171.33 18.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.097 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.5 157.31 10.66 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.56 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 111.141 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.28 151.9 30.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.315 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.33 126.89 38.27 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.276 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -140.89 145.57 36.32 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.614 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.419 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 55.18 -98.54 0.05 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.275 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 -25.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 111.311 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.96 12.92 7.28 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 33.8 m-20 -98.91 69.26 1.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.09 127.04 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.716 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.626 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 5.3 ptp -133.04 147.1 52.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.702 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -126.19 130.88 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.447 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -128.08 137.85 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 111.383 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.24 109.5 7.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.773 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.447 ' HB2' HD12 ' C' ' 45' ' ' LEU . 91.5 p -125.24 163.47 22.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.472 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.05 140.27 50.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.963 0.411 . . . . 0.0 111.111 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.417 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 45.2 m-80 -111.76 125.59 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.772 HG21 ' HA ' ' A' ' 81' ' ' VAL . 3.3 pt -136.67 134.43 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.454 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 6.6 pt-20 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.652 ' HZ1' ' HA ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.648 0.261 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . 0.645 ' HA ' ' HZ1' ' C' ' 17' ' ' LYS . 73.8 t80 -62.57 -41.09 98.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.304 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 34.5 mmt180 -73.75 -30.39 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -71.66 -34.5 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.709 HD11 HD11 ' C' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.59 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.604 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.81 -25.57 64.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 6.2 t-20 -66.29 -37.41 85.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.515 ' HD3' ' HB2' ' A' ' 25' ' ' LEU . 6.3 mmp_? -71.05 -44.61 65.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.3 OUTLIER -61.33 -32.52 72.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.565 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -81.82 -28.35 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.79 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.435 ' O ' HG22 ' B' ' 30' ' ' THR . 37.0 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.21 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.671 HD11 ' HA ' ' A' ' 25' ' ' LEU . 11.5 mt -72.1 -28.95 63.63 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.438 ' O ' HG21 ' B' ' 32' ' ' VAL . 25.2 t0 -66.83 -47.42 72.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.909 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.537 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 2.5 t -71.01 -33.79 70.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.81 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.649 HH21 HD23 ' B' ' 28' ' ' LEU . 45.3 ttp85 -67.74 -40.1 84.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.539 HG23 ' NH2' ' C' ' 31' ' ' ARG . 33.8 m -76.15 -29.44 19.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.256 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.669 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 7.2 t70 -62.62 -57.28 11.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' B' ' 30' ' ' THR . 26.8 pttt -70.13 -44.68 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -45.33 81.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.46 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -26.36 63.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 111.075 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' B' ' 68' ' ' ALA . . . -66.53 -37.8 85.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.418 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 52.3 p -82.92 -38.76 22.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.466 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 30.8 t -57.27 -57.33 13.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.56 68.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.65 ' HB1' ' HB1' ' B' ' 70' ' ' ALA . . . -62.18 -45.46 93.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.919 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' B' ' 42' ' ' LEU . 0.3 OUTLIER -66.07 -32.79 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.077 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 1.1 m-20 -82.88 -15.72 50.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.76 -17.72 64.42 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.144 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.746 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -75.39 162.71 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.94 -30.38 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.451 ' CG ' ' HB3' ' B' ' 55' ' ' ASN . 15.7 tt0 72.04 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.0 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.7 Cg_endo -89.15 140.66 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.626 2.217 . . . . 0.0 112.514 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 18.2 m-85 67.05 150.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.461 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . -173.97 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.308 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.01 -19.45 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.159 0.584 . . . . 0.0 112.473 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 148.45 48.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.3 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.07 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.552 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.425 HG22 ' N ' ' B' ' 55' ' ' ASN . 7.2 p -110.41 137.95 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 6.5 t30 -125.84 119.71 28.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 111.706 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -80.3 128.4 33.5 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.201 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.746 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 16.7 p -114.32 119.79 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.99 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.456 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -176.91 166.76 37.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.532 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.38 165.1 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.307 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.05 176.09 21.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.403 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.0 156.28 27.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.549 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.669 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.66 123.25 14.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . 0.58 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 33.5 mtt-85 65.78 -88.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.063 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 64.8 p -137.56 12.89 2.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.22 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -109.33 173.14 6.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.25 177.22 7.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.123 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' B' ' 37' ' ' ALA . . . -163.71 161.14 23.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.607 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tp -119.5 136.21 54.43 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.65 ' HB1' ' HB1' ' B' ' 41' ' ' ALA . . . -136.48 137.82 40.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -137.99 145.79 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.085 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -172.58 -175.37 40.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.463 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.6 p -164.07 158.37 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.17 159.58 28.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.3 118.98 23.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.487 ' HD3' ' HB1' ' B' ' 82' ' ' ALA . 0.0 OUTLIER -105.84 104.03 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.698 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 10.8 p -101.91 126.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.293 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.76 -171.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -118.21 58.32 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.97 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.783 ' HA ' HG21 ' B' ' 103' ' ' ILE . 6.3 p -112.37 143.43 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.487 ' HB1' ' HD3' ' B' ' 76' ' ' ARG . . . -146.7 151.72 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 111.231 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 44.9 tp -136.36 132.57 35.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.623 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.21 47.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.34 18.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.45 157.33 10.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.509 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.167 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.91 30.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.339 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.39 126.81 37.97 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.311 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -140.85 145.61 36.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.581 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 55.17 -98.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.27 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.37 -25.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.725 0.298 . . . . 0.0 111.287 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 92.3 p -126.95 12.88 7.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 33.8 m-20 -98.93 69.27 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.09 127.01 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.059 0.457 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.626 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 5.3 ptp -133.02 147.14 52.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.744 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -126.24 130.85 51.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.388 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -128.02 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.699 0.285 . . . . 0.0 111.449 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.11 109.46 7.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.811 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.434 ' CB ' HD22 ' A' ' 45' ' ' LEU . 91.5 p -125.18 163.56 22.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.435 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -131.09 140.2 49.98 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.085 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.413 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 45.1 m-80 -111.72 125.54 54.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.378 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.783 HG21 ' HA ' ' B' ' 81' ' ' VAL . 3.3 pt -136.66 134.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.824 0.345 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 6.6 pt-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.645 ' HZ1' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.663 0.268 . . . . 0.0 110.571 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . 0.647 ' HA ' ' HZ1' ' A' ' 17' ' ' LYS . 73.8 t80 -62.63 -41.12 98.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 34.6 mmt180 -73.76 -30.29 62.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.813 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -71.74 -34.47 69.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.712 HD11 HD11 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -63.97 -51.67 63.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.57 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.77 -25.59 64.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 6.1 t-20 -66.29 -37.4 85.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.528 ' HD3' ' HB2' ' B' ' 25' ' ' LEU . 6.3 mmp_? -70.96 -44.8 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.681 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -61.24 -32.48 72.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -81.9 -28.3 32.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.432 ' O ' HG22 ' C' ' 30' ' ' THR . 36.9 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.27 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.678 HD11 ' HA ' ' B' ' 25' ' ' LEU . 11.4 mt -72.08 -29.03 63.71 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.439 ' O ' HG21 ' C' ' 32' ' ' VAL . 25.2 t0 -66.68 -47.39 72.58 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.978 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.533 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 2.5 t -71.15 -33.7 70.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.792 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.618 HH21 HD23 ' C' ' 28' ' ' LEU . 45.4 ttp85 -67.8 -40.09 83.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.361 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.537 HG23 ' NH2' ' A' ' 31' ' ' ARG . 33.7 m -76.11 -29.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.233 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . 0.656 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 7.2 t70 -62.47 -57.38 11.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.017 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' C' ' 30' ' ' THR . 26.8 pttt -70.11 -44.65 68.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.797 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.93 -45.33 81.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.15 -26.3 62.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.762 0.315 . . . . 0.0 111.067 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' C' ' 68' ' ' ALA . . . -66.55 -37.8 85.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.441 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.518 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 52.3 p -82.91 -38.77 22.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.689 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' SER . . . . . 0.465 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 30.8 t -57.22 -57.35 12.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 111.089 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.52 68.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . 0.676 ' HB1' ' HB1' ' C' ' 70' ' ' ALA . . . -62.31 -45.29 93.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.956 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' C' ' 42' ' ' LEU . 0.3 OUTLIER -66.18 -32.77 74.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.061 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.553 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.1 m-20 -82.85 -15.8 50.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.74 -17.74 64.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.073 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.738 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -75.36 162.74 28.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.857 177.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.96 -30.38 0.48 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.092 0.472 . . . . 0.0 111.712 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . 0.451 ' CG ' ' HB3' ' C' ' 55' ' ' ASN . 15.7 tt0 72.11 104.32 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.996 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.8 Cg_endo -89.16 140.59 3.94 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.67 2.247 . . . . 0.0 112.53 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 18.2 m-85 67.08 150.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.465 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . -173.87 68.82 0.1 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.278 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 p -92.05 -19.36 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.158 0.583 . . . . 0.0 112.494 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.72 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 148.38 48.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.338 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 -175.11 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.667 0.27 . . . . 0.0 110.563 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.443 HG22 ' N ' ' C' ' 55' ' ' ASN . 7.1 p -110.3 137.97 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.593 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 6.5 t30 -125.9 119.76 28.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 111.67 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -80.32 128.38 33.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.738 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 16.8 p -114.3 119.93 38.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.983 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.32 141.5 25.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.523 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -176.92 166.66 37.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.566 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.29 165.09 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.358 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.05 176.12 21.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.472 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.26 27.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.654 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.656 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.69 123.19 14.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.572 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 33.5 mtt-85 65.82 -88.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.032 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 64.1 p -137.53 12.93 2.98 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.172 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 32.8 t -109.35 173.15 6.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.28 177.22 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.065 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' C' ' 37' ' ' ALA . . . -163.72 161.2 23.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.546 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -119.62 136.13 54.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.762 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.676 ' HB1' ' HB1' ' C' ' 41' ' ' ALA . . . -136.39 137.91 41.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.671 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -138.08 145.81 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.058 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -172.57 -175.46 40.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.0 158.41 19.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.827 0.346 . . . . 0.0 111.043 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.2 159.53 28.06 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.207 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.29 118.99 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.377 . . . . 0.0 111.153 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.487 ' HD3' ' HB1' ' C' ' 82' ' ' ALA . 0.0 OUTLIER -105.8 104.04 13.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.721 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.72 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 10.7 p -101.95 126.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.279 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.87 -171.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.922 0.391 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -118.23 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.59 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -157.01 -53.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.757 ' HA ' HG21 ' C' ' 103' ' ' ILE . 6.4 p -112.41 143.49 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.509 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.487 ' HB1' ' HD3' ' C' ' 76' ' ' ARG . . . -146.72 151.72 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.202 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.4 132.62 35.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 143.21 47.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 171.32 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.45 157.33 10.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.584 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.839 0.352 . . . . 0.0 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.26 151.97 30.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.336 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 126.86 38.08 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.232 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -140.89 145.56 36.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.615 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.415 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 55.23 -98.51 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.201 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.38 -25.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 0.0 111.25 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.98 12.91 7.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 33.9 m-20 -98.96 69.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.07 127.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.706 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.614 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 5.3 ptp -133.03 147.15 52.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.716 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -126.25 130.86 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.422 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -128.03 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.15 109.54 7.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.445 ' CB ' HD22 ' B' ' 45' ' ' LEU . 91.6 p -125.19 163.53 22.27 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.423 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.11 140.23 49.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.426 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 45.1 m-80 -111.77 125.53 54.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.402 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.757 HG21 ' HA ' ' C' ' 81' ' ' VAL . 3.3 pt -136.69 134.45 48.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.831 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.459 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 6.5 pt-20 -111.6 159.45 18.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 50.4 m95 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.666 179.68 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.434 ' HZ1' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.676 0.274 . . . . 0.0 110.582 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.45 ' HA ' ' HZ1' ' B' ' 17' ' ' LYS . 81.6 t80 -58.47 -35.35 72.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 111.258 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.78 -41.93 35.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -59.4 -35.03 73.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.4 HD12 ' HZ2' ' B' ' 17' ' ' LYS . 0.7 OUTLIER -60.84 -59.54 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.538 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -65.57 -21.2 66.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.8 -40.99 75.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HD3' HD11 ' C' ' 25' ' ' LEU . 4.5 mmp_? -71.73 -43.75 65.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.815 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.489 HD11 ' HD3' ' B' ' 24' ' ' ARG . 1.2 tp -59.75 -40.97 89.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.646 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.22 -32.74 64.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.775 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HZ1' HD21 ' C' ' 25' ' ' LEU . 14.5 tttm -71.43 -29.68 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.668 0.27 . . . . 0.0 111.237 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.494 HD13 HD13 ' B' ' 28' ' ' LEU . 4.3 mt -85.16 -31.1 23.44 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.422 ' O ' HG21 ' A' ' 32' ' ' VAL . 25.4 t70 -66.34 -41.21 89.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.976 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.615 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 7.0 t -73.23 -44.54 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.797 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.757 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 24.3 ttp85 -60.46 -37.03 79.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.304 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.614 HG23 ' NH2' ' B' ' 31' ' ' ARG . 33.9 m -75.71 -31.82 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.117 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.33 -50.7 64.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.032 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.757 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 23.2 pttt -71.48 -42.17 68.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.718 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -52.95 47.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.474 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.462 HD22 ' SD ' ' B' ' 96' ' ' MET . 3.6 tp -66.14 -38.3 87.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.087 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.06 77.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.446 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.3 p -75.38 -37.17 60.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.2 t -58.12 -66.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -31.47 35.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.425 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.81 -53.37 59.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HA ' HD23 ' A' ' 42' ' ' LEU . 1.8 tm? -69.36 -32.82 72.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.104 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -75.99 -5.67 47.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -13.81 59.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.135 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.791 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.7 mm? -75.64 172.53 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' C' ' 46' ' ' PHE . 47.2 p90 -153.55 -26.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.66 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.93 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -92.04 144.56 2.86 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.591 2.194 . . . . 0.0 112.57 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 48' ' ' PRO . 11.0 m-85 53.5 154.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . 178.25 79.15 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.279 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.97 -26.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.142 0.577 . . . . 0.0 112.424 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.2 49.35 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.34 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.15 -178.11 5.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.545 0.212 . . . . 0.0 110.642 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.77 144.26 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.498 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' B' ' 104' ' ' GLU . 1.7 t30 -128.75 125.3 37.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.987 0.422 . . . . 0.0 111.662 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.37 128.15 37.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.791 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 10.5 p -113.12 131.8 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.99 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.63 133.17 13.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.424 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -166.64 179.46 40.52 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.588 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.49 177.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.763 0.316 . . . . 0.0 111.4 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 67' ' ' GLN . . . -154.04 172.93 32.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.408 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.68 156.79 28.38 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.486 ' CE1' ' HE2' ' B' ' 96' ' ' MET . 1.1 t80 -146.71 125.89 12.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.751 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 66.04 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.137 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.225 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.64 166.16 13.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -124.1 174.41 7.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 111.093 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.02 157.47 37.66 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -111.8 134.16 53.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.39 136.73 48.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.68 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.84 145.79 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.147 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -175.96 -179.3 46.37 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -160.53 157.93 28.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.22 153.98 25.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.268 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.51 128.77 47.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.428 ' NH2' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -110.76 105.53 14.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.698 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 77' ' ' VAL . 11.4 p -100.86 130.84 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.372 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 56.57 -167.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.056 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.428 ' HA ' ' NH2' ' A' ' 76' ' ' ARG . 58.0 mt-10 -122.59 61.71 0.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.76 -51.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.006 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.69 135.63 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.476 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.16 164.75 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.295 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 84' ' ' LYS . 7.0 tp -142.58 148.27 37.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.624 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.422 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -152.74 136.05 15.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.08 18.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.22 154.63 14.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.571 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.58 42.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.926 0.393 . . . . 0.0 111.027 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.36 147.69 38.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.323 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.36 126.02 44.36 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.253 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.732 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . . . -138.65 152.02 47.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.706 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.48 -97.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.281 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.22 -39.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -115.72 16.42 16.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.158 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.555 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 14.4 m-20 -101.12 65.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.19 119.3 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 110.704 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.502 ' HE2' ' CE1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -117.82 145.31 44.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -124.87 132.66 53.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.686 0.279 . . . . 0.0 111.451 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.05 108.55 4.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.739 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.568 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 85.0 p -128.73 160.87 31.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -125.94 138.35 53.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.908 0.385 . . . . 0.0 111.09 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.634 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 22.9 m-80 -104.73 129.86 52.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.411 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.94 132.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.631 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 8.3 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.45 ' HZ1' ' HA ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.677 0.275 . . . . 0.0 110.558 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . 0.43 ' HA ' ' HZ1' ' C' ' 17' ' ' LYS . 81.8 t80 -58.53 -35.32 72.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.216 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -77.74 -42.0 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -59.43 -34.97 73.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.406 HD12 ' HZ2' ' C' ' 17' ' ' LYS . 0.7 OUTLIER -60.87 -59.51 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.563 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.53 -21.27 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.72 -40.93 75.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.489 ' HD3' HD11 ' A' ' 25' ' ' LEU . 4.5 mmp_? -71.82 -43.66 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.51 HD11 ' HD3' ' C' ' 24' ' ' ARG . 1.2 tp -59.91 -40.89 90.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.18 -32.82 65.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.468 ' HZ1' HD21 ' A' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.63 65.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.193 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 28' ' ' LEU . 4.2 mt -85.15 -31.0 23.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.426 ' O ' HG21 ' B' ' 32' ' ' VAL . 25.3 t70 -66.41 -41.2 89.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.941 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.611 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 7.0 t -73.22 -44.53 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.756 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.1 79.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.313 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.615 HG23 ' NH2' ' C' ' 31' ' ' ARG . 33.8 m -75.63 -31.82 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.233 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.45 -50.57 64.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.756 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 23.1 pttt -71.5 -42.09 68.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.787 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.9 -52.89 48.29 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.412 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.45 HD22 ' SD ' ' C' ' 96' ' ' MET . 3.6 tp -66.04 -38.41 88.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.14 77.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.479 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 70.5 p -75.33 -37.17 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.806 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 46.0 t -58.17 -65.9 0.57 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.157 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -31.4 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.83 -53.37 59.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' B' ' 42' ' ' LEU . 1.8 tm? -69.35 -32.87 72.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -76.01 -5.7 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -13.7 59.82 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.213 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.795 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.7 mm? -75.66 172.44 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.866 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 47.0 p90 -153.48 -26.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.53 107.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.992 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -92.07 144.57 2.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.622 2.214 . . . . 0.0 112.56 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.529 ' O ' ' O ' ' B' ' 48' ' ' PRO . 11.0 m-85 53.39 154.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.412 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . 178.26 78.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.236 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.87 -26.5 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.11 0.564 . . . . 0.0 112.506 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.18 49.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.299 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.21 -178.16 5.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.564 0.221 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.65 144.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.55 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.643 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 1.7 t30 -128.76 125.16 37.26 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.29 128.15 37.01 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.257 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.795 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 10.4 p -113.15 131.77 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.042 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.59 133.13 13.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -166.5 179.54 40.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.67 177.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 0.0 111.35 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' B' ' 67' ' ' GLN . . . -153.97 172.88 32.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.538 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 156.84 28.43 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.531 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' TYR . . . . . 0.503 ' CE1' ' HE2' ' C' ' 96' ' ' MET . 1.1 t80 -146.78 125.79 12.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.764 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.96 -89.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.5 p -137.95 16.75 2.84 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.214 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.74 166.17 13.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.8 OUTLIER -124.06 174.4 7.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.04 157.52 37.72 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.535 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tp -111.83 134.23 53.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.795 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.49 136.71 48.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.677 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.89 145.72 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.319 . . . . 0.0 111.166 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -175.88 -179.28 46.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.406 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.9 p -160.57 157.92 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.918 0.39 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.18 153.99 25.51 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.215 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.56 128.83 47.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' B' ' 79' ' ' GLU . 0.0 OUTLIER -110.72 105.52 14.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.791 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.487 ' O ' HG13 ' B' ' 77' ' ' VAL . 11.4 p -100.89 130.79 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.284 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 56.62 -167.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.945 0.402 . . . . 0.0 111.102 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.429 ' HA ' ' NH2' ' B' ' 76' ' ' ARG . 57.4 mt-10 -122.59 61.79 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.77 -51.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.03 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.57 135.66 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.539 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.2 164.79 29.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' B' ' 84' ' ' LYS . 7.0 tp -142.62 148.3 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . 0.418 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 0.0 OUTLIER -152.81 136.02 15.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.151 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.17 169.05 18.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.17 154.65 14.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.571 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.56 42.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.88 0.372 . . . . 0.0 111.096 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.28 147.68 38.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.348 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.35 125.99 44.32 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.305 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' B' ' 34' ' ' LYS . . . -138.62 152.03 47.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.604 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.46 -97.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.272 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.19 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.64 16.44 16.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.193 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.544 ' HB3' ' HB1' ' B' ' 90' ' ' ALA . 13.9 m-20 -101.15 65.65 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.17 119.38 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.486 ' HE2' ' CE1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -117.89 145.33 44.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.721 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.87 132.6 53.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.19 142.43 49.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.08 108.48 4.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' SER . . . . . 0.562 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 85.1 p -128.71 160.89 31.07 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.431 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 18.2 p90 -125.93 138.35 53.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 0.0 111.038 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.635 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 22.9 m-80 -104.72 129.87 52.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.38 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.94 132.73 61.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.843 0.354 . . . . 0.0 110.801 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.641 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 8.3 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.43 ' HZ1' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.665 0.269 . . . . 0.0 110.504 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . 0.434 ' HA ' ' HZ1' ' A' ' 17' ' ' LYS . 81.6 t80 -58.52 -35.29 72.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 111.241 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.77 -41.94 35.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.44 -34.99 73.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.141 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' LEU . . . . . 0.406 HD12 ' HZ2' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -60.84 -59.5 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.591 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.64 -21.18 66.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.981 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -69.75 -40.99 75.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.51 ' HD3' HD11 ' B' ' 25' ' ' LEU . 4.4 mmp_? -71.83 -43.68 65.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.771 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.499 HD11 ' HD3' ' A' ' 24' ' ' ARG . 1.3 tp -59.82 -40.96 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.18 -32.8 65.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.461 ' HZ1' HD21 ' B' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.69 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.168 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.49 HD13 HD13 ' A' ' 28' ' ' LEU . 4.2 mt -85.07 -31.08 23.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.422 ' O ' HG21 ' C' ' 32' ' ' VAL . 25.5 t70 -66.32 -41.27 89.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.01 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.626 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 7.0 t -73.24 -44.45 59.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.747 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.12 79.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.28 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.616 HG23 ' NH2' ' A' ' 31' ' ' ARG . 33.8 m -75.55 -31.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.4 -50.65 64.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.031 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.747 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 23.1 pttt -71.53 -42.13 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.737 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -53.04 46.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.422 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.464 HD22 ' SD ' ' A' ' 96' ' ' MET . 3.6 tp -66.04 -38.37 88.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 111.052 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.79 -44.03 77.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.416 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 70.7 p -75.37 -37.22 60.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 46.1 t -58.13 -65.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.123 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -31.36 35.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.456 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.8 -53.39 58.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' C' ' 42' ' ' LEU . 1.8 tm? -69.44 -32.82 72.0 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 62.0 m-20 -75.98 -5.63 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -13.75 59.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.098 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.813 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.7 mm? -75.66 172.52 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.878 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 47.0 p90 -153.57 -26.26 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.664 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.59 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.993 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -92.02 144.54 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.675 2.25 . . . . 0.0 112.568 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.525 ' O ' ' O ' ' C' ' 48' ' ' PRO . 11.0 m-85 53.43 154.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.941 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.415 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . 178.23 79.13 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.266 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.9 -26.61 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.153 0.581 . . . . 0.0 112.434 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.24 49.42 0.02 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.299 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.15 -178.05 5.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.587 0.232 . . . . 0.0 110.628 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.74 144.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.558 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.631 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 1.7 t30 -128.74 125.32 37.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.35 128.11 37.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.276 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.813 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 10.2 p -113.17 131.79 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.984 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.56 133.14 13.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.446 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -166.62 179.43 40.53 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.54 177.09 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.349 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' C' ' 67' ' ' GLN . . . -153.96 172.99 32.64 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.424 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.69 156.77 28.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.563 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' TYR . . . . . 0.502 ' CE1' ' HE2' ' A' ' 96' ' ' MET . 1.1 t80 -146.72 125.82 12.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.99 -90.03 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.182 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.7 166.26 12.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.8 OUTLIER -124.18 174.4 7.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.347 . . . . 0.0 111.129 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.98 157.44 37.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.553 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tp -111.82 134.21 53.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.51 136.78 48.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.626 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' C' ' 71' ' ' ILE . 7.6 tp -141.91 145.71 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 111.145 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -175.93 -179.23 46.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.426 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -160.59 157.88 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.964 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.13 153.9 25.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.251 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.47 128.78 47.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.195 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' C' ' 79' ' ' GLU . 0.0 OUTLIER -110.66 105.59 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.494 HG13 ' O ' ' C' ' 77' ' ' VAL . 11.5 p -101.02 130.81 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.964 0.412 . . . . 0.0 111.256 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 56.62 -167.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.089 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' GLU . . . . . 0.429 ' HA ' ' NH2' ' C' ' 76' ' ' ARG . 57.4 mt-10 -122.53 61.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.587 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 -51.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.012 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.66 135.6 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.11 164.81 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.226 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' C' ' 84' ' ' LYS . 7.0 tp -142.65 148.27 37.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . 0.403 ' N ' ' HG ' ' C' ' 83' ' ' LEU . 0.0 OUTLIER -152.75 136.04 15.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.212 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.23 169.05 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.18 154.64 14.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.592 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.56 142.54 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.829 0.347 . . . . 0.0 111.093 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.3 147.71 38.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.39 126.0 44.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.306 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' C' ' 34' ' ' LYS . . . -138.68 152.01 47.68 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.621 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.35 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 42.0 t -151.23 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.333 . . . . 0.0 111.32 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.63 16.4 16.48 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.161 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.544 ' HB3' ' HB1' ' C' ' 90' ' ' ALA . 14.1 m-20 -101.16 65.7 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.26 119.37 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.673 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.503 ' HE2' ' CE1' ' B' ' 63' ' ' TYR . 0.3 OUTLIER -117.85 145.25 44.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.693 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.89 132.65 53.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.443 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.26 142.39 49.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.688 0.28 . . . . 0.0 111.483 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.97 108.49 4.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.738 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 100' ' ' SER . . . . . 0.564 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 84.6 p -128.67 160.85 31.18 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.435 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -125.94 138.38 53.77 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.896 0.379 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 102' ' ' ASN . . . . . 0.613 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 23.1 m-80 -104.73 129.89 52.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.614 HD13 ' HZ2' ' C' ' 105' ' ' TRP . 2.6 pt -132.0 132.67 61.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 104' ' ' GLU . . . . . 0.643 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 8.3 pt-20 -110.95 143.23 41.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 105' ' ' TRP . . . . . 0.614 ' HZ2' HD13 ' C' ' 103' ' ' ILE . 14.6 m95 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.683 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.632 -0.187 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 37.66 -99.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.373 . . . . 0.0 110.975 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -112.32 -52.62 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 178.77 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 t -70.04 -56.55 6.65 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.777 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -52.63 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.68 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m 67.08 53.14 0.82 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.032 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.737 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 24.2 m80 -70.64 -52.89 10.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.774 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.737 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -52.75 123.47 13.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.488 2.125 . . . . 0.0 111.886 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.551 HE21 ' HB2' ' B' ' 17' ' ' LYS . 7.9 mm100 -128.02 -54.8 1.29 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.939 0.399 . . . . 0.0 111.172 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -125.22 -155.35 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.71 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -70.41 -22.73 62.7 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.473 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -140.82 12.17 2.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.489 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.04 -25.97 67.72 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.298 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.624 ' HB2' ' HA ' ' A' ' 9' ' ' PRO . . . -64.77 -41.1 96.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 110.921 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -74.3 -34.97 63.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.943 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.563 ' HB2' HE21 ' C' ' 10' ' ' GLN . 32.9 ttmt -70.14 -44.75 68.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.524 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -38.15 88.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.268 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -68.37 -42.96 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.17 -44.94 95.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.42 . . . . 0.0 111.137 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.471 HD22 ' CD2' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -66.03 -44.19 85.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.526 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.21 -34.17 77.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.011 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -72.77 -37.12 67.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -68.15 -44.02 76.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.734 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.682 ' HG ' HD21 ' C' ' 25' ' ' LEU . 3.9 mt -60.81 -44.92 96.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' OG1' ' A' ' 30' ' ' THR . 49.3 t0 -63.03 -33.85 76.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 11.8 tttt -71.19 -35.89 71.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.54 ' CD1' ' HB3' ' C' ' 28' ' ' LEU . 0.5 OUTLIER -66.42 -52.36 47.33 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HA ' HD23 ' B' ' 28' ' ' LEU . 46.9 t0 -55.56 -39.3 70.46 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.977 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.3 m -61.33 -49.72 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.862 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.623 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 85.0 mmt-85 -58.11 -32.02 67.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 18.9 t -77.3 -36.48 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.162 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.783 ' HB3' ' HG ' ' A' ' 66' ' ' SER . 59.1 m-20 -64.1 -52.8 57.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.94 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.636 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 13.3 pttt -77.22 -37.16 53.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA3' ' HH ' ' C' ' 63' ' ' TYR . . . -61.97 -40.18 98.55 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.433 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.621 HD21 ' CB ' ' B' ' 39' ' ' SER . 0.2 OUTLIER -72.86 -37.38 67.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.91 91.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -50.29 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.632 ' CB ' HD21 ' C' ' 36' ' ' LEU . 96.5 p -52.82 -49.37 65.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.2 73.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -50.53 -42.65 55.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -71.83 -42.51 66.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -75.81 -3.1 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.53 55.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.096 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -97.77 177.13 5.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.816 177.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -169.1 1.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.633 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 33.1 mt-30 63.9 116.38 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.277 9.9 Cg_endo -74.46 95.04 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.587 2.191 . . . . 0.0 112.593 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 87.4 m-85 68.83 -173.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 148.9 90.12 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.207 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -87.78 -14.74 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 123.152 0.581 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.37 48.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.279 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.99 -172.89 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 110.622 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.146 HG13 ' O ' ' B' ' 105' ' ' TRP . 4.5 p -103.48 148.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.571 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.689 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.47 44.12 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 111.656 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.475 ' O ' HG13 ' B' ' 103' ' ' ILE . 1.1 t80 -97.48 124.13 41.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.25 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.456 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.2 p -116.5 127.95 55.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.73 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -159.85 154.87 24.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.45 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.53 165.99 29.61 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.518 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 69' ' ' LEU . 13.6 m -112.08 163.68 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.4 179.65 27.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.56 144.82 11.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.552 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.446 ' HH ' ' HA3' ' B' ' 35' ' ' GLY . 75.1 t80 -136.92 129.48 30.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.314 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 65.72 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -152.25 34.96 0.52 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.158 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.783 ' HG ' ' HB3' ' A' ' 33' ' ' ASP . 2.2 m -130.92 168.01 18.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -140.78 144.35 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.113 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.92 156.18 43.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HA ' HG12 ' A' ' 60' ' ' VAL . 6.7 tp -113.19 125.35 54.24 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.778 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB3' ' HB1' ' A' ' 88' ' ' ALA . . . -119.55 151.14 39.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.706 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.73 HG13 ' HB3' ' A' ' 58' ' ' ALA . 18.4 tt -145.2 164.24 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.438 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 179.58 175.56 46.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.44 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.74 147.69 11.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.92 163.3 30.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.232 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.437 ' H ' HD11 ' A' ' 83' ' ' LEU . 20.6 t80 -108.5 120.72 43.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.496 ' CB ' ' HA3' ' A' ' 50' ' ' GLY . 6.6 mmm180 -96.72 92.38 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.723 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.2 p -96.79 131.83 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.6 m120 64.67 -177.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.078 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.3 24.25 11.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.495 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.059 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 82' ' ' ALA . 7.8 p -109.3 153.67 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.403 ' H ' HG22 ' A' ' 81' ' ' VAL . . . -156.28 173.51 16.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 111.259 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.437 HD11 ' H ' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -163.22 140.32 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.611 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.633 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -140.48 134.27 30.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.188 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.95 133.97 14.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.438 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -160.0 170.54 36.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.546 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 71' ' ' ILE . 9.7 p -117.44 147.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.136 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 70' ' ' ALA . . . -119.39 134.57 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.328 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.18 110.85 22.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.733 ' HB1' ' HB3' ' A' ' 94' ' ' ASP . . . -118.91 136.9 53.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.631 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.536 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 50.63 -111.95 1.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.318 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.39 -53.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.689 0.28 . . . . 0.0 111.307 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.508 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -106.37 26.83 9.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.145 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.733 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -116.85 81.82 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.59 139.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.707 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.417 ' HG2' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -135.36 158.53 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.723 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -134.16 133.5 41.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.468 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.73 161.09 17.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.747 0.308 . . . . 0.0 111.393 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.45 0.18 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.724 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.57 ' HB2' HD11 ' C' ' 45' ' ' LEU . 13.8 p -126.02 178.76 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.426 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -144.44 137.77 27.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.863 0.363 . . . . 0.0 111.121 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.568 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 69.9 m-80 -103.29 148.79 25.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.352 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.476 HG13 ' O ' ' C' ' 56' ' ' PHE . 7.4 pt -152.75 146.66 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.686 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 90.0 mt-10 -90.37 130.99 36.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 1.152 ' O ' HG13 ' C' ' 54' ' ' VAL . 2.9 t-105 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.682 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 112.64 -0.184 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 37.52 -99.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.985 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -112.29 -52.71 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 178.83 -59.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -70.09 -56.48 6.8 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.791 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -52.63 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.685 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m 67.12 53.11 0.81 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.022 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.737 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 24.3 m80 -70.65 -52.83 10.22 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.771 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.737 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -52.73 123.46 13.03 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.489 2.126 . . . . 0.0 111.896 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.549 HE21 ' HB2' ' C' ' 17' ' ' LYS . 7.9 mm100 -127.99 -54.88 1.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.982 0.42 . . . . 0.0 111.122 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.24 -155.41 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.659 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -70.35 -22.69 62.76 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.469 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -140.81 12.1 2.26 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.5 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.01 -25.99 67.76 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.266 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.626 ' HB2' ' HA ' ' B' ' 9' ' ' PRO . . . -64.67 -41.18 96.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.93 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -74.38 -34.8 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.009 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.551 ' HB2' HE21 ' A' ' 10' ' ' GLN . 33.0 ttmt -70.15 -44.7 68.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.538 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -38.11 88.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 mtt85 -68.26 -43.03 78.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.15 -44.94 95.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.471 ' CD2' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.98 -44.24 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.627 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.2 -34.08 76.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.078 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.85 -37.09 67.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mtt180 -68.06 -44.02 77.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.675 ' HG ' HD21 ' A' ' 25' ' ' LEU . 3.9 mt -60.91 -44.9 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.59 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.414 ' O ' ' OG1' ' B' ' 30' ' ' THR . 49.3 t0 -63.04 -33.84 76.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.869 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 11.8 tttt -71.16 -35.88 71.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.221 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.539 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -66.34 -52.41 47.31 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.456 ' HA ' HD23 ' C' ' 28' ' ' LEU . 46.8 t0 -55.54 -39.37 70.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.951 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.492 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 13.8 m -61.3 -49.74 75.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.87 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.625 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 85.0 mmt-85 -58.09 -31.97 67.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 18.8 t -77.35 -36.54 23.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.775 ' HB3' ' HG ' ' B' ' 66' ' ' SER . 59.3 m-20 -64.05 -52.81 57.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.654 ' HD2' ' HB2' ' B' ' 94' ' ' ASP . 13.3 pttt -77.27 -37.09 53.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.791 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.446 ' HA3' ' HH ' ' A' ' 63' ' ' TYR . . . -62.02 -40.18 98.56 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.419 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.629 HD21 ' CB ' ' C' ' 39' ' ' SER . 0.2 OUTLIER -72.84 -37.42 67.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.0 91.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.471 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.98 -50.28 50.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.719 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.621 ' CB ' HD21 ' A' ' 36' ' ' LEU . 96.4 p -52.82 -49.34 65.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.11 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.401 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.618 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . . . -50.54 -42.67 55.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.928 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -71.86 -42.43 66.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.92 -3.09 33.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.83 0.35 55.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.178 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -97.69 177.11 5.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.871 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.11 1.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.716 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.63 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 33.1 mt-30 63.97 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.977 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.277 9.8 Cg_endo -74.51 95.08 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.601 2.201 . . . . 0.0 112.508 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 87.4 m-85 68.84 -173.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 148.95 90.13 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.209 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -87.79 -14.77 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.141 0.576 . . . . 0.0 112.425 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.73 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.39 48.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.315 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.86 -172.9 4.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.605 0.241 . . . . 0.0 110.587 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 1.133 HG13 ' O ' ' C' ' 105' ' ' TRP . 4.6 p -103.37 148.77 7.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.607 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.672 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.5 44.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.928 0.395 . . . . 0.0 111.667 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.484 ' O ' HG13 ' C' ' 103' ' ' ILE . 1.1 t80 -97.5 124.12 41.61 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.277 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.448 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.0 p -116.51 127.89 54.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.941 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.709 ' HB3' HG13 ' B' ' 71' ' ' ILE . . . -159.83 154.75 24.63 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.452 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.62 166.04 29.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.544 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' B' ' 69' ' ' LEU . 13.8 m -112.06 163.69 8.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.347 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.37 179.58 27.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.462 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.54 144.87 11.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.451 ' HH ' ' HA3' ' C' ' 35' ' ' GLY . 75.3 t80 -136.92 129.62 30.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.729 0.299 . . . . 0.0 110.727 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 65.52 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.23 34.84 0.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.775 ' HG ' ' HB3' ' B' ' 33' ' ' ASP . 2.2 m -130.86 168.04 17.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -140.78 144.3 35.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.164 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.88 156.3 43.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.473 ' HA ' HG12 ' B' ' 60' ' ' VAL . 6.8 tp -113.2 125.36 54.25 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.792 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.701 ' HB3' ' HB1' ' B' ' 88' ' ' ALA . . . -119.59 151.15 39.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.699 0.285 . . . . 0.0 111.665 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.709 HG13 ' HB3' ' B' ' 58' ' ' ALA . 18.4 tt -145.19 164.2 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.126 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 179.6 175.52 46.47 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.433 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.74 147.77 11.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.873 0.368 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.91 163.33 30.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.433 ' H ' HD11 ' B' ' 83' ' ' LEU . 20.5 t80 -108.49 120.61 42.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.494 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.49 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.73 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.1 p -96.85 131.91 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.239 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.5 m120 64.6 -177.25 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.925 0.393 . . . . 0.0 111.04 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -116.26 24.21 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.563 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.402 HG22 ' N ' ' B' ' 82' ' ' ALA . 7.8 p -109.24 153.67 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.48 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.402 ' N ' HG22 ' B' ' 81' ' ' VAL . . . -156.33 173.47 16.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.281 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.433 HD11 ' H ' ' B' ' 75' ' ' TYR . 0.4 OUTLIER -163.12 140.39 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.63 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.24 30.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.195 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 134.03 14.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -160.04 170.58 36.18 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' B' ' 71' ' ' ILE . 9.8 p -117.44 147.41 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.85 0.357 . . . . 0.0 111.106 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' B' ' 70' ' ' ALA . . . -119.38 134.61 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.323 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.23 110.84 22.55 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.292 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.72 ' HB1' ' HB3' ' B' ' 94' ' ' ASP . . . -118.8 136.93 53.74 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.636 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.547 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 50.6 -112.05 1.45 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.3 -53.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.691 0.281 . . . . 0.0 111.326 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' SER . . . . . 0.504 ' O ' ' OG ' ' B' ' 93' ' ' SER . 2.2 t -106.35 26.85 9.34 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.198 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.72 ' HB3' ' HB1' ' B' ' 90' ' ' ALA . 0.3 OUTLIER -116.95 81.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.69 139.37 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.41 ' HG2' ' HB2' ' B' ' 88' ' ' ALA . 0.0 OUTLIER -135.38 158.52 44.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.711 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -134.12 133.55 41.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.72 161.05 17.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.51 0.18 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.575 ' HB2' HD11 ' A' ' 45' ' ' LEU . 13.9 p -126.05 178.78 5.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.462 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -144.52 137.76 27.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.002 0.429 . . . . 0.0 111.048 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.571 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 69.8 m-80 -103.2 148.8 25.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.442 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 56' ' ' PHE . 7.4 pt -152.77 146.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.336 . . . . 0.0 110.77 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.689 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 90.1 mt-10 -90.34 131.0 36.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . 1.146 ' O ' HG13 ' A' ' 54' ' ' VAL . 3.0 t-105 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.648 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.675 -0.17 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 37.66 -99.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.853 0.358 . . . . 0.0 110.985 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -112.3 -52.68 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.794 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 178.81 -59.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.011 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -70.02 -56.59 6.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.788 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -52.63 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.692 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m 67.09 53.15 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.996 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.746 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 24.2 m80 -70.72 -52.83 10.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.761 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.746 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -52.67 123.39 12.83 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.496 2.131 . . . . 0.0 111.911 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . 0.563 HE21 ' HB2' ' A' ' 17' ' ' LYS . 7.9 mm100 -127.97 -54.79 1.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 111.144 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.32 -155.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.669 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -70.36 -22.65 62.75 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.497 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -140.87 12.11 2.25 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.536 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.15 -25.89 67.66 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.248 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' C' ' 9' ' ' PRO . . . -64.67 -41.17 96.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.36 . . . . 0.0 110.943 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -74.39 -34.93 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.549 ' HB2' HE21 ' B' ' 10' ' ' GLN . 32.9 ttmt -70.08 -44.78 68.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.573 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -38.02 87.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.306 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -68.36 -43.0 78.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.13 -44.95 95.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.467 ' CD2' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -66.07 -44.15 85.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.554 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -34.13 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.77 -37.18 67.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -67.94 -44.13 77.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.772 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.682 HD21 ' HG ' ' A' ' 25' ' ' LEU . 3.9 mt -60.72 -44.99 95.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . 0.415 ' O ' ' OG1' ' C' ' 30' ' ' THR . 49.3 t0 -62.99 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.875 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 11.8 tttt -71.08 -35.9 72.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.313 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.54 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -66.38 -52.35 47.72 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.448 ' HA ' HD23 ' A' ' 28' ' ' LEU . 46.9 t0 -55.59 -39.28 70.5 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.496 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 14.3 m -61.4 -49.71 75.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.813 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.615 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 85.0 mmt-85 -58.05 -32.07 67.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.376 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 36' ' ' LEU . 18.6 t -77.26 -36.51 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.227 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.771 ' HB3' ' HG ' ' C' ' 66' ' ' SER . 59.0 m-20 -64.03 -52.85 57.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.631 ' HD2' ' HB2' ' C' ' 94' ' ' ASP . 13.2 pttt -77.26 -37.15 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.725 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . 0.451 ' HA3' ' HH ' ' B' ' 63' ' ' TYR . . . -62.02 -40.11 98.47 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.632 HD21 ' CB ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -72.85 -37.39 67.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.05 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.369 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.89 -50.38 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.629 ' CB ' HD21 ' B' ' 36' ' ' LEU . 96.6 p -52.71 -49.41 65.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.09 73.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.459 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.613 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . . . -50.56 -42.68 55.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -71.83 -42.46 66.94 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.88 -3.06 33.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.52 55.81 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.12 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -97.8 177.15 5.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.791 177.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.08 1.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.638 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.634 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 33.1 mt-30 63.99 116.4 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.95 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.4 94.97 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.647 2.231 . . . . 0.0 112.582 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 87.6 m-85 68.9 -173.61 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.9 90.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.247 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.8 -14.78 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.129 0.572 . . . . 0.0 112.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.43 48.77 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.274 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -147.01 -172.89 4.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.547 0.213 . . . . 0.0 110.573 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 1.152 HG13 ' O ' ' A' ' 105' ' ' TRP . 4.6 p -103.42 148.73 8.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.686 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 7.4 m-80 -134.0 136.48 44.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.662 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . 0.476 ' O ' HG13 ' A' ' 103' ' ' ILE . 1.1 t80 -97.49 124.13 41.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.457 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 44.8 p -116.51 127.93 54.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . 0.731 ' HB3' HG13 ' C' ' 71' ' ' ILE . . . -159.82 154.85 24.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.41 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.52 166.07 29.72 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' C' ' 69' ' ' LEU . 13.7 m -112.12 163.7 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.802 0.334 . . . . 0.0 111.339 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.41 179.58 27.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.476 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.49 144.78 11.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.544 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.45 ' HH ' ' HA3' ' A' ' 35' ' ' GLY . 75.5 t80 -136.91 129.57 30.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.723 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.5 mmm-85 65.58 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.22 34.87 0.52 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.16 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' SER . . . . . 0.771 ' HG ' ' HB3' ' C' ' 33' ' ' ASP . 2.2 m -130.93 168.02 18.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . 0.404 HE21 ' HB3' ' C' ' 67' ' ' GLN . 5.7 mm100 -140.73 144.36 35.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.87 156.27 43.44 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.529 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.482 ' HA ' HG12 ' C' ' 60' ' ' VAL . 6.7 tp -113.23 125.38 54.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.702 ' HB3' ' HB1' ' C' ' 88' ' ' ALA . . . -119.54 151.16 39.08 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.695 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.731 HG13 ' HB3' ' C' ' 58' ' ' ALA . 18.3 tt -145.24 164.27 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.19 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.433 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 179.59 175.54 46.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.75 147.77 11.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.967 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.93 163.32 30.43 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.237 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.431 ' H ' HD11 ' C' ' 83' ' ' LEU . 20.6 t80 -108.5 120.64 43.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 111.137 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.495 ' CB ' ' HA3' ' C' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.32 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.675 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.732 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.2 p -96.73 131.87 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 111.332 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.5 m120 64.58 -177.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 111.093 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.33 24.21 11.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.8 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.419 HG22 ' H ' ' C' ' 82' ' ' ALA . 7.9 p -109.19 153.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.544 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.419 ' H ' HG22 ' C' ' 81' ' ' VAL . . . -156.35 173.47 16.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 111.252 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.431 HD11 ' H ' ' C' ' 75' ' ' TYR . 0.4 OUTLIER -163.08 140.34 7.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.595 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.634 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.27 30.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 133.95 14.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . 0.433 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.95 170.58 36.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.597 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -117.48 147.42 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.936 0.398 . . . . 0.0 111.096 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.702 ' HB1' ' HB3' ' C' ' 70' ' ' ALA . . . -119.35 134.61 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.22 110.89 22.63 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' C' ' 94' ' ' ASP . . . -118.88 136.92 53.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.679 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.564 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 50.61 -112.03 1.45 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.255 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.33 -53.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.257 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' C' ' 93' ' ' SER . 2.2 t -106.32 26.83 9.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.721 ' HB3' ' HB1' ' C' ' 90' ' ' ALA . 0.3 OUTLIER -116.88 81.83 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.93 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.63 139.32 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.737 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.411 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.0 OUTLIER -135.34 158.56 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -134.16 133.53 41.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.419 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -113.67 161.09 17.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.403 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.51 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.752 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.565 ' HB2' HD11 ' B' ' 45' ' ' LEU . 13.8 p -126.05 178.69 5.62 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.413 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.4 137.8 27.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.556 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 69.8 m-80 -103.3 148.86 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.377 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.484 HG13 ' O ' ' B' ' 56' ' ' PHE . 7.4 pt -152.79 146.67 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.784 0.326 . . . . 0.0 110.821 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.672 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 90.1 mt-10 -90.39 131.03 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . 1.133 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.9 t-105 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.635 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.669 -0.172 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.49 ' HB2' ' H ' ' A' ' 7' ' ' SER . 86.5 m-20 40.69 -103.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -114.86 -48.64 2.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -177.32 -63.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.044 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.9 t -69.83 -53.52 17.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.727 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -48.43 -86.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.722 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.49 ' H ' ' HB2' ' A' ' 2' ' ' ASP . 19.4 m 65.0 46.66 2.75 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.025 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.705 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 16.6 m170 -73.85 -52.26 4.69 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.747 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.705 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -51.17 116.47 2.69 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.485 2.123 . . . . 0.0 111.889 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 8' ' ' HIS . 12.2 mm100 -128.14 -55.66 1.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.112 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.66 -153.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.687 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.63 -28.2 63.61 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.449 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -138.29 20.65 2.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.49 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.35 -21.0 65.61 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.32 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.7 -44.42 86.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.929 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 30.5 m-70 -71.8 -35.3 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.959 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' O ' HD21 ' A' ' 21' ' ' LEU . 36.1 ttmt -68.3 -47.32 67.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.54 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' CD2' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -67.74 -38.48 83.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -66.77 -45.68 77.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.818 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -64.23 -40.84 96.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.683 HD23 HD22 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -64.51 -45.27 87.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.51 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.69 -28.39 69.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -74.74 -40.33 61.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -70.87 -41.18 71.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.766 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.643 HD21 ' HG ' ' B' ' 25' ' ' LEU . 7.8 mt -62.05 -49.86 74.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.481 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.24 -48.86 79.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 9.0 tmtt? -55.45 -38.02 68.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.168 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.521 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -63.4 -40.4 97.11 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.6 91.93 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.98 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 m -57.74 -48.08 80.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.81 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.542 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 83.9 mmt-85 -57.28 -33.15 67.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 28' ' ' LEU . 44.4 t -76.77 -37.78 28.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.602 ' HB3' ' HG ' ' A' ' 66' ' ' SER . 48.2 m-20 -61.95 -54.34 43.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.012 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.551 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 2.5 pttt -75.87 -36.17 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.795 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 -45.49 87.98 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.422 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -68.19 -39.59 82.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.845 0.355 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.73 90.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.4 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -52.66 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.703 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.699 ' HB3' HD21 ' C' ' 36' ' ' LEU . 78.3 p -50.9 -56.42 12.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.425 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -54.81 -48.95 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.436 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.685 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -49.39 -42.19 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.93 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.63 -36.07 65.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.062 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' C' ' 40' ' ' ALA . 54.4 m-20 -78.27 -3.17 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.704 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.4 t -84.31 1.38 45.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.18 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.792 ' HB3' HG23 ' A' ' 57' ' ' THR . 0.3 OUTLIER -98.26 174.58 6.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.82 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.34 -3.52 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.142 0.496 . . . . 0.0 111.661 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.536 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 35.8 mt-30 64.27 117.55 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.96 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.278 9.8 Cg_endo -74.46 100.39 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.669 2.246 . . . . 0.0 112.577 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 90.3 m-85 67.61 -167.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.26 81.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.203 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -88.26 -12.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.157 0.583 . . . . 0.0 112.396 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.78 45.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.256 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.56 -168.65 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.585 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.956 HG13 ' O ' ' B' ' 105' ' ' TRP . 2.0 p -109.68 145.95 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.496 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.4 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 4.1 m-80 -128.52 135.32 49.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.943 0.402 . . . . 0.0 111.69 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.66 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.792 HG23 ' HB3' ' A' ' 45' ' ' LEU . 22.5 p -111.87 124.66 52.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.006 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.434 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -155.35 149.79 26.1 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.478 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.596 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 173.04 165.56 30.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -111.27 165.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 0.0 111.434 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -177.62 27.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.496 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -160.65 144.42 9.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.537 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.492 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 65.5 t80 -133.54 133.42 42.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.728 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.488 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 3.1 mmm-85 64.5 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.126 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.47 33.28 0.37 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.161 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.602 ' HG ' ' HB3' ' A' ' 33' ' ' ASP . 12.5 m -129.73 168.69 16.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -134.84 140.47 45.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.095 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.32 152.01 48.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.595 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HA ' HG12 ' A' ' 60' ' ' VAL . 4.7 tp -111.16 127.46 55.59 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.745 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.685 ' HB1' ' HB3' ' A' ' 41' ' ' ALA . . . -122.83 151.87 41.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.669 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.441 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.5 tt -147.78 163.72 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.088 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.514 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 175.48 172.65 40.53 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.446 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -162.75 147.24 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.6 161.63 28.69 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.295 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.449 ' H ' HD11 ' A' ' 83' ' ' LEU . 20.5 t80 -106.92 119.26 38.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 111.168 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.68 ' HD2' ' HB3' ' A' ' 82' ' ' ALA . 5.0 mmm180 -95.86 101.02 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.711 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 77' ' ' VAL . 12.6 p -98.62 128.88 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.7 m120 65.23 -175.05 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.82 25.45 10.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.573 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.964 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 82' ' ' ALA . 9.8 p -106.22 151.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.68 ' HB3' ' HD2' ' A' ' 76' ' ' ARG . . . -153.42 169.81 22.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.245 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.449 HD11 ' H ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -162.48 141.23 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.536 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 1.3 ttmp? -141.42 133.46 27.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.27 135.03 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.514 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -159.35 173.86 36.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.581 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 96' ' ' MET . 5.6 p -122.83 144.3 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 70' ' ' ALA . . . -112.92 135.43 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.36 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' OH ' HG11 ' A' ' 87' ' ' VAL . 16.6 m-85 -111.08 111.07 21.91 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.236 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . . . -124.01 135.83 53.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.551 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.91 -113.84 4.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.238 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.83 -58.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.526 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -103.9 28.43 6.68 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.203 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.412 ' CB ' ' HD2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -118.18 82.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.962 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' ' 88' ' ' ALA . 11.5 t -120.76 142.81 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' C' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.15 50.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -128.01 129.41 46.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.429 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.5 159.35 22.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.724 0.297 . . . . 0.0 111.393 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.716 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.737 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.7 p -122.86 178.5 5.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -142.13 146.04 34.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.95 0.405 . . . . 0.0 111.12 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.597 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 70.5 m-80 -112.88 150.73 31.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.326 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 pt -157.24 152.04 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.777 0.323 . . . . 0.0 110.814 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 75.8 mt-10 -94.98 129.54 42.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.972 ' O ' HG13 ' C' ' 54' ' ' VAL . 5.9 t-105 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.688 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.652 -0.179 . . . . 0.0 112.652 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.486 ' HB2' ' H ' ' B' ' 7' ' ' SER . 86.3 m-20 40.63 -103.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.899 0.38 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -114.86 -48.7 2.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.813 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -177.35 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.9 t -69.68 -53.53 18.15 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.752 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -48.53 -86.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.705 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.486 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 19.5 m 64.99 46.71 2.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.013 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.689 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 16.6 m170 -73.72 -52.44 4.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.795 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.689 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -51.03 116.48 2.67 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.481 2.121 . . . . 0.0 111.888 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' B' ' 8' ' ' HIS . 12.2 mm100 -128.14 -55.6 1.27 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.004 0.43 . . . . 0.0 111.171 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.75 -153.51 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.704 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.57 -28.22 63.68 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.44 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -138.28 20.65 2.77 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.535 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.48 -20.95 65.38 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.288 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.38 86.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 0.0 110.861 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' B' ' 20' ' ' GLN . 30.4 m-70 -71.78 -35.32 69.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.025 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.44 ' O ' HD21 ' B' ' 21' ' ' LEU . 36.1 ttmt -68.32 -47.27 67.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.524 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' CD2' ' B' ' 8' ' ' HIS . 0.1 OUTLIER -67.77 -38.46 83.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.297 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -66.81 -45.67 77.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' B' ' 16' ' ' HIS . 0.8 OUTLIER -64.22 -40.85 96.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.684 HD22 HD23 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -64.37 -45.29 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.75 -28.34 69.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.05 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -74.76 -40.32 61.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -70.9 -41.18 71.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.808 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.643 ' HG ' HD21 ' A' ' 25' ' ' LEU . 7.9 mt -61.96 -49.86 74.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.21 -48.87 79.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 9.0 tmtt? -55.43 -37.93 68.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.292 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.518 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.4 OUTLIER -63.49 -40.3 96.73 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -64.18 -44.62 91.48 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.954 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -57.7 -48.06 80.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.535 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 83.9 mmt-85 -57.18 -33.29 67.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.259 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 28' ' ' LEU . 44.5 t -76.78 -37.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.599 ' HB3' ' HG ' ' B' ' 66' ' ' SER . 48.2 m-20 -62.06 -54.28 43.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.999 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.548 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 2.6 pttt -75.9 -36.03 59.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.41 87.61 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -68.18 -39.65 82.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.75 90.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.414 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -52.7 27.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.746 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.702 ' HB3' HD21 ' A' ' 36' ' ' LEU . 78.3 p -50.88 -56.35 12.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.409 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -54.91 -48.95 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.393 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.682 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . . . -49.43 -42.18 41.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 23.8 tp -73.62 -36.04 65.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.426 ' CB ' ' HB3' ' C' ' 43' ' ' ASN . 54.4 m-20 -78.35 -3.14 41.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.712 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -84.26 1.29 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.089 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.775 ' HB3' HG23 ' B' ' 57' ' ' THR . 0.3 OUTLIER -98.21 174.49 6.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.906 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.31 -3.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 111.686 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.553 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.56 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.276 9.9 Cg_endo -74.43 100.38 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.629 2.219 . . . . 0.0 112.608 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 90.2 m-85 67.69 -167.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.2 81.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.228 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -88.28 -12.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.121 0.569 . . . . 0.0 112.402 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.78 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.332 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.77 2.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.637 0.256 . . . . 0.0 110.6 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.966 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.1 p -109.64 145.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.589 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.401 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 4.1 m-80 -128.47 135.31 49.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.648 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.63 122.65 44.26 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.313 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.775 HG23 ' HB3' ' B' ' 45' ' ' LEU . 22.4 p -112.01 124.65 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.932 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.427 ' HB3' HG13 ' B' ' 71' ' ' ILE . . . -155.3 149.84 26.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.602 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 172.97 165.52 30.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 6.9 m -111.31 165.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.05 -177.63 27.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -160.67 144.4 9.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.485 ' CE2' ' HG3' ' B' ' 64' ' ' ARG . 65.8 t80 -133.53 133.49 42.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 110.776 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.485 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 3.1 mmm-85 64.46 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.43 33.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.599 ' HG ' ' HB3' ' B' ' 33' ' ' ASP . 12.5 m -129.75 168.7 16.14 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -134.71 140.54 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.135 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.99 48.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.572 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 tp -111.18 127.35 55.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' B' ' 41' ' ' ALA . . . -122.76 151.89 41.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.726 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.437 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.4 tt -147.72 163.74 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.12 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.503 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 175.47 172.62 40.5 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.466 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 17.9 p -162.8 147.17 11.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.374 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.63 161.64 28.7 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.265 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.456 ' H ' HD11 ' B' ' 83' ' ' LEU . 20.5 t80 -106.85 119.21 38.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 111.146 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.681 ' HD2' ' HB3' ' B' ' 82' ' ' ALA . 5.0 mmm180 -95.85 101.08 12.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.698 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.436 ' O ' HG13 ' B' ' 77' ' ' VAL . 12.7 p -98.66 128.86 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.269 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.8 m120 65.2 -174.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -114.88 25.5 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.559 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.23 -46.38 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.409 HG22 ' N ' ' B' ' 82' ' ' ALA . 9.8 p -106.27 151.12 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.681 ' HB3' ' HD2' ' B' ' 76' ' ' ARG . . . -153.43 169.8 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.235 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.456 HD11 ' H ' ' B' ' 75' ' ' TYR . 0.6 OUTLIER -162.53 141.22 8.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.553 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.553 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.55 27.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.36 135.1 19.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.503 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -159.39 173.9 36.23 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.562 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.442 HG11 ' OH ' ' B' ' 89' ' ' TYR . 5.6 p -122.87 144.31 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.38 . . . . 0.0 111.148 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' B' ' 70' ' ' ALA . . . -112.85 135.38 53.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.313 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . 0.442 ' OH ' HG11 ' B' ' 87' ' ' VAL . 16.7 m-85 -111.12 111.02 21.81 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.3 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' B' ' 34' ' ' LYS . . . -123.92 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.581 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.548 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.84 -113.87 4.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 -58.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 111.293 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' SER . . . . . 0.526 ' O ' ' OG ' ' B' ' 93' ' ' SER . 2.2 t -103.86 28.36 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.153 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.415 ' CB ' ' HD2' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -118.22 82.86 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.446 HG11 ' O ' ' B' ' 88' ' ' ALA . 11.6 t -120.81 142.8 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.724 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.09 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -127.94 129.35 46.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.48 159.3 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.47 0.35 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.761 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.75 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.8 p -122.8 178.56 4.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -142.22 146.07 34.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.587 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.5 m-80 -112.88 150.7 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.409 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 pt -157.25 152.02 7.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 110.757 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.4 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 75.9 mt-10 -94.97 129.52 41.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.977 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . 0.956 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 t-105 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.671 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.646 -0.181 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' C' ' 7' ' ' SER . 86.4 m-20 40.58 -103.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -114.92 -48.61 2.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -177.34 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.019 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 13.9 t -69.8 -53.48 18.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.743 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -48.5 -86.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.644 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' C' ' 2' ' ' ASP . 19.5 m 65.07 46.65 2.71 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.029 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.704 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 16.4 m170 -73.83 -52.28 4.7 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.77 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.3 Cg_exo -50.97 116.45 2.64 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.486 2.124 . . . . 0.0 111.933 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' C' ' 8' ' ' HIS . 12.2 mm100 -128.21 -55.54 1.26 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.943 0.402 . . . . 0.0 111.155 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -125.72 -153.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.732 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.65 -28.18 63.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.41 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -138.3 20.66 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.516 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.39 -21.03 65.42 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.303 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -44.41 86.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 110.94 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' C' ' 20' ' ' GLN . 30.5 m-70 -71.74 -35.37 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.954 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.446 ' O ' HD21 ' C' ' 21' ' ' LEU . 36.1 ttmt -68.32 -47.29 67.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.544 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . 0.401 ' HB3' ' CD2' ' C' ' 8' ' ' HIS . 0.1 OUTLIER -67.71 -38.51 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.272 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -66.77 -45.71 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' C' ' 16' ' ' HIS . 0.8 OUTLIER -64.29 -40.79 96.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.684 HD23 HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -64.45 -45.25 88.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.609 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.74 -28.34 69.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -74.78 -40.31 61.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -70.91 -41.13 71.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.819 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.629 ' HG ' HD21 ' B' ' 25' ' ' LEU . 7.9 mt -62.08 -49.72 74.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.656 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.37 -48.81 79.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.758 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 9.0 tmtt? -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.62 0.248 . . . . 0.0 111.286 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.523 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.4 OUTLIER -63.41 -40.42 97.16 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.69 91.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.954 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -57.6 -48.08 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.908 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.524 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 83.8 mmt-85 -57.28 -33.23 67.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.523 HG23 ' O ' ' C' ' 28' ' ' LEU . 44.4 t -76.78 -37.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.615 ' HB3' ' HG ' ' C' ' 66' ' ' SER . 48.4 m-20 -61.92 -54.42 42.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.578 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 2.5 pttt -75.85 -36.08 59.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.798 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.37 88.16 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -68.27 -39.64 82.12 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 111.012 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.8 91.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.68 -52.76 27.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.722 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.702 ' HB3' HD21 ' B' ' 36' ' ' LEU . 78.2 p -50.83 -56.41 12.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.419 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -54.83 -48.97 72.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.418 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.695 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . . . -49.38 -42.12 41.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.73 -35.95 65.13 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.074 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.426 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 54.5 m-20 -78.3 -3.2 41.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' SER . . . . . 0.695 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.4 t -84.23 1.24 45.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.129 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.776 ' HB3' HG23 ' C' ' 57' ' ' THR . 0.3 OUTLIER -98.18 174.53 6.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.901 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.32 -3.55 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.535 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.65 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.948 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.46 100.41 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.696 2.264 . . . . 0.0 112.552 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.414 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 90.3 m-85 67.59 -167.18 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.23 81.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.255 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -88.19 -13.03 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.143 0.577 . . . . 0.0 112.381 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.85 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.72 2.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.603 0.24 . . . . 0.0 110.584 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.972 HG13 ' O ' ' A' ' 105' ' ' TRP . 2.1 p -109.67 145.88 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.509 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 4.1 m-80 -128.44 135.31 49.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.666 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.64 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.223 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.776 HG23 ' HB3' ' C' ' 45' ' ' LEU . 22.5 p -111.9 124.58 52.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.989 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . 0.419 ' HB3' HG13 ' C' ' 71' ' ' ILE . . . -155.26 149.91 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.483 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.594 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 172.98 165.53 30.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' C' ' 69' ' ' LEU . 6.9 m -111.27 165.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.391 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.95 -177.59 27.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.465 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -160.68 144.36 9.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.495 ' CE2' ' HG3' ' C' ' 64' ' ' ARG . 65.5 t80 -133.5 133.45 42.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.729 0.299 . . . . 0.0 110.775 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.495 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm-85 64.45 -81.11 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.023 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 33.29 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' SER . . . . . 0.615 ' HG ' ' HB3' ' C' ' 33' ' ' ASP . 12.5 m -129.78 168.71 16.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.808 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -134.77 140.53 45.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.37 151.93 47.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.56 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.408 ' HA ' HG12 ' C' ' 60' ' ' VAL . 4.7 tp -111.07 127.43 55.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.787 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.695 ' HB1' ' HB3' ' C' ' 41' ' ' ALA . . . -122.8 151.89 41.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.431 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.6 tt -147.83 163.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 0.0 111.116 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.506 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 175.51 172.7 40.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.8 p -162.86 147.25 11.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.39 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.67 161.6 28.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.245 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.459 ' H ' HD11 ' C' ' 83' ' ' LEU . 20.4 t80 -106.88 119.23 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.142 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.687 ' HD2' ' HB3' ' C' ' 82' ' ' ALA . 5.0 mmm180 -95.8 100.95 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.737 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.439 HG13 ' O ' ' C' ' 77' ' ' VAL . 12.7 p -98.55 128.86 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.272 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.8 m120 65.27 -175.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -114.86 25.42 10.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.582 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.37 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.408 HG22 ' N ' ' C' ' 82' ' ' ALA . 9.8 p -106.21 151.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.514 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.687 ' HB3' ' HD2' ' C' ' 76' ' ' ARG . . . -153.45 169.75 22.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.459 HD11 ' H ' ' C' ' 75' ' ' TYR . 0.6 OUTLIER -162.41 141.22 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.535 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.63 27.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.163 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.42 135.06 19.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.104 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . 0.506 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.36 173.89 36.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.587 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.439 HG22 ' O ' ' C' ' 96' ' ' MET . 5.6 p -122.92 144.29 32.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' C' ' 70' ' ' ALA . . . -112.92 135.34 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.311 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . 0.432 ' OH ' HG11 ' C' ' 87' ' ' VAL . 16.6 m-85 -111.04 111.02 21.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.23 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' C' ' 34' ' ' LYS . . . -123.91 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.605 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.578 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.86 -113.85 4.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.298 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.79 -58.1 0.98 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.778 0.323 . . . . 0.0 111.32 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' C' ' 93' ' ' SER . 2.2 t -103.85 28.38 6.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.161 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.414 ' CB ' ' HD2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -118.23 82.82 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . 0.454 HG11 ' O ' ' C' ' 88' ' ' ALA . 11.5 t -120.8 142.81 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.708 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' B' ' 62' ' ' GLY . 0.8 OUTLIER -136.86 153.15 50.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.72 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -128.01 129.42 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.51 159.31 23.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.447 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.29 98.55 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.76 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.6 p -122.92 178.6 4.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -142.18 146.07 34.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 111.128 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.598 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 70.5 m-80 -112.85 150.64 31.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.397 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 pt -157.2 152.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.774 0.321 . . . . 0.0 110.841 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.401 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 75.6 mt-10 -94.95 129.48 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . 0.966 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.8 t-105 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.706 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 112.634 -0.186 . . . . 0.0 112.634 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 37.38 -100.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.889 0.376 . . . . 0.0 110.965 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -112.48 -52.32 2.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.864 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 179.11 -61.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.4 t -72.82 -49.5 29.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.753 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -52.28 -89.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.713 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.6 m 61.86 52.94 3.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.964 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.851 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 33.6 m170 -74.96 -54.32 2.68 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.873 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.851 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -59.77 123.48 13.37 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.476 2.117 . . . . 0.0 111.915 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.492 ' HG3' ' HE3' ' B' ' 17' ' ' LYS . 14.5 mm-40 -127.18 -51.55 1.41 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.012 0.434 . . . . 0.0 111.15 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -126.6 -157.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.757 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -66.33 -33.17 75.13 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.433 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -132.2 15.9 4.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.527 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.98 -24.39 59.9 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.251 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.34 93.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.892 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 18.3 m-70 -72.23 -30.54 64.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.949 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.505 ' CE ' ' HG3' ' C' ' 10' ' ' GLN . 36.4 ttmt -68.97 -46.6 67.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.518 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -35.45 75.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.309 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.07 -44.07 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -64.55 -46.86 81.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.092 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -36.81 84.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.58 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.17 -35.91 82.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.031 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.82 -42.21 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HD2' HD12 ' C' ' 25' ' ' LEU . 28.2 mtt180 -62.71 -38.13 89.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.747 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD12 ' HD2' ' B' ' 24' ' ' ARG . 12.7 mt -67.35 -53.98 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.95 -47.61 77.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.822 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.88 -44.78 94.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.173 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -58.09 -42.68 86.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -64.65 -40.7 95.9 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.983 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.2 m -61.66 -44.42 96.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.801 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 88.4 mmt-85 -57.07 -37.74 72.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 10.0 t -73.27 -29.53 28.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.153 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.561 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 63.6 m-20 -67.95 -62.73 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.037 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 0.5 OUTLIER -66.53 -44.64 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.771 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.51 ' HA3' ' HH ' ' C' ' 63' ' ' TYR . . . -54.87 -46.17 77.46 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.374 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -68.02 -34.18 76.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.852 0.358 . . . . 0.0 111.147 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -65.31 -45.71 83.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.461 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -54.48 19.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.764 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.509 ' CB ' HD21 ' C' ' 36' ' ' LEU . 47.8 p -49.44 -55.06 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.12 -46.13 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.427 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.638 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -51.87 -39.27 58.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 43.1 tp -80.96 -36.79 30.43 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.01 -3.24 28.04 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.424 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 6.1 t -88.62 -7.52 56.25 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.14 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.773 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.5 OUTLIER -90.72 165.75 13.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.856 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.77 -2.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.14 0.495 . . . . 0.0 111.703 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 40.0 mt-30 67.12 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.907 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 47' ' ' GLN 0.406 9.9 Cg_endo -69.59 99.36 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.673 2.249 . . . . 0.0 112.524 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 60.78 -160.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 149.42 83.44 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.29 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.5 p -90.06 -15.51 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.234 0.614 . . . . 0.0 112.45 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 161.71 48.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.267 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.89 -170.25 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.625 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.921 HG13 ' O ' ' B' ' 105' ' ' TRP . 2.7 p -108.85 141.01 25.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.58 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.44 ' OD1' ' HD2' ' A' ' 48' ' ' PRO . 3.2 m-80 -125.37 133.96 52.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.53 45.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.246 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.635 HG23 ' HB3' ' A' ' 45' ' ' LEU . 24.4 p -114.93 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.06 146.87 22.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.461 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.502 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 176.05 163.05 28.03 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.543 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.3 m -105.7 167.15 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.23 27.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.522 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.67 141.31 7.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.542 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.561 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 72.4 t80 -129.39 139.24 51.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.725 0.298 . . . . 0.0 110.786 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.42 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 3.0 mmm180 61.2 -81.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.045 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 t -155.96 35.57 0.34 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.531 ' HG ' ' HB3' ' A' ' 33' ' ' ASP . 7.1 m -133.06 166.85 21.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.39 142.83 47.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.49 44.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.565 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.1 tp -110.93 131.25 55.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.717 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 41' ' ' ALA . . . -126.26 154.3 43.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.728 0.299 . . . . 0.0 111.613 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 87' ' ' VAL . 20.4 tt -147.76 162.9 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.76 0.314 . . . . 0.0 111.126 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.423 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 178.58 169.73 39.7 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.411 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -161.94 142.45 10.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.966 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.15 160.95 27.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.201 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.651 ' H ' HD11 ' A' ' 83' ' ' LEU . 25.5 t80 -106.59 116.2 31.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 111.133 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.53 ' HD2' ' HB3' ' A' ' 82' ' ' ALA . 5.2 mmm180 -93.87 93.22 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 8.7 p -93.88 126.04 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 12.2 m120 68.98 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -120.02 24.94 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.611 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 6.8 t -126.06 -39.4 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.982 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.06 152.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.504 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.655 ' HB2' ' HB2' ' A' ' 102' ' ' ASN . . . -149.05 174.53 12.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.226 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.651 HD11 ' H ' ' A' ' 75' ' ' TYR . 1.4 pp -163.88 143.63 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HE3' HE21 ' A' ' 47' ' ' GLN . 2.2 ttmp? -146.7 128.19 15.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.55 135.64 15.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.404 ' HA3' ' CA ' ' A' ' 72' ' ' GLY . . . -161.34 178.52 37.23 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.546 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 71' ' ' ILE . 6.0 p -118.21 140.54 41.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 111.14 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.587 ' HB3' ' HE1' ' A' ' 96' ' ' MET . . . -112.57 131.68 55.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.79 112.04 24.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.221 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 94' ' ' ASP . . . -124.96 131.24 53.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.616 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.647 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.05 -116.06 6.36 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.92 -61.22 1.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.303 . . . . 0.0 111.327 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.482 ' O ' ' OG ' ' A' ' 93' ' ' SER . 3.1 t -100.21 28.98 4.55 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.195 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.585 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.76 136.09 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.587 ' HE1' ' HB3' ' A' ' 88' ' ' ALA . 1.1 ptp -131.35 150.11 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.647 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -123.06 134.02 54.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.456 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.95 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.72 0.295 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.21 91.68 0.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.811 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.779 ' HB2' HD11 ' C' ' 45' ' ' LEU . 21.8 p -119.9 177.78 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.417 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -139.52 144.42 37.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.968 0.413 . . . . 0.0 111.068 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.655 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 70.0 m-80 -112.95 143.51 44.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.368 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.63 151.17 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.0 110.777 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.611 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 55.5 mt-10 -92.27 128.21 38.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.917 ' O ' HG13 ' C' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 37.38 -100.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -112.48 -52.31 2.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 179.1 -61.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.028 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.3 t -72.81 -49.48 30.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.715 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -52.34 -89.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.704 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 55.7 m 61.85 52.92 3.27 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.033 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.848 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 33.6 m170 -74.93 -54.44 2.68 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.819 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.848 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -59.69 123.42 13.26 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.554 2.169 . . . . 0.0 111.933 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.499 ' HG3' ' CE ' ' C' ' 17' ' ' LYS . 14.5 mm-40 -127.19 -51.39 1.42 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.911 0.386 . . . . 0.0 111.149 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -126.83 -157.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.669 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.413 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 5.3 mt-10 -66.27 -33.21 75.24 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.458 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -132.26 16.11 4.56 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.513 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.11 -24.39 59.63 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.216 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.41 92.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 0.0 110.875 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' B' ' 20' ' ' GLN . 17.8 m-70 -72.09 -30.64 65.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.004 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.492 ' HE3' ' HG3' ' A' ' 10' ' ' GLN . 36.5 ttmt -68.91 -46.63 67.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.595 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.276 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -70.03 -44.16 69.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.772 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' B' ' 16' ' ' HIS . 0.9 OUTLIER -64.45 -46.87 81.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.125 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -36.73 84.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.523 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.24 -35.81 82.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.87 -42.22 63.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.791 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.464 ' HD2' HD12 ' A' ' 25' ' ' LEU . 28.1 mtt180 -62.71 -38.09 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.476 HD12 ' HD2' ' C' ' 24' ' ' ARG . 12.7 mt -67.33 -54.1 23.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.86 -47.73 76.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.79 -44.77 93.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.249 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.453 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -57.95 -42.74 85.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -64.82 -40.59 95.45 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.932 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.0 m -61.62 -44.4 97.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.816 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.487 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 88.4 mmt-85 -57.27 -37.72 72.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 9.8 t -73.21 -29.49 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.56 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 63.6 m-20 -67.97 -62.74 1.27 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.653 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 0.5 OUTLIER -66.56 -44.59 81.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.51 ' HA3' ' HH ' ' A' ' 63' ' ' TYR . . . -54.89 -46.11 77.87 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.391 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.2 OUTLIER -68.08 -34.19 75.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.751 0.31 . . . . 0.0 111.055 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 41' ' ' ALA . . . -65.35 -45.71 83.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.54 -54.46 19.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.791 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.495 ' CB ' HD21 ' A' ' 36' ' ' LEU . 47.5 p -49.47 -55.06 14.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.11 82.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.403 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.655 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . . . -51.87 -39.24 58.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.891 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 42.7 tp -81.05 -36.75 30.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -74.02 -3.17 27.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.433 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 6.1 t -88.65 -7.59 56.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.105 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.5 OUTLIER -90.62 165.74 13.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.882 177.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 8.6 p90 -154.84 -2.91 0.16 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.102 0.477 . . . . 0.0 111.609 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.426 HE21 ' HE3' ' B' ' 84' ' ' LYS . 39.9 mt-30 66.99 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.993 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.437 ' HD2' ' OD1' ' B' ' 55' ' ' ASN 0.405 9.9 Cg_endo -69.6 99.41 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.685 2.257 . . . . 0.0 112.518 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 60.73 -159.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.976 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 149.27 83.48 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.309 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 9.6 p -90.06 -15.5 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.148 0.579 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 161.71 48.47 0.02 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.27 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.83 -170.11 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.579 0.228 . . . . 0.0 110.614 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.935 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.7 p -108.97 141.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.608 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.437 ' OD1' ' HD2' ' B' ' 48' ' ' PRO . 3.2 m-80 -125.34 133.84 52.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 111.702 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.77 124.54 45.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.243 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.652 HG23 ' HB3' ' B' ' 45' ' ' LEU . 24.4 p -114.93 125.48 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.03 146.93 22.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.431 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 175.99 163.0 27.92 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.545 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.432 ' H ' HG21 ' B' ' 60' ' ' VAL . 6.3 m -105.68 167.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 111.36 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.94 -176.23 27.84 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.71 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.58 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.568 ' HA ' ' HB2' ' C' ' 96' ' ' MET . 72.5 t80 -129.35 139.27 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.658 0.266 . . . . 0.0 110.761 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 3.0 mmm180 61.13 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.08 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 63' ' ' TYR . 8.0 t -155.88 35.51 0.35 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.17 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.522 ' HG ' ' HB3' ' B' ' 33' ' ' ASP . 6.9 m -133.15 166.73 21.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -134.29 142.91 47.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.045 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.96 156.47 44.88 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tp -110.97 131.31 55.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' B' ' 41' ' ' ALA . . . -126.15 154.24 43.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.691 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.552 HG23 ' O ' ' B' ' 87' ' ' VAL . 20.4 tt -147.75 162.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.722 0.296 . . . . 0.0 111.186 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.424 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 178.56 169.66 39.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.45 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.47 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.16 160.87 27.88 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.248 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.645 ' H ' HD11 ' B' ' 83' ' ' LEU . 25.3 t80 -106.53 116.19 31.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.162 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.529 ' HD2' ' HB3' ' B' ' 82' ' ' ALA . 5.2 mmm180 -93.83 93.18 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' B' ' 78' ' ' ASN . 8.7 p -93.89 126.06 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.311 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 12.1 m120 69.04 -172.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -120.03 24.9 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' SER . . . . . 0.61 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 6.8 t -126.0 -39.5 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -114.99 152.54 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' B' ' 102' ' ' ASN . . . -149.0 174.61 12.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.286 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.645 HD11 ' H ' ' B' ' 75' ' ' TYR . 1.4 pp -163.84 143.7 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.617 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.426 ' HE3' HE21 ' B' ' 47' ' ' GLN . 2.2 ttmp? -146.77 128.1 14.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.43 135.65 15.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.32 178.5 37.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.603 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.552 ' O ' HG23 ' B' ' 71' ' ' ILE . 6.0 p -118.18 140.58 41.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.905 0.383 . . . . 0.0 111.123 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.576 ' HB3' ' HE1' ' B' ' 96' ' ' MET . . . -112.55 131.7 55.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.355 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.8 111.96 24.84 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.278 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.593 ' HB1' ' HB3' ' B' ' 94' ' ' ASP . . . -124.91 131.29 53.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.612 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.653 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.0 -116.11 6.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.224 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -127.92 -61.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.313 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' SER . . . . . 0.506 ' O ' ' OG ' ' B' ' 93' ' ' SER . 3.0 t -100.27 29.04 4.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.157 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.593 ' HB3' ' HB1' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -118.35 83.08 1.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.8 136.05 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.576 ' HE1' ' HB3' ' B' ' 88' ' ' ALA . 1.1 ptp -131.34 150.14 52.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -123.17 134.01 54.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.375 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.98 24.94 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.389 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.82 0.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.721 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.773 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.7 p -120.0 177.78 4.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.429 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -139.55 144.38 37.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.092 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.662 ' HB2' ' HB2' ' B' ' 82' ' ' ALA . 70.1 m-80 -112.92 143.6 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.353 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.72 151.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.61 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 55.4 mt-10 -92.3 128.13 38.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . 0.921 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.678 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.659 -0.177 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 37.39 -100.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.87 0.367 . . . . 0.0 110.964 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -112.45 -52.28 2.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 179.08 -61.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -72.83 -49.51 29.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -52.34 -89.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.673 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 56.7 m 61.94 52.94 3.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.965 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.837 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 33.6 m170 -74.97 -54.38 2.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.822 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.837 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -59.74 123.39 13.19 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.458 2.106 . . . . 0.0 111.984 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . 0.505 ' HG3' ' CE ' ' A' ' 17' ' ' LYS . 14.5 mm-40 -127.13 -51.37 1.42 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.951 0.405 . . . . 0.0 111.208 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -126.79 -157.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.671 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -66.27 -33.16 75.12 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.494 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -132.32 16.03 4.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.519 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.0 -24.4 59.82 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.229 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.47 92.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.835 0.35 . . . . 0.0 110.914 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . 0.454 ' O ' ' HB2' ' C' ' 20' ' ' GLN . 18.1 m-70 -72.04 -30.57 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.979 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.499 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 36.4 ttmt -68.99 -46.6 67.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.44 -35.48 75.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.249 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.03 -44.13 69.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.798 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' C' ' 16' ' ' HIS . 0.9 OUTLIER -64.41 -46.91 81.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -36.82 84.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.589 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.11 -35.96 82.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.001 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.81 -42.19 64.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.476 ' HD2' HD12 ' B' ' 25' ' ' LEU . 28.1 mtt180 -62.72 -38.09 89.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.788 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.473 HD12 ' HD2' ' A' ' 24' ' ' ARG . 12.6 mt -67.34 -54.03 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.92 -47.74 76.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.813 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.75 -44.8 93.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.191 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.456 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -58.03 -42.63 85.73 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -64.85 -40.57 95.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.949 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 10.2 m -61.69 -44.39 97.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.789 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.488 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 88.2 mmt-85 -57.2 -37.65 72.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' C' ' 36' ' ' LEU . 9.9 t -73.25 -29.6 28.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.118 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.564 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 63.6 m-20 -67.92 -62.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.023 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.675 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 0.5 OUTLIER -66.51 -44.61 82.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.804 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . 0.498 ' HA3' ' HH ' ' B' ' 63' ' ' TYR . . . -54.86 -46.17 77.38 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.2 OUTLIER -68.07 -34.11 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' C' ' 41' ' ' ALA . . . -65.44 -45.65 82.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -54.48 19.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.504 ' CB ' HD21 ' B' ' 36' ' ' LEU . 47.6 p -49.45 -55.06 14.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.09 82.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.515 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.651 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . . . -51.89 -39.18 58.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' C' ' 70' ' ' ALA . 42.9 tp -81.08 -36.66 30.15 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -74.04 -3.24 28.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' SER . . . . . 0.43 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -88.62 -7.6 56.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.081 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.5 OUTLIER -90.58 165.75 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.924 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 8.6 p90 -154.83 -3.0 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.105 0.479 . . . . 0.0 111.649 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.439 HE21 ' HE3' ' C' ' 84' ' ' LYS . 40.0 mt-30 67.04 122.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.937 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' OD1' ' C' ' 55' ' ' ASN 0.406 9.8 Cg_endo -69.53 99.34 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.632 2.222 . . . . 0.0 112.556 -179.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 60.84 -160.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 149.36 83.55 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.198 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 9.5 p -90.14 -15.52 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.217 0.607 . . . . 0.0 112.393 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 161.73 48.48 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.305 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.88 -170.15 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.675 0.274 . . . . 0.0 110.549 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 105' ' ' TRP . 2.7 p -108.94 141.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.613 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.428 ' OD1' ' HD2' ' C' ' 48' ' ' PRO . 3.2 m-80 -125.42 133.92 52.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.015 0.435 . . . . 0.0 111.661 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.46 45.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.204 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.654 HG23 ' HB3' ' C' ' 45' ' ' LEU . 24.3 p -114.9 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.903 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.94 146.92 22.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 175.97 163.05 27.99 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.565 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.426 ' H ' HG21 ' C' ' 60' ' ' VAL . 6.2 m -105.76 167.21 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 111.226 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.04 -176.25 27.96 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.503 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.69 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.568 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.564 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 72.2 t80 -129.35 139.31 51.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.698 0.285 . . . . 0.0 110.729 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm180 61.09 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.094 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' SER . . . . . 0.4 ' N ' ' O ' ' C' ' 63' ' ' TYR . 8.0 t -155.91 35.41 0.35 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' SER . . . . . 0.509 ' HG ' ' HB3' ' C' ' 33' ' ' ASP . 7.0 m -132.99 166.83 21.48 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.36 142.8 47.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.89 156.51 44.93 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tp -110.95 131.22 55.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' C' ' 41' ' ' ALA . . . -126.15 154.31 43.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.704 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.539 HG23 ' O ' ' C' ' 87' ' ' VAL . 20.4 tt -147.73 162.89 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.749 0.309 . . . . 0.0 111.137 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.422 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 178.52 169.67 39.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.431 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.46 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.05 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.12 160.92 27.88 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.246 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.652 ' H ' HD11 ' C' ' 83' ' ' LEU . 25.4 t80 -106.59 116.23 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.166 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.514 ' HD2' ' HB3' ' C' ' 82' ' ' ALA . 5.2 mmm180 -93.85 93.16 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' C' ' 78' ' ' ASN . 8.7 p -93.87 126.11 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.273 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 12.2 m120 68.89 -171.96 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.921 0.391 . . . . 0.0 111.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -119.98 24.87 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.616 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' SER . . . . . 0.606 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 6.8 t -126.06 -39.36 2.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.994 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.01 152.61 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.678 ' HB2' ' HB2' ' C' ' 102' ' ' ASN . . . -149.05 174.63 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.278 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.652 HD11 ' H ' ' C' ' 75' ' ' TYR . 1.4 pp -163.84 143.74 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.439 ' HE3' HE21 ' C' ' 47' ' ' GLN . 2.2 ttmp? -146.82 128.16 14.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.48 135.66 15.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.36 178.57 37.22 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.556 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.539 ' O ' HG23 ' C' ' 71' ' ' ILE . 6.0 p -118.25 140.64 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.872 0.367 . . . . 0.0 111.088 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.564 ' HB3' ' HE1' ' C' ' 96' ' ' MET . . . -112.6 131.65 55.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.323 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -105.77 112.05 24.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.292 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.597 ' HB1' ' HB3' ' C' ' 94' ' ' ASP . . . -125.01 131.23 53.44 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.579 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.675 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.09 -116.15 6.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.235 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.86 -61.25 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.717 0.294 . . . . 0.0 111.299 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' C' ' 93' ' ' SER . 3.1 t -100.19 28.98 4.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.193 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.597 ' HB3' ' HB1' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 t -118.82 136.05 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.0 110.706 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.568 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 1.1 ptp -131.31 150.07 52.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -123.08 133.96 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.365 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -116.96 157.96 24.88 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.705 0.288 . . . . 0.0 111.471 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.72 0.12 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.771 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.779 ' HB2' HD11 ' B' ' 45' ' ' LEU . 21.6 p -119.91 177.82 4.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.432 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -139.58 144.48 37.8 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.028 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.678 ' HB2' ' HB2' ' C' ' 82' ' ' ALA . 70.0 m-80 -112.96 143.57 44.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.332 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.7 151.19 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.866 0.365 . . . . 0.0 110.77 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.606 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 55.5 mt-10 -92.33 128.2 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . 0.935 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.696 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.681 -0.167 . . . . 0.0 112.681 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 37.93 -106.92 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.42 . . . . 0.0 110.91 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.407 ' O ' ' CB ' ' A' ' 4' ' ' ALA . 43.9 mt-30 -108.29 -45.14 3.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 3' ' ' GLN . . . 167.7 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.055 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.0 t -68.42 -52.49 32.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.787 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -60.91 -78.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.704 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m 54.86 56.4 6.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.02 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.653 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 39.6 m80 -78.12 -48.16 2.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.753 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -55.97 122.21 11.35 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.49 2.127 . . . . 0.0 111.853 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 8' ' ' HIS . 12.7 mm-40 -130.8 -51.98 1.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.934 0.397 . . . . 0.0 111.103 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -130.38 -158.62 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.676 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 mt-10 -64.71 -29.0 69.97 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.506 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -135.57 20.87 3.35 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.529 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.16 -18.66 58.85 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.246 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 9' ' ' PRO . . . -72.04 -45.96 58.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 110.915 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -76.11 -26.07 56.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.963 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -74.27 -47.95 31.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.408 ' O ' ' HD1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -72.49 -34.87 67.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.215 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 18.6 mtt85 -65.97 -40.06 90.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.85 -44.91 63.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 111.134 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.658 HD23 HD22 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -55.61 -37.96 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.591 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.75 -31.13 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.038 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.07 -39.6 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' CB ' HD12 ' C' ' 25' ' ' LEU . 13.7 mtt180 -72.65 -37.56 67.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.782 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.3 mt -68.96 -42.7 76.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.648 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.22 -38.81 92.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.74 74.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.636 0.255 . . . . 0.0 111.181 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.9 -43.73 94.67 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -59.8 -40.5 88.59 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.951 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.504 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 26.0 m -66.67 -41.38 88.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.804 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.337 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.09 -32.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.224 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.694 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 70.4 m-20 -65.56 -63.89 0.99 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.121 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.71 -34.54 62.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.773 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.45 78.44 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.446 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -72.53 -27.31 62.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 111.073 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.61 55.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.399 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.83 -41.58 78.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.62 ' HB3' HD21 ' C' ' 36' ' ' LEU . 31.5 p -55.84 -58.98 5.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.85 -39.54 71.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.444 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.528 ' HB1' ' C ' ' A' ' 60' ' ' VAL . . . -60.73 -37.44 81.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.968 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 tp -75.16 -37.33 61.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.53 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.5 m-20 -76.45 -5.84 49.14 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.523 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.2 t -79.24 -11.23 59.95 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.125 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.728 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -84.2 177.57 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.874 177.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.5 p90 -169.53 -15.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.144 0.497 . . . . 0.0 111.705 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.735 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 40.8 mt-30 81.17 114.64 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.95 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.46 99.43 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.654 2.236 . . . . 0.0 112.558 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.408 ' HB3' ' H ' ' A' ' 50' ' ' GLY . 81.3 m-85 62.24 -160.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.985 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 144.54 93.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.22 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 7.5 p -88.85 -27.1 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.126 0.57 . . . . 0.0 112.444 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 172.25 34.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.269 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.71 -165.43 1.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 110.605 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.655 HG13 ' O ' ' B' ' 105' ' ' TRP . 8.9 p -110.27 141.33 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.508 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.539 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 6.7 m-80 -120.05 135.84 54.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.977 0.417 . . . . 0.0 111.669 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' B' ' 105' ' ' TRP . 2.2 t80 -99.85 128.52 45.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.27 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.728 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 42.7 p -117.64 131.44 56.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.79 143.39 9.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.485 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 178.77 165.5 33.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 69' ' ' LEU . 10.9 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.876 0.369 . . . . 0.0 111.345 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.5 -174.91 25.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.415 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.38 144.52 9.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.694 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 87.7 t80 -130.49 127.74 39.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.773 0.321 . . . . 0.0 110.69 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 6.9 mmm-85 66.35 -86.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.15 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.76 30.33 0.99 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.152 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.661 ' HG ' ' HB3' ' A' ' 33' ' ' ASP . 4.7 m -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.48 159.45 41.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.094 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.52 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.543 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.537 ' HA ' HG12 ' A' ' 60' ' ' VAL . 8.0 tp -115.1 137.33 52.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.768 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.677 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.81 158.39 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.119 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.442 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 177.44 173.2 42.72 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.45 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.19 142.86 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.21 156.5 26.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.226 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -105.11 116.1 31.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 111.101 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.49 ' HD2' ' HB3' ' A' ' 82' ' ' ALA . 9.6 mmm180 -95.98 89.11 5.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.752 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.659 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 7.7 p -95.73 123.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.302 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.562 ' OD1' HG22 ' A' ' 77' ' ' VAL . 19.9 m120 64.15 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.147 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -99.74 32.06 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.603 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.481 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 t -131.74 -37.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.413 HG22 ' N ' ' A' ' 82' ' ' ALA . 13.6 p -118.74 148.81 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 76' ' ' ARG . . . -150.69 171.24 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.252 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.07 148.67 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.611 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.735 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -146.35 131.77 18.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.182 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.67 12.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.442 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -157.99 171.16 34.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.619 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.16 139.29 47.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.87 0.367 . . . . 0.0 111.093 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.32 132.22 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.77 121.52 41.83 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 94' ' ' ASP . . . -130.1 124.34 32.53 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.589 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.46 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 61.93 -110.66 3.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.345 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -132.1 -63.34 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -99.05 24.64 7.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.136 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.535 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -116.4 85.14 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.943 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.76 137.55 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.468 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -129.64 158.12 40.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.713 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.496 ' HH ' ' HB1' ' A' ' 99' ' ' ALA . 45.8 t80 -133.84 137.52 45.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.451 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.63 152.26 45.42 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.745 0.307 . . . . 0.0 111.437 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.496 ' HB1' ' HH ' ' A' ' 97' ' ' TYR . . . -158.76 92.82 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.773 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 79.0 p -115.73 -177.57 3.18 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.41 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.45 140.52 22.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.945 0.403 . . . . 0.0 111.088 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.759 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 66.3 m-80 -112.28 144.01 42.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.435 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.1 pt -154.98 135.07 4.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 110.766 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.54 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 66.3 mt-10 -70.54 131.35 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.936 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.648 ' O ' HG13 ' C' ' 54' ' ' VAL . 32.9 t-105 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.698 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 37.83 -106.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.961 0.41 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.415 ' O ' ' CB ' ' B' ' 4' ' ' ALA . 44.1 mt-30 -108.22 -45.2 3.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' B' ' 3' ' ' GLN . . . 167.67 -60.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -68.54 -52.44 32.01 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -60.91 -78.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.648 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 66.9 m 54.92 56.32 6.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.014 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.651 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 39.6 m80 -78.06 -48.15 2.09 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.774 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.651 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -55.95 122.18 11.3 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.424 2.083 . . . . 0.0 111.898 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' B' ' 8' ' ' HIS . 12.6 mm-40 -130.75 -51.92 1.06 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.996 0.426 . . . . 0.0 111.211 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -130.42 -158.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.578 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.54 -29.09 70.12 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.482 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -135.58 20.85 3.34 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.507 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.19 -18.69 58.76 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.191 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' B' ' 9' ' ' PRO . . . -71.99 -46.09 58.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 110.906 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -75.97 -26.12 56.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.978 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -74.25 -47.95 31.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.548 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . 0.405 ' HD1' ' O ' ' B' ' 18' ' ' PHE . 0.2 OUTLIER -72.47 -34.84 67.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.231 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' B' ' 15' ' ' ALA . 18.5 mtt85 -65.97 -40.09 90.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.81 -44.93 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.118 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.653 HD23 HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.49 -38.06 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.83 -31.05 66.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.16 -39.49 78.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.74 -37.57 67.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.732 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.0 -42.75 76.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -64.22 -38.82 92.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.63 74.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.67 0.271 . . . . 0.0 111.25 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -59.92 -43.75 94.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.73 -40.57 88.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.963 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.507 ' O ' ' HG3' ' B' ' 34' ' ' LYS . 25.9 m -66.65 -41.36 88.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.88 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' B' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.256 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.12 -32.54 22.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.213 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.699 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 70.4 m-20 -65.59 -63.88 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' B' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.46 62.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.799 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.87 -49.43 78.65 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.617 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -72.55 -27.34 62.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.84 -52.63 55.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.409 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.83 -41.55 78.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.74 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.616 ' HB3' HD21 ' A' ' 36' ' ' LEU . 31.5 p -55.83 -59.04 5.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.76 -39.55 71.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.469 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.52 ' HB1' ' C ' ' B' ' 60' ' ' VAL . . . -60.76 -37.45 81.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.22 -37.3 61.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.049 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.4 m-20 -76.48 -5.86 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.538 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.2 t -79.23 -11.2 59.96 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.193 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.716 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 0.7 OUTLIER -84.32 177.59 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.806 178.022 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.655 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 12.6 p90 -169.57 -15.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.622 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.723 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 40.8 mt-30 81.24 114.62 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.906 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.405 9.7 Cg_endo -69.55 99.55 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.623 2.215 . . . . 0.0 112.491 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.414 ' HB3' ' H ' ' B' ' 50' ' ' GLY . 81.4 m-85 62.13 -160.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.013 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 144.56 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.222 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 78' ' ' ASN . 7.5 p -88.91 -27.04 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.194 0.597 . . . . 0.0 112.433 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 172.22 34.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.292 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.66 -165.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.681 0.276 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.656 HG13 ' O ' ' C' ' 105' ' ' TRP . 8.9 p -110.39 141.19 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.523 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.538 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 6.7 m-80 -119.99 135.83 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.952 0.406 . . . . 0.0 111.689 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.572 ' HB2' ' HB2' ' C' ' 105' ' ' TRP . 2.2 t80 -99.9 128.57 45.98 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.212 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.716 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 42.6 p -117.62 131.41 56.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.023 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.8 143.35 9.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.455 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 178.83 165.52 33.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.586 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' B' ' 69' ' ' LEU . 11.0 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.338 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.52 -174.93 25.96 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.45 144.39 9.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.699 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 87.5 t80 -130.37 127.79 40.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 6.9 mmm-85 66.32 -86.57 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.185 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.84 30.43 0.97 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.66 ' HG ' ' HB3' ' B' ' 33' ' ' ASP . 4.7 m -128.23 167.92 16.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.792 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.38 159.46 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 165.61 36.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.539 ' HA ' HG12 ' B' ' 60' ' ' VAL . 8.0 tp -115.1 137.32 52.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.54 148.85 50.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.673 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.76 158.33 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 0.0 111.13 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 177.45 173.12 42.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.422 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.17 142.81 19.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.52 26.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.13 116.17 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 111.14 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.49 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 9.6 mmm180 -95.96 89.16 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.661 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.642 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 7.7 p -95.76 123.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 111.243 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.548 ' OD1' HG22 ' B' ' 77' ' ' VAL . 19.9 m120 64.12 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -99.76 32.13 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.552 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' SER . . . . . 0.476 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 9.8 t -131.84 -37.7 1.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 82' ' ' ALA . 13.8 p -118.78 148.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.485 ' HB3' ' HD2' ' B' ' 76' ' ' ARG . . . -150.56 171.24 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.09 148.71 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.608 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.723 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -146.33 131.83 18.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.177 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.58 126.69 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -158.0 171.2 34.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.603 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.18 139.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.861 0.362 . . . . 0.0 111.06 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.36 132.25 54.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -100.72 121.51 41.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.542 ' HB1' ' HB3' ' B' ' 94' ' ' ASP . . . -130.1 124.23 32.26 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.651 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 61.91 -110.66 3.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.292 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -132.06 -63.44 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.268 . . . . 0.0 111.281 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.96 24.66 7.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.211 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.542 ' HB3' ' HB1' ' B' ' 90' ' ' ALA . 0.4 OUTLIER -116.41 85.11 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.84 137.56 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.46 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -129.62 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.683 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . 0.499 ' HH ' ' HB1' ' B' ' 99' ' ' ALA . 45.7 t80 -133.77 137.53 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.452 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.6 152.22 45.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.727 0.298 . . . . 0.0 111.458 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . 0.499 ' HB1' ' HH ' ' B' ' 97' ' ' TYR . . . -158.8 92.8 1.13 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.523 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 79.0 p -115.7 -177.61 3.19 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.41 140.54 23.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 111.139 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.764 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 66.4 m-80 -112.34 143.99 42.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.356 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 4.2 pt -154.98 135.01 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.838 0.351 . . . . 0.0 110.776 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.539 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 66.1 mt-10 -70.49 131.41 43.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . 0.655 ' O ' HG13 ' A' ' 54' ' ' VAL . 33.2 t-105 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.466 -0.778 . . . . 0.0 110.681 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.639 -0.184 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 37.86 -106.99 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.947 0.403 . . . . 0.0 110.854 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.408 ' O ' ' CB ' ' C' ' 4' ' ' ALA . 44.1 mt-30 -108.21 -45.12 3.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' C' ' 3' ' ' GLN . . . 167.7 -60.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.01 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.0 t -68.45 -52.44 32.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.763 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -60.98 -78.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.67 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m 54.84 56.32 6.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.042 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.66 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 39.6 m80 -78.02 -48.1 2.12 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.841 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.6 Cg_exo -56.05 122.24 11.41 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.472 2.115 . . . . 0.0 111.824 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' C' ' 8' ' ' HIS . 12.6 mm-40 -130.81 -51.91 1.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -130.42 -158.71 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.604 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.65 -29.06 70.06 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.446 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -135.55 20.84 3.35 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.56 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.17 -18.6 58.95 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.302 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' C' ' 9' ' ' PRO . . . -72.07 -46.03 58.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 110.896 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -75.96 -26.13 56.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.977 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -74.22 -48.06 31.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -34.92 68.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.273 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' C' ' 15' ' ' ALA . 18.6 mtt85 -65.86 -40.1 91.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.803 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.88 -44.88 63.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.658 HD22 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.54 -38.08 68.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.623 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.67 -31.15 66.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.14 -39.54 78.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -72.68 -37.52 67.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.741 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.401 HD12 ' CB ' ' A' ' 24' ' ' ARG . 21.1 mt -69.02 -42.69 76.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.626 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.23 -38.82 92.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.824 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 3.0 tmtt? -69.56 -42.66 74.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.253 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.93 -43.8 94.73 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.69 -40.53 88.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.0 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' C' ' 34' ' ' LYS . 25.9 m -66.72 -41.28 88.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.902 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' C' ' 27' ' ' LYS . 86.4 mmt-85 -54.89 -38.06 67.1 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.389 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.13 -32.53 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.218 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.715 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 70.4 m-20 -65.51 -63.96 0.97 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.075 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' C' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.47 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.758 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.39 79.18 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.384 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.62 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -72.56 -27.34 62.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.803 0.335 . . . . 0.0 111.066 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.56 55.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -41.48 78.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.617 ' HB3' HD21 ' B' ' 36' ' ' LEU . 31.3 p -55.86 -58.96 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.61 71.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.441 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.52 ' HB1' ' C ' ' C' ' 60' ' ' VAL . . . -60.66 -37.47 81.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.21 -37.4 61.14 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.53 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 75.4 m-20 -76.32 -5.93 49.28 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' SER . . . . . 0.543 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.2 t -79.21 -11.24 59.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.111 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.724 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 0.7 OUTLIER -84.22 177.63 8.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.784 178.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.634 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 12.6 p90 -169.61 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.611 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.723 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 40.9 mt-30 81.13 114.59 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.986 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.42 99.41 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.709 2.272 . . . . 0.0 112.564 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.413 ' HB3' ' H ' ' C' ' 50' ' ' GLY . 81.2 m-85 62.24 -160.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.005 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 144.55 93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.255 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' C' ' 78' ' ' ASN . 7.5 p -88.86 -27.03 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.154 0.582 . . . . 0.0 112.468 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 172.18 34.55 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.269 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.64 -165.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.646 0.26 . . . . 0.0 110.592 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.648 HG13 ' O ' ' A' ' 105' ' ' TRP . 8.9 p -110.36 141.26 26.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.523 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.54 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 6.8 m-80 -120.01 135.74 54.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.973 0.416 . . . . 0.0 111.73 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . 0.568 ' HB2' ' HB2' ' A' ' 105' ' ' TRP . 2.2 t80 -99.75 128.47 45.85 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.724 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.0 p -117.58 131.46 56.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.97 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.84 143.35 9.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.49 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 178.79 165.55 33.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.538 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' C' ' 69' ' ' LEU . 10.9 m -111.8 168.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.838 0.352 . . . . 0.0 111.326 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.46 -174.9 25.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.418 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.4 144.49 9.71 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.715 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 87.6 t80 -130.48 127.78 39.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 110.736 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 6.8 mmm-85 66.3 -86.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -146.84 30.32 0.98 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' SER . . . . . 0.662 ' HG ' ' HB3' ' C' ' 33' ' ' ASP . 4.7 m -128.25 167.95 16.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.825 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -136.45 159.43 41.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.104 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.53 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.527 ' HA ' HG12 ' C' ' 60' ' ' VAL . 8.0 tp -115.07 137.28 52.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.782 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.53 148.87 50.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.699 0.285 . . . . 0.0 111.651 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.82 158.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.435 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 177.41 173.18 42.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.488 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -155.19 142.72 19.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.12 156.5 26.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.234 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.09 116.19 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.133 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.491 ' HD2' ' HB3' ' C' ' 82' ' ' ALA . 9.6 mmm180 -95.96 89.1 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.723 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.646 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 7.7 p -95.74 123.77 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 111.208 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.558 ' OD1' HG22 ' C' ' 77' ' ' VAL . 19.9 m120 64.27 167.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 111.09 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -99.81 32.09 3.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.572 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' SER . . . . . 0.481 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 9.7 t -131.75 -37.75 1.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.991 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.406 HG22 ' N ' ' C' ' 82' ' ' ALA . 13.7 p -118.75 148.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.513 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.491 ' HB3' ' HD2' ' C' ' 76' ' ' ARG . . . -150.71 171.12 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.258 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -162.96 148.77 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.573 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.723 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -146.37 131.8 18.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.75 12.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . 0.435 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -158.12 171.17 35.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.572 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.2 139.27 48.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 111.114 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.31 54.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.78 121.49 41.78 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.271 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' C' ' 94' ' ' ASP . . . -130.1 124.23 32.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.628 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.474 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 61.94 -110.63 3.32 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.274 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.5 m -132.1 -63.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 0.0 111.295 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.99 24.7 7.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.531 ' HB3' ' HB1' ' C' ' 90' ' ' ALA . 0.4 OUTLIER -116.42 85.1 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.947 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.77 137.6 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.457 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.4 OUTLIER -129.6 158.17 40.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . 0.493 ' HH ' ' HB1' ' C' ' 99' ' ' ALA . 45.7 t80 -133.84 137.58 45.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.388 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.72 152.19 45.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.417 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . 0.493 ' HB1' ' HH ' ' C' ' 97' ' ' TYR . . . -158.78 92.83 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 79.0 p -115.73 -177.61 3.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.447 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.38 140.61 23.11 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.08 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.778 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 66.4 m-80 -112.31 143.94 42.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.418 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 4.1 pt -154.96 135.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.538 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 66.4 mt-10 -70.52 131.35 43.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.977 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . 0.656 ' O ' HG13 ' B' ' 54' ' ' VAL . 33.1 t-105 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.664 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.468 ' OD1' ' OG ' ' A' ' 5' ' ' SER . 3.8 t70 78.28 134.34 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.934 0.397 . . . . 0.0 110.953 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -130.95 -65.15 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.71 32.44 1.82 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.995 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 2' ' ' ASP . 58.4 p -99.94 155.02 17.91 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.758 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -105.91 -80.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.675 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m 59.78 42.17 17.11 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.033 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.871 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 33.1 m170 -80.68 -54.47 0.77 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.825 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.3 Cg_exo -59.27 120.06 7.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.478 2.119 . . . . 0.0 111.971 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -100.2 -65.66 0.95 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.917 0.389 . . . . 0.0 111.146 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -114.7 175.0 5.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.631 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.37 28.6 0.34 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.448 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -46.47 15.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.532 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.1 -26.29 63.29 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.25 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.18 -48.07 83.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.365 . . . . 0.0 110.952 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -76.46 -39.82 52.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.993 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.581 ' HE2' ' HB2' ' C' ' 17' ' ' LYS . 0.2 OUTLIER -60.04 -35.21 74.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.533 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.97 -37.86 64.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.208 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.2 -60.4 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.68 65.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.097 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.653 HD21 HD21 ' A' ' 25' ' ' LEU . 2.3 tm? -66.96 -62.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -62.24 -23.76 66.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.52 -49.51 47.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HD3' HD12 ' C' ' 21' ' ' LEU . 69.0 mtp85 -73.33 -42.15 62.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.653 HD21 HD21 ' A' ' 21' ' ' LEU . 3.9 mm? -61.36 -46.08 91.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.559 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.29 -32.97 74.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.787 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.79 83.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.185 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -47.94 81.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -60.98 -32.0 71.57 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.967 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 30' ' ' THR . 6.3 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.85 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -30.72 46.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.381 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 29' ' ' ASP . 30.3 m -83.5 -33.49 9.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.501 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 57.9 m-20 -66.29 -48.69 69.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.608 ' CD ' ' HA3' ' A' ' 91' ' ' GLY . 6.6 ptpt -85.07 -25.69 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.835 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.91 -40.68 63.08 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.393 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -77.11 -25.73 52.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.329 . . . . 0.0 111.034 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.725 ' HB2' ' HB3' ' A' ' 68' ' ' ALA . . . -72.31 -40.93 67.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.444 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.67 ' HB3' ' HE1' ' A' ' 96' ' ' MET . 13.3 t -79.0 -43.01 25.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.414 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.4 OUTLIER -59.73 -56.71 18.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB1' ' HG ' ' B' ' 39' ' ' SER . . . -57.34 -40.88 78.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.395 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.426 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -56.41 -35.13 67.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 26.0 tp -76.26 -42.4 45.85 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.592 ' CB ' ' HB3' ' B' ' 43' ' ' ASN . 35.6 m-20 -70.83 -13.81 62.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -67.26 -21.88 65.69 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.128 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' B' ' 100' ' ' SER . 1.5 mm? -80.07 171.8 14.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.857 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.477 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.3 p90 -158.11 -3.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.628 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 55' ' ' ASN . 7.1 mt-30 71.51 119.79 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.953 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.262 9.8 Cg_endo -75.09 106.7 2.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.65 2.233 . . . . 0.0 112.497 -179.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.19 -177.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.462 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 173.02 51.34 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.245 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 4.9 p -73.32 -3.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.12 0.568 . . . . 0.0 112.519 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.84 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.9 54.33 0.03 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.272 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.82 -165.04 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 55' ' ' ASN . 12.0 p -113.24 145.08 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.5 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.611 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.5 m-80 -126.16 118.43 25.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.65 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -83.66 130.31 34.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.255 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.467 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 75.5 p -114.66 120.9 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.986 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.482 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -152.26 135.29 15.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.488 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -179.72 168.57 39.06 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.488 ' CG1' HD11 ' A' ' 69' ' ' LEU . 13.3 m -116.96 158.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 111.418 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -144.99 -170.89 14.34 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.481 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -165.5 142.67 7.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.577 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 56.1 t80 -134.01 134.7 42.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.684 0.278 . . . . 0.0 110.771 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.71 28.59 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 1.6 m -133.77 142.05 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.3 157.11 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.099 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.725 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . . . -149.48 167.78 25.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.558 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.488 HD11 ' CG1' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -125.97 136.66 53.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.757 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -128.31 142.55 51.1 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 111.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.482 HD12 ' HB1' ' A' ' 58' ' ' ALA . 10.4 tp -139.38 155.07 25.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' THR . . . 168.12 176.91 38.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.384 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -168.04 155.82 8.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.01 28.57 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.207 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -123.48 135.74 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.17 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.544 HH21 ' HB2' ' A' ' 47' ' ' GLN . 12.3 ttm180 -131.17 133.27 45.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.678 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.84 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 13.8 p -122.32 139.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 88.8 m-20 61.19 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 7.8 pt-20 177.81 -26.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.55 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 59.5 p -65.65 -67.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.39 139.19 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.496 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 102' ' ' ASN . . . -142.07 155.35 45.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.241 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.564 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.468 ' HG3' ' HE2' ' C' ' 46' ' ' PHE . 8.2 tmtt? -155.31 130.19 9.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.217 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 175.41 12.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.16 -173.69 37.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.543 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 71' ' ' ILE . 14.7 p -141.89 143.17 27.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 96' ' ' MET . . . -115.17 144.11 44.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.351 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.424 ' HH ' ' HA ' ' A' ' 92' ' ' SER . 16.5 t80 -119.24 119.03 32.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.282 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -127.89 135.29 49.8 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.657 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.608 ' HA3' ' CD ' ' A' ' 34' ' ' LYS . . . 60.52 -111.56 3.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.276 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.424 ' HA ' ' HH ' ' A' ' 89' ' ' TYR . 56.3 m -149.61 10.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 111.312 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -165.09 23.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.156 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 37.0 m-20 -116.3 67.7 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.408 HG11 ' CE1' ' A' ' 97' ' ' TYR . 21.4 t -94.08 139.67 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 110.745 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.67 ' HE1' ' HB3' ' A' ' 38' ' ' SER . 7.1 ptp -134.25 135.53 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.723 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.408 ' CE1' HG11 ' A' ' 95' ' ' VAL . 72.4 m-85 -113.86 118.71 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.409 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.03 152.63 23.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.79 0.328 . . . . 0.0 111.394 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.753 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.469 ' HA ' ' HA3' ' C' ' 59' ' ' GLY . 14.4 m -118.6 169.09 10.09 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.396 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.06 136.01 31.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.986 0.422 . . . . 0.0 111.056 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.67 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 70.8 m-80 -104.31 132.8 50.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.355 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -138.22 114.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.376 . . . . 0.0 110.716 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -115.97 157.95 23.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.671 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.414 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.465 ' OD1' ' OG ' ' B' ' 5' ' ' SER . 3.8 t70 78.28 134.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.985 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -130.92 -65.09 0.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.69 32.4 1.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.465 ' OG ' ' OD1' ' B' ' 2' ' ' ASP . 58.0 p -99.95 155.03 17.91 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.785 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -105.85 -80.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m 59.89 42.13 16.8 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.991 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.845 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 33.1 m170 -80.66 -54.41 0.78 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.845 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.845 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -59.33 120.13 7.78 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.507 2.138 . . . . 0.0 111.891 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -100.23 -65.77 0.95 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.61 174.93 5.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.73 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.28 28.57 0.35 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.439 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -46.5 15.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.514 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.05 -26.35 63.27 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.231 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.06 83.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.931 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -76.46 -39.85 52.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.024 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.574 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -60.05 -35.19 74.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.578 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.9 -37.87 64.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.23 -60.37 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.63 65.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.983 0.42 . . . . 0.0 111.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.67 HD21 HD21 ' B' ' 25' ' ' LEU . 2.3 tm? -67.04 -62.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.29 -23.73 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.005 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.56 -49.49 47.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.538 ' HD3' HD12 ' A' ' 21' ' ' LEU . 69.1 mtp85 -73.36 -42.15 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.702 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.67 HD21 HD21 ' B' ' 21' ' ' LEU . 3.9 mm? -61.26 -46.08 91.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.603 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.33 -32.92 74.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.773 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.89 -38.7 83.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.647 0.26 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -47.89 81.59 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.562 ' O ' HG22 ' B' ' 32' ' ' VAL . 0.5 OUTLIER -61.06 -31.95 71.6 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 178.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -30.64 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.312 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.562 HG22 ' O ' ' B' ' 29' ' ' ASP . 29.3 m -83.68 -33.33 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.172 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.494 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 58.3 m-20 -66.35 -48.7 69.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.972 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.598 ' CD ' ' HA3' ' B' ' 91' ' ' GLY . 6.6 ptpt -85.17 -25.58 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.92 -40.8 62.95 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.579 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.5 mt -77.03 -25.71 52.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' B' ' 68' ' ' ALA . . . -72.44 -40.76 66.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.411 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.669 ' HB3' ' HE1' ' B' ' 96' ' ' MET . 13.5 t -79.08 -42.97 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.745 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.406 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 0.4 OUTLIER -59.86 -56.71 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.419 ' HB1' ' HG ' ' C' ' 39' ' ' SER . . . -57.28 -40.88 78.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.441 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.43 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -56.48 -35.08 67.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' B' ' 70' ' ' ALA . 26.1 tp -76.3 -42.23 45.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.124 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.593 ' CB ' ' HB3' ' C' ' 43' ' ' ASN . 35.5 m-20 -70.92 -13.77 62.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 46.5 t -67.3 -21.87 65.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.147 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' C' ' 100' ' ' SER . 1.5 mm? -80.05 171.71 14.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.866 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.48 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.3 p90 -158.09 -3.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.162 0.506 . . . . 0.0 111.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.55 ' HB3' ' HB2' ' B' ' 55' ' ' ASN . 7.1 mt-30 71.5 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.992 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.265 10.0 Cg_endo -74.94 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.708 2.272 . . . . 0.0 112.573 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.18 -177.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 173.02 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.219 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 4.9 p -73.42 -3.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.145 0.578 . . . . 0.0 112.466 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.838 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.97 54.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.25 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.81 -165.07 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.445 HG23 ' N ' ' B' ' 55' ' ' ASN . 12.0 p -113.2 145.12 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.561 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' B' ' 48' ' ' PRO . 5.4 m-80 -126.11 118.32 25.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 111.706 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -83.77 130.36 34.94 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.223 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.461 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 75.9 p -114.67 120.9 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.976 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.492 ' HB1' HD12 ' B' ' 71' ' ' ILE . . . -152.28 135.34 15.7 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.458 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -179.77 168.63 39.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.563 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.489 ' CG1' HD11 ' B' ' 69' ' ' LEU . 13.1 m -117.01 158.43 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.811 0.339 . . . . 0.0 111.332 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -144.99 -170.86 14.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.441 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -165.5 142.69 7.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.529 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.564 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 56.0 t80 -134.13 134.7 42.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.672 0.273 . . . . 0.0 110.744 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 64.34 -93.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.73 28.63 1.27 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 1.6 m -133.79 142.1 47.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.36 157.17 17.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.99 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.727 ' HB3' ' HB2' ' B' ' 37' ' ' ALA . . . -149.57 167.74 25.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.523 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.489 HD11 ' CG1' ' B' ' 60' ' ' VAL . 0.6 OUTLIER -125.95 136.61 53.22 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.796 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -128.21 142.53 51.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.668 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.492 HD12 ' HB1' ' B' ' 58' ' ' ALA . 10.4 tp -139.29 155.16 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.103 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.413 ' N ' HG13 ' B' ' 71' ' ' ILE . . . 168.03 176.8 38.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.427 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -167.95 155.89 8.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.027 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.33 171.93 28.66 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.179 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -123.46 135.73 54.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.543 HH21 ' HB2' ' B' ' 47' ' ' GLN . 12.3 ttm180 -131.14 133.33 45.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.838 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 13.7 p -122.44 139.64 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 88.8 m-20 61.25 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 0.0 111.066 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.638 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 7.8 pt-20 177.87 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.585 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' B' ' 103' ' ' ILE . 59.5 p -65.65 -67.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.991 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.4 139.21 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.501 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' B' ' 102' ' ' ASN . . . -142.03 155.35 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.477 ' HG3' ' HE2' ' A' ' 46' ' ' PHE . 8.2 tmtt? -155.28 130.26 9.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.15 175.42 12.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.14 -173.7 37.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.559 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.424 ' O ' HG23 ' B' ' 71' ' ' ILE . 14.7 p -141.89 143.24 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.891 0.377 . . . . 0.0 111.123 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HG2' ' B' ' 96' ' ' MET . . . -115.23 144.1 44.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.33 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . 0.413 ' HH ' ' HA ' ' B' ' 92' ' ' SER . 16.4 t80 -119.24 119.06 32.96 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -127.91 135.36 49.88 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.649 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.598 ' HA3' ' CD ' ' B' ' 34' ' ' LYS . . . 60.48 -111.58 3.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.281 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' SER . . . . . 0.413 ' HA ' ' HH ' ' B' ' 89' ' ' TYR . 56.8 m -149.62 10.3 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.286 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -165.07 23.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.163 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 37.2 m-20 -116.38 67.68 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.416 HG11 ' CE1' ' B' ' 97' ' ' TYR . 21.4 t -94.11 139.61 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.702 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.669 ' HE1' ' HB3' ' B' ' 38' ' ' SER . 7.0 ptp -134.23 135.52 43.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . 0.416 ' CE1' HG11 ' B' ' 95' ' ' VAL . 72.5 m-85 -113.81 118.75 35.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.98 152.62 23.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.692 0.282 . . . . 0.0 111.427 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.49 90.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.698 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.469 ' HB2' HD13 ' A' ' 45' ' ' LEU . 14.3 m -118.56 169.09 10.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.432 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.02 135.89 31.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.692 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.9 m-80 -104.25 132.82 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.426 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -138.19 114.32 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -115.98 157.92 23.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.663 179.671 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . 0.471 ' OD1' ' OG ' ' C' ' 5' ' ' SER . 3.7 t70 78.23 134.31 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.926 0.393 . . . . 0.0 110.998 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -130.94 -65.17 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.63 32.39 1.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' SER . . . . . 0.471 ' OG ' ' OD1' ' C' ' 2' ' ' ASP . 58.1 p -99.9 155.01 17.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.744 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -105.84 -80.96 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.696 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 72.3 m 59.81 42.23 16.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.015 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.857 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 33.2 m170 -80.79 -54.37 0.76 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.761 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.857 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.3 Cg_exo -59.35 120.03 7.63 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.473 2.116 . . . . 0.0 111.977 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -100.12 -65.69 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.988 0.423 . . . . 0.0 111.152 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.64 175.01 5.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.656 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.41 28.63 0.34 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.411 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -46.5 15.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.527 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.11 -26.25 63.27 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.19 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.09 83.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.941 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -76.53 -39.78 51.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.958 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.581 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -60.15 -35.11 74.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.531 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -74.0 -37.82 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.2 -60.42 3.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.38 -28.62 65.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.667 HD21 HD21 ' C' ' 25' ' ' LEU . 2.3 tm? -67.01 -62.7 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.566 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.18 -23.79 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.46 -49.56 47.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.53 ' HD3' HD12 ' B' ' 21' ' ' LEU . 69.0 mtp85 -73.4 -42.05 62.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.797 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.667 HD21 HD21 ' C' ' 21' ' ' LEU . 3.9 mm? -61.31 -46.08 91.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.624 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.32 -32.91 74.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.846 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.73 83.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -47.86 81.71 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.56 ' O ' HG22 ' C' ' 32' ' ' VAL . 0.5 OUTLIER -61.05 -31.87 71.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.96 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -73.9 -30.26 62.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.865 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -30.73 45.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.56 HG22 ' O ' ' C' ' 29' ' ' ASP . 30.1 m -83.57 -33.38 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.502 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 57.8 m-20 -66.43 -48.63 69.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.609 ' CD ' ' HA3' ' C' ' 91' ' ' GLY . 6.6 ptpt -85.16 -25.61 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.93 -40.71 62.91 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.404 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.579 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.5 mt -77.03 -25.78 52.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.92 0.391 . . . . 0.0 111.165 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.726 ' HB2' ' HB3' ' C' ' 68' ' ' ALA . . . -72.33 -40.77 67.17 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.548 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.657 ' HB3' ' HE1' ' C' ' 96' ' ' MET . 13.2 t -79.07 -42.87 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.803 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.419 ' HG ' ' HB1' ' B' ' 40' ' ' ALA . 0.4 OUTLIER -59.92 -56.71 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.4 ' HB1' ' HG ' ' A' ' 39' ' ' SER . . . -57.25 -41.01 78.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.418 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.421 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -56.34 -35.11 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.941 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.574 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 26.2 tp -76.22 -42.38 46.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.148 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.593 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 35.4 m-20 -70.84 -13.85 62.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -67.31 -21.88 65.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.09 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 100' ' ' SER . 1.5 mm? -80.06 171.84 14.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.845 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.468 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.3 p90 -158.1 -3.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.193 0.52 . . . . 0.0 111.721 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' C' ' 55' ' ' ASN . 7.1 mt-30 71.58 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.968 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.263 9.9 Cg_endo -75.03 106.7 2.33 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.635 2.224 . . . . 0.0 112.585 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.15 -177.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 173.03 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.168 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 4.9 p -73.43 -3.42 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.091 0.557 . . . . 0.0 112.465 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.823 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.94 54.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 -165.16 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 0.0 110.615 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.444 HG23 ' N ' ' C' ' 55' ' ' ASN . 12.0 p -113.15 145.1 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.61 ' HB3' ' HD2' ' C' ' 48' ' ' PRO . 5.4 m-80 -126.1 118.38 25.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 111.655 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -83.76 130.33 34.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.206 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.456 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 75.2 p -114.63 120.92 41.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.97 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . 0.479 ' HB1' HD12 ' C' ' 71' ' ' ILE . . . -152.32 135.35 15.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.484 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -179.76 168.57 39.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.552 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.49 ' CG1' HD11 ' C' ' 69' ' ' LEU . 13.3 m -116.9 158.41 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.328 . . . . 0.0 111.357 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -145.04 -170.8 14.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.421 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -165.59 142.72 7.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.574 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 56.2 t80 -134.04 134.69 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.636 0.255 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.103 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.75 28.58 1.27 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' C' ' 33' ' ' ASP . 1.6 m -133.8 142.04 47.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.21 157.3 17.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . 0.726 ' HB3' ' HB2' ' C' ' 37' ' ' ALA . . . -149.64 167.75 25.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.49 HD11 ' CG1' ' C' ' 60' ' ' VAL . 0.6 OUTLIER -126.01 136.63 53.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.574 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -128.25 142.55 51.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.654 0.264 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.479 HD12 ' HB1' ' C' ' 58' ' ' ALA . 10.4 tp -139.29 155.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.761 0.315 . . . . 0.0 111.11 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.408 ' N ' HG13 ' C' ' 71' ' ' ILE . . . 168.04 176.83 38.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.448 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -168.01 155.85 8.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.339 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.36 171.99 28.67 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.527 HH21 ' HB2' ' C' ' 47' ' ' GLN . 12.3 ttm180 -131.19 133.27 45.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.677 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.823 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 13.6 p -122.38 139.68 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 89.0 m-20 61.17 -94.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 111.042 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . 0.647 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 7.8 pt-20 177.86 -26.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' C' ' 103' ' ' ILE . 59.2 p -65.69 -67.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.35 139.17 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' C' ' 102' ' ' ASN . . . -142.07 155.34 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.229 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.69 146.42 34.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.48 ' HG3' ' HE2' ' B' ' 46' ' ' PHE . 8.2 tmtt? -155.3 130.24 9.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.163 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.1 175.48 12.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.09 -173.71 37.57 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.536 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' C' ' 71' ' ' ILE . 14.7 p -141.91 143.21 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.078 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.501 ' HB2' ' HG2' ' C' ' 96' ' ' MET . . . -115.2 144.14 44.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.348 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . 0.416 ' HH ' ' HA ' ' C' ' 92' ' ' SER . 16.4 t80 -119.26 119.13 33.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -128.0 135.29 49.7 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.672 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.609 ' HA3' ' CD ' ' C' ' 34' ' ' LYS . . . 60.64 -111.59 3.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.279 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' SER . . . . . 0.416 ' HA ' ' HH ' ' C' ' 89' ' ' TYR . 56.7 m -149.67 10.38 0.73 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.294 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -165.15 23.93 0.05 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 37.0 m-20 -116.37 67.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . 0.411 HG11 ' CE1' ' C' ' 97' ' ' TYR . 21.5 t -94.13 139.72 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.657 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 7.1 ptp -134.22 135.52 43.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . 0.411 ' CE1' HG11 ' C' ' 95' ' ' VAL . 72.5 m-85 -113.87 118.77 35.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.403 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.1 152.61 23.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.715 0.293 . . . . 0.0 111.382 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.477 ' HB2' HD13 ' B' ' 45' ' ' LEU . 14.4 m -118.65 169.12 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.403 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.12 135.94 31.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.042 0.449 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.677 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 70.9 m-80 -104.24 132.8 50.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.435 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' C' ' 80' ' ' SER . 0.1 OUTLIER -138.17 114.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.719 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -115.97 157.96 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.8 m-90 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.706 179.624 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.641 -0.184 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 40.2 -102.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -112.48 -54.38 2.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.61 -63.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.026 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -68.03 -53.9 22.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.693 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -47.37 -83.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.698 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m 68.28 45.31 1.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.996 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.736 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 23.7 m80 -70.83 -52.38 10.22 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.791 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.736 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -52.0 121.39 8.7 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.515 2.143 . . . . 0.0 111.89 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 8' ' ' HIS . 13.0 mm100 -127.92 -59.16 1.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 0.0 111.115 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -125.97 -154.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.657 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -68.99 -26.6 65.1 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.402 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -135.55 20.69 3.35 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.544 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.82 -22.77 60.97 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.224 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' HB1' ' NH1' ' A' ' 19' ' ' ARG . . . -66.99 -46.07 75.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.869 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.596 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 39.3 m-70 -72.13 -32.15 66.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.989 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.483 ' O ' HD21 ' A' ' 21' ' ' LEU . 34.6 ttmt -73.05 -46.94 48.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.548 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.75 -39.7 80.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.889 0.376 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' NH1' ' HB1' ' A' ' 15' ' ' ALA . 49.5 mtt85 -66.81 -42.89 85.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.779 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -64.7 -41.39 96.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.1 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.74 HD23 HD22 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -62.9 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.83 -30.72 71.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.73 -39.11 57.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.76 ' HG ' HD21 ' C' ' 25' ' ' LEU . 8.0 mt -67.25 -50.98 58.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.571 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.78 -50.91 72.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.826 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HE2' ' CZ ' ' A' ' 31' ' ' ARG . 9.5 tmtt? -54.78 -38.26 67.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.279 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -62.39 -42.69 99.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -63.54 -41.7 98.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.997 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.4 m -57.91 -47.12 83.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.764 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.607 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 83.2 mmt-85 -59.45 -35.5 74.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.318 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 28' ' ' LEU . 41.7 t -73.75 -36.5 46.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.99 -55.88 16.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.995 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.607 ' HE3' ' HD3' ' A' ' 31' ' ' ARG . 3.4 pttt -72.35 -36.5 68.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.774 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.13 96.33 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.369 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -70.14 -37.13 75.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.805 0.336 . . . . 0.0 111.08 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.72 99.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.463 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -54.38 14.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.753 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.65 ' HB3' HD21 ' C' ' 36' ' ' LEU . 86.9 p -49.07 -56.21 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -52.49 -52.61 53.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.471 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.699 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -49.16 -41.58 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.8 tp -73.88 -34.89 64.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.09 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.4 m-20 -78.25 -5.12 51.01 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.41 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.5 t -86.13 -0.6 56.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.12 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.802 ' HB3' HG23 ' A' ' 57' ' ' THR . 0.3 OUTLIER -95.97 172.18 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.881 177.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -165.76 -5.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.662 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' A' ' 55' ' ' ASN . 35.1 mt-30 65.83 118.9 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.945 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.395 9.8 Cg_endo -69.89 98.2 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.692 2.261 . . . . 0.0 112.54 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 66.94 -165.0 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 146.16 82.25 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.7 p -88.72 -11.03 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.094 0.558 . . . . 0.0 112.477 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.685 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 158.34 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.296 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.01 -166.7 2.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.558 0.218 . . . . 0.0 110.65 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.062 HG13 ' O ' ' B' ' 105' ' ' TRP . 2.6 p -109.5 144.05 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.41 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 4.4 m-80 -131.06 134.83 47.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.652 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.452 ' O ' HG13 ' B' ' 103' ' ' ILE . 1.2 t80 -104.53 121.92 44.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.275 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 45' ' ' LEU . 21.1 p -114.57 124.86 52.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.19 150.81 29.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.41 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.519 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.19 164.01 26.17 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.491 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 69' ' ' LEU . 14.5 m -110.21 166.33 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 111.373 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -174.43 22.35 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.53 143.21 8.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.554 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.613 ' CE2' ' HG3' ' A' ' 64' ' ' ARG . 63.2 t80 -132.51 137.1 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.727 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.613 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 2.9 mmm180 61.52 -80.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 63' ' ' TYR . 12.0 t -156.64 32.27 0.31 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -130.11 167.42 18.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.01 142.15 48.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.137 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.43 47.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.61 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.468 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.2 tp -111.32 128.48 55.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.729 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 41' ' ' ALA . . . -122.95 152.09 41.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.708 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.404 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.7 tt -147.54 162.06 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.289 . . . . 0.0 111.183 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.404 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 175.35 169.34 37.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.408 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 p -163.29 147.71 11.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.73 161.85 28.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.245 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.29 119.48 39.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.154 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.608 ' HD2' ' HB3' ' A' ' 82' ' ' ALA . 4.9 mmm180 -96.9 99.21 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.707 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.685 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.0 p -98.23 130.72 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.332 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 8.1 m120 66.27 -170.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.932 0.396 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -120.05 24.53 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.551 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.576 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 5.0 t -129.01 -44.75 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.28 148.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.494 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB3' ' HD2' ' A' ' 76' ' ' ARG . . . -152.07 171.15 18.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 111.205 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.82 143.23 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.606 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.5 23.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.26 135.95 23.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.39 175.04 39.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 96' ' ' MET . 6.3 p -124.08 146.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' HB2' ' HG2' ' A' ' 96' ' ' MET . . . -114.11 134.09 55.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.27 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.86 110.69 22.1 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.259 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 94' ' ' ASP . . . -122.75 132.43 54.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.498 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.84 -113.15 4.04 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.263 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.85 -60.76 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 111.322 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.4 t -101.53 29.77 4.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.221 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.487 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.99 1.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 88' ' ' ALA . 5.0 t -120.4 142.34 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.748 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.547 ' HB2' ' HA ' ' C' ' 63' ' ' TYR . 0.9 OUTLIER -132.57 155.59 48.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -128.48 129.02 45.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.522 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -119.7 160.33 22.74 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.17 99.02 0.12 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.796 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.746 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.2 p -122.67 179.45 4.61 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.43 146.36 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 70.4 m-80 -111.9 150.02 31.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.362 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.46 HG13 ' O ' ' C' ' 56' ' ' PHE . 3.9 pt -156.18 150.99 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.576 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 73.7 mt-10 -96.25 130.56 43.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 1.088 ' O ' HG13 ' C' ' 54' ' ' VAL . 5.7 t-105 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.664 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 40.09 -102.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -112.5 -54.38 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.842 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.58 -63.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -68.07 -53.93 22.03 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.689 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -47.4 -83.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.719 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 19.5 m 68.2 45.4 1.26 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.979 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.723 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 23.6 m170 -70.83 -52.38 10.19 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.771 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -51.95 121.4 8.68 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.462 2.108 . . . . 0.0 111.93 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' B' ' 8' ' ' HIS . 13.0 mm100 -127.95 -59.14 1.2 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.385 . . . . 0.0 111.114 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.99 -154.71 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.667 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -69.01 -26.6 65.08 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.441 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -135.68 20.81 3.32 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.496 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.76 -22.77 61.11 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.309 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.1 -45.95 75.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.598 ' O ' ' HB2' ' B' ' 20' ' ' GLN . 39.2 m-70 -72.17 -32.13 66.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.004 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.491 ' O ' HD21 ' B' ' 21' ' ' LEU . 34.7 ttmt -73.02 -47.0 48.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.612 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -39.83 80.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -66.76 -42.92 85.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' B' ' 16' ' ' HIS . 0.8 OUTLIER -64.71 -41.4 96.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.109 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.84 -43.4 98.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.89 -30.69 71.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.78 -39.11 57.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -73.02 -38.36 66.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.813 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.751 HD21 ' HG ' ' C' ' 25' ' ' LEU . 8.0 mt -67.18 -51.03 58.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.61 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.83 -50.89 72.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.799 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.482 ' HE2' ' CZ ' ' B' ' 31' ' ' ARG . 9.5 tmtt? -54.8 -38.27 67.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.277 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.443 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -62.41 -42.63 99.58 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.52 -41.74 98.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.969 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' B' ' 34' ' ' LYS . 4.4 m -57.94 -47.07 83.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.59 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 83.1 mmt-85 -59.37 -35.56 74.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.352 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 28' ' ' LEU . 41.7 t -73.78 -36.56 46.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.201 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.0 -55.86 16.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.955 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.59 ' HE3' ' HD3' ' B' ' 31' ' ' ARG . 3.4 pttt -72.33 -36.58 68.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.744 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.91 -45.05 96.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.382 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -70.12 -37.23 75.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.79 99.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.427 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.56 -54.33 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.666 ' HB3' HD21 ' A' ' 36' ' ' LEU . 86.9 p -49.16 -56.25 9.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.017 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.54 54.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.465 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.675 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . . . -49.23 -41.56 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 tp -73.89 -34.88 64.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.112 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.503 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.1 m-20 -78.13 -5.23 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.419 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -86.05 -0.65 56.1 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.141 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.8 ' HB3' HG23 ' B' ' 57' ' ' THR . 0.3 OUTLIER -95.83 172.21 8.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.894 177.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -165.84 -5.24 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.097 0.475 . . . . 0.0 111.654 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' B' ' 55' ' ' ASN . 35.1 mt-30 65.86 118.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.395 9.7 Cg_endo -69.88 98.36 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.638 2.225 . . . . 0.0 112.552 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 66.75 -164.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 146.15 82.31 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.188 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 8.7 p -88.78 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.144 0.578 . . . . 0.0 112.422 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 158.25 46.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.259 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.1 -166.69 2.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.586 0.231 . . . . 0.0 110.628 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 1.071 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.6 p -109.52 144.12 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.561 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.41 ' HB2' ' OE1' ' B' ' 47' ' ' GLN . 4.4 m-80 -131.12 134.79 46.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.013 0.435 . . . . 0.0 111.61 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.448 ' O ' HG13 ' C' ' 103' ' ' ILE . 1.2 t80 -104.55 121.96 44.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.24 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.8 HG23 ' HB3' ' B' ' 45' ' ' LEU . 21.1 p -114.59 124.86 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.22 150.75 29.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.484 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.523 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.25 164.01 26.22 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.575 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' B' ' 69' ' ' LEU . 14.4 m -110.26 166.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.61 -174.42 22.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.462 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.52 143.15 8.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.613 ' CE2' ' HG3' ' B' ' 64' ' ' ARG . 63.5 t80 -132.48 137.0 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.291 . . . . 0.0 110.765 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.613 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 2.9 mmm180 61.54 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.029 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 63' ' ' TYR . 12.2 t -156.69 32.3 0.31 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.158 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -130.17 167.46 18.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.802 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.02 142.15 48.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.62 155.49 47.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.529 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.459 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.1 tp -111.33 128.44 55.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.724 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' B' ' 41' ' ' ALA . . . -123.0 152.17 41.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.406 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.7 tt -147.56 162.0 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.751 0.31 . . . . 0.0 111.073 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.406 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 175.38 169.35 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.47 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -163.25 147.71 11.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.76 161.89 28.97 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.255 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.34 119.51 39.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.161 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.601 ' HD2' ' HB3' ' B' ' 82' ' ' ALA . 5.0 mmm180 -96.96 99.15 10.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.667 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.9 p -98.08 130.71 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.328 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 8.1 m120 66.17 -170.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.899 0.381 . . . . 0.0 111.154 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.0 24.59 10.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.598 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' SER . . . . . 0.575 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 5.0 t -129.07 -44.72 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.963 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.33 148.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.601 ' HB3' ' HD2' ' B' ' 76' ' ' ARG . . . -152.01 171.22 18.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.224 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.26 9.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.43 23.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.17 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.27 135.96 23.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.38 175.04 39.69 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 96' ' ' MET . 6.3 p -124.1 146.53 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.473 ' HB2' ' HG2' ' B' ' 96' ' ' MET . . . -114.09 134.09 55.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.89 110.74 22.15 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 94' ' ' ASP . . . -122.78 132.45 54.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.574 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.495 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.95 -113.28 4.21 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.259 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.87 -60.67 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.343 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' B' ' 93' ' ' SER . 2.3 t -101.6 29.75 4.69 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.258 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.504 ' HB3' ' HB1' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -119.72 82.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.988 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.458 HG11 ' O ' ' B' ' 88' ' ' ALA . 5.1 t -120.47 142.35 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.017 0.437 . . . . 0.0 110.703 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.527 ' HB2' ' HA ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -132.49 155.63 48.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -128.5 128.93 45.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.492 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.6 160.27 22.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.688 0.28 . . . . 0.0 111.476 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.18 99.04 0.12 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.738 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.726 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.3 p -122.67 179.47 4.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.452 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -140.43 146.26 38.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.4 m-80 -111.82 150.0 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.374 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 56' ' ' PHE . 4.0 pt -156.1 150.97 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.761 0.315 . . . . 0.0 110.825 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.575 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 73.7 mt-10 -96.31 130.58 43.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . 1.062 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.7 t-105 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.686 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 40.15 -102.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.894 0.378 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -112.44 -54.38 2.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.56 -63.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -67.95 -53.96 22.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.768 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -47.44 -83.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.752 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m 68.24 45.36 1.25 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.985 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.736 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 23.6 m170 -70.85 -52.38 10.15 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.792 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.736 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.5 Cg_exo -51.97 121.36 8.63 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.507 2.138 . . . . 0.0 111.909 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' C' ' 8' ' ' HIS . 13.0 mm100 -127.86 -59.16 1.21 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.956 0.408 . . . . 0.0 111.157 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.02 -154.73 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.648 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -68.98 -26.54 65.08 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.46 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -135.74 20.77 3.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.506 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.76 -22.75 61.15 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.258 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.06 -46.05 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 0.0 110.88 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . 0.592 ' O ' ' HB2' ' C' ' 20' ' ' GLN . 39.2 m-70 -72.1 -32.17 66.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.011 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.489 ' O ' HD21 ' C' ' 21' ' ' LEU . 34.6 ttmt -73.05 -46.92 49.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.556 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -39.88 80.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.202 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 49.7 mtt85 -66.7 -42.88 85.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.592 ' HB2' ' O ' ' C' ' 16' ' ' HIS . 0.8 OUTLIER -64.68 -41.41 96.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.74 HD22 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.87 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -75.76 -39.15 57.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.76 HD21 ' HG ' ' A' ' 25' ' ' LEU . 8.0 mt -67.2 -51.02 58.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -58.77 -50.85 72.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.487 ' HE2' ' CZ ' ' C' ' 31' ' ' ARG . 9.5 tmtt? -54.91 -38.21 67.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.254 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.437 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -62.33 -42.72 99.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.48 -41.77 98.57 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.989 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.481 ' O ' ' CG ' ' C' ' 34' ' ' LYS . 4.4 m -57.89 -46.99 84.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.861 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.589 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 83.2 mmt-85 -59.48 -35.54 74.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.291 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.437 HG23 ' O ' ' C' ' 28' ' ' LEU . 42.0 t -73.8 -36.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.164 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.89 -55.88 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.073 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.589 ' HE3' ' HD3' ' C' ' 31' ' ' ARG . 3.3 pttt -72.39 -36.56 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.732 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.78 -45.18 96.27 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.375 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -70.07 -37.13 75.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.84 0.352 . . . . 0.0 111.149 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.82 99.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.428 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -54.39 14.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.776 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.653 ' HB3' HD21 ' B' ' 36' ' ' LEU . 87.0 p -49.09 -56.18 9.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.073 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -52.55 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.395 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.688 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . . . -49.29 -41.4 37.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.923 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 30.6 tp -74.0 -34.87 64.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.113 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 75.3 m-20 -78.18 -5.13 50.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' SER . . . . . 0.406 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.5 t -86.09 -0.63 56.09 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.156 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.781 ' HB3' HG23 ' C' ' 57' ' ' THR . 0.3 OUTLIER -95.95 172.18 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.892 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -165.76 -5.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.133 0.492 . . . . 0.0 111.66 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.411 ' HG3' HG21 ' C' ' 57' ' ' THR . 35.1 mt-30 65.75 118.93 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.944 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.396 9.8 Cg_endo -69.91 98.23 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.641 2.227 . . . . 0.0 112.565 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 66.96 -164.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 146.17 82.24 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.254 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 8.8 p -88.77 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.391 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.682 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 158.26 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.273 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -142.93 -166.67 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.657 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 1.088 HG13 ' O ' ' A' ' 105' ' ' TRP . 2.6 p -109.54 144.04 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.511 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -131.1 134.83 46.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.067 0.46 . . . . 0.0 111.624 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . 0.46 ' O ' HG13 ' A' ' 103' ' ' ILE . 1.2 t80 -104.62 122.01 44.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.179 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.781 HG23 ' HB3' ' C' ' 45' ' ' LEU . 21.0 p -114.59 124.85 52.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.95 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.2 150.76 29.35 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.23 164.03 26.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' C' ' 69' ' ' LEU . 14.4 m -110.28 166.4 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.62 -174.4 22.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.48 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 143.1 8.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.573 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.608 ' CE2' ' HG3' ' C' ' 64' ' ' ARG . 62.9 t80 -132.45 137.06 47.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.608 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 2.9 mmm180 61.59 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.045 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' SER . . . . . 0.406 ' N ' ' O ' ' C' ' 63' ' ' TYR . 12.1 t -156.68 32.33 0.31 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -130.19 167.5 18.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.05 142.17 48.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.5 47.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.569 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.46 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.1 tp -111.33 128.35 55.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' C' ' 41' ' ' ALA . . . -122.97 152.11 41.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.726 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.411 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.7 tt -147.47 162.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.179 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.411 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 175.3 169.32 36.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.438 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 36.2 p -163.24 147.69 11.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.7 161.91 28.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.273 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.3 119.44 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 111.144 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.605 ' HD2' ' HB3' ' C' ' 82' ' ' ALA . 4.9 mmm180 -96.85 99.16 10.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.772 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.682 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.0 p -98.19 130.62 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.321 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 8.1 m120 66.37 -171.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -120.03 24.56 10.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.561 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' SER . . . . . 0.577 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 5.0 t -129.0 -44.74 1.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.987 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.2 148.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.552 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.605 ' HB3' ' HD2' ' C' ' 76' ' ' ARG . . . -152.02 171.21 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.234 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.22 9.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.52 23.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.145 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 135.91 23.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.02 39.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.609 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.478 HG22 ' O ' ' C' ' 96' ' ' MET . 6.3 p -124.02 146.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.89 0.376 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.463 ' O ' HG11 ' C' ' 95' ' ' VAL . . . -114.03 134.02 55.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.423 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -108.85 110.78 22.21 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.252 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' C' ' 94' ' ' ASP . . . -122.77 132.41 54.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.59 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.515 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.97 -113.18 4.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.209 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.92 -60.73 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' C' ' 93' ' ' SER . 2.3 t -101.59 29.79 4.67 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.486 ' HB3' ' HB1' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . 0.463 HG11 ' O ' ' C' ' 88' ' ' ALA . 5.1 t -120.35 142.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.552 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 0.9 OUTLIER -132.55 155.63 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.687 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -128.5 129.03 45.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.403 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.69 160.29 22.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.666 0.27 . . . . 0.0 111.504 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.2 99.03 0.12 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.728 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.1 p -122.79 179.49 4.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.435 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -140.47 146.28 38.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' C' ' 82' ' ' ALA . 70.4 m-80 -111.77 150.02 30.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.369 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 56' ' ' PHE . 3.9 pt -156.18 150.96 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.577 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 73.8 mt-10 -96.32 130.55 43.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . 1.071 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.6 t-105 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.728 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.655 -0.178 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 t70 70.08 136.74 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.934 0.397 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -133.47 -64.69 0.71 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.28 24.82 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.001 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -98.51 149.11 23.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.744 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.58 ' HB3' ' CE1' ' A' ' 8' ' ' HIS . 30.8 m95 -98.03 -79.19 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.743 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.2 m 61.9 45.13 7.77 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.306 -0.407 . . . . 0.0 109.992 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.664 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 22.3 m170 -89.69 -48.88 0.39 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.807 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -52.62 105.24 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.404 2.069 . . . . 0.0 111.956 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 8' ' ' HIS . 89.6 mt-30 -104.99 -62.26 1.36 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.983 0.42 . . . . 0.0 111.165 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -121.55 171.02 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.711 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.03 25.99 1.89 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.503 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -49.48 57.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.5 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.28 -24.83 59.44 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.297 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.88 90.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 0.0 110.875 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.766 ' HA ' ' HD2' ' A' ' 19' ' ' ARG . 13.5 m-70 -80.19 -26.65 39.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.986 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.97 -44.82 88.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.528 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.29 -26.56 62.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.321 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.766 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 47.9 mtt-85 -66.23 -53.73 33.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.742 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.82 -26.96 61.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.94 0.4 . . . . 0.0 111.188 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.545 ' HA ' HD22 ' A' ' 21' ' ' LEU . 3.0 tm? -62.89 -59.99 4.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.556 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -74.71 -47.76 29.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -74.87 -37.58 62.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.76 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 25' ' ' LEU . 2.8 mm? -63.77 -52.67 59.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -57.0 -42.48 80.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -63.45 -31.68 72.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.276 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.488 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -61.3 -45.88 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -66.73 -31.47 72.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.964 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.37 -35.9 71.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.81 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.628 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -71.96 -39.61 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 29' ' ' ASP . 32.8 m -75.85 -30.88 21.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.575 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 26.2 m-20 -68.38 -45.46 72.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.7 ptpt -75.51 -40.61 56.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.31 99.05 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.383 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.484 HD21 ' HG ' ' B' ' 36' ' ' LEU . 0.6 OUTLIER -74.37 -27.05 60.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.673 ' HB3' ' HA2' ' A' ' 62' ' ' GLY . . . -70.08 -41.48 74.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.512 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 8.2 t -82.98 -38.95 21.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.781 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.49 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 3.2 t -57.99 -55.78 30.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -60.74 -33.6 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.433 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.13 76.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 64.7 tp -81.06 -35.79 31.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.079 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.69 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 84.2 m-20 -75.3 -14.38 60.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.85 -22.31 65.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.171 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.721 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.3 mm? -74.32 165.83 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.875 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.557 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 2.5 p90 -157.06 -3.3 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 111.663 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.491 ' HG2' HG22 ' A' ' 57' ' ' THR . 9.1 mt-30 65.43 125.04 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.912 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -88.49 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.673 2.249 . . . . 0.0 112.589 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 11.5 m-30 66.93 -177.51 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.53 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.279 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -79.96 -12.51 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.168 0.587 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.34 52.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.266 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -163.95 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 55' ' ' ASN . 7.6 p -116.57 141.72 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.526 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' N ' HG23 ' A' ' 54' ' ' VAL . 14.5 m-80 -120.93 114.17 21.16 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.698 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.72 130.46 35.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.262 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.721 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 36.9 p -109.47 126.69 53.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.6 129.75 7.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.406 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' B' ' 100' ' ' SER . . . -174.25 165.18 36.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.558 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.44 160.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.339 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.24 17.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.489 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.673 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -170.15 137.88 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.552 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.575 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 17.8 t80 -123.87 135.0 53.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.708 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 1.7 mmm180 68.54 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.074 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.65 23.51 1.12 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.139 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.0 m -128.86 141.74 51.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.91 27.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -145.92 173.83 11.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.564 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.88 143.29 49.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.776 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.657 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -130.75 135.39 47.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.707 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.504 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.504 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 174.02 -178.49 45.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.446 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.31 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.85 28.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.283 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.66 134.49 50.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.165 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.66 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 15.8 ttm180 -122.46 126.22 47.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.733 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.42 137.99 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 29.8 m-20 60.93 -96.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 111.083 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.36 -19.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.594 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.0 p -73.19 -62.13 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.014 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.69 146.34 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.515 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.66 ' HB2' ' HG3' ' A' ' 76' ' ' ARG . . . -147.39 156.16 42.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.265 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.19 147.2 29.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.553 ' HG3' ' HE2' ' C' ' 46' ' ' PHE . 10.9 tmtt? -150.49 138.83 20.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.155 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.069 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 164.0 -176.0 40.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.529 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 71' ' ' ILE . 12.4 p -142.98 137.68 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.89 144.55 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -117.91 114.55 23.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -120.19 130.81 54.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.599 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.49 -115.84 8.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.242 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.59 7.26 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.343 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 24.74 0.27 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.204 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.438 ' CG ' ' HD2' ' A' ' 34' ' ' LYS . 18.3 m-20 -127.51 80.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.9 t -112.32 139.18 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 110.684 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.525 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 6.8 ptp -133.23 141.31 47.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -112.52 126.01 54.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.475 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.71 152.11 26.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 111.402 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.54 87.24 0.39 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.791 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.613 ' HB3' ' HA3' ' C' ' 59' ' ' GLY . 11.3 m -118.25 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.441 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.412 ' O ' HD11 ' C' ' 45' ' ' LEU . 27.9 p90 -132.4 147.62 52.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.922 0.392 . . . . 0.0 111.136 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.533 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 49.1 m-80 -111.77 130.55 55.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.34 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.02 115.99 22.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.453 ' CG ' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -118.68 158.83 24.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.404 -0.808 . . . . 0.0 110.643 179.696 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 t70 70.15 136.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -133.52 -64.76 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.818 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.26 24.84 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.046 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -98.55 149.11 23.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.786 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.58 ' HB3' ' CE1' ' B' ' 8' ' ' HIS . 30.9 m95 -98.06 -79.19 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.703 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m 61.92 45.15 7.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.952 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.689 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 22.2 m170 -89.7 -48.88 0.39 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.77 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.689 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.3 Cg_exo -52.6 105.15 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.495 2.13 . . . . 0.0 111.962 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' B' ' 8' ' ' HIS . 89.7 mt-30 -104.94 -62.2 1.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.947 0.403 . . . . 0.0 111.152 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -121.6 171.02 9.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.674 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.1 26.05 1.87 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.476 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -49.43 58.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.564 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.29 -24.85 59.49 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.27 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.72 -42.93 90.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 110.92 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.77 ' HA ' ' HD2' ' B' ' 19' ' ' ARG . 13.5 m-70 -80.11 -26.75 39.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.016 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -44.87 88.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.578 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.35 -26.49 62.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.77 ' HD2' ' HA ' ' B' ' 16' ' ' HIS . 47.9 mtt-85 -66.27 -53.68 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -72.84 -26.99 61.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.505 ' HA ' HD22 ' B' ' 21' ' ' LEU . 3.0 tm? -62.8 -60.03 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.637 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.83 -17.84 64.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.68 -47.77 29.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -74.93 -37.54 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.759 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.505 HD23 ' N ' ' B' ' 25' ' ' LEU . 2.8 mm? -63.73 -52.68 59.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.96 -42.58 80.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.492 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 0.9 OUTLIER -63.38 -31.77 73.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.238 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.492 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -61.28 -45.88 92.67 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.479 ' O ' HG22 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -66.69 -31.5 72.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -71.34 -35.93 71.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.637 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.0 OUTLIER -71.89 -39.74 69.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.479 HG22 ' O ' ' B' ' 29' ' ' ASP . 32.8 m -75.76 -30.92 21.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.572 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 26.1 m-20 -68.4 -45.34 72.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.016 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.7 ptpt -75.52 -40.62 56.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.806 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.3 99.16 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.32 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.484 ' HG ' HD21 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.36 -27.03 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.668 ' HB3' ' HA2' ' B' ' 62' ' ' GLY . . . -70.02 -41.56 74.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.49 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 8.2 t -82.96 -38.93 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.494 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.2 t -58.08 -55.8 30.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.491 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -60.74 -33.58 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.363 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -34.11 76.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' B' ' 70' ' ' ALA . 64.7 tp -81.08 -35.78 31.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.69 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 84.1 m-20 -75.29 -14.31 60.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 28.9 t -67.93 -22.36 65.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.088 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.733 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -74.2 165.8 24.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.901 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.564 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 2.5 p90 -157.07 -3.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' B' ' 57' ' ' THR . 9.0 mt-30 65.39 125.02 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.954 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -88.51 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.722 2.282 . . . . 0.0 112.557 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 11.5 m-30 66.88 -177.5 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.6 57.49 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.314 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -79.92 -12.53 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.162 0.585 . . . . 0.0 112.459 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.3 52.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.213 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -164.0 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.644 0.259 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.489 HG23 ' N ' ' B' ' 55' ' ' ASN . 7.6 p -116.52 141.71 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.552 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.489 ' N ' HG23 ' B' ' 54' ' ' VAL . 14.5 m-80 -120.9 114.27 21.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.968 0.414 . . . . 0.0 111.701 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -82.83 130.43 35.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.299 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.733 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.2 p -109.41 126.7 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.023 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.77 7.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.461 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.613 ' HA3' ' HB3' ' C' ' 100' ' ' SER . . . -174.24 165.15 36.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.563 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.41 160.79 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.18 16.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.467 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.668 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -170.13 137.84 4.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.617 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.572 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 17.8 t80 -123.8 135.08 53.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 1.7 mmm180 68.44 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.58 23.46 1.13 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.67 51.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.53 151.9 27.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 111.093 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -145.89 173.94 11.69 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.563 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.97 143.27 49.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.764 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -130.75 135.43 47.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.687 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.507 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.76 0.314 . . . . 0.0 111.098 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.507 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 173.96 -178.49 45.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.446 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.49 146.4 5.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.965 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.64 162.76 28.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.279 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.63 134.55 50.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.644 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 15.9 ttm180 -122.47 126.31 47.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.56 138.06 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 29.6 m-20 60.88 -96.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 111.086 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.4 -19.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.9 p -73.18 -62.2 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 m -91.58 146.39 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.564 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.644 ' HB2' ' HG3' ' B' ' 76' ' ' ARG . . . -147.47 156.11 42.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.268 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.14 147.19 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.617 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.557 ' HG3' ' HE2' ' A' ' 46' ' ' PHE . 11.0 tmtt? -150.48 138.87 20.44 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.47 173.29 14.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 164.0 -175.95 40.07 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.565 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.453 ' O ' HG23 ' B' ' 71' ' ' ILE . 12.3 p -142.99 137.71 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.89 144.52 36.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.321 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -117.99 114.56 23.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.228 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -120.21 130.76 54.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.605 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.57 -115.86 8.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.326 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.6 7.24 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 111.36 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.89 24.72 0.27 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.213 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.441 ' CG ' ' HD2' ' B' ' 34' ' ' LYS . 18.2 m-20 -127.51 80.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.42 139.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.06 0.457 . . . . 0.0 110.633 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.511 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 6.8 ptp -133.18 141.28 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.678 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.51 126.03 54.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.437 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.62 152.09 26.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 111.493 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.53 87.27 0.4 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.843 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.614 ' HB3' ' HA3' ' A' ' 59' ' ' GLY . 11.3 m -118.24 166.22 12.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.396 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.411 ' O ' HD11 ' A' ' 45' ' ' LEU . 27.9 p90 -132.37 147.61 52.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.939 0.399 . . . . 0.0 111.065 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.538 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 49.3 m-80 -111.71 130.62 55.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.412 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.99 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.448 ' CG ' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -118.78 158.8 24.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.634 179.75 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.679 -0.168 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 t70 70.19 136.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.903 0.383 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -133.53 -64.83 0.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.783 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.25 24.75 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -98.53 149.12 23.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.841 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . 0.584 ' HB3' ' CE1' ' C' ' 8' ' ' HIS . 30.9 m95 -98.09 -79.06 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.747 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 69.1 m 61.86 45.09 7.88 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.054 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.688 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 22.2 m170 -89.73 -48.83 0.39 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.793 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.688 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -52.61 105.09 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.55 2.166 . . . . 0.0 111.924 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' C' ' 8' ' ' HIS . 89.6 mt-30 -104.86 -62.25 1.36 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.954 0.407 . . . . 0.0 111.203 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -121.58 171.03 9.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.676 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.13 26.07 1.87 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.462 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -49.44 58.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.517 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.34 -24.88 59.64 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.258 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -42.86 90.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . 0.763 ' HA ' ' HD2' ' C' ' 19' ' ' ARG . 13.5 m-70 -80.2 -26.75 39.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.957 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.92 -44.84 88.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.499 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.4 -26.46 62.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.243 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . 0.763 ' HD2' ' HA ' ' C' ' 16' ' ' HIS . 47.7 mtt-85 -66.29 -53.68 33.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.8 -26.97 61.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.186 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.474 ' HA ' HD22 ' C' ' 21' ' ' LEU . 3.0 tm? -62.92 -60.0 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.53 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -65.8 -17.85 64.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.67 -47.74 30.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 54.5 mtp85 -74.95 -37.51 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.785 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.499 HD23 ' N ' ' C' ' 25' ' ' LEU . 2.8 mm? -63.87 -52.57 59.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -57.05 -42.49 80.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.484 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 0.9 OUTLIER -63.51 -31.71 72.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.609 0.242 . . . . 0.0 111.215 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.484 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -61.25 -45.97 92.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.48 ' O ' HG22 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -66.65 -31.51 72.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.975 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.35 -35.79 71.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.873 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.643 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -72.05 -39.62 68.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.282 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.48 HG22 ' O ' ' C' ' 29' ' ' ASP . 32.8 m -75.83 -30.84 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.587 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 26.1 m-20 -68.45 -45.35 72.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.7 ptpt -75.58 -40.62 56.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.14 99.11 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.395 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.481 HD21 ' HG ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.47 -27.08 60.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.833 0.349 . . . . 0.0 111.043 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.674 ' HB3' ' HA2' ' C' ' 62' ' ' GLY . . . -70.04 -41.49 74.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.493 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 8.2 t -83.08 -38.82 21.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.486 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 3.2 t -58.02 -55.85 29.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.488 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -60.75 -33.52 73.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.447 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.06 76.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.946 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.637 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 64.8 tp -81.14 -35.75 31.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.686 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 84.2 m-20 -75.33 -14.33 60.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.82 -22.37 65.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.158 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.722 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -74.27 165.83 24.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.862 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.553 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 2.5 p90 -157.1 -3.24 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.126 0.488 . . . . 0.0 111.654 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.5 ' HG2' HG22 ' C' ' 57' ' ' THR . 9.0 mt-30 65.42 124.97 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.988 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -88.45 109.26 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.643 2.229 . . . . 0.0 112.591 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 11.5 m-30 66.8 -177.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.944 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.5 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.258 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -79.84 -12.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.195 0.598 . . . . 0.0 112.466 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.45 52.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.265 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.96 -164.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.615 0.245 . . . . 0.0 110.573 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.497 HG23 ' N ' ' C' ' 55' ' ' ASN . 7.6 p -116.54 141.69 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.56 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.497 ' N ' HG23 ' C' ' 54' ' ' VAL . 14.6 m-80 -120.94 114.19 21.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.65 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -82.67 130.45 35.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.3 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.722 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 37.1 p -109.41 126.7 53.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.987 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.71 7.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.395 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.613 ' HA3' ' HB3' ' A' ' 100' ' ' SER . . . -174.23 165.23 36.72 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.512 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.43 160.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.46 -168.24 16.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.478 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.674 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -170.17 137.86 4.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.587 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 17.9 t80 -123.8 135.14 53.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 110.702 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 1.7 mmm180 68.39 -89.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.6 23.45 1.13 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.77 51.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.807 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.83 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.09 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -145.83 173.93 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.578 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.97 143.25 49.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -130.74 135.38 47.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.65 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.506 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.0 tp -134.1 159.31 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.706 0.288 . . . . 0.0 111.203 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.506 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 174.05 -178.47 45.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.434 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.4 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.995 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.68 162.78 28.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.262 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -126.66 134.57 50.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.365 . . . . 0.0 111.148 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.65 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 15.8 ttm180 -122.44 126.21 47.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.778 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.48 137.97 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 29.8 m-20 60.99 -96.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.063 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.39 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.612 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 8.1 p -73.14 -62.18 1.56 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.66 146.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.65 ' HB2' ' HG3' ' C' ' 76' ' ' ARG . . . -147.42 156.16 42.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.15 147.21 29.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.591 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.564 ' HG3' ' HE2' ' B' ' 46' ' ' PHE . 10.9 tmtt? -150.53 138.85 20.36 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.34 14.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.95 -175.85 40.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.597 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.454 ' O ' HG23 ' C' ' 71' ' ' ILE . 12.4 p -143.01 137.71 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.95 144.53 36.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.357 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -117.87 114.61 23.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.261 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -120.12 130.8 54.8 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -115.76 7.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -146.67 7.22 0.96 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.29 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.92 24.8 0.27 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.235 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.435 ' CG ' ' HD2' ' C' ' 34' ' ' LYS . 18.5 m-20 -127.62 80.84 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 65.1 t -112.34 139.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.67 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.509 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 6.8 ptp -133.25 141.34 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.733 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.59 125.97 54.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.55 152.06 25.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.504 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.52 87.19 0.39 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.815 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.613 ' HB3' ' HA3' ' B' ' 59' ' ' GLY . 11.1 m -118.26 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.408 ' O ' HD11 ' B' ' 45' ' ' LEU . 27.6 p90 -132.43 147.56 52.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.912 0.386 . . . . 0.0 111.058 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.535 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 49.4 m-80 -111.71 130.57 55.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.97 22.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.458 ' CG ' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -118.71 158.79 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.688 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 12.1 t70 80.82 131.77 0.05 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -133.55 -72.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.817 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.33 33.84 0.64 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.972 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 p -90.82 158.96 16.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.809 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -101.76 -81.98 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.732 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 m 52.37 43.65 30.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.95 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.816 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 33.8 m80 -77.55 -52.7 1.67 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.807 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.816 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -59.22 116.25 3.14 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.467 2.111 . . . . 0.0 111.954 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -106.82 -67.31 0.95 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.031 0.443 . . . . 0.0 111.142 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -110.86 176.62 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.623 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.97 22.66 0.76 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.454 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.81 -47.07 19.78 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.499 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.37 -30.55 61.7 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.242 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.86 96.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 0.0 110.941 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -72.6 -39.36 67.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.018 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.622 ' HB2' ' HE2' ' B' ' 17' ' ' LYS . 0.3 OUTLIER -63.01 -31.32 72.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.525 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -35.02 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 111.26 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.19 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.423 HE22 ' HG ' ' C' ' 21' ' ' LEU . 1.7 pp0? -60.44 -28.38 68.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD12 ' HD3' ' B' ' 24' ' ' ARG . 2.2 tm? -64.99 -59.43 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.81 -23.08 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.05 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.01 -55.18 15.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.533 ' HD3' HD12 ' C' ' 21' ' ' LEU . 69.5 mtp85 -70.34 -38.21 74.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.779 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.476 HD21 HD21 ' A' ' 21' ' ' LEU . 3.7 mm? -63.75 -48.28 77.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.04 -31.73 73.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 2.1 ttpp -65.34 -42.59 92.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.692 0.282 . . . . 0.0 111.288 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -63.35 -43.93 96.31 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -57.17 -30.01 64.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.925 178.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.6 m -79.71 -29.67 40.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.792 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 -26.64 46.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.32 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 29' ' ' ASP . 33.1 m -82.62 -28.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.219 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.632 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 76.1 m-20 -75.95 -45.07 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.984 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 5.2 ptpt -84.1 -29.1 27.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.74 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 39' ' ' SER . . . -68.65 -42.42 80.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.422 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.447 ' HA ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -80.58 -25.59 38.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.105 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 33' ' ' ASP . . . -75.19 -41.38 58.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.49 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.74 ' HB3' ' HE1' ' A' ' 96' ' ' MET . 10.4 t -77.47 -42.58 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.758 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -62.39 -50.87 69.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.467 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.95 78.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 39.4 tp -76.34 -42.59 44.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -71.65 -7.87 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.77 -23.84 63.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.147 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.566 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.7 mm? -82.19 165.82 20.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.862 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.7 p90 -153.28 -3.85 0.2 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.636 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.922 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.762 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -79.65 113.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.613 2.209 . . . . 0.0 112.487 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.449 ' HH ' ' HB ' ' B' ' 51' ' ' VAL . 6.2 m-30 56.43 173.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.016 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 52.98 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.23 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 7.6 p -72.57 -3.83 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.162 0.585 . . . . 0.0 112.45 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 145.57 52.56 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.341 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -169.6 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 110.615 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 55' ' ' ASN . 12.4 p -109.56 142.66 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.573 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.463 ' N ' HG23 ' A' ' 54' ' ' VAL . 23.9 m-80 -122.88 119.0 29.21 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.451 ' HE2' ' HB1' ' A' ' 58' ' ' ALA . 34.6 t80 -87.25 133.85 33.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.242 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.432 ' HB ' ' CB ' ' A' ' 45' ' ' LEU . 81.8 p -115.35 120.03 38.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.451 ' HB1' ' HE2' ' A' ' 56' ' ' PHE . . . -150.65 135.4 17.39 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.425 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.51 169.03 39.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.534 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 69' ' ' LEU . 15.6 m -120.57 154.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.26 -172.83 13.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.437 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -166.0 140.2 6.22 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.632 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 31.9 t80 -133.25 135.1 44.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.708 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.2 mmm180 66.61 -93.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.125 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 p -145.68 31.16 1.07 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.44 141.02 45.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.33 153.9 22.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.08 170.57 17.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.492 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -119.38 141.15 49.32 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -126.23 140.78 52.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.732 0.301 . . . . 0.0 111.637 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 87' ' ' VAL . 8.3 tp -140.95 151.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.093 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.12 174.72 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.438 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.97 155.05 5.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.23 173.13 29.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.252 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.547 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 44.6 t80 -126.48 135.48 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 11.2 ttm180 -125.14 135.34 52.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.754 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 7.6 p -119.35 137.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.34 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 90.4 m-20 64.13 -94.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 6.2 pt-20 179.11 -23.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.604 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.92 -63.95 1.0 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.536 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -141.27 152.0 44.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.247 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 63.5 tp -134.37 140.28 46.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.426 ' HD3' ' N ' ' A' ' 85' ' ' ALA . 7.3 tmtt? -155.58 126.28 6.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.426 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.72 178.05 10.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.96 36.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 71' ' ' ILE . 7.7 p -143.56 141.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 111.165 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.476 ' HB2' ' SD ' ' A' ' 96' ' ' MET . . . -111.72 139.4 47.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.346 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -114.02 114.39 26.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.173 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.44 135.96 54.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.639 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 57.09 -116.81 8.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.31 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 72.5 m -148.61 16.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.74 0.305 . . . . 0.0 111.316 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.71 20.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.19 68.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.96 139.04 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.73 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.74 ' HE1' ' HB3' ' A' ' 38' ' ' SER . 3.3 ptp -133.26 132.97 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.748 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -110.74 118.59 36.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -107.11 152.68 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.12 0.65 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.773 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.466 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 21.6 m -123.82 176.31 6.37 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.448 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.48 139.44 25.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.922 0.392 . . . . 0.0 111.105 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.748 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 70.6 m-80 -103.2 132.8 49.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.346 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.59 117.39 17.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.802 0.334 . . . . 0.0 110.811 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.75 151.92 36.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 27.9 m-90 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.613 179.743 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 12.0 t70 80.8 131.72 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -133.43 -72.59 0.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.821 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.27 33.87 0.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.971 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 28.5 p -90.78 158.95 16.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.756 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -101.8 -82.01 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.69 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 47.2 m 52.41 43.58 30.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.012 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.816 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 33.9 m80 -77.53 -52.76 1.67 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.79 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.816 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -59.12 116.17 3.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.482 2.121 . . . . 0.0 111.931 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -106.85 -67.25 0.96 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.936 0.398 . . . . 0.0 111.144 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -110.85 176.68 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.638 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.97 22.69 0.76 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.463 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.91 -47.01 19.68 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.462 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.39 -30.53 61.72 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.246 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.85 96.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.893 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -72.57 -39.37 67.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.063 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.622 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -62.94 -31.43 72.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.53 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.41 -35.16 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.194 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.74 -59.24 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.41 HE22 ' HG ' ' A' ' 21' ' ' LEU . 1.7 pp0? -60.37 -28.45 68.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.173 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.544 HD12 ' HD3' ' C' ' 24' ' ' ARG . 2.1 tm? -64.85 -59.56 4.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.574 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -65.77 -23.0 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.059 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.08 -55.16 15.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.541 ' HD3' HD12 ' A' ' 21' ' ' LEU . 69.5 mtp85 -70.36 -38.19 74.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.462 HD21 HD21 ' B' ' 21' ' ' LEU . 3.7 mm? -63.8 -48.34 77.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.588 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.98 -31.66 72.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.477 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 2.1 ttpp -65.48 -42.61 92.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.199 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.477 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -63.22 -44.02 96.47 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.529 ' O ' HG22 ' B' ' 32' ' ' VAL . 0.9 OUTLIER -57.21 -29.96 64.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.926 178.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 5.6 m -79.75 -29.55 40.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -26.54 46.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.326 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.529 HG22 ' O ' ' B' ' 29' ' ' ASP . 33.2 m -82.71 -28.57 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.142 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.646 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 76.2 m-20 -75.97 -44.99 37.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.988 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.428 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 5.3 ptpt -84.19 -29.04 26.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.715 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' B' ' 39' ' ' SER . . . -68.79 -42.29 79.74 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.419 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' C' ' 36' ' ' LEU . 1.5 mt -80.66 -25.54 38.21 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.752 0.311 . . . . 0.0 111.034 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' B' ' 33' ' ' ASP . . . -75.11 -41.52 58.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.51 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.76 ' HB3' ' HE1' ' B' ' 96' ' ' MET . 10.4 t -77.39 -42.6 35.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.785 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 0.9 OUTLIER -62.38 -50.87 69.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.88 85.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.475 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.04 78.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.451 ' HA ' HD11 ' B' ' 42' ' ' LEU . 39.7 tp -76.33 -42.53 44.65 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.07 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -71.68 -7.87 50.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.4 t -69.73 -23.89 63.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.316 -0.856 . . . . 0.0 113.172 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.568 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.7 mm? -82.18 165.88 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.883 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 7.7 p90 -153.35 -3.8 0.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.109 0.48 . . . . 0.0 111.671 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.443 ' HB3' ' CB ' ' B' ' 55' ' ' ASN . 10.1 mt-30 72.03 117.26 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -79.55 113.53 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.645 2.23 . . . . 0.0 112.506 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.448 ' HH ' ' HB ' ' C' ' 51' ' ' VAL . 6.2 m-30 56.48 173.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.71 53.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.289 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 7.7 p -72.57 -3.9 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.117 0.567 . . . . 0.0 112.465 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 145.58 52.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.248 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -169.58 3.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.611 0.243 . . . . 0.0 110.606 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.468 HG23 ' N ' ' B' ' 55' ' ' ASN . 12.4 p -109.59 142.65 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.538 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.468 ' N ' HG23 ' B' ' 54' ' ' VAL . 24.0 m-80 -122.91 118.97 29.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.93 0.395 . . . . 0.0 111.697 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.439 ' HE2' ' HB1' ' B' ' 58' ' ' ALA . 34.5 t80 -87.17 133.83 33.6 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.245 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.435 ' HB ' ' CB ' ' B' ' 45' ' ' LEU . 81.8 p -115.38 119.95 37.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.949 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.439 ' HB1' ' HE2' ' B' ' 56' ' ' PHE . . . -150.58 135.43 17.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.475 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.49 168.98 39.25 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.539 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' B' ' 69' ' ' LEU . 15.6 m -120.52 154.79 23.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.806 0.336 . . . . 0.0 111.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.33 -172.81 13.38 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.409 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.579 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -166.01 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.502 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.646 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 32.0 t80 -133.21 134.98 44.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.74 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.2 mmm180 66.69 -93.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.087 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.63 31.14 1.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.173 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.47 140.98 45.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.35 153.93 22.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.62 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.579 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -119.5 141.2 49.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -126.25 140.64 52.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.589 HG23 ' O ' ' B' ' 87' ' ' VAL . 8.3 tp -140.9 151.84 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.742 0.306 . . . . 0.0 111.11 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.21 174.65 39.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.396 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.94 155.12 5.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.342 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.21 173.19 29.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.245 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 44.8 t80 -126.55 135.58 51.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 11.2 ttm180 -125.22 135.34 52.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.659 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 7.6 p -119.4 137.4 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 90.2 m-20 64.11 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 6.2 pt-20 179.1 -23.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.589 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 17.5 p -70.8 -63.98 0.99 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.98 143.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.58 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -141.29 152.07 44.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.271 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 63.6 tp -134.32 140.2 46.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.604 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' B' ' 85' ' ' ALA . 7.3 tmtt? -155.6 126.13 6.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.141 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.431 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.59 178.07 10.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.88 36.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.534 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.589 ' O ' HG23 ' B' ' 71' ' ' ILE . 7.7 p -143.66 141.44 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.478 ' HB2' ' SD ' ' B' ' 96' ' ' MET . . . -111.82 139.35 47.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.325 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -113.95 114.37 26.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.205 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.36 136.01 54.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.644 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 57.06 -116.92 8.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.248 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.52 16.64 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.75 20.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.197 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -119.22 68.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.957 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.14 139.06 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.76 ' HE1' ' HB3' ' B' ' 38' ' ' SER . 3.3 ptp -133.31 132.99 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.74 118.63 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.415 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.13 152.66 23.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.685 0.279 . . . . 0.0 111.412 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.98 94.11 0.65 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.463 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 21.8 m -123.81 176.44 6.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.391 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -146.65 139.45 25.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.029 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.762 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.6 m-80 -103.22 132.79 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.362 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.35 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.78 151.93 36.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.651 179.706 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.677 -0.169 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' C' ' 1' ' ' GLY . 12.0 t70 80.67 131.82 0.05 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 110.966 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -133.51 -72.56 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.802 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.3 33.82 0.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.99 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 28.4 p -90.75 159.03 16.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.807 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -101.8 -81.98 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.729 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 47.0 m 52.38 43.59 30.72 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.991 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.793 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 33.9 m80 -77.64 -52.63 1.66 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.803 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.793 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -59.11 116.25 3.13 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.575 2.183 . . . . 0.0 111.857 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -106.91 -67.28 0.96 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -110.87 176.67 4.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.668 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.94 22.57 0.77 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.87 -46.99 19.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.496 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.36 -30.55 61.66 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.275 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.87 96.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 0.0 110.904 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -72.63 -39.32 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.994 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.612 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -62.98 -31.38 72.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.55 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -34.99 65.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.259 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.18 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.421 HE22 ' HG ' ' B' ' 21' ' ' LEU . 1.7 pp0? -60.44 -28.36 68.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.136 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.533 HD12 ' HD3' ' A' ' 24' ' ' ARG . 2.1 tm? -64.98 -59.44 4.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.631 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -65.86 -22.96 66.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.07 -55.17 15.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.544 ' HD3' HD12 ' B' ' 21' ' ' LEU . 69.6 mtp85 -70.33 -38.16 74.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.476 HD21 HD21 ' C' ' 21' ' ' LEU . 3.7 mm? -63.89 -48.36 76.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.87 -31.74 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.466 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 2.0 ttpp -65.47 -42.51 92.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.466 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -63.28 -44.0 96.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.522 ' O ' HG22 ' C' ' 32' ' ' VAL . 0.9 OUTLIER -57.19 -29.96 64.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.936 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 5.6 m -79.8 -29.55 40.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -26.63 46.49 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.357 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.522 HG22 ' O ' ' C' ' 29' ' ' ASP . 33.2 m -82.55 -28.72 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.642 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 76.2 m-20 -75.88 -45.11 37.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.005 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.409 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 5.3 ptpt -84.08 -29.07 27.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.806 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' C' ' 39' ' ' SER . . . -68.6 -42.39 80.82 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 36' ' ' LEU . 1.5 mt -80.61 -25.63 38.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.801 0.334 . . . . 0.0 111.06 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' C' ' 33' ' ' ASP . . . -75.23 -41.45 57.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.402 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.72 ' HB3' ' HE1' ' C' ' 96' ' ' MET . 10.5 t -77.43 -42.6 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' C' ' 35' ' ' GLY . 0.9 OUTLIER -62.3 -50.92 69.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.86 85.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.92 -37.02 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.94 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 39.6 tp -76.25 -42.65 45.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.035 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -71.66 -7.9 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.71 -23.91 63.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.149 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.553 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.7 mm? -82.26 165.78 20.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.813 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 7.7 p90 -153.26 -3.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.651 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.444 ' HB3' ' CB ' ' C' ' 55' ' ' ASN . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.963 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -79.61 113.5 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.667 2.245 . . . . 0.0 112.514 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.454 ' HH ' ' HB ' ' A' ' 51' ' ' VAL . 6.2 m-30 56.47 173.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.985 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.73 53.02 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.229 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 7.7 p -72.58 -3.85 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 145.6 52.65 0.03 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.22 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.603 0.239 . . . . 0.0 110.655 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.466 HG23 ' N ' ' C' ' 55' ' ' ASN . 12.4 p -109.6 142.62 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.567 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.466 ' N ' HG23 ' C' ' 54' ' ' VAL . 24.0 m-80 -122.91 118.99 29.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.646 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . 0.436 ' HE2' ' HB1' ' C' ' 58' ' ' ALA . 34.4 t80 -87.19 133.77 33.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.282 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.428 ' HB ' ' CB ' ' C' ' 45' ' ' LEU . 81.9 p -115.31 120.01 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.983 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . 0.436 ' HB1' ' HE2' ' C' ' 56' ' ' PHE . . . -150.66 135.38 17.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.473 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.48 168.95 39.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' C' ' 69' ' ' LEU . 15.6 m -120.52 154.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.806 0.336 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.31 -172.88 13.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.466 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -166.0 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.574 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.642 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 32.1 t80 -133.19 134.99 44.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 110.812 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.2 mmm180 66.64 -93.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.133 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.61 31.12 1.08 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.43 141.05 45.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.781 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.39 153.91 22.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.54 17.56 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.539 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -119.43 141.18 49.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.747 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -126.24 140.69 52.34 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.702 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.586 HG23 ' O ' ' C' ' 87' ' ' VAL . 8.3 tp -140.88 151.83 20.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.14 174.72 39.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.468 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.93 155.09 5.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.24 173.15 29.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.269 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 44.6 t80 -126.56 135.54 51.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.342 . . . . 0.0 111.172 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.463 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 11.2 ttm180 -125.17 135.39 52.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.666 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 7.5 p -119.43 137.39 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 90.2 m-20 64.15 -94.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 6.2 pt-20 179.07 -23.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.527 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.99 -63.87 1.02 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -141.28 152.07 44.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.257 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 63.3 tp -134.37 140.22 46.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 7.3 tmtt? -155.6 126.23 6.87 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . 0.43 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.68 177.99 10.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.71 -167.82 36.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.58 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.586 ' O ' HG23 ' C' ' 71' ' ' ILE . 7.7 p -143.74 141.45 25.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.464 ' HB2' ' SD ' ' C' ' 96' ' ' MET . . . -111.73 139.31 47.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.316 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -113.97 114.45 26.2 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.45 135.95 54.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.624 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 57.11 -116.86 8.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.248 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.58 16.5 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 111.252 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.73 20.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.238 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.25 68.68 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 24.9 t -94.99 139.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.738 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.72 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 3.3 ptp -133.28 132.99 42.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.701 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.8 118.64 36.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.433 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -107.05 152.64 23.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.727 0.298 . . . . 0.0 111.432 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.1 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.47 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 21.8 m -123.8 176.37 6.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.432 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.59 139.42 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.988 0.423 . . . . 0.0 111.101 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.765 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 70.6 m-80 -103.21 132.8 49.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.37 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.3 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.781 0.324 . . . . 0.0 110.798 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.77 151.94 36.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.71 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.619 -0.192 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 20.3 t70 79.74 131.61 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 110.882 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -131.9 -67.66 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.66 28.04 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.013 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 p -92.21 153.68 19.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.764 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -106.48 -82.0 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.71 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m 53.75 41.88 31.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.991 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.787 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 36.7 m80 -72.6 -51.64 6.95 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.793 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.787 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -50.67 111.87 0.64 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.457 2.105 . . . . 0.0 111.878 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 8' ' ' HIS . 69.6 mt-30 -110.42 -73.21 0.69 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.966 0.413 . . . . 0.0 111.155 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -109.52 177.15 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.711 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.68 20.15 0.81 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.441 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -47.76 35.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.56 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.06 -34.66 58.48 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.216 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.32 -44.85 96.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.867 0.365 . . . . 0.0 110.875 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -68.32 -41.1 81.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.029 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -59.99 -37.61 80.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.534 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.79 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.33 -60.07 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.6 -28.13 69.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.654 HD23 HD23 ' C' ' 21' ' ' LEU . 2.4 tm? -63.37 -54.61 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.536 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.483 ' HA ' ' NH2' ' B' ' 24' ' ' ARG . 30.2 m-20 -65.28 -27.07 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.981 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.49 -57.53 8.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.654 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.0 mtp85 -61.6 -38.55 87.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.818 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.651 ' HG ' ' HE ' ' B' ' 24' ' ' ARG . 3.1 mm? -62.18 -48.64 79.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.531 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.9 -28.94 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.772 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 1.2 ttpp -65.15 -44.01 89.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.642 0.258 . . . . 0.0 111.223 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.486 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -59.58 -41.66 90.74 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.637 ' HA ' HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -61.1 -27.71 68.57 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.939 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 m -75.58 -39.82 57.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HD3' ' NZ ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -73.06 -22.81 60.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.334 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.637 HG21 ' HA ' ' A' ' 29' ' ' ASP . 32.6 m -90.28 -28.65 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.144 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.615 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 65.1 m-20 -73.63 -47.74 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 30' ' ' THR . 7.9 ptpt -80.8 -28.47 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.759 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.92 53.82 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.422 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 1.6 mt -75.0 -32.22 61.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 111.127 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB3' ' HA2' ' A' ' 62' ' ' GLY . . . -71.2 -41.17 70.62 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.447 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.64 ' HB3' ' HE1' ' A' ' 96' ' ' MET . 9.0 t -74.8 -41.52 59.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.802 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -60.01 -53.34 58.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.087 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.489 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -60.22 -34.04 73.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.339 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.818 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.33 -41.45 93.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.25 -42.14 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.071 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' C' ' 40' ' ' ALA . 9.2 m-20 -72.09 -9.87 59.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 t -68.49 -22.68 64.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.189 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.625 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.6 mm? -82.7 159.17 22.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.875 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.16 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.647 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' OE1' ' HA3' ' A' ' 74' ' ' GLY . 13.8 mt-30 70.7 118.04 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.758 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.7 Cg_endo -78.48 114.85 3.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.585 2.19 . . . . 0.0 112.501 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.75 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 167.72 55.85 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.263 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 8.3 p -75.49 -5.5 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.136 0.575 . . . . 0.0 112.479 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.8 49.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.33 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.599 0.238 . . . . 0.0 110.649 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 55' ' ' ASN . 14.6 p -105.86 141.63 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.524 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.432 ' N ' HG23 ' A' ' 54' ' ' VAL . 10.0 m-80 -122.77 117.52 25.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 111.624 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.487 ' HE1' HD12 ' A' ' 71' ' ' ILE . 20.3 t80 -87.72 140.59 29.36 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.281 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.625 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 68.1 p -117.23 118.97 33.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.91 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' B' ' 101' ' ' PHE . . . -144.9 132.39 20.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.476 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.461 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.83 174.93 46.17 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.574 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.22 160.67 23.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.392 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.818 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -140.33 177.55 20.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.438 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -162.39 141.04 6.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.537 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.624 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 39.1 t80 -137.24 134.12 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.271 . . . . 0.0 110.815 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 62.89 -93.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 p -143.26 32.39 1.35 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.1 145.15 47.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.782 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.01 153.55 26.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.097 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.98 164.33 32.37 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.523 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.58 136.16 53.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.71 51.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.638 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.487 HD12 ' HE1' ' A' ' 56' ' ' PHE . 6.6 tp -143.17 153.41 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.101 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.89 -177.72 45.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.95 151.26 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.469 ' HA3' ' OE1' ' A' ' 47' ' ' GLN . . . -150.24 171.67 30.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.227 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.03 136.59 50.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 111.11 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.654 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 7.1 ttm180 -132.25 133.89 44.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.589 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 4.1 p -122.95 143.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.286 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.3 m-20 60.13 -88.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.986 0.422 . . . . 0.0 111.083 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 10.0 pt-20 172.21 -31.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.535 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.42 -58.92 5.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.023 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.97 138.7 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.61 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.654 ' HB2' ' HG3' ' A' ' 76' ' ' ARG . . . -144.79 148.39 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 111.255 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -136.37 140.3 43.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.641 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.483 ' HD3' ' C ' ' A' ' 84' ' ' LYS . 8.9 tmtt? -153.79 130.42 10.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.478 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.34 177.05 11.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.02 -169.93 40.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.553 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 96' ' ' MET . 7.5 p -145.27 141.64 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.28 145.82 35.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.368 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -111.31 118.29 35.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.207 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.626 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.464 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 48.01 -114.3 1.79 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.286 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.15 17.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.18 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 27.7 m-20 -116.34 71.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.78 132.32 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.64 ' HE1' ' HB3' ' A' ' 38' ' ' SER . 2.7 ptp -122.69 126.67 48.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.89 111.17 23.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.436 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.32 152.43 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.322 . . . . 0.0 111.398 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.15 96.71 1.0 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.464 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 57.4 m -119.94 177.64 4.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.387 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' C' ' 58' ' ' ALA . 22.3 p90 -147.29 138.86 24.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.409 . . . . 0.0 111.082 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.741 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 74.5 m-20 -100.78 130.65 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.606 HG21 ' CZ2' ' A' ' 105' ' ' TRP . 0.2 OUTLIER -129.92 112.06 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.749 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.404 ' HG2' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -117.26 146.87 43.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.606 ' CZ2' HG21 ' A' ' 103' ' ' ILE . 27.4 m-90 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.645 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.649 -0.18 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 20.3 t70 79.7 131.56 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -131.9 -67.64 0.67 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.823 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.64 28.0 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 24.2 p -92.29 153.74 19.05 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.788 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -106.49 -81.99 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.755 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m 53.69 41.87 31.97 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.022 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.774 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 36.6 m80 -72.52 -51.66 7.13 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.82 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.774 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -50.67 111.86 0.63 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.411 2.074 . . . . 0.0 111.944 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' B' ' 8' ' ' HIS . 69.6 mt-30 -110.33 -73.19 0.69 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.051 0.453 . . . . 0.0 111.177 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -109.57 177.14 4.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.726 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.73 20.24 0.8 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.478 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -47.79 35.83 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.529 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.14 -34.59 58.71 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.198 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.98 96.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -68.29 -41.11 81.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.979 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.647 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER -59.86 -37.72 80.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.531 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.11 -38.81 66.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.222 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.3 -60.11 4.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.758 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.58 -28.15 69.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.653 HD23 HD23 ' A' ' 21' ' ' LEU . 2.4 tm? -63.32 -54.65 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.479 ' HA ' ' NH2' ' C' ' 24' ' ' ARG . 30.5 m-20 -65.39 -26.9 68.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.017 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.58 -57.41 9.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.651 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.0 mtp85 -61.71 -38.52 88.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.661 ' HG ' ' HE ' ' C' ' 24' ' ' ARG . 3.1 mm? -62.2 -48.55 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.92 -29.01 70.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.771 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.469 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 1.3 ttpp -65.17 -43.92 90.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.228 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.469 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -59.61 -41.65 90.84 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.635 ' HA ' HG21 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -61.08 -27.67 68.53 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.988 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 4.1 m -75.73 -39.72 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.841 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.418 ' HD3' ' NZ ' ' B' ' 27' ' ' LYS . 0.6 OUTLIER -73.14 -22.79 60.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.284 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' B' ' 29' ' ' ASP . 32.5 m -90.19 -28.69 4.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.22 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.615 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 65.5 m-20 -73.55 -47.87 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.036 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' B' ' 30' ' ' THR . 7.9 ptpt -80.76 -28.38 36.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.805 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.54 -40.75 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.413 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 1.6 mt -75.11 -32.15 61.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.328 . . . . 0.0 111.105 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.546 ' HB3' ' HA2' ' B' ' 62' ' ' GLY . . . -71.23 -41.14 70.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.413 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.665 ' HB3' ' HE1' ' B' ' 96' ' ' MET . 9.1 t -74.85 -41.62 59.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.93 -53.36 58.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.48 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -60.25 -34.0 73.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.404 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.826 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.4 -41.35 93.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.959 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.419 ' HA ' HD11 ' B' ' 42' ' ' LEU . 38.7 tp -72.25 -42.19 65.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.061 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 40' ' ' ALA . 9.2 m-20 -72.07 -9.89 59.02 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.8 t -68.5 -22.64 64.52 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.181 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.631 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.6 mm? -82.73 159.16 22.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.823 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.18 0.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.649 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' B' ' 46' ' ' PHE . 13.8 mt-30 70.68 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.947 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.35 114.64 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.747 2.298 . . . . 0.0 112.571 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.82 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.59 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 167.72 55.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.316 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 8.3 p -75.59 -5.52 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.105 0.562 . . . . 0.0 112.425 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.82 49.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.209 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -173.12 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.629 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.439 HG23 ' N ' ' B' ' 55' ' ' ASN . 14.5 p -105.9 141.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.516 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.439 ' N ' HG23 ' B' ' 54' ' ' VAL . 10.0 m-80 -122.85 117.47 25.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 111.63 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.473 ' HE1' HD12 ' B' ' 71' ' ' ILE . 20.4 t80 -87.71 140.56 29.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.252 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.631 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 67.9 p -117.21 118.9 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.931 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' C' ' 101' ' ' PHE . . . -144.89 132.39 20.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.82 174.93 46.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.614 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.19 160.68 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.347 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . 0.826 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -140.33 177.59 20.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.518 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -162.39 140.93 6.85 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.603 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.626 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 39.1 t80 -137.17 134.25 36.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.31 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 62.96 -93.45 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.979 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 17.3 p -143.23 32.46 1.35 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.143 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.19 145.17 47.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.03 153.54 26.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.0 164.33 32.42 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.517 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.53 136.14 53.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.793 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.72 51.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.473 HD12 ' HE1' ' B' ' 56' ' ' PHE . 6.6 tp -143.19 153.39 16.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.157 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.9 -177.69 45.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.441 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.92 151.3 4.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.389 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.454 ' HA3' ' OE1' ' B' ' 47' ' ' GLN . . . -150.32 171.61 30.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.203 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.94 136.51 50.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.134 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.658 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 7.1 ttm180 -132.19 133.95 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.607 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 4.1 p -122.96 143.1 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.267 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 96.3 m-20 60.21 -88.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.927 0.394 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 10.0 pt-20 172.25 -31.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.555 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 15.6 p -62.49 -58.89 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.06 138.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.5 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.658 ' HB2' ' HG3' ' B' ' 76' ' ' ARG . . . -144.81 148.43 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.27 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 53.4 tp -136.43 140.32 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.581 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' B' ' 85' ' ' ALA . 8.9 tmtt? -153.75 130.44 10.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.38 177.11 11.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.04 -169.89 40.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.592 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.477 HG21 ' O ' ' B' ' 96' ' ' MET . 7.5 p -145.34 141.65 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.32 145.91 35.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.276 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -111.38 118.28 35.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.289 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' B' ' 94' ' ' ASP . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.581 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' B' ' 34' ' ' LYS . . . 47.97 -114.24 1.75 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 39.1 m -149.57 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.687 0.28 . . . . 0.0 111.275 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.24 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 27.3 m-20 -116.39 71.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 39.1 t -99.83 132.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.675 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.665 ' HE1' ' HB3' ' B' ' 38' ' ' SER . 2.7 ptp -122.72 126.62 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.733 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.92 111.26 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.405 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.38 152.42 24.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.724 0.297 . . . . 0.0 111.459 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.18 96.74 1.0 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.461 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 56.5 m -119.96 177.64 4.91 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.428 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' ALA . 21.9 p90 -147.3 138.79 23.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 111.093 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.758 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 74.5 m-20 -100.77 130.6 46.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.433 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.608 HG21 ' CZ2' ' B' ' 105' ' ' TRP . 0.2 OUTLIER -129.85 112.05 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -117.25 146.86 43.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . 0.608 ' CZ2' HG21 ' B' ' 103' ' ' ILE . 27.3 m-90 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.677 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' C' ' 1' ' ' GLY . 20.4 t70 79.71 131.52 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.895 0.378 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -131.85 -67.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.63 27.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 24.3 p -92.28 153.7 19.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.703 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -106.46 -82.02 0.54 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m 53.75 41.87 31.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.028 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.762 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 36.7 m80 -72.56 -51.72 6.98 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.744 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.762 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -50.54 111.83 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.499 2.133 . . . . 0.0 111.884 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' C' ' 8' ' ' HIS . 69.3 mt-30 -110.4 -73.14 0.69 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.998 0.428 . . . . 0.0 111.231 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -109.64 177.07 4.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.742 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.61 20.18 0.82 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.478 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -47.74 35.83 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.546 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.08 -34.55 58.43 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.298 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.38 -44.85 96.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 110.903 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -68.29 -41.11 81.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.005 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.65 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER -59.94 -37.62 80.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.541 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.78 66.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.32 -60.07 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.63 -28.17 69.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.42 . . . . 0.0 111.149 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.654 HD23 HD23 ' A' ' 21' ' ' LEU . 2.4 tm? -63.26 -54.67 33.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.545 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . 0.477 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 30.1 m-20 -65.31 -26.99 68.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.085 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.54 -57.45 9.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.661 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.0 mtp85 -61.65 -38.58 88.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.734 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.654 ' HG ' ' HE ' ' A' ' 24' ' ' ARG . 3.1 mm? -62.14 -48.57 79.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.9 -29.01 70.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.816 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.474 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 1.2 ttpp -65.18 -43.92 90.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.652 0.263 . . . . 0.0 111.249 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.474 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -59.59 -41.67 90.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.61 ' HA ' HG21 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -61.12 -27.71 68.58 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.917 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.461 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 4.1 m -75.59 -39.85 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.411 ' HD3' ' NZ ' ' C' ' 27' ' ' LYS . 0.6 OUTLIER -73.05 -22.71 60.58 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' C' ' 29' ' ' ASP . 32.4 m -90.27 -28.7 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.619 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 65.5 m-20 -73.63 -47.76 37.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.469 ' HD3' ' CA ' ' C' ' 91' ' ' GLY . 7.9 ptpt -80.85 -28.37 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.803 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.45 -40.85 53.63 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.478 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 1.6 mt -74.98 -32.36 61.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 111.07 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.559 ' HB3' ' HA2' ' C' ' 62' ' ' GLY . . . -71.12 -41.21 70.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.44 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.643 ' HB3' ' HE1' ' C' ' 96' ' ' MET . 9.1 t -74.81 -41.57 59.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.746 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.96 -53.28 59.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.169 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.487 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -60.27 -33.95 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.403 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.834 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.44 -41.38 93.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.467 ' HA ' HD11 ' C' ' 42' ' ' LEU . 38.9 tp -72.24 -42.23 65.89 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.073 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' B' ' 40' ' ' ALA . 9.1 m-20 -72.02 -9.84 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.9 t -68.54 -22.68 64.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.158 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.6 mm? -82.68 159.15 22.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.866 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 15.1 p90 -148.5 -2.28 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.619 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.471 ' OE1' ' HA3' ' C' ' 74' ' ' GLY . 13.8 mt-30 70.72 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.936 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.44 114.78 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.679 2.253 . . . . 0.0 112.487 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.76 -176.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.612 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 167.69 55.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.246 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 8.3 p -75.48 -5.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.178 0.591 . . . . 0.0 112.445 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.84 49.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.283 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.644 0.259 . . . . 0.0 110.621 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.438 HG23 ' N ' ' C' ' 55' ' ' ASN . 14.7 p -105.84 141.5 21.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.585 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.438 ' N ' HG23 ' C' ' 54' ' ' VAL . 9.8 m-80 -122.74 117.6 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 111.664 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . 0.462 ' HE1' HD12 ' C' ' 71' ' ' ILE . 20.4 t80 -87.8 140.54 29.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.34 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.628 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 67.7 p -117.15 118.9 33.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.001 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 101' ' ' PHE . . . -144.87 132.39 20.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.81 174.9 46.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.586 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.16 160.72 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 111.399 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . 0.834 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -140.35 177.64 20.54 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.4 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.559 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -162.47 141.04 6.92 Favored Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.619 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 39.0 t80 -137.29 134.26 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.711 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 62.9 -93.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.114 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -143.23 32.37 1.35 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.15 145.14 47.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.05 153.56 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 111.097 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.94 164.3 32.45 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.61 136.2 53.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.96 140.69 51.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.462 HD12 ' HE1' ' C' ' 56' ' ' PHE . 6.6 tp -143.25 153.4 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.768 0.318 . . . . 0.0 111.098 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.94 -177.71 45.29 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.456 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.91 151.32 4.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . 0.471 ' HA3' ' OE1' ' C' ' 47' ' ' GLN . . . -150.26 171.75 30.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -129.12 136.49 50.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.636 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 7.1 ttm180 -132.11 134.09 45.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.682 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.601 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 4.1 p -123.09 143.12 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.274 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 96.3 m-20 60.15 -88.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 111.104 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 10.1 pt-20 172.18 -31.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.47 -58.93 5.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.942 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 32.2 m -94.05 138.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.525 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.636 ' HB2' ' HG3' ' C' ' 76' ' ' ARG . . . -144.9 148.39 33.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.279 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 53.6 tp -136.38 140.37 43.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.491 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 8.9 tmtt? -153.85 130.44 10.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . 0.491 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.37 177.1 11.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.043 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.0 -169.91 40.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.555 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.471 HG21 ' O ' ' C' ' 96' ' ' MET . 7.5 p -145.29 141.69 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.872 0.368 . . . . 0.0 111.099 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.28 145.84 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.339 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.38 118.2 35.17 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.277 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' C' ' 94' ' ' ASP . . . -126.02 140.63 52.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.591 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.469 ' CA ' ' HD3' ' C' ' 34' ' ' LYS . . . 48.02 -114.34 1.81 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.244 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -149.47 16.72 0.91 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.264 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.23 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 27.3 m-20 -116.39 71.01 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.81 132.33 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.006 0.432 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.643 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 2.7 ptp -122.65 126.65 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -105.98 111.28 23.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.408 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.31 152.46 24.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.457 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.2 96.74 0.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.468 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 56.5 m -119.95 177.63 4.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.438 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' B' ' 58' ' ' ALA . 22.1 p90 -147.31 138.83 24.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.757 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 74.5 m-20 -100.79 130.62 46.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.358 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.608 HG21 ' CZ2' ' C' ' 105' ' ' TRP . 0.2 OUTLIER -129.93 112.08 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -117.24 146.87 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . 0.608 ' CZ2' HG21 ' C' ' 103' ' ' ILE . 27.3 m-90 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.705 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.2 t0 73.13 141.41 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.892 0.377 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -129.13 -63.97 0.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.74 24.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -97.22 153.69 17.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.808 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.675 ' HB3' ' CE1' ' A' ' 8' ' ' HIS . 32.0 m95 -105.68 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.739 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.8 m 61.21 46.39 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.053 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.699 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 23.6 m170 -88.19 -49.86 0.42 Allowed Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.801 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.699 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -58.48 106.95 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.469 2.113 . . . . 0.0 111.945 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -109.67 -57.31 2.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.951 0.405 . . . . 0.0 111.157 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -120.64 169.91 9.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.652 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 25.71 1.65 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.473 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.636 ' HE2' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -68.72 -50.36 51.41 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.568 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.21 -28.64 64.51 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.254 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.09 86.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.342 . . . . 0.0 110.873 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 19' ' ' ARG . 18.2 m-70 -78.45 -29.42 46.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.002 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.636 ' HD3' ' HE2' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -66.38 -41.88 88.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.561 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.82 -32.31 67.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.371 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.43 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 53.0 mtt-85 -64.1 -57.64 8.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.74 -31.18 70.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 25' ' ' LEU . 3.2 tm? -61.98 -59.76 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.12 -18.79 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -74.13 -45.99 45.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -77.02 -37.14 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 21' ' ' LEU . 3.3 mm? -66.42 -52.18 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.63 -42.24 92.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.3 ttpp -66.88 -28.95 68.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.419 HD22 HD13 ' C' ' 25' ' ' LEU . 0.0 OUTLIER -62.28 -48.81 78.27 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.561 ' HA ' HG21 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -64.33 -33.09 75.04 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.925 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -67.93 -38.83 83.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.717 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.83 64.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.561 HG21 ' HA ' ' A' ' 29' ' ' ASP . 32.8 m -74.24 -33.46 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.628 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 16.6 m-20 -69.07 -45.28 70.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.717 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.3 ptpt -75.19 -40.65 59.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.729 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.414 ' HA3' ' OH ' ' C' ' 63' ' ' TYR . . . -57.37 -43.63 93.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.381 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.778 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.03 -24.65 58.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.159 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.814 ' HB3' ' HA2' ' A' ' 62' ' ' GLY . . . -69.21 -41.96 76.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.461 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.597 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 8.5 t -82.81 -39.97 21.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.745 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.5 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 4.0 t -58.11 -54.79 43.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' HB3' HD22 ' B' ' 98' ' ' ASN . . . -61.5 -33.51 73.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.445 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.73 -33.6 76.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.643 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 60.1 tp -82.65 -32.37 28.27 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.678 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 87.6 m-20 -75.84 -16.34 60.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.85 -18.83 64.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.207 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.61 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.7 mm? -77.53 163.87 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.909 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.2 p90 -156.56 0.41 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.632 ' HG2' HG22 ' A' ' 57' ' ' THR . 6.0 mt-30 63.07 125.07 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.965 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -83.95 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.671 2.247 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.468 ' OH ' ' HB ' ' B' ' 51' ' ' VAL . 13.7 m-30 63.7 -175.3 0.16 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.595 ' HA3' ' HD2' ' A' ' 76' ' ' ARG . . . 166.69 55.44 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.237 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -81.44 -10.66 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.159 0.584 . . . . 0.0 112.432 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.67 48.17 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.284 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -150.92 -163.92 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.656 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 74' ' ' GLY . 9.0 p -116.72 142.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.553 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.484 ' CB ' ' HB3' ' A' ' 47' ' ' GLN . 10.4 m-80 -124.82 113.32 17.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.677 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.55 129.64 34.98 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.273 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.632 HG22 ' HG2' ' A' ' 47' ' ' GLN . 37.7 p -109.36 122.09 46.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.992 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.495 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -154.62 133.68 12.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.436 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.46 170.49 43.31 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.531 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 69' ' ' LEU . 2.7 m -121.15 161.41 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.366 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.23 17.96 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.461 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.814 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -172.21 138.73 4.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.628 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 34.0 t80 -120.84 131.85 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.685 0.278 . . . . 0.0 110.738 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.4 mmm180 69.52 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.1 p -143.76 26.22 1.58 Allowed 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.159 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.38 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.33 150.96 28.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -146.55 171.79 14.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.548 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -119.98 142.8 48.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.811 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -132.62 137.19 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.686 0.279 . . . . 0.0 111.636 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.55 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.5 tp -137.65 162.1 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.784 0.326 . . . . 0.0 111.05 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.55 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 171.37 179.9 42.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.397 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.61 148.77 12.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.892 0.377 . . . . 0.0 110.965 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -151.49 166.78 30.77 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.228 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.591 ' CE2' ' HB ' ' A' ' 77' ' ' VAL . 38.8 t80 -131.85 134.49 45.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.156 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.598 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 16.4 ttm180 -125.18 121.56 34.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.611 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 8.6 p -110.88 137.99 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 49.7 m-20 64.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.451 ' HB3' ' CE2' ' C' ' 49' ' ' TYR . 10.5 pt-20 175.42 -20.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.59 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 p -70.85 -66.36 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.032 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 m -90.85 141.34 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.589 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.598 ' HB2' ' HG3' ' A' ' 76' ' ' ARG . . . -149.47 153.82 37.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.172 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 101' ' ' PHE . 25.3 tp -148.82 149.88 32.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.618 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HG3' ' HE2' ' C' ' 46' ' ' PHE . 12.1 tmtt? -149.34 141.67 24.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.162 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.17 176.02 11.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.44 -173.06 41.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.587 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.09 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.853 0.358 . . . . 0.0 111.16 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.25 144.23 39.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.351 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -121.97 113.01 18.99 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.39 -116.13 8.72 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.293 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.87 8.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.322 . . . . 0.0 111.337 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t -155.03 22.62 0.44 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.108 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 10.8 m-20 -127.11 82.86 2.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.87 139.4 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.537 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 6.9 ptp -134.22 141.58 47.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -113.26 124.31 52.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.455 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.51 HD22 ' HB3' ' C' ' 40' ' ' ALA . 17.1 m120 -109.57 148.01 32.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.296 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.7 86.9 0.38 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.592 ' CB ' HD13 ' C' ' 45' ' ' LEU . 4.1 m -115.61 162.34 17.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.471 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.598 ' HB3' HD11 ' A' ' 83' ' ' LEU . 31.8 p90 -130.31 145.64 51.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.976 0.417 . . . . 0.0 111.055 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.574 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 56.0 m-80 -115.34 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.399 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.14 119.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.819 0.343 . . . . 0.0 110.726 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.92 159.8 22.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.406 -0.806 . . . . 0.0 110.598 179.693 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 112.651 -0.179 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 16.2 t0 73.12 141.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.946 0.403 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -129.12 -64.0 0.93 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.824 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.77 24.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -97.35 153.73 17.89 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.819 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.678 ' HB3' ' CE1' ' B' ' 8' ' ' HIS . 32.2 m95 -105.67 -75.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.676 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 70.8 m 61.24 46.43 7.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.981 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.72 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 23.7 m170 -88.22 -49.81 0.42 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.811 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.72 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -58.53 106.93 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.504 2.136 . . . . 0.0 111.92 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -109.61 -57.3 2.2 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.944 0.402 . . . . 0.0 111.175 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -120.71 169.96 9.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.595 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.52 25.78 1.65 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.482 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.633 ' HE2' ' HD3' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -68.72 -50.39 51.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.489 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.27 -28.54 64.53 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.262 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.96 -44.2 85.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' B' ' 19' ' ' ARG . 18.2 m-70 -78.41 -29.39 47.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.988 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.633 ' HD3' ' HE2' ' B' ' 13' ' ' LYS . 0.6 OUTLIER -66.48 -41.77 88.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.5 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.92 -32.3 67.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' B' ' 16' ' ' HIS . 53.0 mtt-85 -63.99 -57.71 8.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.707 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.83 -31.1 70.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.559 HD21 HD21 ' B' ' 25' ' ' LEU . 3.2 tm? -61.95 -59.81 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.591 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -65.07 -18.78 65.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.18 -46.0 44.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -76.94 -37.14 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.794 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.559 HD21 HD21 ' B' ' 21' ' ' LEU . 3.3 mm? -66.47 -52.16 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.641 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.61 -42.19 92.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' B' ' 27' ' ' LYS . 1.3 ttpp -66.93 -29.02 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.418 HD22 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.2 -48.82 78.3 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.559 ' HA ' HG21 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -64.46 -32.9 74.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 178.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 5.9 m -68.03 -38.81 82.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.858 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.732 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -73.3 -39.85 64.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.246 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' B' ' 29' ' ' ASP . 32.6 m -74.21 -33.41 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.223 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.627 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 16.6 m-20 -69.18 -45.25 70.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.732 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.3 ptpt -75.17 -40.61 59.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.416 ' HA3' ' OH ' ' A' ' 63' ' ' TYR . . . -57.37 -43.62 93.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.78 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.06 -24.65 58.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.812 ' HB3' ' HA2' ' B' ' 62' ' ' GLY . . . -69.18 -42.03 76.39 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.577 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 8.5 t -82.72 -40.01 21.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.741 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.494 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.9 t -58.12 -54.62 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.505 ' HB3' HD22 ' C' ' 98' ' ' ASN . . . -61.66 -33.47 74.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.409 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.69 76.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.67 ' HB2' ' HB3' ' B' ' 70' ' ' ALA . 59.6 tp -82.6 -32.29 28.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.689 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 87.4 m-20 -75.8 -16.37 60.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.99 -18.69 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.148 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.6 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.7 mm? -77.63 163.88 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.846 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.468 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.2 p90 -156.54 0.37 0.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 111.714 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.628 ' HG2' HG22 ' B' ' 57' ' ' THR . 6.1 mt-30 63.15 124.98 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.967 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -83.94 109.92 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.642 2.228 . . . . 0.0 112.605 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' C' ' 51' ' ' VAL . 13.6 m-30 63.71 -175.31 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.934 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.58 ' HA3' ' HD2' ' B' ' 76' ' ' ARG . . . 166.72 55.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.245 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -81.34 -10.67 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.161 0.584 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.63 48.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.268 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.435 ' O ' ' CD1' ' B' ' 75' ' ' TYR . 0.0 OUTLIER -150.89 -163.87 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.601 0.239 . . . . 0.0 110.639 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.566 HG23 ' O ' ' B' ' 74' ' ' GLY . 9.1 p -116.78 142.65 29.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.586 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.489 ' CB ' ' HB3' ' B' ' 47' ' ' GLN . 10.4 m-80 -124.8 113.43 17.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.973 0.416 . . . . 0.0 111.663 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.67 129.7 34.96 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.195 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.628 HG22 ' HG2' ' B' ' 47' ' ' GLN . 37.6 p -109.42 122.07 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.943 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.473 ' HB1' HD12 ' B' ' 71' ' ' ILE . . . -154.61 133.7 12.41 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.368 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.47 170.49 43.32 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' B' ' 69' ' ' LEU . 2.7 m -121.16 161.52 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.773 0.321 . . . . 0.0 111.383 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.23 -167.16 17.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.473 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.812 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -172.23 138.75 4.94 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.627 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 34.1 t80 -120.87 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.695 0.283 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.5 mmm180 69.47 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -143.75 26.18 1.58 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.17 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.4 51.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -110.44 151.06 27.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.577 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -146.66 171.7 14.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.537 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.459 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.8 OUTLIER -120.0 142.75 48.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.808 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.67 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -132.58 137.2 47.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.681 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.556 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.5 tp -137.64 162.07 32.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.738 0.304 . . . . 0.0 111.119 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.556 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 171.34 179.87 42.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.444 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.58 148.73 12.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.566 ' O ' HG23 ' B' ' 54' ' ' VAL . . . -151.41 166.8 30.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.598 ' CE2' ' HB ' ' B' ' 77' ' ' VAL . 38.6 t80 -131.88 134.47 45.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.609 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 16.4 ttm180 -125.19 121.47 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.613 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 8.6 p -110.88 138.04 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.344 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 50.2 m-20 64.3 -97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.46 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 10.4 pt-20 175.44 -20.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.541 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.81 -66.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 m -90.84 141.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' B' ' 76' ' ' ARG . . . -149.42 153.82 37.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 0.0 111.225 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' B' ' 101' ' ' PHE . 25.2 tp -148.79 149.88 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.582 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.484 ' HG3' ' HE2' ' A' ' 46' ' ' PHE . 12.1 tmtt? -149.38 141.72 24.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.18 176.05 11.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.086 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.36 -173.1 41.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.556 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.21 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.347 . . . . 0.0 111.107 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.31 144.16 39.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.366 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.89 113.03 19.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.235 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -119.5 129.97 54.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.608 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.28 -116.04 8.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.31 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.92 8.11 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 111.332 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.1 22.65 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 10.9 m-20 -127.07 82.8 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 99.7 t -108.87 139.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.969 0.414 . . . . 0.0 110.653 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.542 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 6.9 ptp -134.22 141.6 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.693 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -113.28 124.3 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.498 HD22 ' HB3' ' A' ' 40' ' ' ALA . 17.0 m120 -109.54 147.99 32.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 111.42 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.76 86.92 0.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.757 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.603 ' CB ' HD13 ' A' ' 45' ' ' LEU . 4.1 m -115.55 162.33 17.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.399 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.592 ' HB3' HD11 ' B' ' 83' ' ' LEU . 32.3 p90 -130.32 145.59 51.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.418 . . . . 0.0 111.073 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.582 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.0 m-80 -115.31 131.85 56.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.401 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.08 119.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.849 0.356 . . . . 0.0 110.776 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.99 159.81 22.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.672 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 16.2 t0 73.03 141.44 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.91 0.386 . . . . 0.0 110.988 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -129.1 -64.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.811 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.73 24.64 0.58 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.991 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -97.26 153.66 17.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.807 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . 0.675 ' HB3' ' CE1' ' C' ' 8' ' ' HIS . 32.2 m95 -105.58 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.789 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m 61.21 46.4 8.0 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.028 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.721 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 23.7 m170 -88.26 -49.79 0.42 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.758 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.721 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.5 Cg_exo -58.52 106.96 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.519 2.146 . . . . 0.0 111.933 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -109.64 -57.36 2.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 111.153 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -120.65 169.86 9.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.634 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 25.74 1.66 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.472 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.638 ' HE2' ' HD3' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -68.7 -50.4 51.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.536 -179.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.3 -28.58 64.66 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.195 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.98 -44.06 85.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 0.0 110.928 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' C' ' 19' ' ' ARG . 18.2 m-70 -78.43 -29.4 47.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.977 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.638 ' HD3' ' HE2' ' C' ' 13' ' ' LYS . 0.6 OUTLIER -66.51 -41.72 88.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.478 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.98 -32.26 67.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 111.245 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' C' ' 16' ' ' HIS . 53.1 mtt-85 -64.04 -57.72 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.79 -31.04 70.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.222 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.556 HD21 HD21 ' C' ' 25' ' ' LEU . 3.2 tm? -62.06 -59.75 4.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.53 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.11 -18.8 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.948 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.15 -45.97 45.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -76.98 -37.15 55.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.751 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.556 HD21 HD21 ' C' ' 21' ' ' LEU . 3.3 mm? -66.52 -52.13 49.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.646 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -59.59 -42.29 92.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' C' ' 27' ' ' LYS . 1.3 ttpp -66.79 -29.02 68.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.229 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.415 HD22 HD13 ' B' ' 25' ' ' LEU . 0.0 OUTLIER -62.32 -48.72 78.59 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.557 ' HA ' HG21 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -64.4 -32.99 74.83 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.994 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 5.9 m -67.92 -38.94 83.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.813 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.716 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.78 65.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.271 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' C' ' 29' ' ' ASP . 32.7 m -74.16 -33.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.622 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 16.6 m-20 -68.97 -45.3 71.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.716 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.3 ptpt -75.12 -40.71 59.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.777 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . 0.416 ' HA3' ' OH ' ' B' ' 63' ' ' TYR . . . -57.34 -43.57 93.75 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.419 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.78 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -75.13 -24.65 58.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.875 0.369 . . . . 0.0 111.092 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.814 ' HB3' ' HA2' ' C' ' 62' ' ' GLY . . . -69.17 -42.03 76.42 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.429 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.573 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 8.5 t -82.75 -39.93 21.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.502 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 4.0 t -58.11 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.51 ' HB3' HD22 ' A' ' 98' ' ' ASN . . . -61.67 -33.45 73.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.392 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.69 -33.66 76.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 59.9 tp -82.61 -32.29 28.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.689 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 87.4 m-20 -75.79 -16.43 60.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -67.9 -18.74 64.88 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.149 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.7 mm? -77.68 163.89 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.858 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.48 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.2 p90 -156.53 0.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.657 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.625 ' HG2' HG22 ' C' ' 57' ' ' THR . 6.1 mt-30 63.13 125.06 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.926 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -83.92 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.632 2.221 . . . . 0.0 112.629 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.465 ' OH ' ' HB ' ' A' ' 51' ' ' VAL . 13.7 m-30 63.74 -175.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.962 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.594 ' HA3' ' HD2' ' C' ' 76' ' ' ARG . . . 166.76 55.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.208 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -81.4 -10.59 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.157 0.583 . . . . 0.0 112.452 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.54 48.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.297 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -150.88 -163.82 1.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.625 0.25 . . . . 0.0 110.619 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.544 HG23 ' O ' ' C' ' 74' ' ' GLY . 9.1 p -116.89 142.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.578 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.488 ' CB ' ' HB3' ' C' ' 47' ' ' GLN . 10.4 m-80 -124.83 113.4 17.85 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.011 0.434 . . . . 0.0 111.659 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -83.63 129.71 34.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.226 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.625 HG22 ' HG2' ' C' ' 47' ' ' GLN . 37.6 p -109.42 122.06 46.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . 0.477 ' HB1' HD12 ' C' ' 71' ' ' ILE . . . -154.61 133.62 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.44 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.39 170.5 43.35 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.554 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' C' ' 69' ' ' LEU . 2.7 m -121.12 161.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.21 17.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.451 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.814 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -172.18 138.76 4.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.548 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.622 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 34.1 t80 -120.9 131.96 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.757 0.313 . . . . 0.0 110.746 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.5 mmm180 69.34 -92.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.1 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.4 p -143.77 26.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.1 141.42 51.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.42 150.96 28.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -146.58 171.75 14.61 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.548 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.461 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.8 OUTLIER -120.01 142.69 48.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -132.55 137.17 47.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.69 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.544 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.5 tp -137.52 162.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.544 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 171.36 179.86 42.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.59 148.75 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . 0.544 ' O ' HG23 ' C' ' 54' ' ' VAL . . . -151.41 166.81 30.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.15 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.604 ' CE2' ' HB ' ' C' ' 77' ' ' VAL . 39.2 t80 -131.91 134.45 45.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.92 0.391 . . . . 0.0 111.153 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.606 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 16.5 ttm180 -125.16 121.56 34.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.731 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.611 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 8.7 p -110.96 138.06 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.291 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 49.8 m-20 64.4 -97.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.013 0.435 . . . . 0.0 111.12 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . 0.464 ' HB3' ' CE2' ' B' ' 49' ' ' TYR . 10.5 pt-20 175.43 -20.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.62 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.87 -66.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -90.97 141.3 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.485 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.606 ' HB2' ' HG3' ' C' ' 76' ' ' ARG . . . -149.38 153.83 37.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.276 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' C' ' 101' ' ' PHE . 25.3 tp -148.77 149.89 32.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.6 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.468 ' HG3' ' HE2' ' B' ' 46' ' ' PHE . 12.1 tmtt? -149.41 141.74 24.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.27 175.94 11.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.056 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.43 -173.18 41.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.546 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.09 138.2 19.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.102 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.39 144.22 39.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.32 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.99 112.93 18.88 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -119.43 129.98 55.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.4 -116.1 8.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.308 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m -148.95 8.09 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.331 . . . . 0.0 111.285 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.07 22.64 0.43 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 10.8 m-20 -127.1 82.77 2.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.76 139.33 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.769 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.542 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 6.8 ptp -134.17 141.61 47.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.3 124.25 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.495 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.505 HD22 ' HB3' ' B' ' 40' ' ' ALA . 17.1 m120 -109.52 148.08 31.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 111.443 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.74 86.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.764 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.592 ' CB ' HD13 ' B' ' 45' ' ' LEU . 4.1 m -115.53 162.35 17.32 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.594 ' HB3' HD11 ' C' ' 83' ' ' LEU . 32.0 p90 -130.34 145.61 51.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 111.064 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.585 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 55.6 m-80 -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.378 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.06 119.7 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.794 0.331 . . . . 0.0 110.737 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.95 159.82 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.663 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.669 -0.172 . . . . 0.0 112.669 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 17.8 t70 71.13 130.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.944 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -108.4 -74.2 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.897 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.92 21.99 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -115.31 145.33 42.59 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.782 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.541 ' HB3' ' CE1' ' A' ' 8' ' ' HIS . 17.8 m95 -106.98 -52.92 2.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.74 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m 59.29 61.93 1.93 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.978 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.704 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 35.0 m80 -86.0 -49.73 0.52 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.773 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -67.69 110.03 2.01 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.387 2.058 . . . . 0.0 111.971 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -110.3 -58.27 2.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.442 ' HD1' ' H ' ' A' ' 13' ' ' LYS . 55.1 p90 -109.92 172.69 6.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.7 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.74 12.93 5.85 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.469 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' H ' ' HD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -63.92 -39.2 93.62 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.446 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.66 -29.81 72.8 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.224 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' HD2' ' A' ' 19' ' ' ARG . . . -70.83 -57.73 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 0.0 110.901 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -57.37 -29.11 63.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.954 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -68.19 -52.3 35.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.55 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.09 -20.26 64.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 111.211 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 15' ' ' ALA . 14.7 mtt-85 -70.74 -60.28 2.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.795 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.534 HE22 HD12 ' C' ' 21' ' ' LEU . 4.4 pp0? -73.14 -17.37 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.152 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -67.71 -49.81 60.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.557 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -73.53 -28.05 61.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.038 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.05 -51.57 45.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -62.5 -44.76 95.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.755 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.44 -50.37 73.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.18 -39.48 82.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 ttpp -60.46 -34.09 73.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.202 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -41.95 81.27 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.45 -25.02 64.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.3 m -79.63 -41.0 27.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.852 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.658 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.4 mpt_? -68.93 -35.83 77.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.303 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.0 m -77.58 -32.13 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.159 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -66.79 -44.84 80.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 4.2 ptpt -77.76 -31.69 52.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.24 67.84 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.393 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.89 -27.77 60.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.23 -46.37 16.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.407 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.542 ' OG ' ' HB2' ' A' ' 88' ' ' ALA . 48.4 t -67.06 -40.59 87.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.504 ' OG ' ' HB1' ' C' ' 40' ' ' ALA . 37.4 t -67.42 -52.89 34.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HB1' ' OG ' ' B' ' 39' ' ' SER . . . -61.88 -25.82 67.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.494 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -65.96 -38.28 88.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 21.7 tp -79.36 -33.63 42.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -73.68 -13.58 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.493 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 30.5 t -71.54 -19.27 62.19 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.182 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.598 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.0 mm? -80.45 157.83 26.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.856 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 8.1 p90 -146.06 -10.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.699 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.518 ' HG2' HG22 ' A' ' 57' ' ' THR . 5.1 mt-30 73.43 121.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.935 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -77.72 101.1 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HH ' ' H ' ' B' ' 50' ' ' GLY . 18.3 m-30 62.1 -170.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 163.03 60.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.5 p -69.89 -18.81 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.146 0.578 . . . . 0.0 112.459 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.764 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.02 51.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.313 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.16 -157.03 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.56 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 55' ' ' ASN . 2.8 p -120.67 145.13 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.579 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.52 ' N ' HG23 ' A' ' 54' ' ' VAL . 11.5 m-80 -126.83 122.06 33.65 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.979 0.418 . . . . 0.0 111.727 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.411 ' CE2' HD12 ' A' ' 71' ' ' ILE . 22.2 t80 -84.27 124.47 31.26 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.267 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.598 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 72.1 p -107.04 120.61 42.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.007 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.85 137.49 20.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.405 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . 178.14 165.48 33.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.533 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 69' ' ' LEU . 30.2 m -121.13 178.76 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.375 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.99 -179.34 38.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -158.14 134.22 3.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.522 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.648 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 26.1 t80 -124.91 124.19 41.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.74 0.305 . . . . 0.0 110.746 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER 68.67 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 p -146.05 16.89 1.39 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.44 140.89 49.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.43 47.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 172.08 13.19 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.671 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.0 tt -123.47 145.16 49.04 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' A' ' 41' ' ' ALA . . . -132.1 119.52 21.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.411 HD12 ' CE2' ' A' ' 56' ' ' PHE . 8.1 tp -118.67 152.74 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.91 -172.12 44.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.446 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.61 158.11 6.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.25 177.75 22.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.25 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.601 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 35.0 t80 -138.12 132.8 32.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 14.1 ttm180 -126.54 117.25 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.764 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.9 p -106.12 138.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.284 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 78.9 m-20 68.82 -92.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 78' ' ' ASN . 14.8 pt-20 172.92 -24.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.579 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -78.46 -52.21 8.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.01 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.44 137.39 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.469 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -144.55 163.77 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.295 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.1 tp -158.88 154.31 25.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.431 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 10.8 tmtt? -159.59 133.97 7.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.1 18.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.83 -174.57 42.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.628 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 96' ' ' MET . 7.9 p -130.24 139.56 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 111.112 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.542 ' HB2' ' OG ' ' A' ' 38' ' ' SER . . . -113.05 136.51 52.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.293 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.19 51.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.294 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 34' ' ' LYS . . . -131.61 135.72 47.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.591 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.541 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.71 -123.26 29.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.281 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.58 9.58 2.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.791 0.329 . . . . 0.0 111.318 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.48 32.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.201 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -132.32 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.25 150.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.01 0.433 . . . . 0.0 110.724 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.632 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 1.2 ptp -146.52 159.69 43.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.594 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.69 141.06 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.444 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -118.05 145.68 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.764 0.316 . . . . 0.0 111.393 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.48 87.6 1.32 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 16.7 m -121.49 148.99 43.73 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.393 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.705 ' HD2' HD13 ' A' ' 103' ' ' ILE . 1.8 p90 -124.47 142.91 50.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.423 . . . . 0.0 111.05 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.75 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 64.1 m-80 -109.45 126.72 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.705 HD13 ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -129.59 121.1 52.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.96 165.96 19.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.656 179.697 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.521 ' O ' ' HB3' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.663 -0.175 . . . . 0.0 112.663 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' B' ' 1' ' ' GLY . 17.9 t70 71.18 130.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.4 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -108.45 -74.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.92 21.97 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.012 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -115.29 145.36 42.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.797 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.537 ' HB3' ' CE1' ' B' ' 8' ' ' HIS . 17.8 m95 -107.05 -52.92 2.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.697 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 10.0 m 59.3 61.88 1.94 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.017 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.676 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 35.0 m80 -85.9 -49.76 0.53 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.838 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.676 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -67.68 109.97 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.531 2.154 . . . . 0.0 111.949 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -110.21 -58.41 2.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 111.144 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.468 ' HD1' ' H ' ' B' ' 13' ' ' LYS . 55.0 p90 -109.9 172.66 6.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.625 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.63 12.89 5.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.507 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.468 ' H ' ' HD1' ' B' ' 11' ' ' PHE . 0.0 OUTLIER -63.88 -39.18 93.6 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.484 -179.202 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.68 -29.83 72.79 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.213 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.417 ' O ' ' HD2' ' B' ' 19' ' ' ARG . . . -70.86 -57.69 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 110.905 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -57.31 -29.17 63.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.996 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.592 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER -68.19 -52.33 35.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.529 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.02 -20.32 64.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.227 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' B' ' 15' ' ' ALA . 14.7 mtt-85 -70.6 -60.4 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.749 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.523 HE22 HD12 ' A' ' 21' ' ' LEU . 4.4 pp0? -73.1 -17.37 61.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.151 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -67.69 -49.86 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -73.44 -28.17 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.993 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.98 -51.54 46.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -62.49 -44.82 95.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.8 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.4 -50.46 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.08 -39.48 82.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.871 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.492 ' O ' ' HD3' ' B' ' 31' ' ' ARG . 12.9 ttpp -60.38 -34.2 73.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.212 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.07 -41.87 81.28 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.925 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 1.3 m -79.52 -40.98 28.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.667 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.4 mpt_? -68.87 -36.0 77.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 18.9 m -77.53 -32.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.207 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 9.9 m-20 -66.73 -44.78 80.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.04 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 4.2 ptpt -77.97 -31.53 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.56 -35.23 67.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.88 -27.78 60.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.31 -46.32 16.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.396 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' B' ' 88' ' ' ALA . 48.5 t -67.09 -40.53 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.785 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.513 ' OG ' ' HB1' ' A' ' 40' ' ' ALA . 37.4 t -67.46 -52.94 33.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.512 ' HB1' ' OG ' ' C' ' 39' ' ' SER . . . -61.82 -25.87 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.43 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.604 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . . . -65.87 -38.41 88.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.607 ' HB2' ' HB3' ' B' ' 70' ' ' ALA . 21.6 tp -79.26 -33.65 43.31 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 57.8 m-20 -73.64 -13.59 61.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.495 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 30.4 t -71.58 -19.27 62.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.135 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.614 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.0 mm? -80.48 157.8 26.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.831 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.433 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 8.1 p90 -146.0 -10.43 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.188 0.518 . . . . 0.0 111.717 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.517 ' HG2' HG22 ' B' ' 57' ' ' THR . 5.1 mt-30 73.51 121.16 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.882 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -77.69 101.14 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.623 2.216 . . . . 0.0 112.54 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.5 ' HH ' ' H ' ' C' ' 50' ' ' GLY . 18.4 m-30 62.03 -170.51 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.946 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.509 ' H ' ' HH ' ' A' ' 49' ' ' TYR . . . 163.03 60.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.288 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.4 p -70.0 -18.86 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.186 0.594 . . . . 0.0 112.454 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.762 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.04 51.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.298 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.05 -156.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.546 0.212 . . . . 0.0 110.671 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.514 HG23 ' N ' ' B' ' 55' ' ' ASN . 2.8 p -120.81 145.15 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.577 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.514 ' N ' HG23 ' B' ' 54' ' ' VAL . 11.5 m-80 -126.84 122.09 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.008 0.433 . . . . 0.0 111.669 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.418 ' CE2' HD12 ' B' ' 71' ' ' ILE . 22.2 t80 -84.34 124.5 31.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.248 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.614 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 73.4 p -107.1 120.64 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.81 137.56 20.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.418 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . 178.1 165.51 33.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' B' ' 69' ' ' LEU . 30.3 m -121.16 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.03 -179.39 38.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.453 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -158.12 134.17 3.77 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.646 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 26.2 t80 -124.91 124.18 41.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.734 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 73.3 p -145.99 16.87 1.4 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.81 49.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.42 47.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.107 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.41 172.11 13.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.49 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.689 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.0 tt -123.52 145.19 49.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.762 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -132.19 119.63 21.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.725 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.418 HD12 ' CE2' ' B' ' 56' ' ' PHE . 8.1 tp -118.72 152.72 20.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.96 -172.18 44.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.405 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.52 158.06 6.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.851 0.358 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.2 177.78 22.61 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.267 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.595 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 34.8 t80 -138.13 132.71 32.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.873 0.368 . . . . 0.0 111.166 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 14.0 ttm180 -126.49 117.27 22.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.762 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.9 p -106.16 138.91 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.011 0.434 . . . . 0.0 111.278 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 78.9 m-20 68.81 -92.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.0 111.14 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 14.8 pt-20 172.97 -24.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.1 p -78.48 -52.21 8.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.44 137.36 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -144.58 163.78 32.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.868 0.365 . . . . 0.0 111.255 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 34.6 tp -158.9 154.32 25.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.428 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 10.8 tmtt? -159.66 133.97 7.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.58 171.06 18.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.87 -174.46 42.83 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.626 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.442 HG21 ' O ' ' B' ' 96' ' ' MET . 7.9 p -130.29 139.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.059 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.551 ' HB2' ' OG ' ' B' ' 38' ' ' SER . . . -113.01 136.48 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.359 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.68 125.2 51.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' B' ' 34' ' ' LYS . . . -131.53 135.69 47.24 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.664 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.556 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.76 -123.37 30.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.342 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.28 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.9 t -165.48 32.84 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.242 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.32 82.3 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.24 150.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.648 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 1.2 ptp -146.56 159.65 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.667 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -127.65 141.17 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.366 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -118.14 145.66 44.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 111.359 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 87.51 1.32 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.74 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 16.7 m -121.42 149.01 43.65 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.4 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.701 ' HD2' HD13 ' B' ' 103' ' ' ILE . 1.9 p90 -124.44 142.88 50.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.957 0.408 . . . . 0.0 111.153 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.773 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 64.1 m-80 -109.4 126.78 53.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.701 HD13 ' HD2' ' B' ' 101' ' ' PHE . 0.9 OUTLIER -129.64 121.11 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.866 0.365 . . . . 0.0 110.756 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.99 165.97 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.683 179.666 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.677 -0.169 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' C' ' 1' ' ' GLY . 17.8 t70 71.12 130.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.96 0.409 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -108.49 -74.26 0.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.861 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.94 22.16 1.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.011 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -115.39 145.33 42.64 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.748 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . 0.548 ' HB3' ' CE1' ' C' ' 8' ' ' HIS . 17.8 m95 -107.0 -52.96 2.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.75 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m 59.31 61.92 1.93 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.977 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.697 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 35.0 m80 -85.96 -49.76 0.52 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.761 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.697 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -67.73 110.07 2.03 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.436 2.091 . . . . 0.0 111.93 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -110.27 -58.35 2.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.947 0.403 . . . . 0.0 111.117 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.46 ' HD1' ' H ' ' C' ' 13' ' ' LYS . 55.0 p90 -109.84 172.71 6.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.654 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.75 12.97 5.85 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.455 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.46 ' H ' ' HD1' ' C' ' 11' ' ' PHE . 0.0 OUTLIER -63.99 -39.13 93.44 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.453 -179.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.68 -29.88 72.78 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.241 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . 0.417 ' O ' ' HD2' ' C' ' 19' ' ' ARG . . . -70.81 -57.67 4.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -57.5 -29.03 63.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.926 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.584 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER -68.25 -52.26 36.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.591 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -69.0 -20.27 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.297 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' C' ' 15' ' ' ALA . 14.6 mtt-85 -70.73 -60.33 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.529 HE22 HD12 ' B' ' 21' ' ' LEU . 4.4 pp0? -73.1 -17.4 61.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.177 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 0.8 OUTLIER -67.73 -49.81 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.558 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -73.45 -28.16 61.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.99 -51.52 46.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -62.52 -44.78 95.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.722 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.52 -50.34 73.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.611 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -59.15 -39.48 82.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.806 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' C' ' 31' ' ' ARG . 12.9 ttpp -60.44 -34.16 73.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.204 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -41.98 81.21 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.29 -25.11 64.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.987 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.447 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 1.3 m -79.54 -41.03 28.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.853 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.651 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.4 mpt_? -68.91 -35.87 77.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.28 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 19.0 m -77.58 -32.18 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -66.74 -44.79 80.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.045 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.651 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 4.2 ptpt -77.83 -31.68 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.48 -35.31 68.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mt -74.79 -27.82 60.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.113 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.24 -46.33 16.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.452 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.538 ' OG ' ' HB2' ' C' ' 88' ' ' ALA . 48.5 t -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.756 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.512 ' OG ' ' HB1' ' B' ' 40' ' ' ALA . 37.6 t -67.47 -52.96 33.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.504 ' HB1' ' OG ' ' A' ' 39' ' ' SER . . . -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.475 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . . . -65.86 -38.37 88.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 21.6 tp -79.28 -33.69 43.18 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 57.6 m-20 -73.6 -13.62 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' SER . . . . . 0.488 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 30.4 t -71.63 -19.23 62.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.154 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.588 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.0 mm? -80.51 157.78 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.836 177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.431 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 8.1 p90 -145.98 -10.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.172 0.51 . . . . 0.0 111.703 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.516 ' HG2' HG22 ' C' ' 57' ' ' THR . 5.1 mt-30 73.53 121.12 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.932 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 10.0 Cg_endo -77.66 101.08 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.657 2.238 . . . . 0.0 112.57 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.494 ' HH ' ' H ' ' A' ' 50' ' ' GLY . 18.4 m-30 62.12 -170.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.963 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.5 ' H ' ' HH ' ' B' ' 49' ' ' TYR . . . 163.1 60.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.251 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.4 p -69.92 -18.88 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.258 0.623 . . . . 0.0 112.383 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.742 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.01 51.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.356 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 -157.03 0.76 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.594 0.235 . . . . 0.0 110.591 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.518 HG23 ' N ' ' C' ' 55' ' ' ASN . 2.8 p -120.8 145.18 27.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.518 ' N ' HG23 ' C' ' 54' ' ' VAL . 11.5 m-80 -126.82 121.99 33.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.977 0.418 . . . . 0.0 111.696 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . 0.415 ' CE2' HD12 ' C' ' 71' ' ' ILE . 22.3 t80 -84.23 124.47 31.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.272 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.588 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 72.3 p -106.98 120.63 42.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.999 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.84 137.53 20.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.422 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . 178.05 165.49 32.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' C' ' 69' ' ' LEU . 30.5 m -121.18 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.0 -179.41 38.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.521 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -158.1 134.2 3.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.552 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.632 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 26.1 t80 -124.95 124.23 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.091 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 73.4 p -146.02 16.88 1.39 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.82 49.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.32 145.44 47.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.43 172.08 13.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.496 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.0 tt -123.41 145.23 48.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.79 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' C' ' 41' ' ' ALA . . . -132.23 119.62 21.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.653 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' C' ' 56' ' ' PHE . 8.1 tp -118.67 152.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.188 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.98 -172.17 44.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.57 158.11 6.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.19 177.74 22.63 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.236 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.581 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 34.8 t80 -138.14 132.69 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 14.0 ttm180 -126.49 117.3 22.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.742 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.9 p -106.13 138.83 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 78.8 m-20 68.92 -92.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 111.076 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 14.8 pt-20 172.95 -24.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.593 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -78.49 -52.27 8.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.0 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.37 137.42 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -144.61 163.77 32.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.236 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 34.3 tp -158.87 154.27 25.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.595 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.433 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 10.8 tmtt? -159.58 133.94 7.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.13 18.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.81 -174.47 42.8 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.572 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.441 HG21 ' O ' ' C' ' 96' ' ' MET . 8.0 p -130.27 139.55 51.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.125 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.538 ' HB2' ' OG ' ' C' ' 38' ' ' SER . . . -113.09 136.49 52.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.346 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.21 51.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' C' ' 34' ' ' LYS . . . -131.62 135.72 47.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.603 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.544 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.75 -123.34 30.25 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 33.3 m -138.52 9.61 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.53 32.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.193 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.26 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.27 150.61 11.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.646 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 1.2 ptp -146.59 159.68 43.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.685 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.7 141.14 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -118.08 145.7 44.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.708 0.289 . . . . 0.0 111.415 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.54 1.31 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 16.7 m -121.4 148.98 43.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.449 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.7 ' HD2' HD13 ' C' ' 103' ' ' ILE . 1.8 p90 -124.41 142.87 50.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 111.04 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.771 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 64.0 m-80 -109.43 126.73 53.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.38 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.7 HD13 ' HD2' ' C' ' 101' ' ' PHE . 1.0 OUTLIER -129.62 121.06 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.77 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.96 165.95 19.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.665 179.694 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.964 ' N ' ' HD1' ' B' ' 11' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.686 -0.166 . . . . 0.0 112.686 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.39 148.44 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.969 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -47.71 84.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.815 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.29 148.09 45.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.598 ' OG ' ' HB2' ' A' ' 8' ' ' HIS . 21.4 t -100.96 149.11 24.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.802 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -130.67 75.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.77 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.3 t 73.94 55.22 0.1 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.002 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.598 ' HB2' ' OG ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -96.53 -45.16 0.25 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.768 -178.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -53.75 113.76 1.47 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.424 2.082 . . . . 0.0 111.919 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -82.66 -172.87 4.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.976 0.417 . . . . 0.0 111.113 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.962 ' HD1' ' N ' ' C' ' 1' ' ' GLY . 12.5 t80 -127.1 -31.72 2.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.658 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.59 -69.89 0.29 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.5 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -105.19 -19.89 13.67 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.479 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.03 -46.29 93.78 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.244 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . -62.34 -33.7 75.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.918 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -70.31 -37.03 74.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.985 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 2.8 mmpt? -67.15 -53.11 33.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.523 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.68 -31.28 70.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.247 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 19.8 ttp180 -63.07 -58.69 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.18 83.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.117 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.403 HD23 HD12 ' C' ' 21' ' ' LEU . 12.1 mt -60.0 -47.49 85.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.559 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -66.81 -32.25 73.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.093 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.53 -42.31 95.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.53 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.733 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.62 -33.42 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -73.73 -41.2 62.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -63.02 -42.06 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.285 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' C' ' 29' ' ' ASP . 0.2 OUTLIER -62.9 -50.35 71.22 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.483 ' HB2' HD23 ' B' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.14 61.43 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.912 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.15 -40.65 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.472 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.6 mpt_? -60.87 -32.56 71.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.316 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 6.4 m -80.12 -28.94 12.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.216 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -51.88 61.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 20.3 pttt -74.13 -39.28 63.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.751 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.32 -36.21 92.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.534 HD23 ' HG ' ' B' ' 36' ' ' LEU . 5.9 mt -73.53 -31.16 63.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.068 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.91 -45.29 36.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.457 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.475 ' HB3' ' HE2' ' A' ' 96' ' ' MET . 22.7 t -63.86 -44.89 91.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.8 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.536 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 11.5 t -59.13 -46.47 88.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.631 ' HB1' ' OD1' ' B' ' 98' ' ' ASN . . . -67.26 -29.04 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . . . -65.13 -39.88 93.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.06 -38.9 51.69 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -72.12 -15.94 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 t -66.58 -32.92 74.56 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.15 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' B' ' 100' ' ' SER . 1.0 OUTLIER -64.21 143.66 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.881 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.492 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 35.0 p90 -112.69 -42.53 3.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.11 0.481 . . . . 0.0 111.677 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 33.8 mt-30 70.26 109.43 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.948 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.545 ' HD3' ' ND2' ' B' ' 102' ' ' ASN 0.256 9.8 Cg_endo -75.25 -161.16 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.617 2.211 . . . . 0.0 112.576 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 17.5 m-30 68.16 167.02 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.962 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.4 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.193 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' HA ' ' HG3' ' A' ' 79' ' ' GLU . 9.6 p -88.84 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.198 0.599 . . . . 0.0 112.4 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.39 69.1 0.01 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.261 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -143.79 -178.16 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.619 0.247 . . . . 0.0 110.561 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG12 ' CE3' ' B' ' 105' ' ' TRP . 10.1 p -119.02 142.17 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' N ' HG22 ' A' ' 54' ' ' VAL . 1.7 m-80 -125.0 178.08 5.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.62 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.572 ' HB2' ' CH2' ' B' ' 105' ' ' TRP . 11.3 t80 -151.48 143.39 23.82 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.531 ' HB ' HD21 ' A' ' 45' ' ' LEU . 30.2 p -117.3 142.08 47.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.953 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -177.5 127.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.463 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -179.34 -165.27 33.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.04 154.61 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.367 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 41' ' ' ALA . . . -134.43 171.72 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.504 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 66' ' ' SER . . . -156.73 141.31 7.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.571 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.409 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 84.4 t80 -135.56 110.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.697 0.284 . . . . 0.0 110.74 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 28.0 mtt180 66.28 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.128 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 37.86 1.33 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.122 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' HA2' ' A' ' 62' ' ' GLY . 32.1 t -134.77 157.68 46.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.67 148.31 40.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.42 173.06 14.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tp -124.75 126.66 46.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.702 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.44 ' HB3' ' HB1' ' A' ' 88' ' ' ALA . . . -117.51 163.32 16.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 57' ' ' THR . 2.3 tt -158.71 176.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.77 34.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.462 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 p -164.13 160.03 20.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.45 176.26 29.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.217 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.498 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 5.0 t80 -143.27 127.0 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 111.159 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.483 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.63 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 7.2 p -83.2 127.41 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.284 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.588 ' OD1' HG21 ' A' ' 77' ' ' VAL . 31.3 m120 61.15 162.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 51' ' ' VAL . 32.5 mt-10 -99.48 39.1 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.569 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.31 -52.21 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.25 169.85 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.53 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.53 165.24 12.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 111.29 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -139.25 168.73 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.564 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 85' ' ' ALA . 2.0 tmtp? -157.73 122.85 4.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -132.6 161.04 34.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.32 158.57 18.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.605 HG11 ' CZ ' ' A' ' 89' ' ' TYR . 7.0 p -124.91 130.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.522 ' HB3' ' HE2' ' A' ' 96' ' ' MET . . . -102.05 115.04 29.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.355 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.605 ' CZ ' HG11 ' A' ' 87' ' ' VAL . 77.9 m-85 -91.7 108.8 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -115.02 124.11 50.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.659 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.05 -85.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.67 -50.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.319 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.0 m -104.35 14.43 30.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.624 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 4.0 t70 -116.43 57.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -95.2 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.747 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 39' ' ' SER . 2.9 ptp -146.77 151.44 37.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -130.34 138.21 50.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.422 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.632 ' OD1' ' HB1' ' C' ' 40' ' ' ALA . 8.3 m-80 -132.56 137.15 47.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 111.404 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.32 95.64 2.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.716 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.572 ' HB3' HD13 ' C' ' 45' ' ' LEU . 29.6 m -125.95 161.5 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 8.6 p90 -127.67 145.48 50.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.027 0.442 . . . . 0.0 111.044 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.543 ' ND2' ' HD3' ' C' ' 48' ' ' PRO . 1.8 p-10 -120.0 153.08 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.86 134.91 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.856 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' C' ' 49' ' ' TYR . 18.2 pm0 -120.01 132.47 55.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.937 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.577 ' CH2' ' HB2' ' C' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.618 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.978 ' N ' ' HD1' ' C' ' 11' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.669 -0.173 . . . . 0.0 112.669 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.3 148.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.956 0.408 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -47.67 84.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.822 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.26 148.01 45.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.042 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.605 ' OG ' ' HB2' ' B' ' 8' ' ' HIS . 21.4 t -100.85 149.11 24.2 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.805 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -130.68 75.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.728 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 5.3 t 73.92 55.14 0.1 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.022 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.605 ' HB2' ' OG ' ' B' ' 5' ' ' SER . 0.2 OUTLIER -96.42 -45.18 0.25 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.82 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -53.73 113.71 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.409 2.073 . . . . 0.0 111.928 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -82.56 -172.85 4.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.957 0.408 . . . . 0.0 111.148 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.964 ' HD1' ' N ' ' A' ' 1' ' ' GLY . 12.5 t80 -127.16 -31.71 2.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.667 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.55 -69.94 0.28 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.482 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -105.17 -19.95 13.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.468 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.97 -46.33 93.76 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.288 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' B' ' 19' ' ' ARG . . . -62.24 -33.78 75.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.375 . . . . 0.0 110.963 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 5' ' ' SER . 14.6 m-70 -70.28 -37.04 74.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.011 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.534 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 2.8 mmpt? -67.17 -53.11 33.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.566 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -68.66 -31.25 70.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.259 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' B' ' 15' ' ' ALA . 19.8 ttp180 -63.11 -58.71 6.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.769 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -36.19 83.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.406 HD12 HD23 ' C' ' 21' ' ' LEU . 12.1 mt -60.04 -47.47 85.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.601 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -66.81 -32.26 73.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.836 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.48 34.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.757 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.74 -33.34 72.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.632 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -73.73 -41.24 62.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.802 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -63.02 -42.08 99.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.241 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -62.89 -50.26 71.59 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.491 ' HB2' HD23 ' C' ' 28' ' ' LEU . 0.8 OUTLIER -56.61 -29.16 61.83 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.942 178.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.11 -40.57 37.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.863 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.47 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.6 mpt_? -60.81 -32.68 72.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 6.4 m -80.06 -28.98 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.172 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -51.94 61.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 20.3 pttt -73.96 -39.44 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.717 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.35 -36.15 92.34 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.534 ' HG ' HD23 ' A' ' 36' ' ' LEU . 5.8 mt -73.54 -31.18 63.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.787 0.327 . . . . 0.0 111.045 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.08 -45.17 35.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.379 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.466 ' HB3' ' HE2' ' B' ' 96' ' ' MET . 22.7 t -63.9 -44.87 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.537 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 11.5 t -59.17 -46.46 88.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.619 ' HB1' ' OD1' ' C' ' 98' ' ' ASN . . . -67.2 -29.07 68.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.483 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.442 ' HB3' ' HA3' ' B' ' 61' ' ' GLY . . . -65.11 -39.89 93.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.01 -39.0 51.89 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -72.01 -15.97 62.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.6 -32.96 74.63 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.08 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.573 HD13 ' HB3' ' C' ' 100' ' ' SER . 1.0 OUTLIER -64.29 143.71 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.929 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 34.6 p90 -112.73 -42.48 3.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.467 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' B' ' 46' ' ' PHE . 33.8 mt-30 70.29 109.47 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' ND2' ' C' ' 102' ' ' ASN 0.257 9.8 Cg_endo -75.3 -161.15 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.632 2.222 . . . . 0.0 112.61 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 17.5 m-30 68.16 167.05 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.969 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' B' ' 76' ' ' ARG . . . 178.37 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.201 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.482 ' HA ' ' HG3' ' B' ' 79' ' ' GLU . 9.7 p -88.83 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.187 0.595 . . . . 0.0 112.409 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.34 69.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.317 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -143.79 -178.1 5.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.508 ' HB ' ' CE2' ' B' ' 75' ' ' TYR . 10.1 p -119.08 142.14 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.537 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.483 ' N ' HG22 ' B' ' 54' ' ' VAL . 1.7 m-80 -124.99 178.03 5.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.657 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.583 ' HB2' ' CH2' ' C' ' 105' ' ' TRP . 11.4 t80 -151.42 143.46 23.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.276 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.52 ' HB ' HD21 ' B' ' 45' ' ' LEU . 30.2 p -117.38 142.09 47.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.93 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -177.52 127.81 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.479 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -179.26 -165.17 33.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.08 154.61 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 111.343 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' B' ' 41' ' ' ALA . . . -134.4 171.77 22.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.487 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' B' ' 66' ' ' SER . . . -156.77 141.3 7.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.409 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 84.2 t80 -135.59 110.84 8.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.124 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.65 37.86 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.438 ' O ' ' HA2' ' B' ' 62' ' ' GLY . 32.0 t -134.83 157.62 46.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.64 148.32 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.139 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.03 15.04 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tp -124.67 126.73 46.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.756 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.436 ' HB3' ' HB1' ' B' ' 88' ' ' ALA . . . -117.58 163.37 16.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.623 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.473 HG13 ' O ' ' B' ' 57' ' ' THR . 2.3 tt -158.78 176.04 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.154 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.62 -167.82 34.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.36 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 16.6 p -164.16 160.04 20.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.46 176.37 29.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.158 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 5.0 t80 -143.36 126.9 16.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 111.17 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.47 ' O ' ' HA2' ' B' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.33 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.628 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 7.3 p -83.26 127.44 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.592 ' OD1' HG21 ' B' ' 77' ' ' VAL . 31.3 m120 61.04 162.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.482 ' HG3' ' HA ' ' B' ' 51' ' ' VAL . 32.5 mt-10 -99.47 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.6 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.25 -52.23 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.29 169.83 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.57 165.21 12.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.22 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' B' ' 101' ' ' PHE . 0.6 OUTLIER -139.16 168.75 19.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.54 ' HD3' ' N ' ' B' ' 85' ' ' ALA . 2.0 tmtp? -157.8 122.89 4.43 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.54 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -132.65 161.01 35.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.11 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.63 18.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.633 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.612 HG11 ' CZ ' ' B' ' 89' ' ' TYR . 7.1 p -124.97 130.69 73.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.347 . . . . 0.0 111.149 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.508 ' HB3' ' HE2' ' B' ' 96' ' ' MET . . . -102.03 115.15 29.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.32 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . 0.612 ' CZ ' HG11 ' B' ' 87' ' ' VAL . 77.7 m-85 -91.72 108.82 20.18 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.194 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.626 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . . . -115.12 124.15 50.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.08 -85.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.282 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.61 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.391 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.4 14.33 30.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.164 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.626 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 3.9 t70 -116.31 57.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.958 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' B' ' 89' ' ' TYR . 0.3 OUTLIER -95.26 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.699 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.537 ' SD ' ' HB2' ' B' ' 39' ' ' SER . 2.9 ptp -146.79 151.41 37.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.722 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -130.21 138.21 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.447 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.631 ' OD1' ' HB1' ' A' ' 40' ' ' ALA . 8.3 m-80 -132.58 137.22 47.0 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.781 0.324 . . . . 0.0 111.409 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.46 95.77 2.72 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.684 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.577 ' HB3' HD13 ' A' ' 45' ' ' LEU . 29.3 m -126.0 161.39 27.64 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.396 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 8.6 p90 -127.6 145.54 50.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.969 0.414 . . . . 0.0 111.049 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.545 ' ND2' ' HD3' ' A' ' 48' ' ' PRO . 1.8 p-10 -120.07 152.92 36.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.4 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.79 135.01 61.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.483 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 18.2 pm0 -120.08 132.46 55.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . 0.572 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.606 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.962 ' N ' ' HD1' ' A' ' 11' ' ' PHE . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 t0 71.35 148.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -47.66 84.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.35 148.04 45.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.016 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' SER . . . . . 0.604 ' OG ' ' HB2' ' C' ' 8' ' ' HIS . 21.2 t -100.87 149.06 24.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.855 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -130.66 75.22 1.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.743 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 5.2 t 73.88 55.16 0.1 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.052 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.604 ' HB2' ' OG ' ' C' ' 5' ' ' SER . 0.2 OUTLIER -96.46 -45.13 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.809 -178.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -53.77 113.73 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.424 2.083 . . . . 0.0 111.94 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -82.6 -172.86 4.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.943 0.402 . . . . 0.0 111.142 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.978 ' HD1' ' N ' ' B' ' 1' ' ' GLY . 12.6 t80 -127.12 -31.75 2.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.659 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.56 -69.9 0.29 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.476 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -105.12 -19.98 13.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.563 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.05 -46.23 93.87 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.332 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' C' ' 19' ' ' ARG . . . -62.29 -33.76 75.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 110.909 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' B' ' 5' ' ' SER . 14.6 m-70 -70.3 -36.99 74.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.513 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 2.8 mmpt? -67.28 -53.02 33.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.55 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.72 -31.29 70.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' C' ' 15' ' ' ALA . 19.8 ttp180 -63.04 -58.7 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.79 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -36.21 83.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.406 HD23 HD12 ' B' ' 21' ' ' LEU . 12.1 mt -59.93 -47.48 85.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -66.91 -32.27 73.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.028 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -74.4 -47.53 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.751 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.63 -33.42 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.625 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -73.66 -41.3 62.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -62.98 -42.11 99.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.267 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.491 HD23 ' HB2' ' B' ' 29' ' ' ASP . 0.2 OUTLIER -62.8 -50.35 71.34 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.478 ' HB2' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.18 61.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.961 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 m -78.08 -40.62 37.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.475 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.6 mpt_? -60.84 -32.62 72.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' C' ' 36' ' ' LEU . 6.5 m -80.07 -28.92 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -51.76 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 20.3 pttt -74.08 -39.32 63.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.815 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.13 92.24 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.527 ' HG ' HD23 ' B' ' 36' ' ' LEU . 5.8 mt -73.55 -31.18 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.328 . . . . 0.0 111.085 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.21 35.97 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.429 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.479 ' HB3' ' HE2' ' C' ' 96' ' ' MET . 22.9 t -63.95 -44.88 91.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.736 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.54 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 11.6 t -59.12 -46.46 88.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.632 ' HB1' ' OD1' ' A' ' 98' ' ' ASN . . . -67.31 -29.04 68.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.444 ' HB3' ' HA3' ' C' ' 61' ' ' GLY . . . -65.13 -39.85 93.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.06 -38.92 51.62 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -72.12 -15.99 61.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.59 -32.92 74.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 100' ' ' SER . 1.0 OUTLIER -64.24 143.74 57.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.888 177.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 34.6 p90 -112.78 -42.46 3.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.121 0.486 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' C' ' 46' ' ' PHE . 33.8 mt-30 70.3 109.44 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.958 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.543 ' HD3' ' ND2' ' A' ' 102' ' ' ASN 0.257 9.9 Cg_endo -75.24 -161.2 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.707 2.272 . . . . 0.0 112.633 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.482 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 17.5 m-30 68.1 167.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.4 -3.19 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.194 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.496 ' HA ' ' HG3' ' C' ' 79' ' ' GLU . 9.5 p -88.86 -34.72 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.136 0.574 . . . . 0.0 112.393 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.34 69.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.306 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -143.72 -178.11 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.539 0.209 . . . . 0.0 110.642 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.504 HG12 ' CE3' ' A' ' 105' ' ' TRP . 10.2 p -119.04 142.12 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.533 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.465 ' N ' HG22 ' C' ' 54' ' ' VAL . 1.7 m-80 -124.94 178.1 5.69 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.695 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . 0.577 ' HB2' ' CH2' ' A' ' 105' ' ' TRP . 11.2 t80 -151.46 143.38 23.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.231 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.514 ' HB ' HD21 ' C' ' 45' ' ' LEU . 30.1 p -117.31 142.1 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -177.54 127.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.486 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -179.28 -165.26 33.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.551 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.0 154.7 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 111.368 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' C' ' 41' ' ' ALA . . . -134.46 171.73 22.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.472 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' C' ' 66' ' ' SER . . . -156.79 141.25 7.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.575 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 84.3 t80 -135.5 110.83 9.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.334 . . . . 0.0 110.728 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.79 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.168 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.68 37.82 1.34 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.142 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' SER . . . . . 0.45 ' O ' ' HA2' ' C' ' 62' ' ' GLY . 32.1 t -134.8 157.69 46.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.83 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.76 148.31 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.38 173.03 15.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.602 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 8.3 tp -124.69 126.61 45.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.766 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.422 ' HB3' ' HB1' ' C' ' 88' ' ' ALA . . . -117.52 163.27 16.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.694 0.283 . . . . 0.0 111.683 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.467 HG13 ' O ' ' C' ' 57' ' ' THR . 2.3 tt -158.64 176.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.318 . . . . 0.0 111.105 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.79 34.69 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.466 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.0 p -164.09 160.05 21.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.038 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.47 176.35 29.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.234 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.498 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 5.0 t80 -143.32 126.94 16.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 111.151 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.474 ' O ' ' HA2' ' C' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.736 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.617 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 7.3 p -83.19 127.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.998 0.427 . . . . 0.0 111.291 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.598 ' OD1' HG21 ' C' ' 77' ' ' VAL . 31.3 m120 61.14 162.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.088 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' C' ' 51' ' ' VAL . 32.5 mt-10 -99.49 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 2.6 m -121.33 -52.17 2.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.987 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.2 169.82 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.572 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.5 165.23 12.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' C' ' 101' ' ' PHE . 0.6 OUTLIER -139.19 168.79 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.626 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 2.0 tmtp? -157.85 122.76 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . 0.524 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -132.53 161.04 34.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.66 19.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.552 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.607 HG11 ' CZ ' ' C' ' 89' ' ' TYR . 7.0 p -124.93 130.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.523 ' HB3' ' HE2' ' C' ' 96' ' ' MET . . . -102.0 115.07 29.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.307 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . 0.607 ' CZ ' HG11 ' C' ' 87' ' ' VAL . 77.8 m-85 -91.72 108.73 20.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' C' ' 94' ' ' ASP . . . -114.98 124.14 50.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.6 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -85.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.263 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 82.8 p -166.67 -50.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.309 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.35 14.35 30.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.221 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 4.0 t70 -116.42 57.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' C' ' 89' ' ' TYR . 0.3 OUTLIER -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.696 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.54 ' SD ' ' HB2' ' C' ' 39' ' ' SER . 2.9 ptp -146.78 151.38 37.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.711 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -130.2 138.29 50.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.439 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.619 ' OD1' ' HB1' ' B' ' 40' ' ' ALA . 8.2 m-80 -132.63 137.06 46.88 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.31 95.66 2.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.573 ' HB3' HD13 ' B' ' 45' ' ' LEU . 28.7 m -125.88 161.44 27.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.474 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' C' ' 83' ' ' LEU . 8.6 p90 -127.6 145.51 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.956 0.408 . . . . 0.0 111.085 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.54 ' ND2' ' HD3' ' B' ' 48' ' ' PRO . 1.8 p-10 -120.08 152.98 36.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.387 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.79 135.01 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.49 ' HB2' ' CE2' ' B' ' 49' ' ' TYR . 18.3 pm0 -120.1 132.45 55.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . 0.583 ' CH2' ' HB2' ' B' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.59 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 6.0 t70 83.75 134.23 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.885 0.374 . . . . 0.0 111.012 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -129.36 -69.46 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.31 35.57 0.65 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 p -96.42 155.08 16.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.758 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -102.04 -79.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.731 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.0 m 55.59 40.68 31.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.993 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.798 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 35.6 m170 -76.1 -53.02 2.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.859 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.798 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -58.45 118.66 5.58 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.51 2.14 . . . . 0.0 111.895 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -106.86 -66.69 1.0 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.965 0.412 . . . . 0.0 111.207 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -112.51 177.24 4.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.709 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.89 25.69 0.56 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.476 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -45.21 17.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.486 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.05 -32.34 79.95 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.285 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.02 95.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 0.0 110.856 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -75.53 -40.01 57.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.006 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -62.35 -34.68 77.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.514 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.82 -38.78 70.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.301 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.16 -61.81 1.83 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.27 -30.14 59.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.1 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.623 HD23 HD23 ' C' ' 21' ' ' LEU . 2.6 tm? -64.62 -60.46 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.603 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -65.03 -23.77 67.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -63.91 -54.12 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.3 mtp85 -69.78 -37.94 76.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.792 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HG ' ' HE ' ' B' ' 24' ' ' ARG . 3.6 mm? -63.88 -44.71 92.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.605 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.89 -33.19 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HG2' ' HD3' ' A' ' 31' ' ' ARG . 1.2 ttpp -67.91 -37.66 81.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.212 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -45.48 81.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -60.12 -36.55 77.73 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.859 179.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.86 -30.35 56.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.517 ' HD3' ' HG2' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -78.47 -27.18 46.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.28 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 29' ' ' ASP . 27.3 m -84.61 -32.39 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.21 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.504 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 55.6 m-20 -69.0 -43.91 73.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.989 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 5.0 ptpt -84.46 -30.22 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.0 -41.73 86.82 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.422 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.618 HD21 ' HG ' ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.81 -22.82 42.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.712 ' HB3' ' HA2' ' A' ' 62' ' ' GLY . . . -76.61 -39.77 51.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.419 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.925 ' HB3' ' HE1' ' A' ' 96' ' ' MET . 8.6 t -77.64 -39.86 43.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.745 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.42 ' HG ' ' HB1' ' C' ' 40' ' ' ALA . 0.9 OUTLIER -60.06 -55.46 33.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB3' HD22 ' B' ' 98' ' ' ASN . . . -58.87 -39.16 80.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.374 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.47 71.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.958 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 28.3 tp -76.62 -42.21 43.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.093 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' HB3' ' CB ' ' C' ' 43' ' ' ASN . 32.4 m-20 -70.63 -9.86 57.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.486 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 41.7 t -69.26 -20.65 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.1 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.3 mm? -83.05 169.93 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.833 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.4 -1.66 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 0.0 111.727 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.58 ' OE1' ' HG2' ' A' ' 84' ' ' LYS . 6.0 mt-30 68.49 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.967 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -78.82 109.16 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.56 2.174 . . . . 0.0 112.527 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 59.57 177.48 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.74 50.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.191 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.7 p -71.58 -1.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.166 0.586 . . . . 0.0 112.407 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 143.63 53.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.254 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 -165.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.572 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 74' ' ' GLY . 9.9 p -114.7 142.17 28.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.534 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 47' ' ' GLN . 12.8 m-80 -122.03 118.73 29.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 111.756 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.52 ' CE2' HD12 ' A' ' 71' ' ' ILE . 30.1 t80 -84.84 131.67 34.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.267 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.492 HG23 ' HB3' ' A' ' 45' ' ' LEU . 40.9 p -113.72 121.2 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.9 136.99 18.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.486 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.15 166.51 33.58 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.555 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.0 m -116.43 158.13 17.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 111.304 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.98 -171.43 13.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.484 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.712 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -168.2 141.48 6.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.615 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.516 ' CE1' ' HE2' ' B' ' 96' ' ' MET . 52.0 t80 -135.81 133.06 37.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 0.0 110.789 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 3.1 mmm180 69.52 -94.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 p -144.67 29.22 1.25 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.408 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 5.1 m -135.9 141.72 44.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.73 157.9 17.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.129 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.72 169.04 20.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.572 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.62 54.58 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.735 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -126.52 139.2 53.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.677 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.52 HD12 ' CE2' ' A' ' 56' ' ' PHE . 10.7 tp -141.07 147.91 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.763 0.316 . . . . 0.0 111.128 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.42 -179.68 42.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.402 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.403 ' HB2' ' HA ' ' A' ' 56' ' ' PHE . 1.2 p -166.76 158.59 13.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.496 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -148.23 171.7 28.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.216 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 39.6 t80 -126.37 138.58 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 0.0 111.113 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.558 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 13.7 ttm180 -131.41 134.7 46.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.581 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.8 p -120.9 140.86 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.318 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.0 m-20 64.79 -94.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.072 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.606 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -73.35 -63.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.27 139.64 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.558 ' HB2' ' HG3' ' A' ' 76' ' ' ARG . . . -138.29 156.15 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.532 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 30.3 tp -136.93 141.75 42.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.621 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.58 ' HG2' ' OE1' ' A' ' 47' ' ' GLN . 7.9 tmtt? -153.39 128.71 9.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.71 175.86 11.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.06 -173.45 34.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.593 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' ILE . 7.7 p -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 111.131 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.6 144.68 41.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.329 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.6 120.48 40.31 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.244 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 34' ' ' LYS . . . -127.8 131.07 49.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.605 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.21 -114.44 5.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.301 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.8 m -150.42 17.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.709 0.29 . . . . 0.0 111.331 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -167.24 19.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.192 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 34.0 m-20 -119.44 67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.31 138.01 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.043 0.449 . . . . 0.0 110.75 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.925 ' HE1' ' HB3' ' A' ' 38' ' ' SER . 4.4 ptp -134.84 134.62 40.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.684 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.81 122.46 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.403 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.517 HD22 ' HB3' ' C' ' 40' ' ' ALA . 15.5 m120 -108.24 150.51 27.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 0.0 111.389 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.47 90.58 0.48 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 19.3 m -118.98 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.465 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.43 135.06 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 111.059 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.718 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 73.9 m-80 -102.17 134.39 45.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.78 115.29 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.774 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.404 ' HB3' ' HA ' ' C' ' 55' ' ' ASN . 0.0 OUTLIER -115.29 157.42 23.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 30.3 m-90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.674 179.678 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 6.0 t70 83.72 134.23 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -129.4 -69.48 0.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.26 35.56 0.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 49.4 p -96.39 155.03 16.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.799 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -101.94 -79.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.748 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 68.4 m 55.48 40.69 31.26 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.045 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.808 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 35.6 m170 -76.16 -53.04 2.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.777 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.808 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -58.38 118.62 5.54 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.489 2.126 . . . . 0.0 111.933 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -106.87 -66.75 0.99 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 111.125 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -112.48 177.23 4.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.689 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.88 25.73 0.56 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.463 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -45.29 17.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.468 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.05 -32.33 79.9 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.292 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.1 94.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.898 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.54 -40.05 57.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.981 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.3 OUTLIER -62.28 -34.71 77.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.533 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.77 -38.87 70.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.275 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.1 -61.83 1.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.24 -30.1 59.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.119 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.614 HD23 HD23 ' A' ' 21' ' ' LEU . 2.6 tm? -64.69 -60.44 3.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.592 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -65.06 -23.73 67.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -63.87 -54.15 39.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.942 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.494 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.4 mtp85 -69.79 -37.97 76.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.747 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.498 ' HG ' ' HE ' ' C' ' 24' ' ' ARG . 3.5 mm? -63.85 -44.67 92.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.661 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.97 -33.15 75.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.522 ' HG2' ' HD3' ' B' ' 31' ' ' ARG . 1.2 ttpp -67.95 -37.59 81.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.227 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.401 ' O ' HG12 ' B' ' 32' ' ' VAL . 0.0 OUTLIER -65.97 -45.52 81.42 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.583 ' O ' HG22 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -60.15 -36.49 77.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.939 178.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.94 -30.27 55.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.522 ' HD3' ' HG2' ' B' ' 27' ' ' LYS . 0.1 OUTLIER -78.42 -27.27 46.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.347 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 29' ' ' ASP . 27.4 m -84.65 -32.3 7.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.206 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.505 ' O ' ' HB1' ' B' ' 37' ' ' ALA . 55.8 m-20 -69.04 -43.9 73.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.989 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.615 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 4.9 ptpt -84.44 -30.24 25.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.765 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.75 87.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.435 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.618 ' HG ' HD21 ' A' ' 36' ' ' LEU . 1.0 OUTLIER -79.88 -22.85 42.37 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.723 ' HB3' ' HA2' ' B' ' 62' ' ' GLY . . . -76.61 -39.75 51.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.465 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.92 ' HB3' ' HE1' ' B' ' 96' ' ' MET . 8.6 t -77.56 -39.96 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.417 ' HG ' ' HB1' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -59.89 -55.56 32.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.515 ' HB3' HD22 ' C' ' 98' ' ' ASN . . . -58.92 -39.09 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.363 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.46 71.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.5 ' HA ' HD11 ' B' ' 42' ' ' LEU . 28.1 tp -76.63 -42.16 43.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.429 ' HB3' ' CB ' ' A' ' 43' ' ' ASN . 32.5 m-20 -70.67 -9.87 58.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.471 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 41.6 t -69.38 -20.51 63.82 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.107 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.52 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.3 mm? -83.09 169.85 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.849 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.29 -1.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.191 0.52 . . . . 0.0 111.665 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.592 ' OE1' ' HG2' ' B' ' 84' ' ' LYS . 6.0 mt-30 68.54 116.95 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.984 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.733 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.69 109.0 2.53 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.723 2.282 . . . . 0.0 112.557 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.81 50.72 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.31 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.8 p -71.5 -1.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.158 0.583 . . . . 0.0 112.412 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 143.65 53.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.265 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.8 -165.26 1.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 110.653 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.497 HG23 ' O ' ' B' ' 74' ' ' GLY . 9.9 p -114.71 142.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.584 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' B' ' 47' ' ' GLN . 12.9 m-80 -122.03 118.76 29.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.703 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.521 ' CE2' HD12 ' B' ' 71' ' ' ILE . 30.2 t80 -84.86 131.63 34.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.226 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.489 HG23 ' HB3' ' B' ' 45' ' ' LEU . 40.9 p -113.72 121.25 43.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.976 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.87 137.02 18.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.447 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.13 166.43 33.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.576 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' B' ' 69' ' ' LEU . 7.0 m -116.32 158.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.816 0.341 . . . . 0.0 111.388 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.5 13.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.41 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.723 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -168.08 141.43 6.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.622 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.524 ' CE1' ' HE2' ' C' ' 96' ' ' MET . 52.1 t80 -135.73 133.17 37.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.739 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 3.1 mmm180 69.5 -94.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 15.2 p -144.67 29.23 1.25 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.138 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 5.1 m -136.0 141.72 44.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.69 157.93 17.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.094 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.76 169.03 20.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.578 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.66 54.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.751 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.684 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' B' ' 56' ' ' PHE . 10.7 tp -140.97 147.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.41 -179.62 42.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' B' ' 56' ' ' PHE . 1.2 p -166.87 158.6 12.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.497 ' O ' HG23 ' B' ' 54' ' ' VAL . . . -148.25 171.69 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.531 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 39.7 t80 -126.3 138.61 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 111.197 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.559 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 13.7 ttm180 -131.44 134.72 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.58 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.8 p -120.98 140.87 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.256 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 97.1 m-20 64.73 -94.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.916 0.389 . . . . 0.0 111.111 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 5.6 pt-20 177.11 -23.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 23.9 p -73.39 -63.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.013 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.3 139.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' B' ' 76' ' ' ARG . . . -138.36 156.1 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.316 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.531 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 30.2 tp -136.91 141.76 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.621 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.592 ' HG2' ' OE1' ' B' ' 47' ' ' GLN . 8.0 tmtt? -153.42 128.68 9.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.148 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.81 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.14 -173.43 34.06 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' B' ' 71' ' ' ILE . 7.7 p -141.56 143.47 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.65 144.7 41.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.373 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -114.61 120.51 40.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.266 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' B' ' 34' ' ' LYS . . . -127.85 130.94 49.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.649 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.615 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.37 -114.43 5.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.287 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -150.51 17.44 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.802 0.334 . . . . 0.0 111.296 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -167.18 18.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.205 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -119.38 67.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.971 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.3 137.99 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 110.655 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.92 ' HE1' ' HB3' ' B' ' 38' ' ' SER . 4.4 ptp -134.86 134.66 40.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.708 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -109.89 122.47 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.433 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.525 HD22 ' HB3' ' A' ' 40' ' ' ALA . 15.6 m120 -108.19 150.37 27.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.718 0.294 . . . . 0.0 111.416 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.36 90.59 0.49 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.774 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 19.3 m -119.01 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.373 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -143.42 135.12 26.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.732 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 73.8 m-80 -102.24 134.27 45.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.392 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.68 115.26 10.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.83 0.347 . . . . 0.0 110.779 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -115.23 157.41 23.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.404 -0.808 . . . . 0.0 110.613 179.702 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' C' ' 1' ' ' GLY . 6.0 t70 83.73 134.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.895 0.378 . . . . 0.0 110.973 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -129.4 -69.43 0.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.29 35.5 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.024 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 48.3 p -96.4 155.02 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -102.01 -79.1 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.679 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 68.6 m 55.61 40.65 31.04 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.019 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.806 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 35.5 m170 -76.22 -53.07 2.27 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.669 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.806 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -58.3 118.59 5.5 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.497 2.131 . . . . 0.0 111.979 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.85 -66.75 0.99 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.951 0.405 . . . . 0.0 111.175 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -112.5 177.33 4.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.655 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.95 25.67 0.55 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.532 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -45.19 17.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.53 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.09 -32.34 80.03 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.258 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.98 95.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 0.0 110.955 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -75.67 -39.9 56.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.982 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.3 OUTLIER -62.36 -34.63 77.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.522 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -38.83 69.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.191 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.09 -61.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.35 -30.03 59.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.623 HD23 HD23 ' A' ' 21' ' ' LEU . 2.6 tm? -64.58 -60.55 3.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.02 -23.71 67.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.993 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.03 -54.09 39.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.498 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.3 mtp85 -69.69 -38.06 76.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.75 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.487 ' HG ' ' HE ' ' A' ' 24' ' ' ARG . 3.6 mm? -63.78 -44.8 92.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.566 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.85 -33.19 75.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.853 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.532 ' HG2' ' HD3' ' C' ' 31' ' ' ARG . 1.2 ttpp -67.92 -37.61 81.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.23 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -45.44 81.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.584 ' O ' HG22 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -60.17 -36.49 77.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.908 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.93 -30.36 56.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.532 ' HD3' ' HG2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -78.38 -27.28 46.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.288 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.584 HG22 ' O ' ' C' ' 29' ' ' ASP . 27.3 m -84.55 -32.42 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.249 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.503 ' O ' ' HB1' ' C' ' 37' ' ' ALA . 55.7 m-20 -68.95 -43.96 73.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.614 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 5.0 ptpt -84.42 -30.22 25.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.817 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -41.78 87.16 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.42 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.613 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.79 -22.86 42.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.727 ' HB3' ' HA2' ' C' ' 62' ' ' GLY . . . -76.58 -39.8 51.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.46 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.903 ' HB3' ' HE1' ' C' ' 96' ' ' MET . 8.6 t -77.63 -39.88 43.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.719 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.422 ' HG ' ' HB1' ' B' ' 40' ' ' ALA . 0.9 OUTLIER -59.95 -55.52 33.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.132 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.517 ' HB3' HD22 ' A' ' 98' ' ' ASN . . . -58.88 -39.02 80.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.469 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.4 71.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 28.6 tp -76.62 -42.31 42.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.434 ' CB ' ' HB3' ' A' ' 43' ' ' ASN . 32.1 m-20 -70.59 -9.9 58.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' SER . . . . . 0.487 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 41.7 t -69.22 -20.63 63.96 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.156 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.539 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.4 mm? -83.02 169.85 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.946 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -157.35 -1.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.219 0.533 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.591 ' OE1' ' HG2' ' C' ' 84' ' ' LYS . 6.0 mt-30 68.39 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.718 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.76 109.08 2.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.605 2.203 . . . . 0.0 112.582 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.002 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.77 50.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.235 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.7 p -71.49 -1.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.194 0.598 . . . . 0.0 112.483 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 143.58 53.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.282 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 -165.27 1.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.594 0.235 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.492 HG23 ' O ' ' C' ' 74' ' ' GLY . 9.9 p -114.68 142.17 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.598 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' C' ' 47' ' ' GLN . 12.9 m-80 -122.0 118.73 29.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.71 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . 0.519 ' CE2' HD12 ' C' ' 71' ' ' ILE . 29.9 t80 -84.74 131.68 34.53 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.296 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.486 HG23 ' HB3' ' C' ' 45' ' ' LEU . 40.8 p -113.78 121.21 43.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.91 136.99 18.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.1 166.43 33.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.572 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' C' ' 69' ' ' LEU . 7.0 m -116.33 158.14 16.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 111.371 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.41 13.44 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.465 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.727 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -168.15 141.52 6.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.518 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.521 ' CE1' ' HE2' ' A' ' 96' ' ' MET . 52.2 t80 -135.8 133.04 37.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.276 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.1 mmm180 69.53 -94.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 15.0 p -144.68 29.19 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 5.0 m -135.93 141.69 44.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.68 157.99 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.73 169.07 20.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.565 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.551 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -123.36 138.61 54.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.749 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -126.5 139.2 53.41 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.655 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.519 HD12 ' CE2' ' C' ' 56' ' ' PHE . 10.7 tp -141.03 147.97 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.747 0.308 . . . . 0.0 111.085 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.4 -179.65 42.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' C' ' 56' ' ' PHE . 1.2 p -166.82 158.57 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.997 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . 0.492 ' O ' HG23 ' C' ' 54' ' ' VAL . . . -148.21 171.7 28.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.214 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 39.8 t80 -126.33 138.62 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.18 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 13.7 ttm180 -131.49 134.72 46.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.667 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.562 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.9 p -121.0 140.89 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 97.2 m-20 64.73 -94.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.56 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 23.8 p -73.42 -63.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.28 139.77 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.553 ' HB2' ' HG3' ' C' ' 76' ' ' ARG . . . -138.47 156.08 47.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.267 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.533 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 30.4 tp -136.91 141.69 42.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.591 ' HG2' ' OE1' ' C' ' 47' ' ' GLN . 8.0 tmtt? -153.41 128.69 9.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.91 11.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.051 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.05 -173.44 34.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.616 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' C' ' 71' ' ' ILE . 7.9 p -141.56 143.4 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.65 144.68 41.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -114.59 120.52 40.48 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.186 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' C' ' 34' ' ' LYS . . . -127.86 131.0 49.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.631 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.614 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.37 -114.46 5.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.263 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 62.1 m -150.43 17.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.759 0.314 . . . . 0.0 111.294 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -167.25 19.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.21 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -119.47 67.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.25 137.95 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.903 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 4.4 ptp -134.84 134.74 41.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.86 122.44 47.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.404 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.515 HD22 ' HB3' ' B' ' 40' ' ' ALA . 15.5 m120 -108.26 150.42 27.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.713 0.292 . . . . 0.0 111.447 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.37 90.57 0.49 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 19.3 m -119.01 172.22 7.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.407 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.44 135.18 26.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.733 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 73.9 m-80 -102.27 134.39 45.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.385 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 115.26 10.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 110.789 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.411 ' HB3' ' HA ' ' B' ' 55' ' ' ASN . 0.0 OUTLIER -115.22 157.4 23.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.672 179.665 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 t70 64.66 135.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.98 0.419 . . . . 0.0 110.969 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -126.59 -63.21 1.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.1 27.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 p -102.71 148.72 25.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.747 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.559 ' HB3' ' CE1' ' A' ' 8' ' ' HIS . 37.6 m95 -101.15 -84.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.693 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.9 m 63.53 44.76 5.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.005 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.704 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 28.9 m170 -82.97 -49.38 0.75 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.804 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.3 Cg_exo -49.95 106.01 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.471 2.114 . . . . 0.0 111.891 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 8' ' ' HIS . 86.6 mt-30 -99.65 -67.64 0.84 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 111.164 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -117.4 171.32 8.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.618 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.42 24.9 2.07 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.468 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -42.32 92.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.49 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.33 -30.8 68.43 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.264 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.15 90.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.814 0.34 . . . . 0.0 110.855 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.575 ' HA ' ' HD2' ' A' ' 19' ' ' ARG . 15.3 m-70 -77.89 -36.6 49.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.971 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -65.61 -38.5 89.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.466 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.11 -30.5 66.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.19 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.575 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 43.5 mtt-85 -63.26 -64.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.723 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 2.6 pp0? -64.0 -27.65 69.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.199 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 2.3 tm? -63.42 -69.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.541 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.46 -23.37 57.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.018 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.08 -47.99 66.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 47.7 mtp85 -70.87 -40.88 72.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 25' ' ' LEU . 2.3 mm? -57.29 -51.12 70.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.547 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.7 -39.44 84.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.549 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 1.1 ttpp -63.13 -37.12 85.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.207 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.549 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -60.93 -38.21 85.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.672 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -73.37 -30.56 63.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 178.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.47 -34.34 72.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -33.83 62.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 29' ' ' ASP . 33.4 m -78.02 -26.67 14.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.182 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.58 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 40.8 m-20 -71.93 -43.19 65.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.047 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 7.0 ptpt -82.88 -28.84 29.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.829 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.58 74.15 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.446 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.611 HD12 ' CE2' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -74.93 -29.61 61.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 111.158 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.621 ' HB3' ' HA2' ' A' ' 62' ' ' GLY . . . -71.17 -42.4 69.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.451 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.728 ' HB3' ' HE1' ' A' ' 96' ' ' MET . 11.5 t -74.73 -45.61 42.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.659 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.589 ' HG ' ' HB1' ' C' ' 40' ' ' ALA . 1.0 OUTLIER -58.42 -49.26 77.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -66.99 -36.87 83.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.456 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.03 85.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 35.9 tp -74.33 -40.88 61.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.016 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.603 ' ND2' ' HA ' ' C' ' 40' ' ' ALA . 63.5 m-20 -73.16 -9.74 59.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.5 t -69.03 -18.88 64.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.149 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 1.5 mm? -80.55 167.72 19.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.911 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -156.24 -3.39 0.12 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.641 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.5 ' HG2' HG22 ' A' ' 57' ' ' THR . 12.7 mt-30 66.2 122.29 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.998 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -84.02 104.66 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.599 2.199 . . . . 0.0 112.51 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 9.2 m-30 66.78 -179.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.959 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 170.37 55.49 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.236 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.3 p -74.68 -5.62 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.133 0.573 . . . . 0.0 112.451 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.56 56.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.369 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.83 -163.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.644 0.259 . . . . 0.0 110.616 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 55' ' ' ASN . 9.1 p -115.95 138.9 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.494 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' N ' HG23 ' A' ' 54' ' ' VAL . 15.3 m-80 -123.0 115.22 21.53 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 111.666 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HB2' ' HZ3' ' B' ' 105' ' ' TRP . 37.5 t80 -81.45 129.97 34.86 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.207 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.622 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.9 p -110.57 126.12 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.656 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -156.12 133.15 10.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.581 ' HA3' ' HB3' ' B' ' 100' ' ' SER . . . -175.25 171.43 44.56 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.57 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.06 159.59 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 111.318 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 -169.88 16.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.444 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . -167.03 135.95 3.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.518 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.611 ' CE2' HD12 ' A' ' 36' ' ' LEU . 28.6 t80 -123.89 141.62 51.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 110.744 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HG3' ' OD1' ' A' ' 33' ' ' ASP . 2.5 mmm180 60.55 -95.63 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 p -142.34 24.31 1.95 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.34 142.03 50.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.82 156.37 18.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.14 168.67 22.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.598 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.15 138.26 54.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.796 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -131.99 139.2 48.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.671 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.656 HD12 ' HB1' ' A' ' 58' ' ' ALA . 5.5 tp -137.49 162.4 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.121 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.637 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 169.96 -176.07 43.84 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.404 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.78 3.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.01 27.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.268 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.574 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 54.4 t80 -126.4 130.92 51.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 0.0 111.11 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 10.9 ttm180 -122.32 120.88 35.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.777 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.2 p -108.04 140.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.256 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.598 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 38.7 m-20 62.9 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.077 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 p -72.37 -61.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.992 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.09 142.17 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.571 ' HB2' ' HG3' ' A' ' 76' ' ' ARG . . . -141.19 158.83 43.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.85 147.01 31.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.575 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -158.54 132.46 7.76 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.189 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.25 -179.73 8.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.081 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.407 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . 160.53 -173.1 37.04 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.545 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 71' ' ' ILE . 14.8 p -140.43 138.08 36.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.114 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.2 145.85 40.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.303 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.469 ' HH ' ' HA ' ' A' ' 92' ' ' SER . 34.2 t80 -118.48 115.58 24.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.248 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -123.01 131.14 53.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.669 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.538 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 63.46 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.263 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.469 ' HA ' ' HH ' ' A' ' 89' ' ' TYR . 49.9 m -149.28 9.17 0.74 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.329 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.57 25.18 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.219 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-20 -121.03 71.76 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.517 HG11 ' CE1' ' A' ' 97' ' ' TYR . 86.5 t -101.91 137.35 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.071 0.463 . . . . 0.0 110.695 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.728 ' HE1' ' HB3' ' A' ' 38' ' ' SER . 10.2 ptp -130.32 136.87 49.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.517 ' CE1' HG11 ' A' ' 95' ' ' VAL . 77.4 m-85 -112.33 121.95 46.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.361 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.48 154.96 25.07 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 111.419 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.783 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.602 ' HB3' ' HA3' ' C' ' 59' ' ' GLY . 12.8 m -113.83 168.85 9.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.406 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.72 140.7 47.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.955 0.407 . . . . 0.0 111.108 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.633 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 57.1 m-80 -108.6 132.1 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.3 117.49 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.851 0.357 . . . . 0.0 110.712 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.64 161.07 20.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.486 ' HZ3' ' HB2' ' C' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.633 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 t70 64.66 135.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.908 0.385 . . . . 0.0 110.968 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -126.6 -63.23 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.09 27.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 16.6 p -102.69 148.75 25.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.55 ' HB3' ' CE1' ' B' ' 8' ' ' HIS . 37.7 m95 -101.15 -84.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.695 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' B' ' 6' ' ' TRP . 63.5 m 63.47 44.79 5.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.98 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.68 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 29.0 m170 -82.93 -49.39 0.76 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.818 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.68 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -50.0 105.97 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.51 2.14 . . . . 0.0 111.894 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' B' ' 8' ' ' HIS . 86.6 mt-30 -99.54 -67.72 0.84 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.002 0.43 . . . . 0.0 111.161 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -117.35 171.36 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.693 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.53 24.94 2.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.426 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -42.17 92.47 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.534 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.44 -30.78 68.79 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.231 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.07 -38.12 89.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.89 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.578 ' HA ' ' HD2' ' B' ' 19' ' ' ARG . 15.2 m-70 -77.87 -36.7 49.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.953 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.577 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.5 OUTLIER -65.57 -38.43 89.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.471 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.18 -30.43 66.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.251 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' B' ' 16' ' ' HIS . 43.5 mtt-85 -63.22 -64.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.629 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 2.6 pp0? -64.05 -27.66 69.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.102 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 2.3 tm? -63.36 -69.21 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.41 -23.39 57.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.009 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.02 -48.12 66.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' B' ' 20' ' ' GLN . 47.8 mtp85 -70.83 -40.87 72.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.802 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.468 HD23 ' N ' ' B' ' 25' ' ' LEU . 2.3 mm? -57.23 -51.11 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.636 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -59.68 -39.53 84.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.766 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.565 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 1.2 ttpp -63.15 -37.05 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.218 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.565 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -60.94 -38.21 85.05 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.672 ' O ' HG22 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -73.38 -30.62 63.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.905 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.41 -34.43 72.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -33.9 62.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.276 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.672 HG22 ' O ' ' B' ' 29' ' ' ASP . 33.3 m -77.95 -26.65 14.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.211 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.589 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 40.5 m-20 -71.96 -43.28 65.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.957 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.547 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 6.9 ptpt -82.88 -28.76 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.1 -38.58 73.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' B' ' 63' ' ' TYR . 0.5 OUTLIER -74.98 -29.63 60.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.765 0.317 . . . . 0.0 111.058 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.636 ' HB3' ' HA2' ' B' ' 62' ' ' GLY . . . -71.24 -42.31 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.459 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.715 ' HB3' ' HE1' ' B' ' 96' ' ' MET . 11.4 t -74.73 -45.57 43.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.75 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.587 ' HG ' ' HB1' ' A' ' 40' ' ' ALA . 1.1 t -58.45 -49.2 78.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.607 ' HB1' ' HG ' ' C' ' 39' ' ' SER . . . -67.08 -36.94 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.386 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.0 85.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' B' ' 70' ' ' ALA . 36.2 tp -74.41 -40.8 61.79 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.605 ' ND2' ' HA ' ' A' ' 40' ' ' ALA . 63.6 m-20 -73.16 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 29.4 t -69.05 -18.85 64.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.125 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.603 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 1.6 mm? -80.59 167.7 19.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.889 177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.24 -3.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.131 0.491 . . . . 0.0 111.649 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.514 ' HG2' HG22 ' B' ' 57' ' ' THR . 12.7 mt-30 66.37 122.19 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.956 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -84.0 104.68 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.572 2.181 . . . . 0.0 112.548 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 9.1 m-30 66.8 -179.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 170.37 55.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.252 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.3 p -74.66 -5.67 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.103 0.561 . . . . 0.0 112.454 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.783 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.64 56.11 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.228 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 -163.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.432 HG23 ' N ' ' B' ' 55' ' ' ASN . 9.1 p -115.94 138.9 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.518 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.432 ' N ' HG23 ' B' ' 54' ' ' VAL . 15.4 m-80 -122.93 115.15 21.44 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 111.669 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.484 ' HB2' ' HZ3' ' C' ' 105' ' ' TRP . 37.6 t80 -81.37 130.01 34.86 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.603 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.8 p -110.57 126.09 54.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.959 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.635 ' HB1' HD12 ' B' ' 71' ' ' ILE . . . -156.15 133.24 10.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.403 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.589 ' HA3' ' HB3' ' C' ' 100' ' ' SER . . . -175.33 171.44 44.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.573 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -126.02 159.52 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.16 -169.81 16.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.454 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.636 ' HA2' ' HB3' ' B' ' 37' ' ' ALA . . . -167.1 135.85 3.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.595 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.615 ' CE2' HD12 ' B' ' 36' ' ' LEU . 28.6 t80 -123.8 141.65 51.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.725 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' OD1' ' B' ' 33' ' ' ASP . 2.5 mmm180 60.49 -95.7 0.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 16.8 p -142.26 24.33 1.96 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.23 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.35 141.98 50.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.78 156.39 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 168.71 22.57 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.13 138.31 54.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.782 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' B' ' 42' ' ' LEU . . . -131.97 139.15 48.56 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.635 HD12 ' HB1' ' B' ' 58' ' ' ALA . 5.5 tp -137.5 162.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 111.113 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.608 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 170.02 -176.0 43.89 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.452 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.8 p -170.02 150.72 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.991 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.09 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.239 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.572 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 54.5 t80 -126.38 130.97 51.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 111.159 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.573 ' HG3' ' HB2' ' B' ' 82' ' ' ALA . 11.0 ttm180 -122.47 120.96 35.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.783 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.2 p -108.04 140.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 38.5 m-20 62.9 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 176.0 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.567 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.46 -61.43 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 16.3 m -89.11 142.27 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.573 ' HB2' ' HG3' ' B' ' 76' ' ' ARG . . . -141.21 158.85 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.207 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.9 146.98 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -158.49 132.39 7.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.22 -179.72 8.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.074 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.405 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 160.53 -173.11 37.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.61 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.492 ' O ' HG23 ' B' ' 71' ' ' ILE . 14.9 p -140.44 137.99 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.15 145.96 40.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.294 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . 0.47 ' HH ' ' HA ' ' B' ' 92' ' ' SER . 34.3 t80 -118.59 115.6 24.89 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.221 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -123.01 131.24 53.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.547 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 63.31 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.262 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' SER . . . . . 0.47 ' HA ' ' HH ' ' B' ' 89' ' ' TYR . 50.0 m -149.23 9.17 0.74 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.355 . . . . 0.0 111.343 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.61 25.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.184 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 19.1 m-20 -121.09 71.79 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.527 HG11 ' CE1' ' B' ' 97' ' ' TYR . 87.4 t -101.89 137.36 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 110.657 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.715 ' HE1' ' HB3' ' B' ' 38' ' ' SER . 10.2 ptp -130.36 136.89 49.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.652 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . 0.527 ' CE1' HG11 ' B' ' 95' ' ' VAL . 77.7 m-85 -112.4 121.87 46.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.387 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -112.41 154.91 25.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.482 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.18 88.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.762 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.581 ' HB3' ' HA3' ' A' ' 59' ' ' GLY . 12.7 m -113.7 168.91 9.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.446 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.82 140.63 47.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 111.074 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.642 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 57.2 m-80 -108.59 131.96 54.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.373 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.14 117.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.65 161.17 20.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.859 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . 0.479 ' HZ3' ' HB2' ' A' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.685 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.639 -0.184 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 t70 64.66 135.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -126.59 -63.34 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.06 27.48 1.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.047 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 16.4 p -102.73 148.75 25.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.763 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . 0.551 ' HB3' ' CE1' ' C' ' 8' ' ' HIS . 37.7 m95 -101.14 -84.17 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.72 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 63.8 m 63.41 44.74 5.23 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.025 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.704 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 28.9 m170 -82.87 -49.37 0.77 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.874 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -49.94 105.96 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.52 2.147 . . . . 0.0 111.929 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' C' ' 8' ' ' HIS . 86.6 mt-30 -99.6 -67.69 0.84 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.955 0.407 . . . . 0.0 111.183 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -117.37 171.36 8.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.65 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.46 24.91 2.06 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.472 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -42.36 92.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.477 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.31 -30.81 68.38 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.238 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.02 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.915 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . 0.566 ' HA ' ' HD2' ' C' ' 19' ' ' ARG . 15.1 m-70 -77.86 -36.62 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.005 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.5 OUTLIER -65.52 -38.56 90.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.556 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.98 -30.59 66.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.306 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . 0.566 ' HD2' ' HA ' ' C' ' 16' ' ' HIS . 43.6 mtt-85 -63.16 -64.09 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.771 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.641 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 2.6 pp0? -64.07 -27.71 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.108 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 2.3 tm? -63.44 -69.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.554 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -58.54 -23.28 57.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.017 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.11 -48.01 66.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.641 ' HG3' ' O ' ' C' ' 20' ' ' GLN . 48.1 mtp85 -70.89 -40.83 71.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.775 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.466 HD13 HD22 ' A' ' 28' ' ' LEU . 2.3 mm? -57.31 -51.1 70.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.67 -39.52 84.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.803 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.559 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 1.2 ttpp -63.12 -37.08 85.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.192 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.559 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -61.01 -38.06 84.75 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.667 ' O ' HG22 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -73.43 -30.68 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.92 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.34 -34.47 72.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.848 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -33.9 62.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.322 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.667 HG22 ' O ' ' C' ' 29' ' ' ASP . 33.4 m -77.94 -26.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.579 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 40.2 m-20 -71.96 -43.21 65.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.552 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 6.9 ptpt -82.84 -28.87 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.799 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.99 -38.6 74.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.475 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.605 HD12 ' CE2' ' C' ' 63' ' ' TYR . 0.5 OUTLIER -74.96 -29.65 60.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.819 0.342 . . . . 0.0 111.067 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.64 ' HB3' ' HA2' ' C' ' 62' ' ' GLY . . . -71.27 -42.26 68.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.429 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.706 ' HB3' ' HE1' ' C' ' 96' ' ' MET . 11.5 t -74.77 -45.54 43.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.607 ' HG ' ' HB1' ' B' ' 40' ' ' ALA . 1.0 OUTLIER -58.5 -49.2 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.083 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.603 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -67.1 -36.81 82.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.428 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.97 85.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.906 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' C' ' 70' ' ' ALA . 36.0 tp -74.35 -40.83 61.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.599 ' ND2' ' HA ' ' B' ' 40' ' ' ALA . 63.5 m-20 -73.21 -9.67 58.96 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.2 t -69.16 -18.71 63.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 1.5 mm? -80.65 167.69 19.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.872 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.18 -3.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 111.702 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.516 ' HG2' HG22 ' C' ' 57' ' ' THR . 12.7 mt-30 66.31 122.27 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -84.04 104.71 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.573 2.182 . . . . 0.0 112.528 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 9.2 m-30 66.73 -179.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 170.42 55.56 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.201 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.2 p -74.7 -5.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.197 0.599 . . . . 0.0 112.445 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.763 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.51 56.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.323 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 -163.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.656 0.265 . . . . 0.0 110.597 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.431 HG23 ' N ' ' C' ' 55' ' ' ASN . 9.1 p -115.88 138.83 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.584 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.431 ' N ' HG23 ' C' ' 54' ' ' VAL . 15.4 m-80 -122.98 115.18 21.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.022 0.439 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . 0.486 ' HB2' ' HZ3' ' A' ' 105' ' ' TRP . 37.7 t80 -81.45 129.96 34.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.238 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.622 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 45.7 p -110.56 126.07 54.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . 0.65 ' HB1' HD12 ' C' ' 71' ' ' ILE . . . -156.05 133.21 10.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.45 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' ' 100' ' ' SER . . . -175.31 171.5 44.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.588 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -126.12 159.55 34.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.336 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.19 -169.87 16.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.478 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' C' ' 37' ' ' ALA . . . -167.08 135.96 3.91 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.52 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.605 ' CE2' HD12 ' C' ' 36' ' ' LEU . 28.7 t80 -123.87 141.66 51.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.674 0.273 . . . . 0.0 110.816 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.428 ' HG3' ' OD1' ' C' ' 33' ' ' ASP . 2.5 mmm180 60.44 -95.61 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.097 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -142.32 24.35 1.95 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.164 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.3 141.98 50.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.76 156.43 18.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.23 168.61 22.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.605 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.08 138.32 54.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.787 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' C' ' 42' ' ' LEU . . . -132.0 139.19 48.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.633 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.65 HD12 ' HB1' ' C' ' 58' ' ' ALA . 5.5 tp -137.5 162.46 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.634 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 169.97 -176.09 43.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.477 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.7 3.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.1 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.224 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.573 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 54.6 t80 -126.38 130.94 51.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 111.097 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.559 ' HG3' ' HB2' ' C' ' 82' ' ' ALA . 10.9 ttm180 -122.35 120.92 35.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.743 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.763 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.2 p -108.08 140.69 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.292 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 38.6 m-20 62.91 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.556 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.36 -61.56 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.953 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.08 142.26 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.497 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' C' ' 76' ' ' ARG . . . -141.21 158.82 43.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.268 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.88 146.99 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -158.49 132.4 7.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.169 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.23 -179.67 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.53 -173.06 37.04 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.552 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.479 ' O ' HG23 ' C' ' 71' ' ' ILE . 14.8 p -140.4 138.06 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 111.164 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.2 145.94 40.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . 0.469 ' HH ' ' HA ' ' C' ' 92' ' ' SER . 34.1 t80 -118.59 115.62 24.93 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.188 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -123.11 131.13 53.57 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.574 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.552 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 63.45 -112.4 4.94 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.213 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' SER . . . . . 0.469 ' HA ' ' HH ' ' C' ' 89' ' ' TYR . 49.8 m -149.29 9.19 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 111.297 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.62 25.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.573 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 19.4 m-20 -121.0 71.8 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . 0.531 HG11 ' CE1' ' C' ' 97' ' ' TYR . 86.8 t -101.86 137.39 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 0.0 110.663 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.706 ' HE1' ' HB3' ' C' ' 38' ' ' SER . 10.2 ptp -130.35 136.82 49.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . 0.531 ' CE1' HG11 ' C' ' 95' ' ' VAL . 78.0 m-85 -112.33 121.96 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.435 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.45 154.92 25.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.456 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.66 0.15 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.767 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.589 ' HB3' ' HA3' ' B' ' 59' ' ' GLY . 12.6 m -113.71 168.91 9.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.47 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -133.79 140.54 47.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.085 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.631 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 56.9 m-80 -108.49 132.03 54.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.392 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.19 117.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.727 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.65 161.18 20.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . 0.484 ' HZ3' ' HB2' ' B' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.675 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 60.62 120.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.869 0.366 . . . . 0.0 110.989 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -123.22 58.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.12 -54.35 2.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.417 ' HA ' ' NE2' ' A' ' 8' ' ' HIS . 0.7 OUTLIER -116.78 107.29 14.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.791 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.483 ' HZ3' ' HB3' ' A' ' 19' ' ' ARG . 59.6 t-105 -151.15 114.31 4.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.727 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t 60.89 71.13 0.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.053 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.708 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 8.1 m-70 -109.6 -53.91 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.753 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.339 31.3 Cg_exo -72.27 139.8 32.75 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.483 2.122 . . . . 0.0 111.967 179.24 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.81 -44.16 97.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.899 0.381 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -93.03 106.86 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.714 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -160.35 114.91 2.22 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.49 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -129.03 -66.21 0.83 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.485 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.5 72.08 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.279 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.99 -54.89 31.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 110.879 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -53.53 -41.64 66.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.932 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HZ1' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER -62.74 -39.41 94.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.523 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.503 ' HA ' ' HZ1' ' B' ' 17' ' ' LYS . 82.1 t80 -60.94 -31.5 71.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.193 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 32.2 mmt180 -75.58 -30.06 59.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.597 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 29.5 mt-30 -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.11 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.47 -50.28 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 22.8 m-20 -71.98 -19.97 61.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 12.9 t-20 -77.4 -41.22 40.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 3.6 mmp_? -71.58 -46.25 59.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.559 HD11 ' HD3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.67 94.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.73 -28.98 66.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.805 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -75.96 -38.1 57.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.241 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.586 ' O ' HG21 ' A' ' 32' ' ' VAL . 8.0 mt -76.5 -34.8 58.61 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -66.76 -47.21 72.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 9.7 t -71.63 -40.19 69.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.599 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 21.2 ttp85 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.348 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.586 HG21 ' O ' ' A' ' 28' ' ' LEU . 28.4 m -76.61 -27.67 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.567 ' OD2' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t70 -64.08 -56.18 16.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.96 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.652 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 23.0 pttt -68.71 -37.63 79.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.826 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.67 -48.2 87.42 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.421 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.673 HD22 ' HB2' ' B' ' 39' ' ' SER . 0.4 OUTLIER -67.48 -31.69 72.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.801 0.334 . . . . 0.0 111.095 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -38.44 90.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.405 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.623 ' HG ' ' HE3' ' A' ' 96' ' ' MET . 78.7 p -79.96 -43.52 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.66 ' HB2' HD22 ' C' ' 36' ' ' LEU . 46.7 t -53.24 -60.95 2.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.7 -30.25 60.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.02 74.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -66.99 -32.91 74.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.123 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 1.4 m-20 -78.75 -13.63 59.71 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -19.08 65.68 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.134 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.792 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.2 mm? -75.55 158.57 32.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.9 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 47.3 p90 -146.47 -31.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.645 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 8.3 tt0 75.64 108.58 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.924 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -90.81 137.26 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.668 2.246 . . . . 0.0 112.576 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 14.5 m-85 67.56 154.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.574 ' CA ' ' HB3' ' A' ' 76' ' ' ARG . . . -173.94 73.06 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.228 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' CD ' ' A' ' 53' ' ' LYS . 11.4 p -95.88 -22.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.157 0.583 . . . . 0.0 112.521 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.765 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.89 48.99 0.02 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.301 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.49 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -143.76 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.576 0.227 . . . . 0.0 110.57 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.41 143.4 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.557 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.475 HD22 ' HB3' ' B' ' 102' ' ' ASN . 1.0 OUTLIER -135.14 116.49 14.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.03 0.443 . . . . 0.0 111.697 179.541 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -80.29 131.03 35.59 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.279 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.792 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 27.7 p -110.53 120.96 44.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.971 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.525 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -143.49 139.9 30.06 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.402 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.01 164.68 33.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.536 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.6 m -118.79 164.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.879 0.371 . . . . 0.0 111.282 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 67' ' ' GLN . . . -139.5 177.5 20.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.48 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.05 155.13 26.3 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.517 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.452 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 1.3 t80 -142.04 122.32 13.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 110.736 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.567 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 24.9 mtt-85 67.63 -93.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.107 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -131.89 9.49 4.55 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.167 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 22.9 t -109.93 173.88 6.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -135.31 -179.27 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.61 158.28 23.11 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.515 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 69' ' ' LEU . 3.9 tp -118.11 134.62 54.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.733 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.71 139.06 30.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.68 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.525 HD11 ' HB1' ' A' ' 58' ' ' ALA . 8.9 tp -138.33 150.55 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.718 0.295 . . . . 0.0 111.09 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.7 -177.26 37.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.2 p -160.23 155.26 24.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.61 30.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.242 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.42 120.58 17.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 111.147 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.574 ' HB3' ' CA ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.695 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.765 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 14.9 p -102.47 130.09 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 58.98 -171.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.97 66.02 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.3 p -160.07 -51.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.53 142.08 36.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.83 153.09 45.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 0.0 111.272 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 130.7 32.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.694 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.494 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -135.02 144.02 47.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.062 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.439 ' HA3' HD13 ' A' ' 42' ' ' LEU . . . 173.42 161.11 23.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.588 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.418 ' O ' HD21 ' A' ' 42' ' ' LEU . 4.3 p -130.39 150.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.79 140.68 52.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CD2' HG21 ' A' ' 95' ' ' VAL . 1.3 t80 -125.23 128.4 48.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.247 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 38' ' ' SER . . . -136.33 151.09 49.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.672 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.652 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 50.21 -99.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.256 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.33 -27.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.727 0.298 . . . . 0.0 111.308 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.5 p -123.75 15.03 9.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.2 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.469 ' CB ' ' HB1' ' A' ' 90' ' ' ALA . 41.6 m-20 -101.52 69.91 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.401 HG21 ' CD2' ' A' ' 89' ' ' TYR . 34.9 t -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.74 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.623 ' HE3' ' HG ' ' A' ' 38' ' ' SER . 1.3 ptp -135.2 139.48 44.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.771 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -117.56 129.91 56.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.454 ' ND2' ' HA3' ' C' ' 61' ' ' GLY . 15.1 m120 -129.27 145.43 51.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.661 0.267 . . . . 0.0 111.441 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.52 7.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.746 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.582 ' CB ' HD22 ' C' ' 45' ' ' LEU . 83.9 p -127.99 164.41 22.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.437 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.28 142.62 35.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.951 0.405 . . . . 0.0 111.096 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.512 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 17.0 m-80 -109.32 134.99 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.366 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.58 126.3 48.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.808 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' C' ' 55' ' ' ASN . 3.8 pt-20 -104.67 148.58 26.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 57.6 m95 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.672 179.69 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.67 -0.172 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 60.59 120.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.889 0.376 . . . . 0.0 110.925 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -123.21 58.79 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.21 -54.29 2.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.988 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.411 ' HA ' ' NE2' ' B' ' 8' ' ' HIS . 0.7 OUTLIER -116.91 107.36 14.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.712 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.484 ' HZ3' ' HB3' ' B' ' 19' ' ' ARG . 59.5 t-105 -151.23 114.29 4.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.79 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t 60.88 71.08 0.58 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.069 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.728 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 8.1 m-70 -109.54 -53.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.786 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.341 31.4 Cg_exo -72.35 139.73 32.38 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.539 2.159 . . . . 0.0 111.923 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.65 -44.19 97.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.974 0.416 . . . . 0.0 111.186 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -92.97 106.88 18.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.7 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -160.42 114.88 2.2 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.439 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -128.94 -66.27 0.83 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.528 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.12 -46.43 72.4 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.284 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.06 -54.8 32.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -53.59 -41.59 66.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.984 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.503 ' HZ1' ' HA ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -62.79 -39.38 94.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . 0.504 ' HA ' ' HZ1' ' C' ' 17' ' ' LYS . 82.3 t80 -60.78 -31.53 70.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 111.296 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 32.4 mmt180 -75.66 -30.02 59.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 29.6 mt-30 -73.12 -37.04 66.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.159 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -50.24 68.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.569 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 22.7 m-20 -72.0 -19.99 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.971 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 13.0 t-20 -77.37 -41.2 41.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 3.6 mmp_? -71.54 -46.29 59.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.762 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.571 HD11 ' HD3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.65 94.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.75 -28.98 66.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.835 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -76.01 -37.99 57.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.251 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.587 ' O ' HG21 ' B' ' 32' ' ' VAL . 8.0 mt -76.62 -34.82 58.33 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -66.58 -47.35 73.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.942 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 9.7 t -71.66 -40.11 69.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.885 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.59 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 21.3 ttp85 -62.73 -38.3 89.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.297 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.587 HG21 ' O ' ' B' ' 28' ' ' LEU . 28.6 m -76.69 -27.68 17.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.178 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.564 ' OD2' ' HD2' ' B' ' 64' ' ' ARG . 10.4 t70 -64.0 -56.17 17.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.004 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.653 ' HD2' ' HA3' ' B' ' 91' ' ' GLY . 23.0 pttt -68.77 -37.56 79.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.06 88.12 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.425 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' C' ' 39' ' ' SER . 0.4 OUTLIER -67.64 -31.62 71.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 111.057 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.52 90.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.418 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.631 ' HG ' ' HE3' ' B' ' 96' ' ' MET . 78.4 p -79.93 -43.58 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.673 ' HB2' HD22 ' A' ' 36' ' ' LEU . 46.7 t -53.19 -60.88 2.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.75 -30.22 60.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.403 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.97 74.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -67.04 -32.96 74.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 1.4 m-20 -78.79 -13.58 59.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.12 65.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.131 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.797 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.2 mm? -75.58 158.63 32.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.894 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.436 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 47.4 p90 -146.52 -30.99 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.169 0.509 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.444 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 8.3 tt0 75.45 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.978 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -90.79 137.16 2.25 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.208 . . . . 0.0 112.613 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 14.4 m-85 67.53 154.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.576 ' CA ' ' HB3' ' B' ' 76' ' ' ARG . . . -173.89 73.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.215 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.495 HG11 ' CD ' ' B' ' 53' ' ' LYS . 11.5 p -96.02 -22.88 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 123.162 0.585 . . . . 0.0 112.446 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.739 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.83 49.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.495 ' CD ' HG11 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.631 0.253 . . . . 0.0 110.546 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.43 143.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.571 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.466 HD22 ' HB3' ' C' ' 102' ' ' ASN . 1.0 OUTLIER -135.18 116.49 14.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 111.663 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -80.32 131.07 35.58 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.215 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.797 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 27.8 p -110.63 120.81 43.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.941 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.529 ' HB1' HD11 ' B' ' 71' ' ' ILE . . . -143.37 139.85 30.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.441 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.02 164.63 33.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.522 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -118.68 164.37 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.879 0.371 . . . . 0.0 111.293 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' B' ' 67' ' ' GLN . . . -139.57 177.47 20.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.482 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.0 155.12 26.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.469 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 1.3 t80 -142.05 122.34 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.564 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 25.1 mtt-85 67.59 -93.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.088 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.41 4.54 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.45 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 22.8 t -109.89 173.91 6.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.811 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.6 OUTLIER -135.32 -179.35 5.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.061 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.56 158.22 23.15 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.552 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' B' ' 69' ' ' LEU . 3.9 tp -118.02 134.64 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.72 139.03 30.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.694 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.529 HD11 ' HB1' ' B' ' 58' ' ' ALA . 8.9 tp -138.29 150.47 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.15 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.406 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -164.59 -177.19 37.02 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.423 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -160.28 155.22 24.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.58 30.06 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.235 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.4 120.52 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 111.108 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.576 ' HB3' ' CA ' ' B' ' 50' ' ' GLY . 0.0 OUTLIER -105.21 107.63 18.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.762 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.739 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 14.9 p -102.52 130.07 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 59.0 -171.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -118.99 66.01 0.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 69.9 p -160.03 -51.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.022 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.53 142.07 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.563 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.85 153.15 45.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.895 0.378 . . . . 0.0 111.245 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.57 130.71 32.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -135.09 143.95 46.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.21 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.496 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -148.28 169.11 20.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' B' ' 42' ' ' LEU . . . 173.37 161.02 22.92 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.553 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.426 ' O ' HD21 ' B' ' 42' ' ' LEU . 4.3 p -130.33 150.16 34.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.74 140.67 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.16 128.35 48.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.268 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 38' ' ' SER . . . -136.32 151.09 49.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.625 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.653 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 50.22 -99.64 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.307 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 25.9 t -152.28 -27.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 15.08 9.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.191 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.463 ' CB ' ' HB1' ' B' ' 90' ' ' ALA . 41.5 m-20 -101.59 69.95 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -113.33 127.94 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.747 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.631 ' HE3' ' HG ' ' B' ' 38' ' ' SER . 1.3 ptp -135.19 139.48 44.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -117.57 129.92 56.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.463 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.444 ' ND2' ' HA3' ' A' ' 61' ' ' GLY . 15.0 m120 -129.29 145.43 51.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.7 0.285 . . . . 0.0 111.419 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.45 7.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.695 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.575 ' CB ' HD22 ' A' ' 45' ' ' LEU . 84.1 p -127.99 164.49 22.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.424 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -140.36 142.54 35.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.508 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 17.1 m-80 -109.3 134.95 51.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.57 126.2 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.796 0.331 . . . . 0.0 110.781 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 3.8 pt-20 -104.63 148.64 26.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 58.1 m95 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.406 -0.806 . . . . 0.0 110.649 179.732 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.64 -0.184 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 t70 60.57 120.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.397 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -123.19 58.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.13 -54.34 2.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.83 107.38 14.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.784 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . 0.495 ' HZ3' ' HB3' ' C' ' 19' ' ' ARG . 59.5 t-105 -151.22 114.3 4.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.718 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t 60.9 71.04 0.58 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.059 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.734 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 8.1 m-70 -109.51 -53.92 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.794 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.338 31.4 Cg_exo -72.24 139.76 32.77 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.471 2.114 . . . . 0.0 111.942 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.69 -44.14 97.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.991 0.424 . . . . 0.0 111.234 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -93.02 106.92 18.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.672 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -160.44 114.9 2.19 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.483 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -128.97 -66.25 0.83 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.557 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.45 72.53 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.272 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.08 -54.82 32.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.906 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -53.5 -41.68 66.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.979 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.504 ' HZ1' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER -62.81 -39.34 93.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.534 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . 0.497 ' HA ' ' HZ1' ' A' ' 17' ' ' LYS . 82.2 t80 -60.87 -31.5 70.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 32.3 mmt180 -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.735 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.6 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 29.6 mt-30 -73.07 -37.0 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 111.212 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.57 -50.25 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 22.7 m-20 -71.91 -20.06 61.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 12.8 t-20 -77.31 -41.27 41.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' C' ' 20' ' ' GLN . 3.6 mmp_? -71.45 -46.4 60.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.555 HD11 ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -59.83 -43.72 94.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.643 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.79 -28.9 66.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -75.98 -38.08 57.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.661 0.267 . . . . 0.0 111.265 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.593 ' O ' HG21 ' C' ' 32' ' ' VAL . 8.0 mt -76.52 -34.91 58.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.54 -47.32 73.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.003 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 9.7 t -71.62 -40.23 69.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.595 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 21.3 ttp85 -62.58 -38.51 90.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.325 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.593 HG21 ' O ' ' C' ' 28' ' ' LEU . 28.3 m -76.59 -27.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.235 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.558 ' OD2' ' HD2' ' C' ' 64' ' ' ARG . 10.4 t70 -63.98 -56.2 16.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.667 ' HD2' ' HA3' ' C' ' 91' ' ' GLY . 23.1 pttt -68.78 -37.56 79.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.807 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 -48.08 88.01 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.384 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.66 HD22 ' HB2' ' A' ' 39' ' ' SER . 0.4 OUTLIER -67.67 -31.56 71.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.28 -38.44 90.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.482 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.629 ' HG ' ' HE3' ' C' ' 96' ' ' MET . 78.7 p -79.9 -43.59 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.67 ' HB2' HD22 ' B' ' 36' ' ' LEU . 46.7 t -53.15 -60.99 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.66 -30.29 60.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.95 -48.98 74.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' C' ' 42' ' ' LEU . 0.6 OUTLIER -67.01 -32.94 74.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.067 179.33 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.3 m-20 -78.77 -13.6 59.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.07 65.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.144 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.805 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.2 mm? -75.65 158.71 32.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.87 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.448 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 47.5 p90 -146.56 -31.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.194 0.521 . . . . 0.0 111.69 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.461 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 8.3 tt0 75.59 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.979 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -90.85 137.17 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.625 2.217 . . . . 0.0 112.545 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 14.6 m-85 67.59 154.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.58 ' CA ' ' HB3' ' C' ' 76' ' ' ARG . . . -173.95 73.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.253 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.501 HG11 ' CD ' ' C' ' 53' ' ' LYS . 11.4 p -95.87 -22.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.198 0.599 . . . . 0.0 112.453 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.9 48.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.296 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . 0.501 ' CD ' HG11 ' C' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.49 7.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.593 0.235 . . . . 0.0 110.566 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.45 143.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.525 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.472 HD22 ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -135.19 116.45 14.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.006 0.431 . . . . 0.0 111.68 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -80.35 131.09 35.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.269 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.805 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 27.6 p -110.63 120.82 43.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.972 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . 0.53 ' HB1' HD11 ' C' ' 71' ' ' ILE . . . -143.37 139.93 30.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.431 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.05 164.61 33.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.563 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.62 164.38 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.331 . . . . 0.0 111.386 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . 0.529 ' O ' ' HG2' ' C' ' 67' ' ' GLN . . . -139.52 177.46 20.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.496 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.99 155.07 26.22 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 1.3 t80 -141.95 122.31 14.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.76 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.558 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 24.9 mtt-85 67.54 -93.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.104 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.45 4.54 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.19 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' SER . . . . . 0.441 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 22.8 t -109.92 173.93 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.6 OUTLIER -135.33 -179.39 5.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.093 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.55 158.27 23.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.549 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' C' ' 69' ' ' LEU . 3.8 tp -118.08 134.63 54.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.69 138.99 30.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.675 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' C' ' 58' ' ' ALA . 8.9 tp -138.3 150.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.712 0.291 . . . . 0.0 111.162 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.401 ' N ' HG13 ' C' ' 71' ' ' ILE . . . -164.62 -177.25 37.09 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.399 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.2 p -160.3 155.12 24.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.65 163.66 30.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.223 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -136.4 120.45 17.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 111.171 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.58 ' HB3' ' CA ' ' C' ' 50' ' ' GLY . 0.0 OUTLIER -105.18 107.65 18.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.796 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.735 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 14.9 p -102.48 130.07 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.291 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 59.01 -171.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.96 66.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.567 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 69.2 p -160.08 -51.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.044 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.59 141.94 37.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.08 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.294 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.48 130.81 33.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.627 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -135.11 144.03 46.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.179 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . 0.496 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . 0.43 ' HA3' HD13 ' C' ' 42' ' ' LEU . . . 173.47 161.09 23.11 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.589 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.43 ' O ' HD21 ' C' ' 42' ' ' LEU . 4.2 p -130.36 150.12 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.897 0.38 . . . . 0.0 111.074 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.71 140.73 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.356 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . 0.409 ' CD2' HG21 ' C' ' 95' ' ' VAL . 1.3 t80 -125.19 128.41 48.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' C' ' 38' ' ' SER . . . -136.38 151.07 49.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.613 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.667 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 50.21 -99.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.334 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.35 -27.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.753 0.311 . . . . 0.0 111.348 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 14.98 9.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.205 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.461 ' CB ' ' HB1' ' C' ' 90' ' ' ALA . 41.4 m-20 -101.48 69.8 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . 0.409 HG21 ' CD2' ' C' ' 89' ' ' TYR . 34.8 t -113.29 127.98 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.989 0.424 . . . . 0.0 110.742 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.629 ' HE3' ' HG ' ' C' ' 38' ' ' SER . 1.3 ptp -135.2 139.52 44.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.746 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -117.57 129.9 56.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.472 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.455 ' ND2' ' HA3' ' B' ' 61' ' ' GLY . 15.0 m120 -129.25 145.37 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.676 0.275 . . . . 0.0 111.43 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.59 114.49 7.33 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.575 ' CB ' HD22 ' B' ' 45' ' ' LEU . 83.9 p -128.04 164.43 22.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.426 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.31 142.5 35.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.967 0.413 . . . . 0.0 111.114 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.508 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 17.4 m-80 -109.24 135.05 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.56 126.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.776 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' B' ' 55' ' ' ASN . 3.8 pt-20 -104.69 148.58 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 57.7 m95 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.705 179.723 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 t70 64.4 118.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.959 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -123.87 55.0 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.877 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.78 -52.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.41 103.99 12.11 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.729 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -153.87 111.64 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.682 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t 60.4 71.47 0.57 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.996 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.707 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 7.8 m-70 -109.14 -53.79 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.844 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.707 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.284 31.5 Cg_exo -70.19 141.36 43.26 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.473 2.115 . . . . 0.0 111.923 179.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.52 -49.83 67.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.888 0.375 . . . . 0.0 111.092 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -88.92 104.18 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.694 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.33 115.85 2.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.485 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -129.28 -66.13 0.83 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.56 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.3 -50.53 59.31 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.267 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.99 -54.37 46.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 0.0 110.849 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.419 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 1.3 t60 -53.15 -46.06 68.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.96 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -63.32 -40.72 98.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.534 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.421 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 92.9 t80 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.182 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.02 -30.18 55.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.744 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.525 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.7 mt-30 -71.14 -33.87 70.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.217 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -48.29 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 15.9 m-20 -70.93 -20.44 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.977 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.79 -42.94 57.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 2.6 mmp_? -70.66 -48.82 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.736 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -72.1 -28.9 63.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.813 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -76.0 -37.16 58.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.259 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.497 HD11 ' HA ' ' C' ' 25' ' ' LEU . 9.5 mt -76.13 -32.75 59.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.483 ' O ' HG21 ' A' ' 32' ' ' VAL . 20.9 t0 -67.38 -48.56 67.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 10.0 t -68.7 -37.92 79.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.854 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.582 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 18.9 ttp85 -63.65 -39.09 93.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 29' ' ' ASP . 30.2 m -75.33 -28.25 20.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 13.8 t70 -62.55 -55.12 30.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.001 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 18.7 pttt -70.78 -40.65 72.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.728 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.28 90.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.422 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.516 HD22 ' SD ' ' B' ' 96' ' ' MET . 0.6 OUTLIER -66.95 -34.78 78.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.805 0.336 . . . . 0.0 111.057 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.6 94.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.398 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.514 ' HG ' ' HE3' ' A' ' 96' ' ' MET . 55.6 p -78.38 -39.28 39.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.737 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.0 t -54.66 -64.66 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -54.48 -31.09 55.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.428 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HB1' ' HB1' ' A' ' 70' ' ' ALA . . . -62.39 -48.52 79.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.544 ' HA ' HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -68.59 -32.72 72.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.3 m-20 -80.26 -15.04 57.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -17.55 64.79 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.156 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.767 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.8 mm? -76.59 156.07 33.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.871 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.18 -30.29 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.569 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 7.9 tt0 72.17 108.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.031 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.9 Cg_endo -91.29 139.43 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.637 2.225 . . . . 0.0 112.535 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.0 m-85 69.1 154.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.0 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.408 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -176.62 75.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.255 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.497 HG11 ' CD ' ' A' ' 53' ' ' LYS . 11.7 p -95.57 -24.92 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.067 0.547 . . . . 0.0 112.464 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.812 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.19 48.33 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.246 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.497 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -145.03 179.69 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.6 0.238 . . . . 0.0 110.643 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 11.4 p -105.18 145.3 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.553 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.569 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 0.9 OUTLIER -135.08 119.62 18.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 111.687 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -83.01 132.28 35.15 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.18 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.767 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 43.6 p -111.04 122.73 48.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.926 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.54 143.59 31.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.465 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.89 37.04 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.596 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.14 163.78 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.767 0.317 . . . . 0.0 111.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.19 177.75 19.79 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.447 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.32 26.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.76 123.82 14.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.438 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 27.2 mtt-85 64.18 -94.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.065 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 p -130.69 6.41 4.73 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.203 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.419 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 30.6 t -104.6 174.34 5.92 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.98 177.08 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.46 153.93 20.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.556 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tp -117.26 132.0 56.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -138.8 136.1 35.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.692 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 tp -136.29 145.44 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.28 155.99 34.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.68 163.46 29.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.216 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.437 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t80 -138.43 120.91 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 111.128 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.408 ' HG3' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -110.39 105.58 14.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.685 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.812 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.6 p -104.58 130.8 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.329 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 59.5 -174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 111.143 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.18 68.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.535 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.2 p -160.03 -50.7 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.036 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.26 143.48 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.578 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 154.52 45.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.265 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.88 132.37 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.57 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.445 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -134.72 139.8 45.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.445 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.07 169.42 19.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.68 162.69 25.97 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.532 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.12 33.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.157 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.06 141.33 48.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -124.23 127.86 48.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.269 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -135.59 148.1 48.93 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.7 -98.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.278 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 -28.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 111.323 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.9 p -121.56 15.34 11.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 38.1 m-20 -103.12 70.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.7 t -110.44 128.27 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.722 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.517 ' SD ' HD22 ' C' ' 36' ' ' LEU . 1.6 ptp -135.58 139.44 43.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.74 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -118.93 128.82 54.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.459 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.26 147.37 51.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.36 116.0 5.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.745 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.581 ' CB ' HD22 ' C' ' 45' ' ' LEU . 94.8 p -127.94 163.14 25.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.383 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -136.57 144.58 44.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 111.012 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.425 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 21.6 m-80 -109.83 131.9 54.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.38 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 pt -131.41 126.74 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.75 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.448 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 3.8 pt-20 -105.94 152.88 22.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 44.9 m95 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.685 179.649 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 t70 64.31 119.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.917 0.389 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -123.89 55.04 1.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.84 -52.82 1.99 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.983 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.35 103.95 12.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.781 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -153.82 111.6 3.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.756 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t 60.5 71.43 0.57 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.965 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.701 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 7.7 m-70 -109.27 -53.81 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.762 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.701 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.282 31.2 Cg_exo -70.05 141.29 43.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.427 2.085 . . . . 0.0 111.994 179.191 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.47 -49.73 67.99 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -88.92 104.2 16.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.678 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.37 115.88 2.6 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.429 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -129.31 -66.13 0.82 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.576 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.33 -50.51 59.37 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.219 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.99 -54.39 46.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.886 0.374 . . . . 0.0 110.914 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.412 ' O ' ' HG3' ' B' ' 20' ' ' GLN . 1.3 t60 -53.13 -46.0 68.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.994 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -63.33 -40.79 98.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.546 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . 0.431 ' O ' ' OD2' ' B' ' 22' ' ' ASP . 92.7 t80 -65.59 -32.23 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.205 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -77.14 -30.08 54.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.735 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.525 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 mt-30 -71.24 -33.85 70.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.099 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.406 HD22 ' HG3' ' C' ' 24' ' ' ARG . 0.5 OUTLIER -65.15 -48.28 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.5 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 15.7 m-20 -70.87 -20.41 62.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.76 -43.03 56.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 2.6 mmp_? -70.63 -48.8 53.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.746 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -60.41 -41.8 94.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.644 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -72.04 -28.96 63.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -75.9 -37.2 59.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.259 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.484 HD11 ' HA ' ' A' ' 25' ' ' LEU . 9.6 mt -76.17 -32.83 59.26 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.479 ' O ' HG21 ' B' ' 32' ' ' VAL . 20.9 t0 -67.26 -48.64 67.13 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.981 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 10.1 t -68.66 -37.93 80.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.579 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 19.0 ttp85 -63.67 -39.06 93.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.479 HG21 ' O ' ' B' ' 29' ' ' ASP . 30.2 m -75.36 -28.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.182 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.492 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 13.8 t70 -62.61 -55.11 30.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 18.7 pttt -70.7 -40.68 72.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.31 90.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.4 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.518 HD22 ' SD ' ' C' ' 96' ' ' MET . 0.6 OUTLIER -66.88 -34.84 78.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.086 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.54 94.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.522 ' HG ' ' HE3' ' B' ' 96' ' ' MET . 56.0 p -78.48 -39.21 39.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -54.77 -64.6 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.101 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.401 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -54.46 -31.15 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.478 ' HB1' ' HB1' ' B' ' 70' ' ' ALA . . . -62.28 -48.65 78.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' B' ' 42' ' ' LEU . 0.4 OUTLIER -68.51 -32.76 72.95 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 2.3 m-20 -80.24 -15.02 57.93 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -17.56 64.8 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.081 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.762 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.8 mm? -76.5 156.17 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.38 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.613 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.576 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 7.9 tt0 72.22 108.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.929 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.8 Cg_endo -91.34 139.39 2.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.617 2.212 . . . . 0.0 112.516 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.0 m-85 69.1 154.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.58 75.35 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.227 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.498 HG11 ' CD ' ' B' ' 53' ' ' LYS . 11.7 p -95.59 -24.89 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 123.147 0.579 . . . . 0.0 112.467 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.784 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.11 48.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.277 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.498 ' CD ' HG11 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -145.12 179.61 7.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 110.634 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' B' ' 75' ' ' TYR . 11.4 p -105.12 145.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.606 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.576 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 0.9 OUTLIER -135.05 119.66 18.17 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 111.606 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -82.94 132.33 35.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.21 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.762 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 43.6 p -111.08 122.76 48.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.972 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.55 143.54 31.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.403 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.59 167.88 37.01 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.547 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.09 163.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 111.335 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.14 177.77 19.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.464 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.64 155.36 26.68 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.583 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.492 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.83 123.69 14.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.77 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.439 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 27.3 mtt-85 64.24 -94.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.044 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 68.8 p -130.74 6.35 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.136 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.416 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 30.3 t -104.53 174.31 5.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.93 177.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.45 153.91 20.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.538 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' B' ' 69' ' ' LEU . 6.0 tp -117.26 132.04 56.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.478 ' HB1' ' HB1' ' B' ' 41' ' ' ALA . . . -138.84 136.13 35.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.689 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 111.097 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.76 179.96 35.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.45 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.2 155.95 34.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.59 163.45 29.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.239 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.428 ' CD2' ' HB ' ' B' ' 54' ' ' VAL . 13.0 t80 -138.53 120.84 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.32 105.54 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.748 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.784 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.5 p -104.6 130.97 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 59.55 -174.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 111.109 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -118.18 68.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.7 p -160.04 -50.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.18 143.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 154.42 45.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.82 132.49 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.452 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.79 45.42 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.153 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.452 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.06 169.52 19.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.55 162.68 25.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.621 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.08 33.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.131 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.03 141.22 48.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.365 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.26 127.84 48.28 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.243 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -135.5 148.2 49.11 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.675 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.61 -98.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.334 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.14 -28.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.316 . . . . 0.0 111.32 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -121.53 15.29 11.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.161 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 38.1 m-20 -103.14 70.67 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.4 128.27 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.522 ' HE3' ' HG ' ' B' ' 38' ' ' SER . 1.6 ptp -135.63 139.49 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.701 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.01 128.84 54.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.482 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -129.21 147.36 51.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 111.389 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.3 116.01 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.784 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.581 ' CB ' HD22 ' A' ' 45' ' ' LEU . 94.2 p -127.91 163.12 25.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.411 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.5 144.58 44.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.945 0.402 . . . . 0.0 111.088 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.435 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 21.5 m-80 -109.8 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 pt -131.46 126.62 58.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.846 0.355 . . . . 0.0 110.855 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.447 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 3.9 pt-20 -105.91 152.95 22.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 44.3 m95 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.666 179.654 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.713 -0.155 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 t70 64.33 118.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.906 0.384 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -123.91 55.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.78 -52.79 1.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.014 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.33 103.94 12.08 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -153.84 111.59 3.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.731 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t 60.44 71.47 0.57 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.003 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.701 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 7.8 m-70 -109.24 -53.73 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.801 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.701 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.281 31.4 Cg_exo -70.1 141.39 43.73 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.515 2.144 . . . . 0.0 111.907 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.54 -49.84 67.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.914 0.387 . . . . 0.0 111.121 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -88.9 104.23 16.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.645 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.36 115.85 2.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.459 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -129.35 -66.05 0.83 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.481 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.37 -50.54 59.05 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.201 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.96 -54.4 46.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.917 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . 0.42 ' O ' ' HG3' ' C' ' 20' ' ' GLN . 1.3 t60 -53.13 -46.01 68.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.953 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -63.38 -40.75 98.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.518 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . 0.424 ' O ' ' OD2' ' C' ' 22' ' ' ASP . 92.9 t80 -65.53 -32.35 73.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.247 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.04 -30.15 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.781 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.8 mt-30 -71.17 -33.88 70.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.404 HD22 ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -65.18 -48.27 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 15.8 m-20 -70.84 -20.42 62.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.053 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -74.85 -42.9 57.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' C' ' 20' ' ' GLN . 2.6 mmp_? -70.7 -48.77 52.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.497 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -60.41 -41.71 94.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.676 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -72.19 -28.83 63.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.781 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -75.97 -37.21 58.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.18 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.475 HD11 ' HA ' ' B' ' 25' ' ' LEU . 9.7 mt -76.18 -32.73 59.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.481 ' O ' HG21 ' C' ' 32' ' ' VAL . 21.0 t0 -67.4 -48.49 67.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.945 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 10.1 t -68.75 -37.89 79.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.862 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.559 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 18.9 ttp85 -63.74 -39.02 93.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.325 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.481 HG21 ' O ' ' C' ' 29' ' ' ASP . 29.9 m -75.31 -28.27 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.204 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.497 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 13.8 t70 -62.74 -55.08 29.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.945 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 18.7 pttt -70.64 -40.74 72.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.25 90.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.402 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.517 HD22 ' SD ' ' A' ' 96' ' ' MET . 0.6 OUTLIER -67.02 -34.68 78.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 111.096 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.84 -39.51 94.58 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.4 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.514 ' HG ' ' HE3' ' C' ' 96' ' ' MET . 56.6 p -78.51 -39.27 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 35.9 t -54.7 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.55 -31.12 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.407 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' C' ' 70' ' ' ALA . . . -62.33 -48.5 79.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.511 ' HA ' HD23 ' C' ' 42' ' ' LEU . 0.4 OUTLIER -68.61 -32.64 72.66 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.464 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 2.2 m-20 -80.24 -15.15 57.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -17.59 64.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.144 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.752 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.8 mm? -76.56 156.14 33.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.877 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.27 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.651 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.574 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 7.9 tt0 72.11 108.78 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.019 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.523 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.9 Cg_endo -91.32 139.4 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.617 2.211 . . . . 0.0 112.565 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.1 m-85 69.13 154.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.027 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.57 75.35 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.243 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.495 HG11 ' CD ' ' C' ' 53' ' ' LYS . 11.7 p -95.51 -25.0 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.162 0.585 . . . . 0.0 112.44 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.814 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.17 48.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.316 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . 0.495 ' CD ' HG11 ' C' ' 51' ' ' VAL . 0.6 OUTLIER -145.02 179.69 7.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.595 0.236 . . . . 0.0 110.645 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 11.4 p -105.25 145.32 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.517 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.574 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 0.9 OUTLIER -135.06 119.61 18.09 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.971 0.415 . . . . 0.0 111.679 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -82.94 132.34 35.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.273 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.752 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.1 p -111.12 122.65 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 143.63 31.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.453 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.92 37.09 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 26.1 m -119.17 163.86 16.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 111.39 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.18 177.85 19.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.473 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.7 155.33 26.64 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.556 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.497 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.77 123.75 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.429 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 27.3 mtt-85 64.18 -93.97 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.038 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 68.3 p -130.76 6.39 4.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' SER . . . . . 0.404 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 30.6 t -104.57 174.41 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.08 177.07 7.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.116 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.49 153.91 20.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.58 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' C' ' 69' ' ' LEU . 6.0 tp -117.23 131.96 56.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.795 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' C' ' 41' ' ' ALA . . . -138.73 136.18 35.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.637 0.256 . . . . 0.0 111.664 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -155.3 155.96 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 110.965 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.66 163.42 29.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.262 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.434 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.0 t80 -138.51 120.86 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 105.64 14.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.5 p -104.64 130.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 59.49 -174.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.134 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.16 68.11 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.523 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 41.2 p -160.09 -50.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.986 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 143.51 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.3 154.43 45.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.897 0.38 . . . . 0.0 111.295 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.81 132.5 32.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.77 45.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . 0.449 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.06 169.5 19.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.6 162.75 26.02 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.532 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.22 147.09 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.04 141.33 48.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.329 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.3 127.87 48.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -135.54 148.18 49.03 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.645 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.67 -98.67 0.02 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.322 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.19 -28.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 111.326 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -121.57 15.32 11.13 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 38.2 m-20 -103.14 70.58 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.38 128.24 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 110.709 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.518 ' SD ' HD22 ' B' ' 36' ' ' LEU . 1.6 ptp -135.63 139.54 43.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.696 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.03 128.87 54.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.433 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -129.25 147.36 51.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.366 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.37 115.96 5.88 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.718 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.57 ' CB ' HD22 ' B' ' 45' ' ' LEU . 93.9 p -127.85 163.11 25.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.57 144.51 44.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.008 0.432 . . . . 0.0 111.072 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.429 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 21.4 m-80 -109.69 131.87 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.382 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 pt -131.42 126.68 58.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.441 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 3.9 pt-20 -105.84 152.93 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.989 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 44.6 m95 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.7 179.657 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 t70 68.83 123.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.885 0.374 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -126.91 58.53 1.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.2 -58.27 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.452 ' HA ' ' NE2' ' A' ' 8' ' ' HIS . 0.7 OUTLIER -116.69 103.56 10.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.745 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.7 t-105 -151.73 114.43 4.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.767 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t 60.53 70.02 0.65 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.063 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.731 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 7.7 m-70 -110.13 -54.64 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.755 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.731 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.337 31.5 Cg_exo -72.19 143.29 39.49 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.516 2.144 . . . . 0.0 111.88 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -64.15 -49.57 71.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.988 0.423 . . . . 0.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.47 103.9 13.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.614 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 16.5 pt-20 -158.52 108.87 2.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.473 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 19.5 tttm -124.31 -71.43 0.71 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.516 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.37 90.73 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.282 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.84 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.349 . . . . 0.0 110.895 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 1.5 t60 -57.91 -43.2 86.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.969 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.595 ' HZ1' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER -60.42 -39.32 87.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.526 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.581 ' HA ' ' HZ1' ' B' ' 17' ' ' LYS . 90.3 t80 -63.18 -32.88 74.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.38 -38.27 55.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.767 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.544 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 12.7 mt-30 -67.2 -30.87 70.93 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.191 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.9 -56.08 13.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.589 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.9 -23.99 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -67.16 -39.43 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.561 ' HB3' HD13 ' C' ' 25' ' ' LEU . 5.4 mmp_? -71.82 -48.11 48.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.777 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.581 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.6 OUTLIER -56.4 -52.21 65.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.65 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -64.31 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.772 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -71.76 -36.68 70.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.205 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.567 HD11 ' HA ' ' C' ' 25' ' ' LEU . 3.5 mt -79.17 -33.6 43.85 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.18 96.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.941 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.4 t -76.57 -40.64 49.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.879 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.422 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 21.3 ttp85 -61.68 -40.99 96.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.277 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 28' ' ' LEU . 30.7 m -73.43 -29.04 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.597 ' OD1' ' HB2' ' A' ' 64' ' ' ARG . 17.8 t70 -62.92 -52.58 62.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 26.5 pttt -70.74 -39.55 73.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.738 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.89 97.33 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.427 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' B' ' 39' ' ' SER . 0.5 OUTLIER -66.74 -33.57 75.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 111.077 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -61.99 -43.06 99.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.457 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.449 ' HA ' ' HB1' ' A' ' 68' ' ' ALA . 79.3 p -75.22 -41.04 58.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.742 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.441 ' HB2' HD22 ' C' ' 36' ' ' LEU . 38.2 t -57.55 -62.11 2.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.17 48.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.467 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' HB1' ' HB1' ' A' ' 70' ' ' ALA . . . -65.84 -48.07 72.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.943 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.48 ' HA ' HD23 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -66.1 -32.83 74.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.9 m-20 -79.77 -12.6 59.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -14.82 63.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.137 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.828 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.5 mm? -76.55 156.81 32.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.888 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.13 -26.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 10.1 tt0 71.58 110.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.927 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -90.03 137.13 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.645 2.23 . . . . 0.0 112.549 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.9 m-85 64.64 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.953 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.34 75.43 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.8 p -95.11 -25.26 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.148 0.579 . . . . 0.0 112.415 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.88 48.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.313 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.456 ' HD3' ' H ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -143.44 -178.0 5.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.591 0.234 . . . . 0.0 110.643 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.504 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 8.2 p -106.17 145.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.587 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.597 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 1.4 t30 -134.88 122.69 22.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -85.76 132.86 34.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.235 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.828 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 33.7 p -113.22 125.22 54.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.016 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.45 139.68 22.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.449 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.41 167.3 38.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.434 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' HD12 ' A' ' 69' ' ' LEU . 22.8 m -120.02 161.55 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.326 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.2 177.45 20.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.404 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.35 156.82 28.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.612 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.4 t80 -143.13 128.28 18.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.597 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 16.2 mtt-85 64.97 -91.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 p -135.63 6.1 3.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.496 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 19.3 t -105.18 168.38 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.4 179.29 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.138 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 38' ' ' SER . . . -164.78 150.54 10.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.571 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.583 HD12 ' CG1' ' A' ' 60' ' ' VAL . 12.5 tp -116.22 127.91 55.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.767 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -132.55 136.23 46.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.729 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 tp -132.81 146.68 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.138 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -163.89 -179.44 38.18 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.407 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -154.65 152.04 29.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.257 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.504 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.5 t80 -132.57 122.03 24.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.228 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.34 101.84 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.74 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.5 p -103.56 136.31 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.37 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.943 0.401 . . . . 0.0 111.112 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.47 61.35 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.573 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.76 -44.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.8 p -122.32 141.35 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.258 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.8 134.86 32.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -139.74 138.16 35.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.38 167.93 23.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.41 163.67 25.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 96' ' ' MET . 3.4 p -128.96 145.44 35.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.897 0.38 . . . . 0.0 111.044 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 70' ' ' ALA . . . -114.49 141.12 48.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.18 130.69 54.69 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.273 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 94' ' ' ASP . . . -139.63 145.25 38.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.596 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.428 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 52.19 -96.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.26 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -155.37 -30.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.731 0.3 . . . . 0.0 111.336 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -121.5 16.56 11.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.194 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.523 ' CB ' ' HB1' ' A' ' 90' ' ' ALA . 41.6 m-20 -104.44 73.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.2 t -114.79 131.96 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.642 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 1.2 ptp -136.27 142.27 43.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.714 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -119.95 128.75 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.483 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -125.99 148.94 49.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.346 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.09 114.52 5.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.709 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.476 ' CB ' HD22 ' C' ' 45' ' ' LEU . 53.7 p -130.43 161.24 31.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.463 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -134.0 142.71 47.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.97 0.414 . . . . 0.0 111.072 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 20.7 m-80 -111.68 128.62 56.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.79 131.49 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.8 0.333 . . . . 0.0 110.796 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.51 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 5.4 pt-20 -112.55 154.89 25.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 31.5 m95 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.682 179.682 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 112.678 -0.169 . . . . 0.0 112.678 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 t70 68.73 123.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.881 0.372 . . . . 0.0 111.048 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -126.84 58.63 1.41 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.27 -58.34 1.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.0 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.455 ' HA ' ' NE2' ' B' ' 8' ' ' HIS . 0.7 OUTLIER -116.69 103.57 10.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.791 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -151.76 114.45 4.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.728 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t 60.58 70.11 0.64 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.943 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.757 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 7.7 m-70 -110.16 -54.61 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.824 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.757 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.337 31.5 Cg_exo -72.17 143.38 39.76 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.427 2.085 . . . . 0.0 111.905 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -64.22 -49.5 71.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.951 0.405 . . . . 0.0 111.207 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.56 103.97 13.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.607 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' B' ' 16' ' ' HIS . 16.5 pt-20 -158.58 108.8 2.05 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.546 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' B' ' 17' ' ' LYS . 19.5 tttm -124.23 -71.47 0.71 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.544 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.37 -44.35 90.7 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.27 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 -54.65 37.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.867 0.365 . . . . 0.0 110.937 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' B' ' 12' ' ' GLU . 1.5 t60 -58.0 -43.12 86.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.003 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.581 ' HZ1' ' HA ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -60.53 -39.29 87.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . 0.597 ' HA ' ' HZ1' ' C' ' 17' ' ' LYS . 90.3 t80 -63.12 -32.94 74.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.311 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.4 -38.35 55.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.741 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.548 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 12.7 mt-30 -67.1 -30.88 71.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.973 0.416 . . . . 0.0 111.23 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.88 -56.04 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -69.01 -23.91 64.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -67.17 -39.43 86.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 5.4 mmp_? -71.84 -48.19 47.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.701 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.588 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.6 OUTLIER -56.31 -52.26 65.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -64.29 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.762 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -71.65 -36.83 70.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.603 0.239 . . . . 0.0 111.203 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.581 HD11 ' HA ' ' A' ' 25' ' ' LEU . 3.5 mt -79.08 -33.69 44.31 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.46 -42.16 96.09 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 4.5 t -76.59 -40.7 48.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.422 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 21.2 ttp85 -61.6 -41.05 96.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.474 HG21 ' O ' ' B' ' 28' ' ' LEU . 30.6 m -73.37 -29.11 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.161 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.601 ' OD1' ' HB2' ' B' ' 64' ' ' ARG . 17.8 t70 -62.85 -52.69 62.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HD2' ' HA3' ' B' ' 91' ' ' GLY . 26.5 pttt -70.69 -39.5 73.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.755 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.65 -44.95 97.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.425 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' C' ' 39' ' ' SER . 0.5 OUTLIER -66.73 -33.59 75.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 111.054 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' B' ' 41' ' ' ALA . . . -61.93 -43.09 99.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.424 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.451 ' HA ' ' HB1' ' B' ' 68' ' ' ALA . 79.9 p -75.24 -40.95 58.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.77 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.457 ' HB2' HD22 ' A' ' 36' ' ' LEU . 38.4 t -57.63 -62.11 2.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.18 -30.2 48.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.433 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.429 ' HB1' ' HB1' ' B' ' 70' ' ' ALA . . . -65.86 -48.01 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' B' ' 42' ' ' LEU . 0.7 OUTLIER -66.2 -32.76 74.39 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 2.9 m-20 -79.8 -12.66 59.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -14.94 63.22 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.156 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.818 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.5 mm? -76.46 156.84 32.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.847 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.1 -26.93 0.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.17 0.509 . . . . 0.0 111.683 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 10.1 tt0 71.69 109.87 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.914 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -89.86 137.13 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.709 2.273 . . . . 0.0 112.547 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.9 m-85 64.57 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.957 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.35 75.41 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.242 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 12.7 p -95.04 -25.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.469 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.733 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.88 48.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.45 ' HD3' ' H ' ' B' ' 52' ' ' GLY . 0.4 OUTLIER -143.54 -178.05 5.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.507 ' HB ' ' CE2' ' B' ' 75' ' ' TYR . 8.3 p -106.08 145.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.589 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.597 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 1.4 t30 -134.95 122.61 22.15 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 111.658 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -85.65 132.8 34.09 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.309 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.818 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 33.8 p -113.18 125.27 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.004 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.56 139.64 22.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.439 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.33 38.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.526 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.572 ' CG1' HD12 ' B' ' 69' ' ' LEU . 22.6 m -120.04 161.58 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.786 0.327 . . . . 0.0 111.382 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.23 177.48 20.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.459 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' B' ' 37' ' ' ALA . . . -162.34 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.562 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.48 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.4 t80 -143.13 128.22 18.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.66 0.267 . . . . 0.0 110.801 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.601 ' HB2' ' OD1' ' B' ' 33' ' ' ASP . 16.3 mtt-85 64.95 -91.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.087 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 p -135.64 6.09 3.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.5 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 19.4 t -105.2 168.36 9.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.33 179.36 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' B' ' 38' ' ' SER . . . -164.87 150.48 9.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.539 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.572 HD12 ' CG1' ' B' ' 60' ' ' VAL . 12.3 tp -116.16 127.92 55.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.429 ' HB1' ' HB1' ' B' ' 41' ' ' ALA . . . -132.59 136.22 46.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.67 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 tp -132.81 146.74 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.119 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -163.87 -179.42 38.15 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.41 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 64.5 p -154.7 152.09 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.85 0.357 . . . . 0.0 111.043 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.64 156.91 27.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.25 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.507 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 13.7 t80 -132.59 122.06 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 101.93 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.688 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.733 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.5 p -103.49 136.36 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.3 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.142 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.46 61.27 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.568 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -159.65 -44.84 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.988 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -122.32 141.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 155.72 48.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.258 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.75 134.91 32.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.561 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.438 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.19 35.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.438 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.44 167.9 23.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.073 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.41 163.63 25.71 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 96' ' ' MET . 3.4 p -128.96 145.33 35.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.041 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' B' ' 70' ' ' ALA . . . -114.42 141.1 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.363 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.14 130.65 54.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.262 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.521 ' HB1' ' CB ' ' B' ' 94' ' ' ASP . . . -139.69 145.25 38.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.562 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.424 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 52.25 -96.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.276 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.36 -30.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.339 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -121.51 16.44 11.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.521 ' CB ' ' HB1' ' B' ' 90' ' ' ALA . 41.6 m-20 -104.3 73.52 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 56.3 t -114.74 132.01 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.483 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.2 ptp -136.31 142.27 43.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -120.07 128.77 53.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.37 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.0 148.87 49.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.401 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.06 114.51 5.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.709 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.485 ' CB ' HD22 ' A' ' 45' ' ' LEU . 53.7 p -130.42 161.27 31.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.48 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -134.0 142.65 47.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.111 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.511 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 20.4 m-80 -111.59 128.65 56.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.443 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 110.784 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.506 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 5.4 pt-20 -112.66 154.87 25.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 31.5 m95 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.417 -0.802 . . . . 0.0 110.686 179.655 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 112.64 -0.184 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 t70 68.75 123.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.937 0.399 . . . . 0.0 110.976 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -126.86 58.64 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.27 -58.4 1.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' SER . . . . . 0.453 ' HA ' ' NE2' ' C' ' 8' ' ' HIS . 0.7 OUTLIER -116.67 103.62 10.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.74 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -151.85 114.35 4.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.701 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t 60.66 70.06 0.64 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.982 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.761 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 7.7 m-70 -110.22 -54.55 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.804 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.761 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.338 31.5 Cg_exo -72.23 143.32 39.4 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.437 2.092 . . . . 0.0 111.938 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -64.14 -49.61 71.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.966 0.412 . . . . 0.0 111.2 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -83.4 103.89 13.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.649 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' C' ' 16' ' ' HIS . 16.5 pt-20 -158.53 108.86 2.07 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.504 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' C' ' 17' ' ' LYS . 19.6 tttm -124.31 -71.39 0.72 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.489 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -44.31 90.7 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.294 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.31 -54.76 35.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.906 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' C' ' 12' ' ' GLU . 1.5 t60 -57.96 -43.13 86.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.025 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.597 ' HZ1' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER -60.39 -39.32 86.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.555 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . 0.595 ' HA ' ' HZ1' ' A' ' 17' ' ' LYS . 90.2 t80 -63.17 -32.98 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.37 -38.28 56.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.542 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 12.7 mt-30 -67.26 -30.78 70.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.95 -56.04 13.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.564 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 -23.98 64.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -67.17 -39.43 86.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' B' ' 25' ' ' LEU . 5.4 mmp_? -71.81 -48.18 48.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.788 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.567 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -56.3 -52.28 65.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -64.23 -28.01 69.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.818 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -71.62 -36.8 70.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.248 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.588 HD11 ' HA ' ' B' ' 25' ' ' LEU . 3.5 mt -79.11 -33.66 44.16 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.14 96.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.921 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 4.5 t -76.55 -40.72 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.864 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.435 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 21.3 ttp85 -61.64 -41.0 96.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.469 HG21 ' O ' ' C' ' 28' ' ' LEU . 30.7 m -73.4 -29.09 26.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.596 ' OD1' ' HB2' ' C' ' 64' ' ' ARG . 17.8 t70 -62.77 -52.65 62.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.027 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 26.5 pttt -70.78 -39.44 73.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.94 97.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.386 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 39' ' ' SER . 0.5 OUTLIER -66.68 -33.71 76.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' C' ' 41' ' ' ALA . . . -61.77 -43.16 99.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.441 ' HA ' ' HB1' ' C' ' 68' ' ' ALA . 79.7 p -75.23 -41.02 58.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.46 ' HB2' HD22 ' B' ' 36' ' ' LEU . 38.0 t -57.51 -62.17 1.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.18 48.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.443 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.437 ' HB1' ' HB1' ' C' ' 70' ' ' ALA . . . -65.81 -48.01 73.14 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' C' ' 42' ' ' LEU . 0.7 OUTLIER -66.18 -32.85 74.53 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.409 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 2.8 m-20 -79.71 -12.66 59.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -14.85 63.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.17 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.809 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.5 mm? -76.49 156.86 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.869 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.15 -26.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.206 0.527 . . . . 0.0 111.706 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.58 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 10.1 tt0 71.5 109.91 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.021 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -89.94 137.19 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.554 2.169 . . . . 0.0 112.59 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.8 m-85 64.6 152.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.39 75.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.228 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.94 -25.27 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.18 0.592 . . . . 0.0 112.509 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.714 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.91 48.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.298 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . 0.447 ' HD3' ' H ' ' C' ' 52' ' ' GLY . 0.4 OUTLIER -143.52 -178.07 5.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.585 0.231 . . . . 0.0 110.608 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.507 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 8.2 p -106.16 145.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.557 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.58 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 1.4 t30 -134.88 122.72 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -85.74 132.89 34.05 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.172 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.809 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 33.5 p -113.29 125.27 54.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.895 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.57 139.67 22.11 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.4 38.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.586 ' CG1' HD12 ' C' ' 69' ' ' LEU . 22.6 m -120.12 161.57 19.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 111.33 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.22 177.47 20.29 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.418 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' C' ' 37' ' ' ALA . . . -162.33 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.4 t80 -143.09 128.29 18.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.686 0.279 . . . . 0.0 110.746 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.596 ' HB2' ' OD1' ' C' ' 33' ' ' ASP . 16.3 mtt-85 64.94 -91.07 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.096 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.0 p -135.59 6.15 3.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.227 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' SER . . . . . 0.495 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 19.4 t -105.26 168.4 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.778 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.41 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' C' ' 38' ' ' SER . . . -164.83 150.47 9.97 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.556 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.586 HD12 ' CG1' ' C' ' 60' ' ' VAL . 12.4 tp -116.17 127.9 55.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.437 ' HB1' ' HB1' ' C' ' 41' ' ' ALA . . . -132.63 136.19 46.34 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 tp -132.74 146.75 32.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.732 0.301 . . . . 0.0 111.134 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -163.9 -179.39 38.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.435 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.4 p -154.71 152.0 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 111.056 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.26 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.507 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.7 t80 -132.64 122.05 24.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 111.128 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 101.83 10.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.714 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.5 p -103.46 136.36 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 63.3 -171.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.391 . . . . 0.0 111.089 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.55 61.35 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.72 -44.77 0.05 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.33 141.37 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.69 155.78 47.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.74 134.85 32.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.539 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.21 35.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.157 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.45 167.86 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.49 163.65 25.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.574 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.407 HG22 ' O ' ' C' ' 96' ' ' MET . 3.5 p -128.87 145.41 35.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.137 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' C' ' 70' ' ' ALA . . . -114.5 141.14 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.347 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 130.69 54.71 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.288 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' C' ' 94' ' ' ASP . . . -139.68 145.21 38.11 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.595 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 52.28 -96.33 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.258 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.38 -30.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.281 . . . . 0.0 111.296 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.6 p -121.42 16.45 11.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.239 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.519 ' CB ' ' HB1' ' C' ' 90' ' ' ALA . 41.5 m-20 -104.39 73.54 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -114.79 132.03 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 0.0 110.636 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.48 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 1.2 ptp -136.33 142.2 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.642 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.96 128.72 53.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -125.95 148.84 49.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.299 . . . . 0.0 111.419 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.05 114.5 5.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.829 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.48 ' CB ' HD22 ' B' ' 45' ' ' LEU . 53.6 p -130.44 161.21 31.89 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.393 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -133.95 142.65 47.78 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.917 0.389 . . . . 0.0 111.113 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 20.9 m-80 -111.6 128.68 56.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.79 131.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.743 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.513 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 5.4 pt-20 -112.63 154.92 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 31.0 m95 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.706 179.669 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.628 -0.189 . . . . 0.0 112.628 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 t70 67.06 123.63 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 110.952 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -128.94 48.35 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.35 -54.33 2.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.439 ' HA ' ' NE2' ' A' ' 8' ' ' HIS . 0.7 OUTLIER -114.1 105.46 13.23 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.723 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -153.81 112.99 3.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.718 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t 61.58 78.18 0.3 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.969 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.629 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 8.9 m-70 -107.85 -49.36 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.815 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.319 31.4 Cg_exo -71.48 146.9 51.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.501 2.134 . . . . 0.0 111.944 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -64.3 -52.72 57.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.985 0.421 . . . . 0.0 111.213 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -89.72 112.3 23.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.681 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -158.1 114.13 2.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.448 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -125.27 -70.99 0.72 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.511 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -44.88 67.17 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.274 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.02 -55.12 38.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.851 0.358 . . . . 0.0 110.939 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.87 -47.58 82.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.97 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -53.03 -40.87 64.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.57 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 24.9 mmt180 -76.8 -36.88 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.725 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.6 mt-30 -67.5 -32.94 74.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' B' ' 24' ' ' ARG . 1.4 tt -68.6 -55.84 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.558 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.13 -25.46 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 24.6 t-20 -71.76 -42.48 67.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 3.7 mmp_? -69.27 -45.28 70.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.814 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.692 HD13 HD11 ' B' ' 28' ' ' LEU . 1.9 tp -56.29 -49.09 75.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.562 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.79 -32.08 73.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -69.98 -32.89 71.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.26 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.7 HD11 HD13 ' C' ' 25' ' ' LEU . 1.7 mt -81.06 -32.37 34.04 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.69 -40.21 88.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.017 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.3 t -76.73 -39.34 52.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.427 HH22 HG23 ' C' ' 32' ' ' VAL . 43.6 ttp85 -59.46 -41.81 90.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 28' ' ' LEU . 27.2 m -78.29 -23.6 13.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.204 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 18.6 t70 -67.63 -51.54 48.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.446 ' NZ ' ' HA3' ' A' ' 91' ' ' GLY . 32.7 pttt -76.38 -40.28 51.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.93 98.75 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -67.09 -33.9 76.47 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.882 0.372 . . . . 0.0 111.156 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.17 99.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.457 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.491 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 94.4 p -76.29 -37.31 57.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.637 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 33.0 t -63.73 -55.01 26.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.98 -32.1 69.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.564 ' HB1' ' HB1' ' A' ' 70' ' ' ALA . . . -64.88 -46.47 81.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.955 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -66.22 -30.39 70.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.3 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 9.7 m-20 -81.36 -15.71 54.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.46 -15.04 62.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.112 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.715 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.9 mm? -71.39 164.52 25.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.911 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 25.0 p90 -152.55 -32.02 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.148 0.499 . . . . 0.0 111.701 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.522 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 15.3 tt0 73.53 106.71 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.96 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -93.07 136.34 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.628 2.219 . . . . 0.0 112.552 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 10.6 m-85 65.52 151.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 178.62 78.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.235 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.31 -23.28 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.206 0.603 . . . . 0.0 112.411 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 157.5 49.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.278 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.65 -176.73 5.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.605 0.24 . . . . 0.0 110.563 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.22 150.57 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.568 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 2.2 t30 -132.91 124.37 27.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.66 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -87.18 128.17 35.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.319 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.715 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 38.2 p -114.71 123.08 48.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.047 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.29 136.78 18.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.451 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.05 44.35 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.582 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.495 HG12 HD12 ' A' ' 69' ' ' LEU . 16.4 m -126.9 166.98 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.801 0.334 . . . . 0.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA3' HD21 ' B' ' 98' ' ' ASN . . . -141.35 172.32 23.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.44 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.47 152.36 23.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.547 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.3 t80 -142.44 128.68 19.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.686 0.279 . . . . 0.0 110.737 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.36 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 p -140.35 10.07 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.455 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 9.8 t -109.6 167.6 10.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.67 -179.09 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.19 156.46 10.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.526 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 60' ' ' VAL . 7.6 tp -114.58 130.97 56.83 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -129.62 141.43 50.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.682 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 72' ' ' GLY . 7.9 tp -138.14 150.38 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.092 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 71' ' ' ILE . . . -169.28 177.41 42.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.395 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.6 146.4 18.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.25 158.41 27.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.519 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 30.9 t80 -126.3 125.02 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.154 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.487 ' NH2' ' HB2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -113.1 102.71 10.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.586 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.0 p -104.41 138.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 59.88 -167.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -126.59 66.08 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.419 ' HA ' ' HG3' ' A' ' 104' ' ' GLU . 19.9 p -165.4 -46.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.986 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.47 ' HA ' HG21 ' A' ' 103' ' ' ILE . 14.7 p -118.24 139.86 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.49 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.46 45.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.293 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.16 138.91 33.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.638 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.124 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . . . -143.34 169.75 17.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.103 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.04 157.62 14.33 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.507 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 88' ' ' ALA . 1.5 p -124.05 144.89 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 111.079 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.425 ' N ' HG22 ' A' ' 87' ' ' VAL . . . -112.57 142.43 45.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.99 122.89 39.63 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.31 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -137.34 147.3 45.47 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.6 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.446 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 57.03 -94.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.276 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 t -159.4 -33.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 111.357 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.77 13.83 12.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 32.6 m-20 -101.85 72.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.969 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 t -116.08 127.05 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.987 0.423 . . . . 0.0 110.759 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 39' ' ' SER . 1.3 ptp -131.85 140.2 49.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.681 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -121.55 126.69 49.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.428 HD21 ' HA3' ' C' ' 61' ' ' GLY . 17.0 m120 -128.42 141.51 51.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . . . -144.83 117.21 8.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.781 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.49 162.13 27.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.452 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.06 133.52 50.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.103 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 28.7 m-80 -108.38 127.86 54.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.458 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.47 HG21 ' HA ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -131.74 138.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.77 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 80' ' ' SER . 4.6 pt-20 -112.59 146.98 37.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 40.3 m95 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.666 179.633 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.67 -0.172 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 15.3 t70 66.92 123.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -128.85 48.39 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.37 -54.27 2.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.438 ' HA ' ' NE2' ' B' ' 8' ' ' HIS . 0.7 OUTLIER -114.15 105.44 13.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.795 -179.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -153.74 112.93 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.758 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t 61.67 78.1 0.3 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.041 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.625 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 9.1 m-70 -107.87 -49.42 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.769 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.32 31.5 Cg_exo -71.47 146.96 51.19 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.458 2.105 . . . . 0.0 111.906 179.314 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -64.36 -52.81 56.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.975 0.417 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -89.65 112.21 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.735 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -157.99 114.1 2.8 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.499 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -125.24 -70.94 0.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.558 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.89 -44.94 65.92 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.241 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.88 -55.14 38.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 0.0 110.942 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.96 -47.46 82.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.99 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -53.08 -40.88 64.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.566 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.45 -29.86 70.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.259 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 24.9 mmt180 -76.74 -36.89 56.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.61 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.6 mt-30 -67.46 -32.96 74.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.578 HD22 ' HG3' ' C' ' 24' ' ' ARG . 1.4 tt -68.61 -55.77 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.15 -25.44 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 24.6 t-20 -71.79 -42.54 66.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.61 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 3.7 mmp_? -69.3 -45.25 70.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.709 HD13 HD11 ' C' ' 28' ' ' LEU . 1.9 tp -56.36 -49.06 75.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.582 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.73 -32.08 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.814 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -70.02 -32.9 71.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.237 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.692 HD11 HD13 ' A' ' 25' ' ' LEU . 1.7 mt -81.05 -32.34 34.08 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.7 -40.29 88.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.936 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 4.3 t -76.68 -39.38 52.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.814 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.427 HH22 HG23 ' A' ' 32' ' ' VAL . 43.4 ttp85 -59.31 -41.91 90.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.336 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.547 HG21 ' O ' ' B' ' 28' ' ' LEU . 27.2 m -78.28 -23.63 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.157 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' B' ' 66' ' ' SER . 18.6 t70 -67.6 -51.59 48.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.986 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.448 ' NZ ' ' HA3' ' B' ' 91' ' ' GLY . 32.7 pttt -76.28 -40.41 51.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.792 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.21 -43.92 98.77 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.5 OUTLIER -67.14 -33.87 76.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' B' ' 41' ' ' ALA . . . -62.62 -43.13 99.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.47 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 94.5 p -76.33 -37.33 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.758 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.629 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 32.7 t -63.76 -54.97 27.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.0 69.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.567 ' HB1' ' HB1' ' B' ' 70' ' ' ALA . . . -64.83 -46.59 81.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' B' ' 42' ' ' LEU . 0.6 OUTLIER -66.05 -30.49 71.02 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.555 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 9.7 m-20 -81.39 -15.64 54.59 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -15.11 62.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.073 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.723 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.9 mm? -71.4 164.59 25.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.837 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.414 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 24.9 p90 -152.58 -32.08 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.15 0.5 . . . . 0.0 111.625 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.528 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 15.4 tt0 73.49 106.61 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.0 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.487 ' HB2' ' NH2' ' C' ' 76' ' ' ARG . 9.8 Cg_endo -93.02 136.32 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.668 2.245 . . . . 0.0 112.52 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 10.6 m-85 65.56 151.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 178.57 78.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.264 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.22 -23.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 123.108 0.563 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 157.54 49.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.299 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.31 150.59 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.543 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.528 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 2.2 t30 -132.94 124.34 27.62 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.981 0.42 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -87.21 128.23 35.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.224 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.723 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.7 p -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.965 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.3 136.76 18.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.366 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.07 44.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.572 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.496 HG12 HD12 ' B' ' 69' ' ' LEU . 16.4 m -126.89 166.96 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.377 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . 0.421 ' HA3' HD21 ' C' ' 98' ' ' ASN . . . -141.32 172.34 23.87 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.451 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.51 152.42 23.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.579 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.3 t80 -142.53 128.6 19.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 0.0 110.716 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 63.47 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.083 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 34.8 p -140.37 10.17 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.224 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.458 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 9.8 t -109.63 167.63 10.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.72 -179.13 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.13 156.59 10.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.532 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.496 HD12 HG12 ' B' ' 60' ' ' VAL . 7.6 tp -114.66 130.95 56.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.777 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.567 ' HB1' ' HB1' ' B' ' 41' ' ' ALA . . . -129.66 141.45 50.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.446 HG13 ' N ' ' B' ' 72' ' ' GLY . 7.9 tp -138.16 150.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.77 0.319 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.446 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -169.14 177.43 42.86 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.55 146.51 18.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.31 158.37 27.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.254 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . 0.522 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 30.8 t80 -126.3 125.01 41.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.476 ' NH2' ' HB2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.09 102.68 10.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.663 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.6 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.1 p -104.36 138.3 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.95 -167.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -126.58 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' SER . . . . . 0.416 ' HA ' ' HG3' ' B' ' 104' ' ' GLU . 20.1 p -165.47 -46.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.955 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.487 ' HA ' HG21 ' B' ' 103' ' ' ILE . 14.8 p -118.2 139.88 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.557 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.15 155.48 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.273 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.21 138.86 33.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' B' ' 99' ' ' ALA . . . -143.36 169.78 17.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.082 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.99 157.58 14.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.587 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.427 HG22 ' N ' ' B' ' 88' ' ' ALA . 1.5 p -124.08 144.85 32.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.427 ' N ' HG22 ' B' ' 87' ' ' VAL . . . -112.55 142.46 45.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.323 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.05 122.9 39.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -137.35 147.23 45.38 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.585 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.448 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 57.16 -94.64 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.252 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.1 t -159.37 -33.83 0.06 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.735 0.303 . . . . 0.0 111.312 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -119.75 13.87 12.47 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 32.6 m-20 -101.86 72.2 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -116.02 127.11 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.029 0.442 . . . . 0.0 110.712 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.629 ' SD ' ' HB2' ' B' ' 39' ' ' SER . 1.3 ptp -131.98 140.16 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -121.51 126.6 49.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.406 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.419 HD21 ' HA3' ' A' ' 61' ' ' GLY . 16.9 m120 -128.35 141.46 51.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.487 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . 0.642 ' HB2' ' HB3' ' B' ' 85' ' ' ALA . . . -144.71 117.27 8.61 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.58 162.11 28.03 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.446 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -127.03 133.52 50.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.951 0.405 . . . . 0.0 111.079 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.493 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 28.7 m-80 -108.41 127.78 54.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.365 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.487 HG21 ' HA ' ' B' ' 81' ' ' VAL . 0.7 OUTLIER -131.65 138.13 53.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.795 0.331 . . . . 0.0 110.827 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.423 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 4.6 pt-20 -112.69 147.0 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 40.3 m95 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.634 179.736 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.624 -0.19 . . . . 0.0 112.624 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 t70 66.96 123.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -128.9 48.34 2.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.886 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.24 -54.38 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.995 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' SER . . . . . 0.448 ' HA ' ' NE2' ' C' ' 8' ' ' HIS . 0.6 OUTLIER -114.14 105.45 13.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.695 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -153.81 113.0 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.714 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t 61.6 78.16 0.3 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.005 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.619 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 9.0 m-70 -107.84 -49.4 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.808 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.619 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.317 31.5 Cg_exo -71.41 146.97 51.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.497 2.131 . . . . 0.0 111.9 179.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -64.43 -52.69 56.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.163 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -89.74 112.28 23.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.661 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -158.05 114.05 2.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.488 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -125.22 -70.98 0.72 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.556 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -44.9 67.05 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.311 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.01 -55.1 39.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 110.938 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.93 -47.45 82.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.999 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -53.16 -40.82 64.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.524 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.279 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 24.8 mmt180 -76.73 -36.96 56.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.606 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.6 mt-30 -67.48 -32.91 74.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.16 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.567 HD22 ' HG3' ' A' ' 24' ' ' ARG . 1.4 tt -68.54 -55.86 10.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -66.15 -25.5 66.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 24.5 t-20 -71.72 -42.51 67.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' C' ' 20' ' ' GLN . 3.7 mmp_? -69.26 -45.29 70.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.7 HD13 HD11 ' A' ' 28' ' ' LEU . 1.9 tp -56.32 -49.09 75.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.581 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.77 -32.06 73.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.787 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -69.97 -32.96 71.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.253 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.709 HD11 HD13 ' B' ' 25' ' ' LEU . 1.7 mt -81.0 -32.4 34.24 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.76 -40.19 88.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.94 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 4.4 t -76.66 -39.29 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.899 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.429 HH22 HG23 ' B' ' 32' ' ' VAL . 43.5 ttp85 -59.51 -41.83 90.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.289 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.54 HG21 ' O ' ' C' ' 28' ' ' LEU . 27.3 m -78.36 -23.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' C' ' 66' ' ' SER . 18.6 t70 -67.51 -51.53 49.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.062 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' C' ' 30' ' ' THR . 32.6 pttt -76.46 -40.3 50.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.755 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.91 98.78 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.43 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.5 OUTLIER -67.1 -34.01 76.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.24 99.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.475 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 95.1 p -76.27 -37.38 57.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.642 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 33.1 t -63.72 -54.88 28.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.15 -32.03 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' C' ' 70' ' ' ALA . . . -64.86 -46.59 81.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' C' ' 42' ' ' LEU . 0.6 OUTLIER -66.12 -30.37 70.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.072 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 43' ' ' ASN . 9.6 m-20 -81.39 -15.73 54.35 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -14.95 62.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.159 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.73 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.9 mm? -71.52 164.56 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.89 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 24.8 p90 -152.55 -32.03 0.14 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.129 0.49 . . . . 0.0 111.705 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.527 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 15.4 tt0 73.49 106.64 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.974 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -92.93 136.31 1.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.647 2.231 . . . . 0.0 112.546 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 10.7 m-85 65.61 151.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 178.62 78.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.266 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.212 0.605 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 157.55 49.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.321 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.604 0.24 . . . . 0.0 110.579 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.27 150.62 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.613 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.527 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 2.2 t30 -132.99 124.28 27.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 111.686 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -87.15 128.26 35.13 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.223 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.73 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 38.1 p -114.82 123.17 48.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.97 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.31 136.66 18.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.474 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.21 176.99 44.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.554 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.502 HG12 HD12 ' C' ' 69' ' ' LEU . 16.4 m -126.87 166.91 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.315 . . . . 0.0 111.418 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . 0.428 ' HA3' HD21 ' A' ' 98' ' ' ASN . . . -141.25 172.41 23.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.518 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.6 152.33 23.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.587 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.582 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.3 t80 -142.46 128.62 19.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.751 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.41 -86.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.6 p -140.38 10.1 2.29 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' SER . . . . . 0.448 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 9.7 t -109.57 167.67 9.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.76 -179.08 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 111.104 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.23 156.51 10.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.541 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . 0.502 HD12 HG12 ' C' ' 60' ' ' VAL . 7.6 tp -114.62 130.87 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.762 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' C' ' 41' ' ' ALA . . . -129.55 141.49 50.96 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.721 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.465 HG13 ' N ' ' C' ' 72' ' ' GLY . 7.9 tp -138.15 150.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.816 0.341 . . . . 0.0 111.065 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.465 ' N ' HG13 ' C' ' 71' ' ' ILE . . . -169.27 177.42 42.94 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.476 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -158.61 146.47 18.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 110.976 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.26 158.38 27.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.255 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.529 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 30.7 t80 -126.27 125.03 41.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.487 ' NH2' ' HB2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -113.12 102.77 10.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.588 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.0 p -104.48 138.3 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.9 -167.39 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -126.62 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.518 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' SER . . . . . 0.426 ' HA ' ' HG3' ' C' ' 104' ' ' GLU . 20.1 p -165.43 -46.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.009 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.481 ' HA ' HG21 ' C' ' 103' ' ' ILE . 14.8 p -118.2 139.77 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.575 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.48 45.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.302 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.25 138.81 33.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.558 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.414 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -145.43 132.57 20.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.15 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' C' ' 99' ' ' ALA . . . -143.31 169.77 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.08 157.58 14.27 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.564 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . 0.427 HG22 ' N ' ' C' ' 88' ' ' ALA . 1.5 p -124.12 144.85 32.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 111.098 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.427 ' N ' HG22 ' C' ' 87' ' ' VAL . . . -112.46 142.44 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.334 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.08 122.95 39.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -137.3 147.36 45.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.64 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.434 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 56.92 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.331 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.3 t -159.37 -33.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.714 0.292 . . . . 0.0 111.338 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.78 13.85 12.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.162 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 32.5 m-20 -101.91 72.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.03 127.15 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.629 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.642 ' SD ' ' HB2' ' C' ' 39' ' ' SER . 1.3 ptp -131.91 140.13 48.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.684 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -121.45 126.7 49.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.402 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.421 HD21 ' HA3' ' B' ' 61' ' ' GLY . 17.0 m120 -128.4 141.52 51.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.38 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' C' ' 85' ' ' ALA . . . -144.82 117.24 8.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.53 162.19 27.82 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.474 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.12 133.53 50.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.0 111.084 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.484 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 28.5 m-80 -108.4 127.84 54.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.345 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.481 HG21 ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -131.67 138.0 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.821 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.426 ' HG3' ' HA ' ' C' ' 80' ' ' SER . 4.7 pt-20 -112.56 147.02 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 40.0 m95 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 179.675 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 t70 65.14 124.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -125.71 52.41 1.65 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.907 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.38 -49.89 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.032 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -129.19 113.83 15.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.722 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -156.69 103.83 2.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.773 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 t 68.44 71.39 0.3 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.067 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.71 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 8.6 m-70 -110.35 -53.97 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.704 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.71 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.313 31.4 Cg_exo -71.31 138.46 33.07 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.468 2.112 . . . . 0.0 111.973 179.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.07 -35.07 75.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.937 0.398 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.28 109.21 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.67 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -164.32 115.72 1.29 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.403 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.631 ' HE3' ' HE3' ' B' ' 13' ' ' LYS . 4.3 tttm -133.15 -59.49 0.88 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.505 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.56 -39.56 86.68 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.296 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -74.51 -52.37 12.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.859 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.639 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 0.7 OUTLIER -56.02 -47.36 77.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.057 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.647 ' HZ1' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER -61.94 -42.4 99.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.514 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.652 ' HA ' ' HZ1' ' B' ' 17' ' ' LYS . 74.1 t80 -62.6 -41.13 98.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.245 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 34.5 mmt180 -73.7 -30.43 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 16' ' ' HIS . 19.2 mt-30 -71.66 -34.47 69.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.712 HD11 HD11 ' C' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.61 63.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.633 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.85 -25.51 64.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.041 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 6.2 t-20 -66.43 -37.26 84.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HD3' ' HB2' ' C' ' 25' ' ' LEU . 6.3 mmp_? -71.02 -44.8 65.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.671 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.3 OUTLIER -61.11 -32.66 72.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.608 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -81.78 -28.3 33.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' O ' HG22 ' A' ' 30' ' ' THR . 36.9 tttm -73.16 -43.28 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.67 0.272 . . . . 0.0 111.217 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.681 HD11 ' HA ' ' C' ' 25' ' ' LEU . 11.4 mt -72.05 -29.01 63.73 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.445 ' O ' HG21 ' A' ' 32' ' ' VAL . 25.2 t0 -66.78 -47.41 72.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.961 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.529 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.5 t -71.0 -33.81 70.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.869 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.626 HH21 HD23 ' A' ' 28' ' ' LEU . 45.2 ttp85 -67.71 -40.11 84.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.546 HG23 ' NH2' ' B' ' 31' ' ' ARG . 33.8 m -76.09 -29.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.659 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 7.2 t70 -62.42 -57.25 11.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.053 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 30' ' ' THR . 26.8 pttt -70.26 -44.58 68.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.756 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.3 82.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.439 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -26.32 62.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.819 0.342 . . . . 0.0 111.097 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 68' ' ' ALA . . . -66.69 -37.68 85.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.402 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 52.3 p -82.96 -38.75 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.688 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.456 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 31.0 t -57.39 -57.2 13.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -32.54 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.651 ' HB1' ' HB1' ' A' ' 70' ' ' ALA . . . -62.31 -45.31 93.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -66.14 -32.8 74.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.043 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 1.1 m-20 -82.83 -15.82 50.09 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.64 -17.75 64.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.135 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.749 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.4 mm? -75.41 162.66 28.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.812 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.534 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 45.1 p90 -143.83 -30.46 0.48 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 111.706 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.45 ' CG ' ' HB3' ' A' ' 55' ' ' ASN . 15.8 tt0 72.03 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.983 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.7 Cg_endo -89.13 140.6 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.693 2.262 . . . . 0.0 112.52 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 18.2 m-85 67.01 150.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.477 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -173.94 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.329 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.02 -19.41 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.154 0.582 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 148.44 48.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.294 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.09 4.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.674 0.273 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 55' ' ' ASN . 7.1 p -110.35 137.94 40.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.582 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' B' ' 104' ' ' GLU . 6.5 t30 -125.95 119.7 28.42 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.02 0.438 . . . . 0.0 111.686 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -80.3 128.35 33.44 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.269 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.749 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 16.7 p -114.29 119.86 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.498 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -176.96 166.77 37.69 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.573 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.28 165.12 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.843 0.354 . . . . 0.0 111.316 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.15 176.09 21.2 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.396 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.31 27.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.659 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.72 123.33 14.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.57 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 33.3 mtt-85 65.75 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 p -137.59 12.91 2.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.7 t -109.34 173.15 6.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.35 177.21 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.111 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . . . -163.72 161.19 23.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -119.6 136.24 54.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.713 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.651 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -136.43 137.94 40.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.638 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -138.09 145.77 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 111.135 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -172.55 -175.34 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.452 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.11 158.36 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.776 0.322 . . . . 0.0 111.046 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.48 28.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.294 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -129.31 119.02 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 111.135 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HD3' ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -105.82 104.0 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.739 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.712 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 10.8 p -101.9 126.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 63.86 -171.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -118.25 58.34 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.557 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.051 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.772 ' HA ' HG21 ' A' ' 103' ' ' ILE . 6.3 p -112.33 143.45 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.513 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.488 ' HB1' ' HD3' ' A' ' 76' ' ' ARG . . . -146.64 151.78 37.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.36 132.61 35.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.578 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.17 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.64 171.33 18.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.097 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.5 157.31 10.66 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.56 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 111.141 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.28 151.9 30.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.315 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.33 126.89 38.27 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.276 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -140.89 145.57 36.32 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.614 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.419 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 55.18 -98.54 0.05 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.275 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 -25.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 111.311 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.96 12.92 7.28 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 33.8 m-20 -98.91 69.26 1.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.09 127.04 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.716 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.626 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 5.3 ptp -133.04 147.1 52.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.702 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -126.19 130.88 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.447 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -128.08 137.85 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 111.383 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.24 109.5 7.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.773 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.447 ' HB2' HD12 ' C' ' 45' ' ' LEU . 91.5 p -125.24 163.47 22.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.472 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.05 140.27 50.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.963 0.411 . . . . 0.0 111.111 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.417 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 45.2 m-80 -111.76 125.59 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.772 HG21 ' HA ' ' A' ' 81' ' ' VAL . 3.3 pt -136.67 134.43 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.454 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 6.6 pt-20 -111.66 159.45 18.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 50.4 m95 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.446 -0.788 . . . . 0.0 110.701 179.68 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.648 -0.181 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 t70 65.15 124.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.893 0.377 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -125.68 52.52 1.64 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.37 -49.85 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.08 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -129.23 113.84 15.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.707 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 32.3 t-105 -156.67 103.85 2.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.757 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t 68.42 71.44 0.3 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.996 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.72 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 8.8 m-70 -110.31 -54.02 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.775 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.72 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.313 31.4 Cg_exo -71.22 138.44 33.28 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.495 2.13 . . . . 0.0 111.958 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.08 -35.1 76.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.903 0.382 . . . . 0.0 111.147 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -98.29 109.21 22.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.646 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -164.29 115.71 1.29 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.445 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.631 ' HE3' ' HE3' ' A' ' 13' ' ' LYS . 4.3 tttm -133.16 -59.46 0.88 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.484 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.58 -39.64 86.54 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.231 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' B' ' 19' ' ' ARG . . . -74.41 -52.37 12.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.802 0.334 . . . . 0.0 110.94 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.63 ' O ' ' HG3' ' B' ' 20' ' ' GLN . 0.7 OUTLIER -56.1 -47.43 78.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.959 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.652 ' HZ1' ' HA ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -61.93 -42.37 99.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.533 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . 0.645 ' HA ' ' HZ1' ' C' ' 17' ' ' LYS . 73.8 t80 -62.57 -41.09 98.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.304 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 34.5 mmt180 -73.75 -30.39 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.63 ' HG3' ' O ' ' B' ' 16' ' ' HIS . 19.0 mt-30 -71.66 -34.5 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.709 HD11 HD11 ' C' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.59 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.604 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.81 -25.57 64.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 6.2 t-20 -66.29 -37.41 85.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.515 ' HD3' ' HB2' ' A' ' 25' ' ' LEU . 6.3 mmp_? -71.05 -44.61 65.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.3 OUTLIER -61.33 -32.52 72.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.565 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -81.82 -28.35 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.79 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.435 ' O ' HG22 ' B' ' 30' ' ' THR . 37.0 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.21 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.671 HD11 ' HA ' ' A' ' 25' ' ' LEU . 11.5 mt -72.1 -28.95 63.63 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.438 ' O ' HG21 ' B' ' 32' ' ' VAL . 25.2 t0 -66.83 -47.42 72.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.909 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.537 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 2.5 t -71.01 -33.79 70.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.81 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.649 HH21 HD23 ' B' ' 28' ' ' LEU . 45.3 ttp85 -67.74 -40.1 84.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.539 HG23 ' NH2' ' C' ' 31' ' ' ARG . 33.8 m -76.15 -29.44 19.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.256 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.669 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 7.2 t70 -62.62 -57.28 11.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' B' ' 30' ' ' THR . 26.8 pttt -70.13 -44.68 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -45.33 81.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.46 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -26.36 63.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 111.075 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' B' ' 68' ' ' ALA . . . -66.53 -37.8 85.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.418 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 52.3 p -82.92 -38.76 22.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.466 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 30.8 t -57.27 -57.33 13.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.56 68.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.65 ' HB1' ' HB1' ' B' ' 70' ' ' ALA . . . -62.18 -45.46 93.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.919 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' B' ' 42' ' ' LEU . 0.3 OUTLIER -66.07 -32.79 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.077 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 1.1 m-20 -82.88 -15.72 50.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.76 -17.72 64.42 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.144 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.746 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -75.39 162.71 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.94 -30.38 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.451 ' CG ' ' HB3' ' B' ' 55' ' ' ASN . 15.7 tt0 72.04 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.0 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.7 Cg_endo -89.15 140.66 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.626 2.217 . . . . 0.0 112.514 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 18.2 m-85 67.05 150.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.461 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . -173.97 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.308 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.01 -19.45 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.159 0.584 . . . . 0.0 112.473 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 148.45 48.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.3 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.07 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.552 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.425 HG22 ' N ' ' B' ' 55' ' ' ASN . 7.2 p -110.41 137.95 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 6.5 t30 -125.84 119.71 28.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 111.706 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -80.3 128.4 33.5 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.201 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.746 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 16.7 p -114.32 119.79 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.99 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.456 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -176.91 166.76 37.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.532 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.38 165.1 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.307 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.05 176.09 21.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.403 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.0 156.28 27.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.549 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.669 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.66 123.25 14.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . 0.58 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 33.5 mtt-85 65.78 -88.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.063 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 64.8 p -137.56 12.89 2.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.22 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -109.33 173.14 6.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.25 177.22 7.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.123 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' B' ' 37' ' ' ALA . . . -163.71 161.14 23.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.607 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tp -119.5 136.21 54.43 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.65 ' HB1' ' HB1' ' B' ' 41' ' ' ALA . . . -136.48 137.82 40.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -137.99 145.79 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.085 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -172.58 -175.37 40.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.463 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.6 p -164.07 158.37 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.17 159.58 28.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.3 118.98 23.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.487 ' HD3' ' HB1' ' B' ' 82' ' ' ALA . 0.0 OUTLIER -105.84 104.03 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.698 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 10.8 p -101.91 126.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.293 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.76 -171.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -118.21 58.32 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.97 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.783 ' HA ' HG21 ' B' ' 103' ' ' ILE . 6.3 p -112.37 143.43 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.487 ' HB1' ' HD3' ' B' ' 76' ' ' ARG . . . -146.7 151.72 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 111.231 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 44.9 tp -136.36 132.57 35.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.623 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.21 47.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.34 18.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.45 157.33 10.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.509 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.167 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.91 30.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.339 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.39 126.81 37.97 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.311 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -140.85 145.61 36.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.581 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 55.17 -98.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.27 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.37 -25.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.725 0.298 . . . . 0.0 111.287 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 92.3 p -126.95 12.88 7.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 33.8 m-20 -98.93 69.27 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.09 127.01 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.059 0.457 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.626 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 5.3 ptp -133.02 147.14 52.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.744 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -126.24 130.85 51.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.388 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -128.02 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.699 0.285 . . . . 0.0 111.449 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.11 109.46 7.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.811 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.434 ' CB ' HD22 ' A' ' 45' ' ' LEU . 91.5 p -125.18 163.56 22.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.435 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -131.09 140.2 49.98 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.085 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.413 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 45.1 m-80 -111.72 125.54 54.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.378 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.783 HG21 ' HA ' ' B' ' 81' ' ' VAL . 3.3 pt -136.66 134.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.824 0.345 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 6.6 pt-20 -111.64 159.49 18.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 50.5 m95 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.623 179.685 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 t70 65.12 124.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.906 0.384 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -125.7 52.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.854 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.37 -49.99 1.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -129.2 113.83 15.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.672 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -156.69 103.88 2.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.694 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t 68.49 71.37 0.3 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.993 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.707 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 8.9 m-70 -110.3 -54.0 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.807 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.707 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.313 31.5 Cg_exo -71.28 138.48 33.19 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.433 2.089 . . . . 0.0 111.921 179.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.09 -35.08 76.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.931 0.396 . . . . 0.0 111.15 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.34 109.27 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.633 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -164.3 115.67 1.29 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.472 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.626 ' HE3' ' HE3' ' B' ' 13' ' ' LYS . 4.3 tttm -133.1 -59.58 0.88 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.482 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.46 -39.62 87.04 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.296 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' C' ' 19' ' ' ARG . . . -74.43 -52.38 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 110.916 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . 0.644 ' O ' ' HG3' ' C' ' 20' ' ' GLN . 0.7 OUTLIER -56.05 -47.43 77.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.992 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.645 ' HZ1' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER -61.89 -42.32 98.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . 0.647 ' HA ' ' HZ1' ' A' ' 17' ' ' LYS . 73.8 t80 -62.63 -41.12 98.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' C' ' 15' ' ' ALA . 34.6 mmt180 -73.76 -30.29 62.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.813 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' C' ' 16' ' ' HIS . 19.0 mt-30 -71.74 -34.47 69.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.712 HD11 HD11 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -63.97 -51.67 63.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.57 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.77 -25.59 64.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 6.1 t-20 -66.29 -37.4 85.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.528 ' HD3' ' HB2' ' B' ' 25' ' ' LEU . 6.3 mmp_? -70.96 -44.8 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.681 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -61.24 -32.48 72.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -81.9 -28.3 32.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.432 ' O ' HG22 ' C' ' 30' ' ' THR . 36.9 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.27 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.678 HD11 ' HA ' ' B' ' 25' ' ' LEU . 11.4 mt -72.08 -29.03 63.71 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.439 ' O ' HG21 ' C' ' 32' ' ' VAL . 25.2 t0 -66.68 -47.39 72.58 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.978 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.533 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 2.5 t -71.15 -33.7 70.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.792 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.618 HH21 HD23 ' C' ' 28' ' ' LEU . 45.4 ttp85 -67.8 -40.09 83.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.361 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.537 HG23 ' NH2' ' A' ' 31' ' ' ARG . 33.7 m -76.11 -29.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.233 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . 0.656 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 7.2 t70 -62.47 -57.38 11.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.017 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' C' ' 30' ' ' THR . 26.8 pttt -70.11 -44.65 68.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.797 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.93 -45.33 81.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.15 -26.3 62.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.762 0.315 . . . . 0.0 111.067 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' C' ' 68' ' ' ALA . . . -66.55 -37.8 85.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.441 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.518 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 52.3 p -82.91 -38.77 22.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.689 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' SER . . . . . 0.465 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 30.8 t -57.22 -57.35 12.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 111.089 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.52 68.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . 0.676 ' HB1' ' HB1' ' C' ' 70' ' ' ALA . . . -62.31 -45.29 93.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.956 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' C' ' 42' ' ' LEU . 0.3 OUTLIER -66.18 -32.77 74.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.061 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.553 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.1 m-20 -82.85 -15.8 50.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.74 -17.74 64.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.073 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.738 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -75.36 162.74 28.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.857 177.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.96 -30.38 0.48 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.092 0.472 . . . . 0.0 111.712 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . 0.451 ' CG ' ' HB3' ' C' ' 55' ' ' ASN . 15.7 tt0 72.11 104.32 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.996 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.8 Cg_endo -89.16 140.59 3.94 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.67 2.247 . . . . 0.0 112.53 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 18.2 m-85 67.08 150.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.465 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . -173.87 68.82 0.1 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.278 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 p -92.05 -19.36 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.158 0.583 . . . . 0.0 112.494 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.72 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 148.38 48.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.338 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 -175.11 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.667 0.27 . . . . 0.0 110.563 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.443 HG22 ' N ' ' C' ' 55' ' ' ASN . 7.1 p -110.3 137.97 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.593 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 6.5 t30 -125.9 119.76 28.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 111.67 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -80.32 128.38 33.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.738 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 16.8 p -114.3 119.93 38.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.983 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.32 141.5 25.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.523 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -176.92 166.66 37.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.566 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.29 165.09 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.358 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.05 176.12 21.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.472 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.26 27.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.654 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.656 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.69 123.19 14.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.572 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 33.5 mtt-85 65.82 -88.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.032 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 64.1 p -137.53 12.93 2.98 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.172 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 32.8 t -109.35 173.15 6.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.28 177.22 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.065 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' C' ' 37' ' ' ALA . . . -163.72 161.2 23.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.546 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -119.62 136.13 54.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.762 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.676 ' HB1' ' HB1' ' C' ' 41' ' ' ALA . . . -136.39 137.91 41.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.671 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -138.08 145.81 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.058 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -172.57 -175.46 40.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.0 158.41 19.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.827 0.346 . . . . 0.0 111.043 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.2 159.53 28.06 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.207 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.29 118.99 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.377 . . . . 0.0 111.153 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.487 ' HD3' ' HB1' ' C' ' 82' ' ' ALA . 0.0 OUTLIER -105.8 104.04 13.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.721 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.72 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 10.7 p -101.95 126.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.279 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.87 -171.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.922 0.391 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -118.23 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.59 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -157.01 -53.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.757 ' HA ' HG21 ' C' ' 103' ' ' ILE . 6.4 p -112.41 143.49 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.509 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.487 ' HB1' ' HD3' ' C' ' 76' ' ' ARG . . . -146.72 151.72 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.202 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.4 132.62 35.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 143.21 47.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 171.32 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.45 157.33 10.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.584 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.839 0.352 . . . . 0.0 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.26 151.97 30.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.336 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 126.86 38.08 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.232 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -140.89 145.56 36.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.615 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.415 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 55.23 -98.51 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.201 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.38 -25.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 0.0 111.25 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.98 12.91 7.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 33.9 m-20 -98.96 69.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.07 127.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.706 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.614 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 5.3 ptp -133.03 147.15 52.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.716 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -126.25 130.86 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.422 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -128.03 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.15 109.54 7.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.445 ' CB ' HD22 ' B' ' 45' ' ' LEU . 91.6 p -125.19 163.53 22.27 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.423 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.11 140.23 49.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.426 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 45.1 m-80 -111.77 125.53 54.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.402 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.757 HG21 ' HA ' ' C' ' 81' ' ' VAL . 3.3 pt -136.69 134.45 48.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.831 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.459 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 6.5 pt-20 -111.6 159.45 18.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 50.4 m95 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.666 179.68 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.666 -0.173 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 t70 67.9 127.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.0 110.938 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.72 49.19 2.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.29 -49.88 1.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.028 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.45 104.71 13.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.792 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.515 ' HZ2' ' HG2' ' A' ' 20' ' ' GLN . 57.6 t-105 -165.3 115.56 1.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.699 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t 64.77 83.34 0.17 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.007 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.623 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 6.0 m-70 -112.92 -47.39 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.833 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.285 31.5 Cg_exo -70.19 149.52 64.29 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.511 2.141 . . . . 0.0 111.879 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -72.02 -45.14 62.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.87 0.367 . . . . 0.0 111.088 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -94.84 110.53 22.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.69 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 7.5 pt-20 -158.53 111.79 2.37 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.432 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -125.82 -70.85 0.72 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.476 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.42 -37.54 69.82 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.251 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.99 -54.26 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.884 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 1.8 t60 -53.79 -52.32 60.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.012 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.434 ' HZ1' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER -59.27 -40.42 86.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.582 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.45 ' HA ' ' HZ1' ' B' ' 17' ' ' LYS . 81.6 t80 -58.47 -35.35 72.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 111.258 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.78 -41.93 35.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.515 ' HG2' ' HZ2' ' A' ' 6' ' ' TRP . 28.8 mt-30 -59.4 -35.03 73.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.4 HD12 ' HZ2' ' B' ' 17' ' ' LYS . 0.7 OUTLIER -60.84 -59.54 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.538 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -65.57 -21.2 66.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.8 -40.99 75.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HD3' HD11 ' C' ' 25' ' ' LEU . 4.5 mmp_? -71.73 -43.75 65.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.815 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.489 HD11 ' HD3' ' B' ' 24' ' ' ARG . 1.2 tp -59.75 -40.97 89.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.646 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.22 -32.74 64.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.775 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HZ1' HD21 ' C' ' 25' ' ' LEU . 14.5 tttm -71.43 -29.68 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.668 0.27 . . . . 0.0 111.237 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.494 HD13 HD13 ' B' ' 28' ' ' LEU . 4.3 mt -85.16 -31.1 23.44 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.422 ' O ' HG21 ' A' ' 32' ' ' VAL . 25.4 t70 -66.34 -41.21 89.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.976 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.615 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 7.0 t -73.23 -44.54 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.797 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.757 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 24.3 ttp85 -60.46 -37.03 79.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.304 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.614 HG23 ' NH2' ' B' ' 31' ' ' ARG . 33.9 m -75.71 -31.82 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.117 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.33 -50.7 64.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.032 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.757 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 23.2 pttt -71.48 -42.17 68.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.718 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -52.95 47.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.474 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.462 HD22 ' SD ' ' B' ' 96' ' ' MET . 3.6 tp -66.14 -38.3 87.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.087 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.06 77.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.446 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.3 p -75.38 -37.17 60.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.2 t -58.12 -66.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -31.47 35.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.425 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.81 -53.37 59.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HA ' HD23 ' A' ' 42' ' ' LEU . 1.8 tm? -69.36 -32.82 72.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.104 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -75.99 -5.67 47.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -13.81 59.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.135 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.791 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.7 mm? -75.64 172.53 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' C' ' 46' ' ' PHE . 47.2 p90 -153.55 -26.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.66 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.93 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -92.04 144.56 2.86 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.591 2.194 . . . . 0.0 112.57 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 48' ' ' PRO . 11.0 m-85 53.5 154.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . 178.25 79.15 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.279 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.97 -26.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.142 0.577 . . . . 0.0 112.424 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.2 49.35 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.34 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.15 -178.11 5.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.545 0.212 . . . . 0.0 110.642 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.77 144.26 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.498 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' B' ' 104' ' ' GLU . 1.7 t30 -128.75 125.3 37.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.987 0.422 . . . . 0.0 111.662 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.37 128.15 37.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.791 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 10.5 p -113.12 131.8 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.99 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.63 133.17 13.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.424 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -166.64 179.46 40.52 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.588 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.49 177.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.763 0.316 . . . . 0.0 111.4 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 67' ' ' GLN . . . -154.04 172.93 32.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.408 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.68 156.79 28.38 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.486 ' CE1' ' HE2' ' B' ' 96' ' ' MET . 1.1 t80 -146.71 125.89 12.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.751 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 66.04 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.137 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.225 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.64 166.16 13.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -124.1 174.41 7.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 111.093 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.02 157.47 37.66 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -111.8 134.16 53.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.39 136.73 48.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.68 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.84 145.79 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.147 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -175.96 -179.3 46.37 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -160.53 157.93 28.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.22 153.98 25.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.268 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.51 128.77 47.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.428 ' NH2' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -110.76 105.53 14.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.698 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 77' ' ' VAL . 11.4 p -100.86 130.84 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.372 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 56.57 -167.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.056 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' HA ' ' NH2' ' A' ' 76' ' ' ARG . 58.0 mt-10 -122.59 61.71 0.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.76 -51.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.006 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.69 135.63 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.476 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.16 164.75 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.295 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 84' ' ' LYS . 7.0 tp -142.58 148.27 37.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.624 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.422 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -152.74 136.05 15.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.08 18.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.22 154.63 14.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.571 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.58 42.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.926 0.393 . . . . 0.0 111.027 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.36 147.69 38.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.323 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.36 126.02 44.36 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.253 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.732 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . . . -138.65 152.02 47.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.706 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.48 -97.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.281 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.22 -39.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -115.72 16.42 16.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.158 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.555 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 14.4 m-20 -101.12 65.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.19 119.3 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 110.704 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.502 ' HE2' ' CE1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -117.82 145.31 44.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -124.87 132.66 53.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.686 0.279 . . . . 0.0 111.451 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.05 108.55 4.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.739 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.568 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 85.0 p -128.73 160.87 31.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -125.94 138.35 53.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.908 0.385 . . . . 0.0 111.09 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.634 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 22.9 m-80 -104.73 129.86 52.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.411 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.63 HD13 ' HZ2' ' A' ' 105' ' ' TRP . 2.6 pt -131.94 132.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.631 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 8.3 pt-20 -110.97 143.25 41.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.63 ' HZ2' HD13 ' A' ' 103' ' ' ILE . 14.6 m95 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.671 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 35.8 t70 67.92 127.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -133.7 49.13 2.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.827 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.3 -49.97 1.91 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.969 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.39 104.77 13.92 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.813 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.514 ' HZ2' ' HG2' ' B' ' 20' ' ' GLN . 57.6 t-105 -165.33 115.54 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.744 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t 64.72 83.37 0.17 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.972 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.612 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 6.0 m-70 -112.96 -47.34 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.749 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.284 31.5 Cg_exo -70.19 149.54 64.3 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.525 2.15 . . . . 0.0 111.856 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -72.07 -45.1 62.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -94.76 110.48 22.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.683 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' B' ' 16' ' ' HIS . 7.5 pt-20 -158.56 111.71 2.36 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.476 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -125.79 -70.84 0.72 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.506 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.46 69.32 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.274 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.05 -54.24 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 0.0 110.908 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.642 ' HB2' ' HB2' ' B' ' 12' ' ' GLU . 1.8 t60 -53.67 -52.34 60.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.071 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.45 ' HZ1' ' HA ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -59.35 -40.34 86.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.558 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . 0.43 ' HA ' ' HZ1' ' C' ' 17' ' ' LYS . 81.8 t80 -58.53 -35.32 72.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.216 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -77.74 -42.0 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.514 ' HG2' ' HZ2' ' B' ' 6' ' ' TRP . 28.8 mt-30 -59.43 -34.97 73.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.406 HD12 ' HZ2' ' C' ' 17' ' ' LYS . 0.7 OUTLIER -60.87 -59.51 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.563 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.53 -21.27 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.72 -40.93 75.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.489 ' HD3' HD11 ' A' ' 25' ' ' LEU . 4.5 mmp_? -71.82 -43.66 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.51 HD11 ' HD3' ' C' ' 24' ' ' ARG . 1.2 tp -59.91 -40.89 90.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.18 -32.82 65.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.468 ' HZ1' HD21 ' A' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.63 65.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.193 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 28' ' ' LEU . 4.2 mt -85.15 -31.0 23.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.426 ' O ' HG21 ' B' ' 32' ' ' VAL . 25.3 t70 -66.41 -41.2 89.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.941 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.611 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 7.0 t -73.22 -44.53 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.756 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.1 79.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.313 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.615 HG23 ' NH2' ' C' ' 31' ' ' ARG . 33.8 m -75.63 -31.82 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.233 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.45 -50.57 64.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.756 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 23.1 pttt -71.5 -42.09 68.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.787 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.9 -52.89 48.29 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.412 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.45 HD22 ' SD ' ' C' ' 96' ' ' MET . 3.6 tp -66.04 -38.41 88.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.14 77.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.479 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 70.5 p -75.33 -37.17 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.806 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 46.0 t -58.17 -65.9 0.57 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.157 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -31.4 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.83 -53.37 59.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' B' ' 42' ' ' LEU . 1.8 tm? -69.35 -32.87 72.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -76.01 -5.7 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -13.7 59.82 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.213 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.795 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.7 mm? -75.66 172.44 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.866 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 47.0 p90 -153.48 -26.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.53 107.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.992 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -92.07 144.57 2.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.622 2.214 . . . . 0.0 112.56 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.529 ' O ' ' O ' ' B' ' 48' ' ' PRO . 11.0 m-85 53.39 154.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.412 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . 178.26 78.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.236 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.87 -26.5 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.11 0.564 . . . . 0.0 112.506 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.18 49.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.299 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.21 -178.16 5.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.564 0.221 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.65 144.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.55 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.643 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 1.7 t30 -128.76 125.16 37.26 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.29 128.15 37.01 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.257 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.795 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 10.4 p -113.15 131.77 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.042 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.59 133.13 13.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -166.5 179.54 40.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.67 177.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 0.0 111.35 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' B' ' 67' ' ' GLN . . . -153.97 172.88 32.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.538 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 156.84 28.43 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.531 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' TYR . . . . . 0.503 ' CE1' ' HE2' ' C' ' 96' ' ' MET . 1.1 t80 -146.78 125.79 12.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.764 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.96 -89.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.5 p -137.95 16.75 2.84 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.214 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.74 166.17 13.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.8 OUTLIER -124.06 174.4 7.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.04 157.52 37.72 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.535 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tp -111.83 134.23 53.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.795 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.49 136.71 48.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.677 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.89 145.72 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.319 . . . . 0.0 111.166 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -175.88 -179.28 46.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.406 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.9 p -160.57 157.92 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.918 0.39 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.18 153.99 25.51 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.215 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.56 128.83 47.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' B' ' 79' ' ' GLU . 0.0 OUTLIER -110.72 105.52 14.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.791 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.487 ' O ' HG13 ' B' ' 77' ' ' VAL . 11.4 p -100.89 130.79 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.284 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 56.62 -167.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.945 0.402 . . . . 0.0 111.102 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.429 ' HA ' ' NH2' ' B' ' 76' ' ' ARG . 57.4 mt-10 -122.59 61.79 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.77 -51.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.03 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.57 135.66 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.539 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.2 164.79 29.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' B' ' 84' ' ' LYS . 7.0 tp -142.62 148.3 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.418 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 0.0 OUTLIER -152.81 136.02 15.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.151 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.17 169.05 18.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.17 154.65 14.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.571 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.56 42.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.88 0.372 . . . . 0.0 111.096 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.28 147.68 38.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.348 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.35 125.99 44.32 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.305 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' B' ' 34' ' ' LYS . . . -138.62 152.03 47.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.604 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.46 -97.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.272 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.19 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.64 16.44 16.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.193 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.544 ' HB3' ' HB1' ' B' ' 90' ' ' ALA . 13.9 m-20 -101.15 65.65 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.17 119.38 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.486 ' HE2' ' CE1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -117.89 145.33 44.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.721 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.87 132.6 53.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.19 142.43 49.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.08 108.48 4.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' SER . . . . . 0.562 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 85.1 p -128.71 160.89 31.07 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.431 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 18.2 p90 -125.93 138.35 53.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 0.0 111.038 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.635 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 22.9 m-80 -104.72 129.87 52.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.38 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.617 HD13 ' HZ2' ' B' ' 105' ' ' TRP . 2.6 pt -131.94 132.73 61.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.843 0.354 . . . . 0.0 110.801 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.641 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 8.3 pt-20 -111.02 143.2 42.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . 0.617 ' HZ2' HD13 ' B' ' 103' ' ' ILE . 14.8 m95 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.705 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' C' ' 1' ' ' GLY . 35.8 t70 67.79 127.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.912 0.387 . . . . 0.0 110.972 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.75 49.19 2.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.811 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.36 -49.9 1.9 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.5 104.84 13.96 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.753 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' TRP . . . . . 0.51 ' HZ2' ' HG2' ' C' ' 20' ' ' GLN . 57.4 t-105 -165.33 115.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.779 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t 64.9 83.27 0.17 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.977 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.628 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 6.0 m-70 -112.93 -47.37 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.755 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' PRO . . . . . 0.628 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.282 31.4 Cg_exo -70.12 149.58 64.81 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.477 2.118 . . . . 0.0 111.881 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -72.07 -45.16 61.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.957 0.408 . . . . 0.0 111.092 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -94.84 110.52 22.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.707 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' C' ' 16' ' ' HIS . 7.5 pt-20 -158.46 111.66 2.38 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.441 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -125.79 -70.77 0.72 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.524 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.44 -37.5 69.62 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.256 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.14 -54.22 19.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' HIS . . . . . 0.635 ' HB2' ' HB2' ' C' ' 12' ' ' GLU . 1.8 t60 -53.69 -52.35 60.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.016 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.43 ' HZ1' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER -59.41 -40.33 86.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.504 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . 0.434 ' HA ' ' HZ1' ' A' ' 17' ' ' LYS . 81.6 t80 -58.52 -35.29 72.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 111.241 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.77 -41.94 35.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.51 ' HG2' ' HZ2' ' C' ' 6' ' ' TRP . 28.9 mt-30 -59.44 -34.99 73.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.141 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' LEU . . . . . 0.406 HD12 ' HZ2' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -60.84 -59.5 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.591 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.64 -21.18 66.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.981 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -69.75 -40.99 75.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.51 ' HD3' HD11 ' B' ' 25' ' ' LEU . 4.4 mmp_? -71.83 -43.68 65.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.771 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.499 HD11 ' HD3' ' A' ' 24' ' ' ARG . 1.3 tp -59.82 -40.96 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.18 -32.8 65.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.461 ' HZ1' HD21 ' B' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.69 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.168 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.49 HD13 HD13 ' A' ' 28' ' ' LEU . 4.2 mt -85.07 -31.08 23.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.422 ' O ' HG21 ' C' ' 32' ' ' VAL . 25.5 t70 -66.32 -41.27 89.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.01 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.626 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 7.0 t -73.24 -44.45 59.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.747 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.12 79.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.28 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.616 HG23 ' NH2' ' A' ' 31' ' ' ARG . 33.8 m -75.55 -31.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.4 -50.65 64.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.031 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.747 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 23.1 pttt -71.53 -42.13 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.737 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -53.04 46.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.422 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.464 HD22 ' SD ' ' A' ' 96' ' ' MET . 3.6 tp -66.04 -38.37 88.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 111.052 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.79 -44.03 77.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.416 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 70.7 p -75.37 -37.22 60.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 46.1 t -58.13 -65.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.123 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -31.36 35.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.456 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.8 -53.39 58.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' C' ' 42' ' ' LEU . 1.8 tm? -69.44 -32.82 72.0 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 62.0 m-20 -75.98 -5.63 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -13.75 59.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.098 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.813 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.7 mm? -75.66 172.52 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.878 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 47.0 p90 -153.57 -26.26 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.664 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.59 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.993 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -92.02 144.54 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.675 2.25 . . . . 0.0 112.568 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.525 ' O ' ' O ' ' C' ' 48' ' ' PRO . 11.0 m-85 53.43 154.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.941 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.415 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . 178.23 79.13 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.266 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.9 -26.61 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.153 0.581 . . . . 0.0 112.434 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.24 49.42 0.02 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.299 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.15 -178.05 5.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.587 0.232 . . . . 0.0 110.628 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.74 144.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.558 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.631 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 1.7 t30 -128.74 125.32 37.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.35 128.11 37.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.276 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.813 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 10.2 p -113.17 131.79 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.984 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.56 133.14 13.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.446 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -166.62 179.43 40.53 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.54 177.09 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.349 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' C' ' 67' ' ' GLN . . . -153.96 172.99 32.64 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.424 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.69 156.77 28.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.563 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' TYR . . . . . 0.502 ' CE1' ' HE2' ' A' ' 96' ' ' MET . 1.1 t80 -146.72 125.82 12.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.99 -90.03 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.182 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.7 166.26 12.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.8 OUTLIER -124.18 174.4 7.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.347 . . . . 0.0 111.129 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.98 157.44 37.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.553 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tp -111.82 134.21 53.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.51 136.78 48.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.626 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' C' ' 71' ' ' ILE . 7.6 tp -141.91 145.71 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 111.145 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -175.93 -179.23 46.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.426 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -160.59 157.88 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.964 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.13 153.9 25.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.251 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.47 128.78 47.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.195 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' C' ' 79' ' ' GLU . 0.0 OUTLIER -110.66 105.59 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.494 HG13 ' O ' ' C' ' 77' ' ' VAL . 11.5 p -101.02 130.81 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.964 0.412 . . . . 0.0 111.256 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 56.62 -167.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.089 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' GLU . . . . . 0.429 ' HA ' ' NH2' ' C' ' 76' ' ' ARG . 57.4 mt-10 -122.53 61.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.587 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 -51.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.012 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.66 135.6 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.11 164.81 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.226 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' C' ' 84' ' ' LYS . 7.0 tp -142.65 148.27 37.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . 0.403 ' N ' ' HG ' ' C' ' 83' ' ' LEU . 0.0 OUTLIER -152.75 136.04 15.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.212 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.23 169.05 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.18 154.64 14.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.592 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.56 142.54 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.829 0.347 . . . . 0.0 111.093 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.3 147.71 38.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.39 126.0 44.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.306 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' C' ' 34' ' ' LYS . . . -138.68 152.01 47.68 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.621 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.35 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 42.0 t -151.23 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.333 . . . . 0.0 111.32 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.63 16.4 16.48 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.161 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.544 ' HB3' ' HB1' ' C' ' 90' ' ' ALA . 14.1 m-20 -101.16 65.7 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.26 119.37 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.673 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.503 ' HE2' ' CE1' ' B' ' 63' ' ' TYR . 0.3 OUTLIER -117.85 145.25 44.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.693 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.89 132.65 53.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.443 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.26 142.39 49.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.688 0.28 . . . . 0.0 111.483 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.97 108.49 4.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.738 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' SER . . . . . 0.564 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 84.6 p -128.67 160.85 31.18 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.435 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -125.94 138.38 53.77 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.896 0.379 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' ASN . . . . . 0.613 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 23.1 m-80 -104.73 129.89 52.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.614 HD13 ' HZ2' ' C' ' 105' ' ' TRP . 2.6 pt -132.0 132.67 61.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . 0.643 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 8.3 pt-20 -110.95 143.23 41.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' TRP . . . . . 0.614 ' HZ2' HD13 ' C' ' 103' ' ' ILE . 14.6 m95 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.683 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.708 0.29 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -38.15 88.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.268 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -68.37 -42.96 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.17 -44.94 95.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.42 . . . . 0.0 111.137 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -66.03 -44.19 85.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.526 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.21 -34.17 77.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.011 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -72.77 -37.12 67.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -68.15 -44.02 76.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.734 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.708 ' HG ' HD21 ' C' ' 25' ' ' LEU . 3.9 mt -60.81 -44.92 96.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -63.03 -33.85 76.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 11.8 tttt -71.19 -35.89 71.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.727 HD21 ' HA ' ' C' ' 29' ' ' ASP . 0.5 OUTLIER -66.42 -52.36 47.33 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.736 ' HA ' HD21 ' B' ' 28' ' ' LEU . 46.9 t0 -55.56 -39.3 70.46 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.977 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.3 m -61.33 -49.72 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.862 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.639 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 85.0 mmt-85 -58.11 -32.02 67.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.772 HG11 HG22 ' B' ' 32' ' ' VAL . 18.9 t -77.3 -36.48 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.162 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -64.1 -52.8 57.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.94 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 13.3 pttt -77.22 -37.16 53.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.97 -40.18 98.55 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.433 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.573 HD22 ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -72.86 -37.38 67.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.91 91.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.669 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -68.99 -50.29 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.555 ' HB3' HD21 ' C' ' 36' ' ' LEU . 96.5 p -52.82 -49.37 65.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.2 73.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.53 -42.65 55.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.913 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.511 HD23 ' OD1' ' A' ' 98' ' ' ASN . 16.2 tp -71.83 -42.51 66.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -75.81 -3.1 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.53 55.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.096 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.49 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -97.77 177.13 5.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.816 177.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -169.1 1.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.657 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 64.6 mt-30 63.9 116.38 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.277 9.9 Cg_endo -74.46 95.04 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.587 2.191 . . . . 0.0 112.593 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 87.4 m-85 68.83 -173.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 148.9 90.12 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.207 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -87.78 -14.74 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 123.152 0.581 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.37 48.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.279 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.99 -172.89 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 110.622 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.48 148.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.571 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.704 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.47 44.12 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 111.656 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.534 ' HE2' HD11 ' A' ' 71' ' ' ILE . 1.1 t80 -97.48 124.13 41.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.25 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.479 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.2 p -116.5 127.95 55.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.65 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -159.85 154.87 24.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.45 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.53 165.99 29.61 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.518 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 69' ' ' LEU . 13.6 m -112.08 163.68 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.4 179.65 27.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.56 144.82 11.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.552 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CD1' HD22 ' A' ' 36' ' ' LEU . 75.1 t80 -136.92 129.48 30.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.314 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 3.5 mmm-85 65.72 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -152.25 34.96 0.52 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.158 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.92 168.01 18.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -140.78 144.35 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.113 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.92 156.18 43.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' A' ' 60' ' ' VAL . 6.7 tp -113.19 125.35 54.24 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.778 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -119.55 151.14 39.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.706 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.65 HG13 ' HB2' ' A' ' 58' ' ' ALA . 18.4 tt -145.2 164.24 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.479 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 179.58 175.56 46.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.44 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.74 147.69 11.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.92 163.3 30.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.232 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -108.5 120.72 43.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.505 ' CB ' ' HA3' ' A' ' 50' ' ' GLY . 6.6 mmm180 -96.72 92.38 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.743 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.2 p -96.79 131.83 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.6 m120 64.67 -177.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.078 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.3 24.25 11.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.495 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.059 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.3 153.67 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -156.28 173.51 16.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 111.259 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.22 140.32 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.611 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.657 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -140.48 134.27 30.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.188 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.95 133.97 14.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.479 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -160.0 170.54 36.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.546 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 71' ' ' ILE . 9.7 p -117.44 147.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.136 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.58 ' HB3' ' SD ' ' A' ' 96' ' ' MET . . . -119.39 134.57 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.328 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.18 110.85 22.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -118.91 136.9 53.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.631 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.562 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 50.63 -111.95 1.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.318 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.39 -53.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.689 0.28 . . . . 0.0 111.307 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.505 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -106.37 26.83 9.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.145 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.751 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -116.85 81.82 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.59 139.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.707 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -135.36 158.53 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.723 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -134.16 133.5 41.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.468 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.511 ' OD1' HD23 ' A' ' 42' ' ' LEU . 33.7 m120 -113.73 161.09 17.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.747 0.308 . . . . 0.0 111.393 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.45 0.18 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.724 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.493 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 13.8 p -126.02 178.76 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.426 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -144.44 137.77 27.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.863 0.363 . . . . 0.0 111.121 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 69.9 m-80 -103.29 148.79 25.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.352 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.499 HG13 ' O ' ' C' ' 56' ' ' PHE . 7.4 pt -152.75 146.66 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.7 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 90.0 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.681 0.277 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -38.11 88.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 mtt85 -68.26 -43.03 78.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.15 -44.94 95.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.479 HD23 HD21 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -65.98 -44.24 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.627 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.2 -34.08 76.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.078 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.85 -37.09 67.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mtt180 -68.06 -44.02 77.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.712 HD21 ' HG ' ' C' ' 25' ' ' LEU . 3.9 mt -60.91 -44.9 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.59 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -63.04 -33.84 76.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.869 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 11.8 tttt -71.16 -35.88 71.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.221 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.736 HD21 ' HA ' ' A' ' 29' ' ' ASP . 0.5 OUTLIER -66.34 -52.41 47.31 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.737 ' HA ' HD21 ' C' ' 28' ' ' LEU . 46.8 t0 -55.54 -39.37 70.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.951 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 13.8 m -61.3 -49.74 75.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.87 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.645 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 85.0 mmt-85 -58.09 -31.97 67.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.772 HG22 HG11 ' A' ' 32' ' ' VAL . 18.8 t -77.35 -36.54 23.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -64.05 -52.81 57.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.671 ' HD2' ' HB2' ' B' ' 94' ' ' ASP . 13.3 pttt -77.27 -37.09 53.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.791 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.02 -40.18 98.56 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.419 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' B' ' 63' ' ' TYR . 0.2 OUTLIER -72.84 -37.42 67.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.0 91.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.471 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.665 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -68.98 -50.28 50.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.719 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.556 ' HB3' HD21 ' A' ' 36' ' ' LEU . 96.4 p -52.82 -49.34 65.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.11 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.401 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.54 -42.67 55.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.515 HD23 ' OD1' ' B' ' 98' ' ' ASN . 16.1 tp -71.86 -42.43 66.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.92 -3.09 33.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.83 0.35 55.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.178 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -97.69 177.11 5.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.871 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.11 1.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.716 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.656 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 64.6 mt-30 63.97 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.977 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.277 9.8 Cg_endo -74.51 95.08 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.601 2.201 . . . . 0.0 112.508 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 87.4 m-85 68.84 -173.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 148.95 90.13 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.209 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -87.79 -14.77 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.141 0.576 . . . . 0.0 112.425 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.39 48.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.315 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.86 -172.9 4.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.605 0.241 . . . . 0.0 110.587 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 1.074 HG13 ' O ' ' C' ' 105' ' ' TRP . 4.6 p -103.37 148.77 7.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.607 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.683 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.5 44.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.928 0.395 . . . . 0.0 111.667 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.522 ' HE2' HD11 ' B' ' 71' ' ' ILE . 1.1 t80 -97.5 124.12 41.61 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.277 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.471 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.0 p -116.51 127.89 54.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.941 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.651 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -159.83 154.75 24.63 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.452 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.503 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.62 166.04 29.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.544 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 69' ' ' LEU . 13.8 m -112.06 163.69 8.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.347 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.37 179.58 27.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.462 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.54 144.87 11.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.579 ' CD1' HD22 ' B' ' 36' ' ' LEU . 75.3 t80 -136.92 129.62 30.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.729 0.299 . . . . 0.0 110.727 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 3.5 mmm-85 65.52 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.23 34.84 0.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.86 168.04 17.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -140.78 144.3 35.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.164 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.88 156.3 43.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' B' ' 60' ' ' VAL . 6.8 tp -113.2 125.36 54.25 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.792 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -119.59 151.15 39.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.699 0.285 . . . . 0.0 111.665 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' B' ' 58' ' ' ALA . 18.4 tt -145.19 164.2 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.126 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 179.6 175.52 46.47 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.433 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.74 147.77 11.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.873 0.368 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.91 163.33 30.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -108.49 120.61 42.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.504 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.49 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.749 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.1 p -96.85 131.91 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.239 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.5 m120 64.6 -177.25 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.925 0.393 . . . . 0.0 111.04 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -116.26 24.21 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.563 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.24 153.67 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.48 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -156.33 173.47 16.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.281 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.12 140.39 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.656 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.24 30.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.195 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 134.03 14.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -160.04 170.58 36.18 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' B' ' 71' ' ' ILE . 9.8 p -117.44 147.41 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.85 0.357 . . . . 0.0 111.106 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.585 ' HB3' ' SD ' ' B' ' 96' ' ' MET . . . -119.38 134.61 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.323 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.23 110.84 22.55 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.292 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . . . -118.8 136.93 53.74 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.636 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.567 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 50.6 -112.05 1.45 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.3 -53.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.691 0.281 . . . . 0.0 111.326 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' B' ' 93' ' ' SER . 2.2 t -106.35 26.85 9.34 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.198 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.75 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.3 OUTLIER -116.95 81.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.69 139.37 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' B' ' 88' ' ' ALA . 0.0 OUTLIER -135.38 158.52 44.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.711 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -134.12 133.55 41.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.515 ' OD1' HD23 ' B' ' 42' ' ' LEU . 33.7 m120 -113.72 161.05 17.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.51 0.18 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.5 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 13.9 p -126.05 178.78 5.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.462 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -144.52 137.76 27.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.002 0.429 . . . . 0.0 111.048 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.674 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 69.8 m-80 -103.2 148.8 25.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.442 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 56' ' ' PHE . 7.4 pt -152.77 146.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.336 . . . . 0.0 110.77 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.704 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 90.1 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' C' ' 17' ' ' LYS . 32.9 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.767 0.317 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -38.02 87.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.306 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -68.36 -43.0 78.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.13 -44.95 95.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.479 HD21 HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -66.07 -44.15 85.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.554 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -34.13 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.77 -37.18 67.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -67.94 -44.13 77.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.772 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.712 ' HG ' HD21 ' B' ' 25' ' ' LEU . 3.9 mt -60.72 -44.99 95.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -62.99 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.875 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 11.8 tttt -71.08 -35.9 72.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.313 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.737 HD21 ' HA ' ' B' ' 29' ' ' ASP . 0.5 OUTLIER -66.38 -52.35 47.72 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ASP . . . . . 0.727 ' HA ' HD21 ' A' ' 28' ' ' LEU . 46.9 t0 -55.59 -39.28 70.5 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.519 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 14.3 m -61.4 -49.71 75.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.813 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.644 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 85.0 mmt-85 -58.05 -32.07 67.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.376 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.764 HG11 HG22 ' A' ' 32' ' ' VAL . 18.6 t -77.26 -36.51 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.227 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -64.03 -52.85 57.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.652 ' HD2' ' HB2' ' C' ' 94' ' ' ASP . 13.2 pttt -77.26 -37.15 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.725 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.02 -40.11 98.47 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' C' ' 63' ' ' TYR . 0.2 OUTLIER -72.85 -37.39 67.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.05 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.369 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.673 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -68.89 -50.38 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.558 ' HB3' HD21 ' B' ' 36' ' ' LEU . 96.6 p -52.71 -49.41 65.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.09 73.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.459 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.56 -42.68 55.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.5 HD23 ' OD1' ' C' ' 98' ' ' ASN . 16.2 tp -71.83 -42.46 66.94 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.88 -3.06 33.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.52 55.81 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.12 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -97.8 177.15 5.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.791 177.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.08 1.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.638 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.655 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 64.8 mt-30 63.99 116.4 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.95 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.4 94.97 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.647 2.231 . . . . 0.0 112.582 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 87.6 m-85 68.9 -173.61 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.9 90.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.247 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.8 -14.78 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.129 0.572 . . . . 0.0 112.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.751 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.43 48.77 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.274 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -147.01 -172.89 4.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.547 0.213 . . . . 0.0 110.573 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 4.6 p -103.42 148.73 8.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.7 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 7.4 m-80 -134.0 136.48 44.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.662 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 56' ' ' PHE . . . . . 0.546 ' HE2' HD11 ' C' ' 71' ' ' ILE . 1.1 t80 -97.49 124.13 41.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.483 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 44.8 p -116.51 127.93 54.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -159.82 154.85 24.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.41 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.52 166.07 29.72 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' C' ' 69' ' ' LEU . 13.7 m -112.12 163.7 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.802 0.334 . . . . 0.0 111.339 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.41 179.58 27.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.476 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.49 144.78 11.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.544 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.581 ' CD1' HD22 ' C' ' 36' ' ' LEU . 75.5 t80 -136.91 129.57 30.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.723 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.5 mmm-85 65.58 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.22 34.87 0.52 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.16 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.93 168.02 18.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -140.73 144.36 35.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.121 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.87 156.27 43.44 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.529 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.55 ' HA ' HG12 ' C' ' 60' ' ' VAL . 6.7 tp -113.23 125.38 54.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -119.54 151.16 39.08 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.695 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' C' ' 58' ' ' ALA . 18.3 tt -145.24 164.27 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.19 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 179.59 175.54 46.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.75 147.77 11.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.967 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.93 163.32 30.43 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.237 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -108.5 120.64 43.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 111.137 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.505 ' CB ' ' HA3' ' C' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.32 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.675 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.751 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.2 p -96.73 131.87 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 111.332 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.5 m120 64.58 -177.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 111.093 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.33 24.21 11.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.8 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.19 153.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.544 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -156.35 173.47 16.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 111.252 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.08 140.34 7.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.595 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.655 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.27 30.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 133.95 14.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.95 170.58 36.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.597 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -117.48 147.42 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.936 0.398 . . . . 0.0 111.096 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.58 ' HB3' ' SD ' ' C' ' 96' ' ' MET . . . -119.35 134.61 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.22 110.89 22.63 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' C' ' 94' ' ' ASP . . . -118.88 136.92 53.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.679 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.593 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 50.61 -112.03 1.45 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.255 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.33 -53.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.257 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.2 t -106.32 26.83 9.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.756 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.3 OUTLIER -116.88 81.83 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.93 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.63 139.32 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.737 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' C' ' 88' ' ' ALA . 0.0 OUTLIER -135.34 158.56 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -134.16 133.53 41.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.419 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.5 ' OD1' HD23 ' C' ' 42' ' ' LEU . 33.8 m120 -113.67 161.09 17.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.403 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.51 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.752 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.503 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 13.8 p -126.05 178.69 5.62 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.413 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.4 137.8 27.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.665 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 69.8 m-80 -103.3 148.86 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.377 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.509 HG13 ' O ' ' B' ' 56' ' ' PHE . 7.4 pt -152.79 146.67 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.784 0.326 . . . . 0.0 110.821 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.683 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 90.1 mt-10 -90.39 131.03 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 1.074 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.9 t-105 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.635 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' O ' HD22 ' A' ' 21' ' ' LEU . 36.1 ttmt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.793 0.33 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -38.48 83.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -66.77 -45.68 77.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.818 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -40.84 96.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.757 HD21 HD23 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -64.51 -45.27 87.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.51 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.69 -28.39 69.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -74.74 -40.33 61.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HD2' HD13 ' C' ' 25' ' ' LEU . 32.1 mtt180 -70.87 -41.18 71.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.766 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.679 HD21 ' HG ' ' B' ' 25' ' ' LEU . 7.8 mt -62.05 -49.86 74.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.481 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.24 -48.86 79.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 9.0 tmtt? -55.45 -38.02 68.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.168 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -63.4 -40.4 97.11 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.6 91.93 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.98 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.58 HG22 ' HE2' ' A' ' 34' ' ' LYS . 3.9 m -57.74 -48.08 80.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.81 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.559 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 83.9 mmt-85 -57.28 -33.15 67.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 28' ' ' LEU . 44.4 t -76.77 -37.78 28.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 48.2 m-20 -61.95 -54.34 43.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.012 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.998 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 2.5 pttt -75.87 -36.17 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.795 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 -45.49 87.98 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.422 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.703 HD22 ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -68.19 -39.59 82.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.845 0.355 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.73 90.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.4 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.667 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -68.72 -52.66 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.703 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.497 ' HB3' HD21 ' C' ' 36' ' ' LEU . 78.3 p -50.9 -56.42 12.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.81 -48.95 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.436 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.39 -42.19 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.64 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 24.0 tp -73.63 -36.07 65.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.062 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' HB3' ' CB ' ' C' ' 43' ' ' ASN . 11.4 m120 -78.27 -3.17 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.702 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.4 t -84.31 1.38 45.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.18 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -98.26 174.58 6.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.82 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.34 -3.52 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.142 0.496 . . . . 0.0 111.661 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.555 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 35.8 mt-30 64.27 117.55 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.96 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.278 9.8 Cg_endo -74.46 100.39 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.669 2.246 . . . . 0.0 112.577 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 90.3 m-85 67.61 -167.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 148.26 81.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.203 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' CG ' ' A' ' 79' ' ' GLU . 15.0 p -88.26 -12.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.157 0.583 . . . . 0.0 112.396 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.78 45.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.256 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.56 -168.65 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.585 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.0 p -109.68 145.95 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.496 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 4.1 m-80 -128.52 135.32 49.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.943 0.402 . . . . 0.0 111.69 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.66 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 45' ' ' LEU . 22.5 p -111.87 124.66 52.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.006 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.455 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -155.35 149.79 26.1 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.478 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.604 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 173.04 165.56 30.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -111.27 165.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 0.0 111.434 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -177.62 27.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.496 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -160.65 144.42 9.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.537 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.703 ' CD1' HD22 ' A' ' 36' ' ' LEU . 65.5 t80 -133.54 133.42 42.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.728 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.51 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 3.1 mmm-85 64.5 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.126 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.47 33.28 0.37 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.161 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.73 168.69 16.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -134.84 140.47 45.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.095 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.32 152.01 48.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.595 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.444 ' HA ' HG12 ' A' ' 60' ' ' VAL . 4.7 tp -111.16 127.46 55.59 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.745 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -122.83 151.87 41.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.669 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.463 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.5 tt -147.78 163.72 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.088 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 175.48 172.65 40.53 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.446 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -162.75 147.24 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.6 161.63 28.69 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.295 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -106.92 119.26 38.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 111.168 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 76' ' ' ARG . 5.0 mmm180 -95.86 101.02 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.711 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 12.6 p -98.62 128.88 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.7 m120 65.23 -175.05 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.415 ' CG ' HG23 ' A' ' 51' ' ' VAL . 33.4 mt-10 -114.82 25.45 10.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.573 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.964 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.22 151.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -153.42 169.81 22.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.245 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -162.48 141.23 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 1.3 ttmp? -141.42 133.46 27.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.27 135.03 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -159.35 173.86 36.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.581 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.83 144.3 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.453 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -112.92 135.43 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.36 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -111.08 111.07 21.91 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.236 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.998 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -124.01 135.83 53.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.574 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.91 -113.84 4.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.238 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.83 -58.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.526 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -103.9 28.43 6.68 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.203 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.426 ' CB ' ' HD2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -118.18 82.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.962 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.76 142.81 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' C' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.15 50.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -128.01 129.41 46.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.429 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -117.5 159.35 22.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.724 0.297 . . . . 0.0 111.393 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.716 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.728 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.7 p -122.86 178.5 5.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 39.3 p90 -142.13 146.04 34.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.95 0.405 . . . . 0.0 111.12 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.5 m-80 -112.88 150.73 31.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.326 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 102' ' ' ASN . 2.9 pt -157.24 152.04 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.777 0.323 . . . . 0.0 110.814 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.424 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 75.8 mt-10 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.413 ' O ' HD22 ' B' ' 21' ' ' LEU . 36.1 ttmt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -38.46 83.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.297 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -66.81 -45.67 77.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -40.85 96.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.757 HD21 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -64.37 -45.29 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.75 -28.34 69.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.05 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -74.76 -40.32 61.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.478 ' HD2' HD13 ' A' ' 25' ' ' LEU . 32.2 mtt180 -70.9 -41.18 71.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.808 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.679 ' HG ' HD21 ' A' ' 25' ' ' LEU . 7.9 mt -61.96 -49.86 74.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.21 -48.87 79.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 9.0 tmtt? -55.43 -37.93 68.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.292 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.635 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.4 OUTLIER -63.49 -40.3 96.73 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -64.18 -44.62 91.48 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.954 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.59 HG22 ' HE2' ' B' ' 34' ' ' LYS . 3.8 m -57.7 -48.06 80.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.551 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 83.9 mmt-85 -57.18 -33.29 67.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.259 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 28' ' ' LEU . 44.5 t -76.78 -37.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.496 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 48.2 m-20 -62.06 -54.28 43.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.999 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.945 ' HB2' ' HB1' ' B' ' 90' ' ' ALA . 2.6 pttt -75.9 -36.03 59.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.41 87.61 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.717 HD22 ' CD1' ' B' ' 63' ' ' TYR . 0.3 OUTLIER -68.18 -39.65 82.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.75 90.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.414 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.671 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -68.73 -52.7 27.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.746 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.487 ' HB3' HD21 ' A' ' 36' ' ' LEU . 78.3 p -50.88 -56.35 12.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.95 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.393 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.43 -42.18 41.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.635 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 23.8 tp -73.62 -36.04 65.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.433 ' CB ' ' HB3' ' C' ' 43' ' ' ASN . 11.3 m120 -78.35 -3.14 41.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.706 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -84.26 1.29 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.089 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -98.21 174.49 6.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.906 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' B' ' 47' ' ' GLN . 7.4 p90 -165.31 -3.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 111.686 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.573 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.56 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.276 9.9 Cg_endo -74.43 100.38 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.629 2.219 . . . . 0.0 112.608 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 90.2 m-85 67.69 -167.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.405 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 148.2 81.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.228 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.418 HG23 ' CG ' ' B' ' 79' ' ' GLU . 15.0 p -88.28 -12.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.121 0.569 . . . . 0.0 112.402 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.78 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.332 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.77 2.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.637 0.256 . . . . 0.0 110.6 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 1.03 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.1 p -109.64 145.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.589 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 4.1 m-80 -128.47 135.31 49.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.648 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.63 122.65 44.26 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.313 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.487 ' HB ' ' CG ' ' B' ' 45' ' ' LEU . 22.4 p -112.01 124.65 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.932 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -155.3 149.84 26.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.611 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 172.97 165.52 30.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' B' ' 69' ' ' LEU . 6.9 m -111.31 165.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.05 -177.63 27.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -160.67 144.4 9.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.717 ' CD1' HD22 ' B' ' 36' ' ' LEU . 65.8 t80 -133.53 133.49 42.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 110.776 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.507 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 3.1 mmm-85 64.46 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.43 33.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.75 168.7 16.14 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -134.71 140.54 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.135 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.99 48.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.572 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.445 ' HA ' HG12 ' B' ' 60' ' ' VAL . 4.6 tp -111.18 127.35 55.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -122.76 151.89 41.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.726 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.458 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.4 tt -147.72 163.74 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.12 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 175.47 172.62 40.5 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.466 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 17.9 p -162.8 147.17 11.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.374 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.63 161.64 28.7 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.265 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -106.85 119.21 38.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 111.146 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.405 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 5.0 mmm180 -95.85 101.08 12.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.698 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' B' ' 78' ' ' ASN . 12.7 p -98.66 128.86 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.269 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.8 m120 65.2 -174.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.418 ' CG ' HG23 ' B' ' 51' ' ' VAL . 33.5 mt-10 -114.88 25.5 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.559 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.23 -46.38 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.27 151.12 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -153.43 169.8 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.235 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' B' ' 101' ' ' PHE . 0.6 OUTLIER -162.53 141.22 8.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.553 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.573 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.55 27.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.36 135.1 19.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -159.39 173.9 36.23 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.562 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.87 144.31 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.38 . . . . 0.0 111.148 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.459 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -112.85 135.38 53.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.313 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -111.12 111.02 21.81 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.3 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.945 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -123.92 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.581 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.573 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.84 -113.87 4.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 -58.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 111.293 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' SER . . . . . 0.526 ' OG ' ' O ' ' B' ' 93' ' ' SER . 2.2 t -103.86 28.36 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.153 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.427 ' CB ' ' HD2' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -118.22 82.86 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.81 142.8 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.724 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.09 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -127.94 129.35 46.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -117.48 159.3 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.47 0.35 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.761 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.74 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.8 p -122.8 178.56 4.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 39.3 p90 -142.22 146.07 34.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.642 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.5 m-80 -112.88 150.7 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.409 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.461 HG23 ' O ' ' B' ' 102' ' ' ASN . 2.9 pt -157.25 152.02 7.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 110.757 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 75.9 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.402 ' O ' HD22 ' C' ' 21' ' ' LEU . 36.1 ttmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.716 0.293 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.71 -38.51 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.272 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -66.77 -45.71 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -40.79 96.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.757 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -64.45 -45.25 88.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.609 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.74 -28.34 69.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -74.78 -40.31 61.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.493 ' HD2' HD13 ' B' ' 25' ' ' LEU . 32.2 mtt180 -70.91 -41.13 71.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.819 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.669 HD21 ' HG ' ' A' ' 25' ' ' LEU . 7.9 mt -62.08 -49.72 74.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.656 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.37 -48.81 79.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.758 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 9.0 tmtt? -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.62 0.248 . . . . 0.0 111.286 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.645 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.4 OUTLIER -63.41 -40.42 97.16 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.092 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.69 91.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.954 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.577 HG22 ' HE2' ' C' ' 34' ' ' LYS . 3.8 m -57.6 -48.08 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.908 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.541 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 83.8 mmt-85 -57.28 -33.23 67.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.645 HG23 ' O ' ' C' ' 28' ' ' LEU . 44.4 t -76.78 -37.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.5 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 48.4 m-20 -61.92 -54.42 42.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.972 ' HB2' ' HB1' ' C' ' 90' ' ' ALA . 2.5 pttt -75.85 -36.08 59.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.798 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.37 88.16 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.708 HD22 ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -68.27 -39.64 82.12 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 111.012 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.8 91.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.655 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -68.68 -52.76 27.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.722 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.495 ' HB3' HD21 ' B' ' 36' ' ' LEU . 78.2 p -50.83 -56.41 12.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.83 -48.97 72.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.418 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.38 -42.12 41.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.96 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.619 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 24.0 tp -73.73 -35.95 65.13 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.074 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 11.4 m120 -78.3 -3.2 41.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' SER . . . . . 0.69 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.4 t -84.23 1.24 45.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.129 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -98.18 174.53 6.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.901 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.32 -3.55 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.553 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.65 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.948 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.46 100.41 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.696 2.264 . . . . 0.0 112.552 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 90.3 m-85 67.59 -167.18 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.23 81.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.255 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.418 HG23 ' CG ' ' C' ' 79' ' ' GLU . 15.0 p -88.19 -13.03 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.143 0.577 . . . . 0.0 112.381 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.85 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.72 2.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.603 0.24 . . . . 0.0 110.584 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 p -109.67 145.88 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.509 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.424 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 4.1 m-80 -128.44 135.31 49.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.666 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.64 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.223 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.479 ' HB ' ' CG ' ' C' ' 45' ' ' LEU . 22.5 p -111.9 124.58 52.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.989 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.441 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -155.26 149.91 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.483 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.602 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 172.98 165.53 30.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' C' ' 69' ' ' LEU . 6.9 m -111.27 165.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.391 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.95 -177.59 27.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.465 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -160.68 144.36 9.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.708 ' CD1' HD22 ' C' ' 36' ' ' LEU . 65.5 t80 -133.5 133.45 42.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.729 0.299 . . . . 0.0 110.775 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.518 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm-85 64.45 -81.11 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.023 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 33.29 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.78 168.71 16.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.808 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -134.77 140.53 45.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.37 151.93 47.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.56 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.446 ' HA ' HG12 ' C' ' 60' ' ' VAL . 4.7 tp -111.07 127.43 55.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.787 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -122.8 151.89 41.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.452 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.6 tt -147.83 163.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 0.0 111.116 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 175.51 172.7 40.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.8 p -162.86 147.25 11.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.39 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.67 161.6 28.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.245 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -106.88 119.23 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.142 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' C' ' 76' ' ' ARG . 5.0 mmm180 -95.8 100.95 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.737 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' C' ' 78' ' ' ASN . 12.7 p -98.55 128.86 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.272 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.8 m120 65.27 -175.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' GLU . . . . . 0.418 ' CG ' HG23 ' C' ' 51' ' ' VAL . 33.5 mt-10 -114.86 25.42 10.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.582 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.37 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.21 151.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.514 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -153.45 169.75 22.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' C' ' 101' ' ' PHE . 0.6 OUTLIER -162.41 141.22 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.553 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.63 27.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.163 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.42 135.06 19.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.104 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.36 173.89 36.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.587 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.92 144.29 32.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.458 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -112.92 135.34 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.311 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -111.04 111.02 21.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.23 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.972 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -123.91 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.605 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.597 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.86 -113.85 4.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.298 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.79 -58.1 0.98 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.778 0.323 . . . . 0.0 111.32 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' SER . . . . . 0.513 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.2 t -103.85 28.38 6.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.161 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -118.23 82.82 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.8 142.81 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.708 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' B' ' 62' ' ' GLY . 0.8 OUTLIER -136.86 153.15 50.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.72 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -128.01 129.42 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -117.51 159.31 23.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.447 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.29 98.55 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.73 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.6 p -122.92 178.6 4.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' C' ' 83' ' ' LEU . 39.6 p90 -142.18 146.07 34.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 111.128 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.639 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.5 m-80 -112.85 150.64 31.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.397 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.452 HG23 ' O ' ' C' ' 102' ' ' ASN . 2.9 pt -157.2 152.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.774 0.321 . . . . 0.0 110.841 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 75.6 mt-10 -94.95 129.48 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 1.03 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.8 t-105 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.706 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.749 0.309 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -35.45 75.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.309 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.07 -44.07 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.55 -46.86 81.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.092 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.06 -36.81 84.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.58 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.17 -35.91 82.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.031 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.82 -42.21 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.602 ' HD2' HD13 ' C' ' 25' ' ' LEU . 28.2 mtt180 -62.71 -38.13 89.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.747 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.614 HD13 ' HD2' ' B' ' 24' ' ' ARG . 12.7 mt -67.35 -53.98 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.95 -47.61 77.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.822 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.88 -44.78 94.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.173 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' C' ' 29' ' ' ASP . 0.6 OUTLIER -58.09 -42.68 86.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.619 ' HA ' HD21 ' B' ' 28' ' ' LEU . 39.9 t0 -64.65 -40.7 95.9 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.983 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.404 HG22 ' HE2' ' A' ' 34' ' ' LYS . 10.2 m -61.66 -44.42 96.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.801 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 88.4 mmt-85 -57.07 -37.74 72.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.7 HG22 HG11 ' C' ' 32' ' ' VAL . 10.0 t -73.27 -29.53 28.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.153 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.571 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 63.6 m-20 -67.95 -62.73 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.037 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.672 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -66.53 -44.64 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.771 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.87 -46.17 77.46 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.374 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -68.02 -34.18 76.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.852 0.358 . . . . 0.0 111.147 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.31 -45.71 83.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.461 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.813 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -67.56 -54.48 19.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.764 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.8 p -49.44 -55.06 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.12 -46.13 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.427 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.27 58.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 45' ' ' LEU . 43.1 tp -80.96 -36.79 30.43 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.01 -3.24 28.04 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.418 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 6.1 t -88.62 -7.52 56.25 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.14 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.5 OUTLIER -90.72 165.75 13.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.856 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.77 -2.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.14 0.495 . . . . 0.0 111.703 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 40.0 mt-30 67.12 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.907 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 47' ' ' GLN 0.406 9.9 Cg_endo -69.59 99.36 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.673 2.249 . . . . 0.0 112.524 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 60.78 -160.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 149.42 83.44 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.29 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.532 HG23 ' CG ' ' A' ' 79' ' ' GLU . 9.5 p -90.06 -15.51 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.234 0.614 . . . . 0.0 112.45 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 161.71 48.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.267 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.89 -170.25 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.625 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.85 141.01 25.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.58 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' A' ' 48' ' ' PRO . 3.2 m-80 -125.37 133.96 52.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.53 45.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.246 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 47' ' ' GLN . 24.4 p -114.93 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.06 146.87 22.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.461 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 176.05 163.05 28.03 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.543 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 69' ' ' LEU . 6.3 m -105.7 167.15 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.23 27.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.522 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.67 141.31 7.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.542 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.574 ' HA ' ' HB2' ' B' ' 96' ' ' MET . 72.4 t80 -129.39 139.24 51.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.725 0.298 . . . . 0.0 110.786 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.46 HH11 ' HD3' ' A' ' 64' ' ' ARG . 3.0 mmm180 61.2 -81.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.045 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 t -155.96 35.57 0.34 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.1 m -133.06 166.85 21.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.39 142.83 47.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.49 44.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.565 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' HG12 ' A' ' 60' ' ' VAL . 9.1 tp -110.93 131.25 55.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.717 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -126.26 154.3 43.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.728 0.299 . . . . 0.0 111.613 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.449 HG12 ' N ' ' A' ' 72' ' ' GLY . 20.4 tt -147.76 162.9 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.76 0.314 . . . . 0.0 111.126 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.449 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 178.58 169.73 39.7 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.411 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -161.94 142.45 10.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.966 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.15 160.95 27.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.201 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.495 ' H ' HD11 ' A' ' 83' ' ' LEU . 25.5 t80 -106.59 116.2 31.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 111.133 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.487 HH11 ' HB2' ' A' ' 82' ' ' ALA . 5.2 mmm180 -93.87 93.22 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.509 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 8.7 p -93.88 126.04 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 12.2 m120 68.98 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.532 ' CG ' HG23 ' A' ' 51' ' ' VAL . 26.8 mt-10 -120.02 24.94 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.618 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 6.8 t -126.06 -39.4 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.982 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.06 152.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.504 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -149.05 174.53 12.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.226 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.495 HD11 ' H ' ' A' ' 75' ' ' TYR . 1.4 pp -163.88 143.63 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.44 ' HE3' HE21 ' A' ' 47' ' ' GLN . 2.2 ttmp? -146.7 128.19 15.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.55 135.64 15.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' HA3' ' CA ' ' A' ' 72' ' ' GLY . . . -161.34 178.52 37.23 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.546 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.21 140.54 41.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 111.14 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.571 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -112.57 131.68 55.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.79 112.04 24.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.221 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -124.96 131.24 53.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.616 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.668 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.05 -116.06 6.36 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.92 -61.22 1.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.303 . . . . 0.0 111.327 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 93' ' ' SER . 3.1 t -100.21 28.98 4.55 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.195 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.76 136.09 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.585 ' HB2' ' HA ' ' C' ' 63' ' ' TYR . 1.1 ptp -131.35 150.11 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.647 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -123.06 134.02 54.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.456 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.95 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.72 0.295 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.21 91.68 0.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.811 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.858 ' HB2' HD11 ' C' ' 45' ' ' LEU . 21.8 p -119.9 177.78 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.417 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -139.52 144.42 37.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.968 0.413 . . . . 0.0 111.068 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.954 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.0 m-80 -112.95 143.51 44.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.368 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.63 151.17 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.0 110.777 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.618 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 55.5 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.741 0.305 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.276 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -70.03 -44.16 69.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.772 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.45 -46.87 81.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.125 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -63.13 -36.73 84.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.523 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.24 -35.81 82.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.87 -42.22 63.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.791 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.614 ' HD2' HD13 ' A' ' 25' ' ' LEU . 28.1 mtt180 -62.71 -38.09 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.608 HD13 ' HD2' ' C' ' 24' ' ' ARG . 12.7 mt -67.33 -54.1 23.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.86 -47.73 76.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.79 -44.77 93.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.249 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -57.95 -42.74 85.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.604 ' HA ' HD21 ' C' ' 28' ' ' LEU . 40.1 t0 -64.82 -40.59 95.45 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.932 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.408 HG22 ' HE2' ' B' ' 34' ' ' LYS . 10.0 m -61.62 -44.4 97.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.816 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.498 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 88.4 mmt-85 -57.27 -37.72 72.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.696 HG22 HG11 ' A' ' 32' ' ' VAL . 9.8 t -73.21 -29.49 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.566 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 63.6 m-20 -67.97 -62.74 1.27 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.681 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 0.5 OUTLIER -66.56 -44.59 81.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.89 -46.11 77.87 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.391 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.2 OUTLIER -68.08 -34.19 75.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.751 0.31 . . . . 0.0 111.055 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.71 83.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.804 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -67.54 -54.46 19.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.791 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.406 ' HB3' ' SD ' ' B' ' 96' ' ' MET . 47.5 p -49.47 -55.06 14.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.11 82.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.403 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.24 58.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.616 HD12 HD23 ' B' ' 45' ' ' LEU . 42.7 tp -81.05 -36.75 30.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.02 -3.17 27.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 6.1 t -88.65 -7.59 56.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.105 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.859 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.5 OUTLIER -90.62 165.74 13.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.882 177.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 8.6 p90 -154.84 -2.91 0.16 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.102 0.477 . . . . 0.0 111.609 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.437 ' HG2' HG23 ' B' ' 57' ' ' THR . 39.9 mt-30 66.99 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.993 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.44 ' HD2' ' OD1' ' B' ' 55' ' ' ASN 0.405 9.9 Cg_endo -69.6 99.41 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.685 2.257 . . . . 0.0 112.518 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 60.73 -159.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.976 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 149.27 83.48 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.309 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.527 HG23 ' CG ' ' B' ' 79' ' ' GLU . 9.6 p -90.06 -15.5 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.148 0.579 . . . . 0.0 112.495 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 161.71 48.47 0.02 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.27 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.83 -170.11 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.579 0.228 . . . . 0.0 110.614 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 1.026 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.7 p -108.97 141.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.608 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.44 ' OD1' ' HD2' ' B' ' 48' ' ' PRO . 3.2 m-80 -125.34 133.84 52.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 111.702 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.77 124.54 45.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.243 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.437 HG23 ' HG2' ' B' ' 47' ' ' GLN . 24.4 p -114.93 125.48 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.03 146.93 22.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.431 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.512 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 175.99 163.0 27.92 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.545 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' B' ' 69' ' ' LEU . 6.3 m -105.68 167.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 111.36 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.94 -176.23 27.84 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.71 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.58 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.6 ' HA ' ' HB2' ' C' ' 96' ' ' MET . 72.5 t80 -129.35 139.27 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.658 0.266 . . . . 0.0 110.761 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' B' ' 64' ' ' ARG . 3.0 mmm180 61.13 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.08 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 63' ' ' TYR . 8.0 t -155.88 35.51 0.35 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.17 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.9 m -133.15 166.73 21.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -134.29 142.91 47.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.045 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.96 156.47 44.88 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' B' ' 60' ' ' VAL . 9.2 tp -110.97 131.31 55.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.725 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -126.15 154.24 43.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.691 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.449 HG12 ' N ' ' B' ' 72' ' ' GLY . 20.4 tt -147.75 162.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.722 0.296 . . . . 0.0 111.186 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.449 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 178.56 169.66 39.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.45 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.47 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.16 160.87 27.88 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.248 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.506 ' H ' HD11 ' B' ' 83' ' ' LEU . 25.3 t80 -106.53 116.19 31.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.162 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.496 HH11 ' HB2' ' B' ' 82' ' ' ALA . 5.2 mmm180 -93.83 93.18 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' B' ' 78' ' ' ASN . 8.7 p -93.89 126.06 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.311 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 12.1 m120 69.04 -172.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.527 ' CG ' HG23 ' B' ' 51' ' ' VAL . 26.8 mt-10 -120.03 24.9 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.619 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 6.8 t -126.0 -39.5 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -114.99 152.54 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.963 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -149.0 174.61 12.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.286 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.506 HD11 ' H ' ' B' ' 75' ' ' TYR . 1.4 pp -163.84 143.7 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.617 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.429 ' HE3' HE21 ' B' ' 47' ' ' GLN . 2.2 ttmp? -146.77 128.1 14.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.43 135.65 15.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' CA ' ' B' ' 72' ' ' GLY . . . -161.32 178.5 37.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.603 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.18 140.58 41.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.905 0.383 . . . . 0.0 111.123 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.572 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -112.55 131.7 55.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.355 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.8 111.96 24.84 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.278 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -124.91 131.29 53.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.612 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.681 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.0 -116.11 6.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.224 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -127.92 -61.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.313 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.0 t -100.27 29.04 4.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.157 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -118.35 83.08 1.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.8 136.05 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' TYR . 1.1 ptp -131.34 150.14 52.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -123.17 134.01 54.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.375 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.98 24.94 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.389 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.82 0.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.721 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.856 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.7 p -120.0 177.78 4.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.429 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -139.55 144.38 37.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.092 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.963 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.1 m-80 -112.92 143.6 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.353 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.72 151.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.619 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 55.4 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.705 0.288 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.44 -35.48 75.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.249 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.03 -44.13 69.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.798 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -46.91 81.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' C' ' 21' ' ' LEU . 0.0 OUTLIER -63.06 -36.82 84.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.589 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.11 -35.96 82.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.001 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.81 -42.19 64.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.608 ' HD2' HD13 ' B' ' 25' ' ' LEU . 28.1 mtt180 -62.72 -38.09 89.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.788 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.602 HD13 ' HD2' ' A' ' 24' ' ' ARG . 12.6 mt -67.34 -54.03 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.92 -47.74 76.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.813 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.75 -44.8 93.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.191 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.604 HD21 ' HA ' ' B' ' 29' ' ' ASP . 0.6 OUTLIER -58.03 -42.63 85.73 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ASP . . . . . 0.612 ' HA ' HD21 ' A' ' 28' ' ' LEU . 40.1 t0 -64.85 -40.57 95.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.949 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.405 HG22 ' HE2' ' C' ' 34' ' ' LYS . 10.2 m -61.69 -44.39 97.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.789 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.495 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 88.2 mmt-85 -57.2 -37.65 72.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.7 HG11 HG22 ' A' ' 32' ' ' VAL . 9.9 t -73.25 -29.6 28.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.118 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.572 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 63.6 m-20 -67.92 -62.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.023 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 0.5 OUTLIER -66.51 -44.61 82.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.804 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.86 -46.17 77.38 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.2 OUTLIER -68.07 -34.11 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.65 82.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.82 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -67.53 -54.48 19.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.406 ' HB3' ' SD ' ' C' ' 96' ' ' MET . 47.6 p -49.45 -55.06 14.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.09 82.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.515 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.89 -39.18 58.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.608 HD12 HD23 ' C' ' 45' ' ' LEU . 42.9 tp -81.08 -36.66 30.15 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.04 -3.24 28.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -88.62 -7.6 56.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.081 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.5 OUTLIER -90.58 165.75 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.924 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.83 -3.0 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.105 0.479 . . . . 0.0 111.649 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.448 HE21 ' HE3' ' C' ' 84' ' ' LYS . 40.0 mt-30 67.04 122.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.937 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' OD1' ' C' ' 55' ' ' ASN 0.406 9.8 Cg_endo -69.53 99.34 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.632 2.222 . . . . 0.0 112.556 -179.306 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 60.84 -160.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 149.36 83.55 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.198 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.522 HG23 ' CG ' ' C' ' 79' ' ' GLU . 9.5 p -90.14 -15.52 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.217 0.607 . . . . 0.0 112.393 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 161.73 48.48 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.305 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.88 -170.15 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.675 0.274 . . . . 0.0 110.549 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.94 141.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.613 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.428 ' OD1' ' HD2' ' C' ' 48' ' ' PRO . 3.2 m-80 -125.42 133.92 52.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.015 0.435 . . . . 0.0 111.661 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.46 45.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.204 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.447 HG23 ' HG2' ' C' ' 47' ' ' GLN . 24.3 p -114.9 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.903 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.94 146.92 22.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 175.97 163.05 27.99 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.565 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' C' ' 69' ' ' LEU . 6.2 m -105.76 167.21 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 111.226 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.04 -176.25 27.96 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.503 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.69 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.568 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 96' ' ' MET . 72.2 t80 -129.35 139.31 51.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.698 0.285 . . . . 0.0 110.729 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.446 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm180 61.09 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.094 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 65' ' ' SER . . . . . 0.4 ' N ' ' O ' ' C' ' 63' ' ' TYR . 8.0 t -155.91 35.41 0.35 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 7.0 m -132.99 166.83 21.48 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.36 142.8 47.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.89 156.51 44.93 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' C' ' 60' ' ' VAL . 9.4 tp -110.95 131.22 55.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -126.15 154.31 43.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.704 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.448 HG12 ' N ' ' C' ' 72' ' ' GLY . 20.4 tt -147.73 162.89 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.749 0.309 . . . . 0.0 111.137 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.448 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 178.52 169.67 39.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.431 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.46 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.05 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.12 160.92 27.88 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.246 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.507 ' H ' HD11 ' C' ' 83' ' ' LEU . 25.4 t80 -106.59 116.23 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.166 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.476 HH11 ' HB2' ' C' ' 82' ' ' ALA . 5.2 mmm180 -93.85 93.16 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' C' ' 78' ' ' ASN . 8.7 p -93.87 126.11 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.273 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 12.2 m120 68.89 -171.96 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.921 0.391 . . . . 0.0 111.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' GLU . . . . . 0.522 ' CG ' HG23 ' C' ' 51' ' ' VAL . 26.3 mt-10 -119.98 24.87 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.616 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' SER . . . . . 0.615 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 6.8 t -126.06 -39.36 2.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.994 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.01 152.61 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.971 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -149.05 174.63 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.278 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.507 HD11 ' H ' ' C' ' 75' ' ' TYR . 1.4 pp -163.84 143.74 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.448 ' HE3' HE21 ' C' ' 47' ' ' GLN . 2.2 ttmp? -146.82 128.16 14.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.48 135.66 15.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.412 ' HA3' ' CA ' ' C' ' 72' ' ' GLY . . . -161.36 178.57 37.22 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.556 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.25 140.64 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.872 0.367 . . . . 0.0 111.088 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.572 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -112.6 131.65 55.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.323 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -105.77 112.05 24.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.292 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.82 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -125.01 131.23 53.44 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.579 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.695 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.09 -116.15 6.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.235 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.86 -61.25 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.717 0.294 . . . . 0.0 111.299 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' SER . . . . . 0.486 ' O ' ' OG ' ' C' ' 93' ' ' SER . 3.1 t -100.19 28.98 4.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.193 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 t -118.82 136.05 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.0 110.706 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.6 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 1.1 ptp -131.31 150.07 52.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -123.08 133.96 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.365 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -116.96 157.96 24.88 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.705 0.288 . . . . 0.0 111.471 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.72 0.12 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.771 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.859 ' HB2' HD11 ' B' ' 45' ' ' LEU . 21.6 p -119.91 177.82 4.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.432 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -139.58 144.48 37.8 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.028 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.971 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.0 m-80 -112.96 143.57 44.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.332 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.7 151.19 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.866 0.365 . . . . 0.0 110.77 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.615 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 55.5 mt-10 -92.33 128.2 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 1.026 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.696 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -72.49 -34.87 67.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.215 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.6 mtt85 -65.97 -40.06 90.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.85 -44.91 63.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 111.134 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.853 HD23 HD21 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.61 -37.96 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.591 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.75 -31.13 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.038 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.07 -39.6 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.65 -37.56 67.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.782 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.3 mt -68.96 -42.7 76.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.648 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.22 -38.81 92.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.74 74.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.636 0.255 . . . . 0.0 111.181 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' C' ' 28' ' ' LEU . 0.5 OUTLIER -59.9 -43.73 94.67 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -59.8 -40.5 88.59 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.951 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 34' ' ' LYS . 26.0 m -66.67 -41.38 88.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.804 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.337 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 28' ' ' LEU . 3.0 t -76.09 -32.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.224 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.701 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 70.4 m-20 -65.56 -63.89 0.99 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.121 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.71 -34.54 62.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.773 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.45 78.44 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.446 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -72.53 -27.31 62.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 111.073 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.61 55.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.399 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -68.83 -41.58 78.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.9 ' HB3' HD21 ' C' ' 36' ' ' LEU . 31.5 p -55.84 -58.98 5.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.446 ' HB3' HD21 ' B' ' 98' ' ' ASN . . . -55.85 -39.54 71.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.444 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -60.73 -37.44 81.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.968 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 tp -75.16 -37.33 61.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.5 m-20 -76.45 -5.84 49.14 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.519 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.2 t -79.24 -11.23 59.95 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.125 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.754 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -84.2 177.57 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.874 177.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.651 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.5 p90 -169.53 -15.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.144 0.497 . . . . 0.0 111.705 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.762 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 40.8 mt-30 81.17 114.64 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.95 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.46 99.43 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.654 2.236 . . . . 0.0 112.558 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 62.24 -160.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.985 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 144.54 93.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.22 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 7.5 p -88.85 -27.1 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.126 0.57 . . . . 0.0 112.444 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 172.25 34.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.269 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.71 -165.43 1.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 110.605 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -110.27 141.33 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.508 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.561 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 6.7 m-80 -120.05 135.84 54.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.977 0.417 . . . . 0.0 111.669 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -99.85 128.52 45.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.27 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.754 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 42.7 p -117.64 131.44 56.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.79 143.39 9.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.485 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 178.77 165.5 33.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 69' ' ' LEU . 10.9 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.876 0.369 . . . . 0.0 111.345 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -155.5 -174.91 25.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.415 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.38 144.52 9.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.701 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 87.7 t80 -130.49 127.74 39.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.773 0.321 . . . . 0.0 110.69 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 6.9 mmm-85 66.35 -86.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.15 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.76 30.33 0.99 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.152 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.48 159.45 41.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.094 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.52 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.543 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' VAL . 8.0 tp -115.1 137.33 52.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.768 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.677 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.81 158.39 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.119 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 177.44 173.2 42.72 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.45 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.19 142.86 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.21 156.5 26.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.226 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -105.11 116.1 31.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 111.101 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.502 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 9.6 mmm180 -95.98 89.11 5.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.752 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.702 HG22 ' OD1' ' A' ' 78' ' ' ASN . 7.7 p -95.73 123.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.302 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.702 ' OD1' HG22 ' A' ' 77' ' ' VAL . 19.9 m120 64.15 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.147 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -99.74 32.06 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.603 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.488 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 t -131.74 -37.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.521 HG13 HG13 ' A' ' 77' ' ' VAL . 13.6 p -118.74 148.81 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -150.69 171.24 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.252 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.07 148.67 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.611 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.762 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -146.35 131.77 18.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.182 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.67 12.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -157.99 171.16 34.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.619 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.16 139.29 47.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.87 0.367 . . . . 0.0 111.093 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.32 132.22 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.77 121.52 41.83 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -130.1 124.34 32.53 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.589 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 61.93 -110.66 3.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.345 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -132.1 -63.34 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -99.05 24.64 7.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.136 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -116.4 85.14 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.943 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.76 137.55 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.484 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -129.64 158.12 40.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.713 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -133.84 137.52 45.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.451 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.463 HD21 ' HB3' ' C' ' 40' ' ' ALA . 34.6 m120 -125.63 152.26 45.42 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.745 0.307 . . . . 0.0 111.437 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.76 92.82 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.773 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.562 ' HB2' HD11 ' C' ' 45' ' ' LEU . 79.0 p -115.73 -177.57 3.18 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.41 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.45 140.52 22.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.945 0.403 . . . . 0.0 111.088 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.756 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 66.3 m-80 -112.28 144.01 42.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.435 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.419 ' CG2' HG23 ' A' ' 81' ' ' VAL . 4.1 pt -154.98 135.07 4.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 110.766 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.56 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 66.3 mt-10 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.729 0.3 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 18' ' ' PHE . . . . . 0.401 ' O ' ' HD1' ' B' ' 18' ' ' PHE . 0.2 OUTLIER -72.47 -34.84 67.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.231 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 18.5 mtt85 -65.97 -40.09 90.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.81 -44.93 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.118 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.853 HD21 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.49 -38.06 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.83 -31.05 66.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.16 -39.49 78.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.74 -37.57 67.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.732 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.0 -42.75 76.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -64.22 -38.82 92.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.63 74.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.67 0.271 . . . . 0.0 111.25 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' C' ' 28' ' ' LEU . 0.5 OUTLIER -59.92 -43.75 94.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.73 -40.57 88.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.963 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.622 HG22 ' HE2' ' B' ' 34' ' ' LYS . 25.9 m -66.65 -41.36 88.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.88 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' B' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.256 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 28' ' ' LEU . 3.0 t -76.12 -32.54 22.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.213 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.704 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 70.4 m-20 -65.59 -63.88 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' B' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.46 62.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.799 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.87 -49.43 78.65 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.874 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -72.55 -27.34 62.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.84 -52.63 55.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.409 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.3 OUTLIER -68.83 -41.55 78.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.74 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.884 ' HB3' HD21 ' A' ' 36' ' ' LEU . 31.5 p -55.83 -59.04 5.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' C' ' 98' ' ' ASN . . . -55.76 -39.55 71.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.469 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.489 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -60.76 -37.45 81.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.22 -37.3 61.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.049 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.566 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.4 m-20 -76.48 -5.86 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.531 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.2 t -79.23 -11.2 59.96 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.193 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.743 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 0.7 OUTLIER -84.32 177.59 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.806 178.022 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.648 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 12.6 p90 -169.57 -15.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.622 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.749 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 40.8 mt-30 81.24 114.62 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.906 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.405 9.7 Cg_endo -69.55 99.55 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.623 2.215 . . . . 0.0 112.491 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 62.13 -160.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.013 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 144.56 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.222 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 78' ' ' ASN . 7.5 p -88.91 -27.04 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.194 0.597 . . . . 0.0 112.433 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 172.22 34.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.292 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.66 -165.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.681 0.276 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.588 HG13 ' O ' ' C' ' 105' ' ' TRP . 8.9 p -110.39 141.19 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.523 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.557 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 6.7 m-80 -119.99 135.83 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.952 0.406 . . . . 0.0 111.689 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.585 ' HB2' ' HB2' ' C' ' 105' ' ' TRP . 2.2 t80 -99.9 128.57 45.98 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.212 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.743 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 42.6 p -117.62 131.41 56.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.023 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.8 143.35 9.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.455 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 178.83 165.52 33.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.586 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' B' ' 69' ' ' LEU . 11.0 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.338 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -155.52 -174.93 25.96 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.45 144.39 9.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.704 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 87.5 t80 -130.37 127.79 40.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 6.9 mmm-85 66.32 -86.57 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.185 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.84 30.43 0.97 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.23 167.92 16.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.792 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.38 159.46 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 165.61 36.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.545 ' HA ' HG12 ' B' ' 60' ' ' VAL . 8.0 tp -115.1 137.32 52.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.54 148.85 50.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.673 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.76 158.33 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 0.0 111.13 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 177.45 173.12 42.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.422 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.17 142.81 19.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.52 26.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.13 116.17 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 111.14 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.51 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 9.6 mmm180 -95.96 89.16 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.661 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.714 HG22 ' OD1' ' B' ' 78' ' ' ASN . 7.7 p -95.76 123.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 111.243 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.714 ' OD1' HG22 ' B' ' 77' ' ' VAL . 19.9 m120 64.12 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -99.76 32.13 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.552 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.482 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 9.8 t -131.84 -37.7 1.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.505 HG13 HG13 ' B' ' 77' ' ' VAL . 13.8 p -118.78 148.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -150.56 171.24 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.09 148.71 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.608 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.749 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -146.33 131.83 18.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.177 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.58 126.69 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -158.0 171.2 34.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.603 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.18 139.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.861 0.362 . . . . 0.0 111.06 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.36 132.25 54.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -100.72 121.51 41.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . . . -130.1 124.23 32.26 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.651 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.491 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 61.91 -110.66 3.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.292 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -132.06 -63.44 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.268 . . . . 0.0 111.281 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.96 24.66 7.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.211 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.4 OUTLIER -116.41 85.11 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.84 137.56 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.476 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -129.62 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.683 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.77 137.53 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.452 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.446 HD21 ' HB3' ' A' ' 40' ' ' ALA . 34.6 m120 -125.6 152.22 45.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.727 0.298 . . . . 0.0 111.458 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.8 92.8 1.13 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 45' ' ' LEU . 79.0 p -115.7 -177.61 3.19 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.41 140.54 23.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 111.139 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.775 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 66.4 m-80 -112.34 143.99 42.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.356 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.421 ' CG2' HG23 ' B' ' 81' ' ' VAL . 4.2 pt -154.98 135.01 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.838 0.351 . . . . 0.0 110.776 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.561 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 66.1 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.714 0.292 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -34.92 68.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.273 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 18.6 mtt85 -65.86 -40.1 91.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.803 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.88 -44.88 63.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.843 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.54 -38.08 68.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.623 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.67 -31.15 66.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.14 -39.54 78.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -72.68 -37.52 67.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.741 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.02 -42.69 76.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.626 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.23 -38.82 92.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.824 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 3.0 tmtt? -69.56 -42.66 74.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.253 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.93 -43.8 94.73 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.69 -40.53 88.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.0 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.622 HG22 ' HE2' ' C' ' 34' ' ' LYS . 25.9 m -66.72 -41.28 88.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.902 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' C' ' 27' ' ' LYS . 86.4 mmt-85 -54.89 -38.06 67.1 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.389 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.5 HG23 ' O ' ' C' ' 28' ' ' LEU . 3.0 t -76.13 -32.53 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.218 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.722 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 70.4 m-20 -65.51 -63.96 0.97 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.075 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' C' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.47 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.758 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.39 79.18 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.384 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.9 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -72.56 -27.34 62.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.803 0.335 . . . . 0.0 111.066 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.56 55.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.3 OUTLIER -68.87 -41.48 78.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.874 ' HB3' HD21 ' B' ' 36' ' ' LEU . 31.3 p -55.86 -58.96 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.463 ' HB3' HD21 ' A' ' 98' ' ' ASN . . . -55.86 -39.61 71.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.441 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -60.66 -37.47 81.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.21 -37.4 61.14 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 75.4 m-20 -76.32 -5.93 49.28 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' SER . . . . . 0.534 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.2 t -79.21 -11.24 59.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.111 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 0.7 OUTLIER -84.22 177.63 8.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.784 178.062 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.629 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 12.6 p90 -169.61 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.611 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.742 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 40.9 mt-30 81.13 114.59 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.986 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.42 99.41 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.709 2.272 . . . . 0.0 112.564 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 62.24 -160.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.005 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 144.55 93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.255 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' C' ' 78' ' ' ASN . 7.5 p -88.86 -27.03 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.154 0.582 . . . . 0.0 112.468 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 172.18 34.55 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.269 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.64 -165.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.646 0.26 . . . . 0.0 110.592 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -110.36 141.26 26.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.523 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.56 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 6.8 m-80 -120.01 135.74 54.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.973 0.416 . . . . 0.0 111.73 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -99.75 128.47 45.85 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.75 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.0 p -117.58 131.46 56.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.97 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.84 143.35 9.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.49 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 178.79 165.55 33.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.538 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' C' ' 69' ' ' LEU . 10.9 m -111.8 168.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.838 0.352 . . . . 0.0 111.326 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -155.46 -174.9 25.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.418 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.4 144.49 9.71 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.722 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 87.6 t80 -130.48 127.78 39.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 110.736 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 6.8 mmm-85 66.3 -86.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -146.84 30.32 0.98 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.25 167.95 16.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -136.45 159.43 41.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.104 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.53 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.561 ' HA ' HG12 ' C' ' 60' ' ' VAL . 8.0 tp -115.07 137.28 52.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.782 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.53 148.87 50.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.699 0.285 . . . . 0.0 111.651 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.82 158.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 177.41 173.18 42.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.488 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -155.19 142.72 19.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.12 156.5 26.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.234 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.09 116.19 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.133 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.504 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 9.6 mmm180 -95.96 89.1 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.723 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.711 HG22 ' OD1' ' C' ' 78' ' ' ASN . 7.7 p -95.74 123.77 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 111.208 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.711 ' OD1' HG22 ' C' ' 77' ' ' VAL . 19.9 m120 64.27 167.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 111.09 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -99.81 32.09 3.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.572 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 80' ' ' SER . . . . . 0.489 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 9.7 t -131.75 -37.75 1.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.991 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.51 HG13 HG13 ' C' ' 77' ' ' VAL . 13.7 p -118.75 148.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.513 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -150.71 171.12 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.258 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -162.96 148.77 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.573 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.742 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -146.37 131.8 18.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.75 12.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -158.12 171.17 35.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.572 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.2 139.27 48.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 111.114 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.31 54.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.78 121.49 41.78 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.271 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' C' ' 94' ' ' ASP . . . -130.1 124.23 32.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.628 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.488 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 61.94 -110.63 3.32 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.274 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.5 m -132.1 -63.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 0.0 111.295 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.99 24.7 7.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.4 OUTLIER -116.42 85.1 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.947 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.77 137.6 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.4 OUTLIER -129.6 158.17 40.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.84 137.58 45.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.388 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.455 HD21 ' HB3' ' B' ' 40' ' ' ALA . 34.6 m120 -125.72 152.19 45.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.417 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.78 92.83 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.562 ' HB2' HD11 ' B' ' 45' ' ' LEU . 79.0 p -115.73 -177.61 3.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.447 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.38 140.61 23.11 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.08 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.786 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 66.4 m-80 -112.31 143.94 42.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.418 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.423 ' CG2' HG23 ' C' ' 81' ' ' VAL . 4.1 pt -154.96 135.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.557 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 66.4 mt-10 -70.52 131.35 43.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.977 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 0.588 ' O ' HG13 ' B' ' 54' ' ' VAL . 33.1 t-105 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.664 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.623 ' HE2' ' HB2' ' C' ' 17' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.717 0.294 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.97 -37.86 64.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.208 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.2 -60.4 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.68 65.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.097 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.699 HD22 HD23 ' A' ' 25' ' ' LEU . 2.3 tm? -66.96 -62.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -62.24 -23.76 66.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.52 -49.51 47.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.606 ' HD3' HD11 ' C' ' 21' ' ' LEU . 69.0 mtp85 -73.33 -42.15 62.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.024 HD22 HD11 ' C' ' 25' ' ' LEU . 3.9 mm? -61.36 -46.08 91.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.559 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.29 -32.97 74.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.787 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.79 83.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.185 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -62.6 -47.94 81.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.115 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.52 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -60.98 -32.0 71.57 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.967 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.52 HG22 ' HE2' ' A' ' 34' ' ' LYS . 6.3 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.85 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.402 HH12 ' HB3' ' A' ' 93' ' ' SER . 0.0 OUTLIER -78.73 -30.72 46.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.381 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 29' ' ' ASP . 30.3 m -83.5 -33.49 9.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.515 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 57.9 m-20 -66.29 -48.69 69.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' CD ' ' HA3' ' A' ' 91' ' ' GLY . 6.6 ptpt -85.07 -25.69 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.835 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.91 -40.68 63.08 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.393 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.59 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -77.11 -25.73 52.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.329 . . . . 0.0 111.034 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.409 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -72.31 -40.93 67.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.444 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.671 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 13.3 t -79.0 -43.01 25.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.426 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.4 OUTLIER -59.73 -56.71 18.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.34 -40.88 78.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.395 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.41 -35.13 67.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 26.0 tp -76.26 -42.4 45.85 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.601 ' CB ' ' HB3' ' B' ' 43' ' ' ASN . 8.6 m120 -70.83 -13.81 62.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -67.26 -21.88 65.69 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.128 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' B' ' 100' ' ' SER . 1.5 mm? -80.07 171.8 14.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.857 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.488 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.3 p90 -158.11 -3.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.628 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.576 ' HB2' HH21 ' A' ' 76' ' ' ARG . 7.1 mt-30 71.51 119.79 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.953 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.262 9.8 Cg_endo -75.09 106.7 2.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.65 2.233 . . . . 0.0 112.497 -179.226 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.19 -177.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 173.02 51.34 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.245 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 4.9 p -73.32 -3.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.12 0.568 . . . . 0.0 112.519 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.9 54.33 0.03 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.272 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.82 -165.04 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.24 145.08 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.5 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.642 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.5 m-80 -126.16 118.43 25.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.65 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' A' ' 73' ' ' SER . 31.8 t80 -83.66 130.31 34.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.255 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.494 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 75.5 p -114.66 120.9 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.986 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 71' ' ' ILE . . . -152.26 135.29 15.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.488 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -179.72 168.57 39.06 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.55 ' CG1' HD12 ' A' ' 69' ' ' LEU . 13.3 m -116.96 158.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 111.418 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.99 -170.89 14.34 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.481 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.409 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -165.5 142.67 7.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.593 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 56.1 t80 -134.01 134.7 42.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.684 0.278 . . . . 0.0 110.771 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.71 28.59 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 1.6 m -133.77 142.05 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.3 157.11 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.099 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.671 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -149.48 167.78 25.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.558 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.55 HD12 ' CG1' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -125.97 136.66 53.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.757 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -128.31 142.55 51.1 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 111.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 87' ' ' VAL . 10.4 tp -139.38 155.07 25.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' THR . . . 168.12 176.91 38.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.384 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 56' ' ' PHE . 1.1 p -168.04 155.82 8.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.01 28.57 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.207 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -123.48 135.74 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.17 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.576 HH21 ' HB2' ' A' ' 47' ' ' GLN . 12.3 ttm180 -131.17 133.27 45.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.678 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.829 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 13.8 p -122.32 139.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 88.8 m-20 61.19 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.661 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 7.8 pt-20 177.81 -26.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.55 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 59.5 p -65.65 -67.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.39 139.19 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.496 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.666 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -142.07 155.35 45.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.241 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.564 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HG3' ' HE2' ' C' ' 46' ' ' PHE . 8.2 tmtt? -155.31 130.19 9.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.217 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 175.41 12.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.16 -173.69 37.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.543 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 71' ' ' ILE . 14.7 p -141.89 143.17 27.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.897 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -115.17 144.11 44.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.351 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -119.24 119.03 32.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.282 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -127.89 135.29 49.8 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.657 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.618 ' HA3' ' CD ' ' A' ' 34' ' ' LYS . . . 60.52 -111.56 3.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.276 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.3 m -149.61 10.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 111.312 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.402 ' HB3' HH12 ' A' ' 31' ' ' ARG . 1.6 t -165.09 23.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.156 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 37.0 m-20 -116.3 67.7 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.08 139.67 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 110.745 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.897 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 7.1 ptp -134.25 135.53 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.723 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.86 118.71 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.409 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -107.03 152.63 23.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.79 0.328 . . . . 0.0 111.394 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.753 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.504 ' HB3' HD11 ' C' ' 45' ' ' LEU . 14.4 m -118.6 169.09 10.09 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.396 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.06 136.01 31.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.986 0.422 . . . . 0.0 111.056 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.8 m-80 -104.31 132.8 50.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.355 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -138.22 114.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.376 . . . . 0.0 110.716 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' C' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.614 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.67 0.271 . . . . 0.0 110.578 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.9 -37.87 64.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.23 -60.37 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.63 65.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.983 0.42 . . . . 0.0 111.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.71 HD22 HD23 ' B' ' 25' ' ' LEU . 2.3 tm? -67.04 -62.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.29 -23.73 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.005 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.56 -49.49 47.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.601 ' HD3' HD11 ' A' ' 21' ' ' LEU . 69.1 mtp85 -73.36 -42.15 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.702 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 1.008 HD22 HD11 ' A' ' 25' ' ' LEU . 3.9 mm? -61.26 -46.08 91.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.603 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.33 -32.92 74.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.773 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.89 -38.7 83.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.647 0.26 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' B' ' 28' ' ' LEU . 0.0 OUTLIER -62.74 -47.89 81.59 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.501 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.5 OUTLIER -61.06 -31.95 71.6 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 178.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.514 HG22 ' HE2' ' B' ' 34' ' ' LYS . 6.2 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -30.64 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.312 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' B' ' 29' ' ' ASP . 29.3 m -83.68 -33.33 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.172 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 58.3 m-20 -66.35 -48.7 69.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.972 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.604 ' CD ' ' HA3' ' B' ' 91' ' ' GLY . 6.6 ptpt -85.17 -25.58 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.92 -40.8 62.95 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.601 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.5 mt -77.03 -25.71 52.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.413 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -72.44 -40.76 66.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.411 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.66 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 13.5 t -79.08 -42.97 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.745 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.418 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 0.4 OUTLIER -59.86 -56.71 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.88 78.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.441 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.48 -35.08 67.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.555 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 26.1 tp -76.3 -42.23 45.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.124 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.601 ' HB3' ' CB ' ' A' ' 43' ' ' ASN . 8.6 m120 -70.92 -13.77 62.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 46.5 t -67.3 -21.87 65.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.147 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' C' ' 100' ' ' SER . 1.5 mm? -80.05 171.71 14.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.866 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.489 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.3 p90 -158.09 -3.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.162 0.506 . . . . 0.0 111.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.579 ' HB2' HH21 ' B' ' 76' ' ' ARG . 7.1 mt-30 71.5 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.992 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.669 ' HB2' ' O ' ' C' ' 79' ' ' GLU 0.265 10.0 Cg_endo -74.94 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.708 2.272 . . . . 0.0 112.573 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.18 -177.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 173.02 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.219 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 4.9 p -73.42 -3.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.145 0.578 . . . . 0.0 112.466 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.831 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.97 54.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.25 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.81 -165.07 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.2 145.12 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.561 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.637 ' HB3' ' HD2' ' B' ' 48' ' ' PRO . 5.4 m-80 -126.11 118.32 25.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 111.706 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' B' ' 73' ' ' SER . 32.1 t80 -83.77 130.36 34.94 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.223 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.487 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 75.9 p -114.67 120.9 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.976 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' B' ' 71' ' ' ILE . . . -152.28 135.34 15.7 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.458 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -179.77 168.63 39.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.563 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.548 ' CG1' HD12 ' B' ' 69' ' ' LEU . 13.1 m -117.01 158.43 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.811 0.339 . . . . 0.0 111.332 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.99 -170.86 14.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.441 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLY . . . . . 0.413 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -165.5 142.69 7.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.529 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.572 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 56.0 t80 -134.13 134.7 42.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.672 0.273 . . . . 0.0 110.744 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 64.34 -93.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.73 28.63 1.27 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 1.6 m -133.79 142.1 47.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.36 157.17 17.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.99 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -149.57 167.74 25.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.523 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.548 HD12 ' CG1' ' B' ' 60' ' ' VAL . 0.6 OUTLIER -125.95 136.61 53.22 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.796 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -128.21 142.53 51.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.668 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' B' ' 87' ' ' VAL . 10.4 tp -139.29 155.16 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.103 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.408 ' N ' HG13 ' B' ' 71' ' ' ILE . . . 168.03 176.8 38.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.427 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' B' ' 56' ' ' PHE . 1.1 p -167.95 155.89 8.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.33 171.93 28.66 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.179 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -123.46 135.73 54.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.579 HH21 ' HB2' ' B' ' 47' ' ' GLN . 12.3 ttm180 -131.14 133.33 45.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.831 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 13.7 p -122.44 139.64 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 88.8 m-20 61.25 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 0.0 111.066 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 7.8 pt-20 177.87 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.585 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' B' ' 103' ' ' ILE . 59.5 p -65.65 -67.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.991 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.4 139.21 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.501 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -142.03 155.35 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.488 ' HG3' ' HE2' ' A' ' 46' ' ' PHE . 8.2 tmtt? -155.28 130.26 9.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.15 175.42 12.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.14 -173.7 37.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.559 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' B' ' 71' ' ' ILE . 14.7 p -141.89 143.24 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.891 0.377 . . . . 0.0 111.123 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.884 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -115.23 144.1 44.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.33 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -119.24 119.06 32.96 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -127.91 135.36 49.88 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.649 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.604 ' HA3' ' CD ' ' B' ' 34' ' ' LYS . . . 60.48 -111.58 3.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.281 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 56.8 m -149.62 10.3 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.286 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -165.07 23.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.163 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 37.2 m-20 -116.38 67.68 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.11 139.61 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.702 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.884 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 7.0 ptp -134.23 135.52 43.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.81 118.75 35.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -106.98 152.62 23.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.692 0.282 . . . . 0.0 111.427 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.49 90.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.698 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.499 ' HB3' HD11 ' A' ' 45' ' ' LEU . 14.3 m -118.56 169.09 10.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.432 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.02 135.89 31.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.676 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.9 m-80 -104.25 132.82 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.426 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -138.19 114.32 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.623 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.709 0.29 . . . . 0.0 110.531 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -74.0 -37.82 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.2 -60.42 3.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.38 -28.62 65.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.723 HD22 HD23 ' C' ' 25' ' ' LEU . 2.3 tm? -67.01 -62.7 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.566 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.18 -23.79 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.46 -49.56 47.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.623 ' HD3' HD11 ' B' ' 21' ' ' LEU . 69.0 mtp85 -73.4 -42.05 62.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.797 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 1.024 HD11 HD22 ' A' ' 25' ' ' LEU . 3.9 mm? -61.31 -46.08 91.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.624 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.32 -32.91 74.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.846 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.73 83.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -47.86 81.71 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ASP . . . . . 0.516 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.5 OUTLIER -61.05 -31.87 71.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.96 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.516 HG22 ' HE2' ' C' ' 34' ' ' LYS . 6.2 m -73.9 -30.26 62.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.865 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -30.73 45.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' C' ' 29' ' ' ASP . 30.1 m -83.57 -33.38 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.517 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 57.8 m-20 -66.43 -48.63 69.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.617 ' CD ' ' HA3' ' C' ' 91' ' ' GLY . 6.6 ptpt -85.16 -25.61 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.93 -40.71 62.91 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.404 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.601 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.5 mt -77.03 -25.78 52.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.92 0.391 . . . . 0.0 111.165 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.404 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -72.33 -40.77 67.17 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.548 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.664 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 13.2 t -79.07 -42.87 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.803 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.43 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 0.4 OUTLIER -59.92 -56.71 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.25 -41.01 78.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.418 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.34 -35.11 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.941 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.564 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 26.2 tp -76.22 -42.38 46.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.148 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.599 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 8.6 m120 -70.84 -13.85 62.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -67.31 -21.88 65.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.09 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 100' ' ' SER . 1.5 mm? -80.06 171.84 14.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.845 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.48 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.3 p90 -158.1 -3.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.193 0.52 . . . . 0.0 111.721 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.565 ' HB2' HH21 ' C' ' 76' ' ' ARG . 7.1 mt-30 71.58 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.968 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.263 9.9 Cg_endo -75.03 106.7 2.33 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.635 2.224 . . . . 0.0 112.585 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.15 -177.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 173.03 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.168 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 4.9 p -73.43 -3.42 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.091 0.557 . . . . 0.0 112.465 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.812 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.94 54.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 -165.16 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 0.0 110.615 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.15 145.1 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.641 ' HB3' ' HD2' ' C' ' 48' ' ' PRO . 5.4 m-80 -126.1 118.38 25.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 111.655 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' C' ' 73' ' ' SER . 32.1 t80 -83.76 130.33 34.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.206 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.481 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 75.2 p -114.63 120.92 41.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.97 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.419 ' HB2' HD12 ' C' ' 71' ' ' ILE . . . -152.32 135.35 15.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.484 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -179.76 168.57 39.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.552 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.549 ' CG1' HD12 ' C' ' 69' ' ' LEU . 13.3 m -116.9 158.41 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.328 . . . . 0.0 111.357 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.04 -170.8 14.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.421 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' GLY . . . . . 0.404 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -165.59 142.72 7.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.583 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 56.2 t80 -134.04 134.69 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.636 0.255 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.103 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.75 28.58 1.27 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' C' ' 33' ' ' ASP . 1.6 m -133.8 142.04 47.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.21 157.3 17.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ALA . . . . . 0.664 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -149.64 167.75 25.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.549 HD12 ' CG1' ' C' ' 60' ' ' VAL . 0.6 OUTLIER -126.01 136.63 53.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -128.25 142.55 51.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.654 0.264 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' C' ' 87' ' ' VAL . 10.4 tp -139.29 155.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.761 0.315 . . . . 0.0 111.11 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.401 ' N ' HG13 ' C' ' 71' ' ' ILE . . . 168.04 176.83 38.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.448 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 73' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' C' ' 56' ' ' PHE . 1.1 p -168.01 155.85 8.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.339 . . . . 0.0 110.969 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.36 171.99 28.67 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.565 HH21 ' HB2' ' C' ' 47' ' ' GLN . 12.3 ttm180 -131.19 133.27 45.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.677 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.812 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 13.6 p -122.38 139.68 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 89.0 m-20 61.17 -94.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 111.042 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 79' ' ' GLU . . . . . 0.669 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 7.8 pt-20 177.86 -26.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' C' ' 103' ' ' ILE . 59.2 p -65.69 -67.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.35 139.17 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -142.07 155.34 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.229 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.69 146.42 34.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.489 ' HG3' ' HE2' ' B' ' 46' ' ' PHE . 8.2 tmtt? -155.3 130.24 9.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.163 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.1 175.48 12.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.09 -173.71 37.57 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.536 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' C' ' 71' ' ' ILE . 14.7 p -141.91 143.21 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.078 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.896 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -115.2 144.14 44.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.348 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -119.26 119.13 33.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -128.0 135.29 49.7 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.672 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.617 ' HA3' ' CD ' ' C' ' 34' ' ' LYS . . . 60.64 -111.59 3.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.279 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 56.7 m -149.67 10.38 0.73 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.294 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -165.15 23.93 0.05 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 37.0 m-20 -116.37 67.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.13 139.72 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.896 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 7.1 ptp -134.22 135.52 43.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.87 118.77 35.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.403 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -107.1 152.61 23.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.715 0.293 . . . . 0.0 111.382 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.511 ' HB3' HD11 ' B' ' 45' ' ' LEU . 14.4 m -118.65 169.12 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.403 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.12 135.94 31.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.042 0.449 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.661 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.9 m-80 -104.24 132.8 50.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.435 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' C' ' 80' ' ' SER . 0.1 OUTLIER -138.17 114.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.719 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -115.97 157.96 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.8 m-90 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.706 179.624 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' O ' HD22 ' A' ' 21' ' ' LEU . 34.6 ttmt . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.733 0.302 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.75 -39.7 80.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.889 0.376 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -66.81 -42.89 85.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.779 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.7 -41.39 96.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.1 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.758 HD21 HD23 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -62.9 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.83 -30.72 71.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.73 -39.11 57.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.768 HD21 ' HG ' ' B' ' 25' ' ' LEU . 8.0 mt -67.25 -50.98 58.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.571 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.78 -50.91 72.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.826 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HE2' ' CZ ' ' A' ' 31' ' ' ARG . 9.5 tmtt? -54.78 -38.26 67.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.279 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -62.39 -42.69 99.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -63.54 -41.7 98.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.997 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.796 HG22 ' HE2' ' A' ' 34' ' ' LYS . 4.4 m -57.91 -47.12 83.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.764 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.614 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 83.2 mmt-85 -59.45 -35.5 74.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.318 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.861 HG22 HG11 ' C' ' 32' ' ' VAL . 41.7 t -73.75 -36.5 46.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.99 -55.88 16.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.995 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.814 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 3.4 pttt -72.35 -36.5 68.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.774 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.13 96.33 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.369 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.565 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -70.14 -37.13 75.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.805 0.336 . . . . 0.0 111.08 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.72 99.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.463 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -69.58 -54.38 14.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.753 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.545 ' HB3' HD21 ' C' ' 36' ' ' LEU . 86.9 p -49.07 -56.21 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.49 -52.61 53.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.471 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.16 -41.58 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.537 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 30.8 tp -73.88 -34.89 64.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.09 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 18.3 m120 -78.25 -5.12 51.01 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.404 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.5 t -86.13 -0.6 56.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.12 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -95.97 172.18 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.881 177.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.427 ' H ' ' H ' ' A' ' 47' ' ' GLN . 10.3 p90 -165.76 -5.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.662 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 35.1 mt-30 65.83 118.9 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.945 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.395 9.8 Cg_endo -69.89 98.2 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.692 2.261 . . . . 0.0 112.54 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 66.94 -165.0 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 146.16 82.25 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 79' ' ' GLU . 8.7 p -88.72 -11.03 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.094 0.558 . . . . 0.0 112.477 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 158.34 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.296 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.01 -166.7 2.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.558 0.218 . . . . 0.0 110.65 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.5 144.05 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.428 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 4.4 m-80 -131.06 134.83 47.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.652 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.476 ' O ' HG13 ' B' ' 103' ' ' ILE . 1.2 t80 -104.53 121.92 44.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.275 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.702 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 21.1 p -114.57 124.86 52.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.19 150.81 29.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.41 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.19 164.01 26.17 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.491 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 69' ' ' LEU . 14.5 m -110.21 166.33 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 111.373 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -174.43 22.35 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.53 143.21 8.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.554 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.636 ' CE2' ' HG3' ' A' ' 64' ' ' ARG . 63.2 t80 -132.51 137.1 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.727 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.636 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 2.9 mmm180 61.52 -80.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 63' ' ' TYR . 12.0 t -156.64 32.27 0.31 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -130.11 167.42 18.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.01 142.15 48.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.137 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.43 47.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.61 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.2 tp -111.32 128.48 55.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.729 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -122.95 152.09 41.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.708 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.429 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.7 tt -147.54 162.06 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.289 . . . . 0.0 111.183 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 175.35 169.34 37.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.408 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 p -163.29 147.71 11.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.73 161.85 28.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.245 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.29 119.48 39.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.154 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.484 ' CB ' ' HA3' ' A' ' 50' ' ' GLY . 4.9 mmm180 -96.9 99.21 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.707 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.697 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.0 p -98.23 130.72 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.332 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.48 ' OD1' HG22 ' A' ' 77' ' ' VAL . 8.1 m120 66.27 -170.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.932 0.396 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 51' ' ' VAL . 38.5 mt-10 -120.05 24.53 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.551 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.584 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 5.0 t -129.01 -44.75 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.28 148.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.494 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.845 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -152.07 171.15 18.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 111.205 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.82 143.23 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.606 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.5 23.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.26 135.95 23.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.39 175.04 39.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 96' ' ' MET . 6.3 p -124.08 146.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB3' ' SD ' ' A' ' 96' ' ' MET . . . -114.11 134.09 55.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.27 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.86 110.69 22.1 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.259 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -122.75 132.43 54.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.522 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.84 -113.15 4.04 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.263 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.85 -60.76 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 111.322 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.4 t -101.53 29.77 4.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.221 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.99 1.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.4 142.34 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.748 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.577 ' HB2' ' HA ' ' C' ' 63' ' ' TYR . 0.9 OUTLIER -132.57 155.59 48.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -128.48 129.02 45.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.522 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -119.7 160.33 22.74 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.17 99.02 0.12 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.796 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.751 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.2 p -122.67 179.45 4.61 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.43 146.36 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.845 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.4 m-80 -111.9 150.02 31.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.362 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.482 HG13 ' O ' ' C' ' 56' ' ' PHE . 3.9 pt -156.18 150.99 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.584 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 73.7 mt-10 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.485 ' O ' HD22 ' B' ' 21' ' ' LEU . 34.7 ttmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.75 0.31 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -39.83 80.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -66.76 -42.92 85.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -41.4 96.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.109 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.765 HD23 HD21 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -62.84 -43.4 98.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.89 -30.69 71.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.78 -39.11 57.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -73.02 -38.36 66.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.813 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.772 HD21 ' HG ' ' C' ' 25' ' ' LEU . 8.0 mt -67.18 -51.03 58.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.61 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.83 -50.89 72.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.799 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.499 ' HE2' ' CZ ' ' B' ' 31' ' ' ARG . 9.5 tmtt? -54.8 -38.27 67.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.277 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.571 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -62.41 -42.63 99.58 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.52 -41.74 98.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.969 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.804 HG22 ' HE2' ' B' ' 34' ' ' LYS . 4.4 m -57.94 -47.07 83.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.603 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 83.1 mmt-85 -59.37 -35.56 74.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.352 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.851 HG22 HG11 ' A' ' 32' ' ' VAL . 41.7 t -73.78 -36.56 46.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.201 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.0 -55.86 16.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.955 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.814 ' HB2' ' HB1' ' B' ' 90' ' ' ALA . 3.4 pttt -72.33 -36.58 68.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.744 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.91 -45.05 96.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.382 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -70.12 -37.23 75.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.79 99.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.427 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.756 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -69.56 -54.33 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.565 ' HB3' HD21 ' A' ' 36' ' ' LEU . 86.9 p -49.16 -56.25 9.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.017 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.54 54.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.465 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.23 -41.56 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.864 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.54 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 30.7 tp -73.89 -34.88 64.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.112 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.544 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 18.3 m120 -78.13 -5.23 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.417 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -86.05 -0.65 56.1 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.141 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -95.83 172.21 8.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.894 177.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -165.84 -5.24 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.097 0.475 . . . . 0.0 111.654 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' B' ' 55' ' ' ASN . 35.1 mt-30 65.86 118.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.395 9.7 Cg_endo -69.88 98.36 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.638 2.225 . . . . 0.0 112.552 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 66.75 -164.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 146.15 82.31 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.188 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' B' ' 79' ' ' GLU . 8.7 p -88.78 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.144 0.578 . . . . 0.0 112.422 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.683 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 158.25 46.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.259 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.1 -166.69 2.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.586 0.231 . . . . 0.0 110.628 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 1.175 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.6 p -109.52 144.12 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.561 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.428 ' HB2' ' OE1' ' B' ' 47' ' ' GLN . 4.4 m-80 -131.12 134.79 46.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.013 0.435 . . . . 0.0 111.61 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.47 ' O ' HG13 ' C' ' 103' ' ' ILE . 1.2 t80 -104.55 121.96 44.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.24 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.682 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 21.1 p -114.59 124.86 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.22 150.75 29.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.484 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.529 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.25 164.01 26.22 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.575 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 69' ' ' LEU . 14.4 m -110.26 166.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.61 -174.42 22.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.462 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.52 143.15 8.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.635 ' CE2' ' HG3' ' B' ' 64' ' ' ARG . 63.5 t80 -132.48 137.0 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.291 . . . . 0.0 110.765 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.635 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 2.9 mmm180 61.54 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.029 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 63' ' ' TYR . 12.2 t -156.69 32.3 0.31 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.158 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -130.17 167.46 18.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.802 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.02 142.15 48.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.62 155.49 47.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.529 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.1 tp -111.33 128.44 55.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.724 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -123.0 152.17 41.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.429 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.7 tt -147.56 162.0 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.751 0.31 . . . . 0.0 111.073 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.429 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 175.38 169.35 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.47 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -163.25 147.71 11.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.76 161.89 28.97 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.255 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.34 119.51 39.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.161 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.492 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 5.0 mmm180 -96.96 99.15 10.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.683 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.9 p -98.08 130.71 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.328 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.474 ' OD1' HG22 ' B' ' 77' ' ' VAL . 8.1 m120 66.17 -170.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.899 0.381 . . . . 0.0 111.154 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.504 ' HG3' HG23 ' B' ' 51' ' ' VAL . 38.6 mt-10 -120.0 24.59 10.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.598 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.583 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 5.0 t -129.07 -44.72 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.963 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.33 148.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.851 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -152.01 171.22 18.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.224 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.26 9.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.43 23.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.17 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.27 135.96 23.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.38 175.04 39.69 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.448 HG23 ' O ' ' B' ' 96' ' ' MET . 6.3 p -124.1 146.53 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.5 ' HB3' ' SD ' ' B' ' 96' ' ' MET . . . -114.09 134.09 55.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.89 110.74 22.15 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -122.78 132.45 54.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.574 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.521 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.95 -113.28 4.21 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.259 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.87 -60.67 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.343 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' SER . . . . . 0.527 ' OG ' ' O ' ' B' ' 93' ' ' SER . 2.3 t -101.6 29.75 4.69 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.258 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -119.72 82.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.988 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.47 142.35 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.017 0.437 . . . . 0.0 110.703 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.554 ' HB2' ' HA ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -132.49 155.63 48.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -128.5 128.93 45.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.492 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.6 160.27 22.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.688 0.28 . . . . 0.0 111.476 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.18 99.04 0.12 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.738 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.733 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.3 p -122.67 179.47 4.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.452 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -140.43 146.26 38.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.851 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.4 m-80 -111.82 150.0 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.374 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 56' ' ' PHE . 4.0 pt -156.1 150.97 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.761 0.315 . . . . 0.0 110.825 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 73.7 mt-10 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.487 ' O ' HD22 ' C' ' 21' ' ' LEU . 34.6 ttmt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.758 0.313 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -39.88 80.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.202 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 49.7 mtt85 -66.7 -42.88 85.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.68 -41.41 96.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.765 HD21 HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -62.87 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -75.76 -39.15 57.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.772 ' HG ' HD21 ' B' ' 25' ' ' LEU . 8.0 mt -67.2 -51.02 58.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -58.77 -50.85 72.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.5 ' HE2' ' CZ ' ' C' ' 31' ' ' ARG . 9.5 tmtt? -54.91 -38.21 67.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.254 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.576 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -62.33 -42.72 99.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.48 -41.77 98.57 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.989 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.786 HG22 ' HE2' ' C' ' 34' ' ' LYS . 4.4 m -57.89 -46.99 84.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.861 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.6 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 83.2 mmt-85 -59.48 -35.54 74.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.291 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.861 HG11 HG22 ' A' ' 32' ' ' VAL . 42.0 t -73.8 -36.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.164 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.89 -55.88 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.073 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.826 ' HB2' ' HB1' ' C' ' 90' ' ' ALA . 3.3 pttt -72.39 -36.56 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.732 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.78 -45.18 96.27 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.375 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -70.07 -37.13 75.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.84 0.352 . . . . 0.0 111.149 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.82 99.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.428 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -69.5 -54.39 14.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.776 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.555 ' HB3' HD21 ' B' ' 36' ' ' LEU . 87.0 p -49.09 -56.18 9.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.073 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -52.55 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.395 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.29 -41.4 37.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.534 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 30.6 tp -74.0 -34.87 64.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.113 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 18.3 m120 -78.18 -5.13 50.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' SER . . . . . 0.402 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.5 t -86.09 -0.63 56.09 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.156 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -95.95 172.18 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.892 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.407 ' H ' ' H ' ' C' ' 47' ' ' GLN . 10.4 p90 -165.76 -5.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.133 0.492 . . . . 0.0 111.66 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 35.1 mt-30 65.75 118.93 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.944 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.396 9.8 Cg_endo -69.91 98.23 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.641 2.227 . . . . 0.0 112.565 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 66.96 -164.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 146.17 82.24 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.254 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' C' ' 79' ' ' GLU . 8.8 p -88.77 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.391 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 158.26 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.273 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -142.93 -166.67 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.657 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.54 144.04 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.511 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.42 ' HB2' ' OE1' ' C' ' 47' ' ' GLN . 4.4 m-80 -131.1 134.83 46.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.067 0.46 . . . . 0.0 111.624 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' PHE . . . . . 0.482 ' O ' HG13 ' A' ' 103' ' ' ILE . 1.2 t80 -104.62 122.01 44.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.179 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.686 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 21.0 p -114.59 124.85 52.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.95 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.2 150.76 29.35 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.23 164.03 26.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' C' ' 69' ' ' LEU . 14.4 m -110.28 166.4 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.62 -174.4 22.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.48 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 143.1 8.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.573 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' C' ' 64' ' ' ARG . 62.9 t80 -132.45 137.06 47.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.633 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 2.9 mmm180 61.59 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.045 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 65' ' ' SER . . . . . 0.406 ' N ' ' O ' ' C' ' 63' ' ' TYR . 12.1 t -156.68 32.33 0.31 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -130.19 167.5 18.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.05 142.17 48.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.5 47.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.569 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.1 tp -111.33 128.35 55.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -122.97 152.11 41.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.726 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.434 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.7 tt -147.47 162.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.179 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.434 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 175.3 169.32 36.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.438 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 36.2 p -163.24 147.69 11.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.7 161.91 28.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.273 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.3 119.44 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 111.144 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.492 ' CB ' ' HA3' ' C' ' 50' ' ' GLY . 4.9 mmm180 -96.85 99.16 10.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.772 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.689 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.0 p -98.19 130.62 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.321 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' C' ' 77' ' ' VAL . 8.1 m120 66.37 -171.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' C' ' 51' ' ' VAL . 38.8 mt-10 -120.03 24.56 10.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.561 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' SER . . . . . 0.583 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 5.0 t -129.0 -44.74 1.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.987 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.2 148.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.552 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -152.02 171.21 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.234 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.22 9.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.52 23.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.145 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 135.91 23.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.02 39.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.609 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' VAL . . . . . 0.456 HG23 ' O ' ' C' ' 96' ' ' MET . 6.3 p -124.02 146.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.89 0.376 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.513 ' HB3' ' SD ' ' C' ' 96' ' ' MET . . . -114.03 134.02 55.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.423 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -108.85 110.78 22.21 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.252 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.826 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -122.77 132.41 54.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.59 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.544 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.97 -113.18 4.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.209 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.92 -60.73 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.3 t -101.59 29.79 4.67 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.35 142.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.58 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 0.9 OUTLIER -132.55 155.63 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.687 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -128.5 129.03 45.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.403 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.69 160.29 22.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.666 0.27 . . . . 0.0 111.504 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.2 99.03 0.12 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.721 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.1 p -122.79 179.49 4.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.435 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -140.47 146.28 38.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.836 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.4 m-80 -111.77 150.02 30.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.369 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.47 HG13 ' O ' ' B' ' 56' ' ' PHE . 3.9 pt -156.18 150.96 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 73.8 mt-10 -96.32 130.55 43.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 1.175 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.6 t-105 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.728 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.73 0.3 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.29 -26.56 62.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.321 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -66.23 -53.73 33.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.742 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.82 -26.96 61.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.94 0.4 . . . . 0.0 111.188 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.89 -59.99 4.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.556 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -74.71 -47.76 29.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 54.4 mtp85 -74.87 -37.58 62.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.76 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.711 HD11 HD22 ' B' ' 25' ' ' LEU . 2.8 mm? -63.77 -52.67 59.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -57.0 -42.48 80.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.45 -31.68 72.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.276 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -45.88 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.476 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -66.73 -31.47 72.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.964 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.37 -35.9 71.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.81 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.646 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -71.96 -39.61 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.8 m -75.85 -30.88 21.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.589 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 26.2 m-20 -68.38 -45.46 72.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.646 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.7 ptpt -75.51 -40.61 56.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.31 99.05 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.383 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.502 HD21 ' HG ' ' B' ' 36' ' ' LEU . 0.6 OUTLIER -74.37 -27.05 60.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -70.08 -41.48 74.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.465 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 8.2 t -82.98 -38.95 21.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.781 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.487 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 3.2 t -57.99 -55.78 30.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.74 -33.6 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.433 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.13 76.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.668 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 64.7 tp -81.06 -35.79 31.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.079 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 19.9 m120 -75.3 -14.38 60.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.85 -22.31 65.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.171 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.748 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.3 mm? -74.32 165.83 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.875 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.558 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 2.5 p90 -157.06 -3.3 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 111.663 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 9.1 mt-30 65.43 125.04 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.912 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -88.49 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.673 2.249 . . . . 0.0 112.589 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 11.5 m-30 66.93 -177.51 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.53 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.279 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -79.96 -12.51 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.168 0.587 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.34 52.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.266 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -163.95 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.57 141.72 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.526 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -120.93 114.17 21.16 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.698 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.72 130.46 35.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.262 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.748 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 36.9 p -109.47 126.69 53.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.6 129.75 7.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.406 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.604 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -174.25 165.18 36.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.558 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 69' ' ' LEU . 16.0 m -119.44 160.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.339 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.24 17.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.489 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -170.15 137.88 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.552 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.589 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 17.8 t80 -123.87 135.0 53.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.708 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 1.7 mmm180 68.54 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.074 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.65 23.51 1.12 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.139 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.0 m -128.86 141.74 51.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.91 27.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -145.92 173.83 11.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.564 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -121.88 143.29 49.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.776 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -130.75 135.39 47.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.707 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.467 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 174.02 -178.49 45.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.446 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.31 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.85 28.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.283 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.66 134.49 50.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.165 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -122.46 126.22 47.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.733 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.42 137.99 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 29.8 m-20 60.93 -96.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 111.083 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.36 -19.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.594 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.0 p -73.19 -62.13 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.014 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.69 146.34 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.515 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.749 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -147.39 156.16 42.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.265 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.19 147.2 29.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.683 ' HE3' HG21 ' A' ' 57' ' ' THR . 10.9 tmtt? -150.49 138.83 20.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.155 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.069 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 164.0 -176.0 40.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.529 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 p -142.98 137.68 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.554 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -108.89 144.55 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -117.91 114.55 23.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -120.19 130.81 54.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.599 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.49 -115.84 8.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.242 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.59 7.26 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.343 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 24.74 0.27 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.204 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.435 ' CG ' ' HD2' ' A' ' 34' ' ' LYS . 18.3 m-20 -127.51 80.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.9 t -112.32 139.18 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 110.684 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.554 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 6.8 ptp -133.23 141.31 47.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -112.52 126.01 54.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.475 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.71 152.11 26.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 111.402 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.54 87.24 0.39 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.791 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.612 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 11.3 m -118.25 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.441 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -132.4 147.62 52.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.922 0.392 . . . . 0.0 111.136 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.749 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 49.1 m-80 -111.77 130.55 55.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.34 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.02 115.99 22.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' CG ' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.717 0.294 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.35 -26.49 62.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -66.27 -53.68 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -72.84 -26.99 61.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.8 -60.03 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.83 -17.84 64.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.68 -47.77 29.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.41 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 54.4 mtp85 -74.93 -37.54 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.759 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.711 HD22 HD11 ' A' ' 25' ' ' LEU . 2.8 mm? -63.73 -52.68 59.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.96 -42.58 80.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' B' ' 27' ' ' LYS . 0.9 OUTLIER -63.38 -31.77 73.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.238 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -45.88 92.67 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.46 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -66.69 -31.5 72.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -71.34 -35.93 71.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.662 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.0 OUTLIER -71.89 -39.74 69.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.8 m -75.76 -30.92 21.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.586 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 26.1 m-20 -68.4 -45.34 72.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.016 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.7 ptpt -75.52 -40.62 56.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.806 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.3 99.16 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.32 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.502 ' HG ' HD21 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.36 -27.03 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.456 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -70.02 -41.56 74.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.472 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 8.2 t -82.96 -38.93 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.491 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.2 t -58.08 -55.8 30.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.74 -33.58 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.363 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -34.11 76.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.65 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 64.7 tp -81.08 -35.78 31.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 20.0 m120 -75.29 -14.31 60.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 28.9 t -67.93 -22.36 65.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.088 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.76 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -74.2 165.8 24.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.901 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.561 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 2.5 p90 -157.07 -3.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 65.39 125.02 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.954 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -88.51 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.722 2.282 . . . . 0.0 112.557 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 11.5 m-30 66.88 -177.5 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.6 57.49 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.314 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -79.92 -12.53 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.162 0.585 . . . . 0.0 112.459 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.3 52.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.213 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -164.0 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.644 0.259 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.52 141.71 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.552 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -120.9 114.27 21.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.968 0.414 . . . . 0.0 111.701 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -82.83 130.43 35.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.299 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.76 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.2 p -109.41 126.7 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.023 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.77 7.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.461 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.609 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -174.24 165.15 36.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.563 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' B' ' 69' ' ' LEU . 16.0 m -119.41 160.79 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.18 16.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.467 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -170.13 137.84 4.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.617 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.586 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 17.8 t80 -123.8 135.08 53.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 1.7 mmm180 68.44 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.58 23.46 1.13 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.67 51.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.53 151.9 27.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 111.093 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -145.89 173.94 11.69 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.563 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.9 OUTLIER -121.97 143.27 49.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.764 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -130.75 135.43 47.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.687 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.479 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.76 0.314 . . . . 0.0 111.098 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.479 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 173.96 -178.49 45.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.446 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.49 146.4 5.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.965 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.64 162.76 28.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.279 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.63 134.55 50.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -122.47 126.31 47.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.56 138.06 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 29.6 m-20 60.88 -96.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 111.086 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.4 -19.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.9 p -73.18 -62.2 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 m -91.58 146.39 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.564 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -147.47 156.11 42.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.268 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.14 147.19 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.617 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.675 ' HE3' HG21 ' B' ' 57' ' ' THR . 11.0 tmtt? -150.48 138.87 20.44 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.47 173.29 14.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 164.0 -175.95 40.07 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.565 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.99 137.71 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -108.89 144.52 36.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.321 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -117.99 114.56 23.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.228 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -120.21 130.76 54.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.605 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.57 -115.86 8.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.326 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.6 7.24 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 111.36 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.89 24.72 0.27 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.213 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.436 ' CG ' ' HD2' ' B' ' 34' ' ' LYS . 18.2 m-20 -127.51 80.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.42 139.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.06 0.457 . . . . 0.0 110.633 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.552 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 6.8 ptp -133.18 141.28 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.678 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.51 126.03 54.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.437 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.62 152.09 26.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 111.493 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.53 87.27 0.4 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.843 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.604 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 11.3 m -118.24 166.22 12.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.396 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -132.37 147.61 52.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.939 0.399 . . . . 0.0 111.065 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 49.3 m-80 -111.71 130.62 55.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.412 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.99 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.442 ' CG ' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.66 0.267 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.4 -26.46 62.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.243 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 47.7 mtt-85 -66.29 -53.68 33.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.8 -26.97 61.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.186 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.92 -60.0 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.53 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -65.8 -17.85 64.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.67 -47.74 30.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.425 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 54.5 mtp85 -74.95 -37.51 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.785 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.683 HD22 HD11 ' B' ' 25' ' ' LEU . 2.8 mm? -63.87 -52.57 59.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -57.05 -42.49 80.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 27' ' ' LYS . 0.9 OUTLIER -63.51 -31.71 72.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.609 0.242 . . . . 0.0 111.215 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' C' ' 28' ' ' LEU . 0.0 OUTLIER -61.25 -45.97 92.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ASP . . . . . 0.467 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -66.65 -31.51 72.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.975 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.35 -35.79 71.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.873 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.665 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -72.05 -39.62 68.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.282 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.8 m -75.83 -30.84 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.605 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 26.1 m-20 -68.45 -45.35 72.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.665 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.7 ptpt -75.58 -40.62 56.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.14 99.11 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.395 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.499 HD21 ' HG ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.47 -27.08 60.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.833 0.349 . . . . 0.0 111.043 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.459 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -70.04 -41.49 74.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.458 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 8.2 t -83.08 -38.82 21.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.486 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 3.2 t -58.02 -55.85 29.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.52 73.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.447 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.06 76.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.946 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.646 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 64.8 tp -81.14 -35.75 31.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 20.0 m120 -75.33 -14.33 60.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.82 -22.37 65.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.158 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -74.27 165.83 24.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.862 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.553 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 2.5 p90 -157.1 -3.24 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.126 0.488 . . . . 0.0 111.654 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 9.0 mt-30 65.42 124.97 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.988 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -88.45 109.26 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.643 2.229 . . . . 0.0 112.591 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 11.5 m-30 66.8 -177.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.944 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.5 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.258 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -79.84 -12.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.195 0.598 . . . . 0.0 112.466 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.45 52.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.265 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.96 -164.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.615 0.245 . . . . 0.0 110.573 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.54 141.69 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.56 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -120.94 114.19 21.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.65 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -82.67 130.45 35.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.3 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.75 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 37.1 p -109.41 126.7 53.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.987 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.71 7.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.395 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.612 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -174.23 165.23 36.72 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.512 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' C' ' 69' ' ' LEU . 16.0 m -119.43 160.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.46 -168.24 16.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.478 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -170.17 137.86 4.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.605 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 17.9 t80 -123.8 135.14 53.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 110.702 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 1.7 mmm180 68.39 -89.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.6 23.45 1.13 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.77 51.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.807 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.83 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.09 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -145.83 173.93 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.578 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.431 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.9 OUTLIER -121.97 143.25 49.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.716 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.646 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -130.74 135.38 47.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.65 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.477 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.0 tp -134.1 159.31 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.706 0.288 . . . . 0.0 111.203 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.477 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 174.05 -178.47 45.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.434 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.4 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.995 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.68 162.78 28.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.262 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -126.66 134.57 50.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.365 . . . . 0.0 111.148 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -122.44 126.21 47.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.778 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.48 137.97 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 29.8 m-20 60.99 -96.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.063 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.39 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.612 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 8.1 p -73.14 -62.18 1.56 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.66 146.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.762 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -147.42 156.16 42.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.15 147.21 29.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.591 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.693 ' HE3' HG21 ' C' ' 57' ' ' THR . 10.9 tmtt? -150.53 138.85 20.36 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.34 14.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 163.95 -175.85 40.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.597 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.01 137.71 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -108.95 144.53 36.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.357 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -117.87 114.61 23.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.261 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -120.12 130.8 54.8 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -115.76 7.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -146.67 7.22 0.96 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.29 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.92 24.8 0.27 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.235 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.432 ' CG ' ' HD2' ' C' ' 34' ' ' LYS . 18.5 m-20 -127.62 80.84 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 65.1 t -112.34 139.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.67 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.55 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 6.8 ptp -133.25 141.34 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.733 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.59 125.97 54.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.55 152.06 25.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.504 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.52 87.19 0.39 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.815 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.609 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 11.1 m -118.26 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -132.43 147.56 52.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.912 0.386 . . . . 0.0 111.058 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.762 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 49.4 m-80 -111.71 130.57 55.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.97 22.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -118.71 158.79 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.688 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.667 ' HB2' ' HE2' ' B' ' 17' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.631 0.253 . . . . 0.0 110.525 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -35.02 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 111.26 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.19 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.433 HE22 HD12 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -60.44 -28.38 68.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.696 HD11 ' HD3' ' B' ' 24' ' ' ARG . 2.2 tm? -64.99 -59.43 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.81 -23.08 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.05 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.01 -55.18 15.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.696 ' HD3' HD11 ' C' ' 21' ' ' LEU . 69.5 mtp85 -70.34 -38.21 74.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.779 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.929 HD11 HD22 ' B' ' 25' ' ' LEU . 3.7 mm? -63.75 -48.28 77.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.04 -31.73 73.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 2.1 ttpp -65.34 -42.59 92.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.692 0.282 . . . . 0.0 111.288 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -63.35 -43.93 96.31 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.17 -30.01 64.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.925 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.589 HG22 ' HE2' ' A' ' 34' ' ' LYS . 5.6 m -79.71 -29.67 40.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.792 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 -26.64 46.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.32 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.62 -28.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.219 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.643 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 76.1 m-20 -75.95 -45.07 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.984 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.589 ' HE2' HG22 ' A' ' 30' ' ' THR . 5.2 ptpt -84.1 -29.1 27.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.74 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 39' ' ' SER . . . -68.65 -42.42 80.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.422 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -80.58 -25.59 38.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.105 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.19 -41.38 58.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.49 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 10.4 t -77.47 -42.58 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.758 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -62.39 -50.87 69.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.467 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . . . -59.97 -36.95 78.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.34 -42.59 44.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -71.65 -7.87 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.77 -23.84 63.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.147 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.7 mm? -82.19 165.82 20.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.862 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.7 p90 -153.28 -3.85 0.2 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.636 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HB3' ' CB ' ' A' ' 55' ' ' ASN . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.922 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -79.65 113.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.613 2.209 . . . . 0.0 112.487 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.43 173.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.016 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 52.98 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.23 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 7.6 p -72.57 -3.83 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.162 0.585 . . . . 0.0 112.45 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 145.57 52.56 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.341 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -169.6 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 110.615 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 75' ' ' TYR . 12.4 p -109.56 142.66 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.573 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' GLN . 23.9 m-80 -122.88 119.0 29.21 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 58' ' ' ALA . 34.6 t80 -87.25 133.85 33.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.242 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.551 HG21 ' CE ' ' A' ' 84' ' ' LYS . 81.8 p -115.35 120.03 38.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 56' ' ' PHE . . . -150.65 135.4 17.39 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.425 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.51 169.03 39.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.534 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 69' ' ' LEU . 15.6 m -120.57 154.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.26 -172.83 13.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.437 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.0 140.2 6.22 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.643 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 31.9 t80 -133.25 135.1 44.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.708 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.2 mmm180 66.61 -93.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.125 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 p -145.68 31.16 1.07 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.44 141.02 45.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.33 153.9 22.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.08 170.57 17.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.541 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -119.38 141.15 49.32 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . . . -126.23 140.78 52.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.732 0.301 . . . . 0.0 111.637 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -140.95 151.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.093 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.12 174.72 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.438 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.97 155.05 5.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.23 173.13 29.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.252 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.559 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 44.6 t80 -126.48 135.48 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.14 135.34 52.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.754 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.431 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 7.6 p -119.35 137.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.34 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 90.4 m-20 64.13 -94.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 6.2 pt-20 179.11 -23.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.604 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.92 -63.95 1.0 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.536 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.005 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -141.27 152.0 44.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.247 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 63.5 tp -134.37 140.28 46.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.551 ' CE ' HG21 ' A' ' 57' ' ' THR . 7.3 tmtt? -155.58 126.28 6.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.72 178.05 10.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.96 36.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.56 141.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 111.165 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.734 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -111.72 139.4 47.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.346 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -114.02 114.39 26.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.173 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -123.44 135.96 54.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.639 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.448 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 57.09 -116.81 8.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.31 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 72.5 m -148.61 16.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.74 0.305 . . . . 0.0 111.316 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.71 20.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.19 68.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.96 139.04 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.73 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.734 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 3.3 ptp -133.26 132.97 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.748 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -110.74 118.59 36.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -107.11 152.68 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.12 0.65 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.773 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 21.6 m -123.82 176.31 6.37 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.448 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.48 139.44 25.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.922 0.392 . . . . 0.0 111.105 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 1.005 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.6 m-80 -103.2 132.8 49.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.346 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.59 117.39 17.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.802 0.334 . . . . 0.0 110.811 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.667 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.649 0.262 . . . . 0.0 110.53 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.41 -35.16 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.194 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.74 -59.24 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.433 HE22 HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -60.37 -28.45 68.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.173 -179.731 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.705 HD11 ' HD3' ' C' ' 24' ' ' ARG . 2.1 tm? -64.85 -59.56 4.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.574 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -65.77 -23.0 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.059 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.08 -55.16 15.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.696 ' HD3' HD11 ' A' ' 21' ' ' LEU . 69.5 mtp85 -70.36 -38.19 74.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.934 HD11 HD22 ' C' ' 25' ' ' LEU . 3.7 mm? -63.8 -48.34 77.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.588 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.98 -31.66 72.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.591 ' HZ1' HD22 ' B' ' 28' ' ' LEU . 2.1 ttpp -65.48 -42.61 92.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.199 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.591 HD22 ' HZ1' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -63.22 -44.02 96.47 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.21 -29.96 64.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.926 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.591 HG22 ' HE2' ' B' ' 34' ' ' LYS . 5.6 m -79.75 -29.55 40.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -26.54 46.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.326 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.71 -28.57 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.142 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.657 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 76.2 m-20 -75.97 -44.99 37.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.988 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' B' ' 30' ' ' THR . 5.3 ptpt -84.19 -29.04 26.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.715 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' B' ' 39' ' ' SER . . . -68.79 -42.29 79.74 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.419 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.462 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.5 mt -80.66 -25.54 38.21 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.752 0.311 . . . . 0.0 111.034 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.11 -41.52 58.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.51 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 10.4 t -77.39 -42.6 35.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.785 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 0.9 OUTLIER -62.38 -50.87 69.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.88 85.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.475 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' B' ' 70' ' ' ALA . . . -59.94 -37.04 78.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.405 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 39.7 tp -76.33 -42.53 44.65 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.07 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -71.68 -7.87 50.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.4 t -69.73 -23.89 63.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.316 -0.856 . . . . 0.0 113.172 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.564 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.7 mm? -82.18 165.88 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.883 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 7.7 p90 -153.35 -3.8 0.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.109 0.48 . . . . 0.0 111.671 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.435 ' HB3' ' CB ' ' B' ' 55' ' ' ASN . 10.1 mt-30 72.03 117.26 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -79.55 113.53 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.645 2.23 . . . . 0.0 112.506 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.48 173.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.71 53.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.289 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 7.7 p -72.57 -3.9 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.117 0.567 . . . . 0.0 112.465 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 145.58 52.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.248 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -169.58 3.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.611 0.243 . . . . 0.0 110.606 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' B' ' 75' ' ' TYR . 12.4 p -109.59 142.65 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.538 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.435 ' CB ' ' HB3' ' B' ' 47' ' ' GLN . 24.0 m-80 -122.91 118.97 29.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.93 0.395 . . . . 0.0 111.697 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.447 ' HE2' ' HB2' ' B' ' 58' ' ' ALA . 34.5 t80 -87.17 133.83 33.6 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.245 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.558 HG21 ' CE ' ' B' ' 84' ' ' LYS . 81.8 p -115.38 119.95 37.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.949 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.447 ' HB2' ' HE2' ' B' ' 56' ' ' PHE . . . -150.58 135.43 17.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.475 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.479 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.49 168.98 39.25 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.539 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' B' ' 69' ' ' LEU . 15.6 m -120.52 154.79 23.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.806 0.336 . . . . 0.0 111.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.33 -172.81 13.38 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.409 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.01 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.657 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 32.0 t80 -133.21 134.98 44.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.74 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.2 mmm180 66.69 -93.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.087 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.63 31.14 1.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.173 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.47 140.98 45.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.35 153.93 22.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.62 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.579 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.531 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -119.5 141.2 49.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' B' ' 41' ' ' ALA . . . -126.25 140.64 52.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 71' ' ' ILE . 8.3 tp -140.9 151.84 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.742 0.306 . . . . 0.0 111.11 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.21 174.65 39.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.396 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.94 155.12 5.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.342 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.21 173.19 29.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.245 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.557 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 44.8 t80 -126.55 135.58 51.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.22 135.34 52.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.659 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.437 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 7.6 p -119.4 137.4 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 90.2 m-20 64.11 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 6.2 pt-20 179.1 -23.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.589 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 17.5 p -70.8 -63.98 0.99 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.98 143.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.58 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -141.29 152.07 44.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.271 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 63.6 tp -134.32 140.2 46.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.604 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.558 ' CE ' HG21 ' B' ' 57' ' ' THR . 7.3 tmtt? -155.6 126.13 6.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.141 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.44 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.59 178.07 10.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.88 36.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.534 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.411 ' O ' HG22 ' B' ' 71' ' ' ILE . 7.7 p -143.66 141.44 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.74 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -111.82 139.35 47.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.325 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -113.95 114.37 26.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.205 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -123.36 136.01 54.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.644 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 57.06 -116.92 8.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.248 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.52 16.64 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.75 20.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.197 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -119.22 68.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.957 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.14 139.06 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.74 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 3.3 ptp -133.31 132.99 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.74 118.63 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.415 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -107.13 152.66 23.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.685 0.279 . . . . 0.0 111.412 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.98 94.11 0.65 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.472 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 21.8 m -123.81 176.44 6.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.391 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -146.65 139.45 25.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.029 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.954 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.6 m-80 -103.22 132.79 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.362 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.35 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.65 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.666 0.27 . . . . 0.0 110.55 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -34.99 65.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.259 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.18 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.444 HE22 HD12 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -60.44 -28.36 68.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.136 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.696 HD11 ' HD3' ' A' ' 24' ' ' ARG . 2.1 tm? -64.98 -59.44 4.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.631 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -65.86 -22.96 66.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.07 -55.17 15.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.705 ' HD3' HD11 ' B' ' 21' ' ' LEU . 69.6 mtp85 -70.33 -38.16 74.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.934 HD22 HD11 ' B' ' 25' ' ' LEU . 3.7 mm? -63.89 -48.36 76.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.87 -31.74 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.437 ' HZ1' HD22 ' C' ' 28' ' ' LEU . 2.0 ttpp -65.47 -42.51 92.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' C' ' 28' ' ' LEU . 0.0 OUTLIER -63.28 -44.0 96.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -29.96 64.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.936 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.582 HG22 ' HE2' ' C' ' 34' ' ' LYS . 5.6 m -79.8 -29.55 40.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -26.63 46.49 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.357 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.55 -28.72 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.143 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.654 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 76.2 m-20 -75.88 -45.11 37.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.005 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.582 ' HE2' HG22 ' C' ' 30' ' ' THR . 5.3 ptpt -84.08 -29.07 27.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.806 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' C' ' 39' ' ' SER . . . -68.6 -42.39 80.82 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.462 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.5 mt -80.61 -25.63 38.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.801 0.334 . . . . 0.0 111.06 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.45 57.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.402 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 10.5 t -77.43 -42.6 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' C' ' 35' ' ' GLY . 0.9 OUTLIER -62.3 -50.92 69.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.86 85.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' C' ' 70' ' ' ALA . . . -59.92 -37.02 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.94 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.41 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 39.6 tp -76.25 -42.65 45.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.035 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -71.66 -7.9 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.71 -23.91 63.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.149 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.547 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.7 mm? -82.26 165.78 20.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.813 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 7.7 p90 -153.26 -3.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.651 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' C' ' 55' ' ' ASN . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.963 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.735 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -79.61 113.5 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.667 2.245 . . . . 0.0 112.514 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.47 173.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.985 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.73 53.02 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.229 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 7.7 p -72.58 -3.85 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 145.6 52.65 0.03 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.22 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.603 0.239 . . . . 0.0 110.655 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' C' ' 75' ' ' TYR . 12.4 p -109.6 142.62 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.567 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.439 ' CB ' ' HB3' ' C' ' 47' ' ' GLN . 24.0 m-80 -122.91 118.99 29.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.646 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 56' ' ' PHE . . . . . 0.454 ' HE2' ' HB2' ' C' ' 58' ' ' ALA . 34.4 t80 -87.19 133.77 33.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.282 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.565 HG21 ' CE ' ' C' ' 84' ' ' LYS . 81.9 p -115.31 120.01 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.983 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.454 ' HB2' ' HE2' ' C' ' 56' ' ' PHE . . . -150.66 135.38 17.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.473 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.48 168.95 39.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' C' ' 69' ' ' LEU . 15.6 m -120.52 154.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.806 0.336 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.31 -172.88 13.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.466 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.0 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.574 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.654 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 32.1 t80 -133.19 134.99 44.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 110.812 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.2 mmm180 66.64 -93.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.133 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.61 31.12 1.08 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.43 141.05 45.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.781 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.39 153.91 22.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.54 17.56 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.539 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.53 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -119.43 141.18 49.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.747 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' C' ' 41' ' ' ALA . . . -126.24 140.69 52.34 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.702 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.408 HG22 ' O ' ' C' ' 87' ' ' VAL . 8.3 tp -140.88 151.83 20.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.14 174.72 39.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.468 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.93 155.09 5.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.24 173.15 29.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.269 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.554 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 44.6 t80 -126.56 135.54 51.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.342 . . . . 0.0 111.172 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.17 135.39 52.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.666 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.444 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 7.5 p -119.43 137.39 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 90.2 m-20 64.15 -94.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 79' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 6.2 pt-20 179.07 -23.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.527 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.99 -63.87 1.02 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.965 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -141.28 152.07 44.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.257 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 63.3 tp -134.37 140.22 46.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.565 ' CE ' HG21 ' C' ' 57' ' ' THR . 7.3 tmtt? -155.6 126.23 6.87 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 85' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.68 177.99 10.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.71 -167.82 36.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.58 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' VAL . . . . . 0.408 ' O ' HG22 ' C' ' 71' ' ' ILE . 7.7 p -143.74 141.45 25.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -111.73 139.31 47.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.316 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -113.97 114.45 26.2 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -123.45 135.95 54.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.624 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 57.11 -116.86 8.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.248 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.58 16.5 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 111.252 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.73 20.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.238 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.25 68.68 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 24.9 t -94.99 139.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.738 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.745 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 3.3 ptp -133.28 132.99 42.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.701 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.8 118.64 36.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.433 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -107.05 152.64 23.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.727 0.298 . . . . 0.0 111.432 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.1 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.479 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 21.8 m -123.8 176.37 6.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.432 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.59 139.42 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.988 0.423 . . . . 0.0 111.101 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.965 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.6 m-80 -103.21 132.8 49.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.37 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.3 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.781 0.324 . . . . 0.0 110.798 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.77 151.94 36.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.71 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.681 0.276 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.79 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.33 -60.07 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.6 -28.13 69.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.706 ' O ' HD23 ' A' ' 25' ' ' LEU . 2.4 tm? -63.37 -54.61 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.536 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' NH2' ' B' ' 24' ' ' ARG . 30.2 m-20 -65.28 -27.07 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.981 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.49 -57.53 8.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.703 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.0 mtp85 -61.6 -38.55 87.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.818 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.797 HD11 HD22 ' B' ' 25' ' ' LEU . 3.1 mm? -62.18 -48.64 79.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.531 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.9 -28.94 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.772 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' NZ ' ' HD3' ' A' ' 31' ' ' ARG . 1.2 ttpp -65.15 -44.01 89.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.642 0.258 . . . . 0.0 111.223 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.444 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -59.58 -41.66 90.74 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.553 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -61.1 -27.71 68.57 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.939 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 m -75.58 -39.82 57.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HD3' ' NZ ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -73.06 -22.81 60.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.334 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.6 m -90.28 -28.65 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.144 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.632 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 65.1 m-20 -73.63 -47.74 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 91' ' ' GLY . 7.9 ptpt -80.8 -28.47 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.759 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.92 53.82 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.422 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 1.6 mt -75.0 -32.22 61.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 111.127 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.2 -41.17 70.62 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.447 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.745 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 9.0 t -74.8 -41.52 59.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.802 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -60.01 -53.34 58.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.087 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -60.22 -34.04 73.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.339 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.784 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.33 -41.45 93.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.25 -42.14 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.071 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 3.0 m120 -72.09 -9.87 59.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 t -68.49 -22.68 64.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.189 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.648 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.6 mm? -82.7 159.17 22.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.875 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.16 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.647 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.458 ' OE1' ' HA3' ' A' ' 74' ' ' GLY . 13.8 mt-30 70.7 118.04 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.7 Cg_endo -78.48 114.85 3.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.585 2.19 . . . . 0.0 112.501 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.75 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.631 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 167.72 55.85 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.263 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 8.3 p -75.49 -5.5 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.136 0.575 . . . . 0.0 112.479 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.8 49.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.33 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.599 0.238 . . . . 0.0 110.649 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 p -105.86 141.63 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.524 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -122.77 117.52 25.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 111.624 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -87.72 140.59 29.36 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.281 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.648 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 68.1 p -117.23 118.97 33.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.91 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' B' ' 101' ' ' PHE . . . -144.9 132.39 20.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.476 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.83 174.93 46.17 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.574 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.22 160.67 23.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.392 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.784 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -140.33 177.55 20.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.438 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -162.39 141.04 6.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.537 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.636 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 39.1 t80 -137.24 134.12 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.271 . . . . 0.0 110.815 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 64' ' ' ARG . 1.9 mmm180 62.89 -93.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 p -143.26 32.39 1.35 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.1 145.15 47.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.782 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.01 153.55 26.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.097 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.98 164.33 32.37 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.523 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.58 136.16 53.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.71 51.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.638 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.17 153.41 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.101 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 172.89 -177.72 45.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.95 151.26 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.458 ' HA3' ' OE1' ' A' ' 47' ' ' GLN . . . -150.24 171.67 30.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.227 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.03 136.59 50.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 111.11 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.631 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 7.1 ttm180 -132.25 133.89 44.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.583 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 4.1 p -122.95 143.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.286 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.3 m-20 60.13 -88.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.986 0.422 . . . . 0.0 111.083 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 10.0 pt-20 172.21 -31.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.535 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.42 -58.92 5.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.023 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.97 138.7 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.61 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.717 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -144.79 148.39 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 111.255 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -136.37 140.3 43.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.641 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.49 ' C ' ' HD3' ' A' ' 84' ' ' LYS . 8.9 tmtt? -153.79 130.42 10.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.481 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.34 177.05 11.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . 166.02 -169.93 40.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.553 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.27 141.64 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.145 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -109.28 145.82 35.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.368 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -111.31 118.29 35.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.207 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.626 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 48.01 -114.3 1.79 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.286 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.15 17.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.18 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -116.34 71.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.78 132.32 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.628 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 2.7 ptp -122.69 126.67 48.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.89 111.17 23.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.436 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -107.32 152.43 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.322 . . . . 0.0 111.398 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.15 96.71 1.0 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.472 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 57.4 m -119.94 177.64 4.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.387 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' C' ' 58' ' ' ALA . 22.3 p90 -147.29 138.86 24.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.409 . . . . 0.0 111.082 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.728 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 74.5 m-20 -100.78 130.65 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.92 112.06 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.749 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HG2' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.66 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.711 0.291 . . . . 0.0 110.531 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.11 -38.81 66.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.222 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.3 -60.11 4.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.758 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.58 -28.15 69.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.715 ' O ' HD23 ' B' ' 25' ' ' LEU . 2.4 tm? -63.32 -54.65 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.484 ' HA ' ' NH2' ' C' ' 24' ' ' ARG . 30.5 m-20 -65.39 -26.9 68.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.017 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.58 -57.41 9.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.695 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.0 mtp85 -61.71 -38.52 88.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.797 HD22 HD11 ' A' ' 25' ' ' LEU . 3.1 mm? -62.2 -48.55 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.92 -29.01 70.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.771 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.411 ' NZ ' ' HD3' ' B' ' 31' ' ' ARG . 1.3 ttpp -65.17 -43.92 90.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.228 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.433 ' O ' HG13 ' B' ' 32' ' ' VAL . 0.0 OUTLIER -59.61 -41.65 90.84 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.569 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -61.08 -27.67 68.53 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.988 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 4.1 m -75.73 -39.72 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.841 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.411 ' HD3' ' NZ ' ' B' ' 27' ' ' LYS . 0.6 OUTLIER -73.14 -22.79 60.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.284 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.569 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.5 m -90.19 -28.69 4.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.22 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.629 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 65.5 m-20 -73.55 -47.87 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.036 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' B' ' 91' ' ' GLY . 7.9 ptpt -80.76 -28.38 36.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.805 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.54 -40.75 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.413 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 1.6 mt -75.11 -32.15 61.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.328 . . . . 0.0 111.105 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -41.14 70.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.413 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.763 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 9.1 t -74.85 -41.62 59.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.93 -53.36 58.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.25 -34.0 73.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.404 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.806 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.4 -41.35 93.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.959 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 tp -72.25 -42.19 65.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.061 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 40' ' ' ALA . 9.2 m-20 -72.07 -9.89 59.02 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.8 t -68.5 -22.64 64.52 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.181 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.657 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.6 mm? -82.73 159.16 22.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.823 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.18 0.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.649 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' B' ' 46' ' ' PHE . 13.8 mt-30 70.68 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.947 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.35 114.64 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.747 2.298 . . . . 0.0 112.571 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.82 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 167.72 55.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.316 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 8.3 p -75.59 -5.52 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.105 0.562 . . . . 0.0 112.425 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.82 49.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.209 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -173.12 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.629 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -105.9 141.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.516 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -122.85 117.47 25.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 111.63 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -87.71 140.56 29.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.252 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.657 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 67.9 p -117.21 118.9 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.931 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' C' ' 101' ' ' PHE . . . -144.89 132.39 20.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.82 174.93 46.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.614 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.19 160.68 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.347 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.806 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -140.33 177.59 20.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.518 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -162.39 140.93 6.85 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.603 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.636 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 39.1 t80 -137.17 134.25 36.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.31 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' B' ' 64' ' ' ARG . 1.9 mmm180 62.96 -93.45 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.979 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 17.3 p -143.23 32.46 1.35 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.143 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.19 145.17 47.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.03 153.54 26.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.0 164.33 32.42 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.517 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.53 136.14 53.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.793 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.72 51.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.19 153.39 16.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.157 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 172.9 -177.69 45.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.441 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.92 151.3 4.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.389 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.443 ' HA3' ' OE1' ' B' ' 47' ' ' GLN . . . -150.32 171.61 30.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.203 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.94 136.51 50.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.134 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.614 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 7.1 ttm180 -132.19 133.95 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.602 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 4.1 p -122.96 143.1 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.267 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 96.3 m-20 60.21 -88.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.927 0.394 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 10.0 pt-20 172.25 -31.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.555 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 15.6 p -62.49 -58.89 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.06 138.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.5 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -144.81 148.43 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.27 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 53.4 tp -136.43 140.32 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.581 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.483 ' HD3' ' C ' ' B' ' 84' ' ' LYS . 8.9 tmtt? -153.75 130.44 10.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.38 177.11 11.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 166.04 -169.89 40.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.592 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.34 141.65 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 111.104 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.763 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -109.32 145.91 35.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.276 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -111.38 118.28 35.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.289 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.581 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.482 ' N ' ' HD3' ' B' ' 34' ' ' LYS . . . 47.97 -114.24 1.75 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 39.1 m -149.57 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.687 0.28 . . . . 0.0 111.275 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.24 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -116.39 71.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 39.1 t -99.83 132.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.675 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.636 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 2.7 ptp -122.72 126.62 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.733 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.92 111.26 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.405 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -107.38 152.42 24.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.724 0.297 . . . . 0.0 111.459 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.18 96.74 1.0 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.467 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 56.5 m -119.96 177.64 4.91 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.428 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' ALA . 21.9 p90 -147.3 138.79 23.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 111.093 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.75 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 74.5 m-20 -100.77 130.6 46.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.433 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.85 112.05 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.664 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.711 0.291 . . . . 0.0 110.541 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.78 66.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.32 -60.07 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.63 -28.17 69.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.42 . . . . 0.0 111.149 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.715 ' O ' HD23 ' C' ' 25' ' ' LEU . 2.4 tm? -63.26 -54.67 33.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.545 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' ASP . . . . . 0.481 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 30.1 m-20 -65.31 -26.99 68.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.085 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.54 -57.45 9.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.712 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.0 mtp85 -61.65 -38.58 88.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.734 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.789 HD11 HD22 ' A' ' 25' ' ' LEU . 3.1 mm? -62.14 -48.57 79.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.9 -29.01 70.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.816 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.407 ' NZ ' ' HD3' ' C' ' 31' ' ' ARG . 1.2 ttpp -65.18 -43.92 90.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.652 0.263 . . . . 0.0 111.249 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.43 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.0 OUTLIER -59.59 -41.67 90.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.107 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ASP . . . . . 0.547 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -61.12 -27.71 68.58 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.917 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 4.1 m -75.59 -39.85 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.407 ' HD3' ' NZ ' ' C' ' 27' ' ' LYS . 0.6 OUTLIER -73.05 -22.71 60.58 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.4 m -90.27 -28.7 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.635 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 65.5 m-20 -73.63 -47.76 37.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.489 ' HD3' ' CA ' ' C' ' 91' ' ' GLY . 7.9 ptpt -80.85 -28.37 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.803 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.45 -40.85 53.63 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.478 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 1.6 mt -74.98 -32.36 61.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 111.07 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.21 70.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.44 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.743 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 9.1 t -74.81 -41.57 59.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.746 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.96 -53.28 59.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.169 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.95 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.403 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' ALA . . . . . 0.773 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.44 -41.38 93.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.24 -42.23 65.89 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.073 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 43' ' ' ASN . 3.0 m120 -72.02 -9.84 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.9 t -68.54 -22.68 64.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.158 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.652 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.6 mm? -82.68 159.15 22.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.866 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 15.1 p90 -148.5 -2.28 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.619 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' C' ' 46' ' ' PHE . 13.8 mt-30 70.72 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.936 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.44 114.78 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.679 2.253 . . . . 0.0 112.487 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.76 -176.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.634 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 167.69 55.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.246 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 8.3 p -75.48 -5.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.178 0.591 . . . . 0.0 112.445 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.84 49.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.283 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.644 0.259 . . . . 0.0 110.621 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.84 141.5 21.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.585 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -122.74 117.6 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 111.664 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -87.8 140.54 29.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.34 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.652 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 67.7 p -117.15 118.9 33.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.001 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 101' ' ' PHE . . . -144.87 132.39 20.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.81 174.9 46.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.586 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.16 160.72 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 111.399 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -140.35 177.64 20.54 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.4 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -162.47 141.04 6.92 Favored Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.635 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 39.0 t80 -137.29 134.26 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.711 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' C' ' 64' ' ' ARG . 1.9 mmm180 62.9 -93.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.114 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -143.23 32.37 1.35 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.15 145.14 47.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.05 153.56 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 111.097 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.94 164.3 32.45 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.61 136.2 53.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.96 140.69 51.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.25 153.4 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.768 0.318 . . . . 0.0 111.098 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 172.94 -177.71 45.29 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.456 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.91 151.32 4.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 74' ' ' GLY . . . . . 0.458 ' HA3' ' OE1' ' C' ' 47' ' ' GLN . . . -150.26 171.75 30.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -129.12 136.49 50.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.634 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 7.1 ttm180 -132.11 134.09 45.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.682 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.604 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 4.1 p -123.09 143.12 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.274 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 96.3 m-20 60.15 -88.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 111.104 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 10.1 pt-20 172.18 -31.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.47 -58.93 5.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.942 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 32.2 m -94.05 138.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.525 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.736 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -144.9 148.39 33.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.279 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 53.6 tp -136.38 140.37 43.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 8.9 tmtt? -153.85 130.44 10.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' ALA . . . . . 0.492 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.37 177.1 11.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.043 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 166.0 -169.91 40.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.555 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.29 141.69 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.872 0.368 . . . . 0.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.743 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -109.28 145.84 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.339 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.38 118.2 35.17 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.277 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.02 140.63 52.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.591 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.489 ' CA ' ' HD3' ' C' ' 34' ' ' LYS . . . 48.02 -114.34 1.81 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.244 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -149.47 16.72 0.91 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.264 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.23 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -116.39 71.01 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.81 132.33 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.006 0.432 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.636 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 2.7 ptp -122.65 126.65 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -105.98 111.28 23.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.408 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -107.31 152.46 24.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.457 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.2 96.74 0.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 56.5 m -119.95 177.63 4.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.438 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' B' ' 58' ' ' ALA . 22.1 p90 -147.31 138.83 24.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.743 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 74.5 m-20 -100.79 130.62 46.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.358 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.93 112.08 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -117.24 146.87 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.705 179.681 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.671 0.272 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.82 -32.31 67.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.371 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -64.1 -57.64 8.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.74 -31.18 70.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 3.2 tm? -61.98 -59.76 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.12 -18.79 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -74.13 -45.99 45.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.58 ' HB3' HD12 ' C' ' 25' ' ' LEU . 61.4 mtp85 -77.02 -37.14 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.818 HD11 HD22 ' B' ' 25' ' ' LEU . 3.3 mm? -66.42 -52.18 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.63 -42.24 92.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.3 ttpp -66.88 -28.95 68.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -48.81 78.27 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.614 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -64.33 -33.09 75.04 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.925 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -67.93 -38.83 83.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.732 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.83 64.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.8 m -74.24 -33.46 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.641 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 16.6 m-20 -69.07 -45.28 70.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.3 ptpt -75.19 -40.65 59.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.729 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.43 ' HA3' ' OH ' ' C' ' 63' ' ' TYR . . . -57.37 -43.63 93.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.381 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.793 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.03 -24.65 58.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.159 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.59 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -69.21 -41.96 76.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.461 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.527 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 8.5 t -82.81 -39.97 21.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.745 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.504 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 4.0 t -58.11 -54.79 43.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.51 73.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.445 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.73 -33.6 76.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.663 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 60.1 tp -82.65 -32.37 28.27 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.712 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 19.8 m120 -75.84 -16.34 60.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.85 -18.83 64.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.207 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.635 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.7 mm? -77.53 163.87 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.909 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.478 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.2 p90 -156.56 0.41 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HB3' ' CB ' ' A' ' 55' ' ' ASN . 6.0 mt-30 63.07 125.07 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.965 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -83.95 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.671 2.247 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.482 ' OH ' ' HB ' ' B' ' 51' ' ' VAL . 13.7 m-30 63.7 -175.3 0.16 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.569 ' HA3' ' HD2' ' A' ' 76' ' ' ARG . . . 166.69 55.44 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.237 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -81.44 -10.66 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.159 0.584 . . . . 0.0 112.432 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.67 48.17 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.284 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -150.92 -163.92 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.656 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -116.72 142.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.553 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.48 ' CB ' ' HB3' ' A' ' 47' ' ' GLN . 10.4 m-80 -124.82 113.32 17.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.677 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.55 129.64 34.98 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.273 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.701 HG21 ' HE3' ' A' ' 84' ' ' LYS . 37.7 p -109.36 122.09 46.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.992 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -154.62 133.68 12.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.436 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.46 170.49 43.31 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.531 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 69' ' ' LEU . 2.7 m -121.15 161.41 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.366 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.23 17.96 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.461 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -172.21 138.73 4.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.641 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 34.0 t80 -120.84 131.85 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.685 0.278 . . . . 0.0 110.738 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.4 mmm180 69.52 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.1 p -143.76 26.22 1.58 Allowed 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.159 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.38 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.33 150.96 28.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -146.55 171.79 14.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.548 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.49 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -119.98 142.8 48.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.811 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -132.62 137.19 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.686 0.279 . . . . 0.0 111.636 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.521 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.5 tp -137.65 162.1 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.784 0.326 . . . . 0.0 111.05 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.521 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 171.37 179.9 42.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.397 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.61 148.77 12.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.892 0.377 . . . . 0.0 110.965 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.49 166.78 30.77 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.228 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.601 ' CE2' ' HB ' ' A' ' 77' ' ' VAL . 38.8 t80 -131.85 134.49 45.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.156 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.569 ' HD2' ' HA3' ' A' ' 50' ' ' GLY . 16.4 ttm180 -125.18 121.56 34.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.621 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 8.6 p -110.88 137.99 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 49.7 m-20 64.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' HB3' ' CE2' ' C' ' 49' ' ' TYR . 10.5 pt-20 175.42 -20.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.59 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 p -70.85 -66.36 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.032 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 m -90.85 141.34 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.589 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.47 153.82 37.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.172 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.3 tp -148.82 149.88 32.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.618 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.701 ' HE3' HG21 ' A' ' 57' ' ' THR . 12.1 tmtt? -149.34 141.67 24.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.162 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.17 176.02 11.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.44 -173.06 41.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.587 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.09 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.853 0.358 . . . . 0.0 111.16 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.767 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -110.25 144.23 39.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.351 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -121.97 113.01 18.99 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.39 -116.13 8.72 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.293 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.87 8.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.322 . . . . 0.0 111.337 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t -155.03 22.62 0.44 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.108 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 10.8 m-20 -127.11 82.86 2.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.87 139.4 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.767 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 6.9 ptp -134.22 141.58 47.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -113.26 124.31 52.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.455 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.417 ' ND2' HD23 ' A' ' 42' ' ' LEU . 36.0 m-80 -109.57 148.01 32.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.296 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.7 86.9 0.38 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.61 162.34 17.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.471 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -130.31 145.64 51.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.976 0.417 . . . . 0.0 111.055 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.553 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 56.0 m-80 -115.34 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.399 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.14 119.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.819 0.343 . . . . 0.0 110.726 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.704 0.288 . . . . 0.0 110.5 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.92 -32.3 67.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -63.99 -57.71 8.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.707 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.83 -31.1 70.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 3.2 tm? -61.95 -59.81 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.591 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -65.07 -18.78 65.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.18 -46.0 44.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.58 ' HB3' HD12 ' A' ' 25' ' ' LEU . 61.3 mtp85 -76.94 -37.14 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.794 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.818 HD22 HD11 ' A' ' 25' ' ' LEU . 3.3 mm? -66.47 -52.16 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.641 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.61 -42.19 92.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.93 -29.02 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.245 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -48.82 78.3 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.604 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -64.46 -32.9 74.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 178.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 5.9 m -68.03 -38.81 82.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.858 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.749 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -73.3 -39.85 64.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.246 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.6 m -74.21 -33.41 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.223 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.644 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 16.6 m-20 -69.18 -45.25 70.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.749 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.3 ptpt -75.17 -40.61 59.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.434 ' HA3' ' OH ' ' A' ' 63' ' ' TYR . . . -57.37 -43.62 93.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.794 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.06 -24.65 58.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.592 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -69.18 -42.03 76.39 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.54 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 8.5 t -82.72 -40.01 21.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.741 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.5 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.9 t -58.12 -54.62 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.66 -33.47 74.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.409 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.69 76.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.691 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 59.6 tp -82.6 -32.29 28.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.718 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 19.9 m120 -75.8 -16.37 60.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.99 -18.69 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.148 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.627 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.7 mm? -77.63 163.88 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.846 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.462 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.2 p90 -156.54 0.37 0.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 111.714 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.488 ' HB3' ' CB ' ' B' ' 55' ' ' ASN . 6.1 mt-30 63.15 124.98 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.967 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -83.94 109.92 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.642 2.228 . . . . 0.0 112.605 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.484 ' CE2' ' HB3' ' C' ' 79' ' ' GLU . 13.6 m-30 63.71 -175.31 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.934 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.566 ' HA3' ' HD2' ' B' ' 76' ' ' ARG . . . 166.72 55.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.245 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -81.34 -10.67 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.161 0.584 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.63 48.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.268 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.435 ' O ' ' CD1' ' B' ' 75' ' ' TYR . 0.0 OUTLIER -150.89 -163.87 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.601 0.239 . . . . 0.0 110.639 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -116.78 142.65 29.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.586 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.488 ' CB ' ' HB3' ' B' ' 47' ' ' GLN . 10.4 m-80 -124.8 113.43 17.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.973 0.416 . . . . 0.0 111.663 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.67 129.7 34.96 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.195 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.704 HG21 ' HE3' ' B' ' 84' ' ' LYS . 37.6 p -109.42 122.07 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.943 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -154.61 133.7 12.41 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.368 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.47 170.49 43.32 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' B' ' 69' ' ' LEU . 2.7 m -121.16 161.52 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.773 0.321 . . . . 0.0 111.383 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.23 -167.16 17.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.473 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLY . . . . . 0.592 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -172.23 138.75 4.94 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.644 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 34.1 t80 -120.87 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.695 0.283 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.5 mmm180 69.47 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -143.75 26.18 1.58 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.17 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.4 51.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -110.44 151.06 27.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -146.66 171.7 14.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.537 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.493 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.8 OUTLIER -120.0 142.75 48.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.808 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.691 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -132.58 137.2 47.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.681 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.531 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.5 tp -137.64 162.07 32.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.738 0.304 . . . . 0.0 111.119 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.531 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 171.34 179.87 42.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.444 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.58 148.73 12.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.41 166.8 30.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.609 ' CE2' ' HB ' ' B' ' 77' ' ' VAL . 38.6 t80 -131.88 134.47 45.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.566 ' HD2' ' HA3' ' B' ' 50' ' ' GLY . 16.4 ttm180 -125.19 121.47 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.626 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 8.6 p -110.88 138.04 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.344 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 50.2 m-20 64.3 -97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.481 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 10.4 pt-20 175.44 -20.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.541 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.81 -66.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 m -90.84 141.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.42 153.82 37.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 0.0 111.225 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 25.2 tp -148.79 149.88 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.582 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.704 ' HE3' HG21 ' B' ' 57' ' ' THR . 12.1 tmtt? -149.38 141.72 24.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.18 176.05 11.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.086 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.36 -173.1 41.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.556 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.21 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.347 . . . . 0.0 111.107 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.791 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -110.31 144.16 39.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.366 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.89 113.03 19.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.235 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -119.5 129.97 54.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.608 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.28 -116.04 8.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.31 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.92 8.11 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 111.332 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.1 22.65 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 10.9 m-20 -127.07 82.8 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 99.7 t -108.87 139.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.969 0.414 . . . . 0.0 110.653 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.791 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 6.9 ptp -134.22 141.6 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.693 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -113.28 124.3 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.434 ' ND2' HD23 ' B' ' 42' ' ' LEU . 36.2 m-80 -109.54 147.99 32.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 111.42 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.76 86.92 0.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.757 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.55 162.33 17.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.399 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -130.32 145.59 51.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.418 . . . . 0.0 111.073 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.564 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.0 m-80 -115.31 131.85 56.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.401 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.08 119.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.849 0.356 . . . . 0.0 110.776 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.478 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.98 -32.26 67.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 111.245 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -64.04 -57.72 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.79 -31.04 70.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.222 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 3.2 tm? -62.06 -59.75 4.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.53 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.11 -18.8 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.948 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.15 -45.97 45.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.587 ' HB3' HD12 ' B' ' 25' ' ' LEU . 61.4 mtp85 -76.98 -37.15 55.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.751 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.8 HD11 HD22 ' A' ' 25' ' ' LEU . 3.3 mm? -66.52 -52.13 49.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.646 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -59.59 -42.29 92.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.79 -29.02 68.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.229 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' C' ' 28' ' ' LEU . 0.0 OUTLIER -62.32 -48.72 78.59 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ASP . . . . . 0.595 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -64.4 -32.99 74.83 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.994 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 5.9 m -67.92 -38.94 83.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.813 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.729 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.78 65.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.271 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.7 m -74.16 -33.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.638 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 16.6 m-20 -68.97 -45.3 71.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.729 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.3 ptpt -75.12 -40.71 59.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.777 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' GLY . . . . . 0.431 ' HA3' ' OH ' ' B' ' 63' ' ' TYR . . . -57.34 -43.57 93.75 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.419 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.794 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -75.13 -24.65 58.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.875 0.369 . . . . 0.0 111.092 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.606 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -69.17 -42.03 76.42 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.429 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.541 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 8.5 t -82.75 -39.93 21.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.504 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 4.0 t -58.11 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.45 73.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.392 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.69 -33.66 76.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.683 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 59.9 tp -82.61 -32.29 28.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.718 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 19.8 m120 -75.79 -16.43 60.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -67.9 -18.74 64.88 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.149 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.649 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.7 mm? -77.68 163.89 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.858 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.472 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.2 p90 -156.53 0.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.657 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.487 ' HB3' ' CB ' ' C' ' 55' ' ' ASN . 6.1 mt-30 63.13 125.06 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.926 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -83.92 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.632 2.221 . . . . 0.0 112.629 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.481 ' OH ' ' HB ' ' A' ' 51' ' ' VAL . 13.7 m-30 63.74 -175.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.962 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.573 ' HA3' ' HD2' ' C' ' 76' ' ' ARG . . . 166.76 55.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.208 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -81.4 -10.59 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.157 0.583 . . . . 0.0 112.452 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.54 48.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.297 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -150.88 -163.82 1.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.625 0.25 . . . . 0.0 110.619 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -116.89 142.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.578 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' C' ' 47' ' ' GLN . 10.4 m-80 -124.83 113.4 17.85 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.011 0.434 . . . . 0.0 111.659 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -83.63 129.71 34.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.226 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.701 HG21 ' HE3' ' C' ' 84' ' ' LYS . 37.6 p -109.42 122.06 46.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.496 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -154.61 133.62 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.44 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.39 170.5 43.35 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.554 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' C' ' 69' ' ' LEU . 2.7 m -121.12 161.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.21 17.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.451 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' GLY . . . . . 0.606 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -172.18 138.76 4.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.548 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.638 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 34.1 t80 -120.9 131.96 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.757 0.313 . . . . 0.0 110.746 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.5 mmm180 69.34 -92.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.1 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.4 p -143.77 26.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.1 141.42 51.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.42 150.96 28.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -146.58 171.75 14.61 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.548 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.494 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.8 OUTLIER -120.01 142.69 48.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.683 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.55 137.17 47.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.69 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.515 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.5 tp -137.52 162.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.515 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 171.36 179.86 42.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.59 148.75 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.41 166.81 30.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.15 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.615 ' CE2' ' HB ' ' C' ' 77' ' ' VAL . 39.2 t80 -131.91 134.45 45.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.92 0.391 . . . . 0.0 111.153 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.573 ' HD2' ' HA3' ' C' ' 50' ' ' GLY . 16.5 ttm180 -125.16 121.56 34.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.731 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.625 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 8.7 p -110.96 138.06 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.291 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 49.8 m-20 64.4 -97.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.013 0.435 . . . . 0.0 111.12 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' GLU . . . . . 0.484 ' HB3' ' CE2' ' B' ' 49' ' ' TYR . 10.5 pt-20 175.43 -20.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.62 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.87 -66.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -90.97 141.3 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.485 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.38 153.83 37.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.276 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 25.3 tp -148.77 149.89 32.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.6 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.701 ' HE3' HG21 ' C' ' 57' ' ' THR . 12.1 tmtt? -149.41 141.74 24.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.27 175.94 11.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.056 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.43 -173.18 41.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.546 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.09 138.2 19.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.102 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.782 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -110.39 144.22 39.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.32 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.99 112.93 18.88 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -119.43 129.98 55.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.4 -116.1 8.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.308 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m -148.95 8.09 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.331 . . . . 0.0 111.285 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.07 22.64 0.43 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 10.8 m-20 -127.1 82.77 2.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.76 139.33 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.769 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.782 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 6.8 ptp -134.17 141.61 47.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.3 124.25 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.495 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.435 ' ND2' HD23 ' C' ' 42' ' ' LEU . 36.1 m-80 -109.52 148.08 31.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 111.443 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.74 86.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.764 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.53 162.35 17.32 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -130.34 145.61 51.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 111.064 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 55.6 m-80 -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.378 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.06 119.7 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.794 0.331 . . . . 0.0 110.737 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.95 159.82 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.663 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.721 0.296 . . . . 0.0 110.55 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.09 -20.26 64.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 111.211 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 mtt-85 -70.74 -60.28 2.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.795 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.14 -17.37 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.152 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -67.71 -49.81 60.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.557 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -73.53 -28.05 61.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.038 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.05 -51.57 45.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.439 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 76.5 mtp85 -62.5 -44.76 95.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.755 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.508 HD21 ' CD2' ' B' ' 25' ' ' LEU . 0.5 OUTLIER -57.44 -50.37 73.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.18 -39.48 82.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 ttpp -60.46 -34.09 73.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.202 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.564 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -68.05 -41.95 81.27 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.45 -25.02 64.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.3 m -79.63 -41.0 27.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.852 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.68 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.4 mpt_? -68.93 -35.83 77.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.303 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 28' ' ' LEU . 19.0 m -77.58 -32.13 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.159 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 9.9 m-20 -66.79 -44.84 80.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.68 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 4.2 ptpt -77.76 -31.69 52.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.24 67.84 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.393 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.89 -27.77 60.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.23 -46.37 16.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.407 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.646 ' CB ' ' HB2' ' A' ' 90' ' ' ALA . 48.4 t -67.06 -40.59 87.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.481 ' OG ' ' HB2' ' C' ' 40' ' ' ALA . 37.4 t -67.42 -52.89 34.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' OG ' ' B' ' 39' ' ' SER . . . -61.88 -25.82 67.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.494 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.96 -38.28 88.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.523 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 21.7 tp -79.36 -33.63 42.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 11.6 m120 -73.68 -13.58 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.49 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 30.5 t -71.54 -19.27 62.19 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.182 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.625 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.0 mm? -80.45 157.83 26.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.856 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.434 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 8.1 p90 -146.06 -10.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.699 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HG2' ' CG2' ' A' ' 57' ' ' THR . 5.1 mt-30 73.43 121.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.935 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -77.72 101.1 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 62.1 -170.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.518 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 163.03 60.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.5 p -69.89 -18.81 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.146 0.578 . . . . 0.0 112.459 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.781 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.02 51.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.313 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HZ2' ' HA2' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -152.16 -157.03 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.56 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 74' ' ' GLY . 2.8 p -120.67 145.13 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.579 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.83 122.06 33.65 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.979 0.418 . . . . 0.0 111.727 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -84.27 124.47 31.26 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.267 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.625 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 72.1 p -107.04 120.61 42.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.007 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -149.85 137.49 20.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.405 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . 178.14 165.48 33.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.533 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 69' ' ' LEU . 30.2 m -121.13 178.76 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.375 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.99 -179.34 38.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -158.14 134.22 3.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.522 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.665 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 26.1 t80 -124.91 124.19 41.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.74 0.305 . . . . 0.0 110.746 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER 68.67 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 p -146.05 16.89 1.39 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.44 140.89 49.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.43 47.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 172.08 13.19 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.0 tt -123.47 145.16 49.04 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -132.1 119.52 21.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 58' ' ' ALA . 8.1 tp -118.67 152.74 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.91 -172.12 44.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.446 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.61 158.11 6.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -144.25 177.75 22.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.25 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.61 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 35.0 t80 -138.12 132.8 32.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.518 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 14.1 ttm180 -126.54 117.25 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.781 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.9 p -106.12 138.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.284 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 78.9 m-20 68.82 -92.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 14.8 pt-20 172.92 -24.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.579 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -78.46 -52.21 8.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.01 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.44 137.39 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.469 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -144.55 163.77 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.295 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 84' ' ' LYS . 34.1 tp -158.88 154.31 25.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 10.8 tmtt? -159.59 133.97 7.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.1 18.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.83 -174.57 42.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.628 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.24 139.56 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 111.112 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.51 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -113.05 136.51 52.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.293 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.19 51.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.294 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.646 ' HB2' ' CB ' ' A' ' 38' ' ' SER . . . -131.61 135.72 47.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.591 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.572 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.71 -123.26 29.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.281 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.58 9.58 2.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.791 0.329 . . . . 0.0 111.318 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.48 32.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.201 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -132.32 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.25 150.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.01 0.433 . . . . 0.0 110.724 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.647 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 1.2 ptp -146.52 159.69 43.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.594 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.69 141.06 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.444 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.43 ' OD1' HD23 ' A' ' 42' ' ' LEU . 25.7 m120 -118.05 145.68 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.764 0.316 . . . . 0.0 111.393 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.48 87.6 1.32 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 16.7 m -121.49 148.99 43.73 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.393 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.728 ' HD2' HD11 ' A' ' 103' ' ' ILE . 1.8 p90 -124.47 142.91 50.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.423 . . . . 0.0 111.05 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.925 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 64.1 m-80 -109.45 126.72 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.728 HD11 ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -129.59 121.1 52.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.655 0.264 . . . . 0.0 110.529 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.02 -20.32 64.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.227 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 mtt-85 -70.6 -60.4 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.749 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.1 -17.37 61.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.151 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -67.69 -49.86 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -73.44 -28.17 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.993 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.98 -51.54 46.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.437 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 76.6 mtp85 -62.49 -44.82 95.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.8 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.508 ' CD2' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.4 -50.46 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.08 -39.48 82.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.871 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' B' ' 31' ' ' ARG . 12.9 ttpp -60.38 -34.2 73.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.212 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.566 ' O ' HG13 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -68.07 -41.87 81.28 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.925 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 1.3 m -79.52 -40.98 28.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.677 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.4 mpt_? -68.87 -36.0 77.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.566 HG13 ' O ' ' B' ' 28' ' ' LEU . 18.9 m -77.53 -32.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.207 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 9.9 m-20 -66.73 -44.78 80.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.04 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.677 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 4.2 ptpt -77.97 -31.53 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.56 -35.23 67.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.88 -27.78 60.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.31 -46.32 16.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.396 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.652 ' CB ' ' HB2' ' B' ' 90' ' ' ALA . 48.5 t -67.09 -40.53 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.785 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 40' ' ' ALA . 37.4 t -67.46 -52.94 33.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' OG ' ' C' ' 39' ' ' SER . . . -61.82 -25.87 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.43 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.41 88.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.503 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 21.6 tp -79.26 -33.65 43.31 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 11.6 m120 -73.64 -13.59 61.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.494 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 30.4 t -71.58 -19.27 62.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.135 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.643 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.0 mm? -80.48 157.8 26.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.831 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 8.1 p90 -146.0 -10.43 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.188 0.518 . . . . 0.0 111.717 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.487 ' HG2' ' CG2' ' B' ' 57' ' ' THR . 5.1 mt-30 73.51 121.16 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.882 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -77.69 101.14 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.623 2.216 . . . . 0.0 112.54 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 62.03 -170.51 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.946 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 163.03 60.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.288 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.4 p -70.0 -18.86 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.186 0.594 . . . . 0.0 112.454 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.04 51.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.298 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.489 ' HZ2' ' HA2' ' B' ' 50' ' ' GLY . 0.0 OUTLIER -152.05 -156.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.546 0.212 . . . . 0.0 110.671 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 74' ' ' GLY . 2.8 p -120.81 145.15 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.577 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.84 122.09 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.008 0.433 . . . . 0.0 111.669 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -84.34 124.5 31.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.248 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.643 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 73.4 p -107.1 120.64 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -149.81 137.56 20.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.418 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . 178.1 165.51 33.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' B' ' 69' ' ' LEU . 30.3 m -121.16 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.03 -179.39 38.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.453 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -158.12 134.17 3.77 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.664 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 26.2 t80 -124.91 124.18 41.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.734 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 73.3 p -145.99 16.87 1.4 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.81 49.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.42 47.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.107 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.41 172.11 13.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.49 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.709 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.0 tt -123.52 145.19 49.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.762 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -132.19 119.63 21.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.725 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' B' ' 58' ' ' ALA . 8.1 tp -118.72 152.72 20.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.96 -172.18 44.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.405 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.52 158.06 6.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.851 0.358 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.583 ' O ' HG23 ' B' ' 54' ' ' VAL . . . -144.2 177.78 22.61 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.267 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.604 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 34.8 t80 -138.13 132.71 32.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.873 0.368 . . . . 0.0 111.166 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.513 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 14.0 ttm180 -126.49 117.27 22.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.78 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.9 p -106.16 138.91 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.011 0.434 . . . . 0.0 111.278 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' B' ' 79' ' ' GLU . 78.9 m-20 68.81 -92.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.0 111.14 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 14.8 pt-20 172.97 -24.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.1 p -78.48 -52.21 8.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.44 137.36 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.891 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -144.58 163.78 32.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.868 0.365 . . . . 0.0 111.255 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.419 HD12 ' H ' ' B' ' 84' ' ' LYS . 34.6 tp -158.9 154.32 25.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.434 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 10.8 tmtt? -159.66 133.97 7.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.58 171.06 18.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.87 -174.46 42.83 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.626 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.29 139.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.059 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.499 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -113.01 136.48 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.359 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.68 125.2 51.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.652 ' HB2' ' CB ' ' B' ' 38' ' ' SER . . . -131.53 135.69 47.24 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.664 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.589 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.76 -123.37 30.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.342 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.28 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.9 t -165.48 32.84 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.242 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.32 82.3 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.24 150.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.665 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 1.2 ptp -146.56 159.65 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.667 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -127.65 141.17 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.366 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.432 ' OD1' HD23 ' B' ' 42' ' ' LEU . 25.7 m120 -118.14 145.66 44.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 111.359 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 87.51 1.32 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.74 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 16.7 m -121.42 149.01 43.65 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.4 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 101' ' ' PHE . . . . . 0.726 ' HD2' HD11 ' B' ' 103' ' ' ILE . 1.9 p90 -124.44 142.88 50.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.957 0.408 . . . . 0.0 111.153 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.891 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 64.1 m-80 -109.4 126.78 53.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.726 HD11 ' HD2' ' B' ' 101' ' ' PHE . 0.9 OUTLIER -129.64 121.11 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.866 0.365 . . . . 0.0 110.756 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.677 0.275 . . . . 0.0 110.591 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -69.0 -20.27 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.297 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -70.73 -60.33 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.1 -17.4 61.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.177 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 0.8 OUTLIER -67.73 -49.81 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.558 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -73.45 -28.16 61.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.99 -51.52 46.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.444 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 76.6 mtp85 -62.52 -44.78 95.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.722 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.507 HD21 ' CD2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.52 -50.34 73.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.611 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -59.15 -39.48 82.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.806 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' C' ' 31' ' ' ARG . 12.9 ttpp -60.44 -34.16 73.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.204 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.549 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -68.05 -41.98 81.21 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.29 -25.11 64.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.987 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 1.3 m -79.54 -41.03 28.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.853 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.669 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.4 mpt_? -68.91 -35.87 77.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.28 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.549 HG13 ' O ' ' C' ' 28' ' ' LEU . 19.0 m -77.58 -32.18 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 9.9 m-20 -66.74 -44.79 80.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.045 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.669 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 4.2 ptpt -77.83 -31.68 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.48 -35.31 68.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mt -74.79 -27.82 60.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.113 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.24 -46.33 16.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.452 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.657 ' CB ' ' HB2' ' C' ' 90' ' ' ALA . 48.5 t -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.756 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' B' ' 40' ' ' ALA . 37.6 t -67.47 -52.96 33.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' OG ' ' A' ' 39' ' ' SER . . . -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.475 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.86 -38.37 88.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.507 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 21.6 tp -79.28 -33.69 43.18 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 11.5 m120 -73.6 -13.62 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' SER . . . . . 0.484 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 30.4 t -71.63 -19.23 62.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.154 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.614 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.0 mm? -80.51 157.78 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.836 177.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 8.1 p90 -145.98 -10.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.172 0.51 . . . . 0.0 111.703 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.492 ' HG2' ' CG2' ' C' ' 57' ' ' THR . 5.1 mt-30 73.53 121.12 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.932 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 10.0 Cg_endo -77.66 101.08 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.657 2.238 . . . . 0.0 112.57 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 62.12 -170.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.963 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 163.1 60.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.251 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.4 p -69.92 -18.88 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.258 0.623 . . . . 0.0 112.383 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.766 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.01 51.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.356 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 53' ' ' LYS . . . . . 0.495 ' HZ2' ' HA2' ' C' ' 50' ' ' GLY . 0.0 OUTLIER -152.11 -157.03 0.76 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.594 0.235 . . . . 0.0 110.591 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.588 HG23 ' O ' ' C' ' 74' ' ' GLY . 2.8 p -120.8 145.18 27.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.82 121.99 33.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.977 0.418 . . . . 0.0 111.696 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -84.23 124.47 31.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.272 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.614 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 72.3 p -106.98 120.63 42.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.999 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -149.84 137.53 20.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.422 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . 178.05 165.49 32.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' C' ' 69' ' ' LEU . 30.5 m -121.18 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.0 -179.41 38.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.521 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 62' ' ' GLY . . . . . 0.629 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -158.1 134.2 3.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.552 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.647 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 26.1 t80 -124.95 124.23 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.091 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 73.4 p -146.02 16.88 1.39 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.82 49.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.32 145.44 47.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.43 172.08 13.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.496 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.709 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.0 tt -123.41 145.23 48.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.79 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.23 119.62 21.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.653 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.42 HD12 ' CB ' ' C' ' 58' ' ' ALA . 8.1 tp -118.67 152.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.188 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.98 -172.17 44.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.57 158.11 6.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 74' ' ' GLY . . . . . 0.588 ' O ' HG23 ' C' ' 54' ' ' VAL . . . -144.19 177.74 22.63 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.236 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.589 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 34.8 t80 -138.14 132.69 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.517 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 14.0 ttm180 -126.49 117.3 22.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.766 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.9 p -106.13 138.83 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 78.8 m-20 68.92 -92.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 111.076 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 14.8 pt-20 172.95 -24.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.593 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -78.49 -52.27 8.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.0 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.37 137.42 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.898 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -144.61 163.77 32.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.236 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.413 HD12 ' H ' ' C' ' 84' ' ' LYS . 34.3 tp -158.87 154.27 25.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.595 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 10.8 tmtt? -159.58 133.94 7.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.13 18.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.81 -174.47 42.8 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.572 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 8.0 p -130.27 139.55 51.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.125 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.504 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -113.09 136.49 52.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.346 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.21 51.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.657 ' HB2' ' CB ' ' C' ' 38' ' ' SER . . . -131.62 135.72 47.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.603 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.572 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.75 -123.34 30.25 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 33.3 m -138.52 9.61 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.53 32.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.193 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.26 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.27 150.61 11.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.664 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 1.2 ptp -146.59 159.68 43.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.685 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.7 141.14 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.43 ' OD1' HD23 ' C' ' 42' ' ' LEU . 25.7 m120 -118.08 145.7 44.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.708 0.289 . . . . 0.0 111.415 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.54 1.31 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 16.7 m -121.4 148.98 43.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.449 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.716 ' HD2' HD11 ' C' ' 103' ' ' ILE . 1.8 p90 -124.41 142.87 50.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 111.04 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.898 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 64.0 m-80 -109.43 126.73 53.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.38 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.716 HD11 ' HD2' ' C' ' 101' ' ' PHE . 1.0 OUTLIER -129.62 121.06 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.77 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.96 165.95 19.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 0.423 ' HE3' HG13 ' B' ' 54' ' ' VAL . 3.5 m-90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.665 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 2.8 mmpt? . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.699 0.285 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.68 -31.28 70.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.247 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -63.07 -58.69 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.18 83.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.117 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.017 HD21 HD13 ' C' ' 21' ' ' LEU . 12.1 mt -60.0 -47.49 85.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.559 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 29.4 t0 -66.81 -32.25 73.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.093 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.53 -42.31 95.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.53 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.733 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.62 -33.42 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 28.4 t0 -73.73 -41.2 62.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -63.02 -42.06 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.285 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' C' ' 29' ' ' ASP . 0.2 OUTLIER -62.9 -50.35 71.22 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.789 ' HB2' HD21 ' B' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.14 61.43 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.912 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.15 -40.65 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.6 mpt_? -60.87 -32.56 71.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.316 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 6.4 m -80.12 -28.94 12.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.216 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -51.88 61.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 20.3 pttt -74.13 -39.28 63.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.751 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.32 -36.21 92.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.52 ' HG ' HD21 ' C' ' 36' ' ' LEU . 5.9 mt -73.53 -31.16 63.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.068 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.91 -45.29 36.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.457 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.65 ' CB ' ' HB2' ' A' ' 90' ' ' ALA . 22.7 t -63.86 -44.89 91.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.8 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 11.5 t -59.13 -46.47 88.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.04 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.544 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.13 -39.88 93.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.556 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 2.6 tm? -77.06 -38.9 51.69 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -72.12 -15.94 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 t -66.58 -32.92 74.56 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.15 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.512 ' CG ' ' HB ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -64.21 143.66 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.881 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.568 ' HZ ' ' HB1' ' B' ' 82' ' ' ALA . 35.0 p90 -112.69 -42.53 3.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.11 0.481 . . . . 0.0 111.677 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.49 HE22 ' HG2' ' A' ' 84' ' ' LYS . 33.8 mt-30 70.26 109.43 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.948 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 49' ' ' TYR 0.256 9.8 Cg_endo -75.25 -161.16 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.617 2.211 . . . . 0.0 112.576 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 17.5 m-30 68.16 167.02 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.962 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 76' ' ' ARG . . . 178.4 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.193 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.519 ' HA ' ' HG3' ' A' ' 79' ' ' GLU . 9.6 p -88.84 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.198 0.599 . . . . 0.0 112.4 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.39 69.1 0.01 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.261 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 76' ' ' ARG . 1.5 mptp? -143.79 -178.16 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.619 0.247 . . . . 0.0 110.561 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.509 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 10.1 p -119.02 142.17 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.433 ' OD1' ' HD2' ' A' ' 48' ' ' PRO . 1.7 m-80 -125.0 178.08 5.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.62 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -151.48 143.39 23.82 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.512 ' HB ' ' CG ' ' A' ' 45' ' ' LEU . 30.2 p -117.3 142.08 47.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.953 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -177.5 127.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.463 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.515 ' O ' HD12 ' A' ' 69' ' ' LEU . . . -179.34 -165.27 33.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.04 154.61 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.367 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -134.43 171.72 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.504 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 66' ' ' SER . . . -156.73 141.31 7.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.571 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 84.4 t80 -135.56 110.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.697 0.284 . . . . 0.0 110.74 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 28.0 mtt180 66.28 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.128 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 37.86 1.33 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.122 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.463 ' O ' ' HA2' ' A' ' 62' ' ' GLY . 32.1 t -134.77 157.68 46.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.67 148.31 40.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.42 173.06 14.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 59' ' ' GLY . 8.2 tp -124.75 126.66 46.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.702 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -117.51 163.32 16.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 58' ' ' ALA . 2.3 tt -158.71 176.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.77 34.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.462 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 p -164.13 160.03 20.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.45 176.26 29.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.217 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.509 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 5.0 t80 -143.27 127.0 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 111.159 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.473 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.735 HG22 ' OD1' ' A' ' 78' ' ' ASN . 7.2 p -83.2 127.41 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.284 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.735 ' OD1' HG22 ' A' ' 77' ' ' VAL . 31.3 m120 61.15 162.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.519 ' HG3' ' HA ' ' A' ' 51' ' ' VAL . 32.5 mt-10 -99.48 39.1 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.569 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.31 -52.21 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 82' ' ' ALA . 3.6 p -131.25 169.85 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.53 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB1' ' HZ ' ' C' ' 46' ' ' PHE . . . -168.53 165.24 12.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 111.29 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -139.25 168.73 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.564 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 85' ' ' ALA . 2.0 tmtp? -157.73 122.85 4.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.544 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -132.6 161.04 34.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.32 158.57 18.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.91 130.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -102.05 115.04 29.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.355 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.5 ' HA ' HG13 ' A' ' 95' ' ' VAL . 77.9 m-85 -91.7 108.8 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB2' ' CB ' ' A' ' 38' ' ' SER . . . -115.02 124.11 50.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.659 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.05 -85.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.67 -50.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.319 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.0 m -104.35 14.43 30.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 4.0 t70 -116.43 57.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.5 HG13 ' HA ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -95.2 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.747 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.608 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 2.9 ptp -146.77 151.44 37.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -130.34 138.21 50.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.422 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 8.3 m-80 -132.56 137.15 47.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 111.404 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.32 95.64 2.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.716 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB3' HD11 ' C' ' 45' ' ' LEU . 29.6 m -125.95 161.5 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 8.6 p90 -127.67 145.48 50.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.027 0.442 . . . . 0.0 111.044 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' OD1' ' HD3' ' C' ' 48' ' ' PRO . 8.2 p30 -120.0 153.08 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.4 mp -119.86 134.91 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.856 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.479 ' HB2' ' CE2' ' C' ' 49' ' ' TYR . 18.2 pm0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 2.8 mmpt? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.68 0.276 . . . . 0.0 110.566 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -68.66 -31.25 70.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.259 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -63.11 -58.71 6.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.769 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -36.19 83.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 1.033 HD13 HD21 ' C' ' 21' ' ' LEU . 12.1 mt -60.04 -47.47 85.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.601 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' B' ' 26' ' ' ASP . 29.4 t0 -66.81 -32.26 73.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.036 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.836 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.48 34.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.757 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.74 -33.34 72.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.632 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 28.3 t0 -73.73 -41.24 62.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -63.02 -42.08 99.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.241 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -62.89 -50.26 71.59 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.779 ' HB2' HD21 ' C' ' 28' ' ' LEU . 0.8 OUTLIER -56.61 -29.16 61.83 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.942 178.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.11 -40.57 37.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.863 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.6 mpt_? -60.81 -32.68 72.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 6.4 m -80.06 -28.98 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.172 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -51.94 61.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 20.3 pttt -73.96 -39.44 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.717 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.35 -36.15 92.34 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' A' ' 36' ' ' LEU . 5.8 mt -73.54 -31.18 63.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.787 0.327 . . . . 0.0 111.045 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.08 -45.17 35.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.379 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.666 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 22.7 t -63.9 -44.87 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 11.5 t -59.17 -46.46 88.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.2 -29.07 68.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.483 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.537 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.11 -39.89 93.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.575 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 2.6 tm? -77.01 -39.0 51.89 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -72.01 -15.97 62.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.6 -32.96 74.63 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.08 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.533 ' CG ' ' HB ' ' B' ' 57' ' ' THR . 1.0 OUTLIER -64.29 143.71 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.929 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.555 ' HZ ' ' HB1' ' C' ' 82' ' ' ALA . 34.6 p90 -112.73 -42.48 3.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.467 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.504 HE22 ' HG2' ' B' ' 84' ' ' LYS . 33.8 mt-30 70.29 109.47 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' B' ' 49' ' ' TYR 0.257 9.8 Cg_endo -75.3 -161.15 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.632 2.222 . . . . 0.0 112.61 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 17.5 m-30 68.16 167.05 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.969 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' B' ' 76' ' ' ARG . . . 178.37 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.201 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.508 ' HA ' ' HG3' ' B' ' 79' ' ' GLU . 9.7 p -88.83 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.187 0.595 . . . . 0.0 112.409 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.34 69.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.317 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' B' ' 76' ' ' ARG . 1.5 mptp? -143.79 -178.1 5.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.579 HG13 ' HE3' ' C' ' 105' ' ' TRP . 10.1 p -119.08 142.14 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.537 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' B' ' 48' ' ' PRO . 1.7 m-80 -124.99 178.03 5.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.657 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.6 ' HB2' ' CH2' ' C' ' 105' ' ' TRP . 11.4 t80 -151.42 143.46 23.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.276 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' B' ' 45' ' ' LEU . 30.2 p -117.38 142.09 47.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.93 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.494 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -177.52 127.81 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.479 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.527 ' O ' HD12 ' B' ' 69' ' ' LEU . . . -179.26 -165.17 33.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.08 154.61 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 111.343 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.537 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -134.4 171.77 22.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.487 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 66' ' ' SER . . . -156.77 141.3 7.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 84.2 t80 -135.59 110.84 8.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.124 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.65 37.86 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.455 ' O ' ' HA2' ' B' ' 62' ' ' GLY . 32.0 t -134.83 157.62 46.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.64 148.32 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.139 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.03 15.04 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.527 HD12 ' O ' ' B' ' 59' ' ' GLY . 8.4 tp -124.67 126.73 46.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.756 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -117.58 163.37 16.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.623 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.495 HG13 ' O ' ' B' ' 57' ' ' THR . 2.3 tt -158.78 176.04 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.154 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.62 -167.82 34.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.36 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 16.6 p -164.16 160.04 20.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.46 176.37 29.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.158 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 5.0 t80 -143.36 126.9 16.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 111.17 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.461 ' O ' ' HA2' ' B' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.33 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.73 HG22 ' OD1' ' B' ' 78' ' ' ASN . 7.3 p -83.26 127.44 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.73 ' OD1' HG22 ' B' ' 77' ' ' VAL . 31.3 m120 61.04 162.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.508 ' HG3' ' HA ' ' B' ' 51' ' ' VAL . 32.5 mt-10 -99.47 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.6 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.25 -52.23 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.531 HG22 ' H ' ' B' ' 82' ' ' ALA . 3.6 p -131.29 169.83 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.568 ' HB1' ' HZ ' ' A' ' 46' ' ' PHE . . . -168.57 165.21 12.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.22 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' B' ' 101' ' ' PHE . 0.6 OUTLIER -139.16 168.75 19.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' B' ' 85' ' ' ALA . 2.0 tmtp? -157.8 122.89 4.43 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.547 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -132.65 161.01 35.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.11 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.63 18.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.633 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.97 130.69 73.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.347 . . . . 0.0 111.149 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.609 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -102.03 115.15 29.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.32 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' TYR . . . . . 0.497 ' HA ' HG13 ' B' ' 95' ' ' VAL . 77.7 m-85 -91.72 108.82 20.18 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.194 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.666 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -115.12 124.15 50.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.08 -85.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.282 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.61 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.391 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.4 14.33 30.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.164 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' B' ' 90' ' ' ALA . 3.9 t70 -116.31 57.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.958 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' B' ' 89' ' ' TYR . 0.3 OUTLIER -95.26 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.699 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.602 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 2.9 ptp -146.79 151.41 37.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.722 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -130.21 138.21 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.447 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' B' ' 85' ' ' ALA . 8.3 m-80 -132.58 137.22 47.0 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.781 0.324 . . . . 0.0 111.409 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.46 95.77 2.72 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.684 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.444 ' HB3' HD11 ' A' ' 45' ' ' LEU . 29.3 m -126.0 161.39 27.64 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.396 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 8.6 p90 -127.6 145.54 50.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.969 0.414 . . . . 0.0 111.049 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.409 ' OD1' ' HD3' ' A' ' 48' ' ' PRO . 8.3 p30 -120.07 152.92 36.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.4 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 103' ' ' ILE . 4.4 mp -119.79 135.01 61.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 18.2 pm0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 2.8 mmpt? . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.692 0.282 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.72 -31.29 70.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -63.04 -58.7 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.79 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -36.21 83.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 1.033 HD21 HD13 ' B' ' 21' ' ' LEU . 12.1 mt -59.93 -47.48 85.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 22' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' C' ' 26' ' ' ASP . 29.1 t0 -66.91 -32.27 73.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.028 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -74.4 -47.53 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.751 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.63 -33.42 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.625 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' C' ' 22' ' ' ASP . 28.3 t0 -73.66 -41.3 62.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -62.98 -42.11 99.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.267 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' B' ' 29' ' ' ASP . 0.2 OUTLIER -62.8 -50.35 71.34 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.083 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 29' ' ' ASP . . . . . 0.761 ' HB2' HD21 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.18 61.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.961 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 m -78.08 -40.62 37.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.507 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.6 mpt_? -60.84 -32.62 72.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' C' ' 36' ' ' LEU . 6.5 m -80.07 -28.92 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -51.76 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 20.3 pttt -74.08 -39.32 63.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.815 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.13 92.24 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 36' ' ' LEU . 5.8 mt -73.55 -31.18 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.328 . . . . 0.0 111.085 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.21 35.97 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.429 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 22.9 t -63.95 -44.88 91.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.736 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.545 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 11.6 t -59.12 -46.46 88.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.31 -29.04 68.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.13 -39.85 93.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.566 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 2.6 tm? -77.06 -38.92 51.62 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -72.12 -15.99 61.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.59 -32.92 74.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.526 ' CG ' ' HB ' ' C' ' 57' ' ' THR . 1.0 OUTLIER -64.24 143.74 57.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.888 177.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.563 ' HZ ' ' HB1' ' A' ' 82' ' ' ALA . 34.6 p90 -112.78 -42.46 3.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.121 0.486 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.505 HE22 ' HG2' ' C' ' 84' ' ' LYS . 33.8 mt-30 70.3 109.44 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.958 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' C' ' 49' ' ' TYR 0.257 9.9 Cg_endo -75.24 -161.2 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.707 2.272 . . . . 0.0 112.633 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 17.5 m-30 68.1 167.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' C' ' 76' ' ' ARG . . . 178.4 -3.19 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.194 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.527 ' HA ' ' HG3' ' C' ' 79' ' ' GLU . 9.5 p -88.86 -34.72 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.136 0.574 . . . . 0.0 112.393 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.34 69.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.306 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 53' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' C' ' 76' ' ' ARG . 1.5 mptp? -143.72 -178.11 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.539 0.209 . . . . 0.0 110.642 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.509 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 10.2 p -119.04 142.12 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.533 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' C' ' 48' ' ' PRO . 1.7 m-80 -124.94 178.1 5.69 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.695 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -151.46 143.38 23.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.231 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' C' ' 45' ' ' LEU . 30.1 p -117.31 142.1 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.497 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -177.54 127.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.486 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.53 ' O ' HD12 ' C' ' 69' ' ' LEU . . . -179.28 -165.26 33.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.551 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.0 154.7 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 111.368 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 61' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -134.46 171.73 22.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.472 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 62' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' C' ' 66' ' ' SER . . . -156.79 141.25 7.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.575 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 84.3 t80 -135.5 110.83 9.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.334 . . . . 0.0 110.728 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.79 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.168 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.68 37.82 1.34 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.142 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 66' ' ' SER . . . . . 0.464 ' O ' ' HA2' ' C' ' 62' ' ' GLY . 32.1 t -134.8 157.69 46.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.83 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.76 148.31 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.38 173.03 15.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.602 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.53 HD12 ' O ' ' C' ' 59' ' ' GLY . 8.3 tp -124.69 126.61 45.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.766 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -117.52 163.27 16.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.694 0.283 . . . . 0.0 111.683 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' C' ' 58' ' ' ALA . 2.3 tt -158.64 176.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.318 . . . . 0.0 111.105 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.79 34.69 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.466 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.0 p -164.09 160.05 21.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.038 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.47 176.35 29.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.234 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.509 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 5.0 t80 -143.32 126.94 16.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 111.151 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.462 ' O ' ' HA2' ' C' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.736 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.733 HG22 ' OD1' ' C' ' 78' ' ' ASN . 7.3 p -83.19 127.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.998 0.427 . . . . 0.0 111.291 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' C' ' 77' ' ' VAL . 31.3 m120 61.14 162.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.088 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 79' ' ' GLU . . . . . 0.527 ' HG3' ' HA ' ' C' ' 51' ' ' VAL . 32.5 mt-10 -99.49 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 2.6 m -121.33 -52.17 2.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.987 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.542 HG22 ' H ' ' C' ' 82' ' ' ALA . 3.6 p -131.2 169.82 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.572 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.555 ' HB1' ' HZ ' ' B' ' 46' ' ' PHE . . . -168.5 165.23 12.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' C' ' 101' ' ' PHE . 0.6 OUTLIER -139.19 168.79 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.626 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.532 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 2.0 tmtp? -157.85 122.76 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 85' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -132.53 161.04 34.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.66 19.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.552 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.93 130.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.616 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -102.0 115.07 29.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.307 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 89' ' ' TYR . . . . . 0.511 ' HA ' HG13 ' C' ' 95' ' ' VAL . 77.8 m-85 -91.72 108.73 20.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -114.98 124.14 50.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.6 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -85.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.263 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 82.8 p -166.67 -50.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.309 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.35 14.35 30.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.221 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.572 ' O ' ' HB3' ' C' ' 90' ' ' ALA . 4.0 t70 -116.42 57.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 95' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' C' ' 89' ' ' TYR . 0.3 OUTLIER -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.696 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.614 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 2.9 ptp -146.78 151.38 37.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.711 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -130.2 138.29 50.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.439 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' C' ' 85' ' ' ALA . 8.2 m-80 -132.63 137.06 46.88 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.31 95.66 2.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.452 ' HB3' HD11 ' B' ' 45' ' ' LEU . 28.7 m -125.88 161.44 27.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.474 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' C' ' 83' ' ' LEU . 8.6 p90 -127.6 145.51 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.956 0.408 . . . . 0.0 111.085 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' B' ' 48' ' ' PRO . 8.2 p30 -120.08 152.98 36.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.387 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.408 HD12 ' N ' ' C' ' 103' ' ' ILE . 4.4 mp -119.79 135.01 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.488 ' HB2' ' CE2' ' B' ' 49' ' ' TYR . 18.3 pm0 -120.1 132.45 55.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 0.6 ' CH2' ' HB2' ' B' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.59 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.704 0.288 . . . . 0.0 110.514 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.82 -38.78 70.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.301 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.16 -61.81 1.83 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.27 -30.14 59.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.1 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.496 HD11 ' HD3' ' B' ' 24' ' ' ARG . 2.6 tm? -64.62 -60.46 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.603 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -65.03 -23.77 67.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -63.91 -54.12 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.533 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.3 mtp85 -69.78 -37.94 76.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.792 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.795 HD22 HD11 ' C' ' 25' ' ' LEU . 3.6 mm? -63.88 -44.71 92.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.605 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.89 -33.19 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG2' ' HD3' ' A' ' 31' ' ' ARG . 1.2 ttpp -67.91 -37.66 81.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.212 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -65.96 -45.48 81.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.414 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -60.12 -36.55 77.73 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.859 179.008 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.86 -30.35 56.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HD3' ' HG2' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -78.47 -27.18 46.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.28 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 28' ' ' LEU . 27.3 m -84.61 -32.39 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.21 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 55.6 m-20 -69.0 -43.91 73.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.989 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 5.0 ptpt -84.46 -30.22 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.0 -41.73 86.82 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.422 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.642 HD21 ' HG ' ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.81 -22.82 42.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.469 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -76.61 -39.77 51.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.419 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.644 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 8.6 t -77.64 -39.86 43.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.745 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -55.46 33.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.87 -39.16 80.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.374 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.47 71.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.958 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.437 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 28.3 tp -76.62 -42.21 43.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.093 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' CB ' ' C' ' 43' ' ' ASN . 32.4 m-20 -70.63 -9.86 57.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 41.7 t -69.26 -20.65 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.1 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.518 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.3 mm? -83.05 169.93 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.833 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.4 -1.66 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 0.0 111.727 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.597 ' OE1' ' HG2' ' A' ' 84' ' ' LYS . 6.0 mt-30 68.49 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.967 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -78.82 109.16 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.56 2.174 . . . . 0.0 112.527 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 59.57 177.48 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 174.74 50.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.191 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.7 p -71.58 -1.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.166 0.586 . . . . 0.0 112.407 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 143.63 53.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.254 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 -165.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.572 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.7 142.17 28.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.534 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 47' ' ' GLN . 12.8 m-80 -122.03 118.73 29.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 111.756 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.425 ' HA ' ' HB2' ' A' ' 73' ' ' SER . 30.1 t80 -84.84 131.67 34.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.267 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.527 HG21 ' HE3' ' A' ' 84' ' ' LYS . 40.9 p -113.72 121.2 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.9 136.99 18.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.486 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.15 166.51 33.58 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.555 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.0 m -116.43 158.13 17.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 111.304 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.98 -171.43 13.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.484 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -168.2 141.48 6.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.615 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.517 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 52.0 t80 -135.81 133.06 37.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 0.0 110.789 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 3.1 mmm180 69.52 -94.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 p -144.67 29.22 1.25 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.421 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 5.1 m -135.9 141.72 44.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.73 157.9 17.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.129 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.72 169.04 20.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.572 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.589 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.62 54.58 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.735 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -126.52 139.2 53.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.677 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 87' ' ' VAL . 10.7 tp -141.07 147.91 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.763 0.316 . . . . 0.0 111.128 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.42 -179.68 42.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.402 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' A' ' 56' ' ' PHE . 1.2 p -166.76 158.59 13.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.23 171.7 28.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.216 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 39.6 t80 -126.37 138.58 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 0.0 111.113 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.477 HH21 ' HB2' ' A' ' 47' ' ' GLN . 13.7 ttm180 -131.41 134.7 46.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.8 p -120.9 140.86 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.318 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.0 m-20 64.79 -94.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.072 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.606 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -73.35 -63.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.27 139.64 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -138.29 156.15 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 30.3 tp -136.93 141.75 42.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.621 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.597 ' HG2' ' OE1' ' A' ' 47' ' ' GLN . 7.9 tmtt? -153.39 128.71 9.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.71 175.86 11.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.06 -173.45 34.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.593 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' ILE . 7.7 p -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 111.131 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.591 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -112.6 144.68 41.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.329 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.6 120.48 40.31 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.244 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.644 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -127.8 131.07 49.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.638 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.21 -114.44 5.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.301 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.8 m -150.42 17.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.709 0.29 . . . . 0.0 111.331 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -167.24 19.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.192 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -119.44 67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.31 138.01 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.043 0.449 . . . . 0.0 110.75 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.591 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 4.4 ptp -134.84 134.62 40.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.684 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.81 122.46 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.403 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.24 150.51 27.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 0.0 111.389 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.47 90.58 0.48 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 19.3 m -118.98 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.465 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.43 135.06 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 111.059 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.76 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 73.9 m-80 -102.17 134.39 45.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' C' ' 56' ' ' PHE . 0.1 OUTLIER -138.78 115.29 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.774 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' C' ' 55' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.734 0.302 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.77 -38.87 70.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.275 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.1 -61.83 1.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.24 -30.1 59.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.119 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.517 HD11 ' HD3' ' C' ' 24' ' ' ARG . 2.6 tm? -64.69 -60.44 3.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.592 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -65.06 -23.73 67.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -63.87 -54.15 39.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.942 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.542 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.4 mtp85 -69.79 -37.97 76.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.747 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' C' ' 25' ' ' LEU . 3.5 mm? -63.85 -44.67 92.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.661 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.97 -33.15 75.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' HD3' ' B' ' 31' ' ' ARG . 1.2 ttpp -67.95 -37.59 81.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.227 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -65.97 -45.52 81.42 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.403 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -60.15 -36.49 77.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.939 178.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.94 -30.27 55.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.535 ' HD3' ' HG2' ' B' ' 27' ' ' LYS . 0.1 OUTLIER -78.42 -27.27 46.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.347 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.454 HG13 ' O ' ' B' ' 28' ' ' LEU . 27.4 m -84.65 -32.3 7.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.206 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 55.8 m-20 -69.04 -43.9 73.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.989 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.649 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 4.9 ptpt -84.44 -30.24 25.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.765 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.75 87.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.435 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.643 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -79.88 -22.85 42.37 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.485 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -76.61 -39.75 51.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.465 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.668 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 8.6 t -77.56 -39.96 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.89 -55.56 32.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.09 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.363 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.46 71.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.429 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 28.1 tp -76.63 -42.16 43.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 7.9 m120 -70.67 -9.87 58.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.472 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 41.6 t -69.38 -20.51 63.82 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.107 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.514 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.3 mm? -83.09 169.85 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.849 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.29 -1.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.191 0.52 . . . . 0.0 111.665 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.611 ' OE1' ' HG2' ' B' ' 84' ' ' LYS . 6.0 mt-30 68.54 116.95 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.984 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.724 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.69 109.0 2.53 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.723 2.282 . . . . 0.0 112.557 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 174.81 50.72 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.31 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.8 p -71.5 -1.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.158 0.583 . . . . 0.0 112.412 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 143.65 53.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.265 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.8 -165.26 1.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 110.653 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.71 142.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.584 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' B' ' 47' ' ' GLN . 12.9 m-80 -122.03 118.76 29.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.703 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.432 ' HA ' ' HB2' ' B' ' 73' ' ' SER . 30.2 t80 -84.86 131.63 34.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.226 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.54 HG21 ' HE3' ' B' ' 84' ' ' LYS . 40.9 p -113.72 121.25 43.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.976 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.87 137.02 18.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.447 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.13 166.43 33.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.576 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' B' ' 69' ' ' LEU . 7.0 m -116.32 158.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.816 0.341 . . . . 0.0 111.388 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.5 13.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.41 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -168.08 141.43 6.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.622 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 52.1 t80 -135.73 133.17 37.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.739 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 3.1 mmm180 69.5 -94.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 15.2 p -144.67 29.23 1.25 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.138 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 5.1 m -136.0 141.72 44.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.69 157.93 17.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.094 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.76 169.03 20.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.578 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.66 54.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.751 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.684 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' B' ' 87' ' ' VAL . 10.7 tp -140.97 147.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.41 -179.62 42.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' B' ' 56' ' ' PHE . 1.2 p -166.87 158.6 12.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.25 171.69 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 39.7 t80 -126.3 138.61 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 111.197 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.479 HH21 ' HB2' ' B' ' 47' ' ' GLN . 13.7 ttm180 -131.44 134.72 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.585 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.8 p -120.98 140.87 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.256 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 97.1 m-20 64.73 -94.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.916 0.389 . . . . 0.0 111.111 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 5.6 pt-20 177.11 -23.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 23.9 p -73.39 -63.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.013 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.3 139.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -138.36 156.1 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.316 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 30.2 tp -136.91 141.76 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.621 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.611 ' HG2' ' OE1' ' B' ' 47' ' ' GLN . 8.0 tmtt? -153.42 128.68 9.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.148 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.81 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.14 -173.43 34.06 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' B' ' 71' ' ' ILE . 7.7 p -141.56 143.47 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.59 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -112.65 144.7 41.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.373 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -114.61 120.51 40.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.266 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -127.85 130.94 49.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.649 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.649 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.37 -114.43 5.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.287 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -150.51 17.44 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.802 0.334 . . . . 0.0 111.296 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' SER . . . . . 0.414 ' HB3' HH12 ' B' ' 31' ' ' ARG . 1.3 t -167.18 18.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.205 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -119.38 67.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.971 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.3 137.99 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 110.655 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.59 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 4.4 ptp -134.86 134.66 40.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.708 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -109.89 122.47 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.433 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.19 150.37 27.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.718 0.294 . . . . 0.0 111.416 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.36 90.59 0.49 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.774 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 19.3 m -119.01 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.373 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -143.42 135.12 26.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.774 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 73.8 m-80 -102.24 134.27 45.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.392 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.68 115.26 10.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.83 0.347 . . . . 0.0 110.779 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.725 0.298 . . . . 0.0 110.522 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -38.83 69.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.191 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.09 -61.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.35 -30.03 59.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.491 HD11 ' HD3' ' A' ' 24' ' ' ARG . 2.6 tm? -64.58 -60.55 3.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.02 -23.71 67.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.993 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.03 -54.09 39.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.544 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.3 mtp85 -69.69 -38.06 76.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.75 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' A' ' 25' ' ' LEU . 3.6 mm? -63.78 -44.8 92.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.566 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.85 -33.19 75.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.853 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.551 ' HG2' ' HD3' ' C' ' 31' ' ' ARG . 1.2 ttpp -67.92 -37.61 81.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.23 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.457 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.0 OUTLIER -65.97 -45.44 81.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.105 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 29' ' ' ASP . . . . . 0.41 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -60.17 -36.49 77.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.908 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.93 -30.36 56.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.551 ' HD3' ' HG2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -78.38 -27.28 46.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.288 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.457 HG13 ' O ' ' C' ' 28' ' ' LEU . 27.3 m -84.55 -32.42 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.249 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.507 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 55.7 m-20 -68.95 -43.96 73.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.644 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 5.0 ptpt -84.42 -30.22 25.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.817 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -41.78 87.16 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.42 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.643 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.79 -22.86 42.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.466 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -76.58 -39.8 51.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.46 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.659 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 8.6 t -77.63 -39.88 43.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.719 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.95 -55.52 33.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.132 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.02 80.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.469 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.4 71.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.438 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 28.6 tp -76.62 -42.31 42.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 7.9 m120 -70.59 -9.9 58.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 44' ' ' SER . . . . . 0.491 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 41.7 t -69.22 -20.63 63.96 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.156 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.534 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.4 mm? -83.02 169.85 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.946 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -157.35 -1.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.219 0.533 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.61 ' OE1' ' HG2' ' C' ' 84' ' ' LYS . 6.0 mt-30 68.39 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.76 109.08 2.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.605 2.203 . . . . 0.0 112.582 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.002 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 174.77 50.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.235 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.7 p -71.49 -1.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.194 0.598 . . . . 0.0 112.483 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 143.58 53.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.282 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 -165.27 1.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.594 0.235 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.68 142.17 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.598 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' C' ' 47' ' ' GLN . 12.9 m-80 -122.0 118.73 29.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.71 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 56' ' ' PHE . . . . . 0.435 ' HA ' ' HB2' ' C' ' 73' ' ' SER . 29.9 t80 -84.74 131.68 34.53 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.296 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.52 HG21 ' HE3' ' C' ' 84' ' ' LYS . 40.8 p -113.78 121.21 43.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.91 136.99 18.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.1 166.43 33.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.572 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' C' ' 69' ' ' LEU . 7.0 m -116.33 158.14 16.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 111.371 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.41 13.44 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.465 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 62' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -168.15 141.52 6.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.518 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 52.2 t80 -135.8 133.04 37.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.276 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.1 mmm180 69.53 -94.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 15.0 p -144.68 29.19 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' C' ' 33' ' ' ASP . 5.0 m -135.93 141.69 44.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.68 157.99 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.73 169.07 20.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.565 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.584 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -123.36 138.61 54.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.749 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -126.5 139.2 53.41 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.655 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' C' ' 87' ' ' VAL . 10.7 tp -141.03 147.97 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.747 0.308 . . . . 0.0 111.085 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.4 -179.65 42.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' C' ' 56' ' ' PHE . 1.2 p -166.82 158.57 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.997 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.21 171.7 28.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.214 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 39.8 t80 -126.33 138.62 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.18 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.481 HH21 ' HB2' ' C' ' 47' ' ' GLN . 13.7 ttm180 -131.49 134.72 46.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.667 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.569 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.9 p -121.0 140.89 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 97.2 m-20 64.73 -94.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 79' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.56 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 23.8 p -73.42 -63.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.28 139.77 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -138.47 156.08 47.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.267 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 30.4 tp -136.91 141.69 42.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.61 ' HG2' ' OE1' ' C' ' 47' ' ' GLN . 8.0 tmtt? -153.41 128.69 9.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.91 11.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.051 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.05 -173.44 34.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.616 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 87' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' C' ' 71' ' ' ILE . 7.9 p -141.56 143.4 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.586 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -112.65 144.68 41.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -114.59 120.52 40.48 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.186 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -127.86 131.0 49.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.631 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.644 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.37 -114.46 5.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.263 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 62.1 m -150.43 17.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.759 0.314 . . . . 0.0 111.294 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 93' ' ' SER . . . . . 0.402 ' HB3' HH12 ' C' ' 31' ' ' ARG . 1.3 t -167.25 19.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.21 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -119.47 67.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.25 137.95 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.586 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 4.4 ptp -134.84 134.74 41.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.86 122.44 47.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.404 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.26 150.42 27.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.713 0.292 . . . . 0.0 111.447 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.37 90.57 0.49 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 19.3 m -119.01 172.22 7.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.407 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.44 135.18 26.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.79 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 73.9 m-80 -102.27 134.39 45.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.385 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 115.26 10.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 110.789 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' B' ' 55' ' ' ASN . 0.0 OUTLIER -115.22 157.4 23.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.672 179.665 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.593 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.68 0.276 . . . . 0.0 110.466 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.11 -30.5 66.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.19 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -63.26 -64.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.723 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.638 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 2.6 pp0? -64.0 -27.65 69.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.199 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.608 HD21 HD23 ' B' ' 21' ' ' LEU . 2.3 tm? -63.42 -69.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.541 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.46 -23.37 57.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.018 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.08 -47.99 66.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 47.7 mtp85 -70.87 -40.88 72.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' B' ' 25' ' ' LEU . 2.3 mm? -57.29 -51.12 70.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.547 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.7 -39.44 84.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 1.1 ttpp -63.13 -37.12 85.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.207 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -60.93 -38.21 85.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.544 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -73.37 -30.56 63.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 178.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.47 -34.34 72.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -33.83 62.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 29' ' ' ASP . 33.4 m -78.02 -26.67 14.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.182 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.595 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 40.8 m-20 -71.93 -43.19 65.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.047 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 7.0 ptpt -82.88 -28.84 29.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.829 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.58 74.15 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.446 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -74.93 -29.61 61.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 111.158 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' A' ' 63' ' ' TYR . . . -71.17 -42.4 69.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.451 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.8 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 11.5 t -74.73 -45.61 42.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.659 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.474 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 1.0 OUTLIER -58.42 -49.26 77.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HA ' ' OD1' ' B' ' 43' ' ' ASN . . . -66.99 -36.87 83.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.456 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.03 85.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 35.9 tp -74.33 -40.88 61.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.016 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.466 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 13.0 m120 -73.16 -9.74 59.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.5 t -69.03 -18.88 64.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.149 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.649 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 1.5 mm? -80.55 167.72 19.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.911 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -156.24 -3.39 0.12 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.641 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 12.7 mt-30 66.2 122.29 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.998 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -84.02 104.66 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.599 2.199 . . . . 0.0 112.51 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 9.2 m-30 66.78 -179.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.959 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 170.37 55.49 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.236 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.3 p -74.68 -5.62 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.133 0.573 . . . . 0.0 112.451 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.56 56.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.369 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.83 -163.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.644 0.259 . . . . 0.0 110.616 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.95 138.9 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.494 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.4 ' OD1' ' HB3' ' B' ' 104' ' ' GLU . 15.3 m-80 -123.0 115.22 21.53 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 111.666 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -81.45 129.97 34.86 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.207 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.649 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.9 p -110.57 126.12 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.593 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -156.12 133.15 10.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' HB3' ' B' ' 100' ' ' SER . . . -175.25 171.43 44.56 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.57 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.06 159.59 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 111.318 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 -169.88 16.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.444 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.426 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -167.03 135.95 3.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.518 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.649 ' CE2' HD13 ' A' ' 36' ' ' LEU . 28.6 t80 -123.89 141.62 51.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 110.744 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.429 ' HG3' ' OD1' ' A' ' 33' ' ' ASP . 2.5 mmm180 60.55 -95.63 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 p -142.34 24.31 1.95 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.34 142.03 50.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.82 156.37 18.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.14 168.67 22.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.598 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.15 138.26 54.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.796 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -131.99 139.2 48.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.671 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 72' ' ' GLY . 5.5 tp -137.49 162.4 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.121 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.606 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 169.96 -176.07 43.84 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.404 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.78 3.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.01 27.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.268 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.587 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 54.4 t80 -126.4 130.92 51.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 0.0 111.11 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.482 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 10.9 ttm180 -122.32 120.88 35.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.789 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.2 p -108.04 140.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.256 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 38.7 m-20 62.9 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.077 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 p -72.37 -61.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.992 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.09 142.17 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.816 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -141.19 158.83 43.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.85 147.01 31.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.575 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HE3' HG21 ' A' ' 57' ' ' THR . 11.5 tmtt? -158.54 132.46 7.76 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.25 -179.73 8.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.081 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.444 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . 160.53 -173.1 37.04 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.545 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.43 138.08 36.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.114 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.8 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -113.2 145.85 40.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.303 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -118.48 115.58 24.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.248 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -123.01 131.14 53.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.669 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.56 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 63.46 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.263 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.9 m -149.28 9.17 0.74 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.57 25.18 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.219 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-20 -121.03 71.76 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.5 t -101.91 137.35 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.071 0.463 . . . . 0.0 110.695 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.575 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 10.2 ptp -130.32 136.87 49.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -112.33 121.95 46.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.361 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.48 154.96 25.07 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 111.419 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.783 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB3' ' HA3' ' C' ' 59' ' ' GLY . 12.8 m -113.83 168.85 9.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.406 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.72 140.7 47.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.955 0.407 . . . . 0.0 111.108 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.816 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 57.1 m-80 -108.6 132.1 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.3 117.49 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.851 0.357 . . . . 0.0 110.712 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.406 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.6 0.238 . . . . 0.0 110.471 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.18 -30.43 66.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.251 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -63.22 -64.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.629 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 2.6 pp0? -64.05 -27.66 69.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.102 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.622 HD21 HD23 ' C' ' 21' ' ' LEU . 2.3 tm? -63.36 -69.21 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.41 -23.39 57.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.009 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.02 -48.12 66.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' B' ' 20' ' ' GLN . 47.8 mtp85 -70.83 -40.87 72.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.802 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.795 HD22 HD11 ' A' ' 25' ' ' LEU . 2.3 mm? -57.23 -51.11 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.636 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -59.68 -39.53 84.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.766 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.562 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 1.2 ttpp -63.15 -37.05 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.218 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.562 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -60.94 -38.21 85.05 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.549 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -73.38 -30.62 63.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.905 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.41 -34.43 72.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -33.9 62.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.276 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' B' ' 29' ' ' ASP . 33.3 m -77.95 -26.65 14.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.211 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.604 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 40.5 m-20 -71.96 -43.28 65.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.957 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.578 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 6.9 ptpt -82.88 -28.76 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.1 -38.58 73.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.658 HD13 ' CE2' ' B' ' 63' ' ' TYR . 0.5 OUTLIER -74.98 -29.63 60.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.765 0.317 . . . . 0.0 111.058 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' B' ' 63' ' ' TYR . . . -71.24 -42.31 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.459 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.799 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 11.4 t -74.73 -45.57 43.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.75 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.475 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 1.1 t -58.45 -49.2 78.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.457 ' HA ' ' OD1' ' C' ' 43' ' ' ASN . . . -67.08 -36.94 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.386 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.0 85.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.493 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 36.2 tp -74.41 -40.8 61.79 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 13.1 m120 -73.16 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 29.4 t -69.05 -18.85 64.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.125 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 1.6 mm? -80.59 167.7 19.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.889 177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.24 -3.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.131 0.491 . . . . 0.0 111.649 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' B' ' 48' ' ' PRO . 12.7 mt-30 66.37 122.19 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.956 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -84.0 104.68 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.572 2.181 . . . . 0.0 112.548 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 9.1 m-30 66.8 -179.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 170.37 55.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.252 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.3 p -74.66 -5.67 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.103 0.561 . . . . 0.0 112.454 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.798 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.64 56.11 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.228 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 -163.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.94 138.9 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.518 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 15.4 m-80 -122.93 115.15 21.44 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 111.669 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.502 ' HB2' ' HZ3' ' C' ' 105' ' ' TRP . 37.6 t80 -81.37 130.01 34.86 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.628 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.8 p -110.57 126.09 54.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.959 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.594 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -156.15 133.24 10.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.403 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' C' ' 100' ' ' SER . . . -175.33 171.44 44.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.573 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -126.02 159.52 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.16 -169.81 16.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.454 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -167.1 135.85 3.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.595 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.658 ' CE2' HD13 ' B' ' 36' ' ' LEU . 28.6 t80 -123.8 141.65 51.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.725 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' OD1' ' B' ' 33' ' ' ASP . 2.5 mmm180 60.49 -95.7 0.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 16.8 p -142.26 24.33 1.96 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.23 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.35 141.98 50.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.78 156.39 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 168.71 22.57 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.13 138.31 54.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.782 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -131.97 139.15 48.56 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.594 HD12 ' CB ' ' B' ' 58' ' ' ALA . 5.5 tp -137.5 162.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 111.113 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.584 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 170.02 -176.0 43.89 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.452 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.8 p -170.02 150.72 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.991 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.09 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.239 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.583 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 54.5 t80 -126.38 130.97 51.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 111.159 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.479 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 11.0 ttm180 -122.47 120.96 35.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.798 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.2 p -108.04 140.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 38.5 m-20 62.9 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 176.0 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.567 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.46 -61.43 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 16.3 m -89.11 142.27 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.81 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -141.21 158.85 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.207 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.9 146.98 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.448 ' HE3' HG21 ' B' ' 57' ' ' THR . 11.5 tmtt? -158.49 132.39 7.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.22 -179.72 8.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.074 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.442 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 160.53 -173.11 37.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.61 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.44 137.99 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.799 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -113.15 145.96 40.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.294 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -118.59 115.6 24.89 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.221 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.681 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -123.01 131.24 53.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.578 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 63.31 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.262 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 50.0 m -149.23 9.17 0.74 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.355 . . . . 0.0 111.343 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.61 25.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.184 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 19.1 m-20 -121.09 71.79 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 87.4 t -101.89 137.36 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 110.657 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.58 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 10.2 ptp -130.36 136.89 49.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.652 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -112.4 121.87 46.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.387 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -112.41 154.91 25.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.482 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.18 88.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.762 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.576 ' HB3' ' HA3' ' A' ' 59' ' ' GLY . 12.7 m -113.7 168.91 9.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.446 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.82 140.63 47.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 111.074 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.81 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 57.2 m-80 -108.59 131.96 54.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.373 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.14 117.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.4 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.859 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.733 0.301 . . . . 0.0 110.556 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.98 -30.59 66.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.306 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 43.6 mtt-85 -63.16 -64.09 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.771 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.637 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 2.6 pp0? -64.07 -27.71 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.108 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.622 HD23 HD21 ' B' ' 21' ' ' LEU . 2.3 tm? -63.44 -69.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.554 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -58.54 -23.28 57.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.017 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.11 -48.01 66.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' C' ' 20' ' ' GLN . 48.1 mtp85 -70.89 -40.83 71.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.775 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.788 HD22 HD11 ' B' ' 25' ' ' LEU . 2.3 mm? -57.31 -51.1 70.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.67 -39.52 84.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.803 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.428 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 1.2 ttpp -63.12 -37.08 85.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.192 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.428 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -61.01 -38.06 84.75 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 29' ' ' ASP . . . . . 0.543 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -73.43 -30.68 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.92 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.34 -34.47 72.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.848 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -33.9 62.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.322 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.543 HG22 ' HA ' ' C' ' 29' ' ' ASP . 33.4 m -77.94 -26.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.592 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 40.2 m-20 -71.96 -43.21 65.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.582 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 6.9 ptpt -82.84 -28.87 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.799 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.99 -38.6 74.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.475 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' C' ' 63' ' ' TYR . 0.5 OUTLIER -74.96 -29.65 60.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.819 0.342 . . . . 0.0 111.067 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.434 ' HB2' ' H ' ' C' ' 63' ' ' TYR . . . -71.27 -42.26 68.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.429 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.801 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 11.5 t -74.77 -45.54 43.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.469 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 1.0 OUTLIER -58.5 -49.2 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.083 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.458 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . . . -67.1 -36.81 82.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.428 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.97 85.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.906 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 36.0 tp -74.35 -40.83 61.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 13.0 m120 -73.21 -9.67 58.96 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.2 t -69.16 -18.71 63.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.647 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 1.5 mm? -80.65 167.69 19.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.872 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.18 -3.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 111.702 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 12.7 mt-30 66.31 122.27 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -84.04 104.71 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.573 2.182 . . . . 0.0 112.528 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 9.2 m-30 66.73 -179.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 170.42 55.56 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.201 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.2 p -74.7 -5.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.197 0.599 . . . . 0.0 112.445 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.779 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.51 56.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.323 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 -163.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.656 0.265 . . . . 0.0 110.597 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.88 138.83 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.584 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 15.4 m-80 -122.98 115.18 21.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.022 0.439 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 56' ' ' PHE . . . . . 0.402 ' CE2' HD11 ' C' ' 71' ' ' ILE . 37.7 t80 -81.45 129.96 34.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.238 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.647 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 45.7 p -110.56 126.07 54.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.597 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -156.05 133.21 10.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.45 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 100' ' ' SER . . . -175.31 171.5 44.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.588 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -126.12 159.55 34.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.336 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.19 -169.87 16.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.478 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 62' ' ' GLY . . . . . 0.43 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -167.08 135.96 3.91 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.52 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.648 ' CE2' HD13 ' C' ' 36' ' ' LEU . 28.7 t80 -123.87 141.66 51.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.674 0.273 . . . . 0.0 110.816 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' OD1' ' C' ' 33' ' ' ASP . 2.5 mmm180 60.44 -95.61 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.097 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -142.32 24.35 1.95 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.164 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.3 141.98 50.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.76 156.43 18.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.23 168.61 22.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.605 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.08 138.32 54.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.787 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.0 139.19 48.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.633 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.608 HG13 ' H ' ' C' ' 72' ' ' GLY . 5.5 tp -137.5 162.46 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.608 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 169.97 -176.09 43.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.477 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.7 3.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.1 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.224 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.585 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 54.6 t80 -126.38 130.94 51.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 111.097 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.475 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 10.9 ttm180 -122.35 120.92 35.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.743 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.779 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.2 p -108.08 140.69 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.292 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 38.6 m-20 62.91 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.556 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.36 -61.56 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.953 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.08 142.26 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.497 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.785 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -141.21 158.82 43.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.268 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.88 146.99 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.446 ' HE3' HG21 ' C' ' 57' ' ' THR . 11.6 tmtt? -158.49 132.4 7.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.169 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.23 -179.67 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 160.53 -173.06 37.04 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.552 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.4 138.06 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 111.164 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.801 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -113.2 145.94 40.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -118.59 115.62 24.93 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.188 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -123.11 131.13 53.57 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.574 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.582 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 63.45 -112.4 4.94 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.213 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -149.29 9.19 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 111.297 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.62 25.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 19.4 m-20 -121.0 71.8 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -101.86 137.39 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 0.0 110.663 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.576 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 10.2 ptp -130.35 136.82 49.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.33 121.96 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.435 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.45 154.92 25.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.456 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.66 0.15 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.767 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.583 ' HB3' ' HA3' ' B' ' 59' ' ' GLY . 12.6 m -113.71 168.91 9.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.47 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -133.79 140.54 47.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.085 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.785 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 56.9 m-80 -108.49 132.03 54.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.392 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.19 117.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.727 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' C' ' 104' ' ' GLU . 0.0 OUTLIER -118.65 161.18 20.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 0.502 ' HZ3' ' HB2' ' B' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.675 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.671 0.272 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.41 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 82.1 t80 -60.94 -31.5 71.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.193 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.566 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 32.2 mmt180 -75.58 -30.06 59.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.619 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 29.5 mt-30 -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.11 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.433 ' HA ' HD11 ' C' ' 21' ' ' LEU . 0.5 OUTLIER -64.47 -50.28 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 22.8 m-20 -71.98 -19.97 61.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 12.9 t-20 -77.4 -41.22 40.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.735 ' HD3' HD13 ' C' ' 25' ' ' LEU . 3.6 mmp_? -71.58 -46.25 59.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.727 HD13 ' HD3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.67 94.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.698 ' O ' HG22 ' A' ' 30' ' ' THR . 51.7 t0 -69.73 -28.98 66.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.805 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -75.96 -38.1 57.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.241 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.636 ' O ' HG22 ' A' ' 32' ' ' VAL . 8.0 mt -76.5 -34.8 58.61 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -66.76 -47.21 72.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 26' ' ' ASP . 9.7 t -71.63 -40.19 69.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.678 ' HG2' HH11 ' A' ' 31' ' ' ARG . 21.2 ttp85 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.348 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 28' ' ' LEU . 28.4 m -76.61 -27.67 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.582 ' OD2' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t70 -64.08 -56.18 16.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.96 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.679 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 23.0 pttt -68.71 -37.63 79.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.826 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.67 -48.2 87.42 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.421 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' B' ' 39' ' ' SER . 0.4 OUTLIER -67.48 -31.69 72.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.801 0.334 . . . . 0.0 111.095 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -38.44 90.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.405 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.685 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 78.7 p -79.96 -43.52 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.573 ' HB2' HD21 ' C' ' 36' ' ' LEU . 46.7 t -53.24 -60.95 2.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.7 -30.25 60.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.567 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -63.98 -49.02 74.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.926 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -66.99 -32.91 74.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.123 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 1.4 m-20 -78.75 -13.63 59.71 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -19.08 65.68 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.134 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.815 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.2 mm? -75.55 158.57 32.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.9 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 47.3 p90 -146.47 -31.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.645 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 8.3 tt0 75.64 108.58 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.924 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -90.81 137.26 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.668 2.246 . . . . 0.0 112.576 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 14.5 m-85 67.56 154.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.576 ' CA ' ' HB3' ' A' ' 76' ' ' ARG . . . -173.94 73.06 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.228 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.826 HG12 ' HE2' ' A' ' 53' ' ' LYS . 11.4 p -95.88 -22.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.157 0.583 . . . . 0.0 112.521 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.89 48.99 0.02 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.301 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.826 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -143.76 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.576 0.227 . . . . 0.0 110.57 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.41 143.4 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.557 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.496 HD21 ' HB3' ' B' ' 102' ' ' ASN . 1.0 OUTLIER -135.14 116.49 14.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.03 0.443 . . . . 0.0 111.697 179.541 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 71' ' ' ILE . 12.0 t80 -80.29 131.03 35.59 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.279 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.815 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 27.7 p -110.53 120.96 44.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.971 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 71' ' ' ILE . . . -143.49 139.9 30.06 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.402 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.01 164.68 33.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.536 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.428 HG12 HD13 ' A' ' 69' ' ' LEU . 28.6 m -118.79 164.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.879 0.371 . . . . 0.0 111.282 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.567 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.5 177.5 20.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.48 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 67' ' ' GLN . . . -162.05 155.13 26.3 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.517 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 1.3 t80 -142.04 122.32 13.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 110.736 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.582 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 24.9 mtt-85 67.63 -93.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.107 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -131.89 9.49 4.55 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.167 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 22.9 t -109.93 173.88 6.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -135.31 -179.27 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.685 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -162.61 158.28 23.11 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.515 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD12 ' H ' ' A' ' 70' ' ' ALA . 3.9 tp -118.11 134.62 54.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.733 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.926 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -142.71 139.06 30.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.68 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.561 HD11 ' CE2' ' A' ' 56' ' ' PHE . 8.9 tp -138.33 150.55 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.718 0.295 . . . . 0.0 111.09 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.7 -177.26 37.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.2 p -160.23 155.26 24.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.61 30.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.242 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.42 120.58 17.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 111.147 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.576 ' HB3' ' CA ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.695 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.777 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 14.9 p -102.47 130.09 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 58.98 -171.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.97 66.02 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.3 p -160.07 -51.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' A' ' 103' ' ' ILE . 9.8 p -119.53 142.08 36.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.83 153.09 45.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 0.0 111.272 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 130.7 32.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.694 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -135.02 144.02 47.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.062 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 173.42 161.11 23.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.588 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.39 150.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -121.79 140.68 52.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.23 128.4 48.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.247 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 94' ' ' ASP . . . -136.33 151.09 49.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.672 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.679 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 50.21 -99.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.256 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.33 -27.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.727 0.298 . . . . 0.0 111.308 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.5 p -123.75 15.03 9.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.2 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.536 ' CB ' ' HB3' ' A' ' 90' ' ' ALA . 41.6 m-20 -101.52 69.91 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.74 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.512 ' SD ' HD23 ' C' ' 36' ' ' LEU . 1.3 ptp -135.2 139.48 44.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.771 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -117.56 129.91 56.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -129.27 145.43 51.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.661 0.267 . . . . 0.0 111.441 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.52 7.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.746 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.9 p -127.99 164.41 22.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.437 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.28 142.62 35.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.951 0.405 . . . . 0.0 111.096 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 17.0 m-80 -109.32 134.99 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.366 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' A' ' 81' ' ' VAL . 1.2 pt -134.58 126.3 48.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.808 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' C' ' 55' ' ' ASN . 3.8 pt-20 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.655 0.264 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' PHE . . . . . 0.404 ' O ' ' OD2' ' B' ' 22' ' ' ASP . 82.3 t80 -60.78 -31.53 70.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 111.296 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 32.4 mmt180 -75.66 -30.02 59.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.618 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 29.6 mt-30 -73.12 -37.04 66.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.159 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' C' ' 21' ' ' LEU . 0.5 OUTLIER -64.52 -50.24 68.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.569 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 22.7 m-20 -72.0 -19.99 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.971 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 13.0 t-20 -77.37 -41.2 41.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.727 ' HD3' HD13 ' A' ' 25' ' ' LEU . 3.6 mmp_? -71.54 -46.29 59.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.762 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.725 HD13 ' HD3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.65 94.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.693 ' O ' HG22 ' B' ' 30' ' ' THR . 51.7 t0 -69.75 -28.98 66.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.835 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -76.01 -37.99 57.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.251 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.631 ' O ' HG22 ' B' ' 32' ' ' VAL . 8.0 mt -76.62 -34.82 58.33 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -66.58 -47.35 73.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.942 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.693 HG22 ' O ' ' B' ' 26' ' ' ASP . 9.7 t -71.66 -40.11 69.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.885 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.689 HH11 ' HG2' ' B' ' 31' ' ' ARG . 21.3 ttp85 -62.73 -38.3 89.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.297 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.631 HG22 ' O ' ' B' ' 28' ' ' LEU . 28.6 m -76.69 -27.68 17.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.178 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.575 ' OD2' ' HD2' ' B' ' 64' ' ' ARG . 10.4 t70 -64.0 -56.17 17.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.004 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.682 ' HD2' ' HA3' ' B' ' 91' ' ' GLY . 23.0 pttt -68.77 -37.56 79.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.06 88.12 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.425 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' C' ' 39' ' ' SER . 0.4 OUTLIER -67.64 -31.62 71.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 111.057 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.52 90.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.418 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.694 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 78.4 p -79.93 -43.58 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.55 ' HB2' HD21 ' A' ' 36' ' ' LEU . 46.7 t -53.19 -60.88 2.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.75 -30.22 60.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.403 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.571 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -64.03 -48.97 74.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.927 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.6 OUTLIER -67.04 -32.96 74.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 1.4 m-20 -78.79 -13.58 59.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.12 65.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.131 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.814 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.2 mm? -75.58 158.63 32.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.894 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.441 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 47.4 p90 -146.52 -30.99 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.169 0.509 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 8.3 tt0 75.45 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.978 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -90.79 137.16 2.25 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.208 . . . . 0.0 112.613 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 14.4 m-85 67.53 154.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.582 ' CA ' ' HB3' ' B' ' 76' ' ' ARG . . . -173.89 73.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.215 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.814 HG12 ' HE2' ' B' ' 53' ' ' LYS . 11.5 p -96.02 -22.88 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 123.162 0.585 . . . . 0.0 112.446 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.83 49.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.814 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.631 0.253 . . . . 0.0 110.546 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.43 143.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.571 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.492 HD21 ' HB3' ' C' ' 102' ' ' ASN . 1.0 OUTLIER -135.18 116.49 14.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 111.663 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' B' ' 71' ' ' ILE . 12.0 t80 -80.32 131.07 35.58 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.215 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.814 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 27.8 p -110.63 120.81 43.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.941 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' B' ' 71' ' ' ILE . . . -143.37 139.85 30.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.441 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.02 164.63 33.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.522 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.425 HG12 HD13 ' B' ' 69' ' ' LEU . 28.5 m -118.68 164.37 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.879 0.371 . . . . 0.0 111.293 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.571 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.57 177.47 20.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.482 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 67' ' ' GLN . . . -162.0 155.12 26.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 1.3 t80 -142.05 122.34 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.575 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 25.1 mtt-85 67.59 -93.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.088 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.41 4.54 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.472 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 22.8 t -109.89 173.91 6.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.811 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.6 OUTLIER -135.32 -179.35 5.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.061 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.694 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -162.56 158.22 23.15 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.552 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.593 HD12 ' H ' ' B' ' 70' ' ' ALA . 3.9 tp -118.02 134.64 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.927 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -142.72 139.03 30.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.694 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.558 HD11 ' CE2' ' B' ' 56' ' ' PHE . 8.9 tp -138.29 150.47 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.15 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.4 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -164.59 -177.19 37.02 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.423 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -160.28 155.22 24.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.58 30.06 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.235 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.4 120.52 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 111.108 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.582 ' HB3' ' CA ' ' B' ' 50' ' ' GLY . 0.0 OUTLIER -105.21 107.63 18.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.762 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.768 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 14.9 p -102.52 130.07 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 59.0 -171.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -118.99 66.01 0.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 69.9 p -160.03 -51.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.022 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' B' ' 103' ' ' ILE . 9.8 p -119.53 142.07 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.563 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.85 153.15 45.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.895 0.378 . . . . 0.0 111.245 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.57 130.71 32.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.477 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -135.09 143.95 46.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.21 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.477 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -148.28 169.11 20.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.793 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 173.37 161.02 22.92 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.553 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.33 150.16 34.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -121.74 140.67 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.16 128.35 48.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.268 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.542 ' HB3' ' CB ' ' B' ' 94' ' ' ASP . . . -136.32 151.09 49.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.625 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.682 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 50.22 -99.64 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.307 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 25.9 t -152.28 -27.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 15.08 9.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.191 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.542 ' CB ' ' HB3' ' B' ' 90' ' ' ALA . 41.5 m-20 -101.59 69.95 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -113.33 127.94 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.747 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.505 ' SD ' HD23 ' A' ' 36' ' ' LEU . 1.3 ptp -135.19 139.48 44.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -117.57 129.92 56.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.463 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -129.29 145.43 51.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.7 0.285 . . . . 0.0 111.419 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.45 7.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.695 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 84.1 p -127.99 164.49 22.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.424 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -140.36 142.54 35.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.521 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 17.1 m-80 -109.3 134.95 51.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' B' ' 81' ' ' VAL . 1.2 pt -134.57 126.2 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.796 0.331 . . . . 0.0 110.781 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 3.8 pt-20 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.65 0.262 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 18' ' ' PHE . . . . . 0.418 ' O ' ' OD2' ' C' ' 22' ' ' ASP . 82.2 t80 -60.87 -31.5 70.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 19' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 32.3 mmt180 -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.735 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 29.6 mt-30 -73.07 -37.0 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 111.212 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.437 ' HA ' HD11 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -64.57 -50.25 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 22.7 m-20 -71.91 -20.06 61.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 23' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 12.8 t-20 -77.31 -41.27 41.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.725 ' HD3' HD13 ' B' ' 25' ' ' LEU . 3.6 mmp_? -71.45 -46.4 60.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.735 HD13 ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -59.83 -43.72 94.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.643 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 26' ' ' ASP . . . . . 0.69 ' O ' HG22 ' C' ' 30' ' ' THR . 51.7 t0 -69.79 -28.9 66.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -75.98 -38.08 57.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.661 0.267 . . . . 0.0 111.265 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.639 ' O ' HG22 ' C' ' 32' ' ' VAL . 8.0 mt -76.52 -34.91 58.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.54 -47.32 73.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.003 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.69 HG22 ' O ' ' C' ' 26' ' ' ASP . 9.7 t -71.62 -40.23 69.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.699 HH11 ' HG2' ' C' ' 31' ' ' ARG . 21.3 ttp85 -62.58 -38.51 90.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.325 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.639 HG22 ' O ' ' C' ' 28' ' ' LEU . 28.3 m -76.59 -27.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.235 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.573 ' OD2' ' HD2' ' C' ' 64' ' ' ARG . 10.4 t70 -63.98 -56.2 16.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HD2' ' HA3' ' C' ' 91' ' ' GLY . 23.1 pttt -68.78 -37.56 79.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.807 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 -48.08 88.01 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.384 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.4 OUTLIER -67.67 -31.56 71.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.28 -38.44 90.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.482 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.701 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 78.7 p -79.9 -43.59 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.545 ' HB2' HD21 ' B' ' 36' ' ' LEU . 46.7 t -53.15 -60.99 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.66 -30.29 60.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' ALA . . . . . 0.58 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -63.95 -48.98 74.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.923 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.6 OUTLIER -67.01 -32.94 74.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.067 179.33 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.3 m-20 -78.77 -13.6 59.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.07 65.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.144 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.826 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.2 mm? -75.65 158.71 32.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.87 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.452 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 47.5 p90 -146.56 -31.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.194 0.521 . . . . 0.0 111.69 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.477 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 8.3 tt0 75.59 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.979 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -90.85 137.17 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.625 2.217 . . . . 0.0 112.545 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 14.6 m-85 67.59 154.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.583 ' CA ' ' HB3' ' C' ' 76' ' ' ARG . . . -173.95 73.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.253 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.811 HG12 ' HE2' ' C' ' 53' ' ' LYS . 11.4 p -95.87 -22.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.198 0.599 . . . . 0.0 112.453 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.9 48.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.296 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 53' ' ' LYS . . . . . 0.811 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.49 7.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.593 0.235 . . . . 0.0 110.566 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.45 143.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.525 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.489 HD21 ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -135.19 116.45 14.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.006 0.431 . . . . 0.0 111.68 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 56' ' ' PHE . . . . . 0.556 ' CE2' HD11 ' C' ' 71' ' ' ILE . 12.0 t80 -80.35 131.09 35.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.269 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.826 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 27.6 p -110.63 120.82 43.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.972 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.562 ' HB2' ' CD1' ' C' ' 71' ' ' ILE . . . -143.37 139.93 30.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.431 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.05 164.61 33.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.563 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.438 HG12 HD13 ' C' ' 69' ' ' LEU . 28.2 m -118.62 164.38 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.331 . . . . 0.0 111.386 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 61' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.52 177.46 20.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.496 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' C' ' 67' ' ' GLN . . . -161.99 155.07 26.22 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 1.3 t80 -141.95 122.31 14.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.76 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.573 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 24.9 mtt-85 67.54 -93.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.104 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.45 4.54 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.19 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' SER . . . . . 0.462 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 22.8 t -109.92 173.93 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 67' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.6 OUTLIER -135.33 -179.39 5.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.093 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 68' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -162.55 158.27 23.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.549 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.59 HD12 ' H ' ' C' ' 70' ' ' ALA . 3.8 tp -118.08 134.63 54.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.923 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -142.69 138.99 30.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.675 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.562 ' CD1' ' HB2' ' C' ' 58' ' ' ALA . 8.9 tp -138.3 150.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.712 0.291 . . . . 0.0 111.162 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.62 -177.25 37.09 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.399 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.2 p -160.3 155.12 24.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.65 163.66 30.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.223 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -136.4 120.45 17.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 111.171 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.583 ' HB3' ' CA ' ' C' ' 50' ' ' GLY . 0.0 OUTLIER -105.18 107.65 18.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.796 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.754 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 14.9 p -102.48 130.07 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.291 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 59.01 -171.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.96 66.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.567 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 69.2 p -160.08 -51.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.044 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' CG2' ' C' ' 103' ' ' ILE . 9.8 p -119.59 141.94 37.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.08 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.294 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.48 130.81 33.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.627 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -135.11 144.03 46.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.179 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 85' ' ' ALA . . . . . 0.481 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.782 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 173.47 161.09 23.11 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.589 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.36 150.12 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.897 0.38 . . . . 0.0 111.074 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -121.71 140.73 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.356 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.19 128.41 48.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.543 ' HB3' ' CB ' ' C' ' 94' ' ' ASP . . . -136.38 151.07 49.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.613 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.695 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 50.21 -99.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.334 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.35 -27.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.753 0.311 . . . . 0.0 111.348 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 14.98 9.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.205 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' C' ' 90' ' ' ALA . 41.4 m-20 -101.48 69.8 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 t -113.29 127.98 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.989 0.424 . . . . 0.0 110.742 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.513 ' SD ' HD23 ' B' ' 36' ' ' LEU . 1.3 ptp -135.2 139.52 44.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.746 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -117.57 129.9 56.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.472 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -129.25 145.37 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.676 0.275 . . . . 0.0 111.43 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.59 114.49 7.33 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 83.9 p -128.04 164.43 22.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.426 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.31 142.5 35.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.967 0.413 . . . . 0.0 111.114 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.521 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 17.4 m-80 -109.24 135.05 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.542 HD12 ' HE1' ' C' ' 105' ' ' TRP . 1.2 pt -134.56 126.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.776 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' B' ' 55' ' ' ASN . 3.8 pt-20 -104.69 148.58 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 0.542 ' HE1' HD12 ' C' ' 103' ' ' ILE . 57.7 m95 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.705 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.709 0.29 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.421 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 92.9 t80 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.182 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.02 -30.18 55.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.744 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.7 mt-30 -71.14 -33.87 70.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.217 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.445 HD21 ' HG3' ' B' ' 24' ' ' ARG . 0.5 OUTLIER -65.1 -48.29 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 15.9 m-20 -70.93 -20.44 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.977 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.79 -42.94 57.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.618 ' HB3' HD13 ' C' ' 25' ' ' LEU . 2.6 mmp_? -70.66 -48.82 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.736 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 30' ' ' THR . 49.8 t0 -72.1 -28.9 63.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.813 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -76.0 -37.16 58.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.259 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.568 HD11 ' HA ' ' C' ' 25' ' ' LEU . 9.5 mt -76.13 -32.75 59.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 32' ' ' VAL . 20.9 t0 -67.38 -48.56 67.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 26' ' ' ASP . 10.0 t -68.7 -37.92 79.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.854 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.666 HH11 ' HG2' ' A' ' 31' ' ' ARG . 18.9 ttp85 -63.65 -39.09 93.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 28' ' ' LEU . 30.2 m -75.33 -28.25 20.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.505 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 13.8 t70 -62.55 -55.12 30.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.001 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 18.7 pttt -70.78 -40.65 72.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.728 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.28 90.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.422 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.95 -34.78 78.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.805 0.336 . . . . 0.0 111.057 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.6 94.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.398 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.438 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 55.6 p -78.38 -39.28 39.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.737 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.0 t -54.66 -64.66 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.408 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -54.48 -31.09 55.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.428 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -62.39 -48.52 79.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.798 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -68.59 -32.72 72.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.363 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.3 m-20 -80.26 -15.04 57.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -17.55 64.79 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.156 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.782 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.8 mm? -76.59 156.07 33.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.871 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.18 -30.29 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.58 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 7.9 tt0 72.17 108.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.031 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.9 Cg_endo -91.29 139.43 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.637 2.225 . . . . 0.0 112.535 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.0 m-85 69.1 154.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.0 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -176.62 75.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.255 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.841 HG12 ' HE2' ' A' ' 53' ' ' LYS . 11.7 p -95.57 -24.92 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.067 0.547 . . . . 0.0 112.464 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.828 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.19 48.33 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.246 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.841 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -145.03 179.69 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.6 0.238 . . . . 0.0 110.643 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 11.4 p -105.18 145.3 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.553 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.58 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 0.9 OUTLIER -135.08 119.62 18.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 111.687 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 71' ' ' ILE . 10.1 t80 -83.01 132.28 35.15 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.18 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.782 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 43.6 p -111.04 122.73 48.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.926 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.54 143.59 31.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.465 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.89 37.04 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.596 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.14 163.78 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.767 0.317 . . . . 0.0 111.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -138.19 177.75 19.79 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.447 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.32 26.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.505 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.76 123.82 14.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 27.2 mtt-85 64.18 -94.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.065 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 p -130.69 6.41 4.73 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.203 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.44 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 30.6 t -104.6 174.34 5.92 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.98 177.08 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -161.46 153.93 20.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.556 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 70' ' ' ALA . 6.0 tp -117.26 132.0 56.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.806 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.798 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -138.8 136.1 35.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.692 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.472 HD11 ' CE2' ' A' ' 56' ' ' PHE . 8.8 tp -136.29 145.44 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.28 155.99 34.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.68 163.46 29.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.216 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t80 -138.43 120.91 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 111.128 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HG3' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -110.39 105.58 14.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.685 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.828 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.6 p -104.58 130.8 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.329 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.432 ' CG ' HG22 ' A' ' 77' ' ' VAL . 9.1 m-20 59.5 -174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.18 68.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.535 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.2 p -160.03 -50.7 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.036 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.26 143.48 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.578 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 154.52 45.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.265 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.88 132.37 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.57 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -134.72 139.8 45.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.422 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.07 169.42 19.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.672 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 173.68 162.69 25.97 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.532 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.12 33.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.157 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -119.06 141.33 48.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -124.23 127.86 48.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.269 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.569 ' HB3' ' CB ' ' A' ' 94' ' ' ASP . . . -135.59 148.1 48.93 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.7 -98.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.278 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 -28.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 111.323 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.9 p -121.56 15.34 11.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.569 ' CB ' ' HB3' ' A' ' 90' ' ' ALA . 38.1 m-20 -103.12 70.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.7 t -110.44 128.27 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.722 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.444 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 1.6 ptp -135.58 139.44 43.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.74 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -118.93 128.82 54.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.459 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -129.26 147.37 51.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.36 116.0 5.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.745 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 94.8 p -127.94 163.14 25.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.383 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -136.57 144.58 44.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 111.012 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.438 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 21.6 m-80 -109.83 131.9 54.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.38 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 pt -131.41 126.74 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.75 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 3.8 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.764 0.316 . . . . 0.0 110.546 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' PHE . . . . . 0.431 ' O ' ' OD2' ' B' ' 22' ' ' ASP . 92.7 t80 -65.59 -32.23 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.205 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -77.14 -30.08 54.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.735 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.548 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 mt-30 -71.24 -33.85 70.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.099 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.455 HD21 ' HG3' ' C' ' 24' ' ' ARG . 0.5 OUTLIER -65.15 -48.28 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.5 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 15.7 m-20 -70.87 -20.41 62.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.76 -43.03 56.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.603 ' HB3' HD13 ' A' ' 25' ' ' LEU . 2.6 mmp_? -70.63 -48.8 53.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.746 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.612 HD13 ' HB3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -60.41 -41.8 94.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.644 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.513 ' O ' HG22 ' B' ' 30' ' ' THR . 49.8 t0 -72.04 -28.96 63.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -75.9 -37.2 59.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.259 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 25' ' ' LEU . 9.6 mt -76.17 -32.83 59.26 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.455 ' O ' HG22 ' B' ' 32' ' ' VAL . 20.9 t0 -67.26 -48.64 67.13 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.981 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.513 HG22 ' O ' ' B' ' 26' ' ' ASP . 10.1 t -68.66 -37.93 80.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.672 HH11 ' HG2' ' B' ' 31' ' ' ARG . 19.0 ttp85 -63.67 -39.06 93.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.507 HG13 ' O ' ' B' ' 28' ' ' LEU . 30.2 m -75.36 -28.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.182 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.503 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 13.8 t70 -62.61 -55.11 30.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 18.7 pttt -70.7 -40.68 72.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.31 90.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.4 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.88 -34.84 78.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.086 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.54 94.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.421 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 56.0 p -78.48 -39.21 39.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -54.77 -64.6 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.101 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.563 ' HB1' HD22 ' C' ' 43' ' ' ASN . . . -54.46 -31.15 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.469 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -62.28 -48.65 78.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.822 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.4 OUTLIER -68.51 -32.76 72.95 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 2.3 m-20 -80.24 -15.02 57.93 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -17.56 64.8 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.081 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.778 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.8 mm? -76.5 156.17 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.38 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.613 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 7.9 tt0 72.22 108.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.929 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.523 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.8 Cg_endo -91.34 139.39 2.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.617 2.212 . . . . 0.0 112.516 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.0 m-85 69.1 154.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.58 75.35 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.227 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.84 HG12 ' HE2' ' B' ' 53' ' ' LYS . 11.7 p -95.59 -24.89 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 123.147 0.579 . . . . 0.0 112.467 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.801 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.11 48.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.277 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.84 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -145.12 179.61 7.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 110.634 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' B' ' 75' ' ' TYR . 11.4 p -105.12 145.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.606 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.589 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 0.9 OUTLIER -135.05 119.66 18.17 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 111.606 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.469 ' CE2' HD11 ' B' ' 71' ' ' ILE . 10.1 t80 -82.94 132.33 35.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.21 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.778 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 43.6 p -111.08 122.76 48.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.972 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.55 143.54 31.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.403 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.59 167.88 37.01 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.547 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.09 163.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 111.335 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -138.14 177.77 19.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.464 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.64 155.36 26.68 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.583 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.83 123.69 14.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.77 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 27.3 mtt-85 64.24 -94.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.044 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 68.8 p -130.74 6.35 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.136 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.437 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 30.3 t -104.53 174.31 5.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.93 177.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -161.45 153.91 20.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.538 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.5 HD12 ' N ' ' B' ' 70' ' ' ALA . 6.0 tp -117.26 132.04 56.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.822 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -138.84 136.13 35.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.689 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.469 HD11 ' CE2' ' B' ' 56' ' ' PHE . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 111.097 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.76 179.96 35.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.45 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.2 155.95 34.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.59 163.45 29.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.239 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.436 ' CD2' ' HB ' ' B' ' 54' ' ' VAL . 13.0 t80 -138.53 120.84 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.32 105.54 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.748 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.801 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.5 p -104.6 130.97 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.431 ' CG ' HG22 ' B' ' 77' ' ' VAL . 9.1 m-20 59.55 -174.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 111.109 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -118.18 68.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.7 p -160.04 -50.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.18 143.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 154.42 45.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.82 132.49 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.43 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.79 45.42 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.153 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.43 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.06 169.52 19.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.683 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 173.55 162.68 25.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.621 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.08 33.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.131 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -119.03 141.22 48.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.365 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.26 127.84 48.28 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.243 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.575 ' HB3' ' CB ' ' B' ' 94' ' ' ASP . . . -135.5 148.2 49.11 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.675 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.61 -98.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.334 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.14 -28.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.316 . . . . 0.0 111.32 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -121.53 15.29 11.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.161 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.575 ' CB ' ' HB3' ' B' ' 90' ' ' ALA . 38.1 m-20 -103.14 70.67 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.4 128.27 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.434 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.6 ptp -135.63 139.49 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.701 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.01 128.84 54.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.482 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -129.21 147.36 51.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 111.389 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.3 116.01 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.784 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 94.2 p -127.91 163.12 25.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.411 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.5 144.58 44.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.945 0.402 . . . . 0.0 111.088 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.45 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 21.5 m-80 -109.8 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 pt -131.46 126.62 58.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.846 0.355 . . . . 0.0 110.855 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.443 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 3.9 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.622 0.249 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 18' ' ' PHE . . . . . 0.424 ' O ' ' OD2' ' C' ' 22' ' ' ASP . 92.9 t80 -65.53 -32.35 73.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.247 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.04 -30.15 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.781 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.8 mt-30 -71.17 -33.88 70.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.452 HD21 ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -65.18 -48.27 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 22' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 15.8 m-20 -70.84 -20.42 62.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.053 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -74.85 -42.9 57.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.612 ' HB3' HD13 ' B' ' 25' ' ' LEU . 2.6 mmp_? -70.7 -48.77 52.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.618 HD13 ' HB3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -60.41 -41.71 94.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.676 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 26' ' ' ASP . . . . . 0.512 ' O ' HG22 ' C' ' 30' ' ' THR . 49.9 t0 -72.19 -28.83 63.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.781 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -75.97 -37.21 58.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.18 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' B' ' 25' ' ' LEU . 9.7 mt -76.18 -32.73 59.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 29' ' ' ASP . . . . . 0.454 ' O ' HG22 ' C' ' 32' ' ' VAL . 21.0 t0 -67.4 -48.49 67.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.945 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.512 HG22 ' O ' ' C' ' 26' ' ' ASP . 10.1 t -68.75 -37.89 79.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.862 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.675 HH11 ' HG2' ' C' ' 31' ' ' ARG . 18.9 ttp85 -63.74 -39.02 93.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.325 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.516 HG13 ' O ' ' C' ' 28' ' ' LEU . 29.9 m -75.31 -28.27 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.204 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.509 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 13.8 t70 -62.74 -55.08 29.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.945 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 18.7 pttt -70.64 -40.74 72.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.25 90.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.402 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.02 -34.68 78.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 111.096 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.84 -39.51 94.58 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.4 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.423 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 56.6 p -78.51 -39.27 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 35.9 t -54.7 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.405 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -54.55 -31.12 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.407 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 41' ' ' ALA . . . . . 0.452 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -62.33 -48.5 79.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.805 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.4 OUTLIER -68.61 -32.64 72.66 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.563 HD22 ' HB1' ' B' ' 40' ' ' ALA . 1.1 m120 -80.24 -15.15 57.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -17.59 64.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.144 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.773 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.8 mm? -76.56 156.14 33.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.877 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.27 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.651 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.582 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 7.9 tt0 72.11 108.78 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.019 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.9 Cg_endo -91.32 139.4 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.617 2.211 . . . . 0.0 112.565 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.1 m-85 69.13 154.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.027 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.57 75.35 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.243 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.828 HG12 ' HE2' ' C' ' 53' ' ' LYS . 11.7 p -95.51 -25.0 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.162 0.585 . . . . 0.0 112.44 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.822 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.17 48.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.316 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 53' ' ' LYS . . . . . 0.828 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.6 OUTLIER -145.02 179.69 7.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.595 0.236 . . . . 0.0 110.645 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 11.4 p -105.25 145.32 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.517 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.582 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 0.9 OUTLIER -135.06 119.61 18.09 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.971 0.415 . . . . 0.0 111.679 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 56' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' C' ' 71' ' ' ILE . 10.0 t80 -82.94 132.34 35.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.273 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.773 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.1 p -111.12 122.65 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 143.63 31.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.453 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.92 37.09 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 26.1 m -119.17 163.86 16.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 111.39 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 61' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -138.18 177.85 19.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.473 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.7 155.33 26.64 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.556 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.77 123.75 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.447 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 27.3 mtt-85 64.18 -93.97 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.038 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 68.3 p -130.76 6.39 4.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 66' ' ' SER . . . . . 0.422 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 30.6 t -104.57 174.41 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.08 177.07 7.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.116 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 68' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -161.49 153.91 20.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.58 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.498 HD12 ' H ' ' C' ' 70' ' ' ALA . 6.0 tp -117.23 131.96 56.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.795 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.805 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -138.73 136.18 35.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.637 0.256 . . . . 0.0 111.664 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.477 HD11 ' CE2' ' C' ' 56' ' ' PHE . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -155.3 155.96 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 110.965 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.66 163.42 29.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.262 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.0 t80 -138.51 120.86 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 105.64 14.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.822 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.5 p -104.64 130.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.441 ' CG ' HG22 ' C' ' 77' ' ' VAL . 9.2 m-20 59.49 -174.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.134 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.16 68.11 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.523 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 41.2 p -160.09 -50.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.986 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 143.51 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.3 154.43 45.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.897 0.38 . . . . 0.0 111.295 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.81 132.5 32.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.77 45.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 85' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.06 169.5 19.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.68 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 173.6 162.75 26.02 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.532 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.22 147.09 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -119.04 141.33 48.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.329 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.3 127.87 48.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' C' ' 94' ' ' ASP . . . -135.54 148.18 49.03 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.645 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.67 -98.67 0.02 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.322 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.19 -28.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 111.326 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -121.57 15.32 11.13 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.573 ' CB ' ' HB3' ' C' ' 90' ' ' ALA . 38.2 m-20 -103.14 70.58 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.38 128.24 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 110.709 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.444 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 1.6 ptp -135.63 139.54 43.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.696 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.03 128.87 54.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.433 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -129.25 147.36 51.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.366 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.37 115.96 5.88 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.718 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 93.9 p -127.85 163.11 25.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.57 144.51 44.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.008 0.432 . . . . 0.0 111.072 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.441 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 21.4 m-80 -109.69 131.87 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.382 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.487 HD12 ' HE1' ' C' ' 105' ' ' TRP . 1.6 pt -131.42 126.68 58.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.435 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 3.9 pt-20 -105.84 152.93 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.989 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 0.487 ' HE1' HD12 ' C' ' 103' ' ' ILE . 44.6 m95 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.7 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.642 0.258 . . . . 0.0 110.526 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.18 -32.88 74.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 31.2 mmt180 -76.38 -38.27 55.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.767 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 12.7 mt-30 -67.2 -30.87 70.93 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.191 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.579 ' HA ' HD11 ' C' ' 21' ' ' LEU . 0.6 OUTLIER -65.9 -56.08 13.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.589 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.9 -23.99 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 22.4 t-20 -67.16 -39.43 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 5.4 mmp_? -71.82 -48.11 48.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.777 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.64 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.6 OUTLIER -56.4 -52.21 65.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.65 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.713 ' O ' HG22 ' A' ' 30' ' ' THR . 33.6 t0 -64.31 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 26.6 tttm -71.76 -36.68 70.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.205 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 32' ' ' VAL . 3.5 mt -79.17 -33.6 43.85 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.18 96.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.941 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 26' ' ' ASP . 4.4 t -76.57 -40.64 49.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.879 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HG2' HH11 ' A' ' 31' ' ' ARG . 21.3 ttp85 -61.68 -40.99 96.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.277 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 28' ' ' LEU . 30.7 m -73.43 -29.04 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.598 ' OD1' ' HB2' ' A' ' 64' ' ' ARG . 17.8 t70 -62.92 -52.58 62.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 26.5 pttt -70.74 -39.55 73.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.738 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.89 97.33 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.427 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' B' ' 39' ' ' SER . 0.5 OUTLIER -66.74 -33.57 75.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 111.077 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -61.99 -43.06 99.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.457 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.741 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 79.3 p -75.22 -41.04 58.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.742 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.505 ' HB2' HD21 ' C' ' 36' ' ' LEU . 38.2 t -57.55 -62.11 2.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.17 48.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.467 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.84 -48.07 72.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.943 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.701 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -66.1 -32.83 74.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.9 m-20 -79.77 -12.6 59.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -14.82 63.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.137 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.844 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.5 mm? -76.55 156.81 32.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.888 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.13 -26.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.608 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 10.1 tt0 71.58 110.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.927 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -90.03 137.13 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.645 2.23 . . . . 0.0 112.549 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.9 m-85 64.64 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.953 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.34 75.43 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.638 HG12 ' HE2' ' A' ' 53' ' ' LYS . 12.8 p -95.11 -25.26 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.148 0.579 . . . . 0.0 112.415 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.88 48.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.313 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.638 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -143.44 -178.0 5.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.591 0.234 . . . . 0.0 110.643 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 8.2 p -106.17 145.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.587 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.608 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 1.4 t30 -134.88 122.69 22.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.499 ' CE2' HD11 ' A' ' 71' ' ' ILE . 11.5 t80 -85.76 132.86 34.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.235 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.844 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 33.7 p -113.22 125.22 54.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.016 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 71' ' ' ILE . . . -149.45 139.68 22.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.449 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.41 167.3 38.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.434 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.551 HG12 HD13 ' A' ' 69' ' ' LEU . 22.8 m -120.02 161.55 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.326 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.2 177.45 20.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.404 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.455 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -162.35 156.82 28.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.612 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.4 t80 -143.13 128.28 18.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.598 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 16.2 mtt-85 64.97 -91.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 p -135.63 6.1 3.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.522 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 19.3 t -105.18 168.38 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.4 179.29 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.138 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -164.78 150.54 10.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.571 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.551 HD13 HG12 ' A' ' 60' ' ' VAL . 12.5 tp -116.22 127.91 55.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.767 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -132.55 136.23 46.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.729 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 58' ' ' ALA . 10.6 tp -132.81 146.68 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.138 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -163.89 -179.44 38.18 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.407 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -154.65 152.04 29.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.257 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.5 t80 -132.57 122.03 24.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.228 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.34 101.84 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.752 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.5 p -103.56 136.31 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.37 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.943 0.401 . . . . 0.0 111.112 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.47 61.35 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.573 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.76 -44.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.8 p -122.32 141.35 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.258 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.8 134.86 32.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.406 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -139.74 138.16 35.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.406 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.38 167.93 23.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.506 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 171.41 163.67 25.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.96 145.44 35.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.897 0.38 . . . . 0.0 111.044 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -114.49 141.12 48.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.18 130.69 54.69 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.273 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . . . -139.63 145.25 38.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.596 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 52.19 -96.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.26 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -155.37 -30.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.731 0.3 . . . . 0.0 111.336 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -121.5 16.56 11.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.194 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 90' ' ' ALA . 41.6 m-20 -104.44 73.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.2 t -114.79 131.96 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.642 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.489 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 1.2 ptp -136.27 142.27 43.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.714 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -119.95 128.75 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.483 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -125.99 148.94 49.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.346 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.09 114.52 5.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.709 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.7 p -130.43 161.24 31.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.463 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -134.0 142.71 47.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.97 0.414 . . . . 0.0 111.072 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 20.7 m-80 -111.68 128.62 56.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.79 131.49 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.8 0.333 . . . . 0.0 110.796 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 5.4 pt-20 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.662 0.267 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.12 -32.94 74.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.311 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 31.2 mmt180 -76.4 -38.35 55.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.741 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 12.7 mt-30 -67.1 -30.88 71.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.973 0.416 . . . . 0.0 111.23 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.584 HD11 ' HA ' ' C' ' 21' ' ' LEU . 0.6 OUTLIER -65.88 -56.04 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -69.01 -23.91 64.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 22.3 t-20 -67.17 -39.43 86.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 5.4 mmp_? -71.84 -48.19 47.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.701 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.647 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.6 OUTLIER -56.31 -52.26 65.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.717 ' O ' HG22 ' B' ' 30' ' ' THR . 33.7 t0 -64.29 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.762 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.442 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 26.7 tttm -71.65 -36.83 70.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.603 0.239 . . . . 0.0 111.203 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.656 ' O ' HG13 ' B' ' 32' ' ' VAL . 3.5 mt -79.08 -33.69 44.31 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.46 -42.16 96.09 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.717 HG22 ' O ' ' B' ' 26' ' ' ASP . 4.5 t -76.59 -40.7 48.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.645 HH11 ' HG2' ' B' ' 31' ' ' ARG . 21.2 ttp85 -61.6 -41.05 96.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.656 HG13 ' O ' ' B' ' 28' ' ' LEU . 30.6 m -73.37 -29.11 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.161 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.606 ' OD1' ' HB2' ' B' ' 64' ' ' ARG . 17.8 t70 -62.85 -52.69 62.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 26.5 pttt -70.69 -39.5 73.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.755 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.65 -44.95 97.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.425 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' C' ' 39' ' ' SER . 0.5 OUTLIER -66.73 -33.59 75.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 111.054 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.442 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -61.93 -43.09 99.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.424 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.757 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 79.9 p -75.24 -40.95 58.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.77 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.498 ' HB2' HD21 ' A' ' 36' ' ' LEU . 38.4 t -57.63 -62.11 2.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.18 -30.2 48.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.433 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.615 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.86 -48.01 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.7 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.7 OUTLIER -66.2 -32.76 74.39 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.44 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 2.9 m-20 -79.8 -12.66 59.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -14.94 63.22 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.156 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.832 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.5 mm? -76.46 156.84 32.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.847 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.1 -26.93 0.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.17 0.509 . . . . 0.0 111.683 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.613 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 10.1 tt0 71.69 109.87 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.914 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -89.86 137.13 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.709 2.273 . . . . 0.0 112.547 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.9 m-85 64.57 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.957 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.35 75.41 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.242 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.641 HG12 ' HE2' ' B' ' 53' ' ' LYS . 12.7 p -95.04 -25.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.469 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.88 48.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.641 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -143.54 -178.05 5.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.517 ' HB ' ' CE2' ' B' ' 75' ' ' TYR . 8.3 p -106.08 145.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.589 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.613 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 1.4 t30 -134.95 122.61 22.15 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 111.658 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' B' ' 71' ' ' ILE . 11.6 t80 -85.65 132.8 34.09 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.309 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.832 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 33.8 p -113.18 125.27 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.004 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' B' ' 71' ' ' ILE . . . -149.56 139.64 22.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.439 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.33 38.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.526 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.534 HG12 HD13 ' B' ' 69' ' ' LEU . 22.6 m -120.04 161.58 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.786 0.327 . . . . 0.0 111.382 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.23 177.48 20.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.459 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' GLY . . . . . 0.442 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -162.34 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.562 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.49 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.4 t80 -143.13 128.22 18.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.66 0.267 . . . . 0.0 110.801 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.606 ' HB2' ' OD1' ' B' ' 33' ' ' ASP . 16.3 mtt-85 64.95 -91.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.087 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 p -135.64 6.09 3.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.524 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 19.4 t -105.2 168.36 9.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.33 179.36 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -164.87 150.48 9.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.539 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.534 HD13 HG12 ' B' ' 60' ' ' VAL . 12.3 tp -116.16 127.92 55.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.7 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -132.59 136.22 46.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.67 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' B' ' 58' ' ' ALA . 10.6 tp -132.81 146.74 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.119 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -163.87 -179.42 38.15 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.41 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 64.5 p -154.7 152.09 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.85 0.357 . . . . 0.0 111.043 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.64 156.91 27.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.25 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 13.7 t80 -132.59 122.06 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 101.93 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.688 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.745 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.5 p -103.49 136.36 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.3 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.142 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.46 61.27 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.568 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -159.65 -44.84 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.988 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -122.32 141.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 155.72 48.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.258 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.75 134.91 32.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.561 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.19 35.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.418 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.44 167.9 23.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.073 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.489 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 171.41 163.63 25.71 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.96 145.33 35.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -114.42 141.1 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.363 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.14 130.65 54.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.262 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . . . -139.69 145.25 38.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.562 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 52.25 -96.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.276 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.36 -30.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.339 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -121.51 16.44 11.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.565 ' HB2' ' HB3' ' B' ' 90' ' ' ALA . 41.6 m-20 -104.3 73.52 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 56.3 t -114.74 132.01 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.493 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.2 ptp -136.31 142.27 43.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -120.07 128.77 53.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.37 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -126.0 148.87 49.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.401 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.06 114.51 5.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.709 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 53.7 p -130.42 161.27 31.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.48 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -134.0 142.65 47.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.111 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.553 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 20.4 m-80 -111.59 128.65 56.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.443 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 110.784 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.503 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 5.4 pt-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.688 0.28 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -63.17 -32.98 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 31.2 mmt180 -76.37 -38.28 56.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 12.7 mt-30 -67.26 -30.78 70.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.584 ' HA ' HD11 ' B' ' 21' ' ' LEU . 0.6 OUTLIER -65.95 -56.04 13.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.564 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 -23.98 64.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 22.3 t-20 -67.17 -39.43 86.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' C' ' 20' ' ' GLN . 5.4 mmp_? -71.81 -48.18 48.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.788 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.627 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -56.3 -52.28 65.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 26' ' ' ASP . . . . . 0.702 ' O ' HG22 ' C' ' 30' ' ' THR . 33.5 t0 -64.23 -28.01 69.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.818 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -71.62 -36.8 70.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.248 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.664 ' O ' HG13 ' C' ' 32' ' ' VAL . 3.5 mt -79.11 -33.66 44.16 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.14 96.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.921 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.702 HG22 ' O ' ' C' ' 26' ' ' ASP . 4.5 t -76.55 -40.72 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.864 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.663 HH11 ' HG2' ' C' ' 31' ' ' ARG . 21.3 ttp85 -61.64 -41.0 96.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.664 HG13 ' O ' ' C' ' 28' ' ' LEU . 30.7 m -73.4 -29.09 26.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.599 ' OD1' ' HB2' ' C' ' 64' ' ' ARG . 17.8 t70 -62.77 -52.65 62.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.027 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 26.5 pttt -70.78 -39.44 73.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.94 97.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.386 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.505 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.5 OUTLIER -66.68 -33.71 76.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.457 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -61.77 -43.16 99.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.745 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 79.7 p -75.23 -41.02 58.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.488 ' HB2' HD21 ' B' ' 36' ' ' LEU . 38.0 t -57.51 -62.17 1.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.18 48.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.443 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' ALA . . . . . 0.609 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.81 -48.01 73.14 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.701 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.7 OUTLIER -66.18 -32.85 74.53 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 2.8 m-20 -79.71 -12.66 59.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -14.85 63.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.17 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.821 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.5 mm? -76.49 156.86 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.869 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.15 -26.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.206 0.527 . . . . 0.0 111.706 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 10.1 tt0 71.5 109.91 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.021 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -89.94 137.19 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.554 2.169 . . . . 0.0 112.59 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.8 m-85 64.6 152.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.39 75.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.228 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.635 HG12 ' HE2' ' C' ' 53' ' ' LYS . 12.6 p -94.94 -25.27 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.18 0.592 . . . . 0.0 112.509 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.91 48.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.298 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 53' ' ' LYS . . . . . 0.635 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.4 OUTLIER -143.52 -178.07 5.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.585 0.231 . . . . 0.0 110.608 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.516 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 8.2 p -106.16 145.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.557 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.589 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 1.4 t30 -134.88 122.72 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 56' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' C' ' 71' ' ' ILE . 11.7 t80 -85.74 132.89 34.05 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.172 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.821 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 33.5 p -113.29 125.27 54.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.895 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.52 ' HB2' ' CD1' ' C' ' 71' ' ' ILE . . . -149.57 139.67 22.11 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.4 38.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.545 HG12 HD13 ' C' ' 69' ' ' LEU . 22.6 m -120.12 161.57 19.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 111.33 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 61' ' ' GLY . . . . . 0.609 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.22 177.47 20.29 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.418 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 62' ' ' GLY . . . . . 0.457 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -162.33 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.4 t80 -143.09 128.29 18.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.686 0.279 . . . . 0.0 110.746 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.599 ' HB2' ' OD1' ' C' ' 33' ' ' ASP . 16.3 mtt-85 64.94 -91.07 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.096 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.0 p -135.59 6.15 3.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.227 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 66' ' ' SER . . . . . 0.517 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 19.4 t -105.26 168.4 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.778 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.41 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 68' ' ' ALA . . . . . 0.745 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -164.83 150.47 9.97 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.556 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.545 HD13 HG12 ' C' ' 60' ' ' VAL . 12.4 tp -116.17 127.9 55.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.701 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -132.63 136.19 46.34 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' C' ' 58' ' ' ALA . 10.6 tp -132.74 146.75 32.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.732 0.301 . . . . 0.0 111.134 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -163.9 -179.39 38.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.435 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.4 p -154.71 152.0 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 111.056 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.26 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.516 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.7 t80 -132.64 122.05 24.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 111.128 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' C' ' 76' ' ' ARG . 0.0 OUTLIER -111.41 101.83 10.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.732 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.5 p -103.46 136.36 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 63.3 -171.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.391 . . . . 0.0 111.089 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.55 61.35 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.72 -44.77 0.05 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.33 141.37 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.69 155.78 47.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.74 134.85 32.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.539 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.412 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.21 35.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.157 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 85' ' ' ALA . . . . . 0.412 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.45 167.86 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.499 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 171.49 163.65 25.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.574 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.87 145.41 35.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.137 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -114.5 141.14 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.347 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 130.69 54.71 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.288 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' C' ' 94' ' ' ASP . . . -139.68 145.21 38.11 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.595 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 52.28 -96.33 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.258 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.38 -30.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.281 . . . . 0.0 111.296 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.6 p -121.42 16.45 11.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.239 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.568 ' HB2' ' HB3' ' C' ' 90' ' ' ALA . 41.5 m-20 -104.39 73.54 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -114.79 132.03 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 0.0 110.636 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.49 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 1.2 ptp -136.33 142.2 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.642 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.96 128.72 53.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -125.95 148.84 49.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.299 . . . . 0.0 111.419 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.05 114.5 5.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.829 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 53.6 p -130.44 161.21 31.89 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.393 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -133.95 142.65 47.78 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.917 0.389 . . . . 0.0 111.113 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.571 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 20.9 m-80 -111.6 128.68 56.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.462 HD12 ' HE1' ' C' ' 105' ' ' TRP . 3.0 pt -130.79 131.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.743 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.511 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 5.4 pt-20 -112.63 154.92 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 0.462 ' HE1' HD12 ' C' ' 103' ' ' ILE . 31.0 m95 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.706 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.667 0.27 . . . . 0.0 110.57 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 24.9 mmt180 -76.8 -36.88 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.725 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.637 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.6 mt-30 -67.5 -32.94 74.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.799 HD21 ' HG3' ' B' ' 24' ' ' ARG . 1.4 tt -68.6 -55.84 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.558 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.13 -25.46 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 24.6 t-20 -71.76 -42.48 67.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.79 ' HG3' HD21 ' C' ' 21' ' ' LEU . 3.7 mmp_? -69.27 -45.28 70.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.814 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 HD11 ' B' ' 28' ' ' LEU . 1.9 tp -56.29 -49.09 75.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.562 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 30' ' ' THR . 33.3 t0 -64.79 -32.08 73.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 27.2 tttm -69.98 -32.89 71.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.26 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.754 HD11 HD12 ' C' ' 25' ' ' LEU . 1.7 mt -81.06 -32.37 34.04 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.69 -40.21 88.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.017 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 26' ' ' ASP . 4.3 t -76.73 -39.34 52.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.492 HH22 HG21 ' C' ' 32' ' ' VAL . 43.6 ttp85 -59.46 -41.81 90.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 28' ' ' LEU . 27.2 m -78.29 -23.6 13.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.204 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.479 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 18.6 t70 -67.63 -51.54 48.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' NZ ' ' HA3' ' A' ' 91' ' ' GLY . 32.7 pttt -76.38 -40.28 51.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.93 98.75 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -67.09 -33.9 76.47 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.882 0.372 . . . . 0.0 111.156 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.17 99.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.457 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.753 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 94.4 p -76.29 -37.31 57.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.637 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 33.0 t -63.73 -55.01 26.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.98 -32.1 69.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.51 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -64.88 -46.47 81.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.955 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -66.22 -30.39 70.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.3 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.584 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 9.7 m-20 -81.36 -15.71 54.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.46 -15.04 62.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.112 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.737 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.9 mm? -71.39 164.52 25.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.911 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 25.0 p90 -152.55 -32.02 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.148 0.499 . . . . 0.0 111.701 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 15.3 tt0 73.53 106.71 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.96 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -93.07 136.34 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.628 2.219 . . . . 0.0 112.552 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 10.6 m-85 65.52 151.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 178.62 78.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.235 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.31 -23.28 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.206 0.603 . . . . 0.0 112.411 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 157.5 49.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.278 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 52' ' ' GLY . 0.5 OUTLIER -146.65 -176.73 5.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.605 0.24 . . . . 0.0 110.563 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.22 150.57 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.568 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.529 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 2.2 t30 -132.91 124.37 27.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.66 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 71' ' ' ILE . 24.1 t80 -87.18 128.17 35.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.319 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.737 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 38.2 p -114.71 123.08 48.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.047 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.29 136.78 18.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.451 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.05 44.35 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.582 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.424 HG12 HD13 ' A' ' 69' ' ' LEU . 16.4 m -126.9 166.98 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.801 0.334 . . . . 0.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -141.35 172.32 23.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.44 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.47 152.36 23.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.547 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.3 t80 -142.44 128.68 19.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.686 0.279 . . . . 0.0 110.737 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.36 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 p -140.35 10.07 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.479 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 9.8 t -109.6 167.6 10.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.67 -179.09 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -167.19 156.46 10.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.526 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.424 HD13 HG12 ' A' ' 60' ' ' VAL . 7.6 tp -114.58 130.97 56.83 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -129.62 141.43 50.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.682 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.666 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 7.9 tp -138.14 150.38 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.092 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.437 ' N ' HG13 ' A' ' 71' ' ' ILE . . . -169.28 177.41 42.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.395 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.6 146.4 18.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.25 158.41 27.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.528 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 30.9 t80 -126.3 125.02 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.154 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.504 ' NH2' ' HB2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -113.1 102.71 10.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.607 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.0 p -104.41 138.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 59.88 -167.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -126.59 66.08 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.451 ' HA ' ' HG3' ' A' ' 104' ' ' GLU . 19.9 p -165.4 -46.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.986 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.24 139.86 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.49 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.46 45.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.293 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.16 138.91 33.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.638 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.124 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.34 169.75 17.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.103 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.413 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 172.04 157.62 14.33 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.507 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.05 144.89 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 111.079 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -112.57 142.43 45.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.99 122.89 39.63 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.31 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -137.34 147.3 45.47 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.6 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.457 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 57.03 -94.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.276 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 t -159.4 -33.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 111.357 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.77 13.83 12.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 32.6 m-20 -101.85 72.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.969 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 t -116.08 127.05 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.987 0.423 . . . . 0.0 110.759 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 39' ' ' SER . 1.3 ptp -131.85 140.2 49.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.681 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -121.55 126.69 49.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -128.42 141.51 51.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.83 117.21 8.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.781 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.49 162.13 27.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.452 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.06 133.52 50.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.103 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.542 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 28.7 m-80 -108.38 127.86 54.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.458 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.74 138.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.77 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 80' ' ' SER . 4.6 pt-20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.684 0.278 . . . . 0.0 110.566 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.45 -29.86 70.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.259 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 24.9 mmt180 -76.74 -36.89 56.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.633 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.6 mt-30 -67.46 -32.96 74.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.786 HD21 ' HG3' ' C' ' 24' ' ' ARG . 1.4 tt -68.61 -55.77 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.15 -25.44 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 24.6 t-20 -71.79 -42.54 66.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.799 ' HG3' HD21 ' A' ' 21' ' ' LEU . 3.7 mmp_? -69.3 -45.25 70.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.782 HD12 HD11 ' C' ' 28' ' ' LEU . 1.9 tp -56.36 -49.06 75.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.582 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.618 ' O ' HG22 ' B' ' 30' ' ' THR . 33.3 t0 -64.73 -32.08 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.814 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.615 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 27.2 tttm -70.02 -32.9 71.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.237 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.777 HD11 HD12 ' A' ' 25' ' ' LEU . 1.7 mt -81.05 -32.34 34.08 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.7 -40.29 88.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.936 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.618 HG22 ' O ' ' B' ' 26' ' ' ASP . 4.3 t -76.68 -39.38 52.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.814 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.493 HH22 HG21 ' A' ' 32' ' ' VAL . 43.4 ttp85 -59.31 -41.91 90.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.336 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.523 HG22 ' O ' ' B' ' 28' ' ' LEU . 27.2 m -78.28 -23.63 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.157 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' B' ' 66' ' ' SER . 18.6 t70 -67.6 -51.59 48.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.986 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.46 ' NZ ' ' HA3' ' B' ' 91' ' ' GLY . 32.7 pttt -76.28 -40.41 51.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.792 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.21 -43.92 98.77 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.5 OUTLIER -67.14 -33.87 76.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.13 99.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.47 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.75 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 94.5 p -76.33 -37.33 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.758 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.628 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 32.7 t -63.76 -54.97 27.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.0 69.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.517 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -64.83 -46.59 81.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.612 HD13 ' O ' ' B' ' 42' ' ' LEU . 0.6 OUTLIER -66.05 -30.49 71.02 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 9.7 m-20 -81.39 -15.64 54.59 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -15.11 62.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.073 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.744 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.9 mm? -71.4 164.59 25.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.837 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 24.9 p90 -152.58 -32.08 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.15 0.5 . . . . 0.0 111.625 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.536 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 15.4 tt0 73.49 106.61 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.0 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -93.02 136.32 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.668 2.245 . . . . 0.0 112.52 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 10.6 m-85 65.56 151.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 178.57 78.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.264 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.22 -23.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 123.108 0.563 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 157.54 49.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.299 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' B' ' 52' ' ' GLY . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.31 150.59 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.543 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.536 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 2.2 t30 -132.94 124.34 27.62 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.981 0.42 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.68 ' CZ ' HD11 ' B' ' 71' ' ' ILE . 24.4 t80 -87.21 128.23 35.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.224 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.744 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.7 p -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.965 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.3 136.76 18.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.366 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.07 44.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.572 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.427 HG12 HD13 ' B' ' 69' ' ' LEU . 16.4 m -126.89 166.96 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.377 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -141.32 172.34 23.87 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.451 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.51 152.42 23.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.3 t80 -142.53 128.6 19.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 0.0 110.716 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 63.47 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.083 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 34.8 p -140.37 10.17 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.224 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.482 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 9.8 t -109.63 167.63 10.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.72 -179.13 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -167.13 156.59 10.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.532 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.427 HD13 HG12 ' B' ' 60' ' ' VAL . 7.6 tp -114.66 130.95 56.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.777 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.568 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -129.66 141.45 50.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.68 HD11 ' CZ ' ' B' ' 56' ' ' PHE . 7.9 tp -138.16 150.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.77 0.319 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.439 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -169.14 177.43 42.86 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.55 146.51 18.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.31 158.37 27.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.254 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.528 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 30.8 t80 -126.3 125.01 41.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.491 ' NH2' ' HB2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.09 102.68 10.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.663 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.602 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.1 p -104.36 138.3 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.95 -167.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -126.58 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.447 ' HA ' ' HG3' ' B' ' 104' ' ' GLU . 20.1 p -165.47 -46.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.955 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.2 139.88 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.557 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.15 155.48 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.273 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.21 138.86 33.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.36 169.78 17.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.082 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 171.99 157.58 14.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.587 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.08 144.85 32.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -112.55 142.46 45.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.323 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.05 122.9 39.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -137.35 147.23 45.38 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.585 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.46 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 57.16 -94.64 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.252 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.1 t -159.37 -33.83 0.06 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.735 0.303 . . . . 0.0 111.312 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -119.75 13.87 12.47 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 32.6 m-20 -101.86 72.2 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -116.02 127.11 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.029 0.442 . . . . 0.0 110.712 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' B' ' 39' ' ' SER . 1.3 ptp -131.98 140.16 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -121.51 126.6 49.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.406 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -128.35 141.46 51.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.487 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.71 117.27 8.61 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.58 162.11 28.03 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.446 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -127.03 133.52 50.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.951 0.405 . . . . 0.0 111.079 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 28.7 m-80 -108.41 127.78 54.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.365 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.65 138.13 53.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.795 0.331 . . . . 0.0 110.827 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.447 ' HG3' ' HA ' ' B' ' 80' ' ' SER . 4.6 pt-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.648 0.261 . . . . 0.0 110.524 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.279 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 24.8 mmt180 -76.73 -36.96 56.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.63 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.6 mt-30 -67.48 -32.91 74.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.16 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.79 HD21 ' HG3' ' A' ' 24' ' ' ARG . 1.4 tt -68.54 -55.86 10.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -66.15 -25.5 66.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 24.5 t-20 -71.72 -42.51 67.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.786 ' HG3' HD21 ' B' ' 21' ' ' LEU . 3.7 mmp_? -69.26 -45.29 70.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 28' ' ' LEU . 1.9 tp -56.32 -49.09 75.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.581 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 26' ' ' ASP . . . . . 0.6 ' O ' HG22 ' C' ' 30' ' ' THR . 33.3 t0 -64.77 -32.06 73.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.787 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.564 ' HZ2' HD11 ' B' ' 25' ' ' LEU . 27.2 tttm -69.97 -32.96 71.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.253 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.782 HD11 HD12 ' B' ' 25' ' ' LEU . 1.7 mt -81.0 -32.4 34.24 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.76 -40.19 88.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.94 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.6 HG22 ' O ' ' C' ' 26' ' ' ASP . 4.4 t -76.66 -39.29 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.899 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.495 HH22 HG21 ' B' ' 32' ' ' VAL . 43.5 ttp85 -59.51 -41.83 90.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.289 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.513 HG22 ' O ' ' C' ' 28' ' ' LEU . 27.3 m -78.36 -23.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' C' ' 66' ' ' SER . 18.6 t70 -67.51 -51.53 49.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.062 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' C' ' 30' ' ' THR . 32.6 pttt -76.46 -40.3 50.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.755 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.91 98.78 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.43 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.5 OUTLIER -67.1 -34.01 76.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.24 99.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.475 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.765 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 95.1 p -76.27 -37.38 57.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.641 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 33.1 t -63.72 -54.88 28.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.15 -32.03 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 41' ' ' ALA . . . . . 0.504 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -64.86 -46.59 81.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.628 ' O ' HD13 ' C' ' 42' ' ' LEU . 0.6 OUTLIER -66.12 -30.37 70.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.072 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 43' ' ' ASN . 9.6 m-20 -81.39 -15.73 54.35 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -14.95 62.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.159 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.751 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.9 mm? -71.52 164.56 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.89 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 24.8 p90 -152.55 -32.03 0.14 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.129 0.49 . . . . 0.0 111.705 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.531 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 15.4 tt0 73.49 106.64 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.974 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -92.93 136.31 1.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.647 2.231 . . . . 0.0 112.546 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 10.7 m-85 65.61 151.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 178.62 78.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.266 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.212 0.605 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 157.55 49.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.321 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 53' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' C' ' 52' ' ' GLY . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.604 0.24 . . . . 0.0 110.579 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.27 150.62 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.613 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.531 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 2.2 t30 -132.99 124.28 27.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 111.686 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 56' ' ' PHE . . . . . 0.68 ' CZ ' HD11 ' C' ' 71' ' ' ILE . 24.3 t80 -87.15 128.26 35.13 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.223 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.751 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 38.1 p -114.82 123.17 48.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.97 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.31 136.66 18.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.474 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.21 176.99 44.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.554 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.414 HG12 HD13 ' C' ' 69' ' ' LEU . 16.4 m -126.87 166.91 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.315 . . . . 0.0 111.418 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 61' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -141.25 172.41 23.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.518 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.6 152.33 23.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.587 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.3 t80 -142.46 128.62 19.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.751 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.41 -86.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.6 p -140.38 10.1 2.29 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 66' ' ' SER . . . . . 0.471 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 9.7 t -109.57 167.67 9.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.76 -179.08 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 111.104 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 68' ' ' ALA . . . . . 0.765 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -167.23 156.51 10.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.541 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.414 HD13 HG12 ' C' ' 60' ' ' VAL . 7.6 tp -114.62 130.87 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.762 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.553 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -129.55 141.49 50.96 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.721 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.68 HD11 ' CZ ' ' C' ' 56' ' ' PHE . 7.9 tp -138.15 150.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.816 0.341 . . . . 0.0 111.065 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.456 ' N ' HG13 ' C' ' 71' ' ' ILE . . . -169.27 177.42 42.94 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.476 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -158.61 146.47 18.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 110.976 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.26 158.38 27.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.255 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.535 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 30.7 t80 -126.27 125.03 41.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.501 ' NH2' ' HB2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -113.12 102.77 10.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.0 p -104.48 138.3 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.9 -167.39 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -126.62 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.518 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 80' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' C' ' 104' ' ' GLU . 20.1 p -165.43 -46.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.009 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.2 139.77 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.575 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.48 45.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.302 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.25 138.81 33.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.558 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -145.43 132.57 20.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.15 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.31 169.77 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 172.08 157.58 14.27 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.564 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.12 144.85 32.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 111.098 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -112.46 142.44 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.334 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.08 122.95 39.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -137.3 147.36 45.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.64 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 56.92 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.331 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.3 t -159.37 -33.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.714 0.292 . . . . 0.0 111.338 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.78 13.85 12.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.162 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 32.5 m-20 -101.91 72.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.03 127.15 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.629 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.641 ' SD ' ' HB2' ' C' ' 39' ' ' SER . 1.3 ptp -131.91 140.13 48.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.684 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -121.45 126.7 49.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.402 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -128.4 141.52 51.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.38 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.82 117.24 8.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.53 162.19 27.82 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.474 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.12 133.53 50.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.0 111.084 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.533 ' OD1' HG22 ' B' ' 57' ' ' THR . 28.5 m-80 -108.4 127.84 54.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.345 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.489 HD12 ' HE1' ' C' ' 105' ' ' TRP . 0.7 OUTLIER -131.67 138.0 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.821 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' C' ' 80' ' ' SER . 4.7 pt-20 -112.56 147.02 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 0.489 ' HE1' HD12 ' C' ' 103' ' ' ILE . 40.0 m95 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.491 ' HZ2' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.609 0.242 . . . . 0.0 110.514 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -62.6 -41.13 98.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.245 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 34.5 mmt180 -73.7 -30.43 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -71.66 -34.47 69.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.9 HD12 HD12 ' C' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.61 63.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.633 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.85 -25.51 64.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.041 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 6.2 t-20 -66.43 -37.26 84.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.551 ' HD3' ' HB2' ' C' ' 25' ' ' LEU . 6.3 mmp_? -71.02 -44.8 65.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.655 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.3 OUTLIER -61.11 -32.66 72.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.608 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 30' ' ' THR . 56.6 t0 -81.78 -28.3 33.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -73.16 -43.28 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.67 0.272 . . . . 0.0 111.217 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.642 HD11 ' HA ' ' C' ' 25' ' ' LEU . 11.4 mt -72.05 -29.01 63.73 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.78 -47.41 72.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.961 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 26' ' ' ASP . 2.5 t -71.0 -33.81 70.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.869 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.503 ' NH2' HG21 ' C' ' 32' ' ' VAL . 45.2 ttp85 -67.71 -40.11 84.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 28' ' ' LEU . 33.8 m -76.09 -29.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.669 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 7.2 t70 -62.42 -57.25 11.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.053 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 30' ' ' THR . 26.8 pttt -70.26 -44.58 68.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.756 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.3 82.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.439 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.468 HD12 HD11 ' C' ' 36' ' ' LEU . 0.4 OUTLIER -71.1 -26.32 62.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.819 0.342 . . . . 0.0 111.097 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.69 -37.68 85.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.402 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 52.3 p -82.96 -38.75 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.688 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.471 ' HB2' HD21 ' C' ' 36' ' ' LEU . 31.0 t -57.39 -57.2 13.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -32.54 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.578 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -62.31 -45.31 93.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.689 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -66.14 -32.8 74.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.043 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 0.7 OUTLIER -82.83 -15.82 50.09 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.623 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.64 -17.75 64.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.135 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.769 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.4 mm? -75.41 162.66 28.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.812 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.534 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 45.1 p90 -143.83 -30.46 0.48 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 111.706 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.452 ' CG ' ' HB3' ' A' ' 55' ' ' ASN . 15.8 tt0 72.03 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.983 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.7 Cg_endo -89.13 140.6 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.693 2.262 . . . . 0.0 112.52 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 18.2 m-85 67.01 150.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.474 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -173.94 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.329 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.02 -19.41 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.154 0.582 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 148.44 48.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.294 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.09 4.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.674 0.273 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.35 137.94 40.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.582 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' B' ' 104' ' ' GLU . 6.5 t30 -125.95 119.7 28.42 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.02 0.438 . . . . 0.0 111.686 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.732 ' CZ ' HD11 ' A' ' 71' ' ' ILE . 17.9 t80 -80.3 128.35 33.44 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.269 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.769 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 16.7 p -114.29 119.86 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB2' HD12 ' A' ' 71' ' ' ILE . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.498 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -176.96 166.77 37.69 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.573 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.46 HG12 HD13 ' A' ' 69' ' ' LEU . 29.5 m -110.28 165.12 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.843 0.354 . . . . 0.0 111.316 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.15 176.09 21.2 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.396 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.31 27.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.669 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.72 123.33 14.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.592 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 33.3 mtt-85 65.75 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 p -137.59 12.91 2.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.7 t -109.34 173.15 6.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.35 177.21 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.111 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.72 161.19 23.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 60' ' ' VAL . 7.7 tp -119.6 136.24 54.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.713 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.689 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -136.43 137.94 40.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.638 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 8.3 tp -138.09 145.77 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 111.135 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -172.55 -175.34 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.452 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.11 158.36 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.776 0.322 . . . . 0.0 111.046 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.48 28.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.294 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -129.31 119.02 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 111.135 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.603 ' HD3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -105.82 104.0 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.739 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.731 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 10.8 p -101.9 126.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 63.86 -171.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -118.25 58.34 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.557 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.051 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.719 ' HA ' HG22 ' A' ' 103' ' ' ILE . 6.3 p -112.33 143.45 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.513 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . . . -146.64 151.78 37.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.36 132.61 35.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.578 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.17 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.64 171.33 18.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.097 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 167.5 157.31 10.66 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.56 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 111.141 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.28 151.9 30.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.315 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.33 126.89 38.27 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.276 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -140.89 145.57 36.32 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.614 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 55.18 -98.54 0.05 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.275 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 -25.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 111.311 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.96 12.92 7.28 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 33.8 m-20 -98.91 69.26 1.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.09 127.04 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.716 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.642 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 5.3 ptp -133.04 147.1 52.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.702 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -126.19 130.88 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.447 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -128.08 137.85 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 111.383 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.24 109.5 7.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.773 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.448 ' HA ' ' HA3' ' C' ' 59' ' ' GLY . 91.5 p -125.24 163.47 22.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.472 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.05 140.27 50.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.963 0.411 . . . . 0.0 111.111 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.678 ' OD1' HG22 ' C' ' 57' ' ' THR . 45.2 m-80 -111.76 125.59 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.719 HG22 ' HA ' ' A' ' 81' ' ' VAL . 3.3 pt -136.67 134.43 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' C' ' 55' ' ' ASN . 6.6 pt-20 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.498 ' HZ3' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.648 0.261 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -62.57 -41.09 98.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.304 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 34.5 mmt180 -73.75 -30.39 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -71.66 -34.5 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.59 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.604 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.81 -25.57 64.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 6.2 t-20 -66.29 -37.41 85.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.537 ' HD3' ' HB2' ' A' ' 25' ' ' LEU . 6.3 mmp_? -71.05 -44.61 65.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.65 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.3 OUTLIER -61.33 -32.52 72.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.565 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.616 ' O ' HG22 ' B' ' 30' ' ' THR . 56.6 t0 -81.82 -28.35 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.79 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.21 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 25' ' ' LEU . 11.5 mt -72.1 -28.95 63.63 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.83 -47.42 72.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.909 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.616 HG22 ' O ' ' B' ' 26' ' ' ASP . 2.5 t -71.01 -33.79 70.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.81 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.506 ' NH2' HG21 ' A' ' 32' ' ' VAL . 45.3 ttp85 -67.74 -40.1 84.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.585 HG13 ' O ' ' B' ' 28' ' ' LEU . 33.8 m -76.15 -29.44 19.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.256 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.681 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 7.2 t70 -62.62 -57.28 11.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' B' ' 30' ' ' THR . 26.8 pttt -70.13 -44.68 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -45.33 81.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.46 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -71.07 -26.36 63.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 111.075 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.53 -37.8 85.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.418 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' B' ' 90' ' ' ALA . 52.3 p -82.92 -38.76 22.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.453 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 30.8 t -57.27 -57.33 13.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.56 68.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.573 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -62.18 -45.46 93.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.919 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.679 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.3 OUTLIER -66.07 -32.79 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.077 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 0.7 OUTLIER -82.88 -15.72 50.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.652 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.76 -17.72 64.42 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.144 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.767 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -75.39 162.71 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.94 -30.38 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.464 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 15.7 tt0 72.04 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.0 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.7 Cg_endo -89.15 140.66 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.626 2.217 . . . . 0.0 112.514 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.487 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 18.2 m-85 67.05 150.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . -173.97 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.308 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.01 -19.45 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.159 0.584 . . . . 0.0 112.473 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 148.45 48.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.3 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.07 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.552 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.41 137.95 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' C' ' 104' ' ' GLU . 6.5 t30 -125.84 119.71 28.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 111.706 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.743 ' CZ ' HD11 ' B' ' 71' ' ' ILE . 17.7 t80 -80.3 128.4 33.5 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.201 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.767 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 16.7 p -114.32 119.79 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.99 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' B' ' 71' ' ' ILE . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.456 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -176.91 166.76 37.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.532 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.457 HG12 HD13 ' B' ' 69' ' ' LEU . 29.6 m -110.38 165.1 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.307 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.573 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.05 176.09 21.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.403 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.0 156.28 27.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.549 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.681 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.66 123.25 14.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' ARG . . . . . 0.599 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 33.5 mtt-85 65.78 -88.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.063 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 64.8 p -137.56 12.89 2.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.22 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -109.33 173.14 6.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.25 177.22 7.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.123 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.71 161.14 23.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.607 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.457 HD13 HG12 ' B' ' 60' ' ' VAL . 7.8 tp -119.5 136.21 54.43 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.679 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -136.48 137.82 40.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' B' ' 56' ' ' PHE . 8.3 tp -137.99 145.79 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.085 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -172.58 -175.37 40.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.463 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.6 p -164.07 158.37 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.17 159.58 28.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.3 118.98 23.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.605 ' HD3' ' HB2' ' B' ' 82' ' ' ALA . 0.0 OUTLIER -105.84 104.03 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.712 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 10.8 p -101.91 126.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.293 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.76 -171.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -118.21 58.32 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.97 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.721 ' HA ' HG22 ' B' ' 103' ' ' ILE . 6.3 p -112.37 143.43 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.605 ' HB2' ' HD3' ' B' ' 76' ' ' ARG . . . -146.7 151.72 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 111.231 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 44.9 tp -136.36 132.57 35.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.623 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.21 47.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.34 18.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.444 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 167.45 157.33 10.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.509 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.167 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.91 30.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.339 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.39 126.81 37.97 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.311 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -140.85 145.61 36.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.581 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 55.17 -98.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.27 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.37 -25.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.725 0.298 . . . . 0.0 111.287 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 92.3 p -126.95 12.88 7.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 33.8 m-20 -98.93 69.27 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.09 127.01 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.059 0.457 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.644 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 5.3 ptp -133.02 147.14 52.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.744 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -126.24 130.85 51.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.388 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -128.02 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.699 0.285 . . . . 0.0 111.449 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.11 109.46 7.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.811 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.45 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . 91.5 p -125.18 163.56 22.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.435 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -131.09 140.2 49.98 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.085 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.685 ' OD1' HG22 ' A' ' 57' ' ' THR . 45.1 m-80 -111.72 125.54 54.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.378 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.721 HG22 ' HA ' ' B' ' 81' ' ' VAL . 3.3 pt -136.66 134.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.824 0.345 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 6.6 pt-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.521 ' HZ3' HD13 ' B' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.663 0.268 . . . . 0.0 110.571 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 18' ' ' PHE . . . . . 0.491 ' HA ' ' HZ2' ' A' ' 17' ' ' LYS . 73.8 t80 -62.63 -41.12 98.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 19' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 34.6 mmt180 -73.76 -30.29 62.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.813 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -71.74 -34.47 69.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 21' ' ' LEU . . . . . 0.9 HD12 HD12 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -63.97 -51.67 63.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.57 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.77 -25.59 64.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 6.1 t-20 -66.29 -37.4 85.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' B' ' 25' ' ' LEU . 6.3 mmp_? -70.96 -44.8 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.642 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -61.24 -32.48 72.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 26' ' ' ASP . . . . . 0.607 ' O ' HG22 ' C' ' 30' ' ' THR . 56.6 t0 -81.9 -28.3 32.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.27 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' B' ' 25' ' ' LEU . 11.4 mt -72.08 -29.03 63.71 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.68 -47.39 72.58 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.978 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.607 HG22 ' O ' ' C' ' 26' ' ' ASP . 2.5 t -71.15 -33.7 70.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.792 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.499 ' NH2' HG21 ' B' ' 32' ' ' VAL . 45.4 ttp85 -67.8 -40.09 83.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.361 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.598 HG13 ' O ' ' C' ' 28' ' ' LEU . 33.7 m -76.11 -29.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.233 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 33' ' ' ASP . . . . . 0.666 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 7.2 t70 -62.47 -57.38 11.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.017 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' C' ' 30' ' ' THR . 26.8 pttt -70.11 -44.65 68.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.797 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.93 -45.33 81.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.4 OUTLIER -71.15 -26.3 62.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.762 0.315 . . . . 0.0 111.067 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.55 -37.8 85.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.441 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' C' ' 90' ' ' ALA . 52.3 p -82.91 -38.77 22.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.689 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 39' ' ' SER . . . . . 0.461 ' HB2' HD21 ' B' ' 36' ' ' LEU . 30.8 t -57.22 -57.35 12.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 111.089 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.52 68.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 41' ' ' ALA . . . . . 0.565 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -62.31 -45.29 93.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.956 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.696 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.3 OUTLIER -66.18 -32.77 74.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.061 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.58 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.1 m-20 -82.85 -15.8 50.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.74 -17.74 64.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.073 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.755 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -75.36 162.74 28.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.857 177.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.96 -30.38 0.48 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.092 0.472 . . . . 0.0 111.712 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.458 ' CG ' ' HB3' ' C' ' 55' ' ' ASN . 15.7 tt0 72.11 104.32 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.996 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.8 Cg_endo -89.16 140.59 3.94 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.67 2.247 . . . . 0.0 112.53 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 18.2 m-85 67.08 150.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . -173.87 68.82 0.1 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.278 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 p -92.05 -19.36 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.158 0.583 . . . . 0.0 112.494 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 148.38 48.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.338 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 -175.11 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.667 0.27 . . . . 0.0 110.563 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.3 137.97 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.593 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 6.5 t30 -125.9 119.76 28.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 111.67 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 56' ' ' PHE . . . . . 0.75 ' CZ ' HD11 ' C' ' 71' ' ' ILE . 17.8 t80 -80.32 128.38 33.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.755 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 16.8 p -114.3 119.93 38.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.983 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 58' ' ' ALA . . . . . 0.473 ' HB2' HD12 ' C' ' 71' ' ' ILE . . . -148.32 141.5 25.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.523 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -176.92 166.66 37.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.566 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 60' ' ' VAL . . . . . 0.461 HG12 HD13 ' C' ' 69' ' ' LEU . 29.5 m -110.29 165.09 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.358 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.05 176.12 21.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.472 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.26 27.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.654 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.69 123.19 14.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.595 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 33.5 mtt-85 65.82 -88.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.032 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 64.1 p -137.53 12.93 2.98 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.172 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 32.8 t -109.35 173.15 6.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.28 177.22 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.065 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.72 161.2 23.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.546 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.461 HD13 HG12 ' C' ' 60' ' ' VAL . 7.7 tp -119.62 136.13 54.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.762 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.696 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -136.39 137.91 41.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.671 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 71' ' ' ILE . . . . . 0.75 HD11 ' CZ ' ' C' ' 56' ' ' PHE . 8.3 tp -138.08 145.81 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.058 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -172.57 -175.46 40.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.0 158.41 19.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.827 0.346 . . . . 0.0 111.043 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.2 159.53 28.06 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.207 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.29 118.99 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.377 . . . . 0.0 111.153 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.605 ' HD3' ' HB2' ' C' ' 82' ' ' ALA . 0.0 OUTLIER -105.8 104.04 13.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.721 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.734 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 10.7 p -101.95 126.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.279 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.87 -171.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.922 0.391 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -118.23 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.59 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -157.01 -53.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.718 ' HA ' HG22 ' C' ' 103' ' ' ILE . 6.4 p -112.41 143.49 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.509 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.605 ' HB2' ' HD3' ' C' ' 76' ' ' ARG . . . -146.72 151.72 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.202 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.4 132.62 35.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 143.21 47.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 171.32 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.454 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 167.45 157.33 10.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.584 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.839 0.352 . . . . 0.0 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.26 151.97 30.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.336 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 126.86 38.08 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.232 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -140.89 145.56 36.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.615 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.427 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 55.23 -98.51 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.201 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.38 -25.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 0.0 111.25 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.98 12.91 7.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 33.9 m-20 -98.96 69.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.07 127.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.706 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.629 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 5.3 ptp -133.03 147.15 52.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.716 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -126.25 130.86 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.422 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -128.03 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.15 109.54 7.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.459 ' HA ' ' HA3' ' B' ' 59' ' ' GLY . 91.6 p -125.19 163.53 22.27 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.423 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.11 140.23 49.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.695 ' OD1' HG22 ' B' ' 57' ' ' THR . 45.1 m-80 -111.77 125.53 54.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.402 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' C' ' 81' ' ' VAL . 3.3 pt -136.69 134.45 48.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.831 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' B' ' 55' ' ' ASN . 6.5 pt-20 -111.6 159.45 18.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 0.481 ' HE1' HD12 ' C' ' 103' ' ' ILE . 50.4 m95 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.666 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.676 0.274 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -58.47 -35.35 72.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 111.258 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.78 -41.93 35.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -59.4 -35.03 73.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -59.54 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.538 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -65.57 -21.2 66.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.8 -40.99 75.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.691 ' HD3' HD13 ' C' ' 25' ' ' LEU . 4.5 mmp_? -71.73 -43.75 65.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.815 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.67 HD13 ' HD3' ' B' ' 24' ' ' ARG . 1.2 tp -59.75 -40.97 89.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.646 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.22 -32.74 64.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.775 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 14.5 tttm -71.43 -29.68 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.668 0.27 . . . . 0.0 111.237 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.709 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.3 mt -85.16 -31.1 23.44 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.429 ' O ' HG22 ' A' ' 32' ' ' VAL . 25.4 t70 -66.34 -41.21 89.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.976 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.638 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 7.0 t -73.23 -44.54 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.797 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.792 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 24.3 ttp85 -60.46 -37.03 79.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.304 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 28' ' ' LEU . 33.9 m -75.71 -31.82 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.117 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.33 -50.7 64.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.032 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.792 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 23.2 pttt -71.48 -42.17 68.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.718 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -52.95 47.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.474 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.14 -38.3 87.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.087 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.06 77.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.446 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.666 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 70.3 p -75.38 -37.17 60.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.2 t -58.12 -66.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -31.47 35.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.425 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -58.81 -53.37 59.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.617 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.8 tm? -69.36 -32.82 72.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.104 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -75.99 -5.67 47.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -13.81 59.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.135 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.805 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.7 mm? -75.64 172.53 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' C' ' 46' ' ' PHE . 47.2 p90 -153.55 -26.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.66 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.93 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -92.04 144.56 2.86 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.591 2.194 . . . . 0.0 112.57 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 48' ' ' PRO . 11.0 m-85 53.5 154.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.25 79.15 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.279 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.97 -26.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.142 0.577 . . . . 0.0 112.424 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.2 49.35 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.34 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -146.15 -178.11 5.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.545 0.212 . . . . 0.0 110.642 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.77 144.26 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.498 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.645 ' OD1' ' HB3' ' B' ' 104' ' ' GLU . 1.7 t30 -128.75 125.3 37.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.987 0.422 . . . . 0.0 111.662 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.37 128.15 37.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.805 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 10.5 p -113.12 131.8 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.99 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.63 133.17 13.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.424 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -166.64 179.46 40.52 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.588 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.49 177.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.763 0.316 . . . . 0.0 111.4 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.562 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -154.04 172.93 32.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.408 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.68 156.79 28.38 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.1 t80 -146.71 125.89 12.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.751 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 66.04 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.137 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.225 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.64 166.16 13.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -124.1 174.41 7.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 111.093 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.02 157.47 37.66 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 70' ' ' ALA . 6.8 tp -111.8 134.16 53.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.48 ' H ' HD12 ' A' ' 69' ' ' LEU . . . -131.39 136.73 48.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.68 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.84 145.79 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.147 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -175.96 -179.3 46.37 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -160.53 157.93 28.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.22 153.98 25.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.268 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.51 128.77 47.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.442 ' NH2' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -110.76 105.53 14.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.698 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.434 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.4 p -100.86 130.84 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.372 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 56.57 -167.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.056 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' HA ' ' NH2' ' A' ' 76' ' ' ARG . 58.0 mt-10 -122.59 61.71 0.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.76 -51.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.006 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.69 135.63 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.476 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.16 164.75 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.295 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.44 HD12 ' HB3' ' A' ' 101' ' ' PHE . 7.0 tp -142.58 148.27 37.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.624 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.436 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -152.74 136.05 15.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.08 18.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.412 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . -179.22 154.63 14.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.571 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.58 42.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.926 0.393 . . . . 0.0 111.027 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -114.36 147.69 38.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.323 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.36 126.02 44.36 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.253 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -138.65 152.02 47.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.706 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.48 -97.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.281 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.22 -39.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -115.72 16.42 16.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.158 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.63 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 14.4 m-20 -101.12 65.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.19 119.3 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 110.704 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.476 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -117.82 145.31 44.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -124.87 132.66 53.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.686 0.279 . . . . 0.0 111.451 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.05 108.55 4.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.739 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.579 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 85.0 p -128.73 160.87 31.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB3' HD12 ' A' ' 83' ' ' LEU . 18.3 p90 -125.94 138.35 53.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.908 0.385 . . . . 0.0 111.09 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.677 ' OD1' HG22 ' C' ' 57' ' ' THR . 22.9 m-80 -104.73 129.86 52.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.411 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.94 132.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.636 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 8.3 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.677 0.275 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' PHE . . . . . 0.426 ' HA ' ' HZ2' ' C' ' 17' ' ' LYS . 81.8 t80 -58.53 -35.32 72.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.216 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -77.74 -42.0 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -59.43 -34.97 73.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -59.51 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.563 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.53 -21.27 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.72 -40.93 75.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.67 ' HD3' HD13 ' A' ' 25' ' ' LEU . 4.5 mmp_? -71.82 -43.66 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.671 HD13 ' HD3' ' C' ' 24' ' ' ARG . 1.2 tp -59.91 -40.89 90.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.18 -32.82 65.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.529 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.63 65.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.193 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.712 ' O ' HG13 ' B' ' 32' ' ' VAL . 4.2 mt -85.15 -31.0 23.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.432 ' O ' HG22 ' B' ' 32' ' ' VAL . 25.3 t70 -66.41 -41.2 89.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.941 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.63 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 7.0 t -73.22 -44.53 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.78 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.1 79.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.313 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.712 HG13 ' O ' ' B' ' 28' ' ' LEU . 33.8 m -75.63 -31.82 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.233 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.45 -50.57 64.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.78 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 23.1 pttt -71.5 -42.09 68.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.787 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.9 -52.89 48.29 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.412 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.04 -38.41 88.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.14 77.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.479 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.668 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . 70.5 p -75.33 -37.17 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.806 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 46.0 t -58.17 -65.9 0.57 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.157 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -31.4 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -58.83 -53.37 59.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.913 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.626 HD13 ' O ' ' B' ' 42' ' ' LEU . 1.8 tm? -69.35 -32.87 72.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -76.01 -5.7 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -13.7 59.82 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.213 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.821 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.7 mm? -75.66 172.44 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.866 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 47.0 p90 -153.48 -26.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.53 107.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.992 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -92.07 144.57 2.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.622 2.214 . . . . 0.0 112.56 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.529 ' O ' ' O ' ' B' ' 48' ' ' PRO . 11.0 m-85 53.39 154.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . 178.26 78.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.236 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.87 -26.5 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.11 0.564 . . . . 0.0 112.506 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.18 49.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.299 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' B' ' 52' ' ' GLY . 0.4 OUTLIER -146.21 -178.16 5.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.564 0.221 . . . . 0.0 110.62 179.697 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.65 144.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.55 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.644 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 1.7 t30 -128.76 125.16 37.26 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.29 128.15 37.01 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.257 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.821 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 10.4 p -113.15 131.77 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.042 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.59 133.13 13.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -166.5 179.54 40.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.67 177.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 0.0 111.35 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -153.97 172.88 32.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.538 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 156.84 28.43 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.531 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' TYR . . . . . 0.481 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.1 t80 -146.78 125.79 12.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.764 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.96 -89.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.5 p -137.95 16.75 2.84 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.214 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.74 166.17 13.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.8 OUTLIER -124.06 174.4 7.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.04 157.52 37.72 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.535 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.485 HD12 ' H ' ' B' ' 70' ' ' ALA . 6.7 tp -111.83 134.23 53.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.795 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.485 ' H ' HD12 ' B' ' 69' ' ' LEU . . . -131.49 136.71 48.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.677 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.89 145.72 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.319 . . . . 0.0 111.166 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -175.88 -179.28 46.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.406 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.9 p -160.57 157.92 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.918 0.39 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.18 153.99 25.51 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.215 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.56 128.83 47.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' ARG . . . . . 0.442 ' NH2' ' HA ' ' B' ' 79' ' ' GLU . 0.0 OUTLIER -110.72 105.52 14.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.791 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.424 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.4 p -100.89 130.79 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.284 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 56.62 -167.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.945 0.402 . . . . 0.0 111.102 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.442 ' HA ' ' NH2' ' B' ' 76' ' ' ARG . 57.4 mt-10 -122.59 61.79 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.77 -51.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.03 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.57 135.66 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.539 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.2 164.79 29.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' B' ' 84' ' ' LYS . 7.0 tp -142.62 148.3 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' LYS . . . . . 0.433 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 0.0 OUTLIER -152.81 136.02 15.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.151 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.17 169.05 18.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.407 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . -179.17 154.65 14.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.571 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.56 42.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.88 0.372 . . . . 0.0 111.096 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -114.28 147.68 38.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.348 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.35 125.99 44.32 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.305 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.737 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -138.62 152.03 47.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.604 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.46 -97.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.272 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.19 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.64 16.44 16.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.193 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.634 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 13.9 m-20 -101.15 65.65 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.17 119.38 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -117.89 145.33 44.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.721 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.87 132.6 53.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.19 142.43 49.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.08 108.48 4.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' SER . . . . . 0.575 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 85.1 p -128.71 160.89 31.07 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.431 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 101' ' ' PHE . . . . . 0.433 ' HB3' HD12 ' B' ' 83' ' ' LEU . 18.2 p90 -125.93 138.35 53.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 0.0 111.038 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.679 ' OD1' HG22 ' A' ' 57' ' ' THR . 22.9 m-80 -104.72 129.87 52.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.38 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.94 132.73 61.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.843 0.354 . . . . 0.0 110.801 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.645 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 8.3 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.426 ' HZ2' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.665 0.269 . . . . 0.0 110.504 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -58.52 -35.29 72.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 111.241 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.77 -41.94 35.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.44 -34.99 73.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.141 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -59.5 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.591 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.64 -21.18 66.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.981 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -69.75 -40.99 75.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.671 ' HD3' HD13 ' B' ' 25' ' ' LEU . 4.4 mmp_? -71.83 -43.68 65.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.771 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.691 HD13 ' HD3' ' A' ' 24' ' ' ARG . 1.3 tp -59.82 -40.96 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.18 -32.8 65.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.508 ' HZ2' HD11 ' B' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.69 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.168 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.717 ' O ' HG13 ' C' ' 32' ' ' VAL . 4.2 mt -85.07 -31.08 23.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 29' ' ' ASP . . . . . 0.43 ' O ' HG22 ' C' ' 32' ' ' VAL . 25.5 t70 -66.32 -41.27 89.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.01 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.647 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 7.0 t -73.24 -44.45 59.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.783 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.12 79.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.28 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.717 HG13 ' O ' ' C' ' 28' ' ' LEU . 33.8 m -75.55 -31.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.4 -50.65 64.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.031 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.783 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 23.1 pttt -71.53 -42.13 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.737 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -53.04 46.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.422 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.04 -38.37 88.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 111.052 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.79 -44.03 77.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.416 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.677 ' HB2' ' HB1' ' C' ' 88' ' ' ALA . 70.7 p -75.37 -37.22 60.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 46.1 t -58.13 -65.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.123 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -31.36 35.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.456 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -58.8 -53.39 58.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.62 ' O ' HD13 ' C' ' 42' ' ' LEU . 1.8 tm? -69.44 -32.82 72.0 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 43' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 62.0 m-20 -75.98 -5.63 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -13.75 59.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.098 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.832 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.7 mm? -75.66 172.52 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.878 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 47.0 p90 -153.57 -26.26 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.664 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.59 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.993 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -92.02 144.54 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.675 2.25 . . . . 0.0 112.568 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.525 ' O ' ' O ' ' C' ' 48' ' ' PRO . 11.0 m-85 53.43 154.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.941 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . 178.23 79.13 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.266 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.9 -26.61 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.153 0.581 . . . . 0.0 112.434 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 52' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.24 49.42 0.02 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.299 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 53' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' C' ' 52' ' ' GLY . 0.4 OUTLIER -146.15 -178.05 5.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.587 0.232 . . . . 0.0 110.628 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.74 144.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.558 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 1.7 t30 -128.74 125.32 37.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.35 128.11 37.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.276 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.832 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 10.2 p -113.17 131.79 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.984 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.56 133.14 13.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.446 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.579 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -166.62 179.43 40.53 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.54 177.09 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.349 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 61' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -153.96 172.99 32.64 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.424 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.69 156.77 28.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.563 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 63' ' ' TYR . . . . . 0.476 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.1 t80 -146.72 125.82 12.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.99 -90.03 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.182 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.7 166.26 12.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 67' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.8 OUTLIER -124.18 174.4 7.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.347 . . . . 0.0 111.129 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 68' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -154.98 157.44 37.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.553 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.492 HD12 ' H ' ' C' ' 70' ' ' ALA . 6.6 tp -111.82 134.21 53.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.492 ' H ' HD12 ' C' ' 69' ' ' LEU . . . -131.51 136.78 48.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.91 145.71 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 111.145 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -175.93 -179.23 46.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.426 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -160.59 157.88 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.964 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.13 153.9 25.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.251 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.47 128.78 47.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.195 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 76' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' C' ' 79' ' ' GLU . 0.0 OUTLIER -110.66 105.59 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.5 p -101.02 130.81 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.964 0.412 . . . . 0.0 111.256 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 56.62 -167.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.089 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 79' ' ' GLU . . . . . 0.443 ' HA ' ' NH2' ' C' ' 76' ' ' ARG . 57.4 mt-10 -122.53 61.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.587 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 -51.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.012 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.66 135.6 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.11 164.81 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.226 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' C' ' 101' ' ' PHE . 7.0 tp -142.65 148.27 37.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 84' ' ' LYS . . . . . 0.417 ' N ' ' HG ' ' C' ' 83' ' ' LEU . 0.0 OUTLIER -152.75 136.04 15.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.212 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.23 169.05 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . -179.18 154.64 14.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.592 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.56 142.54 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.829 0.347 . . . . 0.0 111.093 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.677 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -114.3 147.71 38.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.39 126.0 44.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.306 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.725 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -138.68 152.01 47.68 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.621 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.35 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 42.0 t -151.23 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.333 . . . . 0.0 111.32 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.63 16.4 16.48 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.161 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.629 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 14.1 m-20 -101.16 65.7 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.26 119.37 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.673 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.481 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.3 OUTLIER -117.85 145.25 44.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.693 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.89 132.65 53.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.443 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.26 142.39 49.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.688 0.28 . . . . 0.0 111.483 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.97 108.49 4.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.738 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 100' ' ' SER . . . . . 0.576 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 84.6 p -128.67 160.85 31.18 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.435 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.439 ' HB3' HD12 ' C' ' 83' ' ' LEU . 18.3 p90 -125.94 138.38 53.77 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.896 0.379 . . . . 0.0 111.108 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 102' ' ' ASN . . . . . 0.668 ' OD1' HG22 ' B' ' 57' ' ' THR . 23.1 m-80 -104.73 129.89 52.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.448 HD12 ' HE1' ' C' ' 105' ' ' TRP . 2.6 pt -132.0 132.67 61.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 104' ' ' GLU . . . . . 0.644 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 8.3 pt-20 -110.95 143.23 41.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 105' ' ' TRP . . . . . 0.448 ' HE1' HD12 ' C' ' 103' ' ' ILE . 14.6 m95 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.683 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.632 -0.187 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 37.66 -99.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.373 . . . . 0.0 110.975 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 48.9 mt-30 -112.32 -52.62 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.832 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . 178.77 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 t -70.04 -56.55 6.65 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.777 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -52.63 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.68 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m 67.08 53.14 0.82 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.032 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.779 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 24.2 m80 -70.64 -52.89 10.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.774 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.779 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -52.75 123.47 13.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.488 2.125 . . . . 0.0 111.886 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.555 ' NE2' ' HE3' ' B' ' 13' ' ' LYS . 3.1 mm-40 -128.02 -54.8 1.29 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.939 0.399 . . . . 0.0 111.172 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -125.22 -155.35 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.71 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -70.41 -22.73 62.7 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.473 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HE3' ' NE2' ' C' ' 10' ' ' GLN . 14.8 mtpp -140.82 12.17 2.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.489 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.04 -25.97 67.72 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.298 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 9' ' ' PRO . . . -64.77 -41.1 96.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 110.921 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -74.3 -34.97 63.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.943 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HE3' ' HG3' ' C' ' 10' ' ' GLN . 32.9 ttmt -70.14 -44.75 68.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.524 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -38.15 88.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.268 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -68.37 -42.96 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.17 -44.94 95.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.42 . . . . 0.0 111.137 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -66.03 -44.19 85.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.526 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.21 -34.17 77.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.011 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -72.77 -37.12 67.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -68.15 -44.02 76.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.734 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.708 ' HG ' HD21 ' C' ' 25' ' ' LEU . 3.9 mt -60.81 -44.92 96.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -63.03 -33.85 76.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 11.8 tttt -71.19 -35.89 71.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.727 HD21 ' HA ' ' C' ' 29' ' ' ASP . 0.5 OUTLIER -66.42 -52.36 47.33 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.736 ' HA ' HD21 ' B' ' 28' ' ' LEU . 46.9 t0 -55.56 -39.3 70.46 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.977 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.3 m -61.33 -49.72 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.862 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.639 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 85.0 mmt-85 -58.11 -32.02 67.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.772 HG11 HG22 ' B' ' 32' ' ' VAL . 18.9 t -77.3 -36.48 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.162 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -64.1 -52.8 57.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.94 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 13.3 pttt -77.22 -37.16 53.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.97 -40.18 98.55 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.433 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.573 HD22 ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -72.86 -37.38 67.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.91 91.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.669 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -68.99 -50.29 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.555 ' HB3' HD21 ' C' ' 36' ' ' LEU . 96.5 p -52.82 -49.37 65.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.2 73.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.53 -42.65 55.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.913 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.511 HD23 ' OD1' ' A' ' 98' ' ' ASN . 16.2 tp -71.83 -42.51 66.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -75.81 -3.1 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.53 55.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.096 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.49 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -97.77 177.13 5.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.816 177.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -169.1 1.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.657 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 64.6 mt-30 63.9 116.38 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.277 9.9 Cg_endo -74.46 95.04 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.587 2.191 . . . . 0.0 112.593 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 87.4 m-85 68.83 -173.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 148.9 90.12 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.207 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -87.78 -14.74 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 123.152 0.581 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.37 48.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.279 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.99 -172.89 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 110.622 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.115 HG13 ' O ' ' B' ' 105' ' ' TRP . 4.5 p -103.48 148.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.571 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.704 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.47 44.12 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 111.656 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.534 ' HE2' HD11 ' A' ' 71' ' ' ILE . 1.1 t80 -97.48 124.13 41.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.25 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.479 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.2 p -116.5 127.95 55.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.65 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -159.85 154.87 24.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.45 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.53 165.99 29.61 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.518 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 69' ' ' LEU . 13.6 m -112.08 163.68 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.4 179.65 27.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.56 144.82 11.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.552 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CD1' HD22 ' A' ' 36' ' ' LEU . 75.1 t80 -136.92 129.48 30.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.314 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 3.5 mmm-85 65.72 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -152.25 34.96 0.52 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.158 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.92 168.01 18.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -140.78 144.35 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.113 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.92 156.18 43.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' A' ' 60' ' ' VAL . 6.7 tp -113.19 125.35 54.24 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.778 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -119.55 151.14 39.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.706 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.65 HG13 ' HB2' ' A' ' 58' ' ' ALA . 18.4 tt -145.2 164.24 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.479 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 179.58 175.56 46.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.44 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.74 147.69 11.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.92 163.3 30.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.232 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -108.5 120.72 43.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.505 ' CB ' ' HA3' ' A' ' 50' ' ' GLY . 6.6 mmm180 -96.72 92.38 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.743 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.2 p -96.79 131.83 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.6 m120 64.67 -177.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.078 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.3 24.25 11.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.495 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.059 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.3 153.67 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -156.28 173.51 16.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 111.259 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.22 140.32 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.611 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.657 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -140.48 134.27 30.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.188 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.95 133.97 14.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.479 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -160.0 170.54 36.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.546 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 71' ' ' ILE . 9.7 p -117.44 147.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.136 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.58 ' HB3' ' SD ' ' A' ' 96' ' ' MET . . . -119.39 134.57 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.328 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.18 110.85 22.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -118.91 136.9 53.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.631 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.562 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 50.63 -111.95 1.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.318 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.39 -53.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.689 0.28 . . . . 0.0 111.307 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.505 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -106.37 26.83 9.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.145 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.751 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -116.85 81.82 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.59 139.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.707 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -135.36 158.53 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.723 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -134.16 133.5 41.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.468 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.511 ' OD1' HD23 ' A' ' 42' ' ' LEU . 33.7 m120 -113.73 161.09 17.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.747 0.308 . . . . 0.0 111.393 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.45 0.18 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.724 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.493 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 13.8 p -126.02 178.76 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.426 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -144.44 137.77 27.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.863 0.363 . . . . 0.0 111.121 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 69.9 m-80 -103.29 148.79 25.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.352 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.499 HG13 ' O ' ' C' ' 56' ' ' PHE . 7.4 pt -152.75 146.66 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.7 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 90.0 mt-10 -90.37 130.99 36.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.094 ' O ' HG13 ' C' ' 54' ' ' VAL . 2.9 t-105 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.682 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 112.64 -0.184 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 37.52 -99.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.985 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -112.29 -52.71 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 178.83 -59.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -70.09 -56.48 6.8 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.791 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -52.63 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.685 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m 67.12 53.11 0.81 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.022 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.76 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 24.3 m80 -70.65 -52.83 10.22 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.771 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.76 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -52.73 123.46 13.03 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.489 2.126 . . . . 0.0 111.896 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.538 ' NE2' ' HE3' ' C' ' 13' ' ' LYS . 3.1 mm-40 -127.99 -54.88 1.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.982 0.42 . . . . 0.0 111.122 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.24 -155.41 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.659 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -70.35 -22.69 62.76 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.469 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.555 ' HE3' ' NE2' ' A' ' 10' ' ' GLN . 14.8 mtpp -140.81 12.1 2.26 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.5 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.01 -25.99 67.76 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.266 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' B' ' 9' ' ' PRO . . . -64.67 -41.18 96.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.93 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -74.38 -34.8 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.009 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.463 ' HE3' ' HG3' ' A' ' 10' ' ' GLN . 33.0 ttmt -70.15 -44.7 68.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.538 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -38.11 88.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 mtt85 -68.26 -43.03 78.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.15 -44.94 95.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.479 HD23 HD21 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -65.98 -44.24 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.627 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.2 -34.08 76.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.078 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.85 -37.09 67.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mtt180 -68.06 -44.02 77.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.712 HD21 ' HG ' ' C' ' 25' ' ' LEU . 3.9 mt -60.91 -44.9 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.59 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -63.04 -33.84 76.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.869 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 11.8 tttt -71.16 -35.88 71.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.221 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.736 HD21 ' HA ' ' A' ' 29' ' ' ASP . 0.5 OUTLIER -66.34 -52.41 47.31 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.737 ' HA ' HD21 ' C' ' 28' ' ' LEU . 46.8 t0 -55.54 -39.37 70.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.951 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 13.8 m -61.3 -49.74 75.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.87 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.645 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 85.0 mmt-85 -58.09 -31.97 67.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.772 HG22 HG11 ' A' ' 32' ' ' VAL . 18.8 t -77.35 -36.54 23.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -64.05 -52.81 57.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.671 ' HD2' ' HB2' ' B' ' 94' ' ' ASP . 13.3 pttt -77.27 -37.09 53.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.791 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.02 -40.18 98.56 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.419 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' B' ' 63' ' ' TYR . 0.2 OUTLIER -72.84 -37.42 67.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.0 91.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.471 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.665 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -68.98 -50.28 50.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.719 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.556 ' HB3' HD21 ' A' ' 36' ' ' LEU . 96.4 p -52.82 -49.34 65.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.11 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.401 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.54 -42.67 55.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.515 HD23 ' OD1' ' B' ' 98' ' ' ASN . 16.1 tp -71.86 -42.43 66.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.92 -3.09 33.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.83 0.35 55.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.178 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -97.69 177.11 5.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.871 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.11 1.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.716 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.656 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 64.6 mt-30 63.97 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.977 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.277 9.8 Cg_endo -74.51 95.08 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.601 2.201 . . . . 0.0 112.508 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 87.4 m-85 68.84 -173.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 148.95 90.13 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.209 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -87.79 -14.77 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.141 0.576 . . . . 0.0 112.425 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.39 48.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.315 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.86 -172.9 4.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.605 0.241 . . . . 0.0 110.587 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 1.074 HG13 ' O ' ' C' ' 105' ' ' TRP . 4.6 p -103.37 148.77 7.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.607 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.683 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.5 44.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.928 0.395 . . . . 0.0 111.667 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.522 ' HE2' HD11 ' B' ' 71' ' ' ILE . 1.1 t80 -97.5 124.12 41.61 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.277 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.471 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.0 p -116.51 127.89 54.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.941 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.651 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -159.83 154.75 24.63 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.452 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.503 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.62 166.04 29.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.544 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 69' ' ' LEU . 13.8 m -112.06 163.69 8.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.347 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.37 179.58 27.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.462 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.54 144.87 11.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.579 ' CD1' HD22 ' B' ' 36' ' ' LEU . 75.3 t80 -136.92 129.62 30.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.729 0.299 . . . . 0.0 110.727 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 3.5 mmm-85 65.52 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.23 34.84 0.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.86 168.04 17.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -140.78 144.3 35.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.164 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.88 156.3 43.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' B' ' 60' ' ' VAL . 6.8 tp -113.2 125.36 54.25 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.792 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -119.59 151.15 39.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.699 0.285 . . . . 0.0 111.665 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' B' ' 58' ' ' ALA . 18.4 tt -145.19 164.2 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.126 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 179.6 175.52 46.47 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.433 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.74 147.77 11.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.873 0.368 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.91 163.33 30.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -108.49 120.61 42.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.504 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.49 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.749 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.1 p -96.85 131.91 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.239 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.5 m120 64.6 -177.25 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.925 0.393 . . . . 0.0 111.04 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -116.26 24.21 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.563 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.24 153.67 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.48 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -156.33 173.47 16.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.281 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.12 140.39 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.656 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.24 30.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.195 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 134.03 14.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -160.04 170.58 36.18 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' B' ' 71' ' ' ILE . 9.8 p -117.44 147.41 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.85 0.357 . . . . 0.0 111.106 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.585 ' HB3' ' SD ' ' B' ' 96' ' ' MET . . . -119.38 134.61 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.323 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.23 110.84 22.55 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.292 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . . . -118.8 136.93 53.74 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.636 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.567 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 50.6 -112.05 1.45 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.3 -53.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.691 0.281 . . . . 0.0 111.326 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' B' ' 93' ' ' SER . 2.2 t -106.35 26.85 9.34 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.198 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.75 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.3 OUTLIER -116.95 81.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.69 139.37 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' B' ' 88' ' ' ALA . 0.0 OUTLIER -135.38 158.52 44.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.711 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -134.12 133.55 41.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.515 ' OD1' HD23 ' B' ' 42' ' ' LEU . 33.7 m120 -113.72 161.05 17.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.51 0.18 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.5 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 13.9 p -126.05 178.78 5.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.462 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -144.52 137.76 27.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.002 0.429 . . . . 0.0 111.048 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.674 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 69.8 m-80 -103.2 148.8 25.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.442 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 56' ' ' PHE . 7.4 pt -152.77 146.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.336 . . . . 0.0 110.77 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.704 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 90.1 mt-10 -90.34 131.0 36.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 1.115 ' O ' HG13 ' A' ' 54' ' ' VAL . 3.0 t-105 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.648 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.675 -0.17 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 37.66 -99.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.853 0.358 . . . . 0.0 110.985 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -112.3 -52.68 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.794 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 178.81 -59.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.011 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -70.02 -56.59 6.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.788 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -52.63 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.692 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m 67.09 53.15 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.996 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.783 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 24.2 m80 -70.72 -52.83 10.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.761 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.783 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -52.67 123.39 12.83 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.496 2.131 . . . . 0.0 111.911 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' GLN . . . . . 0.545 ' NE2' ' HE3' ' A' ' 13' ' ' LYS . 3.1 mm-40 -127.97 -54.79 1.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 111.144 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.32 -155.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.669 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -70.36 -22.65 62.75 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.497 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.538 ' HE3' ' NE2' ' B' ' 10' ' ' GLN . 14.7 mtpp -140.87 12.11 2.25 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.536 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.15 -25.89 67.66 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.248 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' C' ' 9' ' ' PRO . . . -64.67 -41.17 96.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.36 . . . . 0.0 110.943 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -74.39 -34.93 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.455 ' HE3' ' HG3' ' B' ' 10' ' ' GLN . 32.9 ttmt -70.08 -44.78 68.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.573 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -38.02 87.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.306 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -68.36 -43.0 78.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.13 -44.95 95.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.479 HD21 HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -66.07 -44.15 85.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.554 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -34.13 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.77 -37.18 67.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -67.94 -44.13 77.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.772 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.712 ' HG ' HD21 ' B' ' 25' ' ' LEU . 3.9 mt -60.72 -44.99 95.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -62.99 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.875 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 11.8 tttt -71.08 -35.9 72.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.313 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.737 HD21 ' HA ' ' B' ' 29' ' ' ASP . 0.5 OUTLIER -66.38 -52.35 47.72 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ASP . . . . . 0.727 ' HA ' HD21 ' A' ' 28' ' ' LEU . 46.9 t0 -55.59 -39.28 70.5 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.519 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 14.3 m -61.4 -49.71 75.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.813 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.644 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 85.0 mmt-85 -58.05 -32.07 67.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.376 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.764 HG11 HG22 ' A' ' 32' ' ' VAL . 18.6 t -77.26 -36.51 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.227 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -64.03 -52.85 57.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.652 ' HD2' ' HB2' ' C' ' 94' ' ' ASP . 13.2 pttt -77.26 -37.15 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.725 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.02 -40.11 98.47 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' C' ' 63' ' ' TYR . 0.2 OUTLIER -72.85 -37.39 67.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.05 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.369 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.673 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -68.89 -50.38 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.558 ' HB3' HD21 ' B' ' 36' ' ' LEU . 96.6 p -52.71 -49.41 65.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.09 73.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.459 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.56 -42.68 55.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.5 HD23 ' OD1' ' C' ' 98' ' ' ASN . 16.2 tp -71.83 -42.46 66.94 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.88 -3.06 33.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.52 55.81 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.12 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -97.8 177.15 5.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.791 177.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.08 1.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.638 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.655 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 64.8 mt-30 63.99 116.4 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.95 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.4 94.97 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.647 2.231 . . . . 0.0 112.582 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 87.6 m-85 68.9 -173.61 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.9 90.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.247 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.8 -14.78 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.129 0.572 . . . . 0.0 112.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.751 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.43 48.77 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.274 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -147.01 -172.89 4.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.547 0.213 . . . . 0.0 110.573 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 1.094 HG13 ' O ' ' A' ' 105' ' ' TRP . 4.6 p -103.42 148.73 8.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.7 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 7.4 m-80 -134.0 136.48 44.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.662 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.546 ' HE2' HD11 ' C' ' 71' ' ' ILE . 1.1 t80 -97.49 124.13 41.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.483 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 44.8 p -116.51 127.93 54.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -159.82 154.85 24.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.41 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.52 166.07 29.72 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' C' ' 69' ' ' LEU . 13.7 m -112.12 163.7 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.802 0.334 . . . . 0.0 111.339 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.41 179.58 27.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.476 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.49 144.78 11.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.544 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.581 ' CD1' HD22 ' C' ' 36' ' ' LEU . 75.5 t80 -136.91 129.57 30.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.723 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.5 mmm-85 65.58 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.22 34.87 0.52 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.16 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.93 168.02 18.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -140.73 144.36 35.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.121 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.87 156.27 43.44 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.529 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.55 ' HA ' HG12 ' C' ' 60' ' ' VAL . 6.7 tp -113.23 125.38 54.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -119.54 151.16 39.08 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.695 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' C' ' 58' ' ' ALA . 18.3 tt -145.24 164.27 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.19 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 179.59 175.54 46.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.75 147.77 11.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.967 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.93 163.32 30.43 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.237 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -108.5 120.64 43.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 111.137 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.505 ' CB ' ' HA3' ' C' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.32 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.675 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.751 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.2 p -96.73 131.87 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 111.332 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.5 m120 64.58 -177.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 111.093 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.33 24.21 11.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.8 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.19 153.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.544 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -156.35 173.47 16.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 111.252 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.08 140.34 7.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.595 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.655 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.27 30.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 133.95 14.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.95 170.58 36.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.597 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -117.48 147.42 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.936 0.398 . . . . 0.0 111.096 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.58 ' HB3' ' SD ' ' C' ' 96' ' ' MET . . . -119.35 134.61 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.22 110.89 22.63 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' C' ' 94' ' ' ASP . . . -118.88 136.92 53.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.679 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.593 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 50.61 -112.03 1.45 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.255 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.33 -53.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.257 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.2 t -106.32 26.83 9.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.756 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.3 OUTLIER -116.88 81.83 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.93 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.63 139.32 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.737 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' C' ' 88' ' ' ALA . 0.0 OUTLIER -135.34 158.56 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -134.16 133.53 41.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.419 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.5 ' OD1' HD23 ' C' ' 42' ' ' LEU . 33.8 m120 -113.67 161.09 17.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.403 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.51 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.752 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.503 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 13.8 p -126.05 178.69 5.62 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.413 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.4 137.8 27.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.665 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 69.8 m-80 -103.3 148.86 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.377 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.509 HG13 ' O ' ' B' ' 56' ' ' PHE . 7.4 pt -152.79 146.67 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.784 0.326 . . . . 0.0 110.821 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.683 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 90.1 mt-10 -90.39 131.03 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 1.074 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.9 t-105 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.635 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.669 -0.172 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.549 ' HB2' ' H ' ' A' ' 7' ' ' SER . 86.5 m-20 40.69 -103.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -114.86 -48.64 2.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -177.32 -63.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.044 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.9 t -69.83 -53.52 17.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.727 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 2' ' ' ASP . 75.5 m95 -48.43 -86.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.549 ' H ' ' HB2' ' A' ' 2' ' ' ASP . 19.4 m 65.0 46.66 2.75 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.025 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.742 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 16.6 m170 -73.85 -52.26 4.69 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.747 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.742 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -51.17 116.47 2.69 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.485 2.123 . . . . 0.0 111.889 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 8' ' ' HIS . 12.2 mm100 -128.14 -55.66 1.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.112 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.66 -153.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.687 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.63 -28.2 63.61 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.449 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -138.29 20.65 2.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.49 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.35 -21.0 65.61 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.32 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.7 -44.42 86.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.929 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 30.5 m-70 -71.8 -35.3 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.959 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' O ' HD22 ' A' ' 21' ' ' LEU . 36.1 ttmt -68.3 -47.32 67.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.54 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -38.48 83.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -66.77 -45.68 77.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.818 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -64.23 -40.84 96.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.757 HD21 HD23 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -64.51 -45.27 87.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.51 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.69 -28.39 69.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -74.74 -40.33 61.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HD2' HD13 ' C' ' 25' ' ' LEU . 32.1 mtt180 -70.87 -41.18 71.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.766 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.679 HD21 ' HG ' ' B' ' 25' ' ' LEU . 7.8 mt -62.05 -49.86 74.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.481 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.24 -48.86 79.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 9.0 tmtt? -55.45 -38.02 68.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.168 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -63.4 -40.4 97.11 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.6 91.93 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.98 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.58 HG22 ' HE2' ' A' ' 34' ' ' LYS . 3.9 m -57.74 -48.08 80.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.81 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.559 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 83.9 mmt-85 -57.28 -33.15 67.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 28' ' ' LEU . 44.4 t -76.77 -37.78 28.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 48.2 m-20 -61.95 -54.34 43.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.012 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.998 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 2.5 pttt -75.87 -36.17 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.795 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 -45.49 87.98 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.422 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.703 HD22 ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -68.19 -39.59 82.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.845 0.355 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.73 90.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.4 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.667 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -68.72 -52.66 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.703 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.497 ' HB3' HD21 ' C' ' 36' ' ' LEU . 78.3 p -50.9 -56.42 12.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.81 -48.95 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.436 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.39 -42.19 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.64 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 24.0 tp -73.63 -36.07 65.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.062 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' HB3' ' CB ' ' C' ' 43' ' ' ASN . 11.4 m120 -78.27 -3.17 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.702 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.4 t -84.31 1.38 45.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.18 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -98.26 174.58 6.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.82 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.34 -3.52 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.142 0.496 . . . . 0.0 111.661 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.555 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 35.8 mt-30 64.27 117.55 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.96 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.278 9.8 Cg_endo -74.46 100.39 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.669 2.246 . . . . 0.0 112.577 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 90.3 m-85 67.61 -167.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 148.26 81.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.203 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' CG ' ' A' ' 79' ' ' GLU . 15.0 p -88.26 -12.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.157 0.583 . . . . 0.0 112.396 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.78 45.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.256 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.56 -168.65 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.585 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.032 HG13 ' O ' ' B' ' 105' ' ' TRP . 2.0 p -109.68 145.95 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.496 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 4.1 m-80 -128.52 135.32 49.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.943 0.402 . . . . 0.0 111.69 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.66 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 45' ' ' LEU . 22.5 p -111.87 124.66 52.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.006 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.455 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -155.35 149.79 26.1 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.478 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.604 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 173.04 165.56 30.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -111.27 165.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 0.0 111.434 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -177.62 27.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.496 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -160.65 144.42 9.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.537 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.703 ' CD1' HD22 ' A' ' 36' ' ' LEU . 65.5 t80 -133.54 133.42 42.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.728 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.51 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 3.1 mmm-85 64.5 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.126 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.47 33.28 0.37 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.161 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.73 168.69 16.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -134.84 140.47 45.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.095 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.32 152.01 48.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.595 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.444 ' HA ' HG12 ' A' ' 60' ' ' VAL . 4.7 tp -111.16 127.46 55.59 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.745 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -122.83 151.87 41.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.669 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.463 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.5 tt -147.78 163.72 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.088 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 175.48 172.65 40.53 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.446 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -162.75 147.24 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.6 161.63 28.69 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.295 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -106.92 119.26 38.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 111.168 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 76' ' ' ARG . 5.0 mmm180 -95.86 101.02 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.711 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 12.6 p -98.62 128.88 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.7 m120 65.23 -175.05 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' CG ' HG23 ' A' ' 51' ' ' VAL . 33.4 mt-10 -114.82 25.45 10.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.573 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.964 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.22 151.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -153.42 169.81 22.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.245 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -162.48 141.23 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 1.3 ttmp? -141.42 133.46 27.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.27 135.03 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -159.35 173.86 36.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.581 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.83 144.3 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.453 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -112.92 135.43 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.36 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -111.08 111.07 21.91 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.236 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.998 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -124.01 135.83 53.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.574 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.91 -113.84 4.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.238 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.83 -58.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.526 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -103.9 28.43 6.68 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.203 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.426 ' CB ' ' HD2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -118.18 82.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.962 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.76 142.81 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' C' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.15 50.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -128.01 129.41 46.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.429 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -117.5 159.35 22.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.724 0.297 . . . . 0.0 111.393 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.716 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.728 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.7 p -122.86 178.5 5.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 39.3 p90 -142.13 146.04 34.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.95 0.405 . . . . 0.0 111.12 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.5 m-80 -112.88 150.73 31.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.326 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 102' ' ' ASN . 2.9 pt -157.24 152.04 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.777 0.323 . . . . 0.0 110.814 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.424 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 75.8 mt-10 -94.98 129.54 42.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.038 ' O ' HG13 ' C' ' 54' ' ' VAL . 5.9 t-105 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.688 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.652 -0.179 . . . . 0.0 112.652 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.539 ' HB2' ' H ' ' B' ' 7' ' ' SER . 86.3 m-20 40.63 -103.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.899 0.38 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -114.86 -48.7 2.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.813 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -177.35 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.9 t -69.68 -53.53 18.15 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.752 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.41 ' HB2' ' HB2' ' B' ' 2' ' ' ASP . 75.3 m95 -48.53 -86.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.705 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.539 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 19.5 m 64.99 46.71 2.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.013 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.727 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 16.6 m170 -73.72 -52.44 4.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.795 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.727 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -51.03 116.48 2.67 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.481 2.121 . . . . 0.0 111.888 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' B' ' 8' ' ' HIS . 12.2 mm100 -128.14 -55.6 1.27 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.004 0.43 . . . . 0.0 111.171 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.75 -153.51 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.704 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.57 -28.22 63.68 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.44 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -138.28 20.65 2.77 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.535 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.48 -20.95 65.38 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.288 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.38 86.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 0.0 110.861 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' B' ' 20' ' ' GLN . 30.4 m-70 -71.78 -35.32 69.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.025 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.413 ' O ' HD22 ' B' ' 21' ' ' LEU . 36.1 ttmt -68.32 -47.27 67.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.524 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -38.46 83.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.297 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -66.81 -45.67 77.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' B' ' 16' ' ' HIS . 0.8 OUTLIER -64.22 -40.85 96.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.757 HD21 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -64.37 -45.29 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.75 -28.34 69.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.05 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -74.76 -40.32 61.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.478 ' HD2' HD13 ' A' ' 25' ' ' LEU . 32.2 mtt180 -70.9 -41.18 71.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.808 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.679 ' HG ' HD21 ' A' ' 25' ' ' LEU . 7.9 mt -61.96 -49.86 74.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.21 -48.87 79.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 9.0 tmtt? -55.43 -37.93 68.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.292 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.635 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.4 OUTLIER -63.49 -40.3 96.73 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -64.18 -44.62 91.48 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.954 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.59 HG22 ' HE2' ' B' ' 34' ' ' LYS . 3.8 m -57.7 -48.06 80.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.551 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 83.9 mmt-85 -57.18 -33.29 67.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.259 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 28' ' ' LEU . 44.5 t -76.78 -37.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.496 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 48.2 m-20 -62.06 -54.28 43.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.999 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.945 ' HB2' ' HB1' ' B' ' 90' ' ' ALA . 2.6 pttt -75.9 -36.03 59.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.41 87.61 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.717 HD22 ' CD1' ' B' ' 63' ' ' TYR . 0.3 OUTLIER -68.18 -39.65 82.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.75 90.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.414 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.671 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -68.73 -52.7 27.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.746 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.487 ' HB3' HD21 ' A' ' 36' ' ' LEU . 78.3 p -50.88 -56.35 12.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.95 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.393 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.43 -42.18 41.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.635 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 23.8 tp -73.62 -36.04 65.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.433 ' CB ' ' HB3' ' C' ' 43' ' ' ASN . 11.3 m120 -78.35 -3.14 41.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.706 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -84.26 1.29 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.089 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -98.21 174.49 6.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.906 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' B' ' 47' ' ' GLN . 7.4 p90 -165.31 -3.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 111.686 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.573 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.56 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.276 9.9 Cg_endo -74.43 100.38 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.629 2.219 . . . . 0.0 112.608 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 90.2 m-85 67.69 -167.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.405 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 148.2 81.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.228 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.418 HG23 ' CG ' ' B' ' 79' ' ' GLU . 15.0 p -88.28 -12.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.121 0.569 . . . . 0.0 112.402 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.78 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.332 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.77 2.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.637 0.256 . . . . 0.0 110.6 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 1.03 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.1 p -109.64 145.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.589 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 4.1 m-80 -128.47 135.31 49.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.648 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.63 122.65 44.26 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.313 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.487 ' HB ' ' CG ' ' B' ' 45' ' ' LEU . 22.4 p -112.01 124.65 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.932 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -155.3 149.84 26.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.611 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 172.97 165.52 30.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' B' ' 69' ' ' LEU . 6.9 m -111.31 165.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.05 -177.63 27.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -160.67 144.4 9.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.717 ' CD1' HD22 ' B' ' 36' ' ' LEU . 65.8 t80 -133.53 133.49 42.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 110.776 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.507 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 3.1 mmm-85 64.46 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.43 33.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.75 168.7 16.14 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -134.71 140.54 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.135 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.99 48.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.572 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.445 ' HA ' HG12 ' B' ' 60' ' ' VAL . 4.6 tp -111.18 127.35 55.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -122.76 151.89 41.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.726 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.458 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.4 tt -147.72 163.74 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.12 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 175.47 172.62 40.5 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.466 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 17.9 p -162.8 147.17 11.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.374 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.63 161.64 28.7 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.265 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -106.85 119.21 38.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 111.146 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.405 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 5.0 mmm180 -95.85 101.08 12.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.698 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' B' ' 78' ' ' ASN . 12.7 p -98.66 128.86 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.269 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.8 m120 65.2 -174.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.418 ' CG ' HG23 ' B' ' 51' ' ' VAL . 33.5 mt-10 -114.88 25.5 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.559 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.23 -46.38 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.27 151.12 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -153.43 169.8 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.235 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' B' ' 101' ' ' PHE . 0.6 OUTLIER -162.53 141.22 8.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.553 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.573 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.55 27.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.36 135.1 19.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -159.39 173.9 36.23 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.562 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.87 144.31 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.38 . . . . 0.0 111.148 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.459 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -112.85 135.38 53.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.313 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -111.12 111.02 21.81 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.3 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.945 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -123.92 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.581 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.573 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.84 -113.87 4.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 -58.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 111.293 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' SER . . . . . 0.526 ' OG ' ' O ' ' B' ' 93' ' ' SER . 2.2 t -103.86 28.36 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.153 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.427 ' CB ' ' HD2' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -118.22 82.86 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.81 142.8 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.724 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.09 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -127.94 129.35 46.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -117.48 159.3 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.47 0.35 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.761 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.74 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.8 p -122.8 178.56 4.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 39.3 p90 -142.22 146.07 34.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.642 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.5 m-80 -112.88 150.7 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.409 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.461 HG23 ' O ' ' B' ' 102' ' ' ASN . 2.9 pt -157.25 152.02 7.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 110.757 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 75.9 mt-10 -94.97 129.52 41.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.977 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 1.032 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 t-105 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.671 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.646 -0.181 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ASP . . . . . 0.549 ' HB2' ' H ' ' C' ' 7' ' ' SER . 86.4 m-20 40.58 -103.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -114.92 -48.61 2.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -177.34 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.019 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 13.9 t -69.8 -53.48 18.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.743 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' TRP . . . . . 0.408 ' HB2' ' HB2' ' C' ' 2' ' ' ASP . 75.5 m95 -48.5 -86.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.644 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.549 ' H ' ' HB2' ' C' ' 2' ' ' ASP . 19.5 m 65.07 46.65 2.71 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.029 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.736 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 16.4 m170 -73.83 -52.28 4.7 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.77 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.736 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.3 Cg_exo -50.97 116.45 2.64 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.486 2.124 . . . . 0.0 111.933 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' C' ' 8' ' ' HIS . 12.2 mm100 -128.21 -55.54 1.26 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.943 0.402 . . . . 0.0 111.155 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -125.72 -153.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.732 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.65 -28.18 63.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.41 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -138.3 20.66 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.516 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.39 -21.03 65.42 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.303 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -44.41 86.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 110.94 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' C' ' 20' ' ' GLN . 30.5 m-70 -71.74 -35.37 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.954 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.402 ' O ' HD22 ' C' ' 21' ' ' LEU . 36.1 ttmt -68.32 -47.29 67.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.544 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.71 -38.51 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.272 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -66.77 -45.71 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' C' ' 16' ' ' HIS . 0.8 OUTLIER -64.29 -40.79 96.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.757 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -64.45 -45.25 88.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.609 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.74 -28.34 69.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -74.78 -40.31 61.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.493 ' HD2' HD13 ' B' ' 25' ' ' LEU . 32.2 mtt180 -70.91 -41.13 71.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.819 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.669 HD21 ' HG ' ' A' ' 25' ' ' LEU . 7.9 mt -62.08 -49.72 74.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.656 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.37 -48.81 79.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.758 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 9.0 tmtt? -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.62 0.248 . . . . 0.0 111.286 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.645 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.4 OUTLIER -63.41 -40.42 97.16 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.69 91.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.954 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.577 HG22 ' HE2' ' C' ' 34' ' ' LYS . 3.8 m -57.6 -48.08 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.908 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.541 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 83.8 mmt-85 -57.28 -33.23 67.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.645 HG23 ' O ' ' C' ' 28' ' ' LEU . 44.4 t -76.78 -37.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.5 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 48.4 m-20 -61.92 -54.42 42.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.972 ' HB2' ' HB1' ' C' ' 90' ' ' ALA . 2.5 pttt -75.85 -36.08 59.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.798 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.37 88.16 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.708 HD22 ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -68.27 -39.64 82.12 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 111.012 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.8 91.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.655 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -68.68 -52.76 27.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.722 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.495 ' HB3' HD21 ' B' ' 36' ' ' LEU . 78.2 p -50.83 -56.41 12.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.83 -48.97 72.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.418 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.38 -42.12 41.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.96 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.619 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 24.0 tp -73.73 -35.95 65.13 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.074 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 11.4 m120 -78.3 -3.2 41.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' SER . . . . . 0.69 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.4 t -84.23 1.24 45.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.129 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -98.18 174.53 6.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.901 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.32 -3.55 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.553 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.65 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.948 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.46 100.41 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.696 2.264 . . . . 0.0 112.552 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 90.3 m-85 67.59 -167.18 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.23 81.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.255 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.418 HG23 ' CG ' ' C' ' 79' ' ' GLU . 15.0 p -88.19 -13.03 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.143 0.577 . . . . 0.0 112.381 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.85 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.72 2.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.603 0.24 . . . . 0.0 110.584 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 1.038 HG13 ' O ' ' A' ' 105' ' ' TRP . 2.1 p -109.67 145.88 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.509 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.424 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 4.1 m-80 -128.44 135.31 49.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.666 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.64 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.223 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.479 ' HB ' ' CG ' ' C' ' 45' ' ' LEU . 22.5 p -111.9 124.58 52.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.989 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.441 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -155.26 149.91 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.483 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.602 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 172.98 165.53 30.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' C' ' 69' ' ' LEU . 6.9 m -111.27 165.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.391 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.95 -177.59 27.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.465 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -160.68 144.36 9.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.708 ' CD1' HD22 ' C' ' 36' ' ' LEU . 65.5 t80 -133.5 133.45 42.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.729 0.299 . . . . 0.0 110.775 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.518 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm-85 64.45 -81.11 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.023 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 33.29 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.78 168.71 16.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.808 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -134.77 140.53 45.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.37 151.93 47.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.56 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.446 ' HA ' HG12 ' C' ' 60' ' ' VAL . 4.7 tp -111.07 127.43 55.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.787 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -122.8 151.89 41.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.452 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.6 tt -147.83 163.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 0.0 111.116 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 175.51 172.7 40.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.8 p -162.86 147.25 11.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.39 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.67 161.6 28.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.245 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -106.88 119.23 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.142 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' C' ' 76' ' ' ARG . 5.0 mmm180 -95.8 100.95 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.737 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' C' ' 78' ' ' ASN . 12.7 p -98.55 128.86 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.272 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.8 m120 65.27 -175.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' GLU . . . . . 0.418 ' CG ' HG23 ' C' ' 51' ' ' VAL . 33.5 mt-10 -114.86 25.42 10.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.582 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.37 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.21 151.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.514 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -153.45 169.75 22.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' C' ' 101' ' ' PHE . 0.6 OUTLIER -162.41 141.22 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.553 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.63 27.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.163 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.42 135.06 19.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.104 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.36 173.89 36.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.587 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.92 144.29 32.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.458 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -112.92 135.34 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.311 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -111.04 111.02 21.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.23 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.972 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -123.91 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.605 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.597 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.86 -113.85 4.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.298 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.79 -58.1 0.98 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.778 0.323 . . . . 0.0 111.32 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' SER . . . . . 0.513 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.2 t -103.85 28.38 6.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.161 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -118.23 82.82 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.8 142.81 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.708 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' B' ' 62' ' ' GLY . 0.8 OUTLIER -136.86 153.15 50.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.72 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -128.01 129.42 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -117.51 159.31 23.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.447 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.29 98.55 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.73 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.6 p -122.92 178.6 4.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' C' ' 83' ' ' LEU . 39.6 p90 -142.18 146.07 34.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 111.128 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.639 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.5 m-80 -112.85 150.64 31.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.397 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.452 HG23 ' O ' ' C' ' 102' ' ' ASN . 2.9 pt -157.2 152.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.774 0.321 . . . . 0.0 110.841 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 75.6 mt-10 -94.95 129.48 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 1.03 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.8 t-105 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.706 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 112.634 -0.186 . . . . 0.0 112.634 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' A' ' 7' ' ' SER . 87.2 m-20 37.38 -100.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.889 0.376 . . . . 0.0 110.965 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -112.48 -52.32 2.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.864 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 179.11 -61.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.4 t -72.82 -49.5 29.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.753 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -52.28 -89.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.713 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 2' ' ' ASP . 56.6 m 61.86 52.94 3.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.964 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.871 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 33.6 m170 -74.96 -54.32 2.68 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.873 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -59.77 123.48 13.37 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.476 2.117 . . . . 0.0 111.915 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.502 ' HG3' ' HE3' ' B' ' 17' ' ' LYS . 14.5 mm-40 -127.18 -51.55 1.41 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.012 0.434 . . . . 0.0 111.15 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -126.6 -157.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.757 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -66.33 -33.17 75.13 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.433 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -132.2 15.9 4.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.527 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.98 -24.39 59.9 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.251 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.34 93.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.892 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 18.3 m-70 -72.23 -30.54 64.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.949 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.515 ' CE ' ' HG3' ' C' ' 10' ' ' GLN . 36.4 ttmt -68.97 -46.6 67.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.518 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -35.45 75.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.309 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.07 -44.07 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -64.55 -46.86 81.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.092 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.06 -36.81 84.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.58 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.17 -35.91 82.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.031 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.82 -42.21 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.602 ' HD2' HD13 ' C' ' 25' ' ' LEU . 28.2 mtt180 -62.71 -38.13 89.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.747 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.614 HD13 ' HD2' ' B' ' 24' ' ' ARG . 12.7 mt -67.35 -53.98 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.95 -47.61 77.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.822 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.88 -44.78 94.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.173 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' C' ' 29' ' ' ASP . 0.6 OUTLIER -58.09 -42.68 86.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.619 ' HA ' HD21 ' B' ' 28' ' ' LEU . 39.9 t0 -64.65 -40.7 95.9 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.983 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.404 HG22 ' HE2' ' A' ' 34' ' ' LYS . 10.2 m -61.66 -44.42 96.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.801 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 88.4 mmt-85 -57.07 -37.74 72.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.7 HG22 HG11 ' C' ' 32' ' ' VAL . 10.0 t -73.27 -29.53 28.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.153 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.571 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 63.6 m-20 -67.95 -62.73 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.037 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.672 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -66.53 -44.64 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.771 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.87 -46.17 77.46 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.374 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -68.02 -34.18 76.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.852 0.358 . . . . 0.0 111.147 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.31 -45.71 83.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.461 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.813 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -67.56 -54.48 19.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.764 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.8 p -49.44 -55.06 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.12 -46.13 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.427 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.27 58.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 45' ' ' LEU . 43.1 tp -80.96 -36.79 30.43 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.01 -3.24 28.04 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.418 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 6.1 t -88.62 -7.52 56.25 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.14 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.5 OUTLIER -90.72 165.75 13.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.856 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.77 -2.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.14 0.495 . . . . 0.0 111.703 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 40.0 mt-30 67.12 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.907 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 47' ' ' GLN 0.406 9.9 Cg_endo -69.59 99.36 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.673 2.249 . . . . 0.0 112.524 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 60.78 -160.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 149.42 83.44 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.29 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.532 HG23 ' CG ' ' A' ' 79' ' ' GLU . 9.5 p -90.06 -15.51 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.234 0.614 . . . . 0.0 112.45 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 161.71 48.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.267 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.89 -170.25 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.625 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.036 HG13 ' O ' ' B' ' 105' ' ' TRP . 2.7 p -108.85 141.01 25.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.58 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' A' ' 48' ' ' PRO . 3.2 m-80 -125.37 133.96 52.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.53 45.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.246 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 47' ' ' GLN . 24.4 p -114.93 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.06 146.87 22.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.461 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 176.05 163.05 28.03 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.543 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 69' ' ' LEU . 6.3 m -105.7 167.15 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.23 27.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.522 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.67 141.31 7.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.542 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.574 ' HA ' ' HB2' ' B' ' 96' ' ' MET . 72.4 t80 -129.39 139.24 51.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.725 0.298 . . . . 0.0 110.786 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.46 HH11 ' HD3' ' A' ' 64' ' ' ARG . 3.0 mmm180 61.2 -81.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.045 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 t -155.96 35.57 0.34 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.1 m -133.06 166.85 21.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.39 142.83 47.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.49 44.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.565 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' HG12 ' A' ' 60' ' ' VAL . 9.1 tp -110.93 131.25 55.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.717 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -126.26 154.3 43.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.728 0.299 . . . . 0.0 111.613 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.449 HG12 ' N ' ' A' ' 72' ' ' GLY . 20.4 tt -147.76 162.9 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.76 0.314 . . . . 0.0 111.126 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.449 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 178.58 169.73 39.7 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.411 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -161.94 142.45 10.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.966 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.15 160.95 27.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.201 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.495 ' H ' HD11 ' A' ' 83' ' ' LEU . 25.5 t80 -106.59 116.2 31.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 111.133 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.487 HH11 ' HB2' ' A' ' 82' ' ' ALA . 5.2 mmm180 -93.87 93.22 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.509 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 8.7 p -93.88 126.04 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 12.2 m120 68.98 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.532 ' CG ' HG23 ' A' ' 51' ' ' VAL . 26.8 mt-10 -120.02 24.94 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.618 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 6.8 t -126.06 -39.4 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.982 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.06 152.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.504 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -149.05 174.53 12.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.226 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.495 HD11 ' H ' ' A' ' 75' ' ' TYR . 1.4 pp -163.88 143.63 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.44 ' HE3' HE21 ' A' ' 47' ' ' GLN . 2.2 ttmp? -146.7 128.19 15.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.55 135.64 15.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' HA3' ' CA ' ' A' ' 72' ' ' GLY . . . -161.34 178.52 37.23 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.546 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.21 140.54 41.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 111.14 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.571 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -112.57 131.68 55.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.79 112.04 24.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.221 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -124.96 131.24 53.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.616 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.668 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.05 -116.06 6.36 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.92 -61.22 1.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.303 . . . . 0.0 111.327 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 93' ' ' SER . 3.1 t -100.21 28.98 4.55 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.195 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.76 136.09 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.585 ' HB2' ' HA ' ' C' ' 63' ' ' TYR . 1.1 ptp -131.35 150.11 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.647 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -123.06 134.02 54.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.456 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.95 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.72 0.295 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.21 91.68 0.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.811 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.858 ' HB2' HD11 ' C' ' 45' ' ' LEU . 21.8 p -119.9 177.78 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.417 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -139.52 144.42 37.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.968 0.413 . . . . 0.0 111.068 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.954 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.0 m-80 -112.95 143.51 44.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.368 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.63 151.17 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.0 110.777 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.618 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 55.5 mt-10 -92.27 128.21 38.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.054 ' O ' HG13 ' C' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' B' ' 7' ' ' SER . 87.1 m-20 37.38 -100.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.954 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' B' ' 4' ' ' ALA . 59.2 mt-30 -112.48 -52.31 2.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' B' ' 3' ' ' GLN . . . 179.1 -61.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.028 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.3 t -72.81 -49.48 30.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.715 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -52.34 -89.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.704 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.414 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 55.7 m 61.85 52.92 3.27 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.033 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.871 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 33.6 m170 -74.93 -54.44 2.68 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.819 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -59.69 123.42 13.26 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.554 2.169 . . . . 0.0 111.933 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.51 ' HG3' ' HE3' ' C' ' 17' ' ' LYS . 14.5 mm-40 -127.19 -51.39 1.42 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.911 0.386 . . . . 0.0 111.149 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -126.83 -157.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.669 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -66.27 -33.21 75.24 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.458 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -132.26 16.11 4.56 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.513 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.11 -24.39 59.63 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.216 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.41 92.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 0.0 110.875 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' B' ' 20' ' ' GLN . 17.8 m-70 -72.09 -30.64 65.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.004 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.502 ' HE3' ' HG3' ' A' ' 10' ' ' GLN . 36.5 ttmt -68.91 -46.63 67.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.595 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.276 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -70.03 -44.16 69.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.772 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' B' ' 16' ' ' HIS . 0.9 OUTLIER -64.45 -46.87 81.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.125 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -63.13 -36.73 84.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.523 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.24 -35.81 82.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.87 -42.22 63.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.791 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.614 ' HD2' HD13 ' A' ' 25' ' ' LEU . 28.1 mtt180 -62.71 -38.09 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.608 HD13 ' HD2' ' C' ' 24' ' ' ARG . 12.7 mt -67.33 -54.1 23.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.86 -47.73 76.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.79 -44.77 93.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.249 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -57.95 -42.74 85.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.604 ' HA ' HD21 ' C' ' 28' ' ' LEU . 40.1 t0 -64.82 -40.59 95.45 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.932 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.408 HG22 ' HE2' ' B' ' 34' ' ' LYS . 10.0 m -61.62 -44.4 97.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.816 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.498 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 88.4 mmt-85 -57.27 -37.72 72.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.696 HG22 HG11 ' A' ' 32' ' ' VAL . 9.8 t -73.21 -29.49 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.566 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 63.6 m-20 -67.97 -62.74 1.27 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.681 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 0.5 OUTLIER -66.56 -44.59 81.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.89 -46.11 77.87 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.391 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.2 OUTLIER -68.08 -34.19 75.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.751 0.31 . . . . 0.0 111.055 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.71 83.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.804 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -67.54 -54.46 19.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.791 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.406 ' HB3' ' SD ' ' B' ' 96' ' ' MET . 47.5 p -49.47 -55.06 14.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.11 82.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.403 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.24 58.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.616 HD12 HD23 ' B' ' 45' ' ' LEU . 42.7 tp -81.05 -36.75 30.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.02 -3.17 27.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 6.1 t -88.65 -7.59 56.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.105 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.859 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.5 OUTLIER -90.62 165.74 13.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.882 177.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 8.6 p90 -154.84 -2.91 0.16 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.102 0.477 . . . . 0.0 111.609 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.437 ' HG2' HG23 ' B' ' 57' ' ' THR . 39.9 mt-30 66.99 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.993 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.44 ' HD2' ' OD1' ' B' ' 55' ' ' ASN 0.405 9.9 Cg_endo -69.6 99.41 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.685 2.257 . . . . 0.0 112.518 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 60.73 -159.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.976 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 149.27 83.48 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.309 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.527 HG23 ' CG ' ' B' ' 79' ' ' GLU . 9.6 p -90.06 -15.5 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.148 0.579 . . . . 0.0 112.495 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 161.71 48.47 0.02 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.27 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.83 -170.11 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.579 0.228 . . . . 0.0 110.614 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 1.026 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.7 p -108.97 141.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.608 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.44 ' OD1' ' HD2' ' B' ' 48' ' ' PRO . 3.2 m-80 -125.34 133.84 52.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 111.702 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.77 124.54 45.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.243 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.437 HG23 ' HG2' ' B' ' 47' ' ' GLN . 24.4 p -114.93 125.48 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.03 146.93 22.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.431 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.512 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 175.99 163.0 27.92 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.545 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' B' ' 69' ' ' LEU . 6.3 m -105.68 167.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 111.36 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.94 -176.23 27.84 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.71 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.58 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.6 ' HA ' ' HB2' ' C' ' 96' ' ' MET . 72.5 t80 -129.35 139.27 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.658 0.266 . . . . 0.0 110.761 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' B' ' 64' ' ' ARG . 3.0 mmm180 61.13 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.08 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 63' ' ' TYR . 8.0 t -155.88 35.51 0.35 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.17 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.9 m -133.15 166.73 21.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -134.29 142.91 47.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.045 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.96 156.47 44.88 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' B' ' 60' ' ' VAL . 9.2 tp -110.97 131.31 55.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.725 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -126.15 154.24 43.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.691 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.449 HG12 ' N ' ' B' ' 72' ' ' GLY . 20.4 tt -147.75 162.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.722 0.296 . . . . 0.0 111.186 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.449 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 178.56 169.66 39.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.45 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.47 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.16 160.87 27.88 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.248 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.506 ' H ' HD11 ' B' ' 83' ' ' LEU . 25.3 t80 -106.53 116.19 31.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.162 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.496 HH11 ' HB2' ' B' ' 82' ' ' ALA . 5.2 mmm180 -93.83 93.18 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' B' ' 78' ' ' ASN . 8.7 p -93.89 126.06 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.311 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 12.1 m120 69.04 -172.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.527 ' CG ' HG23 ' B' ' 51' ' ' VAL . 26.8 mt-10 -120.03 24.9 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.619 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 6.8 t -126.0 -39.5 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -114.99 152.54 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.963 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -149.0 174.61 12.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.286 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.506 HD11 ' H ' ' B' ' 75' ' ' TYR . 1.4 pp -163.84 143.7 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.617 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.429 ' HE3' HE21 ' B' ' 47' ' ' GLN . 2.2 ttmp? -146.77 128.1 14.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.43 135.65 15.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' CA ' ' B' ' 72' ' ' GLY . . . -161.32 178.5 37.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.603 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.18 140.58 41.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.905 0.383 . . . . 0.0 111.123 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.572 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -112.55 131.7 55.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.355 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.8 111.96 24.84 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.278 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -124.91 131.29 53.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.612 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.681 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.0 -116.11 6.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.224 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -127.92 -61.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.313 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.0 t -100.27 29.04 4.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.157 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -118.35 83.08 1.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.8 136.05 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' TYR . 1.1 ptp -131.34 150.14 52.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -123.17 134.01 54.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.375 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.98 24.94 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.389 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.82 0.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.721 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.856 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.7 p -120.0 177.78 4.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.429 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -139.55 144.38 37.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.092 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.963 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.1 m-80 -112.92 143.6 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.353 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.72 151.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.619 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 55.4 mt-10 -92.3 128.13 38.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 1.036 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.678 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.659 -0.177 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' C' ' 7' ' ' SER . 87.2 m-20 37.39 -100.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.87 0.367 . . . . 0.0 110.964 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -112.45 -52.28 2.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 179.08 -61.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -72.83 -49.51 29.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -52.34 -89.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.673 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.409 ' H ' ' HB2' ' C' ' 2' ' ' ASP . 56.7 m 61.94 52.94 3.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.965 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.848 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 33.6 m170 -74.97 -54.38 2.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.822 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.848 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -59.74 123.39 13.19 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.458 2.106 . . . . 0.0 111.984 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' GLN . . . . . 0.515 ' HG3' ' CE ' ' A' ' 17' ' ' LYS . 14.5 mm-40 -127.13 -51.37 1.42 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.951 0.405 . . . . 0.0 111.208 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -126.79 -157.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.671 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' C' ' 12' ' ' GLU . 5.2 mt-10 -66.27 -33.16 75.12 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.494 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -132.32 16.03 4.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.519 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.0 -24.4 59.82 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.229 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.47 92.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.835 0.35 . . . . 0.0 110.914 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' C' ' 20' ' ' GLN . 18.1 m-70 -72.04 -30.57 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.979 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.51 ' HE3' ' HG3' ' B' ' 10' ' ' GLN . 36.4 ttmt -68.99 -46.6 67.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.44 -35.48 75.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.249 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.03 -44.13 69.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.798 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' C' ' 16' ' ' HIS . 0.9 OUTLIER -64.41 -46.91 81.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' C' ' 21' ' ' LEU . 0.0 OUTLIER -63.06 -36.82 84.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.589 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.11 -35.96 82.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.001 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.81 -42.19 64.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.608 ' HD2' HD13 ' B' ' 25' ' ' LEU . 28.1 mtt180 -62.72 -38.09 89.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.788 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.602 HD13 ' HD2' ' A' ' 24' ' ' ARG . 12.6 mt -67.34 -54.03 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.92 -47.74 76.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.813 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.75 -44.8 93.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.191 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.604 HD21 ' HA ' ' B' ' 29' ' ' ASP . 0.6 OUTLIER -58.03 -42.63 85.73 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ASP . . . . . 0.612 ' HA ' HD21 ' A' ' 28' ' ' LEU . 40.1 t0 -64.85 -40.57 95.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.949 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.405 HG22 ' HE2' ' C' ' 34' ' ' LYS . 10.2 m -61.69 -44.39 97.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.789 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.495 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 88.2 mmt-85 -57.2 -37.65 72.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.7 HG11 HG22 ' A' ' 32' ' ' VAL . 9.9 t -73.25 -29.6 28.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.118 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.572 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 63.6 m-20 -67.92 -62.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.023 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 0.5 OUTLIER -66.51 -44.61 82.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.804 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.86 -46.17 77.38 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.2 OUTLIER -68.07 -34.11 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.65 82.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.82 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -67.53 -54.48 19.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.406 ' HB3' ' SD ' ' C' ' 96' ' ' MET . 47.6 p -49.45 -55.06 14.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.09 82.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.515 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.89 -39.18 58.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.608 HD12 HD23 ' C' ' 45' ' ' LEU . 42.9 tp -81.08 -36.66 30.15 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.04 -3.24 28.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -88.62 -7.6 56.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.081 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.5 OUTLIER -90.58 165.75 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.924 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.83 -3.0 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.105 0.479 . . . . 0.0 111.649 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.448 HE21 ' HE3' ' C' ' 84' ' ' LYS . 40.0 mt-30 67.04 122.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.937 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' OD1' ' C' ' 55' ' ' ASN 0.406 9.8 Cg_endo -69.53 99.34 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.632 2.222 . . . . 0.0 112.556 -179.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 60.84 -160.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 149.36 83.55 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.198 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.522 HG23 ' CG ' ' C' ' 79' ' ' GLU . 9.5 p -90.14 -15.52 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.217 0.607 . . . . 0.0 112.393 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 161.73 48.48 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.305 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.88 -170.15 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.675 0.274 . . . . 0.0 110.549 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 1.054 HG13 ' O ' ' A' ' 105' ' ' TRP . 2.7 p -108.94 141.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.613 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.428 ' OD1' ' HD2' ' C' ' 48' ' ' PRO . 3.2 m-80 -125.42 133.92 52.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.015 0.435 . . . . 0.0 111.661 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.46 45.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.204 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.447 HG23 ' HG2' ' C' ' 47' ' ' GLN . 24.3 p -114.9 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.903 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.94 146.92 22.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 175.97 163.05 27.99 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.565 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' C' ' 69' ' ' LEU . 6.2 m -105.76 167.21 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 111.226 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.04 -176.25 27.96 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.503 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.69 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.568 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 96' ' ' MET . 72.2 t80 -129.35 139.31 51.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.698 0.285 . . . . 0.0 110.729 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.446 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm180 61.09 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.094 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 65' ' ' SER . . . . . 0.4 ' N ' ' O ' ' C' ' 63' ' ' TYR . 8.0 t -155.91 35.41 0.35 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 7.0 m -132.99 166.83 21.48 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.36 142.8 47.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.89 156.51 44.93 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' C' ' 60' ' ' VAL . 9.4 tp -110.95 131.22 55.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -126.15 154.31 43.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.704 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.448 HG12 ' N ' ' C' ' 72' ' ' GLY . 20.4 tt -147.73 162.89 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.749 0.309 . . . . 0.0 111.137 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.448 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 178.52 169.67 39.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.431 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.46 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.05 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.12 160.92 27.88 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.246 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.507 ' H ' HD11 ' C' ' 83' ' ' LEU . 25.4 t80 -106.59 116.23 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.166 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.476 HH11 ' HB2' ' C' ' 82' ' ' ALA . 5.2 mmm180 -93.85 93.16 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' C' ' 78' ' ' ASN . 8.7 p -93.87 126.11 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.273 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 12.2 m120 68.89 -171.96 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.921 0.391 . . . . 0.0 111.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' GLU . . . . . 0.522 ' CG ' HG23 ' C' ' 51' ' ' VAL . 26.3 mt-10 -119.98 24.87 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.616 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' SER . . . . . 0.615 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 6.8 t -126.06 -39.36 2.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.994 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.01 152.61 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.971 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -149.05 174.63 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.278 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.507 HD11 ' H ' ' C' ' 75' ' ' TYR . 1.4 pp -163.84 143.74 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.448 ' HE3' HE21 ' C' ' 47' ' ' GLN . 2.2 ttmp? -146.82 128.16 14.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.48 135.66 15.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.412 ' HA3' ' CA ' ' C' ' 72' ' ' GLY . . . -161.36 178.57 37.22 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.556 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.25 140.64 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.872 0.367 . . . . 0.0 111.088 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.572 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -112.6 131.65 55.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.323 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -105.77 112.05 24.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.292 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.82 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -125.01 131.23 53.44 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.579 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.695 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.09 -116.15 6.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.235 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.86 -61.25 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.717 0.294 . . . . 0.0 111.299 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' SER . . . . . 0.486 ' O ' ' OG ' ' C' ' 93' ' ' SER . 3.1 t -100.19 28.98 4.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.193 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 t -118.82 136.05 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.0 110.706 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.6 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 1.1 ptp -131.31 150.07 52.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -123.08 133.96 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.365 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -116.96 157.96 24.88 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.705 0.288 . . . . 0.0 111.471 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.72 0.12 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.771 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.859 ' HB2' HD11 ' B' ' 45' ' ' LEU . 21.6 p -119.91 177.82 4.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.432 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -139.58 144.48 37.8 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.028 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.971 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.0 m-80 -112.96 143.57 44.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.332 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.7 151.19 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.866 0.365 . . . . 0.0 110.77 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.615 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 55.5 mt-10 -92.33 128.2 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 1.026 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.696 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.681 -0.167 . . . . 0.0 112.681 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 7' ' ' SER . 71.6 m-20 37.93 -106.92 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.42 . . . . 0.0 110.91 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.591 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 43.9 mt-30 -108.29 -45.14 3.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . 167.7 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.055 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.0 t -68.42 -52.49 32.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.787 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -60.91 -78.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.704 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.466 ' H ' ' HB2' ' A' ' 2' ' ' ASP . 66.7 m 54.86 56.4 6.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.02 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.669 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 39.6 m80 -78.12 -48.16 2.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.753 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.669 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -55.97 122.21 11.35 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.49 2.127 . . . . 0.0 111.853 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 8' ' ' HIS . 12.7 mm-40 -130.8 -51.98 1.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.934 0.397 . . . . 0.0 111.103 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -130.38 -158.62 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.676 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 mt-10 -64.71 -29.0 69.97 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.506 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -135.57 20.87 3.35 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.529 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.16 -18.66 58.85 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.246 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . -72.04 -45.96 58.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 110.915 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -76.11 -26.07 56.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.963 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -74.27 -47.95 31.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -72.49 -34.87 67.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.215 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 18.6 mtt85 -65.97 -40.06 90.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.85 -44.91 63.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 111.134 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.853 HD23 HD21 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.61 -37.96 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.591 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.75 -31.13 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.038 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.07 -39.6 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.65 -37.56 67.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.782 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.3 mt -68.96 -42.7 76.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.648 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.22 -38.81 92.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.74 74.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.636 0.255 . . . . 0.0 111.181 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' C' ' 28' ' ' LEU . 0.5 OUTLIER -59.9 -43.73 94.67 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -59.8 -40.5 88.59 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.951 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 34' ' ' LYS . 26.0 m -66.67 -41.38 88.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.804 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.337 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 28' ' ' LEU . 3.0 t -76.09 -32.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.224 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.701 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 70.4 m-20 -65.56 -63.89 0.99 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.121 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.71 -34.54 62.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.773 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.45 78.44 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.446 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -72.53 -27.31 62.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 111.073 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.61 55.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.399 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -68.83 -41.58 78.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.9 ' HB3' HD21 ' C' ' 36' ' ' LEU . 31.5 p -55.84 -58.98 5.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.446 ' HB3' HD21 ' B' ' 98' ' ' ASN . . . -55.85 -39.54 71.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.444 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -60.73 -37.44 81.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.968 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 tp -75.16 -37.33 61.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.5 m-20 -76.45 -5.84 49.14 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.519 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.2 t -79.24 -11.23 59.95 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.125 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.754 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -84.2 177.57 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.874 177.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.651 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.5 p90 -169.53 -15.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.144 0.497 . . . . 0.0 111.705 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.762 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 40.8 mt-30 81.17 114.64 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.95 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.46 99.43 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.654 2.236 . . . . 0.0 112.558 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 62.24 -160.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.985 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 144.54 93.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.22 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 7.5 p -88.85 -27.1 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.126 0.57 . . . . 0.0 112.444 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 172.25 34.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.269 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.71 -165.43 1.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 110.605 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' O ' ' B' ' 105' ' ' TRP . 8.9 p -110.27 141.33 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.508 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.561 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 6.7 m-80 -120.05 135.84 54.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.977 0.417 . . . . 0.0 111.669 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.578 ' HB2' ' HB2' ' B' ' 105' ' ' TRP . 2.2 t80 -99.85 128.52 45.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.27 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.754 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 42.7 p -117.64 131.44 56.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.79 143.39 9.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.485 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 178.77 165.5 33.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 69' ' ' LEU . 10.9 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.876 0.369 . . . . 0.0 111.345 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -155.5 -174.91 25.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.415 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.38 144.52 9.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.701 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 87.7 t80 -130.49 127.74 39.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.773 0.321 . . . . 0.0 110.69 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 6.9 mmm-85 66.35 -86.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.15 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.76 30.33 0.99 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.152 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.48 159.45 41.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.094 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.52 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.543 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' VAL . 8.0 tp -115.1 137.33 52.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.768 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.677 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.81 158.39 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.119 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 177.44 173.2 42.72 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.45 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.19 142.86 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.21 156.5 26.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.226 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -105.11 116.1 31.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 111.101 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.502 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 9.6 mmm180 -95.98 89.11 5.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.752 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.702 HG22 ' OD1' ' A' ' 78' ' ' ASN . 7.7 p -95.73 123.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.302 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.702 ' OD1' HG22 ' A' ' 77' ' ' VAL . 19.9 m120 64.15 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.147 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -99.74 32.06 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.603 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.488 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 t -131.74 -37.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.521 HG13 HG13 ' A' ' 77' ' ' VAL . 13.6 p -118.74 148.81 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -150.69 171.24 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.252 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.07 148.67 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.611 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.762 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -146.35 131.77 18.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.182 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.67 12.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -157.99 171.16 34.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.619 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.16 139.29 47.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.87 0.367 . . . . 0.0 111.093 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.32 132.22 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.77 121.52 41.83 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -130.1 124.34 32.53 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.589 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 61.93 -110.66 3.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.345 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -132.1 -63.34 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -99.05 24.64 7.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.136 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -116.4 85.14 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.943 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.76 137.55 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.484 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -129.64 158.12 40.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.713 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -133.84 137.52 45.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.451 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.463 HD21 ' HB3' ' C' ' 40' ' ' ALA . 34.6 m120 -125.63 152.26 45.42 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.745 0.307 . . . . 0.0 111.437 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.76 92.82 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.773 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.562 ' HB2' HD11 ' C' ' 45' ' ' LEU . 79.0 p -115.73 -177.57 3.18 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.41 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.45 140.52 22.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.945 0.403 . . . . 0.0 111.088 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.756 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 66.3 m-80 -112.28 144.01 42.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.435 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.419 ' CG2' HG23 ' A' ' 81' ' ' VAL . 4.1 pt -154.98 135.07 4.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 110.766 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.56 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 66.3 mt-10 -70.54 131.35 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.936 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.585 ' O ' HG13 ' C' ' 54' ' ' VAL . 32.9 t-105 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.698 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' B' ' 7' ' ' SER . 71.4 m-20 37.83 -106.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.961 0.41 . . . . 0.0 110.853 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' B' ' 4' ' ' ALA . 44.1 mt-30 -108.22 -45.2 3.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' B' ' 3' ' ' GLN . . . 167.67 -60.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -68.54 -52.44 32.01 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -60.91 -78.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.648 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.455 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 66.9 m 54.92 56.32 6.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.014 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.662 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 39.6 m80 -78.06 -48.15 2.09 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.774 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -55.95 122.18 11.3 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.424 2.083 . . . . 0.0 111.898 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' B' ' 8' ' ' HIS . 12.6 mm-40 -130.75 -51.92 1.06 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.996 0.426 . . . . 0.0 111.211 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -130.42 -158.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.578 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' B' ' 12' ' ' GLU . 3.0 mt-10 -64.54 -29.09 70.12 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.482 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -135.58 20.85 3.34 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.507 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.19 -18.69 58.76 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.191 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -46.09 58.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 110.906 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -75.97 -26.12 56.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.978 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -74.25 -47.95 31.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.548 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' PHE . . . . . 0.401 ' O ' ' HD1' ' B' ' 18' ' ' PHE . 0.2 OUTLIER -72.47 -34.84 67.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.231 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 18.5 mtt85 -65.97 -40.09 90.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.81 -44.93 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.118 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.853 HD21 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.49 -38.06 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.83 -31.05 66.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.16 -39.49 78.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.74 -37.57 67.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.732 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.0 -42.75 76.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -64.22 -38.82 92.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.63 74.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.67 0.271 . . . . 0.0 111.25 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' C' ' 28' ' ' LEU . 0.5 OUTLIER -59.92 -43.75 94.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.73 -40.57 88.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.963 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.622 HG22 ' HE2' ' B' ' 34' ' ' LYS . 25.9 m -66.65 -41.36 88.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.88 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' B' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.256 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 28' ' ' LEU . 3.0 t -76.12 -32.54 22.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.213 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.704 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 70.4 m-20 -65.59 -63.88 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' B' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.46 62.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.799 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.87 -49.43 78.65 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.874 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -72.55 -27.34 62.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.84 -52.63 55.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.409 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.3 OUTLIER -68.83 -41.55 78.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.74 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.884 ' HB3' HD21 ' A' ' 36' ' ' LEU . 31.5 p -55.83 -59.04 5.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' C' ' 98' ' ' ASN . . . -55.76 -39.55 71.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.469 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.489 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -60.76 -37.45 81.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.22 -37.3 61.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.049 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.566 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.4 m-20 -76.48 -5.86 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.531 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.2 t -79.23 -11.2 59.96 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.193 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.743 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 0.7 OUTLIER -84.32 177.59 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.806 178.022 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.648 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 12.6 p90 -169.57 -15.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.622 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.749 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 40.8 mt-30 81.24 114.62 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.906 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.405 9.7 Cg_endo -69.55 99.55 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.623 2.215 . . . . 0.0 112.491 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 62.13 -160.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.013 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 144.56 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.222 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 78' ' ' ASN . 7.5 p -88.91 -27.04 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.194 0.597 . . . . 0.0 112.433 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 172.22 34.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.292 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.66 -165.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.681 0.276 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.588 HG13 ' O ' ' C' ' 105' ' ' TRP . 8.9 p -110.39 141.19 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.523 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.557 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 6.7 m-80 -119.99 135.83 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.952 0.406 . . . . 0.0 111.689 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.585 ' HB2' ' HB2' ' C' ' 105' ' ' TRP . 2.2 t80 -99.9 128.57 45.98 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.212 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.743 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 42.6 p -117.62 131.41 56.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.023 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.8 143.35 9.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.455 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 178.83 165.52 33.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.586 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' B' ' 69' ' ' LEU . 11.0 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.338 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -155.52 -174.93 25.96 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.45 144.39 9.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.704 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 87.5 t80 -130.37 127.79 40.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 6.9 mmm-85 66.32 -86.57 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.185 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.84 30.43 0.97 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.23 167.92 16.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.792 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.38 159.46 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 165.61 36.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.545 ' HA ' HG12 ' B' ' 60' ' ' VAL . 8.0 tp -115.1 137.32 52.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.54 148.85 50.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.673 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.76 158.33 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 0.0 111.13 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 177.45 173.12 42.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.422 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.17 142.81 19.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.52 26.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.13 116.17 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 111.14 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.51 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 9.6 mmm180 -95.96 89.16 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.661 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.714 HG22 ' OD1' ' B' ' 78' ' ' ASN . 7.7 p -95.76 123.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 111.243 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.714 ' OD1' HG22 ' B' ' 77' ' ' VAL . 19.9 m120 64.12 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -99.76 32.13 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.552 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.482 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 9.8 t -131.84 -37.7 1.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.505 HG13 HG13 ' B' ' 77' ' ' VAL . 13.8 p -118.78 148.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -150.56 171.24 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.09 148.71 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.608 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.749 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -146.33 131.83 18.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.177 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.58 126.69 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -158.0 171.2 34.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.603 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.18 139.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.861 0.362 . . . . 0.0 111.06 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.36 132.25 54.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -100.72 121.51 41.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . . . -130.1 124.23 32.26 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.651 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.491 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 61.91 -110.66 3.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.292 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -132.06 -63.44 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.268 . . . . 0.0 111.281 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.96 24.66 7.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.211 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.4 OUTLIER -116.41 85.11 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.84 137.56 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.476 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -129.62 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.683 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.77 137.53 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.452 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.446 HD21 ' HB3' ' A' ' 40' ' ' ALA . 34.6 m120 -125.6 152.22 45.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.727 0.298 . . . . 0.0 111.458 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.8 92.8 1.13 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 45' ' ' LEU . 79.0 p -115.7 -177.61 3.19 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.41 140.54 23.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 111.139 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.775 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 66.4 m-80 -112.34 143.99 42.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.356 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.421 ' CG2' HG23 ' B' ' 81' ' ' VAL . 4.2 pt -154.98 135.01 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.838 0.351 . . . . 0.0 110.776 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.561 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 66.1 mt-10 -70.49 131.41 43.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 56' ' ' PHE . 33.2 t-105 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.466 -0.778 . . . . 0.0 110.681 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.639 -0.184 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ASP . . . . . 0.462 ' HB2' ' H ' ' C' ' 7' ' ' SER . 71.5 m-20 37.86 -106.99 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.947 0.403 . . . . 0.0 110.854 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' C' ' 4' ' ' ALA . 44.1 mt-30 -108.21 -45.12 3.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 4' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' C' ' 3' ' ' GLN . . . 167.7 -60.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.01 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.0 t -68.45 -52.44 32.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.763 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -60.98 -78.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.67 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' C' ' 2' ' ' ASP . 66.7 m 54.84 56.32 6.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.042 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.664 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 39.6 m80 -78.02 -48.1 2.12 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.841 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.6 Cg_exo -56.05 122.24 11.41 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.472 2.115 . . . . 0.0 111.824 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 10' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' C' ' 8' ' ' HIS . 12.6 mm-40 -130.81 -51.91 1.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -130.42 -158.71 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.604 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' GLU . . . . . 0.49 ' H ' ' HG3' ' C' ' 12' ' ' GLU . 3.0 mt-10 -64.65 -29.06 70.06 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.446 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -135.55 20.84 3.35 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.56 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.17 -18.6 58.95 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.302 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' C' ' 19' ' ' ARG . . . -72.07 -46.03 58.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 110.896 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -75.96 -26.13 56.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.977 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -74.22 -48.06 31.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -34.92 68.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.273 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 19' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' C' ' 15' ' ' ALA . 18.6 mtt85 -65.86 -40.1 91.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.803 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.88 -44.88 63.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.843 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.54 -38.08 68.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.623 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.67 -31.15 66.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.14 -39.54 78.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -72.68 -37.52 67.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.741 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.02 -42.69 76.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.626 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.23 -38.82 92.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.824 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 3.0 tmtt? -69.56 -42.66 74.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.253 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.93 -43.8 94.73 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.69 -40.53 88.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.0 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.622 HG22 ' HE2' ' C' ' 34' ' ' LYS . 25.9 m -66.72 -41.28 88.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.902 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' C' ' 27' ' ' LYS . 86.4 mmt-85 -54.89 -38.06 67.1 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.389 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.5 HG23 ' O ' ' C' ' 28' ' ' LEU . 3.0 t -76.13 -32.53 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.218 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.722 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 70.4 m-20 -65.51 -63.96 0.97 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.075 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' C' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.47 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.758 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.39 79.18 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.384 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.9 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -72.56 -27.34 62.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.803 0.335 . . . . 0.0 111.066 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.56 55.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.3 OUTLIER -68.87 -41.48 78.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.874 ' HB3' HD21 ' B' ' 36' ' ' LEU . 31.3 p -55.86 -58.96 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.463 ' HB3' HD21 ' A' ' 98' ' ' ASN . . . -55.86 -39.61 71.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.441 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -60.66 -37.47 81.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.21 -37.4 61.14 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 75.4 m-20 -76.32 -5.93 49.28 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' SER . . . . . 0.534 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.2 t -79.21 -11.24 59.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.111 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 0.7 OUTLIER -84.22 177.63 8.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.784 178.062 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.629 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 12.6 p90 -169.61 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.611 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.742 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 40.9 mt-30 81.13 114.59 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.986 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.42 99.41 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.709 2.272 . . . . 0.0 112.564 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 62.24 -160.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.005 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 144.55 93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.255 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' C' ' 78' ' ' ASN . 7.5 p -88.86 -27.03 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.154 0.582 . . . . 0.0 112.468 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 172.18 34.55 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.269 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.64 -165.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.646 0.26 . . . . 0.0 110.592 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 105' ' ' TRP . 8.9 p -110.36 141.26 26.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.523 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.56 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 6.8 m-80 -120.01 135.74 54.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.973 0.416 . . . . 0.0 111.73 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.58 ' HB2' ' HB2' ' A' ' 105' ' ' TRP . 2.2 t80 -99.75 128.47 45.85 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.75 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.0 p -117.58 131.46 56.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.97 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.84 143.35 9.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.49 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 178.79 165.55 33.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.538 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' C' ' 69' ' ' LEU . 10.9 m -111.8 168.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.838 0.352 . . . . 0.0 111.326 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -155.46 -174.9 25.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.418 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.4 144.49 9.71 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.722 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 87.6 t80 -130.48 127.78 39.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 110.736 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 6.8 mmm-85 66.3 -86.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -146.84 30.32 0.98 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.25 167.95 16.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -136.45 159.43 41.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.104 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.53 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.561 ' HA ' HG12 ' C' ' 60' ' ' VAL . 8.0 tp -115.07 137.28 52.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.782 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.53 148.87 50.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.699 0.285 . . . . 0.0 111.651 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.82 158.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 177.41 173.18 42.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.488 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -155.19 142.72 19.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.12 156.5 26.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.234 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.09 116.19 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.133 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.504 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 9.6 mmm180 -95.96 89.1 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.723 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.711 HG22 ' OD1' ' C' ' 78' ' ' ASN . 7.7 p -95.74 123.77 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 111.208 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.711 ' OD1' HG22 ' C' ' 77' ' ' VAL . 19.9 m120 64.27 167.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 111.09 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -99.81 32.09 3.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.572 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 80' ' ' SER . . . . . 0.489 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 9.7 t -131.75 -37.75 1.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.991 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.51 HG13 HG13 ' C' ' 77' ' ' VAL . 13.7 p -118.75 148.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.513 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -150.71 171.12 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.258 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -162.96 148.77 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.573 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.742 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -146.37 131.8 18.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.75 12.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -158.12 171.17 35.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.572 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.2 139.27 48.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 111.114 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.31 54.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.78 121.49 41.78 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.271 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' C' ' 94' ' ' ASP . . . -130.1 124.23 32.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.628 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.488 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 61.94 -110.63 3.32 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.274 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.5 m -132.1 -63.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 0.0 111.295 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.99 24.7 7.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.4 OUTLIER -116.42 85.1 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.947 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.77 137.6 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.4 OUTLIER -129.6 158.17 40.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.84 137.58 45.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.388 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.455 HD21 ' HB3' ' B' ' 40' ' ' ALA . 34.6 m120 -125.72 152.19 45.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.417 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.78 92.83 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.562 ' HB2' HD11 ' B' ' 45' ' ' LEU . 79.0 p -115.73 -177.61 3.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.447 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.38 140.61 23.11 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.08 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.786 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 66.4 m-80 -112.31 143.94 42.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.418 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.423 ' CG2' HG23 ' C' ' 81' ' ' VAL . 4.1 pt -154.96 135.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.557 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 66.4 mt-10 -70.52 131.35 43.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.977 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 0.588 ' O ' HG13 ' B' ' 54' ' ' VAL . 33.1 t-105 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.664 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.468 ' OD1' ' OG ' ' A' ' 5' ' ' SER . 3.8 t70 78.28 134.34 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.934 0.397 . . . . 0.0 110.953 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -130.95 -65.15 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.71 32.44 1.82 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.995 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 2' ' ' ASP . 58.4 p -99.94 155.02 17.91 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.758 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -105.91 -80.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.675 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m 59.78 42.17 17.11 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.033 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.88 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 33.1 m170 -80.68 -54.47 0.77 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.825 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.88 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.3 Cg_exo -59.27 120.06 7.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.478 2.119 . . . . 0.0 111.971 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -100.2 -65.66 0.95 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.917 0.389 . . . . 0.0 111.146 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -114.7 175.0 5.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.631 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.37 28.6 0.34 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.448 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -46.47 15.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.532 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.1 -26.29 63.29 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.25 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.18 -48.07 83.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.365 . . . . 0.0 110.952 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -76.46 -39.82 52.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.993 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.623 ' HE2' ' HB2' ' C' ' 17' ' ' LYS . 0.2 OUTLIER -60.04 -35.21 74.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.533 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.97 -37.86 64.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.208 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.2 -60.4 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.68 65.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.097 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.699 HD22 HD23 ' A' ' 25' ' ' LEU . 2.3 tm? -66.96 -62.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -62.24 -23.76 66.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.52 -49.51 47.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.606 ' HD3' HD11 ' C' ' 21' ' ' LEU . 69.0 mtp85 -73.33 -42.15 62.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.024 HD22 HD11 ' C' ' 25' ' ' LEU . 3.9 mm? -61.36 -46.08 91.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.559 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.29 -32.97 74.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.787 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.79 83.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.185 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -62.6 -47.94 81.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.115 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.52 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -60.98 -32.0 71.57 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.967 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.52 HG22 ' HE2' ' A' ' 34' ' ' LYS . 6.3 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.85 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.402 HH12 ' HB3' ' A' ' 93' ' ' SER . 0.0 OUTLIER -78.73 -30.72 46.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.381 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 29' ' ' ASP . 30.3 m -83.5 -33.49 9.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.515 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 57.9 m-20 -66.29 -48.69 69.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' CD ' ' HA3' ' A' ' 91' ' ' GLY . 6.6 ptpt -85.07 -25.69 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.835 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.91 -40.68 63.08 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.393 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.59 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -77.11 -25.73 52.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.329 . . . . 0.0 111.034 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.409 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -72.31 -40.93 67.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.444 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.671 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 13.3 t -79.0 -43.01 25.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.426 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.4 OUTLIER -59.73 -56.71 18.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.34 -40.88 78.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.395 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.41 -35.13 67.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 26.0 tp -76.26 -42.4 45.85 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.601 ' CB ' ' HB3' ' B' ' 43' ' ' ASN . 8.6 m120 -70.83 -13.81 62.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -67.26 -21.88 65.69 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.128 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' B' ' 100' ' ' SER . 1.5 mm? -80.07 171.8 14.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.857 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.488 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.3 p90 -158.11 -3.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.628 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.576 ' HB2' HH21 ' A' ' 76' ' ' ARG . 7.1 mt-30 71.51 119.79 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.953 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.262 9.8 Cg_endo -75.09 106.7 2.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.65 2.233 . . . . 0.0 112.497 -179.226 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.19 -177.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 173.02 51.34 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.245 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 4.9 p -73.32 -3.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.12 0.568 . . . . 0.0 112.519 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.9 54.33 0.03 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.272 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.82 -165.04 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.24 145.08 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.5 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.642 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.5 m-80 -126.16 118.43 25.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.65 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' A' ' 73' ' ' SER . 31.8 t80 -83.66 130.31 34.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.255 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.494 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 75.5 p -114.66 120.9 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.986 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 71' ' ' ILE . . . -152.26 135.29 15.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.488 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -179.72 168.57 39.06 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.55 ' CG1' HD12 ' A' ' 69' ' ' LEU . 13.3 m -116.96 158.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 111.418 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.99 -170.89 14.34 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.481 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -165.5 142.67 7.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.593 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 56.1 t80 -134.01 134.7 42.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.684 0.278 . . . . 0.0 110.771 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.71 28.59 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 1.6 m -133.77 142.05 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.3 157.11 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.099 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.671 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -149.48 167.78 25.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.558 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.55 HD12 ' CG1' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -125.97 136.66 53.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.757 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -128.31 142.55 51.1 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 111.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 87' ' ' VAL . 10.4 tp -139.38 155.07 25.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' THR . . . 168.12 176.91 38.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.384 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 56' ' ' PHE . 1.1 p -168.04 155.82 8.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.01 28.57 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.207 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -123.48 135.74 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.17 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.576 HH21 ' HB2' ' A' ' 47' ' ' GLN . 12.3 ttm180 -131.17 133.27 45.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.678 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.829 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 13.8 p -122.32 139.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 88.8 m-20 61.19 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.661 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 7.8 pt-20 177.81 -26.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.55 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 59.5 p -65.65 -67.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.39 139.19 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.496 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.666 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -142.07 155.35 45.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.241 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.564 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HG3' ' HE2' ' C' ' 46' ' ' PHE . 8.2 tmtt? -155.31 130.19 9.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.217 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 175.41 12.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.16 -173.69 37.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.543 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 71' ' ' ILE . 14.7 p -141.89 143.17 27.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.897 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -115.17 144.11 44.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.351 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -119.24 119.03 32.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.282 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -127.89 135.29 49.8 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.657 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.618 ' HA3' ' CD ' ' A' ' 34' ' ' LYS . . . 60.52 -111.56 3.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.276 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.3 m -149.61 10.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 111.312 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.402 ' HB3' HH12 ' A' ' 31' ' ' ARG . 1.6 t -165.09 23.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.156 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 37.0 m-20 -116.3 67.7 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.08 139.67 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 110.745 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.897 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 7.1 ptp -134.25 135.53 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.723 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.86 118.71 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.409 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -107.03 152.63 23.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.79 0.328 . . . . 0.0 111.394 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.753 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.504 ' HB3' HD11 ' C' ' 45' ' ' LEU . 14.4 m -118.6 169.09 10.09 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.396 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.06 136.01 31.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.986 0.422 . . . . 0.0 111.056 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.8 m-80 -104.31 132.8 50.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.355 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -138.22 114.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.376 . . . . 0.0 110.716 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -115.97 157.95 23.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.671 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.414 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.465 ' OD1' ' OG ' ' B' ' 5' ' ' SER . 3.8 t70 78.28 134.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.985 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -130.92 -65.09 0.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.69 32.4 1.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.465 ' OG ' ' OD1' ' B' ' 2' ' ' ASP . 58.0 p -99.95 155.03 17.91 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.785 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -105.85 -80.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m 59.89 42.13 16.8 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.991 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.872 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 33.1 m170 -80.66 -54.41 0.78 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.845 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -59.33 120.13 7.78 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.507 2.138 . . . . 0.0 111.891 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -100.23 -65.77 0.95 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.61 174.93 5.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.73 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.28 28.57 0.35 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.439 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -46.5 15.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.514 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.05 -26.35 63.27 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.231 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.06 83.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.931 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -76.46 -39.85 52.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.024 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.614 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -60.05 -35.19 74.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.578 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.9 -37.87 64.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.23 -60.37 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.63 65.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.983 0.42 . . . . 0.0 111.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.71 HD22 HD23 ' B' ' 25' ' ' LEU . 2.3 tm? -67.04 -62.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.29 -23.73 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.005 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.56 -49.49 47.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.601 ' HD3' HD11 ' A' ' 21' ' ' LEU . 69.1 mtp85 -73.36 -42.15 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.702 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 1.008 HD22 HD11 ' A' ' 25' ' ' LEU . 3.9 mm? -61.26 -46.08 91.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.603 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.33 -32.92 74.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.773 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.89 -38.7 83.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.647 0.26 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' B' ' 28' ' ' LEU . 0.0 OUTLIER -62.74 -47.89 81.59 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.501 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.5 OUTLIER -61.06 -31.95 71.6 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 178.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.514 HG22 ' HE2' ' B' ' 34' ' ' LYS . 6.2 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -30.64 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.312 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' B' ' 29' ' ' ASP . 29.3 m -83.68 -33.33 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.172 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 58.3 m-20 -66.35 -48.7 69.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.972 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.604 ' CD ' ' HA3' ' B' ' 91' ' ' GLY . 6.6 ptpt -85.17 -25.58 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.92 -40.8 62.95 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.601 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.5 mt -77.03 -25.71 52.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.413 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -72.44 -40.76 66.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.411 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.66 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 13.5 t -79.08 -42.97 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.745 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.418 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 0.4 OUTLIER -59.86 -56.71 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.88 78.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.441 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.48 -35.08 67.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.555 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 26.1 tp -76.3 -42.23 45.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.124 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.601 ' HB3' ' CB ' ' A' ' 43' ' ' ASN . 8.6 m120 -70.92 -13.77 62.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 46.5 t -67.3 -21.87 65.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.147 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' C' ' 100' ' ' SER . 1.5 mm? -80.05 171.71 14.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.866 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.489 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.3 p90 -158.09 -3.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.162 0.506 . . . . 0.0 111.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.579 ' HB2' HH21 ' B' ' 76' ' ' ARG . 7.1 mt-30 71.5 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.992 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.669 ' HB2' ' O ' ' C' ' 79' ' ' GLU 0.265 10.0 Cg_endo -74.94 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.708 2.272 . . . . 0.0 112.573 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.18 -177.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 173.02 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.219 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 4.9 p -73.42 -3.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.145 0.578 . . . . 0.0 112.466 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.831 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.97 54.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.25 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.81 -165.07 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.2 145.12 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.561 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.637 ' HB3' ' HD2' ' B' ' 48' ' ' PRO . 5.4 m-80 -126.11 118.32 25.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 111.706 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' B' ' 73' ' ' SER . 32.1 t80 -83.77 130.36 34.94 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.223 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.487 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 75.9 p -114.67 120.9 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.976 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' B' ' 71' ' ' ILE . . . -152.28 135.34 15.7 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.458 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -179.77 168.63 39.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.563 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.548 ' CG1' HD12 ' B' ' 69' ' ' LEU . 13.1 m -117.01 158.43 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.811 0.339 . . . . 0.0 111.332 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.99 -170.86 14.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.441 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.413 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -165.5 142.69 7.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.529 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.572 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 56.0 t80 -134.13 134.7 42.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.672 0.273 . . . . 0.0 110.744 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 64.34 -93.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.73 28.63 1.27 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 1.6 m -133.79 142.1 47.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.36 157.17 17.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.99 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -149.57 167.74 25.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.523 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.548 HD12 ' CG1' ' B' ' 60' ' ' VAL . 0.6 OUTLIER -125.95 136.61 53.22 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.796 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -128.21 142.53 51.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.668 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' B' ' 87' ' ' VAL . 10.4 tp -139.29 155.16 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.103 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.408 ' N ' HG13 ' B' ' 71' ' ' ILE . . . 168.03 176.8 38.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.427 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' B' ' 56' ' ' PHE . 1.1 p -167.95 155.89 8.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.33 171.93 28.66 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.179 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -123.46 135.73 54.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.579 HH21 ' HB2' ' B' ' 47' ' ' GLN . 12.3 ttm180 -131.14 133.33 45.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.831 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 13.7 p -122.44 139.64 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 88.8 m-20 61.25 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 0.0 111.066 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 7.8 pt-20 177.87 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.585 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' B' ' 103' ' ' ILE . 59.5 p -65.65 -67.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.991 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.4 139.21 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.501 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -142.03 155.35 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.488 ' HG3' ' HE2' ' A' ' 46' ' ' PHE . 8.2 tmtt? -155.28 130.26 9.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.15 175.42 12.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.14 -173.7 37.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.559 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' B' ' 71' ' ' ILE . 14.7 p -141.89 143.24 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.891 0.377 . . . . 0.0 111.123 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.884 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -115.23 144.1 44.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.33 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -119.24 119.06 32.96 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -127.91 135.36 49.88 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.649 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.604 ' HA3' ' CD ' ' B' ' 34' ' ' LYS . . . 60.48 -111.58 3.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.281 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 56.8 m -149.62 10.3 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.286 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -165.07 23.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.163 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 37.2 m-20 -116.38 67.68 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.11 139.61 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.702 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.884 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 7.0 ptp -134.23 135.52 43.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.81 118.75 35.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -106.98 152.62 23.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.692 0.282 . . . . 0.0 111.427 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.49 90.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.698 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.499 ' HB3' HD11 ' A' ' 45' ' ' LEU . 14.3 m -118.56 169.09 10.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.432 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.02 135.89 31.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.676 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.9 m-80 -104.25 132.82 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.426 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -138.19 114.32 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -115.98 157.92 23.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.663 179.671 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ASP . . . . . 0.471 ' OD1' ' OG ' ' C' ' 5' ' ' SER . 3.7 t70 78.23 134.31 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.926 0.393 . . . . 0.0 110.998 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -130.94 -65.17 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.63 32.39 1.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' SER . . . . . 0.471 ' OG ' ' OD1' ' C' ' 2' ' ' ASP . 58.1 p -99.9 155.01 17.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.744 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -105.84 -80.96 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.696 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 72.3 m 59.81 42.23 16.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.015 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.877 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 33.2 m170 -80.79 -54.37 0.76 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.761 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.877 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.3 Cg_exo -59.35 120.03 7.63 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.473 2.116 . . . . 0.0 111.977 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -100.12 -65.69 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.988 0.423 . . . . 0.0 111.152 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.64 175.01 5.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.656 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.41 28.63 0.34 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.411 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -46.5 15.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.527 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.11 -26.25 63.27 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.19 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.09 83.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.941 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -76.53 -39.78 51.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.958 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.623 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -60.15 -35.11 74.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.531 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -74.0 -37.82 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.2 -60.42 3.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.38 -28.62 65.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.723 HD22 HD23 ' C' ' 25' ' ' LEU . 2.3 tm? -67.01 -62.7 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.566 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.18 -23.79 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.46 -49.56 47.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.623 ' HD3' HD11 ' B' ' 21' ' ' LEU . 69.0 mtp85 -73.4 -42.05 62.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.797 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 1.024 HD11 HD22 ' A' ' 25' ' ' LEU . 3.9 mm? -61.31 -46.08 91.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.624 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.32 -32.91 74.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.846 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.73 83.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -47.86 81.71 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ASP . . . . . 0.516 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.5 OUTLIER -61.05 -31.87 71.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.96 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.516 HG22 ' HE2' ' C' ' 34' ' ' LYS . 6.2 m -73.9 -30.26 62.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.865 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -30.73 45.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' C' ' 29' ' ' ASP . 30.1 m -83.57 -33.38 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.517 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 57.8 m-20 -66.43 -48.63 69.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.617 ' CD ' ' HA3' ' C' ' 91' ' ' GLY . 6.6 ptpt -85.16 -25.61 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.93 -40.71 62.91 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.404 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.601 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.5 mt -77.03 -25.78 52.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.92 0.391 . . . . 0.0 111.165 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.404 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -72.33 -40.77 67.17 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.548 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.664 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 13.2 t -79.07 -42.87 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.803 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.43 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 0.4 OUTLIER -59.92 -56.71 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.25 -41.01 78.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.418 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.34 -35.11 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.941 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.564 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 26.2 tp -76.22 -42.38 46.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.148 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.599 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 8.6 m120 -70.84 -13.85 62.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -67.31 -21.88 65.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.09 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 100' ' ' SER . 1.5 mm? -80.06 171.84 14.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.845 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.48 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.3 p90 -158.1 -3.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.193 0.52 . . . . 0.0 111.721 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.565 ' HB2' HH21 ' C' ' 76' ' ' ARG . 7.1 mt-30 71.58 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.968 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.263 9.9 Cg_endo -75.03 106.7 2.33 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.635 2.224 . . . . 0.0 112.585 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.15 -177.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 173.03 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.168 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 4.9 p -73.43 -3.42 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.091 0.557 . . . . 0.0 112.465 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.812 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.94 54.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 -165.16 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 0.0 110.615 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.15 145.1 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.641 ' HB3' ' HD2' ' C' ' 48' ' ' PRO . 5.4 m-80 -126.1 118.38 25.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 111.655 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' C' ' 73' ' ' SER . 32.1 t80 -83.76 130.33 34.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.206 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.481 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 75.2 p -114.63 120.92 41.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.97 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.419 ' HB2' HD12 ' C' ' 71' ' ' ILE . . . -152.32 135.35 15.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.484 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -179.76 168.57 39.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.552 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.549 ' CG1' HD12 ' C' ' 69' ' ' LEU . 13.3 m -116.9 158.41 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.328 . . . . 0.0 111.357 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.04 -170.8 14.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.421 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.404 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -165.59 142.72 7.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.583 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 56.2 t80 -134.04 134.69 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.636 0.255 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.103 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.75 28.58 1.27 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' C' ' 33' ' ' ASP . 1.6 m -133.8 142.04 47.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.21 157.3 17.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ALA . . . . . 0.664 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -149.64 167.75 25.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.549 HD12 ' CG1' ' C' ' 60' ' ' VAL . 0.6 OUTLIER -126.01 136.63 53.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -128.25 142.55 51.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.654 0.264 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' C' ' 87' ' ' VAL . 10.4 tp -139.29 155.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.761 0.315 . . . . 0.0 111.11 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.401 ' N ' HG13 ' C' ' 71' ' ' ILE . . . 168.04 176.83 38.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.448 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 73' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' C' ' 56' ' ' PHE . 1.1 p -168.01 155.85 8.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.339 . . . . 0.0 110.969 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.36 171.99 28.67 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.565 HH21 ' HB2' ' C' ' 47' ' ' GLN . 12.3 ttm180 -131.19 133.27 45.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.677 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.812 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 13.6 p -122.38 139.68 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 89.0 m-20 61.17 -94.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 111.042 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 79' ' ' GLU . . . . . 0.669 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 7.8 pt-20 177.86 -26.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' C' ' 103' ' ' ILE . 59.2 p -65.69 -67.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.35 139.17 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -142.07 155.34 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.229 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.69 146.42 34.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.489 ' HG3' ' HE2' ' B' ' 46' ' ' PHE . 8.2 tmtt? -155.3 130.24 9.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.163 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.1 175.48 12.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.09 -173.71 37.57 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.536 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' C' ' 71' ' ' ILE . 14.7 p -141.91 143.21 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.078 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.896 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -115.2 144.14 44.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.348 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -119.26 119.13 33.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -128.0 135.29 49.7 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.672 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.617 ' HA3' ' CD ' ' C' ' 34' ' ' LYS . . . 60.64 -111.59 3.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.279 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 56.7 m -149.67 10.38 0.73 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.294 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -165.15 23.93 0.05 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 37.0 m-20 -116.37 67.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.13 139.72 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.896 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 7.1 ptp -134.22 135.52 43.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.87 118.77 35.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.403 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -107.1 152.61 23.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.715 0.293 . . . . 0.0 111.382 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.511 ' HB3' HD11 ' B' ' 45' ' ' LEU . 14.4 m -118.65 169.12 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.403 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.12 135.94 31.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.042 0.449 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.661 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.9 m-80 -104.24 132.8 50.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.435 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' C' ' 80' ' ' SER . 0.1 OUTLIER -138.17 114.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.719 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -115.97 157.96 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.8 m-90 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.706 179.624 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.641 -0.184 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 40.2 -102.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -112.48 -54.38 2.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.61 -63.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.026 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -68.03 -53.9 22.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.693 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -47.37 -83.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.698 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m 68.28 45.31 1.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.996 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.772 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 23.7 m80 -70.83 -52.38 10.22 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.791 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.772 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -52.0 121.39 8.7 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.515 2.143 . . . . 0.0 111.89 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 8' ' ' HIS . 13.0 mm100 -127.92 -59.16 1.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 0.0 111.115 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -125.97 -154.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.657 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -68.99 -26.6 65.1 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.402 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -135.55 20.69 3.35 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.544 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.82 -22.77 60.97 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.224 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB1' ' NH1' ' A' ' 19' ' ' ARG . . . -66.99 -46.07 75.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.869 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 39.3 m-70 -72.13 -32.15 66.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.989 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' O ' HD22 ' A' ' 21' ' ' LEU . 34.6 ttmt -73.05 -46.94 48.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.548 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.75 -39.7 80.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.889 0.376 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.412 ' NH1' ' HB1' ' A' ' 15' ' ' ALA . 49.5 mtt85 -66.81 -42.89 85.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.779 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.608 ' HB2' ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -64.7 -41.39 96.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.1 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.758 HD21 HD23 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -62.9 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.83 -30.72 71.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.73 -39.11 57.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.768 HD21 ' HG ' ' B' ' 25' ' ' LEU . 8.0 mt -67.25 -50.98 58.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.571 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.78 -50.91 72.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.826 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HE2' ' CZ ' ' A' ' 31' ' ' ARG . 9.5 tmtt? -54.78 -38.26 67.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.279 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -62.39 -42.69 99.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -63.54 -41.7 98.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.997 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.796 HG22 ' HE2' ' A' ' 34' ' ' LYS . 4.4 m -57.91 -47.12 83.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.764 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.614 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 83.2 mmt-85 -59.45 -35.5 74.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.318 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.861 HG22 HG11 ' C' ' 32' ' ' VAL . 41.7 t -73.75 -36.5 46.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.99 -55.88 16.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.995 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.814 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 3.4 pttt -72.35 -36.5 68.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.774 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.13 96.33 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.369 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.565 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -70.14 -37.13 75.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.805 0.336 . . . . 0.0 111.08 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.72 99.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.463 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -69.58 -54.38 14.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.753 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.545 ' HB3' HD21 ' C' ' 36' ' ' LEU . 86.9 p -49.07 -56.21 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.49 -52.61 53.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.471 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.16 -41.58 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.537 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 30.8 tp -73.88 -34.89 64.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.09 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 18.3 m120 -78.25 -5.12 51.01 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.404 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.5 t -86.13 -0.6 56.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.12 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -95.97 172.18 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.881 177.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.427 ' H ' ' H ' ' A' ' 47' ' ' GLN . 10.3 p90 -165.76 -5.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.662 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 35.1 mt-30 65.83 118.9 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.945 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.395 9.8 Cg_endo -69.89 98.2 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.692 2.261 . . . . 0.0 112.54 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 66.94 -165.0 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 146.16 82.25 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 79' ' ' GLU . 8.7 p -88.72 -11.03 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.094 0.558 . . . . 0.0 112.477 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 158.34 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.296 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.01 -166.7 2.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.558 0.218 . . . . 0.0 110.65 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.158 HG13 ' O ' ' B' ' 105' ' ' TRP . 2.6 p -109.5 144.05 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.428 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 4.4 m-80 -131.06 134.83 47.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.652 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.476 ' O ' HG13 ' B' ' 103' ' ' ILE . 1.2 t80 -104.53 121.92 44.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.275 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.702 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 21.1 p -114.57 124.86 52.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.19 150.81 29.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.41 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.19 164.01 26.17 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.491 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 69' ' ' LEU . 14.5 m -110.21 166.33 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 111.373 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -174.43 22.35 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.53 143.21 8.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.554 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.636 ' CE2' ' HG3' ' A' ' 64' ' ' ARG . 63.2 t80 -132.51 137.1 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.727 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.636 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 2.9 mmm180 61.52 -80.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 63' ' ' TYR . 12.0 t -156.64 32.27 0.31 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -130.11 167.42 18.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.01 142.15 48.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.137 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.43 47.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.61 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.2 tp -111.32 128.48 55.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.729 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -122.95 152.09 41.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.708 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.429 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.7 tt -147.54 162.06 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.289 . . . . 0.0 111.183 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 175.35 169.34 37.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.408 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 p -163.29 147.71 11.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.73 161.85 28.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.245 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.29 119.48 39.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.154 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.484 ' CB ' ' HA3' ' A' ' 50' ' ' GLY . 4.9 mmm180 -96.9 99.21 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.707 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.697 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.0 p -98.23 130.72 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.332 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.48 ' OD1' HG22 ' A' ' 77' ' ' VAL . 8.1 m120 66.27 -170.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.932 0.396 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 51' ' ' VAL . 38.5 mt-10 -120.05 24.53 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.551 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.584 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 5.0 t -129.01 -44.75 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.28 148.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.494 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.845 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -152.07 171.15 18.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 111.205 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.82 143.23 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.606 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.5 23.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.26 135.95 23.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.39 175.04 39.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 96' ' ' MET . 6.3 p -124.08 146.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB3' ' SD ' ' A' ' 96' ' ' MET . . . -114.11 134.09 55.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.27 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.86 110.69 22.1 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.259 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -122.75 132.43 54.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.522 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.84 -113.15 4.04 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.263 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.85 -60.76 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 111.322 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.4 t -101.53 29.77 4.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.221 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.99 1.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.4 142.34 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.748 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.577 ' HB2' ' HA ' ' C' ' 63' ' ' TYR . 0.9 OUTLIER -132.57 155.59 48.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -128.48 129.02 45.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.522 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -119.7 160.33 22.74 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.17 99.02 0.12 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.796 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.751 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.2 p -122.67 179.45 4.61 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.43 146.36 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.845 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.4 m-80 -111.9 150.02 31.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.362 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.482 HG13 ' O ' ' C' ' 56' ' ' PHE . 3.9 pt -156.18 150.99 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.584 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 73.7 mt-10 -96.25 130.56 43.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.163 ' O ' HG13 ' C' ' 54' ' ' VAL . 5.7 t-105 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.664 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 40.09 -102.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -112.5 -54.38 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.842 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.58 -63.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -68.07 -53.93 22.03 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.689 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -47.4 -83.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.719 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 19.5 m 68.2 45.4 1.26 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.979 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.76 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 23.6 m170 -70.83 -52.38 10.19 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.771 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.76 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -51.95 121.4 8.68 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.462 2.108 . . . . 0.0 111.93 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' B' ' 8' ' ' HIS . 13.0 mm100 -127.95 -59.14 1.2 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.385 . . . . 0.0 111.114 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.99 -154.71 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.667 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -69.01 -26.6 65.08 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.441 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -135.68 20.81 3.32 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.496 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.76 -22.77 61.11 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.309 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.1 -45.95 75.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' B' ' 20' ' ' GLN . 39.2 m-70 -72.17 -32.13 66.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.004 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.485 ' O ' HD22 ' B' ' 21' ' ' LEU . 34.7 ttmt -73.02 -47.0 48.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.612 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -39.83 80.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -66.76 -42.92 85.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.609 ' HB2' ' O ' ' B' ' 16' ' ' HIS . 0.8 OUTLIER -64.71 -41.4 96.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.109 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.765 HD23 HD21 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -62.84 -43.4 98.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.89 -30.69 71.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.78 -39.11 57.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -73.02 -38.36 66.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.813 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.772 HD21 ' HG ' ' C' ' 25' ' ' LEU . 8.0 mt -67.18 -51.03 58.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.61 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.83 -50.89 72.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.799 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.499 ' HE2' ' CZ ' ' B' ' 31' ' ' ARG . 9.5 tmtt? -54.8 -38.27 67.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.277 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.571 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -62.41 -42.63 99.58 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.52 -41.74 98.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.969 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.804 HG22 ' HE2' ' B' ' 34' ' ' LYS . 4.4 m -57.94 -47.07 83.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.603 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 83.1 mmt-85 -59.37 -35.56 74.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.352 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.851 HG22 HG11 ' A' ' 32' ' ' VAL . 41.7 t -73.78 -36.56 46.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.201 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.0 -55.86 16.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.955 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.814 ' HB2' ' HB1' ' B' ' 90' ' ' ALA . 3.4 pttt -72.33 -36.58 68.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.744 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.91 -45.05 96.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.382 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -70.12 -37.23 75.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.79 99.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.427 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.756 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -69.56 -54.33 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.565 ' HB3' HD21 ' A' ' 36' ' ' LEU . 86.9 p -49.16 -56.25 9.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.017 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.54 54.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.465 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.23 -41.56 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.864 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.54 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 30.7 tp -73.89 -34.88 64.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.112 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.544 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 18.3 m120 -78.13 -5.23 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.417 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -86.05 -0.65 56.1 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.141 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -95.83 172.21 8.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.894 177.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -165.84 -5.24 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.097 0.475 . . . . 0.0 111.654 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' B' ' 55' ' ' ASN . 35.1 mt-30 65.86 118.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.395 9.7 Cg_endo -69.88 98.36 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.638 2.225 . . . . 0.0 112.552 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 66.75 -164.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 146.15 82.31 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.188 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' B' ' 79' ' ' GLU . 8.7 p -88.78 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.144 0.578 . . . . 0.0 112.422 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.683 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 158.25 46.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.259 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.1 -166.69 2.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.586 0.231 . . . . 0.0 110.628 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 1.175 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.6 p -109.52 144.12 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.561 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.428 ' HB2' ' OE1' ' B' ' 47' ' ' GLN . 4.4 m-80 -131.12 134.79 46.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.013 0.435 . . . . 0.0 111.61 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.47 ' O ' HG13 ' C' ' 103' ' ' ILE . 1.2 t80 -104.55 121.96 44.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.24 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.682 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 21.1 p -114.59 124.86 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.22 150.75 29.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.484 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.529 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.25 164.01 26.22 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.575 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 69' ' ' LEU . 14.4 m -110.26 166.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.61 -174.42 22.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.462 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.52 143.15 8.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.635 ' CE2' ' HG3' ' B' ' 64' ' ' ARG . 63.5 t80 -132.48 137.0 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.291 . . . . 0.0 110.765 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.635 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 2.9 mmm180 61.54 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.029 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 63' ' ' TYR . 12.2 t -156.69 32.3 0.31 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.158 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -130.17 167.46 18.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.802 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.02 142.15 48.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.62 155.49 47.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.529 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.1 tp -111.33 128.44 55.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.724 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -123.0 152.17 41.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.429 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.7 tt -147.56 162.0 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.751 0.31 . . . . 0.0 111.073 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.429 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 175.38 169.35 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.47 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -163.25 147.71 11.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.76 161.89 28.97 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.255 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.34 119.51 39.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.161 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.492 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 5.0 mmm180 -96.96 99.15 10.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.683 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.9 p -98.08 130.71 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.328 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.474 ' OD1' HG22 ' B' ' 77' ' ' VAL . 8.1 m120 66.17 -170.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.899 0.381 . . . . 0.0 111.154 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.504 ' HG3' HG23 ' B' ' 51' ' ' VAL . 38.6 mt-10 -120.0 24.59 10.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.598 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.583 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 5.0 t -129.07 -44.72 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.963 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.33 148.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.851 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -152.01 171.22 18.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.224 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.26 9.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.43 23.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.17 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.27 135.96 23.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.38 175.04 39.69 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.448 HG23 ' O ' ' B' ' 96' ' ' MET . 6.3 p -124.1 146.53 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.5 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -114.09 134.09 55.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.89 110.74 22.15 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -122.78 132.45 54.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.574 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.521 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.95 -113.28 4.21 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.259 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.87 -60.67 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.343 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' B' ' 93' ' ' SER . 2.3 t -101.6 29.75 4.69 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.258 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -119.72 82.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.988 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.47 142.35 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.017 0.437 . . . . 0.0 110.703 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.554 ' HB2' ' HA ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -132.49 155.63 48.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -128.5 128.93 45.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.492 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.6 160.27 22.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.688 0.28 . . . . 0.0 111.476 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.18 99.04 0.12 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.738 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.733 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.3 p -122.67 179.47 4.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.452 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -140.43 146.26 38.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.851 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.4 m-80 -111.82 150.0 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.374 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 56' ' ' PHE . 4.0 pt -156.1 150.97 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.761 0.315 . . . . 0.0 110.825 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 73.7 mt-10 -96.31 130.58 43.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 1.158 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.7 t-105 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.686 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 40.15 -102.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.894 0.378 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -112.44 -54.38 2.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.56 -63.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -67.95 -53.96 22.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.768 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -47.44 -83.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.752 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m 68.24 45.36 1.25 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.985 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.765 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 23.6 m170 -70.85 -52.38 10.15 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.792 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.765 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.5 Cg_exo -51.97 121.36 8.63 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.507 2.138 . . . . 0.0 111.909 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 10' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' C' ' 8' ' ' HIS . 13.0 mm100 -127.86 -59.16 1.21 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.956 0.408 . . . . 0.0 111.157 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.02 -154.73 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.648 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -68.98 -26.54 65.08 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.46 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -135.74 20.77 3.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.506 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.76 -22.75 61.15 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.258 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ALA . . . . . 0.406 ' HB1' ' NH1' ' C' ' 19' ' ' ARG . . . -67.06 -46.05 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 0.0 110.88 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' HIS . . . . . 0.599 ' O ' ' HB2' ' C' ' 20' ' ' GLN . 39.2 m-70 -72.1 -32.17 66.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.011 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.487 ' O ' HD22 ' C' ' 21' ' ' LEU . 34.6 ttmt -73.05 -46.92 49.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.556 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -39.88 80.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.202 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 19' ' ' ARG . . . . . 0.406 ' NH1' ' HB1' ' C' ' 15' ' ' ALA . 49.7 mtt85 -66.7 -42.88 85.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' C' ' 16' ' ' HIS . 0.8 OUTLIER -64.68 -41.41 96.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.765 HD21 HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -62.87 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -75.76 -39.15 57.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.772 ' HG ' HD21 ' B' ' 25' ' ' LEU . 8.0 mt -67.2 -51.02 58.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -58.77 -50.85 72.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.5 ' HE2' ' CZ ' ' C' ' 31' ' ' ARG . 9.5 tmtt? -54.91 -38.21 67.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.254 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.576 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -62.33 -42.72 99.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.48 -41.77 98.57 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.989 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.786 HG22 ' HE2' ' C' ' 34' ' ' LYS . 4.4 m -57.89 -46.99 84.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.861 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.6 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 83.2 mmt-85 -59.48 -35.54 74.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.291 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.861 HG11 HG22 ' A' ' 32' ' ' VAL . 42.0 t -73.8 -36.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.164 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.89 -55.88 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.073 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.826 ' HB2' ' HB1' ' C' ' 90' ' ' ALA . 3.3 pttt -72.39 -36.56 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.732 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.78 -45.18 96.27 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.375 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -70.07 -37.13 75.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.84 0.352 . . . . 0.0 111.149 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.82 99.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.428 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -69.5 -54.39 14.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.776 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.555 ' HB3' HD21 ' B' ' 36' ' ' LEU . 87.0 p -49.09 -56.18 9.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.073 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -52.55 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.395 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.29 -41.4 37.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.534 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 30.6 tp -74.0 -34.87 64.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.113 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 18.3 m120 -78.18 -5.13 50.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' SER . . . . . 0.402 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.5 t -86.09 -0.63 56.09 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.156 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -95.95 172.18 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.892 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.407 ' H ' ' H ' ' C' ' 47' ' ' GLN . 10.4 p90 -165.76 -5.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.133 0.492 . . . . 0.0 111.66 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 35.1 mt-30 65.75 118.93 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.944 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.396 9.8 Cg_endo -69.91 98.23 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.641 2.227 . . . . 0.0 112.565 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 66.96 -164.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 146.17 82.24 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.254 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' C' ' 79' ' ' GLU . 8.8 p -88.77 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.391 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 158.26 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.273 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -142.93 -166.67 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.657 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 1.163 HG13 ' O ' ' A' ' 105' ' ' TRP . 2.6 p -109.54 144.04 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.511 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.42 ' HB2' ' OE1' ' C' ' 47' ' ' GLN . 4.4 m-80 -131.1 134.83 46.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.067 0.46 . . . . 0.0 111.624 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.482 ' O ' HG13 ' A' ' 103' ' ' ILE . 1.2 t80 -104.62 122.01 44.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.179 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.686 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 21.0 p -114.59 124.85 52.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.95 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.2 150.76 29.35 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.23 164.03 26.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' C' ' 69' ' ' LEU . 14.4 m -110.28 166.4 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.62 -174.4 22.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.48 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 143.1 8.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.573 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' C' ' 64' ' ' ARG . 62.9 t80 -132.45 137.06 47.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.633 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 2.9 mmm180 61.59 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.045 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' SER . . . . . 0.406 ' N ' ' O ' ' C' ' 63' ' ' TYR . 12.1 t -156.68 32.33 0.31 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -130.19 167.5 18.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.05 142.17 48.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.5 47.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.569 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.1 tp -111.33 128.35 55.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -122.97 152.11 41.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.726 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.434 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.7 tt -147.47 162.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.179 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.434 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 175.3 169.32 36.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.438 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 36.2 p -163.24 147.69 11.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.7 161.91 28.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.273 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.3 119.44 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 111.144 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.492 ' CB ' ' HA3' ' C' ' 50' ' ' GLY . 4.9 mmm180 -96.85 99.16 10.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.772 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.689 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.0 p -98.19 130.62 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.321 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' C' ' 77' ' ' VAL . 8.1 m120 66.37 -171.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' C' ' 51' ' ' VAL . 38.8 mt-10 -120.03 24.56 10.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.561 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' SER . . . . . 0.583 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 5.0 t -129.0 -44.74 1.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.987 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.2 148.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.552 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -152.02 171.21 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.234 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.22 9.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.52 23.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.145 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 135.91 23.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.02 39.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.609 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' VAL . . . . . 0.456 HG23 ' O ' ' C' ' 96' ' ' MET . 6.3 p -124.02 146.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.89 0.376 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.513 ' HB3' ' SD ' ' C' ' 96' ' ' MET . . . -114.03 134.02 55.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.423 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -108.85 110.78 22.21 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.252 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.826 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -122.77 132.41 54.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.59 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.544 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.97 -113.18 4.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.209 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.92 -60.73 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.3 t -101.59 29.79 4.67 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.35 142.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.58 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 0.9 OUTLIER -132.55 155.63 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.687 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -128.5 129.03 45.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.403 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.69 160.29 22.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.666 0.27 . . . . 0.0 111.504 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.2 99.03 0.12 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.721 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.1 p -122.79 179.49 4.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.435 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -140.47 146.28 38.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.836 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.4 m-80 -111.77 150.02 30.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.369 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.47 HG13 ' O ' ' B' ' 56' ' ' PHE . 3.9 pt -156.18 150.96 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 73.8 mt-10 -96.32 130.55 43.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 1.175 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.6 t-105 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.728 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.655 -0.178 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 t70 70.08 136.74 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.934 0.397 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -133.47 -64.69 0.71 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.28 24.82 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.001 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -98.51 149.11 23.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.744 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.58 ' HB3' ' CE1' ' A' ' 8' ' ' HIS . 30.8 m95 -98.03 -79.19 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.743 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.2 m 61.9 45.13 7.77 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.306 -0.407 . . . . 0.0 109.992 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.667 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 22.3 m170 -89.69 -48.88 0.39 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.807 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -52.62 105.24 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.404 2.069 . . . . 0.0 111.956 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 8' ' ' HIS . 89.6 mt-30 -104.99 -62.26 1.36 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.983 0.42 . . . . 0.0 111.165 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -121.55 171.02 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.711 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.03 25.99 1.89 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.503 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HE2' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -68.92 -49.48 57.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.5 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.28 -24.83 59.44 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.297 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.88 90.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 0.0 110.875 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.785 ' HA ' ' HD2' ' A' ' 19' ' ' ARG . 13.5 m-70 -80.19 -26.65 39.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.986 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HD3' ' HE2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.97 -44.82 88.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.528 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.29 -26.56 62.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.321 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.785 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 47.9 mtt-85 -66.23 -53.73 33.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.742 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.82 -26.96 61.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.94 0.4 . . . . 0.0 111.188 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.89 -59.99 4.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.556 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -74.71 -47.76 29.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 54.4 mtp85 -74.87 -37.58 62.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.76 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.711 HD11 HD22 ' B' ' 25' ' ' LEU . 2.8 mm? -63.77 -52.67 59.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -57.0 -42.48 80.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.45 -31.68 72.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.276 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -45.88 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.476 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -66.73 -31.47 72.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.964 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.37 -35.9 71.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.81 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.646 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -71.96 -39.61 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.8 m -75.85 -30.88 21.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.589 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 26.2 m-20 -68.38 -45.46 72.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.646 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.7 ptpt -75.51 -40.61 56.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.31 99.05 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.383 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.502 HD21 ' HG ' ' B' ' 36' ' ' LEU . 0.6 OUTLIER -74.37 -27.05 60.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -70.08 -41.48 74.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.465 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 8.2 t -82.98 -38.95 21.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.781 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.487 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 3.2 t -57.99 -55.78 30.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.74 -33.6 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.433 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.13 76.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.668 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 64.7 tp -81.06 -35.79 31.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.079 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 19.9 m120 -75.3 -14.38 60.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.85 -22.31 65.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.171 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.748 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.3 mm? -74.32 165.83 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.875 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.558 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 2.5 p90 -157.06 -3.3 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 111.663 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 9.1 mt-30 65.43 125.04 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.912 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -88.49 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.673 2.249 . . . . 0.0 112.589 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 11.5 m-30 66.93 -177.51 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.53 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.279 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -79.96 -12.51 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.168 0.587 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.34 52.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.266 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -163.95 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.57 141.72 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.526 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -120.93 114.17 21.16 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.698 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.72 130.46 35.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.262 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.748 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 36.9 p -109.47 126.69 53.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.6 129.75 7.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.406 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.604 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -174.25 165.18 36.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.558 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 69' ' ' LEU . 16.0 m -119.44 160.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.339 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.24 17.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.489 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -170.15 137.88 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.552 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.589 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 17.8 t80 -123.87 135.0 53.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.708 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 1.7 mmm180 68.54 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.074 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.65 23.51 1.12 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.139 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.0 m -128.86 141.74 51.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.91 27.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -145.92 173.83 11.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.564 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -121.88 143.29 49.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.776 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -130.75 135.39 47.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.707 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.467 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 174.02 -178.49 45.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.446 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.31 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.85 28.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.283 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.66 134.49 50.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.165 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -122.46 126.22 47.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.733 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.42 137.99 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 29.8 m-20 60.93 -96.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 111.083 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.36 -19.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.594 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.0 p -73.19 -62.13 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.014 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.69 146.34 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.515 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.749 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -147.39 156.16 42.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.265 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.19 147.2 29.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.683 ' HE3' HG21 ' A' ' 57' ' ' THR . 10.9 tmtt? -150.49 138.83 20.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.155 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.069 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 164.0 -176.0 40.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.529 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 p -142.98 137.68 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.554 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -108.89 144.55 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -117.91 114.55 23.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -120.19 130.81 54.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.599 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.49 -115.84 8.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.242 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.59 7.26 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.343 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 24.74 0.27 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.204 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.435 ' CG ' ' HD2' ' A' ' 34' ' ' LYS . 18.3 m-20 -127.51 80.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.9 t -112.32 139.18 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 110.684 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.554 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 6.8 ptp -133.23 141.31 47.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -112.52 126.01 54.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.475 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.71 152.11 26.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 111.402 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.54 87.24 0.39 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.791 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.612 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 11.3 m -118.25 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.441 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -132.4 147.62 52.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.922 0.392 . . . . 0.0 111.136 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.749 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 49.1 m-80 -111.77 130.55 55.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.34 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.02 115.99 22.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' CG ' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -118.68 158.83 24.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.404 -0.808 . . . . 0.0 110.643 179.696 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 t70 70.15 136.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -133.52 -64.76 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.818 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.26 24.84 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.046 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -98.55 149.11 23.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.786 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.578 ' HB3' ' CE1' ' B' ' 8' ' ' HIS . 30.9 m95 -98.06 -79.19 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.703 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m 61.92 45.15 7.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.952 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.691 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 22.2 m170 -89.7 -48.88 0.39 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.77 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.3 Cg_exo -52.6 105.15 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.495 2.13 . . . . 0.0 111.962 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' B' ' 8' ' ' HIS . 89.7 mt-30 -104.94 -62.2 1.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.947 0.403 . . . . 0.0 111.152 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -121.6 171.02 9.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.674 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.1 26.05 1.87 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.476 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -49.43 58.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.564 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.29 -24.85 59.49 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.27 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.72 -42.93 90.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 110.92 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.786 ' HA ' ' HD2' ' B' ' 19' ' ' ARG . 13.5 m-70 -80.11 -26.75 39.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.016 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -44.87 88.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.578 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.35 -26.49 62.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.786 ' HD2' ' HA ' ' B' ' 16' ' ' HIS . 47.9 mtt-85 -66.27 -53.68 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -72.84 -26.99 61.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.8 -60.03 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.83 -17.84 64.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.68 -47.77 29.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.41 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 54.4 mtp85 -74.93 -37.54 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.759 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.711 HD22 HD11 ' A' ' 25' ' ' LEU . 2.8 mm? -63.73 -52.68 59.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.96 -42.58 80.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' B' ' 27' ' ' LYS . 0.9 OUTLIER -63.38 -31.77 73.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.238 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -45.88 92.67 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.46 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -66.69 -31.5 72.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -71.34 -35.93 71.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.662 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.0 OUTLIER -71.89 -39.74 69.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.8 m -75.76 -30.92 21.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.586 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 26.1 m-20 -68.4 -45.34 72.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.016 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.7 ptpt -75.52 -40.62 56.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.806 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.3 99.16 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.32 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.502 ' HG ' HD21 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.36 -27.03 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.456 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -70.02 -41.56 74.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.472 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 8.2 t -82.96 -38.93 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.491 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.2 t -58.08 -55.8 30.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.74 -33.58 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.363 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -34.11 76.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.65 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 64.7 tp -81.08 -35.78 31.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 20.0 m120 -75.29 -14.31 60.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 28.9 t -67.93 -22.36 65.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.088 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.76 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -74.2 165.8 24.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.901 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.561 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 2.5 p90 -157.07 -3.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 65.39 125.02 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.954 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -88.51 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.722 2.282 . . . . 0.0 112.557 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 11.5 m-30 66.88 -177.5 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.6 57.49 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.314 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -79.92 -12.53 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.162 0.585 . . . . 0.0 112.459 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.3 52.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.213 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -164.0 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.644 0.259 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.52 141.71 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.552 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -120.9 114.27 21.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.968 0.414 . . . . 0.0 111.701 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -82.83 130.43 35.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.299 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.76 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.2 p -109.41 126.7 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.023 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.77 7.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.461 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.609 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -174.24 165.15 36.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.563 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' B' ' 69' ' ' LEU . 16.0 m -119.41 160.79 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.18 16.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.467 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -170.13 137.84 4.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.617 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.586 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 17.8 t80 -123.8 135.08 53.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 1.7 mmm180 68.44 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.58 23.46 1.13 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.67 51.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.53 151.9 27.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 111.093 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -145.89 173.94 11.69 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.563 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.9 OUTLIER -121.97 143.27 49.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.764 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -130.75 135.43 47.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.687 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.479 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.76 0.314 . . . . 0.0 111.098 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.479 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 173.96 -178.49 45.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.446 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.49 146.4 5.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.965 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.64 162.76 28.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.279 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.63 134.55 50.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -122.47 126.31 47.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.56 138.06 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 29.6 m-20 60.88 -96.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 111.086 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.4 -19.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.9 p -73.18 -62.2 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 m -91.58 146.39 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.564 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -147.47 156.11 42.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.268 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.14 147.19 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.617 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.675 ' HE3' HG21 ' B' ' 57' ' ' THR . 11.0 tmtt? -150.48 138.87 20.44 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.47 173.29 14.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 164.0 -175.95 40.07 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.565 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.99 137.71 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -108.89 144.52 36.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.321 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -117.99 114.56 23.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.228 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -120.21 130.76 54.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.605 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.57 -115.86 8.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.326 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.6 7.24 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 111.36 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.89 24.72 0.27 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.213 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.436 ' CG ' ' HD2' ' B' ' 34' ' ' LYS . 18.2 m-20 -127.51 80.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.42 139.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.06 0.457 . . . . 0.0 110.633 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.552 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 6.8 ptp -133.18 141.28 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.678 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.51 126.03 54.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.437 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.62 152.09 26.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 111.493 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.53 87.27 0.4 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.843 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.604 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 11.3 m -118.24 166.22 12.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.396 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -132.37 147.61 52.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.939 0.399 . . . . 0.0 111.065 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 49.3 m-80 -111.71 130.62 55.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.412 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.99 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.442 ' CG ' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -118.78 158.8 24.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.634 179.75 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.679 -0.168 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 t70 70.19 136.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.903 0.383 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -133.53 -64.83 0.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.783 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.25 24.75 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -98.53 149.12 23.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.841 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' TRP . . . . . 0.585 ' HB3' ' CE1' ' C' ' 8' ' ' HIS . 30.9 m95 -98.09 -79.06 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.747 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 69.1 m 61.86 45.09 7.88 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.054 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.684 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 22.2 m170 -89.73 -48.83 0.39 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.793 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.684 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -52.61 105.09 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.55 2.166 . . . . 0.0 111.924 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' C' ' 8' ' ' HIS . 89.6 mt-30 -104.86 -62.25 1.36 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.954 0.407 . . . . 0.0 111.203 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -121.58 171.03 9.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.676 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.13 26.07 1.87 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.462 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.416 ' HE2' ' HD3' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -68.91 -49.44 58.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.517 -179.315 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.34 -24.88 59.64 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.258 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -42.86 90.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' HIS . . . . . 0.773 ' HA ' ' HD2' ' C' ' 19' ' ' ARG . 13.5 m-70 -80.2 -26.75 39.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.957 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.416 ' HD3' ' HE2' ' C' ' 13' ' ' LYS . 0.4 OUTLIER -64.92 -44.84 88.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.499 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.4 -26.46 62.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.243 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' ARG . . . . . 0.773 ' HD2' ' HA ' ' C' ' 16' ' ' HIS . 47.7 mtt-85 -66.29 -53.68 33.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.8 -26.97 61.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.186 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.92 -60.0 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.53 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -65.8 -17.85 64.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.67 -47.74 30.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.425 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 54.5 mtp85 -74.95 -37.51 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.785 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.683 HD22 HD11 ' B' ' 25' ' ' LEU . 2.8 mm? -63.87 -52.57 59.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -57.05 -42.49 80.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 27' ' ' LYS . 0.9 OUTLIER -63.51 -31.71 72.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.609 0.242 . . . . 0.0 111.215 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' C' ' 28' ' ' LEU . 0.0 OUTLIER -61.25 -45.97 92.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ASP . . . . . 0.467 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -66.65 -31.51 72.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.975 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.35 -35.79 71.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.873 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.665 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -72.05 -39.62 68.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.282 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.8 m -75.83 -30.84 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.605 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 26.1 m-20 -68.45 -45.35 72.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.665 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.7 ptpt -75.58 -40.62 56.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.14 99.11 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.395 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.499 HD21 ' HG ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.47 -27.08 60.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.833 0.349 . . . . 0.0 111.043 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.459 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -70.04 -41.49 74.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.458 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 8.2 t -83.08 -38.82 21.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.486 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 3.2 t -58.02 -55.85 29.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.52 73.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.447 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.06 76.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.946 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.646 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 64.8 tp -81.14 -35.75 31.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 20.0 m120 -75.33 -14.33 60.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.82 -22.37 65.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.158 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -74.27 165.83 24.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.862 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.553 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 2.5 p90 -157.1 -3.24 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.126 0.488 . . . . 0.0 111.654 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 9.0 mt-30 65.42 124.97 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.988 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -88.45 109.26 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.643 2.229 . . . . 0.0 112.591 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 11.5 m-30 66.8 -177.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.944 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.5 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.258 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -79.84 -12.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.195 0.598 . . . . 0.0 112.466 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.45 52.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.265 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.96 -164.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.615 0.245 . . . . 0.0 110.573 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.54 141.69 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.56 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -120.94 114.19 21.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.65 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -82.67 130.45 35.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.3 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.75 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 37.1 p -109.41 126.7 53.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.987 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.71 7.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.395 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.612 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -174.23 165.23 36.72 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.512 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' C' ' 69' ' ' LEU . 16.0 m -119.43 160.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.46 -168.24 16.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.478 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -170.17 137.86 4.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.605 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 17.9 t80 -123.8 135.14 53.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 110.702 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 1.7 mmm180 68.39 -89.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.6 23.45 1.13 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.77 51.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.807 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.83 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.09 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -145.83 173.93 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.578 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.431 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.9 OUTLIER -121.97 143.25 49.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.716 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.646 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -130.74 135.38 47.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.65 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.477 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.0 tp -134.1 159.31 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.706 0.288 . . . . 0.0 111.203 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.477 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 174.05 -178.47 45.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.434 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.4 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.995 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.68 162.78 28.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.262 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -126.66 134.57 50.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.365 . . . . 0.0 111.148 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -122.44 126.21 47.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.778 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.48 137.97 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 29.8 m-20 60.99 -96.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.063 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.39 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.612 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 8.1 p -73.14 -62.18 1.56 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.66 146.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.762 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -147.42 156.16 42.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.15 147.21 29.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.591 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.693 ' HE3' HG21 ' C' ' 57' ' ' THR . 10.9 tmtt? -150.53 138.85 20.36 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.34 14.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 163.95 -175.85 40.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.597 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.01 137.71 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -108.95 144.53 36.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.357 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -117.87 114.61 23.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.261 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -120.12 130.8 54.8 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -115.76 7.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -146.67 7.22 0.96 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.29 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.92 24.8 0.27 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.235 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.432 ' CG ' ' HD2' ' C' ' 34' ' ' LYS . 18.5 m-20 -127.62 80.84 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 65.1 t -112.34 139.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.67 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.55 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 6.8 ptp -133.25 141.34 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.733 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.59 125.97 54.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.55 152.06 25.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.504 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.52 87.19 0.39 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.815 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.609 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 11.1 m -118.26 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -132.43 147.56 52.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.912 0.386 . . . . 0.0 111.058 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.762 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 49.4 m-80 -111.71 130.57 55.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.97 22.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -118.71 158.79 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.688 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 12.1 t70 80.82 131.77 0.05 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -133.55 -72.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.817 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.33 33.84 0.64 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.972 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 p -90.82 158.96 16.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.809 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -101.76 -81.98 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.732 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 m 52.37 43.65 30.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.95 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.826 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 33.8 m80 -77.55 -52.7 1.67 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.807 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -59.22 116.25 3.14 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.467 2.111 . . . . 0.0 111.954 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -106.82 -67.31 0.95 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.031 0.443 . . . . 0.0 111.142 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -110.86 176.62 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.623 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.97 22.66 0.76 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.454 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.81 -47.07 19.78 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.499 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.37 -30.55 61.7 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.242 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.86 96.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 0.0 110.941 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -72.6 -39.36 67.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.018 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.667 ' HB2' ' HE2' ' B' ' 17' ' ' LYS . 0.3 OUTLIER -63.01 -31.32 72.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.525 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -35.02 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 111.26 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.19 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.433 HE22 HD12 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -60.44 -28.38 68.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.696 HD11 ' HD3' ' B' ' 24' ' ' ARG . 2.2 tm? -64.99 -59.43 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.81 -23.08 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.05 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.01 -55.18 15.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.696 ' HD3' HD11 ' C' ' 21' ' ' LEU . 69.5 mtp85 -70.34 -38.21 74.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.779 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.929 HD11 HD22 ' B' ' 25' ' ' LEU . 3.7 mm? -63.75 -48.28 77.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.04 -31.73 73.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 2.1 ttpp -65.34 -42.59 92.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.692 0.282 . . . . 0.0 111.288 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -63.35 -43.93 96.31 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.17 -30.01 64.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.925 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.589 HG22 ' HE2' ' A' ' 34' ' ' LYS . 5.6 m -79.71 -29.67 40.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.792 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 -26.64 46.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.32 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.62 -28.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.219 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.643 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 76.1 m-20 -75.95 -45.07 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.984 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.589 ' HE2' HG22 ' A' ' 30' ' ' THR . 5.2 ptpt -84.1 -29.1 27.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.74 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 39' ' ' SER . . . -68.65 -42.42 80.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.422 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -80.58 -25.59 38.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.105 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.19 -41.38 58.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.49 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 10.4 t -77.47 -42.58 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.758 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -62.39 -50.87 69.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.467 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . . . -59.97 -36.95 78.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.34 -42.59 44.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -71.65 -7.87 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.77 -23.84 63.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.147 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.7 mm? -82.19 165.82 20.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.862 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.7 p90 -153.28 -3.85 0.2 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.636 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HB3' ' CB ' ' A' ' 55' ' ' ASN . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.922 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -79.65 113.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.613 2.209 . . . . 0.0 112.487 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.43 173.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.016 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 52.98 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.23 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 7.6 p -72.57 -3.83 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.162 0.585 . . . . 0.0 112.45 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 145.57 52.56 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.341 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -169.6 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 110.615 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 75' ' ' TYR . 12.4 p -109.56 142.66 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.573 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' GLN . 23.9 m-80 -122.88 119.0 29.21 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 58' ' ' ALA . 34.6 t80 -87.25 133.85 33.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.242 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.551 HG21 ' CE ' ' A' ' 84' ' ' LYS . 81.8 p -115.35 120.03 38.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 56' ' ' PHE . . . -150.65 135.4 17.39 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.425 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.51 169.03 39.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.534 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 69' ' ' LEU . 15.6 m -120.57 154.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.26 -172.83 13.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.437 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.0 140.2 6.22 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.643 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 31.9 t80 -133.25 135.1 44.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.708 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.2 mmm180 66.61 -93.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.125 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 p -145.68 31.16 1.07 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.44 141.02 45.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.33 153.9 22.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.08 170.57 17.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.541 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -119.38 141.15 49.32 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . . . -126.23 140.78 52.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.732 0.301 . . . . 0.0 111.637 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -140.95 151.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.093 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.12 174.72 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.438 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.97 155.05 5.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.23 173.13 29.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.252 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.559 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 44.6 t80 -126.48 135.48 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.14 135.34 52.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.754 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.431 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 7.6 p -119.35 137.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.34 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 90.4 m-20 64.13 -94.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 6.2 pt-20 179.11 -23.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.604 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.92 -63.95 1.0 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.536 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.005 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -141.27 152.0 44.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.247 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 63.5 tp -134.37 140.28 46.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.551 ' CE ' HG21 ' A' ' 57' ' ' THR . 7.3 tmtt? -155.58 126.28 6.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.72 178.05 10.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.96 36.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.56 141.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 111.165 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.734 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -111.72 139.4 47.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.346 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -114.02 114.39 26.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.173 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -123.44 135.96 54.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.639 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.448 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 57.09 -116.81 8.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.31 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 72.5 m -148.61 16.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.74 0.305 . . . . 0.0 111.316 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.71 20.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.19 68.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.96 139.04 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.73 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.734 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 3.3 ptp -133.26 132.97 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.748 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -110.74 118.59 36.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -107.11 152.68 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.12 0.65 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.773 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 21.6 m -123.82 176.31 6.37 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.448 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.48 139.44 25.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.922 0.392 . . . . 0.0 111.105 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 1.005 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.6 m-80 -103.2 132.8 49.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.346 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.59 117.39 17.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.802 0.334 . . . . 0.0 110.811 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.75 151.92 36.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 27.9 m-90 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.613 179.743 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 12.0 t70 80.8 131.72 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -133.43 -72.59 0.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.821 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.27 33.87 0.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.971 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 28.5 p -90.78 158.95 16.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.756 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -101.8 -82.01 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.69 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 47.2 m 52.41 43.58 30.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.012 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.829 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 33.9 m80 -77.53 -52.76 1.67 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.79 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.829 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -59.12 116.17 3.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.482 2.121 . . . . 0.0 111.931 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -106.85 -67.25 0.96 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.936 0.398 . . . . 0.0 111.144 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -110.85 176.68 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.638 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.97 22.69 0.76 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.463 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.91 -47.01 19.68 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.462 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.39 -30.53 61.72 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.246 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.85 96.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.893 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -72.57 -39.37 67.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.063 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.667 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -62.94 -31.43 72.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.53 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.41 -35.16 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.194 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.74 -59.24 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.433 HE22 HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -60.37 -28.45 68.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.173 -179.731 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.705 HD11 ' HD3' ' C' ' 24' ' ' ARG . 2.1 tm? -64.85 -59.56 4.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.574 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -65.77 -23.0 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.059 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.08 -55.16 15.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.696 ' HD3' HD11 ' A' ' 21' ' ' LEU . 69.5 mtp85 -70.36 -38.19 74.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.934 HD11 HD22 ' C' ' 25' ' ' LEU . 3.7 mm? -63.8 -48.34 77.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.588 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.98 -31.66 72.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.591 ' HZ1' HD22 ' B' ' 28' ' ' LEU . 2.1 ttpp -65.48 -42.61 92.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.199 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.591 HD22 ' HZ1' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -63.22 -44.02 96.47 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.21 -29.96 64.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.926 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.591 HG22 ' HE2' ' B' ' 34' ' ' LYS . 5.6 m -79.75 -29.55 40.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -26.54 46.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.326 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.71 -28.57 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.142 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.657 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 76.2 m-20 -75.97 -44.99 37.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.988 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' B' ' 30' ' ' THR . 5.3 ptpt -84.19 -29.04 26.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.715 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' B' ' 39' ' ' SER . . . -68.79 -42.29 79.74 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.419 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.462 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.5 mt -80.66 -25.54 38.21 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.752 0.311 . . . . 0.0 111.034 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.11 -41.52 58.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.51 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 10.4 t -77.39 -42.6 35.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.785 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 0.9 OUTLIER -62.38 -50.87 69.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.88 85.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.475 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' B' ' 70' ' ' ALA . . . -59.94 -37.04 78.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.405 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 39.7 tp -76.33 -42.53 44.65 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.07 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -71.68 -7.87 50.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.4 t -69.73 -23.89 63.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.316 -0.856 . . . . 0.0 113.172 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.564 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.7 mm? -82.18 165.88 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.883 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 7.7 p90 -153.35 -3.8 0.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.109 0.48 . . . . 0.0 111.671 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.435 ' HB3' ' CB ' ' B' ' 55' ' ' ASN . 10.1 mt-30 72.03 117.26 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -79.55 113.53 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.645 2.23 . . . . 0.0 112.506 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.48 173.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.71 53.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.289 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 7.7 p -72.57 -3.9 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.117 0.567 . . . . 0.0 112.465 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 145.58 52.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.248 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -169.58 3.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.611 0.243 . . . . 0.0 110.606 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' B' ' 75' ' ' TYR . 12.4 p -109.59 142.65 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.538 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.435 ' CB ' ' HB3' ' B' ' 47' ' ' GLN . 24.0 m-80 -122.91 118.97 29.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.93 0.395 . . . . 0.0 111.697 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.447 ' HE2' ' HB2' ' B' ' 58' ' ' ALA . 34.5 t80 -87.17 133.83 33.6 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.245 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.558 HG21 ' CE ' ' B' ' 84' ' ' LYS . 81.8 p -115.38 119.95 37.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.949 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.447 ' HB2' ' HE2' ' B' ' 56' ' ' PHE . . . -150.58 135.43 17.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.475 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.479 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.49 168.98 39.25 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.539 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' B' ' 69' ' ' LEU . 15.6 m -120.52 154.79 23.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.806 0.336 . . . . 0.0 111.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.33 -172.81 13.38 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.409 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.01 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.657 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 32.0 t80 -133.21 134.98 44.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.74 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.2 mmm180 66.69 -93.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.087 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.63 31.14 1.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.173 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.47 140.98 45.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.35 153.93 22.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.62 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.579 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.531 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -119.5 141.2 49.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' B' ' 41' ' ' ALA . . . -126.25 140.64 52.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 71' ' ' ILE . 8.3 tp -140.9 151.84 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.742 0.306 . . . . 0.0 111.11 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.21 174.65 39.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.396 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.94 155.12 5.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.342 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.21 173.19 29.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.245 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.557 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 44.8 t80 -126.55 135.58 51.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.22 135.34 52.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.659 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.437 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 7.6 p -119.4 137.4 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 90.2 m-20 64.11 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 6.2 pt-20 179.1 -23.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.589 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 17.5 p -70.8 -63.98 0.99 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.98 143.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.58 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -141.29 152.07 44.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.271 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 63.6 tp -134.32 140.2 46.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.604 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.558 ' CE ' HG21 ' B' ' 57' ' ' THR . 7.3 tmtt? -155.6 126.13 6.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.141 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.44 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.59 178.07 10.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.88 36.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.534 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.411 ' O ' HG22 ' B' ' 71' ' ' ILE . 7.7 p -143.66 141.44 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.74 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -111.82 139.35 47.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.325 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -113.95 114.37 26.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.205 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -123.36 136.01 54.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.644 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 57.06 -116.92 8.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.248 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.52 16.64 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.75 20.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.197 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -119.22 68.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.957 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.14 139.06 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.74 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 3.3 ptp -133.31 132.99 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.74 118.63 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.415 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -107.13 152.66 23.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.685 0.279 . . . . 0.0 111.412 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.98 94.11 0.65 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.472 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 21.8 m -123.81 176.44 6.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.391 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -146.65 139.45 25.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.029 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.954 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.6 m-80 -103.22 132.79 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.362 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.35 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.78 151.93 36.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.651 179.706 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.677 -0.169 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' C' ' 1' ' ' GLY . 12.0 t70 80.67 131.82 0.05 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 110.966 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -133.51 -72.56 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.802 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.3 33.82 0.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.99 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 28.4 p -90.75 159.03 16.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.807 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -101.8 -81.98 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.729 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 47.0 m 52.38 43.59 30.72 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.991 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.808 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 33.9 m80 -77.64 -52.63 1.66 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.803 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.808 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -59.11 116.25 3.13 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.575 2.183 . . . . 0.0 111.857 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -106.91 -67.28 0.96 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -110.87 176.67 4.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.668 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.94 22.57 0.77 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.87 -46.99 19.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.496 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.36 -30.55 61.66 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.275 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.87 96.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 0.0 110.904 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -72.63 -39.32 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.994 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.65 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -62.98 -31.38 72.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.55 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -34.99 65.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.259 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.18 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.444 HE22 HD12 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -60.44 -28.36 68.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.136 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.696 HD11 ' HD3' ' A' ' 24' ' ' ARG . 2.1 tm? -64.98 -59.44 4.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.631 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -65.86 -22.96 66.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.07 -55.17 15.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.705 ' HD3' HD11 ' B' ' 21' ' ' LEU . 69.6 mtp85 -70.33 -38.16 74.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.934 HD22 HD11 ' B' ' 25' ' ' LEU . 3.7 mm? -63.89 -48.36 76.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.87 -31.74 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.437 ' HZ1' HD22 ' C' ' 28' ' ' LEU . 2.0 ttpp -65.47 -42.51 92.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' C' ' 28' ' ' LEU . 0.0 OUTLIER -63.28 -44.0 96.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -29.96 64.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.936 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.582 HG22 ' HE2' ' C' ' 34' ' ' LYS . 5.6 m -79.8 -29.55 40.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -26.63 46.49 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.357 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.55 -28.72 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.143 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.654 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 76.2 m-20 -75.88 -45.11 37.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.005 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.582 ' HE2' HG22 ' C' ' 30' ' ' THR . 5.3 ptpt -84.08 -29.07 27.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.806 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' C' ' 39' ' ' SER . . . -68.6 -42.39 80.82 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.462 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.5 mt -80.61 -25.63 38.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.801 0.334 . . . . 0.0 111.06 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.45 57.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.402 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 10.5 t -77.43 -42.6 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' C' ' 35' ' ' GLY . 0.9 OUTLIER -62.3 -50.92 69.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.86 85.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' C' ' 70' ' ' ALA . . . -59.92 -37.02 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.94 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.41 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 39.6 tp -76.25 -42.65 45.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.035 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -71.66 -7.9 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.71 -23.91 63.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.149 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.547 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.7 mm? -82.26 165.78 20.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.813 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 7.7 p90 -153.26 -3.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.651 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' C' ' 55' ' ' ASN . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.963 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.735 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -79.61 113.5 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.667 2.245 . . . . 0.0 112.514 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.47 173.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.985 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.73 53.02 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.229 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 7.7 p -72.58 -3.85 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 145.6 52.65 0.03 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.22 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.603 0.239 . . . . 0.0 110.655 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' C' ' 75' ' ' TYR . 12.4 p -109.6 142.62 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.567 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.439 ' CB ' ' HB3' ' C' ' 47' ' ' GLN . 24.0 m-80 -122.91 118.99 29.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.646 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.454 ' HE2' ' HB2' ' C' ' 58' ' ' ALA . 34.4 t80 -87.19 133.77 33.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.282 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.565 HG21 ' CE ' ' C' ' 84' ' ' LYS . 81.9 p -115.31 120.01 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.983 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.454 ' HB2' ' HE2' ' C' ' 56' ' ' PHE . . . -150.66 135.38 17.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.473 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.48 168.95 39.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' C' ' 69' ' ' LEU . 15.6 m -120.52 154.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.806 0.336 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.31 -172.88 13.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.466 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.0 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.574 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.654 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 32.1 t80 -133.19 134.99 44.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 110.812 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.2 mmm180 66.64 -93.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.133 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.61 31.12 1.08 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.43 141.05 45.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.781 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.39 153.91 22.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.54 17.56 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.539 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.53 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -119.43 141.18 49.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.747 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' C' ' 41' ' ' ALA . . . -126.24 140.69 52.34 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.702 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.408 HG22 ' O ' ' C' ' 87' ' ' VAL . 8.3 tp -140.88 151.83 20.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.14 174.72 39.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.468 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.93 155.09 5.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.24 173.15 29.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.269 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.554 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 44.6 t80 -126.56 135.54 51.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.342 . . . . 0.0 111.172 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.17 135.39 52.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.666 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.444 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 7.5 p -119.43 137.39 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 90.2 m-20 64.15 -94.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 79' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 6.2 pt-20 179.07 -23.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.527 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.99 -63.87 1.02 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.965 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -141.28 152.07 44.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.257 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 63.3 tp -134.37 140.22 46.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.565 ' CE ' HG21 ' C' ' 57' ' ' THR . 7.3 tmtt? -155.6 126.23 6.87 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 85' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.68 177.99 10.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.71 -167.82 36.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.58 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' VAL . . . . . 0.408 ' O ' HG22 ' C' ' 71' ' ' ILE . 7.7 p -143.74 141.45 25.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -111.73 139.31 47.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.316 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -113.97 114.45 26.2 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -123.45 135.95 54.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.624 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 57.11 -116.86 8.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.248 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.58 16.5 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 111.252 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.73 20.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.238 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.25 68.68 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 24.9 t -94.99 139.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.738 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.745 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 3.3 ptp -133.28 132.99 42.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.701 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.8 118.64 36.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.433 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -107.05 152.64 23.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.727 0.298 . . . . 0.0 111.432 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.1 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.479 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 21.8 m -123.8 176.37 6.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.432 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.59 139.42 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.988 0.423 . . . . 0.0 111.101 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.965 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.6 m-80 -103.21 132.8 49.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.37 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.3 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.781 0.324 . . . . 0.0 110.798 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.77 151.94 36.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.71 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.619 -0.192 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 20.3 t70 79.74 131.61 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 110.882 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -131.9 -67.66 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.66 28.04 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.013 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 p -92.21 153.68 19.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.764 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -106.48 -82.0 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.71 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m 53.75 41.88 31.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.991 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.801 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 36.7 m80 -72.6 -51.64 6.95 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.793 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.801 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -50.67 111.87 0.64 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.457 2.105 . . . . 0.0 111.878 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 8' ' ' HIS . 69.6 mt-30 -110.42 -73.21 0.69 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.966 0.413 . . . . 0.0 111.155 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -109.52 177.15 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.711 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.68 20.15 0.81 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.441 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -47.76 35.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.56 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.06 -34.66 58.48 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.216 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.32 -44.85 96.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.867 0.365 . . . . 0.0 110.875 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -68.32 -41.1 81.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.029 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -59.99 -37.61 80.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.534 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.79 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.33 -60.07 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.6 -28.13 69.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.706 ' O ' HD23 ' A' ' 25' ' ' LEU . 2.4 tm? -63.37 -54.61 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.536 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' NH2' ' B' ' 24' ' ' ARG . 30.2 m-20 -65.28 -27.07 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.981 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.49 -57.53 8.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.703 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.0 mtp85 -61.6 -38.55 87.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.818 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.797 HD11 HD22 ' B' ' 25' ' ' LEU . 3.1 mm? -62.18 -48.64 79.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.531 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.9 -28.94 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.772 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' NZ ' ' HD3' ' A' ' 31' ' ' ARG . 1.2 ttpp -65.15 -44.01 89.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.642 0.258 . . . . 0.0 111.223 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.444 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -59.58 -41.66 90.74 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.553 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -61.1 -27.71 68.57 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.939 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 m -75.58 -39.82 57.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HD3' ' NZ ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -73.06 -22.81 60.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.334 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.6 m -90.28 -28.65 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.144 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.632 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 65.1 m-20 -73.63 -47.74 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 91' ' ' GLY . 7.9 ptpt -80.8 -28.47 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.759 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.92 53.82 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.422 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 1.6 mt -75.0 -32.22 61.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 111.127 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.2 -41.17 70.62 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.447 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.745 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 9.0 t -74.8 -41.52 59.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.802 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -60.01 -53.34 58.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.087 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -60.22 -34.04 73.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.339 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.784 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.33 -41.45 93.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.25 -42.14 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.071 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 3.0 m120 -72.09 -9.87 59.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 t -68.49 -22.68 64.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.189 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.648 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.6 mm? -82.7 159.17 22.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.875 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.16 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.647 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' OE1' ' HA3' ' A' ' 74' ' ' GLY . 13.8 mt-30 70.7 118.04 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.7 Cg_endo -78.48 114.85 3.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.585 2.19 . . . . 0.0 112.501 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.75 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.631 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 167.72 55.85 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.263 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 8.3 p -75.49 -5.5 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.136 0.575 . . . . 0.0 112.479 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.8 49.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.33 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.599 0.238 . . . . 0.0 110.649 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 p -105.86 141.63 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.524 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -122.77 117.52 25.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 111.624 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -87.72 140.59 29.36 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.281 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.648 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 68.1 p -117.23 118.97 33.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.91 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' B' ' 101' ' ' PHE . . . -144.9 132.39 20.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.476 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.83 174.93 46.17 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.574 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.22 160.67 23.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.392 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.784 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -140.33 177.55 20.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.438 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -162.39 141.04 6.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.537 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.636 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 39.1 t80 -137.24 134.12 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.271 . . . . 0.0 110.815 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 64' ' ' ARG . 1.9 mmm180 62.89 -93.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 p -143.26 32.39 1.35 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.1 145.15 47.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.782 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.01 153.55 26.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.097 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.98 164.33 32.37 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.523 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.58 136.16 53.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.71 51.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.638 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.17 153.41 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.101 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 172.89 -177.72 45.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.95 151.26 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.458 ' HA3' ' OE1' ' A' ' 47' ' ' GLN . . . -150.24 171.67 30.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.227 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.03 136.59 50.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 111.11 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.631 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 7.1 ttm180 -132.25 133.89 44.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.583 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 4.1 p -122.95 143.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.286 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.3 m-20 60.13 -88.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.986 0.422 . . . . 0.0 111.083 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 10.0 pt-20 172.21 -31.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.535 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.42 -58.92 5.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.023 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.97 138.7 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.61 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.717 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -144.79 148.39 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 111.255 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -136.37 140.3 43.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.641 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.49 ' C ' ' HD3' ' A' ' 84' ' ' LYS . 8.9 tmtt? -153.79 130.42 10.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.481 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.34 177.05 11.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . 166.02 -169.93 40.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.553 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.27 141.64 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.145 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -109.28 145.82 35.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.368 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -111.31 118.29 35.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.207 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.626 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 48.01 -114.3 1.79 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.286 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.15 17.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.18 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -116.34 71.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.78 132.32 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.628 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 2.7 ptp -122.69 126.67 48.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.89 111.17 23.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.436 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -107.32 152.43 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.322 . . . . 0.0 111.398 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.15 96.71 1.0 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.472 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 57.4 m -119.94 177.64 4.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.387 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' C' ' 58' ' ' ALA . 22.3 p90 -147.29 138.86 24.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.409 . . . . 0.0 111.082 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.728 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 74.5 m-20 -100.78 130.65 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.92 112.06 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.749 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HG2' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -117.26 146.87 43.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.645 179.764 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.649 -0.18 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 20.3 t70 79.7 131.56 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -131.9 -67.64 0.67 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.823 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.64 28.0 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 24.2 p -92.29 153.74 19.05 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.788 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -106.49 -81.99 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.755 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m 53.69 41.87 31.97 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.022 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.791 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 36.6 m80 -72.52 -51.66 7.13 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.82 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.791 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -50.67 111.86 0.63 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.411 2.074 . . . . 0.0 111.944 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' B' ' 8' ' ' HIS . 69.6 mt-30 -110.33 -73.19 0.69 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.051 0.453 . . . . 0.0 111.177 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -109.57 177.14 4.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.726 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.73 20.24 0.8 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.478 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -47.79 35.83 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.529 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.14 -34.59 58.71 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.198 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.98 96.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -68.29 -41.11 81.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.979 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.66 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER -59.86 -37.72 80.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.531 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.11 -38.81 66.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.222 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.3 -60.11 4.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.758 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.58 -28.15 69.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.715 ' O ' HD23 ' B' ' 25' ' ' LEU . 2.4 tm? -63.32 -54.65 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.484 ' HA ' ' NH2' ' C' ' 24' ' ' ARG . 30.5 m-20 -65.39 -26.9 68.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.017 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.58 -57.41 9.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.695 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.0 mtp85 -61.71 -38.52 88.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.797 HD22 HD11 ' A' ' 25' ' ' LEU . 3.1 mm? -62.2 -48.55 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.92 -29.01 70.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.771 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.411 ' NZ ' ' HD3' ' B' ' 31' ' ' ARG . 1.3 ttpp -65.17 -43.92 90.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.228 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.433 ' O ' HG13 ' B' ' 32' ' ' VAL . 0.0 OUTLIER -59.61 -41.65 90.84 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.569 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -61.08 -27.67 68.53 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.988 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 4.1 m -75.73 -39.72 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.841 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.411 ' HD3' ' NZ ' ' B' ' 27' ' ' LYS . 0.6 OUTLIER -73.14 -22.79 60.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.284 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.569 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.5 m -90.19 -28.69 4.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.22 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.629 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 65.5 m-20 -73.55 -47.87 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.036 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' B' ' 91' ' ' GLY . 7.9 ptpt -80.76 -28.38 36.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.805 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.54 -40.75 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.413 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 1.6 mt -75.11 -32.15 61.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.328 . . . . 0.0 111.105 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -41.14 70.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.413 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.763 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 9.1 t -74.85 -41.62 59.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.93 -53.36 58.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.25 -34.0 73.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.404 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.806 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.4 -41.35 93.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.959 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 tp -72.25 -42.19 65.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.061 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 40' ' ' ALA . 9.2 m-20 -72.07 -9.89 59.02 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.8 t -68.5 -22.64 64.52 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.181 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.657 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.6 mm? -82.73 159.16 22.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.823 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.18 0.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.649 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' B' ' 46' ' ' PHE . 13.8 mt-30 70.68 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.947 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.35 114.64 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.747 2.298 . . . . 0.0 112.571 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.82 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 167.72 55.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.316 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 8.3 p -75.59 -5.52 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.105 0.562 . . . . 0.0 112.425 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.82 49.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.209 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -173.12 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.629 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -105.9 141.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.516 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -122.85 117.47 25.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 111.63 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -87.71 140.56 29.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.252 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.657 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 67.9 p -117.21 118.9 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.931 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' C' ' 101' ' ' PHE . . . -144.89 132.39 20.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.82 174.93 46.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.614 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.19 160.68 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.347 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.806 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -140.33 177.59 20.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.518 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -162.39 140.93 6.85 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.603 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.636 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 39.1 t80 -137.17 134.25 36.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.31 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' B' ' 64' ' ' ARG . 1.9 mmm180 62.96 -93.45 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.979 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 17.3 p -143.23 32.46 1.35 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.143 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.19 145.17 47.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.03 153.54 26.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.0 164.33 32.42 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.517 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.53 136.14 53.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.793 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.72 51.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.19 153.39 16.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.157 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 172.9 -177.69 45.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.441 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.92 151.3 4.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.389 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.443 ' HA3' ' OE1' ' B' ' 47' ' ' GLN . . . -150.32 171.61 30.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.203 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.94 136.51 50.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.134 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.614 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 7.1 ttm180 -132.19 133.95 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.602 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 4.1 p -122.96 143.1 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.267 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 96.3 m-20 60.21 -88.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.927 0.394 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 10.0 pt-20 172.25 -31.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.555 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 15.6 p -62.49 -58.89 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.06 138.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.5 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -144.81 148.43 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.27 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 53.4 tp -136.43 140.32 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.581 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.483 ' HD3' ' C ' ' B' ' 84' ' ' LYS . 8.9 tmtt? -153.75 130.44 10.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.38 177.11 11.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 166.04 -169.89 40.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.592 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.34 141.65 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 111.104 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.763 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -109.32 145.91 35.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.276 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -111.38 118.28 35.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.289 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.581 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.482 ' N ' ' HD3' ' B' ' 34' ' ' LYS . . . 47.97 -114.24 1.75 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 39.1 m -149.57 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.687 0.28 . . . . 0.0 111.275 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.24 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -116.39 71.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 39.1 t -99.83 132.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.675 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.636 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 2.7 ptp -122.72 126.62 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.733 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.92 111.26 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.405 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -107.38 152.42 24.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.724 0.297 . . . . 0.0 111.459 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.18 96.74 1.0 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.467 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 56.5 m -119.96 177.64 4.91 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.428 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' ALA . 21.9 p90 -147.3 138.79 23.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 111.093 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.75 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 74.5 m-20 -100.77 130.6 46.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.433 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.85 112.05 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -117.25 146.86 43.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.677 179.721 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' C' ' 1' ' ' GLY . 20.4 t70 79.71 131.52 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.895 0.378 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -131.85 -67.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.63 27.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 24.3 p -92.28 153.7 19.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.703 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -106.46 -82.02 0.54 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m 53.75 41.87 31.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.028 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.788 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 36.7 m80 -72.56 -51.72 6.98 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.744 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.788 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -50.54 111.83 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.499 2.133 . . . . 0.0 111.884 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 10' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' C' ' 8' ' ' HIS . 69.3 mt-30 -110.4 -73.14 0.69 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.998 0.428 . . . . 0.0 111.231 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -109.64 177.07 4.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.742 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.61 20.18 0.82 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.478 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -47.74 35.83 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.546 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.08 -34.55 58.43 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.298 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.38 -44.85 96.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 110.903 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -68.29 -41.11 81.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.005 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.664 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER -59.94 -37.62 80.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.541 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.78 66.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.32 -60.07 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.63 -28.17 69.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.42 . . . . 0.0 111.149 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.715 ' O ' HD23 ' C' ' 25' ' ' LEU . 2.4 tm? -63.26 -54.67 33.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.545 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' ASP . . . . . 0.481 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 30.1 m-20 -65.31 -26.99 68.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.085 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.54 -57.45 9.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.712 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.0 mtp85 -61.65 -38.58 88.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.734 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.789 HD11 HD22 ' A' ' 25' ' ' LEU . 3.1 mm? -62.14 -48.57 79.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.9 -29.01 70.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.816 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.407 ' NZ ' ' HD3' ' C' ' 31' ' ' ARG . 1.2 ttpp -65.18 -43.92 90.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.652 0.263 . . . . 0.0 111.249 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.43 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.0 OUTLIER -59.59 -41.67 90.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ASP . . . . . 0.547 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -61.12 -27.71 68.58 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.917 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 4.1 m -75.59 -39.85 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.407 ' HD3' ' NZ ' ' C' ' 27' ' ' LYS . 0.6 OUTLIER -73.05 -22.71 60.58 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.4 m -90.27 -28.7 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.635 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 65.5 m-20 -73.63 -47.76 37.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.489 ' HD3' ' CA ' ' C' ' 91' ' ' GLY . 7.9 ptpt -80.85 -28.37 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.803 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.45 -40.85 53.63 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.478 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 1.6 mt -74.98 -32.36 61.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 111.07 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.21 70.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.44 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.743 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 9.1 t -74.81 -41.57 59.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.746 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.96 -53.28 59.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.169 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.95 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.403 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' ALA . . . . . 0.773 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.44 -41.38 93.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.24 -42.23 65.89 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.073 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 43' ' ' ASN . 3.0 m120 -72.02 -9.84 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.9 t -68.54 -22.68 64.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.158 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.652 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.6 mm? -82.68 159.15 22.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.866 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 15.1 p90 -148.5 -2.28 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.619 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' C' ' 46' ' ' PHE . 13.8 mt-30 70.72 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.936 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.44 114.78 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.679 2.253 . . . . 0.0 112.487 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.76 -176.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.634 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 167.69 55.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.246 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 8.3 p -75.48 -5.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.178 0.591 . . . . 0.0 112.445 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.84 49.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.283 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.644 0.259 . . . . 0.0 110.621 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.84 141.5 21.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.585 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -122.74 117.6 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 111.664 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -87.8 140.54 29.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.34 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.652 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 67.7 p -117.15 118.9 33.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.001 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 101' ' ' PHE . . . -144.87 132.39 20.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.81 174.9 46.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.586 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.16 160.72 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 111.399 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -140.35 177.64 20.54 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.4 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -162.47 141.04 6.92 Favored Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.635 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 39.0 t80 -137.29 134.26 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.711 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' C' ' 64' ' ' ARG . 1.9 mmm180 62.9 -93.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.114 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -143.23 32.37 1.35 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.15 145.14 47.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.05 153.56 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 111.097 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.94 164.3 32.45 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.61 136.2 53.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.96 140.69 51.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.25 153.4 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.768 0.318 . . . . 0.0 111.098 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 172.94 -177.71 45.29 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.456 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.91 151.32 4.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' GLY . . . . . 0.458 ' HA3' ' OE1' ' C' ' 47' ' ' GLN . . . -150.26 171.75 30.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -129.12 136.49 50.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.634 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 7.1 ttm180 -132.11 134.09 45.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.682 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.604 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 4.1 p -123.09 143.12 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.274 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 96.3 m-20 60.15 -88.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 111.104 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 10.1 pt-20 172.18 -31.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.47 -58.93 5.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.942 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 32.2 m -94.05 138.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.525 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.736 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -144.9 148.39 33.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.279 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 53.6 tp -136.38 140.37 43.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 8.9 tmtt? -153.85 130.44 10.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' ALA . . . . . 0.492 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.37 177.1 11.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.043 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 166.0 -169.91 40.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.555 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.29 141.69 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.872 0.368 . . . . 0.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.743 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -109.28 145.84 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.339 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.38 118.2 35.17 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.277 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.02 140.63 52.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.591 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.489 ' CA ' ' HD3' ' C' ' 34' ' ' LYS . . . 48.02 -114.34 1.81 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.244 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -149.47 16.72 0.91 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.264 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.23 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -116.39 71.01 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.81 132.33 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.006 0.432 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.636 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 2.7 ptp -122.65 126.65 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -105.98 111.28 23.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.408 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -107.31 152.46 24.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.457 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.2 96.74 0.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 56.5 m -119.95 177.63 4.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.438 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' B' ' 58' ' ' ALA . 22.1 p90 -147.31 138.83 24.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.743 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 74.5 m-20 -100.79 130.62 46.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.358 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.93 112.08 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -117.24 146.87 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.705 179.681 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.2 t0 73.13 141.41 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.892 0.377 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -129.13 -63.97 0.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.74 24.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -97.22 153.69 17.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.808 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.505 ' HB3' ' CD2' ' A' ' 8' ' ' HIS . 32.0 m95 -105.68 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.739 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.8 m 61.21 46.39 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.053 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.704 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 30.7 m-70 -88.19 -49.86 0.42 Allowed Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.801 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -58.48 106.95 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.469 2.113 . . . . 0.0 111.945 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -109.67 -57.31 2.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.951 0.405 . . . . 0.0 111.157 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -120.64 169.91 9.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.652 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 25.71 1.65 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.473 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.651 ' HE2' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -68.72 -50.36 51.41 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.568 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.21 -28.64 64.51 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.254 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.09 86.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.342 . . . . 0.0 110.873 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 19' ' ' ARG . 18.2 m-70 -78.45 -29.42 46.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.002 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.651 ' HD3' ' HE2' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -66.38 -41.88 88.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.561 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.82 -32.31 67.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.371 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 53.0 mtt-85 -64.1 -57.64 8.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.74 -31.18 70.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 3.2 tm? -61.98 -59.76 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.12 -18.79 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -74.13 -45.99 45.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.58 ' HB3' HD12 ' C' ' 25' ' ' LEU . 61.4 mtp85 -77.02 -37.14 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.818 HD11 HD22 ' B' ' 25' ' ' LEU . 3.3 mm? -66.42 -52.18 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.63 -42.24 92.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.3 ttpp -66.88 -28.95 68.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -48.81 78.27 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.614 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -64.33 -33.09 75.04 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.925 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -67.93 -38.83 83.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.732 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.83 64.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.8 m -74.24 -33.46 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.641 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 16.6 m-20 -69.07 -45.28 70.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.3 ptpt -75.19 -40.65 59.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.729 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.43 ' HA3' ' OH ' ' C' ' 63' ' ' TYR . . . -57.37 -43.63 93.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.381 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.793 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.03 -24.65 58.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.159 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.59 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -69.21 -41.96 76.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.461 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.527 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 8.5 t -82.81 -39.97 21.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.745 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.504 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 4.0 t -58.11 -54.79 43.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.51 73.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.445 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.73 -33.6 76.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.663 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 60.1 tp -82.65 -32.37 28.27 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.712 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 19.8 m120 -75.84 -16.34 60.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.85 -18.83 64.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.207 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.635 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.7 mm? -77.53 163.87 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.909 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.478 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.2 p90 -156.56 0.41 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HB3' ' CB ' ' A' ' 55' ' ' ASN . 6.0 mt-30 63.07 125.07 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.965 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -83.95 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.671 2.247 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.482 ' OH ' ' HB ' ' B' ' 51' ' ' VAL . 13.7 m-30 63.7 -175.3 0.16 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.569 ' HA3' ' HD2' ' A' ' 76' ' ' ARG . . . 166.69 55.44 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.237 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -81.44 -10.66 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.159 0.584 . . . . 0.0 112.432 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.67 48.17 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.284 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -150.92 -163.92 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.656 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -116.72 142.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.553 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.48 ' CB ' ' HB3' ' A' ' 47' ' ' GLN . 10.4 m-80 -124.82 113.32 17.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.677 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.55 129.64 34.98 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.273 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.701 HG21 ' HE3' ' A' ' 84' ' ' LYS . 37.7 p -109.36 122.09 46.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.992 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -154.62 133.68 12.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.436 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.46 170.49 43.31 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.531 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 69' ' ' LEU . 2.7 m -121.15 161.41 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.366 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.23 17.96 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.461 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -172.21 138.73 4.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.641 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 34.0 t80 -120.84 131.85 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.685 0.278 . . . . 0.0 110.738 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.4 mmm180 69.52 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.1 p -143.76 26.22 1.58 Allowed 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.159 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.38 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.33 150.96 28.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -146.55 171.79 14.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.548 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.49 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -119.98 142.8 48.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.811 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -132.62 137.19 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.686 0.279 . . . . 0.0 111.636 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.521 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.5 tp -137.65 162.1 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.784 0.326 . . . . 0.0 111.05 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.521 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 171.37 179.9 42.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.397 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.61 148.77 12.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.892 0.377 . . . . 0.0 110.965 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.49 166.78 30.77 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.228 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.601 ' CE2' ' HB ' ' A' ' 77' ' ' VAL . 38.8 t80 -131.85 134.49 45.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.156 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.569 ' HD2' ' HA3' ' A' ' 50' ' ' GLY . 16.4 ttm180 -125.18 121.56 34.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.621 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 8.6 p -110.88 137.99 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 49.7 m-20 64.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' HB3' ' CE2' ' C' ' 49' ' ' TYR . 10.5 pt-20 175.42 -20.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.59 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 p -70.85 -66.36 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.032 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 m -90.85 141.34 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.589 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.47 153.82 37.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.172 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.3 tp -148.82 149.88 32.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.618 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.701 ' HE3' HG21 ' A' ' 57' ' ' THR . 12.1 tmtt? -149.34 141.67 24.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.162 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.17 176.02 11.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.44 -173.06 41.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.587 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.09 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.853 0.358 . . . . 0.0 111.16 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.767 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -110.25 144.23 39.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.351 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -121.97 113.01 18.99 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.39 -116.13 8.72 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.293 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.87 8.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.322 . . . . 0.0 111.337 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t -155.03 22.62 0.44 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.108 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 10.8 m-20 -127.11 82.86 2.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.87 139.4 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.767 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 6.9 ptp -134.22 141.58 47.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -113.26 124.31 52.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.455 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.417 ' ND2' HD23 ' A' ' 42' ' ' LEU . 36.0 m-80 -109.57 148.01 32.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.296 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.7 86.9 0.38 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.61 162.34 17.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.471 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -130.31 145.64 51.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.976 0.417 . . . . 0.0 111.055 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.553 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 56.0 m-80 -115.34 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.399 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.14 119.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.819 0.343 . . . . 0.0 110.726 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.92 159.8 22.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.406 -0.806 . . . . 0.0 110.598 179.693 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 112.651 -0.179 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 16.2 t0 73.12 141.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.946 0.403 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -129.12 -64.0 0.93 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.824 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.77 24.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -97.35 153.73 17.89 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.819 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.677 ' HB3' ' CE1' ' B' ' 8' ' ' HIS . 32.2 m95 -105.67 -75.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.676 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 70.8 m 61.24 46.43 7.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.981 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.728 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 23.7 m170 -88.22 -49.81 0.42 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.811 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -58.53 106.93 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.504 2.136 . . . . 0.0 111.92 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -109.61 -57.3 2.2 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.944 0.402 . . . . 0.0 111.175 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -120.71 169.96 9.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.595 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.52 25.78 1.65 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.482 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.653 ' HE2' ' HD3' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -68.72 -50.39 51.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.489 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.27 -28.54 64.53 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.262 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.96 -44.2 85.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.434 ' HA ' ' HD2' ' B' ' 19' ' ' ARG . 18.2 m-70 -78.41 -29.39 47.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.988 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.653 ' HD3' ' HE2' ' B' ' 13' ' ' LYS . 0.6 OUTLIER -66.48 -41.77 88.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.5 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.92 -32.3 67.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' B' ' 16' ' ' HIS . 53.0 mtt-85 -63.99 -57.71 8.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.707 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.83 -31.1 70.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 3.2 tm? -61.95 -59.81 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.591 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -65.07 -18.78 65.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.18 -46.0 44.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.58 ' HB3' HD12 ' A' ' 25' ' ' LEU . 61.3 mtp85 -76.94 -37.14 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.794 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.818 HD22 HD11 ' A' ' 25' ' ' LEU . 3.3 mm? -66.47 -52.16 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.641 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.61 -42.19 92.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.93 -29.02 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.245 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -48.82 78.3 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.604 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -64.46 -32.9 74.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 178.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 5.9 m -68.03 -38.81 82.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.858 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.749 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -73.3 -39.85 64.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.246 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.6 m -74.21 -33.41 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.223 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.644 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 16.6 m-20 -69.18 -45.25 70.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.749 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.3 ptpt -75.17 -40.61 59.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.434 ' HA3' ' OH ' ' A' ' 63' ' ' TYR . . . -57.37 -43.62 93.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.794 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.06 -24.65 58.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.592 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -69.18 -42.03 76.39 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.54 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 8.5 t -82.72 -40.01 21.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.741 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.5 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.9 t -58.12 -54.62 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.66 -33.47 74.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.409 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.69 76.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.691 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 59.6 tp -82.6 -32.29 28.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.718 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 19.9 m120 -75.8 -16.37 60.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.99 -18.69 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.148 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.627 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.7 mm? -77.63 163.88 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.846 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.462 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.2 p90 -156.54 0.37 0.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 111.714 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.488 ' HB3' ' CB ' ' B' ' 55' ' ' ASN . 6.1 mt-30 63.15 124.98 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.967 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -83.94 109.92 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.642 2.228 . . . . 0.0 112.605 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.484 ' CE2' ' HB3' ' C' ' 79' ' ' GLU . 13.6 m-30 63.71 -175.31 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.934 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.566 ' HA3' ' HD2' ' B' ' 76' ' ' ARG . . . 166.72 55.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.245 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -81.34 -10.67 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.161 0.584 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.63 48.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.268 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.435 ' O ' ' CD1' ' B' ' 75' ' ' TYR . 0.0 OUTLIER -150.89 -163.87 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.601 0.239 . . . . 0.0 110.639 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -116.78 142.65 29.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.586 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.488 ' CB ' ' HB3' ' B' ' 47' ' ' GLN . 10.4 m-80 -124.8 113.43 17.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.973 0.416 . . . . 0.0 111.663 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.67 129.7 34.96 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.195 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.704 HG21 ' HE3' ' B' ' 84' ' ' LYS . 37.6 p -109.42 122.07 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.943 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -154.61 133.7 12.41 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.368 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.47 170.49 43.32 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' B' ' 69' ' ' LEU . 2.7 m -121.16 161.52 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.773 0.321 . . . . 0.0 111.383 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.23 -167.16 17.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.473 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.592 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -172.23 138.75 4.94 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.644 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 34.1 t80 -120.87 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.695 0.283 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.5 mmm180 69.47 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -143.75 26.18 1.58 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.17 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.4 51.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -110.44 151.06 27.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -146.66 171.7 14.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.537 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.493 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.8 OUTLIER -120.0 142.75 48.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.808 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.691 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -132.58 137.2 47.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.681 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.531 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.5 tp -137.64 162.07 32.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.738 0.304 . . . . 0.0 111.119 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.531 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 171.34 179.87 42.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.444 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.58 148.73 12.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.41 166.8 30.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.609 ' CE2' ' HB ' ' B' ' 77' ' ' VAL . 38.6 t80 -131.88 134.47 45.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.566 ' HD2' ' HA3' ' B' ' 50' ' ' GLY . 16.4 ttm180 -125.19 121.47 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.626 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 8.6 p -110.88 138.04 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.344 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 50.2 m-20 64.3 -97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.481 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 10.4 pt-20 175.44 -20.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.541 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.81 -66.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 m -90.84 141.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.42 153.82 37.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 0.0 111.225 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 25.2 tp -148.79 149.88 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.582 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.704 ' HE3' HG21 ' B' ' 57' ' ' THR . 12.1 tmtt? -149.38 141.72 24.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.18 176.05 11.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.086 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.36 -173.1 41.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.556 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.21 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.347 . . . . 0.0 111.107 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.791 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -110.31 144.16 39.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.366 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.89 113.03 19.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.235 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -119.5 129.97 54.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.608 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.28 -116.04 8.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.31 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.92 8.11 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 111.332 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.1 22.65 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 10.9 m-20 -127.07 82.8 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 99.7 t -108.87 139.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.969 0.414 . . . . 0.0 110.653 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.791 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 6.9 ptp -134.22 141.6 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.693 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -113.28 124.3 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.434 ' ND2' HD23 ' B' ' 42' ' ' LEU . 36.2 m-80 -109.54 147.99 32.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 111.42 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.76 86.92 0.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.757 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.55 162.33 17.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.399 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -130.32 145.59 51.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.418 . . . . 0.0 111.073 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.564 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.0 m-80 -115.31 131.85 56.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.401 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.08 119.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.849 0.356 . . . . 0.0 110.776 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.99 159.81 22.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.672 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 16.2 t0 73.03 141.44 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.91 0.386 . . . . 0.0 110.988 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -129.1 -64.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.811 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.73 24.64 0.58 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.991 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -97.26 153.66 17.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.807 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' TRP . . . . . 0.517 ' HB3' ' CD2' ' C' ' 8' ' ' HIS . 32.2 m95 -105.58 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.789 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m 61.21 46.4 8.0 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.028 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.724 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 30.7 m-70 -88.26 -49.79 0.42 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.758 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.5 Cg_exo -58.52 106.96 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.519 2.146 . . . . 0.0 111.933 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -109.64 -57.36 2.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 111.153 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -120.65 169.86 9.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.634 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 25.74 1.66 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.472 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.649 ' HE2' ' HD3' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -68.7 -50.4 51.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.536 -179.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.3 -28.58 64.66 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.195 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.98 -44.06 85.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 0.0 110.928 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' HIS . . . . . 0.425 ' HA ' ' HD2' ' C' ' 19' ' ' ARG . 18.2 m-70 -78.43 -29.4 47.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.977 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.649 ' HD3' ' HE2' ' C' ' 13' ' ' LYS . 0.6 OUTLIER -66.51 -41.72 88.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.478 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.98 -32.26 67.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 111.245 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' C' ' 16' ' ' HIS . 53.1 mtt-85 -64.04 -57.72 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.79 -31.04 70.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.222 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 3.2 tm? -62.06 -59.75 4.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.53 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.11 -18.8 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.948 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.15 -45.97 45.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.587 ' HB3' HD12 ' B' ' 25' ' ' LEU . 61.4 mtp85 -76.98 -37.15 55.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.751 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.8 HD11 HD22 ' A' ' 25' ' ' LEU . 3.3 mm? -66.52 -52.13 49.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.646 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -59.59 -42.29 92.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.79 -29.02 68.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.229 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' C' ' 28' ' ' LEU . 0.0 OUTLIER -62.32 -48.72 78.59 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ASP . . . . . 0.595 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -64.4 -32.99 74.83 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.994 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 5.9 m -67.92 -38.94 83.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.813 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.729 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.78 65.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.271 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.7 m -74.16 -33.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.638 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 16.6 m-20 -68.97 -45.3 71.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.729 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.3 ptpt -75.12 -40.71 59.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.777 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' GLY . . . . . 0.431 ' HA3' ' OH ' ' B' ' 63' ' ' TYR . . . -57.34 -43.57 93.75 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.419 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.794 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -75.13 -24.65 58.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.875 0.369 . . . . 0.0 111.092 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.606 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -69.17 -42.03 76.42 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.429 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.541 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 8.5 t -82.75 -39.93 21.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.504 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 4.0 t -58.11 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.45 73.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.392 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.69 -33.66 76.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.683 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 59.9 tp -82.61 -32.29 28.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.718 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 19.8 m120 -75.79 -16.43 60.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -67.9 -18.74 64.88 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.149 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.649 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.7 mm? -77.68 163.89 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.858 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.472 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.2 p90 -156.53 0.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.657 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.487 ' HB3' ' CB ' ' C' ' 55' ' ' ASN . 6.1 mt-30 63.13 125.06 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.926 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -83.92 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.632 2.221 . . . . 0.0 112.629 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.481 ' OH ' ' HB ' ' A' ' 51' ' ' VAL . 13.7 m-30 63.74 -175.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.962 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.573 ' HA3' ' HD2' ' C' ' 76' ' ' ARG . . . 166.76 55.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.208 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -81.4 -10.59 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.157 0.583 . . . . 0.0 112.452 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.54 48.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.297 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -150.88 -163.82 1.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.625 0.25 . . . . 0.0 110.619 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -116.89 142.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.578 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' C' ' 47' ' ' GLN . 10.4 m-80 -124.83 113.4 17.85 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.011 0.434 . . . . 0.0 111.659 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -83.63 129.71 34.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.226 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.701 HG21 ' HE3' ' C' ' 84' ' ' LYS . 37.6 p -109.42 122.06 46.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.496 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -154.61 133.62 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.44 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.39 170.5 43.35 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.554 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' C' ' 69' ' ' LEU . 2.7 m -121.12 161.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.21 17.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.451 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.606 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -172.18 138.76 4.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.548 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.638 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 34.1 t80 -120.9 131.96 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.757 0.313 . . . . 0.0 110.746 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.5 mmm180 69.34 -92.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.1 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.4 p -143.77 26.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.1 141.42 51.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.42 150.96 28.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -146.58 171.75 14.61 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.548 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.494 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.8 OUTLIER -120.01 142.69 48.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.683 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.55 137.17 47.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.69 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.515 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.5 tp -137.52 162.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.515 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 171.36 179.86 42.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.59 148.75 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.41 166.81 30.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.15 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.615 ' CE2' ' HB ' ' C' ' 77' ' ' VAL . 39.2 t80 -131.91 134.45 45.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.92 0.391 . . . . 0.0 111.153 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.573 ' HD2' ' HA3' ' C' ' 50' ' ' GLY . 16.5 ttm180 -125.16 121.56 34.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.731 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.625 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 8.7 p -110.96 138.06 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.291 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 49.8 m-20 64.4 -97.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.013 0.435 . . . . 0.0 111.12 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' GLU . . . . . 0.484 ' HB3' ' CE2' ' B' ' 49' ' ' TYR . 10.5 pt-20 175.43 -20.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.62 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.87 -66.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -90.97 141.3 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.485 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.38 153.83 37.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.276 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 25.3 tp -148.77 149.89 32.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.6 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.701 ' HE3' HG21 ' C' ' 57' ' ' THR . 12.1 tmtt? -149.41 141.74 24.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.27 175.94 11.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.056 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.43 -173.18 41.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.546 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.09 138.2 19.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.102 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.782 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -110.39 144.22 39.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.32 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.99 112.93 18.88 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -119.43 129.98 55.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.4 -116.1 8.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.308 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m -148.95 8.09 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.331 . . . . 0.0 111.285 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.07 22.64 0.43 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 10.8 m-20 -127.1 82.77 2.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.76 139.33 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.769 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.782 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 6.8 ptp -134.17 141.61 47.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.3 124.25 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.495 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.435 ' ND2' HD23 ' C' ' 42' ' ' LEU . 36.1 m-80 -109.52 148.08 31.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 111.443 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.74 86.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.764 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.53 162.35 17.32 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -130.34 145.61 51.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 111.064 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 55.6 m-80 -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.378 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.06 119.7 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.794 0.331 . . . . 0.0 110.737 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.95 159.82 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.663 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.669 -0.172 . . . . 0.0 112.669 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 17.8 t70 71.13 130.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.944 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -108.4 -74.2 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.897 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.92 21.99 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -115.31 145.33 42.59 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.782 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 8' ' ' HIS . 17.8 m95 -106.98 -52.92 2.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.74 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m 59.29 61.93 1.93 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.978 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.724 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 68.4 m-70 -86.0 -49.73 0.52 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.773 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -67.69 110.03 2.01 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.387 2.058 . . . . 0.0 111.971 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -110.3 -58.27 2.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.466 ' HD1' ' H ' ' A' ' 13' ' ' LYS . 55.1 p90 -109.92 172.69 6.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.7 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.74 12.93 5.85 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.469 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' H ' ' HD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -63.92 -39.2 93.62 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.446 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.66 -29.81 72.8 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.224 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' HD2' ' A' ' 19' ' ' ARG . . . -70.83 -57.73 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 0.0 110.901 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -57.37 -29.11 63.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.954 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -68.19 -52.3 35.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.55 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.09 -20.26 64.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 111.211 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 15' ' ' ALA . 14.7 mtt-85 -70.74 -60.28 2.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.795 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.14 -17.37 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.152 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -67.71 -49.81 60.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.557 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -73.53 -28.05 61.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.038 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.05 -51.57 45.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.439 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 76.5 mtp85 -62.5 -44.76 95.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.755 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.508 HD21 ' CD2' ' B' ' 25' ' ' LEU . 0.5 OUTLIER -57.44 -50.37 73.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.18 -39.48 82.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 ttpp -60.46 -34.09 73.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.202 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.564 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -68.05 -41.95 81.27 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.45 -25.02 64.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.3 m -79.63 -41.0 27.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.852 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.68 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.4 mpt_? -68.93 -35.83 77.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.303 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 28' ' ' LEU . 19.0 m -77.58 -32.13 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.159 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 9.9 m-20 -66.79 -44.84 80.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.68 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 4.2 ptpt -77.76 -31.69 52.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.24 67.84 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.393 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.89 -27.77 60.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.23 -46.37 16.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.407 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.646 ' CB ' ' HB2' ' A' ' 90' ' ' ALA . 48.4 t -67.06 -40.59 87.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.481 ' OG ' ' HB2' ' C' ' 40' ' ' ALA . 37.4 t -67.42 -52.89 34.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' OG ' ' B' ' 39' ' ' SER . . . -61.88 -25.82 67.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.494 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.96 -38.28 88.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.523 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 21.7 tp -79.36 -33.63 42.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 11.6 m120 -73.68 -13.58 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.49 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 30.5 t -71.54 -19.27 62.19 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.182 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.625 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.0 mm? -80.45 157.83 26.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.856 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.434 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 8.1 p90 -146.06 -10.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.699 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HG2' ' CG2' ' A' ' 57' ' ' THR . 5.1 mt-30 73.43 121.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.935 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -77.72 101.1 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 62.1 -170.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.518 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 163.03 60.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.5 p -69.89 -18.81 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.146 0.578 . . . . 0.0 112.459 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.781 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.02 51.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.313 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HZ2' ' HA2' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -152.16 -157.03 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.56 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 74' ' ' GLY . 2.8 p -120.67 145.13 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.579 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.83 122.06 33.65 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.979 0.418 . . . . 0.0 111.727 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -84.27 124.47 31.26 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.267 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.625 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 72.1 p -107.04 120.61 42.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.007 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -149.85 137.49 20.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.405 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . 178.14 165.48 33.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.533 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 69' ' ' LEU . 30.2 m -121.13 178.76 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.375 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.99 -179.34 38.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -158.14 134.22 3.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.522 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.665 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 26.1 t80 -124.91 124.19 41.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.74 0.305 . . . . 0.0 110.746 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER 68.67 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 p -146.05 16.89 1.39 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.44 140.89 49.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.43 47.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 172.08 13.19 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.0 tt -123.47 145.16 49.04 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -132.1 119.52 21.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 58' ' ' ALA . 8.1 tp -118.67 152.74 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.91 -172.12 44.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.446 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.61 158.11 6.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -144.25 177.75 22.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.25 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.61 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 35.0 t80 -138.12 132.8 32.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.518 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 14.1 ttm180 -126.54 117.25 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.781 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.9 p -106.12 138.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.284 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 78.9 m-20 68.82 -92.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 14.8 pt-20 172.92 -24.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.579 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -78.46 -52.21 8.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.01 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.44 137.39 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.469 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -144.55 163.77 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.295 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 84' ' ' LYS . 34.1 tp -158.88 154.31 25.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 10.8 tmtt? -159.59 133.97 7.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.1 18.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.83 -174.57 42.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.628 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.24 139.56 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 111.112 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.51 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -113.05 136.51 52.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.293 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.19 51.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.294 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.646 ' HB2' ' CB ' ' A' ' 38' ' ' SER . . . -131.61 135.72 47.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.591 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.572 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.71 -123.26 29.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.281 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.58 9.58 2.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.791 0.329 . . . . 0.0 111.318 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.48 32.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.201 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -132.32 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.25 150.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.01 0.433 . . . . 0.0 110.724 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.647 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 1.2 ptp -146.52 159.69 43.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.594 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.69 141.06 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.444 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.43 ' OD1' HD23 ' A' ' 42' ' ' LEU . 25.7 m120 -118.05 145.68 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.764 0.316 . . . . 0.0 111.393 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.48 87.6 1.32 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 16.7 m -121.49 148.99 43.73 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.393 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.728 ' HD2' HD11 ' A' ' 103' ' ' ILE . 1.8 p90 -124.47 142.91 50.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.423 . . . . 0.0 111.05 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.925 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 64.1 m-80 -109.45 126.72 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.728 HD11 ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -129.59 121.1 52.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.96 165.96 19.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.423 ' HE3' HG13 ' C' ' 54' ' ' VAL . 3.4 m-90 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.656 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.531 ' O ' ' HB3' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.663 -0.175 . . . . 0.0 112.663 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' B' ' 1' ' ' GLY . 17.9 t70 71.18 130.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.4 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -108.45 -74.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.92 21.97 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.012 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -115.29 145.36 42.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.797 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.4 ' HB3' ' CE1' ' B' ' 8' ' ' HIS . 17.8 m95 -107.05 -52.92 2.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.697 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 10.0 m 59.3 61.88 1.94 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.017 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.708 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 68.5 m-70 -85.9 -49.76 0.53 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.838 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -67.68 109.97 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.531 2.154 . . . . 0.0 111.949 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -110.21 -58.41 2.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 111.144 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.499 ' HD1' ' H ' ' B' ' 13' ' ' LYS . 55.0 p90 -109.9 172.66 6.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.625 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.63 12.89 5.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.507 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.499 ' H ' ' HD1' ' B' ' 11' ' ' PHE . 0.0 OUTLIER -63.88 -39.18 93.6 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.484 -179.202 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.68 -29.83 72.79 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.213 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.413 ' O ' ' HD2' ' B' ' 19' ' ' ARG . . . -70.86 -57.69 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 110.905 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -57.31 -29.17 63.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.996 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER -68.19 -52.33 35.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.529 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.02 -20.32 64.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.227 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' B' ' 15' ' ' ALA . 14.7 mtt-85 -70.6 -60.4 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.749 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.1 -17.37 61.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.151 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -67.69 -49.86 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -73.44 -28.17 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.993 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.98 -51.54 46.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.437 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 76.6 mtp85 -62.49 -44.82 95.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.8 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.508 ' CD2' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.4 -50.46 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.08 -39.48 82.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.871 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' B' ' 31' ' ' ARG . 12.9 ttpp -60.38 -34.2 73.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.212 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.566 ' O ' HG13 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -68.07 -41.87 81.28 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.925 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 1.3 m -79.52 -40.98 28.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.677 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.4 mpt_? -68.87 -36.0 77.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.566 HG13 ' O ' ' B' ' 28' ' ' LEU . 18.9 m -77.53 -32.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.207 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 9.9 m-20 -66.73 -44.78 80.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.04 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.677 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 4.2 ptpt -77.97 -31.53 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.56 -35.23 67.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.88 -27.78 60.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.31 -46.32 16.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.396 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.652 ' CB ' ' HB2' ' B' ' 90' ' ' ALA . 48.5 t -67.09 -40.53 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.785 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 40' ' ' ALA . 37.4 t -67.46 -52.94 33.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' OG ' ' C' ' 39' ' ' SER . . . -61.82 -25.87 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.43 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.41 88.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.503 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 21.6 tp -79.26 -33.65 43.31 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 11.6 m120 -73.64 -13.59 61.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.494 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 30.4 t -71.58 -19.27 62.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.135 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.643 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.0 mm? -80.48 157.8 26.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.831 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 8.1 p90 -146.0 -10.43 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.188 0.518 . . . . 0.0 111.717 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.487 ' HG2' ' CG2' ' B' ' 57' ' ' THR . 5.1 mt-30 73.51 121.16 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.882 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -77.69 101.14 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.623 2.216 . . . . 0.0 112.54 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 62.03 -170.51 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.946 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 163.03 60.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.288 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.4 p -70.0 -18.86 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.186 0.594 . . . . 0.0 112.454 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.04 51.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.298 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.489 ' HZ2' ' HA2' ' B' ' 50' ' ' GLY . 0.0 OUTLIER -152.05 -156.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.546 0.212 . . . . 0.0 110.671 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 74' ' ' GLY . 2.8 p -120.81 145.15 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.577 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.84 122.09 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.008 0.433 . . . . 0.0 111.669 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -84.34 124.5 31.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.248 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.643 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 73.4 p -107.1 120.64 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -149.81 137.56 20.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.418 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . 178.1 165.51 33.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' B' ' 69' ' ' LEU . 30.3 m -121.16 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.03 -179.39 38.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.453 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -158.12 134.17 3.77 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.664 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 26.2 t80 -124.91 124.18 41.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.734 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 73.3 p -145.99 16.87 1.4 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.81 49.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.42 47.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.107 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.41 172.11 13.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.49 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.709 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.0 tt -123.52 145.19 49.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.762 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -132.19 119.63 21.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.725 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' B' ' 58' ' ' ALA . 8.1 tp -118.72 152.72 20.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.96 -172.18 44.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.405 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.52 158.06 6.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.851 0.358 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.583 ' O ' HG23 ' B' ' 54' ' ' VAL . . . -144.2 177.78 22.61 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.267 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.604 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 34.8 t80 -138.13 132.71 32.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.873 0.368 . . . . 0.0 111.166 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.513 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 14.0 ttm180 -126.49 117.27 22.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.78 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.9 p -106.16 138.91 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.011 0.434 . . . . 0.0 111.278 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' B' ' 79' ' ' GLU . 78.9 m-20 68.81 -92.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.0 111.14 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 14.8 pt-20 172.97 -24.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.1 p -78.48 -52.21 8.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.44 137.36 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.891 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -144.58 163.78 32.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.868 0.365 . . . . 0.0 111.255 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.419 HD12 ' H ' ' B' ' 84' ' ' LYS . 34.6 tp -158.9 154.32 25.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.434 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 10.8 tmtt? -159.66 133.97 7.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.58 171.06 18.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.87 -174.46 42.83 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.626 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.29 139.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.059 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.499 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -113.01 136.48 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.359 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.68 125.2 51.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.652 ' HB2' ' CB ' ' B' ' 38' ' ' SER . . . -131.53 135.69 47.24 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.664 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.589 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.76 -123.37 30.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.342 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.28 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.9 t -165.48 32.84 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.242 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.32 82.3 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.24 150.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.665 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 1.2 ptp -146.56 159.65 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.667 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -127.65 141.17 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.366 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.432 ' OD1' HD23 ' B' ' 42' ' ' LEU . 25.7 m120 -118.14 145.66 44.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 111.359 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 87.51 1.32 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.74 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 16.7 m -121.42 149.01 43.65 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.4 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' PHE . . . . . 0.726 ' HD2' HD11 ' B' ' 103' ' ' ILE . 1.9 p90 -124.44 142.88 50.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.957 0.408 . . . . 0.0 111.153 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.891 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 64.1 m-80 -109.4 126.78 53.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.726 HD11 ' HD2' ' B' ' 101' ' ' PHE . 0.9 OUTLIER -129.64 121.11 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.866 0.365 . . . . 0.0 110.756 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.99 165.97 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 0.421 ' HE3' HG13 ' A' ' 54' ' ' VAL . 3.5 m-90 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.683 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.531 ' O ' ' HB3' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.677 -0.169 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 2' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' C' ' 1' ' ' GLY . 17.8 t70 71.12 130.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.96 0.409 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -108.49 -74.26 0.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.861 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.94 22.16 1.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.011 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -115.39 145.33 42.64 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.748 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -107.0 -52.96 2.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.75 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m 59.31 61.92 1.93 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.977 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.727 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 69.0 m-70 -85.96 -49.76 0.52 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.761 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.727 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -67.73 110.07 2.03 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.436 2.091 . . . . 0.0 111.93 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -110.27 -58.35 2.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.947 0.403 . . . . 0.0 111.117 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.483 ' HD1' ' H ' ' C' ' 13' ' ' LYS . 55.0 p90 -109.84 172.71 6.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.654 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.75 12.97 5.85 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.455 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.483 ' H ' ' HD1' ' C' ' 11' ' ' PHE . 0.0 OUTLIER -63.99 -39.13 93.44 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.453 -179.191 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.68 -29.88 72.78 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.241 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' ALA . . . . . 0.411 ' O ' ' HD2' ' C' ' 19' ' ' ARG . . . -70.81 -57.67 4.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -57.5 -29.03 63.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.926 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER -68.25 -52.26 36.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.591 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -69.0 -20.27 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.297 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' C' ' 15' ' ' ALA . 14.6 mtt-85 -70.73 -60.33 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.1 -17.4 61.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.177 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 0.8 OUTLIER -67.73 -49.81 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.558 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -73.45 -28.16 61.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.99 -51.52 46.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.444 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 76.6 mtp85 -62.52 -44.78 95.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.722 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.507 HD21 ' CD2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.52 -50.34 73.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.611 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -59.15 -39.48 82.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.806 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' C' ' 31' ' ' ARG . 12.9 ttpp -60.44 -34.16 73.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.204 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.549 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -68.05 -41.98 81.21 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.29 -25.11 64.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.987 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 1.3 m -79.54 -41.03 28.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.853 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.669 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.4 mpt_? -68.91 -35.87 77.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.28 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.549 HG13 ' O ' ' C' ' 28' ' ' LEU . 19.0 m -77.58 -32.18 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 9.9 m-20 -66.74 -44.79 80.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.045 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.669 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 4.2 ptpt -77.83 -31.68 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.48 -35.31 68.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mt -74.79 -27.82 60.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.113 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.24 -46.33 16.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.452 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.657 ' CB ' ' HB2' ' C' ' 90' ' ' ALA . 48.5 t -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.756 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' B' ' 40' ' ' ALA . 37.6 t -67.47 -52.96 33.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' OG ' ' A' ' 39' ' ' SER . . . -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.475 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.86 -38.37 88.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.507 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 21.6 tp -79.28 -33.69 43.18 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 11.5 m120 -73.6 -13.62 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' SER . . . . . 0.484 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 30.4 t -71.63 -19.23 62.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.154 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.614 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.0 mm? -80.51 157.78 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.836 177.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 8.1 p90 -145.98 -10.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.172 0.51 . . . . 0.0 111.703 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.492 ' HG2' ' CG2' ' C' ' 57' ' ' THR . 5.1 mt-30 73.53 121.12 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.932 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 10.0 Cg_endo -77.66 101.08 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.657 2.238 . . . . 0.0 112.57 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 62.12 -170.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.963 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 163.1 60.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.251 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.4 p -69.92 -18.88 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.258 0.623 . . . . 0.0 112.383 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.766 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.01 51.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.356 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 53' ' ' LYS . . . . . 0.495 ' HZ2' ' HA2' ' C' ' 50' ' ' GLY . 0.0 OUTLIER -152.11 -157.03 0.76 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.594 0.235 . . . . 0.0 110.591 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.588 HG23 ' O ' ' C' ' 74' ' ' GLY . 2.8 p -120.8 145.18 27.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.82 121.99 33.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.977 0.418 . . . . 0.0 111.696 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -84.23 124.47 31.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.272 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.614 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 72.3 p -106.98 120.63 42.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.999 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -149.84 137.53 20.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.422 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . 178.05 165.49 32.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' C' ' 69' ' ' LEU . 30.5 m -121.18 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.0 -179.41 38.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.521 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.629 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -158.1 134.2 3.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.552 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.647 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 26.1 t80 -124.95 124.23 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.091 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 73.4 p -146.02 16.88 1.39 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.82 49.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.32 145.44 47.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.43 172.08 13.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.496 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.709 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.0 tt -123.41 145.23 48.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.79 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.23 119.62 21.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.653 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.42 HD12 ' CB ' ' C' ' 58' ' ' ALA . 8.1 tp -118.67 152.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.188 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.98 -172.17 44.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.57 158.11 6.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 74' ' ' GLY . . . . . 0.588 ' O ' HG23 ' C' ' 54' ' ' VAL . . . -144.19 177.74 22.63 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.236 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.589 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 34.8 t80 -138.14 132.69 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.517 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 14.0 ttm180 -126.49 117.3 22.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.766 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.9 p -106.13 138.83 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 78.8 m-20 68.92 -92.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 111.076 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 14.8 pt-20 172.95 -24.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.593 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -78.49 -52.27 8.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.0 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.37 137.42 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.898 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -144.61 163.77 32.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.236 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.413 HD12 ' H ' ' C' ' 84' ' ' LYS . 34.3 tp -158.87 154.27 25.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.595 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 10.8 tmtt? -159.58 133.94 7.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.13 18.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.81 -174.47 42.8 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.572 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 8.0 p -130.27 139.55 51.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.125 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.504 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -113.09 136.49 52.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.346 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.21 51.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.657 ' HB2' ' CB ' ' C' ' 38' ' ' SER . . . -131.62 135.72 47.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.603 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.572 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.75 -123.34 30.25 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 33.3 m -138.52 9.61 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.53 32.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.193 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.26 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.27 150.61 11.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.664 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 1.2 ptp -146.59 159.68 43.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.685 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.7 141.14 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.43 ' OD1' HD23 ' C' ' 42' ' ' LEU . 25.7 m120 -118.08 145.7 44.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.708 0.289 . . . . 0.0 111.415 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.54 1.31 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 16.7 m -121.4 148.98 43.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.449 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.716 ' HD2' HD11 ' C' ' 103' ' ' ILE . 1.8 p90 -124.41 142.87 50.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 111.04 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.898 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 64.0 m-80 -109.43 126.73 53.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.38 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.716 HD11 ' HD2' ' C' ' 101' ' ' PHE . 1.0 OUTLIER -129.62 121.06 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.77 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.96 165.95 19.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 0.423 ' HE3' HG13 ' B' ' 54' ' ' VAL . 3.5 m-90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.665 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.968 ' N ' ' HD1' ' B' ' 11' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.686 -0.166 . . . . 0.0 112.686 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.39 148.44 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.969 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -47.71 84.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.815 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.29 148.09 45.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.593 ' OG ' ' HB2' ' A' ' 8' ' ' HIS . 21.4 t -100.96 149.11 24.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.802 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -130.67 75.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.77 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.3 t 73.94 55.22 0.1 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.002 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.593 ' HB2' ' OG ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -96.53 -45.16 0.25 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.768 -178.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -53.75 113.76 1.47 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.424 2.082 . . . . 0.0 111.919 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -82.66 -172.87 4.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.976 0.417 . . . . 0.0 111.113 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.965 ' HD1' ' N ' ' C' ' 1' ' ' GLY . 12.5 t80 -127.1 -31.72 2.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.658 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.59 -69.89 0.29 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.5 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -105.19 -19.89 13.67 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.479 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.03 -46.29 93.78 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.244 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . -62.34 -33.7 75.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.918 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -70.31 -37.03 74.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.985 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 2.8 mmpt? -67.15 -53.11 33.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.523 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.68 -31.28 70.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.247 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 19.8 ttp180 -63.07 -58.69 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.18 83.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.117 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.017 HD21 HD13 ' C' ' 21' ' ' LEU . 12.1 mt -60.0 -47.49 85.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.559 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 29.4 t0 -66.81 -32.25 73.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.093 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.53 -42.31 95.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.53 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.733 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.62 -33.42 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 28.4 t0 -73.73 -41.2 62.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -63.02 -42.06 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.285 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' C' ' 29' ' ' ASP . 0.2 OUTLIER -62.9 -50.35 71.22 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.789 ' HB2' HD21 ' B' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.14 61.43 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.912 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.15 -40.65 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.6 mpt_? -60.87 -32.56 71.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.316 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 6.4 m -80.12 -28.94 12.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.216 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -51.88 61.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 20.3 pttt -74.13 -39.28 63.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.751 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.32 -36.21 92.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.52 ' HG ' HD21 ' C' ' 36' ' ' LEU . 5.9 mt -73.53 -31.16 63.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.068 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.91 -45.29 36.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.457 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.65 ' CB ' ' HB2' ' A' ' 90' ' ' ALA . 22.7 t -63.86 -44.89 91.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.8 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 11.5 t -59.13 -46.47 88.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.04 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.544 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.13 -39.88 93.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.556 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 2.6 tm? -77.06 -38.9 51.69 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -72.12 -15.94 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 t -66.58 -32.92 74.56 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.15 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.512 ' CG ' ' HB ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -64.21 143.66 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.881 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.568 ' HZ ' ' HB1' ' B' ' 82' ' ' ALA . 35.0 p90 -112.69 -42.53 3.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.11 0.481 . . . . 0.0 111.677 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.49 HE22 ' HG2' ' A' ' 84' ' ' LYS . 33.8 mt-30 70.26 109.43 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.948 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 49' ' ' TYR 0.256 9.8 Cg_endo -75.25 -161.16 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.617 2.211 . . . . 0.0 112.576 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 17.5 m-30 68.16 167.02 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.962 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 76' ' ' ARG . . . 178.4 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.193 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.519 ' HA ' ' HG3' ' A' ' 79' ' ' GLU . 9.6 p -88.84 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.198 0.599 . . . . 0.0 112.4 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.39 69.1 0.01 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.261 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 76' ' ' ARG . 1.5 mptp? -143.79 -178.16 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.619 0.247 . . . . 0.0 110.561 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.577 HG13 ' HE3' ' B' ' 105' ' ' TRP . 10.1 p -119.02 142.17 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.433 ' OD1' ' HD2' ' A' ' 48' ' ' PRO . 1.7 m-80 -125.0 178.08 5.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.62 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.588 ' HB2' ' CH2' ' B' ' 105' ' ' TRP . 11.3 t80 -151.48 143.39 23.82 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.512 ' HB ' ' CG ' ' A' ' 45' ' ' LEU . 30.2 p -117.3 142.08 47.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.953 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -177.5 127.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.463 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.515 ' O ' HD12 ' A' ' 69' ' ' LEU . . . -179.34 -165.27 33.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.04 154.61 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.367 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -134.43 171.72 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.504 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 66' ' ' SER . . . -156.73 141.31 7.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.571 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 84.4 t80 -135.56 110.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.697 0.284 . . . . 0.0 110.74 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 28.0 mtt180 66.28 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.128 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 37.86 1.33 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.122 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.463 ' O ' ' HA2' ' A' ' 62' ' ' GLY . 32.1 t -134.77 157.68 46.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.67 148.31 40.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.42 173.06 14.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 59' ' ' GLY . 8.2 tp -124.75 126.66 46.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.702 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -117.51 163.32 16.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 58' ' ' ALA . 2.3 tt -158.71 176.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.77 34.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.462 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 p -164.13 160.03 20.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.45 176.26 29.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.217 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.509 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 5.0 t80 -143.27 127.0 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 111.159 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.473 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.735 HG22 ' OD1' ' A' ' 78' ' ' ASN . 7.2 p -83.2 127.41 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.284 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.735 ' OD1' HG22 ' A' ' 77' ' ' VAL . 31.3 m120 61.15 162.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.519 ' HG3' ' HA ' ' A' ' 51' ' ' VAL . 32.5 mt-10 -99.48 39.1 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.569 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.31 -52.21 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 82' ' ' ALA . 3.6 p -131.25 169.85 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.53 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB1' ' HZ ' ' C' ' 46' ' ' PHE . . . -168.53 165.24 12.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 111.29 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -139.25 168.73 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.564 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 85' ' ' ALA . 2.0 tmtp? -157.73 122.85 4.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.544 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -132.6 161.04 34.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.32 158.57 18.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.91 130.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -102.05 115.04 29.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.355 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.5 ' HA ' HG13 ' A' ' 95' ' ' VAL . 77.9 m-85 -91.7 108.8 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB2' ' CB ' ' A' ' 38' ' ' SER . . . -115.02 124.11 50.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.659 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.05 -85.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.67 -50.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.319 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.0 m -104.35 14.43 30.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 4.0 t70 -116.43 57.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.5 HG13 ' HA ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -95.2 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.747 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.608 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 2.9 ptp -146.77 151.44 37.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -130.34 138.21 50.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.422 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 8.3 m-80 -132.56 137.15 47.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 111.404 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.32 95.64 2.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.716 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB3' HD11 ' C' ' 45' ' ' LEU . 29.6 m -125.95 161.5 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 8.6 p90 -127.67 145.48 50.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.027 0.442 . . . . 0.0 111.044 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' OD1' ' HD3' ' C' ' 48' ' ' PRO . 8.2 p30 -120.0 153.08 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.4 mp -119.86 134.91 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.856 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.479 ' HB2' ' CE2' ' C' ' 49' ' ' TYR . 18.2 pm0 -120.01 132.47 55.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.937 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.592 ' CH2' ' HB2' ' C' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.618 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.982 ' N ' ' HD1' ' C' ' 11' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.669 -0.173 . . . . 0.0 112.669 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.3 148.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.956 0.408 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -47.67 84.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.822 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.26 148.01 45.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.042 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.598 ' OG ' ' HB2' ' B' ' 8' ' ' HIS . 21.4 t -100.85 149.11 24.2 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.805 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -130.68 75.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.728 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 5.3 t 73.92 55.14 0.1 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.022 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.598 ' HB2' ' OG ' ' B' ' 5' ' ' SER . 0.2 OUTLIER -96.42 -45.18 0.25 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.82 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -53.73 113.71 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.409 2.073 . . . . 0.0 111.928 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -82.56 -172.85 4.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.957 0.408 . . . . 0.0 111.148 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.968 ' HD1' ' N ' ' A' ' 1' ' ' GLY . 12.5 t80 -127.16 -31.71 2.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.667 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.55 -69.94 0.28 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.482 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -105.17 -19.95 13.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.468 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.97 -46.33 93.76 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.288 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' B' ' 19' ' ' ARG . . . -62.24 -33.78 75.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.375 . . . . 0.0 110.963 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.403 ' CE1' ' HB2' ' A' ' 5' ' ' SER . 14.6 m-70 -70.28 -37.04 74.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.011 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 2.8 mmpt? -67.17 -53.11 33.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.566 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -68.66 -31.25 70.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.259 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 15' ' ' ALA . 19.8 ttp180 -63.11 -58.71 6.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.769 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -36.19 83.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 1.033 HD13 HD21 ' C' ' 21' ' ' LEU . 12.1 mt -60.04 -47.47 85.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.601 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' B' ' 26' ' ' ASP . 29.4 t0 -66.81 -32.26 73.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.036 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.836 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.48 34.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.757 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.74 -33.34 72.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.632 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 28.3 t0 -73.73 -41.24 62.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -63.02 -42.08 99.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.241 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -62.89 -50.26 71.59 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.779 ' HB2' HD21 ' C' ' 28' ' ' LEU . 0.8 OUTLIER -56.61 -29.16 61.83 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.942 178.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.11 -40.57 37.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.863 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.6 mpt_? -60.81 -32.68 72.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 6.4 m -80.06 -28.98 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.172 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -51.94 61.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 20.3 pttt -73.96 -39.44 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.717 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.35 -36.15 92.34 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' A' ' 36' ' ' LEU . 5.8 mt -73.54 -31.18 63.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.787 0.327 . . . . 0.0 111.045 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.08 -45.17 35.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.379 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.666 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 22.7 t -63.9 -44.87 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 11.5 t -59.17 -46.46 88.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.2 -29.07 68.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.483 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.537 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.11 -39.89 93.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.575 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 2.6 tm? -77.01 -39.0 51.89 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -72.01 -15.97 62.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.6 -32.96 74.63 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.08 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.533 ' CG ' ' HB ' ' B' ' 57' ' ' THR . 1.0 OUTLIER -64.29 143.71 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.929 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.555 ' HZ ' ' HB1' ' C' ' 82' ' ' ALA . 34.6 p90 -112.73 -42.48 3.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.467 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.504 HE22 ' HG2' ' B' ' 84' ' ' LYS . 33.8 mt-30 70.29 109.47 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' B' ' 49' ' ' TYR 0.257 9.8 Cg_endo -75.3 -161.15 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.632 2.222 . . . . 0.0 112.61 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 17.5 m-30 68.16 167.05 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.969 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' B' ' 76' ' ' ARG . . . 178.37 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.201 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.508 ' HA ' ' HG3' ' B' ' 79' ' ' GLU . 9.7 p -88.83 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.187 0.595 . . . . 0.0 112.409 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.34 69.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.317 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' B' ' 76' ' ' ARG . 1.5 mptp? -143.79 -178.1 5.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.579 HG13 ' HE3' ' C' ' 105' ' ' TRP . 10.1 p -119.08 142.14 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.537 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' B' ' 48' ' ' PRO . 1.7 m-80 -124.99 178.03 5.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.657 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.6 ' HB2' ' CH2' ' C' ' 105' ' ' TRP . 11.4 t80 -151.42 143.46 23.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.276 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' B' ' 45' ' ' LEU . 30.2 p -117.38 142.09 47.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.93 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.494 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -177.52 127.81 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.479 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.527 ' O ' HD12 ' B' ' 69' ' ' LEU . . . -179.26 -165.17 33.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.08 154.61 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 111.343 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.537 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -134.4 171.77 22.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.487 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 66' ' ' SER . . . -156.77 141.3 7.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 84.2 t80 -135.59 110.84 8.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.124 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.65 37.86 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.455 ' O ' ' HA2' ' B' ' 62' ' ' GLY . 32.0 t -134.83 157.62 46.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.64 148.32 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.139 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.03 15.04 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.527 HD12 ' O ' ' B' ' 59' ' ' GLY . 8.4 tp -124.67 126.73 46.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.756 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -117.58 163.37 16.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.623 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.495 HG13 ' O ' ' B' ' 57' ' ' THR . 2.3 tt -158.78 176.04 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.154 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.62 -167.82 34.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.36 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 16.6 p -164.16 160.04 20.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.46 176.37 29.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.158 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 5.0 t80 -143.36 126.9 16.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 111.17 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.461 ' O ' ' HA2' ' B' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.33 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.73 HG22 ' OD1' ' B' ' 78' ' ' ASN . 7.3 p -83.26 127.44 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.73 ' OD1' HG22 ' B' ' 77' ' ' VAL . 31.3 m120 61.04 162.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.508 ' HG3' ' HA ' ' B' ' 51' ' ' VAL . 32.5 mt-10 -99.47 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.6 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.25 -52.23 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.531 HG22 ' H ' ' B' ' 82' ' ' ALA . 3.6 p -131.29 169.83 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.568 ' HB1' ' HZ ' ' A' ' 46' ' ' PHE . . . -168.57 165.21 12.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.22 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' B' ' 101' ' ' PHE . 0.6 OUTLIER -139.16 168.75 19.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' B' ' 85' ' ' ALA . 2.0 tmtp? -157.8 122.89 4.43 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.547 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -132.65 161.01 35.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.11 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.63 18.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.633 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.97 130.69 73.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.347 . . . . 0.0 111.149 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.609 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -102.03 115.15 29.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.32 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' TYR . . . . . 0.497 ' HA ' HG13 ' B' ' 95' ' ' VAL . 77.7 m-85 -91.72 108.82 20.18 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.194 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.666 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -115.12 124.15 50.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.08 -85.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.282 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.61 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.391 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.4 14.33 30.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.164 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' B' ' 90' ' ' ALA . 3.9 t70 -116.31 57.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.958 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' B' ' 89' ' ' TYR . 0.3 OUTLIER -95.26 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.699 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.602 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 2.9 ptp -146.79 151.41 37.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.722 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -130.21 138.21 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.447 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' B' ' 85' ' ' ALA . 8.3 m-80 -132.58 137.22 47.0 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.781 0.324 . . . . 0.0 111.409 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.46 95.77 2.72 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.684 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.444 ' HB3' HD11 ' A' ' 45' ' ' LEU . 29.3 m -126.0 161.39 27.64 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.396 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 8.6 p90 -127.6 145.54 50.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.969 0.414 . . . . 0.0 111.049 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.409 ' OD1' ' HD3' ' A' ' 48' ' ' PRO . 8.3 p30 -120.07 152.92 36.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.4 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.412 ' N ' HD12 ' B' ' 103' ' ' ILE . 4.4 mp -119.79 135.01 61.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 18.2 pm0 -120.08 132.46 55.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 0.588 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.606 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.965 ' N ' ' HD1' ' A' ' 11' ' ' PHE . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 t0 71.35 148.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -47.66 84.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.35 148.04 45.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.016 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' SER . . . . . 0.596 ' OG ' ' HB2' ' C' ' 8' ' ' HIS . 21.2 t -100.87 149.06 24.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.855 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -130.66 75.22 1.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.743 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 5.2 t 73.88 55.16 0.1 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.052 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.596 ' HB2' ' OG ' ' C' ' 5' ' ' SER . 0.2 OUTLIER -96.46 -45.13 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.809 -178.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -53.77 113.73 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.424 2.083 . . . . 0.0 111.94 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -82.6 -172.86 4.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.943 0.402 . . . . 0.0 111.142 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.982 ' HD1' ' N ' ' B' ' 1' ' ' GLY . 12.6 t80 -127.12 -31.75 2.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.659 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.56 -69.9 0.29 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.476 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -105.12 -19.98 13.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.563 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.05 -46.23 93.87 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.332 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' C' ' 19' ' ' ARG . . . -62.29 -33.76 75.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 110.909 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -70.3 -36.99 74.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.977 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 2.8 mmpt? -67.28 -53.02 33.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.55 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.72 -31.29 70.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' C' ' 15' ' ' ALA . 19.8 ttp180 -63.04 -58.7 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.79 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -36.21 83.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 1.033 HD21 HD13 ' B' ' 21' ' ' LEU . 12.1 mt -59.93 -47.48 85.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 22' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' C' ' 26' ' ' ASP . 29.1 t0 -66.91 -32.27 73.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.028 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -74.4 -47.53 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.751 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.63 -33.42 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.625 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' C' ' 22' ' ' ASP . 28.3 t0 -73.66 -41.3 62.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -62.98 -42.11 99.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.267 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' B' ' 29' ' ' ASP . 0.2 OUTLIER -62.8 -50.35 71.34 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.083 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 29' ' ' ASP . . . . . 0.761 ' HB2' HD21 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.18 61.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.961 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 m -78.08 -40.62 37.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.507 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.6 mpt_? -60.84 -32.62 72.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' C' ' 36' ' ' LEU . 6.5 m -80.07 -28.92 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -51.76 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 20.3 pttt -74.08 -39.32 63.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.815 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.13 92.24 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 36' ' ' LEU . 5.8 mt -73.55 -31.18 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.328 . . . . 0.0 111.085 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.21 35.97 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.429 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 22.9 t -63.95 -44.88 91.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.736 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.545 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 11.6 t -59.12 -46.46 88.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.31 -29.04 68.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.13 -39.85 93.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.566 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 2.6 tm? -77.06 -38.92 51.62 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -72.12 -15.99 61.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.59 -32.92 74.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.526 ' CG ' ' HB ' ' C' ' 57' ' ' THR . 1.0 OUTLIER -64.24 143.74 57.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.888 177.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.563 ' HZ ' ' HB1' ' A' ' 82' ' ' ALA . 34.6 p90 -112.78 -42.46 3.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.121 0.486 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.505 HE22 ' HG2' ' C' ' 84' ' ' LYS . 33.8 mt-30 70.3 109.44 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.958 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' C' ' 49' ' ' TYR 0.257 9.9 Cg_endo -75.24 -161.2 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.707 2.272 . . . . 0.0 112.633 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 17.5 m-30 68.1 167.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' C' ' 76' ' ' ARG . . . 178.4 -3.19 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.194 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.527 ' HA ' ' HG3' ' C' ' 79' ' ' GLU . 9.5 p -88.86 -34.72 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.136 0.574 . . . . 0.0 112.393 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.34 69.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.306 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 53' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' C' ' 76' ' ' ARG . 1.5 mptp? -143.72 -178.11 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.539 0.209 . . . . 0.0 110.642 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.574 HG13 ' HE3' ' A' ' 105' ' ' TRP . 10.2 p -119.04 142.12 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.533 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' C' ' 48' ' ' PRO . 1.7 m-80 -124.94 178.1 5.69 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.695 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.592 ' HB2' ' CH2' ' A' ' 105' ' ' TRP . 11.2 t80 -151.46 143.38 23.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.231 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' C' ' 45' ' ' LEU . 30.1 p -117.31 142.1 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.497 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -177.54 127.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.486 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.53 ' O ' HD12 ' C' ' 69' ' ' LEU . . . -179.28 -165.26 33.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.551 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.0 154.7 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 111.368 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 61' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -134.46 171.73 22.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.472 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' C' ' 66' ' ' SER . . . -156.79 141.25 7.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.575 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 84.3 t80 -135.5 110.83 9.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.334 . . . . 0.0 110.728 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.79 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.168 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.68 37.82 1.34 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.142 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 66' ' ' SER . . . . . 0.464 ' O ' ' HA2' ' C' ' 62' ' ' GLY . 32.1 t -134.8 157.69 46.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.83 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.76 148.31 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.38 173.03 15.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.602 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.53 HD12 ' O ' ' C' ' 59' ' ' GLY . 8.3 tp -124.69 126.61 45.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.766 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -117.52 163.27 16.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.694 0.283 . . . . 0.0 111.683 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' C' ' 58' ' ' ALA . 2.3 tt -158.64 176.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.318 . . . . 0.0 111.105 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.79 34.69 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.466 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.0 p -164.09 160.05 21.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.038 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.47 176.35 29.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.234 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.509 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 5.0 t80 -143.32 126.94 16.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 111.151 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.462 ' O ' ' HA2' ' C' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.736 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.733 HG22 ' OD1' ' C' ' 78' ' ' ASN . 7.3 p -83.19 127.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.998 0.427 . . . . 0.0 111.291 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' C' ' 77' ' ' VAL . 31.3 m120 61.14 162.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.088 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 79' ' ' GLU . . . . . 0.527 ' HG3' ' HA ' ' C' ' 51' ' ' VAL . 32.5 mt-10 -99.49 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 2.6 m -121.33 -52.17 2.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.987 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.542 HG22 ' H ' ' C' ' 82' ' ' ALA . 3.6 p -131.2 169.82 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.572 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.555 ' HB1' ' HZ ' ' B' ' 46' ' ' PHE . . . -168.5 165.23 12.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' C' ' 101' ' ' PHE . 0.6 OUTLIER -139.19 168.79 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.626 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.532 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 2.0 tmtp? -157.85 122.76 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 85' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -132.53 161.04 34.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.66 19.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.552 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.93 130.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.616 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -102.0 115.07 29.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.307 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 89' ' ' TYR . . . . . 0.511 ' HA ' HG13 ' C' ' 95' ' ' VAL . 77.8 m-85 -91.72 108.73 20.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -114.98 124.14 50.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.6 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -85.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.263 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 82.8 p -166.67 -50.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.309 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.35 14.35 30.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.221 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.572 ' O ' ' HB3' ' C' ' 90' ' ' ALA . 4.0 t70 -116.42 57.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 95' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' C' ' 89' ' ' TYR . 0.3 OUTLIER -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.696 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.614 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 2.9 ptp -146.78 151.38 37.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.711 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -130.2 138.29 50.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.439 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' C' ' 85' ' ' ALA . 8.2 m-80 -132.63 137.06 46.88 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.31 95.66 2.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.452 ' HB3' HD11 ' B' ' 45' ' ' LEU . 28.7 m -125.88 161.44 27.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.474 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' C' ' 83' ' ' LEU . 8.6 p90 -127.6 145.51 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.956 0.408 . . . . 0.0 111.085 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' B' ' 48' ' ' PRO . 8.2 p30 -120.08 152.98 36.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.387 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.408 HD12 ' N ' ' C' ' 103' ' ' ILE . 4.4 mp -119.79 135.01 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.488 ' HB2' ' CE2' ' B' ' 49' ' ' TYR . 18.3 pm0 -120.1 132.45 55.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 0.6 ' CH2' ' HB2' ' B' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.59 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 6.0 t70 83.75 134.23 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.885 0.374 . . . . 0.0 111.012 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -129.36 -69.46 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.31 35.57 0.65 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 p -96.42 155.08 16.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.758 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -102.04 -79.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.731 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.0 m 55.59 40.68 31.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.993 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.83 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 35.6 m170 -76.1 -53.02 2.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.859 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.83 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -58.45 118.66 5.58 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.51 2.14 . . . . 0.0 111.895 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -106.86 -66.69 1.0 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.965 0.412 . . . . 0.0 111.207 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -112.51 177.24 4.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.709 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.89 25.69 0.56 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.476 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -80.59 -45.21 17.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.486 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.05 -32.34 79.95 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.285 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.02 95.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 0.0 110.856 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -75.53 -40.01 57.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.006 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -62.35 -34.68 77.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.514 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.82 -38.78 70.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.301 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.16 -61.81 1.83 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.27 -30.14 59.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.1 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.496 HD11 ' HD3' ' B' ' 24' ' ' ARG . 2.6 tm? -64.62 -60.46 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.603 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -65.03 -23.77 67.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -63.91 -54.12 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.533 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.3 mtp85 -69.78 -37.94 76.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.792 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.795 HD22 HD11 ' C' ' 25' ' ' LEU . 3.6 mm? -63.88 -44.71 92.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.605 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.89 -33.19 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG2' ' HD3' ' A' ' 31' ' ' ARG . 1.2 ttpp -67.91 -37.66 81.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.212 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -65.96 -45.48 81.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.414 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -60.12 -36.55 77.73 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.859 179.008 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.86 -30.35 56.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HD3' ' HG2' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -78.47 -27.18 46.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.28 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 28' ' ' LEU . 27.3 m -84.61 -32.39 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.21 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 55.6 m-20 -69.0 -43.91 73.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.989 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 5.0 ptpt -84.46 -30.22 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.0 -41.73 86.82 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.422 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.642 HD21 ' HG ' ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.81 -22.82 42.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -76.61 -39.77 51.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.419 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.644 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 8.6 t -77.64 -39.86 43.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.745 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -55.46 33.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.87 -39.16 80.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.374 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.47 71.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.958 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.437 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 28.3 tp -76.62 -42.21 43.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.093 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' CB ' ' C' ' 43' ' ' ASN . 32.4 m-20 -70.63 -9.86 57.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 41.7 t -69.26 -20.65 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.1 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.518 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.3 mm? -83.05 169.93 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.833 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.4 -1.66 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 0.0 111.727 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.597 ' OE1' ' HG2' ' A' ' 84' ' ' LYS . 6.0 mt-30 68.49 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.967 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -78.82 109.16 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.56 2.174 . . . . 0.0 112.527 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 59.57 177.48 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 174.74 50.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.191 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.7 p -71.58 -1.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.166 0.586 . . . . 0.0 112.407 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 143.63 53.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.254 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 -165.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.572 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.7 142.17 28.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.534 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 47' ' ' GLN . 12.8 m-80 -122.03 118.73 29.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 111.756 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.425 ' HA ' ' HB2' ' A' ' 73' ' ' SER . 30.1 t80 -84.84 131.67 34.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.267 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.527 HG21 ' HE3' ' A' ' 84' ' ' LYS . 40.9 p -113.72 121.2 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.9 136.99 18.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.486 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.15 166.51 33.58 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.555 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.0 m -116.43 158.13 17.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 111.304 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.98 -171.43 13.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.484 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -168.2 141.48 6.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.615 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.517 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 52.0 t80 -135.81 133.06 37.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 0.0 110.789 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 3.1 mmm180 69.52 -94.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 p -144.67 29.22 1.25 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.421 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 5.1 m -135.9 141.72 44.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.73 157.9 17.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.129 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.72 169.04 20.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.572 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.589 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.62 54.58 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.735 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -126.52 139.2 53.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.677 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 87' ' ' VAL . 10.7 tp -141.07 147.91 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.763 0.316 . . . . 0.0 111.128 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.42 -179.68 42.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.402 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' A' ' 56' ' ' PHE . 1.2 p -166.76 158.59 13.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.23 171.7 28.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.216 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 39.6 t80 -126.37 138.58 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 0.0 111.113 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.477 HH21 ' HB2' ' A' ' 47' ' ' GLN . 13.7 ttm180 -131.41 134.7 46.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.8 p -120.9 140.86 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.318 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.0 m-20 64.79 -94.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.072 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.606 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -73.35 -63.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.27 139.64 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -138.29 156.15 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 30.3 tp -136.93 141.75 42.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.621 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.597 ' HG2' ' OE1' ' A' ' 47' ' ' GLN . 7.9 tmtt? -153.39 128.71 9.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.71 175.86 11.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.06 -173.45 34.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.593 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' ILE . 7.7 p -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 111.131 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.591 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -112.6 144.68 41.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.329 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.6 120.48 40.31 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.244 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.644 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -127.8 131.07 49.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.638 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.21 -114.44 5.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.301 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.8 m -150.42 17.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.709 0.29 . . . . 0.0 111.331 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -167.24 19.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.192 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -119.44 67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.31 138.01 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.043 0.449 . . . . 0.0 110.75 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.591 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 4.4 ptp -134.84 134.62 40.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.684 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.81 122.46 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.403 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.24 150.51 27.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 0.0 111.389 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.47 90.58 0.48 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 19.3 m -118.98 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.465 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.43 135.06 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 111.059 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.76 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 73.9 m-80 -102.17 134.39 45.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' C' ' 56' ' ' PHE . 0.1 OUTLIER -138.78 115.29 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.774 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' C' ' 55' ' ' ASN . 0.0 OUTLIER -115.29 157.42 23.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 30.3 m-90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.674 179.678 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 6.0 t70 83.72 134.23 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -129.4 -69.48 0.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.26 35.56 0.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 49.4 p -96.39 155.03 16.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.799 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -101.94 -79.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.748 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 68.4 m 55.48 40.69 31.26 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.045 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.806 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 35.6 m170 -76.16 -53.04 2.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.777 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.806 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -58.38 118.62 5.54 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.489 2.126 . . . . 0.0 111.933 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -106.87 -66.75 0.99 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 111.125 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -112.48 177.23 4.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.689 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.88 25.73 0.56 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.463 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -80.58 -45.29 17.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.468 -179.214 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.05 -32.33 79.9 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.292 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.1 94.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.898 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.54 -40.05 57.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.981 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.3 OUTLIER -62.28 -34.71 77.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.533 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.77 -38.87 70.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.275 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.1 -61.83 1.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.24 -30.1 59.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.119 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.517 HD11 ' HD3' ' C' ' 24' ' ' ARG . 2.6 tm? -64.69 -60.44 3.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.592 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -65.06 -23.73 67.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -63.87 -54.15 39.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.942 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.542 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.4 mtp85 -69.79 -37.97 76.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.747 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' C' ' 25' ' ' LEU . 3.5 mm? -63.85 -44.67 92.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.661 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.97 -33.15 75.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' HD3' ' B' ' 31' ' ' ARG . 1.2 ttpp -67.95 -37.59 81.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.227 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -65.97 -45.52 81.42 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.403 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -60.15 -36.49 77.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.939 178.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.94 -30.27 55.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.535 ' HD3' ' HG2' ' B' ' 27' ' ' LYS . 0.1 OUTLIER -78.42 -27.27 46.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.347 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.454 HG13 ' O ' ' B' ' 28' ' ' LEU . 27.4 m -84.65 -32.3 7.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.206 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 55.8 m-20 -69.04 -43.9 73.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.989 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.649 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 4.9 ptpt -84.44 -30.24 25.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.765 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.75 87.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.435 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.643 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -79.88 -22.85 42.37 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.485 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -76.61 -39.75 51.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.465 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.668 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 8.6 t -77.56 -39.96 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.89 -55.56 32.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.09 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.363 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.46 71.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.429 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 28.1 tp -76.63 -42.16 43.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 7.9 m120 -70.67 -9.87 58.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.472 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 41.6 t -69.38 -20.51 63.82 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.107 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.514 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.3 mm? -83.09 169.85 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.849 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.29 -1.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.191 0.52 . . . . 0.0 111.665 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.611 ' OE1' ' HG2' ' B' ' 84' ' ' LYS . 6.0 mt-30 68.54 116.95 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.984 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.724 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.69 109.0 2.53 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.723 2.282 . . . . 0.0 112.557 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 174.81 50.72 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.31 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.8 p -71.5 -1.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.158 0.583 . . . . 0.0 112.412 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 143.65 53.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.265 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.8 -165.26 1.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 110.653 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.71 142.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.584 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' B' ' 47' ' ' GLN . 12.9 m-80 -122.03 118.76 29.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.703 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.432 ' HA ' ' HB2' ' B' ' 73' ' ' SER . 30.2 t80 -84.86 131.63 34.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.226 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.54 HG21 ' HE3' ' B' ' 84' ' ' LYS . 40.9 p -113.72 121.25 43.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.976 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.87 137.02 18.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.447 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.13 166.43 33.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.576 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' B' ' 69' ' ' LEU . 7.0 m -116.32 158.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.816 0.341 . . . . 0.0 111.388 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.5 13.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.41 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -168.08 141.43 6.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.622 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 52.1 t80 -135.73 133.17 37.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.739 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 3.1 mmm180 69.5 -94.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 15.2 p -144.67 29.23 1.25 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.138 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 5.1 m -136.0 141.72 44.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.69 157.93 17.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.094 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.76 169.03 20.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.578 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.66 54.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.751 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.684 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' B' ' 87' ' ' VAL . 10.7 tp -140.97 147.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.41 -179.62 42.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' B' ' 56' ' ' PHE . 1.2 p -166.87 158.6 12.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.25 171.69 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 39.7 t80 -126.3 138.61 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 111.197 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.479 HH21 ' HB2' ' B' ' 47' ' ' GLN . 13.7 ttm180 -131.44 134.72 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.585 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.8 p -120.98 140.87 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.256 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 97.1 m-20 64.73 -94.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.916 0.389 . . . . 0.0 111.111 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 5.6 pt-20 177.11 -23.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 23.9 p -73.39 -63.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.013 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.3 139.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -138.36 156.1 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.316 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 30.2 tp -136.91 141.76 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.621 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.611 ' HG2' ' OE1' ' B' ' 47' ' ' GLN . 8.0 tmtt? -153.42 128.68 9.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.148 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.81 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.14 -173.43 34.06 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' B' ' 71' ' ' ILE . 7.7 p -141.56 143.47 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.59 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -112.65 144.7 41.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.373 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -114.61 120.51 40.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.266 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -127.85 130.94 49.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.649 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.649 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.37 -114.43 5.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.287 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -150.51 17.44 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.802 0.334 . . . . 0.0 111.296 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' SER . . . . . 0.414 ' HB3' HH12 ' B' ' 31' ' ' ARG . 1.3 t -167.18 18.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.205 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -119.38 67.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.971 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.3 137.99 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 110.655 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.59 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 4.4 ptp -134.86 134.66 40.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.708 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -109.89 122.47 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.433 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.19 150.37 27.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.718 0.294 . . . . 0.0 111.416 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.36 90.59 0.49 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.774 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 19.3 m -119.01 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.373 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -143.42 135.12 26.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.774 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 73.8 m-80 -102.24 134.27 45.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.392 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.68 115.26 10.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.83 0.347 . . . . 0.0 110.779 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -115.23 157.41 23.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.404 -0.808 . . . . 0.0 110.613 179.702 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 2' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' C' ' 1' ' ' GLY . 6.0 t70 83.73 134.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.895 0.378 . . . . 0.0 110.973 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -129.4 -69.43 0.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.29 35.5 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.024 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 48.3 p -96.4 155.02 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -102.01 -79.1 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.679 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 68.6 m 55.61 40.65 31.04 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.019 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.81 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 35.5 m170 -76.22 -53.07 2.27 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.669 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.81 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -58.3 118.59 5.5 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.497 2.131 . . . . 0.0 111.979 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.85 -66.75 0.99 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.951 0.405 . . . . 0.0 111.175 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -112.5 177.33 4.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.655 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.95 25.67 0.55 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.532 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -80.54 -45.19 17.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.53 -179.263 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.09 -32.34 80.03 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.258 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.98 95.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 0.0 110.955 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -75.67 -39.9 56.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.982 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.3 OUTLIER -62.36 -34.63 77.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.522 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -38.83 69.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.191 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.09 -61.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.35 -30.03 59.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.491 HD11 ' HD3' ' A' ' 24' ' ' ARG . 2.6 tm? -64.58 -60.55 3.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.02 -23.71 67.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.993 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.03 -54.09 39.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.544 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.3 mtp85 -69.69 -38.06 76.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.75 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' A' ' 25' ' ' LEU . 3.6 mm? -63.78 -44.8 92.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.566 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.85 -33.19 75.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.853 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.551 ' HG2' ' HD3' ' C' ' 31' ' ' ARG . 1.2 ttpp -67.92 -37.61 81.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.23 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.457 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.0 OUTLIER -65.97 -45.44 81.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.105 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 29' ' ' ASP . . . . . 0.41 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -60.17 -36.49 77.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.908 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.93 -30.36 56.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.551 ' HD3' ' HG2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -78.38 -27.28 46.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.288 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.457 HG13 ' O ' ' C' ' 28' ' ' LEU . 27.3 m -84.55 -32.42 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.249 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.507 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 55.7 m-20 -68.95 -43.96 73.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.644 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 5.0 ptpt -84.42 -30.22 25.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.817 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -41.78 87.16 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.42 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.643 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.79 -22.86 42.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.466 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -76.58 -39.8 51.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.46 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.659 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 8.6 t -77.63 -39.88 43.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.719 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.95 -55.52 33.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.132 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.02 80.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.469 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.4 71.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.438 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 28.6 tp -76.62 -42.31 42.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 7.9 m120 -70.59 -9.9 58.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' SER . . . . . 0.491 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 41.7 t -69.22 -20.63 63.96 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.156 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.534 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.4 mm? -83.02 169.85 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.946 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -157.35 -1.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.219 0.533 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.61 ' OE1' ' HG2' ' C' ' 84' ' ' LYS . 6.0 mt-30 68.39 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.76 109.08 2.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.605 2.203 . . . . 0.0 112.582 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.002 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 174.77 50.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.235 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.7 p -71.49 -1.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.194 0.598 . . . . 0.0 112.483 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 143.58 53.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.282 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 -165.27 1.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.594 0.235 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.68 142.17 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.598 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' C' ' 47' ' ' GLN . 12.9 m-80 -122.0 118.73 29.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.71 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.435 ' HA ' ' HB2' ' C' ' 73' ' ' SER . 29.9 t80 -84.74 131.68 34.53 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.296 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.52 HG21 ' HE3' ' C' ' 84' ' ' LYS . 40.8 p -113.78 121.21 43.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.91 136.99 18.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.1 166.43 33.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.572 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' C' ' 69' ' ' LEU . 7.0 m -116.33 158.14 16.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 111.371 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.41 13.44 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.465 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -168.15 141.52 6.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.518 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 52.2 t80 -135.8 133.04 37.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.276 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.1 mmm180 69.53 -94.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 15.0 p -144.68 29.19 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' C' ' 33' ' ' ASP . 5.0 m -135.93 141.69 44.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.68 157.99 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.73 169.07 20.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.565 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.584 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -123.36 138.61 54.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.749 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -126.5 139.2 53.41 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.655 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' C' ' 87' ' ' VAL . 10.7 tp -141.03 147.97 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.747 0.308 . . . . 0.0 111.085 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.4 -179.65 42.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' C' ' 56' ' ' PHE . 1.2 p -166.82 158.57 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.997 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.21 171.7 28.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.214 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 39.8 t80 -126.33 138.62 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.18 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.481 HH21 ' HB2' ' C' ' 47' ' ' GLN . 13.7 ttm180 -131.49 134.72 46.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.667 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.569 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.9 p -121.0 140.89 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 97.2 m-20 64.73 -94.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 79' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.56 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 23.8 p -73.42 -63.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.28 139.77 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -138.47 156.08 47.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.267 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 30.4 tp -136.91 141.69 42.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.61 ' HG2' ' OE1' ' C' ' 47' ' ' GLN . 8.0 tmtt? -153.41 128.69 9.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.91 11.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.051 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.05 -173.44 34.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.616 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 87' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' C' ' 71' ' ' ILE . 7.9 p -141.56 143.4 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.586 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -112.65 144.68 41.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -114.59 120.52 40.48 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.186 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -127.86 131.0 49.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.631 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.644 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.37 -114.46 5.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.263 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 62.1 m -150.43 17.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.759 0.314 . . . . 0.0 111.294 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' SER . . . . . 0.402 ' HB3' HH12 ' C' ' 31' ' ' ARG . 1.3 t -167.25 19.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.21 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -119.47 67.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.25 137.95 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.586 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 4.4 ptp -134.84 134.74 41.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.86 122.44 47.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.404 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.26 150.42 27.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.713 0.292 . . . . 0.0 111.447 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.37 90.57 0.49 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 19.3 m -119.01 172.22 7.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.407 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.44 135.18 26.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.79 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 73.9 m-80 -102.27 134.39 45.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.385 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 115.26 10.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 110.789 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' B' ' 55' ' ' ASN . 0.0 OUTLIER -115.22 157.4 23.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.672 179.665 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 t70 64.66 135.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.98 0.419 . . . . 0.0 110.969 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -126.59 -63.21 1.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.1 27.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 p -102.71 148.72 25.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.747 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.44 ' HB3' ' CD2' ' A' ' 8' ' ' HIS . 37.6 m95 -101.15 -84.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.693 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.9 m 63.53 44.76 5.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.005 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.713 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 53.9 m-70 -82.97 -49.38 0.75 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.804 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.713 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.3 Cg_exo -49.95 106.01 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.471 2.114 . . . . 0.0 111.891 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 8' ' ' HIS . 86.6 mt-30 -99.65 -67.64 0.84 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 111.164 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -117.4 171.32 8.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.618 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.42 24.9 2.07 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.468 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -42.32 92.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.49 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.33 -30.8 68.43 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.264 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.15 90.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.814 0.34 . . . . 0.0 110.855 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.599 ' HA ' ' HD2' ' A' ' 19' ' ' ARG . 15.3 m-70 -77.89 -36.6 49.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.971 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.593 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -65.61 -38.5 89.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.466 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.11 -30.5 66.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.19 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.599 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 43.5 mtt-85 -63.26 -64.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.723 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.638 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 2.6 pp0? -64.0 -27.65 69.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.199 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.608 HD21 HD23 ' B' ' 21' ' ' LEU . 2.3 tm? -63.42 -69.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.541 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.46 -23.37 57.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.018 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.08 -47.99 66.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 47.7 mtp85 -70.87 -40.88 72.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' B' ' 25' ' ' LEU . 2.3 mm? -57.29 -51.12 70.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.547 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.7 -39.44 84.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 1.1 ttpp -63.13 -37.12 85.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.207 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -60.93 -38.21 85.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.544 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -73.37 -30.56 63.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 178.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.47 -34.34 72.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -33.83 62.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 29' ' ' ASP . 33.4 m -78.02 -26.67 14.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.182 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.595 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 40.8 m-20 -71.93 -43.19 65.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.047 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 7.0 ptpt -82.88 -28.84 29.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.829 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.58 74.15 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.446 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -74.93 -29.61 61.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 111.158 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' A' ' 63' ' ' TYR . . . -71.17 -42.4 69.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.451 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.8 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 11.5 t -74.73 -45.61 42.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.659 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.474 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 1.0 OUTLIER -58.42 -49.26 77.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HA ' ' OD1' ' B' ' 43' ' ' ASN . . . -66.99 -36.87 83.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.456 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.03 85.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 35.9 tp -74.33 -40.88 61.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.016 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.466 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 13.0 m120 -73.16 -9.74 59.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.5 t -69.03 -18.88 64.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.149 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.649 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 1.5 mm? -80.55 167.72 19.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.911 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -156.24 -3.39 0.12 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.641 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 12.7 mt-30 66.2 122.29 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.998 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -84.02 104.66 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.599 2.199 . . . . 0.0 112.51 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 9.2 m-30 66.78 -179.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.959 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 170.37 55.49 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.236 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.3 p -74.68 -5.62 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.133 0.573 . . . . 0.0 112.451 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.56 56.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.369 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.83 -163.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.644 0.259 . . . . 0.0 110.616 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.95 138.9 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.494 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.4 ' OD1' ' HB3' ' B' ' 104' ' ' GLU . 15.3 m-80 -123.0 115.22 21.53 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 111.666 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.497 ' HB2' ' HZ3' ' B' ' 105' ' ' TRP . 37.5 t80 -81.45 129.97 34.86 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.207 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.649 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.9 p -110.57 126.12 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.593 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -156.12 133.15 10.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' HB3' ' B' ' 100' ' ' SER . . . -175.25 171.43 44.56 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.57 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.06 159.59 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 111.318 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 -169.88 16.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.444 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.426 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -167.03 135.95 3.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.518 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.649 ' CE2' HD13 ' A' ' 36' ' ' LEU . 28.6 t80 -123.89 141.62 51.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 110.744 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.429 ' HG3' ' OD1' ' A' ' 33' ' ' ASP . 2.5 mmm180 60.55 -95.63 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 p -142.34 24.31 1.95 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.34 142.03 50.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.82 156.37 18.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.14 168.67 22.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.598 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.15 138.26 54.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.796 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -131.99 139.2 48.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.671 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 72' ' ' GLY . 5.5 tp -137.49 162.4 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.121 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.606 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 169.96 -176.07 43.84 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.404 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.78 3.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.01 27.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.268 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.587 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 54.4 t80 -126.4 130.92 51.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 0.0 111.11 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.482 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 10.9 ttm180 -122.32 120.88 35.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.789 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.2 p -108.04 140.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.256 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 38.7 m-20 62.9 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.077 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 p -72.37 -61.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.992 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.09 142.17 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.816 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -141.19 158.83 43.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.85 147.01 31.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.575 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HE3' HG21 ' A' ' 57' ' ' THR . 11.5 tmtt? -158.54 132.46 7.76 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.25 -179.73 8.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.081 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.444 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . 160.53 -173.1 37.04 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.545 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.43 138.08 36.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.114 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.8 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -113.2 145.85 40.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.303 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -118.48 115.58 24.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.248 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -123.01 131.14 53.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.669 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.56 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 63.46 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.263 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.9 m -149.28 9.17 0.74 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.57 25.18 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.219 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-20 -121.03 71.76 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.5 t -101.91 137.35 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.071 0.463 . . . . 0.0 110.695 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.575 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 10.2 ptp -130.32 136.87 49.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -112.33 121.95 46.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.361 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.48 154.96 25.07 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 111.419 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.783 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB3' ' HA3' ' C' ' 59' ' ' GLY . 12.8 m -113.83 168.85 9.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.406 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.72 140.7 47.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.955 0.407 . . . . 0.0 111.108 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.816 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 57.1 m-80 -108.6 132.1 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.3 117.49 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.851 0.357 . . . . 0.0 110.712 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.406 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 0.0 OUTLIER -118.64 161.07 20.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.505 ' HZ3' ' HB2' ' C' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.633 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 t70 64.66 135.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.908 0.385 . . . . 0.0 110.968 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -126.6 -63.23 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.09 27.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 16.6 p -102.69 148.75 25.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.445 ' HB3' ' CD2' ' B' ' 8' ' ' HIS . 37.7 m95 -101.15 -84.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.695 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 63.5 m 63.47 44.79 5.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.98 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.687 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 53.5 m-70 -82.93 -49.39 0.76 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.818 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -50.0 105.97 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.51 2.14 . . . . 0.0 111.894 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' B' ' 8' ' ' HIS . 86.6 mt-30 -99.54 -67.72 0.84 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.002 0.43 . . . . 0.0 111.161 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -117.35 171.36 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.693 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.53 24.94 2.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.426 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -42.17 92.47 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.534 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.44 -30.78 68.79 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.231 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.07 -38.12 89.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.89 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.599 ' HA ' ' HD2' ' B' ' 19' ' ' ARG . 15.2 m-70 -77.87 -36.7 49.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.953 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.5 OUTLIER -65.57 -38.43 89.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.471 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.18 -30.43 66.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.251 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.599 ' HD2' ' HA ' ' B' ' 16' ' ' HIS . 43.5 mtt-85 -63.22 -64.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.629 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 2.6 pp0? -64.05 -27.66 69.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.102 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.622 HD21 HD23 ' C' ' 21' ' ' LEU . 2.3 tm? -63.36 -69.21 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.41 -23.39 57.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.009 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.02 -48.12 66.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' B' ' 20' ' ' GLN . 47.8 mtp85 -70.83 -40.87 72.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.802 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.795 HD22 HD11 ' A' ' 25' ' ' LEU . 2.3 mm? -57.23 -51.11 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.636 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -59.68 -39.53 84.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.766 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.562 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 1.2 ttpp -63.15 -37.05 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.218 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.562 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -60.94 -38.21 85.05 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.549 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -73.38 -30.62 63.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.905 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.41 -34.43 72.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -33.9 62.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.276 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' B' ' 29' ' ' ASP . 33.3 m -77.95 -26.65 14.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.211 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.604 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 40.5 m-20 -71.96 -43.28 65.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.957 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.578 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 6.9 ptpt -82.88 -28.76 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.1 -38.58 73.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.658 HD13 ' CE2' ' B' ' 63' ' ' TYR . 0.5 OUTLIER -74.98 -29.63 60.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.765 0.317 . . . . 0.0 111.058 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' B' ' 63' ' ' TYR . . . -71.24 -42.31 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.459 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.799 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 11.4 t -74.73 -45.57 43.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.75 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.475 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 1.1 t -58.45 -49.2 78.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.457 ' HA ' ' OD1' ' C' ' 43' ' ' ASN . . . -67.08 -36.94 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.386 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.0 85.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.493 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 36.2 tp -74.41 -40.8 61.79 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 13.1 m120 -73.16 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 29.4 t -69.05 -18.85 64.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.125 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 1.6 mm? -80.59 167.7 19.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.889 177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.24 -3.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.131 0.491 . . . . 0.0 111.649 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' B' ' 48' ' ' PRO . 12.7 mt-30 66.37 122.19 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.956 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -84.0 104.68 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.572 2.181 . . . . 0.0 112.548 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 9.1 m-30 66.8 -179.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 170.37 55.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.252 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.3 p -74.66 -5.67 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.103 0.561 . . . . 0.0 112.454 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.798 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.64 56.11 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.228 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 -163.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.94 138.9 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.518 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 15.4 m-80 -122.93 115.15 21.44 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 111.669 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.502 ' HB2' ' HZ3' ' C' ' 105' ' ' TRP . 37.6 t80 -81.37 130.01 34.86 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.628 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.8 p -110.57 126.09 54.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.959 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.594 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -156.15 133.24 10.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.403 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' C' ' 100' ' ' SER . . . -175.33 171.44 44.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.573 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -126.02 159.52 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.16 -169.81 16.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.454 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -167.1 135.85 3.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.595 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.658 ' CE2' HD13 ' B' ' 36' ' ' LEU . 28.6 t80 -123.8 141.65 51.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.725 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' OD1' ' B' ' 33' ' ' ASP . 2.5 mmm180 60.49 -95.7 0.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 16.8 p -142.26 24.33 1.96 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.23 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.35 141.98 50.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.78 156.39 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 168.71 22.57 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.13 138.31 54.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.782 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -131.97 139.15 48.56 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.594 HD12 ' CB ' ' B' ' 58' ' ' ALA . 5.5 tp -137.5 162.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 111.113 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.584 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 170.02 -176.0 43.89 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.452 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.8 p -170.02 150.72 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.991 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.09 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.239 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.583 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 54.5 t80 -126.38 130.97 51.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 111.159 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.479 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 11.0 ttm180 -122.47 120.96 35.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.798 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.2 p -108.04 140.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 38.5 m-20 62.9 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 176.0 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.567 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.46 -61.43 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 16.3 m -89.11 142.27 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.81 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -141.21 158.85 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.207 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.9 146.98 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.448 ' HE3' HG21 ' B' ' 57' ' ' THR . 11.5 tmtt? -158.49 132.39 7.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.22 -179.72 8.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.074 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.442 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 160.53 -173.11 37.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.61 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.44 137.99 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.799 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -113.15 145.96 40.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.294 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -118.59 115.6 24.89 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.221 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.681 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -123.01 131.24 53.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.578 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 63.31 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.262 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 50.0 m -149.23 9.17 0.74 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.355 . . . . 0.0 111.343 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.61 25.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.184 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 19.1 m-20 -121.09 71.79 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 87.4 t -101.89 137.36 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 110.657 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.58 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 10.2 ptp -130.36 136.89 49.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.652 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -112.4 121.87 46.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.387 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -112.41 154.91 25.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.482 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.18 88.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.762 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.576 ' HB3' ' HA3' ' A' ' 59' ' ' GLY . 12.7 m -113.7 168.91 9.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.446 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.82 140.63 47.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 111.074 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.81 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 57.2 m-80 -108.59 131.96 54.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.373 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.14 117.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.4 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -118.65 161.17 20.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.859 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 0.497 ' HZ3' ' HB2' ' A' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.685 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.639 -0.184 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 t70 64.66 135.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -126.59 -63.34 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.06 27.48 1.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.047 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 16.4 p -102.73 148.75 25.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.763 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' TRP . . . . . 0.442 ' HB3' ' CD2' ' C' ' 8' ' ' HIS . 37.7 m95 -101.14 -84.17 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.72 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.405 ' H ' ' HB2' ' C' ' 6' ' ' TRP . 63.8 m 63.41 44.74 5.23 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.025 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.706 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 53.5 m-70 -82.87 -49.37 0.77 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.874 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -49.94 105.96 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.52 2.147 . . . . 0.0 111.929 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 10' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' C' ' 8' ' ' HIS . 86.6 mt-30 -99.6 -67.69 0.84 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.955 0.407 . . . . 0.0 111.183 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -117.37 171.36 8.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.65 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.46 24.91 2.06 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.472 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -42.36 92.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.477 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.31 -30.81 68.38 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.238 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.02 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.915 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' HIS . . . . . 0.588 ' HA ' ' HD2' ' C' ' 19' ' ' ARG . 15.1 m-70 -77.86 -36.62 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.005 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.5 OUTLIER -65.52 -38.56 90.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.556 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.98 -30.59 66.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.306 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' ARG . . . . . 0.588 ' HD2' ' HA ' ' C' ' 16' ' ' HIS . 43.6 mtt-85 -63.16 -64.09 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.771 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.637 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 2.6 pp0? -64.07 -27.71 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.108 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.622 HD23 HD21 ' B' ' 21' ' ' LEU . 2.3 tm? -63.44 -69.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.554 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -58.54 -23.28 57.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.017 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.11 -48.01 66.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' C' ' 20' ' ' GLN . 48.1 mtp85 -70.89 -40.83 71.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.775 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.788 HD22 HD11 ' B' ' 25' ' ' LEU . 2.3 mm? -57.31 -51.1 70.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.67 -39.52 84.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.803 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.428 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 1.2 ttpp -63.12 -37.08 85.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.192 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.428 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -61.01 -38.06 84.75 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 29' ' ' ASP . . . . . 0.543 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -73.43 -30.68 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.92 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.34 -34.47 72.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.848 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -33.9 62.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.322 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.543 HG22 ' HA ' ' C' ' 29' ' ' ASP . 33.4 m -77.94 -26.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.592 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 40.2 m-20 -71.96 -43.21 65.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.582 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 6.9 ptpt -82.84 -28.87 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.799 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.99 -38.6 74.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.475 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' C' ' 63' ' ' TYR . 0.5 OUTLIER -74.96 -29.65 60.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.819 0.342 . . . . 0.0 111.067 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.434 ' HB2' ' H ' ' C' ' 63' ' ' TYR . . . -71.27 -42.26 68.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.429 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.801 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 11.5 t -74.77 -45.54 43.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.469 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 1.0 OUTLIER -58.5 -49.2 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.083 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.458 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . . . -67.1 -36.81 82.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.428 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.97 85.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.906 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 36.0 tp -74.35 -40.83 61.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 13.0 m120 -73.21 -9.67 58.96 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.2 t -69.16 -18.71 63.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.647 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 1.5 mm? -80.65 167.69 19.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.872 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.18 -3.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 111.702 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 12.7 mt-30 66.31 122.27 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -84.04 104.71 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.573 2.182 . . . . 0.0 112.528 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 9.2 m-30 66.73 -179.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 170.42 55.56 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.201 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.2 p -74.7 -5.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.197 0.599 . . . . 0.0 112.445 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.779 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.51 56.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.323 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 -163.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.656 0.265 . . . . 0.0 110.597 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.88 138.83 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.584 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 15.4 m-80 -122.98 115.18 21.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.022 0.439 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.505 ' HB2' ' HZ3' ' A' ' 105' ' ' TRP . 37.7 t80 -81.45 129.96 34.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.238 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.647 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 45.7 p -110.56 126.07 54.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.597 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -156.05 133.21 10.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.45 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 100' ' ' SER . . . -175.31 171.5 44.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.588 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -126.12 159.55 34.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.336 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.19 -169.87 16.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.478 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.43 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -167.08 135.96 3.91 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.52 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.648 ' CE2' HD13 ' C' ' 36' ' ' LEU . 28.7 t80 -123.87 141.66 51.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.674 0.273 . . . . 0.0 110.816 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' OD1' ' C' ' 33' ' ' ASP . 2.5 mmm180 60.44 -95.61 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.097 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -142.32 24.35 1.95 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.164 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.3 141.98 50.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.76 156.43 18.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.23 168.61 22.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.605 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.08 138.32 54.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.787 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.0 139.19 48.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.633 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.608 HG13 ' H ' ' C' ' 72' ' ' GLY . 5.5 tp -137.5 162.46 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.608 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 169.97 -176.09 43.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.477 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.7 3.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.1 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.224 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.585 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 54.6 t80 -126.38 130.94 51.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 111.097 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.475 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 10.9 ttm180 -122.35 120.92 35.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.743 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.779 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.2 p -108.08 140.69 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.292 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 38.6 m-20 62.91 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.556 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.36 -61.56 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.953 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.08 142.26 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.497 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.785 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -141.21 158.82 43.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.268 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.88 146.99 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.446 ' HE3' HG21 ' C' ' 57' ' ' THR . 11.6 tmtt? -158.49 132.4 7.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.169 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.23 -179.67 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 160.53 -173.06 37.04 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.552 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.4 138.06 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 111.164 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.801 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -113.2 145.94 40.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -118.59 115.62 24.93 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.188 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -123.11 131.13 53.57 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.574 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.582 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 63.45 -112.4 4.94 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.213 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -149.29 9.19 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 111.297 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.62 25.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 19.4 m-20 -121.0 71.8 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -101.86 137.39 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 0.0 110.663 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.576 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 10.2 ptp -130.35 136.82 49.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.33 121.96 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.435 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.45 154.92 25.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.456 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.66 0.15 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.767 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.583 ' HB3' ' HA3' ' B' ' 59' ' ' GLY . 12.6 m -113.71 168.91 9.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.47 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -133.79 140.54 47.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.085 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.785 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 56.9 m-80 -108.49 132.03 54.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.392 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.19 117.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.727 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' C' ' 104' ' ' GLU . 0.0 OUTLIER -118.65 161.18 20.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 0.502 ' HZ3' ' HB2' ' B' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.675 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 60.62 120.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.869 0.366 . . . . 0.0 110.989 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -123.22 58.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.12 -54.35 2.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.428 ' HA ' ' NE2' ' A' ' 8' ' ' HIS . 0.7 OUTLIER -116.78 107.29 14.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.791 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.501 ' HZ3' ' HB3' ' A' ' 19' ' ' ARG . 59.6 t-105 -151.15 114.31 4.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.727 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t 60.89 71.13 0.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.053 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.738 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 8.1 m-70 -109.6 -53.91 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.753 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.738 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.339 31.3 Cg_exo -72.27 139.8 32.75 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.483 2.122 . . . . 0.0 111.967 179.24 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.81 -44.16 97.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.899 0.381 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -93.03 106.86 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.714 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -160.35 114.91 2.22 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.49 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -129.03 -66.21 0.83 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.485 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.5 72.08 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.279 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.99 -54.89 31.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 110.879 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -53.53 -41.64 66.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.932 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -39.41 94.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.523 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.41 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 82.1 t80 -60.94 -31.5 71.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.193 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.566 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 32.2 mmt180 -75.58 -30.06 59.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.619 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 29.5 mt-30 -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.11 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.433 ' HA ' HD11 ' C' ' 21' ' ' LEU . 0.5 OUTLIER -64.47 -50.28 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 22.8 m-20 -71.98 -19.97 61.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 12.9 t-20 -77.4 -41.22 40.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.735 ' HD3' HD13 ' C' ' 25' ' ' LEU . 3.6 mmp_? -71.58 -46.25 59.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.727 HD13 ' HD3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.67 94.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.698 ' O ' HG22 ' A' ' 30' ' ' THR . 51.7 t0 -69.73 -28.98 66.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.805 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -75.96 -38.1 57.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.241 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.636 ' O ' HG22 ' A' ' 32' ' ' VAL . 8.0 mt -76.5 -34.8 58.61 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -66.76 -47.21 72.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 26' ' ' ASP . 9.7 t -71.63 -40.19 69.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.678 ' HG2' HH11 ' A' ' 31' ' ' ARG . 21.2 ttp85 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.348 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 28' ' ' LEU . 28.4 m -76.61 -27.67 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.582 ' OD2' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t70 -64.08 -56.18 16.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.96 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.679 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 23.0 pttt -68.71 -37.63 79.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.826 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.67 -48.2 87.42 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.421 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' B' ' 39' ' ' SER . 0.4 OUTLIER -67.48 -31.69 72.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.801 0.334 . . . . 0.0 111.095 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -38.44 90.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.405 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.685 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 78.7 p -79.96 -43.52 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.573 ' HB2' HD21 ' C' ' 36' ' ' LEU . 46.7 t -53.24 -60.95 2.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.7 -30.25 60.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.567 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -63.98 -49.02 74.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.926 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -66.99 -32.91 74.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.123 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 1.4 m-20 -78.75 -13.63 59.71 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -19.08 65.68 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.134 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.815 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.2 mm? -75.55 158.57 32.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.9 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 47.3 p90 -146.47 -31.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.645 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 8.3 tt0 75.64 108.58 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.924 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -90.81 137.26 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.668 2.246 . . . . 0.0 112.576 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 14.5 m-85 67.56 154.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.576 ' CA ' ' HB3' ' A' ' 76' ' ' ARG . . . -173.94 73.06 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.228 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.826 HG12 ' HE2' ' A' ' 53' ' ' LYS . 11.4 p -95.88 -22.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.157 0.583 . . . . 0.0 112.521 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.89 48.99 0.02 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.301 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.826 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -143.76 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.576 0.227 . . . . 0.0 110.57 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.41 143.4 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.557 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.496 HD21 ' HB3' ' B' ' 102' ' ' ASN . 1.0 OUTLIER -135.14 116.49 14.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.03 0.443 . . . . 0.0 111.697 179.541 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 71' ' ' ILE . 12.0 t80 -80.29 131.03 35.59 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.279 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.815 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 27.7 p -110.53 120.96 44.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.971 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 71' ' ' ILE . . . -143.49 139.9 30.06 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.402 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.01 164.68 33.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.536 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.428 HG12 HD13 ' A' ' 69' ' ' LEU . 28.6 m -118.79 164.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.879 0.371 . . . . 0.0 111.282 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.567 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.5 177.5 20.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.48 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 67' ' ' GLN . . . -162.05 155.13 26.3 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.517 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 1.3 t80 -142.04 122.32 13.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 110.736 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.582 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 24.9 mtt-85 67.63 -93.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.107 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -131.89 9.49 4.55 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.167 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 22.9 t -109.93 173.88 6.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -135.31 -179.27 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.685 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -162.61 158.28 23.11 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.515 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD12 ' H ' ' A' ' 70' ' ' ALA . 3.9 tp -118.11 134.62 54.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.733 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.926 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -142.71 139.06 30.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.68 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.561 HD11 ' CE2' ' A' ' 56' ' ' PHE . 8.9 tp -138.33 150.55 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.718 0.295 . . . . 0.0 111.09 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.7 -177.26 37.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.2 p -160.23 155.26 24.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.61 30.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.242 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.42 120.58 17.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 111.147 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.576 ' HB3' ' CA ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.695 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.777 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 14.9 p -102.47 130.09 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 58.98 -171.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.97 66.02 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.3 p -160.07 -51.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' A' ' 103' ' ' ILE . 9.8 p -119.53 142.08 36.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.83 153.09 45.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 0.0 111.272 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 130.7 32.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.694 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -135.02 144.02 47.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.062 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 173.42 161.11 23.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.588 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.39 150.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -121.79 140.68 52.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.23 128.4 48.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.247 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 94' ' ' ASP . . . -136.33 151.09 49.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.672 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.679 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 50.21 -99.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.256 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.33 -27.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.727 0.298 . . . . 0.0 111.308 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.5 p -123.75 15.03 9.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.2 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.536 ' CB ' ' HB3' ' A' ' 90' ' ' ALA . 41.6 m-20 -101.52 69.91 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.74 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.512 ' SD ' HD23 ' C' ' 36' ' ' LEU . 1.3 ptp -135.2 139.48 44.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.771 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -117.56 129.91 56.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -129.27 145.43 51.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.661 0.267 . . . . 0.0 111.441 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.52 7.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.746 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.9 p -127.99 164.41 22.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.437 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.28 142.62 35.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.951 0.405 . . . . 0.0 111.096 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 17.0 m-80 -109.32 134.99 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.366 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.558 HD12 ' HE1' ' A' ' 105' ' ' TRP . 1.2 pt -134.58 126.3 48.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.808 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' C' ' 55' ' ' ASN . 3.8 pt-20 -104.67 148.58 26.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.558 ' HE1' HD12 ' A' ' 103' ' ' ILE . 57.6 m95 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.672 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.67 -0.172 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 60.59 120.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.889 0.376 . . . . 0.0 110.925 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -123.21 58.79 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.21 -54.29 2.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.988 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.422 ' HA ' ' NE2' ' B' ' 8' ' ' HIS . 0.7 OUTLIER -116.91 107.36 14.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.712 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.504 ' HZ3' ' HB3' ' B' ' 19' ' ' ARG . 59.5 t-105 -151.23 114.29 4.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.79 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t 60.88 71.08 0.58 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.069 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.765 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 8.1 m-70 -109.54 -53.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.786 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.765 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.341 31.4 Cg_exo -72.35 139.73 32.38 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.539 2.159 . . . . 0.0 111.923 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.65 -44.19 97.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.974 0.416 . . . . 0.0 111.186 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -92.97 106.88 18.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.7 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -160.42 114.88 2.2 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.439 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -128.94 -66.27 0.83 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.528 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.12 -46.43 72.4 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.284 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.06 -54.8 32.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -53.59 -41.59 66.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.984 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -39.38 94.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' PHE . . . . . 0.404 ' O ' ' OD2' ' B' ' 22' ' ' ASP . 82.3 t80 -60.78 -31.53 70.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 111.296 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 32.4 mmt180 -75.66 -30.02 59.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.618 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 29.6 mt-30 -73.12 -37.04 66.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.159 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' C' ' 21' ' ' LEU . 0.5 OUTLIER -64.52 -50.24 68.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.569 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 22.7 m-20 -72.0 -19.99 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.971 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 13.0 t-20 -77.37 -41.2 41.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.727 ' HD3' HD13 ' A' ' 25' ' ' LEU . 3.6 mmp_? -71.54 -46.29 59.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.762 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.725 HD13 ' HD3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.65 94.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.693 ' O ' HG22 ' B' ' 30' ' ' THR . 51.7 t0 -69.75 -28.98 66.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.835 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -76.01 -37.99 57.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.251 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.631 ' O ' HG22 ' B' ' 32' ' ' VAL . 8.0 mt -76.62 -34.82 58.33 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -66.58 -47.35 73.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.942 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.693 HG22 ' O ' ' B' ' 26' ' ' ASP . 9.7 t -71.66 -40.11 69.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.885 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.689 HH11 ' HG2' ' B' ' 31' ' ' ARG . 21.3 ttp85 -62.73 -38.3 89.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.297 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.631 HG22 ' O ' ' B' ' 28' ' ' LEU . 28.6 m -76.69 -27.68 17.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.178 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.575 ' OD2' ' HD2' ' B' ' 64' ' ' ARG . 10.4 t70 -64.0 -56.17 17.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.004 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.682 ' HD2' ' HA3' ' B' ' 91' ' ' GLY . 23.0 pttt -68.77 -37.56 79.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.06 88.12 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.425 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' C' ' 39' ' ' SER . 0.4 OUTLIER -67.64 -31.62 71.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 111.057 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.52 90.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.418 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.694 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 78.4 p -79.93 -43.58 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.55 ' HB2' HD21 ' A' ' 36' ' ' LEU . 46.7 t -53.19 -60.88 2.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.75 -30.22 60.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.403 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.571 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -64.03 -48.97 74.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.927 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.6 OUTLIER -67.04 -32.96 74.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 1.4 m-20 -78.79 -13.58 59.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.12 65.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.131 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.814 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.2 mm? -75.58 158.63 32.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.894 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.441 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 47.4 p90 -146.52 -30.99 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.169 0.509 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 8.3 tt0 75.45 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.978 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -90.79 137.16 2.25 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.208 . . . . 0.0 112.613 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 14.4 m-85 67.53 154.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.582 ' CA ' ' HB3' ' B' ' 76' ' ' ARG . . . -173.89 73.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.215 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.814 HG12 ' HE2' ' B' ' 53' ' ' LYS . 11.5 p -96.02 -22.88 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 123.162 0.585 . . . . 0.0 112.446 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.83 49.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.814 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.631 0.253 . . . . 0.0 110.546 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.43 143.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.571 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.492 HD21 ' HB3' ' C' ' 102' ' ' ASN . 1.0 OUTLIER -135.18 116.49 14.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 111.663 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' B' ' 71' ' ' ILE . 12.0 t80 -80.32 131.07 35.58 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.215 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.814 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 27.8 p -110.63 120.81 43.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.941 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' B' ' 71' ' ' ILE . . . -143.37 139.85 30.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.441 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.02 164.63 33.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.522 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.425 HG12 HD13 ' B' ' 69' ' ' LEU . 28.5 m -118.68 164.37 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.879 0.371 . . . . 0.0 111.293 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.571 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.57 177.47 20.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.482 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 67' ' ' GLN . . . -162.0 155.12 26.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 1.3 t80 -142.05 122.34 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.575 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 25.1 mtt-85 67.59 -93.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.088 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.41 4.54 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.472 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 22.8 t -109.89 173.91 6.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.811 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.6 OUTLIER -135.32 -179.35 5.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.061 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.694 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -162.56 158.22 23.15 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.552 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.593 HD12 ' H ' ' B' ' 70' ' ' ALA . 3.9 tp -118.02 134.64 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.927 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -142.72 139.03 30.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.694 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.558 HD11 ' CE2' ' B' ' 56' ' ' PHE . 8.9 tp -138.29 150.47 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.15 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.4 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -164.59 -177.19 37.02 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.423 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -160.28 155.22 24.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.58 30.06 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.235 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.4 120.52 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 111.108 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.582 ' HB3' ' CA ' ' B' ' 50' ' ' GLY . 0.0 OUTLIER -105.21 107.63 18.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.762 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.768 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 14.9 p -102.52 130.07 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 59.0 -171.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -118.99 66.01 0.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 69.9 p -160.03 -51.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.022 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' B' ' 103' ' ' ILE . 9.8 p -119.53 142.07 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.563 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.85 153.15 45.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.895 0.378 . . . . 0.0 111.245 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.57 130.71 32.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.477 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -135.09 143.95 46.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.21 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.477 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -148.28 169.11 20.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.793 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 173.37 161.02 22.92 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.553 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.33 150.16 34.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -121.74 140.67 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.16 128.35 48.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.268 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.542 ' HB3' ' CB ' ' B' ' 94' ' ' ASP . . . -136.32 151.09 49.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.625 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.682 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 50.22 -99.64 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.307 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 25.9 t -152.28 -27.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 15.08 9.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.191 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.542 ' CB ' ' HB3' ' B' ' 90' ' ' ALA . 41.5 m-20 -101.59 69.95 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -113.33 127.94 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.747 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.505 ' SD ' HD23 ' A' ' 36' ' ' LEU . 1.3 ptp -135.19 139.48 44.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -117.57 129.92 56.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.463 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -129.29 145.43 51.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.7 0.285 . . . . 0.0 111.419 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.45 7.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.695 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 84.1 p -127.99 164.49 22.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.424 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -140.36 142.54 35.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.521 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 17.1 m-80 -109.3 134.95 51.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.545 HD12 ' HE1' ' B' ' 105' ' ' TRP . 1.2 pt -134.57 126.2 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.796 0.331 . . . . 0.0 110.781 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 3.8 pt-20 -104.63 148.64 26.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 0.545 ' HE1' HD12 ' B' ' 103' ' ' ILE . 58.1 m95 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.406 -0.806 . . . . 0.0 110.649 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.64 -0.184 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 t70 60.57 120.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.397 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -123.19 58.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.13 -54.34 2.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' SER . . . . . 0.411 ' HA ' ' NE2' ' C' ' 8' ' ' HIS . 0.7 OUTLIER -116.83 107.38 14.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.784 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 6' ' ' TRP . . . . . 0.515 ' HZ3' ' HB3' ' C' ' 19' ' ' ARG . 59.5 t-105 -151.22 114.3 4.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.718 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t 60.9 71.04 0.58 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.059 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.762 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 8.1 m-70 -109.51 -53.92 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.794 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.762 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.338 31.4 Cg_exo -72.24 139.76 32.77 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.471 2.114 . . . . 0.0 111.942 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.69 -44.14 97.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.991 0.424 . . . . 0.0 111.234 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -93.02 106.92 18.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.672 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -160.44 114.9 2.19 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.483 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -128.97 -66.25 0.83 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.557 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.45 72.53 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.272 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.08 -54.82 32.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.906 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -53.5 -41.68 66.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.979 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -39.34 93.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.534 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' PHE . . . . . 0.418 ' O ' ' OD2' ' C' ' 22' ' ' ASP . 82.2 t80 -60.87 -31.5 70.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 19' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 32.3 mmt180 -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.735 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 29.6 mt-30 -73.07 -37.0 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 111.212 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.437 ' HA ' HD11 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -64.57 -50.25 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 22.7 m-20 -71.91 -20.06 61.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 23' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 12.8 t-20 -77.31 -41.27 41.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.725 ' HD3' HD13 ' B' ' 25' ' ' LEU . 3.6 mmp_? -71.45 -46.4 60.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.735 HD13 ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -59.83 -43.72 94.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.643 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 26' ' ' ASP . . . . . 0.69 ' O ' HG22 ' C' ' 30' ' ' THR . 51.7 t0 -69.79 -28.9 66.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -75.98 -38.08 57.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.661 0.267 . . . . 0.0 111.265 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.639 ' O ' HG22 ' C' ' 32' ' ' VAL . 8.0 mt -76.52 -34.91 58.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.54 -47.32 73.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.003 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.69 HG22 ' O ' ' C' ' 26' ' ' ASP . 9.7 t -71.62 -40.23 69.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.699 HH11 ' HG2' ' C' ' 31' ' ' ARG . 21.3 ttp85 -62.58 -38.51 90.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.325 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.639 HG22 ' O ' ' C' ' 28' ' ' LEU . 28.3 m -76.59 -27.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.235 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.573 ' OD2' ' HD2' ' C' ' 64' ' ' ARG . 10.4 t70 -63.98 -56.2 16.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HD2' ' HA3' ' C' ' 91' ' ' GLY . 23.1 pttt -68.78 -37.56 79.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.807 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 -48.08 88.01 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.384 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.4 OUTLIER -67.67 -31.56 71.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.28 -38.44 90.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.482 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.701 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 78.7 p -79.9 -43.59 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.545 ' HB2' HD21 ' B' ' 36' ' ' LEU . 46.7 t -53.15 -60.99 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.66 -30.29 60.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' ALA . . . . . 0.58 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -63.95 -48.98 74.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.923 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.6 OUTLIER -67.01 -32.94 74.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.067 179.33 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.3 m-20 -78.77 -13.6 59.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.07 65.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.144 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.826 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.2 mm? -75.65 158.71 32.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.87 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.452 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 47.5 p90 -146.56 -31.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.194 0.521 . . . . 0.0 111.69 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.477 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 8.3 tt0 75.59 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.979 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -90.85 137.17 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.625 2.217 . . . . 0.0 112.545 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 14.6 m-85 67.59 154.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.583 ' CA ' ' HB3' ' C' ' 76' ' ' ARG . . . -173.95 73.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.253 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.811 HG12 ' HE2' ' C' ' 53' ' ' LYS . 11.4 p -95.87 -22.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.198 0.599 . . . . 0.0 112.453 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.9 48.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.296 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 53' ' ' LYS . . . . . 0.811 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.49 7.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.593 0.235 . . . . 0.0 110.566 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.45 143.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.525 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.489 HD21 ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -135.19 116.45 14.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.006 0.431 . . . . 0.0 111.68 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.556 ' CE2' HD11 ' C' ' 71' ' ' ILE . 12.0 t80 -80.35 131.09 35.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.269 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.826 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 27.6 p -110.63 120.82 43.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.972 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.562 ' HB2' ' CD1' ' C' ' 71' ' ' ILE . . . -143.37 139.93 30.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.431 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.05 164.61 33.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.563 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.438 HG12 HD13 ' C' ' 69' ' ' LEU . 28.2 m -118.62 164.38 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.331 . . . . 0.0 111.386 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 61' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.52 177.46 20.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.496 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' C' ' 67' ' ' GLN . . . -161.99 155.07 26.22 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 1.3 t80 -141.95 122.31 14.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.76 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.573 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 24.9 mtt-85 67.54 -93.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.104 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.45 4.54 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.19 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' SER . . . . . 0.462 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 22.8 t -109.92 173.93 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 67' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.6 OUTLIER -135.33 -179.39 5.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.093 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 68' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -162.55 158.27 23.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.549 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.59 HD12 ' H ' ' C' ' 70' ' ' ALA . 3.8 tp -118.08 134.63 54.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.923 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -142.69 138.99 30.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.675 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.562 ' CD1' ' HB2' ' C' ' 58' ' ' ALA . 8.9 tp -138.3 150.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.712 0.291 . . . . 0.0 111.162 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.62 -177.25 37.09 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.399 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.2 p -160.3 155.12 24.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.65 163.66 30.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.223 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -136.4 120.45 17.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 111.171 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.583 ' HB3' ' CA ' ' C' ' 50' ' ' GLY . 0.0 OUTLIER -105.18 107.65 18.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.796 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.754 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 14.9 p -102.48 130.07 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.291 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 59.01 -171.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.96 66.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.567 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 69.2 p -160.08 -51.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.044 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' CG2' ' C' ' 103' ' ' ILE . 9.8 p -119.59 141.94 37.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.08 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.294 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.48 130.81 33.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.627 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -135.11 144.03 46.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.179 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 85' ' ' ALA . . . . . 0.481 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.782 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 173.47 161.09 23.11 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.589 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.36 150.12 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.897 0.38 . . . . 0.0 111.074 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -121.71 140.73 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.356 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.19 128.41 48.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.543 ' HB3' ' CB ' ' C' ' 94' ' ' ASP . . . -136.38 151.07 49.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.613 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.695 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 50.21 -99.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.334 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.35 -27.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.753 0.311 . . . . 0.0 111.348 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 14.98 9.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.205 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' C' ' 90' ' ' ALA . 41.4 m-20 -101.48 69.8 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 t -113.29 127.98 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.989 0.424 . . . . 0.0 110.742 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.513 ' SD ' HD23 ' B' ' 36' ' ' LEU . 1.3 ptp -135.2 139.52 44.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.746 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -117.57 129.9 56.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.472 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -129.25 145.37 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.676 0.275 . . . . 0.0 111.43 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.59 114.49 7.33 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 83.9 p -128.04 164.43 22.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.426 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.31 142.5 35.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.967 0.413 . . . . 0.0 111.114 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.521 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 17.4 m-80 -109.24 135.05 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.542 HD12 ' HE1' ' C' ' 105' ' ' TRP . 1.2 pt -134.56 126.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.776 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' B' ' 55' ' ' ASN . 3.8 pt-20 -104.69 148.58 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 0.542 ' HE1' HD12 ' C' ' 103' ' ' ILE . 57.7 m95 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.705 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 t70 64.4 118.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.959 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -123.87 55.0 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.877 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.78 -52.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.41 103.99 12.11 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.729 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -153.87 111.64 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.682 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t 60.4 71.47 0.57 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.996 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.75 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 7.8 m-70 -109.14 -53.79 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.844 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.75 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.284 31.5 Cg_exo -70.19 141.36 43.26 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.473 2.115 . . . . 0.0 111.923 179.3 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.52 -49.83 67.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.888 0.375 . . . . 0.0 111.092 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -88.92 104.18 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.694 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.33 115.85 2.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.485 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -129.28 -66.13 0.83 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.56 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.3 -50.53 59.31 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.267 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -59.99 -54.37 46.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 0.0 110.849 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.428 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 1.3 t60 -53.15 -46.06 68.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.96 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -63.32 -40.72 98.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.534 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.421 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 92.9 t80 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.182 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 33.1 mmt180 -77.02 -30.18 55.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.744 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.7 mt-30 -71.14 -33.87 70.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.217 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.445 HD21 ' HG3' ' B' ' 24' ' ' ARG . 0.5 OUTLIER -65.1 -48.29 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 15.9 m-20 -70.93 -20.44 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.977 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.79 -42.94 57.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.618 ' HB3' HD13 ' C' ' 25' ' ' LEU . 2.6 mmp_? -70.66 -48.82 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.736 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 30' ' ' THR . 49.8 t0 -72.1 -28.9 63.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.813 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -76.0 -37.16 58.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.259 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.568 HD11 ' HA ' ' C' ' 25' ' ' LEU . 9.5 mt -76.13 -32.75 59.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 32' ' ' VAL . 20.9 t0 -67.38 -48.56 67.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 26' ' ' ASP . 10.0 t -68.7 -37.92 79.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.854 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.666 HH11 ' HG2' ' A' ' 31' ' ' ARG . 18.9 ttp85 -63.65 -39.09 93.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 28' ' ' LEU . 30.2 m -75.33 -28.25 20.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.505 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 13.8 t70 -62.55 -55.12 30.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.001 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 18.7 pttt -70.78 -40.65 72.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.728 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.28 90.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.422 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.95 -34.78 78.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.805 0.336 . . . . 0.0 111.057 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.6 94.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.398 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.438 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 55.6 p -78.38 -39.28 39.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.737 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.0 t -54.66 -64.66 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.408 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -54.48 -31.09 55.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.428 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -62.39 -48.52 79.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.798 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -68.59 -32.72 72.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.363 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.3 m-20 -80.26 -15.04 57.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -17.55 64.79 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.156 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.782 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.8 mm? -76.59 156.07 33.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.871 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.18 -30.29 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.58 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 7.9 tt0 72.17 108.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.031 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.9 Cg_endo -91.29 139.43 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.637 2.225 . . . . 0.0 112.535 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.0 m-85 69.1 154.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.0 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -176.62 75.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.255 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.841 HG12 ' HE2' ' A' ' 53' ' ' LYS . 11.7 p -95.57 -24.92 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.067 0.547 . . . . 0.0 112.464 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.828 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.19 48.33 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.246 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.841 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -145.03 179.69 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.6 0.238 . . . . 0.0 110.643 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 11.4 p -105.18 145.3 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.553 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.58 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 0.9 OUTLIER -135.08 119.62 18.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 111.687 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 71' ' ' ILE . 10.1 t80 -83.01 132.28 35.15 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.18 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.782 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 43.6 p -111.04 122.73 48.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.926 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.54 143.59 31.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.465 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.89 37.04 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.596 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.14 163.78 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.767 0.317 . . . . 0.0 111.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -138.19 177.75 19.79 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.447 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.32 26.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.76 123.82 14.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 27.2 mtt-85 64.18 -94.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.065 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 p -130.69 6.41 4.73 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.203 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.44 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 30.6 t -104.6 174.34 5.92 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.98 177.08 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -161.46 153.93 20.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.556 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 70' ' ' ALA . 6.0 tp -117.26 132.0 56.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.806 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.798 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -138.8 136.1 35.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.692 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.472 HD11 ' CE2' ' A' ' 56' ' ' PHE . 8.8 tp -136.29 145.44 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.28 155.99 34.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.68 163.46 29.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.216 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t80 -138.43 120.91 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 111.128 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HG3' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -110.39 105.58 14.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.685 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.828 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.6 p -104.58 130.8 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.329 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.432 ' CG ' HG22 ' A' ' 77' ' ' VAL . 9.1 m-20 59.5 -174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.18 68.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.535 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.2 p -160.03 -50.7 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.036 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.26 143.48 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.578 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 154.52 45.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.265 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.88 132.37 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.57 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -134.72 139.8 45.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.422 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.07 169.42 19.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.672 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 173.68 162.69 25.97 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.532 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.12 33.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.157 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -119.06 141.33 48.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -124.23 127.86 48.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.269 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.569 ' HB3' ' CB ' ' A' ' 94' ' ' ASP . . . -135.59 148.1 48.93 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.7 -98.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.278 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 -28.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 111.323 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.9 p -121.56 15.34 11.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.569 ' CB ' ' HB3' ' A' ' 90' ' ' ALA . 38.1 m-20 -103.12 70.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.7 t -110.44 128.27 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.722 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.444 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 1.6 ptp -135.58 139.44 43.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.74 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -118.93 128.82 54.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.459 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -129.26 147.37 51.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.36 116.0 5.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.745 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 94.8 p -127.94 163.14 25.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.383 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -136.57 144.58 44.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 111.012 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 21.6 m-80 -109.83 131.9 54.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.38 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.475 HD12 ' HE1' ' A' ' 105' ' ' TRP . 1.6 pt -131.41 126.74 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.75 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 3.8 pt-20 -105.94 152.88 22.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.475 ' HE1' HD12 ' A' ' 103' ' ' ILE . 44.9 m95 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.685 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 t70 64.31 119.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.917 0.389 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -123.89 55.04 1.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.84 -52.82 1.99 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.983 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.35 103.95 12.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.781 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -153.82 111.6 3.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.756 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t 60.5 71.43 0.57 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.965 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.722 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 7.7 m-70 -109.27 -53.81 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.762 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.722 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.282 31.2 Cg_exo -70.05 141.29 43.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.427 2.085 . . . . 0.0 111.994 179.191 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.47 -49.73 67.99 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -88.92 104.2 16.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.678 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.37 115.88 2.6 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.429 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -129.31 -66.13 0.82 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.576 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.33 -50.51 59.37 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.219 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.99 -54.39 46.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.886 0.374 . . . . 0.0 110.914 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.422 ' O ' ' HG3' ' B' ' 20' ' ' GLN . 1.3 t60 -53.13 -46.0 68.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.994 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -63.33 -40.79 98.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.546 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 18' ' ' PHE . . . . . 0.431 ' O ' ' OD2' ' B' ' 22' ' ' ASP . 92.7 t80 -65.59 -32.23 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.205 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -77.14 -30.08 54.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.735 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.548 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 mt-30 -71.24 -33.85 70.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.099 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.455 HD21 ' HG3' ' C' ' 24' ' ' ARG . 0.5 OUTLIER -65.15 -48.28 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.5 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 15.7 m-20 -70.87 -20.41 62.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.76 -43.03 56.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.603 ' HB3' HD13 ' A' ' 25' ' ' LEU . 2.6 mmp_? -70.63 -48.8 53.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.746 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.612 HD13 ' HB3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -60.41 -41.8 94.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.644 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.513 ' O ' HG22 ' B' ' 30' ' ' THR . 49.8 t0 -72.04 -28.96 63.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -75.9 -37.2 59.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.259 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 25' ' ' LEU . 9.6 mt -76.17 -32.83 59.26 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.455 ' O ' HG22 ' B' ' 32' ' ' VAL . 20.9 t0 -67.26 -48.64 67.13 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.981 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.513 HG22 ' O ' ' B' ' 26' ' ' ASP . 10.1 t -68.66 -37.93 80.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.672 HH11 ' HG2' ' B' ' 31' ' ' ARG . 19.0 ttp85 -63.67 -39.06 93.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.507 HG13 ' O ' ' B' ' 28' ' ' LEU . 30.2 m -75.36 -28.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.182 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.503 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 13.8 t70 -62.61 -55.11 30.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 18.7 pttt -70.7 -40.68 72.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.31 90.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.4 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.88 -34.84 78.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.086 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.54 94.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.421 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 56.0 p -78.48 -39.21 39.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -54.77 -64.6 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.101 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.563 ' HB1' HD22 ' C' ' 43' ' ' ASN . . . -54.46 -31.15 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.469 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -62.28 -48.65 78.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.822 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.4 OUTLIER -68.51 -32.76 72.95 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 2.3 m-20 -80.24 -15.02 57.93 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -17.56 64.8 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.081 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.778 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.8 mm? -76.5 156.17 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.38 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.613 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 7.9 tt0 72.22 108.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.929 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.523 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.8 Cg_endo -91.34 139.39 2.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.617 2.212 . . . . 0.0 112.516 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.0 m-85 69.1 154.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.58 75.35 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.227 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.84 HG12 ' HE2' ' B' ' 53' ' ' LYS . 11.7 p -95.59 -24.89 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 123.147 0.579 . . . . 0.0 112.467 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.801 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.11 48.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.277 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.84 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -145.12 179.61 7.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 110.634 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' B' ' 75' ' ' TYR . 11.4 p -105.12 145.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.606 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.589 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 0.9 OUTLIER -135.05 119.66 18.17 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 111.606 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.469 ' CE2' HD11 ' B' ' 71' ' ' ILE . 10.1 t80 -82.94 132.33 35.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.21 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.778 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 43.6 p -111.08 122.76 48.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.972 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.55 143.54 31.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.403 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.59 167.88 37.01 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.547 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.09 163.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 111.335 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -138.14 177.77 19.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.464 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.64 155.36 26.68 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.583 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.83 123.69 14.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.77 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 27.3 mtt-85 64.24 -94.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.044 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 68.8 p -130.74 6.35 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.136 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.437 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 30.3 t -104.53 174.31 5.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.93 177.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -161.45 153.91 20.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.538 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.5 HD12 ' N ' ' B' ' 70' ' ' ALA . 6.0 tp -117.26 132.04 56.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.822 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -138.84 136.13 35.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.689 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.469 HD11 ' CE2' ' B' ' 56' ' ' PHE . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 111.097 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.76 179.96 35.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.45 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.2 155.95 34.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.59 163.45 29.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.239 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.436 ' CD2' ' HB ' ' B' ' 54' ' ' VAL . 13.0 t80 -138.53 120.84 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.32 105.54 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.748 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.801 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.5 p -104.6 130.97 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.431 ' CG ' HG22 ' B' ' 77' ' ' VAL . 9.1 m-20 59.55 -174.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 111.109 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -118.18 68.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.7 p -160.04 -50.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.18 143.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 154.42 45.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.82 132.49 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.43 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.79 45.42 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.153 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.43 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.06 169.52 19.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.683 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 173.55 162.68 25.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.621 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.08 33.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.131 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -119.03 141.22 48.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.365 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.26 127.84 48.28 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.243 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.575 ' HB3' ' CB ' ' B' ' 94' ' ' ASP . . . -135.5 148.2 49.11 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.675 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.61 -98.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.334 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.14 -28.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.316 . . . . 0.0 111.32 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -121.53 15.29 11.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.161 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.575 ' CB ' ' HB3' ' B' ' 90' ' ' ALA . 38.1 m-20 -103.14 70.67 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.4 128.27 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.434 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.6 ptp -135.63 139.49 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.701 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.01 128.84 54.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.482 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -129.21 147.36 51.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 111.389 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.3 116.01 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.784 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 94.2 p -127.91 163.12 25.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.411 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.5 144.58 44.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.945 0.402 . . . . 0.0 111.088 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.45 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 21.5 m-80 -109.8 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.493 HD12 ' HE1' ' B' ' 105' ' ' TRP . 1.6 pt -131.46 126.62 58.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.846 0.355 . . . . 0.0 110.855 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.443 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 3.9 pt-20 -105.91 152.95 22.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 0.493 ' HE1' HD12 ' B' ' 103' ' ' ILE . 44.3 m95 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.666 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.713 -0.155 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 t70 64.33 118.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.906 0.384 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -123.91 55.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.78 -52.79 1.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.014 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.33 103.94 12.08 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -153.84 111.59 3.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.731 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t 60.44 71.47 0.57 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.003 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.743 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 7.8 m-70 -109.24 -53.73 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.801 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.281 31.4 Cg_exo -70.1 141.39 43.73 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.515 2.144 . . . . 0.0 111.907 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.54 -49.84 67.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.914 0.387 . . . . 0.0 111.121 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -88.9 104.23 16.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.645 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.36 115.85 2.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.459 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -129.35 -66.05 0.83 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.481 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.37 -50.54 59.05 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.201 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.96 -54.4 46.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.917 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' HIS . . . . . 0.428 ' O ' ' HG3' ' C' ' 20' ' ' GLN . 1.3 t60 -53.13 -46.01 68.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.953 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -63.38 -40.75 98.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.518 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 18' ' ' PHE . . . . . 0.424 ' O ' ' OD2' ' C' ' 22' ' ' ASP . 92.9 t80 -65.53 -32.35 73.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.247 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.04 -30.15 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.781 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.8 mt-30 -71.17 -33.88 70.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.452 HD21 ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -65.18 -48.27 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 22' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 15.8 m-20 -70.84 -20.42 62.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.053 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -74.85 -42.9 57.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.612 ' HB3' HD13 ' B' ' 25' ' ' LEU . 2.6 mmp_? -70.7 -48.77 52.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.618 HD13 ' HB3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -60.41 -41.71 94.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.676 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 26' ' ' ASP . . . . . 0.512 ' O ' HG22 ' C' ' 30' ' ' THR . 49.9 t0 -72.19 -28.83 63.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.781 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -75.97 -37.21 58.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.18 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' B' ' 25' ' ' LEU . 9.7 mt -76.18 -32.73 59.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 29' ' ' ASP . . . . . 0.454 ' O ' HG22 ' C' ' 32' ' ' VAL . 21.0 t0 -67.4 -48.49 67.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.945 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.512 HG22 ' O ' ' C' ' 26' ' ' ASP . 10.1 t -68.75 -37.89 79.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.862 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.675 HH11 ' HG2' ' C' ' 31' ' ' ARG . 18.9 ttp85 -63.74 -39.02 93.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.325 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.516 HG13 ' O ' ' C' ' 28' ' ' LEU . 29.9 m -75.31 -28.27 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.204 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.509 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 13.8 t70 -62.74 -55.08 29.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.945 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 18.7 pttt -70.64 -40.74 72.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.25 90.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.402 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.02 -34.68 78.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 111.096 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.84 -39.51 94.58 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.4 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.423 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 56.6 p -78.51 -39.27 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 35.9 t -54.7 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.405 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -54.55 -31.12 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.407 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 41' ' ' ALA . . . . . 0.452 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -62.33 -48.5 79.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.805 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.4 OUTLIER -68.61 -32.64 72.66 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.563 HD22 ' HB1' ' B' ' 40' ' ' ALA . 1.1 m120 -80.24 -15.15 57.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -17.59 64.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.144 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.773 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.8 mm? -76.56 156.14 33.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.877 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.27 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.651 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.582 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 7.9 tt0 72.11 108.78 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.019 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.9 Cg_endo -91.32 139.4 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.617 2.211 . . . . 0.0 112.565 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.1 m-85 69.13 154.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.027 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.57 75.35 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.243 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.828 HG12 ' HE2' ' C' ' 53' ' ' LYS . 11.7 p -95.51 -25.0 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.162 0.585 . . . . 0.0 112.44 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.822 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.17 48.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.316 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 53' ' ' LYS . . . . . 0.828 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.6 OUTLIER -145.02 179.69 7.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.595 0.236 . . . . 0.0 110.645 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 11.4 p -105.25 145.32 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.517 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.582 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 0.9 OUTLIER -135.06 119.61 18.09 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.971 0.415 . . . . 0.0 111.679 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' C' ' 71' ' ' ILE . 10.0 t80 -82.94 132.34 35.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.273 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.773 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.1 p -111.12 122.65 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 143.63 31.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.453 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.92 37.09 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 26.1 m -119.17 163.86 16.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 111.39 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 61' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -138.18 177.85 19.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.473 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.7 155.33 26.64 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.556 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.77 123.75 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.447 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 27.3 mtt-85 64.18 -93.97 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.038 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 68.3 p -130.76 6.39 4.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 66' ' ' SER . . . . . 0.422 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 30.6 t -104.57 174.41 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.08 177.07 7.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.116 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 68' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -161.49 153.91 20.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.58 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.498 HD12 ' H ' ' C' ' 70' ' ' ALA . 6.0 tp -117.23 131.96 56.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.795 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.805 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -138.73 136.18 35.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.637 0.256 . . . . 0.0 111.664 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.477 HD11 ' CE2' ' C' ' 56' ' ' PHE . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -155.3 155.96 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 110.965 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.66 163.42 29.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.262 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.0 t80 -138.51 120.86 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 105.64 14.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.822 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.5 p -104.64 130.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.441 ' CG ' HG22 ' C' ' 77' ' ' VAL . 9.2 m-20 59.49 -174.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.134 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.16 68.11 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.523 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 41.2 p -160.09 -50.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.986 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 143.51 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.3 154.43 45.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.897 0.38 . . . . 0.0 111.295 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.81 132.5 32.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.77 45.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 85' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.06 169.5 19.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.68 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 173.6 162.75 26.02 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.532 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.22 147.09 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -119.04 141.33 48.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.329 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.3 127.87 48.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' C' ' 94' ' ' ASP . . . -135.54 148.18 49.03 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.645 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.67 -98.67 0.02 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.322 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.19 -28.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 111.326 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -121.57 15.32 11.13 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.573 ' CB ' ' HB3' ' C' ' 90' ' ' ALA . 38.2 m-20 -103.14 70.58 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.38 128.24 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 110.709 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.444 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 1.6 ptp -135.63 139.54 43.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.696 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.03 128.87 54.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.433 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -129.25 147.36 51.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.366 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.37 115.96 5.88 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.718 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 93.9 p -127.85 163.11 25.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.57 144.51 44.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.008 0.432 . . . . 0.0 111.072 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.441 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 21.4 m-80 -109.69 131.87 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.382 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.487 HD12 ' HE1' ' C' ' 105' ' ' TRP . 1.6 pt -131.42 126.68 58.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.435 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 3.9 pt-20 -105.84 152.93 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.989 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 0.487 ' HE1' HD12 ' C' ' 103' ' ' ILE . 44.6 m95 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.7 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 t70 68.83 123.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.885 0.374 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -126.91 58.53 1.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.2 -58.27 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.463 ' HA ' ' NE2' ' A' ' 8' ' ' HIS . 0.7 OUTLIER -116.69 103.56 10.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.745 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' A' ' 19' ' ' ARG . 55.7 t-105 -151.73 114.43 4.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.767 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t 60.53 70.02 0.65 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.063 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.77 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 7.7 m-70 -110.13 -54.64 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.755 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.77 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.337 31.5 Cg_exo -72.19 143.29 39.49 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.516 2.144 . . . . 0.0 111.88 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -64.15 -49.57 71.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.988 0.423 . . . . 0.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.47 103.9 13.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.614 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 16.5 pt-20 -158.52 108.87 2.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.473 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 19.5 tttm -124.31 -71.43 0.71 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.516 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.37 90.73 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.282 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.84 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.349 . . . . 0.0 110.895 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 1.5 t60 -57.91 -43.2 86.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.969 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -60.42 -39.32 87.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.526 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.18 -32.88 74.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 6' ' ' TRP . 31.2 mmt180 -76.38 -38.27 55.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.767 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 12.7 mt-30 -67.2 -30.87 70.93 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.191 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.579 ' HA ' HD11 ' C' ' 21' ' ' LEU . 0.6 OUTLIER -65.9 -56.08 13.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.589 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.9 -23.99 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 22.4 t-20 -67.16 -39.43 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 5.4 mmp_? -71.82 -48.11 48.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.777 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.64 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.6 OUTLIER -56.4 -52.21 65.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.65 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.713 ' O ' HG22 ' A' ' 30' ' ' THR . 33.6 t0 -64.31 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 26.6 tttm -71.76 -36.68 70.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.205 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 32' ' ' VAL . 3.5 mt -79.17 -33.6 43.85 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.18 96.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.941 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 26' ' ' ASP . 4.4 t -76.57 -40.64 49.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.879 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HG2' HH11 ' A' ' 31' ' ' ARG . 21.3 ttp85 -61.68 -40.99 96.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.277 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 28' ' ' LEU . 30.7 m -73.43 -29.04 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.598 ' OD1' ' HB2' ' A' ' 64' ' ' ARG . 17.8 t70 -62.92 -52.58 62.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 26.5 pttt -70.74 -39.55 73.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.738 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.89 97.33 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.427 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' B' ' 39' ' ' SER . 0.5 OUTLIER -66.74 -33.57 75.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 111.077 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -61.99 -43.06 99.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.457 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.741 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 79.3 p -75.22 -41.04 58.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.742 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.505 ' HB2' HD21 ' C' ' 36' ' ' LEU . 38.2 t -57.55 -62.11 2.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.17 48.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.467 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.84 -48.07 72.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.943 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.701 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -66.1 -32.83 74.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.9 m-20 -79.77 -12.6 59.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -14.82 63.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.137 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.844 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.5 mm? -76.55 156.81 32.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.888 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.13 -26.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.608 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 10.1 tt0 71.58 110.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.927 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -90.03 137.13 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.645 2.23 . . . . 0.0 112.549 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.9 m-85 64.64 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.953 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.34 75.43 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.638 HG12 ' HE2' ' A' ' 53' ' ' LYS . 12.8 p -95.11 -25.26 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.148 0.579 . . . . 0.0 112.415 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.88 48.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.313 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.638 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -143.44 -178.0 5.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.591 0.234 . . . . 0.0 110.643 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 8.2 p -106.17 145.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.587 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.608 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 1.4 t30 -134.88 122.69 22.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.499 ' CE2' HD11 ' A' ' 71' ' ' ILE . 11.5 t80 -85.76 132.86 34.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.235 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.844 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 33.7 p -113.22 125.22 54.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.016 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 71' ' ' ILE . . . -149.45 139.68 22.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.449 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.41 167.3 38.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.434 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.551 HG12 HD13 ' A' ' 69' ' ' LEU . 22.8 m -120.02 161.55 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.326 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.2 177.45 20.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.404 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.455 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -162.35 156.82 28.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.612 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.4 t80 -143.13 128.28 18.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.598 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 16.2 mtt-85 64.97 -91.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 p -135.63 6.1 3.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.522 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 19.3 t -105.18 168.38 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.4 179.29 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.138 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -164.78 150.54 10.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.571 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.551 HD13 HG12 ' A' ' 60' ' ' VAL . 12.5 tp -116.22 127.91 55.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.767 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -132.55 136.23 46.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.729 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 58' ' ' ALA . 10.6 tp -132.81 146.68 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.138 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -163.89 -179.44 38.18 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.407 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -154.65 152.04 29.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.257 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.5 t80 -132.57 122.03 24.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.228 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.34 101.84 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.752 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.5 p -103.56 136.31 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.37 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.943 0.401 . . . . 0.0 111.112 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.47 61.35 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.573 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.76 -44.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.8 p -122.32 141.35 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.258 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.8 134.86 32.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.406 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -139.74 138.16 35.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.406 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.38 167.93 23.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.506 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 171.41 163.67 25.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.96 145.44 35.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.897 0.38 . . . . 0.0 111.044 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -114.49 141.12 48.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.18 130.69 54.69 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.273 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . . . -139.63 145.25 38.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.596 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 52.19 -96.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.26 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -155.37 -30.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.731 0.3 . . . . 0.0 111.336 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -121.5 16.56 11.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.194 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 90' ' ' ALA . 41.6 m-20 -104.44 73.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.2 t -114.79 131.96 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.642 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.489 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 1.2 ptp -136.27 142.27 43.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.714 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -119.95 128.75 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.483 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -125.99 148.94 49.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.346 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.09 114.52 5.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.709 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.7 p -130.43 161.24 31.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.463 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -134.0 142.71 47.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.97 0.414 . . . . 0.0 111.072 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 20.7 m-80 -111.68 128.62 56.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.459 HD12 ' HE1' ' A' ' 105' ' ' TRP . 3.0 pt -130.79 131.49 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.8 0.333 . . . . 0.0 110.796 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 5.4 pt-20 -112.55 154.89 25.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.459 ' HE1' HD12 ' A' ' 103' ' ' ILE . 31.5 m95 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.682 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 112.678 -0.169 . . . . 0.0 112.678 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 t70 68.73 123.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.881 0.372 . . . . 0.0 111.048 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -126.84 58.63 1.41 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.27 -58.34 1.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.0 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.466 ' HA ' ' NE2' ' B' ' 8' ' ' HIS . 0.7 OUTLIER -116.69 103.57 10.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.791 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' B' ' 19' ' ' ARG . 55.9 t-105 -151.76 114.45 4.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.728 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t 60.58 70.11 0.64 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.943 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.797 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 7.7 m-70 -110.16 -54.61 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.824 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.797 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.337 31.5 Cg_exo -72.17 143.38 39.76 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.427 2.085 . . . . 0.0 111.905 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -64.22 -49.5 71.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.951 0.405 . . . . 0.0 111.207 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.56 103.97 13.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.607 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' B' ' 16' ' ' HIS . 16.5 pt-20 -158.58 108.8 2.05 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.546 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' B' ' 17' ' ' LYS . 19.5 tttm -124.23 -71.47 0.71 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.544 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.37 -44.35 90.7 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.27 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 -54.65 37.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.867 0.365 . . . . 0.0 110.937 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.495 ' HB2' ' HB2' ' B' ' 12' ' ' GLU . 1.5 t60 -58.0 -43.12 86.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.003 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -60.53 -39.29 87.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.12 -32.94 74.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.311 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 31.2 mmt180 -76.4 -38.35 55.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.741 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 12.7 mt-30 -67.1 -30.88 71.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.973 0.416 . . . . 0.0 111.23 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.584 HD11 ' HA ' ' C' ' 21' ' ' LEU . 0.6 OUTLIER -65.88 -56.04 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -69.01 -23.91 64.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 22.3 t-20 -67.17 -39.43 86.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 5.4 mmp_? -71.84 -48.19 47.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.701 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.647 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.6 OUTLIER -56.31 -52.26 65.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.717 ' O ' HG22 ' B' ' 30' ' ' THR . 33.7 t0 -64.29 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.762 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.442 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 26.7 tttm -71.65 -36.83 70.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.603 0.239 . . . . 0.0 111.203 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.656 ' O ' HG13 ' B' ' 32' ' ' VAL . 3.5 mt -79.08 -33.69 44.31 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.46 -42.16 96.09 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.717 HG22 ' O ' ' B' ' 26' ' ' ASP . 4.5 t -76.59 -40.7 48.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.645 HH11 ' HG2' ' B' ' 31' ' ' ARG . 21.2 ttp85 -61.6 -41.05 96.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.656 HG13 ' O ' ' B' ' 28' ' ' LEU . 30.6 m -73.37 -29.11 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.161 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.606 ' OD1' ' HB2' ' B' ' 64' ' ' ARG . 17.8 t70 -62.85 -52.69 62.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 26.5 pttt -70.69 -39.5 73.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.755 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.65 -44.95 97.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.425 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' C' ' 39' ' ' SER . 0.5 OUTLIER -66.73 -33.59 75.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 111.054 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.442 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -61.93 -43.09 99.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.424 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.757 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 79.9 p -75.24 -40.95 58.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.77 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.498 ' HB2' HD21 ' A' ' 36' ' ' LEU . 38.4 t -57.63 -62.11 2.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.18 -30.2 48.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.433 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.615 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.86 -48.01 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.7 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.7 OUTLIER -66.2 -32.76 74.39 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.44 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 2.9 m-20 -79.8 -12.66 59.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -14.94 63.22 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.156 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.832 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.5 mm? -76.46 156.84 32.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.847 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.1 -26.93 0.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.17 0.509 . . . . 0.0 111.683 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.613 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 10.1 tt0 71.69 109.87 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.914 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -89.86 137.13 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.709 2.273 . . . . 0.0 112.547 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.9 m-85 64.57 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.957 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.35 75.41 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.242 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.641 HG12 ' HE2' ' B' ' 53' ' ' LYS . 12.7 p -95.04 -25.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.469 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.88 48.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.641 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -143.54 -178.05 5.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.517 ' HB ' ' CE2' ' B' ' 75' ' ' TYR . 8.3 p -106.08 145.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.589 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.613 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 1.4 t30 -134.95 122.61 22.15 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 111.658 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' B' ' 71' ' ' ILE . 11.6 t80 -85.65 132.8 34.09 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.309 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.832 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 33.8 p -113.18 125.27 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.004 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' B' ' 71' ' ' ILE . . . -149.56 139.64 22.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.439 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.33 38.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.526 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.534 HG12 HD13 ' B' ' 69' ' ' LEU . 22.6 m -120.04 161.58 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.786 0.327 . . . . 0.0 111.382 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.23 177.48 20.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.459 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.442 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -162.34 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.562 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.49 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.4 t80 -143.13 128.22 18.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.66 0.267 . . . . 0.0 110.801 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.606 ' HB2' ' OD1' ' B' ' 33' ' ' ASP . 16.3 mtt-85 64.95 -91.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.087 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 p -135.64 6.09 3.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.524 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 19.4 t -105.2 168.36 9.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.33 179.36 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -164.87 150.48 9.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.539 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.534 HD13 HG12 ' B' ' 60' ' ' VAL . 12.3 tp -116.16 127.92 55.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.7 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -132.59 136.22 46.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.67 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' B' ' 58' ' ' ALA . 10.6 tp -132.81 146.74 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.119 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -163.87 -179.42 38.15 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.41 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 64.5 p -154.7 152.09 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.85 0.357 . . . . 0.0 111.043 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.64 156.91 27.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.25 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 13.7 t80 -132.59 122.06 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 101.93 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.688 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.745 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.5 p -103.49 136.36 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.3 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.142 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.46 61.27 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.568 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -159.65 -44.84 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.988 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -122.32 141.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 155.72 48.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.258 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.75 134.91 32.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.561 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.19 35.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.418 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.44 167.9 23.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.073 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.489 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 171.41 163.63 25.71 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.96 145.33 35.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -114.42 141.1 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.363 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.14 130.65 54.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.262 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . . . -139.69 145.25 38.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.562 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 52.25 -96.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.276 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.36 -30.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.339 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -121.51 16.44 11.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.565 ' HB2' ' HB3' ' B' ' 90' ' ' ALA . 41.6 m-20 -104.3 73.52 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 56.3 t -114.74 132.01 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.493 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.2 ptp -136.31 142.27 43.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -120.07 128.77 53.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.37 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -126.0 148.87 49.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.401 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.06 114.51 5.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.709 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 53.7 p -130.42 161.27 31.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.48 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -134.0 142.65 47.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.111 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.553 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 20.4 m-80 -111.59 128.65 56.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.443 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.458 HD12 ' HE1' ' B' ' 105' ' ' TRP . 3.0 pt -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 110.784 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.503 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 5.4 pt-20 -112.66 154.87 25.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 0.458 ' HE1' HD12 ' B' ' 103' ' ' ILE . 31.5 m95 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.417 -0.802 . . . . 0.0 110.686 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 112.64 -0.184 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 t70 68.75 123.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.937 0.399 . . . . 0.0 110.976 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -126.86 58.64 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.27 -58.4 1.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' SER . . . . . 0.464 ' HA ' ' NE2' ' C' ' 8' ' ' HIS . 0.7 OUTLIER -116.67 103.62 10.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.74 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 6' ' ' TRP . . . . . 0.411 ' CZ3' ' HB3' ' C' ' 19' ' ' ARG . 55.8 t-105 -151.85 114.35 4.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.701 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t 60.66 70.06 0.64 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.982 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.797 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 7.7 m-70 -110.22 -54.55 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.804 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.797 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.338 31.5 Cg_exo -72.23 143.32 39.4 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.437 2.092 . . . . 0.0 111.938 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -64.14 -49.61 71.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.966 0.412 . . . . 0.0 111.2 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -83.4 103.89 13.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.649 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' C' ' 16' ' ' HIS . 16.5 pt-20 -158.53 108.86 2.07 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.504 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' C' ' 17' ' ' LYS . 19.6 tttm -124.31 -71.39 0.72 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.489 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -44.31 90.7 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.294 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.31 -54.76 35.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.906 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' C' ' 12' ' ' GLU . 1.5 t60 -57.96 -43.13 86.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.025 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' C' ' 13' ' ' LYS . 0.0 OUTLIER -60.39 -39.32 86.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.555 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -63.17 -32.98 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' ARG . . . . . 0.411 ' HB3' ' CZ3' ' C' ' 6' ' ' TRP . 31.2 mmt180 -76.37 -38.28 56.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 12.7 mt-30 -67.26 -30.78 70.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.584 ' HA ' HD11 ' B' ' 21' ' ' LEU . 0.6 OUTLIER -65.95 -56.04 13.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.564 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 -23.98 64.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 22.3 t-20 -67.17 -39.43 86.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' C' ' 20' ' ' GLN . 5.4 mmp_? -71.81 -48.18 48.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.788 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.627 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -56.3 -52.28 65.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 26' ' ' ASP . . . . . 0.702 ' O ' HG22 ' C' ' 30' ' ' THR . 33.5 t0 -64.23 -28.01 69.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.818 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -71.62 -36.8 70.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.248 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.664 ' O ' HG13 ' C' ' 32' ' ' VAL . 3.5 mt -79.11 -33.66 44.16 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.14 96.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.921 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.702 HG22 ' O ' ' C' ' 26' ' ' ASP . 4.5 t -76.55 -40.72 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.864 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.663 HH11 ' HG2' ' C' ' 31' ' ' ARG . 21.3 ttp85 -61.64 -41.0 96.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.664 HG13 ' O ' ' C' ' 28' ' ' LEU . 30.7 m -73.4 -29.09 26.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.599 ' OD1' ' HB2' ' C' ' 64' ' ' ARG . 17.8 t70 -62.77 -52.65 62.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.027 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 26.5 pttt -70.78 -39.44 73.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.94 97.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.386 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.505 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.5 OUTLIER -66.68 -33.71 76.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.457 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -61.77 -43.16 99.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.745 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 79.7 p -75.23 -41.02 58.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.488 ' HB2' HD21 ' B' ' 36' ' ' LEU . 38.0 t -57.51 -62.17 1.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.18 48.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.443 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' ALA . . . . . 0.609 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.81 -48.01 73.14 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.701 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.7 OUTLIER -66.18 -32.85 74.53 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 2.8 m-20 -79.71 -12.66 59.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -14.85 63.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.17 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.821 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.5 mm? -76.49 156.86 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.869 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.15 -26.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.206 0.527 . . . . 0.0 111.706 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 10.1 tt0 71.5 109.91 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.021 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -89.94 137.19 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.554 2.169 . . . . 0.0 112.59 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.8 m-85 64.6 152.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.39 75.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.228 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.635 HG12 ' HE2' ' C' ' 53' ' ' LYS . 12.6 p -94.94 -25.27 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.18 0.592 . . . . 0.0 112.509 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.91 48.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.298 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 53' ' ' LYS . . . . . 0.635 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.4 OUTLIER -143.52 -178.07 5.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.585 0.231 . . . . 0.0 110.608 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.516 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 8.2 p -106.16 145.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.557 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.589 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 1.4 t30 -134.88 122.72 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' C' ' 71' ' ' ILE . 11.7 t80 -85.74 132.89 34.05 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.172 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.821 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 33.5 p -113.29 125.27 54.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.895 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.52 ' HB2' ' CD1' ' C' ' 71' ' ' ILE . . . -149.57 139.67 22.11 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.4 38.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.545 HG12 HD13 ' C' ' 69' ' ' LEU . 22.6 m -120.12 161.57 19.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 111.33 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 61' ' ' GLY . . . . . 0.609 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.22 177.47 20.29 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.418 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.457 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -162.33 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.4 t80 -143.09 128.29 18.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.686 0.279 . . . . 0.0 110.746 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.599 ' HB2' ' OD1' ' C' ' 33' ' ' ASP . 16.3 mtt-85 64.94 -91.07 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.096 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.0 p -135.59 6.15 3.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.227 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 66' ' ' SER . . . . . 0.517 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 19.4 t -105.26 168.4 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.778 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.41 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 68' ' ' ALA . . . . . 0.745 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -164.83 150.47 9.97 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.556 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.545 HD13 HG12 ' C' ' 60' ' ' VAL . 12.4 tp -116.17 127.9 55.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.701 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -132.63 136.19 46.34 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' C' ' 58' ' ' ALA . 10.6 tp -132.74 146.75 32.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.732 0.301 . . . . 0.0 111.134 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -163.9 -179.39 38.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.435 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.4 p -154.71 152.0 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 111.056 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.26 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.516 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.7 t80 -132.64 122.05 24.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 111.128 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' C' ' 76' ' ' ARG . 0.0 OUTLIER -111.41 101.83 10.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.732 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.5 p -103.46 136.36 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 63.3 -171.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.391 . . . . 0.0 111.089 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.55 61.35 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.72 -44.77 0.05 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.33 141.37 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.69 155.78 47.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.74 134.85 32.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.539 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.412 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.21 35.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.157 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 85' ' ' ALA . . . . . 0.412 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.45 167.86 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.499 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 171.49 163.65 25.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.574 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.87 145.41 35.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.137 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -114.5 141.14 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.347 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 130.69 54.71 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.288 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' C' ' 94' ' ' ASP . . . -139.68 145.21 38.11 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.595 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 52.28 -96.33 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.258 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.38 -30.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.281 . . . . 0.0 111.296 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.6 p -121.42 16.45 11.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.239 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.568 ' HB2' ' HB3' ' C' ' 90' ' ' ALA . 41.5 m-20 -104.39 73.54 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -114.79 132.03 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 0.0 110.636 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.49 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 1.2 ptp -136.33 142.2 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.642 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.96 128.72 53.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -125.95 148.84 49.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.299 . . . . 0.0 111.419 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.05 114.5 5.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.829 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 53.6 p -130.44 161.21 31.89 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.393 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -133.95 142.65 47.78 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.917 0.389 . . . . 0.0 111.113 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.571 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 20.9 m-80 -111.6 128.68 56.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.462 HD12 ' HE1' ' C' ' 105' ' ' TRP . 3.0 pt -130.79 131.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.743 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.511 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 5.4 pt-20 -112.63 154.92 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 0.462 ' HE1' HD12 ' C' ' 103' ' ' ILE . 31.0 m95 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.706 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.628 -0.189 . . . . 0.0 112.628 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 t70 67.06 123.63 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 110.952 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -128.94 48.35 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.35 -54.33 2.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.451 ' HA ' ' NE2' ' A' ' 8' ' ' HIS . 0.7 OUTLIER -114.1 105.46 13.23 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.723 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -153.81 112.99 3.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.718 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t 61.58 78.18 0.3 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.969 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.648 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 8.9 m-70 -107.85 -49.36 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.815 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.319 31.4 Cg_exo -71.48 146.9 51.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.501 2.134 . . . . 0.0 111.944 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -64.3 -52.72 57.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.985 0.421 . . . . 0.0 111.213 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -89.72 112.3 23.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.681 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -158.1 114.13 2.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.448 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 24.5 tttm -125.27 -70.99 0.72 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.511 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -44.88 67.17 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.274 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.02 -55.12 38.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.851 0.358 . . . . 0.0 110.939 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.87 -47.58 82.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.97 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -53.03 -40.87 64.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.57 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 24.9 mmt180 -76.8 -36.88 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.725 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.637 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.6 mt-30 -67.5 -32.94 74.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.799 HD21 ' HG3' ' B' ' 24' ' ' ARG . 1.4 tt -68.6 -55.84 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.558 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.13 -25.46 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 24.6 t-20 -71.76 -42.48 67.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.79 ' HG3' HD21 ' C' ' 21' ' ' LEU . 3.7 mmp_? -69.27 -45.28 70.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.814 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 HD11 ' B' ' 28' ' ' LEU . 1.9 tp -56.29 -49.09 75.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.562 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 30' ' ' THR . 33.3 t0 -64.79 -32.08 73.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 27.2 tttm -69.98 -32.89 71.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.26 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.754 HD11 HD12 ' C' ' 25' ' ' LEU . 1.7 mt -81.06 -32.37 34.04 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.69 -40.21 88.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.017 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 26' ' ' ASP . 4.3 t -76.73 -39.34 52.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.492 HH22 HG21 ' C' ' 32' ' ' VAL . 43.6 ttp85 -59.46 -41.81 90.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 28' ' ' LEU . 27.2 m -78.29 -23.6 13.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.204 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.479 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 18.6 t70 -67.63 -51.54 48.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' NZ ' ' HA3' ' A' ' 91' ' ' GLY . 32.7 pttt -76.38 -40.28 51.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.93 98.75 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -67.09 -33.9 76.47 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.882 0.372 . . . . 0.0 111.156 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.17 99.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.457 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.753 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 94.4 p -76.29 -37.31 57.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.637 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 33.0 t -63.73 -55.01 26.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.98 -32.1 69.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.51 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -64.88 -46.47 81.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.955 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -66.22 -30.39 70.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.3 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.584 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 9.7 m-20 -81.36 -15.71 54.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.46 -15.04 62.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.112 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.737 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.9 mm? -71.39 164.52 25.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.911 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 25.0 p90 -152.55 -32.02 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.148 0.499 . . . . 0.0 111.701 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 15.3 tt0 73.53 106.71 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.96 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -93.07 136.34 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.628 2.219 . . . . 0.0 112.552 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 10.6 m-85 65.52 151.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 178.62 78.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.235 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.31 -23.28 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.206 0.603 . . . . 0.0 112.411 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 157.5 49.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.278 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 52' ' ' GLY . 0.5 OUTLIER -146.65 -176.73 5.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.605 0.24 . . . . 0.0 110.563 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.22 150.57 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.568 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.529 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 2.2 t30 -132.91 124.37 27.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.66 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 71' ' ' ILE . 24.1 t80 -87.18 128.17 35.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.319 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.737 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 38.2 p -114.71 123.08 48.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.047 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.29 136.78 18.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.451 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.05 44.35 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.582 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.424 HG12 HD13 ' A' ' 69' ' ' LEU . 16.4 m -126.9 166.98 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.801 0.334 . . . . 0.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -141.35 172.32 23.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.44 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.47 152.36 23.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.547 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.3 t80 -142.44 128.68 19.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.686 0.279 . . . . 0.0 110.737 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.36 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 p -140.35 10.07 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.479 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 9.8 t -109.6 167.6 10.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.67 -179.09 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -167.19 156.46 10.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.526 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.424 HD13 HG12 ' A' ' 60' ' ' VAL . 7.6 tp -114.58 130.97 56.83 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -129.62 141.43 50.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.682 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.666 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 7.9 tp -138.14 150.38 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.092 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.437 ' N ' HG13 ' A' ' 71' ' ' ILE . . . -169.28 177.41 42.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.395 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.6 146.4 18.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.25 158.41 27.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.528 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 30.9 t80 -126.3 125.02 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.154 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.504 ' NH2' ' HB2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -113.1 102.71 10.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.607 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.0 p -104.41 138.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 59.88 -167.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -126.59 66.08 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.451 ' HA ' ' HG3' ' A' ' 104' ' ' GLU . 19.9 p -165.4 -46.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.986 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.24 139.86 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.49 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.46 45.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.293 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.16 138.91 33.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.638 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.124 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.34 169.75 17.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.103 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.413 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 172.04 157.62 14.33 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.507 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.05 144.89 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 111.079 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -112.57 142.43 45.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.99 122.89 39.63 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.31 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -137.34 147.3 45.47 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.6 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.457 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 57.03 -94.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.276 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 t -159.4 -33.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 111.357 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.77 13.83 12.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 32.6 m-20 -101.85 72.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.969 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 t -116.08 127.05 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.987 0.423 . . . . 0.0 110.759 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 39' ' ' SER . 1.3 ptp -131.85 140.2 49.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.681 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -121.55 126.69 49.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -128.42 141.51 51.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.83 117.21 8.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.781 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.49 162.13 27.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.452 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.06 133.52 50.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.103 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.542 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 28.7 m-80 -108.38 127.86 54.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.458 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.485 HD12 ' HE1' ' A' ' 105' ' ' TRP . 0.7 OUTLIER -131.74 138.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.77 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 80' ' ' SER . 4.6 pt-20 -112.59 146.98 37.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.485 ' HE1' HD12 ' A' ' 103' ' ' ILE . 40.3 m95 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.666 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.67 -0.172 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 15.3 t70 66.92 123.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -128.85 48.39 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.37 -54.27 2.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.45 ' HA ' ' NE2' ' B' ' 8' ' ' HIS . 0.7 OUTLIER -114.15 105.44 13.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.795 -179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -153.74 112.93 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.758 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t 61.67 78.1 0.3 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.041 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.641 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 9.1 m-70 -107.87 -49.42 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.769 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.32 31.5 Cg_exo -71.47 146.96 51.19 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.458 2.105 . . . . 0.0 111.906 179.314 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -64.36 -52.81 56.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.975 0.417 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -89.65 112.21 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.735 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -157.99 114.1 2.8 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.499 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' B' ' 17' ' ' LYS . 24.5 tttm -125.24 -70.94 0.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.558 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.89 -44.94 65.92 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.241 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.88 -55.14 38.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 0.0 110.942 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.96 -47.46 82.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.99 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -53.08 -40.88 64.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.566 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.45 -29.86 70.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.259 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 24.9 mmt180 -76.74 -36.89 56.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.633 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.6 mt-30 -67.46 -32.96 74.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.786 HD21 ' HG3' ' C' ' 24' ' ' ARG . 1.4 tt -68.61 -55.77 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.15 -25.44 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 24.6 t-20 -71.79 -42.54 66.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.799 ' HG3' HD21 ' A' ' 21' ' ' LEU . 3.7 mmp_? -69.3 -45.25 70.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.782 HD12 HD11 ' C' ' 28' ' ' LEU . 1.9 tp -56.36 -49.06 75.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.582 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.618 ' O ' HG22 ' B' ' 30' ' ' THR . 33.3 t0 -64.73 -32.08 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.814 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.615 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 27.2 tttm -70.02 -32.9 71.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.237 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.777 HD11 HD12 ' A' ' 25' ' ' LEU . 1.7 mt -81.05 -32.34 34.08 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.7 -40.29 88.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.936 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.618 HG22 ' O ' ' B' ' 26' ' ' ASP . 4.3 t -76.68 -39.38 52.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.814 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.493 HH22 HG21 ' A' ' 32' ' ' VAL . 43.4 ttp85 -59.31 -41.91 90.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.336 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.523 HG22 ' O ' ' B' ' 28' ' ' LEU . 27.2 m -78.28 -23.63 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.157 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' B' ' 66' ' ' SER . 18.6 t70 -67.6 -51.59 48.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.986 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.46 ' NZ ' ' HA3' ' B' ' 91' ' ' GLY . 32.7 pttt -76.28 -40.41 51.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.792 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.21 -43.92 98.77 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.5 OUTLIER -67.14 -33.87 76.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.13 99.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.47 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.75 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 94.5 p -76.33 -37.33 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.758 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.628 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 32.7 t -63.76 -54.97 27.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.0 69.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.517 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -64.83 -46.59 81.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.612 HD13 ' O ' ' B' ' 42' ' ' LEU . 0.6 OUTLIER -66.05 -30.49 71.02 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 9.7 m-20 -81.39 -15.64 54.59 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -15.11 62.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.073 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.744 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.9 mm? -71.4 164.59 25.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.837 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 24.9 p90 -152.58 -32.08 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.15 0.5 . . . . 0.0 111.625 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.536 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 15.4 tt0 73.49 106.61 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.0 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -93.02 136.32 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.668 2.245 . . . . 0.0 112.52 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 10.6 m-85 65.56 151.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 178.57 78.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.264 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.22 -23.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 123.108 0.563 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 157.54 49.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.299 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' B' ' 52' ' ' GLY . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.31 150.59 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.543 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.536 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 2.2 t30 -132.94 124.34 27.62 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.981 0.42 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.68 ' CZ ' HD11 ' B' ' 71' ' ' ILE . 24.4 t80 -87.21 128.23 35.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.224 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.744 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.7 p -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.965 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.3 136.76 18.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.366 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.07 44.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.572 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.427 HG12 HD13 ' B' ' 69' ' ' LEU . 16.4 m -126.89 166.96 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.377 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -141.32 172.34 23.87 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.451 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.51 152.42 23.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.3 t80 -142.53 128.6 19.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 0.0 110.716 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 63.47 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.083 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 34.8 p -140.37 10.17 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.224 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.482 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 9.8 t -109.63 167.63 10.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.72 -179.13 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -167.13 156.59 10.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.532 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.427 HD13 HG12 ' B' ' 60' ' ' VAL . 7.6 tp -114.66 130.95 56.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.777 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.568 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -129.66 141.45 50.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.68 HD11 ' CZ ' ' B' ' 56' ' ' PHE . 7.9 tp -138.16 150.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.77 0.319 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.439 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -169.14 177.43 42.86 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.55 146.51 18.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.31 158.37 27.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.254 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.528 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 30.8 t80 -126.3 125.01 41.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.491 ' NH2' ' HB2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.09 102.68 10.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.663 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.602 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.1 p -104.36 138.3 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.95 -167.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -126.58 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.447 ' HA ' ' HG3' ' B' ' 104' ' ' GLU . 20.1 p -165.47 -46.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.955 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.2 139.88 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.557 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.15 155.48 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.273 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.21 138.86 33.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.36 169.78 17.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.082 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 171.99 157.58 14.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.587 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.08 144.85 32.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -112.55 142.46 45.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.323 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.05 122.9 39.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -137.35 147.23 45.38 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.585 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.46 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 57.16 -94.64 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.252 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.1 t -159.37 -33.83 0.06 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.735 0.303 . . . . 0.0 111.312 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -119.75 13.87 12.47 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 32.6 m-20 -101.86 72.2 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -116.02 127.11 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.029 0.442 . . . . 0.0 110.712 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' B' ' 39' ' ' SER . 1.3 ptp -131.98 140.16 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -121.51 126.6 49.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.406 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -128.35 141.46 51.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.487 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.71 117.27 8.61 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.58 162.11 28.03 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.446 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -127.03 133.52 50.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.951 0.405 . . . . 0.0 111.079 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 28.7 m-80 -108.41 127.78 54.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.365 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.489 HD12 ' HE1' ' B' ' 105' ' ' TRP . 0.7 OUTLIER -131.65 138.13 53.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.795 0.331 . . . . 0.0 110.827 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.447 ' HG3' ' HA ' ' B' ' 80' ' ' SER . 4.6 pt-20 -112.69 147.0 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 0.489 ' HE1' HD12 ' B' ' 103' ' ' ILE . 40.3 m95 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.634 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.624 -0.19 . . . . 0.0 112.624 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 t70 66.96 123.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -128.9 48.34 2.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.886 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.24 -54.38 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.995 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' SER . . . . . 0.462 ' HA ' ' NE2' ' C' ' 8' ' ' HIS . 0.6 OUTLIER -114.14 105.45 13.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.695 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -153.81 113.0 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.714 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t 61.6 78.16 0.3 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.005 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.642 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 9.0 m-70 -107.84 -49.4 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.808 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.317 31.5 Cg_exo -71.41 146.97 51.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.497 2.131 . . . . 0.0 111.9 179.277 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -64.43 -52.69 56.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.163 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -89.74 112.28 23.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.661 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -158.05 114.05 2.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.488 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' C' ' 17' ' ' LYS . 24.5 tttm -125.22 -70.98 0.72 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.556 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -44.9 67.05 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.311 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.01 -55.1 39.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 110.938 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.93 -47.45 82.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.999 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -53.16 -40.82 64.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.524 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.279 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 24.8 mmt180 -76.73 -36.96 56.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.63 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.6 mt-30 -67.48 -32.91 74.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.16 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.79 HD21 ' HG3' ' A' ' 24' ' ' ARG . 1.4 tt -68.54 -55.86 10.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -66.15 -25.5 66.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 24.5 t-20 -71.72 -42.51 67.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.786 ' HG3' HD21 ' B' ' 21' ' ' LEU . 3.7 mmp_? -69.26 -45.29 70.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 28' ' ' LEU . 1.9 tp -56.32 -49.09 75.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.581 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 26' ' ' ASP . . . . . 0.6 ' O ' HG22 ' C' ' 30' ' ' THR . 33.3 t0 -64.77 -32.06 73.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.787 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.564 ' HZ2' HD11 ' B' ' 25' ' ' LEU . 27.2 tttm -69.97 -32.96 71.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.253 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.782 HD11 HD12 ' B' ' 25' ' ' LEU . 1.7 mt -81.0 -32.4 34.24 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.76 -40.19 88.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.94 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.6 HG22 ' O ' ' C' ' 26' ' ' ASP . 4.4 t -76.66 -39.29 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.899 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.495 HH22 HG21 ' B' ' 32' ' ' VAL . 43.5 ttp85 -59.51 -41.83 90.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.289 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.513 HG22 ' O ' ' C' ' 28' ' ' LEU . 27.3 m -78.36 -23.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' C' ' 66' ' ' SER . 18.6 t70 -67.51 -51.53 49.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.062 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' C' ' 30' ' ' THR . 32.6 pttt -76.46 -40.3 50.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.755 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.91 98.78 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.43 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.5 OUTLIER -67.1 -34.01 76.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.24 99.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.475 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.765 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 95.1 p -76.27 -37.38 57.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.641 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 33.1 t -63.72 -54.88 28.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.15 -32.03 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 41' ' ' ALA . . . . . 0.504 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -64.86 -46.59 81.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.628 ' O ' HD13 ' C' ' 42' ' ' LEU . 0.6 OUTLIER -66.12 -30.37 70.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.072 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 43' ' ' ASN . 9.6 m-20 -81.39 -15.73 54.35 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -14.95 62.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.159 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.751 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.9 mm? -71.52 164.56 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.89 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 24.8 p90 -152.55 -32.03 0.14 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.129 0.49 . . . . 0.0 111.705 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.531 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 15.4 tt0 73.49 106.64 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.974 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -92.93 136.31 1.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.647 2.231 . . . . 0.0 112.546 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 10.7 m-85 65.61 151.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 178.62 78.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.266 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.212 0.605 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 157.55 49.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.321 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 53' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' C' ' 52' ' ' GLY . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.604 0.24 . . . . 0.0 110.579 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.27 150.62 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.613 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.531 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 2.2 t30 -132.99 124.28 27.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 111.686 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.68 ' CZ ' HD11 ' C' ' 71' ' ' ILE . 24.3 t80 -87.15 128.26 35.13 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.223 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.751 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 38.1 p -114.82 123.17 48.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.97 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.31 136.66 18.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.474 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.21 176.99 44.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.554 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.414 HG12 HD13 ' C' ' 69' ' ' LEU . 16.4 m -126.87 166.91 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.315 . . . . 0.0 111.418 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 61' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -141.25 172.41 23.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.518 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.6 152.33 23.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.587 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.3 t80 -142.46 128.62 19.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.751 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.41 -86.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.6 p -140.38 10.1 2.29 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 66' ' ' SER . . . . . 0.471 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 9.7 t -109.57 167.67 9.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.76 -179.08 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 111.104 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 68' ' ' ALA . . . . . 0.765 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -167.23 156.51 10.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.541 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.414 HD13 HG12 ' C' ' 60' ' ' VAL . 7.6 tp -114.62 130.87 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.762 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.553 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -129.55 141.49 50.96 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.721 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.68 HD11 ' CZ ' ' C' ' 56' ' ' PHE . 7.9 tp -138.15 150.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.816 0.341 . . . . 0.0 111.065 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.456 ' N ' HG13 ' C' ' 71' ' ' ILE . . . -169.27 177.42 42.94 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.476 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -158.61 146.47 18.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 110.976 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.26 158.38 27.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.255 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.535 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 30.7 t80 -126.27 125.03 41.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.501 ' NH2' ' HB2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -113.12 102.77 10.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.0 p -104.48 138.3 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.9 -167.39 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -126.62 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.518 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 80' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' C' ' 104' ' ' GLU . 20.1 p -165.43 -46.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.009 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.2 139.77 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.575 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.48 45.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.302 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.25 138.81 33.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.558 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -145.43 132.57 20.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.15 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.31 169.77 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 172.08 157.58 14.27 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.564 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.12 144.85 32.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 111.098 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -112.46 142.44 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.334 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.08 122.95 39.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -137.3 147.36 45.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.64 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 56.92 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.331 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.3 t -159.37 -33.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.714 0.292 . . . . 0.0 111.338 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.78 13.85 12.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.162 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 32.5 m-20 -101.91 72.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.03 127.15 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.629 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.641 ' SD ' ' HB2' ' C' ' 39' ' ' SER . 1.3 ptp -131.91 140.13 48.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.684 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -121.45 126.7 49.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.402 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -128.4 141.52 51.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.38 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.82 117.24 8.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.53 162.19 27.82 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.474 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.12 133.53 50.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.0 111.084 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.533 ' OD1' HG22 ' B' ' 57' ' ' THR . 28.5 m-80 -108.4 127.84 54.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.345 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.489 HD12 ' HE1' ' C' ' 105' ' ' TRP . 0.7 OUTLIER -131.67 138.0 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.821 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' C' ' 80' ' ' SER . 4.7 pt-20 -112.56 147.02 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 0.489 ' HE1' HD12 ' C' ' 103' ' ' ILE . 40.0 m95 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 t70 65.14 124.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -125.71 52.41 1.65 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.907 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.38 -49.89 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.032 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -129.19 113.83 15.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.722 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -156.69 103.83 2.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.773 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 t 68.44 71.39 0.3 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.067 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.751 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 8.6 m-70 -110.35 -53.97 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.704 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.751 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.313 31.4 Cg_exo -71.31 138.46 33.07 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.468 2.112 . . . . 0.0 111.973 179.256 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.07 -35.07 75.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.937 0.398 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.28 109.21 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.67 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -164.32 115.72 1.29 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.403 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.639 ' HE3' ' HE3' ' B' ' 13' ' ' LYS . 4.3 tttm -133.15 -59.49 0.88 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.505 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.56 -39.56 86.68 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.296 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.567 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -74.51 -52.37 12.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.859 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.64 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 0.7 OUTLIER -56.02 -47.36 77.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.057 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.491 ' HZ2' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER -61.94 -42.4 99.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.514 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -62.6 -41.13 98.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.245 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 34.5 mmt180 -73.7 -30.43 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 16' ' ' HIS . 19.2 mt-30 -71.66 -34.47 69.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.9 HD12 HD12 ' C' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.61 63.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.633 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.85 -25.51 64.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.041 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 6.2 t-20 -66.43 -37.26 84.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.551 ' HD3' ' HB2' ' C' ' 25' ' ' LEU . 6.3 mmp_? -71.02 -44.8 65.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.655 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.3 OUTLIER -61.11 -32.66 72.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.608 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 30' ' ' THR . 56.6 t0 -81.78 -28.3 33.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -73.16 -43.28 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.67 0.272 . . . . 0.0 111.217 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.642 HD11 ' HA ' ' C' ' 25' ' ' LEU . 11.4 mt -72.05 -29.01 63.73 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.78 -47.41 72.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.961 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 26' ' ' ASP . 2.5 t -71.0 -33.81 70.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.869 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.503 ' NH2' HG21 ' C' ' 32' ' ' VAL . 45.2 ttp85 -67.71 -40.11 84.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 28' ' ' LEU . 33.8 m -76.09 -29.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.669 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 7.2 t70 -62.42 -57.25 11.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.053 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 30' ' ' THR . 26.8 pttt -70.26 -44.58 68.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.756 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.3 82.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.439 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.468 HD12 HD11 ' C' ' 36' ' ' LEU . 0.4 OUTLIER -71.1 -26.32 62.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.819 0.342 . . . . 0.0 111.097 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.69 -37.68 85.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.402 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 52.3 p -82.96 -38.75 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.688 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.471 ' HB2' HD21 ' C' ' 36' ' ' LEU . 31.0 t -57.39 -57.2 13.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -32.54 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.578 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -62.31 -45.31 93.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.689 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -66.14 -32.8 74.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.043 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 0.7 OUTLIER -82.83 -15.82 50.09 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.64 -17.75 64.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.135 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.769 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.4 mm? -75.41 162.66 28.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.812 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.534 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 45.1 p90 -143.83 -30.46 0.48 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 111.706 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.452 ' CG ' ' HB3' ' A' ' 55' ' ' ASN . 15.8 tt0 72.03 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.983 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.7 Cg_endo -89.13 140.6 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.693 2.262 . . . . 0.0 112.52 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 18.2 m-85 67.01 150.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.474 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -173.94 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.329 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.02 -19.41 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.154 0.582 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 148.44 48.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.294 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.09 4.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.674 0.273 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.35 137.94 40.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.582 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' B' ' 104' ' ' GLU . 6.5 t30 -125.95 119.7 28.42 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.02 0.438 . . . . 0.0 111.686 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.732 ' CZ ' HD11 ' A' ' 71' ' ' ILE . 17.9 t80 -80.3 128.35 33.44 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.269 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.769 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 16.7 p -114.29 119.86 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB2' HD12 ' A' ' 71' ' ' ILE . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.498 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -176.96 166.77 37.69 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.573 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.46 HG12 HD13 ' A' ' 69' ' ' LEU . 29.5 m -110.28 165.12 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.843 0.354 . . . . 0.0 111.316 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.15 176.09 21.2 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.396 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.31 27.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.669 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.72 123.33 14.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.592 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 33.3 mtt-85 65.75 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 p -137.59 12.91 2.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.7 t -109.34 173.15 6.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.35 177.21 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.111 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.72 161.19 23.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 60' ' ' VAL . 7.7 tp -119.6 136.24 54.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.713 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.689 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -136.43 137.94 40.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.638 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 8.3 tp -138.09 145.77 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 111.135 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -172.55 -175.34 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.452 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.11 158.36 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.776 0.322 . . . . 0.0 111.046 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.48 28.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.294 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -129.31 119.02 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 111.135 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.603 ' HD3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -105.82 104.0 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.739 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.731 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 10.8 p -101.9 126.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 63.86 -171.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -118.25 58.34 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.557 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.051 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.719 ' HA ' HG22 ' A' ' 103' ' ' ILE . 6.3 p -112.33 143.45 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.513 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . . . -146.64 151.78 37.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.36 132.61 35.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.578 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.17 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.64 171.33 18.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.097 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 167.5 157.31 10.66 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.56 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 111.141 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.28 151.9 30.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.315 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.33 126.89 38.27 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.276 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -140.89 145.57 36.32 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.614 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 55.18 -98.54 0.05 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.275 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 -25.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 111.311 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.96 12.92 7.28 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 33.8 m-20 -98.91 69.26 1.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.09 127.04 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.716 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.642 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 5.3 ptp -133.04 147.1 52.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.702 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -126.19 130.88 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.447 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -128.08 137.85 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 111.383 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.24 109.5 7.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.773 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.448 ' HA ' ' HA3' ' C' ' 59' ' ' GLY . 91.5 p -125.24 163.47 22.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.472 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.05 140.27 50.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.963 0.411 . . . . 0.0 111.111 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.678 ' OD1' HG22 ' C' ' 57' ' ' THR . 45.2 m-80 -111.76 125.59 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.719 HG22 ' HA ' ' A' ' 81' ' ' VAL . 3.3 pt -136.67 134.43 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' C' ' 55' ' ' ASN . 6.6 pt-20 -111.66 159.45 18.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.481 ' HE1' HD12 ' A' ' 103' ' ' ILE . 50.4 m95 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.446 -0.788 . . . . 0.0 110.701 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.648 -0.181 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 t70 65.15 124.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.893 0.377 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -125.68 52.52 1.64 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.37 -49.85 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.08 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -129.23 113.84 15.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.707 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 32.3 t-105 -156.67 103.85 2.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.757 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t 68.42 71.44 0.3 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.996 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.761 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 8.8 m-70 -110.31 -54.02 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.775 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.761 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.313 31.4 Cg_exo -71.22 138.44 33.28 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.495 2.13 . . . . 0.0 111.958 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.08 -35.1 76.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.903 0.382 . . . . 0.0 111.147 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -98.29 109.21 22.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.646 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -164.29 115.71 1.29 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.445 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.639 ' HE3' ' HE3' ' A' ' 13' ' ' LYS . 4.3 tttm -133.16 -59.46 0.88 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.484 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.58 -39.64 86.54 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.231 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' B' ' 19' ' ' ARG . . . -74.41 -52.37 12.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.802 0.334 . . . . 0.0 110.94 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.636 ' O ' ' HG3' ' B' ' 20' ' ' GLN . 0.7 OUTLIER -56.1 -47.43 78.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.959 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.498 ' HZ3' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -61.93 -42.37 99.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.533 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -62.57 -41.09 98.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.304 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 34.5 mmt180 -73.75 -30.39 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' B' ' 16' ' ' HIS . 19.0 mt-30 -71.66 -34.5 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.59 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.604 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.81 -25.57 64.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 6.2 t-20 -66.29 -37.41 85.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.537 ' HD3' ' HB2' ' A' ' 25' ' ' LEU . 6.3 mmp_? -71.05 -44.61 65.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.65 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.3 OUTLIER -61.33 -32.52 72.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.565 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.616 ' O ' HG22 ' B' ' 30' ' ' THR . 56.6 t0 -81.82 -28.35 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.79 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.21 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 25' ' ' LEU . 11.5 mt -72.1 -28.95 63.63 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.83 -47.42 72.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.909 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.616 HG22 ' O ' ' B' ' 26' ' ' ASP . 2.5 t -71.01 -33.79 70.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.81 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.506 ' NH2' HG21 ' A' ' 32' ' ' VAL . 45.3 ttp85 -67.74 -40.1 84.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.585 HG13 ' O ' ' B' ' 28' ' ' LEU . 33.8 m -76.15 -29.44 19.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.256 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.681 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 7.2 t70 -62.62 -57.28 11.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' B' ' 30' ' ' THR . 26.8 pttt -70.13 -44.68 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -45.33 81.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.46 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -71.07 -26.36 63.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 111.075 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.53 -37.8 85.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.418 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' B' ' 90' ' ' ALA . 52.3 p -82.92 -38.76 22.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.453 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 30.8 t -57.27 -57.33 13.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.56 68.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.573 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -62.18 -45.46 93.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.919 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.679 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.3 OUTLIER -66.07 -32.79 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.077 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 0.7 OUTLIER -82.88 -15.72 50.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.652 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.76 -17.72 64.42 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.144 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.767 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -75.39 162.71 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.94 -30.38 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.464 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 15.7 tt0 72.04 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.0 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.7 Cg_endo -89.15 140.66 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.626 2.217 . . . . 0.0 112.514 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.487 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 18.2 m-85 67.05 150.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . -173.97 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.308 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.01 -19.45 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.159 0.584 . . . . 0.0 112.473 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 148.45 48.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.3 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.07 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.552 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.41 137.95 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' C' ' 104' ' ' GLU . 6.5 t30 -125.84 119.71 28.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 111.706 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.743 ' CZ ' HD11 ' B' ' 71' ' ' ILE . 17.7 t80 -80.3 128.4 33.5 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.201 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.767 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 16.7 p -114.32 119.79 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.99 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' B' ' 71' ' ' ILE . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.456 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -176.91 166.76 37.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.532 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.457 HG12 HD13 ' B' ' 69' ' ' LEU . 29.6 m -110.38 165.1 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.307 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.573 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.05 176.09 21.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.403 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.0 156.28 27.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.549 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.681 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.66 123.25 14.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' ARG . . . . . 0.599 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 33.5 mtt-85 65.78 -88.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.063 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 64.8 p -137.56 12.89 2.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.22 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -109.33 173.14 6.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.25 177.22 7.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.123 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.71 161.14 23.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.607 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.457 HD13 HG12 ' B' ' 60' ' ' VAL . 7.8 tp -119.5 136.21 54.43 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.679 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -136.48 137.82 40.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' B' ' 56' ' ' PHE . 8.3 tp -137.99 145.79 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.085 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -172.58 -175.37 40.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.463 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.6 p -164.07 158.37 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.17 159.58 28.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.3 118.98 23.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.605 ' HD3' ' HB2' ' B' ' 82' ' ' ALA . 0.0 OUTLIER -105.84 104.03 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.712 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 10.8 p -101.91 126.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.293 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.76 -171.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -118.21 58.32 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.97 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.721 ' HA ' HG22 ' B' ' 103' ' ' ILE . 6.3 p -112.37 143.43 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.605 ' HB2' ' HD3' ' B' ' 76' ' ' ARG . . . -146.7 151.72 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 111.231 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 44.9 tp -136.36 132.57 35.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.623 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.21 47.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.34 18.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.444 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 167.45 157.33 10.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.509 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.167 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.91 30.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.339 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.39 126.81 37.97 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.311 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -140.85 145.61 36.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.581 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 55.17 -98.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.27 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.37 -25.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.725 0.298 . . . . 0.0 111.287 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 92.3 p -126.95 12.88 7.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 33.8 m-20 -98.93 69.27 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.09 127.01 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.059 0.457 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.644 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 5.3 ptp -133.02 147.14 52.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.744 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -126.24 130.85 51.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.388 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -128.02 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.699 0.285 . . . . 0.0 111.449 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.11 109.46 7.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.811 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.45 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . 91.5 p -125.18 163.56 22.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.435 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -131.09 140.2 49.98 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.085 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.685 ' OD1' HG22 ' A' ' 57' ' ' THR . 45.1 m-80 -111.72 125.54 54.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.378 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.721 HG22 ' HA ' ' B' ' 81' ' ' VAL . 3.3 pt -136.66 134.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.824 0.345 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 6.6 pt-20 -111.64 159.49 18.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 0.474 ' HE1' HD12 ' B' ' 103' ' ' ILE . 50.5 m95 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.623 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 t70 65.12 124.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.906 0.384 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -125.7 52.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.854 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.37 -49.99 1.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -129.2 113.83 15.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.672 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -156.69 103.88 2.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.694 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t 68.49 71.37 0.3 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.993 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.746 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 8.9 m-70 -110.3 -54.0 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.807 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.746 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.313 31.5 Cg_exo -71.28 138.48 33.19 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.433 2.089 . . . . 0.0 111.921 179.227 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.09 -35.08 76.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.931 0.396 . . . . 0.0 111.15 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.34 109.27 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.633 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -164.3 115.67 1.29 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.472 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.637 ' HE3' ' HE3' ' B' ' 13' ' ' LYS . 4.3 tttm -133.1 -59.58 0.88 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.482 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.46 -39.62 87.04 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.296 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 15' ' ' ALA . . . . . 0.556 ' O ' ' HG2' ' C' ' 19' ' ' ARG . . . -74.43 -52.38 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 110.916 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 16' ' ' HIS . . . . . 0.647 ' O ' ' HG3' ' C' ' 20' ' ' GLN . 0.7 OUTLIER -56.05 -47.43 77.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.992 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.521 ' HZ3' HD13 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.89 -42.32 98.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 18' ' ' PHE . . . . . 0.491 ' HA ' ' HZ2' ' A' ' 17' ' ' LYS . 73.8 t80 -62.63 -41.12 98.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 19' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' C' ' 15' ' ' ALA . 34.6 mmt180 -73.76 -30.29 62.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.813 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.647 ' HG3' ' O ' ' C' ' 16' ' ' HIS . 19.0 mt-30 -71.74 -34.47 69.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 21' ' ' LEU . . . . . 0.9 HD12 HD12 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -63.97 -51.67 63.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.57 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.77 -25.59 64.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 6.1 t-20 -66.29 -37.4 85.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' B' ' 25' ' ' LEU . 6.3 mmp_? -70.96 -44.8 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.642 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -61.24 -32.48 72.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 26' ' ' ASP . . . . . 0.607 ' O ' HG22 ' C' ' 30' ' ' THR . 56.6 t0 -81.9 -28.3 32.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.27 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' B' ' 25' ' ' LEU . 11.4 mt -72.08 -29.03 63.71 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.68 -47.39 72.58 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.978 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.607 HG22 ' O ' ' C' ' 26' ' ' ASP . 2.5 t -71.15 -33.7 70.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.792 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.499 ' NH2' HG21 ' B' ' 32' ' ' VAL . 45.4 ttp85 -67.8 -40.09 83.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.361 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.598 HG13 ' O ' ' C' ' 28' ' ' LEU . 33.7 m -76.11 -29.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.233 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 33' ' ' ASP . . . . . 0.666 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 7.2 t70 -62.47 -57.38 11.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.017 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' C' ' 30' ' ' THR . 26.8 pttt -70.11 -44.65 68.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.797 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.93 -45.33 81.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.4 OUTLIER -71.15 -26.3 62.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.762 0.315 . . . . 0.0 111.067 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.55 -37.8 85.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.441 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' C' ' 90' ' ' ALA . 52.3 p -82.91 -38.77 22.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.689 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 39' ' ' SER . . . . . 0.461 ' HB2' HD21 ' B' ' 36' ' ' LEU . 30.8 t -57.22 -57.35 12.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 111.089 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.52 68.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 41' ' ' ALA . . . . . 0.565 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -62.31 -45.29 93.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.956 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.696 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.3 OUTLIER -66.18 -32.77 74.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.061 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.58 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.1 m-20 -82.85 -15.8 50.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.74 -17.74 64.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.073 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.755 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -75.36 162.74 28.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.857 177.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.96 -30.38 0.48 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.092 0.472 . . . . 0.0 111.712 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.458 ' CG ' ' HB3' ' C' ' 55' ' ' ASN . 15.7 tt0 72.11 104.32 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.996 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.8 Cg_endo -89.16 140.59 3.94 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.67 2.247 . . . . 0.0 112.53 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 18.2 m-85 67.08 150.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . -173.87 68.82 0.1 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.278 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 p -92.05 -19.36 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.158 0.583 . . . . 0.0 112.494 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 148.38 48.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.338 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 -175.11 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.667 0.27 . . . . 0.0 110.563 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.3 137.97 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.593 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 6.5 t30 -125.9 119.76 28.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 111.67 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 56' ' ' PHE . . . . . 0.75 ' CZ ' HD11 ' C' ' 71' ' ' ILE . 17.8 t80 -80.32 128.38 33.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.755 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 16.8 p -114.3 119.93 38.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.983 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 58' ' ' ALA . . . . . 0.473 ' HB2' HD12 ' C' ' 71' ' ' ILE . . . -148.32 141.5 25.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.523 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -176.92 166.66 37.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.566 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.461 HG12 HD13 ' C' ' 69' ' ' LEU . 29.5 m -110.29 165.09 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.358 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.05 176.12 21.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.472 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.26 27.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.654 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.69 123.19 14.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.595 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 33.5 mtt-85 65.82 -88.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.032 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 64.1 p -137.53 12.93 2.98 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.172 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 32.8 t -109.35 173.15 6.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.28 177.22 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.065 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.72 161.2 23.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.546 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.461 HD13 HG12 ' C' ' 60' ' ' VAL . 7.7 tp -119.62 136.13 54.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.762 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.696 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -136.39 137.91 41.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.671 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 71' ' ' ILE . . . . . 0.75 HD11 ' CZ ' ' C' ' 56' ' ' PHE . 8.3 tp -138.08 145.81 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.058 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -172.57 -175.46 40.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.0 158.41 19.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.827 0.346 . . . . 0.0 111.043 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.2 159.53 28.06 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.207 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.29 118.99 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.377 . . . . 0.0 111.153 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.605 ' HD3' ' HB2' ' C' ' 82' ' ' ALA . 0.0 OUTLIER -105.8 104.04 13.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.721 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.734 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 10.7 p -101.95 126.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.279 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.87 -171.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.922 0.391 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -118.23 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.59 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -157.01 -53.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.718 ' HA ' HG22 ' C' ' 103' ' ' ILE . 6.4 p -112.41 143.49 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.509 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.605 ' HB2' ' HD3' ' C' ' 76' ' ' ARG . . . -146.72 151.72 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.202 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.4 132.62 35.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 143.21 47.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 171.32 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.454 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 167.45 157.33 10.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.584 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.839 0.352 . . . . 0.0 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.26 151.97 30.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.336 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 126.86 38.08 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.232 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -140.89 145.56 36.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.615 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.427 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 55.23 -98.51 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.201 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.38 -25.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 0.0 111.25 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.98 12.91 7.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 33.9 m-20 -98.96 69.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.07 127.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.706 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.629 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 5.3 ptp -133.03 147.15 52.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.716 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -126.25 130.86 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.422 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -128.03 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.15 109.54 7.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.459 ' HA ' ' HA3' ' B' ' 59' ' ' GLY . 91.6 p -125.19 163.53 22.27 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.423 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.11 140.23 49.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.695 ' OD1' HG22 ' B' ' 57' ' ' THR . 45.1 m-80 -111.77 125.53 54.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.402 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' C' ' 81' ' ' VAL . 3.3 pt -136.69 134.45 48.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.831 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' B' ' 55' ' ' ASN . 6.5 pt-20 -111.6 159.45 18.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 0.481 ' HE1' HD12 ' C' ' 103' ' ' ILE . 50.4 m95 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.666 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.666 -0.173 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 35.7 t70 67.9 127.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.0 110.938 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.72 49.19 2.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.29 -49.88 1.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.028 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.45 104.71 13.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.792 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.525 ' HZ2' ' HG2' ' A' ' 20' ' ' GLN . 57.6 t-105 -165.3 115.56 1.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.699 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t 64.77 83.34 0.17 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.007 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.646 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 6.0 m-70 -112.92 -47.39 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.833 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.646 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.285 31.5 Cg_exo -70.19 149.52 64.29 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.511 2.141 . . . . 0.0 111.879 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -72.02 -45.14 62.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.87 0.367 . . . . 0.0 111.088 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -94.84 110.53 22.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.69 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 7.5 pt-20 -158.53 111.79 2.37 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.432 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -125.82 -70.85 0.72 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.476 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.42 -37.54 69.82 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.251 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.99 -54.26 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.884 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.649 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 1.8 t60 -53.79 -52.32 60.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.012 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -40.42 86.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.582 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -58.47 -35.35 72.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 111.258 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.78 -41.93 35.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.525 ' HG2' ' HZ2' ' A' ' 6' ' ' TRP . 28.8 mt-30 -59.4 -35.03 73.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -59.54 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.538 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -65.57 -21.2 66.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.8 -40.99 75.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.691 ' HD3' HD13 ' C' ' 25' ' ' LEU . 4.5 mmp_? -71.73 -43.75 65.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.815 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.67 HD13 ' HD3' ' B' ' 24' ' ' ARG . 1.2 tp -59.75 -40.97 89.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.646 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.22 -32.74 64.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.775 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 14.5 tttm -71.43 -29.68 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.668 0.27 . . . . 0.0 111.237 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.709 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.3 mt -85.16 -31.1 23.44 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' O ' HG22 ' A' ' 32' ' ' VAL . 25.4 t70 -66.34 -41.21 89.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.976 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.638 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 7.0 t -73.23 -44.54 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.797 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.792 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 24.3 ttp85 -60.46 -37.03 79.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.304 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 28' ' ' LEU . 33.9 m -75.71 -31.82 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.117 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.33 -50.7 64.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.032 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.792 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 23.2 pttt -71.48 -42.17 68.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.718 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -52.95 47.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.474 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.14 -38.3 87.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.087 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.06 77.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.446 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.666 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 70.3 p -75.38 -37.17 60.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.2 t -58.12 -66.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -31.47 35.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.425 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -58.81 -53.37 59.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.617 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.8 tm? -69.36 -32.82 72.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.104 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -75.99 -5.67 47.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -13.81 59.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.135 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.805 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.7 mm? -75.64 172.53 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' C' ' 46' ' ' PHE . 47.2 p90 -153.55 -26.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.66 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.93 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -92.04 144.56 2.86 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.591 2.194 . . . . 0.0 112.57 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 48' ' ' PRO . 11.0 m-85 53.5 154.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.25 79.15 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.279 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.97 -26.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.142 0.577 . . . . 0.0 112.424 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.2 49.35 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.34 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -146.15 -178.11 5.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.545 0.212 . . . . 0.0 110.642 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.77 144.26 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.498 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.645 ' OD1' ' HB3' ' B' ' 104' ' ' GLU . 1.7 t30 -128.75 125.3 37.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.987 0.422 . . . . 0.0 111.662 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.37 128.15 37.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.805 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 10.5 p -113.12 131.8 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.99 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.63 133.17 13.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.424 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -166.64 179.46 40.52 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.588 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.49 177.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.763 0.316 . . . . 0.0 111.4 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.562 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -154.04 172.93 32.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.408 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.68 156.79 28.38 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.1 t80 -146.71 125.89 12.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.751 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 66.04 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.137 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.225 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.64 166.16 13.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -124.1 174.41 7.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 111.093 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.02 157.47 37.66 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 70' ' ' ALA . 6.8 tp -111.8 134.16 53.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.48 ' H ' HD12 ' A' ' 69' ' ' LEU . . . -131.39 136.73 48.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.68 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.84 145.79 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.147 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -175.96 -179.3 46.37 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -160.53 157.93 28.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.22 153.98 25.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.268 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.51 128.77 47.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.442 ' NH2' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -110.76 105.53 14.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.698 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.434 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.4 p -100.86 130.84 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.372 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 56.57 -167.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.056 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' HA ' ' NH2' ' A' ' 76' ' ' ARG . 58.0 mt-10 -122.59 61.71 0.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.76 -51.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.006 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.69 135.63 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.476 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.16 164.75 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.295 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.44 HD12 ' HB3' ' A' ' 101' ' ' PHE . 7.0 tp -142.58 148.27 37.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.624 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.436 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -152.74 136.05 15.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.08 18.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.412 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . -179.22 154.63 14.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.571 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.58 42.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.926 0.393 . . . . 0.0 111.027 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -114.36 147.69 38.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.323 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.36 126.02 44.36 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.253 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -138.65 152.02 47.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.706 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.48 -97.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.281 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.22 -39.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -115.72 16.42 16.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.158 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.63 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 14.4 m-20 -101.12 65.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.19 119.3 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 110.704 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.476 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -117.82 145.31 44.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -124.87 132.66 53.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.686 0.279 . . . . 0.0 111.451 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.05 108.55 4.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.739 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.579 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 85.0 p -128.73 160.87 31.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB3' HD12 ' A' ' 83' ' ' LEU . 18.3 p90 -125.94 138.35 53.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.908 0.385 . . . . 0.0 111.09 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.677 ' OD1' HG22 ' C' ' 57' ' ' THR . 22.9 m-80 -104.73 129.86 52.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.411 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.436 HD12 ' HE1' ' A' ' 105' ' ' TRP . 2.6 pt -131.94 132.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.636 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 8.3 pt-20 -110.97 143.25 41.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.436 ' HE1' HD12 ' A' ' 103' ' ' ILE . 14.6 m95 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.671 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' B' ' 1' ' ' GLY . 35.8 t70 67.92 127.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 110.95 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -133.7 49.13 2.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.827 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.3 -49.97 1.91 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.969 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.39 104.77 13.92 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.813 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.525 ' HZ2' ' HG2' ' B' ' 20' ' ' GLN . 57.6 t-105 -165.33 115.54 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.744 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t 64.72 83.37 0.17 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.972 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.635 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 6.0 m-70 -112.96 -47.34 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.749 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.284 31.5 Cg_exo -70.19 149.54 64.3 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.525 2.15 . . . . 0.0 111.856 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -72.07 -45.1 62.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -94.76 110.48 22.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.683 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.656 ' HB2' ' HB2' ' B' ' 16' ' ' HIS . 7.5 pt-20 -158.56 111.71 2.36 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.476 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -125.79 -70.84 0.72 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.506 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.46 69.32 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.274 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.05 -54.24 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 0.0 110.908 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.656 ' HB2' ' HB2' ' B' ' 12' ' ' GLU . 1.8 t60 -53.67 -52.34 60.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.071 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -40.34 86.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.558 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' PHE . . . . . 0.426 ' HA ' ' HZ2' ' C' ' 17' ' ' LYS . 81.8 t80 -58.53 -35.32 72.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.216 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -77.74 -42.0 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.525 ' HG2' ' HZ2' ' B' ' 6' ' ' TRP . 28.8 mt-30 -59.43 -34.97 73.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -59.51 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.563 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.53 -21.27 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.72 -40.93 75.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.67 ' HD3' HD13 ' A' ' 25' ' ' LEU . 4.5 mmp_? -71.82 -43.66 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.671 HD13 ' HD3' ' C' ' 24' ' ' ARG . 1.2 tp -59.91 -40.89 90.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.18 -32.82 65.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.529 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.63 65.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.193 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.712 ' O ' HG13 ' B' ' 32' ' ' VAL . 4.2 mt -85.15 -31.0 23.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.432 ' O ' HG22 ' B' ' 32' ' ' VAL . 25.3 t70 -66.41 -41.2 89.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.941 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.63 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 7.0 t -73.22 -44.53 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.78 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.1 79.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.313 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.712 HG13 ' O ' ' B' ' 28' ' ' LEU . 33.8 m -75.63 -31.82 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.233 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.45 -50.57 64.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.78 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 23.1 pttt -71.5 -42.09 68.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.787 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.9 -52.89 48.29 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.412 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.04 -38.41 88.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.14 77.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.479 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.668 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . 70.5 p -75.33 -37.17 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.806 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 46.0 t -58.17 -65.9 0.57 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.157 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -31.4 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -58.83 -53.37 59.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.913 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.626 HD13 ' O ' ' B' ' 42' ' ' LEU . 1.8 tm? -69.35 -32.87 72.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -76.01 -5.7 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -13.7 59.82 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.213 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.821 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.7 mm? -75.66 172.44 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.866 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 47.0 p90 -153.48 -26.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.53 107.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.992 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -92.07 144.57 2.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.622 2.214 . . . . 0.0 112.56 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.529 ' O ' ' O ' ' B' ' 48' ' ' PRO . 11.0 m-85 53.39 154.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . 178.26 78.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.236 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.87 -26.5 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.11 0.564 . . . . 0.0 112.506 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.18 49.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.299 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' B' ' 52' ' ' GLY . 0.4 OUTLIER -146.21 -178.16 5.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.564 0.221 . . . . 0.0 110.62 179.697 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.65 144.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.55 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.644 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 1.7 t30 -128.76 125.16 37.26 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.29 128.15 37.01 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.257 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.821 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 10.4 p -113.15 131.77 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.042 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.59 133.13 13.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -166.5 179.54 40.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.67 177.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 0.0 111.35 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -153.97 172.88 32.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.538 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 156.84 28.43 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.531 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' TYR . . . . . 0.481 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.1 t80 -146.78 125.79 12.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.764 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.96 -89.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.5 p -137.95 16.75 2.84 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.214 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.74 166.17 13.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.8 OUTLIER -124.06 174.4 7.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.04 157.52 37.72 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.535 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.485 HD12 ' H ' ' B' ' 70' ' ' ALA . 6.7 tp -111.83 134.23 53.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.795 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.485 ' H ' HD12 ' B' ' 69' ' ' LEU . . . -131.49 136.71 48.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.677 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.89 145.72 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.319 . . . . 0.0 111.166 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -175.88 -179.28 46.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.406 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.9 p -160.57 157.92 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.918 0.39 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.18 153.99 25.51 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.215 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.56 128.83 47.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' ARG . . . . . 0.442 ' NH2' ' HA ' ' B' ' 79' ' ' GLU . 0.0 OUTLIER -110.72 105.52 14.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.791 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.424 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.4 p -100.89 130.79 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.284 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 56.62 -167.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.945 0.402 . . . . 0.0 111.102 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.442 ' HA ' ' NH2' ' B' ' 76' ' ' ARG . 57.4 mt-10 -122.59 61.79 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.77 -51.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.03 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.57 135.66 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.539 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.2 164.79 29.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' B' ' 84' ' ' LYS . 7.0 tp -142.62 148.3 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.433 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 0.0 OUTLIER -152.81 136.02 15.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.151 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.17 169.05 18.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.407 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . -179.17 154.65 14.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.571 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.56 42.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.88 0.372 . . . . 0.0 111.096 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -114.28 147.68 38.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.348 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.35 125.99 44.32 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.305 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.737 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -138.62 152.03 47.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.604 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.46 -97.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.272 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.19 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.64 16.44 16.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.193 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.634 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 13.9 m-20 -101.15 65.65 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.17 119.38 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -117.89 145.33 44.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.721 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.87 132.6 53.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.19 142.43 49.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.08 108.48 4.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' SER . . . . . 0.575 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 85.1 p -128.71 160.89 31.07 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.431 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 101' ' ' PHE . . . . . 0.433 ' HB3' HD12 ' B' ' 83' ' ' LEU . 18.2 p90 -125.93 138.35 53.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 0.0 111.038 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.679 ' OD1' HG22 ' A' ' 57' ' ' THR . 22.9 m-80 -104.72 129.87 52.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.38 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.445 HD12 ' HE1' ' B' ' 105' ' ' TRP . 2.6 pt -131.94 132.73 61.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.843 0.354 . . . . 0.0 110.801 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.645 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 8.3 pt-20 -111.02 143.2 42.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' TRP . . . . . 0.445 ' HE1' HD12 ' B' ' 103' ' ' ILE . 14.8 m95 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.705 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 2' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' C' ' 1' ' ' GLY . 35.8 t70 67.79 127.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.912 0.387 . . . . 0.0 110.972 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.75 49.19 2.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.811 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.36 -49.9 1.9 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.5 104.84 13.96 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.753 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 6' ' ' TRP . . . . . 0.518 ' HZ2' ' HG2' ' C' ' 20' ' ' GLN . 57.4 t-105 -165.33 115.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.779 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t 64.9 83.27 0.17 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.977 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.651 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 6.0 m-70 -112.93 -47.37 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.755 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 9' ' ' PRO . . . . . 0.651 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.282 31.4 Cg_exo -70.12 149.58 64.81 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.477 2.118 . . . . 0.0 111.881 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -72.07 -45.16 61.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.957 0.408 . . . . 0.0 111.092 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -94.84 110.52 22.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.707 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 12' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 16' ' ' HIS . 7.5 pt-20 -158.46 111.66 2.38 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.441 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -125.79 -70.77 0.72 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.524 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.44 -37.5 69.62 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.256 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.14 -54.22 19.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 16' ' ' HIS . . . . . 0.634 ' HB2' ' HB2' ' C' ' 12' ' ' GLU . 1.8 t60 -53.69 -52.35 60.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.016 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.426 ' HZ2' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER -59.41 -40.33 86.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.504 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -58.52 -35.29 72.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 111.241 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.77 -41.94 35.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.518 ' HG2' ' HZ2' ' C' ' 6' ' ' TRP . 28.9 mt-30 -59.44 -34.99 73.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.141 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -59.5 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.591 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.64 -21.18 66.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.981 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -69.75 -40.99 75.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.671 ' HD3' HD13 ' B' ' 25' ' ' LEU . 4.4 mmp_? -71.83 -43.68 65.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.771 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.691 HD13 ' HD3' ' A' ' 24' ' ' ARG . 1.3 tp -59.82 -40.96 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.18 -32.8 65.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.508 ' HZ2' HD11 ' B' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.69 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.168 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.717 ' O ' HG13 ' C' ' 32' ' ' VAL . 4.2 mt -85.07 -31.08 23.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 29' ' ' ASP . . . . . 0.43 ' O ' HG22 ' C' ' 32' ' ' VAL . 25.5 t70 -66.32 -41.27 89.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.01 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.647 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 7.0 t -73.24 -44.45 59.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.783 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.12 79.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.28 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.717 HG13 ' O ' ' C' ' 28' ' ' LEU . 33.8 m -75.55 -31.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.4 -50.65 64.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.031 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.783 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 23.1 pttt -71.53 -42.13 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.737 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -53.04 46.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.422 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.04 -38.37 88.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 111.052 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.79 -44.03 77.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.416 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.677 ' HB2' ' HB1' ' C' ' 88' ' ' ALA . 70.7 p -75.37 -37.22 60.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 46.1 t -58.13 -65.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.123 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -31.36 35.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.456 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -58.8 -53.39 58.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.62 ' O ' HD13 ' C' ' 42' ' ' LEU . 1.8 tm? -69.44 -32.82 72.0 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 43' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 62.0 m-20 -75.98 -5.63 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -13.75 59.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.098 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.832 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.7 mm? -75.66 172.52 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.878 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 47.0 p90 -153.57 -26.26 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.664 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.59 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.993 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -92.02 144.54 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.675 2.25 . . . . 0.0 112.568 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.525 ' O ' ' O ' ' C' ' 48' ' ' PRO . 11.0 m-85 53.43 154.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.941 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . 178.23 79.13 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.266 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.9 -26.61 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.153 0.581 . . . . 0.0 112.434 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 52' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.24 49.42 0.02 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.299 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 53' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' C' ' 52' ' ' GLY . 0.4 OUTLIER -146.15 -178.05 5.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.587 0.232 . . . . 0.0 110.628 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.74 144.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.558 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 1.7 t30 -128.74 125.32 37.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.35 128.11 37.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.276 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.832 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 10.2 p -113.17 131.79 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.984 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.56 133.14 13.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.446 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.579 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -166.62 179.43 40.53 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.54 177.09 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.349 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 61' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -153.96 172.99 32.64 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.424 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.69 156.77 28.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.563 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 63' ' ' TYR . . . . . 0.476 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.1 t80 -146.72 125.82 12.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.99 -90.03 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.182 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.7 166.26 12.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 67' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.8 OUTLIER -124.18 174.4 7.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.347 . . . . 0.0 111.129 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 68' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -154.98 157.44 37.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.553 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.492 HD12 ' H ' ' C' ' 70' ' ' ALA . 6.6 tp -111.82 134.21 53.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.492 ' H ' HD12 ' C' ' 69' ' ' LEU . . . -131.51 136.78 48.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.91 145.71 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 111.145 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -175.93 -179.23 46.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.426 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -160.59 157.88 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.964 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.13 153.9 25.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.251 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.47 128.78 47.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.195 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 76' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' C' ' 79' ' ' GLU . 0.0 OUTLIER -110.66 105.59 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.5 p -101.02 130.81 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.964 0.412 . . . . 0.0 111.256 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 56.62 -167.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.089 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 79' ' ' GLU . . . . . 0.443 ' HA ' ' NH2' ' C' ' 76' ' ' ARG . 57.4 mt-10 -122.53 61.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.587 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 -51.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.012 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.66 135.6 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.11 164.81 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.226 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' C' ' 101' ' ' PHE . 7.0 tp -142.65 148.27 37.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 84' ' ' LYS . . . . . 0.417 ' N ' ' HG ' ' C' ' 83' ' ' LEU . 0.0 OUTLIER -152.75 136.04 15.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.212 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.23 169.05 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . -179.18 154.64 14.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.592 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.56 142.54 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.829 0.347 . . . . 0.0 111.093 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.677 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -114.3 147.71 38.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.39 126.0 44.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.306 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.725 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -138.68 152.01 47.68 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.621 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.35 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 42.0 t -151.23 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.333 . . . . 0.0 111.32 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.63 16.4 16.48 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.161 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.629 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 14.1 m-20 -101.16 65.7 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.26 119.37 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.673 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.481 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.3 OUTLIER -117.85 145.25 44.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.693 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.89 132.65 53.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.443 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.26 142.39 49.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.688 0.28 . . . . 0.0 111.483 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.97 108.49 4.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.738 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 100' ' ' SER . . . . . 0.576 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 84.6 p -128.67 160.85 31.18 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.435 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.439 ' HB3' HD12 ' C' ' 83' ' ' LEU . 18.3 p90 -125.94 138.38 53.77 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.896 0.379 . . . . 0.0 111.108 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 102' ' ' ASN . . . . . 0.668 ' OD1' HG22 ' B' ' 57' ' ' THR . 23.1 m-80 -104.73 129.89 52.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.448 HD12 ' HE1' ' C' ' 105' ' ' TRP . 2.6 pt -132.0 132.67 61.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 104' ' ' GLU . . . . . 0.644 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 8.3 pt-20 -110.95 143.23 41.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 105' ' ' TRP . . . . . 0.448 ' HE1' HD12 ' C' ' 103' ' ' ILE . 14.6 m95 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.683 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.708 0.29 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -38.15 88.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.268 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -68.37 -42.96 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.17 -44.94 95.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.42 . . . . 0.0 111.137 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -66.03 -44.19 85.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.526 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.21 -34.17 77.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.011 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -72.77 -37.12 67.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -68.15 -44.02 76.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.734 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.708 ' HG ' HD21 ' C' ' 25' ' ' LEU . 3.9 mt -60.81 -44.92 96.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -63.03 -33.85 76.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 11.8 tttt -71.19 -35.89 71.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.727 HD21 ' HA ' ' C' ' 29' ' ' ASP . 0.5 OUTLIER -66.42 -52.36 47.33 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.736 ' HA ' HD21 ' B' ' 28' ' ' LEU . 46.9 t0 -55.56 -39.3 70.46 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.977 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.3 m -61.33 -49.72 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.862 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.639 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 85.0 mmt-85 -58.11 -32.02 67.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.772 HG11 HG22 ' B' ' 32' ' ' VAL . 18.9 t -77.3 -36.48 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.162 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -64.1 -52.8 57.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.94 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 13.3 pttt -77.22 -37.16 53.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.97 -40.18 98.55 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.433 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.573 HD22 ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -72.86 -37.38 67.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.91 91.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.669 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -68.99 -50.29 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.555 ' HB3' HD21 ' C' ' 36' ' ' LEU . 96.5 p -52.82 -49.37 65.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.2 73.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.53 -42.65 55.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.913 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.511 HD23 ' OD1' ' A' ' 98' ' ' ASN . 16.2 tp -71.83 -42.51 66.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -75.81 -3.1 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.53 55.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.096 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.49 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -97.77 177.13 5.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.816 177.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -169.1 1.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.657 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 33.1 mt-30 63.9 116.38 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.277 9.9 Cg_endo -74.46 95.04 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.587 2.191 . . . . 0.0 112.593 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 87.4 m-85 68.83 -173.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 148.9 90.12 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.207 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -87.78 -14.74 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 123.152 0.581 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.37 48.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.279 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.99 -172.89 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 110.622 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.48 148.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.571 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.704 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.47 44.12 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 111.656 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.534 ' HE2' HD11 ' A' ' 71' ' ' ILE . 1.1 t80 -97.48 124.13 41.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.25 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.479 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.2 p -116.5 127.95 55.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.65 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -159.85 154.87 24.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.45 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.53 165.99 29.61 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.518 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 69' ' ' LEU . 13.6 m -112.08 163.68 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.4 179.65 27.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.56 144.82 11.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.552 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CD1' HD22 ' A' ' 36' ' ' LEU . 75.1 t80 -136.92 129.48 30.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.314 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 3.5 mmm-85 65.72 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -152.25 34.96 0.52 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.158 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.92 168.01 18.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -140.78 144.35 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.113 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.92 156.18 43.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' A' ' 60' ' ' VAL . 6.7 tp -113.19 125.35 54.24 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.778 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -119.55 151.14 39.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.706 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.65 HG13 ' HB2' ' A' ' 58' ' ' ALA . 18.4 tt -145.2 164.24 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.479 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 179.58 175.56 46.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.44 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.74 147.69 11.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.92 163.3 30.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.232 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -108.5 120.72 43.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.505 ' CB ' ' HA3' ' A' ' 50' ' ' GLY . 6.6 mmm180 -96.72 92.38 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.743 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.2 p -96.79 131.83 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.6 m120 64.67 -177.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.078 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.3 24.25 11.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.495 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.059 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.3 153.67 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -156.28 173.51 16.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 111.259 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.22 140.32 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.611 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.657 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -140.48 134.27 30.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.188 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.95 133.97 14.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.479 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -160.0 170.54 36.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.546 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 71' ' ' ILE . 9.7 p -117.44 147.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.136 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.58 ' HB3' ' SD ' ' A' ' 96' ' ' MET . . . -119.39 134.57 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.328 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.18 110.85 22.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -118.91 136.9 53.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.631 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.562 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 50.63 -111.95 1.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.318 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.39 -53.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.689 0.28 . . . . 0.0 111.307 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.505 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -106.37 26.83 9.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.145 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.751 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -116.85 81.82 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.59 139.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.707 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -135.36 158.53 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.723 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -134.16 133.5 41.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.468 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.511 ' OD1' HD23 ' A' ' 42' ' ' LEU . 33.7 m120 -113.73 161.09 17.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.747 0.308 . . . . 0.0 111.393 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.45 0.18 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.724 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.493 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 13.8 p -126.02 178.76 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.426 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -144.44 137.77 27.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.863 0.363 . . . . 0.0 111.121 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 69.9 m-80 -103.29 148.79 25.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.352 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.499 HG13 ' O ' ' C' ' 56' ' ' PHE . 7.4 pt -152.75 146.66 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.7 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 90.0 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.681 0.277 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -38.11 88.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 mtt85 -68.26 -43.03 78.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.15 -44.94 95.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.479 HD23 HD21 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -65.98 -44.24 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.627 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.2 -34.08 76.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.078 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.85 -37.09 67.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mtt180 -68.06 -44.02 77.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.712 HD21 ' HG ' ' C' ' 25' ' ' LEU . 3.9 mt -60.91 -44.9 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.59 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -63.04 -33.84 76.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.869 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 11.8 tttt -71.16 -35.88 71.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.221 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.736 HD21 ' HA ' ' A' ' 29' ' ' ASP . 0.5 OUTLIER -66.34 -52.41 47.31 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.737 ' HA ' HD21 ' C' ' 28' ' ' LEU . 46.8 t0 -55.54 -39.37 70.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.951 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 13.8 m -61.3 -49.74 75.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.87 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.645 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 85.0 mmt-85 -58.09 -31.97 67.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.772 HG22 HG11 ' A' ' 32' ' ' VAL . 18.8 t -77.35 -36.54 23.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -64.05 -52.81 57.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.671 ' HD2' ' HB2' ' B' ' 94' ' ' ASP . 13.3 pttt -77.27 -37.09 53.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.791 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.02 -40.18 98.56 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.419 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' B' ' 63' ' ' TYR . 0.2 OUTLIER -72.84 -37.42 67.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.0 91.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.471 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.665 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -68.98 -50.28 50.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.719 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.556 ' HB3' HD21 ' A' ' 36' ' ' LEU . 96.4 p -52.82 -49.34 65.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.11 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.401 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.54 -42.67 55.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.515 HD23 ' OD1' ' B' ' 98' ' ' ASN . 16.1 tp -71.86 -42.43 66.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.92 -3.09 33.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.83 0.35 55.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.178 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -97.69 177.11 5.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.871 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.11 1.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.716 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.656 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 33.1 mt-30 63.97 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.977 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.277 9.8 Cg_endo -74.51 95.08 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.601 2.201 . . . . 0.0 112.508 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 87.4 m-85 68.84 -173.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 148.95 90.13 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.209 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -87.79 -14.77 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.141 0.576 . . . . 0.0 112.425 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.39 48.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.315 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.86 -172.9 4.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.605 0.241 . . . . 0.0 110.587 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 1.074 HG13 ' O ' ' C' ' 105' ' ' TRP . 4.6 p -103.37 148.77 7.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.607 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.683 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.5 44.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.928 0.395 . . . . 0.0 111.667 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.522 ' HE2' HD11 ' B' ' 71' ' ' ILE . 1.1 t80 -97.5 124.12 41.61 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.277 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.471 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.0 p -116.51 127.89 54.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.941 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.651 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -159.83 154.75 24.63 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.452 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.503 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.62 166.04 29.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.544 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 69' ' ' LEU . 13.8 m -112.06 163.69 8.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.347 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.37 179.58 27.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.462 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.54 144.87 11.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.579 ' CD1' HD22 ' B' ' 36' ' ' LEU . 75.3 t80 -136.92 129.62 30.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.729 0.299 . . . . 0.0 110.727 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 3.5 mmm-85 65.52 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.23 34.84 0.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.86 168.04 17.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -140.78 144.3 35.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.164 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.88 156.3 43.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' B' ' 60' ' ' VAL . 6.8 tp -113.2 125.36 54.25 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.792 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -119.59 151.15 39.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.699 0.285 . . . . 0.0 111.665 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' B' ' 58' ' ' ALA . 18.4 tt -145.19 164.2 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.126 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 179.6 175.52 46.47 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.433 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.74 147.77 11.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.873 0.368 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.91 163.33 30.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -108.49 120.61 42.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.504 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.49 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.749 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.1 p -96.85 131.91 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.239 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.5 m120 64.6 -177.25 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.925 0.393 . . . . 0.0 111.04 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -116.26 24.21 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.563 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.24 153.67 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.48 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -156.33 173.47 16.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.281 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.12 140.39 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.656 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.24 30.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.195 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 134.03 14.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -160.04 170.58 36.18 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' B' ' 71' ' ' ILE . 9.8 p -117.44 147.41 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.85 0.357 . . . . 0.0 111.106 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.585 ' HB3' ' SD ' ' B' ' 96' ' ' MET . . . -119.38 134.61 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.323 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.23 110.84 22.55 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.292 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . . . -118.8 136.93 53.74 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.636 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.567 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 50.6 -112.05 1.45 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.3 -53.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.691 0.281 . . . . 0.0 111.326 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' B' ' 93' ' ' SER . 2.2 t -106.35 26.85 9.34 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.198 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.75 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.3 OUTLIER -116.95 81.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.69 139.37 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' B' ' 88' ' ' ALA . 0.0 OUTLIER -135.38 158.52 44.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.711 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -134.12 133.55 41.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.515 ' OD1' HD23 ' B' ' 42' ' ' LEU . 33.7 m120 -113.72 161.05 17.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.51 0.18 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.5 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 13.9 p -126.05 178.78 5.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.462 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -144.52 137.76 27.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.002 0.429 . . . . 0.0 111.048 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.674 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 69.8 m-80 -103.2 148.8 25.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.442 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 56' ' ' PHE . 7.4 pt -152.77 146.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.336 . . . . 0.0 110.77 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.704 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 90.1 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' C' ' 17' ' ' LYS . 32.9 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.767 0.317 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -38.02 87.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.306 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -68.36 -43.0 78.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.13 -44.95 95.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.479 HD21 HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -66.07 -44.15 85.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.554 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -34.13 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.77 -37.18 67.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -67.94 -44.13 77.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.772 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.712 ' HG ' HD21 ' B' ' 25' ' ' LEU . 3.9 mt -60.72 -44.99 95.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -62.99 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.875 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 11.8 tttt -71.08 -35.9 72.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.313 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.737 HD21 ' HA ' ' B' ' 29' ' ' ASP . 0.5 OUTLIER -66.38 -52.35 47.72 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . 0.727 ' HA ' HD21 ' A' ' 28' ' ' LEU . 46.9 t0 -55.59 -39.28 70.5 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.519 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 14.3 m -61.4 -49.71 75.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.813 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.644 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 85.0 mmt-85 -58.05 -32.07 67.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.376 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.764 HG11 HG22 ' A' ' 32' ' ' VAL . 18.6 t -77.26 -36.51 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.227 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -64.03 -52.85 57.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.652 ' HD2' ' HB2' ' C' ' 94' ' ' ASP . 13.2 pttt -77.26 -37.15 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.725 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.02 -40.11 98.47 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' C' ' 63' ' ' TYR . 0.2 OUTLIER -72.85 -37.39 67.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.05 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.369 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.673 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -68.89 -50.38 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.558 ' HB3' HD21 ' B' ' 36' ' ' LEU . 96.6 p -52.71 -49.41 65.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.09 73.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.459 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.56 -42.68 55.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.5 HD23 ' OD1' ' C' ' 98' ' ' ASN . 16.2 tp -71.83 -42.46 66.94 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.88 -3.06 33.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.52 55.81 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.12 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -97.8 177.15 5.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.791 177.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.08 1.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.638 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.655 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 33.1 mt-30 63.99 116.4 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.95 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.4 94.97 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.647 2.231 . . . . 0.0 112.582 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 87.6 m-85 68.9 -173.61 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.9 90.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.247 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.8 -14.78 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.129 0.572 . . . . 0.0 112.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.751 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.43 48.77 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.274 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -147.01 -172.89 4.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.547 0.213 . . . . 0.0 110.573 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 4.6 p -103.42 148.73 8.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.7 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 7.4 m-80 -134.0 136.48 44.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.662 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . 0.546 ' HE2' HD11 ' C' ' 71' ' ' ILE . 1.1 t80 -97.49 124.13 41.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.483 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 44.8 p -116.51 127.93 54.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -159.82 154.85 24.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.41 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.52 166.07 29.72 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' C' ' 69' ' ' LEU . 13.7 m -112.12 163.7 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.802 0.334 . . . . 0.0 111.339 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.41 179.58 27.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.476 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.49 144.78 11.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.544 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.581 ' CD1' HD22 ' C' ' 36' ' ' LEU . 75.5 t80 -136.91 129.57 30.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.723 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.5 mmm-85 65.58 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.22 34.87 0.52 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.16 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.93 168.02 18.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -140.73 144.36 35.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.121 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.87 156.27 43.44 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.529 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.55 ' HA ' HG12 ' C' ' 60' ' ' VAL . 6.7 tp -113.23 125.38 54.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -119.54 151.16 39.08 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.695 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' C' ' 58' ' ' ALA . 18.3 tt -145.24 164.27 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.19 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 179.59 175.54 46.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.75 147.77 11.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.967 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.93 163.32 30.43 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.237 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -108.5 120.64 43.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 111.137 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.505 ' CB ' ' HA3' ' C' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.32 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.675 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.751 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.2 p -96.73 131.87 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 111.332 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.5 m120 64.58 -177.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 111.093 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.33 24.21 11.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.8 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.19 153.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.544 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -156.35 173.47 16.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 111.252 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.08 140.34 7.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.595 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.655 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.27 30.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 133.95 14.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.95 170.58 36.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.597 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -117.48 147.42 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.936 0.398 . . . . 0.0 111.096 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.58 ' HB3' ' SD ' ' C' ' 96' ' ' MET . . . -119.35 134.61 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.22 110.89 22.63 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' C' ' 94' ' ' ASP . . . -118.88 136.92 53.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.679 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.593 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 50.61 -112.03 1.45 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.255 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.33 -53.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.257 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.2 t -106.32 26.83 9.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.756 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.3 OUTLIER -116.88 81.83 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.93 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.63 139.32 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.737 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' C' ' 88' ' ' ALA . 0.0 OUTLIER -135.34 158.56 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -134.16 133.53 41.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.419 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.5 ' OD1' HD23 ' C' ' 42' ' ' LEU . 33.8 m120 -113.67 161.09 17.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.403 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.51 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.752 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.503 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 13.8 p -126.05 178.69 5.62 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.413 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.4 137.8 27.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.665 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 69.8 m-80 -103.3 148.86 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.377 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.509 HG13 ' O ' ' B' ' 56' ' ' PHE . 7.4 pt -152.79 146.67 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.784 0.326 . . . . 0.0 110.821 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.683 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 90.1 mt-10 -90.39 131.03 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 1.074 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.9 t-105 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.635 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' O ' HD22 ' A' ' 21' ' ' LEU . 36.1 ttmt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.793 0.33 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -38.48 83.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -66.77 -45.68 77.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.818 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -40.84 96.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.757 HD21 HD23 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -64.51 -45.27 87.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.51 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.69 -28.39 69.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -74.74 -40.33 61.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HD2' HD13 ' C' ' 25' ' ' LEU . 32.1 mtt180 -70.87 -41.18 71.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.766 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.679 HD21 ' HG ' ' B' ' 25' ' ' LEU . 7.8 mt -62.05 -49.86 74.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.481 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.24 -48.86 79.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 9.0 tmtt? -55.45 -38.02 68.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.168 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -63.4 -40.4 97.11 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.6 91.93 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.98 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.58 HG22 ' HE2' ' A' ' 34' ' ' LYS . 3.9 m -57.74 -48.08 80.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.81 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.559 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 83.9 mmt-85 -57.28 -33.15 67.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 28' ' ' LEU . 44.4 t -76.77 -37.78 28.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 48.2 m-20 -61.95 -54.34 43.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.012 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.998 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 2.5 pttt -75.87 -36.17 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.795 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 -45.49 87.98 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.422 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.703 HD22 ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -68.19 -39.59 82.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.845 0.355 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.73 90.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.4 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.667 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -68.72 -52.66 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.703 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.497 ' HB3' HD21 ' C' ' 36' ' ' LEU . 78.3 p -50.9 -56.42 12.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.43 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -54.81 -48.95 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.436 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.39 -42.19 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.64 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 24.0 tp -73.63 -36.07 65.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.062 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' HB3' ' CB ' ' C' ' 43' ' ' ASN . 54.4 m-20 -78.27 -3.17 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.702 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.4 t -84.31 1.38 45.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.18 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -98.26 174.58 6.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.82 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.34 -3.52 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.142 0.496 . . . . 0.0 111.661 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.555 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 35.8 mt-30 64.27 117.55 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.96 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.278 9.8 Cg_endo -74.46 100.39 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.669 2.246 . . . . 0.0 112.577 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 90.3 m-85 67.61 -167.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 148.26 81.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.203 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' CG ' ' A' ' 79' ' ' GLU . 15.0 p -88.26 -12.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.157 0.583 . . . . 0.0 112.396 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.78 45.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.256 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.56 -168.65 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.585 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.0 p -109.68 145.95 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.496 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 4.1 m-80 -128.52 135.32 49.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.943 0.402 . . . . 0.0 111.69 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.66 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 45' ' ' LEU . 22.5 p -111.87 124.66 52.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.006 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.455 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -155.35 149.79 26.1 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.478 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.604 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 173.04 165.56 30.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -111.27 165.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 0.0 111.434 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -177.62 27.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.496 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -160.65 144.42 9.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.537 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.703 ' CD1' HD22 ' A' ' 36' ' ' LEU . 65.5 t80 -133.54 133.42 42.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.728 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.51 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 3.1 mmm-85 64.5 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.126 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.47 33.28 0.37 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.161 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.73 168.69 16.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -134.84 140.47 45.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.095 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.32 152.01 48.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.595 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.444 ' HA ' HG12 ' A' ' 60' ' ' VAL . 4.7 tp -111.16 127.46 55.59 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.745 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -122.83 151.87 41.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.669 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.463 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.5 tt -147.78 163.72 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.088 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 175.48 172.65 40.53 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.446 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -162.75 147.24 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.6 161.63 28.69 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.295 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -106.92 119.26 38.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 111.168 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 76' ' ' ARG . 5.0 mmm180 -95.86 101.02 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.711 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 12.6 p -98.62 128.88 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.7 m120 65.23 -175.05 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.415 ' CG ' HG23 ' A' ' 51' ' ' VAL . 33.4 mt-10 -114.82 25.45 10.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.573 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.964 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.22 151.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -153.42 169.81 22.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.245 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -162.48 141.23 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 1.3 ttmp? -141.42 133.46 27.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.27 135.03 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -159.35 173.86 36.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.581 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.83 144.3 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.453 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -112.92 135.43 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.36 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -111.08 111.07 21.91 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.236 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.998 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -124.01 135.83 53.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.574 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.91 -113.84 4.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.238 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.83 -58.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.526 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -103.9 28.43 6.68 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.203 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.426 ' CB ' ' HD2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -118.18 82.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.962 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.76 142.81 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' C' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.15 50.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -128.01 129.41 46.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.429 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.5 159.35 22.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.724 0.297 . . . . 0.0 111.393 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.716 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.728 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.7 p -122.86 178.5 5.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 39.3 p90 -142.13 146.04 34.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.95 0.405 . . . . 0.0 111.12 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.5 m-80 -112.88 150.73 31.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.326 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 102' ' ' ASN . 2.9 pt -157.24 152.04 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.777 0.323 . . . . 0.0 110.814 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.424 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 75.8 mt-10 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.413 ' O ' HD22 ' B' ' 21' ' ' LEU . 36.1 ttmt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -38.46 83.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.297 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -66.81 -45.67 77.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -40.85 96.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.757 HD21 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -64.37 -45.29 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.75 -28.34 69.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.05 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -74.76 -40.32 61.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.478 ' HD2' HD13 ' A' ' 25' ' ' LEU . 32.2 mtt180 -70.9 -41.18 71.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.808 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.679 ' HG ' HD21 ' A' ' 25' ' ' LEU . 7.9 mt -61.96 -49.86 74.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.21 -48.87 79.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 9.0 tmtt? -55.43 -37.93 68.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.292 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.635 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.4 OUTLIER -63.49 -40.3 96.73 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -64.18 -44.62 91.48 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.954 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.59 HG22 ' HE2' ' B' ' 34' ' ' LYS . 3.8 m -57.7 -48.06 80.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.551 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 83.9 mmt-85 -57.18 -33.29 67.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.259 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 28' ' ' LEU . 44.5 t -76.78 -37.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.496 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 48.2 m-20 -62.06 -54.28 43.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.999 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.945 ' HB2' ' HB1' ' B' ' 90' ' ' ALA . 2.6 pttt -75.9 -36.03 59.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.41 87.61 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.717 HD22 ' CD1' ' B' ' 63' ' ' TYR . 0.3 OUTLIER -68.18 -39.65 82.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.75 90.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.414 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.671 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -68.73 -52.7 27.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.746 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.487 ' HB3' HD21 ' A' ' 36' ' ' LEU . 78.3 p -50.88 -56.35 12.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.415 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -54.91 -48.95 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.393 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.43 -42.18 41.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.635 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 23.8 tp -73.62 -36.04 65.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.433 ' CB ' ' HB3' ' C' ' 43' ' ' ASN . 54.4 m-20 -78.35 -3.14 41.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.706 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -84.26 1.29 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.089 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -98.21 174.49 6.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.906 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' B' ' 47' ' ' GLN . 7.4 p90 -165.31 -3.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 111.686 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.573 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.56 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.276 9.9 Cg_endo -74.43 100.38 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.629 2.219 . . . . 0.0 112.608 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 90.2 m-85 67.69 -167.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.405 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 148.2 81.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.228 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.418 HG23 ' CG ' ' B' ' 79' ' ' GLU . 15.0 p -88.28 -12.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.121 0.569 . . . . 0.0 112.402 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.78 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.332 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.77 2.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.637 0.256 . . . . 0.0 110.6 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 1.03 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.1 p -109.64 145.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.589 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 4.1 m-80 -128.47 135.31 49.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.648 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.63 122.65 44.26 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.313 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.487 ' HB ' ' CG ' ' B' ' 45' ' ' LEU . 22.4 p -112.01 124.65 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.932 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -155.3 149.84 26.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.611 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 172.97 165.52 30.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' B' ' 69' ' ' LEU . 6.9 m -111.31 165.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.05 -177.63 27.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -160.67 144.4 9.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.717 ' CD1' HD22 ' B' ' 36' ' ' LEU . 65.8 t80 -133.53 133.49 42.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 110.776 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.507 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 3.1 mmm-85 64.46 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.43 33.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.75 168.7 16.14 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -134.71 140.54 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.135 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.99 48.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.572 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.445 ' HA ' HG12 ' B' ' 60' ' ' VAL . 4.6 tp -111.18 127.35 55.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -122.76 151.89 41.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.726 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.458 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.4 tt -147.72 163.74 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.12 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 175.47 172.62 40.5 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.466 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 17.9 p -162.8 147.17 11.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.374 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.63 161.64 28.7 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.265 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -106.85 119.21 38.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 111.146 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.405 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 5.0 mmm180 -95.85 101.08 12.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.698 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' B' ' 78' ' ' ASN . 12.7 p -98.66 128.86 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.269 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.8 m120 65.2 -174.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.418 ' CG ' HG23 ' B' ' 51' ' ' VAL . 33.5 mt-10 -114.88 25.5 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.559 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.23 -46.38 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.27 151.12 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -153.43 169.8 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.235 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' B' ' 101' ' ' PHE . 0.6 OUTLIER -162.53 141.22 8.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.553 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.573 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.55 27.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.36 135.1 19.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -159.39 173.9 36.23 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.562 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.87 144.31 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.38 . . . . 0.0 111.148 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.459 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -112.85 135.38 53.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.313 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -111.12 111.02 21.81 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.3 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.945 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -123.92 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.581 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.573 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.84 -113.87 4.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 -58.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 111.293 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . 0.526 ' OG ' ' O ' ' B' ' 93' ' ' SER . 2.2 t -103.86 28.36 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.153 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.427 ' CB ' ' HD2' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -118.22 82.86 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.81 142.8 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.724 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.09 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -127.94 129.35 46.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.48 159.3 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.47 0.35 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.761 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.74 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.8 p -122.8 178.56 4.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 39.3 p90 -142.22 146.07 34.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.642 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.5 m-80 -112.88 150.7 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.409 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.461 HG23 ' O ' ' B' ' 102' ' ' ASN . 2.9 pt -157.25 152.02 7.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 110.757 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 75.9 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.402 ' O ' HD22 ' C' ' 21' ' ' LEU . 36.1 ttmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.716 0.293 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.71 -38.51 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.272 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -66.77 -45.71 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -40.79 96.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.757 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -64.45 -45.25 88.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.609 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.74 -28.34 69.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -74.78 -40.31 61.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.493 ' HD2' HD13 ' B' ' 25' ' ' LEU . 32.2 mtt180 -70.91 -41.13 71.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.819 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.669 HD21 ' HG ' ' A' ' 25' ' ' LEU . 7.9 mt -62.08 -49.72 74.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.656 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.37 -48.81 79.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.758 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 9.0 tmtt? -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.62 0.248 . . . . 0.0 111.286 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.645 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.4 OUTLIER -63.41 -40.42 97.16 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.69 91.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.954 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.577 HG22 ' HE2' ' C' ' 34' ' ' LYS . 3.8 m -57.6 -48.08 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.908 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.541 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 83.8 mmt-85 -57.28 -33.23 67.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.645 HG23 ' O ' ' C' ' 28' ' ' LEU . 44.4 t -76.78 -37.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.5 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 48.4 m-20 -61.92 -54.42 42.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.972 ' HB2' ' HB1' ' C' ' 90' ' ' ALA . 2.5 pttt -75.85 -36.08 59.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.798 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.37 88.16 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.708 HD22 ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -68.27 -39.64 82.12 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 111.012 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.8 91.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.655 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -68.68 -52.76 27.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.722 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.495 ' HB3' HD21 ' B' ' 36' ' ' LEU . 78.2 p -50.83 -56.41 12.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.426 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -54.83 -48.97 72.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.418 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.38 -42.12 41.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.96 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.619 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 24.0 tp -73.73 -35.95 65.13 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.074 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 54.5 m-20 -78.3 -3.2 41.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . 0.69 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.4 t -84.23 1.24 45.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.129 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -98.18 174.53 6.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.901 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.32 -3.55 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.553 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.65 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.948 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.46 100.41 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.696 2.264 . . . . 0.0 112.552 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 90.3 m-85 67.59 -167.18 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.23 81.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.255 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.418 HG23 ' CG ' ' C' ' 79' ' ' GLU . 15.0 p -88.19 -13.03 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.143 0.577 . . . . 0.0 112.381 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.85 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.72 2.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.603 0.24 . . . . 0.0 110.584 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 p -109.67 145.88 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.509 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.424 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 4.1 m-80 -128.44 135.31 49.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.666 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.64 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.223 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.479 ' HB ' ' CG ' ' C' ' 45' ' ' LEU . 22.5 p -111.9 124.58 52.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.989 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.441 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -155.26 149.91 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.483 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.602 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 172.98 165.53 30.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' C' ' 69' ' ' LEU . 6.9 m -111.27 165.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.391 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.95 -177.59 27.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.465 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -160.68 144.36 9.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.708 ' CD1' HD22 ' C' ' 36' ' ' LEU . 65.5 t80 -133.5 133.45 42.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.729 0.299 . . . . 0.0 110.775 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.518 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm-85 64.45 -81.11 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.023 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 33.29 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.78 168.71 16.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.808 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -134.77 140.53 45.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.37 151.93 47.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.56 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.446 ' HA ' HG12 ' C' ' 60' ' ' VAL . 4.7 tp -111.07 127.43 55.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.787 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -122.8 151.89 41.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.452 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.6 tt -147.83 163.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 0.0 111.116 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 175.51 172.7 40.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.8 p -162.86 147.25 11.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.39 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.67 161.6 28.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.245 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -106.88 119.23 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.142 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' C' ' 76' ' ' ARG . 5.0 mmm180 -95.8 100.95 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.737 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' C' ' 78' ' ' ASN . 12.7 p -98.55 128.86 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.272 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.8 m120 65.27 -175.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . 0.418 ' CG ' HG23 ' C' ' 51' ' ' VAL . 33.5 mt-10 -114.86 25.42 10.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.582 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.37 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.21 151.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.514 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -153.45 169.75 22.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' C' ' 101' ' ' PHE . 0.6 OUTLIER -162.41 141.22 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.553 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.63 27.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.163 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.42 135.06 19.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.104 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.36 173.89 36.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.587 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.92 144.29 32.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.458 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -112.92 135.34 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.311 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -111.04 111.02 21.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.23 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.972 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -123.91 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.605 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.597 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.86 -113.85 4.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.298 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.79 -58.1 0.98 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.778 0.323 . . . . 0.0 111.32 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . 0.513 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.2 t -103.85 28.38 6.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.161 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -118.23 82.82 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.8 142.81 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.708 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' B' ' 62' ' ' GLY . 0.8 OUTLIER -136.86 153.15 50.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.72 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -128.01 129.42 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.51 159.31 23.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.447 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.29 98.55 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.73 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.6 p -122.92 178.6 4.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' C' ' 83' ' ' LEU . 39.6 p90 -142.18 146.07 34.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 111.128 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.639 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.5 m-80 -112.85 150.64 31.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.397 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.452 HG23 ' O ' ' C' ' 102' ' ' ASN . 2.9 pt -157.2 152.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.774 0.321 . . . . 0.0 110.841 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 75.6 mt-10 -94.95 129.48 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 1.03 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.8 t-105 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.706 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.749 0.309 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -35.45 75.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.309 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.07 -44.07 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.55 -46.86 81.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.092 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.06 -36.81 84.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.58 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.17 -35.91 82.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.031 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.82 -42.21 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.602 ' HD2' HD13 ' C' ' 25' ' ' LEU . 28.2 mtt180 -62.71 -38.13 89.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.747 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.614 HD13 ' HD2' ' B' ' 24' ' ' ARG . 12.7 mt -67.35 -53.98 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.95 -47.61 77.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.822 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.88 -44.78 94.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.173 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' C' ' 29' ' ' ASP . 0.6 OUTLIER -58.09 -42.68 86.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.619 ' HA ' HD21 ' B' ' 28' ' ' LEU . 39.9 t0 -64.65 -40.7 95.9 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.983 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.404 HG22 ' HE2' ' A' ' 34' ' ' LYS . 10.2 m -61.66 -44.42 96.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.801 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 88.4 mmt-85 -57.07 -37.74 72.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.7 HG22 HG11 ' C' ' 32' ' ' VAL . 10.0 t -73.27 -29.53 28.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.153 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.571 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 63.6 m-20 -67.95 -62.73 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.037 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.672 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -66.53 -44.64 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.771 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.87 -46.17 77.46 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.374 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -68.02 -34.18 76.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.852 0.358 . . . . 0.0 111.147 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.31 -45.71 83.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.461 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.813 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -67.56 -54.48 19.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.764 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.8 p -49.44 -55.06 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.414 ' CB ' HD21 ' B' ' 43' ' ' ASN . . . -57.12 -46.13 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.427 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.27 58.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 45' ' ' LEU . 43.1 tp -80.96 -36.79 30.43 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.418 HD21 ' CB ' ' C' ' 40' ' ' ALA . 84.4 m-20 -74.01 -3.24 28.04 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.418 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 6.1 t -88.62 -7.52 56.25 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.14 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.5 OUTLIER -90.72 165.75 13.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.856 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.77 -2.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.14 0.495 . . . . 0.0 111.703 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 40.0 mt-30 67.12 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.907 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 47' ' ' GLN 0.406 9.9 Cg_endo -69.59 99.36 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.673 2.249 . . . . 0.0 112.524 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 60.78 -160.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 149.42 83.44 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.29 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.532 HG23 ' CG ' ' A' ' 79' ' ' GLU . 9.5 p -90.06 -15.51 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.234 0.614 . . . . 0.0 112.45 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 161.71 48.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.267 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.89 -170.25 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.625 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.85 141.01 25.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.58 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' A' ' 48' ' ' PRO . 3.2 m-80 -125.37 133.96 52.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.53 45.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.246 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 47' ' ' GLN . 24.4 p -114.93 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.06 146.87 22.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.461 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 176.05 163.05 28.03 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.543 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 69' ' ' LEU . 6.3 m -105.7 167.15 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.23 27.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.522 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.67 141.31 7.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.542 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.574 ' HA ' ' HB2' ' B' ' 96' ' ' MET . 72.4 t80 -129.39 139.24 51.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.725 0.298 . . . . 0.0 110.786 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.46 HH11 ' HD3' ' A' ' 64' ' ' ARG . 3.0 mmm180 61.2 -81.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.045 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 t -155.96 35.57 0.34 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.1 m -133.06 166.85 21.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.39 142.83 47.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.49 44.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.565 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' HG12 ' A' ' 60' ' ' VAL . 9.1 tp -110.93 131.25 55.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.717 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -126.26 154.3 43.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.728 0.299 . . . . 0.0 111.613 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.449 HG12 ' N ' ' A' ' 72' ' ' GLY . 20.4 tt -147.76 162.9 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.76 0.314 . . . . 0.0 111.126 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.449 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 178.58 169.73 39.7 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.411 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -161.94 142.45 10.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.966 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.15 160.95 27.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.201 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.495 ' H ' HD11 ' A' ' 83' ' ' LEU . 25.5 t80 -106.59 116.2 31.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 111.133 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.487 HH11 ' HB2' ' A' ' 82' ' ' ALA . 5.2 mmm180 -93.87 93.22 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.509 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 8.7 p -93.88 126.04 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 12.2 m120 68.98 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.532 ' CG ' HG23 ' A' ' 51' ' ' VAL . 26.8 mt-10 -120.02 24.94 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.618 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 6.8 t -126.06 -39.4 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.982 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.06 152.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.504 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -149.05 174.53 12.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.226 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.495 HD11 ' H ' ' A' ' 75' ' ' TYR . 1.4 pp -163.88 143.63 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.44 ' HE3' HE21 ' A' ' 47' ' ' GLN . 2.2 ttmp? -146.7 128.19 15.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.55 135.64 15.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' HA3' ' CA ' ' A' ' 72' ' ' GLY . . . -161.34 178.52 37.23 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.546 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.21 140.54 41.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 111.14 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.571 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -112.57 131.68 55.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.79 112.04 24.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.221 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -124.96 131.24 53.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.616 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.668 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.05 -116.06 6.36 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.92 -61.22 1.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.303 . . . . 0.0 111.327 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 93' ' ' SER . 3.1 t -100.21 28.98 4.55 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.195 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.76 136.09 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.585 ' HB2' ' HA ' ' C' ' 63' ' ' TYR . 1.1 ptp -131.35 150.11 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.647 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -123.06 134.02 54.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.456 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.95 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.72 0.295 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.21 91.68 0.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.811 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.858 ' HB2' HD11 ' C' ' 45' ' ' LEU . 21.8 p -119.9 177.78 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.417 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -139.52 144.42 37.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.968 0.413 . . . . 0.0 111.068 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.954 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.0 m-80 -112.95 143.51 44.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.368 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.63 151.17 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.0 110.777 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.618 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 55.5 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.741 0.305 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.276 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -70.03 -44.16 69.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.772 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.45 -46.87 81.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.125 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -63.13 -36.73 84.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.523 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.24 -35.81 82.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.87 -42.22 63.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.791 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.614 ' HD2' HD13 ' A' ' 25' ' ' LEU . 28.1 mtt180 -62.71 -38.09 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.608 HD13 ' HD2' ' C' ' 24' ' ' ARG . 12.7 mt -67.33 -54.1 23.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.86 -47.73 76.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.79 -44.77 93.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.249 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -57.95 -42.74 85.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.604 ' HA ' HD21 ' C' ' 28' ' ' LEU . 40.1 t0 -64.82 -40.59 95.45 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.932 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.408 HG22 ' HE2' ' B' ' 34' ' ' LYS . 10.0 m -61.62 -44.4 97.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.816 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.498 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 88.4 mmt-85 -57.27 -37.72 72.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.696 HG22 HG11 ' A' ' 32' ' ' VAL . 9.8 t -73.21 -29.49 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.566 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 63.6 m-20 -67.97 -62.74 1.27 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.681 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 0.5 OUTLIER -66.56 -44.59 81.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.89 -46.11 77.87 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.391 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.2 OUTLIER -68.08 -34.19 75.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.751 0.31 . . . . 0.0 111.055 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.71 83.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.804 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -67.54 -54.46 19.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.791 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.406 ' HB3' ' SD ' ' B' ' 96' ' ' MET . 47.5 p -49.47 -55.06 14.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.41 ' CB ' HD21 ' C' ' 43' ' ' ASN . . . -57.13 -46.11 82.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.403 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.24 58.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.616 HD12 HD23 ' B' ' 45' ' ' LEU . 42.7 tp -81.05 -36.75 30.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.414 HD21 ' CB ' ' A' ' 40' ' ' ALA . 84.3 m-20 -74.02 -3.17 27.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 6.1 t -88.65 -7.59 56.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.105 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.859 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.5 OUTLIER -90.62 165.74 13.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.882 177.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 8.6 p90 -154.84 -2.91 0.16 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.102 0.477 . . . . 0.0 111.609 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.437 ' HG2' HG23 ' B' ' 57' ' ' THR . 39.9 mt-30 66.99 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.993 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.44 ' HD2' ' OD1' ' B' ' 55' ' ' ASN 0.405 9.9 Cg_endo -69.6 99.41 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.685 2.257 . . . . 0.0 112.518 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 60.73 -159.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.976 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 149.27 83.48 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.309 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.527 HG23 ' CG ' ' B' ' 79' ' ' GLU . 9.6 p -90.06 -15.5 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.148 0.579 . . . . 0.0 112.495 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 161.71 48.47 0.02 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.27 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.83 -170.11 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.579 0.228 . . . . 0.0 110.614 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 1.026 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.7 p -108.97 141.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.608 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.44 ' OD1' ' HD2' ' B' ' 48' ' ' PRO . 3.2 m-80 -125.34 133.84 52.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 111.702 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.77 124.54 45.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.243 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.437 HG23 ' HG2' ' B' ' 47' ' ' GLN . 24.4 p -114.93 125.48 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.03 146.93 22.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.431 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.512 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 175.99 163.0 27.92 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.545 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' B' ' 69' ' ' LEU . 6.3 m -105.68 167.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 111.36 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.94 -176.23 27.84 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.71 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.58 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.6 ' HA ' ' HB2' ' C' ' 96' ' ' MET . 72.5 t80 -129.35 139.27 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.658 0.266 . . . . 0.0 110.761 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' B' ' 64' ' ' ARG . 3.0 mmm180 61.13 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.08 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 63' ' ' TYR . 8.0 t -155.88 35.51 0.35 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.17 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.9 m -133.15 166.73 21.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -134.29 142.91 47.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.045 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.96 156.47 44.88 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' B' ' 60' ' ' VAL . 9.2 tp -110.97 131.31 55.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.725 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -126.15 154.24 43.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.691 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.449 HG12 ' N ' ' B' ' 72' ' ' GLY . 20.4 tt -147.75 162.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.722 0.296 . . . . 0.0 111.186 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.449 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 178.56 169.66 39.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.45 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.47 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.16 160.87 27.88 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.248 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.506 ' H ' HD11 ' B' ' 83' ' ' LEU . 25.3 t80 -106.53 116.19 31.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.162 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.496 HH11 ' HB2' ' B' ' 82' ' ' ALA . 5.2 mmm180 -93.83 93.18 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' B' ' 78' ' ' ASN . 8.7 p -93.89 126.06 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.311 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 12.1 m120 69.04 -172.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.527 ' CG ' HG23 ' B' ' 51' ' ' VAL . 26.8 mt-10 -120.03 24.9 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.619 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 6.8 t -126.0 -39.5 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -114.99 152.54 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.963 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -149.0 174.61 12.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.286 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.506 HD11 ' H ' ' B' ' 75' ' ' TYR . 1.4 pp -163.84 143.7 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.617 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.429 ' HE3' HE21 ' B' ' 47' ' ' GLN . 2.2 ttmp? -146.77 128.1 14.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.43 135.65 15.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' CA ' ' B' ' 72' ' ' GLY . . . -161.32 178.5 37.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.603 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.18 140.58 41.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.905 0.383 . . . . 0.0 111.123 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.572 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -112.55 131.7 55.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.355 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.8 111.96 24.84 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.278 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -124.91 131.29 53.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.612 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.681 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.0 -116.11 6.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.224 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -127.92 -61.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.313 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.0 t -100.27 29.04 4.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.157 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -118.35 83.08 1.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.8 136.05 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' TYR . 1.1 ptp -131.34 150.14 52.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -123.17 134.01 54.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.375 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.98 24.94 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.389 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.82 0.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.721 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.856 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.7 p -120.0 177.78 4.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.429 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -139.55 144.38 37.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.092 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.963 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.1 m-80 -112.92 143.6 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.353 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.72 151.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.619 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 55.4 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.705 0.288 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.44 -35.48 75.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.249 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.03 -44.13 69.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.798 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -46.91 81.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' C' ' 21' ' ' LEU . 0.0 OUTLIER -63.06 -36.82 84.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.589 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.11 -35.96 82.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.001 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.81 -42.19 64.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.608 ' HD2' HD13 ' B' ' 25' ' ' LEU . 28.1 mtt180 -62.72 -38.09 89.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.788 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.602 HD13 ' HD2' ' A' ' 24' ' ' ARG . 12.6 mt -67.34 -54.03 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.92 -47.74 76.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.813 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.75 -44.8 93.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.191 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.604 HD21 ' HA ' ' B' ' 29' ' ' ASP . 0.6 OUTLIER -58.03 -42.63 85.73 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . 0.612 ' HA ' HD21 ' A' ' 28' ' ' LEU . 40.1 t0 -64.85 -40.57 95.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.949 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.405 HG22 ' HE2' ' C' ' 34' ' ' LYS . 10.2 m -61.69 -44.39 97.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.789 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.495 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 88.2 mmt-85 -57.2 -37.65 72.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.7 HG11 HG22 ' A' ' 32' ' ' VAL . 9.9 t -73.25 -29.6 28.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.118 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.572 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 63.6 m-20 -67.92 -62.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.023 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 0.5 OUTLIER -66.51 -44.61 82.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.804 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.86 -46.17 77.38 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.2 OUTLIER -68.07 -34.11 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.65 82.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.82 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -67.53 -54.48 19.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.406 ' HB3' ' SD ' ' C' ' 96' ' ' MET . 47.6 p -49.45 -55.06 14.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.418 ' CB ' HD21 ' A' ' 43' ' ' ASN . . . -57.1 -46.09 82.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.515 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.89 -39.18 58.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.608 HD12 HD23 ' C' ' 45' ' ' LEU . 42.9 tp -81.08 -36.66 30.15 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.41 HD21 ' CB ' ' B' ' 40' ' ' ALA . 84.5 m-20 -74.04 -3.24 28.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -88.62 -7.6 56.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.081 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.5 OUTLIER -90.58 165.75 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.924 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.83 -3.0 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.105 0.479 . . . . 0.0 111.649 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.448 HE21 ' HE3' ' C' ' 84' ' ' LYS . 40.0 mt-30 67.04 122.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.937 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' OD1' ' C' ' 55' ' ' ASN 0.406 9.8 Cg_endo -69.53 99.34 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.632 2.222 . . . . 0.0 112.556 -179.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 60.84 -160.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 149.36 83.55 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.198 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.522 HG23 ' CG ' ' C' ' 79' ' ' GLU . 9.5 p -90.14 -15.52 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.217 0.607 . . . . 0.0 112.393 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 161.73 48.48 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.305 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.88 -170.15 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.675 0.274 . . . . 0.0 110.549 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.94 141.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.613 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.428 ' OD1' ' HD2' ' C' ' 48' ' ' PRO . 3.2 m-80 -125.42 133.92 52.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.015 0.435 . . . . 0.0 111.661 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.46 45.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.204 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.447 HG23 ' HG2' ' C' ' 47' ' ' GLN . 24.3 p -114.9 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.903 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.94 146.92 22.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 175.97 163.05 27.99 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.565 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' C' ' 69' ' ' LEU . 6.2 m -105.76 167.21 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 111.226 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.04 -176.25 27.96 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.503 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.69 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.568 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 96' ' ' MET . 72.2 t80 -129.35 139.31 51.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.698 0.285 . . . . 0.0 110.729 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.446 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm180 61.09 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.094 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . 0.4 ' N ' ' O ' ' C' ' 63' ' ' TYR . 8.0 t -155.91 35.41 0.35 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 7.0 m -132.99 166.83 21.48 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.36 142.8 47.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.89 156.51 44.93 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' C' ' 60' ' ' VAL . 9.4 tp -110.95 131.22 55.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -126.15 154.31 43.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.704 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.448 HG12 ' N ' ' C' ' 72' ' ' GLY . 20.4 tt -147.73 162.89 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.749 0.309 . . . . 0.0 111.137 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.448 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 178.52 169.67 39.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.431 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.46 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.05 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.12 160.92 27.88 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.246 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.507 ' H ' HD11 ' C' ' 83' ' ' LEU . 25.4 t80 -106.59 116.23 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.166 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.476 HH11 ' HB2' ' C' ' 82' ' ' ALA . 5.2 mmm180 -93.85 93.16 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' C' ' 78' ' ' ASN . 8.7 p -93.87 126.11 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.273 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 12.2 m120 68.89 -171.96 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.921 0.391 . . . . 0.0 111.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . 0.522 ' CG ' HG23 ' C' ' 51' ' ' VAL . 26.3 mt-10 -119.98 24.87 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.616 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . 0.615 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 6.8 t -126.06 -39.36 2.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.994 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.01 152.61 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.971 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -149.05 174.63 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.278 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.507 HD11 ' H ' ' C' ' 75' ' ' TYR . 1.4 pp -163.84 143.74 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.448 ' HE3' HE21 ' C' ' 47' ' ' GLN . 2.2 ttmp? -146.82 128.16 14.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.48 135.66 15.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.412 ' HA3' ' CA ' ' C' ' 72' ' ' GLY . . . -161.36 178.57 37.22 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.556 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.25 140.64 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.872 0.367 . . . . 0.0 111.088 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.572 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -112.6 131.65 55.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.323 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -105.77 112.05 24.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.292 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.82 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -125.01 131.23 53.44 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.579 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.695 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.09 -116.15 6.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.235 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.86 -61.25 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.717 0.294 . . . . 0.0 111.299 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . 0.486 ' O ' ' OG ' ' C' ' 93' ' ' SER . 3.1 t -100.19 28.98 4.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.193 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 t -118.82 136.05 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.0 110.706 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.6 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 1.1 ptp -131.31 150.07 52.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -123.08 133.96 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.365 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -116.96 157.96 24.88 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.705 0.288 . . . . 0.0 111.471 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.72 0.12 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.771 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.859 ' HB2' HD11 ' B' ' 45' ' ' LEU . 21.6 p -119.91 177.82 4.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.432 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -139.58 144.48 37.8 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.028 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.971 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.0 m-80 -112.96 143.57 44.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.332 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.7 151.19 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.866 0.365 . . . . 0.0 110.77 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.615 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 55.5 mt-10 -92.33 128.2 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 1.026 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.696 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -72.49 -34.87 67.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.215 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.6 mtt85 -65.97 -40.06 90.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.85 -44.91 63.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 111.134 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.853 HD23 HD21 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.61 -37.96 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.591 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.75 -31.13 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.038 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.07 -39.6 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.65 -37.56 67.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.782 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.3 mt -68.96 -42.7 76.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.648 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.22 -38.81 92.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.74 74.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.636 0.255 . . . . 0.0 111.181 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' C' ' 28' ' ' LEU . 0.5 OUTLIER -59.9 -43.73 94.67 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -59.8 -40.5 88.59 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.951 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 34' ' ' LYS . 26.0 m -66.67 -41.38 88.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.804 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.337 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 28' ' ' LEU . 3.0 t -76.09 -32.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.224 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.701 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 70.4 m-20 -65.56 -63.89 0.99 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.121 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.71 -34.54 62.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.773 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.45 78.44 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.446 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -72.53 -27.31 62.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 111.073 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.61 55.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.399 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -68.83 -41.58 78.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.9 ' HB3' HD21 ' C' ' 36' ' ' LEU . 31.5 p -55.84 -58.98 5.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.446 ' HB3' HD21 ' B' ' 98' ' ' ASN . . . -55.85 -39.54 71.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.444 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -60.73 -37.44 81.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.968 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 tp -75.16 -37.33 61.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.5 m-20 -76.45 -5.84 49.14 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.519 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.2 t -79.24 -11.23 59.95 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.125 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.754 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -84.2 177.57 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.874 177.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.651 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.5 p90 -169.53 -15.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.144 0.497 . . . . 0.0 111.705 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.762 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 40.8 mt-30 81.17 114.64 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.95 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.46 99.43 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.654 2.236 . . . . 0.0 112.558 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 62.24 -160.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.985 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 144.54 93.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.22 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 7.5 p -88.85 -27.1 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.126 0.57 . . . . 0.0 112.444 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 172.25 34.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.269 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.71 -165.43 1.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 110.605 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -110.27 141.33 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.508 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.561 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 6.7 m-80 -120.05 135.84 54.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.977 0.417 . . . . 0.0 111.669 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -99.85 128.52 45.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.27 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.754 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 42.7 p -117.64 131.44 56.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.79 143.39 9.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.485 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 178.77 165.5 33.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 69' ' ' LEU . 10.9 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.876 0.369 . . . . 0.0 111.345 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -155.5 -174.91 25.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.415 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.38 144.52 9.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.701 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 87.7 t80 -130.49 127.74 39.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.773 0.321 . . . . 0.0 110.69 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 6.9 mmm-85 66.35 -86.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.15 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.76 30.33 0.99 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.152 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.48 159.45 41.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.094 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.52 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.543 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' VAL . 8.0 tp -115.1 137.33 52.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.768 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.677 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.81 158.39 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.119 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 177.44 173.2 42.72 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.45 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.19 142.86 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.21 156.5 26.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.226 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -105.11 116.1 31.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 111.101 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.502 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 9.6 mmm180 -95.98 89.11 5.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.752 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.702 HG22 ' OD1' ' A' ' 78' ' ' ASN . 7.7 p -95.73 123.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.302 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.702 ' OD1' HG22 ' A' ' 77' ' ' VAL . 19.9 m120 64.15 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.147 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -99.74 32.06 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.603 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.488 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 t -131.74 -37.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.521 HG13 HG13 ' A' ' 77' ' ' VAL . 13.6 p -118.74 148.81 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -150.69 171.24 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.252 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.07 148.67 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.611 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.762 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -146.35 131.77 18.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.182 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.67 12.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -157.99 171.16 34.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.619 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.16 139.29 47.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.87 0.367 . . . . 0.0 111.093 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.32 132.22 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.77 121.52 41.83 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -130.1 124.34 32.53 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.589 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 61.93 -110.66 3.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.345 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -132.1 -63.34 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -99.05 24.64 7.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.136 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -116.4 85.14 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.943 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.76 137.55 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.484 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -129.64 158.12 40.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.713 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -133.84 137.52 45.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.451 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.463 HD21 ' HB3' ' C' ' 40' ' ' ALA . 34.6 m120 -125.63 152.26 45.42 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.745 0.307 . . . . 0.0 111.437 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.76 92.82 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.773 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.562 ' HB2' HD11 ' C' ' 45' ' ' LEU . 79.0 p -115.73 -177.57 3.18 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.41 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.45 140.52 22.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.945 0.403 . . . . 0.0 111.088 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.756 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 66.3 m-80 -112.28 144.01 42.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.435 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.419 ' CG2' HG23 ' A' ' 81' ' ' VAL . 4.1 pt -154.98 135.07 4.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 110.766 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.56 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 66.3 mt-10 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.729 0.3 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . 0.401 ' O ' ' HD1' ' B' ' 18' ' ' PHE . 0.2 OUTLIER -72.47 -34.84 67.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.231 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 18.5 mtt85 -65.97 -40.09 90.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.81 -44.93 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.118 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.853 HD21 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.49 -38.06 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.83 -31.05 66.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.16 -39.49 78.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.74 -37.57 67.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.732 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.0 -42.75 76.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -64.22 -38.82 92.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.63 74.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.67 0.271 . . . . 0.0 111.25 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' C' ' 28' ' ' LEU . 0.5 OUTLIER -59.92 -43.75 94.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.73 -40.57 88.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.963 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.622 HG22 ' HE2' ' B' ' 34' ' ' LYS . 25.9 m -66.65 -41.36 88.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.88 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' B' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.256 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 28' ' ' LEU . 3.0 t -76.12 -32.54 22.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.213 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.704 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 70.4 m-20 -65.59 -63.88 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' B' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.46 62.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.799 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.87 -49.43 78.65 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.874 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -72.55 -27.34 62.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.84 -52.63 55.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.409 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.3 OUTLIER -68.83 -41.55 78.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.74 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.884 ' HB3' HD21 ' A' ' 36' ' ' LEU . 31.5 p -55.83 -59.04 5.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' C' ' 98' ' ' ASN . . . -55.76 -39.55 71.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.469 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.489 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -60.76 -37.45 81.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.22 -37.3 61.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.049 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.566 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.4 m-20 -76.48 -5.86 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.531 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.2 t -79.23 -11.2 59.96 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.193 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.743 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 0.7 OUTLIER -84.32 177.59 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.806 178.022 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.648 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 12.6 p90 -169.57 -15.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.622 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.749 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 40.8 mt-30 81.24 114.62 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.906 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.405 9.7 Cg_endo -69.55 99.55 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.623 2.215 . . . . 0.0 112.491 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 62.13 -160.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.013 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 144.56 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.222 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 78' ' ' ASN . 7.5 p -88.91 -27.04 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.194 0.597 . . . . 0.0 112.433 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 172.22 34.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.292 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.66 -165.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.681 0.276 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.588 HG13 ' O ' ' C' ' 105' ' ' TRP . 8.9 p -110.39 141.19 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.523 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.557 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 6.7 m-80 -119.99 135.83 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.952 0.406 . . . . 0.0 111.689 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.585 ' HB2' ' HB2' ' C' ' 105' ' ' TRP . 2.2 t80 -99.9 128.57 45.98 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.212 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.743 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 42.6 p -117.62 131.41 56.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.023 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.8 143.35 9.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.455 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 178.83 165.52 33.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.586 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' B' ' 69' ' ' LEU . 11.0 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.338 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -155.52 -174.93 25.96 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.45 144.39 9.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.704 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 87.5 t80 -130.37 127.79 40.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 6.9 mmm-85 66.32 -86.57 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.185 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.84 30.43 0.97 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.23 167.92 16.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.792 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.38 159.46 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 165.61 36.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.545 ' HA ' HG12 ' B' ' 60' ' ' VAL . 8.0 tp -115.1 137.32 52.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.54 148.85 50.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.673 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.76 158.33 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 0.0 111.13 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 177.45 173.12 42.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.422 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.17 142.81 19.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.52 26.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.13 116.17 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 111.14 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.51 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 9.6 mmm180 -95.96 89.16 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.661 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.714 HG22 ' OD1' ' B' ' 78' ' ' ASN . 7.7 p -95.76 123.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 111.243 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.714 ' OD1' HG22 ' B' ' 77' ' ' VAL . 19.9 m120 64.12 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -99.76 32.13 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.552 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.482 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 9.8 t -131.84 -37.7 1.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.505 HG13 HG13 ' B' ' 77' ' ' VAL . 13.8 p -118.78 148.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -150.56 171.24 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.09 148.71 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.608 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.749 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -146.33 131.83 18.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.177 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.58 126.69 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -158.0 171.2 34.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.603 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.18 139.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.861 0.362 . . . . 0.0 111.06 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.36 132.25 54.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -100.72 121.51 41.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . . . -130.1 124.23 32.26 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.651 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.491 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 61.91 -110.66 3.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.292 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -132.06 -63.44 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.268 . . . . 0.0 111.281 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.96 24.66 7.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.211 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.4 OUTLIER -116.41 85.11 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.84 137.56 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.476 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -129.62 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.683 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.77 137.53 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.452 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.446 HD21 ' HB3' ' A' ' 40' ' ' ALA . 34.6 m120 -125.6 152.22 45.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.727 0.298 . . . . 0.0 111.458 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.8 92.8 1.13 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 45' ' ' LEU . 79.0 p -115.7 -177.61 3.19 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.41 140.54 23.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 111.139 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.775 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 66.4 m-80 -112.34 143.99 42.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.356 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.421 ' CG2' HG23 ' B' ' 81' ' ' VAL . 4.2 pt -154.98 135.01 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.838 0.351 . . . . 0.0 110.776 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.561 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 66.1 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.714 0.292 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -34.92 68.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.273 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 18.6 mtt85 -65.86 -40.1 91.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.803 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.88 -44.88 63.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.843 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.54 -38.08 68.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.623 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.67 -31.15 66.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.14 -39.54 78.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -72.68 -37.52 67.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.741 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.02 -42.69 76.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.626 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.23 -38.82 92.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.824 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 3.0 tmtt? -69.56 -42.66 74.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.253 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.93 -43.8 94.73 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.69 -40.53 88.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.0 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.622 HG22 ' HE2' ' C' ' 34' ' ' LYS . 25.9 m -66.72 -41.28 88.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.902 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' C' ' 27' ' ' LYS . 86.4 mmt-85 -54.89 -38.06 67.1 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.389 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.5 HG23 ' O ' ' C' ' 28' ' ' LEU . 3.0 t -76.13 -32.53 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.218 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.722 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 70.4 m-20 -65.51 -63.96 0.97 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.075 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' C' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.47 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.758 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.39 79.18 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.384 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.9 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -72.56 -27.34 62.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.803 0.335 . . . . 0.0 111.066 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.56 55.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.3 OUTLIER -68.87 -41.48 78.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.874 ' HB3' HD21 ' B' ' 36' ' ' LEU . 31.3 p -55.86 -58.96 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.463 ' HB3' HD21 ' A' ' 98' ' ' ASN . . . -55.86 -39.61 71.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.441 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -60.66 -37.47 81.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.21 -37.4 61.14 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 75.4 m-20 -76.32 -5.93 49.28 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . 0.534 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.2 t -79.21 -11.24 59.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.111 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 0.7 OUTLIER -84.22 177.63 8.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.784 178.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.629 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 12.6 p90 -169.61 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.611 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.742 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 40.9 mt-30 81.13 114.59 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.986 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.42 99.41 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.709 2.272 . . . . 0.0 112.564 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 62.24 -160.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.005 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 144.55 93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.255 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' C' ' 78' ' ' ASN . 7.5 p -88.86 -27.03 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.154 0.582 . . . . 0.0 112.468 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 172.18 34.55 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.269 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.64 -165.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.646 0.26 . . . . 0.0 110.592 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -110.36 141.26 26.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.523 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.56 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 6.8 m-80 -120.01 135.74 54.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.973 0.416 . . . . 0.0 111.73 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -99.75 128.47 45.85 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.75 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.0 p -117.58 131.46 56.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.97 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.84 143.35 9.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.49 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 178.79 165.55 33.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.538 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' C' ' 69' ' ' LEU . 10.9 m -111.8 168.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.838 0.352 . . . . 0.0 111.326 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -155.46 -174.9 25.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.418 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.4 144.49 9.71 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.722 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 87.6 t80 -130.48 127.78 39.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 110.736 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 6.8 mmm-85 66.3 -86.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -146.84 30.32 0.98 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.25 167.95 16.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -136.45 159.43 41.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.104 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.53 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.561 ' HA ' HG12 ' C' ' 60' ' ' VAL . 8.0 tp -115.07 137.28 52.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.782 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.53 148.87 50.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.699 0.285 . . . . 0.0 111.651 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.82 158.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 177.41 173.18 42.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.488 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -155.19 142.72 19.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.12 156.5 26.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.234 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.09 116.19 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.133 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.504 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 9.6 mmm180 -95.96 89.1 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.723 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.711 HG22 ' OD1' ' C' ' 78' ' ' ASN . 7.7 p -95.74 123.77 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 111.208 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.711 ' OD1' HG22 ' C' ' 77' ' ' VAL . 19.9 m120 64.27 167.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 111.09 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -99.81 32.09 3.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.572 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . 0.489 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 9.7 t -131.75 -37.75 1.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.991 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.51 HG13 HG13 ' C' ' 77' ' ' VAL . 13.7 p -118.75 148.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.513 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -150.71 171.12 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.258 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -162.96 148.77 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.573 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.742 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -146.37 131.8 18.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.75 12.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -158.12 171.17 35.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.572 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.2 139.27 48.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 111.114 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.31 54.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.78 121.49 41.78 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.271 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' C' ' 94' ' ' ASP . . . -130.1 124.23 32.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.628 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.488 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 61.94 -110.63 3.32 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.274 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.5 m -132.1 -63.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 0.0 111.295 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.99 24.7 7.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.4 OUTLIER -116.42 85.1 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.947 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.77 137.6 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.4 OUTLIER -129.6 158.17 40.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.84 137.58 45.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.388 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.455 HD21 ' HB3' ' B' ' 40' ' ' ALA . 34.6 m120 -125.72 152.19 45.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.417 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.78 92.83 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.562 ' HB2' HD11 ' B' ' 45' ' ' LEU . 79.0 p -115.73 -177.61 3.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.447 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.38 140.61 23.11 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.08 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.786 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 66.4 m-80 -112.31 143.94 42.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.418 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.423 ' CG2' HG23 ' C' ' 81' ' ' VAL . 4.1 pt -154.96 135.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.557 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 66.4 mt-10 -70.52 131.35 43.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.977 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 0.588 ' O ' HG13 ' B' ' 54' ' ' VAL . 33.1 t-105 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.664 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.623 ' HE2' ' HB2' ' C' ' 17' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.717 0.294 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.97 -37.86 64.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.208 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.2 -60.4 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.68 65.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.097 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.699 HD22 HD23 ' A' ' 25' ' ' LEU . 2.3 tm? -66.96 -62.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -62.24 -23.76 66.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.52 -49.51 47.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.606 ' HD3' HD11 ' C' ' 21' ' ' LEU . 69.0 mtp85 -73.33 -42.15 62.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.024 HD22 HD11 ' C' ' 25' ' ' LEU . 3.9 mm? -61.36 -46.08 91.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.559 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.29 -32.97 74.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.787 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.79 83.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.185 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -62.6 -47.94 81.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.52 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -60.98 -32.0 71.57 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.967 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.52 HG22 ' HE2' ' A' ' 34' ' ' LYS . 6.3 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.85 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.402 HH12 ' HB3' ' A' ' 93' ' ' SER . 0.0 OUTLIER -78.73 -30.72 46.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.381 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 29' ' ' ASP . 30.3 m -83.5 -33.49 9.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.515 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 57.9 m-20 -66.29 -48.69 69.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' CD ' ' HA3' ' A' ' 91' ' ' GLY . 6.6 ptpt -85.07 -25.69 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.835 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.91 -40.68 63.08 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.393 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.59 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -77.11 -25.73 52.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.329 . . . . 0.0 111.034 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.409 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -72.31 -40.93 67.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.444 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.671 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 13.3 t -79.0 -43.01 25.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.426 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.4 OUTLIER -59.73 -56.71 18.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.34 -40.88 78.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.395 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.41 -35.13 67.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 26.0 tp -76.26 -42.4 45.85 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.601 ' CB ' ' HB3' ' B' ' 43' ' ' ASN . 35.6 m-20 -70.83 -13.81 62.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -67.26 -21.88 65.69 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.128 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' B' ' 100' ' ' SER . 1.5 mm? -80.07 171.8 14.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.857 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.488 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.3 p90 -158.11 -3.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.628 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.576 ' HB2' HH21 ' A' ' 76' ' ' ARG . 7.1 mt-30 71.51 119.79 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.953 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.262 9.8 Cg_endo -75.09 106.7 2.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.65 2.233 . . . . 0.0 112.497 -179.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.19 -177.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 173.02 51.34 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.245 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 4.9 p -73.32 -3.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.12 0.568 . . . . 0.0 112.519 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.9 54.33 0.03 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.272 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.82 -165.04 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.24 145.08 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.5 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.642 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.5 m-80 -126.16 118.43 25.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.65 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' A' ' 73' ' ' SER . 31.8 t80 -83.66 130.31 34.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.255 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.494 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 75.5 p -114.66 120.9 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.986 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 71' ' ' ILE . . . -152.26 135.29 15.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.488 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -179.72 168.57 39.06 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.55 ' CG1' HD12 ' A' ' 69' ' ' LEU . 13.3 m -116.96 158.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 111.418 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.99 -170.89 14.34 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.481 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.409 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -165.5 142.67 7.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.593 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 56.1 t80 -134.01 134.7 42.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.684 0.278 . . . . 0.0 110.771 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.71 28.59 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 1.6 m -133.77 142.05 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.3 157.11 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.099 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.671 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -149.48 167.78 25.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.558 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.55 HD12 ' CG1' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -125.97 136.66 53.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.757 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -128.31 142.55 51.1 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 111.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 87' ' ' VAL . 10.4 tp -139.38 155.07 25.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' THR . . . 168.12 176.91 38.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.384 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 56' ' ' PHE . 1.1 p -168.04 155.82 8.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.01 28.57 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.207 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -123.48 135.74 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.17 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.576 HH21 ' HB2' ' A' ' 47' ' ' GLN . 12.3 ttm180 -131.17 133.27 45.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.678 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.829 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 13.8 p -122.32 139.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 88.8 m-20 61.19 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.661 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 7.8 pt-20 177.81 -26.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.55 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 59.5 p -65.65 -67.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.39 139.19 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.496 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.666 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -142.07 155.35 45.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.241 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.564 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HG3' ' HE2' ' C' ' 46' ' ' PHE . 8.2 tmtt? -155.31 130.19 9.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.217 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 175.41 12.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.16 -173.69 37.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.543 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 71' ' ' ILE . 14.7 p -141.89 143.17 27.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.897 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -115.17 144.11 44.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.351 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -119.24 119.03 32.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.282 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -127.89 135.29 49.8 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.657 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.618 ' HA3' ' CD ' ' A' ' 34' ' ' LYS . . . 60.52 -111.56 3.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.276 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.3 m -149.61 10.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 111.312 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.402 ' HB3' HH12 ' A' ' 31' ' ' ARG . 1.6 t -165.09 23.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.156 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 37.0 m-20 -116.3 67.7 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.08 139.67 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 110.745 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.897 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 7.1 ptp -134.25 135.53 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.723 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.86 118.71 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.409 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.03 152.63 23.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.79 0.328 . . . . 0.0 111.394 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.753 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.504 ' HB3' HD11 ' C' ' 45' ' ' LEU . 14.4 m -118.6 169.09 10.09 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.396 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.06 136.01 31.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.986 0.422 . . . . 0.0 111.056 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.8 m-80 -104.31 132.8 50.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.355 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -138.22 114.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.376 . . . . 0.0 110.716 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' C' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.614 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.67 0.271 . . . . 0.0 110.578 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.9 -37.87 64.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.23 -60.37 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.63 65.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.983 0.42 . . . . 0.0 111.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.71 HD22 HD23 ' B' ' 25' ' ' LEU . 2.3 tm? -67.04 -62.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.29 -23.73 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.005 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.56 -49.49 47.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.601 ' HD3' HD11 ' A' ' 21' ' ' LEU . 69.1 mtp85 -73.36 -42.15 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.702 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 1.008 HD22 HD11 ' A' ' 25' ' ' LEU . 3.9 mm? -61.26 -46.08 91.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.603 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.33 -32.92 74.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.773 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.89 -38.7 83.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.647 0.26 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' B' ' 28' ' ' LEU . 0.0 OUTLIER -62.74 -47.89 81.59 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.501 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.5 OUTLIER -61.06 -31.95 71.6 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 178.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.514 HG22 ' HE2' ' B' ' 34' ' ' LYS . 6.2 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -30.64 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.312 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' B' ' 29' ' ' ASP . 29.3 m -83.68 -33.33 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.172 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 58.3 m-20 -66.35 -48.7 69.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.972 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.604 ' CD ' ' HA3' ' B' ' 91' ' ' GLY . 6.6 ptpt -85.17 -25.58 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.92 -40.8 62.95 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.601 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.5 mt -77.03 -25.71 52.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.413 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -72.44 -40.76 66.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.411 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.66 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 13.5 t -79.08 -42.97 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.745 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.418 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 0.4 OUTLIER -59.86 -56.71 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.88 78.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.441 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.48 -35.08 67.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.555 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 26.1 tp -76.3 -42.23 45.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.124 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.601 ' HB3' ' CB ' ' A' ' 43' ' ' ASN . 35.5 m-20 -70.92 -13.77 62.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 46.5 t -67.3 -21.87 65.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.147 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' C' ' 100' ' ' SER . 1.5 mm? -80.05 171.71 14.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.866 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.489 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.3 p90 -158.09 -3.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.162 0.506 . . . . 0.0 111.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.579 ' HB2' HH21 ' B' ' 76' ' ' ARG . 7.1 mt-30 71.5 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.992 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.669 ' HB2' ' O ' ' C' ' 79' ' ' GLU 0.265 10.0 Cg_endo -74.94 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.708 2.272 . . . . 0.0 112.573 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.18 -177.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 173.02 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.219 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 4.9 p -73.42 -3.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.145 0.578 . . . . 0.0 112.466 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.831 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.97 54.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.25 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.81 -165.07 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.2 145.12 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.561 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.637 ' HB3' ' HD2' ' B' ' 48' ' ' PRO . 5.4 m-80 -126.11 118.32 25.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 111.706 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' B' ' 73' ' ' SER . 32.1 t80 -83.77 130.36 34.94 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.223 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.487 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 75.9 p -114.67 120.9 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.976 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' B' ' 71' ' ' ILE . . . -152.28 135.34 15.7 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.458 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -179.77 168.63 39.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.563 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.548 ' CG1' HD12 ' B' ' 69' ' ' LEU . 13.1 m -117.01 158.43 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.811 0.339 . . . . 0.0 111.332 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.99 -170.86 14.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.441 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . 0.413 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -165.5 142.69 7.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.529 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.572 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 56.0 t80 -134.13 134.7 42.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.672 0.273 . . . . 0.0 110.744 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 64.34 -93.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.73 28.63 1.27 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 1.6 m -133.79 142.1 47.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.36 157.17 17.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.99 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -149.57 167.74 25.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.523 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.548 HD12 ' CG1' ' B' ' 60' ' ' VAL . 0.6 OUTLIER -125.95 136.61 53.22 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.796 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -128.21 142.53 51.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.668 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' B' ' 87' ' ' VAL . 10.4 tp -139.29 155.16 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.103 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.408 ' N ' HG13 ' B' ' 71' ' ' ILE . . . 168.03 176.8 38.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.427 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' B' ' 56' ' ' PHE . 1.1 p -167.95 155.89 8.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.33 171.93 28.66 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.179 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -123.46 135.73 54.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.579 HH21 ' HB2' ' B' ' 47' ' ' GLN . 12.3 ttm180 -131.14 133.33 45.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.831 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 13.7 p -122.44 139.64 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 88.8 m-20 61.25 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 0.0 111.066 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 7.8 pt-20 177.87 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.585 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' B' ' 103' ' ' ILE . 59.5 p -65.65 -67.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.991 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.4 139.21 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.501 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -142.03 155.35 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.488 ' HG3' ' HE2' ' A' ' 46' ' ' PHE . 8.2 tmtt? -155.28 130.26 9.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.15 175.42 12.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.14 -173.7 37.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.559 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' B' ' 71' ' ' ILE . 14.7 p -141.89 143.24 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.891 0.377 . . . . 0.0 111.123 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.884 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -115.23 144.1 44.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.33 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -119.24 119.06 32.96 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -127.91 135.36 49.88 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.649 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.604 ' HA3' ' CD ' ' B' ' 34' ' ' LYS . . . 60.48 -111.58 3.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.281 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 56.8 m -149.62 10.3 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.286 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -165.07 23.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.163 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 37.2 m-20 -116.38 67.68 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.11 139.61 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.702 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.884 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 7.0 ptp -134.23 135.52 43.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.81 118.75 35.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.98 152.62 23.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.692 0.282 . . . . 0.0 111.427 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.49 90.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.698 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.499 ' HB3' HD11 ' A' ' 45' ' ' LEU . 14.3 m -118.56 169.09 10.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.432 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.02 135.89 31.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.676 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.9 m-80 -104.25 132.82 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.426 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -138.19 114.32 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.623 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.709 0.29 . . . . 0.0 110.531 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -74.0 -37.82 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.2 -60.42 3.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.38 -28.62 65.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.723 HD22 HD23 ' C' ' 25' ' ' LEU . 2.3 tm? -67.01 -62.7 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.566 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.18 -23.79 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.46 -49.56 47.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.623 ' HD3' HD11 ' B' ' 21' ' ' LEU . 69.0 mtp85 -73.4 -42.05 62.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.797 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 1.024 HD11 HD22 ' A' ' 25' ' ' LEU . 3.9 mm? -61.31 -46.08 91.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.624 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.32 -32.91 74.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.846 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.73 83.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -47.86 81.71 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . 0.516 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.5 OUTLIER -61.05 -31.87 71.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.96 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.516 HG22 ' HE2' ' C' ' 34' ' ' LYS . 6.2 m -73.9 -30.26 62.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.865 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -30.73 45.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' C' ' 29' ' ' ASP . 30.1 m -83.57 -33.38 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.517 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 57.8 m-20 -66.43 -48.63 69.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.617 ' CD ' ' HA3' ' C' ' 91' ' ' GLY . 6.6 ptpt -85.16 -25.61 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.93 -40.71 62.91 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.404 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.601 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.5 mt -77.03 -25.78 52.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.92 0.391 . . . . 0.0 111.165 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.404 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -72.33 -40.77 67.17 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.548 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.664 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 13.2 t -79.07 -42.87 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.803 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.43 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 0.4 OUTLIER -59.92 -56.71 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.25 -41.01 78.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.418 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.34 -35.11 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.941 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.564 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 26.2 tp -76.22 -42.38 46.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.148 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.599 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 35.4 m-20 -70.84 -13.85 62.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -67.31 -21.88 65.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.09 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 100' ' ' SER . 1.5 mm? -80.06 171.84 14.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.845 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.48 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.3 p90 -158.1 -3.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.193 0.52 . . . . 0.0 111.721 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.565 ' HB2' HH21 ' C' ' 76' ' ' ARG . 7.1 mt-30 71.58 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.968 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.263 9.9 Cg_endo -75.03 106.7 2.33 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.635 2.224 . . . . 0.0 112.585 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.15 -177.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 173.03 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.168 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 4.9 p -73.43 -3.42 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.091 0.557 . . . . 0.0 112.465 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.812 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.94 54.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 -165.16 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 0.0 110.615 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.15 145.1 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.641 ' HB3' ' HD2' ' C' ' 48' ' ' PRO . 5.4 m-80 -126.1 118.38 25.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 111.655 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' C' ' 73' ' ' SER . 32.1 t80 -83.76 130.33 34.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.206 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.481 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 75.2 p -114.63 120.92 41.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.97 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.419 ' HB2' HD12 ' C' ' 71' ' ' ILE . . . -152.32 135.35 15.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.484 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -179.76 168.57 39.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.552 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.549 ' CG1' HD12 ' C' ' 69' ' ' LEU . 13.3 m -116.9 158.41 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.328 . . . . 0.0 111.357 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.04 -170.8 14.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.421 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . 0.404 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -165.59 142.72 7.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.583 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 56.2 t80 -134.04 134.69 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.636 0.255 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.103 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.75 28.58 1.27 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' C' ' 33' ' ' ASP . 1.6 m -133.8 142.04 47.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.21 157.3 17.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . 0.664 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -149.64 167.75 25.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.549 HD12 ' CG1' ' C' ' 60' ' ' VAL . 0.6 OUTLIER -126.01 136.63 53.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -128.25 142.55 51.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.654 0.264 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' C' ' 87' ' ' VAL . 10.4 tp -139.29 155.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.761 0.315 . . . . 0.0 111.11 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.401 ' N ' HG13 ' C' ' 71' ' ' ILE . . . 168.04 176.83 38.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.448 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' C' ' 56' ' ' PHE . 1.1 p -168.01 155.85 8.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.339 . . . . 0.0 110.969 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.36 171.99 28.67 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.565 HH21 ' HB2' ' C' ' 47' ' ' GLN . 12.3 ttm180 -131.19 133.27 45.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.677 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.812 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 13.6 p -122.38 139.68 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 89.0 m-20 61.17 -94.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 111.042 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . 0.669 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 7.8 pt-20 177.86 -26.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' C' ' 103' ' ' ILE . 59.2 p -65.69 -67.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.35 139.17 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -142.07 155.34 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.229 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.69 146.42 34.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.489 ' HG3' ' HE2' ' B' ' 46' ' ' PHE . 8.2 tmtt? -155.3 130.24 9.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.163 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.1 175.48 12.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.09 -173.71 37.57 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.536 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' C' ' 71' ' ' ILE . 14.7 p -141.91 143.21 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.078 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.896 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -115.2 144.14 44.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.348 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -119.26 119.13 33.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -128.0 135.29 49.7 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.672 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.617 ' HA3' ' CD ' ' C' ' 34' ' ' LYS . . . 60.64 -111.59 3.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.279 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 56.7 m -149.67 10.38 0.73 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.294 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -165.15 23.93 0.05 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 37.0 m-20 -116.37 67.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.13 139.72 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.896 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 7.1 ptp -134.22 135.52 43.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.87 118.77 35.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.403 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.1 152.61 23.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.715 0.293 . . . . 0.0 111.382 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.511 ' HB3' HD11 ' B' ' 45' ' ' LEU . 14.4 m -118.65 169.12 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.403 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.12 135.94 31.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.042 0.449 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.661 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.9 m-80 -104.24 132.8 50.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.435 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' C' ' 80' ' ' SER . 0.1 OUTLIER -138.17 114.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.719 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -115.97 157.96 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.8 m-90 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.706 179.624 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' O ' HD22 ' A' ' 21' ' ' LEU . 34.6 ttmt . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.733 0.302 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.75 -39.7 80.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.889 0.376 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -66.81 -42.89 85.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.779 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.7 -41.39 96.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.1 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.758 HD21 HD23 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -62.9 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.83 -30.72 71.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.73 -39.11 57.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.768 HD21 ' HG ' ' B' ' 25' ' ' LEU . 8.0 mt -67.25 -50.98 58.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.571 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.78 -50.91 72.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.826 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HE2' ' CZ ' ' A' ' 31' ' ' ARG . 9.5 tmtt? -54.78 -38.26 67.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.279 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -62.39 -42.69 99.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -63.54 -41.7 98.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.997 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.796 HG22 ' HE2' ' A' ' 34' ' ' LYS . 4.4 m -57.91 -47.12 83.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.764 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.614 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 83.2 mmt-85 -59.45 -35.5 74.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.318 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.861 HG22 HG11 ' C' ' 32' ' ' VAL . 41.7 t -73.75 -36.5 46.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.99 -55.88 16.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.995 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.814 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 3.4 pttt -72.35 -36.5 68.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.774 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.13 96.33 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.369 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.565 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -70.14 -37.13 75.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.805 0.336 . . . . 0.0 111.08 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.72 99.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.463 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -69.58 -54.38 14.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.753 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.545 ' HB3' HD21 ' C' ' 36' ' ' LEU . 86.9 p -49.07 -56.21 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -52.49 -52.61 53.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.471 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.16 -41.58 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.537 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 30.8 tp -73.88 -34.89 64.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.09 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.4 m-20 -78.25 -5.12 51.01 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.404 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.5 t -86.13 -0.6 56.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.12 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -95.97 172.18 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.881 177.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.427 ' H ' ' H ' ' A' ' 47' ' ' GLN . 10.3 p90 -165.76 -5.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.662 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 35.1 mt-30 65.83 118.9 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.945 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.395 9.8 Cg_endo -69.89 98.2 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.692 2.261 . . . . 0.0 112.54 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 66.94 -165.0 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 146.16 82.25 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 79' ' ' GLU . 8.7 p -88.72 -11.03 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.094 0.558 . . . . 0.0 112.477 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 158.34 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.296 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.01 -166.7 2.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.558 0.218 . . . . 0.0 110.65 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.5 144.05 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.428 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 4.4 m-80 -131.06 134.83 47.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.652 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.476 ' O ' HG13 ' B' ' 103' ' ' ILE . 1.2 t80 -104.53 121.92 44.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.275 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.702 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 21.1 p -114.57 124.86 52.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.19 150.81 29.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.41 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.19 164.01 26.17 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.491 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 69' ' ' LEU . 14.5 m -110.21 166.33 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 111.373 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -174.43 22.35 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.53 143.21 8.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.554 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.636 ' CE2' ' HG3' ' A' ' 64' ' ' ARG . 63.2 t80 -132.51 137.1 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.727 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.636 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 2.9 mmm180 61.52 -80.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 63' ' ' TYR . 12.0 t -156.64 32.27 0.31 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -130.11 167.42 18.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.01 142.15 48.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.137 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.43 47.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.61 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.2 tp -111.32 128.48 55.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.729 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -122.95 152.09 41.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.708 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.429 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.7 tt -147.54 162.06 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.289 . . . . 0.0 111.183 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 175.35 169.34 37.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.408 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 p -163.29 147.71 11.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.73 161.85 28.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.245 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.29 119.48 39.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.154 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.484 ' CB ' ' HA3' ' A' ' 50' ' ' GLY . 4.9 mmm180 -96.9 99.21 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.707 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.697 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.0 p -98.23 130.72 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.332 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.48 ' OD1' HG22 ' A' ' 77' ' ' VAL . 8.1 m120 66.27 -170.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.932 0.396 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 51' ' ' VAL . 38.5 mt-10 -120.05 24.53 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.551 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.584 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 5.0 t -129.01 -44.75 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.28 148.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.494 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.845 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -152.07 171.15 18.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 111.205 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.82 143.23 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.606 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.5 23.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.26 135.95 23.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.39 175.04 39.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 96' ' ' MET . 6.3 p -124.08 146.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB3' ' SD ' ' A' ' 96' ' ' MET . . . -114.11 134.09 55.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.27 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.86 110.69 22.1 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.259 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -122.75 132.43 54.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.522 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.84 -113.15 4.04 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.263 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.85 -60.76 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 111.322 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.4 t -101.53 29.77 4.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.221 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.99 1.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.4 142.34 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.748 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.577 ' HB2' ' HA ' ' C' ' 63' ' ' TYR . 0.9 OUTLIER -132.57 155.59 48.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -128.48 129.02 45.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.522 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -119.7 160.33 22.74 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.17 99.02 0.12 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.796 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.751 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.2 p -122.67 179.45 4.61 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.43 146.36 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.845 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.4 m-80 -111.9 150.02 31.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.362 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.482 HG13 ' O ' ' C' ' 56' ' ' PHE . 3.9 pt -156.18 150.99 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.584 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 73.7 mt-10 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.485 ' O ' HD22 ' B' ' 21' ' ' LEU . 34.7 ttmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.75 0.31 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -39.83 80.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -66.76 -42.92 85.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -41.4 96.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.109 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.765 HD23 HD21 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -62.84 -43.4 98.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.89 -30.69 71.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.78 -39.11 57.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -73.02 -38.36 66.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.813 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.772 HD21 ' HG ' ' C' ' 25' ' ' LEU . 8.0 mt -67.18 -51.03 58.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.61 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.83 -50.89 72.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.799 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.499 ' HE2' ' CZ ' ' B' ' 31' ' ' ARG . 9.5 tmtt? -54.8 -38.27 67.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.277 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.571 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -62.41 -42.63 99.58 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.52 -41.74 98.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.969 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.804 HG22 ' HE2' ' B' ' 34' ' ' LYS . 4.4 m -57.94 -47.07 83.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.603 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 83.1 mmt-85 -59.37 -35.56 74.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.352 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.851 HG22 HG11 ' A' ' 32' ' ' VAL . 41.7 t -73.78 -36.56 46.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.201 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.0 -55.86 16.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.955 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.814 ' HB2' ' HB1' ' B' ' 90' ' ' ALA . 3.4 pttt -72.33 -36.58 68.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.744 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.91 -45.05 96.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.382 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -70.12 -37.23 75.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.79 99.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.427 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.756 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -69.56 -54.33 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.565 ' HB3' HD21 ' A' ' 36' ' ' LEU . 86.9 p -49.16 -56.25 9.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.017 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.54 54.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.465 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.23 -41.56 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.864 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.54 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 30.7 tp -73.89 -34.88 64.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.112 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.544 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.1 m-20 -78.13 -5.23 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.417 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -86.05 -0.65 56.1 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.141 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -95.83 172.21 8.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.894 177.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -165.84 -5.24 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.097 0.475 . . . . 0.0 111.654 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' B' ' 55' ' ' ASN . 35.1 mt-30 65.86 118.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.395 9.7 Cg_endo -69.88 98.36 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.638 2.225 . . . . 0.0 112.552 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 66.75 -164.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 146.15 82.31 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.188 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' B' ' 79' ' ' GLU . 8.7 p -88.78 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.144 0.578 . . . . 0.0 112.422 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.683 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 158.25 46.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.259 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.1 -166.69 2.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.586 0.231 . . . . 0.0 110.628 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 1.175 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.6 p -109.52 144.12 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.561 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.428 ' HB2' ' OE1' ' B' ' 47' ' ' GLN . 4.4 m-80 -131.12 134.79 46.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.013 0.435 . . . . 0.0 111.61 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.47 ' O ' HG13 ' C' ' 103' ' ' ILE . 1.2 t80 -104.55 121.96 44.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.24 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.682 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 21.1 p -114.59 124.86 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.22 150.75 29.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.484 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.529 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.25 164.01 26.22 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.575 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 69' ' ' LEU . 14.4 m -110.26 166.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.61 -174.42 22.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.462 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.52 143.15 8.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.635 ' CE2' ' HG3' ' B' ' 64' ' ' ARG . 63.5 t80 -132.48 137.0 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.291 . . . . 0.0 110.765 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.635 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 2.9 mmm180 61.54 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.029 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 63' ' ' TYR . 12.2 t -156.69 32.3 0.31 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.158 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -130.17 167.46 18.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.802 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.02 142.15 48.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.62 155.49 47.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.529 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.1 tp -111.33 128.44 55.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.724 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -123.0 152.17 41.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.429 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.7 tt -147.56 162.0 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.751 0.31 . . . . 0.0 111.073 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.429 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 175.38 169.35 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.47 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -163.25 147.71 11.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.76 161.89 28.97 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.255 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.34 119.51 39.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.161 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.492 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 5.0 mmm180 -96.96 99.15 10.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.683 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.9 p -98.08 130.71 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.328 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.474 ' OD1' HG22 ' B' ' 77' ' ' VAL . 8.1 m120 66.17 -170.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.899 0.381 . . . . 0.0 111.154 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.504 ' HG3' HG23 ' B' ' 51' ' ' VAL . 38.6 mt-10 -120.0 24.59 10.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.598 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.583 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 5.0 t -129.07 -44.72 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.963 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.33 148.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.851 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -152.01 171.22 18.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.224 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.26 9.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.43 23.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.17 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.27 135.96 23.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.38 175.04 39.69 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.448 HG23 ' O ' ' B' ' 96' ' ' MET . 6.3 p -124.1 146.53 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.5 ' HB3' ' SD ' ' B' ' 96' ' ' MET . . . -114.09 134.09 55.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.89 110.74 22.15 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -122.78 132.45 54.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.574 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.521 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.95 -113.28 4.21 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.259 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.87 -60.67 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.343 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . 0.527 ' OG ' ' O ' ' B' ' 93' ' ' SER . 2.3 t -101.6 29.75 4.69 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.258 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -119.72 82.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.988 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.47 142.35 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.017 0.437 . . . . 0.0 110.703 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.554 ' HB2' ' HA ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -132.49 155.63 48.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -128.5 128.93 45.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.492 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.6 160.27 22.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.688 0.28 . . . . 0.0 111.476 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.18 99.04 0.12 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.738 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.733 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.3 p -122.67 179.47 4.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.452 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -140.43 146.26 38.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.851 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.4 m-80 -111.82 150.0 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.374 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 56' ' ' PHE . 4.0 pt -156.1 150.97 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.761 0.315 . . . . 0.0 110.825 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 73.7 mt-10 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.487 ' O ' HD22 ' C' ' 21' ' ' LEU . 34.6 ttmt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.758 0.313 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -39.88 80.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.202 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 49.7 mtt85 -66.7 -42.88 85.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.68 -41.41 96.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.765 HD21 HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -62.87 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -75.76 -39.15 57.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.772 ' HG ' HD21 ' B' ' 25' ' ' LEU . 8.0 mt -67.2 -51.02 58.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -58.77 -50.85 72.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.5 ' HE2' ' CZ ' ' C' ' 31' ' ' ARG . 9.5 tmtt? -54.91 -38.21 67.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.254 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.576 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -62.33 -42.72 99.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.48 -41.77 98.57 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.989 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.786 HG22 ' HE2' ' C' ' 34' ' ' LYS . 4.4 m -57.89 -46.99 84.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.861 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.6 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 83.2 mmt-85 -59.48 -35.54 74.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.291 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.861 HG11 HG22 ' A' ' 32' ' ' VAL . 42.0 t -73.8 -36.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.164 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.89 -55.88 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.073 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.826 ' HB2' ' HB1' ' C' ' 90' ' ' ALA . 3.3 pttt -72.39 -36.56 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.732 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.78 -45.18 96.27 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.375 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -70.07 -37.13 75.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.84 0.352 . . . . 0.0 111.149 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.82 99.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.428 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -69.5 -54.39 14.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.776 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.555 ' HB3' HD21 ' B' ' 36' ' ' LEU . 87.0 p -49.09 -56.18 9.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.073 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.404 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -52.6 -52.55 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.395 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.29 -41.4 37.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.534 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 30.6 tp -74.0 -34.87 64.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.113 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 75.3 m-20 -78.18 -5.13 50.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . 0.402 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.5 t -86.09 -0.63 56.09 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.156 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -95.95 172.18 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.892 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.407 ' H ' ' H ' ' C' ' 47' ' ' GLN . 10.4 p90 -165.76 -5.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.133 0.492 . . . . 0.0 111.66 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 35.1 mt-30 65.75 118.93 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.944 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.396 9.8 Cg_endo -69.91 98.23 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.641 2.227 . . . . 0.0 112.565 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 66.96 -164.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 146.17 82.24 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.254 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' C' ' 79' ' ' GLU . 8.8 p -88.77 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.391 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 158.26 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.273 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -142.93 -166.67 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.657 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.54 144.04 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.511 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.42 ' HB2' ' OE1' ' C' ' 47' ' ' GLN . 4.4 m-80 -131.1 134.83 46.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.067 0.46 . . . . 0.0 111.624 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . 0.482 ' O ' HG13 ' A' ' 103' ' ' ILE . 1.2 t80 -104.62 122.01 44.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.179 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.686 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 21.0 p -114.59 124.85 52.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.95 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.2 150.76 29.35 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.23 164.03 26.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' C' ' 69' ' ' LEU . 14.4 m -110.28 166.4 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.62 -174.4 22.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.48 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 143.1 8.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.573 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' C' ' 64' ' ' ARG . 62.9 t80 -132.45 137.06 47.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.633 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 2.9 mmm180 61.59 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.045 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . 0.406 ' N ' ' O ' ' C' ' 63' ' ' TYR . 12.1 t -156.68 32.33 0.31 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -130.19 167.5 18.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.05 142.17 48.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.5 47.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.569 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.1 tp -111.33 128.35 55.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -122.97 152.11 41.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.726 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.434 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.7 tt -147.47 162.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.179 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.434 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 175.3 169.32 36.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.438 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 36.2 p -163.24 147.69 11.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.7 161.91 28.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.273 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.3 119.44 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 111.144 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.492 ' CB ' ' HA3' ' C' ' 50' ' ' GLY . 4.9 mmm180 -96.85 99.16 10.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.772 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.689 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.0 p -98.19 130.62 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.321 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' C' ' 77' ' ' VAL . 8.1 m120 66.37 -171.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' C' ' 51' ' ' VAL . 38.8 mt-10 -120.03 24.56 10.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.561 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . 0.583 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 5.0 t -129.0 -44.74 1.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.987 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.2 148.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.552 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -152.02 171.21 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.234 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.22 9.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.52 23.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.145 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 135.91 23.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.02 39.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.609 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . 0.456 HG23 ' O ' ' C' ' 96' ' ' MET . 6.3 p -124.02 146.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.89 0.376 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.513 ' HB3' ' SD ' ' C' ' 96' ' ' MET . . . -114.03 134.02 55.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.423 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -108.85 110.78 22.21 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.252 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.826 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -122.77 132.41 54.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.59 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.544 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.97 -113.18 4.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.209 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.92 -60.73 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.3 t -101.59 29.79 4.67 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.35 142.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.58 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 0.9 OUTLIER -132.55 155.63 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.687 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -128.5 129.03 45.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.403 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.69 160.29 22.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.666 0.27 . . . . 0.0 111.504 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.2 99.03 0.12 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.721 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.1 p -122.79 179.49 4.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.435 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -140.47 146.28 38.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.836 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.4 m-80 -111.77 150.02 30.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.369 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.47 HG13 ' O ' ' B' ' 56' ' ' PHE . 3.9 pt -156.18 150.96 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 73.8 mt-10 -96.32 130.55 43.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 1.175 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.6 t-105 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.728 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.73 0.3 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.29 -26.56 62.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.321 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -66.23 -53.73 33.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.742 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.82 -26.96 61.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.94 0.4 . . . . 0.0 111.188 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.89 -59.99 4.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.556 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -74.71 -47.76 29.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 54.4 mtp85 -74.87 -37.58 62.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.76 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.711 HD11 HD22 ' B' ' 25' ' ' LEU . 2.8 mm? -63.77 -52.67 59.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -57.0 -42.48 80.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.45 -31.68 72.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.276 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -45.88 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.476 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -66.73 -31.47 72.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.964 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.37 -35.9 71.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.81 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.646 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -71.96 -39.61 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.8 m -75.85 -30.88 21.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.589 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 26.2 m-20 -68.38 -45.46 72.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.646 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.7 ptpt -75.51 -40.61 56.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.31 99.05 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.383 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.502 HD21 ' HG ' ' B' ' 36' ' ' LEU . 0.6 OUTLIER -74.37 -27.05 60.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -70.08 -41.48 74.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.465 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 8.2 t -82.98 -38.95 21.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.781 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.487 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 3.2 t -57.99 -55.78 30.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.496 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -60.74 -33.6 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.433 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.13 76.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.668 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 64.7 tp -81.06 -35.79 31.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.079 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 84.2 m-20 -75.3 -14.38 60.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.85 -22.31 65.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.171 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.748 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.3 mm? -74.32 165.83 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.875 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.558 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 2.5 p90 -157.06 -3.3 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 111.663 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 9.1 mt-30 65.43 125.04 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.912 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -88.49 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.673 2.249 . . . . 0.0 112.589 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 11.5 m-30 66.93 -177.51 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.53 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.279 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -79.96 -12.51 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.168 0.587 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.34 52.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.266 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -163.95 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.57 141.72 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.526 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -120.93 114.17 21.16 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.698 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.72 130.46 35.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.262 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.748 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 36.9 p -109.47 126.69 53.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.6 129.75 7.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.406 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.604 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -174.25 165.18 36.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.558 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 69' ' ' LEU . 16.0 m -119.44 160.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.339 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.24 17.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.489 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -170.15 137.88 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.552 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.589 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 17.8 t80 -123.87 135.0 53.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.708 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 1.7 mmm180 68.54 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.074 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.65 23.51 1.12 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.139 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.0 m -128.86 141.74 51.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.91 27.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -145.92 173.83 11.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.564 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -121.88 143.29 49.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.776 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -130.75 135.39 47.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.707 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.467 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 174.02 -178.49 45.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.446 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.31 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.85 28.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.283 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.66 134.49 50.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.165 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -122.46 126.22 47.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.733 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.42 137.99 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 29.8 m-20 60.93 -96.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 111.083 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.36 -19.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.594 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.0 p -73.19 -62.13 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.014 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.69 146.34 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.515 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.749 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -147.39 156.16 42.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.265 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.19 147.2 29.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.683 ' HE3' HG21 ' A' ' 57' ' ' THR . 10.9 tmtt? -150.49 138.83 20.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.155 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.069 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 164.0 -176.0 40.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.529 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 p -142.98 137.68 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.554 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -108.89 144.55 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -117.91 114.55 23.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -120.19 130.81 54.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.599 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.49 -115.84 8.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.242 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.59 7.26 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.343 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 24.74 0.27 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.204 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.435 ' CG ' ' HD2' ' A' ' 34' ' ' LYS . 18.3 m-20 -127.51 80.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.9 t -112.32 139.18 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 110.684 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.554 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 6.8 ptp -133.23 141.31 47.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -112.52 126.01 54.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.475 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.71 152.11 26.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 111.402 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.54 87.24 0.39 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.791 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.612 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 11.3 m -118.25 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.441 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -132.4 147.62 52.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.922 0.392 . . . . 0.0 111.136 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.749 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 49.1 m-80 -111.77 130.55 55.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.34 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.02 115.99 22.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' CG ' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.717 0.294 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.35 -26.49 62.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -66.27 -53.68 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -72.84 -26.99 61.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.8 -60.03 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.83 -17.84 64.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.68 -47.77 29.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.41 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 54.4 mtp85 -74.93 -37.54 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.759 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.711 HD22 HD11 ' A' ' 25' ' ' LEU . 2.8 mm? -63.73 -52.68 59.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.96 -42.58 80.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' B' ' 27' ' ' LYS . 0.9 OUTLIER -63.38 -31.77 73.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.238 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -45.88 92.67 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.46 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -66.69 -31.5 72.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -71.34 -35.93 71.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.662 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.0 OUTLIER -71.89 -39.74 69.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.8 m -75.76 -30.92 21.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.586 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 26.1 m-20 -68.4 -45.34 72.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.016 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.7 ptpt -75.52 -40.62 56.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.806 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.3 99.16 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.32 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.502 ' HG ' HD21 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.36 -27.03 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.456 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -70.02 -41.56 74.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.472 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 8.2 t -82.96 -38.93 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.491 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.2 t -58.08 -55.8 30.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.498 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -60.74 -33.58 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.363 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -34.11 76.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.65 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 64.7 tp -81.08 -35.78 31.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 84.1 m-20 -75.29 -14.31 60.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 28.9 t -67.93 -22.36 65.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.088 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.76 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -74.2 165.8 24.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.901 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.561 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 2.5 p90 -157.07 -3.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 65.39 125.02 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.954 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -88.51 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.722 2.282 . . . . 0.0 112.557 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 11.5 m-30 66.88 -177.5 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.6 57.49 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.314 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -79.92 -12.53 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.162 0.585 . . . . 0.0 112.459 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.3 52.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.213 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -164.0 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.644 0.259 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.52 141.71 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.552 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -120.9 114.27 21.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.968 0.414 . . . . 0.0 111.701 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -82.83 130.43 35.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.299 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.76 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.2 p -109.41 126.7 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.023 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.77 7.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.461 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.609 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -174.24 165.15 36.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.563 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' B' ' 69' ' ' LEU . 16.0 m -119.41 160.79 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.18 16.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.467 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -170.13 137.84 4.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.617 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.586 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 17.8 t80 -123.8 135.08 53.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 1.7 mmm180 68.44 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.58 23.46 1.13 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.67 51.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.53 151.9 27.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 111.093 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -145.89 173.94 11.69 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.563 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.9 OUTLIER -121.97 143.27 49.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.764 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -130.75 135.43 47.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.687 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.479 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.76 0.314 . . . . 0.0 111.098 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.479 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 173.96 -178.49 45.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.446 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.49 146.4 5.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.965 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.64 162.76 28.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.279 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.63 134.55 50.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -122.47 126.31 47.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.56 138.06 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 29.6 m-20 60.88 -96.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 111.086 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.4 -19.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.9 p -73.18 -62.2 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 m -91.58 146.39 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.564 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -147.47 156.11 42.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.268 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.14 147.19 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.617 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.675 ' HE3' HG21 ' B' ' 57' ' ' THR . 11.0 tmtt? -150.48 138.87 20.44 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.47 173.29 14.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 164.0 -175.95 40.07 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.565 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.99 137.71 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -108.89 144.52 36.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.321 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -117.99 114.56 23.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.228 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -120.21 130.76 54.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.605 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.57 -115.86 8.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.326 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.6 7.24 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 111.36 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.89 24.72 0.27 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.213 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.436 ' CG ' ' HD2' ' B' ' 34' ' ' LYS . 18.2 m-20 -127.51 80.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.42 139.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.06 0.457 . . . . 0.0 110.633 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.552 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 6.8 ptp -133.18 141.28 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.678 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.51 126.03 54.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.437 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.62 152.09 26.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 111.493 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.53 87.27 0.4 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.843 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.604 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 11.3 m -118.24 166.22 12.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.396 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -132.37 147.61 52.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.939 0.399 . . . . 0.0 111.065 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 49.3 m-80 -111.71 130.62 55.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.412 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.99 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.442 ' CG ' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.66 0.267 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.4 -26.46 62.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.243 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 47.7 mtt-85 -66.29 -53.68 33.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.8 -26.97 61.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.186 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.92 -60.0 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.53 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -65.8 -17.85 64.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.67 -47.74 30.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.425 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 54.5 mtp85 -74.95 -37.51 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.785 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.683 HD22 HD11 ' B' ' 25' ' ' LEU . 2.8 mm? -63.87 -52.57 59.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -57.05 -42.49 80.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 27' ' ' LYS . 0.9 OUTLIER -63.51 -31.71 72.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.609 0.242 . . . . 0.0 111.215 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' C' ' 28' ' ' LEU . 0.0 OUTLIER -61.25 -45.97 92.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . 0.467 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -66.65 -31.51 72.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.975 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.35 -35.79 71.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.873 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.665 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -72.05 -39.62 68.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.282 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.8 m -75.83 -30.84 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.605 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 26.1 m-20 -68.45 -45.35 72.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.665 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.7 ptpt -75.58 -40.62 56.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.14 99.11 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.395 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.499 HD21 ' HG ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.47 -27.08 60.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.833 0.349 . . . . 0.0 111.043 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.459 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -70.04 -41.49 74.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.458 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 8.2 t -83.08 -38.82 21.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.486 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 3.2 t -58.02 -55.85 29.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.494 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -60.75 -33.52 73.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.447 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.06 76.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.946 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.646 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 64.8 tp -81.14 -35.75 31.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 84.2 m-20 -75.33 -14.33 60.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.82 -22.37 65.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.158 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -74.27 165.83 24.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.862 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.553 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 2.5 p90 -157.1 -3.24 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.126 0.488 . . . . 0.0 111.654 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 9.0 mt-30 65.42 124.97 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.988 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -88.45 109.26 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.643 2.229 . . . . 0.0 112.591 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 11.5 m-30 66.8 -177.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.944 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.5 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.258 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -79.84 -12.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.195 0.598 . . . . 0.0 112.466 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.45 52.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.265 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.96 -164.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.615 0.245 . . . . 0.0 110.573 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.54 141.69 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.56 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -120.94 114.19 21.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.65 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -82.67 130.45 35.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.3 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.75 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 37.1 p -109.41 126.7 53.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.987 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.71 7.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.395 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.612 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -174.23 165.23 36.72 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.512 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' C' ' 69' ' ' LEU . 16.0 m -119.43 160.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.46 -168.24 16.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.478 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -170.17 137.86 4.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.605 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 17.9 t80 -123.8 135.14 53.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 110.702 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 1.7 mmm180 68.39 -89.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.6 23.45 1.13 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.77 51.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.807 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.83 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.09 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -145.83 173.93 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.578 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.431 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.9 OUTLIER -121.97 143.25 49.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.716 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.646 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -130.74 135.38 47.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.65 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.477 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.0 tp -134.1 159.31 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.706 0.288 . . . . 0.0 111.203 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.477 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 174.05 -178.47 45.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.434 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.4 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.995 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.68 162.78 28.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.262 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -126.66 134.57 50.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.365 . . . . 0.0 111.148 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -122.44 126.21 47.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.778 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.48 137.97 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 29.8 m-20 60.99 -96.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.063 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.39 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.612 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 8.1 p -73.14 -62.18 1.56 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.66 146.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.762 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -147.42 156.16 42.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.15 147.21 29.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.591 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.693 ' HE3' HG21 ' C' ' 57' ' ' THR . 10.9 tmtt? -150.53 138.85 20.36 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.34 14.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 163.95 -175.85 40.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.597 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.01 137.71 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -108.95 144.53 36.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.357 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -117.87 114.61 23.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.261 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -120.12 130.8 54.8 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -115.76 7.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -146.67 7.22 0.96 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.29 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.92 24.8 0.27 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.235 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.432 ' CG ' ' HD2' ' C' ' 34' ' ' LYS . 18.5 m-20 -127.62 80.84 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 65.1 t -112.34 139.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.67 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.55 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 6.8 ptp -133.25 141.34 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.733 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.59 125.97 54.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.55 152.06 25.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.504 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.52 87.19 0.39 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.815 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.609 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 11.1 m -118.26 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -132.43 147.56 52.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.912 0.386 . . . . 0.0 111.058 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.762 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 49.4 m-80 -111.71 130.57 55.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.97 22.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -118.71 158.79 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.688 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.667 ' HB2' ' HE2' ' B' ' 17' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.631 0.253 . . . . 0.0 110.525 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -35.02 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 111.26 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.19 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.459 HE22 ' HG ' ' C' ' 21' ' ' LEU . 1.7 pp0? -60.44 -28.38 68.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.696 HD11 ' HD3' ' B' ' 24' ' ' ARG . 2.2 tm? -64.99 -59.43 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.81 -23.08 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.05 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.01 -55.18 15.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.696 ' HD3' HD11 ' C' ' 21' ' ' LEU . 69.5 mtp85 -70.34 -38.21 74.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.779 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.929 HD11 HD22 ' B' ' 25' ' ' LEU . 3.7 mm? -63.75 -48.28 77.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.04 -31.73 73.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 2.1 ttpp -65.34 -42.59 92.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.692 0.282 . . . . 0.0 111.288 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -63.35 -43.93 96.31 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.17 -30.01 64.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.925 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.589 HG22 ' HE2' ' A' ' 34' ' ' LYS . 5.6 m -79.71 -29.67 40.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.792 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 -26.64 46.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.32 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.62 -28.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.219 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.643 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 76.1 m-20 -75.95 -45.07 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.984 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.589 ' HE2' HG22 ' A' ' 30' ' ' THR . 5.2 ptpt -84.1 -29.1 27.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.74 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 39' ' ' SER . . . -68.65 -42.42 80.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.422 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -80.58 -25.59 38.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.105 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.19 -41.38 58.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.49 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 10.4 t -77.47 -42.58 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.758 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -62.39 -50.87 69.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.467 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . . . -59.97 -36.95 78.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.34 -42.59 44.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -71.65 -7.87 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.77 -23.84 63.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.147 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.7 mm? -82.19 165.82 20.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.862 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.7 p90 -153.28 -3.85 0.2 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.636 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HB3' ' CB ' ' A' ' 55' ' ' ASN . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.922 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -79.65 113.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.613 2.209 . . . . 0.0 112.487 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.43 173.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.016 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 52.98 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.23 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 7.6 p -72.57 -3.83 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.162 0.585 . . . . 0.0 112.45 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 145.57 52.56 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.341 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -169.6 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 110.615 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 75' ' ' TYR . 12.4 p -109.56 142.66 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.573 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' GLN . 23.9 m-80 -122.88 119.0 29.21 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 58' ' ' ALA . 34.6 t80 -87.25 133.85 33.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.242 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.551 HG21 ' CE ' ' A' ' 84' ' ' LYS . 81.8 p -115.35 120.03 38.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 56' ' ' PHE . . . -150.65 135.4 17.39 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.425 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.51 169.03 39.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.534 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 69' ' ' LEU . 15.6 m -120.57 154.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.26 -172.83 13.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.437 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.0 140.2 6.22 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.643 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 31.9 t80 -133.25 135.1 44.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.708 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.2 mmm180 66.61 -93.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.125 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 p -145.68 31.16 1.07 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.44 141.02 45.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.33 153.9 22.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.08 170.57 17.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.541 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -119.38 141.15 49.32 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . . . -126.23 140.78 52.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.732 0.301 . . . . 0.0 111.637 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -140.95 151.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.093 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.12 174.72 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.438 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.97 155.05 5.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.23 173.13 29.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.252 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.559 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 44.6 t80 -126.48 135.48 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.14 135.34 52.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.754 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.431 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 7.6 p -119.35 137.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.34 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 90.4 m-20 64.13 -94.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 6.2 pt-20 179.11 -23.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.604 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.92 -63.95 1.0 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.536 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.005 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -141.27 152.0 44.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.247 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 63.5 tp -134.37 140.28 46.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.551 ' CE ' HG21 ' A' ' 57' ' ' THR . 7.3 tmtt? -155.58 126.28 6.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.72 178.05 10.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.96 36.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.56 141.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 111.165 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.734 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -111.72 139.4 47.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.346 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -114.02 114.39 26.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.173 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -123.44 135.96 54.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.639 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.448 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 57.09 -116.81 8.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.31 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 72.5 m -148.61 16.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.74 0.305 . . . . 0.0 111.316 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.71 20.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.19 68.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.96 139.04 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.73 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.734 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 3.3 ptp -133.26 132.97 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.748 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -110.74 118.59 36.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -107.11 152.68 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.12 0.65 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.773 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 21.6 m -123.82 176.31 6.37 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.448 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.48 139.44 25.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.922 0.392 . . . . 0.0 111.105 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 1.005 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.6 m-80 -103.2 132.8 49.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.346 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.59 117.39 17.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.802 0.334 . . . . 0.0 110.811 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.667 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.649 0.262 . . . . 0.0 110.53 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.41 -35.16 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.194 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.74 -59.24 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.446 HE22 ' HG ' ' A' ' 21' ' ' LEU . 1.7 pp0? -60.37 -28.45 68.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.173 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.705 HD11 ' HD3' ' C' ' 24' ' ' ARG . 2.1 tm? -64.85 -59.56 4.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.574 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -65.77 -23.0 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.059 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.08 -55.16 15.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.696 ' HD3' HD11 ' A' ' 21' ' ' LEU . 69.5 mtp85 -70.36 -38.19 74.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.934 HD11 HD22 ' C' ' 25' ' ' LEU . 3.7 mm? -63.8 -48.34 77.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.588 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.98 -31.66 72.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.591 ' HZ1' HD22 ' B' ' 28' ' ' LEU . 2.1 ttpp -65.48 -42.61 92.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.199 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.591 HD22 ' HZ1' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -63.22 -44.02 96.47 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.21 -29.96 64.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.926 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.591 HG22 ' HE2' ' B' ' 34' ' ' LYS . 5.6 m -79.75 -29.55 40.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -26.54 46.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.326 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.71 -28.57 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.142 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.657 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 76.2 m-20 -75.97 -44.99 37.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.988 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' B' ' 30' ' ' THR . 5.3 ptpt -84.19 -29.04 26.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.715 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' B' ' 39' ' ' SER . . . -68.79 -42.29 79.74 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.419 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.462 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.5 mt -80.66 -25.54 38.21 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.752 0.311 . . . . 0.0 111.034 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.11 -41.52 58.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.51 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 10.4 t -77.39 -42.6 35.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.785 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 0.9 OUTLIER -62.38 -50.87 69.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.88 85.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.475 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' B' ' 70' ' ' ALA . . . -59.94 -37.04 78.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.405 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 39.7 tp -76.33 -42.53 44.65 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.07 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -71.68 -7.87 50.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.4 t -69.73 -23.89 63.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.316 -0.856 . . . . 0.0 113.172 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.564 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.7 mm? -82.18 165.88 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.883 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 7.7 p90 -153.35 -3.8 0.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.109 0.48 . . . . 0.0 111.671 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.435 ' HB3' ' CB ' ' B' ' 55' ' ' ASN . 10.1 mt-30 72.03 117.26 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -79.55 113.53 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.645 2.23 . . . . 0.0 112.506 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.48 173.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.71 53.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.289 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 7.7 p -72.57 -3.9 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.117 0.567 . . . . 0.0 112.465 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 145.58 52.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.248 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -169.58 3.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.611 0.243 . . . . 0.0 110.606 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' B' ' 75' ' ' TYR . 12.4 p -109.59 142.65 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.538 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.435 ' CB ' ' HB3' ' B' ' 47' ' ' GLN . 24.0 m-80 -122.91 118.97 29.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.93 0.395 . . . . 0.0 111.697 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.447 ' HE2' ' HB2' ' B' ' 58' ' ' ALA . 34.5 t80 -87.17 133.83 33.6 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.245 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.558 HG21 ' CE ' ' B' ' 84' ' ' LYS . 81.8 p -115.38 119.95 37.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.949 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.447 ' HB2' ' HE2' ' B' ' 56' ' ' PHE . . . -150.58 135.43 17.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.475 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.479 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.49 168.98 39.25 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.539 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' B' ' 69' ' ' LEU . 15.6 m -120.52 154.79 23.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.806 0.336 . . . . 0.0 111.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.33 -172.81 13.38 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.409 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.01 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.657 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 32.0 t80 -133.21 134.98 44.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.74 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.2 mmm180 66.69 -93.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.087 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.63 31.14 1.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.173 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.47 140.98 45.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.35 153.93 22.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.62 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.579 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.531 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -119.5 141.2 49.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' B' ' 41' ' ' ALA . . . -126.25 140.64 52.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 71' ' ' ILE . 8.3 tp -140.9 151.84 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.742 0.306 . . . . 0.0 111.11 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.21 174.65 39.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.396 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.94 155.12 5.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.342 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.21 173.19 29.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.245 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.557 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 44.8 t80 -126.55 135.58 51.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.22 135.34 52.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.659 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.437 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 7.6 p -119.4 137.4 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 90.2 m-20 64.11 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 6.2 pt-20 179.1 -23.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.589 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 17.5 p -70.8 -63.98 0.99 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.98 143.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.58 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -141.29 152.07 44.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.271 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 63.6 tp -134.32 140.2 46.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.604 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.558 ' CE ' HG21 ' B' ' 57' ' ' THR . 7.3 tmtt? -155.6 126.13 6.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.141 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.44 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.59 178.07 10.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.88 36.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.534 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.411 ' O ' HG22 ' B' ' 71' ' ' ILE . 7.7 p -143.66 141.44 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.74 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -111.82 139.35 47.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.325 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -113.95 114.37 26.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.205 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -123.36 136.01 54.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.644 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 57.06 -116.92 8.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.248 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.52 16.64 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.75 20.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.197 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -119.22 68.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.957 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.14 139.06 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.74 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 3.3 ptp -133.31 132.99 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.74 118.63 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.415 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.13 152.66 23.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.685 0.279 . . . . 0.0 111.412 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.98 94.11 0.65 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.472 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 21.8 m -123.81 176.44 6.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.391 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -146.65 139.45 25.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.029 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.954 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.6 m-80 -103.22 132.79 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.362 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.35 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.65 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.666 0.27 . . . . 0.0 110.55 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -34.99 65.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.259 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.18 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.457 HE22 ' HG ' ' B' ' 21' ' ' LEU . 1.7 pp0? -60.44 -28.36 68.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.136 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.696 HD11 ' HD3' ' A' ' 24' ' ' ARG . 2.1 tm? -64.98 -59.44 4.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.631 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -65.86 -22.96 66.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.07 -55.17 15.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.705 ' HD3' HD11 ' B' ' 21' ' ' LEU . 69.6 mtp85 -70.33 -38.16 74.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.934 HD22 HD11 ' B' ' 25' ' ' LEU . 3.7 mm? -63.89 -48.36 76.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.87 -31.74 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.437 ' HZ1' HD22 ' C' ' 28' ' ' LEU . 2.0 ttpp -65.47 -42.51 92.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' C' ' 28' ' ' LEU . 0.0 OUTLIER -63.28 -44.0 96.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -29.96 64.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.936 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.582 HG22 ' HE2' ' C' ' 34' ' ' LYS . 5.6 m -79.8 -29.55 40.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -26.63 46.49 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.357 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.55 -28.72 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.143 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.654 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 76.2 m-20 -75.88 -45.11 37.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.005 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.582 ' HE2' HG22 ' C' ' 30' ' ' THR . 5.3 ptpt -84.08 -29.07 27.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.806 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' C' ' 39' ' ' SER . . . -68.6 -42.39 80.82 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.462 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.5 mt -80.61 -25.63 38.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.801 0.334 . . . . 0.0 111.06 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.45 57.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.402 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 10.5 t -77.43 -42.6 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' C' ' 35' ' ' GLY . 0.9 OUTLIER -62.3 -50.92 69.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.86 85.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' C' ' 70' ' ' ALA . . . -59.92 -37.02 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.94 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.41 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 39.6 tp -76.25 -42.65 45.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.035 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -71.66 -7.9 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.71 -23.91 63.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.149 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.547 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.7 mm? -82.26 165.78 20.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.813 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 7.7 p90 -153.26 -3.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.651 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' C' ' 55' ' ' ASN . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.963 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.735 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -79.61 113.5 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.667 2.245 . . . . 0.0 112.514 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.47 173.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.985 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.73 53.02 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.229 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 7.7 p -72.58 -3.85 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 145.6 52.65 0.03 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.22 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.603 0.239 . . . . 0.0 110.655 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' C' ' 75' ' ' TYR . 12.4 p -109.6 142.62 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.567 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.439 ' CB ' ' HB3' ' C' ' 47' ' ' GLN . 24.0 m-80 -122.91 118.99 29.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.646 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . 0.454 ' HE2' ' HB2' ' C' ' 58' ' ' ALA . 34.4 t80 -87.19 133.77 33.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.282 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.565 HG21 ' CE ' ' C' ' 84' ' ' LYS . 81.9 p -115.31 120.01 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.983 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.454 ' HB2' ' HE2' ' C' ' 56' ' ' PHE . . . -150.66 135.38 17.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.473 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.48 168.95 39.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' C' ' 69' ' ' LEU . 15.6 m -120.52 154.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.806 0.336 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.31 -172.88 13.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.466 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.0 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.574 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.654 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 32.1 t80 -133.19 134.99 44.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 110.812 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.2 mmm180 66.64 -93.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.133 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.61 31.12 1.08 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.43 141.05 45.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.781 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.39 153.91 22.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.54 17.56 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.539 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.53 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -119.43 141.18 49.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.747 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' C' ' 41' ' ' ALA . . . -126.24 140.69 52.34 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.702 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.408 HG22 ' O ' ' C' ' 87' ' ' VAL . 8.3 tp -140.88 151.83 20.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.14 174.72 39.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.468 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.93 155.09 5.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.24 173.15 29.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.269 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.554 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 44.6 t80 -126.56 135.54 51.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.342 . . . . 0.0 111.172 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.17 135.39 52.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.666 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.444 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 7.5 p -119.43 137.39 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 90.2 m-20 64.15 -94.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 6.2 pt-20 179.07 -23.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.527 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.99 -63.87 1.02 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.965 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -141.28 152.07 44.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.257 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 63.3 tp -134.37 140.22 46.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.565 ' CE ' HG21 ' C' ' 57' ' ' THR . 7.3 tmtt? -155.6 126.23 6.87 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.68 177.99 10.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.71 -167.82 36.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.58 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . 0.408 ' O ' HG22 ' C' ' 71' ' ' ILE . 7.7 p -143.74 141.45 25.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -111.73 139.31 47.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.316 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -113.97 114.45 26.2 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -123.45 135.95 54.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.624 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 57.11 -116.86 8.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.248 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.58 16.5 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 111.252 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.73 20.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.238 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.25 68.68 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 24.9 t -94.99 139.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.738 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.745 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 3.3 ptp -133.28 132.99 42.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.701 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.8 118.64 36.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.433 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -107.05 152.64 23.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.727 0.298 . . . . 0.0 111.432 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.1 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.479 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 21.8 m -123.8 176.37 6.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.432 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.59 139.42 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.988 0.423 . . . . 0.0 111.101 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.965 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.6 m-80 -103.21 132.8 49.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.37 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.3 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.781 0.324 . . . . 0.0 110.798 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.77 151.94 36.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.71 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.681 0.276 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.79 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.33 -60.07 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.6 -28.13 69.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.706 ' O ' HD23 ' A' ' 25' ' ' LEU . 2.4 tm? -63.37 -54.61 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.536 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' NH2' ' B' ' 24' ' ' ARG . 30.2 m-20 -65.28 -27.07 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.981 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.49 -57.53 8.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.703 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.0 mtp85 -61.6 -38.55 87.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.818 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.797 HD11 HD22 ' B' ' 25' ' ' LEU . 3.1 mm? -62.18 -48.64 79.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.531 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.9 -28.94 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.772 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' NZ ' ' HD3' ' A' ' 31' ' ' ARG . 1.2 ttpp -65.15 -44.01 89.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.642 0.258 . . . . 0.0 111.223 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.444 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -59.58 -41.66 90.74 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.553 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -61.1 -27.71 68.57 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.939 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 m -75.58 -39.82 57.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HD3' ' NZ ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -73.06 -22.81 60.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.334 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.6 m -90.28 -28.65 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.144 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.632 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 65.1 m-20 -73.63 -47.74 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 91' ' ' GLY . 7.9 ptpt -80.8 -28.47 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.759 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.92 53.82 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.422 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 1.6 mt -75.0 -32.22 61.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 111.127 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.2 -41.17 70.62 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.447 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.745 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 9.0 t -74.8 -41.52 59.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.802 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -60.01 -53.34 58.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.087 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -60.22 -34.04 73.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.339 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.784 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.33 -41.45 93.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.25 -42.14 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.071 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.494 ' ND2' ' HA ' ' C' ' 40' ' ' ALA . 9.2 m-20 -72.09 -9.87 59.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 t -68.49 -22.68 64.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.189 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.648 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.6 mm? -82.7 159.17 22.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.875 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.16 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.647 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.458 ' OE1' ' HA3' ' A' ' 74' ' ' GLY . 13.8 mt-30 70.7 118.04 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.7 Cg_endo -78.48 114.85 3.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.585 2.19 . . . . 0.0 112.501 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.75 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.631 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 167.72 55.85 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.263 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 8.3 p -75.49 -5.5 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.136 0.575 . . . . 0.0 112.479 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.8 49.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.33 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.599 0.238 . . . . 0.0 110.649 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 p -105.86 141.63 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.524 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -122.77 117.52 25.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 111.624 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -87.72 140.59 29.36 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.281 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.648 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 68.1 p -117.23 118.97 33.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.91 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' B' ' 101' ' ' PHE . . . -144.9 132.39 20.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.476 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.83 174.93 46.17 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.574 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.22 160.67 23.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.392 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.784 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -140.33 177.55 20.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.438 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -162.39 141.04 6.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.537 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.636 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 39.1 t80 -137.24 134.12 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.271 . . . . 0.0 110.815 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 64' ' ' ARG . 1.9 mmm180 62.89 -93.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 p -143.26 32.39 1.35 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.1 145.15 47.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.782 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.01 153.55 26.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.097 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.98 164.33 32.37 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.523 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.58 136.16 53.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.71 51.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.638 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.17 153.41 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.101 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 172.89 -177.72 45.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.95 151.26 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.458 ' HA3' ' OE1' ' A' ' 47' ' ' GLN . . . -150.24 171.67 30.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.227 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.03 136.59 50.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 111.11 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.631 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 7.1 ttm180 -132.25 133.89 44.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.583 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 4.1 p -122.95 143.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.286 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.3 m-20 60.13 -88.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.986 0.422 . . . . 0.0 111.083 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 10.0 pt-20 172.21 -31.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.535 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.42 -58.92 5.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.023 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.97 138.7 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.61 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.717 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -144.79 148.39 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 111.255 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -136.37 140.3 43.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.641 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.49 ' C ' ' HD3' ' A' ' 84' ' ' LYS . 8.9 tmtt? -153.79 130.42 10.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.481 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.34 177.05 11.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . 166.02 -169.93 40.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.553 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.27 141.64 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.145 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -109.28 145.82 35.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.368 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -111.31 118.29 35.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.207 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.626 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 48.01 -114.3 1.79 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.286 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.15 17.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.18 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -116.34 71.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.78 132.32 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.628 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 2.7 ptp -122.69 126.67 48.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.89 111.17 23.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.436 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.32 152.43 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.322 . . . . 0.0 111.398 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.15 96.71 1.0 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.472 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 57.4 m -119.94 177.64 4.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.387 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' C' ' 58' ' ' ALA . 22.3 p90 -147.29 138.86 24.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.409 . . . . 0.0 111.082 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.728 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 74.5 m-20 -100.78 130.65 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.92 112.06 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.749 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HG2' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.66 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.711 0.291 . . . . 0.0 110.531 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.11 -38.81 66.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.222 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.3 -60.11 4.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.758 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.58 -28.15 69.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.715 ' O ' HD23 ' B' ' 25' ' ' LEU . 2.4 tm? -63.32 -54.65 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.484 ' HA ' ' NH2' ' C' ' 24' ' ' ARG . 30.5 m-20 -65.39 -26.9 68.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.017 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.58 -57.41 9.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.695 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.0 mtp85 -61.71 -38.52 88.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.797 HD22 HD11 ' A' ' 25' ' ' LEU . 3.1 mm? -62.2 -48.55 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.92 -29.01 70.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.771 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.411 ' NZ ' ' HD3' ' B' ' 31' ' ' ARG . 1.3 ttpp -65.17 -43.92 90.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.228 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.433 ' O ' HG13 ' B' ' 32' ' ' VAL . 0.0 OUTLIER -59.61 -41.65 90.84 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.569 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -61.08 -27.67 68.53 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.988 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 4.1 m -75.73 -39.72 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.841 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.411 ' HD3' ' NZ ' ' B' ' 27' ' ' LYS . 0.6 OUTLIER -73.14 -22.79 60.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.284 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.569 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.5 m -90.19 -28.69 4.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.22 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.629 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 65.5 m-20 -73.55 -47.87 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.036 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' B' ' 91' ' ' GLY . 7.9 ptpt -80.76 -28.38 36.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.805 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.54 -40.75 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.413 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 1.6 mt -75.11 -32.15 61.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.328 . . . . 0.0 111.105 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -41.14 70.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.413 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.763 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 9.1 t -74.85 -41.62 59.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.93 -53.36 58.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.486 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -60.25 -34.0 73.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.404 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.806 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.4 -41.35 93.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.959 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 tp -72.25 -42.19 65.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.061 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 40' ' ' ALA . 9.2 m-20 -72.07 -9.89 59.02 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.8 t -68.5 -22.64 64.52 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.181 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.657 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.6 mm? -82.73 159.16 22.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.823 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.18 0.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.649 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' B' ' 46' ' ' PHE . 13.8 mt-30 70.68 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.947 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.35 114.64 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.747 2.298 . . . . 0.0 112.571 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.82 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 167.72 55.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.316 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 8.3 p -75.59 -5.52 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.105 0.562 . . . . 0.0 112.425 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.82 49.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.209 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -173.12 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.629 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -105.9 141.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.516 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -122.85 117.47 25.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 111.63 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -87.71 140.56 29.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.252 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.657 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 67.9 p -117.21 118.9 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.931 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' C' ' 101' ' ' PHE . . . -144.89 132.39 20.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.82 174.93 46.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.614 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.19 160.68 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.347 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.806 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -140.33 177.59 20.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.518 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -162.39 140.93 6.85 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.603 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.636 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 39.1 t80 -137.17 134.25 36.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.31 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' B' ' 64' ' ' ARG . 1.9 mmm180 62.96 -93.45 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.979 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 17.3 p -143.23 32.46 1.35 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.143 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.19 145.17 47.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.03 153.54 26.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.0 164.33 32.42 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.517 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.53 136.14 53.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.793 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.72 51.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.19 153.39 16.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.157 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 172.9 -177.69 45.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.441 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.92 151.3 4.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.389 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.443 ' HA3' ' OE1' ' B' ' 47' ' ' GLN . . . -150.32 171.61 30.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.203 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.94 136.51 50.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.134 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.614 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 7.1 ttm180 -132.19 133.95 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.602 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 4.1 p -122.96 143.1 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.267 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 96.3 m-20 60.21 -88.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.927 0.394 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 10.0 pt-20 172.25 -31.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.555 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 15.6 p -62.49 -58.89 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.06 138.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.5 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -144.81 148.43 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.27 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 53.4 tp -136.43 140.32 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.581 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.483 ' HD3' ' C ' ' B' ' 84' ' ' LYS . 8.9 tmtt? -153.75 130.44 10.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.38 177.11 11.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 166.04 -169.89 40.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.592 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.34 141.65 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 111.104 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.763 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -109.32 145.91 35.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.276 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -111.38 118.28 35.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.289 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.581 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.482 ' N ' ' HD3' ' B' ' 34' ' ' LYS . . . 47.97 -114.24 1.75 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 39.1 m -149.57 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.687 0.28 . . . . 0.0 111.275 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.24 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -116.39 71.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 39.1 t -99.83 132.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.675 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.636 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 2.7 ptp -122.72 126.62 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.733 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.92 111.26 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.405 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.38 152.42 24.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.724 0.297 . . . . 0.0 111.459 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.18 96.74 1.0 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.467 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 56.5 m -119.96 177.64 4.91 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.428 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' ALA . 21.9 p90 -147.3 138.79 23.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 111.093 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.75 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 74.5 m-20 -100.77 130.6 46.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.433 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.85 112.05 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.664 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.711 0.291 . . . . 0.0 110.541 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.78 66.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.32 -60.07 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.63 -28.17 69.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.42 . . . . 0.0 111.149 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.715 ' O ' HD23 ' C' ' 25' ' ' LEU . 2.4 tm? -63.26 -54.67 33.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.545 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . 0.481 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 30.1 m-20 -65.31 -26.99 68.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.085 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.54 -57.45 9.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.712 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.0 mtp85 -61.65 -38.58 88.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.734 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.789 HD11 HD22 ' A' ' 25' ' ' LEU . 3.1 mm? -62.14 -48.57 79.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.9 -29.01 70.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.816 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.407 ' NZ ' ' HD3' ' C' ' 31' ' ' ARG . 1.2 ttpp -65.18 -43.92 90.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.652 0.263 . . . . 0.0 111.249 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.43 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.0 OUTLIER -59.59 -41.67 90.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . 0.547 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -61.12 -27.71 68.58 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.917 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 4.1 m -75.59 -39.85 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.407 ' HD3' ' NZ ' ' C' ' 27' ' ' LYS . 0.6 OUTLIER -73.05 -22.71 60.58 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.4 m -90.27 -28.7 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.635 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 65.5 m-20 -73.63 -47.76 37.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.489 ' HD3' ' CA ' ' C' ' 91' ' ' GLY . 7.9 ptpt -80.85 -28.37 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.803 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.45 -40.85 53.63 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.478 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 1.6 mt -74.98 -32.36 61.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 111.07 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.21 70.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.44 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.743 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 9.1 t -74.81 -41.57 59.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.746 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.96 -53.28 59.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.169 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.494 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -60.27 -33.95 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.403 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . 0.773 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.44 -41.38 93.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.24 -42.23 65.89 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.073 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' B' ' 40' ' ' ALA . 9.1 m-20 -72.02 -9.84 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.9 t -68.54 -22.68 64.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.158 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.652 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.6 mm? -82.68 159.15 22.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.866 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 15.1 p90 -148.5 -2.28 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.619 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' C' ' 46' ' ' PHE . 13.8 mt-30 70.72 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.936 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.44 114.78 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.679 2.253 . . . . 0.0 112.487 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.76 -176.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.634 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 167.69 55.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.246 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 8.3 p -75.48 -5.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.178 0.591 . . . . 0.0 112.445 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.84 49.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.283 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.644 0.259 . . . . 0.0 110.621 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.84 141.5 21.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.585 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -122.74 117.6 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 111.664 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -87.8 140.54 29.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.34 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.652 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 67.7 p -117.15 118.9 33.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.001 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 101' ' ' PHE . . . -144.87 132.39 20.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.81 174.9 46.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.586 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.16 160.72 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 111.399 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -140.35 177.64 20.54 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.4 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -162.47 141.04 6.92 Favored Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.635 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 39.0 t80 -137.29 134.26 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.711 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' C' ' 64' ' ' ARG . 1.9 mmm180 62.9 -93.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.114 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -143.23 32.37 1.35 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.15 145.14 47.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.05 153.56 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 111.097 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.94 164.3 32.45 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.61 136.2 53.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.96 140.69 51.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.25 153.4 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.768 0.318 . . . . 0.0 111.098 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 172.94 -177.71 45.29 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.456 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.91 151.32 4.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . 0.458 ' HA3' ' OE1' ' C' ' 47' ' ' GLN . . . -150.26 171.75 30.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -129.12 136.49 50.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.634 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 7.1 ttm180 -132.11 134.09 45.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.682 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.604 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 4.1 p -123.09 143.12 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.274 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 96.3 m-20 60.15 -88.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 111.104 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 10.1 pt-20 172.18 -31.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.47 -58.93 5.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.942 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 32.2 m -94.05 138.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.525 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.736 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -144.9 148.39 33.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.279 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 53.6 tp -136.38 140.37 43.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 8.9 tmtt? -153.85 130.44 10.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . 0.492 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.37 177.1 11.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.043 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 166.0 -169.91 40.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.555 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.29 141.69 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.872 0.368 . . . . 0.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.743 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -109.28 145.84 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.339 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.38 118.2 35.17 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.277 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.02 140.63 52.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.591 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.489 ' CA ' ' HD3' ' C' ' 34' ' ' LYS . . . 48.02 -114.34 1.81 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.244 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -149.47 16.72 0.91 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.264 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.23 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -116.39 71.01 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.81 132.33 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.006 0.432 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.636 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 2.7 ptp -122.65 126.65 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -105.98 111.28 23.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.408 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.31 152.46 24.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.457 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.2 96.74 0.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 56.5 m -119.95 177.63 4.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.438 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' B' ' 58' ' ' ALA . 22.1 p90 -147.31 138.83 24.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.743 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 74.5 m-20 -100.79 130.62 46.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.358 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.93 112.08 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -117.24 146.87 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.705 179.681 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.671 0.272 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.82 -32.31 67.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.371 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -64.1 -57.64 8.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.74 -31.18 70.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 3.2 tm? -61.98 -59.76 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.12 -18.79 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -74.13 -45.99 45.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.58 ' HB3' HD12 ' C' ' 25' ' ' LEU . 61.4 mtp85 -77.02 -37.14 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.818 HD11 HD22 ' B' ' 25' ' ' LEU . 3.3 mm? -66.42 -52.18 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.63 -42.24 92.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.3 ttpp -66.88 -28.95 68.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -48.81 78.27 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.614 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -64.33 -33.09 75.04 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.925 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -67.93 -38.83 83.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.732 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.83 64.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.8 m -74.24 -33.46 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.641 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 16.6 m-20 -69.07 -45.28 70.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.3 ptpt -75.19 -40.65 59.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.729 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.43 ' HA3' ' OH ' ' C' ' 63' ' ' TYR . . . -57.37 -43.63 93.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.381 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.793 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.03 -24.65 58.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.159 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.59 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -69.21 -41.96 76.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.461 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.527 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 8.5 t -82.81 -39.97 21.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.745 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.504 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 4.0 t -58.11 -54.79 43.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB1' HD21 ' B' ' 98' ' ' ASN . . . -61.5 -33.51 73.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.445 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.73 -33.6 76.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.663 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 60.1 tp -82.65 -32.37 28.27 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.712 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 87.6 m-20 -75.84 -16.34 60.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.85 -18.83 64.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.207 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.635 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.7 mm? -77.53 163.87 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.909 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.478 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.2 p90 -156.56 0.41 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HB3' ' CB ' ' A' ' 55' ' ' ASN . 6.0 mt-30 63.07 125.07 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.965 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -83.95 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.671 2.247 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.482 ' OH ' ' HB ' ' B' ' 51' ' ' VAL . 13.7 m-30 63.7 -175.3 0.16 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.569 ' HA3' ' HD2' ' A' ' 76' ' ' ARG . . . 166.69 55.44 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.237 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -81.44 -10.66 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.159 0.584 . . . . 0.0 112.432 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.67 48.17 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.284 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -150.92 -163.92 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.656 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -116.72 142.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.553 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.48 ' CB ' ' HB3' ' A' ' 47' ' ' GLN . 10.4 m-80 -124.82 113.32 17.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.677 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.55 129.64 34.98 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.273 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.701 HG21 ' HE3' ' A' ' 84' ' ' LYS . 37.7 p -109.36 122.09 46.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.992 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -154.62 133.68 12.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.436 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.46 170.49 43.31 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.531 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 69' ' ' LEU . 2.7 m -121.15 161.41 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.366 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.23 17.96 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.461 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -172.21 138.73 4.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.641 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 34.0 t80 -120.84 131.85 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.685 0.278 . . . . 0.0 110.738 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.4 mmm180 69.52 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.1 p -143.76 26.22 1.58 Allowed 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.159 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.38 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.33 150.96 28.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -146.55 171.79 14.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.548 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.49 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -119.98 142.8 48.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.811 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -132.62 137.19 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.686 0.279 . . . . 0.0 111.636 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.521 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.5 tp -137.65 162.1 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.784 0.326 . . . . 0.0 111.05 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.521 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 171.37 179.9 42.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.397 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.61 148.77 12.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.892 0.377 . . . . 0.0 110.965 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.49 166.78 30.77 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.228 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.601 ' CE2' ' HB ' ' A' ' 77' ' ' VAL . 38.8 t80 -131.85 134.49 45.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.156 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.569 ' HD2' ' HA3' ' A' ' 50' ' ' GLY . 16.4 ttm180 -125.18 121.56 34.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.621 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 8.6 p -110.88 137.99 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 49.7 m-20 64.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' HB3' ' CE2' ' C' ' 49' ' ' TYR . 10.5 pt-20 175.42 -20.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.59 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 p -70.85 -66.36 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.032 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 m -90.85 141.34 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.589 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.47 153.82 37.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.172 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.3 tp -148.82 149.88 32.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.618 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.701 ' HE3' HG21 ' A' ' 57' ' ' THR . 12.1 tmtt? -149.34 141.67 24.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.162 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.17 176.02 11.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.44 -173.06 41.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.587 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.09 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.853 0.358 . . . . 0.0 111.16 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.767 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -110.25 144.23 39.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.351 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -121.97 113.01 18.99 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.39 -116.13 8.72 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.293 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.87 8.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.322 . . . . 0.0 111.337 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t -155.03 22.62 0.44 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.108 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 10.8 m-20 -127.11 82.86 2.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.87 139.4 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.767 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 6.9 ptp -134.22 141.58 47.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -113.26 124.31 52.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.455 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.496 HD21 ' HB1' ' C' ' 40' ' ' ALA . 17.1 m120 -109.57 148.01 32.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.296 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.7 86.9 0.38 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.61 162.34 17.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.471 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -130.31 145.64 51.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.976 0.417 . . . . 0.0 111.055 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.553 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 56.0 m-80 -115.34 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.399 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.14 119.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.819 0.343 . . . . 0.0 110.726 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.704 0.288 . . . . 0.0 110.5 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.92 -32.3 67.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -63.99 -57.71 8.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.707 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.83 -31.1 70.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 3.2 tm? -61.95 -59.81 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.591 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -65.07 -18.78 65.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.18 -46.0 44.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.58 ' HB3' HD12 ' A' ' 25' ' ' LEU . 61.3 mtp85 -76.94 -37.14 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.794 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.818 HD22 HD11 ' A' ' 25' ' ' LEU . 3.3 mm? -66.47 -52.16 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.641 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.61 -42.19 92.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.93 -29.02 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.245 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -48.82 78.3 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.604 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -64.46 -32.9 74.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 178.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 5.9 m -68.03 -38.81 82.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.858 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.749 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -73.3 -39.85 64.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.246 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.6 m -74.21 -33.41 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.223 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.644 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 16.6 m-20 -69.18 -45.25 70.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.749 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.3 ptpt -75.17 -40.61 59.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.434 ' HA3' ' OH ' ' A' ' 63' ' ' TYR . . . -57.37 -43.62 93.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.794 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.06 -24.65 58.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.592 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -69.18 -42.03 76.39 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.54 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 8.5 t -82.72 -40.01 21.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.741 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.5 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.9 t -58.12 -54.62 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.492 ' HB1' HD21 ' C' ' 98' ' ' ASN . . . -61.66 -33.47 74.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.409 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.69 76.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.691 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 59.6 tp -82.6 -32.29 28.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.718 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 87.4 m-20 -75.8 -16.37 60.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.99 -18.69 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.148 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.627 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.7 mm? -77.63 163.88 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.846 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.462 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.2 p90 -156.54 0.37 0.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 111.714 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.488 ' HB3' ' CB ' ' B' ' 55' ' ' ASN . 6.1 mt-30 63.15 124.98 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.967 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -83.94 109.92 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.642 2.228 . . . . 0.0 112.605 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.484 ' CE2' ' HB3' ' C' ' 79' ' ' GLU . 13.6 m-30 63.71 -175.31 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.934 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.566 ' HA3' ' HD2' ' B' ' 76' ' ' ARG . . . 166.72 55.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.245 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -81.34 -10.67 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.161 0.584 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.63 48.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.268 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.435 ' O ' ' CD1' ' B' ' 75' ' ' TYR . 0.0 OUTLIER -150.89 -163.87 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.601 0.239 . . . . 0.0 110.639 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -116.78 142.65 29.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.586 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.488 ' CB ' ' HB3' ' B' ' 47' ' ' GLN . 10.4 m-80 -124.8 113.43 17.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.973 0.416 . . . . 0.0 111.663 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.67 129.7 34.96 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.195 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.704 HG21 ' HE3' ' B' ' 84' ' ' LYS . 37.6 p -109.42 122.07 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.943 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -154.61 133.7 12.41 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.368 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.47 170.49 43.32 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' B' ' 69' ' ' LEU . 2.7 m -121.16 161.52 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.773 0.321 . . . . 0.0 111.383 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.23 -167.16 17.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.473 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . 0.592 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -172.23 138.75 4.94 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.644 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 34.1 t80 -120.87 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.695 0.283 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.5 mmm180 69.47 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -143.75 26.18 1.58 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.17 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.4 51.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -110.44 151.06 27.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -146.66 171.7 14.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.537 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.493 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.8 OUTLIER -120.0 142.75 48.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.808 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.691 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -132.58 137.2 47.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.681 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.531 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.5 tp -137.64 162.07 32.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.738 0.304 . . . . 0.0 111.119 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.531 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 171.34 179.87 42.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.444 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.58 148.73 12.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.41 166.8 30.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.609 ' CE2' ' HB ' ' B' ' 77' ' ' VAL . 38.6 t80 -131.88 134.47 45.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.566 ' HD2' ' HA3' ' B' ' 50' ' ' GLY . 16.4 ttm180 -125.19 121.47 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.626 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 8.6 p -110.88 138.04 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.344 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 50.2 m-20 64.3 -97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.481 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 10.4 pt-20 175.44 -20.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.541 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.81 -66.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 m -90.84 141.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.42 153.82 37.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 0.0 111.225 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 25.2 tp -148.79 149.88 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.582 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.704 ' HE3' HG21 ' B' ' 57' ' ' THR . 12.1 tmtt? -149.38 141.72 24.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.18 176.05 11.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.086 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.36 -173.1 41.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.556 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.21 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.347 . . . . 0.0 111.107 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.791 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -110.31 144.16 39.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.366 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.89 113.03 19.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.235 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -119.5 129.97 54.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.608 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.28 -116.04 8.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.31 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.92 8.11 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 111.332 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.1 22.65 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 10.9 m-20 -127.07 82.8 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 99.7 t -108.87 139.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.969 0.414 . . . . 0.0 110.653 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.791 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 6.9 ptp -134.22 141.6 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.693 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -113.28 124.3 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.497 HD21 ' HB1' ' A' ' 40' ' ' ALA . 17.0 m120 -109.54 147.99 32.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 111.42 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.76 86.92 0.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.757 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.55 162.33 17.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.399 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -130.32 145.59 51.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.418 . . . . 0.0 111.073 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.564 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.0 m-80 -115.31 131.85 56.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.401 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.08 119.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.849 0.356 . . . . 0.0 110.776 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.478 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.98 -32.26 67.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 111.245 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -64.04 -57.72 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.79 -31.04 70.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.222 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 3.2 tm? -62.06 -59.75 4.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.53 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.11 -18.8 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.948 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.15 -45.97 45.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.587 ' HB3' HD12 ' B' ' 25' ' ' LEU . 61.4 mtp85 -76.98 -37.15 55.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.751 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.8 HD11 HD22 ' A' ' 25' ' ' LEU . 3.3 mm? -66.52 -52.13 49.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.646 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -59.59 -42.29 92.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.79 -29.02 68.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.229 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' C' ' 28' ' ' LEU . 0.0 OUTLIER -62.32 -48.72 78.59 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . 0.595 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -64.4 -32.99 74.83 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.994 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 5.9 m -67.92 -38.94 83.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.813 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.729 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.78 65.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.271 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.7 m -74.16 -33.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.638 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 16.6 m-20 -68.97 -45.3 71.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.729 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.3 ptpt -75.12 -40.71 59.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.777 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . 0.431 ' HA3' ' OH ' ' B' ' 63' ' ' TYR . . . -57.34 -43.57 93.75 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.419 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.794 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -75.13 -24.65 58.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.875 0.369 . . . . 0.0 111.092 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.606 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -69.17 -42.03 76.42 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.429 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.541 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 8.5 t -82.75 -39.93 21.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.504 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 4.0 t -58.11 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.496 ' HB1' HD21 ' A' ' 98' ' ' ASN . . . -61.67 -33.45 73.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.392 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.69 -33.66 76.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.683 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 59.9 tp -82.61 -32.29 28.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.718 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 87.4 m-20 -75.79 -16.43 60.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -67.9 -18.74 64.88 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.149 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.649 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.7 mm? -77.68 163.89 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.858 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.472 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.2 p90 -156.53 0.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.657 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.487 ' HB3' ' CB ' ' C' ' 55' ' ' ASN . 6.1 mt-30 63.13 125.06 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.926 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -83.92 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.632 2.221 . . . . 0.0 112.629 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.481 ' OH ' ' HB ' ' A' ' 51' ' ' VAL . 13.7 m-30 63.74 -175.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.962 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.573 ' HA3' ' HD2' ' C' ' 76' ' ' ARG . . . 166.76 55.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.208 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -81.4 -10.59 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.157 0.583 . . . . 0.0 112.452 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.54 48.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.297 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -150.88 -163.82 1.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.625 0.25 . . . . 0.0 110.619 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -116.89 142.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.578 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' C' ' 47' ' ' GLN . 10.4 m-80 -124.83 113.4 17.85 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.011 0.434 . . . . 0.0 111.659 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -83.63 129.71 34.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.226 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.701 HG21 ' HE3' ' C' ' 84' ' ' LYS . 37.6 p -109.42 122.06 46.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.496 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -154.61 133.62 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.44 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.39 170.5 43.35 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.554 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' C' ' 69' ' ' LEU . 2.7 m -121.12 161.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.21 17.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.451 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . 0.606 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -172.18 138.76 4.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.548 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.638 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 34.1 t80 -120.9 131.96 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.757 0.313 . . . . 0.0 110.746 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.5 mmm180 69.34 -92.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.1 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.4 p -143.77 26.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.1 141.42 51.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.42 150.96 28.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -146.58 171.75 14.61 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.548 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.494 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.8 OUTLIER -120.01 142.69 48.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.683 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.55 137.17 47.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.69 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.515 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.5 tp -137.52 162.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.515 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 171.36 179.86 42.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.59 148.75 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.41 166.81 30.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.15 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.615 ' CE2' ' HB ' ' C' ' 77' ' ' VAL . 39.2 t80 -131.91 134.45 45.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.92 0.391 . . . . 0.0 111.153 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.573 ' HD2' ' HA3' ' C' ' 50' ' ' GLY . 16.5 ttm180 -125.16 121.56 34.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.731 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.625 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 8.7 p -110.96 138.06 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.291 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 49.8 m-20 64.4 -97.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.013 0.435 . . . . 0.0 111.12 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . 0.484 ' HB3' ' CE2' ' B' ' 49' ' ' TYR . 10.5 pt-20 175.43 -20.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.62 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.87 -66.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -90.97 141.3 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.485 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.38 153.83 37.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.276 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 25.3 tp -148.77 149.89 32.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.6 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.701 ' HE3' HG21 ' C' ' 57' ' ' THR . 12.1 tmtt? -149.41 141.74 24.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.27 175.94 11.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.056 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.43 -173.18 41.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.546 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.09 138.2 19.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.102 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.782 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -110.39 144.22 39.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.32 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.99 112.93 18.88 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -119.43 129.98 55.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.4 -116.1 8.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.308 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m -148.95 8.09 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.331 . . . . 0.0 111.285 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.07 22.64 0.43 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 10.8 m-20 -127.1 82.77 2.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.76 139.33 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.769 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.782 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 6.8 ptp -134.17 141.61 47.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.3 124.25 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.495 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.492 HD21 ' HB1' ' B' ' 40' ' ' ALA . 17.1 m120 -109.52 148.08 31.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 111.443 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.74 86.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.764 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.53 162.35 17.32 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -130.34 145.61 51.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 111.064 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 55.6 m-80 -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.378 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.06 119.7 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.794 0.331 . . . . 0.0 110.737 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.95 159.82 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.663 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.721 0.296 . . . . 0.0 110.55 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.09 -20.26 64.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 111.211 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 mtt-85 -70.74 -60.28 2.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.795 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.14 -17.37 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.152 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -67.71 -49.81 60.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.557 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -73.53 -28.05 61.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.038 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.05 -51.57 45.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.439 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 76.5 mtp85 -62.5 -44.76 95.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.755 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.508 HD21 ' CD2' ' B' ' 25' ' ' LEU . 0.5 OUTLIER -57.44 -50.37 73.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.18 -39.48 82.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 ttpp -60.46 -34.09 73.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.202 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.564 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -68.05 -41.95 81.27 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.45 -25.02 64.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.3 m -79.63 -41.0 27.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.852 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.68 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.4 mpt_? -68.93 -35.83 77.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.303 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 28' ' ' LEU . 19.0 m -77.58 -32.13 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.159 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 9.9 m-20 -66.79 -44.84 80.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.68 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 4.2 ptpt -77.76 -31.69 52.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.24 67.84 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.393 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.89 -27.77 60.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.23 -46.37 16.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.407 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.646 ' CB ' ' HB2' ' A' ' 90' ' ' ALA . 48.4 t -67.06 -40.59 87.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.481 ' OG ' ' HB2' ' C' ' 40' ' ' ALA . 37.4 t -67.42 -52.89 34.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' OG ' ' B' ' 39' ' ' SER . . . -61.88 -25.82 67.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.494 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.96 -38.28 88.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.523 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 21.7 tp -79.36 -33.63 42.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 58.1 m-20 -73.68 -13.58 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.49 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 30.5 t -71.54 -19.27 62.19 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.182 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.625 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.0 mm? -80.45 157.83 26.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.856 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.434 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 8.1 p90 -146.06 -10.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.699 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HG2' ' CG2' ' A' ' 57' ' ' THR . 5.1 mt-30 73.43 121.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.935 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -77.72 101.1 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 62.1 -170.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.518 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 163.03 60.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.5 p -69.89 -18.81 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.146 0.578 . . . . 0.0 112.459 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.781 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.02 51.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.313 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HZ2' ' HA2' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -152.16 -157.03 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.56 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 74' ' ' GLY . 2.8 p -120.67 145.13 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.579 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.83 122.06 33.65 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.979 0.418 . . . . 0.0 111.727 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -84.27 124.47 31.26 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.267 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.625 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 72.1 p -107.04 120.61 42.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.007 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -149.85 137.49 20.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.405 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . 178.14 165.48 33.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.533 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 69' ' ' LEU . 30.2 m -121.13 178.76 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.375 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.99 -179.34 38.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -158.14 134.22 3.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.522 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.665 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 26.1 t80 -124.91 124.19 41.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.74 0.305 . . . . 0.0 110.746 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER 68.67 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 p -146.05 16.89 1.39 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.44 140.89 49.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.43 47.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 172.08 13.19 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.0 tt -123.47 145.16 49.04 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -132.1 119.52 21.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 58' ' ' ALA . 8.1 tp -118.67 152.74 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.91 -172.12 44.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.446 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.61 158.11 6.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -144.25 177.75 22.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.25 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.61 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 35.0 t80 -138.12 132.8 32.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.518 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 14.1 ttm180 -126.54 117.25 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.781 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.9 p -106.12 138.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.284 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 78.9 m-20 68.82 -92.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 14.8 pt-20 172.92 -24.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.579 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -78.46 -52.21 8.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.01 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.44 137.39 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.469 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -144.55 163.77 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.295 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 84' ' ' LYS . 34.1 tp -158.88 154.31 25.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 10.8 tmtt? -159.59 133.97 7.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.1 18.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.83 -174.57 42.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.628 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.24 139.56 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 111.112 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.51 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -113.05 136.51 52.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.293 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.19 51.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.294 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.646 ' HB2' ' CB ' ' A' ' 38' ' ' SER . . . -131.61 135.72 47.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.591 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.572 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.71 -123.26 29.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.281 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.58 9.58 2.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.791 0.329 . . . . 0.0 111.318 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.48 32.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.201 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -132.32 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.25 150.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.01 0.433 . . . . 0.0 110.724 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.647 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 1.2 ptp -146.52 159.69 43.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.594 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.69 141.06 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.444 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.43 ' OD1' HD23 ' A' ' 42' ' ' LEU . 25.7 m120 -118.05 145.68 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.764 0.316 . . . . 0.0 111.393 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.48 87.6 1.32 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 16.7 m -121.49 148.99 43.73 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.393 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.728 ' HD2' HD11 ' A' ' 103' ' ' ILE . 1.8 p90 -124.47 142.91 50.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.423 . . . . 0.0 111.05 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.925 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 64.1 m-80 -109.45 126.72 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.728 HD11 ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -129.59 121.1 52.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.655 0.264 . . . . 0.0 110.529 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.02 -20.32 64.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.227 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 mtt-85 -70.6 -60.4 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.749 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.1 -17.37 61.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.151 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -67.69 -49.86 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -73.44 -28.17 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.993 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.98 -51.54 46.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.437 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 76.6 mtp85 -62.49 -44.82 95.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.8 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.508 ' CD2' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.4 -50.46 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.08 -39.48 82.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.871 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' B' ' 31' ' ' ARG . 12.9 ttpp -60.38 -34.2 73.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.212 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.566 ' O ' HG13 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -68.07 -41.87 81.28 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.925 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 1.3 m -79.52 -40.98 28.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.677 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.4 mpt_? -68.87 -36.0 77.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.566 HG13 ' O ' ' B' ' 28' ' ' LEU . 18.9 m -77.53 -32.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.207 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 9.9 m-20 -66.73 -44.78 80.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.04 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.677 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 4.2 ptpt -77.97 -31.53 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.56 -35.23 67.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.88 -27.78 60.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.31 -46.32 16.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.396 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.652 ' CB ' ' HB2' ' B' ' 90' ' ' ALA . 48.5 t -67.09 -40.53 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.785 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 40' ' ' ALA . 37.4 t -67.46 -52.94 33.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' OG ' ' C' ' 39' ' ' SER . . . -61.82 -25.87 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.43 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.41 88.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.503 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 21.6 tp -79.26 -33.65 43.31 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 57.8 m-20 -73.64 -13.59 61.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.494 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 30.4 t -71.58 -19.27 62.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.135 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.643 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.0 mm? -80.48 157.8 26.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.831 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 8.1 p90 -146.0 -10.43 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.188 0.518 . . . . 0.0 111.717 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.487 ' HG2' ' CG2' ' B' ' 57' ' ' THR . 5.1 mt-30 73.51 121.16 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.882 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -77.69 101.14 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.623 2.216 . . . . 0.0 112.54 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 62.03 -170.51 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.946 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 163.03 60.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.288 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.4 p -70.0 -18.86 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.186 0.594 . . . . 0.0 112.454 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.04 51.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.298 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.489 ' HZ2' ' HA2' ' B' ' 50' ' ' GLY . 0.0 OUTLIER -152.05 -156.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.546 0.212 . . . . 0.0 110.671 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 74' ' ' GLY . 2.8 p -120.81 145.15 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.577 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.84 122.09 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.008 0.433 . . . . 0.0 111.669 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -84.34 124.5 31.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.248 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.643 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 73.4 p -107.1 120.64 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -149.81 137.56 20.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.418 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . 178.1 165.51 33.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' B' ' 69' ' ' LEU . 30.3 m -121.16 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.03 -179.39 38.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.453 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -158.12 134.17 3.77 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.664 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 26.2 t80 -124.91 124.18 41.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.734 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 73.3 p -145.99 16.87 1.4 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.81 49.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.42 47.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.107 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.41 172.11 13.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.49 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.709 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.0 tt -123.52 145.19 49.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.762 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -132.19 119.63 21.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.725 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' B' ' 58' ' ' ALA . 8.1 tp -118.72 152.72 20.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.96 -172.18 44.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.405 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.52 158.06 6.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.851 0.358 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.583 ' O ' HG23 ' B' ' 54' ' ' VAL . . . -144.2 177.78 22.61 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.267 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.604 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 34.8 t80 -138.13 132.71 32.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.873 0.368 . . . . 0.0 111.166 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.513 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 14.0 ttm180 -126.49 117.27 22.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.78 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.9 p -106.16 138.91 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.011 0.434 . . . . 0.0 111.278 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' B' ' 79' ' ' GLU . 78.9 m-20 68.81 -92.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.0 111.14 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 14.8 pt-20 172.97 -24.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.1 p -78.48 -52.21 8.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.44 137.36 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.891 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -144.58 163.78 32.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.868 0.365 . . . . 0.0 111.255 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.419 HD12 ' H ' ' B' ' 84' ' ' LYS . 34.6 tp -158.9 154.32 25.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.434 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 10.8 tmtt? -159.66 133.97 7.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.58 171.06 18.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.87 -174.46 42.83 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.626 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.29 139.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.059 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.499 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -113.01 136.48 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.359 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.68 125.2 51.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.652 ' HB2' ' CB ' ' B' ' 38' ' ' SER . . . -131.53 135.69 47.24 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.664 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.589 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.76 -123.37 30.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.342 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.28 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.9 t -165.48 32.84 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.242 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.32 82.3 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.24 150.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.665 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 1.2 ptp -146.56 159.65 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.667 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -127.65 141.17 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.366 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.432 ' OD1' HD23 ' B' ' 42' ' ' LEU . 25.7 m120 -118.14 145.66 44.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 111.359 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 87.51 1.32 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.74 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 16.7 m -121.42 149.01 43.65 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.4 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . 0.726 ' HD2' HD11 ' B' ' 103' ' ' ILE . 1.9 p90 -124.44 142.88 50.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.957 0.408 . . . . 0.0 111.153 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.891 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 64.1 m-80 -109.4 126.78 53.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.726 HD11 ' HD2' ' B' ' 101' ' ' PHE . 0.9 OUTLIER -129.64 121.11 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.866 0.365 . . . . 0.0 110.756 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.677 0.275 . . . . 0.0 110.591 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -69.0 -20.27 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.297 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -70.73 -60.33 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.1 -17.4 61.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.177 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 0.8 OUTLIER -67.73 -49.81 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.558 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -73.45 -28.16 61.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.99 -51.52 46.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.444 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 76.6 mtp85 -62.52 -44.78 95.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.722 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.507 HD21 ' CD2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.52 -50.34 73.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.611 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -59.15 -39.48 82.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.806 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' C' ' 31' ' ' ARG . 12.9 ttpp -60.44 -34.16 73.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.204 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.549 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -68.05 -41.98 81.21 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.29 -25.11 64.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.987 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 1.3 m -79.54 -41.03 28.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.853 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.669 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.4 mpt_? -68.91 -35.87 77.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.28 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.549 HG13 ' O ' ' C' ' 28' ' ' LEU . 19.0 m -77.58 -32.18 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 9.9 m-20 -66.74 -44.79 80.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.045 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.669 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 4.2 ptpt -77.83 -31.68 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.48 -35.31 68.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mt -74.79 -27.82 60.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.113 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.24 -46.33 16.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.452 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.657 ' CB ' ' HB2' ' C' ' 90' ' ' ALA . 48.5 t -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.756 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' B' ' 40' ' ' ALA . 37.6 t -67.47 -52.96 33.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' OG ' ' A' ' 39' ' ' SER . . . -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.475 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.86 -38.37 88.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.507 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 21.6 tp -79.28 -33.69 43.18 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 57.6 m-20 -73.6 -13.62 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . 0.484 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 30.4 t -71.63 -19.23 62.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.154 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.614 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.0 mm? -80.51 157.78 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.836 177.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 8.1 p90 -145.98 -10.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.172 0.51 . . . . 0.0 111.703 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.492 ' HG2' ' CG2' ' C' ' 57' ' ' THR . 5.1 mt-30 73.53 121.12 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.932 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 10.0 Cg_endo -77.66 101.08 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.657 2.238 . . . . 0.0 112.57 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 62.12 -170.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.963 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 163.1 60.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.251 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.4 p -69.92 -18.88 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.258 0.623 . . . . 0.0 112.383 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.766 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.01 51.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.356 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . 0.495 ' HZ2' ' HA2' ' C' ' 50' ' ' GLY . 0.0 OUTLIER -152.11 -157.03 0.76 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.594 0.235 . . . . 0.0 110.591 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.588 HG23 ' O ' ' C' ' 74' ' ' GLY . 2.8 p -120.8 145.18 27.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.82 121.99 33.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.977 0.418 . . . . 0.0 111.696 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -84.23 124.47 31.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.272 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.614 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 72.3 p -106.98 120.63 42.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.999 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -149.84 137.53 20.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.422 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . 178.05 165.49 32.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' C' ' 69' ' ' LEU . 30.5 m -121.18 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.0 -179.41 38.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.521 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . 0.629 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -158.1 134.2 3.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.552 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.647 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 26.1 t80 -124.95 124.23 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.091 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 73.4 p -146.02 16.88 1.39 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.82 49.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.32 145.44 47.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.43 172.08 13.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.496 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.709 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.0 tt -123.41 145.23 48.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.79 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.23 119.62 21.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.653 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.42 HD12 ' CB ' ' C' ' 58' ' ' ALA . 8.1 tp -118.67 152.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.188 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.98 -172.17 44.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.57 158.11 6.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . 0.588 ' O ' HG23 ' C' ' 54' ' ' VAL . . . -144.19 177.74 22.63 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.236 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.589 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 34.8 t80 -138.14 132.69 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.517 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 14.0 ttm180 -126.49 117.3 22.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.766 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.9 p -106.13 138.83 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 78.8 m-20 68.92 -92.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 111.076 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 14.8 pt-20 172.95 -24.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.593 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -78.49 -52.27 8.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.0 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.37 137.42 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.898 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -144.61 163.77 32.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.236 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.413 HD12 ' H ' ' C' ' 84' ' ' LYS . 34.3 tp -158.87 154.27 25.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.595 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 10.8 tmtt? -159.58 133.94 7.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.13 18.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.81 -174.47 42.8 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.572 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 8.0 p -130.27 139.55 51.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.125 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.504 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -113.09 136.49 52.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.346 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.21 51.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.657 ' HB2' ' CB ' ' C' ' 38' ' ' SER . . . -131.62 135.72 47.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.603 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.572 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.75 -123.34 30.25 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 33.3 m -138.52 9.61 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.53 32.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.193 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.26 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.27 150.61 11.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.664 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 1.2 ptp -146.59 159.68 43.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.685 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.7 141.14 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.43 ' OD1' HD23 ' C' ' 42' ' ' LEU . 25.7 m120 -118.08 145.7 44.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.708 0.289 . . . . 0.0 111.415 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.54 1.31 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 16.7 m -121.4 148.98 43.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.449 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.716 ' HD2' HD11 ' C' ' 103' ' ' ILE . 1.8 p90 -124.41 142.87 50.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 111.04 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.898 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 64.0 m-80 -109.43 126.73 53.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.38 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.716 HD11 ' HD2' ' C' ' 101' ' ' PHE . 1.0 OUTLIER -129.62 121.06 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.77 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.96 165.95 19.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 0.423 ' HE3' HG13 ' B' ' 54' ' ' VAL . 3.5 m-90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.665 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 2.8 mmpt? . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.699 0.285 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.68 -31.28 70.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.247 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -63.07 -58.69 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.18 83.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.117 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.017 HD21 HD13 ' C' ' 21' ' ' LEU . 12.1 mt -60.0 -47.49 85.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.559 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 29.4 t0 -66.81 -32.25 73.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.093 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.53 -42.31 95.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.53 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.733 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.62 -33.42 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 28.4 t0 -73.73 -41.2 62.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -63.02 -42.06 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.285 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' C' ' 29' ' ' ASP . 0.2 OUTLIER -62.9 -50.35 71.22 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.789 ' HB2' HD21 ' B' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.14 61.43 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.912 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.15 -40.65 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.6 mpt_? -60.87 -32.56 71.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.316 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 6.4 m -80.12 -28.94 12.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.216 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -51.88 61.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 20.3 pttt -74.13 -39.28 63.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.751 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.32 -36.21 92.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.52 ' HG ' HD21 ' C' ' 36' ' ' LEU . 5.9 mt -73.53 -31.16 63.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.068 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.91 -45.29 36.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.457 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.65 ' CB ' ' HB2' ' A' ' 90' ' ' ALA . 22.7 t -63.86 -44.89 91.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.8 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 11.5 t -59.13 -46.47 88.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.04 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.544 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.13 -39.88 93.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.556 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 2.6 tm? -77.06 -38.9 51.69 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -72.12 -15.94 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 t -66.58 -32.92 74.56 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.15 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.512 ' CG ' ' HB ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -64.21 143.66 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.881 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.568 ' HZ ' ' HB1' ' B' ' 82' ' ' ALA . 35.0 p90 -112.69 -42.53 3.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.11 0.481 . . . . 0.0 111.677 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.49 HE22 ' HG2' ' A' ' 84' ' ' LYS . 33.8 mt-30 70.26 109.43 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.948 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HD3' ' ND2' ' B' ' 102' ' ' ASN 0.256 9.8 Cg_endo -75.25 -161.16 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.617 2.211 . . . . 0.0 112.576 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 17.5 m-30 68.16 167.02 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.962 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 76' ' ' ARG . . . 178.4 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.193 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.519 ' HA ' ' HG3' ' A' ' 79' ' ' GLU . 9.6 p -88.84 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.198 0.599 . . . . 0.0 112.4 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.39 69.1 0.01 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.261 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 76' ' ' ARG . 1.5 mptp? -143.79 -178.16 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.619 0.247 . . . . 0.0 110.561 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.509 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 10.1 p -119.02 142.17 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.433 ' OD1' ' HD2' ' A' ' 48' ' ' PRO . 1.7 m-80 -125.0 178.08 5.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.62 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -151.48 143.39 23.82 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.512 ' HB ' ' CG ' ' A' ' 45' ' ' LEU . 30.2 p -117.3 142.08 47.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.953 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -177.5 127.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.463 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.515 ' O ' HD12 ' A' ' 69' ' ' LEU . . . -179.34 -165.27 33.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.04 154.61 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.367 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -134.43 171.72 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.504 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 66' ' ' SER . . . -156.73 141.31 7.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.571 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 84.4 t80 -135.56 110.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.697 0.284 . . . . 0.0 110.74 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 28.0 mtt180 66.28 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.128 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 37.86 1.33 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.122 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.463 ' O ' ' HA2' ' A' ' 62' ' ' GLY . 32.1 t -134.77 157.68 46.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.67 148.31 40.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.42 173.06 14.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 59' ' ' GLY . 8.2 tp -124.75 126.66 46.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.702 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -117.51 163.32 16.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 58' ' ' ALA . 2.3 tt -158.71 176.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.77 34.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.462 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 p -164.13 160.03 20.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.45 176.26 29.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.217 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.509 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 5.0 t80 -143.27 127.0 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 111.159 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.473 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.735 HG22 ' OD1' ' A' ' 78' ' ' ASN . 7.2 p -83.2 127.41 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.284 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.735 ' OD1' HG22 ' A' ' 77' ' ' VAL . 31.3 m120 61.15 162.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.519 ' HG3' ' HA ' ' A' ' 51' ' ' VAL . 32.5 mt-10 -99.48 39.1 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.569 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.31 -52.21 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 82' ' ' ALA . 3.6 p -131.25 169.85 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.53 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB1' ' HZ ' ' C' ' 46' ' ' PHE . . . -168.53 165.24 12.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 111.29 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -139.25 168.73 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.564 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 85' ' ' ALA . 2.0 tmtp? -157.73 122.85 4.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.544 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -132.6 161.04 34.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.32 158.57 18.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.91 130.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -102.05 115.04 29.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.355 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.5 ' HA ' HG13 ' A' ' 95' ' ' VAL . 77.9 m-85 -91.7 108.8 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB2' ' CB ' ' A' ' 38' ' ' SER . . . -115.02 124.11 50.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.659 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.05 -85.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.67 -50.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.319 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.0 m -104.35 14.43 30.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 4.0 t70 -116.43 57.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.5 HG13 ' HA ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -95.2 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.747 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.608 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 2.9 ptp -146.77 151.44 37.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -130.34 138.21 50.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.422 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 8.3 m-80 -132.56 137.15 47.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 111.404 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.32 95.64 2.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.716 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB3' HD11 ' C' ' 45' ' ' LEU . 29.6 m -125.95 161.5 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 8.6 p90 -127.67 145.48 50.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.027 0.442 . . . . 0.0 111.044 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.559 ' ND2' ' HD3' ' C' ' 48' ' ' PRO . 1.8 p-10 -120.0 153.08 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.4 mp -119.86 134.91 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.856 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.479 ' HB2' ' CE2' ' C' ' 49' ' ' TYR . 18.2 pm0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 2.8 mmpt? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.68 0.276 . . . . 0.0 110.566 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -68.66 -31.25 70.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.259 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -63.11 -58.71 6.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.769 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -36.19 83.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 1.033 HD13 HD21 ' C' ' 21' ' ' LEU . 12.1 mt -60.04 -47.47 85.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.601 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' B' ' 26' ' ' ASP . 29.4 t0 -66.81 -32.26 73.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.036 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.836 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.48 34.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.757 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.74 -33.34 72.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.632 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 28.3 t0 -73.73 -41.24 62.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -63.02 -42.08 99.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.241 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -62.89 -50.26 71.59 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.779 ' HB2' HD21 ' C' ' 28' ' ' LEU . 0.8 OUTLIER -56.61 -29.16 61.83 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.942 178.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.11 -40.57 37.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.863 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.6 mpt_? -60.81 -32.68 72.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 6.4 m -80.06 -28.98 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.172 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -51.94 61.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 20.3 pttt -73.96 -39.44 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.717 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.35 -36.15 92.34 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' A' ' 36' ' ' LEU . 5.8 mt -73.54 -31.18 63.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.787 0.327 . . . . 0.0 111.045 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.08 -45.17 35.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.379 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.666 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 22.7 t -63.9 -44.87 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 11.5 t -59.17 -46.46 88.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.2 -29.07 68.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.483 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.537 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.11 -39.89 93.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.575 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 2.6 tm? -77.01 -39.0 51.89 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -72.01 -15.97 62.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.6 -32.96 74.63 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.08 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.533 ' CG ' ' HB ' ' B' ' 57' ' ' THR . 1.0 OUTLIER -64.29 143.71 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.929 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.555 ' HZ ' ' HB1' ' C' ' 82' ' ' ALA . 34.6 p90 -112.73 -42.48 3.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.467 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.504 HE22 ' HG2' ' B' ' 84' ' ' LYS . 33.8 mt-30 70.29 109.47 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.552 ' HD3' ' ND2' ' C' ' 102' ' ' ASN 0.257 9.8 Cg_endo -75.3 -161.15 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.632 2.222 . . . . 0.0 112.61 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 17.5 m-30 68.16 167.05 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.969 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' B' ' 76' ' ' ARG . . . 178.37 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.201 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.508 ' HA ' ' HG3' ' B' ' 79' ' ' GLU . 9.7 p -88.83 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.187 0.595 . . . . 0.0 112.409 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.34 69.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.317 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' B' ' 76' ' ' ARG . 1.5 mptp? -143.79 -178.1 5.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.579 HG13 ' HE3' ' C' ' 105' ' ' TRP . 10.1 p -119.08 142.14 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.537 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' B' ' 48' ' ' PRO . 1.7 m-80 -124.99 178.03 5.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.657 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.6 ' HB2' ' CH2' ' C' ' 105' ' ' TRP . 11.4 t80 -151.42 143.46 23.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.276 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' B' ' 45' ' ' LEU . 30.2 p -117.38 142.09 47.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.93 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.494 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -177.52 127.81 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.479 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.527 ' O ' HD12 ' B' ' 69' ' ' LEU . . . -179.26 -165.17 33.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.08 154.61 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 111.343 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.537 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -134.4 171.77 22.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.487 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 66' ' ' SER . . . -156.77 141.3 7.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 84.2 t80 -135.59 110.84 8.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.124 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.65 37.86 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.455 ' O ' ' HA2' ' B' ' 62' ' ' GLY . 32.0 t -134.83 157.62 46.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.64 148.32 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.139 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.03 15.04 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.527 HD12 ' O ' ' B' ' 59' ' ' GLY . 8.4 tp -124.67 126.73 46.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.756 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -117.58 163.37 16.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.623 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.495 HG13 ' O ' ' B' ' 57' ' ' THR . 2.3 tt -158.78 176.04 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.154 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.62 -167.82 34.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.36 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 16.6 p -164.16 160.04 20.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.46 176.37 29.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.158 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 5.0 t80 -143.36 126.9 16.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 111.17 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.461 ' O ' ' HA2' ' B' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.33 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.73 HG22 ' OD1' ' B' ' 78' ' ' ASN . 7.3 p -83.26 127.44 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.73 ' OD1' HG22 ' B' ' 77' ' ' VAL . 31.3 m120 61.04 162.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.508 ' HG3' ' HA ' ' B' ' 51' ' ' VAL . 32.5 mt-10 -99.47 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.6 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.25 -52.23 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.531 HG22 ' H ' ' B' ' 82' ' ' ALA . 3.6 p -131.29 169.83 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.568 ' HB1' ' HZ ' ' A' ' 46' ' ' PHE . . . -168.57 165.21 12.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.22 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' B' ' 101' ' ' PHE . 0.6 OUTLIER -139.16 168.75 19.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' B' ' 85' ' ' ALA . 2.0 tmtp? -157.8 122.89 4.43 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.547 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -132.65 161.01 35.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.11 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.63 18.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.633 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.97 130.69 73.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.347 . . . . 0.0 111.149 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.609 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -102.03 115.15 29.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.32 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . 0.497 ' HA ' HG13 ' B' ' 95' ' ' VAL . 77.7 m-85 -91.72 108.82 20.18 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.194 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.666 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -115.12 124.15 50.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.08 -85.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.282 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.61 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.391 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.4 14.33 30.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.164 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' B' ' 90' ' ' ALA . 3.9 t70 -116.31 57.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.958 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' B' ' 89' ' ' TYR . 0.3 OUTLIER -95.26 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.699 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.602 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 2.9 ptp -146.79 151.41 37.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.722 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -130.21 138.21 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.447 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' B' ' 85' ' ' ALA . 8.3 m-80 -132.58 137.22 47.0 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.781 0.324 . . . . 0.0 111.409 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.46 95.77 2.72 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.684 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.444 ' HB3' HD11 ' A' ' 45' ' ' LEU . 29.3 m -126.0 161.39 27.64 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.396 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 8.6 p90 -127.6 145.54 50.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.969 0.414 . . . . 0.0 111.049 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.559 ' ND2' ' HD3' ' A' ' 48' ' ' PRO . 1.8 p-10 -120.07 152.92 36.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.4 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 103' ' ' ILE . 4.4 mp -119.79 135.01 61.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 18.2 pm0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 2.8 mmpt? . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.692 0.282 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.72 -31.29 70.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -63.04 -58.7 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.79 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -36.21 83.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 1.033 HD21 HD13 ' B' ' 21' ' ' LEU . 12.1 mt -59.93 -47.48 85.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' C' ' 26' ' ' ASP . 29.1 t0 -66.91 -32.27 73.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.028 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -74.4 -47.53 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.751 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.63 -33.42 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.625 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' C' ' 22' ' ' ASP . 28.3 t0 -73.66 -41.3 62.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -62.98 -42.11 99.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.267 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' B' ' 29' ' ' ASP . 0.2 OUTLIER -62.8 -50.35 71.34 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . 0.761 ' HB2' HD21 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.18 61.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.961 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 m -78.08 -40.62 37.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.507 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.6 mpt_? -60.84 -32.62 72.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' C' ' 36' ' ' LEU . 6.5 m -80.07 -28.92 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -51.76 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 20.3 pttt -74.08 -39.32 63.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.815 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.13 92.24 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 36' ' ' LEU . 5.8 mt -73.55 -31.18 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.328 . . . . 0.0 111.085 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.21 35.97 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.429 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 22.9 t -63.95 -44.88 91.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.736 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.545 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 11.6 t -59.12 -46.46 88.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.31 -29.04 68.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.13 -39.85 93.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.566 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 2.6 tm? -77.06 -38.92 51.62 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -72.12 -15.99 61.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.59 -32.92 74.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.526 ' CG ' ' HB ' ' C' ' 57' ' ' THR . 1.0 OUTLIER -64.24 143.74 57.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.888 177.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.563 ' HZ ' ' HB1' ' A' ' 82' ' ' ALA . 34.6 p90 -112.78 -42.46 3.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.121 0.486 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.505 HE22 ' HG2' ' C' ' 84' ' ' LYS . 33.8 mt-30 70.3 109.44 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.958 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.559 ' HD3' ' ND2' ' A' ' 102' ' ' ASN 0.257 9.9 Cg_endo -75.24 -161.2 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.707 2.272 . . . . 0.0 112.633 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 17.5 m-30 68.1 167.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' C' ' 76' ' ' ARG . . . 178.4 -3.19 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.194 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.527 ' HA ' ' HG3' ' C' ' 79' ' ' GLU . 9.5 p -88.86 -34.72 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.136 0.574 . . . . 0.0 112.393 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.34 69.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.306 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' C' ' 76' ' ' ARG . 1.5 mptp? -143.72 -178.11 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.539 0.209 . . . . 0.0 110.642 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.509 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 10.2 p -119.04 142.12 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.533 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' C' ' 48' ' ' PRO . 1.7 m-80 -124.94 178.1 5.69 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.695 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -151.46 143.38 23.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.231 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' C' ' 45' ' ' LEU . 30.1 p -117.31 142.1 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.497 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -177.54 127.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.486 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.53 ' O ' HD12 ' C' ' 69' ' ' LEU . . . -179.28 -165.26 33.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.551 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.0 154.7 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 111.368 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -134.46 171.73 22.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.472 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' C' ' 66' ' ' SER . . . -156.79 141.25 7.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.575 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 84.3 t80 -135.5 110.83 9.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.334 . . . . 0.0 110.728 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.79 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.168 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.68 37.82 1.34 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.142 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . 0.464 ' O ' ' HA2' ' C' ' 62' ' ' GLY . 32.1 t -134.8 157.69 46.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.83 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.76 148.31 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.38 173.03 15.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.602 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.53 HD12 ' O ' ' C' ' 59' ' ' GLY . 8.3 tp -124.69 126.61 45.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.766 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -117.52 163.27 16.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.694 0.283 . . . . 0.0 111.683 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' C' ' 58' ' ' ALA . 2.3 tt -158.64 176.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.318 . . . . 0.0 111.105 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.79 34.69 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.466 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.0 p -164.09 160.05 21.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.038 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.47 176.35 29.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.234 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.509 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 5.0 t80 -143.32 126.94 16.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 111.151 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.462 ' O ' ' HA2' ' C' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.736 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.733 HG22 ' OD1' ' C' ' 78' ' ' ASN . 7.3 p -83.19 127.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.998 0.427 . . . . 0.0 111.291 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' C' ' 77' ' ' VAL . 31.3 m120 61.14 162.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.088 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . 0.527 ' HG3' ' HA ' ' C' ' 51' ' ' VAL . 32.5 mt-10 -99.49 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 2.6 m -121.33 -52.17 2.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.987 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.542 HG22 ' H ' ' C' ' 82' ' ' ALA . 3.6 p -131.2 169.82 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.572 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.555 ' HB1' ' HZ ' ' B' ' 46' ' ' PHE . . . -168.5 165.23 12.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' C' ' 101' ' ' PHE . 0.6 OUTLIER -139.19 168.79 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.626 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.532 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 2.0 tmtp? -157.85 122.76 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -132.53 161.04 34.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.66 19.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.552 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.93 130.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.616 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -102.0 115.07 29.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.307 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . 0.511 ' HA ' HG13 ' C' ' 95' ' ' VAL . 77.8 m-85 -91.72 108.73 20.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -114.98 124.14 50.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.6 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -85.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.263 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 82.8 p -166.67 -50.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.309 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.35 14.35 30.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.221 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.572 ' O ' ' HB3' ' C' ' 90' ' ' ALA . 4.0 t70 -116.42 57.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' C' ' 89' ' ' TYR . 0.3 OUTLIER -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.696 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.614 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 2.9 ptp -146.78 151.38 37.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.711 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -130.2 138.29 50.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.439 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' C' ' 85' ' ' ALA . 8.2 m-80 -132.63 137.06 46.88 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.31 95.66 2.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.452 ' HB3' HD11 ' B' ' 45' ' ' LEU . 28.7 m -125.88 161.44 27.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.474 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' C' ' 83' ' ' LEU . 8.6 p90 -127.6 145.51 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.956 0.408 . . . . 0.0 111.085 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.552 ' ND2' ' HD3' ' B' ' 48' ' ' PRO . 1.8 p-10 -120.08 152.98 36.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.387 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.408 HD12 ' N ' ' C' ' 103' ' ' ILE . 4.4 mp -119.79 135.01 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.488 ' HB2' ' CE2' ' B' ' 49' ' ' TYR . 18.3 pm0 -120.1 132.45 55.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 0.6 ' CH2' ' HB2' ' B' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.59 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.704 0.288 . . . . 0.0 110.514 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.82 -38.78 70.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.301 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.16 -61.81 1.83 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.27 -30.14 59.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.1 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.496 HD11 ' HD3' ' B' ' 24' ' ' ARG . 2.6 tm? -64.62 -60.46 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.603 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -65.03 -23.77 67.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -63.91 -54.12 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.533 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.3 mtp85 -69.78 -37.94 76.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.792 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.795 HD22 HD11 ' C' ' 25' ' ' LEU . 3.6 mm? -63.88 -44.71 92.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.605 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.89 -33.19 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG2' ' HD3' ' A' ' 31' ' ' ARG . 1.2 ttpp -67.91 -37.66 81.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.212 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -65.96 -45.48 81.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.414 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -60.12 -36.55 77.73 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.859 179.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.86 -30.35 56.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HD3' ' HG2' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -78.47 -27.18 46.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.28 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 28' ' ' LEU . 27.3 m -84.61 -32.39 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.21 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 55.6 m-20 -69.0 -43.91 73.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.989 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 5.0 ptpt -84.46 -30.22 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.0 -41.73 86.82 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.422 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.642 HD21 ' HG ' ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.81 -22.82 42.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.469 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -76.61 -39.77 51.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.419 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.644 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 8.6 t -77.64 -39.86 43.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.745 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -55.46 33.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.87 -39.16 80.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.374 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.47 71.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.958 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.437 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 28.3 tp -76.62 -42.21 43.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.093 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' CB ' ' C' ' 43' ' ' ASN . 32.4 m-20 -70.63 -9.86 57.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 41.7 t -69.26 -20.65 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.1 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.518 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.3 mm? -83.05 169.93 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.833 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.4 -1.66 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 0.0 111.727 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.597 ' OE1' ' HG2' ' A' ' 84' ' ' LYS . 6.0 mt-30 68.49 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.967 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -78.82 109.16 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.56 2.174 . . . . 0.0 112.527 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 59.57 177.48 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 174.74 50.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.191 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.7 p -71.58 -1.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.166 0.586 . . . . 0.0 112.407 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 143.63 53.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.254 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 -165.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.572 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.7 142.17 28.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.534 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 47' ' ' GLN . 12.8 m-80 -122.03 118.73 29.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 111.756 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.425 ' HA ' ' HB2' ' A' ' 73' ' ' SER . 30.1 t80 -84.84 131.67 34.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.267 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.527 HG21 ' HE3' ' A' ' 84' ' ' LYS . 40.9 p -113.72 121.2 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.9 136.99 18.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.486 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.15 166.51 33.58 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.555 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.0 m -116.43 158.13 17.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 111.304 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.98 -171.43 13.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.484 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -168.2 141.48 6.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.615 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.517 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 52.0 t80 -135.81 133.06 37.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 0.0 110.789 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 3.1 mmm180 69.52 -94.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 p -144.67 29.22 1.25 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.421 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 5.1 m -135.9 141.72 44.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.73 157.9 17.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.129 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.72 169.04 20.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.572 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.589 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.62 54.58 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.735 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -126.52 139.2 53.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.677 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 87' ' ' VAL . 10.7 tp -141.07 147.91 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.763 0.316 . . . . 0.0 111.128 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.42 -179.68 42.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.402 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' A' ' 56' ' ' PHE . 1.2 p -166.76 158.59 13.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.23 171.7 28.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.216 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 39.6 t80 -126.37 138.58 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 0.0 111.113 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.477 HH21 ' HB2' ' A' ' 47' ' ' GLN . 13.7 ttm180 -131.41 134.7 46.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.8 p -120.9 140.86 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.318 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.0 m-20 64.79 -94.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.072 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.606 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -73.35 -63.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.27 139.64 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -138.29 156.15 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 30.3 tp -136.93 141.75 42.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.621 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.597 ' HG2' ' OE1' ' A' ' 47' ' ' GLN . 7.9 tmtt? -153.39 128.71 9.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.71 175.86 11.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.06 -173.45 34.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.593 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' ILE . 7.7 p -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 111.131 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.591 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -112.6 144.68 41.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.329 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.6 120.48 40.31 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.244 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.644 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -127.8 131.07 49.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.638 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.21 -114.44 5.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.301 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.8 m -150.42 17.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.709 0.29 . . . . 0.0 111.331 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -167.24 19.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.192 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -119.44 67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.31 138.01 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.043 0.449 . . . . 0.0 110.75 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.591 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 4.4 ptp -134.84 134.62 40.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.684 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.81 122.46 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.403 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.24 150.51 27.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 0.0 111.389 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.47 90.58 0.48 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 19.3 m -118.98 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.465 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.43 135.06 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 111.059 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.76 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 73.9 m-80 -102.17 134.39 45.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' C' ' 56' ' ' PHE . 0.1 OUTLIER -138.78 115.29 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.774 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' C' ' 55' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.734 0.302 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.77 -38.87 70.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.275 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.1 -61.83 1.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.24 -30.1 59.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.119 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.517 HD11 ' HD3' ' C' ' 24' ' ' ARG . 2.6 tm? -64.69 -60.44 3.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.592 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -65.06 -23.73 67.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -63.87 -54.15 39.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.942 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.542 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.4 mtp85 -69.79 -37.97 76.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.747 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' C' ' 25' ' ' LEU . 3.5 mm? -63.85 -44.67 92.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.661 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.97 -33.15 75.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' HD3' ' B' ' 31' ' ' ARG . 1.2 ttpp -67.95 -37.59 81.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.227 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -65.97 -45.52 81.42 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.403 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -60.15 -36.49 77.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.939 178.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.94 -30.27 55.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.535 ' HD3' ' HG2' ' B' ' 27' ' ' LYS . 0.1 OUTLIER -78.42 -27.27 46.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.347 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.454 HG13 ' O ' ' B' ' 28' ' ' LEU . 27.4 m -84.65 -32.3 7.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.206 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 55.8 m-20 -69.04 -43.9 73.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.989 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.649 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 4.9 ptpt -84.44 -30.24 25.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.765 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.75 87.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.435 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.643 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -79.88 -22.85 42.37 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.485 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -76.61 -39.75 51.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.465 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.668 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 8.6 t -77.56 -39.96 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.89 -55.56 32.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.09 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.363 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.46 71.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.429 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 28.1 tp -76.63 -42.16 43.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 32.5 m-20 -70.67 -9.87 58.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.472 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 41.6 t -69.38 -20.51 63.82 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.107 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.514 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.3 mm? -83.09 169.85 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.849 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.29 -1.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.191 0.52 . . . . 0.0 111.665 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.611 ' OE1' ' HG2' ' B' ' 84' ' ' LYS . 6.0 mt-30 68.54 116.95 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.984 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.724 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.69 109.0 2.53 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.723 2.282 . . . . 0.0 112.557 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 174.81 50.72 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.31 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.8 p -71.5 -1.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.158 0.583 . . . . 0.0 112.412 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 143.65 53.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.265 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.8 -165.26 1.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 110.653 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.71 142.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.584 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' B' ' 47' ' ' GLN . 12.9 m-80 -122.03 118.76 29.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.703 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.432 ' HA ' ' HB2' ' B' ' 73' ' ' SER . 30.2 t80 -84.86 131.63 34.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.226 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.54 HG21 ' HE3' ' B' ' 84' ' ' LYS . 40.9 p -113.72 121.25 43.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.976 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.87 137.02 18.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.447 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.13 166.43 33.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.576 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' B' ' 69' ' ' LEU . 7.0 m -116.32 158.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.816 0.341 . . . . 0.0 111.388 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.5 13.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.41 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -168.08 141.43 6.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.622 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 52.1 t80 -135.73 133.17 37.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.739 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 3.1 mmm180 69.5 -94.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 15.2 p -144.67 29.23 1.25 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.138 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 5.1 m -136.0 141.72 44.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.69 157.93 17.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.094 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.76 169.03 20.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.578 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.66 54.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.751 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.684 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' B' ' 87' ' ' VAL . 10.7 tp -140.97 147.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.41 -179.62 42.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' B' ' 56' ' ' PHE . 1.2 p -166.87 158.6 12.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.25 171.69 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 39.7 t80 -126.3 138.61 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 111.197 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.479 HH21 ' HB2' ' B' ' 47' ' ' GLN . 13.7 ttm180 -131.44 134.72 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.585 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.8 p -120.98 140.87 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.256 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 97.1 m-20 64.73 -94.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.916 0.389 . . . . 0.0 111.111 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 5.6 pt-20 177.11 -23.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 23.9 p -73.39 -63.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.013 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.3 139.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -138.36 156.1 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.316 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 30.2 tp -136.91 141.76 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.621 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.611 ' HG2' ' OE1' ' B' ' 47' ' ' GLN . 8.0 tmtt? -153.42 128.68 9.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.148 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.81 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.14 -173.43 34.06 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' B' ' 71' ' ' ILE . 7.7 p -141.56 143.47 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.59 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -112.65 144.7 41.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.373 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -114.61 120.51 40.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.266 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -127.85 130.94 49.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.649 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.649 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.37 -114.43 5.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.287 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -150.51 17.44 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.802 0.334 . . . . 0.0 111.296 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . 0.414 ' HB3' HH12 ' B' ' 31' ' ' ARG . 1.3 t -167.18 18.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.205 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -119.38 67.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.971 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.3 137.99 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 110.655 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.59 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 4.4 ptp -134.86 134.66 40.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.708 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -109.89 122.47 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.433 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.19 150.37 27.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.718 0.294 . . . . 0.0 111.416 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.36 90.59 0.49 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.774 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 19.3 m -119.01 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.373 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -143.42 135.12 26.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.774 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 73.8 m-80 -102.24 134.27 45.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.392 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.68 115.26 10.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.83 0.347 . . . . 0.0 110.779 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.725 0.298 . . . . 0.0 110.522 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -38.83 69.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.191 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.09 -61.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.35 -30.03 59.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.491 HD11 ' HD3' ' A' ' 24' ' ' ARG . 2.6 tm? -64.58 -60.55 3.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.02 -23.71 67.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.993 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.03 -54.09 39.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.544 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.3 mtp85 -69.69 -38.06 76.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.75 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' A' ' 25' ' ' LEU . 3.6 mm? -63.78 -44.8 92.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.566 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.85 -33.19 75.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.853 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.551 ' HG2' ' HD3' ' C' ' 31' ' ' ARG . 1.2 ttpp -67.92 -37.61 81.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.23 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.457 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.0 OUTLIER -65.97 -45.44 81.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.105 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . 0.41 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -60.17 -36.49 77.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.908 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.93 -30.36 56.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.551 ' HD3' ' HG2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -78.38 -27.28 46.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.288 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.457 HG13 ' O ' ' C' ' 28' ' ' LEU . 27.3 m -84.55 -32.42 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.249 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.507 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 55.7 m-20 -68.95 -43.96 73.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.644 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 5.0 ptpt -84.42 -30.22 25.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.817 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -41.78 87.16 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.42 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.643 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.79 -22.86 42.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.466 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -76.58 -39.8 51.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.46 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.659 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 8.6 t -77.63 -39.88 43.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.719 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.95 -55.52 33.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.132 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.02 80.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.469 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.4 71.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.438 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 28.6 tp -76.62 -42.31 42.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 32.1 m-20 -70.59 -9.9 58.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . 0.491 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 41.7 t -69.22 -20.63 63.96 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.156 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.534 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.4 mm? -83.02 169.85 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.946 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -157.35 -1.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.219 0.533 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.61 ' OE1' ' HG2' ' C' ' 84' ' ' LYS . 6.0 mt-30 68.39 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.76 109.08 2.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.605 2.203 . . . . 0.0 112.582 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.002 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 174.77 50.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.235 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.7 p -71.49 -1.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.194 0.598 . . . . 0.0 112.483 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 143.58 53.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.282 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 -165.27 1.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.594 0.235 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.68 142.17 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.598 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' C' ' 47' ' ' GLN . 12.9 m-80 -122.0 118.73 29.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.71 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . 0.435 ' HA ' ' HB2' ' C' ' 73' ' ' SER . 29.9 t80 -84.74 131.68 34.53 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.296 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.52 HG21 ' HE3' ' C' ' 84' ' ' LYS . 40.8 p -113.78 121.21 43.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.91 136.99 18.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.1 166.43 33.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.572 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' C' ' 69' ' ' LEU . 7.0 m -116.33 158.14 16.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 111.371 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.41 13.44 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.465 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -168.15 141.52 6.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.518 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 52.2 t80 -135.8 133.04 37.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.276 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.1 mmm180 69.53 -94.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 15.0 p -144.68 29.19 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' C' ' 33' ' ' ASP . 5.0 m -135.93 141.69 44.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.68 157.99 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.73 169.07 20.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.565 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.584 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -123.36 138.61 54.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.749 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -126.5 139.2 53.41 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.655 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' C' ' 87' ' ' VAL . 10.7 tp -141.03 147.97 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.747 0.308 . . . . 0.0 111.085 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.4 -179.65 42.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' C' ' 56' ' ' PHE . 1.2 p -166.82 158.57 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.997 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.21 171.7 28.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.214 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 39.8 t80 -126.33 138.62 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.18 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.481 HH21 ' HB2' ' C' ' 47' ' ' GLN . 13.7 ttm180 -131.49 134.72 46.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.667 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.569 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.9 p -121.0 140.89 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 97.2 m-20 64.73 -94.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.56 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 23.8 p -73.42 -63.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.28 139.77 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -138.47 156.08 47.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.267 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 30.4 tp -136.91 141.69 42.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.61 ' HG2' ' OE1' ' C' ' 47' ' ' GLN . 8.0 tmtt? -153.41 128.69 9.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.91 11.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.051 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.05 -173.44 34.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.616 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' C' ' 71' ' ' ILE . 7.9 p -141.56 143.4 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.586 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -112.65 144.68 41.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -114.59 120.52 40.48 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.186 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -127.86 131.0 49.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.631 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.644 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.37 -114.46 5.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.263 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 62.1 m -150.43 17.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.759 0.314 . . . . 0.0 111.294 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . 0.402 ' HB3' HH12 ' C' ' 31' ' ' ARG . 1.3 t -167.25 19.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.21 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -119.47 67.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.25 137.95 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.586 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 4.4 ptp -134.84 134.74 41.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.86 122.44 47.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.404 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.26 150.42 27.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.713 0.292 . . . . 0.0 111.447 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.37 90.57 0.49 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 19.3 m -119.01 172.22 7.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.407 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.44 135.18 26.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.79 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 73.9 m-80 -102.27 134.39 45.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.385 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 115.26 10.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 110.789 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' B' ' 55' ' ' ASN . 0.0 OUTLIER -115.22 157.4 23.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.672 179.665 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.593 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.68 0.276 . . . . 0.0 110.466 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.11 -30.5 66.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.19 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -63.26 -64.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.723 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.638 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 2.6 pp0? -64.0 -27.65 69.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.199 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.608 HD21 HD23 ' B' ' 21' ' ' LEU . 2.3 tm? -63.42 -69.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.541 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.46 -23.37 57.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.018 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.08 -47.99 66.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 47.7 mtp85 -70.87 -40.88 72.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' B' ' 25' ' ' LEU . 2.3 mm? -57.29 -51.12 70.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.547 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.7 -39.44 84.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 1.1 ttpp -63.13 -37.12 85.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.207 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -60.93 -38.21 85.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.544 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -73.37 -30.56 63.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 178.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.47 -34.34 72.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -33.83 62.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 29' ' ' ASP . 33.4 m -78.02 -26.67 14.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.182 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.595 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 40.8 m-20 -71.93 -43.19 65.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.047 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 7.0 ptpt -82.88 -28.84 29.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.829 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.58 74.15 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.446 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -74.93 -29.61 61.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 111.158 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' A' ' 63' ' ' TYR . . . -71.17 -42.4 69.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.451 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.8 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 11.5 t -74.73 -45.61 42.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.659 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.474 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 1.0 OUTLIER -58.42 -49.26 77.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.611 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -66.99 -36.87 83.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.456 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.03 85.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 35.9 tp -74.33 -40.88 61.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.016 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' C' ' 40' ' ' ALA . 63.5 m-20 -73.16 -9.74 59.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.5 t -69.03 -18.88 64.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.149 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.649 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 1.5 mm? -80.55 167.72 19.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.911 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -156.24 -3.39 0.12 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.641 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 12.7 mt-30 66.2 122.29 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.998 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -84.02 104.66 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.599 2.199 . . . . 0.0 112.51 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 9.2 m-30 66.78 -179.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.959 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 170.37 55.49 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.236 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.3 p -74.68 -5.62 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.133 0.573 . . . . 0.0 112.451 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.56 56.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.369 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.83 -163.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.644 0.259 . . . . 0.0 110.616 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.95 138.9 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.494 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.4 ' OD1' ' HB3' ' B' ' 104' ' ' GLU . 15.3 m-80 -123.0 115.22 21.53 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 111.666 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -81.45 129.97 34.86 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.207 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.649 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.9 p -110.57 126.12 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.593 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -156.12 133.15 10.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' HB3' ' B' ' 100' ' ' SER . . . -175.25 171.43 44.56 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.57 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.06 159.59 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 111.318 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 -169.88 16.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.444 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.426 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -167.03 135.95 3.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.518 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.649 ' CE2' HD13 ' A' ' 36' ' ' LEU . 28.6 t80 -123.89 141.62 51.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 110.744 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.429 ' HG3' ' OD1' ' A' ' 33' ' ' ASP . 2.5 mmm180 60.55 -95.63 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 p -142.34 24.31 1.95 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.34 142.03 50.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.82 156.37 18.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.14 168.67 22.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.598 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.15 138.26 54.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.796 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -131.99 139.2 48.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.671 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 72' ' ' GLY . 5.5 tp -137.49 162.4 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.121 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.606 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 169.96 -176.07 43.84 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.404 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.78 3.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.01 27.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.268 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.587 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 54.4 t80 -126.4 130.92 51.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 0.0 111.11 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.482 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 10.9 ttm180 -122.32 120.88 35.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.789 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.2 p -108.04 140.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.256 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 38.7 m-20 62.9 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.077 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 p -72.37 -61.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.992 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.09 142.17 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.816 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -141.19 158.83 43.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.85 147.01 31.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.575 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HE3' HG21 ' A' ' 57' ' ' THR . 11.5 tmtt? -158.54 132.46 7.76 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.25 -179.73 8.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.081 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.444 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . 160.53 -173.1 37.04 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.545 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.43 138.08 36.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.114 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.8 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -113.2 145.85 40.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.303 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -118.48 115.58 24.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.248 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -123.01 131.14 53.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.669 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.56 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 63.46 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.263 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.9 m -149.28 9.17 0.74 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.57 25.18 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.219 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-20 -121.03 71.76 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.5 t -101.91 137.35 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.071 0.463 . . . . 0.0 110.695 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.575 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 10.2 ptp -130.32 136.87 49.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -112.33 121.95 46.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.361 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.48 154.96 25.07 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 111.419 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.783 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB3' ' HA3' ' C' ' 59' ' ' GLY . 12.8 m -113.83 168.85 9.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.406 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.72 140.7 47.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.955 0.407 . . . . 0.0 111.108 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.816 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 57.1 m-80 -108.6 132.1 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.3 117.49 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.851 0.357 . . . . 0.0 110.712 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.406 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.6 0.238 . . . . 0.0 110.471 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.18 -30.43 66.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.251 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -63.22 -64.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.629 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 2.6 pp0? -64.05 -27.66 69.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.102 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.622 HD21 HD23 ' C' ' 21' ' ' LEU . 2.3 tm? -63.36 -69.21 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.41 -23.39 57.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.009 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.02 -48.12 66.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' B' ' 20' ' ' GLN . 47.8 mtp85 -70.83 -40.87 72.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.802 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.795 HD22 HD11 ' A' ' 25' ' ' LEU . 2.3 mm? -57.23 -51.11 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.636 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -59.68 -39.53 84.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.766 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.562 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 1.2 ttpp -63.15 -37.05 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.218 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.562 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -60.94 -38.21 85.05 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.549 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -73.38 -30.62 63.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.905 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.41 -34.43 72.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -33.9 62.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.276 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' B' ' 29' ' ' ASP . 33.3 m -77.95 -26.65 14.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.211 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.604 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 40.5 m-20 -71.96 -43.28 65.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.957 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.578 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 6.9 ptpt -82.88 -28.76 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.1 -38.58 73.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.658 HD13 ' CE2' ' B' ' 63' ' ' TYR . 0.5 OUTLIER -74.98 -29.63 60.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.765 0.317 . . . . 0.0 111.058 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' B' ' 63' ' ' TYR . . . -71.24 -42.31 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.459 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.799 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 11.4 t -74.73 -45.57 43.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.75 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.475 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 1.1 t -58.45 -49.2 78.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.607 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -67.08 -36.94 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.386 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.0 85.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.493 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 36.2 tp -74.41 -40.8 61.79 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.611 ' ND2' ' HA ' ' A' ' 40' ' ' ALA . 63.6 m-20 -73.16 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 29.4 t -69.05 -18.85 64.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.125 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 1.6 mm? -80.59 167.7 19.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.889 177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.24 -3.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.131 0.491 . . . . 0.0 111.649 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' B' ' 48' ' ' PRO . 12.7 mt-30 66.37 122.19 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.956 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -84.0 104.68 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.572 2.181 . . . . 0.0 112.548 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 9.1 m-30 66.8 -179.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 170.37 55.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.252 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.3 p -74.66 -5.67 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.103 0.561 . . . . 0.0 112.454 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.798 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.64 56.11 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.228 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 -163.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.94 138.9 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.518 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 15.4 m-80 -122.93 115.15 21.44 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 111.669 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.502 ' HB2' ' HZ3' ' C' ' 105' ' ' TRP . 37.6 t80 -81.37 130.01 34.86 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.628 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.8 p -110.57 126.09 54.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.959 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.594 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -156.15 133.24 10.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.403 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' C' ' 100' ' ' SER . . . -175.33 171.44 44.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.573 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -126.02 159.52 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.16 -169.81 16.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.454 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -167.1 135.85 3.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.595 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.658 ' CE2' HD13 ' B' ' 36' ' ' LEU . 28.6 t80 -123.8 141.65 51.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.725 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' OD1' ' B' ' 33' ' ' ASP . 2.5 mmm180 60.49 -95.7 0.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 16.8 p -142.26 24.33 1.96 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.23 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.35 141.98 50.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.78 156.39 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 168.71 22.57 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.13 138.31 54.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.782 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -131.97 139.15 48.56 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.594 HD12 ' CB ' ' B' ' 58' ' ' ALA . 5.5 tp -137.5 162.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 111.113 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.584 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 170.02 -176.0 43.89 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.452 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.8 p -170.02 150.72 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.991 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.09 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.239 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.583 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 54.5 t80 -126.38 130.97 51.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 111.159 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.479 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 11.0 ttm180 -122.47 120.96 35.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.798 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.2 p -108.04 140.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 38.5 m-20 62.9 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 176.0 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.567 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.46 -61.43 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 16.3 m -89.11 142.27 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.81 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -141.21 158.85 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.207 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.9 146.98 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.448 ' HE3' HG21 ' B' ' 57' ' ' THR . 11.5 tmtt? -158.49 132.39 7.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.22 -179.72 8.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.074 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.442 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 160.53 -173.11 37.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.61 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.44 137.99 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.799 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -113.15 145.96 40.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.294 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -118.59 115.6 24.89 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.221 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.681 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -123.01 131.24 53.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.578 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 63.31 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.262 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 50.0 m -149.23 9.17 0.74 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.355 . . . . 0.0 111.343 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.61 25.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.184 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 19.1 m-20 -121.09 71.79 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 87.4 t -101.89 137.36 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 110.657 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.58 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 10.2 ptp -130.36 136.89 49.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.652 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -112.4 121.87 46.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.387 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -112.41 154.91 25.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.482 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.18 88.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.762 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.576 ' HB3' ' HA3' ' A' ' 59' ' ' GLY . 12.7 m -113.7 168.91 9.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.446 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.82 140.63 47.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 111.074 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.81 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 57.2 m-80 -108.59 131.96 54.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.373 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.14 117.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.4 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.859 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.733 0.301 . . . . 0.0 110.556 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.98 -30.59 66.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.306 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 43.6 mtt-85 -63.16 -64.09 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.771 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.637 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 2.6 pp0? -64.07 -27.71 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.108 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.622 HD23 HD21 ' B' ' 21' ' ' LEU . 2.3 tm? -63.44 -69.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.554 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -58.54 -23.28 57.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.017 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.11 -48.01 66.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' C' ' 20' ' ' GLN . 48.1 mtp85 -70.89 -40.83 71.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.775 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.788 HD22 HD11 ' B' ' 25' ' ' LEU . 2.3 mm? -57.31 -51.1 70.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.67 -39.52 84.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.803 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.428 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 1.2 ttpp -63.12 -37.08 85.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.192 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.428 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -61.01 -38.06 84.75 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . 0.543 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -73.43 -30.68 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.92 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.34 -34.47 72.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.848 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -33.9 62.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.322 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.543 HG22 ' HA ' ' C' ' 29' ' ' ASP . 33.4 m -77.94 -26.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.592 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 40.2 m-20 -71.96 -43.21 65.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.582 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 6.9 ptpt -82.84 -28.87 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.799 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.99 -38.6 74.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.475 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' C' ' 63' ' ' TYR . 0.5 OUTLIER -74.96 -29.65 60.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.819 0.342 . . . . 0.0 111.067 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.434 ' HB2' ' H ' ' C' ' 63' ' ' TYR . . . -71.27 -42.26 68.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.429 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.801 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 11.5 t -74.77 -45.54 43.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.469 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 1.0 OUTLIER -58.5 -49.2 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.083 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.61 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -67.1 -36.81 82.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.428 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.97 85.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.906 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 36.0 tp -74.35 -40.83 61.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.607 ' ND2' ' HA ' ' B' ' 40' ' ' ALA . 63.5 m-20 -73.21 -9.67 58.96 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.2 t -69.16 -18.71 63.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.647 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 1.5 mm? -80.65 167.69 19.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.872 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.18 -3.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 111.702 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 12.7 mt-30 66.31 122.27 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -84.04 104.71 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.573 2.182 . . . . 0.0 112.528 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 9.2 m-30 66.73 -179.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 170.42 55.56 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.201 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.2 p -74.7 -5.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.197 0.599 . . . . 0.0 112.445 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.779 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.51 56.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.323 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 -163.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.656 0.265 . . . . 0.0 110.597 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.88 138.83 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.584 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 15.4 m-80 -122.98 115.18 21.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.022 0.439 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . 0.402 ' CE2' HD11 ' C' ' 71' ' ' ILE . 37.7 t80 -81.45 129.96 34.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.238 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.647 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 45.7 p -110.56 126.07 54.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.597 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -156.05 133.21 10.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.45 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 100' ' ' SER . . . -175.31 171.5 44.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.588 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -126.12 159.55 34.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.336 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.19 -169.87 16.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.478 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . 0.43 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -167.08 135.96 3.91 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.52 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.648 ' CE2' HD13 ' C' ' 36' ' ' LEU . 28.7 t80 -123.87 141.66 51.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.674 0.273 . . . . 0.0 110.816 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' OD1' ' C' ' 33' ' ' ASP . 2.5 mmm180 60.44 -95.61 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.097 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -142.32 24.35 1.95 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.164 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.3 141.98 50.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.76 156.43 18.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.23 168.61 22.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.605 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.08 138.32 54.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.787 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.0 139.19 48.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.633 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.608 HG13 ' H ' ' C' ' 72' ' ' GLY . 5.5 tp -137.5 162.46 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.608 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 169.97 -176.09 43.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.477 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.7 3.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.1 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.224 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.585 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 54.6 t80 -126.38 130.94 51.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 111.097 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.475 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 10.9 ttm180 -122.35 120.92 35.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.743 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.779 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.2 p -108.08 140.69 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.292 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 38.6 m-20 62.91 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.556 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.36 -61.56 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.953 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.08 142.26 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.497 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.785 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -141.21 158.82 43.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.268 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.88 146.99 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.446 ' HE3' HG21 ' C' ' 57' ' ' THR . 11.6 tmtt? -158.49 132.4 7.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.169 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.23 -179.67 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 160.53 -173.06 37.04 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.552 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.4 138.06 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 111.164 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.801 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -113.2 145.94 40.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -118.59 115.62 24.93 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.188 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -123.11 131.13 53.57 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.574 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.582 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 63.45 -112.4 4.94 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.213 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -149.29 9.19 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 111.297 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.62 25.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 19.4 m-20 -121.0 71.8 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -101.86 137.39 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 0.0 110.663 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.576 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 10.2 ptp -130.35 136.82 49.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.33 121.96 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.435 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.45 154.92 25.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.456 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.66 0.15 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.767 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.583 ' HB3' ' HA3' ' B' ' 59' ' ' GLY . 12.6 m -113.71 168.91 9.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.47 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -133.79 140.54 47.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.085 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.785 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 56.9 m-80 -108.49 132.03 54.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.392 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.19 117.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.727 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' C' ' 104' ' ' GLU . 0.0 OUTLIER -118.65 161.18 20.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 0.502 ' HZ3' ' HB2' ' B' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.675 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.671 0.272 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.41 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 82.1 t80 -60.94 -31.5 71.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.193 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.566 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 32.2 mmt180 -75.58 -30.06 59.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.619 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 29.5 mt-30 -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.11 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.433 ' HA ' HD11 ' C' ' 21' ' ' LEU . 0.5 OUTLIER -64.47 -50.28 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 22.8 m-20 -71.98 -19.97 61.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 12.9 t-20 -77.4 -41.22 40.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.735 ' HD3' HD13 ' C' ' 25' ' ' LEU . 3.6 mmp_? -71.58 -46.25 59.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.727 HD13 ' HD3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.67 94.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.698 ' O ' HG22 ' A' ' 30' ' ' THR . 51.7 t0 -69.73 -28.98 66.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.805 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -75.96 -38.1 57.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.241 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.636 ' O ' HG22 ' A' ' 32' ' ' VAL . 8.0 mt -76.5 -34.8 58.61 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -66.76 -47.21 72.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 26' ' ' ASP . 9.7 t -71.63 -40.19 69.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.678 ' HG2' HH11 ' A' ' 31' ' ' ARG . 21.2 ttp85 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.348 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 28' ' ' LEU . 28.4 m -76.61 -27.67 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.582 ' OD2' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t70 -64.08 -56.18 16.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.96 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.679 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 23.0 pttt -68.71 -37.63 79.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.826 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.67 -48.2 87.42 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.421 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' B' ' 39' ' ' SER . 0.4 OUTLIER -67.48 -31.69 72.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.801 0.334 . . . . 0.0 111.095 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -38.44 90.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.405 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.685 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 78.7 p -79.96 -43.52 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.573 ' HB2' HD21 ' C' ' 36' ' ' LEU . 46.7 t -53.24 -60.95 2.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.7 -30.25 60.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.567 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -63.98 -49.02 74.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.926 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -66.99 -32.91 74.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.123 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 1.4 m-20 -78.75 -13.63 59.71 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -19.08 65.68 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.134 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.815 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.2 mm? -75.55 158.57 32.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.9 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 47.3 p90 -146.47 -31.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.645 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 8.3 tt0 75.64 108.58 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.924 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -90.81 137.26 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.668 2.246 . . . . 0.0 112.576 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 14.5 m-85 67.56 154.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.576 ' CA ' ' HB3' ' A' ' 76' ' ' ARG . . . -173.94 73.06 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.228 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.826 HG12 ' HE2' ' A' ' 53' ' ' LYS . 11.4 p -95.88 -22.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.157 0.583 . . . . 0.0 112.521 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.89 48.99 0.02 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.301 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.826 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -143.76 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.576 0.227 . . . . 0.0 110.57 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.41 143.4 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.557 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.496 HD21 ' HB3' ' B' ' 102' ' ' ASN . 1.0 OUTLIER -135.14 116.49 14.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.03 0.443 . . . . 0.0 111.697 179.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 71' ' ' ILE . 12.0 t80 -80.29 131.03 35.59 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.279 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.815 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 27.7 p -110.53 120.96 44.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.971 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 71' ' ' ILE . . . -143.49 139.9 30.06 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.402 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.01 164.68 33.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.536 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.428 HG12 HD13 ' A' ' 69' ' ' LEU . 28.6 m -118.79 164.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.879 0.371 . . . . 0.0 111.282 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.567 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.5 177.5 20.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.48 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 67' ' ' GLN . . . -162.05 155.13 26.3 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.517 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 1.3 t80 -142.04 122.32 13.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 110.736 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.582 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 24.9 mtt-85 67.63 -93.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.107 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -131.89 9.49 4.55 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.167 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 22.9 t -109.93 173.88 6.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -135.31 -179.27 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.685 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -162.61 158.28 23.11 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.515 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD12 ' H ' ' A' ' 70' ' ' ALA . 3.9 tp -118.11 134.62 54.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.733 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.926 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -142.71 139.06 30.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.68 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.561 HD11 ' CE2' ' A' ' 56' ' ' PHE . 8.9 tp -138.33 150.55 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.718 0.295 . . . . 0.0 111.09 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.7 -177.26 37.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.2 p -160.23 155.26 24.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.61 30.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.242 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.42 120.58 17.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 111.147 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.576 ' HB3' ' CA ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.695 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.777 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 14.9 p -102.47 130.09 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 58.98 -171.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.97 66.02 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.3 p -160.07 -51.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' A' ' 103' ' ' ILE . 9.8 p -119.53 142.08 36.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.83 153.09 45.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 0.0 111.272 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 130.7 32.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.694 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -135.02 144.02 47.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.062 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 173.42 161.11 23.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.588 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.39 150.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -121.79 140.68 52.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.23 128.4 48.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.247 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 94' ' ' ASP . . . -136.33 151.09 49.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.672 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.679 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 50.21 -99.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.256 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.33 -27.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.727 0.298 . . . . 0.0 111.308 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.5 p -123.75 15.03 9.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.2 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.536 ' CB ' ' HB3' ' A' ' 90' ' ' ALA . 41.6 m-20 -101.52 69.91 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.74 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.512 ' SD ' HD23 ' C' ' 36' ' ' LEU . 1.3 ptp -135.2 139.48 44.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.771 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -117.56 129.91 56.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.473 ' ND2' ' HA3' ' C' ' 61' ' ' GLY . 15.1 m120 -129.27 145.43 51.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.661 0.267 . . . . 0.0 111.441 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.52 7.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.746 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.9 p -127.99 164.41 22.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.437 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.28 142.62 35.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.951 0.405 . . . . 0.0 111.096 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 17.0 m-80 -109.32 134.99 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.366 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' A' ' 81' ' ' VAL . 1.2 pt -134.58 126.3 48.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.808 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' C' ' 55' ' ' ASN . 3.8 pt-20 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.655 0.264 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . 0.404 ' O ' ' OD2' ' B' ' 22' ' ' ASP . 82.3 t80 -60.78 -31.53 70.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 111.296 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 32.4 mmt180 -75.66 -30.02 59.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.618 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 29.6 mt-30 -73.12 -37.04 66.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.159 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' C' ' 21' ' ' LEU . 0.5 OUTLIER -64.52 -50.24 68.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.569 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 22.7 m-20 -72.0 -19.99 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.971 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 13.0 t-20 -77.37 -41.2 41.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.727 ' HD3' HD13 ' A' ' 25' ' ' LEU . 3.6 mmp_? -71.54 -46.29 59.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.762 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.725 HD13 ' HD3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.65 94.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.693 ' O ' HG22 ' B' ' 30' ' ' THR . 51.7 t0 -69.75 -28.98 66.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.835 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -76.01 -37.99 57.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.251 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.631 ' O ' HG22 ' B' ' 32' ' ' VAL . 8.0 mt -76.62 -34.82 58.33 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -66.58 -47.35 73.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.942 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.693 HG22 ' O ' ' B' ' 26' ' ' ASP . 9.7 t -71.66 -40.11 69.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.885 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.689 HH11 ' HG2' ' B' ' 31' ' ' ARG . 21.3 ttp85 -62.73 -38.3 89.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.297 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.631 HG22 ' O ' ' B' ' 28' ' ' LEU . 28.6 m -76.69 -27.68 17.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.178 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.575 ' OD2' ' HD2' ' B' ' 64' ' ' ARG . 10.4 t70 -64.0 -56.17 17.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.004 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.682 ' HD2' ' HA3' ' B' ' 91' ' ' GLY . 23.0 pttt -68.77 -37.56 79.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.06 88.12 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.425 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' C' ' 39' ' ' SER . 0.4 OUTLIER -67.64 -31.62 71.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 111.057 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.52 90.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.418 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.694 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 78.4 p -79.93 -43.58 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.55 ' HB2' HD21 ' A' ' 36' ' ' LEU . 46.7 t -53.19 -60.88 2.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.75 -30.22 60.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.403 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.571 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -64.03 -48.97 74.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.927 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.6 OUTLIER -67.04 -32.96 74.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 1.4 m-20 -78.79 -13.58 59.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.12 65.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.131 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.814 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.2 mm? -75.58 158.63 32.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.894 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.441 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 47.4 p90 -146.52 -30.99 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.169 0.509 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 8.3 tt0 75.45 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.978 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -90.79 137.16 2.25 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.208 . . . . 0.0 112.613 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 14.4 m-85 67.53 154.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.582 ' CA ' ' HB3' ' B' ' 76' ' ' ARG . . . -173.89 73.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.215 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.814 HG12 ' HE2' ' B' ' 53' ' ' LYS . 11.5 p -96.02 -22.88 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 123.162 0.585 . . . . 0.0 112.446 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.83 49.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.814 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.631 0.253 . . . . 0.0 110.546 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.43 143.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.571 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.492 HD21 ' HB3' ' C' ' 102' ' ' ASN . 1.0 OUTLIER -135.18 116.49 14.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 111.663 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' B' ' 71' ' ' ILE . 12.0 t80 -80.32 131.07 35.58 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.215 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.814 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 27.8 p -110.63 120.81 43.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.941 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' B' ' 71' ' ' ILE . . . -143.37 139.85 30.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.441 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.02 164.63 33.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.522 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.425 HG12 HD13 ' B' ' 69' ' ' LEU . 28.5 m -118.68 164.37 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.879 0.371 . . . . 0.0 111.293 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.571 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.57 177.47 20.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.482 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 67' ' ' GLN . . . -162.0 155.12 26.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 1.3 t80 -142.05 122.34 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.575 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 25.1 mtt-85 67.59 -93.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.088 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.41 4.54 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.472 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 22.8 t -109.89 173.91 6.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.811 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.6 OUTLIER -135.32 -179.35 5.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.061 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.694 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -162.56 158.22 23.15 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.552 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.593 HD12 ' H ' ' B' ' 70' ' ' ALA . 3.9 tp -118.02 134.64 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.927 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -142.72 139.03 30.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.694 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.558 HD11 ' CE2' ' B' ' 56' ' ' PHE . 8.9 tp -138.29 150.47 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.15 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.4 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -164.59 -177.19 37.02 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.423 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -160.28 155.22 24.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.58 30.06 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.235 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.4 120.52 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 111.108 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.582 ' HB3' ' CA ' ' B' ' 50' ' ' GLY . 0.0 OUTLIER -105.21 107.63 18.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.762 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.768 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 14.9 p -102.52 130.07 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 59.0 -171.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -118.99 66.01 0.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 69.9 p -160.03 -51.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.022 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' B' ' 103' ' ' ILE . 9.8 p -119.53 142.07 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.563 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.85 153.15 45.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.895 0.378 . . . . 0.0 111.245 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.57 130.71 32.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.477 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -135.09 143.95 46.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.21 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.477 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -148.28 169.11 20.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.793 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 173.37 161.02 22.92 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.553 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.33 150.16 34.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -121.74 140.67 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.16 128.35 48.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.268 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.542 ' HB3' ' CB ' ' B' ' 94' ' ' ASP . . . -136.32 151.09 49.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.625 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.682 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 50.22 -99.64 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.307 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 25.9 t -152.28 -27.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 15.08 9.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.191 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.542 ' CB ' ' HB3' ' B' ' 90' ' ' ALA . 41.5 m-20 -101.59 69.95 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -113.33 127.94 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.747 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.505 ' SD ' HD23 ' A' ' 36' ' ' LEU . 1.3 ptp -135.19 139.48 44.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -117.57 129.92 56.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.463 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.463 ' ND2' ' HA3' ' A' ' 61' ' ' GLY . 15.0 m120 -129.29 145.43 51.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.7 0.285 . . . . 0.0 111.419 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.45 7.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.695 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 84.1 p -127.99 164.49 22.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.424 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -140.36 142.54 35.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.521 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 17.1 m-80 -109.3 134.95 51.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' B' ' 81' ' ' VAL . 1.2 pt -134.57 126.2 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.796 0.331 . . . . 0.0 110.781 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 3.8 pt-20 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.65 0.262 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . 0.418 ' O ' ' OD2' ' C' ' 22' ' ' ASP . 82.2 t80 -60.87 -31.5 70.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 32.3 mmt180 -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.735 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 29.6 mt-30 -73.07 -37.0 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 111.212 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.437 ' HA ' HD11 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -64.57 -50.25 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 22.7 m-20 -71.91 -20.06 61.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 12.8 t-20 -77.31 -41.27 41.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.725 ' HD3' HD13 ' B' ' 25' ' ' LEU . 3.6 mmp_? -71.45 -46.4 60.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.735 HD13 ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -59.83 -43.72 94.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.643 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . 0.69 ' O ' HG22 ' C' ' 30' ' ' THR . 51.7 t0 -69.79 -28.9 66.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -75.98 -38.08 57.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.661 0.267 . . . . 0.0 111.265 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.639 ' O ' HG22 ' C' ' 32' ' ' VAL . 8.0 mt -76.52 -34.91 58.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.54 -47.32 73.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.003 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.69 HG22 ' O ' ' C' ' 26' ' ' ASP . 9.7 t -71.62 -40.23 69.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.699 HH11 ' HG2' ' C' ' 31' ' ' ARG . 21.3 ttp85 -62.58 -38.51 90.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.325 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.639 HG22 ' O ' ' C' ' 28' ' ' LEU . 28.3 m -76.59 -27.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.235 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.573 ' OD2' ' HD2' ' C' ' 64' ' ' ARG . 10.4 t70 -63.98 -56.2 16.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HD2' ' HA3' ' C' ' 91' ' ' GLY . 23.1 pttt -68.78 -37.56 79.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.807 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 -48.08 88.01 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.384 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.4 OUTLIER -67.67 -31.56 71.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.28 -38.44 90.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.482 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.701 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 78.7 p -79.9 -43.59 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.545 ' HB2' HD21 ' B' ' 36' ' ' LEU . 46.7 t -53.15 -60.99 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.66 -30.29 60.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . 0.58 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -63.95 -48.98 74.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.923 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.6 OUTLIER -67.01 -32.94 74.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.067 179.33 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.3 m-20 -78.77 -13.6 59.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.07 65.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.144 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.826 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.2 mm? -75.65 158.71 32.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.87 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.452 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 47.5 p90 -146.56 -31.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.194 0.521 . . . . 0.0 111.69 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.477 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 8.3 tt0 75.59 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.979 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -90.85 137.17 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.625 2.217 . . . . 0.0 112.545 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 14.6 m-85 67.59 154.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.583 ' CA ' ' HB3' ' C' ' 76' ' ' ARG . . . -173.95 73.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.253 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.811 HG12 ' HE2' ' C' ' 53' ' ' LYS . 11.4 p -95.87 -22.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.198 0.599 . . . . 0.0 112.453 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.9 48.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.296 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . 0.811 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.49 7.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.593 0.235 . . . . 0.0 110.566 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.45 143.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.525 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.489 HD21 ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -135.19 116.45 14.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.006 0.431 . . . . 0.0 111.68 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . 0.556 ' CE2' HD11 ' C' ' 71' ' ' ILE . 12.0 t80 -80.35 131.09 35.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.269 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.826 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 27.6 p -110.63 120.82 43.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.972 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.562 ' HB2' ' CD1' ' C' ' 71' ' ' ILE . . . -143.37 139.93 30.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.431 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.05 164.61 33.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.563 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.438 HG12 HD13 ' C' ' 69' ' ' LEU . 28.2 m -118.62 164.38 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.331 . . . . 0.0 111.386 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.52 177.46 20.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.496 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' C' ' 67' ' ' GLN . . . -161.99 155.07 26.22 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 1.3 t80 -141.95 122.31 14.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.76 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.573 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 24.9 mtt-85 67.54 -93.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.104 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.45 4.54 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.19 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . 0.462 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 22.8 t -109.92 173.93 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.6 OUTLIER -135.33 -179.39 5.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.093 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -162.55 158.27 23.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.549 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.59 HD12 ' H ' ' C' ' 70' ' ' ALA . 3.8 tp -118.08 134.63 54.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.923 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -142.69 138.99 30.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.675 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.562 ' CD1' ' HB2' ' C' ' 58' ' ' ALA . 8.9 tp -138.3 150.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.712 0.291 . . . . 0.0 111.162 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.62 -177.25 37.09 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.399 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.2 p -160.3 155.12 24.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.65 163.66 30.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.223 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -136.4 120.45 17.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 111.171 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.583 ' HB3' ' CA ' ' C' ' 50' ' ' GLY . 0.0 OUTLIER -105.18 107.65 18.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.796 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.754 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 14.9 p -102.48 130.07 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.291 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 59.01 -171.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.96 66.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.567 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 69.2 p -160.08 -51.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.044 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' CG2' ' C' ' 103' ' ' ILE . 9.8 p -119.59 141.94 37.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.08 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.294 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.48 130.81 33.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.627 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -135.11 144.03 46.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.179 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . 0.481 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.782 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 173.47 161.09 23.11 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.589 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.36 150.12 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.897 0.38 . . . . 0.0 111.074 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -121.71 140.73 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.356 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.19 128.41 48.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.543 ' HB3' ' CB ' ' C' ' 94' ' ' ASP . . . -136.38 151.07 49.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.613 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.695 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 50.21 -99.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.334 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.35 -27.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.753 0.311 . . . . 0.0 111.348 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 14.98 9.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.205 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' C' ' 90' ' ' ALA . 41.4 m-20 -101.48 69.8 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 t -113.29 127.98 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.989 0.424 . . . . 0.0 110.742 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.513 ' SD ' HD23 ' B' ' 36' ' ' LEU . 1.3 ptp -135.2 139.52 44.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.746 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -117.57 129.9 56.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.472 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.475 ' ND2' ' HA3' ' B' ' 61' ' ' GLY . 15.0 m120 -129.25 145.37 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.676 0.275 . . . . 0.0 111.43 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.59 114.49 7.33 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 83.9 p -128.04 164.43 22.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.426 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.31 142.5 35.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.967 0.413 . . . . 0.0 111.114 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.521 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 17.4 m-80 -109.24 135.05 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.542 HD12 ' HE1' ' C' ' 105' ' ' TRP . 1.2 pt -134.56 126.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.776 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' B' ' 55' ' ' ASN . 3.8 pt-20 -104.69 148.58 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 0.542 ' HE1' HD12 ' C' ' 103' ' ' ILE . 57.7 m95 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.705 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.709 0.29 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.421 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 92.9 t80 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.182 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.02 -30.18 55.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.744 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.7 mt-30 -71.14 -33.87 70.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.217 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.445 HD21 ' HG3' ' B' ' 24' ' ' ARG . 0.5 OUTLIER -65.1 -48.29 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 15.9 m-20 -70.93 -20.44 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.977 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.79 -42.94 57.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.618 ' HB3' HD13 ' C' ' 25' ' ' LEU . 2.6 mmp_? -70.66 -48.82 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.736 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 30' ' ' THR . 49.8 t0 -72.1 -28.9 63.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.813 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -76.0 -37.16 58.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.259 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.568 HD11 ' HA ' ' C' ' 25' ' ' LEU . 9.5 mt -76.13 -32.75 59.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 32' ' ' VAL . 20.9 t0 -67.38 -48.56 67.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 26' ' ' ASP . 10.0 t -68.7 -37.92 79.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.854 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.666 HH11 ' HG2' ' A' ' 31' ' ' ARG . 18.9 ttp85 -63.65 -39.09 93.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 28' ' ' LEU . 30.2 m -75.33 -28.25 20.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.505 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 13.8 t70 -62.55 -55.12 30.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.001 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 18.7 pttt -70.78 -40.65 72.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.728 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.28 90.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.422 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.95 -34.78 78.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.805 0.336 . . . . 0.0 111.057 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.6 94.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.398 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.438 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 55.6 p -78.38 -39.28 39.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.737 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.0 t -54.66 -64.66 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.408 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -54.48 -31.09 55.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.428 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -62.39 -48.52 79.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.798 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -68.59 -32.72 72.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.3 m-20 -80.26 -15.04 57.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -17.55 64.79 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.156 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.782 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.8 mm? -76.59 156.07 33.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.871 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.18 -30.29 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.58 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 7.9 tt0 72.17 108.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.031 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.9 Cg_endo -91.29 139.43 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.637 2.225 . . . . 0.0 112.535 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.0 m-85 69.1 154.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.0 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -176.62 75.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.255 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.841 HG12 ' HE2' ' A' ' 53' ' ' LYS . 11.7 p -95.57 -24.92 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.067 0.547 . . . . 0.0 112.464 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.828 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.19 48.33 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.246 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.841 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -145.03 179.69 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.6 0.238 . . . . 0.0 110.643 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 11.4 p -105.18 145.3 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.553 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.58 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 0.9 OUTLIER -135.08 119.62 18.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 111.687 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 71' ' ' ILE . 10.1 t80 -83.01 132.28 35.15 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.18 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.782 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 43.6 p -111.04 122.73 48.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.926 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.54 143.59 31.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.465 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.89 37.04 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.596 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.14 163.78 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.767 0.317 . . . . 0.0 111.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -138.19 177.75 19.79 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.447 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.32 26.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.505 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.76 123.82 14.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 27.2 mtt-85 64.18 -94.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.065 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 p -130.69 6.41 4.73 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.203 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.44 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 30.6 t -104.6 174.34 5.92 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.98 177.08 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -161.46 153.93 20.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.556 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 70' ' ' ALA . 6.0 tp -117.26 132.0 56.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.806 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.798 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -138.8 136.1 35.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.692 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.472 HD11 ' CE2' ' A' ' 56' ' ' PHE . 8.8 tp -136.29 145.44 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.28 155.99 34.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.68 163.46 29.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.216 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t80 -138.43 120.91 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 111.128 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HG3' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -110.39 105.58 14.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.685 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.828 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.6 p -104.58 130.8 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.329 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.432 ' CG ' HG22 ' A' ' 77' ' ' VAL . 9.1 m-20 59.5 -174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.18 68.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.535 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.2 p -160.03 -50.7 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.036 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.26 143.48 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.578 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 154.52 45.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.265 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.88 132.37 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.57 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -134.72 139.8 45.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.422 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.07 169.42 19.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.672 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 173.68 162.69 25.97 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.532 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.12 33.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.157 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -119.06 141.33 48.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -124.23 127.86 48.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.269 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.569 ' HB3' ' CB ' ' A' ' 94' ' ' ASP . . . -135.59 148.1 48.93 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.7 -98.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.278 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 -28.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 111.323 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.9 p -121.56 15.34 11.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.569 ' CB ' ' HB3' ' A' ' 90' ' ' ALA . 38.1 m-20 -103.12 70.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.7 t -110.44 128.27 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.722 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.444 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 1.6 ptp -135.58 139.44 43.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.74 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -118.93 128.82 54.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.459 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.26 147.37 51.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.36 116.0 5.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.745 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 94.8 p -127.94 163.14 25.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.383 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -136.57 144.58 44.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 111.012 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.438 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 21.6 m-80 -109.83 131.9 54.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.38 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 pt -131.41 126.74 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.75 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 3.8 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.764 0.316 . . . . 0.0 110.546 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . 0.431 ' O ' ' OD2' ' B' ' 22' ' ' ASP . 92.7 t80 -65.59 -32.23 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.205 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -77.14 -30.08 54.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.735 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.548 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 mt-30 -71.24 -33.85 70.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.099 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.455 HD21 ' HG3' ' C' ' 24' ' ' ARG . 0.5 OUTLIER -65.15 -48.28 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.5 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 15.7 m-20 -70.87 -20.41 62.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.76 -43.03 56.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.603 ' HB3' HD13 ' A' ' 25' ' ' LEU . 2.6 mmp_? -70.63 -48.8 53.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.746 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.612 HD13 ' HB3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -60.41 -41.8 94.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.644 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.513 ' O ' HG22 ' B' ' 30' ' ' THR . 49.8 t0 -72.04 -28.96 63.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -75.9 -37.2 59.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.259 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 25' ' ' LEU . 9.6 mt -76.17 -32.83 59.26 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.455 ' O ' HG22 ' B' ' 32' ' ' VAL . 20.9 t0 -67.26 -48.64 67.13 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.981 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.513 HG22 ' O ' ' B' ' 26' ' ' ASP . 10.1 t -68.66 -37.93 80.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.672 HH11 ' HG2' ' B' ' 31' ' ' ARG . 19.0 ttp85 -63.67 -39.06 93.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.507 HG13 ' O ' ' B' ' 28' ' ' LEU . 30.2 m -75.36 -28.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.182 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.503 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 13.8 t70 -62.61 -55.11 30.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 18.7 pttt -70.7 -40.68 72.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.31 90.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.4 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.88 -34.84 78.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.086 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.54 94.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.421 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 56.0 p -78.48 -39.21 39.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -54.77 -64.6 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.101 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.405 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -54.46 -31.15 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.469 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -62.28 -48.65 78.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.822 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.4 OUTLIER -68.51 -32.76 72.95 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 2.3 m-20 -80.24 -15.02 57.93 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -17.56 64.8 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.081 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.778 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.8 mm? -76.5 156.17 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.38 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.613 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 7.9 tt0 72.22 108.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.929 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.523 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.8 Cg_endo -91.34 139.39 2.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.617 2.212 . . . . 0.0 112.516 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.0 m-85 69.1 154.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.58 75.35 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.227 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.84 HG12 ' HE2' ' B' ' 53' ' ' LYS . 11.7 p -95.59 -24.89 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 123.147 0.579 . . . . 0.0 112.467 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.801 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.11 48.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.277 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.84 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -145.12 179.61 7.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 110.634 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' B' ' 75' ' ' TYR . 11.4 p -105.12 145.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.606 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.589 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 0.9 OUTLIER -135.05 119.66 18.17 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 111.606 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.469 ' CE2' HD11 ' B' ' 71' ' ' ILE . 10.1 t80 -82.94 132.33 35.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.21 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.778 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 43.6 p -111.08 122.76 48.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.972 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.55 143.54 31.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.403 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.59 167.88 37.01 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.547 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.09 163.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 111.335 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -138.14 177.77 19.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.464 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.64 155.36 26.68 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.583 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.83 123.69 14.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.77 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 27.3 mtt-85 64.24 -94.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.044 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 68.8 p -130.74 6.35 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.136 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.437 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 30.3 t -104.53 174.31 5.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.93 177.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -161.45 153.91 20.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.538 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.5 HD12 ' N ' ' B' ' 70' ' ' ALA . 6.0 tp -117.26 132.04 56.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.822 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -138.84 136.13 35.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.689 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.469 HD11 ' CE2' ' B' ' 56' ' ' PHE . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 111.097 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.76 179.96 35.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.45 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.2 155.95 34.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.59 163.45 29.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.239 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.436 ' CD2' ' HB ' ' B' ' 54' ' ' VAL . 13.0 t80 -138.53 120.84 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.32 105.54 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.748 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.801 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.5 p -104.6 130.97 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.431 ' CG ' HG22 ' B' ' 77' ' ' VAL . 9.1 m-20 59.55 -174.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 111.109 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -118.18 68.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.7 p -160.04 -50.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.18 143.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 154.42 45.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.82 132.49 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.43 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.79 45.42 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.153 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.43 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.06 169.52 19.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.683 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 173.55 162.68 25.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.621 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.08 33.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.131 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -119.03 141.22 48.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.365 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.26 127.84 48.28 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.243 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.575 ' HB3' ' CB ' ' B' ' 94' ' ' ASP . . . -135.5 148.2 49.11 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.675 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.61 -98.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.334 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.14 -28.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.316 . . . . 0.0 111.32 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -121.53 15.29 11.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.161 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.575 ' CB ' ' HB3' ' B' ' 90' ' ' ALA . 38.1 m-20 -103.14 70.67 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.4 128.27 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.434 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.6 ptp -135.63 139.49 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.701 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.01 128.84 54.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.482 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -129.21 147.36 51.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 111.389 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.3 116.01 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.784 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 94.2 p -127.91 163.12 25.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.411 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.5 144.58 44.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.945 0.402 . . . . 0.0 111.088 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.45 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 21.5 m-80 -109.8 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 pt -131.46 126.62 58.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.846 0.355 . . . . 0.0 110.855 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.443 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 3.9 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.622 0.249 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . 0.424 ' O ' ' OD2' ' C' ' 22' ' ' ASP . 92.9 t80 -65.53 -32.35 73.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.247 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.04 -30.15 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.781 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.8 mt-30 -71.17 -33.88 70.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.452 HD21 ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -65.18 -48.27 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 15.8 m-20 -70.84 -20.42 62.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.053 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -74.85 -42.9 57.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.612 ' HB3' HD13 ' B' ' 25' ' ' LEU . 2.6 mmp_? -70.7 -48.77 52.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.618 HD13 ' HB3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -60.41 -41.71 94.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.676 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . 0.512 ' O ' HG22 ' C' ' 30' ' ' THR . 49.9 t0 -72.19 -28.83 63.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.781 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -75.97 -37.21 58.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.18 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' B' ' 25' ' ' LEU . 9.7 mt -76.18 -32.73 59.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . 0.454 ' O ' HG22 ' C' ' 32' ' ' VAL . 21.0 t0 -67.4 -48.49 67.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.945 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.512 HG22 ' O ' ' C' ' 26' ' ' ASP . 10.1 t -68.75 -37.89 79.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.862 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.675 HH11 ' HG2' ' C' ' 31' ' ' ARG . 18.9 ttp85 -63.74 -39.02 93.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.325 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.516 HG13 ' O ' ' C' ' 28' ' ' LEU . 29.9 m -75.31 -28.27 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.204 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.509 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 13.8 t70 -62.74 -55.08 29.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.945 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 18.7 pttt -70.64 -40.74 72.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.25 90.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.402 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.02 -34.68 78.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 111.096 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.84 -39.51 94.58 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.4 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.423 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 56.6 p -78.51 -39.27 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 35.9 t -54.7 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.405 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -54.55 -31.12 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.407 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . 0.452 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -62.33 -48.5 79.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.805 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.4 OUTLIER -68.61 -32.64 72.66 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 2.2 m-20 -80.24 -15.15 57.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -17.59 64.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.144 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.773 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.8 mm? -76.56 156.14 33.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.877 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.27 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.651 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.582 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 7.9 tt0 72.11 108.78 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.019 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.9 Cg_endo -91.32 139.4 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.617 2.211 . . . . 0.0 112.565 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.1 m-85 69.13 154.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.027 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.57 75.35 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.243 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.828 HG12 ' HE2' ' C' ' 53' ' ' LYS . 11.7 p -95.51 -25.0 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.162 0.585 . . . . 0.0 112.44 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.822 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.17 48.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.316 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . 0.828 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.6 OUTLIER -145.02 179.69 7.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.595 0.236 . . . . 0.0 110.645 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 11.4 p -105.25 145.32 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.517 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.582 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 0.9 OUTLIER -135.06 119.61 18.09 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.971 0.415 . . . . 0.0 111.679 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' C' ' 71' ' ' ILE . 10.0 t80 -82.94 132.34 35.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.273 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.773 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.1 p -111.12 122.65 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 143.63 31.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.453 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.92 37.09 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 26.1 m -119.17 163.86 16.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 111.39 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -138.18 177.85 19.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.473 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.7 155.33 26.64 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.556 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.77 123.75 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.447 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 27.3 mtt-85 64.18 -93.97 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.038 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 68.3 p -130.76 6.39 4.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . 0.422 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 30.6 t -104.57 174.41 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.08 177.07 7.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.116 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -161.49 153.91 20.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.58 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.498 HD12 ' H ' ' C' ' 70' ' ' ALA . 6.0 tp -117.23 131.96 56.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.795 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.805 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -138.73 136.18 35.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.637 0.256 . . . . 0.0 111.664 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.477 HD11 ' CE2' ' C' ' 56' ' ' PHE . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -155.3 155.96 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 110.965 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.66 163.42 29.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.262 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.0 t80 -138.51 120.86 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 105.64 14.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.822 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.5 p -104.64 130.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.441 ' CG ' HG22 ' C' ' 77' ' ' VAL . 9.2 m-20 59.49 -174.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.134 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.16 68.11 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.523 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 41.2 p -160.09 -50.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.986 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 143.51 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.3 154.43 45.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.897 0.38 . . . . 0.0 111.295 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.81 132.5 32.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.77 45.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.06 169.5 19.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.68 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 173.6 162.75 26.02 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.532 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.22 147.09 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -119.04 141.33 48.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.329 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.3 127.87 48.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' C' ' 94' ' ' ASP . . . -135.54 148.18 49.03 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.645 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.67 -98.67 0.02 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.322 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.19 -28.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 111.326 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -121.57 15.32 11.13 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.573 ' CB ' ' HB3' ' C' ' 90' ' ' ALA . 38.2 m-20 -103.14 70.58 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.38 128.24 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 110.709 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.444 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 1.6 ptp -135.63 139.54 43.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.696 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.03 128.87 54.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.433 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -129.25 147.36 51.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.366 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.37 115.96 5.88 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.718 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 93.9 p -127.85 163.11 25.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.57 144.51 44.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.008 0.432 . . . . 0.0 111.072 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.441 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 21.4 m-80 -109.69 131.87 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.382 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.487 HD12 ' HE1' ' C' ' 105' ' ' TRP . 1.6 pt -131.42 126.68 58.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.435 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 3.9 pt-20 -105.84 152.93 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.989 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 0.487 ' HE1' HD12 ' C' ' 103' ' ' ILE . 44.6 m95 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.7 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.642 0.258 . . . . 0.0 110.526 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.18 -32.88 74.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 31.2 mmt180 -76.38 -38.27 55.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.767 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 12.7 mt-30 -67.2 -30.87 70.93 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.191 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.579 ' HA ' HD11 ' C' ' 21' ' ' LEU . 0.6 OUTLIER -65.9 -56.08 13.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.589 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.9 -23.99 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 22.4 t-20 -67.16 -39.43 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 5.4 mmp_? -71.82 -48.11 48.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.777 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.64 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.6 OUTLIER -56.4 -52.21 65.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.65 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.713 ' O ' HG22 ' A' ' 30' ' ' THR . 33.6 t0 -64.31 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 26.6 tttm -71.76 -36.68 70.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.205 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 32' ' ' VAL . 3.5 mt -79.17 -33.6 43.85 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.18 96.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.941 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 26' ' ' ASP . 4.4 t -76.57 -40.64 49.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.879 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HG2' HH11 ' A' ' 31' ' ' ARG . 21.3 ttp85 -61.68 -40.99 96.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.277 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 28' ' ' LEU . 30.7 m -73.43 -29.04 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.598 ' OD1' ' HB2' ' A' ' 64' ' ' ARG . 17.8 t70 -62.92 -52.58 62.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 26.5 pttt -70.74 -39.55 73.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.738 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.89 97.33 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.427 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' B' ' 39' ' ' SER . 0.5 OUTLIER -66.74 -33.57 75.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 111.077 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -61.99 -43.06 99.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.457 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.741 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 79.3 p -75.22 -41.04 58.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.742 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.505 ' HB2' HD21 ' C' ' 36' ' ' LEU . 38.2 t -57.55 -62.11 2.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.17 48.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.467 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.84 -48.07 72.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.943 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.701 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -66.1 -32.83 74.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.9 m-20 -79.77 -12.6 59.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -14.82 63.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.137 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.844 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.5 mm? -76.55 156.81 32.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.888 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.13 -26.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.608 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 10.1 tt0 71.58 110.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.927 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -90.03 137.13 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.645 2.23 . . . . 0.0 112.549 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.9 m-85 64.64 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.953 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.34 75.43 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.638 HG12 ' HE2' ' A' ' 53' ' ' LYS . 12.8 p -95.11 -25.26 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.148 0.579 . . . . 0.0 112.415 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.88 48.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.313 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.638 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -143.44 -178.0 5.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.591 0.234 . . . . 0.0 110.643 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 8.2 p -106.17 145.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.587 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.608 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 1.4 t30 -134.88 122.69 22.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.499 ' CE2' HD11 ' A' ' 71' ' ' ILE . 11.5 t80 -85.76 132.86 34.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.235 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.844 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 33.7 p -113.22 125.22 54.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.016 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 71' ' ' ILE . . . -149.45 139.68 22.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.449 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.41 167.3 38.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.434 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.551 HG12 HD13 ' A' ' 69' ' ' LEU . 22.8 m -120.02 161.55 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.326 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.2 177.45 20.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.404 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.455 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -162.35 156.82 28.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.612 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.4 t80 -143.13 128.28 18.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.598 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 16.2 mtt-85 64.97 -91.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 p -135.63 6.1 3.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.522 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 19.3 t -105.18 168.38 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.4 179.29 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.138 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -164.78 150.54 10.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.571 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.551 HD13 HG12 ' A' ' 60' ' ' VAL . 12.5 tp -116.22 127.91 55.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.767 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -132.55 136.23 46.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.729 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 58' ' ' ALA . 10.6 tp -132.81 146.68 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.138 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -163.89 -179.44 38.18 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.407 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -154.65 152.04 29.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.257 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.5 t80 -132.57 122.03 24.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.228 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.34 101.84 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.752 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.5 p -103.56 136.31 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.37 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.943 0.401 . . . . 0.0 111.112 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.47 61.35 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.573 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.76 -44.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.8 p -122.32 141.35 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.258 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.8 134.86 32.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.406 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -139.74 138.16 35.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.406 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.38 167.93 23.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.506 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 171.41 163.67 25.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.96 145.44 35.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.897 0.38 . . . . 0.0 111.044 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -114.49 141.12 48.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.18 130.69 54.69 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.273 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . . . -139.63 145.25 38.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.596 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 52.19 -96.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.26 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -155.37 -30.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.731 0.3 . . . . 0.0 111.336 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -121.5 16.56 11.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.194 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 90' ' ' ALA . 41.6 m-20 -104.44 73.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.2 t -114.79 131.96 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.642 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.489 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 1.2 ptp -136.27 142.27 43.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.714 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -119.95 128.75 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.483 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -125.99 148.94 49.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.346 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.09 114.52 5.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.709 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.7 p -130.43 161.24 31.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.463 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -134.0 142.71 47.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.97 0.414 . . . . 0.0 111.072 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 20.7 m-80 -111.68 128.62 56.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.79 131.49 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.8 0.333 . . . . 0.0 110.796 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 5.4 pt-20 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.662 0.267 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.12 -32.94 74.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.311 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 31.2 mmt180 -76.4 -38.35 55.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.741 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 12.7 mt-30 -67.1 -30.88 71.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.973 0.416 . . . . 0.0 111.23 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.584 HD11 ' HA ' ' C' ' 21' ' ' LEU . 0.6 OUTLIER -65.88 -56.04 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -69.01 -23.91 64.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 22.3 t-20 -67.17 -39.43 86.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 5.4 mmp_? -71.84 -48.19 47.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.701 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.647 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.6 OUTLIER -56.31 -52.26 65.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.717 ' O ' HG22 ' B' ' 30' ' ' THR . 33.7 t0 -64.29 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.762 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.442 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 26.7 tttm -71.65 -36.83 70.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.603 0.239 . . . . 0.0 111.203 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.656 ' O ' HG13 ' B' ' 32' ' ' VAL . 3.5 mt -79.08 -33.69 44.31 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.46 -42.16 96.09 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.717 HG22 ' O ' ' B' ' 26' ' ' ASP . 4.5 t -76.59 -40.7 48.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.645 HH11 ' HG2' ' B' ' 31' ' ' ARG . 21.2 ttp85 -61.6 -41.05 96.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.656 HG13 ' O ' ' B' ' 28' ' ' LEU . 30.6 m -73.37 -29.11 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.161 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.606 ' OD1' ' HB2' ' B' ' 64' ' ' ARG . 17.8 t70 -62.85 -52.69 62.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 26.5 pttt -70.69 -39.5 73.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.755 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.65 -44.95 97.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.425 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' C' ' 39' ' ' SER . 0.5 OUTLIER -66.73 -33.59 75.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 111.054 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.442 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -61.93 -43.09 99.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.424 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.757 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 79.9 p -75.24 -40.95 58.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.77 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.498 ' HB2' HD21 ' A' ' 36' ' ' LEU . 38.4 t -57.63 -62.11 2.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.18 -30.2 48.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.433 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.615 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.86 -48.01 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.7 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.7 OUTLIER -66.2 -32.76 74.39 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.44 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 2.9 m-20 -79.8 -12.66 59.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -14.94 63.22 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.156 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.832 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.5 mm? -76.46 156.84 32.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.847 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.1 -26.93 0.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.17 0.509 . . . . 0.0 111.683 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.613 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 10.1 tt0 71.69 109.87 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.914 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -89.86 137.13 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.709 2.273 . . . . 0.0 112.547 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.9 m-85 64.57 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.957 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.35 75.41 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.242 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.641 HG12 ' HE2' ' B' ' 53' ' ' LYS . 12.7 p -95.04 -25.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.469 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.88 48.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.641 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -143.54 -178.05 5.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.517 ' HB ' ' CE2' ' B' ' 75' ' ' TYR . 8.3 p -106.08 145.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.589 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.613 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 1.4 t30 -134.95 122.61 22.15 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 111.658 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' B' ' 71' ' ' ILE . 11.6 t80 -85.65 132.8 34.09 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.309 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.832 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 33.8 p -113.18 125.27 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.004 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' B' ' 71' ' ' ILE . . . -149.56 139.64 22.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.439 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.33 38.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.526 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.534 HG12 HD13 ' B' ' 69' ' ' LEU . 22.6 m -120.04 161.58 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.786 0.327 . . . . 0.0 111.382 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.23 177.48 20.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.459 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . 0.442 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -162.34 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.562 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.49 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.4 t80 -143.13 128.22 18.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.66 0.267 . . . . 0.0 110.801 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.606 ' HB2' ' OD1' ' B' ' 33' ' ' ASP . 16.3 mtt-85 64.95 -91.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.087 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 p -135.64 6.09 3.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.524 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 19.4 t -105.2 168.36 9.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.33 179.36 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -164.87 150.48 9.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.539 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.534 HD13 HG12 ' B' ' 60' ' ' VAL . 12.3 tp -116.16 127.92 55.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.7 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -132.59 136.22 46.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.67 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' B' ' 58' ' ' ALA . 10.6 tp -132.81 146.74 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.119 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -163.87 -179.42 38.15 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.41 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 64.5 p -154.7 152.09 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.85 0.357 . . . . 0.0 111.043 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.64 156.91 27.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.25 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 13.7 t80 -132.59 122.06 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 101.93 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.688 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.745 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.5 p -103.49 136.36 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.3 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.142 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.46 61.27 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.568 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -159.65 -44.84 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.988 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -122.32 141.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 155.72 48.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.258 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.75 134.91 32.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.561 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.19 35.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.418 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.44 167.9 23.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.073 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.489 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 171.41 163.63 25.71 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.96 145.33 35.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -114.42 141.1 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.363 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.14 130.65 54.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.262 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . . . -139.69 145.25 38.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.562 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 52.25 -96.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.276 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.36 -30.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.339 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -121.51 16.44 11.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.565 ' HB2' ' HB3' ' B' ' 90' ' ' ALA . 41.6 m-20 -104.3 73.52 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 56.3 t -114.74 132.01 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.493 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.2 ptp -136.31 142.27 43.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -120.07 128.77 53.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.37 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.0 148.87 49.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.401 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.06 114.51 5.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.709 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 53.7 p -130.42 161.27 31.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.48 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -134.0 142.65 47.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.111 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.553 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 20.4 m-80 -111.59 128.65 56.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.443 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 110.784 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.503 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 5.4 pt-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.688 0.28 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -63.17 -32.98 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 31.2 mmt180 -76.37 -38.28 56.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 12.7 mt-30 -67.26 -30.78 70.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.584 ' HA ' HD11 ' B' ' 21' ' ' LEU . 0.6 OUTLIER -65.95 -56.04 13.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.564 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 -23.98 64.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 22.3 t-20 -67.17 -39.43 86.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' C' ' 20' ' ' GLN . 5.4 mmp_? -71.81 -48.18 48.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.788 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.627 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -56.3 -52.28 65.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . 0.702 ' O ' HG22 ' C' ' 30' ' ' THR . 33.5 t0 -64.23 -28.01 69.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.818 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -71.62 -36.8 70.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.248 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.664 ' O ' HG13 ' C' ' 32' ' ' VAL . 3.5 mt -79.11 -33.66 44.16 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.14 96.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.921 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.702 HG22 ' O ' ' C' ' 26' ' ' ASP . 4.5 t -76.55 -40.72 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.864 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.663 HH11 ' HG2' ' C' ' 31' ' ' ARG . 21.3 ttp85 -61.64 -41.0 96.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.664 HG13 ' O ' ' C' ' 28' ' ' LEU . 30.7 m -73.4 -29.09 26.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.599 ' OD1' ' HB2' ' C' ' 64' ' ' ARG . 17.8 t70 -62.77 -52.65 62.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.027 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 26.5 pttt -70.78 -39.44 73.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.94 97.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.386 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.505 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.5 OUTLIER -66.68 -33.71 76.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.457 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -61.77 -43.16 99.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.745 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 79.7 p -75.23 -41.02 58.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.488 ' HB2' HD21 ' B' ' 36' ' ' LEU . 38.0 t -57.51 -62.17 1.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.18 48.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.443 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . 0.609 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.81 -48.01 73.14 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.701 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.7 OUTLIER -66.18 -32.85 74.53 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 2.8 m-20 -79.71 -12.66 59.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -14.85 63.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.17 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.821 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.5 mm? -76.49 156.86 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.869 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.15 -26.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.206 0.527 . . . . 0.0 111.706 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 10.1 tt0 71.5 109.91 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.021 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -89.94 137.19 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.554 2.169 . . . . 0.0 112.59 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.8 m-85 64.6 152.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.39 75.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.228 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.635 HG12 ' HE2' ' C' ' 53' ' ' LYS . 12.6 p -94.94 -25.27 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.18 0.592 . . . . 0.0 112.509 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.91 48.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.298 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . 0.635 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.4 OUTLIER -143.52 -178.07 5.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.585 0.231 . . . . 0.0 110.608 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.516 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 8.2 p -106.16 145.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.557 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.589 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 1.4 t30 -134.88 122.72 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' C' ' 71' ' ' ILE . 11.7 t80 -85.74 132.89 34.05 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.172 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.821 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 33.5 p -113.29 125.27 54.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.895 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.52 ' HB2' ' CD1' ' C' ' 71' ' ' ILE . . . -149.57 139.67 22.11 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.4 38.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.545 HG12 HD13 ' C' ' 69' ' ' LEU . 22.6 m -120.12 161.57 19.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 111.33 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . 0.609 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.22 177.47 20.29 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.418 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . 0.457 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -162.33 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.4 t80 -143.09 128.29 18.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.686 0.279 . . . . 0.0 110.746 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.599 ' HB2' ' OD1' ' C' ' 33' ' ' ASP . 16.3 mtt-85 64.94 -91.07 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.096 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.0 p -135.59 6.15 3.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.227 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . 0.517 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 19.4 t -105.26 168.4 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.778 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.41 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . 0.745 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -164.83 150.47 9.97 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.556 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.545 HD13 HG12 ' C' ' 60' ' ' VAL . 12.4 tp -116.17 127.9 55.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.701 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -132.63 136.19 46.34 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' C' ' 58' ' ' ALA . 10.6 tp -132.74 146.75 32.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.732 0.301 . . . . 0.0 111.134 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -163.9 -179.39 38.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.435 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.4 p -154.71 152.0 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 111.056 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.26 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.516 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.7 t80 -132.64 122.05 24.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 111.128 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' C' ' 76' ' ' ARG . 0.0 OUTLIER -111.41 101.83 10.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.732 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.5 p -103.46 136.36 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 63.3 -171.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.391 . . . . 0.0 111.089 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.55 61.35 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.72 -44.77 0.05 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.33 141.37 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.69 155.78 47.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.74 134.85 32.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.539 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.412 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.21 35.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.157 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . 0.412 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.45 167.86 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.499 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 171.49 163.65 25.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.574 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.87 145.41 35.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.137 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -114.5 141.14 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.347 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 130.69 54.71 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.288 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' C' ' 94' ' ' ASP . . . -139.68 145.21 38.11 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.595 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 52.28 -96.33 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.258 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.38 -30.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.281 . . . . 0.0 111.296 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.6 p -121.42 16.45 11.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.239 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.568 ' HB2' ' HB3' ' C' ' 90' ' ' ALA . 41.5 m-20 -104.39 73.54 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -114.79 132.03 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 0.0 110.636 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.49 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 1.2 ptp -136.33 142.2 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.642 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.96 128.72 53.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -125.95 148.84 49.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.299 . . . . 0.0 111.419 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.05 114.5 5.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.829 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 53.6 p -130.44 161.21 31.89 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.393 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -133.95 142.65 47.78 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.917 0.389 . . . . 0.0 111.113 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.571 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 20.9 m-80 -111.6 128.68 56.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.462 HD12 ' HE1' ' C' ' 105' ' ' TRP . 3.0 pt -130.79 131.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.743 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.511 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 5.4 pt-20 -112.63 154.92 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 0.462 ' HE1' HD12 ' C' ' 103' ' ' ILE . 31.0 m95 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.706 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.667 0.27 . . . . 0.0 110.57 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 24.9 mmt180 -76.8 -36.88 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.725 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.637 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.6 mt-30 -67.5 -32.94 74.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.799 HD21 ' HG3' ' B' ' 24' ' ' ARG . 1.4 tt -68.6 -55.84 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.558 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.13 -25.46 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 24.6 t-20 -71.76 -42.48 67.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.79 ' HG3' HD21 ' C' ' 21' ' ' LEU . 3.7 mmp_? -69.27 -45.28 70.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.814 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 HD11 ' B' ' 28' ' ' LEU . 1.9 tp -56.29 -49.09 75.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.562 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 30' ' ' THR . 33.3 t0 -64.79 -32.08 73.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 27.2 tttm -69.98 -32.89 71.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.26 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.754 HD11 HD12 ' C' ' 25' ' ' LEU . 1.7 mt -81.06 -32.37 34.04 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.69 -40.21 88.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.017 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 26' ' ' ASP . 4.3 t -76.73 -39.34 52.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.492 HH22 HG21 ' C' ' 32' ' ' VAL . 43.6 ttp85 -59.46 -41.81 90.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 28' ' ' LEU . 27.2 m -78.29 -23.6 13.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.204 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.479 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 18.6 t70 -67.63 -51.54 48.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' NZ ' ' HA3' ' A' ' 91' ' ' GLY . 32.7 pttt -76.38 -40.28 51.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.93 98.75 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -67.09 -33.9 76.47 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.882 0.372 . . . . 0.0 111.156 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.17 99.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.457 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.753 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 94.4 p -76.29 -37.31 57.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.637 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 33.0 t -63.73 -55.01 26.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.98 -32.1 69.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.51 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -64.88 -46.47 81.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.955 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -66.22 -30.39 70.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.3 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.584 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 9.7 m-20 -81.36 -15.71 54.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.46 -15.04 62.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.112 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.737 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.9 mm? -71.39 164.52 25.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.911 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 25.0 p90 -152.55 -32.02 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.148 0.499 . . . . 0.0 111.701 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 15.3 tt0 73.53 106.71 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.96 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -93.07 136.34 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.628 2.219 . . . . 0.0 112.552 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 10.6 m-85 65.52 151.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 178.62 78.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.235 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.31 -23.28 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.206 0.603 . . . . 0.0 112.411 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 157.5 49.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.278 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 52' ' ' GLY . 0.5 OUTLIER -146.65 -176.73 5.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.605 0.24 . . . . 0.0 110.563 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.22 150.57 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.568 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.529 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 2.2 t30 -132.91 124.37 27.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.66 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 71' ' ' ILE . 24.1 t80 -87.18 128.17 35.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.319 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.737 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 38.2 p -114.71 123.08 48.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.047 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.29 136.78 18.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.451 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.05 44.35 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.582 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.424 HG12 HD13 ' A' ' 69' ' ' LEU . 16.4 m -126.9 166.98 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.801 0.334 . . . . 0.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -141.35 172.32 23.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.44 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.47 152.36 23.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.547 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.3 t80 -142.44 128.68 19.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.686 0.279 . . . . 0.0 110.737 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.36 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 p -140.35 10.07 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.479 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 9.8 t -109.6 167.6 10.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.67 -179.09 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -167.19 156.46 10.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.526 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.424 HD13 HG12 ' A' ' 60' ' ' VAL . 7.6 tp -114.58 130.97 56.83 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -129.62 141.43 50.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.682 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.666 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 7.9 tp -138.14 150.38 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.092 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.437 ' N ' HG13 ' A' ' 71' ' ' ILE . . . -169.28 177.41 42.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.395 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.6 146.4 18.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.25 158.41 27.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.528 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 30.9 t80 -126.3 125.02 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.154 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.504 ' NH2' ' HB2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -113.1 102.71 10.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.607 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.0 p -104.41 138.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 59.88 -167.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -126.59 66.08 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.451 ' HA ' ' HG3' ' A' ' 104' ' ' GLU . 19.9 p -165.4 -46.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.986 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.24 139.86 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.49 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.46 45.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.293 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.16 138.91 33.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.638 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.124 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.34 169.75 17.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.103 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.413 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 172.04 157.62 14.33 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.507 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.05 144.89 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 111.079 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -112.57 142.43 45.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.99 122.89 39.63 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.31 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -137.34 147.3 45.47 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.6 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.457 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 57.03 -94.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.276 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 t -159.4 -33.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 111.357 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.77 13.83 12.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 32.6 m-20 -101.85 72.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.969 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 t -116.08 127.05 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.987 0.423 . . . . 0.0 110.759 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 39' ' ' SER . 1.3 ptp -131.85 140.2 49.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.681 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -121.55 126.69 49.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.485 HD22 ' HA3' ' C' ' 61' ' ' GLY . 17.0 m120 -128.42 141.51 51.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.83 117.21 8.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.781 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.49 162.13 27.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.452 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.06 133.52 50.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.103 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.542 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 28.7 m-80 -108.38 127.86 54.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.458 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.74 138.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.77 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 80' ' ' SER . 4.6 pt-20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.684 0.278 . . . . 0.0 110.566 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.45 -29.86 70.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.259 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 24.9 mmt180 -76.74 -36.89 56.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.633 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.6 mt-30 -67.46 -32.96 74.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.786 HD21 ' HG3' ' C' ' 24' ' ' ARG . 1.4 tt -68.61 -55.77 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.15 -25.44 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 24.6 t-20 -71.79 -42.54 66.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.799 ' HG3' HD21 ' A' ' 21' ' ' LEU . 3.7 mmp_? -69.3 -45.25 70.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.782 HD12 HD11 ' C' ' 28' ' ' LEU . 1.9 tp -56.36 -49.06 75.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.582 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.618 ' O ' HG22 ' B' ' 30' ' ' THR . 33.3 t0 -64.73 -32.08 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.814 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.615 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 27.2 tttm -70.02 -32.9 71.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.237 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.777 HD11 HD12 ' A' ' 25' ' ' LEU . 1.7 mt -81.05 -32.34 34.08 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.7 -40.29 88.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.936 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.618 HG22 ' O ' ' B' ' 26' ' ' ASP . 4.3 t -76.68 -39.38 52.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.814 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.493 HH22 HG21 ' A' ' 32' ' ' VAL . 43.4 ttp85 -59.31 -41.91 90.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.336 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.523 HG22 ' O ' ' B' ' 28' ' ' LEU . 27.2 m -78.28 -23.63 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.157 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' B' ' 66' ' ' SER . 18.6 t70 -67.6 -51.59 48.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.986 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.46 ' NZ ' ' HA3' ' B' ' 91' ' ' GLY . 32.7 pttt -76.28 -40.41 51.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.792 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.21 -43.92 98.77 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.5 OUTLIER -67.14 -33.87 76.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.13 99.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.47 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.75 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 94.5 p -76.33 -37.33 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.758 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.628 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 32.7 t -63.76 -54.97 27.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.0 69.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.517 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -64.83 -46.59 81.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.612 HD13 ' O ' ' B' ' 42' ' ' LEU . 0.6 OUTLIER -66.05 -30.49 71.02 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 9.7 m-20 -81.39 -15.64 54.59 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -15.11 62.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.073 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.744 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.9 mm? -71.4 164.59 25.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.837 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 24.9 p90 -152.58 -32.08 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.15 0.5 . . . . 0.0 111.625 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.536 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 15.4 tt0 73.49 106.61 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.0 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -93.02 136.32 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.668 2.245 . . . . 0.0 112.52 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 10.6 m-85 65.56 151.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 178.57 78.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.264 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.22 -23.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 123.108 0.563 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 157.54 49.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.299 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' B' ' 52' ' ' GLY . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.31 150.59 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.543 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.536 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 2.2 t30 -132.94 124.34 27.62 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.981 0.42 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.68 ' CZ ' HD11 ' B' ' 71' ' ' ILE . 24.4 t80 -87.21 128.23 35.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.224 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.744 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.7 p -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.965 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.3 136.76 18.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.366 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.07 44.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.572 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.427 HG12 HD13 ' B' ' 69' ' ' LEU . 16.4 m -126.89 166.96 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.377 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -141.32 172.34 23.87 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.451 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.51 152.42 23.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.3 t80 -142.53 128.6 19.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 0.0 110.716 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 63.47 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.083 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 34.8 p -140.37 10.17 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.224 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.482 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 9.8 t -109.63 167.63 10.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.72 -179.13 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -167.13 156.59 10.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.532 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.427 HD13 HG12 ' B' ' 60' ' ' VAL . 7.6 tp -114.66 130.95 56.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.777 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.568 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -129.66 141.45 50.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.68 HD11 ' CZ ' ' B' ' 56' ' ' PHE . 7.9 tp -138.16 150.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.77 0.319 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.439 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -169.14 177.43 42.86 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.55 146.51 18.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.31 158.37 27.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.254 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.528 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 30.8 t80 -126.3 125.01 41.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.491 ' NH2' ' HB2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.09 102.68 10.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.663 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.602 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.1 p -104.36 138.3 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.95 -167.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -126.58 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.447 ' HA ' ' HG3' ' B' ' 104' ' ' GLU . 20.1 p -165.47 -46.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.955 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.2 139.88 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.557 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.15 155.48 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.273 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.21 138.86 33.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.36 169.78 17.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.082 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 171.99 157.58 14.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.587 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.08 144.85 32.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -112.55 142.46 45.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.323 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.05 122.9 39.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -137.35 147.23 45.38 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.585 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.46 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 57.16 -94.64 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.252 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.1 t -159.37 -33.83 0.06 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.735 0.303 . . . . 0.0 111.312 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -119.75 13.87 12.47 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 32.6 m-20 -101.86 72.2 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -116.02 127.11 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.029 0.442 . . . . 0.0 110.712 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' B' ' 39' ' ' SER . 1.3 ptp -131.98 140.16 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -121.51 126.6 49.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.406 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.474 HD22 ' HA3' ' A' ' 61' ' ' GLY . 16.9 m120 -128.35 141.46 51.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.487 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.71 117.27 8.61 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.58 162.11 28.03 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.446 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -127.03 133.52 50.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.951 0.405 . . . . 0.0 111.079 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 28.7 m-80 -108.41 127.78 54.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.365 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.65 138.13 53.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.795 0.331 . . . . 0.0 110.827 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.447 ' HG3' ' HA ' ' B' ' 80' ' ' SER . 4.6 pt-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.648 0.261 . . . . 0.0 110.524 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.279 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 24.8 mmt180 -76.73 -36.96 56.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.63 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.6 mt-30 -67.48 -32.91 74.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.16 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.79 HD21 ' HG3' ' A' ' 24' ' ' ARG . 1.4 tt -68.54 -55.86 10.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -66.15 -25.5 66.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 24.5 t-20 -71.72 -42.51 67.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.786 ' HG3' HD21 ' B' ' 21' ' ' LEU . 3.7 mmp_? -69.26 -45.29 70.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 28' ' ' LEU . 1.9 tp -56.32 -49.09 75.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.581 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . 0.6 ' O ' HG22 ' C' ' 30' ' ' THR . 33.3 t0 -64.77 -32.06 73.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.787 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.564 ' HZ2' HD11 ' B' ' 25' ' ' LEU . 27.2 tttm -69.97 -32.96 71.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.253 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.782 HD11 HD12 ' B' ' 25' ' ' LEU . 1.7 mt -81.0 -32.4 34.24 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.76 -40.19 88.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.94 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.6 HG22 ' O ' ' C' ' 26' ' ' ASP . 4.4 t -76.66 -39.29 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.899 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.495 HH22 HG21 ' B' ' 32' ' ' VAL . 43.5 ttp85 -59.51 -41.83 90.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.289 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.513 HG22 ' O ' ' C' ' 28' ' ' LEU . 27.3 m -78.36 -23.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' C' ' 66' ' ' SER . 18.6 t70 -67.51 -51.53 49.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.062 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' C' ' 30' ' ' THR . 32.6 pttt -76.46 -40.3 50.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.755 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.91 98.78 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.43 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.5 OUTLIER -67.1 -34.01 76.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.24 99.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.475 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.765 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 95.1 p -76.27 -37.38 57.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.641 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 33.1 t -63.72 -54.88 28.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.15 -32.03 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . 0.504 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -64.86 -46.59 81.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.628 ' O ' HD13 ' C' ' 42' ' ' LEU . 0.6 OUTLIER -66.12 -30.37 70.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.072 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 43' ' ' ASN . 9.6 m-20 -81.39 -15.73 54.35 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -14.95 62.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.159 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.751 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.9 mm? -71.52 164.56 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.89 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 24.8 p90 -152.55 -32.03 0.14 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.129 0.49 . . . . 0.0 111.705 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.531 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 15.4 tt0 73.49 106.64 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.974 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -92.93 136.31 1.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.647 2.231 . . . . 0.0 112.546 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 10.7 m-85 65.61 151.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 178.62 78.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.266 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.212 0.605 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 157.55 49.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.321 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' C' ' 52' ' ' GLY . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.604 0.24 . . . . 0.0 110.579 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.27 150.62 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.613 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.531 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 2.2 t30 -132.99 124.28 27.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 111.686 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . 0.68 ' CZ ' HD11 ' C' ' 71' ' ' ILE . 24.3 t80 -87.15 128.26 35.13 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.223 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.751 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 38.1 p -114.82 123.17 48.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.97 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.31 136.66 18.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.474 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.21 176.99 44.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.554 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.414 HG12 HD13 ' C' ' 69' ' ' LEU . 16.4 m -126.87 166.91 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.315 . . . . 0.0 111.418 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -141.25 172.41 23.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.518 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.6 152.33 23.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.587 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.3 t80 -142.46 128.62 19.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.751 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.41 -86.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.6 p -140.38 10.1 2.29 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . 0.471 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 9.7 t -109.57 167.67 9.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.76 -179.08 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 111.104 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . 0.765 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -167.23 156.51 10.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.541 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.414 HD13 HG12 ' C' ' 60' ' ' VAL . 7.6 tp -114.62 130.87 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.762 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.553 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -129.55 141.49 50.96 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.721 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.68 HD11 ' CZ ' ' C' ' 56' ' ' PHE . 7.9 tp -138.15 150.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.816 0.341 . . . . 0.0 111.065 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.456 ' N ' HG13 ' C' ' 71' ' ' ILE . . . -169.27 177.42 42.94 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.476 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -158.61 146.47 18.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 110.976 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.26 158.38 27.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.255 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.535 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 30.7 t80 -126.27 125.03 41.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.501 ' NH2' ' HB2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -113.12 102.77 10.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.0 p -104.48 138.3 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.9 -167.39 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -126.62 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.518 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' C' ' 104' ' ' GLU . 20.1 p -165.43 -46.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.009 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.2 139.77 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.575 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.48 45.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.302 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.25 138.81 33.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.558 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -145.43 132.57 20.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.15 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.31 169.77 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 172.08 157.58 14.27 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.564 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.12 144.85 32.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 111.098 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -112.46 142.44 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.334 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.08 122.95 39.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -137.3 147.36 45.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.64 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 56.92 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.331 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.3 t -159.37 -33.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.714 0.292 . . . . 0.0 111.338 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.78 13.85 12.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.162 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 32.5 m-20 -101.91 72.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.03 127.15 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.629 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.641 ' SD ' ' HB2' ' C' ' 39' ' ' SER . 1.3 ptp -131.91 140.13 48.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.684 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -121.45 126.7 49.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.402 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.476 HD22 ' HA3' ' B' ' 61' ' ' GLY . 17.0 m120 -128.4 141.52 51.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.38 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.82 117.24 8.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.53 162.19 27.82 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.474 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.12 133.53 50.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.0 111.084 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.533 ' OD1' HG22 ' B' ' 57' ' ' THR . 28.5 m-80 -108.4 127.84 54.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.345 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.489 HD12 ' HE1' ' C' ' 105' ' ' TRP . 0.7 OUTLIER -131.67 138.0 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.821 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' C' ' 80' ' ' SER . 4.7 pt-20 -112.56 147.02 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 0.489 ' HE1' HD12 ' C' ' 103' ' ' ILE . 40.0 m95 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.491 ' HZ2' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.609 0.242 . . . . 0.0 110.514 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -62.6 -41.13 98.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.245 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 34.5 mmt180 -73.7 -30.43 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -71.66 -34.47 69.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.9 HD12 HD12 ' C' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.61 63.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.633 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.85 -25.51 64.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.041 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 6.2 t-20 -66.43 -37.26 84.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.551 ' HD3' ' HB2' ' C' ' 25' ' ' LEU . 6.3 mmp_? -71.02 -44.8 65.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.655 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.3 OUTLIER -61.11 -32.66 72.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.608 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 30' ' ' THR . 56.6 t0 -81.78 -28.3 33.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -73.16 -43.28 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.67 0.272 . . . . 0.0 111.217 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.642 HD11 ' HA ' ' C' ' 25' ' ' LEU . 11.4 mt -72.05 -29.01 63.73 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.78 -47.41 72.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.961 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 26' ' ' ASP . 2.5 t -71.0 -33.81 70.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.869 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.503 ' NH2' HG21 ' C' ' 32' ' ' VAL . 45.2 ttp85 -67.71 -40.11 84.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 28' ' ' LEU . 33.8 m -76.09 -29.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.669 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 7.2 t70 -62.42 -57.25 11.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.053 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 30' ' ' THR . 26.8 pttt -70.26 -44.58 68.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.756 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.3 82.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.439 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.468 HD12 HD11 ' C' ' 36' ' ' LEU . 0.4 OUTLIER -71.1 -26.32 62.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.819 0.342 . . . . 0.0 111.097 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.69 -37.68 85.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.402 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 52.3 p -82.96 -38.75 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.688 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.471 ' HB2' HD21 ' C' ' 36' ' ' LEU . 31.0 t -57.39 -57.2 13.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -32.54 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.578 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -62.31 -45.31 93.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.689 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -66.14 -32.8 74.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.043 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 1.1 m-20 -82.83 -15.82 50.09 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.64 -17.75 64.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.135 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.769 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.4 mm? -75.41 162.66 28.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.812 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.534 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 45.1 p90 -143.83 -30.46 0.48 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 111.706 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.452 ' CG ' ' HB3' ' A' ' 55' ' ' ASN . 15.8 tt0 72.03 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.983 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.7 Cg_endo -89.13 140.6 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.693 2.262 . . . . 0.0 112.52 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 18.2 m-85 67.01 150.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.474 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -173.94 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.329 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.02 -19.41 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.154 0.582 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 148.44 48.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.294 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.09 4.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.674 0.273 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.35 137.94 40.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.582 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' B' ' 104' ' ' GLU . 6.5 t30 -125.95 119.7 28.42 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.02 0.438 . . . . 0.0 111.686 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.732 ' CZ ' HD11 ' A' ' 71' ' ' ILE . 17.9 t80 -80.3 128.35 33.44 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.269 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.769 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 16.7 p -114.29 119.86 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB2' HD12 ' A' ' 71' ' ' ILE . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.498 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -176.96 166.77 37.69 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.573 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.46 HG12 HD13 ' A' ' 69' ' ' LEU . 29.5 m -110.28 165.12 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.843 0.354 . . . . 0.0 111.316 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.15 176.09 21.2 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.396 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.31 27.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.669 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.72 123.33 14.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.592 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 33.3 mtt-85 65.75 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 p -137.59 12.91 2.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.7 t -109.34 173.15 6.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.35 177.21 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.111 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.72 161.19 23.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 60' ' ' VAL . 7.7 tp -119.6 136.24 54.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.713 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.689 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -136.43 137.94 40.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.638 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 8.3 tp -138.09 145.77 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 111.135 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -172.55 -175.34 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.452 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.11 158.36 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.776 0.322 . . . . 0.0 111.046 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.48 28.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.294 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -129.31 119.02 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 111.135 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.603 ' HD3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -105.82 104.0 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.739 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.731 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 10.8 p -101.9 126.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 63.86 -171.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -118.25 58.34 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.557 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.051 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.719 ' HA ' HG22 ' A' ' 103' ' ' ILE . 6.3 p -112.33 143.45 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.513 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . . . -146.64 151.78 37.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.36 132.61 35.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.578 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.17 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.64 171.33 18.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.097 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 167.5 157.31 10.66 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.56 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 111.141 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.28 151.9 30.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.315 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.33 126.89 38.27 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.276 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -140.89 145.57 36.32 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.614 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 55.18 -98.54 0.05 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.275 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 -25.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 111.311 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.96 12.92 7.28 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 33.8 m-20 -98.91 69.26 1.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.09 127.04 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.716 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.642 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 5.3 ptp -133.04 147.1 52.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.702 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -126.19 130.88 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.447 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -128.08 137.85 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 111.383 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.24 109.5 7.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.773 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.448 ' HA ' ' HA3' ' C' ' 59' ' ' GLY . 91.5 p -125.24 163.47 22.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.472 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.05 140.27 50.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.963 0.411 . . . . 0.0 111.111 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.678 ' OD1' HG22 ' C' ' 57' ' ' THR . 45.2 m-80 -111.76 125.59 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.719 HG22 ' HA ' ' A' ' 81' ' ' VAL . 3.3 pt -136.67 134.43 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' C' ' 55' ' ' ASN . 6.6 pt-20 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.498 ' HZ3' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.648 0.261 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -62.57 -41.09 98.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.304 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 34.5 mmt180 -73.75 -30.39 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -71.66 -34.5 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.59 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.604 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.81 -25.57 64.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 6.2 t-20 -66.29 -37.41 85.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.537 ' HD3' ' HB2' ' A' ' 25' ' ' LEU . 6.3 mmp_? -71.05 -44.61 65.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.65 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.3 OUTLIER -61.33 -32.52 72.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.565 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.616 ' O ' HG22 ' B' ' 30' ' ' THR . 56.6 t0 -81.82 -28.35 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.79 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.21 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 25' ' ' LEU . 11.5 mt -72.1 -28.95 63.63 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.83 -47.42 72.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.909 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.616 HG22 ' O ' ' B' ' 26' ' ' ASP . 2.5 t -71.01 -33.79 70.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.81 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.506 ' NH2' HG21 ' A' ' 32' ' ' VAL . 45.3 ttp85 -67.74 -40.1 84.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.585 HG13 ' O ' ' B' ' 28' ' ' LEU . 33.8 m -76.15 -29.44 19.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.256 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.681 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 7.2 t70 -62.62 -57.28 11.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' B' ' 30' ' ' THR . 26.8 pttt -70.13 -44.68 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -45.33 81.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.46 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -71.07 -26.36 63.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 111.075 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.53 -37.8 85.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.418 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' B' ' 90' ' ' ALA . 52.3 p -82.92 -38.76 22.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.453 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 30.8 t -57.27 -57.33 13.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.56 68.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.573 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -62.18 -45.46 93.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.919 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.679 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.3 OUTLIER -66.07 -32.79 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.077 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 1.1 m-20 -82.88 -15.72 50.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.76 -17.72 64.42 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.144 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.767 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -75.39 162.71 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.94 -30.38 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.464 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 15.7 tt0 72.04 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.0 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.7 Cg_endo -89.15 140.66 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.626 2.217 . . . . 0.0 112.514 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.487 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 18.2 m-85 67.05 150.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . -173.97 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.308 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.01 -19.45 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.159 0.584 . . . . 0.0 112.473 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 148.45 48.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.3 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.07 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.552 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.41 137.95 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' C' ' 104' ' ' GLU . 6.5 t30 -125.84 119.71 28.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 111.706 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.743 ' CZ ' HD11 ' B' ' 71' ' ' ILE . 17.7 t80 -80.3 128.4 33.5 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.201 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.767 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 16.7 p -114.32 119.79 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.99 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' B' ' 71' ' ' ILE . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.456 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -176.91 166.76 37.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.532 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.457 HG12 HD13 ' B' ' 69' ' ' LEU . 29.6 m -110.38 165.1 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.307 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.573 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.05 176.09 21.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.403 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.0 156.28 27.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.549 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.681 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.66 123.25 14.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . 0.599 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 33.5 mtt-85 65.78 -88.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.063 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 64.8 p -137.56 12.89 2.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.22 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -109.33 173.14 6.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.25 177.22 7.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.123 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.71 161.14 23.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.607 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.457 HD13 HG12 ' B' ' 60' ' ' VAL . 7.8 tp -119.5 136.21 54.43 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.679 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -136.48 137.82 40.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' B' ' 56' ' ' PHE . 8.3 tp -137.99 145.79 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.085 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -172.58 -175.37 40.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.463 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.6 p -164.07 158.37 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.17 159.58 28.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.3 118.98 23.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.605 ' HD3' ' HB2' ' B' ' 82' ' ' ALA . 0.0 OUTLIER -105.84 104.03 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.712 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 10.8 p -101.91 126.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.293 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.76 -171.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -118.21 58.32 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.97 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.721 ' HA ' HG22 ' B' ' 103' ' ' ILE . 6.3 p -112.37 143.43 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.605 ' HB2' ' HD3' ' B' ' 76' ' ' ARG . . . -146.7 151.72 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 111.231 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 44.9 tp -136.36 132.57 35.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.623 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.21 47.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.34 18.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.444 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 167.45 157.33 10.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.509 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.167 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.91 30.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.339 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.39 126.81 37.97 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.311 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -140.85 145.61 36.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.581 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 55.17 -98.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.27 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.37 -25.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.725 0.298 . . . . 0.0 111.287 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 92.3 p -126.95 12.88 7.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 33.8 m-20 -98.93 69.27 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.09 127.01 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.059 0.457 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.644 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 5.3 ptp -133.02 147.14 52.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.744 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -126.24 130.85 51.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.388 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -128.02 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.699 0.285 . . . . 0.0 111.449 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.11 109.46 7.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.811 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.45 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . 91.5 p -125.18 163.56 22.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.435 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -131.09 140.2 49.98 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.085 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.685 ' OD1' HG22 ' A' ' 57' ' ' THR . 45.1 m-80 -111.72 125.54 54.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.378 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.721 HG22 ' HA ' ' B' ' 81' ' ' VAL . 3.3 pt -136.66 134.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.824 0.345 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 6.6 pt-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.521 ' HZ3' HD13 ' B' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.663 0.268 . . . . 0.0 110.571 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . 0.491 ' HA ' ' HZ2' ' A' ' 17' ' ' LYS . 73.8 t80 -62.63 -41.12 98.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 34.6 mmt180 -73.76 -30.29 62.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.813 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -71.74 -34.47 69.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . 0.9 HD12 HD12 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -63.97 -51.67 63.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.57 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.77 -25.59 64.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 6.1 t-20 -66.29 -37.4 85.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' B' ' 25' ' ' LEU . 6.3 mmp_? -70.96 -44.8 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.642 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -61.24 -32.48 72.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . 0.607 ' O ' HG22 ' C' ' 30' ' ' THR . 56.6 t0 -81.9 -28.3 32.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.27 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' B' ' 25' ' ' LEU . 11.4 mt -72.08 -29.03 63.71 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.68 -47.39 72.58 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.978 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.607 HG22 ' O ' ' C' ' 26' ' ' ASP . 2.5 t -71.15 -33.7 70.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.792 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.499 ' NH2' HG21 ' B' ' 32' ' ' VAL . 45.4 ttp85 -67.8 -40.09 83.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.361 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.598 HG13 ' O ' ' C' ' 28' ' ' LEU . 33.7 m -76.11 -29.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.233 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . 0.666 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 7.2 t70 -62.47 -57.38 11.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.017 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' C' ' 30' ' ' THR . 26.8 pttt -70.11 -44.65 68.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.797 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.93 -45.33 81.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.4 OUTLIER -71.15 -26.3 62.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.762 0.315 . . . . 0.0 111.067 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.55 -37.8 85.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.441 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' C' ' 90' ' ' ALA . 52.3 p -82.91 -38.77 22.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.689 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . 0.461 ' HB2' HD21 ' B' ' 36' ' ' LEU . 30.8 t -57.22 -57.35 12.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 111.089 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.52 68.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . 0.565 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -62.31 -45.29 93.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.956 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.696 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.3 OUTLIER -66.18 -32.77 74.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.061 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.58 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.1 m-20 -82.85 -15.8 50.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.74 -17.74 64.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.073 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.755 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -75.36 162.74 28.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.857 177.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.96 -30.38 0.48 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.092 0.472 . . . . 0.0 111.712 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.458 ' CG ' ' HB3' ' C' ' 55' ' ' ASN . 15.7 tt0 72.11 104.32 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.996 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.8 Cg_endo -89.16 140.59 3.94 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.67 2.247 . . . . 0.0 112.53 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 18.2 m-85 67.08 150.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . -173.87 68.82 0.1 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.278 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 p -92.05 -19.36 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.158 0.583 . . . . 0.0 112.494 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 148.38 48.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.338 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 -175.11 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.667 0.27 . . . . 0.0 110.563 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.3 137.97 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.593 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 6.5 t30 -125.9 119.76 28.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 111.67 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . 0.75 ' CZ ' HD11 ' C' ' 71' ' ' ILE . 17.8 t80 -80.32 128.38 33.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.755 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 16.8 p -114.3 119.93 38.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.983 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . 0.473 ' HB2' HD12 ' C' ' 71' ' ' ILE . . . -148.32 141.5 25.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.523 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -176.92 166.66 37.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.566 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . 0.461 HG12 HD13 ' C' ' 69' ' ' LEU . 29.5 m -110.29 165.09 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.358 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.05 176.12 21.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.472 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.26 27.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.654 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.69 123.19 14.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.595 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 33.5 mtt-85 65.82 -88.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.032 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 64.1 p -137.53 12.93 2.98 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.172 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 32.8 t -109.35 173.15 6.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.28 177.22 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.065 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.72 161.2 23.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.546 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.461 HD13 HG12 ' C' ' 60' ' ' VAL . 7.7 tp -119.62 136.13 54.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.762 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.696 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -136.39 137.91 41.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.671 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . 0.75 HD11 ' CZ ' ' C' ' 56' ' ' PHE . 8.3 tp -138.08 145.81 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.058 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -172.57 -175.46 40.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.0 158.41 19.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.827 0.346 . . . . 0.0 111.043 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.2 159.53 28.06 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.207 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.29 118.99 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.377 . . . . 0.0 111.153 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.605 ' HD3' ' HB2' ' C' ' 82' ' ' ALA . 0.0 OUTLIER -105.8 104.04 13.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.721 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.734 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 10.7 p -101.95 126.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.279 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.87 -171.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.922 0.391 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -118.23 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.59 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -157.01 -53.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.718 ' HA ' HG22 ' C' ' 103' ' ' ILE . 6.4 p -112.41 143.49 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.509 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.605 ' HB2' ' HD3' ' C' ' 76' ' ' ARG . . . -146.72 151.72 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.202 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.4 132.62 35.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 143.21 47.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 171.32 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.454 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 167.45 157.33 10.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.584 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.839 0.352 . . . . 0.0 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.26 151.97 30.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.336 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 126.86 38.08 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.232 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -140.89 145.56 36.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.615 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.427 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 55.23 -98.51 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.201 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.38 -25.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 0.0 111.25 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.98 12.91 7.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 33.9 m-20 -98.96 69.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.07 127.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.706 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.629 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 5.3 ptp -133.03 147.15 52.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.716 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -126.25 130.86 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.422 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -128.03 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.15 109.54 7.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.459 ' HA ' ' HA3' ' B' ' 59' ' ' GLY . 91.6 p -125.19 163.53 22.27 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.423 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.11 140.23 49.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.695 ' OD1' HG22 ' B' ' 57' ' ' THR . 45.1 m-80 -111.77 125.53 54.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.402 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' C' ' 81' ' ' VAL . 3.3 pt -136.69 134.45 48.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.831 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' B' ' 55' ' ' ASN . 6.5 pt-20 -111.6 159.45 18.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 0.481 ' HE1' HD12 ' C' ' 103' ' ' ILE . 50.4 m95 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.666 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.676 0.274 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -58.47 -35.35 72.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 111.258 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.78 -41.93 35.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -59.4 -35.03 73.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -59.54 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.538 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -65.57 -21.2 66.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.8 -40.99 75.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.691 ' HD3' HD13 ' C' ' 25' ' ' LEU . 4.5 mmp_? -71.73 -43.75 65.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.815 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.67 HD13 ' HD3' ' B' ' 24' ' ' ARG . 1.2 tp -59.75 -40.97 89.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.646 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.22 -32.74 64.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.775 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 14.5 tttm -71.43 -29.68 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.668 0.27 . . . . 0.0 111.237 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.709 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.3 mt -85.16 -31.1 23.44 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.429 ' O ' HG22 ' A' ' 32' ' ' VAL . 25.4 t70 -66.34 -41.21 89.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.976 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.638 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 7.0 t -73.23 -44.54 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.797 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.792 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 24.3 ttp85 -60.46 -37.03 79.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.304 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 28' ' ' LEU . 33.9 m -75.71 -31.82 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.117 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.33 -50.7 64.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.032 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.792 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 23.2 pttt -71.48 -42.17 68.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.718 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -52.95 47.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.474 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.14 -38.3 87.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.087 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.06 77.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.446 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.666 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 70.3 p -75.38 -37.17 60.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.2 t -58.12 -66.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -31.47 35.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.425 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -58.81 -53.37 59.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.617 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.8 tm? -69.36 -32.82 72.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.104 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -75.99 -5.67 47.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -13.81 59.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.135 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.805 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.7 mm? -75.64 172.53 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' C' ' 46' ' ' PHE . 47.2 p90 -153.55 -26.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.66 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.93 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -92.04 144.56 2.86 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.591 2.194 . . . . 0.0 112.57 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 48' ' ' PRO . 11.0 m-85 53.5 154.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.25 79.15 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.279 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.97 -26.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.142 0.577 . . . . 0.0 112.424 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.2 49.35 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.34 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -146.15 -178.11 5.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.545 0.212 . . . . 0.0 110.642 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.77 144.26 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.498 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.645 ' OD1' ' HB3' ' B' ' 104' ' ' GLU . 1.7 t30 -128.75 125.3 37.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.987 0.422 . . . . 0.0 111.662 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.37 128.15 37.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.805 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 10.5 p -113.12 131.8 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.99 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.63 133.17 13.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.424 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -166.64 179.46 40.52 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.588 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.49 177.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.763 0.316 . . . . 0.0 111.4 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.562 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -154.04 172.93 32.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.408 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.68 156.79 28.38 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.1 t80 -146.71 125.89 12.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.751 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 66.04 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.137 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.225 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.64 166.16 13.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -124.1 174.41 7.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 111.093 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.02 157.47 37.66 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 70' ' ' ALA . 6.8 tp -111.8 134.16 53.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.48 ' H ' HD12 ' A' ' 69' ' ' LEU . . . -131.39 136.73 48.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.68 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.84 145.79 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.147 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -175.96 -179.3 46.37 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -160.53 157.93 28.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.22 153.98 25.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.268 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.51 128.77 47.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.442 ' NH2' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -110.76 105.53 14.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.698 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.434 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.4 p -100.86 130.84 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.372 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 56.57 -167.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.056 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' HA ' ' NH2' ' A' ' 76' ' ' ARG . 58.0 mt-10 -122.59 61.71 0.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.76 -51.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.006 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.69 135.63 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.476 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.16 164.75 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.295 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.44 HD12 ' HB3' ' A' ' 101' ' ' PHE . 7.0 tp -142.58 148.27 37.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.624 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.436 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -152.74 136.05 15.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.08 18.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.412 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . -179.22 154.63 14.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.571 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.58 42.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.926 0.393 . . . . 0.0 111.027 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -114.36 147.69 38.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.323 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.36 126.02 44.36 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.253 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -138.65 152.02 47.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.706 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.48 -97.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.281 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.22 -39.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -115.72 16.42 16.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.158 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.63 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 14.4 m-20 -101.12 65.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.19 119.3 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 110.704 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.476 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -117.82 145.31 44.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -124.87 132.66 53.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.686 0.279 . . . . 0.0 111.451 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.05 108.55 4.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.739 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.579 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 85.0 p -128.73 160.87 31.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB3' HD12 ' A' ' 83' ' ' LEU . 18.3 p90 -125.94 138.35 53.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.908 0.385 . . . . 0.0 111.09 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.677 ' OD1' HG22 ' C' ' 57' ' ' THR . 22.9 m-80 -104.73 129.86 52.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.411 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.94 132.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.636 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 8.3 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.677 0.275 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . 0.426 ' HA ' ' HZ2' ' C' ' 17' ' ' LYS . 81.8 t80 -58.53 -35.32 72.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.216 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -77.74 -42.0 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -59.43 -34.97 73.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -59.51 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.563 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.53 -21.27 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.72 -40.93 75.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.67 ' HD3' HD13 ' A' ' 25' ' ' LEU . 4.5 mmp_? -71.82 -43.66 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.671 HD13 ' HD3' ' C' ' 24' ' ' ARG . 1.2 tp -59.91 -40.89 90.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.18 -32.82 65.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.529 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.63 65.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.193 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.712 ' O ' HG13 ' B' ' 32' ' ' VAL . 4.2 mt -85.15 -31.0 23.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.432 ' O ' HG22 ' B' ' 32' ' ' VAL . 25.3 t70 -66.41 -41.2 89.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.941 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.63 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 7.0 t -73.22 -44.53 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.78 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.1 79.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.313 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.712 HG13 ' O ' ' B' ' 28' ' ' LEU . 33.8 m -75.63 -31.82 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.233 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.45 -50.57 64.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.78 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 23.1 pttt -71.5 -42.09 68.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.787 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.9 -52.89 48.29 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.412 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.04 -38.41 88.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.14 77.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.479 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.668 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . 70.5 p -75.33 -37.17 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.806 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 46.0 t -58.17 -65.9 0.57 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.157 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -31.4 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -58.83 -53.37 59.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.913 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.626 HD13 ' O ' ' B' ' 42' ' ' LEU . 1.8 tm? -69.35 -32.87 72.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -76.01 -5.7 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -13.7 59.82 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.213 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.821 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.7 mm? -75.66 172.44 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.866 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 47.0 p90 -153.48 -26.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.53 107.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.992 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -92.07 144.57 2.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.622 2.214 . . . . 0.0 112.56 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.529 ' O ' ' O ' ' B' ' 48' ' ' PRO . 11.0 m-85 53.39 154.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . 178.26 78.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.236 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.87 -26.5 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.11 0.564 . . . . 0.0 112.506 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.18 49.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.299 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' B' ' 52' ' ' GLY . 0.4 OUTLIER -146.21 -178.16 5.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.564 0.221 . . . . 0.0 110.62 179.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.65 144.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.55 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.644 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 1.7 t30 -128.76 125.16 37.26 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.29 128.15 37.01 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.257 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.821 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 10.4 p -113.15 131.77 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.042 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.59 133.13 13.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -166.5 179.54 40.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.67 177.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 0.0 111.35 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -153.97 172.88 32.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.538 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 156.84 28.43 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.531 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' TYR . . . . . 0.481 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.1 t80 -146.78 125.79 12.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.764 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.96 -89.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.5 p -137.95 16.75 2.84 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.214 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.74 166.17 13.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.8 OUTLIER -124.06 174.4 7.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.04 157.52 37.72 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.535 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.485 HD12 ' H ' ' B' ' 70' ' ' ALA . 6.7 tp -111.83 134.23 53.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.795 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.485 ' H ' HD12 ' B' ' 69' ' ' LEU . . . -131.49 136.71 48.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.677 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.89 145.72 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.319 . . . . 0.0 111.166 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -175.88 -179.28 46.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.406 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.9 p -160.57 157.92 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.918 0.39 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.18 153.99 25.51 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.215 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.56 128.83 47.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . 0.442 ' NH2' ' HA ' ' B' ' 79' ' ' GLU . 0.0 OUTLIER -110.72 105.52 14.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.791 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.424 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.4 p -100.89 130.79 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.284 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 56.62 -167.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.945 0.402 . . . . 0.0 111.102 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.442 ' HA ' ' NH2' ' B' ' 76' ' ' ARG . 57.4 mt-10 -122.59 61.79 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.77 -51.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.03 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.57 135.66 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.539 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.2 164.79 29.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' B' ' 84' ' ' LYS . 7.0 tp -142.62 148.3 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . 0.433 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 0.0 OUTLIER -152.81 136.02 15.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.151 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.17 169.05 18.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.407 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . -179.17 154.65 14.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.571 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.56 42.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.88 0.372 . . . . 0.0 111.096 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -114.28 147.68 38.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.348 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.35 125.99 44.32 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.305 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.737 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -138.62 152.03 47.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.604 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.46 -97.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.272 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.19 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.64 16.44 16.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.193 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.634 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 13.9 m-20 -101.15 65.65 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.17 119.38 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -117.89 145.33 44.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.721 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.87 132.6 53.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.19 142.43 49.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.08 108.48 4.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' SER . . . . . 0.575 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 85.1 p -128.71 160.89 31.07 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.431 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . 0.433 ' HB3' HD12 ' B' ' 83' ' ' LEU . 18.2 p90 -125.93 138.35 53.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 0.0 111.038 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.679 ' OD1' HG22 ' A' ' 57' ' ' THR . 22.9 m-80 -104.72 129.87 52.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.38 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.94 132.73 61.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.843 0.354 . . . . 0.0 110.801 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.645 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 8.3 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.426 ' HZ2' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.665 0.269 . . . . 0.0 110.504 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -58.52 -35.29 72.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 111.241 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.77 -41.94 35.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.44 -34.99 73.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.141 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -59.5 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.591 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.64 -21.18 66.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.981 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -69.75 -40.99 75.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.671 ' HD3' HD13 ' B' ' 25' ' ' LEU . 4.4 mmp_? -71.83 -43.68 65.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.771 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.691 HD13 ' HD3' ' A' ' 24' ' ' ARG . 1.3 tp -59.82 -40.96 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.18 -32.8 65.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.508 ' HZ2' HD11 ' B' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.69 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.168 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.717 ' O ' HG13 ' C' ' 32' ' ' VAL . 4.2 mt -85.07 -31.08 23.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . 0.43 ' O ' HG22 ' C' ' 32' ' ' VAL . 25.5 t70 -66.32 -41.27 89.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.01 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.647 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 7.0 t -73.24 -44.45 59.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.783 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.12 79.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.28 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.717 HG13 ' O ' ' C' ' 28' ' ' LEU . 33.8 m -75.55 -31.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.4 -50.65 64.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.031 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.783 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 23.1 pttt -71.53 -42.13 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.737 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -53.04 46.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.422 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.04 -38.37 88.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 111.052 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.79 -44.03 77.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.416 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.677 ' HB2' ' HB1' ' C' ' 88' ' ' ALA . 70.7 p -75.37 -37.22 60.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 46.1 t -58.13 -65.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.123 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -31.36 35.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.456 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -58.8 -53.39 58.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.62 ' O ' HD13 ' C' ' 42' ' ' LEU . 1.8 tm? -69.44 -32.82 72.0 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 62.0 m-20 -75.98 -5.63 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -13.75 59.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.098 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.832 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.7 mm? -75.66 172.52 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.878 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 47.0 p90 -153.57 -26.26 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.664 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.59 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.993 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -92.02 144.54 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.675 2.25 . . . . 0.0 112.568 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.525 ' O ' ' O ' ' C' ' 48' ' ' PRO . 11.0 m-85 53.43 154.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.941 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . 178.23 79.13 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.266 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.9 -26.61 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.153 0.581 . . . . 0.0 112.434 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.24 49.42 0.02 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.299 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' C' ' 52' ' ' GLY . 0.4 OUTLIER -146.15 -178.05 5.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.587 0.232 . . . . 0.0 110.628 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.74 144.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.558 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 1.7 t30 -128.74 125.32 37.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.35 128.11 37.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.276 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.832 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 10.2 p -113.17 131.79 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.984 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.56 133.14 13.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.446 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.579 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -166.62 179.43 40.53 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.54 177.09 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.349 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -153.96 172.99 32.64 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.424 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.69 156.77 28.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.563 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' TYR . . . . . 0.476 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.1 t80 -146.72 125.82 12.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.99 -90.03 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.182 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.7 166.26 12.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.8 OUTLIER -124.18 174.4 7.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.347 . . . . 0.0 111.129 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -154.98 157.44 37.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.553 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.492 HD12 ' H ' ' C' ' 70' ' ' ALA . 6.6 tp -111.82 134.21 53.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.492 ' H ' HD12 ' C' ' 69' ' ' LEU . . . -131.51 136.78 48.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.91 145.71 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 111.145 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -175.93 -179.23 46.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.426 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -160.59 157.88 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.964 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.13 153.9 25.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.251 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.47 128.78 47.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.195 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' C' ' 79' ' ' GLU . 0.0 OUTLIER -110.66 105.59 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.5 p -101.02 130.81 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.964 0.412 . . . . 0.0 111.256 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 56.62 -167.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.089 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' GLU . . . . . 0.443 ' HA ' ' NH2' ' C' ' 76' ' ' ARG . 57.4 mt-10 -122.53 61.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.587 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 -51.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.012 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.66 135.6 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.11 164.81 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.226 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' C' ' 101' ' ' PHE . 7.0 tp -142.65 148.27 37.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . 0.417 ' N ' ' HG ' ' C' ' 83' ' ' LEU . 0.0 OUTLIER -152.75 136.04 15.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.212 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.23 169.05 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . -179.18 154.64 14.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.592 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.56 142.54 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.829 0.347 . . . . 0.0 111.093 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.677 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -114.3 147.71 38.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.39 126.0 44.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.306 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.725 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -138.68 152.01 47.68 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.621 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.35 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 42.0 t -151.23 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.333 . . . . 0.0 111.32 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.63 16.4 16.48 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.161 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.629 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 14.1 m-20 -101.16 65.7 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.26 119.37 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.673 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.481 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.3 OUTLIER -117.85 145.25 44.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.693 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.89 132.65 53.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.443 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.26 142.39 49.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.688 0.28 . . . . 0.0 111.483 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.97 108.49 4.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.738 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 100' ' ' SER . . . . . 0.576 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 84.6 p -128.67 160.85 31.18 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.435 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.439 ' HB3' HD12 ' C' ' 83' ' ' LEU . 18.3 p90 -125.94 138.38 53.77 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.896 0.379 . . . . 0.0 111.108 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 102' ' ' ASN . . . . . 0.668 ' OD1' HG22 ' B' ' 57' ' ' THR . 23.1 m-80 -104.73 129.89 52.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.448 HD12 ' HE1' ' C' ' 105' ' ' TRP . 2.6 pt -132.0 132.67 61.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 104' ' ' GLU . . . . . 0.644 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 8.3 pt-20 -110.95 143.23 41.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 105' ' ' TRP . . . . . 0.448 ' HE1' HD12 ' C' ' 103' ' ' ILE . 14.6 m95 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.683 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.632 -0.187 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 37.66 -99.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.373 . . . . 0.0 110.975 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 48.9 mt-30 -112.32 -52.62 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.832 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . 178.77 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 t -70.04 -56.55 6.65 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.777 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -52.63 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.68 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m 67.08 53.14 0.82 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.032 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.779 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 24.2 m80 -70.64 -52.89 10.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.774 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.779 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -52.75 123.47 13.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.488 2.125 . . . . 0.0 111.886 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.617 HE21 ' HB2' ' B' ' 17' ' ' LYS . 7.9 mm100 -128.02 -54.8 1.29 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.939 0.399 . . . . 0.0 111.172 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -125.22 -155.35 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.71 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -70.41 -22.73 62.7 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.473 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -140.82 12.17 2.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.489 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.04 -25.97 67.72 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.298 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 9' ' ' PRO . . . -64.77 -41.1 96.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 110.921 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -74.3 -34.97 63.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.943 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.629 ' HB2' HE21 ' C' ' 10' ' ' GLN . 32.9 ttmt -70.14 -44.75 68.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.524 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -38.15 88.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.268 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -68.37 -42.96 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.17 -44.94 95.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.42 . . . . 0.0 111.137 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -66.03 -44.19 85.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.526 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.21 -34.17 77.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.011 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -72.77 -37.12 67.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -68.15 -44.02 76.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.734 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.708 ' HG ' HD21 ' C' ' 25' ' ' LEU . 3.9 mt -60.81 -44.92 96.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -63.03 -33.85 76.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 11.8 tttt -71.19 -35.89 71.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.727 HD21 ' HA ' ' C' ' 29' ' ' ASP . 0.5 OUTLIER -66.42 -52.36 47.33 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.736 ' HA ' HD21 ' B' ' 28' ' ' LEU . 46.9 t0 -55.56 -39.3 70.46 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.977 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.3 m -61.33 -49.72 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.862 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.639 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 85.0 mmt-85 -58.11 -32.02 67.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.772 HG11 HG22 ' B' ' 32' ' ' VAL . 18.9 t -77.3 -36.48 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.162 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -64.1 -52.8 57.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.94 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 13.3 pttt -77.22 -37.16 53.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.97 -40.18 98.55 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.433 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.573 HD22 ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -72.86 -37.38 67.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.91 91.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.669 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -68.99 -50.29 50.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.555 ' HB3' HD21 ' C' ' 36' ' ' LEU . 96.5 p -52.82 -49.37 65.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.2 73.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.53 -42.65 55.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.913 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.511 HD23 ' OD1' ' A' ' 98' ' ' ASN . 16.2 tp -71.83 -42.51 66.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -75.81 -3.1 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.53 55.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.096 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.49 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -97.77 177.13 5.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.816 177.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -169.1 1.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.657 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 33.1 mt-30 63.9 116.38 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.277 9.9 Cg_endo -74.46 95.04 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.587 2.191 . . . . 0.0 112.593 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 87.4 m-85 68.83 -173.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 148.9 90.12 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.207 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -87.78 -14.74 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 123.152 0.581 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.37 48.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.279 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.99 -172.89 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 110.622 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.115 HG13 ' O ' ' B' ' 105' ' ' TRP . 4.5 p -103.48 148.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.571 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.704 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.47 44.12 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 111.656 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.534 ' HE2' HD11 ' A' ' 71' ' ' ILE . 1.1 t80 -97.48 124.13 41.59 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.25 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.479 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.2 p -116.5 127.95 55.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.65 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -159.85 154.87 24.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.45 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.53 165.99 29.61 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.518 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 69' ' ' LEU . 13.6 m -112.08 163.68 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.4 179.65 27.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.416 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.56 144.82 11.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.552 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CD1' HD22 ' A' ' 36' ' ' LEU . 75.1 t80 -136.92 129.48 30.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.314 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 3.5 mmm-85 65.72 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -152.25 34.96 0.52 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.158 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.92 168.01 18.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -140.78 144.35 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.113 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.92 156.18 43.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' A' ' 60' ' ' VAL . 6.7 tp -113.19 125.35 54.24 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.778 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -119.55 151.14 39.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.706 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.65 HG13 ' HB2' ' A' ' 58' ' ' ALA . 18.4 tt -145.2 164.24 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.479 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 179.58 175.56 46.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.44 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.74 147.69 11.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.92 163.3 30.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.232 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -108.5 120.72 43.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.505 ' CB ' ' HA3' ' A' ' 50' ' ' GLY . 6.6 mmm180 -96.72 92.38 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.743 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.2 p -96.79 131.83 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.6 m120 64.67 -177.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.078 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.3 24.25 11.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.495 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.059 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.3 153.67 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -156.28 173.51 16.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 111.259 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.22 140.32 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.611 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.657 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -140.48 134.27 30.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.188 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.95 133.97 14.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.479 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -160.0 170.54 36.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.546 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 71' ' ' ILE . 9.7 p -117.44 147.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.136 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.58 ' HB3' ' SD ' ' A' ' 96' ' ' MET . . . -119.39 134.57 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.328 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.18 110.85 22.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -118.91 136.9 53.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.631 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.562 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 50.63 -111.95 1.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.318 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.39 -53.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.689 0.28 . . . . 0.0 111.307 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.505 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -106.37 26.83 9.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.145 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.751 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -116.85 81.82 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.59 139.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.707 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -135.36 158.53 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.723 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -134.16 133.5 41.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.468 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.511 ' OD1' HD23 ' A' ' 42' ' ' LEU . 33.7 m120 -113.73 161.09 17.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.747 0.308 . . . . 0.0 111.393 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.45 0.18 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.724 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.493 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 13.8 p -126.02 178.76 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.426 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -144.44 137.77 27.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.863 0.363 . . . . 0.0 111.121 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 69.9 m-80 -103.29 148.79 25.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.352 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.499 HG13 ' O ' ' C' ' 56' ' ' PHE . 7.4 pt -152.75 146.66 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.7 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 90.0 mt-10 -90.37 130.99 36.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.094 ' O ' HG13 ' C' ' 54' ' ' VAL . 2.9 t-105 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.682 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 112.64 -0.184 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 37.52 -99.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.985 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -112.29 -52.71 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 178.83 -59.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -70.09 -56.48 6.8 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.791 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -52.63 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.685 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m 67.12 53.11 0.81 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.022 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.76 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 24.3 m80 -70.65 -52.83 10.22 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.771 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.76 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -52.73 123.46 13.03 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.489 2.126 . . . . 0.0 111.896 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.613 HE21 ' HB2' ' C' ' 17' ' ' LYS . 7.9 mm100 -127.99 -54.88 1.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.982 0.42 . . . . 0.0 111.122 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.24 -155.41 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.659 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -70.35 -22.69 62.76 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.469 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.405 ' HE3' ' OE1' ' A' ' 10' ' ' GLN . 14.8 mtpp -140.81 12.1 2.26 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.5 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.01 -25.99 67.76 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.266 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' B' ' 9' ' ' PRO . . . -64.67 -41.18 96.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.93 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -74.38 -34.8 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.009 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.617 ' HB2' HE21 ' A' ' 10' ' ' GLN . 33.0 ttmt -70.15 -44.7 68.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.538 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -38.11 88.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 mtt85 -68.26 -43.03 78.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.15 -44.94 95.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.479 HD23 HD21 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -65.98 -44.24 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.627 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.2 -34.08 76.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.078 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.85 -37.09 67.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mtt180 -68.06 -44.02 77.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.712 HD21 ' HG ' ' C' ' 25' ' ' LEU . 3.9 mt -60.91 -44.9 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.59 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -63.04 -33.84 76.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.869 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 11.8 tttt -71.16 -35.88 71.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.221 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.736 HD21 ' HA ' ' A' ' 29' ' ' ASP . 0.5 OUTLIER -66.34 -52.41 47.31 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.737 ' HA ' HD21 ' C' ' 28' ' ' LEU . 46.8 t0 -55.54 -39.37 70.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.951 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 13.8 m -61.3 -49.74 75.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.87 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.645 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 85.0 mmt-85 -58.09 -31.97 67.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.772 HG22 HG11 ' A' ' 32' ' ' VAL . 18.8 t -77.35 -36.54 23.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -64.05 -52.81 57.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.671 ' HD2' ' HB2' ' B' ' 94' ' ' ASP . 13.3 pttt -77.27 -37.09 53.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.791 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.02 -40.18 98.56 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.419 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' B' ' 63' ' ' TYR . 0.2 OUTLIER -72.84 -37.42 67.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.0 91.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.471 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.665 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -68.98 -50.28 50.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.719 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.556 ' HB3' HD21 ' A' ' 36' ' ' LEU . 96.4 p -52.82 -49.34 65.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.11 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.401 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.54 -42.67 55.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.515 HD23 ' OD1' ' B' ' 98' ' ' ASN . 16.1 tp -71.86 -42.43 66.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.92 -3.09 33.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.83 0.35 55.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.178 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -97.69 177.11 5.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.871 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.11 1.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.716 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.656 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 33.1 mt-30 63.97 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.977 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.277 9.8 Cg_endo -74.51 95.08 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.601 2.201 . . . . 0.0 112.508 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 87.4 m-85 68.84 -173.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 148.95 90.13 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.209 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -87.79 -14.77 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.141 0.576 . . . . 0.0 112.425 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.39 48.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.315 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -146.86 -172.9 4.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.605 0.241 . . . . 0.0 110.587 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 1.074 HG13 ' O ' ' C' ' 105' ' ' TRP . 4.6 p -103.37 148.77 7.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.607 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.683 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 7.3 m-80 -134.0 136.5 44.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.928 0.395 . . . . 0.0 111.667 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.522 ' HE2' HD11 ' B' ' 71' ' ' ILE . 1.1 t80 -97.5 124.12 41.61 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.277 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.471 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.0 p -116.51 127.89 54.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.941 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.651 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -159.83 154.75 24.63 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.452 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.503 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.62 166.04 29.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.544 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 69' ' ' LEU . 13.8 m -112.06 163.69 8.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.347 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.37 179.58 27.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.462 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.54 144.87 11.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.579 ' CD1' HD22 ' B' ' 36' ' ' LEU . 75.3 t80 -136.92 129.62 30.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.729 0.299 . . . . 0.0 110.727 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 3.5 mmm-85 65.52 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.23 34.84 0.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.86 168.04 17.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -140.78 144.3 35.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.164 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.88 156.3 43.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' B' ' 60' ' ' VAL . 6.8 tp -113.2 125.36 54.25 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.792 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -119.59 151.15 39.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.699 0.285 . . . . 0.0 111.665 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' B' ' 58' ' ' ALA . 18.4 tt -145.19 164.2 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.126 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 179.6 175.52 46.47 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.433 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.74 147.77 11.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.873 0.368 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.91 163.33 30.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -108.49 120.61 42.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.504 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.49 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.749 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.1 p -96.85 131.91 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.239 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.5 m120 64.6 -177.25 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.925 0.393 . . . . 0.0 111.04 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -116.26 24.21 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.563 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.24 153.67 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.48 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -156.33 173.47 16.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.281 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.12 140.39 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.656 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.24 30.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.195 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 134.03 14.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -160.04 170.58 36.18 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' B' ' 71' ' ' ILE . 9.8 p -117.44 147.41 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.85 0.357 . . . . 0.0 111.106 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.585 ' HB3' ' SD ' ' B' ' 96' ' ' MET . . . -119.38 134.61 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.323 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.23 110.84 22.55 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.292 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . . . -118.8 136.93 53.74 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.636 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.567 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 50.6 -112.05 1.45 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.3 -53.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.691 0.281 . . . . 0.0 111.326 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' B' ' 93' ' ' SER . 2.2 t -106.35 26.85 9.34 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.198 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.75 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.3 OUTLIER -116.95 81.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.69 139.37 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' B' ' 88' ' ' ALA . 0.0 OUTLIER -135.38 158.52 44.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.711 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -134.12 133.55 41.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.515 ' OD1' HD23 ' B' ' 42' ' ' LEU . 33.7 m120 -113.72 161.05 17.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.51 0.18 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.5 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 13.9 p -126.05 178.78 5.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.462 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -144.52 137.76 27.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.002 0.429 . . . . 0.0 111.048 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.674 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 69.8 m-80 -103.2 148.8 25.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.442 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 56' ' ' PHE . 7.4 pt -152.77 146.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.336 . . . . 0.0 110.77 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.704 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 90.1 mt-10 -90.34 131.0 36.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 1.115 ' O ' HG13 ' A' ' 54' ' ' VAL . 3.0 t-105 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.648 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.675 -0.17 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 37.66 -99.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.853 0.358 . . . . 0.0 110.985 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -112.3 -52.68 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.794 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 178.81 -59.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.011 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -70.02 -56.59 6.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.788 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -52.63 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.692 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m 67.09 53.15 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.996 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.783 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 24.2 m80 -70.72 -52.83 10.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.761 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.783 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -52.67 123.39 12.83 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.496 2.131 . . . . 0.0 111.911 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . 0.629 HE21 ' HB2' ' A' ' 17' ' ' LYS . 7.9 mm100 -127.97 -54.79 1.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 111.144 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.32 -155.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.669 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -70.36 -22.65 62.75 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.497 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -140.87 12.11 2.25 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.536 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.15 -25.89 67.66 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.248 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' C' ' 9' ' ' PRO . . . -64.67 -41.17 96.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.36 . . . . 0.0 110.943 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -74.39 -34.93 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.613 ' HB2' HE21 ' B' ' 10' ' ' GLN . 32.9 ttmt -70.08 -44.78 68.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.573 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -38.02 87.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.306 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -68.36 -43.0 78.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.13 -44.95 95.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.479 HD21 HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -66.07 -44.15 85.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.554 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -34.13 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -72.77 -37.18 67.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -67.94 -44.13 77.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.772 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.712 ' HG ' HD21 ' B' ' 25' ' ' LEU . 3.9 mt -60.72 -44.99 95.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -62.99 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.875 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 11.8 tttt -71.08 -35.9 72.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.313 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.737 HD21 ' HA ' ' B' ' 29' ' ' ASP . 0.5 OUTLIER -66.38 -52.35 47.72 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . 0.727 ' HA ' HD21 ' A' ' 28' ' ' LEU . 46.9 t0 -55.59 -39.28 70.5 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.519 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 14.3 m -61.4 -49.71 75.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.813 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.644 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 85.0 mmt-85 -58.05 -32.07 67.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.376 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.764 HG11 HG22 ' A' ' 32' ' ' VAL . 18.6 t -77.26 -36.51 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.227 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -64.03 -52.85 57.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.652 ' HD2' ' HB2' ' C' ' 94' ' ' ASP . 13.2 pttt -77.26 -37.15 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.725 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.02 -40.11 98.47 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' C' ' 63' ' ' TYR . 0.2 OUTLIER -72.85 -37.39 67.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.05 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.369 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.673 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -68.89 -50.38 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.558 ' HB3' HD21 ' B' ' 36' ' ' LEU . 96.6 p -52.71 -49.41 65.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.09 73.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.459 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.56 -42.68 55.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.5 HD23 ' OD1' ' C' ' 98' ' ' ASN . 16.2 tp -71.83 -42.46 66.94 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -75.88 -3.06 33.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -87.97 0.52 55.81 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.12 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -97.8 177.15 5.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.791 177.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -169.08 1.07 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.638 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.655 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 33.1 mt-30 63.99 116.4 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.95 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.4 94.97 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.647 2.231 . . . . 0.0 112.582 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 87.6 m-85 68.9 -173.61 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.9 90.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.247 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.8 -14.78 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.129 0.572 . . . . 0.0 112.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.751 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.43 48.77 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.274 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -147.01 -172.89 4.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.547 0.213 . . . . 0.0 110.573 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 1.094 HG13 ' O ' ' A' ' 105' ' ' TRP . 4.6 p -103.42 148.73 8.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.7 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 7.4 m-80 -134.0 136.48 44.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.662 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.546 ' HE2' HD11 ' C' ' 71' ' ' ILE . 1.1 t80 -97.49 124.13 41.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.483 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 44.8 p -116.51 127.93 54.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -159.82 154.85 24.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.41 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.52 166.07 29.72 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' C' ' 69' ' ' LEU . 13.7 m -112.12 163.7 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.802 0.334 . . . . 0.0 111.339 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.41 179.58 27.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.476 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.49 144.78 11.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.544 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.581 ' CD1' HD22 ' C' ' 36' ' ' LEU . 75.5 t80 -136.91 129.57 30.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.723 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.5 mmm-85 65.58 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -152.22 34.87 0.52 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.16 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -130.93 168.02 18.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -140.73 144.36 35.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.121 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.87 156.27 43.44 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.529 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.55 ' HA ' HG12 ' C' ' 60' ' ' VAL . 6.7 tp -113.23 125.38 54.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -119.54 151.16 39.08 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.695 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' C' ' 58' ' ' ALA . 18.3 tt -145.24 164.27 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.19 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 179.59 175.54 46.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.75 147.77 11.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.967 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.93 163.32 30.43 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.237 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -108.5 120.64 43.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 111.137 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.505 ' CB ' ' HA3' ' C' ' 50' ' ' GLY . 6.6 mmm180 -96.69 92.32 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.675 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.751 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.2 p -96.73 131.87 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 111.332 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.5 m120 64.58 -177.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 111.093 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -116.33 24.21 11.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -127.85 -43.8 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.19 153.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.544 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -156.35 173.47 16.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 111.252 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.08 140.34 7.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.595 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.655 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -140.52 134.27 30.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.9 133.95 14.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.95 170.58 36.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.597 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -117.48 147.42 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.936 0.398 . . . . 0.0 111.096 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.58 ' HB3' ' SD ' ' C' ' 96' ' ' MET . . . -119.35 134.61 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.22 110.89 22.63 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' C' ' 94' ' ' ASP . . . -118.88 136.92 53.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.679 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.593 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 50.61 -112.03 1.45 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.255 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -131.33 -53.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.257 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.2 t -106.32 26.83 9.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.756 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.3 OUTLIER -116.88 81.83 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.93 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.63 139.32 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.737 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' C' ' 88' ' ' ALA . 0.0 OUTLIER -135.34 158.56 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -134.16 133.53 41.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.419 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.5 ' OD1' HD23 ' C' ' 42' ' ' LEU . 33.8 m120 -113.67 161.09 17.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.403 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.6 96.51 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.752 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.503 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 13.8 p -126.05 178.69 5.62 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.413 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.4 137.8 27.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.665 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 69.8 m-80 -103.3 148.86 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.377 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.509 HG13 ' O ' ' B' ' 56' ' ' PHE . 7.4 pt -152.79 146.67 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.784 0.326 . . . . 0.0 110.821 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.683 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 90.1 mt-10 -90.39 131.03 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 1.074 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.9 t-105 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.635 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.669 -0.172 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.549 ' HB2' ' H ' ' A' ' 7' ' ' SER . 86.5 m-20 40.69 -103.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -114.86 -48.64 2.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -177.32 -63.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.044 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.9 t -69.83 -53.52 17.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.727 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 2' ' ' ASP . 75.5 m95 -48.43 -86.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.549 ' H ' ' HB2' ' A' ' 2' ' ' ASP . 19.4 m 65.0 46.66 2.75 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.025 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.742 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 16.6 m170 -73.85 -52.26 4.69 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.747 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.742 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -51.17 116.47 2.69 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.485 2.123 . . . . 0.0 111.889 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 8' ' ' HIS . 12.2 mm100 -128.14 -55.66 1.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.112 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.66 -153.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.687 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.63 -28.2 63.61 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.449 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -138.29 20.65 2.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.49 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.35 -21.0 65.61 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.32 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.7 -44.42 86.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.929 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 30.5 m-70 -71.8 -35.3 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.959 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' O ' HD22 ' A' ' 21' ' ' LEU . 36.1 ttmt -68.3 -47.32 67.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.54 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -38.48 83.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -66.77 -45.68 77.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.818 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -64.23 -40.84 96.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.757 HD21 HD23 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -64.51 -45.27 87.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.51 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.69 -28.39 69.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -74.74 -40.33 61.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HD2' HD13 ' C' ' 25' ' ' LEU . 32.1 mtt180 -70.87 -41.18 71.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.766 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.679 HD21 ' HG ' ' B' ' 25' ' ' LEU . 7.8 mt -62.05 -49.86 74.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.481 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.24 -48.86 79.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 9.0 tmtt? -55.45 -38.02 68.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.168 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -63.4 -40.4 97.11 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.6 91.93 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.98 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.58 HG22 ' HE2' ' A' ' 34' ' ' LYS . 3.9 m -57.74 -48.08 80.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.81 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.559 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 83.9 mmt-85 -57.28 -33.15 67.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 28' ' ' LEU . 44.4 t -76.77 -37.78 28.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 48.2 m-20 -61.95 -54.34 43.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.012 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.998 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 2.5 pttt -75.87 -36.17 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.795 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 -45.49 87.98 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.422 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.703 HD22 ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -68.19 -39.59 82.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.845 0.355 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.73 90.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.4 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.667 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -68.72 -52.66 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.703 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.497 ' HB3' HD21 ' C' ' 36' ' ' LEU . 78.3 p -50.9 -56.42 12.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.43 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -54.81 -48.95 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.436 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.39 -42.19 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.64 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 24.0 tp -73.63 -36.07 65.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.062 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' HB3' ' CB ' ' C' ' 43' ' ' ASN . 54.4 m-20 -78.27 -3.17 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.702 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.4 t -84.31 1.38 45.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.18 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -98.26 174.58 6.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.82 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.34 -3.52 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.142 0.496 . . . . 0.0 111.661 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.555 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 35.8 mt-30 64.27 117.55 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.96 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.278 9.8 Cg_endo -74.46 100.39 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.669 2.246 . . . . 0.0 112.577 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 90.3 m-85 67.61 -167.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 148.26 81.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.203 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' CG ' ' A' ' 79' ' ' GLU . 15.0 p -88.26 -12.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.157 0.583 . . . . 0.0 112.396 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.78 45.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.256 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.56 -168.65 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.585 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.032 HG13 ' O ' ' B' ' 105' ' ' TRP . 2.0 p -109.68 145.95 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.496 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 4.1 m-80 -128.52 135.32 49.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.943 0.402 . . . . 0.0 111.69 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.66 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 45' ' ' LEU . 22.5 p -111.87 124.66 52.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.006 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.455 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -155.35 149.79 26.1 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.478 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.604 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 173.04 165.56 30.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -111.27 165.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 0.0 111.434 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -177.62 27.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.496 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -160.65 144.42 9.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.537 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.703 ' CD1' HD22 ' A' ' 36' ' ' LEU . 65.5 t80 -133.54 133.42 42.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.728 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.51 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 3.1 mmm-85 64.5 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.126 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.47 33.28 0.37 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.161 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.73 168.69 16.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -134.84 140.47 45.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.095 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.32 152.01 48.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.595 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.444 ' HA ' HG12 ' A' ' 60' ' ' VAL . 4.7 tp -111.16 127.46 55.59 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.745 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -122.83 151.87 41.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.669 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.463 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.5 tt -147.78 163.72 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.088 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 175.48 172.65 40.53 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.446 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -162.75 147.24 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.6 161.63 28.69 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.295 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -106.92 119.26 38.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 111.168 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 76' ' ' ARG . 5.0 mmm180 -95.86 101.02 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.711 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 12.6 p -98.62 128.88 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 6.7 m120 65.23 -175.05 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' CG ' HG23 ' A' ' 51' ' ' VAL . 33.4 mt-10 -114.82 25.45 10.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.573 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.964 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.22 151.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -153.42 169.81 22.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.245 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -162.48 141.23 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 1.3 ttmp? -141.42 133.46 27.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.27 135.03 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -159.35 173.86 36.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.581 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.83 144.3 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.453 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -112.92 135.43 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.36 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -111.08 111.07 21.91 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.236 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.998 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -124.01 135.83 53.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.574 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.91 -113.84 4.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.238 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.83 -58.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.526 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.2 t -103.9 28.43 6.68 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.203 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.426 ' CB ' ' HD2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -118.18 82.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.962 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.76 142.81 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' C' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.15 50.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -128.01 129.41 46.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.429 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.5 159.35 22.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.724 0.297 . . . . 0.0 111.393 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.716 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.728 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.7 p -122.86 178.5 5.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 39.3 p90 -142.13 146.04 34.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.95 0.405 . . . . 0.0 111.12 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.5 m-80 -112.88 150.73 31.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.326 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 102' ' ' ASN . 2.9 pt -157.24 152.04 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.777 0.323 . . . . 0.0 110.814 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.424 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 75.8 mt-10 -94.98 129.54 42.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.038 ' O ' HG13 ' C' ' 54' ' ' VAL . 5.9 t-105 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.688 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.652 -0.179 . . . . 0.0 112.652 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.539 ' HB2' ' H ' ' B' ' 7' ' ' SER . 86.3 m-20 40.63 -103.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.899 0.38 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -114.86 -48.7 2.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.813 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -177.35 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.9 t -69.68 -53.53 18.15 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.752 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.41 ' HB2' ' HB2' ' B' ' 2' ' ' ASP . 75.3 m95 -48.53 -86.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.705 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.539 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 19.5 m 64.99 46.71 2.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.013 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.727 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 16.6 m170 -73.72 -52.44 4.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.795 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.727 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -51.03 116.48 2.67 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.481 2.121 . . . . 0.0 111.888 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' B' ' 8' ' ' HIS . 12.2 mm100 -128.14 -55.6 1.27 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.004 0.43 . . . . 0.0 111.171 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.75 -153.51 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.704 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.57 -28.22 63.68 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.44 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -138.28 20.65 2.77 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.535 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.48 -20.95 65.38 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.288 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.38 86.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 0.0 110.861 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' B' ' 20' ' ' GLN . 30.4 m-70 -71.78 -35.32 69.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.025 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.413 ' O ' HD22 ' B' ' 21' ' ' LEU . 36.1 ttmt -68.32 -47.27 67.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.524 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -38.46 83.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.297 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -66.81 -45.67 77.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' B' ' 16' ' ' HIS . 0.8 OUTLIER -64.22 -40.85 96.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.757 HD21 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -64.37 -45.29 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.75 -28.34 69.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.05 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -74.76 -40.32 61.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.478 ' HD2' HD13 ' A' ' 25' ' ' LEU . 32.2 mtt180 -70.9 -41.18 71.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.808 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.679 ' HG ' HD21 ' A' ' 25' ' ' LEU . 7.9 mt -61.96 -49.86 74.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.21 -48.87 79.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 9.0 tmtt? -55.43 -37.93 68.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.292 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.635 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.4 OUTLIER -63.49 -40.3 96.73 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -64.18 -44.62 91.48 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.954 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.59 HG22 ' HE2' ' B' ' 34' ' ' LYS . 3.8 m -57.7 -48.06 80.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.551 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 83.9 mmt-85 -57.18 -33.29 67.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.259 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 28' ' ' LEU . 44.5 t -76.78 -37.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.496 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 48.2 m-20 -62.06 -54.28 43.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.999 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.945 ' HB2' ' HB1' ' B' ' 90' ' ' ALA . 2.6 pttt -75.9 -36.03 59.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.41 87.61 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.717 HD22 ' CD1' ' B' ' 63' ' ' TYR . 0.3 OUTLIER -68.18 -39.65 82.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.75 90.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.414 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.671 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -68.73 -52.7 27.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.746 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.487 ' HB3' HD21 ' A' ' 36' ' ' LEU . 78.3 p -50.88 -56.35 12.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.415 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -54.91 -48.95 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.393 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.43 -42.18 41.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.635 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 23.8 tp -73.62 -36.04 65.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.433 ' CB ' ' HB3' ' C' ' 43' ' ' ASN . 54.4 m-20 -78.35 -3.14 41.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.706 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -84.26 1.29 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.089 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -98.21 174.49 6.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.906 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' B' ' 47' ' ' GLN . 7.4 p90 -165.31 -3.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 111.686 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.573 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.56 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.276 9.9 Cg_endo -74.43 100.38 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.629 2.219 . . . . 0.0 112.608 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 90.2 m-85 67.69 -167.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.405 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 148.2 81.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.228 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.418 HG23 ' CG ' ' B' ' 79' ' ' GLU . 15.0 p -88.28 -12.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.121 0.569 . . . . 0.0 112.402 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.78 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.332 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.77 2.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.637 0.256 . . . . 0.0 110.6 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 1.03 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.1 p -109.64 145.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.589 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 4.1 m-80 -128.47 135.31 49.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.648 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.63 122.65 44.26 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.313 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.487 ' HB ' ' CG ' ' B' ' 45' ' ' LEU . 22.4 p -112.01 124.65 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.932 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -155.3 149.84 26.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.611 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 172.97 165.52 30.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' B' ' 69' ' ' LEU . 6.9 m -111.31 165.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.05 -177.63 27.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -160.67 144.4 9.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.717 ' CD1' HD22 ' B' ' 36' ' ' LEU . 65.8 t80 -133.53 133.49 42.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 110.776 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.507 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 3.1 mmm-85 64.46 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 14.0 t -155.43 33.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.75 168.7 16.14 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -134.71 140.54 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.135 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.99 48.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.572 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.445 ' HA ' HG12 ' B' ' 60' ' ' VAL . 4.6 tp -111.18 127.35 55.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -122.76 151.89 41.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.726 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.458 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.4 tt -147.72 163.74 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.12 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 175.47 172.62 40.5 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.466 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 17.9 p -162.8 147.17 11.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.374 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.63 161.64 28.7 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.265 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -106.85 119.21 38.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 111.146 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.405 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 5.0 mmm180 -95.85 101.08 12.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.698 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' B' ' 78' ' ' ASN . 12.7 p -98.66 128.86 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.269 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 6.8 m120 65.2 -174.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.418 ' CG ' HG23 ' B' ' 51' ' ' VAL . 33.5 mt-10 -114.88 25.5 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.559 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.23 -46.38 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.27 151.12 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -153.43 169.8 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.235 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' B' ' 101' ' ' PHE . 0.6 OUTLIER -162.53 141.22 8.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.553 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.573 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.55 27.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.36 135.1 19.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -159.39 173.9 36.23 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.562 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.87 144.31 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.38 . . . . 0.0 111.148 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.459 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -112.85 135.38 53.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.313 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -111.12 111.02 21.81 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.3 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.945 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -123.92 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.581 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.573 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.84 -113.87 4.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 -58.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 111.293 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . 0.526 ' OG ' ' O ' ' B' ' 93' ' ' SER . 2.2 t -103.86 28.36 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.153 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.427 ' CB ' ' HD2' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -118.22 82.86 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.81 142.8 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.724 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -136.82 153.09 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -127.94 129.35 46.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.48 159.3 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.3 98.47 0.35 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.761 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.74 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.8 p -122.8 178.56 4.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 39.3 p90 -142.22 146.07 34.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.642 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.5 m-80 -112.88 150.7 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.409 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.461 HG23 ' O ' ' B' ' 102' ' ' ASN . 2.9 pt -157.25 152.02 7.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 110.757 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 75.9 mt-10 -94.97 129.52 41.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.977 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 1.032 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 t-105 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.671 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.646 -0.181 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . 0.549 ' HB2' ' H ' ' C' ' 7' ' ' SER . 86.4 m-20 40.58 -103.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -114.92 -48.61 2.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -177.34 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.019 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 13.9 t -69.8 -53.48 18.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.743 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . 0.408 ' HB2' ' HB2' ' C' ' 2' ' ' ASP . 75.5 m95 -48.5 -86.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.644 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.549 ' H ' ' HB2' ' C' ' 2' ' ' ASP . 19.5 m 65.07 46.65 2.71 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.029 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.736 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 16.4 m170 -73.83 -52.28 4.7 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.77 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.736 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.3 Cg_exo -50.97 116.45 2.64 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.486 2.124 . . . . 0.0 111.933 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' C' ' 8' ' ' HIS . 12.2 mm100 -128.21 -55.54 1.26 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.943 0.402 . . . . 0.0 111.155 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -125.72 -153.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.732 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.65 -28.18 63.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.41 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -138.3 20.66 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.516 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.39 -21.03 65.42 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.303 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -44.41 86.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 110.94 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' C' ' 20' ' ' GLN . 30.5 m-70 -71.74 -35.37 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.954 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.402 ' O ' HD22 ' C' ' 21' ' ' LEU . 36.1 ttmt -68.32 -47.29 67.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.544 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.71 -38.51 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.272 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -66.77 -45.71 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' C' ' 16' ' ' HIS . 0.8 OUTLIER -64.29 -40.79 96.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.757 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -64.45 -45.25 88.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.609 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.74 -28.34 69.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -74.78 -40.31 61.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.493 ' HD2' HD13 ' B' ' 25' ' ' LEU . 32.2 mtt180 -70.91 -41.13 71.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.819 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.669 HD21 ' HG ' ' A' ' 25' ' ' LEU . 7.9 mt -62.08 -49.72 74.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.656 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -61.37 -48.81 79.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.758 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 9.0 tmtt? -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.62 0.248 . . . . 0.0 111.286 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.645 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.4 OUTLIER -63.41 -40.42 97.16 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -64.06 -44.69 91.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.954 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.577 HG22 ' HE2' ' C' ' 34' ' ' LYS . 3.8 m -57.6 -48.08 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.908 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.541 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 83.8 mmt-85 -57.28 -33.23 67.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.645 HG23 ' O ' ' C' ' 28' ' ' LEU . 44.4 t -76.78 -37.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.5 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 48.4 m-20 -61.92 -54.42 42.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.972 ' HB2' ' HB1' ' C' ' 90' ' ' ALA . 2.5 pttt -75.85 -36.08 59.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.798 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.37 88.16 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.708 HD22 ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -68.27 -39.64 82.12 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 111.012 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.8 91.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.655 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -68.68 -52.76 27.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.722 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.495 ' HB3' HD21 ' B' ' 36' ' ' LEU . 78.2 p -50.83 -56.41 12.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.426 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -54.83 -48.97 72.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.418 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.38 -42.12 41.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.96 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.619 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 24.0 tp -73.73 -35.95 65.13 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.074 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 54.5 m-20 -78.3 -3.2 41.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . 0.69 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.4 t -84.23 1.24 45.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.129 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -98.18 174.53 6.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.901 178.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.32 -3.55 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.553 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 35.8 mt-30 64.24 117.65 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.948 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.279 9.9 Cg_endo -74.46 100.41 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.696 2.264 . . . . 0.0 112.552 -179.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 90.3 m-85 67.59 -167.18 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 148.23 81.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.255 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.418 HG23 ' CG ' ' C' ' 79' ' ' GLU . 15.0 p -88.19 -13.03 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.143 0.577 . . . . 0.0 112.381 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.85 45.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -143.6 -168.72 2.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.603 0.24 . . . . 0.0 110.584 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 1.038 HG13 ' O ' ' A' ' 105' ' ' TRP . 2.1 p -109.67 145.88 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.509 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.424 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 4.1 m-80 -128.44 135.31 49.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.666 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.64 122.62 44.22 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.223 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.479 ' HB ' ' CG ' ' C' ' 45' ' ' LEU . 22.5 p -111.9 124.58 52.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.989 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.441 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -155.26 149.91 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.483 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.602 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 172.98 165.53 30.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' C' ' 69' ' ' LEU . 6.9 m -111.27 165.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.391 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.95 -177.59 27.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.465 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -160.68 144.36 9.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.708 ' CD1' HD22 ' C' ' 36' ' ' LEU . 65.5 t80 -133.5 133.45 42.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.729 0.299 . . . . 0.0 110.775 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.518 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm-85 64.45 -81.11 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.023 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 33.29 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -129.78 168.71 16.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.808 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -134.77 140.53 45.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.37 151.93 47.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.56 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.446 ' HA ' HG12 ' C' ' 60' ' ' VAL . 4.7 tp -111.07 127.43 55.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.787 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -122.8 151.89 41.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.452 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.6 tt -147.83 163.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 0.0 111.116 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 175.51 172.7 40.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.8 p -162.86 147.25 11.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.39 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.67 161.6 28.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.245 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -106.88 119.23 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.142 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' C' ' 76' ' ' ARG . 5.0 mmm180 -95.8 100.95 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.737 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' C' ' 78' ' ' ASN . 12.7 p -98.55 128.86 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.272 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 6.8 m120 65.27 -175.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . 0.418 ' CG ' HG23 ' C' ' 51' ' ' VAL . 33.5 mt-10 -114.86 25.42 10.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.582 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -128.16 -46.37 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.21 151.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.514 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -153.45 169.75 22.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' C' ' 101' ' ' PHE . 0.6 OUTLIER -162.41 141.22 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.553 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 1.3 ttmp? -141.39 133.63 27.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.163 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.42 135.06 19.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.104 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -159.36 173.89 36.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.587 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.92 144.29 32.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.458 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -112.92 135.34 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.311 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -111.04 111.02 21.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.23 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.972 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -123.91 135.88 53.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.605 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.597 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.86 -113.85 4.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.298 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -131.79 -58.1 0.98 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.778 0.323 . . . . 0.0 111.32 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . 0.513 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.2 t -103.85 28.38 6.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.161 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -118.23 82.82 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.8 142.81 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.708 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' B' ' 62' ' ' GLY . 0.8 OUTLIER -136.86 153.15 50.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.72 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -128.01 129.42 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -117.51 159.31 23.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.447 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.29 98.55 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.73 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.6 p -122.92 178.6 4.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' C' ' 83' ' ' LEU . 39.6 p90 -142.18 146.07 34.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 111.128 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.639 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.5 m-80 -112.85 150.64 31.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.397 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.452 HG23 ' O ' ' C' ' 102' ' ' ASN . 2.9 pt -157.2 152.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.774 0.321 . . . . 0.0 110.841 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 75.6 mt-10 -94.95 129.48 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 1.03 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.8 t-105 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.706 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 112.634 -0.186 . . . . 0.0 112.634 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' A' ' 7' ' ' SER . 87.2 m-20 37.38 -100.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.889 0.376 . . . . 0.0 110.965 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -112.48 -52.32 2.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.864 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 179.11 -61.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.4 t -72.82 -49.5 29.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.753 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -52.28 -89.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.713 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 2' ' ' ASP . 56.6 m 61.86 52.94 3.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.964 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.871 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 33.6 m170 -74.96 -54.32 2.68 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.873 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -59.77 123.48 13.37 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.476 2.117 . . . . 0.0 111.915 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.502 ' HG3' ' HE3' ' B' ' 17' ' ' LYS . 14.5 mm-40 -127.18 -51.55 1.41 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.012 0.434 . . . . 0.0 111.15 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -126.6 -157.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.757 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -66.33 -33.17 75.13 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.433 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -132.2 15.9 4.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.527 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.98 -24.39 59.9 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.251 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.34 93.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.892 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 18.3 m-70 -72.23 -30.54 64.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.949 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.515 ' CE ' ' HG3' ' C' ' 10' ' ' GLN . 36.4 ttmt -68.97 -46.6 67.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.518 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -35.45 75.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.309 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.07 -44.07 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -64.55 -46.86 81.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.092 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.06 -36.81 84.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.58 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.17 -35.91 82.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.031 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.82 -42.21 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.602 ' HD2' HD13 ' C' ' 25' ' ' LEU . 28.2 mtt180 -62.71 -38.13 89.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.747 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.614 HD13 ' HD2' ' B' ' 24' ' ' ARG . 12.7 mt -67.35 -53.98 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.95 -47.61 77.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.822 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.88 -44.78 94.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.173 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' C' ' 29' ' ' ASP . 0.6 OUTLIER -58.09 -42.68 86.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.619 ' HA ' HD21 ' B' ' 28' ' ' LEU . 39.9 t0 -64.65 -40.7 95.9 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.983 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.404 HG22 ' HE2' ' A' ' 34' ' ' LYS . 10.2 m -61.66 -44.42 96.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.801 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 88.4 mmt-85 -57.07 -37.74 72.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.7 HG22 HG11 ' C' ' 32' ' ' VAL . 10.0 t -73.27 -29.53 28.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.153 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.571 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 63.6 m-20 -67.95 -62.73 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.037 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.672 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -66.53 -44.64 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.771 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.87 -46.17 77.46 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.374 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -68.02 -34.18 76.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.852 0.358 . . . . 0.0 111.147 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.31 -45.71 83.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.461 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.813 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -67.56 -54.48 19.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.764 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.8 p -49.44 -55.06 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.414 ' CB ' HD21 ' B' ' 43' ' ' ASN . . . -57.12 -46.13 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.427 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.27 58.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 45' ' ' LEU . 43.1 tp -80.96 -36.79 30.43 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.418 HD21 ' CB ' ' C' ' 40' ' ' ALA . 84.4 m-20 -74.01 -3.24 28.04 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.418 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 6.1 t -88.62 -7.52 56.25 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.14 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.5 OUTLIER -90.72 165.75 13.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.856 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.77 -2.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.14 0.495 . . . . 0.0 111.703 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 40.0 mt-30 67.12 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.907 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 47' ' ' GLN 0.406 9.9 Cg_endo -69.59 99.36 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.673 2.249 . . . . 0.0 112.524 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 60.78 -160.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 149.42 83.44 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.29 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.532 HG23 ' CG ' ' A' ' 79' ' ' GLU . 9.5 p -90.06 -15.51 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.234 0.614 . . . . 0.0 112.45 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 161.71 48.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.267 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.89 -170.25 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.625 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.036 HG13 ' O ' ' B' ' 105' ' ' TRP . 2.7 p -108.85 141.01 25.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.58 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' A' ' 48' ' ' PRO . 3.2 m-80 -125.37 133.96 52.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.53 45.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.246 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 47' ' ' GLN . 24.4 p -114.93 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.06 146.87 22.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.461 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 176.05 163.05 28.03 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.543 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 69' ' ' LEU . 6.3 m -105.7 167.15 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.23 27.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.522 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.67 141.31 7.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.542 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.574 ' HA ' ' HB2' ' B' ' 96' ' ' MET . 72.4 t80 -129.39 139.24 51.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.725 0.298 . . . . 0.0 110.786 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.46 HH11 ' HD3' ' A' ' 64' ' ' ARG . 3.0 mmm180 61.2 -81.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.045 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 t -155.96 35.57 0.34 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.1 m -133.06 166.85 21.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.39 142.83 47.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.49 44.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.565 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' HG12 ' A' ' 60' ' ' VAL . 9.1 tp -110.93 131.25 55.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.717 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -126.26 154.3 43.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.728 0.299 . . . . 0.0 111.613 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.449 HG12 ' N ' ' A' ' 72' ' ' GLY . 20.4 tt -147.76 162.9 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.76 0.314 . . . . 0.0 111.126 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.449 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 178.58 169.73 39.7 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.411 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -161.94 142.45 10.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.966 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.15 160.95 27.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.201 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.495 ' H ' HD11 ' A' ' 83' ' ' LEU . 25.5 t80 -106.59 116.2 31.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 111.133 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.487 HH11 ' HB2' ' A' ' 82' ' ' ALA . 5.2 mmm180 -93.87 93.22 7.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.509 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 8.7 p -93.88 126.04 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 12.2 m120 68.98 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.532 ' CG ' HG23 ' A' ' 51' ' ' VAL . 26.8 mt-10 -120.02 24.94 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.618 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 6.8 t -126.06 -39.4 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.982 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.06 152.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.504 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -149.05 174.53 12.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.226 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.495 HD11 ' H ' ' A' ' 75' ' ' TYR . 1.4 pp -163.88 143.63 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.44 ' HE3' HE21 ' A' ' 47' ' ' GLN . 2.2 ttmp? -146.7 128.19 15.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.55 135.64 15.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' HA3' ' CA ' ' A' ' 72' ' ' GLY . . . -161.34 178.52 37.23 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.546 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.21 140.54 41.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 111.14 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.571 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -112.57 131.68 55.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.79 112.04 24.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.221 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -124.96 131.24 53.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.616 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.668 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.05 -116.06 6.36 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.92 -61.22 1.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.303 . . . . 0.0 111.327 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 93' ' ' SER . 3.1 t -100.21 28.98 4.55 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.195 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.76 136.09 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.585 ' HB2' ' HA ' ' C' ' 63' ' ' TYR . 1.1 ptp -131.35 150.11 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.647 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -123.06 134.02 54.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.456 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.95 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.72 0.295 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.21 91.68 0.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.811 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.858 ' HB2' HD11 ' C' ' 45' ' ' LEU . 21.8 p -119.9 177.78 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.417 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -139.52 144.42 37.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.968 0.413 . . . . 0.0 111.068 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.954 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.0 m-80 -112.95 143.51 44.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.368 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.63 151.17 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.0 110.777 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.618 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 55.5 mt-10 -92.27 128.21 38.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.054 ' O ' HG13 ' C' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' B' ' 7' ' ' SER . 87.1 m-20 37.38 -100.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.954 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' B' ' 4' ' ' ALA . 59.2 mt-30 -112.48 -52.31 2.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' B' ' 3' ' ' GLN . . . 179.1 -61.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.028 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.3 t -72.81 -49.48 30.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.715 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -52.34 -89.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.704 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.414 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 55.7 m 61.85 52.92 3.27 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.033 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.871 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 33.6 m170 -74.93 -54.44 2.68 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.819 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -59.69 123.42 13.26 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.554 2.169 . . . . 0.0 111.933 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.51 ' HG3' ' HE3' ' C' ' 17' ' ' LYS . 14.5 mm-40 -127.19 -51.39 1.42 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.911 0.386 . . . . 0.0 111.149 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -126.83 -157.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.669 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -66.27 -33.21 75.24 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.458 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -132.26 16.11 4.56 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.513 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.11 -24.39 59.63 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.216 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.41 92.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 0.0 110.875 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' B' ' 20' ' ' GLN . 17.8 m-70 -72.09 -30.64 65.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.004 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.502 ' HE3' ' HG3' ' A' ' 10' ' ' GLN . 36.5 ttmt -68.91 -46.63 67.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.595 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.276 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -70.03 -44.16 69.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.772 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' B' ' 16' ' ' HIS . 0.9 OUTLIER -64.45 -46.87 81.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.125 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -63.13 -36.73 84.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.523 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.24 -35.81 82.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.87 -42.22 63.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.791 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.614 ' HD2' HD13 ' A' ' 25' ' ' LEU . 28.1 mtt180 -62.71 -38.09 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.608 HD13 ' HD2' ' C' ' 24' ' ' ARG . 12.7 mt -67.33 -54.1 23.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.86 -47.73 76.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.79 -44.77 93.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.249 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -57.95 -42.74 85.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.604 ' HA ' HD21 ' C' ' 28' ' ' LEU . 40.1 t0 -64.82 -40.59 95.45 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.932 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.408 HG22 ' HE2' ' B' ' 34' ' ' LYS . 10.0 m -61.62 -44.4 97.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.816 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.498 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 88.4 mmt-85 -57.27 -37.72 72.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.696 HG22 HG11 ' A' ' 32' ' ' VAL . 9.8 t -73.21 -29.49 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.566 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 63.6 m-20 -67.97 -62.74 1.27 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.681 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 0.5 OUTLIER -66.56 -44.59 81.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.89 -46.11 77.87 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.391 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.2 OUTLIER -68.08 -34.19 75.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.751 0.31 . . . . 0.0 111.055 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.71 83.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.804 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -67.54 -54.46 19.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.791 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.406 ' HB3' ' SD ' ' B' ' 96' ' ' MET . 47.5 p -49.47 -55.06 14.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.41 ' CB ' HD21 ' C' ' 43' ' ' ASN . . . -57.13 -46.11 82.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.403 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.24 58.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.616 HD12 HD23 ' B' ' 45' ' ' LEU . 42.7 tp -81.05 -36.75 30.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.414 HD21 ' CB ' ' A' ' 40' ' ' ALA . 84.3 m-20 -74.02 -3.17 27.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 6.1 t -88.65 -7.59 56.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.105 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.859 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.5 OUTLIER -90.62 165.74 13.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.882 177.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 8.6 p90 -154.84 -2.91 0.16 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.102 0.477 . . . . 0.0 111.609 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.437 ' HG2' HG23 ' B' ' 57' ' ' THR . 39.9 mt-30 66.99 122.75 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.993 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.44 ' HD2' ' OD1' ' B' ' 55' ' ' ASN 0.405 9.9 Cg_endo -69.6 99.41 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.685 2.257 . . . . 0.0 112.518 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 60.73 -159.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.976 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 149.27 83.48 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.309 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.527 HG23 ' CG ' ' B' ' 79' ' ' GLU . 9.6 p -90.06 -15.5 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.148 0.579 . . . . 0.0 112.495 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 161.71 48.47 0.02 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.27 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.83 -170.11 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.579 0.228 . . . . 0.0 110.614 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 1.026 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.7 p -108.97 141.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.608 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.44 ' OD1' ' HD2' ' B' ' 48' ' ' PRO . 3.2 m-80 -125.34 133.84 52.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 111.702 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.77 124.54 45.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.243 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.437 HG23 ' HG2' ' B' ' 47' ' ' GLN . 24.4 p -114.93 125.48 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.03 146.93 22.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.431 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.512 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 175.99 163.0 27.92 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.545 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' B' ' 69' ' ' LEU . 6.3 m -105.68 167.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 111.36 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.94 -176.23 27.84 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.71 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.58 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.6 ' HA ' ' HB2' ' C' ' 96' ' ' MET . 72.5 t80 -129.35 139.27 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.658 0.266 . . . . 0.0 110.761 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' B' ' 64' ' ' ARG . 3.0 mmm180 61.13 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.08 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 63' ' ' TYR . 8.0 t -155.88 35.51 0.35 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.17 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.9 m -133.15 166.73 21.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -134.29 142.91 47.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.045 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.96 156.47 44.88 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' B' ' 60' ' ' VAL . 9.2 tp -110.97 131.31 55.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.725 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -126.15 154.24 43.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.691 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.449 HG12 ' N ' ' B' ' 72' ' ' GLY . 20.4 tt -147.75 162.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.722 0.296 . . . . 0.0 111.186 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.449 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 178.56 169.66 39.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.45 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.47 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.16 160.87 27.88 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.248 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.506 ' H ' HD11 ' B' ' 83' ' ' LEU . 25.3 t80 -106.53 116.19 31.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.162 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.496 HH11 ' HB2' ' B' ' 82' ' ' ALA . 5.2 mmm180 -93.83 93.18 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' B' ' 78' ' ' ASN . 8.7 p -93.89 126.06 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.311 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' B' ' 77' ' ' VAL . 12.1 m120 69.04 -172.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.527 ' CG ' HG23 ' B' ' 51' ' ' VAL . 26.8 mt-10 -120.03 24.9 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.619 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 6.8 t -126.0 -39.5 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -114.99 152.54 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.963 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -149.0 174.61 12.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.286 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.506 HD11 ' H ' ' B' ' 75' ' ' TYR . 1.4 pp -163.84 143.7 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.617 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.429 ' HE3' HE21 ' B' ' 47' ' ' GLN . 2.2 ttmp? -146.77 128.1 14.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.43 135.65 15.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' CA ' ' B' ' 72' ' ' GLY . . . -161.32 178.5 37.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.603 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.18 140.58 41.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.905 0.383 . . . . 0.0 111.123 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.572 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -112.55 131.7 55.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.355 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.8 111.96 24.84 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.278 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -124.91 131.29 53.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.612 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.681 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.0 -116.11 6.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.224 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -127.92 -61.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.313 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.0 t -100.27 29.04 4.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.157 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -118.35 83.08 1.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.8 136.05 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' TYR . 1.1 ptp -131.34 150.14 52.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -123.17 134.01 54.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.375 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -117.06 157.98 24.94 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.389 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.82 0.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.721 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.856 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.7 p -120.0 177.78 4.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.429 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -139.55 144.38 37.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.092 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.963 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.1 m-80 -112.92 143.6 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.353 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.72 151.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.619 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 55.4 mt-10 -92.3 128.13 38.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 1.036 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.678 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.659 -0.177 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' C' ' 7' ' ' SER . 87.2 m-20 37.39 -100.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.87 0.367 . . . . 0.0 110.964 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -112.45 -52.28 2.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 179.08 -61.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -72.83 -49.51 29.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -52.34 -89.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.673 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.409 ' H ' ' HB2' ' C' ' 2' ' ' ASP . 56.7 m 61.94 52.94 3.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.965 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.848 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 33.6 m170 -74.97 -54.38 2.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.822 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.848 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -59.74 123.39 13.19 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.458 2.106 . . . . 0.0 111.984 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . 0.515 ' HG3' ' CE ' ' A' ' 17' ' ' LYS . 14.5 mm-40 -127.13 -51.37 1.42 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.951 0.405 . . . . 0.0 111.208 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -126.79 -157.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.671 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' C' ' 12' ' ' GLU . 5.2 mt-10 -66.27 -33.16 75.12 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.494 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -132.32 16.03 4.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.519 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.0 -24.4 59.82 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.229 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.47 92.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.835 0.35 . . . . 0.0 110.914 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' C' ' 20' ' ' GLN . 18.1 m-70 -72.04 -30.57 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.979 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.51 ' HE3' ' HG3' ' B' ' 10' ' ' GLN . 36.4 ttmt -68.99 -46.6 67.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.44 -35.48 75.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.249 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -70.03 -44.13 69.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.798 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' C' ' 16' ' ' HIS . 0.9 OUTLIER -64.41 -46.91 81.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' C' ' 21' ' ' LEU . 0.0 OUTLIER -63.06 -36.82 84.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.589 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.11 -35.96 82.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.001 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -72.81 -42.19 64.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.608 ' HD2' HD13 ' B' ' 25' ' ' LEU . 28.1 mtt180 -62.72 -38.09 89.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.788 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.602 HD13 ' HD2' ' A' ' 24' ' ' ARG . 12.6 mt -67.34 -54.03 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -55.92 -47.74 76.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.813 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.75 -44.8 93.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.191 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.604 HD21 ' HA ' ' B' ' 29' ' ' ASP . 0.6 OUTLIER -58.03 -42.63 85.73 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . 0.612 ' HA ' HD21 ' A' ' 28' ' ' LEU . 40.1 t0 -64.85 -40.57 95.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.949 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.405 HG22 ' HE2' ' C' ' 34' ' ' LYS . 10.2 m -61.69 -44.39 97.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.789 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.495 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 88.2 mmt-85 -57.2 -37.65 72.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.7 HG11 HG22 ' A' ' 32' ' ' VAL . 9.9 t -73.25 -29.6 28.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.118 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.572 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 63.6 m-20 -67.92 -62.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.023 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 0.5 OUTLIER -66.51 -44.61 82.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.804 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.86 -46.17 77.38 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.2 OUTLIER -68.07 -34.11 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.65 82.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.82 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -67.53 -54.48 19.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.406 ' HB3' ' SD ' ' C' ' 96' ' ' MET . 47.6 p -49.45 -55.06 14.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.418 ' CB ' HD21 ' A' ' 43' ' ' ASN . . . -57.1 -46.09 82.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.515 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.89 -39.18 58.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.608 HD12 HD23 ' C' ' 45' ' ' LEU . 42.9 tp -81.08 -36.66 30.15 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.41 HD21 ' CB ' ' B' ' 40' ' ' ALA . 84.5 m-20 -74.04 -3.24 28.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -88.62 -7.6 56.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.081 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.5 OUTLIER -90.58 165.75 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.924 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.83 -3.0 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.105 0.479 . . . . 0.0 111.649 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.448 HE21 ' HE3' ' C' ' 84' ' ' LYS . 40.0 mt-30 67.04 122.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.937 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' OD1' ' C' ' 55' ' ' ASN 0.406 9.8 Cg_endo -69.53 99.34 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.632 2.222 . . . . 0.0 112.556 -179.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 60.84 -160.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 149.36 83.55 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.198 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.522 HG23 ' CG ' ' C' ' 79' ' ' GLU . 9.5 p -90.14 -15.52 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.217 0.607 . . . . 0.0 112.393 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 161.73 48.48 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.305 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -147.88 -170.15 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.675 0.274 . . . . 0.0 110.549 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 1.054 HG13 ' O ' ' A' ' 105' ' ' TRP . 2.7 p -108.94 141.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.613 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.428 ' OD1' ' HD2' ' C' ' 48' ' ' PRO . 3.2 m-80 -125.42 133.92 52.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.015 0.435 . . . . 0.0 111.661 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 124.46 45.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.204 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.447 HG23 ' HG2' ' C' ' 47' ' ' GLN . 24.3 p -114.9 125.51 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.903 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.94 146.92 22.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 175.97 163.05 27.99 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.565 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' C' ' 69' ' ' LEU . 6.2 m -105.76 167.21 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 111.226 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.04 -176.25 27.96 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.503 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.69 141.26 7.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.568 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 96' ' ' MET . 72.2 t80 -129.35 139.31 51.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.698 0.285 . . . . 0.0 110.729 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.446 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 3.1 mmm180 61.09 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.094 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . 0.4 ' N ' ' O ' ' C' ' 63' ' ' TYR . 8.0 t -155.91 35.41 0.35 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 7.0 m -132.99 166.83 21.48 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -134.36 142.8 47.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.89 156.51 44.93 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' C' ' 60' ' ' VAL . 9.4 tp -110.95 131.22 55.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -126.15 154.31 43.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.704 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.448 HG12 ' N ' ' C' ' 72' ' ' GLY . 20.4 tt -147.73 162.89 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.749 0.309 . . . . 0.0 111.137 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.448 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 178.52 169.67 39.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.431 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -161.88 142.46 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.05 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.12 160.92 27.88 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.246 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.507 ' H ' HD11 ' C' ' 83' ' ' LEU . 25.4 t80 -106.59 116.23 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.166 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.476 HH11 ' HB2' ' C' ' 82' ' ' ALA . 5.2 mmm180 -93.85 93.16 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' C' ' 78' ' ' ASN . 8.7 p -93.87 126.11 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.273 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 12.2 m120 68.89 -171.96 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.921 0.391 . . . . 0.0 111.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . 0.522 ' CG ' HG23 ' C' ' 51' ' ' VAL . 26.3 mt-10 -119.98 24.87 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.616 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . 0.615 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 6.8 t -126.06 -39.36 2.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.994 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.01 152.61 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.971 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -149.05 174.63 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.278 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.507 HD11 ' H ' ' C' ' 75' ' ' TYR . 1.4 pp -163.84 143.74 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.448 ' HE3' HE21 ' C' ' 47' ' ' GLN . 2.2 ttmp? -146.82 128.16 14.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.48 135.66 15.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.412 ' HA3' ' CA ' ' C' ' 72' ' ' GLY . . . -161.36 178.57 37.22 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.556 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.25 140.64 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.872 0.367 . . . . 0.0 111.088 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.572 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -112.6 131.65 55.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.323 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -105.77 112.05 24.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.292 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.82 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -125.01 131.23 53.44 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.579 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.695 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.09 -116.15 6.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.235 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 20.8 m -127.86 -61.25 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.717 0.294 . . . . 0.0 111.299 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . 0.486 ' O ' ' OG ' ' C' ' 93' ' ' SER . 3.1 t -100.19 28.98 4.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.193 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -118.36 83.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 t -118.82 136.05 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.0 110.706 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.6 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 1.1 ptp -131.31 150.07 52.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -123.08 133.96 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.365 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -116.96 157.96 24.88 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.705 0.288 . . . . 0.0 111.471 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.22 91.72 0.12 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.771 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.859 ' HB2' HD11 ' B' ' 45' ' ' LEU . 21.6 p -119.91 177.82 4.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.432 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -139.58 144.48 37.8 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.028 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.971 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.0 m-80 -112.96 143.57 44.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.332 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 2.0 pt -152.7 151.19 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.866 0.365 . . . . 0.0 110.77 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.615 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 55.5 mt-10 -92.33 128.2 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 1.026 ' O ' HG13 ' B' ' 54' ' ' VAL . 2.8 t-105 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.696 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.681 -0.167 . . . . 0.0 112.681 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 7' ' ' SER . 71.6 m-20 37.93 -106.92 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.42 . . . . 0.0 110.91 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.591 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 43.9 mt-30 -108.29 -45.14 3.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . 167.7 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.055 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.0 t -68.42 -52.49 32.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.787 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -60.91 -78.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.704 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.466 ' H ' ' HB2' ' A' ' 2' ' ' ASP . 66.7 m 54.86 56.4 6.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.02 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.669 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 39.6 m80 -78.12 -48.16 2.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.753 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.669 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -55.97 122.21 11.35 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.49 2.127 . . . . 0.0 111.853 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 8' ' ' HIS . 12.7 mm-40 -130.8 -51.98 1.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.934 0.397 . . . . 0.0 111.103 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -130.38 -158.62 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.676 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 mt-10 -64.71 -29.0 69.97 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.506 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -135.57 20.87 3.35 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.529 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.16 -18.66 58.85 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.246 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . -72.04 -45.96 58.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 110.915 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -76.11 -26.07 56.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.963 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -74.27 -47.95 31.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -72.49 -34.87 67.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.215 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 18.6 mtt85 -65.97 -40.06 90.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.85 -44.91 63.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 111.134 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.853 HD23 HD21 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.61 -37.96 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.591 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.75 -31.13 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.038 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.07 -39.6 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.65 -37.56 67.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.782 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.3 mt -68.96 -42.7 76.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.648 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.22 -38.81 92.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.74 74.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.636 0.255 . . . . 0.0 111.181 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' C' ' 28' ' ' LEU . 0.5 OUTLIER -59.9 -43.73 94.67 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -59.8 -40.5 88.59 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.951 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 34' ' ' LYS . 26.0 m -66.67 -41.38 88.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.804 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.337 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 28' ' ' LEU . 3.0 t -76.09 -32.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.224 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.701 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 70.4 m-20 -65.56 -63.89 0.99 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.121 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.71 -34.54 62.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.773 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.45 78.44 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.446 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -72.53 -27.31 62.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 111.073 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.61 55.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.399 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -68.83 -41.58 78.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.9 ' HB3' HD21 ' C' ' 36' ' ' LEU . 31.5 p -55.84 -58.98 5.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.446 ' HB3' HD21 ' B' ' 98' ' ' ASN . . . -55.85 -39.54 71.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.444 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -60.73 -37.44 81.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.968 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 tp -75.16 -37.33 61.34 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.5 m-20 -76.45 -5.84 49.14 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.519 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.2 t -79.24 -11.23 59.95 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.125 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.754 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -84.2 177.57 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.874 177.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.651 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.5 p90 -169.53 -15.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.144 0.497 . . . . 0.0 111.705 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.762 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 40.8 mt-30 81.17 114.64 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.95 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.46 99.43 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.654 2.236 . . . . 0.0 112.558 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 62.24 -160.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.985 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 144.54 93.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.22 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 7.5 p -88.85 -27.1 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.126 0.57 . . . . 0.0 112.444 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 172.25 34.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.269 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.71 -165.43 1.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 110.605 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' O ' ' B' ' 105' ' ' TRP . 8.9 p -110.27 141.33 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.508 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.561 ' OD1' ' HG2' ' B' ' 104' ' ' GLU . 6.7 m-80 -120.05 135.84 54.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.977 0.417 . . . . 0.0 111.669 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.578 ' HB2' ' HB2' ' B' ' 105' ' ' TRP . 2.2 t80 -99.85 128.52 45.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.27 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.754 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 42.7 p -117.64 131.44 56.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.79 143.39 9.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.485 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 178.77 165.5 33.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 69' ' ' LEU . 10.9 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.876 0.369 . . . . 0.0 111.345 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -155.5 -174.91 25.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.415 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.38 144.52 9.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.701 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 87.7 t80 -130.49 127.74 39.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.773 0.321 . . . . 0.0 110.69 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 6.9 mmm-85 66.35 -86.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.15 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.76 30.33 0.99 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.152 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.48 159.45 41.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.094 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.52 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.543 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' VAL . 8.0 tp -115.1 137.33 52.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.768 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.677 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.81 158.39 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 111.119 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 177.44 173.2 42.72 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.45 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.19 142.86 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.21 156.5 26.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.226 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -105.11 116.1 31.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 111.101 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.502 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 9.6 mmm180 -95.98 89.11 5.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.752 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.702 HG22 ' OD1' ' A' ' 78' ' ' ASN . 7.7 p -95.73 123.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.302 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.702 ' OD1' HG22 ' A' ' 77' ' ' VAL . 19.9 m120 64.15 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.147 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -99.74 32.06 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.603 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.488 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 t -131.74 -37.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.521 HG13 HG13 ' A' ' 77' ' ' VAL . 13.6 p -118.74 148.81 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -150.69 171.24 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.252 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.07 148.67 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.611 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.762 ' HE3' ' HG3' ' A' ' 47' ' ' GLN . 3.3 ttmp? -146.35 131.77 18.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.182 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.67 12.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . -157.99 171.16 34.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.619 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.16 139.29 47.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.87 0.367 . . . . 0.0 111.093 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.32 132.22 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.77 121.52 41.83 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -130.1 124.34 32.53 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.589 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 61.93 -110.66 3.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.345 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -132.1 -63.34 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -99.05 24.64 7.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.136 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -116.4 85.14 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.943 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.76 137.55 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.484 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -129.64 158.12 40.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.713 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -133.84 137.52 45.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.451 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.463 HD21 ' HB3' ' C' ' 40' ' ' ALA . 34.6 m120 -125.63 152.26 45.42 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.745 0.307 . . . . 0.0 111.437 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.76 92.82 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.773 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.562 ' HB2' HD11 ' C' ' 45' ' ' LEU . 79.0 p -115.73 -177.57 3.18 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.41 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.45 140.52 22.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.945 0.403 . . . . 0.0 111.088 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.756 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 66.3 m-80 -112.28 144.01 42.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.435 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.419 ' CG2' HG23 ' A' ' 81' ' ' VAL . 4.1 pt -154.98 135.07 4.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 110.766 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.56 ' HG2' ' OD1' ' C' ' 55' ' ' ASN . 66.3 mt-10 -70.54 131.35 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.936 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.585 ' O ' HG13 ' C' ' 54' ' ' VAL . 32.9 t-105 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.698 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' B' ' 7' ' ' SER . 71.4 m-20 37.83 -106.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.961 0.41 . . . . 0.0 110.853 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' B' ' 4' ' ' ALA . 44.1 mt-30 -108.22 -45.2 3.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' B' ' 3' ' ' GLN . . . 167.67 -60.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -68.54 -52.44 32.01 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -60.91 -78.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.648 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.455 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 66.9 m 54.92 56.32 6.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.014 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.662 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 39.6 m80 -78.06 -48.15 2.09 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.774 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -55.95 122.18 11.3 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.424 2.083 . . . . 0.0 111.898 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' B' ' 8' ' ' HIS . 12.6 mm-40 -130.75 -51.92 1.06 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.996 0.426 . . . . 0.0 111.211 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -130.42 -158.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.578 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' B' ' 12' ' ' GLU . 3.0 mt-10 -64.54 -29.09 70.12 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.482 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -135.58 20.85 3.34 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.507 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.19 -18.69 58.76 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.191 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -46.09 58.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 110.906 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -75.97 -26.12 56.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.978 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -74.25 -47.95 31.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.548 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . 0.401 ' O ' ' HD1' ' B' ' 18' ' ' PHE . 0.2 OUTLIER -72.47 -34.84 67.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.231 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 18.5 mtt85 -65.97 -40.09 90.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.81 -44.93 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.118 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.853 HD21 HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.49 -38.06 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.83 -31.05 66.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.16 -39.49 78.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.74 -37.57 67.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.732 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.0 -42.75 76.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -64.22 -38.82 92.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 3.0 tmtt? -69.59 -42.63 74.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.67 0.271 . . . . 0.0 111.25 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' C' ' 28' ' ' LEU . 0.5 OUTLIER -59.92 -43.75 94.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.73 -40.57 88.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.963 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.622 HG22 ' HE2' ' B' ' 34' ' ' LYS . 25.9 m -66.65 -41.36 88.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.88 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' B' ' 27' ' ' LYS . 86.4 mmt-85 -54.87 -38.1 67.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.256 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 28' ' ' LEU . 3.0 t -76.12 -32.54 22.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.213 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.704 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 70.4 m-20 -65.59 -63.88 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' B' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.46 62.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.799 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.87 -49.43 78.65 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.874 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -72.55 -27.34 62.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.84 -52.63 55.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.409 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.3 OUTLIER -68.83 -41.55 78.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.74 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.884 ' HB3' HD21 ' A' ' 36' ' ' LEU . 31.5 p -55.83 -59.04 5.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' C' ' 98' ' ' ASN . . . -55.76 -39.55 71.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.469 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.489 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -60.76 -37.45 81.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.22 -37.3 61.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.049 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.566 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.4 m-20 -76.48 -5.86 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.531 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.2 t -79.23 -11.2 59.96 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.193 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.743 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 0.7 OUTLIER -84.32 177.59 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.806 178.022 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.648 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 12.6 p90 -169.57 -15.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.622 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.749 ' HG3' ' HE3' ' B' ' 84' ' ' LYS . 40.8 mt-30 81.24 114.62 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.906 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.405 9.7 Cg_endo -69.55 99.55 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.623 2.215 . . . . 0.0 112.491 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 62.13 -160.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.013 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 144.56 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.222 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 78' ' ' ASN . 7.5 p -88.91 -27.04 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.194 0.597 . . . . 0.0 112.433 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 172.22 34.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.292 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.66 -165.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.681 0.276 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.588 HG13 ' O ' ' C' ' 105' ' ' TRP . 8.9 p -110.39 141.19 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.523 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.557 ' OD1' ' HG2' ' C' ' 104' ' ' GLU . 6.7 m-80 -119.99 135.83 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.952 0.406 . . . . 0.0 111.689 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.585 ' HB2' ' HB2' ' C' ' 105' ' ' TRP . 2.2 t80 -99.9 128.57 45.98 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.212 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.743 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 42.6 p -117.62 131.41 56.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.023 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.8 143.35 9.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.455 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 178.83 165.52 33.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.586 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' B' ' 69' ' ' LEU . 11.0 m -111.77 168.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.338 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -155.52 -174.93 25.96 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.45 144.39 9.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.704 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 87.5 t80 -130.37 127.79 40.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 6.9 mmm-85 66.32 -86.57 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.185 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -146.84 30.43 0.97 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.23 167.92 16.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.792 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -136.38 159.46 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 165.61 36.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.545 ' HA ' HG12 ' B' ' 60' ' ' VAL . 8.0 tp -115.1 137.32 52.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.54 148.85 50.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.673 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.76 158.33 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 0.0 111.13 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 177.45 173.12 42.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.422 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 96.8 p -155.17 142.81 19.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.52 26.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.13 116.17 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 111.14 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.51 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 9.6 mmm180 -95.96 89.16 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.661 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.714 HG22 ' OD1' ' B' ' 78' ' ' ASN . 7.7 p -95.76 123.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 111.243 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.714 ' OD1' HG22 ' B' ' 77' ' ' VAL . 19.9 m120 64.12 167.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -99.76 32.13 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.552 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.482 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 9.8 t -131.84 -37.7 1.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.505 HG13 HG13 ' B' ' 77' ' ' VAL . 13.8 p -118.78 148.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -150.56 171.24 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.09 148.71 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.608 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.749 ' HE3' ' HG3' ' B' ' 47' ' ' GLN . 3.3 ttmp? -146.33 131.83 18.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.177 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.58 126.69 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . -158.0 171.2 34.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.603 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.18 139.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.861 0.362 . . . . 0.0 111.06 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.36 132.25 54.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -100.72 121.51 41.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . . . -130.1 124.23 32.26 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.651 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.491 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 61.91 -110.66 3.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.292 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -132.06 -63.44 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.268 . . . . 0.0 111.281 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.96 24.66 7.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.211 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.4 OUTLIER -116.41 85.11 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.84 137.56 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.476 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -129.62 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.683 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.77 137.53 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.452 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.446 HD21 ' HB3' ' A' ' 40' ' ' ALA . 34.6 m120 -125.6 152.22 45.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.727 0.298 . . . . 0.0 111.458 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.8 92.8 1.13 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 45' ' ' LEU . 79.0 p -115.7 -177.61 3.19 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -149.41 140.54 23.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 111.139 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.775 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 66.4 m-80 -112.34 143.99 42.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.356 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.421 ' CG2' HG23 ' B' ' 81' ' ' VAL . 4.2 pt -154.98 135.01 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.838 0.351 . . . . 0.0 110.776 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.561 ' HG2' ' OD1' ' A' ' 55' ' ' ASN . 66.1 mt-10 -70.49 131.41 43.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 56' ' ' PHE . 33.2 t-105 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.466 -0.778 . . . . 0.0 110.681 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.639 -0.184 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . 0.462 ' HB2' ' H ' ' C' ' 7' ' ' SER . 71.5 m-20 37.86 -106.99 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.947 0.403 . . . . 0.0 110.854 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' C' ' 4' ' ' ALA . 44.1 mt-30 -108.21 -45.12 3.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' C' ' 3' ' ' GLN . . . 167.7 -60.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.01 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.0 t -68.45 -52.44 32.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.763 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -60.98 -78.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.67 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' C' ' 2' ' ' ASP . 66.7 m 54.84 56.32 6.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.042 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.664 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 39.6 m80 -78.02 -48.1 2.12 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.841 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.6 Cg_exo -56.05 122.24 11.41 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.472 2.115 . . . . 0.0 111.824 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' C' ' 8' ' ' HIS . 12.6 mm-40 -130.81 -51.91 1.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -130.42 -158.71 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.604 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . 0.49 ' H ' ' HG3' ' C' ' 12' ' ' GLU . 3.0 mt-10 -64.65 -29.06 70.06 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.446 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -135.55 20.84 3.35 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.56 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.17 -18.6 58.95 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.302 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' C' ' 19' ' ' ARG . . . -72.07 -46.03 58.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 110.896 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -75.96 -26.13 56.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.977 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -74.22 -48.06 31.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -34.92 68.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.273 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' C' ' 15' ' ' ALA . 18.6 mtt85 -65.86 -40.1 91.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.803 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.88 -44.88 63.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.843 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.54 -38.08 68.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.623 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.67 -31.15 66.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.14 -39.54 78.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -72.68 -37.52 67.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.741 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.02 -42.69 76.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.626 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -64.23 -38.82 92.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.824 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' C' ' 31' ' ' ARG . 3.0 tmtt? -69.56 -42.66 74.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.253 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.93 -43.8 94.73 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.69 -40.53 88.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.0 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.622 HG22 ' HE2' ' C' ' 34' ' ' LYS . 25.9 m -66.72 -41.28 88.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.902 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' C' ' 27' ' ' LYS . 86.4 mmt-85 -54.89 -38.06 67.1 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.389 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.5 HG23 ' O ' ' C' ' 28' ' ' LEU . 3.0 t -76.13 -32.53 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.218 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.722 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 70.4 m-20 -65.51 -63.96 0.97 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.075 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' C' ' 30' ' ' THR . 0.0 OUTLIER -74.69 -34.47 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.758 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.39 79.18 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.384 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.9 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -72.56 -27.34 62.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.803 0.335 . . . . 0.0 111.066 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.56 55.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.3 OUTLIER -68.87 -41.48 78.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.874 ' HB3' HD21 ' B' ' 36' ' ' LEU . 31.3 p -55.86 -58.96 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.463 ' HB3' HD21 ' A' ' 98' ' ' ASN . . . -55.86 -39.61 71.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.441 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -60.66 -37.47 81.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.21 -37.4 61.14 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 75.4 m-20 -76.32 -5.93 49.28 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . 0.534 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.2 t -79.21 -11.24 59.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.111 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 0.7 OUTLIER -84.22 177.63 8.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.784 178.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.629 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 12.6 p90 -169.61 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.611 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.742 ' HG3' ' HE3' ' C' ' 84' ' ' LYS . 40.9 mt-30 81.13 114.59 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.986 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.409 9.9 Cg_endo -69.42 99.41 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.709 2.272 . . . . 0.0 112.564 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 62.24 -160.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.005 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 144.55 93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.255 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' C' ' 78' ' ' ASN . 7.5 p -88.86 -27.03 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.154 0.582 . . . . 0.0 112.468 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 172.18 34.55 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.269 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -130.64 -165.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.646 0.26 . . . . 0.0 110.592 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 105' ' ' TRP . 8.9 p -110.36 141.26 26.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.523 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.56 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 6.8 m-80 -120.01 135.74 54.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.973 0.416 . . . . 0.0 111.73 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.58 ' HB2' ' HB2' ' A' ' 105' ' ' TRP . 2.2 t80 -99.75 128.47 45.85 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.75 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.0 p -117.58 131.46 56.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.97 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.84 143.35 9.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.49 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 178.79 165.55 33.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.538 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' C' ' 69' ' ' LEU . 10.9 m -111.8 168.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.838 0.352 . . . . 0.0 111.326 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -155.46 -174.9 25.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.418 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.4 144.49 9.71 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.722 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 87.6 t80 -130.48 127.78 39.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 110.736 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 6.8 mmm-85 66.3 -86.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -146.84 30.32 0.98 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -128.25 167.95 16.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -136.45 159.43 41.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.104 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.53 165.63 35.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.561 ' HA ' HG12 ' C' ' 60' ' ' VAL . 8.0 tp -115.07 137.28 52.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.782 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.53 148.87 50.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.699 0.285 . . . . 0.0 111.651 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.82 158.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 177.41 173.18 42.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.488 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -155.19 142.72 19.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.12 156.5 26.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.234 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -105.09 116.19 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.133 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.504 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 9.6 mmm180 -95.96 89.1 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.723 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.711 HG22 ' OD1' ' C' ' 78' ' ' ASN . 7.7 p -95.74 123.77 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 111.208 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.711 ' OD1' HG22 ' C' ' 77' ' ' VAL . 19.9 m120 64.27 167.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 111.09 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -99.81 32.09 3.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.572 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . 0.489 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 9.7 t -131.75 -37.75 1.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.991 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.51 HG13 HG13 ' C' ' 77' ' ' VAL . 13.7 p -118.75 148.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.513 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -150.71 171.12 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.258 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pp -162.96 148.77 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.573 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.742 ' HE3' ' HG3' ' C' ' 47' ' ' GLN . 3.3 ttmp? -146.37 131.8 18.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.56 126.75 12.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . -158.12 171.17 35.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.572 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.2 139.27 48.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 111.114 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.31 54.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.78 121.49 41.78 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.271 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' C' ' 94' ' ' ASP . . . -130.1 124.23 32.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.628 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.488 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 61.94 -110.63 3.32 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.274 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.5 m -132.1 -63.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 0.0 111.295 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -98.99 24.7 7.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.4 OUTLIER -116.42 85.1 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.947 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.77 137.6 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.4 OUTLIER -129.6 158.17 40.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.84 137.58 45.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.388 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.455 HD21 ' HB3' ' B' ' 40' ' ' ALA . 34.6 m120 -125.72 152.19 45.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.417 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.78 92.83 1.14 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.562 ' HB2' HD11 ' B' ' 45' ' ' LEU . 79.0 p -115.73 -177.61 3.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.447 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.38 140.61 23.11 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.08 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.786 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 66.4 m-80 -112.31 143.94 42.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.418 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.423 ' CG2' HG23 ' C' ' 81' ' ' VAL . 4.1 pt -154.96 135.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.557 ' HG2' ' OD1' ' B' ' 55' ' ' ASN . 66.4 mt-10 -70.52 131.35 43.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.977 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 0.588 ' O ' HG13 ' B' ' 54' ' ' VAL . 33.1 t-105 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.664 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.468 ' OD1' ' OG ' ' A' ' 5' ' ' SER . 3.8 t70 78.28 134.34 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.934 0.397 . . . . 0.0 110.953 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -130.95 -65.15 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.71 32.44 1.82 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.995 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 2' ' ' ASP . 58.4 p -99.94 155.02 17.91 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.758 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -105.91 -80.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.675 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m 59.78 42.17 17.11 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.033 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.88 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 33.1 m170 -80.68 -54.47 0.77 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.825 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.88 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.3 Cg_exo -59.27 120.06 7.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.478 2.119 . . . . 0.0 111.971 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -100.2 -65.66 0.95 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.917 0.389 . . . . 0.0 111.146 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -114.7 175.0 5.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.631 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.37 28.6 0.34 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.448 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -46.47 15.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.532 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.1 -26.29 63.29 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.25 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.18 -48.07 83.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.365 . . . . 0.0 110.952 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -76.46 -39.82 52.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.993 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.623 ' HE2' ' HB2' ' C' ' 17' ' ' LYS . 0.2 OUTLIER -60.04 -35.21 74.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.533 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.97 -37.86 64.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.208 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.2 -60.4 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.68 65.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.097 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.699 HD22 HD23 ' A' ' 25' ' ' LEU . 2.3 tm? -66.96 -62.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -62.24 -23.76 66.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.52 -49.51 47.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.606 ' HD3' HD11 ' C' ' 21' ' ' LEU . 69.0 mtp85 -73.33 -42.15 62.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.024 HD22 HD11 ' C' ' 25' ' ' LEU . 3.9 mm? -61.36 -46.08 91.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.559 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.29 -32.97 74.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.787 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.79 83.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.185 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -62.6 -47.94 81.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.52 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -60.98 -32.0 71.57 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.967 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.52 HG22 ' HE2' ' A' ' 34' ' ' LYS . 6.3 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.85 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.402 HH12 ' HB3' ' A' ' 93' ' ' SER . 0.0 OUTLIER -78.73 -30.72 46.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.381 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 29' ' ' ASP . 30.3 m -83.5 -33.49 9.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.515 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 57.9 m-20 -66.29 -48.69 69.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' CD ' ' HA3' ' A' ' 91' ' ' GLY . 6.6 ptpt -85.07 -25.69 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.835 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.91 -40.68 63.08 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.393 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.59 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -77.11 -25.73 52.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.329 . . . . 0.0 111.034 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.409 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -72.31 -40.93 67.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.444 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.671 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 13.3 t -79.0 -43.01 25.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.426 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.4 OUTLIER -59.73 -56.71 18.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.34 -40.88 78.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.395 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.41 -35.13 67.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 26.0 tp -76.26 -42.4 45.85 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.601 ' CB ' ' HB3' ' B' ' 43' ' ' ASN . 35.6 m-20 -70.83 -13.81 62.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -67.26 -21.88 65.69 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.128 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' B' ' 100' ' ' SER . 1.5 mm? -80.07 171.8 14.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.857 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.488 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.3 p90 -158.11 -3.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.628 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.576 ' HB2' HH21 ' A' ' 76' ' ' ARG . 7.1 mt-30 71.51 119.79 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.953 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.262 9.8 Cg_endo -75.09 106.7 2.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.65 2.233 . . . . 0.0 112.497 -179.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.19 -177.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 173.02 51.34 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.245 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 4.9 p -73.32 -3.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.12 0.568 . . . . 0.0 112.519 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.9 54.33 0.03 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.272 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.82 -165.04 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.24 145.08 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.5 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.642 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.5 m-80 -126.16 118.43 25.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.65 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' A' ' 73' ' ' SER . 31.8 t80 -83.66 130.31 34.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.255 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.494 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 75.5 p -114.66 120.9 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.986 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 71' ' ' ILE . . . -152.26 135.29 15.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.488 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -179.72 168.57 39.06 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.55 ' CG1' HD12 ' A' ' 69' ' ' LEU . 13.3 m -116.96 158.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 111.418 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.99 -170.89 14.34 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.481 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -165.5 142.67 7.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.593 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 56.1 t80 -134.01 134.7 42.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.684 0.278 . . . . 0.0 110.771 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.71 28.59 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 1.6 m -133.77 142.05 47.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.3 157.11 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.099 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.671 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -149.48 167.78 25.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.558 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.55 HD12 ' CG1' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -125.97 136.66 53.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.757 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -128.31 142.55 51.1 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 111.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 87' ' ' VAL . 10.4 tp -139.38 155.07 25.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' THR . . . 168.12 176.91 38.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.384 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 56' ' ' PHE . 1.1 p -168.04 155.82 8.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.01 28.57 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.207 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -123.48 135.74 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.17 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.576 HH21 ' HB2' ' A' ' 47' ' ' GLN . 12.3 ttm180 -131.17 133.27 45.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.678 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.829 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 13.8 p -122.32 139.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 88.8 m-20 61.19 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.661 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 7.8 pt-20 177.81 -26.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.55 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 59.5 p -65.65 -67.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.39 139.19 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.496 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.666 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -142.07 155.35 45.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.241 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.564 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HG3' ' HE2' ' C' ' 46' ' ' PHE . 8.2 tmtt? -155.31 130.19 9.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.217 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 175.41 12.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.16 -173.69 37.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.543 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 71' ' ' ILE . 14.7 p -141.89 143.17 27.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.897 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -115.17 144.11 44.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.351 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -119.24 119.03 32.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.282 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -127.89 135.29 49.8 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.657 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.618 ' HA3' ' CD ' ' A' ' 34' ' ' LYS . . . 60.52 -111.56 3.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.276 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.3 m -149.61 10.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 111.312 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.402 ' HB3' HH12 ' A' ' 31' ' ' ARG . 1.6 t -165.09 23.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.156 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 37.0 m-20 -116.3 67.7 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.08 139.67 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 110.745 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.897 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 7.1 ptp -134.25 135.53 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.723 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.86 118.71 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.409 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.03 152.63 23.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.79 0.328 . . . . 0.0 111.394 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.753 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.504 ' HB3' HD11 ' C' ' 45' ' ' LEU . 14.4 m -118.6 169.09 10.09 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.396 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.06 136.01 31.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.986 0.422 . . . . 0.0 111.056 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.8 m-80 -104.31 132.8 50.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.355 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -138.22 114.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.376 . . . . 0.0 110.716 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -115.97 157.95 23.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.671 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.414 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.465 ' OD1' ' OG ' ' B' ' 5' ' ' SER . 3.8 t70 78.28 134.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.985 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -130.92 -65.09 0.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.69 32.4 1.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.465 ' OG ' ' OD1' ' B' ' 2' ' ' ASP . 58.0 p -99.95 155.03 17.91 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.785 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -105.85 -80.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m 59.89 42.13 16.8 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.991 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.872 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 33.1 m170 -80.66 -54.41 0.78 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.845 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -59.33 120.13 7.78 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.507 2.138 . . . . 0.0 111.891 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -100.23 -65.77 0.95 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.61 174.93 5.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.73 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.28 28.57 0.35 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.439 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -46.5 15.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.514 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.05 -26.35 63.27 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.231 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.06 83.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.931 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -76.46 -39.85 52.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.024 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.614 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -60.05 -35.19 74.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.578 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -73.9 -37.87 64.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.23 -60.37 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.35 -28.63 65.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.983 0.42 . . . . 0.0 111.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.71 HD22 HD23 ' B' ' 25' ' ' LEU . 2.3 tm? -67.04 -62.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.29 -23.73 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.005 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.56 -49.49 47.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.601 ' HD3' HD11 ' A' ' 21' ' ' LEU . 69.1 mtp85 -73.36 -42.15 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.702 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 1.008 HD22 HD11 ' A' ' 25' ' ' LEU . 3.9 mm? -61.26 -46.08 91.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.603 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.33 -32.92 74.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.773 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.89 -38.7 83.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.647 0.26 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' B' ' 28' ' ' LEU . 0.0 OUTLIER -62.74 -47.89 81.59 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.501 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.5 OUTLIER -61.06 -31.95 71.6 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 178.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.514 HG22 ' HE2' ' B' ' 34' ' ' LYS . 6.2 m -73.8 -30.38 62.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -30.64 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.312 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' B' ' 29' ' ' ASP . 29.3 m -83.68 -33.33 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.172 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 58.3 m-20 -66.35 -48.7 69.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.972 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.604 ' CD ' ' HA3' ' B' ' 91' ' ' GLY . 6.6 ptpt -85.17 -25.58 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.92 -40.8 62.95 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.601 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.5 mt -77.03 -25.71 52.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.413 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -72.44 -40.76 66.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.411 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.66 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 13.5 t -79.08 -42.97 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.745 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.418 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 0.4 OUTLIER -59.86 -56.71 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.88 78.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.441 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.48 -35.08 67.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.555 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 26.1 tp -76.3 -42.23 45.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.124 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.601 ' HB3' ' CB ' ' A' ' 43' ' ' ASN . 35.5 m-20 -70.92 -13.77 62.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 46.5 t -67.3 -21.87 65.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.147 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' C' ' 100' ' ' SER . 1.5 mm? -80.05 171.71 14.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.866 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.489 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.3 p90 -158.09 -3.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.162 0.506 . . . . 0.0 111.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.579 ' HB2' HH21 ' B' ' 76' ' ' ARG . 7.1 mt-30 71.5 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.992 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.669 ' HB2' ' O ' ' C' ' 79' ' ' GLU 0.265 10.0 Cg_endo -74.94 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.708 2.272 . . . . 0.0 112.573 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.18 -177.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 173.02 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.219 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 4.9 p -73.42 -3.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.145 0.578 . . . . 0.0 112.466 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.831 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.97 54.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.25 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.81 -165.07 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.2 145.12 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.561 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.637 ' HB3' ' HD2' ' B' ' 48' ' ' PRO . 5.4 m-80 -126.11 118.32 25.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 111.706 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' B' ' 73' ' ' SER . 32.1 t80 -83.77 130.36 34.94 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.223 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.487 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 75.9 p -114.67 120.9 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.976 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' B' ' 71' ' ' ILE . . . -152.28 135.34 15.7 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.458 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -179.77 168.63 39.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.563 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.548 ' CG1' HD12 ' B' ' 69' ' ' LEU . 13.1 m -117.01 158.43 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.811 0.339 . . . . 0.0 111.332 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.99 -170.86 14.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.441 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.413 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -165.5 142.69 7.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.529 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.572 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 56.0 t80 -134.13 134.7 42.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.672 0.273 . . . . 0.0 110.744 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 64.34 -93.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.73 28.63 1.27 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 1.6 m -133.79 142.1 47.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.36 157.17 17.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.99 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -149.57 167.74 25.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.523 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.548 HD12 ' CG1' ' B' ' 60' ' ' VAL . 0.6 OUTLIER -125.95 136.61 53.22 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.796 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -128.21 142.53 51.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.668 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' B' ' 87' ' ' VAL . 10.4 tp -139.29 155.16 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.103 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.408 ' N ' HG13 ' B' ' 71' ' ' ILE . . . 168.03 176.8 38.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.427 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' B' ' 56' ' ' PHE . 1.1 p -167.95 155.89 8.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.33 171.93 28.66 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.179 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -123.46 135.73 54.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.579 HH21 ' HB2' ' B' ' 47' ' ' GLN . 12.3 ttm180 -131.14 133.33 45.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.831 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 13.7 p -122.44 139.64 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 88.8 m-20 61.25 -94.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 0.0 111.066 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 7.8 pt-20 177.87 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.585 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' B' ' 103' ' ' ILE . 59.5 p -65.65 -67.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.991 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.4 139.21 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.501 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -142.03 155.35 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.72 146.44 34.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.488 ' HG3' ' HE2' ' A' ' 46' ' ' PHE . 8.2 tmtt? -155.28 130.26 9.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.15 175.42 12.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.14 -173.7 37.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.559 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' B' ' 71' ' ' ILE . 14.7 p -141.89 143.24 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.891 0.377 . . . . 0.0 111.123 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.884 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -115.23 144.1 44.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.33 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -119.24 119.06 32.96 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -127.91 135.36 49.88 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.649 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.604 ' HA3' ' CD ' ' B' ' 34' ' ' LYS . . . 60.48 -111.58 3.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.281 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 56.8 m -149.62 10.3 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.286 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -165.07 23.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.163 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 37.2 m-20 -116.38 67.68 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.11 139.61 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.702 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.884 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 7.0 ptp -134.23 135.52 43.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.81 118.75 35.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.98 152.62 23.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.692 0.282 . . . . 0.0 111.427 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.49 90.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.698 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.499 ' HB3' HD11 ' A' ' 45' ' ' LEU . 14.3 m -118.56 169.09 10.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.432 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.02 135.89 31.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.676 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 70.9 m-80 -104.25 132.82 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.426 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -138.19 114.32 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -115.98 157.92 23.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.663 179.671 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . 0.471 ' OD1' ' OG ' ' C' ' 5' ' ' SER . 3.7 t70 78.23 134.31 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.926 0.393 . . . . 0.0 110.998 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -130.94 -65.17 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.63 32.39 1.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . 0.471 ' OG ' ' OD1' ' C' ' 2' ' ' ASP . 58.1 p -99.9 155.01 17.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.744 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -105.84 -80.96 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.696 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 72.3 m 59.81 42.23 16.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.015 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.877 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 33.2 m170 -80.79 -54.37 0.76 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.761 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.877 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.3 Cg_exo -59.35 120.03 7.63 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.473 2.116 . . . . 0.0 111.977 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -100.12 -65.69 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.988 0.423 . . . . 0.0 111.152 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.64 175.01 5.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.656 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.41 28.63 0.34 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.411 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -46.5 15.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.527 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.11 -26.25 63.27 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.19 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.09 83.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.941 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -76.53 -39.78 51.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.958 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.623 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -60.15 -35.11 74.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.531 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -74.0 -37.82 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.2 -60.42 3.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -58.38 -28.62 65.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.723 HD22 HD23 ' C' ' 25' ' ' LEU . 2.3 tm? -67.01 -62.7 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.566 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.18 -23.79 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.46 -49.56 47.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.623 ' HD3' HD11 ' B' ' 21' ' ' LEU . 69.0 mtp85 -73.4 -42.05 62.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.797 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 1.024 HD11 HD22 ' A' ' 25' ' ' LEU . 3.9 mm? -61.31 -46.08 91.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.624 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -66.32 -32.91 74.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.846 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -67.87 -38.73 83.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -47.86 81.71 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . 0.516 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.5 OUTLIER -61.05 -31.87 71.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.96 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.516 HG22 ' HE2' ' C' ' 34' ' ' LYS . 6.2 m -73.9 -30.26 62.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.865 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -30.73 45.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' C' ' 29' ' ' ASP . 30.1 m -83.57 -33.38 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.517 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 57.8 m-20 -66.43 -48.63 69.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.617 ' CD ' ' HA3' ' C' ' 91' ' ' GLY . 6.6 ptpt -85.16 -25.61 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.93 -40.71 62.91 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.404 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.601 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.5 mt -77.03 -25.78 52.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.92 0.391 . . . . 0.0 111.165 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.404 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -72.33 -40.77 67.17 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.548 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.664 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 13.2 t -79.07 -42.87 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.803 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.43 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 0.4 OUTLIER -59.92 -56.71 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.25 -41.01 78.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.418 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.34 -35.11 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.941 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.564 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 26.2 tp -76.22 -42.38 46.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.148 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.599 ' HB3' ' CB ' ' B' ' 43' ' ' ASN . 35.4 m-20 -70.84 -13.85 62.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -67.31 -21.88 65.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.09 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 100' ' ' SER . 1.5 mm? -80.06 171.84 14.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.845 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.48 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.3 p90 -158.1 -3.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.193 0.52 . . . . 0.0 111.721 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.565 ' HB2' HH21 ' C' ' 76' ' ' ARG . 7.1 mt-30 71.58 119.71 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.968 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.263 9.9 Cg_endo -75.03 106.7 2.33 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.635 2.224 . . . . 0.0 112.585 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 59.15 -177.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 173.03 51.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.168 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 4.9 p -73.43 -3.42 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.091 0.557 . . . . 0.0 112.465 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.812 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.94 54.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 -165.16 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 0.0 110.615 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.15 145.1 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.641 ' HB3' ' HD2' ' C' ' 48' ' ' PRO . 5.4 m-80 -126.1 118.38 25.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 111.655 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' C' ' 73' ' ' SER . 32.1 t80 -83.76 130.33 34.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.206 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.481 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 75.2 p -114.63 120.92 41.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.97 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.419 ' HB2' HD12 ' C' ' 71' ' ' ILE . . . -152.32 135.35 15.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.484 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -179.76 168.57 39.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.552 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.549 ' CG1' HD12 ' C' ' 69' ' ' LEU . 13.3 m -116.9 158.41 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.328 . . . . 0.0 111.357 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.04 -170.8 14.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.421 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.404 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -165.59 142.72 7.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.583 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 56.2 t80 -134.04 134.69 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.636 0.255 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.3 mmm180 64.36 -93.26 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.103 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -144.75 28.58 1.27 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' C' ' 33' ' ' ASP . 1.6 m -133.8 142.04 47.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -103.21 157.3 17.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . 0.664 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -149.64 167.75 25.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.549 HD12 ' CG1' ' C' ' 60' ' ' VAL . 0.6 OUTLIER -126.01 136.63 53.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -128.25 142.55 51.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.654 0.264 . . . . 0.0 111.661 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' C' ' 87' ' ' VAL . 10.4 tp -139.29 155.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.761 0.315 . . . . 0.0 111.11 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.401 ' N ' HG13 ' C' ' 71' ' ' ILE . . . 168.04 176.83 38.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.448 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' C' ' 56' ' ' PHE . 1.1 p -168.01 155.85 8.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.339 . . . . 0.0 110.969 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.36 171.99 28.67 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.565 HH21 ' HB2' ' C' ' 47' ' ' GLN . 12.3 ttm180 -131.19 133.27 45.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.677 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.812 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 13.6 p -122.38 139.68 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 89.0 m-20 61.17 -94.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 111.042 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . 0.669 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 7.8 pt-20 177.86 -26.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' C' ' 103' ' ' ILE . 59.2 p -65.69 -67.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.35 139.17 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -142.07 155.34 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.229 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.2 tp -142.69 146.42 34.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.489 ' HG3' ' HE2' ' B' ' 46' ' ' PHE . 8.2 tmtt? -155.3 130.24 9.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.163 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.1 175.48 12.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.09 -173.71 37.57 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.536 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' C' ' 71' ' ' ILE . 14.7 p -141.91 143.21 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.078 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.896 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -115.2 144.14 44.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.348 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -119.26 119.13 33.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -128.0 135.29 49.7 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.672 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.617 ' HA3' ' CD ' ' C' ' 34' ' ' LYS . . . 60.64 -111.59 3.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.279 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 56.7 m -149.67 10.38 0.73 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.294 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -165.15 23.93 0.05 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 37.0 m-20 -116.37 67.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.13 139.72 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.896 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 7.1 ptp -134.22 135.52 43.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.87 118.77 35.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.403 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.1 152.61 23.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.715 0.293 . . . . 0.0 111.382 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.44 90.4 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.511 ' HB3' HD11 ' B' ' 45' ' ' LEU . 14.4 m -118.65 169.12 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.403 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.12 135.94 31.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.042 0.449 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.661 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.9 m-80 -104.24 132.8 50.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.435 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' C' ' 80' ' ' SER . 0.1 OUTLIER -138.17 114.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.719 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -115.97 157.96 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.8 m-90 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.706 179.624 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.641 -0.184 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 40.2 -102.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -112.48 -54.38 2.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.61 -63.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.026 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -68.03 -53.9 22.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.693 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -47.37 -83.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.698 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m 68.28 45.31 1.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.996 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.772 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 23.7 m80 -70.83 -52.38 10.22 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.791 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.772 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -52.0 121.39 8.7 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.515 2.143 . . . . 0.0 111.89 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 8' ' ' HIS . 13.0 mm100 -127.92 -59.16 1.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 0.0 111.115 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -125.97 -154.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.657 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -68.99 -26.6 65.1 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.402 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -135.55 20.69 3.35 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.544 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.82 -22.77 60.97 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.224 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB1' ' NH1' ' A' ' 19' ' ' ARG . . . -66.99 -46.07 75.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.869 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 39.3 m-70 -72.13 -32.15 66.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.989 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' O ' HD22 ' A' ' 21' ' ' LEU . 34.6 ttmt -73.05 -46.94 48.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.548 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.75 -39.7 80.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.889 0.376 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.412 ' NH1' ' HB1' ' A' ' 15' ' ' ALA . 49.5 mtt85 -66.81 -42.89 85.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.779 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.608 ' HB2' ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -64.7 -41.39 96.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.1 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.758 HD21 HD23 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -62.9 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.83 -30.72 71.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.73 -39.11 57.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.768 HD21 ' HG ' ' B' ' 25' ' ' LEU . 8.0 mt -67.25 -50.98 58.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.571 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.78 -50.91 72.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.826 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HE2' ' CZ ' ' A' ' 31' ' ' ARG . 9.5 tmtt? -54.78 -38.26 67.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.279 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -62.39 -42.69 99.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -63.54 -41.7 98.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.997 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.796 HG22 ' HE2' ' A' ' 34' ' ' LYS . 4.4 m -57.91 -47.12 83.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.764 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.614 ' HD3' ' HE3' ' A' ' 34' ' ' LYS . 83.2 mmt-85 -59.45 -35.5 74.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.318 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.861 HG22 HG11 ' C' ' 32' ' ' VAL . 41.7 t -73.75 -36.5 46.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.99 -55.88 16.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.995 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.814 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 3.4 pttt -72.35 -36.5 68.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.774 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.13 96.33 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.369 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.565 HD21 ' HB3' ' B' ' 39' ' ' SER . 0.3 OUTLIER -70.14 -37.13 75.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.805 0.336 . . . . 0.0 111.08 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.72 99.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.463 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -69.58 -54.38 14.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.753 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.545 ' HB3' HD21 ' C' ' 36' ' ' LEU . 86.9 p -49.07 -56.21 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -52.49 -52.61 53.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.471 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.16 -41.58 36.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.537 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 30.8 tp -73.88 -34.89 64.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.09 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.4 m-20 -78.25 -5.12 51.01 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.404 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 3.5 t -86.13 -0.6 56.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.12 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' B' ' 100' ' ' SER . 0.3 OUTLIER -95.97 172.18 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.881 177.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.427 ' H ' ' H ' ' A' ' 47' ' ' GLN . 10.3 p90 -165.76 -5.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.662 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 35.1 mt-30 65.83 118.9 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.945 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' B' ' 102' ' ' ASN 0.395 9.8 Cg_endo -69.89 98.2 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.692 2.261 . . . . 0.0 112.54 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 66.94 -165.0 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 76' ' ' ARG . . . 146.16 82.25 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 79' ' ' GLU . 8.7 p -88.72 -11.03 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.094 0.558 . . . . 0.0 112.477 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 158.34 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.296 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.01 -166.7 2.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.558 0.218 . . . . 0.0 110.65 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.158 HG13 ' O ' ' B' ' 105' ' ' TRP . 2.6 p -109.5 144.05 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.428 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 4.4 m-80 -131.06 134.83 47.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.652 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.476 ' O ' HG13 ' B' ' 103' ' ' ILE . 1.2 t80 -104.53 121.92 44.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.275 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.702 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 21.1 p -114.57 124.86 52.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.19 150.81 29.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.41 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 171.19 164.01 26.17 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.491 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 69' ' ' LEU . 14.5 m -110.21 166.33 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 111.373 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -174.43 22.35 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.53 143.21 8.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.554 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.636 ' CE2' ' HG3' ' A' ' 64' ' ' ARG . 63.2 t80 -132.51 137.1 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.727 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.636 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 2.9 mmm180 61.52 -80.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 63' ' ' TYR . 12.0 t -156.64 32.27 0.31 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -130.11 167.42 18.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.01 142.15 48.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.137 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.43 47.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.61 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.2 tp -111.32 128.48 55.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.729 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -122.95 152.09 41.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.708 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.429 HG12 ' N ' ' A' ' 72' ' ' GLY . 17.7 tt -147.54 162.06 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.289 . . . . 0.0 111.183 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 71' ' ' ILE . . . 175.35 169.34 37.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.408 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 p -163.29 147.71 11.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.73 161.85 28.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.245 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.29 119.48 39.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.154 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.484 ' CB ' ' HA3' ' A' ' 50' ' ' GLY . 4.9 mmm180 -96.9 99.21 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.707 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.697 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.0 p -98.23 130.72 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.332 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.48 ' OD1' HG22 ' A' ' 77' ' ' VAL . 8.1 m120 66.27 -170.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.932 0.396 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 51' ' ' VAL . 38.5 mt-10 -120.05 24.53 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.551 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.584 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 5.0 t -129.01 -44.75 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.28 148.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.494 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.845 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -152.07 171.15 18.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 111.205 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.82 143.23 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.606 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.5 23.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.26 135.95 23.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.39 175.04 39.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 96' ' ' MET . 6.3 p -124.08 146.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB3' ' SD ' ' A' ' 96' ' ' MET . . . -114.11 134.09 55.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.27 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.86 110.69 22.1 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.259 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -122.75 132.43 54.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.522 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.84 -113.15 4.04 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.263 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.85 -60.76 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 111.322 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 93' ' ' SER . 2.4 t -101.53 29.77 4.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.221 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.99 1.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.4 142.34 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.748 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.577 ' HB2' ' HA ' ' C' ' 63' ' ' TYR . 0.9 OUTLIER -132.57 155.59 48.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -128.48 129.02 45.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.522 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -119.7 160.33 22.74 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.17 99.02 0.12 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.796 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.751 ' HB2' HD11 ' C' ' 45' ' ' LEU . 11.2 p -122.67 179.45 4.61 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.43 146.36 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.845 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.4 m-80 -111.9 150.02 31.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.362 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.482 HG13 ' O ' ' C' ' 56' ' ' PHE . 3.9 pt -156.18 150.99 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.584 ' OE1' ' HA ' ' A' ' 80' ' ' SER . 73.7 mt-10 -96.25 130.56 43.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.163 ' O ' HG13 ' C' ' 54' ' ' VAL . 5.7 t-105 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.664 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 40.09 -102.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -112.5 -54.38 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.842 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.58 -63.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -68.07 -53.93 22.03 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.689 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -47.4 -83.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.719 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 19.5 m 68.2 45.4 1.26 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.979 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.76 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 23.6 m170 -70.83 -52.38 10.19 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.771 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.76 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -51.95 121.4 8.68 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.462 2.108 . . . . 0.0 111.93 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' B' ' 8' ' ' HIS . 13.0 mm100 -127.95 -59.14 1.2 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.385 . . . . 0.0 111.114 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.99 -154.71 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.667 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -69.01 -26.6 65.08 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.441 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -135.68 20.81 3.32 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.496 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.76 -22.77 61.11 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.309 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.1 -45.95 75.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' B' ' 20' ' ' GLN . 39.2 m-70 -72.17 -32.13 66.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.004 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.485 ' O ' HD22 ' B' ' 21' ' ' LEU . 34.7 ttmt -73.02 -47.0 48.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.612 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -39.83 80.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -66.76 -42.92 85.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.609 ' HB2' ' O ' ' B' ' 16' ' ' HIS . 0.8 OUTLIER -64.71 -41.4 96.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.109 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.765 HD23 HD21 ' C' ' 21' ' ' LEU . 0.0 OUTLIER -62.84 -43.4 98.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.89 -30.69 71.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -75.78 -39.11 57.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -73.02 -38.36 66.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.813 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.772 HD21 ' HG ' ' C' ' 25' ' ' LEU . 8.0 mt -67.18 -51.03 58.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.61 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.83 -50.89 72.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.799 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.499 ' HE2' ' CZ ' ' B' ' 31' ' ' ARG . 9.5 tmtt? -54.8 -38.27 67.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.277 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.571 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -62.41 -42.63 99.58 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.52 -41.74 98.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.969 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.804 HG22 ' HE2' ' B' ' 34' ' ' LYS . 4.4 m -57.94 -47.07 83.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.603 ' HD3' ' HE3' ' B' ' 34' ' ' LYS . 83.1 mmt-85 -59.37 -35.56 74.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.352 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.851 HG22 HG11 ' A' ' 32' ' ' VAL . 41.7 t -73.78 -36.56 46.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.201 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.0 -55.86 16.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.955 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.814 ' HB2' ' HB1' ' B' ' 90' ' ' ALA . 3.4 pttt -72.33 -36.58 68.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.744 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.91 -45.05 96.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.382 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' C' ' 39' ' ' SER . 0.3 OUTLIER -70.12 -37.23 75.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.79 99.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.427 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.756 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 0.1 OUTLIER -69.56 -54.33 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.565 ' HB3' HD21 ' A' ' 36' ' ' LEU . 86.9 p -49.16 -56.25 9.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.017 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.54 54.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.465 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.23 -41.56 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.864 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.54 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 30.7 tp -73.89 -34.88 64.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.112 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.544 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 75.1 m-20 -78.13 -5.23 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.417 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 3.4 t -86.05 -0.65 56.1 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.141 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' C' ' 100' ' ' SER . 0.3 OUTLIER -95.83 172.21 8.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.894 177.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -165.84 -5.24 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.097 0.475 . . . . 0.0 111.654 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' B' ' 55' ' ' ASN . 35.1 mt-30 65.86 118.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' C' ' 102' ' ' ASN 0.395 9.7 Cg_endo -69.88 98.36 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.638 2.225 . . . . 0.0 112.552 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 66.75 -164.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 76' ' ' ARG . . . 146.15 82.31 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.188 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' B' ' 79' ' ' GLU . 8.7 p -88.78 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.144 0.578 . . . . 0.0 112.422 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.683 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 158.25 46.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.259 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -143.1 -166.69 2.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.586 0.231 . . . . 0.0 110.628 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 1.175 HG13 ' O ' ' C' ' 105' ' ' TRP . 2.6 p -109.52 144.12 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.561 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.428 ' HB2' ' OE1' ' B' ' 47' ' ' GLN . 4.4 m-80 -131.12 134.79 46.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.013 0.435 . . . . 0.0 111.61 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.47 ' O ' HG13 ' C' ' 103' ' ' ILE . 1.2 t80 -104.55 121.96 44.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.24 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.682 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 21.1 p -114.59 124.86 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.22 150.75 29.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.484 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.529 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 171.25 164.01 26.22 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.575 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 69' ' ' LEU . 14.4 m -110.26 166.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.61 -174.42 22.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.462 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.52 143.15 8.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.635 ' CE2' ' HG3' ' B' ' 64' ' ' ARG . 63.5 t80 -132.48 137.0 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.291 . . . . 0.0 110.765 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.635 ' HG3' ' CE2' ' B' ' 63' ' ' TYR . 2.9 mmm180 61.54 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.029 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 63' ' ' TYR . 12.2 t -156.69 32.3 0.31 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.158 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -130.17 167.46 18.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.802 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.02 142.15 48.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.62 155.49 47.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.529 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.1 tp -111.33 128.44 55.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.724 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -123.0 152.17 41.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.429 HG12 ' N ' ' B' ' 72' ' ' GLY . 17.7 tt -147.56 162.0 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.751 0.31 . . . . 0.0 111.073 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.429 ' N ' HG12 ' B' ' 71' ' ' ILE . . . 175.38 169.35 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.47 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -163.25 147.71 11.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.76 161.89 28.97 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.255 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.34 119.51 39.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.161 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.492 ' CB ' ' HA3' ' B' ' 50' ' ' GLY . 5.0 mmm180 -96.96 99.15 10.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.683 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.9 p -98.08 130.71 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.328 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.474 ' OD1' HG22 ' B' ' 77' ' ' VAL . 8.1 m120 66.17 -170.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.899 0.381 . . . . 0.0 111.154 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.504 ' HG3' HG23 ' B' ' 51' ' ' VAL . 38.6 mt-10 -120.0 24.59 10.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.598 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.583 ' HA ' ' OE1' ' B' ' 104' ' ' GLU . 5.0 t -129.07 -44.72 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.963 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.33 148.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.851 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -152.01 171.22 18.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.224 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.26 9.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.43 23.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.17 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.27 135.96 23.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.38 175.04 39.69 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.448 HG23 ' O ' ' B' ' 96' ' ' MET . 6.3 p -124.1 146.53 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.5 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -114.09 134.09 55.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -108.89 110.74 22.15 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -122.78 132.45 54.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.574 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.521 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.95 -113.28 4.21 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.259 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.87 -60.67 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.343 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' B' ' 93' ' ' SER . 2.3 t -101.6 29.75 4.69 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.258 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 0.2 OUTLIER -119.72 82.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.988 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.47 142.35 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.017 0.437 . . . . 0.0 110.703 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.554 ' HB2' ' HA ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -132.49 155.63 48.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -128.5 128.93 45.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.492 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.6 160.27 22.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.688 0.28 . . . . 0.0 111.476 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.18 99.04 0.12 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.738 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.733 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.3 p -122.67 179.47 4.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.452 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -140.43 146.26 38.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.851 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.4 m-80 -111.82 150.0 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.374 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 56' ' ' PHE . 4.0 pt -156.1 150.97 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.761 0.315 . . . . 0.0 110.825 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' B' ' 80' ' ' SER . 73.7 mt-10 -96.31 130.58 43.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 1.158 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.7 t-105 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.686 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 40.15 -102.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.894 0.378 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -112.44 -54.38 2.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.56 -63.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -67.95 -53.96 22.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.768 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -47.44 -83.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.752 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m 68.24 45.36 1.25 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.985 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.765 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 23.6 m170 -70.85 -52.38 10.15 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.792 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.765 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.5 Cg_exo -51.97 121.36 8.63 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.507 2.138 . . . . 0.0 111.909 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' C' ' 8' ' ' HIS . 13.0 mm100 -127.86 -59.16 1.21 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.956 0.408 . . . . 0.0 111.157 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.02 -154.73 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.648 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -68.98 -26.54 65.08 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.46 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -135.74 20.77 3.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.506 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.76 -22.75 61.15 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.258 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . 0.406 ' HB1' ' NH1' ' C' ' 19' ' ' ARG . . . -67.06 -46.05 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 0.0 110.88 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . 0.599 ' O ' ' HB2' ' C' ' 20' ' ' GLN . 39.2 m-70 -72.1 -32.17 66.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.011 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.487 ' O ' HD22 ' C' ' 21' ' ' LEU . 34.6 ttmt -73.05 -46.92 49.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.556 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -39.88 80.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.202 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . 0.406 ' NH1' ' HB1' ' C' ' 15' ' ' ALA . 49.7 mtt85 -66.7 -42.88 85.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' C' ' 16' ' ' HIS . 0.8 OUTLIER -64.68 -41.41 96.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.765 HD21 HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -62.87 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -75.76 -39.15 57.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -73.04 -38.38 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.772 ' HG ' HD21 ' B' ' 25' ' ' LEU . 8.0 mt -67.2 -51.02 58.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -58.77 -50.85 72.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.5 ' HE2' ' CZ ' ' C' ' 31' ' ' ARG . 9.5 tmtt? -54.91 -38.21 67.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.254 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.576 ' O ' HG23 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -62.33 -42.72 99.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.48 -41.77 98.57 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.989 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.786 HG22 ' HE2' ' C' ' 34' ' ' LYS . 4.4 m -57.89 -46.99 84.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.861 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.6 ' HD3' ' HE3' ' C' ' 34' ' ' LYS . 83.2 mmt-85 -59.48 -35.54 74.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.291 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.861 HG11 HG22 ' A' ' 32' ' ' VAL . 42.0 t -73.8 -36.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.164 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.89 -55.88 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.073 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.826 ' HB2' ' HB1' ' C' ' 90' ' ' ALA . 3.3 pttt -72.39 -36.56 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.732 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.78 -45.18 96.27 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.375 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 39' ' ' SER . 0.3 OUTLIER -70.07 -37.13 75.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.84 0.352 . . . . 0.0 111.149 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.82 99.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.428 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 0.1 OUTLIER -69.5 -54.39 14.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.776 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.555 ' HB3' HD21 ' B' ' 36' ' ' LEU . 87.0 p -49.09 -56.18 9.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.073 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.404 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -52.6 -52.55 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.395 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.29 -41.4 37.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.534 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 30.6 tp -74.0 -34.87 64.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.113 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 75.3 m-20 -78.18 -5.13 50.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . 0.402 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 3.5 t -86.09 -0.63 56.09 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.156 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -95.95 172.18 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.892 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.407 ' H ' ' H ' ' C' ' 47' ' ' GLN . 10.4 p90 -165.76 -5.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.133 0.492 . . . . 0.0 111.66 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 35.1 mt-30 65.75 118.93 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.944 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 102' ' ' ASN 0.396 9.8 Cg_endo -69.91 98.23 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.641 2.227 . . . . 0.0 112.565 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 66.96 -164.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' C' ' 76' ' ' ARG . . . 146.17 82.24 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.254 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' C' ' 79' ' ' GLU . 8.8 p -88.77 -10.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.391 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 158.26 46.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.273 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -142.93 -166.67 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.657 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 1.163 HG13 ' O ' ' A' ' 105' ' ' TRP . 2.6 p -109.54 144.04 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.511 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.42 ' HB2' ' OE1' ' C' ' 47' ' ' GLN . 4.4 m-80 -131.1 134.83 46.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.067 0.46 . . . . 0.0 111.624 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.482 ' O ' HG13 ' A' ' 103' ' ' ILE . 1.2 t80 -104.62 122.01 44.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.179 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.686 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 21.0 p -114.59 124.85 52.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.95 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.2 150.76 29.35 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 171.23 164.03 26.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' C' ' 69' ' ' LEU . 14.4 m -110.28 166.4 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.62 -174.4 22.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.48 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 143.1 8.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.573 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' C' ' 64' ' ' ARG . 62.9 t80 -132.45 137.06 47.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.633 ' HG3' ' CE2' ' C' ' 63' ' ' TYR . 2.9 mmm180 61.59 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.045 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . 0.406 ' N ' ' O ' ' C' ' 63' ' ' TYR . 12.1 t -156.68 32.33 0.31 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -130.19 167.5 18.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -133.05 142.17 48.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.59 155.5 47.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.569 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.1 tp -111.33 128.35 55.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -122.97 152.11 41.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.726 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.434 HG12 ' N ' ' C' ' 72' ' ' GLY . 17.7 tt -147.47 162.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.179 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.434 ' N ' HG12 ' C' ' 71' ' ' ILE . . . 175.3 169.32 36.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.438 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 36.2 p -163.24 147.69 11.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.7 161.91 28.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.273 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -107.3 119.44 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 111.144 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.492 ' CB ' ' HA3' ' C' ' 50' ' ' GLY . 4.9 mmm180 -96.85 99.16 10.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.772 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.689 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.0 p -98.19 130.62 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.321 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' C' ' 77' ' ' VAL . 8.1 m120 66.37 -171.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' C' ' 51' ' ' VAL . 38.8 mt-10 -120.03 24.56 10.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.561 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . 0.583 ' HA ' ' OE1' ' C' ' 104' ' ' GLU . 5.0 t -129.0 -44.74 1.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.987 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.2 148.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.552 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -152.02 171.21 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.234 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.83 143.22 9.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.37 130.52 23.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.145 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 135.91 23.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.02 39.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.609 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . 0.456 HG23 ' O ' ' C' ' 96' ' ' MET . 6.3 p -124.02 146.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.89 0.376 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.513 ' HB3' ' SD ' ' C' ' 96' ' ' MET . . . -114.03 134.02 55.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.423 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -108.85 110.78 22.21 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.252 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.826 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -122.77 132.41 54.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.59 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.544 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.97 -113.18 4.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.209 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 2.7 m -130.92 -60.73 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' C' ' 93' ' ' SER . 2.3 t -101.59 29.79 4.67 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 0.2 OUTLIER -119.77 82.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.35 142.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.58 ' HB2' ' HA ' ' B' ' 63' ' ' TYR . 0.9 OUTLIER -132.55 155.63 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.687 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -128.5 129.03 45.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.403 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -119.69 160.29 22.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.666 0.27 . . . . 0.0 111.504 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.2 99.03 0.12 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.721 ' HB2' HD11 ' B' ' 45' ' ' LEU . 11.1 p -122.79 179.49 4.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.435 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -140.47 146.28 38.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.836 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.4 m-80 -111.77 150.02 30.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.369 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.47 HG13 ' O ' ' B' ' 56' ' ' PHE . 3.9 pt -156.18 150.96 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' C' ' 80' ' ' SER . 73.8 mt-10 -96.32 130.55 43.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 1.175 ' O ' HG13 ' B' ' 54' ' ' VAL . 5.6 t-105 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.728 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.655 -0.178 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 t70 70.08 136.74 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.934 0.397 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -133.47 -64.69 0.71 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.28 24.82 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.001 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -98.51 149.11 23.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.744 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.58 ' HB3' ' CE1' ' A' ' 8' ' ' HIS . 30.8 m95 -98.03 -79.19 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.743 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.2 m 61.9 45.13 7.77 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.306 -0.407 . . . . 0.0 109.992 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.667 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 22.3 m170 -89.69 -48.88 0.39 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.807 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -52.62 105.24 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.404 2.069 . . . . 0.0 111.956 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 8' ' ' HIS . 89.6 mt-30 -104.99 -62.26 1.36 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.983 0.42 . . . . 0.0 111.165 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -121.55 171.02 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.711 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.03 25.99 1.89 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.503 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HE2' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -68.92 -49.48 57.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.5 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.28 -24.83 59.44 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.297 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.88 90.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 0.0 110.875 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.785 ' HA ' ' HD2' ' A' ' 19' ' ' ARG . 13.5 m-70 -80.19 -26.65 39.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.986 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HD3' ' HE2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.97 -44.82 88.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.528 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.29 -26.56 62.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.321 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.785 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 47.9 mtt-85 -66.23 -53.73 33.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.742 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.82 -26.96 61.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.94 0.4 . . . . 0.0 111.188 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.89 -59.99 4.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.556 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -74.71 -47.76 29.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 54.4 mtp85 -74.87 -37.58 62.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.76 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.711 HD11 HD22 ' B' ' 25' ' ' LEU . 2.8 mm? -63.77 -52.67 59.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -57.0 -42.48 80.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.45 -31.68 72.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.276 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -45.88 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.476 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -66.73 -31.47 72.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.964 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.37 -35.9 71.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.81 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.646 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -71.96 -39.61 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.8 m -75.85 -30.88 21.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.589 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 26.2 m-20 -68.38 -45.46 72.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.646 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.7 ptpt -75.51 -40.61 56.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.31 99.05 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.383 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.502 HD21 ' HG ' ' B' ' 36' ' ' LEU . 0.6 OUTLIER -74.37 -27.05 60.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -70.08 -41.48 74.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.465 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 8.2 t -82.98 -38.95 21.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.781 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.487 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 3.2 t -57.99 -55.78 30.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.496 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -60.74 -33.6 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.433 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.13 76.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.668 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 64.7 tp -81.06 -35.79 31.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.079 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 84.2 m-20 -75.3 -14.38 60.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.85 -22.31 65.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.171 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.748 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.3 mm? -74.32 165.83 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.875 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.558 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 2.5 p90 -157.06 -3.3 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 111.663 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 9.1 mt-30 65.43 125.04 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.912 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -88.49 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.673 2.249 . . . . 0.0 112.589 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 11.5 m-30 66.93 -177.51 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.53 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.279 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -79.96 -12.51 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.168 0.587 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.34 52.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.266 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -163.95 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.57 141.72 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.526 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -120.93 114.17 21.16 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.698 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.72 130.46 35.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.262 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.748 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 36.9 p -109.47 126.69 53.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.6 129.75 7.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.406 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.604 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -174.25 165.18 36.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.558 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 69' ' ' LEU . 16.0 m -119.44 160.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.339 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.24 17.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.489 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -170.15 137.88 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.552 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.589 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 17.8 t80 -123.87 135.0 53.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.708 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 1.7 mmm180 68.54 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.074 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.65 23.51 1.12 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.139 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.0 m -128.86 141.74 51.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.91 27.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -145.92 173.83 11.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.564 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -121.88 143.29 49.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.776 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -130.75 135.39 47.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.707 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.467 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 174.02 -178.49 45.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.446 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.31 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.85 28.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.283 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.66 134.49 50.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.165 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -122.46 126.22 47.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.733 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.42 137.99 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 29.8 m-20 60.93 -96.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 111.083 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.36 -19.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.594 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.0 p -73.19 -62.13 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.014 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.69 146.34 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.515 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.749 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -147.39 156.16 42.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.265 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.19 147.2 29.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.683 ' HE3' HG21 ' A' ' 57' ' ' THR . 10.9 tmtt? -150.49 138.83 20.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.155 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.069 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 164.0 -176.0 40.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.529 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 p -142.98 137.68 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.554 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -108.89 144.55 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -117.91 114.55 23.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -120.19 130.81 54.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.599 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.49 -115.84 8.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.242 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.59 7.26 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.343 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 24.74 0.27 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.204 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.435 ' CG ' ' HD2' ' A' ' 34' ' ' LYS . 18.3 m-20 -127.51 80.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.9 t -112.32 139.18 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 110.684 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.554 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 6.8 ptp -133.23 141.31 47.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -112.52 126.01 54.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.475 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.71 152.11 26.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 111.402 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.54 87.24 0.39 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.791 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.612 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 11.3 m -118.25 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.441 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -132.4 147.62 52.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.922 0.392 . . . . 0.0 111.136 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.749 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 49.1 m-80 -111.77 130.55 55.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.34 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.02 115.99 22.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' CG ' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -118.68 158.83 24.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.404 -0.808 . . . . 0.0 110.643 179.696 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 t70 70.15 136.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -133.52 -64.76 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.818 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.26 24.84 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.046 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -98.55 149.11 23.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.786 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.578 ' HB3' ' CE1' ' B' ' 8' ' ' HIS . 30.9 m95 -98.06 -79.19 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.703 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m 61.92 45.15 7.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.952 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.691 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 22.2 m170 -89.7 -48.88 0.39 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.77 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.3 Cg_exo -52.6 105.15 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.495 2.13 . . . . 0.0 111.962 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' B' ' 8' ' ' HIS . 89.7 mt-30 -104.94 -62.2 1.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.947 0.403 . . . . 0.0 111.152 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -121.6 171.02 9.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.674 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.1 26.05 1.87 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.476 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -49.43 58.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.564 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.29 -24.85 59.49 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.27 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.72 -42.93 90.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 110.92 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.786 ' HA ' ' HD2' ' B' ' 19' ' ' ARG . 13.5 m-70 -80.11 -26.75 39.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.016 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -44.87 88.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.578 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.35 -26.49 62.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.786 ' HD2' ' HA ' ' B' ' 16' ' ' HIS . 47.9 mtt-85 -66.27 -53.68 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -72.84 -26.99 61.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.8 -60.03 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.83 -17.84 64.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.68 -47.77 29.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.41 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 54.4 mtp85 -74.93 -37.54 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.759 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.711 HD22 HD11 ' A' ' 25' ' ' LEU . 2.8 mm? -63.73 -52.68 59.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.96 -42.58 80.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' B' ' 27' ' ' LYS . 0.9 OUTLIER -63.38 -31.77 73.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.238 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -45.88 92.67 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.46 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -66.69 -31.5 72.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -71.34 -35.93 71.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.662 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.0 OUTLIER -71.89 -39.74 69.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.8 m -75.76 -30.92 21.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.586 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 26.1 m-20 -68.4 -45.34 72.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.016 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.7 ptpt -75.52 -40.62 56.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.806 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.3 99.16 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.32 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.502 ' HG ' HD21 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.36 -27.03 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.456 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -70.02 -41.56 74.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.472 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 8.2 t -82.96 -38.93 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.491 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.2 t -58.08 -55.8 30.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.498 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -60.74 -33.58 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.363 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -34.11 76.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.65 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 64.7 tp -81.08 -35.78 31.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 84.1 m-20 -75.29 -14.31 60.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 28.9 t -67.93 -22.36 65.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.088 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.76 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -74.2 165.8 24.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.901 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.561 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 2.5 p90 -157.07 -3.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 65.39 125.02 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.954 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -88.51 109.24 0.55 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.722 2.282 . . . . 0.0 112.557 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 11.5 m-30 66.88 -177.5 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.6 57.49 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.314 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -79.92 -12.53 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.162 0.585 . . . . 0.0 112.459 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.3 52.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.213 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -164.0 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.644 0.259 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.52 141.71 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.552 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -120.9 114.27 21.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.968 0.414 . . . . 0.0 111.701 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -82.83 130.43 35.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.299 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.76 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.2 p -109.41 126.7 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.023 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.77 7.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.461 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.609 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -174.24 165.15 36.6 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.563 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' B' ' 69' ' ' LEU . 16.0 m -119.41 160.79 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.52 -168.18 16.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.467 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -170.13 137.84 4.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.617 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.586 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 17.8 t80 -123.8 135.08 53.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 1.7 mmm180 68.44 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.58 23.46 1.13 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.67 51.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.53 151.9 27.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 111.093 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -145.89 173.94 11.69 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.563 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.9 OUTLIER -121.97 143.27 49.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.764 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -130.75 135.43 47.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.687 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.479 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.0 tp -134.11 159.35 42.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.76 0.314 . . . . 0.0 111.098 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.479 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 173.96 -178.49 45.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.446 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.49 146.4 5.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.965 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.64 162.76 28.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.279 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -126.63 134.55 50.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -122.47 126.31 47.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.56 138.06 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 29.6 m-20 60.88 -96.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 111.086 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.4 -19.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 7.9 p -73.18 -62.2 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 m -91.58 146.39 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.564 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -147.47 156.11 42.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.268 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.14 147.19 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.617 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.675 ' HE3' HG21 ' B' ' 57' ' ' THR . 11.0 tmtt? -150.48 138.87 20.44 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.47 173.29 14.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 164.0 -175.95 40.07 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.565 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.99 137.71 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -108.89 144.52 36.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.321 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -117.99 114.56 23.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.228 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -120.21 130.76 54.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.605 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.57 -115.86 8.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.326 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 15.6 m -146.6 7.24 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 111.36 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.89 24.72 0.27 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.213 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.436 ' CG ' ' HD2' ' B' ' 34' ' ' LYS . 18.2 m-20 -127.51 80.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.42 139.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.06 0.457 . . . . 0.0 110.633 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.552 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 6.8 ptp -133.18 141.28 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.678 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.51 126.03 54.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.437 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.62 152.09 26.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 111.493 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.53 87.27 0.4 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.843 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.604 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 11.3 m -118.24 166.22 12.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.396 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -132.37 147.61 52.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.939 0.399 . . . . 0.0 111.065 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 49.3 m-80 -111.71 130.62 55.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.412 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.99 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.442 ' CG ' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -118.78 158.8 24.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.634 179.75 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.679 -0.168 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 t70 70.19 136.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.903 0.383 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -133.53 -64.83 0.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.783 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.25 24.75 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -98.53 149.12 23.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.841 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . 0.585 ' HB3' ' CE1' ' C' ' 8' ' ' HIS . 30.9 m95 -98.09 -79.06 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.747 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 69.1 m 61.86 45.09 7.88 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.054 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.684 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 22.2 m170 -89.73 -48.83 0.39 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.793 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.684 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -52.61 105.09 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.55 2.166 . . . . 0.0 111.924 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' C' ' 8' ' ' HIS . 89.6 mt-30 -104.86 -62.25 1.36 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.954 0.407 . . . . 0.0 111.203 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -121.58 171.03 9.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.676 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.13 26.07 1.87 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.462 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.416 ' HE2' ' HD3' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -68.91 -49.44 58.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.517 -179.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.34 -24.88 59.64 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.258 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -42.86 90.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . 0.773 ' HA ' ' HD2' ' C' ' 19' ' ' ARG . 13.5 m-70 -80.2 -26.75 39.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.957 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.416 ' HD3' ' HE2' ' C' ' 13' ' ' LYS . 0.4 OUTLIER -64.92 -44.84 88.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.499 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.4 -26.46 62.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.243 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . 0.773 ' HD2' ' HA ' ' C' ' 16' ' ' HIS . 47.7 mtt-85 -66.29 -53.68 33.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.8 -26.97 61.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.186 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.92 -60.0 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.53 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -65.8 -17.85 64.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -74.67 -47.74 30.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.425 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 54.5 mtp85 -74.95 -37.51 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.785 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.683 HD22 HD11 ' B' ' 25' ' ' LEU . 2.8 mm? -63.87 -52.57 59.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -57.05 -42.49 80.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 27' ' ' LYS . 0.9 OUTLIER -63.51 -31.71 72.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.609 0.242 . . . . 0.0 111.215 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' C' ' 28' ' ' LEU . 0.0 OUTLIER -61.25 -45.97 92.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . 0.467 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -66.65 -31.51 72.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.975 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -71.35 -35.79 71.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.873 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.665 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -72.05 -39.62 68.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.282 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.8 m -75.83 -30.84 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.605 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 26.1 m-20 -68.45 -45.35 72.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.665 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.7 ptpt -75.58 -40.62 56.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.6 -42.14 99.11 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.395 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.499 HD21 ' HG ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -74.47 -27.08 60.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.833 0.349 . . . . 0.0 111.043 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.459 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -70.04 -41.49 74.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.458 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 8.2 t -83.08 -38.82 21.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.486 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 3.2 t -58.02 -55.85 29.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.494 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -60.75 -33.52 73.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.447 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.06 76.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.946 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.646 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 64.8 tp -81.14 -35.75 31.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 84.2 m-20 -75.33 -14.33 60.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -67.82 -22.37 65.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.158 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -74.27 165.83 24.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.862 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.553 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 2.5 p90 -157.1 -3.24 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.126 0.488 . . . . 0.0 111.654 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 9.0 mt-30 65.42 124.97 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.988 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -88.45 109.26 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.643 2.229 . . . . 0.0 112.591 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 11.5 m-30 66.8 -177.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.944 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.63 57.5 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.258 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -79.84 -12.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.195 0.598 . . . . 0.0 112.466 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.45 52.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.265 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.96 -164.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.615 0.245 . . . . 0.0 110.573 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.54 141.69 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.56 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -120.94 114.19 21.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.65 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -82.67 130.45 35.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.3 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.75 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 37.1 p -109.41 126.7 53.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.987 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.66 129.71 7.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.395 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.612 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -174.23 165.23 36.72 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.512 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' C' ' 69' ' ' LEU . 16.0 m -119.43 160.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.46 -168.24 16.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.478 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -170.17 137.86 4.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.605 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 17.9 t80 -123.8 135.14 53.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 110.702 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 1.7 mmm180 68.39 -89.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 78.2 p -147.6 23.45 1.13 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -128.85 141.77 51.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.807 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -110.59 151.83 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.09 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -145.83 173.93 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.578 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.431 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.9 OUTLIER -121.97 143.25 49.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.716 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.646 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -130.74 135.38 47.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.65 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.477 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.0 tp -134.1 159.31 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.706 0.288 . . . . 0.0 111.203 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.477 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 174.05 -178.47 45.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.434 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.9 p -166.54 146.4 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.995 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.68 162.78 28.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.262 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -126.66 134.57 50.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.365 . . . . 0.0 111.148 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -122.44 126.21 47.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.778 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.48 137.97 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 29.8 m-20 60.99 -96.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.063 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 179.39 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.612 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 8.1 p -73.14 -62.18 1.56 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.66 146.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.762 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -147.42 156.16 42.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 17.1 tp -148.15 147.21 29.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.591 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.693 ' HE3' HG21 ' C' ' 57' ' ' THR . 10.9 tmtt? -150.53 138.85 20.36 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.34 14.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 163.95 -175.85 40.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.597 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.01 137.71 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -108.95 144.53 36.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.357 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -117.87 114.61 23.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.261 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -120.12 130.8 54.8 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -115.76 7.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -146.67 7.22 0.96 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.29 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t -157.92 24.8 0.27 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.235 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.432 ' CG ' ' HD2' ' C' ' 34' ' ' LYS . 18.5 m-20 -127.62 80.84 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 65.1 t -112.34 139.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.67 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.55 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 6.8 ptp -133.25 141.34 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.733 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.59 125.97 54.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -109.55 152.06 25.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.504 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.52 87.19 0.39 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.815 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.609 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 11.1 m -118.26 166.24 12.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -132.43 147.56 52.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.912 0.386 . . . . 0.0 111.058 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.762 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 49.4 m-80 -111.71 130.57 55.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.06 115.97 22.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -118.71 158.79 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.688 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 12.1 t70 80.82 131.77 0.05 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -133.55 -72.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.817 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.33 33.84 0.64 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.972 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 p -90.82 158.96 16.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.809 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -101.76 -81.98 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.732 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 m 52.37 43.65 30.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.95 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.826 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 33.8 m80 -77.55 -52.7 1.67 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.807 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -59.22 116.25 3.14 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.467 2.111 . . . . 0.0 111.954 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -106.82 -67.31 0.95 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.031 0.443 . . . . 0.0 111.142 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -110.86 176.62 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.623 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.97 22.66 0.76 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.454 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.81 -47.07 19.78 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.499 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.37 -30.55 61.7 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.242 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.86 96.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 0.0 110.941 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -72.6 -39.36 67.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.018 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.667 ' HB2' ' HE2' ' B' ' 17' ' ' LYS . 0.3 OUTLIER -63.01 -31.32 72.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.525 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -35.02 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 111.26 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.19 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.459 HE22 ' HG ' ' C' ' 21' ' ' LEU . 1.7 pp0? -60.44 -28.38 68.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.696 HD11 ' HD3' ' B' ' 24' ' ' ARG . 2.2 tm? -64.99 -59.43 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.81 -23.08 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.05 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.01 -55.18 15.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.696 ' HD3' HD11 ' C' ' 21' ' ' LEU . 69.5 mtp85 -70.34 -38.21 74.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.779 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.929 HD11 HD22 ' B' ' 25' ' ' LEU . 3.7 mm? -63.75 -48.28 77.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.04 -31.73 73.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 2.1 ttpp -65.34 -42.59 92.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.692 0.282 . . . . 0.0 111.288 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -63.35 -43.93 96.31 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.17 -30.01 64.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.925 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.589 HG22 ' HE2' ' A' ' 34' ' ' LYS . 5.6 m -79.71 -29.67 40.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.792 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 -26.64 46.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.32 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.62 -28.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.219 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.643 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 76.1 m-20 -75.95 -45.07 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.984 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.589 ' HE2' HG22 ' A' ' 30' ' ' THR . 5.2 ptpt -84.1 -29.1 27.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.74 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 39' ' ' SER . . . -68.65 -42.42 80.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.422 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.5 mt -80.58 -25.59 38.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.105 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.19 -41.38 58.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.49 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 10.4 t -77.47 -42.58 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.758 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -62.39 -50.87 69.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.467 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . . . -59.97 -36.95 78.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.34 -42.59 44.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -71.65 -7.87 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.77 -23.84 63.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.147 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.7 mm? -82.19 165.82 20.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.862 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.7 p90 -153.28 -3.85 0.2 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.636 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HB3' ' CB ' ' A' ' 55' ' ' ASN . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.922 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -79.65 113.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.613 2.209 . . . . 0.0 112.487 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.43 173.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.016 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 52.98 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.23 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 7.6 p -72.57 -3.83 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.162 0.585 . . . . 0.0 112.45 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 145.57 52.56 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.341 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -169.6 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 110.615 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 75' ' ' TYR . 12.4 p -109.56 142.66 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.573 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' GLN . 23.9 m-80 -122.88 119.0 29.21 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 58' ' ' ALA . 34.6 t80 -87.25 133.85 33.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.242 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.551 HG21 ' CE ' ' A' ' 84' ' ' LYS . 81.8 p -115.35 120.03 38.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 56' ' ' PHE . . . -150.65 135.4 17.39 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.425 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.51 169.03 39.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.534 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 69' ' ' LEU . 15.6 m -120.57 154.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.26 -172.83 13.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.437 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.0 140.2 6.22 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.643 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 31.9 t80 -133.25 135.1 44.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.708 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.2 mmm180 66.61 -93.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.125 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 p -145.68 31.16 1.07 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.44 141.02 45.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.33 153.9 22.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.08 170.57 17.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.541 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -119.38 141.15 49.32 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . . . -126.23 140.78 52.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.732 0.301 . . . . 0.0 111.637 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -140.95 151.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.093 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.12 174.72 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.438 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.97 155.05 5.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.23 173.13 29.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.252 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.559 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 44.6 t80 -126.48 135.48 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.14 135.34 52.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.754 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.431 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 7.6 p -119.35 137.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.34 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 90.4 m-20 64.13 -94.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 6.2 pt-20 179.11 -23.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.604 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.92 -63.95 1.0 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.536 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.005 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -141.27 152.0 44.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.247 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 63.5 tp -134.37 140.28 46.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.551 ' CE ' HG21 ' A' ' 57' ' ' THR . 7.3 tmtt? -155.58 126.28 6.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.72 178.05 10.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.96 36.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.56 141.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 111.165 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.734 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -111.72 139.4 47.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.346 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -114.02 114.39 26.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.173 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -123.44 135.96 54.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.639 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.448 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 57.09 -116.81 8.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.31 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 72.5 m -148.61 16.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.74 0.305 . . . . 0.0 111.316 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.71 20.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.19 68.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.96 139.04 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.73 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.734 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 3.3 ptp -133.26 132.97 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.748 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -110.74 118.59 36.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -107.11 152.68 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.12 0.65 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.773 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 21.6 m -123.82 176.31 6.37 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.448 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.48 139.44 25.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.922 0.392 . . . . 0.0 111.105 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 1.005 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 70.6 m-80 -103.2 132.8 49.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.346 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.59 117.39 17.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.802 0.334 . . . . 0.0 110.811 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.75 151.92 36.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 27.9 m-90 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.613 179.743 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 12.0 t70 80.8 131.72 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -133.43 -72.59 0.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.821 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.27 33.87 0.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.971 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 28.5 p -90.78 158.95 16.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.756 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -101.8 -82.01 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.69 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 47.2 m 52.41 43.58 30.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.012 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.829 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 33.9 m80 -77.53 -52.76 1.67 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.79 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.829 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -59.12 116.17 3.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.482 2.121 . . . . 0.0 111.931 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -106.85 -67.25 0.96 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.936 0.398 . . . . 0.0 111.144 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -110.85 176.68 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.638 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.97 22.69 0.76 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.463 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.91 -47.01 19.68 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.462 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.39 -30.53 61.72 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.246 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.85 96.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.893 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -72.57 -39.37 67.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.063 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.667 ' HE2' ' HB2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -62.94 -31.43 72.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.53 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.41 -35.16 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.194 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -63.74 -59.24 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.446 HE22 ' HG ' ' A' ' 21' ' ' LEU . 1.7 pp0? -60.37 -28.45 68.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.173 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.705 HD11 ' HD3' ' C' ' 24' ' ' ARG . 2.1 tm? -64.85 -59.56 4.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.574 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -65.77 -23.0 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.059 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.08 -55.16 15.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.696 ' HD3' HD11 ' A' ' 21' ' ' LEU . 69.5 mtp85 -70.36 -38.19 74.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.934 HD11 HD22 ' C' ' 25' ' ' LEU . 3.7 mm? -63.8 -48.34 77.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.588 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.98 -31.66 72.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.591 ' HZ1' HD22 ' B' ' 28' ' ' LEU . 2.1 ttpp -65.48 -42.61 92.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.199 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.591 HD22 ' HZ1' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -63.22 -44.02 96.47 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.21 -29.96 64.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.926 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.591 HG22 ' HE2' ' B' ' 34' ' ' LYS . 5.6 m -79.75 -29.55 40.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -26.54 46.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.326 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.71 -28.57 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.142 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.657 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 76.2 m-20 -75.97 -44.99 37.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.988 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' B' ' 30' ' ' THR . 5.3 ptpt -84.19 -29.04 26.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.715 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' B' ' 39' ' ' SER . . . -68.79 -42.29 79.74 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.419 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.462 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.5 mt -80.66 -25.54 38.21 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.752 0.311 . . . . 0.0 111.034 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.11 -41.52 58.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.51 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 10.4 t -77.39 -42.6 35.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.785 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 0.9 OUTLIER -62.38 -50.87 69.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.88 85.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.475 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' B' ' 70' ' ' ALA . . . -59.94 -37.04 78.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.405 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 39.7 tp -76.33 -42.53 44.65 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.07 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -71.68 -7.87 50.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.4 t -69.73 -23.89 63.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.316 -0.856 . . . . 0.0 113.172 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.564 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.7 mm? -82.18 165.88 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.883 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 7.7 p90 -153.35 -3.8 0.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.109 0.48 . . . . 0.0 111.671 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.435 ' HB3' ' CB ' ' B' ' 55' ' ' ASN . 10.1 mt-30 72.03 117.26 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -79.55 113.53 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.645 2.23 . . . . 0.0 112.506 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.48 173.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.71 53.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.289 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 7.7 p -72.57 -3.9 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.117 0.567 . . . . 0.0 112.465 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 145.58 52.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.248 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 -169.58 3.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.611 0.243 . . . . 0.0 110.606 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' B' ' 75' ' ' TYR . 12.4 p -109.59 142.65 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.538 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.435 ' CB ' ' HB3' ' B' ' 47' ' ' GLN . 24.0 m-80 -122.91 118.97 29.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.93 0.395 . . . . 0.0 111.697 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.447 ' HE2' ' HB2' ' B' ' 58' ' ' ALA . 34.5 t80 -87.17 133.83 33.6 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.245 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.558 HG21 ' CE ' ' B' ' 84' ' ' LYS . 81.8 p -115.38 119.95 37.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.949 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.447 ' HB2' ' HE2' ' B' ' 56' ' ' PHE . . . -150.58 135.43 17.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.475 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.479 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.49 168.98 39.25 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.539 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' B' ' 69' ' ' LEU . 15.6 m -120.52 154.79 23.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.806 0.336 . . . . 0.0 111.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.33 -172.81 13.38 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.409 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.01 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.657 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 32.0 t80 -133.21 134.98 44.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.74 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.2 mmm180 66.69 -93.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.087 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.63 31.14 1.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.173 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.47 140.98 45.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.35 153.93 22.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.62 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.579 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.531 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -119.5 141.2 49.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' B' ' 41' ' ' ALA . . . -126.25 140.64 52.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 71' ' ' ILE . 8.3 tp -140.9 151.84 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.742 0.306 . . . . 0.0 111.11 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.21 174.65 39.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.396 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.94 155.12 5.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.342 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.21 173.19 29.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.245 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.557 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 44.8 t80 -126.55 135.58 51.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.22 135.34 52.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.659 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.437 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 7.6 p -119.4 137.4 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 90.2 m-20 64.11 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 6.2 pt-20 179.1 -23.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.589 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 17.5 p -70.8 -63.98 0.99 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.98 143.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.58 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -141.29 152.07 44.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.271 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 63.6 tp -134.32 140.2 46.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.604 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.558 ' CE ' HG21 ' B' ' 57' ' ' THR . 7.3 tmtt? -155.6 126.13 6.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.141 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.44 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.59 178.07 10.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.69 -167.88 36.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.534 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.411 ' O ' HG22 ' B' ' 71' ' ' ILE . 7.7 p -143.66 141.44 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.74 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -111.82 139.35 47.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.325 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -113.95 114.37 26.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.205 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -123.36 136.01 54.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.644 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 57.06 -116.92 8.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.248 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.52 16.64 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.75 20.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.197 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -119.22 68.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.957 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.14 139.06 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.74 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 3.3 ptp -133.31 132.99 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.74 118.63 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.415 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.13 152.66 23.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.685 0.279 . . . . 0.0 111.412 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.98 94.11 0.65 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.472 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 21.8 m -123.81 176.44 6.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.391 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -146.65 139.45 25.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.029 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.954 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 70.6 m-80 -103.22 132.79 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.362 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.35 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.78 151.93 36.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.651 179.706 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.677 -0.169 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' C' ' 1' ' ' GLY . 12.0 t70 80.67 131.82 0.05 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 110.966 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -133.51 -72.56 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.802 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.3 33.82 0.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.99 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 28.4 p -90.75 159.03 16.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.807 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -101.8 -81.98 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.729 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 47.0 m 52.38 43.59 30.72 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.991 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.808 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 33.9 m80 -77.64 -52.63 1.66 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.803 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.808 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -59.11 116.25 3.13 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.575 2.183 . . . . 0.0 111.857 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -106.91 -67.28 0.96 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -110.87 176.67 4.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.668 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.94 22.57 0.77 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.87 -46.99 19.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.496 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.36 -30.55 61.66 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.275 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.87 96.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 0.0 110.904 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -72.63 -39.32 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.994 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.65 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -62.98 -31.38 72.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.55 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.5 -34.99 65.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.259 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -63.84 -59.18 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.457 HE22 ' HG ' ' B' ' 21' ' ' LEU . 1.7 pp0? -60.44 -28.36 68.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.136 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.696 HD11 ' HD3' ' A' ' 24' ' ' ARG . 2.1 tm? -64.98 -59.44 4.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.631 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -65.86 -22.96 66.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.07 -55.17 15.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.705 ' HD3' HD11 ' B' ' 21' ' ' LEU . 69.6 mtp85 -70.33 -38.16 74.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.934 HD22 HD11 ' B' ' 25' ' ' LEU . 3.7 mm? -63.89 -48.36 76.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.87 -31.74 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.437 ' HZ1' HD22 ' C' ' 28' ' ' LEU . 2.0 ttpp -65.47 -42.51 92.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' C' ' 28' ' ' LEU . 0.0 OUTLIER -63.28 -44.0 96.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -29.96 64.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.936 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.582 HG22 ' HE2' ' C' ' 34' ' ' LYS . 5.6 m -79.8 -29.55 40.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -26.63 46.49 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.357 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.55 -28.72 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.143 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.654 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 76.2 m-20 -75.88 -45.11 37.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.005 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.582 ' HE2' HG22 ' C' ' 30' ' ' THR . 5.3 ptpt -84.08 -29.07 27.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.806 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' C' ' 39' ' ' SER . . . -68.6 -42.39 80.82 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.462 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.5 mt -80.61 -25.63 38.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.801 0.334 . . . . 0.0 111.06 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.45 57.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.402 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 10.5 t -77.43 -42.6 35.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' C' ' 35' ' ' GLY . 0.9 OUTLIER -62.3 -50.92 69.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.86 85.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' C' ' 70' ' ' ALA . . . -59.92 -37.02 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.94 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.41 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 39.6 tp -76.25 -42.65 45.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.035 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -71.66 -7.9 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.7 t -69.71 -23.91 63.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.149 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.547 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.7 mm? -82.26 165.78 20.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.813 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 7.7 p90 -153.26 -3.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.651 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' C' ' 55' ' ' ASN . 10.0 mt-30 72.12 117.31 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.963 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.735 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -79.61 113.5 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.667 2.245 . . . . 0.0 112.514 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 56.47 173.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.985 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.73 53.02 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.229 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 7.7 p -72.58 -3.85 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 145.6 52.65 0.03 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.22 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.603 0.239 . . . . 0.0 110.655 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' C' ' 75' ' ' TYR . 12.4 p -109.6 142.62 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.567 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.439 ' CB ' ' HB3' ' C' ' 47' ' ' GLN . 24.0 m-80 -122.91 118.99 29.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.646 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.454 ' HE2' ' HB2' ' C' ' 58' ' ' ALA . 34.4 t80 -87.19 133.77 33.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.282 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.565 HG21 ' CE ' ' C' ' 84' ' ' LYS . 81.9 p -115.31 120.01 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.983 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.454 ' HB2' ' HE2' ' C' ' 56' ' ' PHE . . . -150.66 135.38 17.36 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.473 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.48 168.95 39.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' C' ' 69' ' ' LEU . 15.6 m -120.52 154.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.806 0.336 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.31 -172.88 13.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.466 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.0 140.23 6.24 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.574 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.654 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 32.1 t80 -133.19 134.99 44.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 110.812 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.2 mmm180 66.64 -93.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.133 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 13.0 p -145.61 31.12 1.08 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -135.43 141.05 45.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.781 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -108.39 153.91 22.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.1 170.54 17.56 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.539 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.53 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -119.43 141.18 49.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.747 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' C' ' 41' ' ' ALA . . . -126.24 140.69 52.34 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.702 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.408 HG22 ' O ' ' C' ' 87' ' ' VAL . 8.3 tp -140.88 151.83 20.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.14 174.72 39.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.468 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.4 p -169.93 155.09 5.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.24 173.15 29.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.269 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.554 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 44.6 t80 -126.56 135.54 51.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.342 . . . . 0.0 111.172 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -125.17 135.39 52.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.666 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.444 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 7.5 p -119.43 137.39 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 90.2 m-20 64.15 -94.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 6.2 pt-20 179.07 -23.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.527 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 16.9 p -70.99 -63.87 1.02 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.992 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.95 143.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.965 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -141.28 152.07 44.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.257 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 63.3 tp -134.37 140.22 46.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.565 ' CE ' HG21 ' C' ' 57' ' ' THR . 7.3 tmtt? -155.6 126.23 6.87 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.68 177.99 10.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.71 -167.82 36.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.58 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . 0.408 ' O ' HG22 ' C' ' 71' ' ' ILE . 7.7 p -143.74 141.45 25.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -111.73 139.31 47.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.316 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -113.97 114.45 26.2 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -123.45 135.95 54.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.624 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 57.11 -116.86 8.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.248 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 72.7 m -148.58 16.5 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 111.252 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -167.73 20.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.238 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -119.25 68.68 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 24.9 t -94.99 139.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.738 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.745 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 3.3 ptp -133.28 132.99 42.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.701 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -110.8 118.64 36.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.433 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -107.05 152.64 23.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.727 0.298 . . . . 0.0 111.432 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -164.99 94.1 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.479 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 21.8 m -123.8 176.37 6.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.432 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -146.59 139.42 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.988 0.423 . . . . 0.0 111.101 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.965 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 70.6 m-80 -103.21 132.8 49.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.37 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 117.3 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.781 0.324 . . . . 0.0 110.798 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.77 151.94 36.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.71 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.619 -0.192 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 20.3 t70 79.74 131.61 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 110.882 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -131.9 -67.66 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.66 28.04 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.013 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 p -92.21 153.68 19.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.764 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -106.48 -82.0 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.71 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m 53.75 41.88 31.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.991 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.801 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 36.7 m80 -72.6 -51.64 6.95 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.793 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.801 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -50.67 111.87 0.64 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.457 2.105 . . . . 0.0 111.878 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 8' ' ' HIS . 69.6 mt-30 -110.42 -73.21 0.69 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.966 0.413 . . . . 0.0 111.155 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -109.52 177.15 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.711 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.68 20.15 0.81 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.441 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -47.76 35.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.56 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.06 -34.66 58.48 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.216 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.32 -44.85 96.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.867 0.365 . . . . 0.0 110.875 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -68.32 -41.1 81.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.029 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -59.99 -37.61 80.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.534 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.79 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.33 -60.07 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.6 -28.13 69.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.706 ' O ' HD23 ' A' ' 25' ' ' LEU . 2.4 tm? -63.37 -54.61 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.536 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' NH2' ' B' ' 24' ' ' ARG . 30.2 m-20 -65.28 -27.07 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.981 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.49 -57.53 8.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.703 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.0 mtp85 -61.6 -38.55 87.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.818 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.797 HD11 HD22 ' B' ' 25' ' ' LEU . 3.1 mm? -62.18 -48.64 79.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.531 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.9 -28.94 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.772 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' NZ ' ' HD3' ' A' ' 31' ' ' ARG . 1.2 ttpp -65.15 -44.01 89.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.642 0.258 . . . . 0.0 111.223 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.444 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -59.58 -41.66 90.74 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.553 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -61.1 -27.71 68.57 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.939 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 m -75.58 -39.82 57.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HD3' ' NZ ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -73.06 -22.81 60.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.334 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.6 m -90.28 -28.65 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.144 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.632 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 65.1 m-20 -73.63 -47.74 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 91' ' ' GLY . 7.9 ptpt -80.8 -28.47 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.759 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.92 53.82 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.422 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 1.6 mt -75.0 -32.22 61.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 111.127 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.2 -41.17 70.62 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.447 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.745 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 9.0 t -74.8 -41.52 59.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.802 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -60.01 -53.34 58.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.087 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -60.22 -34.04 73.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.339 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.784 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.33 -41.45 93.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.25 -42.14 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.071 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.494 ' ND2' ' HA ' ' C' ' 40' ' ' ALA . 9.2 m-20 -72.09 -9.87 59.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 t -68.49 -22.68 64.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.189 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.648 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.6 mm? -82.7 159.17 22.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.875 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.16 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.647 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' OE1' ' HA3' ' A' ' 74' ' ' GLY . 13.8 mt-30 70.7 118.04 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.7 Cg_endo -78.48 114.85 3.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.585 2.19 . . . . 0.0 112.501 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.75 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.631 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 167.72 55.85 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.263 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 8.3 p -75.49 -5.5 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.136 0.575 . . . . 0.0 112.479 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.8 49.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.33 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.599 0.238 . . . . 0.0 110.649 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 p -105.86 141.63 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.524 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -122.77 117.52 25.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 111.624 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -87.72 140.59 29.36 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.281 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.648 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 68.1 p -117.23 118.97 33.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.91 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' B' ' 101' ' ' PHE . . . -144.9 132.39 20.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.476 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . 179.83 174.93 46.17 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.574 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.22 160.67 23.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.392 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.784 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -140.33 177.55 20.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.438 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -162.39 141.04 6.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.537 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.636 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 39.1 t80 -137.24 134.12 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.271 . . . . 0.0 110.815 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 64' ' ' ARG . 1.9 mmm180 62.89 -93.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 p -143.26 32.39 1.35 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.1 145.15 47.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.782 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.01 153.55 26.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.097 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.98 164.33 32.37 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.523 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.58 136.16 53.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.71 51.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.638 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.17 153.41 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.101 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 86' ' ' GLY . . . 172.89 -177.72 45.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.95 151.26 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.458 ' HA3' ' OE1' ' A' ' 47' ' ' GLN . . . -150.24 171.67 30.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.227 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.03 136.59 50.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 111.11 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.631 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 7.1 ttm180 -132.25 133.89 44.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.583 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 4.1 p -122.95 143.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.286 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.3 m-20 60.13 -88.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.986 0.422 . . . . 0.0 111.083 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 10.0 pt-20 172.21 -31.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.535 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.42 -58.92 5.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.023 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.97 138.7 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.61 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.717 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -144.79 148.39 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 111.255 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -136.37 140.3 43.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.641 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.49 ' C ' ' HD3' ' A' ' 84' ' ' LYS . 8.9 tmtt? -153.79 130.42 10.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.481 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -153.34 177.05 11.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . 166.02 -169.93 40.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.553 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.27 141.64 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.145 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -109.28 145.82 35.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.368 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -111.31 118.29 35.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.207 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.626 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 48.01 -114.3 1.79 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.286 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.15 17.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.18 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -116.34 71.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.78 132.32 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.628 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 2.7 ptp -122.69 126.67 48.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.89 111.17 23.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.436 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.32 152.43 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.322 . . . . 0.0 111.398 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.15 96.71 1.0 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.472 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 57.4 m -119.94 177.64 4.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.387 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' C' ' 58' ' ' ALA . 22.3 p90 -147.29 138.86 24.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.409 . . . . 0.0 111.082 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.728 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 74.5 m-20 -100.78 130.65 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.92 112.06 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.749 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HG2' ' HG2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -117.26 146.87 43.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.645 179.764 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.649 -0.18 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 20.3 t70 79.7 131.56 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -131.9 -67.64 0.67 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.823 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.64 28.0 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 24.2 p -92.29 153.74 19.05 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.788 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -106.49 -81.99 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.755 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m 53.69 41.87 31.97 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.022 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.791 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 36.6 m80 -72.52 -51.66 7.13 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.82 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.791 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -50.67 111.86 0.63 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.411 2.074 . . . . 0.0 111.944 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' B' ' 8' ' ' HIS . 69.6 mt-30 -110.33 -73.19 0.69 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.051 0.453 . . . . 0.0 111.177 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -109.57 177.14 4.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.726 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.73 20.24 0.8 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.478 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -47.79 35.83 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.529 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.14 -34.59 58.71 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.198 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.98 96.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -68.29 -41.11 81.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.979 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.66 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER -59.86 -37.72 80.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.531 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.11 -38.81 66.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.222 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.3 -60.11 4.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.758 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.58 -28.15 69.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.715 ' O ' HD23 ' B' ' 25' ' ' LEU . 2.4 tm? -63.32 -54.65 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.484 ' HA ' ' NH2' ' C' ' 24' ' ' ARG . 30.5 m-20 -65.39 -26.9 68.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.017 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -64.58 -57.41 9.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.695 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.0 mtp85 -61.71 -38.52 88.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.797 HD22 HD11 ' A' ' 25' ' ' LEU . 3.1 mm? -62.2 -48.55 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.92 -29.01 70.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.771 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.411 ' NZ ' ' HD3' ' B' ' 31' ' ' ARG . 1.3 ttpp -65.17 -43.92 90.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.228 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.433 ' O ' HG13 ' B' ' 32' ' ' VAL . 0.0 OUTLIER -59.61 -41.65 90.84 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.569 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -61.08 -27.67 68.53 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.988 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 4.1 m -75.73 -39.72 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.841 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.411 ' HD3' ' NZ ' ' B' ' 27' ' ' LYS . 0.6 OUTLIER -73.14 -22.79 60.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.284 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.569 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.5 m -90.19 -28.69 4.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.22 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.629 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 65.5 m-20 -73.55 -47.87 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.036 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' B' ' 91' ' ' GLY . 7.9 ptpt -80.76 -28.38 36.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.805 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.54 -40.75 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.413 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 1.6 mt -75.11 -32.15 61.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.328 . . . . 0.0 111.105 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -41.14 70.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.413 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.763 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 9.1 t -74.85 -41.62 59.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.93 -53.36 58.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.486 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -60.25 -34.0 73.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.404 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.806 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.4 -41.35 93.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.959 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 tp -72.25 -42.19 65.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.061 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 40' ' ' ALA . 9.2 m-20 -72.07 -9.89 59.02 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 37.8 t -68.5 -22.64 64.52 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.181 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.657 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.6 mm? -82.73 159.16 22.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.823 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' B' ' 47' ' ' GLN . 15.0 p90 -148.57 -2.18 0.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.649 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' B' ' 46' ' ' PHE . 13.8 mt-30 70.68 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.947 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.35 114.64 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.747 2.298 . . . . 0.0 112.571 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.82 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 167.72 55.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.316 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 8.3 p -75.59 -5.52 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.105 0.562 . . . . 0.0 112.425 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.82 49.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.209 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -173.12 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 110.629 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -105.9 141.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.516 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -122.85 117.47 25.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 111.63 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -87.71 140.56 29.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.252 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.657 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 67.9 p -117.21 118.9 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.931 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' C' ' 101' ' ' PHE . . . -144.89 132.39 20.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . 179.82 174.93 46.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.614 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.19 160.68 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.347 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.806 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -140.33 177.59 20.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.518 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -162.39 140.93 6.85 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.603 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.636 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 39.1 t80 -137.17 134.25 36.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.31 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' B' ' 64' ' ' ARG . 1.9 mmm180 62.96 -93.45 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.979 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 17.3 p -143.23 32.46 1.35 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.143 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.19 145.17 47.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.03 153.54 26.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.0 164.33 32.42 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.517 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.53 136.14 53.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.793 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.97 140.72 51.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.19 153.39 16.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.157 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 86' ' ' GLY . . . 172.9 -177.69 45.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.441 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.92 151.3 4.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.389 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.443 ' HA3' ' OE1' ' B' ' 47' ' ' GLN . . . -150.32 171.61 30.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.203 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.94 136.51 50.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.134 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.614 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 7.1 ttm180 -132.19 133.95 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.602 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 4.1 p -122.96 143.1 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.267 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 96.3 m-20 60.21 -88.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.927 0.394 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 10.0 pt-20 172.25 -31.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.555 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 15.6 p -62.49 -58.89 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.06 138.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.5 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -144.81 148.43 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.27 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 53.4 tp -136.43 140.32 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.581 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.483 ' HD3' ' C ' ' B' ' 84' ' ' LYS . 8.9 tmtt? -153.75 130.44 10.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -153.38 177.11 11.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 166.04 -169.89 40.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.592 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.34 141.65 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 111.104 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.763 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -109.32 145.91 35.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.276 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -111.38 118.28 35.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.289 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.09 140.64 52.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.581 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.482 ' N ' ' HD3' ' B' ' 34' ' ' LYS . . . 47.97 -114.24 1.75 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 39.1 m -149.57 16.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.687 0.28 . . . . 0.0 111.275 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.24 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -116.39 71.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 39.1 t -99.83 132.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.675 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.636 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 2.7 ptp -122.72 126.62 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.733 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -105.92 111.26 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.405 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.38 152.42 24.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.724 0.297 . . . . 0.0 111.459 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.18 96.74 1.0 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.467 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 56.5 m -119.96 177.64 4.91 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.428 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' ALA . 21.9 p90 -147.3 138.79 23.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 111.093 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.75 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 74.5 m-20 -100.77 130.6 46.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.433 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.85 112.05 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -117.25 146.86 43.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.677 179.721 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' C' ' 1' ' ' GLY . 20.4 t70 79.71 131.52 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.895 0.378 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -131.85 -67.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.63 27.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 24.3 p -92.28 153.7 19.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.703 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -106.46 -82.02 0.54 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m 53.75 41.87 31.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.028 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.788 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 36.7 m80 -72.56 -51.72 6.98 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.744 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.788 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -50.54 111.83 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.499 2.133 . . . . 0.0 111.884 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' C' ' 8' ' ' HIS . 69.3 mt-30 -110.4 -73.14 0.69 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.998 0.428 . . . . 0.0 111.231 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -109.64 177.07 4.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.742 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.61 20.18 0.82 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.478 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -47.74 35.83 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.546 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.08 -34.55 58.43 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.298 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.38 -44.85 96.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 110.903 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -68.29 -41.11 81.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.005 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.664 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER -59.94 -37.62 80.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.541 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.15 -38.78 66.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -61.32 -60.07 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.63 -28.17 69.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.42 . . . . 0.0 111.149 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.715 ' O ' HD23 ' C' ' 25' ' ' LEU . 2.4 tm? -63.26 -54.67 33.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.545 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . 0.481 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 30.1 m-20 -65.31 -26.99 68.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.085 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.54 -57.45 9.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.712 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.0 mtp85 -61.65 -38.58 88.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.734 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.789 HD11 HD22 ' A' ' 25' ' ' LEU . 3.1 mm? -62.14 -48.57 79.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.9 -29.01 70.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.816 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.407 ' NZ ' ' HD3' ' C' ' 31' ' ' ARG . 1.2 ttpp -65.18 -43.92 90.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.652 0.263 . . . . 0.0 111.249 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.43 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.0 OUTLIER -59.59 -41.67 90.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . 0.547 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -61.12 -27.71 68.58 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.917 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 4.1 m -75.59 -39.85 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.407 ' HD3' ' NZ ' ' C' ' 27' ' ' LYS . 0.6 OUTLIER -73.05 -22.71 60.58 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.4 m -90.27 -28.7 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.635 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 65.5 m-20 -73.63 -47.76 37.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.489 ' HD3' ' CA ' ' C' ' 91' ' ' GLY . 7.9 ptpt -80.85 -28.37 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.803 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.45 -40.85 53.63 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.478 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 1.6 mt -74.98 -32.36 61.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 111.07 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.21 70.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.44 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.743 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 9.1 t -74.81 -41.57 59.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.746 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 1.1 t -59.96 -53.28 59.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.169 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.494 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -60.27 -33.95 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.403 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . 0.773 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.44 -41.38 93.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.24 -42.23 65.89 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.073 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' B' ' 40' ' ' ALA . 9.1 m-20 -72.02 -9.84 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 37.9 t -68.54 -22.68 64.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.158 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.652 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.6 mm? -82.68 159.15 22.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.866 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' C' ' 47' ' ' GLN . 15.1 p90 -148.5 -2.28 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.619 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' C' ' 46' ' ' PHE . 13.8 mt-30 70.72 118.07 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.936 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.44 114.78 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.679 2.253 . . . . 0.0 112.487 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 53.76 -176.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.634 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 167.69 55.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.246 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 8.3 p -75.48 -5.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.178 0.591 . . . . 0.0 112.445 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.84 49.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.283 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 -173.11 4.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.644 0.259 . . . . 0.0 110.621 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.84 141.5 21.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.585 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -122.74 117.6 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 111.664 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -87.8 140.54 29.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.34 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.652 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 67.7 p -117.15 118.9 33.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.001 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 101' ' ' PHE . . . -144.87 132.39 20.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . 179.81 174.9 46.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.586 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.16 160.72 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 111.399 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -140.35 177.64 20.54 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.4 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -162.47 141.04 6.92 Favored Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.635 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 39.0 t80 -137.29 134.26 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.711 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' C' ' 64' ' ' ARG . 1.9 mmm180 62.9 -93.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.114 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -143.23 32.37 1.35 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 3.3 m -135.15 145.14 47.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -112.05 153.56 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 111.097 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.94 164.3 32.45 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.61 136.2 53.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.785 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.96 140.69 51.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 6.6 tp -143.25 153.4 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.768 0.318 . . . . 0.0 111.098 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 86' ' ' GLY . . . 172.94 -177.71 45.29 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.456 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -168.91 151.32 4.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . 0.458 ' HA3' ' OE1' ' C' ' 47' ' ' GLN . . . -150.26 171.75 30.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -129.12 136.49 50.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.634 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 7.1 ttm180 -132.11 134.09 45.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.682 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.604 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 4.1 p -123.09 143.12 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.274 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 96.3 m-20 60.15 -88.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 111.104 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 10.1 pt-20 172.18 -31.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.7 p -62.47 -58.93 5.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.942 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 32.2 m -94.05 138.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.525 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.736 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -144.9 148.39 33.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.279 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 53.6 tp -136.38 140.37 43.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 8.9 tmtt? -153.85 130.44 10.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . 0.492 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -153.37 177.1 11.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.043 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 166.0 -169.91 40.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.555 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.29 141.69 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.872 0.368 . . . . 0.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.743 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -109.28 145.84 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.339 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.38 118.2 35.17 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.277 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.02 140.63 52.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.591 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.489 ' CA ' ' HD3' ' C' ' 34' ' ' LYS . . . 48.02 -114.34 1.81 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.244 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -149.47 16.72 0.91 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.264 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -167.23 17.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -116.39 71.01 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.81 132.33 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.006 0.432 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.636 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 2.7 ptp -122.65 126.65 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -105.98 111.28 23.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.408 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -107.31 152.46 24.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.457 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.2 96.74 0.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 56.5 m -119.95 177.63 4.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.438 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' B' ' 58' ' ' ALA . 22.1 p90 -147.31 138.83 24.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.743 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 74.5 m-20 -100.79 130.62 46.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.358 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.93 112.08 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -117.24 146.87 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.705 179.681 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.2 t0 73.13 141.41 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.892 0.377 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -129.13 -63.97 0.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.74 24.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -97.22 153.69 17.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.808 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.676 ' HB3' ' CE1' ' A' ' 8' ' ' HIS . 32.0 m95 -105.68 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.739 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.8 m 61.21 46.39 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.053 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.704 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 23.6 m170 -88.19 -49.86 0.42 Allowed Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.801 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -58.48 106.95 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.469 2.113 . . . . 0.0 111.945 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -109.67 -57.31 2.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.951 0.405 . . . . 0.0 111.157 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -120.64 169.91 9.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.652 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 25.71 1.65 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.473 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.651 ' HE2' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -68.72 -50.36 51.41 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.568 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.21 -28.64 64.51 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.254 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.09 86.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.342 . . . . 0.0 110.873 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 19' ' ' ARG . 18.2 m-70 -78.45 -29.42 46.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.002 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.651 ' HD3' ' HE2' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -66.38 -41.88 88.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.561 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.82 -32.31 67.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.371 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 53.0 mtt-85 -64.1 -57.64 8.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.74 -31.18 70.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 3.2 tm? -61.98 -59.76 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.12 -18.79 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -74.13 -45.99 45.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.58 ' HB3' HD12 ' C' ' 25' ' ' LEU . 61.4 mtp85 -77.02 -37.14 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.818 HD11 HD22 ' B' ' 25' ' ' LEU . 3.3 mm? -66.42 -52.18 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.63 -42.24 92.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.3 ttpp -66.88 -28.95 68.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -48.81 78.27 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.614 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -64.33 -33.09 75.04 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.925 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -67.93 -38.83 83.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.732 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.83 64.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.278 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 29' ' ' ASP . 32.8 m -74.24 -33.46 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.641 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 16.6 m-20 -69.07 -45.28 70.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 7.3 ptpt -75.19 -40.65 59.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.729 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.43 ' HA3' ' OH ' ' C' ' 63' ' ' TYR . . . -57.37 -43.63 93.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.381 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.793 ' HG ' HD21 ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.03 -24.65 58.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.159 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.59 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -69.21 -41.96 76.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.461 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.527 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 8.5 t -82.81 -39.97 21.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.745 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.504 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 4.0 t -58.11 -54.79 43.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB1' HD21 ' B' ' 98' ' ' ASN . . . -61.5 -33.51 73.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.445 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.73 -33.6 76.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.663 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 60.1 tp -82.65 -32.37 28.27 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.712 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 87.6 m-20 -75.84 -16.34 60.09 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.85 -18.83 64.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.207 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.635 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.7 mm? -77.53 163.87 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.909 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.478 ' HE2' ' HG3' ' B' ' 84' ' ' LYS . 3.2 p90 -156.56 0.41 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HB3' ' CB ' ' A' ' 55' ' ' ASN . 6.0 mt-30 63.07 125.07 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.965 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -83.95 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.671 2.247 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.482 ' OH ' ' HB ' ' B' ' 51' ' ' VAL . 13.7 m-30 63.7 -175.3 0.16 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.569 ' HA3' ' HD2' ' A' ' 76' ' ' ARG . . . 166.69 55.44 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.237 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.9 p -81.44 -10.66 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.159 0.584 . . . . 0.0 112.432 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.67 48.17 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.284 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -150.92 -163.92 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.656 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -116.72 142.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.553 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.48 ' CB ' ' HB3' ' A' ' 47' ' ' GLN . 10.4 m-80 -124.82 113.32 17.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.677 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.55 129.64 34.98 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.273 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.701 HG21 ' HE3' ' A' ' 84' ' ' LYS . 37.7 p -109.36 122.09 46.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.992 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -154.62 133.68 12.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.436 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.46 170.49 43.31 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.531 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 69' ' ' LEU . 2.7 m -121.15 161.41 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.366 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.23 17.96 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.461 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -172.21 138.73 4.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.641 ' HD2' ' HA ' ' A' ' 33' ' ' ASP . 34.0 t80 -120.84 131.85 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.685 0.278 . . . . 0.0 110.738 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 2.4 mmm180 69.52 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.1 p -143.76 26.22 1.58 Allowed 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.159 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.38 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.33 150.96 28.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -146.55 171.79 14.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.548 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.49 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -119.98 142.8 48.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.811 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -132.62 137.19 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.686 0.279 . . . . 0.0 111.636 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.521 HG13 ' H ' ' A' ' 72' ' ' GLY . 4.5 tp -137.65 162.1 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.784 0.326 . . . . 0.0 111.05 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.521 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 171.37 179.9 42.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.397 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.61 148.77 12.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.892 0.377 . . . . 0.0 110.965 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.49 166.78 30.77 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.228 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.601 ' CE2' ' HB ' ' A' ' 77' ' ' VAL . 38.8 t80 -131.85 134.49 45.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.156 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.569 ' HD2' ' HA3' ' A' ' 50' ' ' GLY . 16.4 ttm180 -125.18 121.56 34.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.621 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 8.6 p -110.88 137.99 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 49.7 m-20 64.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' HB3' ' CE2' ' C' ' 49' ' ' TYR . 10.5 pt-20 175.42 -20.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.59 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 p -70.85 -66.36 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.032 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 m -90.85 141.34 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.589 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.47 153.82 37.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.172 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.3 tp -148.82 149.88 32.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.618 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.701 ' HE3' HG21 ' A' ' 57' ' ' THR . 12.1 tmtt? -149.34 141.67 24.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.162 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.17 176.02 11.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.44 -173.06 41.15 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.587 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.09 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.853 0.358 . . . . 0.0 111.16 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.767 ' HB3' ' HG2' ' A' ' 96' ' ' MET . . . -110.25 144.23 39.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.351 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -121.97 113.01 18.99 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.39 -116.13 8.72 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.293 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.87 8.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.322 . . . . 0.0 111.337 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t -155.03 22.62 0.44 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.108 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 10.8 m-20 -127.11 82.86 2.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.87 139.4 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.767 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 6.9 ptp -134.22 141.58 47.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -113.26 124.31 52.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.455 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.496 HD21 ' HB1' ' C' ' 40' ' ' ALA . 17.1 m120 -109.57 148.01 32.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.296 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.7 86.9 0.38 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.61 162.34 17.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.471 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -130.31 145.64 51.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.976 0.417 . . . . 0.0 111.055 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.553 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 56.0 m-80 -115.34 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.399 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.14 119.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.819 0.343 . . . . 0.0 110.726 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.92 159.8 22.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.406 -0.806 . . . . 0.0 110.598 179.693 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 112.651 -0.179 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 16.2 t0 73.12 141.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.946 0.403 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -129.12 -64.0 0.93 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.824 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.77 24.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -97.35 153.73 17.89 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.819 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.677 ' HB3' ' CE1' ' B' ' 8' ' ' HIS . 32.2 m95 -105.67 -75.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.676 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 70.8 m 61.24 46.43 7.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.981 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.728 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 23.7 m170 -88.22 -49.81 0.42 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.811 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -58.53 106.93 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.504 2.136 . . . . 0.0 111.92 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -109.61 -57.3 2.2 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.944 0.402 . . . . 0.0 111.175 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -120.71 169.96 9.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.595 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.52 25.78 1.65 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.482 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.653 ' HE2' ' HD3' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -68.72 -50.39 51.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.489 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.27 -28.54 64.53 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.262 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.96 -44.2 85.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.434 ' HA ' ' HD2' ' B' ' 19' ' ' ARG . 18.2 m-70 -78.41 -29.39 47.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.988 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.653 ' HD3' ' HE2' ' B' ' 13' ' ' LYS . 0.6 OUTLIER -66.48 -41.77 88.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.5 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.92 -32.3 67.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' B' ' 16' ' ' HIS . 53.0 mtt-85 -63.99 -57.71 8.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.707 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.83 -31.1 70.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 3.2 tm? -61.95 -59.81 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.591 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -65.07 -18.78 65.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.18 -46.0 44.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.58 ' HB3' HD12 ' A' ' 25' ' ' LEU . 61.3 mtp85 -76.94 -37.14 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.794 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.818 HD22 HD11 ' A' ' 25' ' ' LEU . 3.3 mm? -66.47 -52.16 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.641 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.61 -42.19 92.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.93 -29.02 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.245 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -48.82 78.3 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.604 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -64.46 -32.9 74.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 178.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 5.9 m -68.03 -38.81 82.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.858 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.749 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -73.3 -39.85 64.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.246 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' B' ' 29' ' ' ASP . 32.6 m -74.21 -33.41 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.223 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.644 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 16.6 m-20 -69.18 -45.25 70.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.749 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 7.3 ptpt -75.17 -40.61 59.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.434 ' HA3' ' OH ' ' A' ' 63' ' ' TYR . . . -57.37 -43.62 93.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.794 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -75.06 -24.65 58.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.592 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -69.18 -42.03 76.39 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.54 ' HB2' ' HB1' ' B' ' 68' ' ' ALA . 8.5 t -82.72 -40.01 21.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.741 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.5 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 3.9 t -58.12 -54.62 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.492 ' HB1' HD21 ' C' ' 98' ' ' ASN . . . -61.66 -33.47 74.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.409 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.69 76.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.691 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 59.6 tp -82.6 -32.29 28.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.718 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 87.4 m-20 -75.8 -16.37 60.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -67.99 -18.69 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.148 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.627 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.7 mm? -77.63 163.88 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.846 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.462 ' HE2' ' HG3' ' C' ' 84' ' ' LYS . 3.2 p90 -156.54 0.37 0.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 111.714 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.488 ' HB3' ' CB ' ' B' ' 55' ' ' ASN . 6.1 mt-30 63.15 124.98 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.967 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -83.94 109.92 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.642 2.228 . . . . 0.0 112.605 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.484 ' CE2' ' HB3' ' C' ' 79' ' ' GLU . 13.6 m-30 63.71 -175.31 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.934 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.566 ' HA3' ' HD2' ' B' ' 76' ' ' ARG . . . 166.72 55.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.245 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.9 p -81.34 -10.67 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.161 0.584 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.63 48.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.268 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.435 ' O ' ' CD1' ' B' ' 75' ' ' TYR . 0.0 OUTLIER -150.89 -163.87 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.601 0.239 . . . . 0.0 110.639 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -116.78 142.65 29.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.586 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.488 ' CB ' ' HB3' ' B' ' 47' ' ' GLN . 10.4 m-80 -124.8 113.43 17.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.973 0.416 . . . . 0.0 111.663 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.67 129.7 34.96 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.195 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.704 HG21 ' HE3' ' B' ' 84' ' ' LYS . 37.6 p -109.42 122.07 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.943 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -154.61 133.7 12.41 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.368 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.47 170.49 43.32 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' B' ' 69' ' ' LEU . 2.7 m -121.16 161.52 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.773 0.321 . . . . 0.0 111.383 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.23 -167.16 17.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.473 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.592 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -172.23 138.75 4.94 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.644 ' HD2' ' HA ' ' B' ' 33' ' ' ASP . 34.1 t80 -120.87 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.695 0.283 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 2.5 mmm180 69.47 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -143.75 26.18 1.58 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.17 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.09 141.4 51.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -110.44 151.06 27.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -146.66 171.7 14.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.537 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.493 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.8 OUTLIER -120.0 142.75 48.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.808 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.691 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -132.58 137.2 47.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.681 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.531 HG13 ' H ' ' B' ' 72' ' ' GLY . 4.5 tp -137.64 162.07 32.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.738 0.304 . . . . 0.0 111.119 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.531 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 171.34 179.87 42.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.444 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -162.58 148.73 12.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.41 166.8 30.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.609 ' CE2' ' HB ' ' B' ' 77' ' ' VAL . 38.6 t80 -131.88 134.47 45.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.566 ' HD2' ' HA3' ' B' ' 50' ' ' GLY . 16.4 ttm180 -125.19 121.47 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.626 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 8.6 p -110.88 138.04 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.344 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 50.2 m-20 64.3 -97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.481 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 10.4 pt-20 175.44 -20.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.541 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.81 -66.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 m -90.84 141.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.42 153.82 37.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 0.0 111.225 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 25.2 tp -148.79 149.88 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.582 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.704 ' HE3' HG21 ' B' ' 57' ' ' THR . 12.1 tmtt? -149.38 141.72 24.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.18 176.05 11.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.086 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.36 -173.1 41.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.556 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.17 138.21 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.83 0.347 . . . . 0.0 111.107 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.791 ' HB3' ' HG2' ' B' ' 96' ' ' MET . . . -110.31 144.16 39.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.366 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.89 113.03 19.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.235 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -119.5 129.97 54.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.608 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.28 -116.04 8.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.31 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 24.9 m -148.92 8.11 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 111.332 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.1 22.65 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 10.9 m-20 -127.07 82.8 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 99.7 t -108.87 139.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.969 0.414 . . . . 0.0 110.653 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.791 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 6.9 ptp -134.22 141.6 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.693 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -113.28 124.3 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.497 HD21 ' HB1' ' A' ' 40' ' ' ALA . 17.0 m120 -109.54 147.99 32.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 111.42 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.76 86.92 0.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.757 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.55 162.33 17.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.399 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -130.32 145.59 51.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.418 . . . . 0.0 111.073 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.564 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.0 m-80 -115.31 131.85 56.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.401 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.08 119.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.849 0.356 . . . . 0.0 110.776 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.99 159.81 22.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.672 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 16.2 t0 73.03 141.44 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.91 0.386 . . . . 0.0 110.988 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -129.1 -64.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.811 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.73 24.64 0.58 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.991 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -97.26 153.66 17.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.807 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . 0.673 ' HB3' ' CE1' ' C' ' 8' ' ' HIS . 32.2 m95 -105.58 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.789 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m 61.21 46.4 8.0 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.028 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.724 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 23.7 m170 -88.26 -49.79 0.42 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.758 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.5 Cg_exo -58.52 106.96 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.519 2.146 . . . . 0.0 111.933 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -109.64 -57.36 2.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 111.153 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -120.65 169.86 9.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.634 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 25.74 1.66 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.472 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.649 ' HE2' ' HD3' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -68.7 -50.4 51.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.536 -179.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.3 -28.58 64.66 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.195 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.98 -44.06 85.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 0.0 110.928 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . 0.425 ' HA ' ' HD2' ' C' ' 19' ' ' ARG . 18.2 m-70 -78.43 -29.4 47.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.977 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.649 ' HD3' ' HE2' ' C' ' 13' ' ' LYS . 0.6 OUTLIER -66.51 -41.72 88.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.478 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.98 -32.26 67.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 111.245 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' C' ' 16' ' ' HIS . 53.1 mtt-85 -64.04 -57.72 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -67.79 -31.04 70.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.222 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 3.2 tm? -62.06 -59.75 4.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.53 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.11 -18.8 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.948 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -74.15 -45.97 45.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.587 ' HB3' HD12 ' B' ' 25' ' ' LEU . 61.4 mtp85 -76.98 -37.15 55.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.751 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.8 HD11 HD22 ' A' ' 25' ' ' LEU . 3.3 mm? -66.52 -52.13 49.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.646 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -59.59 -42.29 92.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.79 -29.02 68.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.229 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' C' ' 28' ' ' LEU . 0.0 OUTLIER -62.32 -48.72 78.59 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . 0.595 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -64.4 -32.99 74.83 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.994 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 5.9 m -67.92 -38.94 83.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.813 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.729 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 0.4 OUTLIER -73.32 -39.78 65.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.271 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' C' ' 29' ' ' ASP . 32.7 m -74.16 -33.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.638 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 16.6 m-20 -68.97 -45.3 71.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.729 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 7.3 ptpt -75.12 -40.71 59.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.777 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . 0.431 ' HA3' ' OH ' ' B' ' 63' ' ' TYR . . . -57.34 -43.57 93.75 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.419 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.794 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -75.13 -24.65 58.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.875 0.369 . . . . 0.0 111.092 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.606 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -69.17 -42.03 76.42 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.429 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.541 ' HB2' ' HB1' ' C' ' 68' ' ' ALA . 8.5 t -82.75 -39.93 21.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.504 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 4.0 t -58.11 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.496 ' HB1' HD21 ' A' ' 98' ' ' ASN . . . -61.67 -33.45 73.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.392 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.69 -33.66 76.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.683 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 59.9 tp -82.61 -32.29 28.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.718 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 87.4 m-20 -75.79 -16.43 60.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -67.9 -18.74 64.88 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.149 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.649 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.7 mm? -77.68 163.89 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.858 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.472 ' HE2' ' HG3' ' A' ' 84' ' ' LYS . 3.2 p90 -156.53 0.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.657 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.487 ' HB3' ' CB ' ' C' ' 55' ' ' ASN . 6.1 mt-30 63.13 125.06 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.926 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -83.92 109.91 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.632 2.221 . . . . 0.0 112.629 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.481 ' OH ' ' HB ' ' A' ' 51' ' ' VAL . 13.7 m-30 63.74 -175.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.962 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.573 ' HA3' ' HD2' ' C' ' 76' ' ' ARG . . . 166.76 55.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.208 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.9 p -81.4 -10.59 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.157 0.583 . . . . 0.0 112.452 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.54 48.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.297 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -150.88 -163.82 1.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.625 0.25 . . . . 0.0 110.619 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -116.89 142.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.578 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' C' ' 47' ' ' GLN . 10.4 m-80 -124.83 113.4 17.85 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.011 0.434 . . . . 0.0 111.659 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -83.63 129.71 34.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.226 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.701 HG21 ' HE3' ' C' ' 84' ' ' LYS . 37.6 p -109.42 122.06 46.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.496 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -154.61 133.62 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.44 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.39 170.5 43.35 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.554 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' C' ' 69' ' ' LEU . 2.7 m -121.12 161.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.16 -167.21 17.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.451 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.606 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -172.18 138.76 4.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.548 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.638 ' HD2' ' HA ' ' C' ' 33' ' ' ASP . 34.1 t80 -120.9 131.96 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.757 0.313 . . . . 0.0 110.746 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 2.5 mmm180 69.34 -92.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.1 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.4 p -143.77 26.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -129.1 141.42 51.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -110.42 150.96 28.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -146.58 171.75 14.61 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.548 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.494 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.8 OUTLIER -120.01 142.69 48.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.683 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.55 137.17 47.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.69 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.515 HG13 ' H ' ' C' ' 72' ' ' GLY . 4.5 tp -137.52 162.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.515 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 171.36 179.86 42.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -162.59 148.75 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.41 166.81 30.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.15 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.615 ' CE2' ' HB ' ' C' ' 77' ' ' VAL . 39.2 t80 -131.91 134.45 45.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.92 0.391 . . . . 0.0 111.153 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.573 ' HD2' ' HA3' ' C' ' 50' ' ' GLY . 16.5 ttm180 -125.16 121.56 34.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.731 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.625 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 8.7 p -110.96 138.06 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.291 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 49.8 m-20 64.4 -97.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.013 0.435 . . . . 0.0 111.12 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . 0.484 ' HB3' ' CE2' ' B' ' 49' ' ' TYR . 10.5 pt-20 175.43 -20.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.62 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -70.87 -66.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -90.97 141.3 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.485 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.38 153.83 37.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.276 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 25.3 tp -148.77 149.89 32.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.6 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.701 ' HE3' HG21 ' C' ' 57' ' ' THR . 12.1 tmtt? -149.41 141.74 24.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.27 175.94 11.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.056 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.43 -173.18 41.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.546 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.09 138.2 19.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.102 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.782 ' HB3' ' HG2' ' C' ' 96' ' ' MET . . . -110.39 144.22 39.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.32 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -121.99 112.93 18.88 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -119.43 129.98 55.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.4 -116.1 8.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.308 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m -148.95 8.09 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.331 . . . . 0.0 111.285 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -155.07 22.64 0.43 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 10.8 m-20 -127.1 82.77 2.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.76 139.33 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.769 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.782 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 6.8 ptp -134.17 141.61 47.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.3 124.25 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.495 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.492 HD21 ' HB1' ' B' ' 40' ' ' ALA . 17.1 m120 -109.52 148.08 31.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 111.443 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.74 86.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.764 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -115.53 162.35 17.32 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -130.34 145.61 51.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 111.064 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 55.6 m-80 -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.378 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.06 119.7 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.794 0.331 . . . . 0.0 110.737 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.95 159.82 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.663 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.669 -0.172 . . . . 0.0 112.669 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 17.8 t70 71.13 130.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.944 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -108.4 -74.2 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.897 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.92 21.99 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -115.31 145.33 42.59 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.782 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.555 ' HB3' ' CE1' ' A' ' 8' ' ' HIS . 17.8 m95 -106.98 -52.92 2.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.74 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m 59.29 61.93 1.93 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.978 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.724 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 35.0 m80 -86.0 -49.73 0.52 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.773 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -67.69 110.03 2.01 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.387 2.058 . . . . 0.0 111.971 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -110.3 -58.27 2.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.466 ' HD1' ' H ' ' A' ' 13' ' ' LYS . 55.1 p90 -109.92 172.69 6.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.7 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.74 12.93 5.85 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.469 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' H ' ' HD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -63.92 -39.2 93.62 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.446 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.66 -29.81 72.8 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.224 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' HD2' ' A' ' 19' ' ' ARG . . . -70.83 -57.73 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 0.0 110.901 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -57.37 -29.11 63.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.954 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -68.19 -52.3 35.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.55 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.09 -20.26 64.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 111.211 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 15' ' ' ALA . 14.7 mtt-85 -70.74 -60.28 2.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.795 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.14 -17.37 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.152 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -67.71 -49.81 60.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.557 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -73.53 -28.05 61.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.038 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.05 -51.57 45.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.439 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 76.5 mtp85 -62.5 -44.76 95.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.755 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.508 HD21 ' CD2' ' B' ' 25' ' ' LEU . 0.5 OUTLIER -57.44 -50.37 73.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.18 -39.48 82.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 ttpp -60.46 -34.09 73.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.202 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.564 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -68.05 -41.95 81.27 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.45 -25.02 64.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.3 m -79.63 -41.0 27.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.852 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.68 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.4 mpt_? -68.93 -35.83 77.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.303 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 28' ' ' LEU . 19.0 m -77.58 -32.13 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.159 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 9.9 m-20 -66.79 -44.84 80.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.68 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 4.2 ptpt -77.76 -31.69 52.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.24 67.84 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.393 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.89 -27.77 60.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.23 -46.37 16.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.407 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.646 ' CB ' ' HB2' ' A' ' 90' ' ' ALA . 48.4 t -67.06 -40.59 87.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.481 ' OG ' ' HB2' ' C' ' 40' ' ' ALA . 37.4 t -67.42 -52.89 34.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' OG ' ' B' ' 39' ' ' SER . . . -61.88 -25.82 67.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.494 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.96 -38.28 88.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.523 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 21.7 tp -79.36 -33.63 42.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 58.1 m-20 -73.68 -13.58 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.49 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 30.5 t -71.54 -19.27 62.19 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.182 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.625 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.0 mm? -80.45 157.83 26.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.856 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.434 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 8.1 p90 -146.06 -10.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.699 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HG2' ' CG2' ' A' ' 57' ' ' THR . 5.1 mt-30 73.43 121.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.935 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -77.72 101.1 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 62.1 -170.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.518 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 163.03 60.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 9.5 p -69.89 -18.81 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.146 0.578 . . . . 0.0 112.459 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.781 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 160.02 51.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.313 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HZ2' ' HA2' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -152.16 -157.03 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.56 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 74' ' ' GLY . 2.8 p -120.67 145.13 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.579 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.83 122.06 33.65 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.979 0.418 . . . . 0.0 111.727 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -84.27 124.47 31.26 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.267 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.625 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 72.1 p -107.04 120.61 42.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.007 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -149.85 137.49 20.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.405 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . 178.14 165.48 33.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.533 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 69' ' ' LEU . 30.2 m -121.13 178.76 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.375 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.99 -179.34 38.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -158.14 134.22 3.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.522 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.665 ' HD1' ' HB3' ' B' ' 96' ' ' MET . 26.1 t80 -124.91 124.19 41.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.74 0.305 . . . . 0.0 110.746 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER 68.67 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 p -146.05 16.89 1.39 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.44 140.89 49.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.43 47.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 172.08 13.19 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 60' ' ' VAL . 5.0 tt -123.47 145.16 49.04 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -132.1 119.52 21.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 58' ' ' ALA . 8.1 tp -118.67 152.74 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.91 -172.12 44.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.446 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.61 158.11 6.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -144.25 177.75 22.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.25 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.61 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 35.0 t80 -138.12 132.8 32.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.518 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 14.1 ttm180 -126.54 117.25 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.781 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.9 p -106.12 138.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.284 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 78.9 m-20 68.82 -92.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 14.8 pt-20 172.92 -24.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.579 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -78.46 -52.21 8.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.01 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.44 137.39 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.469 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -144.55 163.77 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.295 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 84' ' ' LYS . 34.1 tp -158.88 154.31 25.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 10.8 tmtt? -159.59 133.97 7.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.1 18.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.83 -174.57 42.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.628 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.24 139.56 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 111.112 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.51 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -113.05 136.51 52.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.293 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.19 51.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.294 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.646 ' HB2' ' CB ' ' A' ' 38' ' ' SER . . . -131.61 135.72 47.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.591 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.572 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 55.71 -123.26 29.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.281 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.58 9.58 2.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.791 0.329 . . . . 0.0 111.318 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.48 32.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.201 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -132.32 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.25 150.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.01 0.433 . . . . 0.0 110.724 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.647 ' HB3' ' HD1' ' C' ' 63' ' ' TYR . 1.2 ptp -146.52 159.69 43.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.594 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.69 141.06 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.444 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.43 ' OD1' HD23 ' A' ' 42' ' ' LEU . 25.7 m120 -118.05 145.68 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.764 0.316 . . . . 0.0 111.393 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.48 87.6 1.32 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 16.7 m -121.49 148.99 43.73 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.393 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.728 ' HD2' HD11 ' A' ' 103' ' ' ILE . 1.8 p90 -124.47 142.91 50.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.423 . . . . 0.0 111.05 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.925 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 64.1 m-80 -109.45 126.72 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.728 HD11 ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -129.59 121.1 52.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.96 165.96 19.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.423 ' HE3' HG13 ' C' ' 54' ' ' VAL . 3.4 m-90 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.656 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.531 ' O ' ' HB3' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.663 -0.175 . . . . 0.0 112.663 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' B' ' 1' ' ' GLY . 17.9 t70 71.18 130.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.4 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -108.45 -74.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.92 21.97 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.012 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -115.29 145.36 42.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.797 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.549 ' HB3' ' CE1' ' B' ' 8' ' ' HIS . 17.8 m95 -107.05 -52.92 2.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.697 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 10.0 m 59.3 61.88 1.94 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.017 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.708 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 35.0 m80 -85.9 -49.76 0.53 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.838 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -67.68 109.97 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.531 2.154 . . . . 0.0 111.949 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -110.21 -58.41 2.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 111.144 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.499 ' HD1' ' H ' ' B' ' 13' ' ' LYS . 55.0 p90 -109.9 172.66 6.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.625 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.63 12.89 5.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.507 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.499 ' H ' ' HD1' ' B' ' 11' ' ' PHE . 0.0 OUTLIER -63.88 -39.18 93.6 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.484 -179.202 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.68 -29.83 72.79 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.213 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.413 ' O ' ' HD2' ' B' ' 19' ' ' ARG . . . -70.86 -57.69 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 110.905 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -57.31 -29.17 63.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.996 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.2 OUTLIER -68.19 -52.33 35.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.529 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -69.02 -20.32 64.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.227 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' B' ' 15' ' ' ALA . 14.7 mtt-85 -70.6 -60.4 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.749 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.1 -17.37 61.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.151 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -67.69 -49.86 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -73.44 -28.17 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.993 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.98 -51.54 46.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.437 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 76.6 mtp85 -62.49 -44.82 95.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.8 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.508 ' CD2' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.4 -50.46 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.08 -39.48 82.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.871 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' B' ' 31' ' ' ARG . 12.9 ttpp -60.38 -34.2 73.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.212 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.566 ' O ' HG13 ' B' ' 32' ' ' VAL . 0.2 OUTLIER -68.07 -41.87 81.28 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.925 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 1.3 m -79.52 -40.98 28.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.677 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.4 mpt_? -68.87 -36.0 77.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.566 HG13 ' O ' ' B' ' 28' ' ' LEU . 18.9 m -77.53 -32.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.207 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 9.9 m-20 -66.73 -44.78 80.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.04 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.677 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 4.2 ptpt -77.97 -31.53 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.56 -35.23 67.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.88 -27.78 60.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.31 -46.32 16.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.396 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.652 ' CB ' ' HB2' ' B' ' 90' ' ' ALA . 48.5 t -67.09 -40.53 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.785 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 40' ' ' ALA . 37.4 t -67.46 -52.94 33.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' OG ' ' C' ' 39' ' ' SER . . . -61.82 -25.87 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.43 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.41 88.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.503 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 21.6 tp -79.26 -33.65 43.31 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 57.8 m-20 -73.64 -13.59 61.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.494 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 30.4 t -71.58 -19.27 62.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.135 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.643 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.0 mm? -80.48 157.8 26.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.831 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 8.1 p90 -146.0 -10.43 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.188 0.518 . . . . 0.0 111.717 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.487 ' HG2' ' CG2' ' B' ' 57' ' ' THR . 5.1 mt-30 73.51 121.16 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.882 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -77.69 101.14 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.623 2.216 . . . . 0.0 112.54 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 62.03 -170.51 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.946 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 163.03 60.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.288 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 9.4 p -70.0 -18.86 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.186 0.594 . . . . 0.0 112.454 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 160.04 51.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.298 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.489 ' HZ2' ' HA2' ' B' ' 50' ' ' GLY . 0.0 OUTLIER -152.05 -156.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.546 0.212 . . . . 0.0 110.671 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 74' ' ' GLY . 2.8 p -120.81 145.15 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.577 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.84 122.09 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.008 0.433 . . . . 0.0 111.669 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -84.34 124.5 31.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.248 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.643 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 73.4 p -107.1 120.64 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -149.81 137.56 20.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.418 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . 178.1 165.51 33.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' B' ' 69' ' ' LEU . 30.3 m -121.16 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.03 -179.39 38.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.453 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -158.12 134.17 3.77 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.664 ' HD1' ' HB3' ' C' ' 96' ' ' MET . 26.2 t80 -124.91 124.18 41.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.734 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 73.3 p -145.99 16.87 1.4 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.81 49.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.37 145.42 47.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.107 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.41 172.11 13.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.49 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.709 ' HA ' HG12 ' B' ' 60' ' ' VAL . 5.0 tt -123.52 145.19 49.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.762 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -132.19 119.63 21.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.725 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' B' ' 58' ' ' ALA . 8.1 tp -118.72 152.72 20.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.96 -172.18 44.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.405 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.52 158.06 6.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.851 0.358 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.583 ' O ' HG23 ' B' ' 54' ' ' VAL . . . -144.2 177.78 22.61 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.267 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.604 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 34.8 t80 -138.13 132.71 32.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.873 0.368 . . . . 0.0 111.166 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.513 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 14.0 ttm180 -126.49 117.27 22.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.78 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.9 p -106.16 138.91 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.011 0.434 . . . . 0.0 111.278 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' B' ' 79' ' ' GLU . 78.9 m-20 68.81 -92.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.0 111.14 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 14.8 pt-20 172.97 -24.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.1 p -78.48 -52.21 8.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.44 137.36 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.891 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -144.58 163.78 32.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.868 0.365 . . . . 0.0 111.255 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.419 HD12 ' H ' ' B' ' 84' ' ' LYS . 34.6 tp -158.9 154.32 25.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.434 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 10.8 tmtt? -159.66 133.97 7.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.58 171.06 18.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.87 -174.46 42.83 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.626 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.29 139.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.059 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.499 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -113.01 136.48 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.359 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.68 125.2 51.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.652 ' HB2' ' CB ' ' B' ' 38' ' ' SER . . . -131.53 135.69 47.24 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.664 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.589 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 55.76 -123.37 30.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.342 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.28 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 3.9 t -165.48 32.84 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.242 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.32 82.3 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.24 150.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.665 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 1.2 ptp -146.56 159.65 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.667 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -127.65 141.17 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.366 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.432 ' OD1' HD23 ' B' ' 42' ' ' LEU . 25.7 m120 -118.14 145.66 44.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 111.359 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 87.51 1.32 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.74 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 16.7 m -121.42 149.01 43.65 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.4 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . 0.726 ' HD2' HD11 ' B' ' 103' ' ' ILE . 1.9 p90 -124.44 142.88 50.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.957 0.408 . . . . 0.0 111.153 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.891 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 64.1 m-80 -109.4 126.78 53.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.726 HD11 ' HD2' ' B' ' 101' ' ' PHE . 0.9 OUTLIER -129.64 121.11 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.866 0.365 . . . . 0.0 110.756 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.99 165.97 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 0.421 ' HE3' HG13 ' A' ' 54' ' ' VAL . 3.5 m-90 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.683 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.531 ' O ' ' HB3' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.677 -0.169 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' C' ' 1' ' ' GLY . 17.8 t70 71.12 130.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.96 0.409 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -108.49 -74.26 0.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.861 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.94 22.16 1.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.011 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -115.39 145.33 42.64 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.748 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . 0.559 ' HB3' ' CE1' ' C' ' 8' ' ' HIS . 17.8 m95 -107.0 -52.96 2.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.75 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m 59.31 61.92 1.93 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.977 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.727 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 35.0 m80 -85.96 -49.76 0.52 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.761 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.727 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -67.73 110.07 2.03 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.436 2.091 . . . . 0.0 111.93 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -110.27 -58.35 2.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.947 0.403 . . . . 0.0 111.117 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.483 ' HD1' ' H ' ' C' ' 13' ' ' LYS . 55.0 p90 -109.84 172.71 6.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.654 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.75 12.97 5.85 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.455 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.483 ' H ' ' HD1' ' C' ' 11' ' ' PHE . 0.0 OUTLIER -63.99 -39.13 93.44 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.453 -179.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.68 -29.88 72.78 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.241 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . 0.411 ' O ' ' HD2' ' C' ' 19' ' ' ARG . . . -70.81 -57.67 4.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -57.5 -29.03 63.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.926 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.2 OUTLIER -68.25 -52.26 36.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.591 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -69.0 -20.27 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.297 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' C' ' 15' ' ' ALA . 14.6 mtt-85 -70.73 -60.33 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -73.1 -17.4 61.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.177 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' O ' ' C' ' 17' ' ' LYS . 0.8 OUTLIER -67.73 -49.81 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.558 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -73.45 -28.16 61.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -67.99 -51.52 46.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.444 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 76.6 mtp85 -62.52 -44.78 95.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.722 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.507 HD21 ' CD2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.52 -50.34 73.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.611 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -59.15 -39.48 82.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.806 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' C' ' 31' ' ' ARG . 12.9 ttpp -60.44 -34.16 73.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.204 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.549 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.2 OUTLIER -68.05 -41.98 81.21 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.29 -25.11 64.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.987 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 1.3 m -79.54 -41.03 28.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.853 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.669 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.4 mpt_? -68.91 -35.87 77.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.28 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.549 HG13 ' O ' ' C' ' 28' ' ' LEU . 19.0 m -77.58 -32.18 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 9.9 m-20 -66.74 -44.79 80.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.045 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.669 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 4.2 ptpt -77.83 -31.68 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.48 -35.31 68.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mt -74.79 -27.82 60.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.113 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.24 -46.33 16.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.452 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.657 ' CB ' ' HB2' ' C' ' 90' ' ' ALA . 48.5 t -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.756 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' B' ' 40' ' ' ALA . 37.6 t -67.47 -52.96 33.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.068 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' OG ' ' A' ' 39' ' ' SER . . . -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.475 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.86 -38.37 88.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.507 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 21.6 tp -79.28 -33.69 43.18 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 57.6 m-20 -73.6 -13.62 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . 0.484 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 30.4 t -71.63 -19.23 62.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.154 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.614 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.0 mm? -80.51 157.78 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.836 177.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 8.1 p90 -145.98 -10.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.172 0.51 . . . . 0.0 111.703 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.492 ' HG2' ' CG2' ' C' ' 57' ' ' THR . 5.1 mt-30 73.53 121.12 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.932 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 10.0 Cg_endo -77.66 101.08 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.657 2.238 . . . . 0.0 112.57 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 62.12 -170.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.963 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 163.1 60.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.251 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 9.4 p -69.92 -18.88 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.258 0.623 . . . . 0.0 112.383 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.766 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 160.01 51.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.356 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . 0.495 ' HZ2' ' HA2' ' C' ' 50' ' ' GLY . 0.0 OUTLIER -152.11 -157.03 0.76 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.594 0.235 . . . . 0.0 110.591 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.588 HG23 ' O ' ' C' ' 74' ' ' GLY . 2.8 p -120.8 145.18 27.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.82 121.99 33.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.977 0.418 . . . . 0.0 111.696 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -84.23 124.47 31.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.272 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.614 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 72.3 p -106.98 120.63 42.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.999 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -149.84 137.53 20.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.422 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . 178.05 165.49 32.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' C' ' 69' ' ' LEU . 30.5 m -121.18 178.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.0 -179.41 38.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.521 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.629 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -158.1 134.2 3.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.552 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.647 ' HD1' ' HB3' ' A' ' 96' ' ' MET . 26.1 t80 -124.95 124.23 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 0.5 OUTLIER 68.69 -85.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.091 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 73.4 p -146.02 16.88 1.39 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -118.43 140.82 49.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -120.32 145.44 47.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.43 172.08 13.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.496 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.709 ' HA ' HG12 ' C' ' 60' ' ' VAL . 5.0 tt -123.41 145.23 48.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.79 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.23 119.62 21.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.653 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.42 HD12 ' CB ' ' C' ' 58' ' ' ALA . 8.1 tp -118.67 152.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.188 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.98 -172.17 44.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 4.8 p -170.57 158.11 6.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . 0.588 ' O ' HG23 ' C' ' 54' ' ' VAL . . . -144.19 177.74 22.63 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.236 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.589 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 34.8 t80 -138.14 132.69 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.517 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 14.0 ttm180 -126.49 117.3 22.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.766 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.9 p -106.13 138.83 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' C' ' 77' ' ' VAL . 78.8 m-20 68.92 -92.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 111.076 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 14.8 pt-20 172.95 -24.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.593 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -78.49 -52.27 8.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.0 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -90.37 137.42 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.898 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -144.61 163.77 32.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.236 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.413 HD12 ' H ' ' C' ' 84' ' ' LYS . 34.3 tp -158.87 154.27 25.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.595 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 10.8 tmtt? -159.58 133.94 7.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.13 18.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.81 -174.47 42.8 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.572 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 8.0 p -130.27 139.55 51.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.125 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.504 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -113.09 136.49 52.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.346 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.69 125.21 51.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.233 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.657 ' HB2' ' CB ' ' C' ' 38' ' ' SER . . . -131.62 135.72 47.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.603 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.572 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 55.75 -123.34 30.25 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 33.3 m -138.52 9.61 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -165.53 32.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.193 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -132.26 82.31 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.27 150.61 11.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.664 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 1.2 ptp -146.59 159.68 43.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.685 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.7 141.14 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.43 ' OD1' HD23 ' C' ' 42' ' ' LEU . 25.7 m120 -118.08 145.7 44.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.708 0.289 . . . . 0.0 111.415 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.54 1.31 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 16.7 m -121.4 148.98 43.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.449 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.716 ' HD2' HD11 ' C' ' 103' ' ' ILE . 1.8 p90 -124.41 142.87 50.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 111.04 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.898 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 64.0 m-80 -109.43 126.73 53.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.38 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.716 HD11 ' HD2' ' C' ' 101' ' ' PHE . 1.0 OUTLIER -129.62 121.06 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.77 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.96 165.95 19.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 0.423 ' HE3' HG13 ' B' ' 54' ' ' VAL . 3.5 m-90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.665 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.968 ' N ' ' HD1' ' B' ' 11' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.686 -0.166 . . . . 0.0 112.686 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.39 148.44 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.969 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -47.71 84.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.815 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.29 148.09 45.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.593 ' OG ' ' HB2' ' A' ' 8' ' ' HIS . 21.4 t -100.96 149.11 24.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.802 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -130.67 75.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.77 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.3 t 73.94 55.22 0.1 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.002 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.593 ' HB2' ' OG ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -96.53 -45.16 0.25 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.768 -178.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 8' ' ' HIS . 31.4 Cg_exo -53.75 113.76 1.47 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.424 2.082 . . . . 0.0 111.919 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -82.66 -172.87 4.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.976 0.417 . . . . 0.0 111.113 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.965 ' HD1' ' N ' ' C' ' 1' ' ' GLY . 12.5 t80 -127.1 -31.72 2.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.658 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.59 -69.89 0.29 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.5 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -105.19 -19.89 13.67 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.479 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.03 -46.29 93.78 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.244 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . -62.34 -33.7 75.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.918 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -70.31 -37.03 74.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.985 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 2.8 mmpt? -67.15 -53.11 33.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.523 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.68 -31.28 70.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.247 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 19.8 ttp180 -63.07 -58.69 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.18 83.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.117 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.017 HD21 HD13 ' C' ' 21' ' ' LEU . 12.1 mt -60.0 -47.49 85.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.559 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 29.4 t0 -66.81 -32.25 73.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.093 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.53 -42.31 95.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.53 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.733 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.62 -33.42 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 28.4 t0 -73.73 -41.2 62.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -63.02 -42.06 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.285 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' C' ' 29' ' ' ASP . 0.2 OUTLIER -62.9 -50.35 71.22 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.789 ' HB2' HD21 ' B' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.14 61.43 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.912 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.15 -40.65 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 2.6 mpt_? -60.87 -32.56 71.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.316 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 6.4 m -80.12 -28.94 12.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.216 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -51.88 61.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 20.3 pttt -74.13 -39.28 63.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.751 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.32 -36.21 92.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.52 ' HG ' HD21 ' C' ' 36' ' ' LEU . 5.9 mt -73.53 -31.16 63.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.068 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.91 -45.29 36.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.457 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.65 ' CB ' ' HB2' ' A' ' 90' ' ' ALA . 22.7 t -63.86 -44.89 91.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.8 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 11.5 t -59.13 -46.47 88.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.04 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.544 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.13 -39.88 93.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.556 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 2.6 tm? -77.06 -38.9 51.69 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -72.12 -15.94 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 t -66.58 -32.92 74.56 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.15 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.512 ' CG ' ' HB ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -64.21 143.66 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.881 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.568 ' HZ ' ' HB1' ' B' ' 82' ' ' ALA . 35.0 p90 -112.69 -42.53 3.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.11 0.481 . . . . 0.0 111.677 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.49 HE22 ' HG2' ' A' ' 84' ' ' LYS . 33.8 mt-30 70.26 109.43 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.948 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HD3' ' ND2' ' B' ' 102' ' ' ASN 0.256 9.8 Cg_endo -75.25 -161.16 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.617 2.211 . . . . 0.0 112.576 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 17.5 m-30 68.16 167.02 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.962 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 76' ' ' ARG . . . 178.4 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.193 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.519 ' HA ' ' HG3' ' A' ' 79' ' ' GLU . 9.6 p -88.84 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.198 0.599 . . . . 0.0 112.4 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.39 69.1 0.01 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.261 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 76' ' ' ARG . 1.5 mptp? -143.79 -178.16 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.619 0.247 . . . . 0.0 110.561 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.577 HG13 ' HE3' ' B' ' 105' ' ' TRP . 10.1 p -119.02 142.17 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.433 ' OD1' ' HD2' ' A' ' 48' ' ' PRO . 1.7 m-80 -125.0 178.08 5.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.62 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.588 ' HB2' ' CH2' ' B' ' 105' ' ' TRP . 11.3 t80 -151.48 143.39 23.82 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.512 ' HB ' ' CG ' ' A' ' 45' ' ' LEU . 30.2 p -117.3 142.08 47.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.953 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -177.5 127.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.463 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.515 ' O ' HD12 ' A' ' 69' ' ' LEU . . . -179.34 -165.27 33.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.04 154.61 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.367 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -134.43 171.72 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.504 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 66' ' ' SER . . . -156.73 141.31 7.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.571 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 84.4 t80 -135.56 110.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.697 0.284 . . . . 0.0 110.74 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 28.0 mtt180 66.28 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.128 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 37.86 1.33 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.122 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.463 ' O ' ' HA2' ' A' ' 62' ' ' GLY . 32.1 t -134.77 157.68 46.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.67 148.31 40.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.42 173.06 14.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 59' ' ' GLY . 8.2 tp -124.75 126.66 46.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.702 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -117.51 163.32 16.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 58' ' ' ALA . 2.3 tt -158.71 176.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.77 34.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.462 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 p -164.13 160.03 20.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.45 176.26 29.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.217 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.509 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 5.0 t80 -143.27 127.0 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 111.159 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.473 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.735 HG22 ' OD1' ' A' ' 78' ' ' ASN . 7.2 p -83.2 127.41 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.284 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.735 ' OD1' HG22 ' A' ' 77' ' ' VAL . 31.3 m120 61.15 162.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.519 ' HG3' ' HA ' ' A' ' 51' ' ' VAL . 32.5 mt-10 -99.48 39.1 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.569 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.31 -52.21 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 82' ' ' ALA . 3.6 p -131.25 169.85 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.53 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB1' ' HZ ' ' C' ' 46' ' ' PHE . . . -168.53 165.24 12.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 111.29 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -139.25 168.73 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.564 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 85' ' ' ALA . 2.0 tmtp? -157.73 122.85 4.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.544 ' N ' ' HD3' ' A' ' 84' ' ' LYS . . . -132.6 161.04 34.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.32 158.57 18.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.91 130.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -102.05 115.04 29.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.355 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.5 ' HA ' HG13 ' A' ' 95' ' ' VAL . 77.9 m-85 -91.7 108.8 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB2' ' CB ' ' A' ' 38' ' ' SER . . . -115.02 124.11 50.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.659 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.05 -85.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.67 -50.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.319 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.0 m -104.35 14.43 30.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 4.0 t70 -116.43 57.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.5 HG13 ' HA ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -95.2 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.747 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.608 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 2.9 ptp -146.77 151.44 37.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -130.34 138.21 50.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.422 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 8.3 m-80 -132.56 137.15 47.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 111.404 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.32 95.64 2.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.716 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB3' HD11 ' C' ' 45' ' ' LEU . 29.6 m -125.95 161.5 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 8.6 p90 -127.67 145.48 50.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.027 0.442 . . . . 0.0 111.044 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.559 ' ND2' ' HD3' ' C' ' 48' ' ' PRO . 1.8 p-10 -120.0 153.08 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.4 mp -119.86 134.91 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.856 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.479 ' HB2' ' CE2' ' C' ' 49' ' ' TYR . 18.2 pm0 -120.01 132.47 55.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.937 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.592 ' CH2' ' HB2' ' C' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.618 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.982 ' N ' ' HD1' ' C' ' 11' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.669 -0.173 . . . . 0.0 112.669 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.3 148.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.956 0.408 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -47.67 84.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.822 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.26 148.01 45.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.042 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.598 ' OG ' ' HB2' ' B' ' 8' ' ' HIS . 21.4 t -100.85 149.11 24.2 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.805 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -130.68 75.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.728 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 5.3 t 73.92 55.14 0.1 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.022 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.598 ' HB2' ' OG ' ' B' ' 5' ' ' SER . 0.2 OUTLIER -96.42 -45.18 0.25 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.82 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -53.73 113.71 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.409 2.073 . . . . 0.0 111.928 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -82.56 -172.85 4.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.957 0.408 . . . . 0.0 111.148 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.968 ' HD1' ' N ' ' A' ' 1' ' ' GLY . 12.5 t80 -127.16 -31.71 2.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.667 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.55 -69.94 0.28 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.482 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -105.17 -19.95 13.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.468 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.97 -46.33 93.76 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.288 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' B' ' 19' ' ' ARG . . . -62.24 -33.78 75.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.375 . . . . 0.0 110.963 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.403 ' CE1' ' HB2' ' A' ' 5' ' ' SER . 14.6 m-70 -70.28 -37.04 74.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.011 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 2.8 mmpt? -67.17 -53.11 33.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.566 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -68.66 -31.25 70.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.259 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 15' ' ' ALA . 19.8 ttp180 -63.11 -58.71 6.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.769 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -36.19 83.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 1.033 HD13 HD21 ' C' ' 21' ' ' LEU . 12.1 mt -60.04 -47.47 85.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.601 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' B' ' 26' ' ' ASP . 29.4 t0 -66.81 -32.26 73.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.036 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.836 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -74.34 -47.48 34.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.757 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.74 -33.34 72.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.632 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 28.3 t0 -73.73 -41.24 62.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -63.02 -42.08 99.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.241 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -62.89 -50.26 71.59 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.779 ' HB2' HD21 ' C' ' 28' ' ' LEU . 0.8 OUTLIER -56.61 -29.16 61.83 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.942 178.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 m -78.11 -40.57 37.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.863 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 2.6 mpt_? -60.81 -32.68 72.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 6.4 m -80.06 -28.98 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.172 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -51.94 61.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 20.3 pttt -73.96 -39.44 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.717 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.35 -36.15 92.34 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' A' ' 36' ' ' LEU . 5.8 mt -73.54 -31.18 63.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.787 0.327 . . . . 0.0 111.045 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.08 -45.17 35.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.379 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.666 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 22.7 t -63.9 -44.87 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 11.5 t -59.17 -46.46 88.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.2 -29.07 68.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.483 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.537 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.11 -39.89 93.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.575 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 2.6 tm? -77.01 -39.0 51.89 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -72.01 -15.97 62.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.6 -32.96 74.63 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.08 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.533 ' CG ' ' HB ' ' B' ' 57' ' ' THR . 1.0 OUTLIER -64.29 143.71 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.929 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.555 ' HZ ' ' HB1' ' C' ' 82' ' ' ALA . 34.6 p90 -112.73 -42.48 3.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.467 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.504 HE22 ' HG2' ' B' ' 84' ' ' LYS . 33.8 mt-30 70.29 109.47 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.552 ' HD3' ' ND2' ' C' ' 102' ' ' ASN 0.257 9.8 Cg_endo -75.3 -161.15 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.632 2.222 . . . . 0.0 112.61 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 17.5 m-30 68.16 167.05 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.969 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' B' ' 76' ' ' ARG . . . 178.37 -3.15 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.201 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.508 ' HA ' ' HG3' ' B' ' 79' ' ' GLU . 9.7 p -88.83 -34.82 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.187 0.595 . . . . 0.0 112.409 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.34 69.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.317 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' B' ' 76' ' ' ARG . 1.5 mptp? -143.79 -178.1 5.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.624 0.25 . . . . 0.0 110.584 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.579 HG13 ' HE3' ' C' ' 105' ' ' TRP . 10.1 p -119.08 142.14 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.537 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' B' ' 48' ' ' PRO . 1.7 m-80 -124.99 178.03 5.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.657 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.6 ' HB2' ' CH2' ' C' ' 105' ' ' TRP . 11.4 t80 -151.42 143.46 23.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.276 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' B' ' 45' ' ' LEU . 30.2 p -117.38 142.09 47.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.93 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.494 ' HB2' HG13 ' B' ' 71' ' ' ILE . . . -177.52 127.81 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.479 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.527 ' O ' HD12 ' B' ' 69' ' ' LEU . . . -179.26 -165.17 33.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.08 154.61 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 111.343 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.537 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -134.4 171.77 22.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.487 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 66' ' ' SER . . . -156.77 141.3 7.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 84.2 t80 -135.59 110.84 8.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.124 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.65 37.86 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.455 ' O ' ' HA2' ' B' ' 62' ' ' GLY . 32.0 t -134.83 157.62 46.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.64 148.32 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.139 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.03 15.04 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.527 HD12 ' O ' ' B' ' 59' ' ' GLY . 8.4 tp -124.67 126.73 46.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.756 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -117.58 163.37 16.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.623 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.495 HG13 ' O ' ' B' ' 57' ' ' THR . 2.3 tt -158.78 176.04 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.154 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.62 -167.82 34.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.36 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 16.6 p -164.16 160.04 20.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.46 176.37 29.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.158 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 5.0 t80 -143.36 126.9 16.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 111.17 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.461 ' O ' ' HA2' ' B' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.33 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.73 HG22 ' OD1' ' B' ' 78' ' ' ASN . 7.3 p -83.26 127.44 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.73 ' OD1' HG22 ' B' ' 77' ' ' VAL . 31.3 m120 61.04 162.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.508 ' HG3' ' HA ' ' B' ' 51' ' ' VAL . 32.5 mt-10 -99.47 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.6 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 2.5 m -121.25 -52.23 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.531 HG22 ' H ' ' B' ' 82' ' ' ALA . 3.6 p -131.29 169.83 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.568 ' HB1' ' HZ ' ' A' ' 46' ' ' PHE . . . -168.57 165.21 12.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.22 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' B' ' 101' ' ' PHE . 0.6 OUTLIER -139.16 168.75 19.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' B' ' 85' ' ' ALA . 2.0 tmtp? -157.8 122.89 4.43 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.547 ' N ' ' HD3' ' B' ' 84' ' ' LYS . . . -132.65 161.01 35.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.11 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.63 18.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.633 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.97 130.69 73.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.347 . . . . 0.0 111.149 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.609 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -102.03 115.15 29.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.32 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . 0.497 ' HA ' HG13 ' B' ' 95' ' ' VAL . 77.7 m-85 -91.72 108.82 20.18 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.194 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.666 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -115.12 124.15 50.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.08 -85.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.282 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 82.9 p -166.61 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.391 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.4 14.33 30.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.164 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' B' ' 90' ' ' ALA . 3.9 t70 -116.31 57.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.958 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' B' ' 89' ' ' TYR . 0.3 OUTLIER -95.26 156.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.699 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.602 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 2.9 ptp -146.79 151.41 37.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.722 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -130.21 138.21 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.447 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' B' ' 85' ' ' ALA . 8.3 m-80 -132.58 137.22 47.0 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.781 0.324 . . . . 0.0 111.409 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.46 95.77 2.72 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.684 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.444 ' HB3' HD11 ' A' ' 45' ' ' LEU . 29.3 m -126.0 161.39 27.64 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.396 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' B' ' 83' ' ' LEU . 8.6 p90 -127.6 145.54 50.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.969 0.414 . . . . 0.0 111.049 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.559 ' ND2' ' HD3' ' A' ' 48' ' ' PRO . 1.8 p-10 -120.07 152.92 36.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.4 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.412 ' N ' HD12 ' B' ' 103' ' ' ILE . 4.4 mp -119.79 135.01 61.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 18.2 pm0 -120.08 132.46 55.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 0.588 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.606 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.965 ' N ' ' HD1' ' A' ' 11' ' ' PHE . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 t0 71.35 148.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -47.66 84.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.35 148.04 45.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.016 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . 0.596 ' OG ' ' HB2' ' C' ' 8' ' ' HIS . 21.2 t -100.87 149.06 24.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.855 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -130.66 75.22 1.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.743 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 5.2 t 73.88 55.16 0.1 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.052 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.596 ' HB2' ' OG ' ' C' ' 5' ' ' SER . 0.2 OUTLIER -96.46 -45.13 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.809 -178.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -53.77 113.73 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.424 2.083 . . . . 0.0 111.94 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -82.6 -172.86 4.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.943 0.402 . . . . 0.0 111.142 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.982 ' HD1' ' N ' ' B' ' 1' ' ' GLY . 12.6 t80 -127.12 -31.75 2.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.659 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.56 -69.9 0.29 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.476 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -105.12 -19.98 13.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.563 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.05 -46.23 93.87 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.332 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' C' ' 19' ' ' ARG . . . -62.29 -33.76 75.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 110.909 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -70.3 -36.99 74.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.977 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 2.8 mmpt? -67.28 -53.02 33.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.55 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -68.72 -31.29 70.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' C' ' 15' ' ' ALA . 19.8 ttp180 -63.04 -58.7 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.79 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -36.21 83.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 1.033 HD21 HD13 ' B' ' 21' ' ' LEU . 12.1 mt -59.93 -47.48 85.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' C' ' 26' ' ' ASP . 29.1 t0 -66.91 -32.27 73.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.028 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -74.4 -47.53 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.751 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.63 -33.42 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.625 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' C' ' 22' ' ' ASP . 28.3 t0 -73.66 -41.3 62.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -62.98 -42.11 99.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.267 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' B' ' 29' ' ' ASP . 0.2 OUTLIER -62.8 -50.35 71.34 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . 0.761 ' HB2' HD21 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -56.49 -29.18 61.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.961 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 m -78.08 -40.62 37.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.507 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 2.6 mpt_? -60.84 -32.62 72.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' C' ' 36' ' ' LEU . 6.5 m -80.07 -28.92 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -51.76 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 20.3 pttt -74.08 -39.32 63.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.815 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.13 92.24 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 36' ' ' LEU . 5.8 mt -73.55 -31.18 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.328 . . . . 0.0 111.085 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.21 35.97 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.429 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 22.9 t -63.95 -44.88 91.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.736 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.545 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 11.6 t -59.12 -46.46 88.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.31 -29.04 68.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.13 -39.85 93.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.566 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 2.6 tm? -77.06 -38.92 51.62 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -72.12 -15.99 61.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 43.4 t -66.59 -32.92 74.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.526 ' CG ' ' HB ' ' C' ' 57' ' ' THR . 1.0 OUTLIER -64.24 143.74 57.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.888 177.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.563 ' HZ ' ' HB1' ' A' ' 82' ' ' ALA . 34.6 p90 -112.78 -42.46 3.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.121 0.486 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.505 HE22 ' HG2' ' C' ' 84' ' ' LYS . 33.8 mt-30 70.3 109.44 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.958 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.559 ' HD3' ' ND2' ' A' ' 102' ' ' ASN 0.257 9.9 Cg_endo -75.24 -161.2 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.707 2.272 . . . . 0.0 112.633 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 17.5 m-30 68.1 167.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' C' ' 76' ' ' ARG . . . 178.4 -3.19 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.194 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.527 ' HA ' ' HG3' ' C' ' 79' ' ' GLU . 9.5 p -88.86 -34.72 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.136 0.574 . . . . 0.0 112.393 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.34 69.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.306 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' C' ' 76' ' ' ARG . 1.5 mptp? -143.72 -178.11 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.539 0.209 . . . . 0.0 110.642 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.574 HG13 ' HE3' ' A' ' 105' ' ' TRP . 10.2 p -119.04 142.12 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.533 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' C' ' 48' ' ' PRO . 1.7 m-80 -124.94 178.1 5.69 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.695 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.592 ' HB2' ' CH2' ' A' ' 105' ' ' TRP . 11.2 t80 -151.46 143.38 23.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.231 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' C' ' 45' ' ' LEU . 30.1 p -117.31 142.1 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.497 ' HB2' HG13 ' C' ' 71' ' ' ILE . . . -177.54 127.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.486 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.53 ' O ' HD12 ' C' ' 69' ' ' LEU . . . -179.28 -165.26 33.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.551 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.0 154.7 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 111.368 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -134.46 171.73 22.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.472 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' C' ' 66' ' ' SER . . . -156.79 141.25 7.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.575 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 84.3 t80 -135.5 110.83 9.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.334 . . . . 0.0 110.728 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 28.0 mtt180 66.3 -80.79 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.168 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.68 37.82 1.34 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.142 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . 0.464 ' O ' ' HA2' ' C' ' 62' ' ' GLY . 32.1 t -134.8 157.69 46.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.83 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.76 148.31 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.38 173.03 15.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.602 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.53 HD12 ' O ' ' C' ' 59' ' ' GLY . 8.3 tp -124.69 126.61 45.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.766 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -117.52 163.27 16.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.694 0.283 . . . . 0.0 111.683 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' C' ' 58' ' ' ALA . 2.3 tt -158.64 176.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.318 . . . . 0.0 111.105 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.57 -167.79 34.69 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.466 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 17.0 p -164.09 160.05 21.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.038 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.47 176.35 29.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.234 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.509 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 5.0 t80 -143.32 126.94 16.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 111.151 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.462 ' O ' ' HA2' ' C' ' 52' ' ' GLY . 0.0 OUTLIER -110.41 71.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.736 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.733 HG22 ' OD1' ' C' ' 78' ' ' ASN . 7.3 p -83.19 127.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.998 0.427 . . . . 0.0 111.291 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' C' ' 77' ' ' VAL . 31.3 m120 61.14 162.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.088 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . 0.527 ' HG3' ' HA ' ' C' ' 51' ' ' VAL . 32.5 mt-10 -99.49 39.04 1.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 2.6 m -121.33 -52.17 2.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.987 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.542 HG22 ' H ' ' C' ' 82' ' ' ALA . 3.6 p -131.2 169.82 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.572 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.555 ' HB1' ' HZ ' ' B' ' 46' ' ' PHE . . . -168.5 165.23 12.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' C' ' 101' ' ' PHE . 0.6 OUTLIER -139.19 168.79 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.626 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.532 ' HD3' ' N ' ' C' ' 85' ' ' ALA . 2.0 tmtp? -157.85 122.76 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' C' ' 84' ' ' LYS . . . -132.53 161.04 34.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.3 158.66 19.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.552 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.93 130.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.616 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -102.0 115.07 29.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.307 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . 0.511 ' HA ' HG13 ' C' ' 95' ' ' VAL . 77.8 m-85 -91.72 108.73 20.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -114.98 124.14 50.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.6 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -85.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.263 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 82.8 p -166.67 -50.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.309 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -104.35 14.35 30.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.221 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.572 ' O ' ' HB3' ' C' ' 90' ' ' ALA . 4.0 t70 -116.42 57.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' C' ' 89' ' ' TYR . 0.3 OUTLIER -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.696 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.614 ' HG2' ' HB3' ' C' ' 88' ' ' ALA . 2.9 ptp -146.78 151.38 37.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.711 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -130.2 138.29 50.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.439 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' C' ' 85' ' ' ALA . 8.2 m-80 -132.63 137.06 46.88 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.31 95.66 2.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.452 ' HB3' HD11 ' B' ' 45' ' ' LEU . 28.7 m -125.88 161.44 27.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.474 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' C' ' 83' ' ' LEU . 8.6 p90 -127.6 145.51 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.956 0.408 . . . . 0.0 111.085 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.552 ' ND2' ' HD3' ' B' ' 48' ' ' PRO . 1.8 p-10 -120.08 152.98 36.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.387 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.408 HD12 ' N ' ' C' ' 103' ' ' ILE . 4.4 mp -119.79 135.01 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.488 ' HB2' ' CE2' ' B' ' 49' ' ' TYR . 18.3 pm0 -120.1 132.45 55.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 0.6 ' CH2' ' HB2' ' B' ' 56' ' ' PHE . 25.0 m-90 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.59 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 6.0 t70 83.75 134.23 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.885 0.374 . . . . 0.0 111.012 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -129.36 -69.46 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.31 35.57 0.65 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 p -96.42 155.08 16.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.758 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -102.04 -79.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.731 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.0 m 55.59 40.68 31.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.993 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.83 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 35.6 m170 -76.1 -53.02 2.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.859 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.83 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.5 Cg_exo -58.45 118.66 5.58 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.51 2.14 . . . . 0.0 111.895 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -106.86 -66.69 1.0 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.965 0.412 . . . . 0.0 111.207 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -112.51 177.24 4.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.709 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.89 25.69 0.56 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.476 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -80.59 -45.21 17.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.486 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.05 -32.34 79.95 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.285 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.02 95.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 0.0 110.856 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -75.53 -40.01 57.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.006 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -62.35 -34.68 77.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.514 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.82 -38.78 70.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.301 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.16 -61.81 1.83 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.27 -30.14 59.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.1 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.496 HD11 ' HD3' ' B' ' 24' ' ' ARG . 2.6 tm? -64.62 -60.46 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.603 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -65.03 -23.77 67.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -63.91 -54.12 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.533 ' HE ' ' HG ' ' C' ' 25' ' ' LEU . 71.3 mtp85 -69.78 -37.94 76.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.792 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.795 HD22 HD11 ' C' ' 25' ' ' LEU . 3.6 mm? -63.88 -44.71 92.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.605 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.89 -33.19 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG2' ' HD3' ' A' ' 31' ' ' ARG . 1.2 ttpp -67.91 -37.66 81.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.212 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -65.96 -45.48 81.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.414 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -60.12 -36.55 77.73 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.859 179.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.86 -30.35 56.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HD3' ' HG2' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -78.47 -27.18 46.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.28 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 28' ' ' LEU . 27.3 m -84.61 -32.39 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.21 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 55.6 m-20 -69.0 -43.91 73.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.989 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 5.0 ptpt -84.46 -30.22 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.0 -41.73 86.82 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.422 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.642 HD21 ' HG ' ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.81 -22.82 42.59 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -76.61 -39.77 51.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.419 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.644 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 8.6 t -77.64 -39.86 43.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.745 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -55.46 33.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.87 -39.16 80.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.374 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.47 71.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.958 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.437 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 28.3 tp -76.62 -42.21 43.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.093 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.439 ' HB3' ' CB ' ' C' ' 43' ' ' ASN . 32.4 m-20 -70.63 -9.86 57.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB3' ' OG ' ' B' ' 100' ' ' SER . 41.7 t -69.26 -20.65 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.1 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.518 ' HB3' ' OD1' ' B' ' 102' ' ' ASN . 1.3 mm? -83.05 169.93 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.833 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.4 -1.66 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 0.0 111.727 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.597 ' OE1' ' HG2' ' A' ' 84' ' ' LYS . 6.0 mt-30 68.49 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.967 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -78.82 109.16 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.56 2.174 . . . . 0.0 112.527 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 59.57 177.48 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 174.74 50.89 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.191 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.7 p -71.58 -1.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.166 0.586 . . . . 0.0 112.407 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 143.63 53.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.254 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 -165.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.572 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.7 142.17 28.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.534 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 47' ' ' GLN . 12.8 m-80 -122.03 118.73 29.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 111.756 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.425 ' HA ' ' HB2' ' A' ' 73' ' ' SER . 30.1 t80 -84.84 131.67 34.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.267 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.527 HG21 ' HE3' ' A' ' 84' ' ' LYS . 40.9 p -113.72 121.2 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.9 136.99 18.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.486 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.15 166.51 33.58 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.555 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.0 m -116.43 158.13 17.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 111.304 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.98 -171.43 13.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.484 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' B' ' 96' ' ' MET . . . -168.2 141.48 6.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.615 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.517 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 52.0 t80 -135.81 133.06 37.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 0.0 110.789 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 3.1 mmm180 69.52 -94.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 p -144.67 29.22 1.25 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.421 ' OG ' ' HB3' ' A' ' 33' ' ' ASP . 5.1 m -135.9 141.72 44.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.73 157.9 17.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.129 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.72 169.04 20.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.572 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.589 ' HA ' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.62 54.58 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.735 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -126.52 139.2 53.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.677 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 87' ' ' VAL . 10.7 tp -141.07 147.91 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.763 0.316 . . . . 0.0 111.128 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.42 -179.68 42.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.402 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' A' ' 56' ' ' PHE . 1.2 p -166.76 158.59 13.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.23 171.7 28.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.216 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' A' ' 83' ' ' LEU . 39.6 t80 -126.37 138.58 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 0.0 111.113 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.477 HH21 ' HB2' ' A' ' 47' ' ' GLN . 13.7 ttm180 -131.41 134.7 46.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.8 p -120.9 140.86 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.318 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.0 m-20 64.79 -94.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.072 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' C' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.606 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -73.35 -63.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.27 139.64 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -138.29 156.15 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 75' ' ' TYR . 30.3 tp -136.93 141.75 42.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.621 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.597 ' HG2' ' OE1' ' A' ' 47' ' ' GLN . 7.9 tmtt? -153.39 128.71 9.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.71 175.86 11.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.06 -173.45 34.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.593 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' ILE . 7.7 p -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 111.131 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.591 ' HB3' ' CG ' ' A' ' 96' ' ' MET . . . -112.6 144.68 41.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.329 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.6 120.48 40.31 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.244 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.644 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -127.8 131.07 49.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.638 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 56.21 -114.44 5.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.301 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.8 m -150.42 17.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.709 0.29 . . . . 0.0 111.331 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -167.24 19.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.192 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -119.44 67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.31 138.01 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.043 0.449 . . . . 0.0 110.75 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.591 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 4.4 ptp -134.84 134.62 40.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.684 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.81 122.46 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.403 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.24 150.51 27.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 0.0 111.389 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.47 90.58 0.48 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' C' ' 44' ' ' SER . 19.3 m -118.98 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.465 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.43 135.06 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 111.059 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.76 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 73.9 m-80 -102.17 134.39 45.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' C' ' 56' ' ' PHE . 0.1 OUTLIER -138.78 115.29 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.774 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' C' ' 55' ' ' ASN . 0.0 OUTLIER -115.29 157.42 23.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 30.3 m-90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.674 179.678 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 6.0 t70 83.72 134.23 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -129.4 -69.48 0.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.26 35.56 0.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 49.4 p -96.39 155.03 16.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.799 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -101.94 -79.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.748 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 68.4 m 55.48 40.69 31.26 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.045 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.806 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 35.6 m170 -76.16 -53.04 2.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.777 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.806 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.4 Cg_exo -58.38 118.62 5.54 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.489 2.126 . . . . 0.0 111.933 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -106.87 -66.75 0.99 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 111.125 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -112.48 177.23 4.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.689 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.88 25.73 0.56 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.463 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -80.58 -45.29 17.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.468 -179.214 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.05 -32.33 79.9 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.292 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.1 94.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.898 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.54 -40.05 57.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.981 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.3 OUTLIER -62.28 -34.71 77.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.533 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.77 -38.87 70.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.275 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.1 -61.83 1.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.24 -30.1 59.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.119 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.517 HD11 ' HD3' ' C' ' 24' ' ' ARG . 2.6 tm? -64.69 -60.44 3.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.592 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -65.06 -23.73 67.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -63.87 -54.15 39.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.942 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.542 ' HE ' ' HG ' ' A' ' 25' ' ' LEU . 71.4 mtp85 -69.79 -37.97 76.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.747 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' C' ' 25' ' ' LEU . 3.5 mm? -63.85 -44.67 92.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.661 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.97 -33.15 75.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' HD3' ' B' ' 31' ' ' ARG . 1.2 ttpp -67.95 -37.59 81.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.227 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -65.97 -45.52 81.42 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.403 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.6 OUTLIER -60.15 -36.49 77.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.939 178.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.94 -30.27 55.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.535 ' HD3' ' HG2' ' B' ' 27' ' ' LYS . 0.1 OUTLIER -78.42 -27.27 46.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.347 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.454 HG13 ' O ' ' B' ' 28' ' ' LEU . 27.4 m -84.65 -32.3 7.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.206 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 55.8 m-20 -69.04 -43.9 73.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.989 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.649 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 4.9 ptpt -84.44 -30.24 25.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.765 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.75 87.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.435 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.643 HD21 ' HG ' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -79.88 -22.85 42.37 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.485 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -76.61 -39.75 51.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.465 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.668 ' HB2' ' HB2' ' B' ' 90' ' ' ALA . 8.6 t -77.56 -39.96 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.89 -55.56 32.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.09 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.363 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.46 71.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.429 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 28.1 tp -76.63 -42.16 43.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 32.5 m-20 -70.67 -9.87 58.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.472 ' HB3' ' OG ' ' C' ' 100' ' ' SER . 41.6 t -69.38 -20.51 63.82 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.107 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.514 ' HB3' ' OD1' ' C' ' 102' ' ' ASN . 1.3 mm? -83.09 169.85 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.849 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.29 -1.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.191 0.52 . . . . 0.0 111.665 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.611 ' OE1' ' HG2' ' B' ' 84' ' ' LYS . 6.0 mt-30 68.54 116.95 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.984 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.724 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -78.69 109.0 2.53 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.723 2.282 . . . . 0.0 112.557 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 174.81 50.72 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.31 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.8 p -71.5 -1.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.158 0.583 . . . . 0.0 112.412 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 143.65 53.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.265 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.8 -165.26 1.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 110.653 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.71 142.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.584 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' B' ' 47' ' ' GLN . 12.9 m-80 -122.03 118.76 29.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.703 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.432 ' HA ' ' HB2' ' B' ' 73' ' ' SER . 30.2 t80 -84.86 131.63 34.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.226 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.54 HG21 ' HE3' ' B' ' 84' ' ' LYS . 40.9 p -113.72 121.25 43.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.976 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.87 137.02 18.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.447 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.13 166.43 33.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.576 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' B' ' 69' ' ' LEU . 7.0 m -116.32 158.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.816 0.341 . . . . 0.0 111.388 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.5 13.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.41 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' C' ' 96' ' ' MET . . . -168.08 141.43 6.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.622 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 52.1 t80 -135.73 133.17 37.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.739 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' B' ' 63' ' ' TYR . 3.1 mmm180 69.5 -94.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 15.2 p -144.67 29.23 1.25 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.138 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' B' ' 33' ' ' ASP . 5.1 m -136.0 141.72 44.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.69 157.93 17.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.094 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.76 169.03 20.63 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.578 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' B' ' 60' ' ' VAL . 0.5 OUTLIER -123.28 138.66 54.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.751 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.684 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' B' ' 87' ' ' VAL . 10.7 tp -140.97 147.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.41 -179.62 42.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' B' ' 56' ' ' PHE . 1.2 p -166.87 158.6 12.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.25 171.69 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' B' ' 83' ' ' LEU . 39.7 t80 -126.3 138.61 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 111.197 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.479 HH21 ' HB2' ' B' ' 47' ' ' GLN . 13.7 ttm180 -131.44 134.72 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.585 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.8 p -120.98 140.87 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.256 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 97.1 m-20 64.73 -94.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.916 0.389 . . . . 0.0 111.111 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 5.6 pt-20 177.11 -23.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 23.9 p -73.39 -63.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.013 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.3 139.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -138.36 156.1 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.316 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' B' ' 75' ' ' TYR . 30.2 tp -136.91 141.76 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.621 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.611 ' HG2' ' OE1' ' B' ' 47' ' ' GLN . 8.0 tmtt? -153.42 128.68 9.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.148 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.81 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.14 -173.43 34.06 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' B' ' 71' ' ' ILE . 7.7 p -141.56 143.47 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.59 ' HB3' ' CG ' ' B' ' 96' ' ' MET . . . -112.65 144.7 41.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.373 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -114.61 120.51 40.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.266 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -127.85 130.94 49.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.649 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.649 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 56.37 -114.43 5.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.287 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -150.51 17.44 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.802 0.334 . . . . 0.0 111.296 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . 0.414 ' HB3' HH12 ' B' ' 31' ' ' ARG . 1.3 t -167.18 18.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.205 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -119.38 67.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.971 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.3 137.99 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 110.655 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.59 ' CG ' ' HB3' ' B' ' 88' ' ' ALA . 4.4 ptp -134.86 134.66 40.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.708 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -109.89 122.47 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.433 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.19 150.37 27.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.718 0.294 . . . . 0.0 111.416 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.36 90.59 0.49 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.774 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 44' ' ' SER . 19.3 m -119.01 172.15 7.75 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.373 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -143.42 135.12 26.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.774 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 73.8 m-80 -102.24 134.27 45.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.392 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.68 115.26 10.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.83 0.347 . . . . 0.0 110.779 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -115.23 157.41 23.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.404 -0.808 . . . . 0.0 110.613 179.702 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' C' ' 1' ' ' GLY . 6.0 t70 83.73 134.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.895 0.378 . . . . 0.0 110.973 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -129.4 -69.43 0.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.29 35.5 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.024 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 48.3 p -96.4 155.02 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -102.01 -79.1 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.679 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 68.6 m 55.61 40.65 31.04 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.019 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.81 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 35.5 m170 -76.22 -53.07 2.27 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.669 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.81 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -58.3 118.59 5.5 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.497 2.131 . . . . 0.0 111.979 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.85 -66.75 0.99 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.951 0.405 . . . . 0.0 111.175 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -112.5 177.33 4.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.655 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.95 25.67 0.55 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.532 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -80.54 -45.19 17.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.53 -179.263 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.09 -32.34 80.03 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.258 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.98 95.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 0.0 110.955 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -75.67 -39.9 56.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.982 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.3 OUTLIER -62.36 -34.63 77.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.522 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -38.83 69.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.191 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -66.09 -61.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -55.35 -30.03 59.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.491 HD11 ' HD3' ' A' ' 24' ' ' ARG . 2.6 tm? -64.58 -60.55 3.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.02 -23.71 67.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.993 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.03 -54.09 39.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.544 ' HE ' ' HG ' ' B' ' 25' ' ' LEU . 71.3 mtp85 -69.69 -38.06 76.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.75 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' A' ' 25' ' ' LEU . 3.6 mm? -63.78 -44.8 92.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.566 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -63.85 -33.19 75.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.853 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.551 ' HG2' ' HD3' ' C' ' 31' ' ' ARG . 1.2 ttpp -67.92 -37.61 81.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.23 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.457 ' O ' HG13 ' C' ' 32' ' ' VAL . 0.0 OUTLIER -65.97 -45.44 81.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.105 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . 0.41 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.6 OUTLIER -60.17 -36.49 77.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.908 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -76.93 -30.36 56.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.551 ' HD3' ' HG2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -78.38 -27.28 46.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.288 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.457 HG13 ' O ' ' C' ' 28' ' ' LEU . 27.3 m -84.55 -32.42 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.249 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.507 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 55.7 m-20 -68.95 -43.96 73.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.644 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 5.0 ptpt -84.42 -30.22 25.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.817 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -41.78 87.16 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.42 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.643 ' HG ' HD21 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -79.79 -22.86 42.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.466 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -76.58 -39.8 51.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.46 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.659 ' HB2' ' HB2' ' C' ' 90' ' ' ALA . 8.6 t -77.63 -39.88 43.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.719 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.95 -55.52 33.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.132 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.02 80.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.469 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.4 71.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.438 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 28.6 tp -76.62 -42.31 42.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 32.1 m-20 -70.59 -9.9 58.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . 0.491 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 41.7 t -69.22 -20.63 63.96 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.156 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.534 ' HB3' ' OD1' ' A' ' 102' ' ' ASN . 1.4 mm? -83.02 169.85 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.946 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -157.35 -1.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.219 0.533 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.61 ' OE1' ' HG2' ' C' ' 84' ' ' LYS . 6.0 mt-30 68.39 117.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -78.76 109.08 2.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.605 2.203 . . . . 0.0 112.582 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 59.55 177.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.002 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 174.77 50.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.235 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.7 p -71.49 -1.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.194 0.598 . . . . 0.0 112.483 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 143.58 53.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.282 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 -165.27 1.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.594 0.235 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.68 142.17 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.598 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' C' ' 47' ' ' GLN . 12.9 m-80 -122.0 118.73 29.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.71 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.435 ' HA ' ' HB2' ' C' ' 73' ' ' SER . 29.9 t80 -84.74 131.68 34.53 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.296 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.52 HG21 ' HE3' ' C' ' 84' ' ' LYS . 40.8 p -113.78 121.21 43.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.91 136.99 18.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.1 166.43 33.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.572 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' C' ' 69' ' ' LEU . 7.0 m -116.33 158.14 16.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 111.371 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.0 -171.41 13.44 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.465 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 96' ' ' MET . . . -168.15 141.52 6.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.518 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 52.2 t80 -135.8 133.04 37.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.276 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' C' ' 63' ' ' TYR . 3.1 mmm180 69.53 -94.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 15.0 p -144.68 29.19 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' C' ' 33' ' ' ASP . 5.0 m -135.93 141.69 44.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -105.68 157.99 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.73 169.07 20.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.565 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.584 ' HA ' HG12 ' C' ' 60' ' ' VAL . 0.5 OUTLIER -123.36 138.61 54.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.749 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -126.5 139.2 53.41 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.655 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' C' ' 87' ' ' VAL . 10.7 tp -141.03 147.97 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.747 0.308 . . . . 0.0 111.085 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.4 -179.65 42.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' C' ' 56' ' ' PHE . 1.2 p -166.82 158.57 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.997 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.21 171.7 28.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.214 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' C' ' 83' ' ' LEU . 39.8 t80 -126.33 138.62 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.18 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.481 HH21 ' HB2' ' C' ' 47' ' ' GLN . 13.7 ttm180 -131.49 134.72 46.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.667 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.569 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.9 p -121.0 140.89 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 97.2 m-20 64.73 -94.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' B' ' 48' ' ' PRO . 5.6 pt-20 177.16 -23.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.56 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 23.8 p -73.42 -63.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.28 139.77 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -138.47 156.08 47.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.267 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' C' ' 75' ' ' TYR . 30.4 tp -136.91 141.69 42.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.61 ' HG2' ' OE1' ' C' ' 47' ' ' GLN . 8.0 tmtt? -153.41 128.69 9.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.67 175.91 11.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.051 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.05 -173.44 34.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.616 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' C' ' 71' ' ' ILE . 7.9 p -141.56 143.4 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.586 ' HB3' ' CG ' ' C' ' 96' ' ' MET . . . -112.65 144.68 41.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -114.59 120.52 40.48 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.186 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -127.86 131.0 49.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.631 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.644 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 56.37 -114.46 5.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.263 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 62.1 m -150.43 17.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.759 0.314 . . . . 0.0 111.294 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . 0.402 ' HB3' HH12 ' C' ' 31' ' ' ARG . 1.3 t -167.25 19.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.21 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -119.47 67.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.25 137.95 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.586 ' CG ' ' HB3' ' C' ' 88' ' ' ALA . 4.4 ptp -134.84 134.74 41.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -109.86 122.44 47.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.404 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.26 150.42 27.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.713 0.292 . . . . 0.0 111.447 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -165.37 90.57 0.49 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' B' ' 44' ' ' SER . 19.3 m -119.01 172.22 7.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.407 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -143.44 135.18 26.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.79 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 73.9 m-80 -102.27 134.39 45.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.385 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 115.26 10.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 110.789 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' B' ' 55' ' ' ASN . 0.0 OUTLIER -115.22 157.4 23.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.672 179.665 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 t70 64.66 135.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.98 0.419 . . . . 0.0 110.969 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -126.59 -63.21 1.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.1 27.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 p -102.71 148.72 25.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.747 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.559 ' HB3' ' CE1' ' A' ' 8' ' ' HIS . 37.6 m95 -101.15 -84.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.693 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.9 m 63.53 44.76 5.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.005 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.713 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 28.9 m170 -82.97 -49.38 0.75 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.804 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.713 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 31.3 Cg_exo -49.95 106.01 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.471 2.114 . . . . 0.0 111.891 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 8' ' ' HIS . 86.6 mt-30 -99.65 -67.64 0.84 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 111.164 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -117.4 171.32 8.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.618 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.42 24.9 2.07 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.468 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -42.32 92.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.49 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.33 -30.8 68.43 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.264 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.15 90.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.814 0.34 . . . . 0.0 110.855 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.599 ' HA ' ' HD2' ' A' ' 19' ' ' ARG . 15.3 m-70 -77.89 -36.6 49.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.971 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.593 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -65.61 -38.5 89.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.466 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.11 -30.5 66.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.19 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.599 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 43.5 mtt-85 -63.26 -64.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.723 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.638 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 2.6 pp0? -64.0 -27.65 69.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.199 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.608 HD21 HD23 ' B' ' 21' ' ' LEU . 2.3 tm? -63.42 -69.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.541 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.46 -23.37 57.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.018 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.08 -47.99 66.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 47.7 mtp85 -70.87 -40.88 72.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.795 HD11 HD22 ' B' ' 25' ' ' LEU . 2.3 mm? -57.29 -51.12 70.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.547 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.7 -39.44 84.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HZ2' ' HA ' ' A' ' 28' ' ' LEU . 1.1 ttpp -63.13 -37.12 85.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.207 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -60.93 -38.21 85.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.544 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -73.37 -30.56 63.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 178.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.47 -34.34 72.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -33.83 62.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 29' ' ' ASP . 33.4 m -78.02 -26.67 14.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.182 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.595 ' HA ' ' HD2' ' A' ' 63' ' ' TYR . 40.8 m-20 -71.93 -43.19 65.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.047 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 7.0 ptpt -82.88 -28.84 29.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.829 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.58 74.15 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.446 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -74.93 -29.61 61.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 111.158 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' A' ' 63' ' ' TYR . . . -71.17 -42.4 69.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.451 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.8 ' OG ' ' HB1' ' A' ' 88' ' ' ALA . 11.5 t -74.73 -45.61 42.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.659 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.474 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 1.0 OUTLIER -58.42 -49.26 77.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.611 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -66.99 -36.87 83.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.456 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.03 85.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 35.9 tp -74.33 -40.88 61.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.016 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' C' ' 40' ' ' ALA . 63.5 m-20 -73.16 -9.74 59.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.5 t -69.03 -18.88 64.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.149 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.649 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 1.5 mm? -80.55 167.72 19.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.911 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -156.24 -3.39 0.12 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.641 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 12.7 mt-30 66.2 122.29 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.998 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -84.02 104.66 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.599 2.199 . . . . 0.0 112.51 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 9.2 m-30 66.78 -179.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.959 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 170.37 55.49 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.236 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 5.3 p -74.68 -5.62 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.133 0.573 . . . . 0.0 112.451 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 144.56 56.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.369 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.83 -163.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.644 0.259 . . . . 0.0 110.616 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.95 138.9 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.494 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.4 ' OD1' ' HB3' ' B' ' 104' ' ' GLU . 15.3 m-80 -123.0 115.22 21.53 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 111.666 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.497 ' HB2' ' HZ3' ' B' ' 105' ' ' TRP . 37.5 t80 -81.45 129.97 34.86 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.207 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.649 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 45.9 p -110.57 126.12 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.593 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -156.12 133.15 10.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' HB3' ' B' ' 100' ' ' SER . . . -175.25 171.43 44.56 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.57 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.06 159.59 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 111.318 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 -169.88 16.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.444 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.426 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -167.03 135.95 3.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.518 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.649 ' CE2' HD13 ' A' ' 36' ' ' LEU . 28.6 t80 -123.89 141.62 51.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 110.744 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.429 ' HG3' ' OD1' ' A' ' 33' ' ' ASP . 2.5 mmm180 60.55 -95.63 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 p -142.34 24.31 1.95 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.34 142.03 50.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.82 156.37 18.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.14 168.67 22.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.598 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.15 138.26 54.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.796 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -131.99 139.2 48.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.671 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 72' ' ' GLY . 5.5 tp -137.49 162.4 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.121 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.606 ' H ' HG13 ' A' ' 71' ' ' ILE . . . 169.96 -176.07 43.84 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.404 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.78 3.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.01 27.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.268 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.587 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 54.4 t80 -126.4 130.92 51.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 0.0 111.11 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.482 ' HB3' ' HA3' ' A' ' 50' ' ' GLY . 10.9 ttm180 -122.32 120.88 35.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.789 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.2 p -108.04 140.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.256 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 38.7 m-20 62.9 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.077 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 p -72.37 -61.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.992 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.09 142.17 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.816 ' HB3' ' HB2' ' A' ' 102' ' ' ASN . . . -141.19 158.83 43.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.85 147.01 31.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.575 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HE3' HG21 ' A' ' 57' ' ' THR . 11.5 tmtt? -158.54 132.46 7.76 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.25 -179.73 8.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.081 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.444 ' HA3' ' HA3' ' A' ' 72' ' ' GLY . . . 160.53 -173.1 37.04 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.545 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.43 138.08 36.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.114 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.8 ' HB1' ' OG ' ' A' ' 38' ' ' SER . . . -113.2 145.85 40.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.303 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -118.48 115.58 24.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.248 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 38' ' ' SER . . . -123.01 131.14 53.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.669 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.56 ' HA3' ' HD3' ' A' ' 34' ' ' LYS . . . 63.46 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.263 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.9 m -149.28 9.17 0.74 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.57 25.18 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.219 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-20 -121.03 71.76 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.5 t -101.91 137.35 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.071 0.463 . . . . 0.0 110.695 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.575 ' HG2' ' HB3' ' A' ' 88' ' ' ALA . 10.2 ptp -130.32 136.87 49.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -112.33 121.95 46.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.361 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.48 154.96 25.07 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 111.419 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.783 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB3' ' HA3' ' C' ' 59' ' ' GLY . 12.8 m -113.83 168.85 9.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.406 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.72 140.7 47.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.955 0.407 . . . . 0.0 111.108 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.816 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 57.1 m-80 -108.6 132.1 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.3 117.49 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.851 0.357 . . . . 0.0 110.712 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.406 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 0.0 OUTLIER -118.64 161.07 20.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.505 ' HZ3' ' HB2' ' C' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.633 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 t70 64.66 135.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.908 0.385 . . . . 0.0 110.968 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -126.6 -63.23 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.09 27.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 16.6 p -102.69 148.75 25.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.547 ' HB3' ' CE1' ' B' ' 8' ' ' HIS . 37.7 m95 -101.15 -84.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.695 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 63.5 m 63.47 44.79 5.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.98 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.687 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 29.0 m170 -82.93 -49.39 0.76 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.818 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' B' ' 8' ' ' HIS . 31.5 Cg_exo -50.0 105.97 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.51 2.14 . . . . 0.0 111.894 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' B' ' 8' ' ' HIS . 86.6 mt-30 -99.54 -67.72 0.84 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.002 0.43 . . . . 0.0 111.161 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -117.35 171.36 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.693 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.53 24.94 2.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.426 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -42.17 92.47 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.534 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.44 -30.78 68.79 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.231 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.07 -38.12 89.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.89 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.599 ' HA ' ' HD2' ' B' ' 19' ' ' ARG . 15.2 m-70 -77.87 -36.7 49.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.953 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' B' ' 21' ' ' LEU . 0.5 OUTLIER -65.57 -38.43 89.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.471 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.18 -30.43 66.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.251 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.599 ' HD2' ' HA ' ' B' ' 16' ' ' HIS . 43.5 mtt-85 -63.22 -64.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.629 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 2.6 pp0? -64.05 -27.66 69.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.102 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.622 HD21 HD23 ' C' ' 21' ' ' LEU . 2.3 tm? -63.36 -69.21 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -58.41 -23.39 57.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.009 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -68.02 -48.12 66.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' B' ' 20' ' ' GLN . 47.8 mtp85 -70.83 -40.87 72.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.802 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.795 HD22 HD11 ' A' ' 25' ' ' LEU . 2.3 mm? -57.23 -51.11 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.636 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -59.68 -39.53 84.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.766 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.562 ' HZ2' ' HA ' ' B' ' 28' ' ' LEU . 1.2 ttpp -63.15 -37.05 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.218 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.562 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -60.94 -38.21 85.05 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.549 ' HA ' HG22 ' B' ' 32' ' ' VAL . 0.3 OUTLIER -73.38 -30.62 63.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.905 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.41 -34.43 72.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -33.9 62.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.276 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' B' ' 29' ' ' ASP . 33.3 m -77.95 -26.65 14.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.211 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.604 ' HA ' ' HD2' ' B' ' 63' ' ' TYR . 40.5 m-20 -71.96 -43.28 65.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.957 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.578 ' HD3' ' HA3' ' B' ' 91' ' ' GLY . 6.9 ptpt -82.88 -28.76 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.1 -38.58 73.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.658 HD13 ' CE2' ' B' ' 63' ' ' TYR . 0.5 OUTLIER -74.98 -29.63 60.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.765 0.317 . . . . 0.0 111.058 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' B' ' 63' ' ' TYR . . . -71.24 -42.31 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.459 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.799 ' OG ' ' HB1' ' B' ' 88' ' ' ALA . 11.4 t -74.73 -45.57 43.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.75 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.475 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 1.1 t -58.45 -49.2 78.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.607 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -67.08 -36.94 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.386 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.0 85.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.493 ' HB2' ' HB1' ' B' ' 70' ' ' ALA . 36.2 tp -74.41 -40.8 61.79 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.611 ' ND2' ' HA ' ' A' ' 40' ' ' ALA . 63.6 m-20 -73.16 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 29.4 t -69.05 -18.85 64.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.125 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 1.6 mm? -80.59 167.7 19.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.889 177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.24 -3.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.131 0.491 . . . . 0.0 111.649 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' B' ' 48' ' ' PRO . 12.7 mt-30 66.37 122.19 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.956 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -84.0 104.68 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.572 2.181 . . . . 0.0 112.548 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 9.1 m-30 66.8 -179.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 170.37 55.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.252 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' B' ' 78' ' ' ASN . 5.3 p -74.66 -5.67 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.103 0.561 . . . . 0.0 112.454 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.798 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 144.64 56.11 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.228 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 -163.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.94 138.9 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.518 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 15.4 m-80 -122.93 115.15 21.44 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 111.669 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.502 ' HB2' ' HZ3' ' C' ' 105' ' ' TRP . 37.6 t80 -81.37 130.01 34.86 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.628 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 45.8 p -110.57 126.09 54.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.959 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.594 ' CB ' HD12 ' B' ' 71' ' ' ILE . . . -156.15 133.24 10.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.403 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' C' ' 100' ' ' SER . . . -175.33 171.44 44.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.573 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -126.02 159.52 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.16 -169.81 16.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.454 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -167.1 135.85 3.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.595 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.658 ' CE2' HD13 ' B' ' 36' ' ' LEU . 28.6 t80 -123.8 141.65 51.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.725 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' OD1' ' B' ' 33' ' ' ASP . 2.5 mmm180 60.49 -95.7 0.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 16.8 p -142.26 24.33 1.96 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.23 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.35 141.98 50.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.78 156.39 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 168.71 22.57 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.13 138.31 54.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.782 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -131.97 139.15 48.56 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.594 HD12 ' CB ' ' B' ' 58' ' ' ALA . 5.5 tp -137.5 162.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 111.113 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.584 ' H ' HG13 ' B' ' 71' ' ' ILE . . . 170.02 -176.0 43.89 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.452 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.8 p -170.02 150.72 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.991 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.09 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.239 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.583 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 54.5 t80 -126.38 130.97 51.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 111.159 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.479 ' HB3' ' HA3' ' B' ' 50' ' ' GLY . 11.0 ttm180 -122.47 120.96 35.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.798 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.2 p -108.04 140.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' B' ' 51' ' ' VAL . 38.5 m-20 62.9 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 176.0 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.567 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.46 -61.43 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 16.3 m -89.11 142.27 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.81 ' HB3' ' HB2' ' B' ' 102' ' ' ASN . . . -141.21 158.85 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.207 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.9 146.98 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.448 ' HE3' HG21 ' B' ' 57' ' ' THR . 11.5 tmtt? -158.49 132.39 7.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.22 -179.72 8.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.074 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.442 ' HA3' ' HA3' ' B' ' 72' ' ' GLY . . . 160.53 -173.11 37.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.61 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.44 137.99 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.799 ' HB1' ' OG ' ' B' ' 38' ' ' SER . . . -113.15 145.96 40.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.294 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -118.59 115.6 24.89 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.221 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.681 ' HB2' ' HB2' ' B' ' 38' ' ' SER . . . -123.01 131.24 53.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.578 ' HA3' ' HD3' ' B' ' 34' ' ' LYS . . . 63.31 -112.44 4.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.262 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 50.0 m -149.23 9.17 0.74 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.355 . . . . 0.0 111.343 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.61 25.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.184 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 19.1 m-20 -121.09 71.79 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 87.4 t -101.89 137.36 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 110.657 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.58 ' HG2' ' HB3' ' B' ' 88' ' ' ALA . 10.2 ptp -130.36 136.89 49.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.652 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -112.4 121.87 46.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.387 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -112.41 154.91 25.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.482 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.18 88.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.762 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.576 ' HB3' ' HA3' ' A' ' 59' ' ' GLY . 12.7 m -113.7 168.91 9.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.446 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -133.82 140.63 47.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 111.074 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.81 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 57.2 m-80 -108.59 131.96 54.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.373 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.14 117.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.4 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -118.65 161.17 20.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.859 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 0.497 ' HZ3' ' HB2' ' A' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.685 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.639 -0.184 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 t70 64.66 135.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -126.59 -63.34 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.06 27.48 1.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.047 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 16.4 p -102.73 148.75 25.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.763 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . 0.55 ' HB3' ' CE1' ' C' ' 8' ' ' HIS . 37.7 m95 -101.14 -84.17 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.72 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.405 ' H ' ' HB2' ' C' ' 6' ' ' TRP . 63.8 m 63.41 44.74 5.23 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.025 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.706 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 28.9 m170 -82.87 -49.37 0.77 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.874 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' C' ' 8' ' ' HIS . 31.4 Cg_exo -49.94 105.96 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.52 2.147 . . . . 0.0 111.929 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' C' ' 8' ' ' HIS . 86.6 mt-30 -99.6 -67.69 0.84 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.955 0.407 . . . . 0.0 111.183 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -117.37 171.36 8.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.65 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.46 24.91 2.06 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.472 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -42.36 92.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.477 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.31 -30.81 68.38 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.238 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.02 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.915 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . 0.588 ' HA ' ' HD2' ' C' ' 19' ' ' ARG . 15.1 m-70 -77.86 -36.62 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.005 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' C' ' 21' ' ' LEU . 0.5 OUTLIER -65.52 -38.56 90.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.556 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.98 -30.59 66.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.306 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . 0.588 ' HD2' ' HA ' ' C' ' 16' ' ' HIS . 43.6 mtt-85 -63.16 -64.09 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.771 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.637 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 2.6 pp0? -64.07 -27.71 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.108 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.622 HD23 HD21 ' B' ' 21' ' ' LEU . 2.3 tm? -63.44 -69.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.554 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -58.54 -23.28 57.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.017 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.11 -48.01 66.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' C' ' 20' ' ' GLN . 48.1 mtp85 -70.89 -40.83 71.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.775 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.788 HD22 HD11 ' B' ' 25' ' ' LEU . 2.3 mm? -57.31 -51.1 70.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -59.67 -39.52 84.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.803 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.428 ' HZ2' ' HA ' ' C' ' 28' ' ' LEU . 1.2 ttpp -63.12 -37.08 85.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.192 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.428 ' HA ' ' HZ2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -61.01 -38.06 84.75 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . 0.543 ' HA ' HG22 ' C' ' 32' ' ' VAL . 0.3 OUTLIER -73.43 -30.68 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.92 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -70.34 -34.47 72.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.848 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -33.9 62.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.322 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.543 HG22 ' HA ' ' C' ' 29' ' ' ASP . 33.4 m -77.94 -26.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.592 ' HA ' ' HD2' ' C' ' 63' ' ' TYR . 40.2 m-20 -71.96 -43.21 65.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.582 ' HD3' ' HA3' ' C' ' 91' ' ' GLY . 6.9 ptpt -82.84 -28.87 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.799 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.99 -38.6 74.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.475 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' C' ' 63' ' ' TYR . 0.5 OUTLIER -74.96 -29.65 60.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.819 0.342 . . . . 0.0 111.067 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.434 ' HB2' ' H ' ' C' ' 63' ' ' TYR . . . -71.27 -42.26 68.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.429 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.801 ' OG ' ' HB1' ' C' ' 88' ' ' ALA . 11.5 t -74.77 -45.54 43.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.469 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 1.0 OUTLIER -58.5 -49.2 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.083 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.61 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -67.1 -36.81 82.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.428 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.97 85.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.906 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' C' ' 70' ' ' ALA . 36.0 tp -74.35 -40.83 61.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.607 ' ND2' ' HA ' ' B' ' 40' ' ' ALA . 63.5 m-20 -73.21 -9.67 58.96 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 29.2 t -69.16 -18.71 63.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.125 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.647 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 1.5 mm? -80.65 167.69 19.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.872 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -156.18 -3.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 111.702 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' C' ' 48' ' ' PRO . 12.7 mt-30 66.31 122.27 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -84.04 104.71 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.573 2.182 . . . . 0.0 112.528 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 9.2 m-30 66.73 -179.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 170.42 55.56 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.201 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' C' ' 78' ' ' ASN . 5.2 p -74.7 -5.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.197 0.599 . . . . 0.0 112.445 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.779 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 144.51 56.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.323 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 -163.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.656 0.265 . . . . 0.0 110.597 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.88 138.83 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.584 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 15.4 m-80 -122.98 115.18 21.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.022 0.439 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.505 ' HB2' ' HZ3' ' A' ' 105' ' ' TRP . 37.7 t80 -81.45 129.96 34.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.238 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.647 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 45.7 p -110.56 126.07 54.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.597 ' CB ' HD12 ' C' ' 71' ' ' ILE . . . -156.05 133.21 10.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.45 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 100' ' ' SER . . . -175.31 171.5 44.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.588 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -126.12 159.55 34.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 111.336 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.19 -169.87 16.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.478 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.43 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -167.08 135.96 3.91 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.52 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.648 ' CE2' HD13 ' C' ' 36' ' ' LEU . 28.7 t80 -123.87 141.66 51.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.674 0.273 . . . . 0.0 110.816 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.424 ' HG3' ' OD1' ' C' ' 33' ' ' ASP . 2.5 mmm180 60.44 -95.61 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.097 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 16.9 p -142.32 24.35 1.95 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.164 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -129.3 141.98 50.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -105.76 156.43 18.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.23 168.61 22.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.605 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.08 138.32 54.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.787 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -132.0 139.19 48.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.633 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.608 HG13 ' H ' ' C' ' 72' ' ' GLY . 5.5 tp -137.5 162.46 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.608 ' H ' HG13 ' C' ' 71' ' ' ILE . . . 169.97 -176.09 43.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.477 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -170.03 150.7 3.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.1 166.06 27.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.224 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.585 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 54.6 t80 -126.38 130.94 51.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 111.097 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.475 ' HB3' ' HA3' ' C' ' 50' ' ' GLY . 10.9 ttm180 -122.35 120.92 35.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.743 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.779 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.2 p -108.08 140.69 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.292 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' C' ' 51' ' ' VAL . 38.6 m-20 62.91 -93.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 175.99 -23.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.556 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 25.0 p -72.36 -61.56 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.953 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -89.08 142.26 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.497 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.785 ' HB3' ' HB2' ' C' ' 102' ' ' ASN . . . -141.21 158.82 43.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.268 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 tp -145.88 146.99 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.446 ' HE3' HG21 ' C' ' 57' ' ' THR . 11.6 tmtt? -158.49 132.4 7.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.169 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.23 -179.67 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' C' ' 72' ' ' GLY . . . 160.53 -173.06 37.04 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.552 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.4 138.06 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 111.164 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.801 ' HB1' ' OG ' ' C' ' 38' ' ' SER . . . -113.2 145.94 40.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -118.59 115.62 24.93 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.188 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' C' ' 38' ' ' SER . . . -123.11 131.13 53.57 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.574 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.582 ' HA3' ' HD3' ' C' ' 34' ' ' LYS . . . 63.45 -112.4 4.94 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.213 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -149.29 9.19 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 111.297 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -164.62 25.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 19.4 m-20 -121.0 71.8 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -101.86 137.39 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 0.0 110.663 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.576 ' HB3' ' HD1' ' B' ' 63' ' ' TYR . 10.2 ptp -130.35 136.82 49.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.33 121.96 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.435 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.45 154.92 25.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.456 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.21 88.66 0.15 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.767 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.583 ' HB3' ' HA3' ' B' ' 59' ' ' GLY . 12.6 m -113.71 168.91 9.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.47 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -133.79 140.54 47.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.085 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.785 ' HB2' ' HB3' ' C' ' 82' ' ' ALA . 56.9 m-80 -108.49 132.03 54.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.392 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.19 117.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.727 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' C' ' 104' ' ' GLU . 0.0 OUTLIER -118.65 161.18 20.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 0.502 ' HZ3' ' HB2' ' B' ' 56' ' ' PHE . 27.9 m-90 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.675 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 60.62 120.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.869 0.366 . . . . 0.0 110.989 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -123.22 58.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.12 -54.35 2.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.428 ' HA ' ' NE2' ' A' ' 8' ' ' HIS . 0.7 OUTLIER -116.78 107.29 14.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.791 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.501 ' HZ3' ' HB3' ' A' ' 19' ' ' ARG . 59.6 t-105 -151.15 114.31 4.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.727 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t 60.89 71.13 0.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.053 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.738 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 8.1 m-70 -109.6 -53.91 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.753 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.738 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.339 31.3 Cg_exo -72.27 139.8 32.75 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.483 2.122 . . . . 0.0 111.967 179.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.81 -44.16 97.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.899 0.381 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -93.03 106.86 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.714 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -160.35 114.91 2.22 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.49 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -129.03 -66.21 0.83 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.485 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.5 72.08 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.279 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.99 -54.89 31.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 110.879 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -53.53 -41.64 66.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.932 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -39.41 94.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.523 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.41 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 82.1 t80 -60.94 -31.5 71.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.193 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.566 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 32.2 mmt180 -75.58 -30.06 59.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.619 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 29.5 mt-30 -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.11 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.433 ' HA ' HD11 ' C' ' 21' ' ' LEU . 0.5 OUTLIER -64.47 -50.28 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 22.8 m-20 -71.98 -19.97 61.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 12.9 t-20 -77.4 -41.22 40.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.735 ' HD3' HD13 ' C' ' 25' ' ' LEU . 3.6 mmp_? -71.58 -46.25 59.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.727 HD13 ' HD3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.67 94.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.698 ' O ' HG22 ' A' ' 30' ' ' THR . 51.7 t0 -69.73 -28.98 66.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.805 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -75.96 -38.1 57.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.241 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.636 ' O ' HG22 ' A' ' 32' ' ' VAL . 8.0 mt -76.5 -34.8 58.61 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -66.76 -47.21 72.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 26' ' ' ASP . 9.7 t -71.63 -40.19 69.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.678 ' HG2' HH11 ' A' ' 31' ' ' ARG . 21.2 ttp85 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.348 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 28' ' ' LEU . 28.4 m -76.61 -27.67 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.582 ' OD2' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t70 -64.08 -56.18 16.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.96 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.679 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 23.0 pttt -68.71 -37.63 79.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.826 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.67 -48.2 87.42 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.421 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' B' ' 39' ' ' SER . 0.4 OUTLIER -67.48 -31.69 72.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.801 0.334 . . . . 0.0 111.095 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -38.44 90.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.405 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.685 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 78.7 p -79.96 -43.52 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.573 ' HB2' HD21 ' C' ' 36' ' ' LEU . 46.7 t -53.24 -60.95 2.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.7 -30.25 60.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.567 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -63.98 -49.02 74.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.926 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -66.99 -32.91 74.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.123 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 1.4 m-20 -78.75 -13.63 59.71 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -19.08 65.68 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.134 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.815 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.2 mm? -75.55 158.57 32.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.9 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 47.3 p90 -146.47 -31.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.645 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 8.3 tt0 75.64 108.58 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.924 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -90.81 137.26 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.668 2.246 . . . . 0.0 112.576 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 14.5 m-85 67.56 154.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.576 ' CA ' ' HB3' ' A' ' 76' ' ' ARG . . . -173.94 73.06 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.228 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.826 HG12 ' HE2' ' A' ' 53' ' ' LYS . 11.4 p -95.88 -22.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.157 0.583 . . . . 0.0 112.521 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 150.89 48.99 0.02 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.301 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.826 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -143.76 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.576 0.227 . . . . 0.0 110.57 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.41 143.4 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.557 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.496 HD21 ' HB3' ' B' ' 102' ' ' ASN . 1.0 OUTLIER -135.14 116.49 14.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.03 0.443 . . . . 0.0 111.697 179.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 71' ' ' ILE . 12.0 t80 -80.29 131.03 35.59 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.279 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.815 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 27.7 p -110.53 120.96 44.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.971 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 71' ' ' ILE . . . -143.49 139.9 30.06 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.402 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.01 164.68 33.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.536 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.428 HG12 HD13 ' A' ' 69' ' ' LEU . 28.6 m -118.79 164.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.879 0.371 . . . . 0.0 111.282 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.567 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.5 177.5 20.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.48 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 67' ' ' GLN . . . -162.05 155.13 26.3 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.517 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 1.3 t80 -142.04 122.32 13.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 110.736 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.582 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 24.9 mtt-85 67.63 -93.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.107 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -131.89 9.49 4.55 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.167 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 22.9 t -109.93 173.88 6.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -135.31 -179.27 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.685 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -162.61 158.28 23.11 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.515 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD12 ' H ' ' A' ' 70' ' ' ALA . 3.9 tp -118.11 134.62 54.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.733 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.926 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -142.71 139.06 30.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.68 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.561 HD11 ' CE2' ' A' ' 56' ' ' PHE . 8.9 tp -138.33 150.55 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.718 0.295 . . . . 0.0 111.09 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.7 -177.26 37.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.2 p -160.23 155.26 24.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.61 30.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.242 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.42 120.58 17.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 111.147 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.576 ' HB3' ' CA ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.695 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.777 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 14.9 p -102.47 130.09 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 58.98 -171.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.97 66.02 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.3 p -160.07 -51.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' A' ' 103' ' ' ILE . 9.8 p -119.53 142.08 36.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.83 153.09 45.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 0.0 111.272 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 130.7 32.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.694 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -135.02 144.02 47.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.062 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 173.42 161.11 23.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.588 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.39 150.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -121.79 140.68 52.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.23 128.4 48.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.247 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 94' ' ' ASP . . . -136.33 151.09 49.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.672 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.679 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 50.21 -99.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.256 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.33 -27.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.727 0.298 . . . . 0.0 111.308 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.5 p -123.75 15.03 9.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.2 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.536 ' CB ' ' HB3' ' A' ' 90' ' ' ALA . 41.6 m-20 -101.52 69.91 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.74 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.512 ' SD ' HD23 ' C' ' 36' ' ' LEU . 1.3 ptp -135.2 139.48 44.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.771 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -117.56 129.91 56.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.473 ' ND2' ' HA3' ' C' ' 61' ' ' GLY . 15.1 m120 -129.27 145.43 51.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.661 0.267 . . . . 0.0 111.441 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.52 7.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.746 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.9 p -127.99 164.41 22.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.437 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.28 142.62 35.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.951 0.405 . . . . 0.0 111.096 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 17.0 m-80 -109.32 134.99 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.366 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.558 HD12 ' HE1' ' A' ' 105' ' ' TRP . 1.2 pt -134.58 126.3 48.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.808 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' C' ' 55' ' ' ASN . 3.8 pt-20 -104.67 148.58 26.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.558 ' HE1' HD12 ' A' ' 103' ' ' ILE . 57.6 m95 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.672 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.67 -0.172 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 60.59 120.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.889 0.376 . . . . 0.0 110.925 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -123.21 58.79 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.21 -54.29 2.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.988 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.422 ' HA ' ' NE2' ' B' ' 8' ' ' HIS . 0.7 OUTLIER -116.91 107.36 14.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.712 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.504 ' HZ3' ' HB3' ' B' ' 19' ' ' ARG . 59.5 t-105 -151.23 114.29 4.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.79 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t 60.88 71.08 0.58 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.069 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.765 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 8.1 m-70 -109.54 -53.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.786 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.765 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.341 31.4 Cg_exo -72.35 139.73 32.38 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.539 2.159 . . . . 0.0 111.923 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.65 -44.19 97.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.974 0.416 . . . . 0.0 111.186 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -92.97 106.88 18.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.7 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -160.42 114.88 2.2 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.439 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -128.94 -66.27 0.83 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.528 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.12 -46.43 72.4 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.284 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.06 -54.8 32.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -53.59 -41.59 66.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.984 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -39.38 94.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . 0.404 ' O ' ' OD2' ' B' ' 22' ' ' ASP . 82.3 t80 -60.78 -31.53 70.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 111.296 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 32.4 mmt180 -75.66 -30.02 59.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.618 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 29.6 mt-30 -73.12 -37.04 66.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.159 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' C' ' 21' ' ' LEU . 0.5 OUTLIER -64.52 -50.24 68.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.569 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 22.7 m-20 -72.0 -19.99 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.971 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 13.0 t-20 -77.37 -41.2 41.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.727 ' HD3' HD13 ' A' ' 25' ' ' LEU . 3.6 mmp_? -71.54 -46.29 59.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.762 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.725 HD13 ' HD3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -59.93 -43.65 94.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.693 ' O ' HG22 ' B' ' 30' ' ' THR . 51.7 t0 -69.75 -28.98 66.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.835 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -76.01 -37.99 57.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.251 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.631 ' O ' HG22 ' B' ' 32' ' ' VAL . 8.0 mt -76.62 -34.82 58.33 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -66.58 -47.35 73.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.942 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.693 HG22 ' O ' ' B' ' 26' ' ' ASP . 9.7 t -71.66 -40.11 69.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.885 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.689 HH11 ' HG2' ' B' ' 31' ' ' ARG . 21.3 ttp85 -62.73 -38.3 89.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.297 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.631 HG22 ' O ' ' B' ' 28' ' ' LEU . 28.6 m -76.69 -27.68 17.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.178 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.575 ' OD2' ' HD2' ' B' ' 64' ' ' ARG . 10.4 t70 -64.0 -56.17 17.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.004 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.682 ' HD2' ' HA3' ' B' ' 91' ' ' GLY . 23.0 pttt -68.77 -37.56 79.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.06 88.12 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.425 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' C' ' 39' ' ' SER . 0.4 OUTLIER -67.64 -31.62 71.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 111.057 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.52 90.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.418 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.694 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 78.4 p -79.93 -43.58 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.55 ' HB2' HD21 ' A' ' 36' ' ' LEU . 46.7 t -53.19 -60.88 2.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.75 -30.22 60.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.403 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.571 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -64.03 -48.97 74.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.927 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.6 OUTLIER -67.04 -32.96 74.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 1.4 m-20 -78.79 -13.58 59.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.12 65.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.131 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.814 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.2 mm? -75.58 158.63 32.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.894 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.441 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 47.4 p90 -146.52 -30.99 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.169 0.509 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 8.3 tt0 75.45 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.978 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -90.79 137.16 2.25 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.208 . . . . 0.0 112.613 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 14.4 m-85 67.53 154.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.582 ' CA ' ' HB3' ' B' ' 76' ' ' ARG . . . -173.89 73.19 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.215 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.814 HG12 ' HE2' ' B' ' 53' ' ' LYS . 11.5 p -96.02 -22.88 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 123.162 0.585 . . . . 0.0 112.446 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 150.83 49.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.814 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.51 7.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.631 0.253 . . . . 0.0 110.546 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.43 143.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.571 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.492 HD21 ' HB3' ' C' ' 102' ' ' ASN . 1.0 OUTLIER -135.18 116.49 14.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 111.663 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' B' ' 71' ' ' ILE . 12.0 t80 -80.32 131.07 35.58 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.215 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.814 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 27.8 p -110.63 120.81 43.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.941 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' B' ' 71' ' ' ILE . . . -143.37 139.85 30.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.441 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.02 164.63 33.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.522 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.425 HG12 HD13 ' B' ' 69' ' ' LEU . 28.5 m -118.68 164.37 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.879 0.371 . . . . 0.0 111.293 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.571 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.57 177.47 20.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.482 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 67' ' ' GLN . . . -162.0 155.12 26.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' B' ' 64' ' ' ARG . 1.3 t80 -142.05 122.34 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.575 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 25.1 mtt-85 67.59 -93.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.088 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.41 4.54 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.472 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 22.8 t -109.89 173.91 6.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.811 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.6 OUTLIER -135.32 -179.35 5.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.061 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.694 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -162.56 158.22 23.15 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.552 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.593 HD12 ' H ' ' B' ' 70' ' ' ALA . 3.9 tp -118.02 134.64 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.927 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -142.72 139.03 30.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.694 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.558 HD11 ' CE2' ' B' ' 56' ' ' PHE . 8.9 tp -138.29 150.47 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.15 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.4 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -164.59 -177.19 37.02 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.423 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -160.28 155.22 24.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.91 0.386 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.73 163.58 30.06 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.235 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -136.4 120.52 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 111.108 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.582 ' HB3' ' CA ' ' B' ' 50' ' ' GLY . 0.0 OUTLIER -105.21 107.63 18.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.762 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.768 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 14.9 p -102.52 130.07 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 59.0 -171.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -118.99 66.01 0.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 69.9 p -160.03 -51.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.022 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' B' ' 103' ' ' ILE . 9.8 p -119.53 142.07 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.563 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.85 153.15 45.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.895 0.378 . . . . 0.0 111.245 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.57 130.71 32.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.477 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -135.09 143.95 46.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.21 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.477 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -148.28 169.11 20.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.793 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 173.37 161.02 22.92 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.553 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.33 150.16 34.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -121.74 140.67 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.16 128.35 48.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.268 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.542 ' HB3' ' CB ' ' B' ' 94' ' ' ASP . . . -136.32 151.09 49.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.625 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.682 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 50.22 -99.64 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.307 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 25.9 t -152.28 -27.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 15.08 9.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.191 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.542 ' CB ' ' HB3' ' B' ' 90' ' ' ALA . 41.5 m-20 -101.59 69.95 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -113.33 127.94 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.747 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.505 ' SD ' HD23 ' A' ' 36' ' ' LEU . 1.3 ptp -135.19 139.48 44.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -117.57 129.92 56.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.463 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.463 ' ND2' ' HA3' ' A' ' 61' ' ' GLY . 15.0 m120 -129.29 145.43 51.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.7 0.285 . . . . 0.0 111.419 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.65 114.45 7.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.695 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 84.1 p -127.99 164.49 22.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.424 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -140.36 142.54 35.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.521 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 17.1 m-80 -109.3 134.95 51.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.545 HD12 ' HE1' ' B' ' 105' ' ' TRP . 1.2 pt -134.57 126.2 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.796 0.331 . . . . 0.0 110.781 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 3.8 pt-20 -104.63 148.64 26.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 0.545 ' HE1' HD12 ' B' ' 103' ' ' ILE . 58.1 m95 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.406 -0.806 . . . . 0.0 110.649 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.64 -0.184 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 t70 60.57 120.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.397 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -123.19 58.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.13 -54.34 2.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . 0.411 ' HA ' ' NE2' ' C' ' 8' ' ' HIS . 0.7 OUTLIER -116.83 107.38 14.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.784 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . 0.515 ' HZ3' ' HB3' ' C' ' 19' ' ' ARG . 59.5 t-105 -151.22 114.3 4.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.718 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t 60.9 71.04 0.58 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.059 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.762 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 8.1 m-70 -109.51 -53.92 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.794 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.762 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.338 31.4 Cg_exo -72.24 139.76 32.77 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.471 2.114 . . . . 0.0 111.942 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.69 -44.14 97.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.991 0.424 . . . . 0.0 111.234 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -93.02 106.92 18.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.672 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -160.44 114.9 2.19 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.483 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -128.97 -66.25 0.83 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.557 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.45 72.53 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.272 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.08 -54.82 32.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.906 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -53.5 -41.68 66.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.979 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -39.34 93.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.534 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . 0.418 ' O ' ' OD2' ' C' ' 22' ' ' ASP . 82.2 t80 -60.87 -31.5 70.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 32.3 mmt180 -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.735 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 29.6 mt-30 -73.07 -37.0 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 111.212 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.437 ' HA ' HD11 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -64.57 -50.25 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 22.7 m-20 -71.91 -20.06 61.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 12.8 t-20 -77.31 -41.27 41.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.725 ' HD3' HD13 ' B' ' 25' ' ' LEU . 3.6 mmp_? -71.45 -46.4 60.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.735 HD13 ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -59.83 -43.72 94.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.643 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . 0.69 ' O ' HG22 ' C' ' 30' ' ' THR . 51.7 t0 -69.79 -28.9 66.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -75.98 -38.08 57.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.661 0.267 . . . . 0.0 111.265 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.639 ' O ' HG22 ' C' ' 32' ' ' VAL . 8.0 mt -76.52 -34.91 58.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.54 -47.32 73.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.003 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.69 HG22 ' O ' ' C' ' 26' ' ' ASP . 9.7 t -71.62 -40.23 69.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.699 HH11 ' HG2' ' C' ' 31' ' ' ARG . 21.3 ttp85 -62.58 -38.51 90.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.325 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.639 HG22 ' O ' ' C' ' 28' ' ' LEU . 28.3 m -76.59 -27.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.235 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.573 ' OD2' ' HD2' ' C' ' 64' ' ' ARG . 10.4 t70 -63.98 -56.2 16.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HD2' ' HA3' ' C' ' 91' ' ' GLY . 23.1 pttt -68.78 -37.56 79.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.807 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 -48.08 88.01 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.384 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.4 OUTLIER -67.67 -31.56 71.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.28 -38.44 90.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.482 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.701 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 78.7 p -79.9 -43.59 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.545 ' HB2' HD21 ' B' ' 36' ' ' LEU . 46.7 t -53.15 -60.99 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.66 -30.29 60.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . 0.58 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -63.95 -48.98 74.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.923 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.6 OUTLIER -67.01 -32.94 74.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.067 179.33 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.3 m-20 -78.77 -13.6 59.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -19.07 65.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.144 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.826 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.2 mm? -75.65 158.71 32.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.87 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.452 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 47.5 p90 -146.56 -31.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.194 0.521 . . . . 0.0 111.69 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.477 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 8.3 tt0 75.59 108.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.979 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -90.85 137.17 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.625 2.217 . . . . 0.0 112.545 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 14.6 m-85 67.59 154.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.583 ' CA ' ' HB3' ' C' ' 76' ' ' ARG . . . -173.95 73.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.253 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.811 HG12 ' HE2' ' C' ' 53' ' ' LYS . 11.4 p -95.87 -22.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.198 0.599 . . . . 0.0 112.453 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 150.9 48.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.296 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . 0.811 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.4 OUTLIER -143.78 179.49 7.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.593 0.235 . . . . 0.0 110.566 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.45 143.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.525 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.489 HD21 ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -135.19 116.45 14.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.006 0.431 . . . . 0.0 111.68 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.556 ' CE2' HD11 ' C' ' 71' ' ' ILE . 12.0 t80 -80.35 131.09 35.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.269 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.826 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 27.6 p -110.63 120.82 43.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.972 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.562 ' HB2' ' CD1' ' C' ' 71' ' ' ILE . . . -143.37 139.93 30.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.431 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.05 164.61 33.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.563 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.438 HG12 HD13 ' C' ' 69' ' ' LEU . 28.2 m -118.62 164.38 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.331 . . . . 0.0 111.386 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.52 177.46 20.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.496 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' C' ' 67' ' ' GLN . . . -161.99 155.07 26.22 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' C' ' 64' ' ' ARG . 1.3 t80 -141.95 122.31 14.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.76 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.573 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 24.9 mtt-85 67.54 -93.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.104 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 79.7 p -131.91 9.45 4.54 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.19 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . 0.462 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 22.8 t -109.92 173.93 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.6 OUTLIER -135.33 -179.39 5.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.093 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -162.55 158.27 23.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.549 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.59 HD12 ' H ' ' C' ' 70' ' ' ALA . 3.8 tp -118.08 134.63 54.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.923 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -142.69 138.99 30.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.675 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.562 ' CD1' ' HB2' ' C' ' 58' ' ' ALA . 8.9 tp -138.3 150.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.712 0.291 . . . . 0.0 111.162 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.62 -177.25 37.09 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.399 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.2 p -160.3 155.12 24.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.65 163.66 30.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.223 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -136.4 120.45 17.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 111.171 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.583 ' HB3' ' CA ' ' C' ' 50' ' ' GLY . 0.0 OUTLIER -105.18 107.65 18.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.796 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.754 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 14.9 p -102.48 130.07 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.291 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 59.01 -171.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -118.96 66.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.567 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 69.2 p -160.08 -51.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.044 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' CG2' ' C' ' 103' ' ' ILE . 9.8 p -119.59 141.94 37.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.08 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.294 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.48 130.81 33.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.627 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -135.11 144.03 46.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.179 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . 0.481 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -148.38 169.15 20.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.782 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 173.47 161.09 23.11 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.589 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.36 150.12 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.897 0.38 . . . . 0.0 111.074 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -121.71 140.73 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.356 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.19 128.41 48.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.287 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.543 ' HB3' ' CB ' ' C' ' 94' ' ' ASP . . . -136.38 151.07 49.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.613 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.695 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 50.21 -99.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.334 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 26.0 t -152.35 -27.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.753 0.311 . . . . 0.0 111.348 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -123.7 14.98 9.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.205 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' C' ' 90' ' ' ALA . 41.4 m-20 -101.48 69.8 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 t -113.29 127.98 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.989 0.424 . . . . 0.0 110.742 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.513 ' SD ' HD23 ' B' ' 36' ' ' LEU . 1.3 ptp -135.2 139.52 44.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.746 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -117.57 129.9 56.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.472 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.475 ' ND2' ' HA3' ' B' ' 61' ' ' GLY . 15.0 m120 -129.25 145.37 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.676 0.275 . . . . 0.0 111.43 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.59 114.49 7.33 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 83.9 p -128.04 164.43 22.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.426 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -140.31 142.5 35.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.967 0.413 . . . . 0.0 111.114 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.521 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 17.4 m-80 -109.24 135.05 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.542 HD12 ' HE1' ' C' ' 105' ' ' TRP . 1.2 pt -134.56 126.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.776 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' B' ' 55' ' ' ASN . 3.8 pt-20 -104.69 148.58 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 0.542 ' HE1' HD12 ' C' ' 103' ' ' ILE . 57.7 m95 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.705 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 t70 64.4 118.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.959 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -123.87 55.0 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.877 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.78 -52.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.41 103.99 12.11 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.729 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -153.87 111.64 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.682 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t 60.4 71.47 0.57 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.996 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.75 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 7.8 m-70 -109.14 -53.79 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.844 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.75 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.284 31.5 Cg_exo -70.19 141.36 43.26 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.473 2.115 . . . . 0.0 111.923 179.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.52 -49.83 67.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.888 0.375 . . . . 0.0 111.092 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -88.92 104.18 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.694 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.33 115.85 2.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.485 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -129.28 -66.13 0.83 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.56 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.3 -50.53 59.31 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.267 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -59.99 -54.37 46.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 0.0 110.849 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.428 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 1.3 t60 -53.15 -46.06 68.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.96 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -63.32 -40.72 98.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.534 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.421 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 92.9 t80 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.182 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 33.1 mmt180 -77.02 -30.18 55.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.744 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.7 mt-30 -71.14 -33.87 70.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.217 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.445 HD21 ' HG3' ' B' ' 24' ' ' ARG . 0.5 OUTLIER -65.1 -48.29 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 18' ' ' PHE . 15.9 m-20 -70.93 -20.44 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.977 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.79 -42.94 57.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.618 ' HB3' HD13 ' C' ' 25' ' ' LEU . 2.6 mmp_? -70.66 -48.82 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.736 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' B' ' 24' ' ' ARG . 0.4 OUTLIER -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 30' ' ' THR . 49.8 t0 -72.1 -28.9 63.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.813 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -76.0 -37.16 58.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.259 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.568 HD11 ' HA ' ' C' ' 25' ' ' LEU . 9.5 mt -76.13 -32.75 59.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 32' ' ' VAL . 20.9 t0 -67.38 -48.56 67.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 26' ' ' ASP . 10.0 t -68.7 -37.92 79.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.854 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.666 HH11 ' HG2' ' A' ' 31' ' ' ARG . 18.9 ttp85 -63.65 -39.09 93.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 28' ' ' LEU . 30.2 m -75.33 -28.25 20.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.505 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 13.8 t70 -62.55 -55.12 30.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.001 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 18.7 pttt -70.78 -40.65 72.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.728 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.28 90.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.422 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.95 -34.78 78.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.805 0.336 . . . . 0.0 111.057 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.6 94.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.398 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.438 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 55.6 p -78.38 -39.28 39.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.737 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.0 t -54.66 -64.66 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.408 ' HA ' ' ND2' ' B' ' 43' ' ' ASN . . . -54.48 -31.09 55.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.428 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -62.39 -48.52 79.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.798 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -68.59 -32.72 72.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.3 m-20 -80.26 -15.04 57.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -17.55 64.79 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.156 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.782 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.8 mm? -76.59 156.07 33.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.871 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.18 -30.29 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.58 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 7.9 tt0 72.17 108.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.031 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.9 Cg_endo -91.29 139.43 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.637 2.225 . . . . 0.0 112.535 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.0 m-85 69.1 154.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.0 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -176.62 75.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.255 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.841 HG12 ' HE2' ' A' ' 53' ' ' LYS . 11.7 p -95.57 -24.92 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.067 0.547 . . . . 0.0 112.464 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.828 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 154.19 48.33 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.246 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.841 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -145.03 179.69 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.6 0.238 . . . . 0.0 110.643 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 11.4 p -105.18 145.3 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.553 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.58 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 0.9 OUTLIER -135.08 119.62 18.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 111.687 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 71' ' ' ILE . 10.1 t80 -83.01 132.28 35.15 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.18 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.782 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 43.6 p -111.04 122.73 48.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.926 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.54 143.59 31.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.465 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.89 37.04 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.596 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.14 163.78 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.767 0.317 . . . . 0.0 111.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -138.19 177.75 19.79 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.447 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.32 26.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.76 123.82 14.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 27.2 mtt-85 64.18 -94.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.065 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 p -130.69 6.41 4.73 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.203 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.44 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 30.6 t -104.6 174.34 5.92 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.98 177.08 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -161.46 153.93 20.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.556 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 70' ' ' ALA . 6.0 tp -117.26 132.0 56.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.806 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.798 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -138.8 136.1 35.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.692 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.472 HD11 ' CE2' ' A' ' 56' ' ' PHE . 8.8 tp -136.29 145.44 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.28 155.99 34.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.68 163.46 29.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.216 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t80 -138.43 120.91 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 111.128 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HG3' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -110.39 105.58 14.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.685 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.828 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 12.6 p -104.58 130.8 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.329 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.432 ' CG ' HG22 ' A' ' 77' ' ' VAL . 9.1 m-20 59.5 -174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.18 68.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.535 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.2 p -160.03 -50.7 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.036 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.26 143.48 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.578 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 154.52 45.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.265 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.88 132.37 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.57 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -134.72 139.8 45.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.422 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.07 169.42 19.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.672 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 173.68 162.69 25.97 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.532 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.12 33.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.157 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -119.06 141.33 48.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -124.23 127.86 48.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.269 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.569 ' HB3' ' CB ' ' A' ' 94' ' ' ASP . . . -135.59 148.1 48.93 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.7 -98.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.278 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 -28.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 111.323 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.9 p -121.56 15.34 11.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.569 ' CB ' ' HB3' ' A' ' 90' ' ' ALA . 38.1 m-20 -103.12 70.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.7 t -110.44 128.27 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.722 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.444 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 1.6 ptp -135.58 139.44 43.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.74 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -118.93 128.82 54.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.459 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.26 147.37 51.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.36 116.0 5.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.745 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 94.8 p -127.94 163.14 25.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.383 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -136.57 144.58 44.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 111.012 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' CB ' ' HD3' ' C' ' 48' ' ' PRO . 21.6 m-80 -109.83 131.9 54.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.38 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.475 HD12 ' HE1' ' A' ' 105' ' ' TRP . 1.6 pt -131.41 126.74 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.75 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 3.8 pt-20 -105.94 152.88 22.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.475 ' HE1' HD12 ' A' ' 103' ' ' ILE . 44.9 m95 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.685 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 t70 64.31 119.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.917 0.389 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -123.89 55.04 1.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.84 -52.82 1.99 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.983 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.35 103.95 12.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.781 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -153.82 111.6 3.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.756 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t 60.5 71.43 0.57 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.965 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.722 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 7.7 m-70 -109.27 -53.81 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.762 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.722 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.282 31.2 Cg_exo -70.05 141.29 43.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.427 2.085 . . . . 0.0 111.994 179.191 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.47 -49.73 67.99 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -88.92 104.2 16.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.678 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.37 115.88 2.6 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.429 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -129.31 -66.13 0.82 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.576 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.33 -50.51 59.37 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.219 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.99 -54.39 46.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.886 0.374 . . . . 0.0 110.914 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.422 ' O ' ' HG3' ' B' ' 20' ' ' GLN . 1.3 t60 -53.13 -46.0 68.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.994 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -63.33 -40.79 98.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.546 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . 0.431 ' O ' ' OD2' ' B' ' 22' ' ' ASP . 92.7 t80 -65.59 -32.23 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.205 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -77.14 -30.08 54.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.735 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.548 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 mt-30 -71.24 -33.85 70.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.099 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.455 HD21 ' HG3' ' C' ' 24' ' ' ARG . 0.5 OUTLIER -65.15 -48.28 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.5 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' B' ' 18' ' ' PHE . 15.7 m-20 -70.87 -20.41 62.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.76 -43.03 56.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.603 ' HB3' HD13 ' A' ' 25' ' ' LEU . 2.6 mmp_? -70.63 -48.8 53.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.746 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.612 HD13 ' HB3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -60.41 -41.8 94.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.644 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.513 ' O ' HG22 ' B' ' 30' ' ' THR . 49.8 t0 -72.04 -28.96 63.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -75.9 -37.2 59.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.259 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 25' ' ' LEU . 9.6 mt -76.17 -32.83 59.26 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.455 ' O ' HG22 ' B' ' 32' ' ' VAL . 20.9 t0 -67.26 -48.64 67.13 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.981 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.513 HG22 ' O ' ' B' ' 26' ' ' ASP . 10.1 t -68.66 -37.93 80.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.672 HH11 ' HG2' ' B' ' 31' ' ' ARG . 19.0 ttp85 -63.67 -39.06 93.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.507 HG13 ' O ' ' B' ' 28' ' ' LEU . 30.2 m -75.36 -28.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.182 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.503 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 13.8 t70 -62.61 -55.11 30.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 18.7 pttt -70.7 -40.68 72.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.31 90.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.4 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.88 -34.84 78.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.086 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.54 94.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.421 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 56.0 p -78.48 -39.21 39.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -54.77 -64.6 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.101 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.405 ' HA ' ' ND2' ' C' ' 43' ' ' ASN . . . -54.46 -31.15 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.469 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -62.28 -48.65 78.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.822 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.4 OUTLIER -68.51 -32.76 72.95 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 2.3 m-20 -80.24 -15.02 57.93 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -17.56 64.8 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.081 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.778 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.8 mm? -76.5 156.17 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.38 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.613 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 7.9 tt0 72.22 108.73 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.929 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.523 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.8 Cg_endo -91.34 139.39 2.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.617 2.212 . . . . 0.0 112.516 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.0 m-85 69.1 154.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.58 75.35 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.227 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.84 HG12 ' HE2' ' B' ' 53' ' ' LYS . 11.7 p -95.59 -24.89 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 123.147 0.579 . . . . 0.0 112.467 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.801 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 154.11 48.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.277 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.84 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -145.12 179.61 7.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 110.634 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' B' ' 75' ' ' TYR . 11.4 p -105.12 145.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.606 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.589 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 0.9 OUTLIER -135.05 119.66 18.17 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 111.606 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.469 ' CE2' HD11 ' B' ' 71' ' ' ILE . 10.1 t80 -82.94 132.33 35.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.21 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.778 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 43.6 p -111.08 122.76 48.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.972 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.55 143.54 31.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.403 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.59 167.88 37.01 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.547 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.09 163.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 111.335 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -138.14 177.77 19.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.464 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.64 155.36 26.68 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.583 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.83 123.69 14.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.77 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 27.3 mtt-85 64.24 -94.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.044 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 68.8 p -130.74 6.35 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.136 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.437 ' HB3' ' OD1' ' B' ' 33' ' ' ASP . 30.3 t -104.53 174.31 5.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.93 177.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -161.45 153.91 20.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.538 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.5 HD12 ' N ' ' B' ' 70' ' ' ALA . 6.0 tp -117.26 132.04 56.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.822 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -138.84 136.13 35.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.689 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.469 HD11 ' CE2' ' B' ' 56' ' ' PHE . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 111.097 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.76 179.96 35.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.45 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -155.2 155.95 34.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.59 163.45 29.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.239 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.436 ' CD2' ' HB ' ' B' ' 54' ' ' VAL . 13.0 t80 -138.53 120.84 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.32 105.54 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.748 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.801 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 12.5 p -104.6 130.97 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.431 ' CG ' HG22 ' B' ' 77' ' ' VAL . 9.1 m-20 59.55 -174.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 111.109 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -118.18 68.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.7 p -160.04 -50.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.18 143.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 154.42 45.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.82 132.49 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.43 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.79 45.42 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.153 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.43 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.06 169.52 19.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.683 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 173.55 162.68 25.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.621 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.09 147.08 33.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.131 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -119.03 141.22 48.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.365 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.26 127.84 48.28 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.243 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.575 ' HB3' ' CB ' ' B' ' 94' ' ' ASP . . . -135.5 148.2 49.11 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.675 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.61 -98.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.334 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.14 -28.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.316 . . . . 0.0 111.32 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -121.53 15.29 11.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.161 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.575 ' CB ' ' HB3' ' B' ' 90' ' ' ALA . 38.1 m-20 -103.14 70.67 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.4 128.27 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.668 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.434 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.6 ptp -135.63 139.49 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.701 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.01 128.84 54.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.482 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -129.21 147.36 51.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 111.389 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.3 116.01 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.784 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 94.2 p -127.91 163.12 25.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.411 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.5 144.58 44.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.945 0.402 . . . . 0.0 111.088 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.45 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 21.5 m-80 -109.8 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.493 HD12 ' HE1' ' B' ' 105' ' ' TRP . 1.6 pt -131.46 126.62 58.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.846 0.355 . . . . 0.0 110.855 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.443 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 3.9 pt-20 -105.91 152.95 22.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 0.493 ' HE1' HD12 ' B' ' 103' ' ' ILE . 44.3 m95 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.666 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.713 -0.155 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 t70 64.33 118.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.906 0.384 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -123.91 55.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.78 -52.79 1.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.014 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.33 103.94 12.08 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -153.84 111.59 3.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.731 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t 60.44 71.47 0.57 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.003 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.743 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 7.8 m-70 -109.24 -53.73 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.801 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.281 31.4 Cg_exo -70.1 141.39 43.73 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.515 2.144 . . . . 0.0 111.907 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.54 -49.84 67.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.914 0.387 . . . . 0.0 111.121 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -88.9 104.23 16.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.645 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.36 115.85 2.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.459 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -129.35 -66.05 0.83 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.481 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.37 -50.54 59.05 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.201 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.96 -54.4 46.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.917 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . 0.428 ' O ' ' HG3' ' C' ' 20' ' ' GLN . 1.3 t60 -53.13 -46.01 68.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.953 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -63.38 -40.75 98.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.518 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . 0.424 ' O ' ' OD2' ' C' ' 22' ' ' ASP . 92.9 t80 -65.53 -32.35 73.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.247 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.04 -30.15 55.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.781 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.8 mt-30 -71.17 -33.88 70.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.452 HD21 ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -65.18 -48.27 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' C' ' 18' ' ' PHE . 15.8 m-20 -70.84 -20.42 62.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.053 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -74.85 -42.9 57.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.612 ' HB3' HD13 ' B' ' 25' ' ' LEU . 2.6 mmp_? -70.7 -48.77 52.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.618 HD13 ' HB3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -60.41 -41.71 94.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.676 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . 0.512 ' O ' HG22 ' C' ' 30' ' ' THR . 49.9 t0 -72.19 -28.83 63.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.781 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -75.97 -37.21 58.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.18 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' B' ' 25' ' ' LEU . 9.7 mt -76.18 -32.73 59.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . 0.454 ' O ' HG22 ' C' ' 32' ' ' VAL . 21.0 t0 -67.4 -48.49 67.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.945 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.512 HG22 ' O ' ' C' ' 26' ' ' ASP . 10.1 t -68.75 -37.89 79.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.862 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.675 HH11 ' HG2' ' C' ' 31' ' ' ARG . 18.9 ttp85 -63.74 -39.02 93.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.325 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.516 HG13 ' O ' ' C' ' 28' ' ' LEU . 29.9 m -75.31 -28.27 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.204 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.509 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 13.8 t70 -62.74 -55.08 29.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.945 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 18.7 pttt -70.64 -40.74 72.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.25 90.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.402 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.02 -34.68 78.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 111.096 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.84 -39.51 94.58 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.4 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.423 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 56.6 p -78.51 -39.27 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.656 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 35.9 t -54.7 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.405 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . . . -54.55 -31.12 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.407 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . 0.452 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -62.33 -48.5 79.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.805 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.4 OUTLIER -68.61 -32.64 72.66 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 2.2 m-20 -80.24 -15.15 57.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -17.59 64.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.144 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.773 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.8 mm? -76.56 156.14 33.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.877 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -145.26 -30.27 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.651 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.582 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 7.9 tt0 72.11 108.78 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.019 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.9 Cg_endo -91.32 139.4 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.617 2.211 . . . . 0.0 112.565 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.1 m-85 69.13 154.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.027 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.57 75.35 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.243 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.828 HG12 ' HE2' ' C' ' 53' ' ' LYS . 11.7 p -95.51 -25.0 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.162 0.585 . . . . 0.0 112.44 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.822 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 154.17 48.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.316 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . 0.828 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.6 OUTLIER -145.02 179.69 7.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.595 0.236 . . . . 0.0 110.645 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 11.4 p -105.25 145.32 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.517 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.582 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 0.9 OUTLIER -135.06 119.61 18.09 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.971 0.415 . . . . 0.0 111.679 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' C' ' 71' ' ' ILE . 10.0 t80 -82.94 132.34 35.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.273 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.773 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 43.1 p -111.12 122.65 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 143.63 31.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.453 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.62 167.92 37.09 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 26.1 m -119.17 163.86 16.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 111.39 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -138.18 177.85 19.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.473 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.7 155.33 26.64 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.556 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.77 123.75 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.447 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 27.3 mtt-85 64.18 -93.97 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.038 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 68.3 p -130.76 6.39 4.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . 0.422 ' HB3' ' OD1' ' C' ' 33' ' ' ASP . 30.6 t -104.57 174.41 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.08 177.07 7.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.116 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -161.49 153.91 20.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.58 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.498 HD12 ' H ' ' C' ' 70' ' ' ALA . 6.0 tp -117.23 131.96 56.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.795 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.805 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -138.73 136.18 35.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.637 0.256 . . . . 0.0 111.664 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.477 HD11 ' CE2' ' C' ' 56' ' ' PHE . 8.8 tp -136.37 145.42 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.72 -179.91 35.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -155.3 155.96 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 110.965 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.66 163.42 29.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.262 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.0 t80 -138.51 120.86 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 105.64 14.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.822 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 12.5 p -104.64 130.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.441 ' CG ' HG22 ' C' ' 77' ' ' VAL . 9.2 m-20 59.49 -174.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.134 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -118.16 68.11 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.523 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 41.2 p -160.09 -50.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.986 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 143.51 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.3 154.43 45.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.897 0.38 . . . . 0.0 111.295 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.81 132.5 32.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -134.76 139.77 45.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.06 169.5 19.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.68 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 173.6 162.75 26.02 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.532 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.22 147.09 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -119.04 141.33 48.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.329 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -124.3 127.87 48.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' C' ' 94' ' ' ASP . . . -135.54 148.18 49.03 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.645 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.67 -98.67 0.02 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.322 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -154.19 -28.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 111.326 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -121.57 15.32 11.13 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.573 ' CB ' ' HB3' ' C' ' 90' ' ' ALA . 38.2 m-20 -103.14 70.58 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.38 128.24 66.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 110.709 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.444 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 1.6 ptp -135.63 139.54 43.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.696 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -119.03 128.87 54.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.433 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -129.25 147.36 51.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.366 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.37 115.96 5.88 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.718 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 93.9 p -127.85 163.11 25.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.57 144.51 44.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.008 0.432 . . . . 0.0 111.072 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.441 ' CB ' ' HD3' ' B' ' 48' ' ' PRO . 21.4 m-80 -109.69 131.87 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.382 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.487 HD12 ' HE1' ' C' ' 105' ' ' TRP . 1.6 pt -131.42 126.68 58.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.435 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 3.9 pt-20 -105.84 152.93 22.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.989 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 0.487 ' HE1' HD12 ' C' ' 103' ' ' ILE . 44.6 m95 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.7 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 t70 68.83 123.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.885 0.374 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -126.91 58.53 1.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.2 -58.27 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.463 ' HA ' ' NE2' ' A' ' 8' ' ' HIS . 0.7 OUTLIER -116.69 103.56 10.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.745 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' A' ' 19' ' ' ARG . 55.7 t-105 -151.73 114.43 4.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.767 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t 60.53 70.02 0.65 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.063 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.77 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 7.7 m-70 -110.13 -54.64 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.755 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.77 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.337 31.5 Cg_exo -72.19 143.29 39.49 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.516 2.144 . . . . 0.0 111.88 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -64.15 -49.57 71.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.988 0.423 . . . . 0.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.47 103.9 13.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.614 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 16.5 pt-20 -158.52 108.87 2.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.473 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 19.5 tttm -124.31 -71.43 0.71 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.516 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.37 90.73 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.282 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.84 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.349 . . . . 0.0 110.895 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 1.5 t60 -57.91 -43.2 86.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.969 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -60.42 -39.32 87.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.526 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.18 -32.88 74.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 6' ' ' TRP . 31.2 mmt180 -76.38 -38.27 55.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.767 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 12.7 mt-30 -67.2 -30.87 70.93 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.191 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.579 ' HA ' HD11 ' C' ' 21' ' ' LEU . 0.6 OUTLIER -65.9 -56.08 13.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.589 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.9 -23.99 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 22.4 t-20 -67.16 -39.43 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 5.4 mmp_? -71.82 -48.11 48.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.777 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.64 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.6 OUTLIER -56.4 -52.21 65.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.65 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.713 ' O ' HG22 ' A' ' 30' ' ' THR . 33.6 t0 -64.31 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 26.6 tttm -71.76 -36.68 70.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.205 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 32' ' ' VAL . 3.5 mt -79.17 -33.6 43.85 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.18 96.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.941 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 26' ' ' ASP . 4.4 t -76.57 -40.64 49.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.879 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HG2' HH11 ' A' ' 31' ' ' ARG . 21.3 ttp85 -61.68 -40.99 96.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.277 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 28' ' ' LEU . 30.7 m -73.43 -29.04 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.598 ' OD1' ' HB2' ' A' ' 64' ' ' ARG . 17.8 t70 -62.92 -52.58 62.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' A' ' 91' ' ' GLY . 26.5 pttt -70.74 -39.55 73.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.738 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.89 97.33 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.427 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' B' ' 39' ' ' SER . 0.5 OUTLIER -66.74 -33.57 75.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 111.077 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB1' ' HA2' ' A' ' 62' ' ' GLY . . . -61.99 -43.06 99.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.457 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.741 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 79.3 p -75.22 -41.04 58.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.742 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.505 ' HB2' HD21 ' C' ' 36' ' ' LEU . 38.2 t -57.55 -62.11 2.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.17 48.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.467 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -65.84 -48.07 72.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.943 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.701 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -66.1 -32.83 74.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 43' ' ' ASN . 2.9 m-20 -79.77 -12.6 59.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -14.82 63.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.137 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.844 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.5 mm? -76.55 156.81 32.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.888 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.13 -26.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.608 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 10.1 tt0 71.58 110.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.927 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -90.03 137.13 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.645 2.23 . . . . 0.0 112.549 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 12.9 m-85 64.64 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.953 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.34 75.43 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.638 HG12 ' HE2' ' A' ' 53' ' ' LYS . 12.8 p -95.11 -25.26 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.148 0.579 . . . . 0.0 112.415 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 155.88 48.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.313 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.638 ' HE2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -143.44 -178.0 5.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.591 0.234 . . . . 0.0 110.643 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HB ' ' CE2' ' A' ' 75' ' ' TYR . 8.2 p -106.17 145.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.587 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.608 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 1.4 t30 -134.88 122.69 22.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.499 ' CE2' HD11 ' A' ' 71' ' ' ILE . 11.5 t80 -85.76 132.86 34.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.235 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.844 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 33.7 p -113.22 125.22 54.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.016 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 71' ' ' ILE . . . -149.45 139.68 22.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.449 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.41 167.3 38.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.434 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.551 HG12 HD13 ' A' ' 69' ' ' LEU . 22.8 m -120.02 161.55 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.326 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.2 177.45 20.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.404 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.455 ' HA2' ' HB1' ' A' ' 37' ' ' ALA . . . -162.35 156.82 28.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.612 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.4 t80 -143.13 128.28 18.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.598 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 16.2 mtt-85 64.97 -91.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 p -135.63 6.1 3.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.522 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 19.3 t -105.18 168.38 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.4 179.29 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.138 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -164.78 150.54 10.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.571 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.551 HD13 HG12 ' A' ' 60' ' ' VAL . 12.5 tp -116.22 127.91 55.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.767 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -132.55 136.23 46.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.729 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 58' ' ' ALA . 10.6 tp -132.81 146.68 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.138 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -163.89 -179.44 38.18 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.407 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -154.65 152.04 29.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.257 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 54' ' ' VAL . 13.5 t80 -132.57 122.03 24.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.228 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.34 101.84 10.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.752 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.5 p -103.56 136.31 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.37 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.943 0.401 . . . . 0.0 111.112 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.47 61.35 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.573 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.76 -44.82 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.8 p -122.32 141.35 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.258 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.8 134.86 32.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.406 ' HD2' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -139.74 138.16 35.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.406 ' H ' ' HD2' ' A' ' 84' ' ' LYS . . . -147.38 167.93 23.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.506 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 171.41 163.67 25.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.96 145.44 35.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.897 0.38 . . . . 0.0 111.044 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -114.49 141.12 48.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.18 130.69 54.69 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.273 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . . . -139.63 145.25 38.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.596 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' A' ' 34' ' ' LYS . . . 52.19 -96.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.26 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -155.37 -30.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.731 0.3 . . . . 0.0 111.336 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -121.5 16.56 11.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.194 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 90' ' ' ALA . 41.6 m-20 -104.44 73.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.2 t -114.79 131.96 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.642 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.489 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 1.2 ptp -136.27 142.27 43.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.714 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -119.95 128.75 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.483 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -125.99 148.94 49.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.346 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.09 114.52 5.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.709 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.7 p -130.43 161.24 31.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.463 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -134.0 142.71 47.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.97 0.414 . . . . 0.0 111.072 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 20.7 m-80 -111.68 128.62 56.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.459 HD12 ' HE1' ' A' ' 105' ' ' TRP . 3.0 pt -130.79 131.49 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.8 0.333 . . . . 0.0 110.796 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 5.4 pt-20 -112.55 154.89 25.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.459 ' HE1' HD12 ' A' ' 103' ' ' ILE . 31.5 m95 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.682 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 112.678 -0.169 . . . . 0.0 112.678 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 t70 68.73 123.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.881 0.372 . . . . 0.0 111.048 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -126.84 58.63 1.41 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.27 -58.34 1.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.0 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.466 ' HA ' ' NE2' ' B' ' 8' ' ' HIS . 0.7 OUTLIER -116.69 103.57 10.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.791 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' B' ' 19' ' ' ARG . 55.9 t-105 -151.76 114.45 4.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.728 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t 60.58 70.11 0.64 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.943 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.797 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 7.7 m-70 -110.16 -54.61 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.824 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.797 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.337 31.5 Cg_exo -72.17 143.38 39.76 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.427 2.085 . . . . 0.0 111.905 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -64.22 -49.5 71.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.951 0.405 . . . . 0.0 111.207 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.56 103.97 13.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.607 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' B' ' 16' ' ' HIS . 16.5 pt-20 -158.58 108.8 2.05 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.546 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' B' ' 17' ' ' LYS . 19.5 tttm -124.23 -71.47 0.71 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.544 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.37 -44.35 90.7 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.27 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 -54.65 37.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.867 0.365 . . . . 0.0 110.937 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.495 ' HB2' ' HB2' ' B' ' 12' ' ' GLU . 1.5 t60 -58.0 -43.12 86.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.003 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -60.53 -39.29 87.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.12 -32.94 74.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.311 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 31.2 mmt180 -76.4 -38.35 55.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.741 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 12.7 mt-30 -67.1 -30.88 71.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.973 0.416 . . . . 0.0 111.23 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.584 HD11 ' HA ' ' C' ' 21' ' ' LEU . 0.6 OUTLIER -65.88 -56.04 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -69.01 -23.91 64.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 22.3 t-20 -67.17 -39.43 86.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' B' ' 20' ' ' GLN . 5.4 mmp_? -71.84 -48.19 47.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.701 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.647 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.6 OUTLIER -56.31 -52.26 65.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.717 ' O ' HG22 ' B' ' 30' ' ' THR . 33.7 t0 -64.29 -27.97 69.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.762 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.442 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 26.7 tttm -71.65 -36.83 70.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.603 0.239 . . . . 0.0 111.203 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.656 ' O ' HG13 ' B' ' 32' ' ' VAL . 3.5 mt -79.08 -33.69 44.31 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.46 -42.16 96.09 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.717 HG22 ' O ' ' B' ' 26' ' ' ASP . 4.5 t -76.59 -40.7 48.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.645 HH11 ' HG2' ' B' ' 31' ' ' ARG . 21.2 ttp85 -61.6 -41.05 96.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.656 HG13 ' O ' ' B' ' 28' ' ' LEU . 30.6 m -73.37 -29.11 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.161 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.606 ' OD1' ' HB2' ' B' ' 64' ' ' ARG . 17.8 t70 -62.85 -52.69 62.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 26.5 pttt -70.69 -39.5 73.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.755 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.65 -44.95 97.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.425 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' C' ' 39' ' ' SER . 0.5 OUTLIER -66.73 -33.59 75.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 111.054 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.442 ' HB1' ' HA2' ' B' ' 62' ' ' GLY . . . -61.93 -43.09 99.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.424 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.757 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 79.9 p -75.24 -40.95 58.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.77 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.498 ' HB2' HD21 ' A' ' 36' ' ' LEU . 38.4 t -57.63 -62.11 2.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.18 -30.2 48.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.433 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.615 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -65.86 -48.01 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.7 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.7 OUTLIER -66.2 -32.76 74.39 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.44 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 2.9 m-20 -79.8 -12.66 59.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -14.94 63.22 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.156 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.832 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.5 mm? -76.46 156.84 32.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.847 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.1 -26.93 0.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.17 0.509 . . . . 0.0 111.683 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.613 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 10.1 tt0 71.69 109.87 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.914 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.9 Cg_endo -89.86 137.13 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.709 2.273 . . . . 0.0 112.547 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 12.9 m-85 64.57 152.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.957 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.35 75.41 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.242 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.641 HG12 ' HE2' ' B' ' 53' ' ' LYS . 12.7 p -95.04 -25.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.469 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 155.88 48.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.641 ' HE2' HG12 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -143.54 -178.05 5.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.517 ' HB ' ' CE2' ' B' ' 75' ' ' TYR . 8.3 p -106.08 145.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.589 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.613 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 1.4 t30 -134.95 122.61 22.15 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 111.658 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' B' ' 71' ' ' ILE . 11.6 t80 -85.65 132.8 34.09 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.309 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.832 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 33.8 p -113.18 125.27 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.004 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' B' ' 71' ' ' ILE . . . -149.56 139.64 22.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.439 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.33 38.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.526 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.534 HG12 HD13 ' B' ' 69' ' ' LEU . 22.6 m -120.04 161.58 19.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.786 0.327 . . . . 0.0 111.382 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.23 177.48 20.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.459 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.442 ' HA2' ' HB1' ' B' ' 37' ' ' ALA . . . -162.34 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.562 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.49 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.4 t80 -143.13 128.22 18.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.66 0.267 . . . . 0.0 110.801 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.606 ' HB2' ' OD1' ' B' ' 33' ' ' ASP . 16.3 mtt-85 64.95 -91.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.087 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 51.6 p -135.64 6.09 3.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.14 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.524 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 19.4 t -105.2 168.36 9.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.33 179.36 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -164.87 150.48 9.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.539 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.534 HD13 HG12 ' B' ' 60' ' ' VAL . 12.3 tp -116.16 127.92 55.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.7 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -132.59 136.22 46.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.67 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' B' ' 58' ' ' ALA . 10.6 tp -132.81 146.74 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.119 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -163.87 -179.42 38.15 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.41 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 64.5 p -154.7 152.09 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.85 0.357 . . . . 0.0 111.043 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.64 156.91 27.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.25 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' B' ' 54' ' ' VAL . 13.7 t80 -132.59 122.06 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 101.93 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.688 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.745 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.5 p -103.49 136.36 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 63.3 -171.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.142 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.46 61.27 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.568 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 16.0 p -159.65 -44.84 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.988 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -122.32 141.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 155.72 48.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.258 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.75 134.91 32.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.561 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' B' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.19 35.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.418 ' H ' ' HD2' ' B' ' 84' ' ' LYS . . . -147.44 167.9 23.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.073 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.489 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 171.41 163.63 25.71 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.96 145.33 35.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -114.42 141.1 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.363 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.14 130.65 54.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.262 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . . . -139.69 145.25 38.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.562 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' B' ' 34' ' ' LYS . . . 52.25 -96.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.276 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.36 -30.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.339 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -121.51 16.44 11.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.565 ' HB2' ' HB3' ' B' ' 90' ' ' ALA . 41.6 m-20 -104.3 73.52 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 56.3 t -114.74 132.01 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.493 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.2 ptp -136.31 142.27 43.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -120.07 128.77 53.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.37 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.0 148.87 49.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.401 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.06 114.51 5.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.709 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 53.7 p -130.42 161.27 31.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.48 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -134.0 142.65 47.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.111 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.553 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 20.4 m-80 -111.59 128.65 56.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.443 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.458 HD12 ' HE1' ' B' ' 105' ' ' TRP . 3.0 pt -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 110.784 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.503 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 5.4 pt-20 -112.66 154.87 25.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 0.458 ' HE1' HD12 ' B' ' 103' ' ' ILE . 31.5 m95 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.417 -0.802 . . . . 0.0 110.686 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 112.64 -0.184 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 t70 68.75 123.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.937 0.399 . . . . 0.0 110.976 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -126.86 58.64 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.27 -58.4 1.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . 0.464 ' HA ' ' NE2' ' C' ' 8' ' ' HIS . 0.7 OUTLIER -116.67 103.62 10.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.74 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . 0.411 ' CZ3' ' HB3' ' C' ' 19' ' ' ARG . 55.8 t-105 -151.85 114.35 4.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.701 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t 60.66 70.06 0.64 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.982 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.797 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 7.7 m-70 -110.22 -54.55 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.804 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.797 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.338 31.5 Cg_exo -72.23 143.32 39.4 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.437 2.092 . . . . 0.0 111.938 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -64.14 -49.61 71.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.966 0.412 . . . . 0.0 111.2 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -83.4 103.89 13.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.649 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' C' ' 16' ' ' HIS . 16.5 pt-20 -158.53 108.86 2.07 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.504 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' C' ' 17' ' ' LYS . 19.6 tttm -124.31 -71.39 0.72 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.489 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -44.31 90.7 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.294 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.31 -54.76 35.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.906 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' C' ' 12' ' ' GLU . 1.5 t60 -57.96 -43.13 86.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.025 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' C' ' 13' ' ' LYS . 0.0 OUTLIER -60.39 -39.32 86.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.555 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -63.17 -32.98 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . 0.411 ' HB3' ' CZ3' ' C' ' 6' ' ' TRP . 31.2 mmt180 -76.37 -38.28 56.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 12.7 mt-30 -67.26 -30.78 70.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.584 ' HA ' HD11 ' B' ' 21' ' ' LEU . 0.6 OUTLIER -65.95 -56.04 13.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.564 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 -23.98 64.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 22.3 t-20 -67.17 -39.43 86.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' C' ' 20' ' ' GLN . 5.4 mmp_? -71.81 -48.18 48.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.788 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.627 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -56.3 -52.28 65.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . 0.702 ' O ' HG22 ' C' ' 30' ' ' THR . 33.5 t0 -64.23 -28.01 69.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.818 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -71.62 -36.8 70.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.248 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.664 ' O ' HG13 ' C' ' 32' ' ' VAL . 3.5 mt -79.11 -33.66 44.16 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -64.49 -42.14 96.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.921 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.702 HG22 ' O ' ' C' ' 26' ' ' ASP . 4.5 t -76.55 -40.72 48.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.864 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.663 HH11 ' HG2' ' C' ' 31' ' ' ARG . 21.3 ttp85 -61.64 -41.0 96.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.664 HG13 ' O ' ' C' ' 28' ' ' LEU . 30.7 m -73.4 -29.09 26.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.599 ' OD1' ' HB2' ' C' ' 64' ' ' ARG . 17.8 t70 -62.77 -52.65 62.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.027 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 26.5 pttt -70.78 -39.44 73.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.94 97.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.386 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.505 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.5 OUTLIER -66.68 -33.71 76.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.457 ' HB1' ' HA2' ' C' ' 62' ' ' GLY . . . -61.77 -43.16 99.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.745 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 79.7 p -75.23 -41.02 58.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.488 ' HB2' HD21 ' B' ' 36' ' ' LEU . 38.0 t -57.51 -62.17 1.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.21 -30.18 48.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.443 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . 0.609 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -65.81 -48.01 73.14 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.701 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.7 OUTLIER -66.18 -32.85 74.53 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 2.8 m-20 -79.71 -12.66 59.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -14.85 63.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.17 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.821 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.5 mm? -76.49 156.86 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.869 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -146.15 -26.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.206 0.527 . . . . 0.0 111.706 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 10.1 tt0 71.5 109.91 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.021 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -89.94 137.19 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.554 2.169 . . . . 0.0 112.59 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 12.8 m-85 64.6 152.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.39 75.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.228 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.635 HG12 ' HE2' ' C' ' 53' ' ' LYS . 12.6 p -94.94 -25.27 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.18 0.592 . . . . 0.0 112.509 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 155.91 48.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.298 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . 0.635 ' HE2' HG12 ' C' ' 51' ' ' VAL . 0.4 OUTLIER -143.52 -178.07 5.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.585 0.231 . . . . 0.0 110.608 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.516 ' HB ' ' CE2' ' C' ' 75' ' ' TYR . 8.2 p -106.16 145.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.557 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.589 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 1.4 t30 -134.88 122.72 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' C' ' 71' ' ' ILE . 11.7 t80 -85.74 132.89 34.05 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.172 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.821 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 33.5 p -113.29 125.27 54.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.895 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.52 ' HB2' ' CD1' ' C' ' 71' ' ' ILE . . . -149.57 139.67 22.11 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.35 167.4 38.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.545 HG12 HD13 ' C' ' 69' ' ' LEU . 22.6 m -120.12 161.57 19.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 111.33 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . 0.609 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.22 177.47 20.29 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.418 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.457 ' HA2' ' HB1' ' C' ' 37' ' ' ALA . . . -162.33 156.82 28.57 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.4 t80 -143.09 128.29 18.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.686 0.279 . . . . 0.0 110.746 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.599 ' HB2' ' OD1' ' C' ' 33' ' ' ASP . 16.3 mtt-85 64.94 -91.07 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.096 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.0 p -135.59 6.15 3.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.227 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . 0.517 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 19.4 t -105.26 168.4 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.778 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.41 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . 0.745 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -164.83 150.47 9.97 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.556 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.545 HD13 HG12 ' C' ' 60' ' ' VAL . 12.4 tp -116.17 127.9 55.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.701 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -132.63 136.19 46.34 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' C' ' 58' ' ' ALA . 10.6 tp -132.74 146.75 32.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.732 0.301 . . . . 0.0 111.134 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -163.9 -179.39 38.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.435 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 63.4 p -154.71 152.0 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 111.056 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.62 156.97 27.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.26 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.516 ' CE2' ' HB ' ' C' ' 54' ' ' VAL . 13.7 t80 -132.64 122.05 24.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 111.128 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' C' ' 76' ' ' ARG . 0.0 OUTLIER -111.41 101.83 10.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.732 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.5 p -103.46 136.36 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 63.3 -171.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.391 . . . . 0.0 111.089 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -124.55 61.35 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 15.9 p -159.72 -44.77 0.05 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.33 141.37 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.69 155.78 47.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.74 134.85 32.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.539 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.412 ' HD2' ' H ' ' C' ' 85' ' ' ALA . 0.0 OUTLIER -139.75 138.21 35.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.157 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . 0.412 ' H ' ' HD2' ' C' ' 84' ' ' LYS . . . -147.45 167.86 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.499 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 171.49 163.65 25.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.574 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.87 145.41 35.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.137 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -114.5 141.14 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.347 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 130.69 54.71 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.288 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' C' ' 94' ' ' ASP . . . -139.68 145.21 38.11 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.595 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' C' ' 34' ' ' LYS . . . 52.28 -96.33 0.02 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.258 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -155.38 -30.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.281 . . . . 0.0 111.296 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 84.6 p -121.42 16.45 11.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.239 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.568 ' HB2' ' HB3' ' C' ' 90' ' ' ALA . 41.5 m-20 -104.39 73.54 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -114.79 132.03 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 0.0 110.636 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.49 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 1.2 ptp -136.33 142.2 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.642 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.96 128.72 53.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -125.95 148.84 49.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.299 . . . . 0.0 111.419 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.05 114.5 5.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.829 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 53.6 p -130.44 161.21 31.89 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.393 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -133.95 142.65 47.78 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.917 0.389 . . . . 0.0 111.113 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.571 ' HB3' ' HD3' ' B' ' 48' ' ' PRO . 20.9 m-80 -111.6 128.68 56.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.462 HD12 ' HE1' ' C' ' 105' ' ' TRP . 3.0 pt -130.79 131.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.743 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.511 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 5.4 pt-20 -112.63 154.92 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 0.462 ' HE1' HD12 ' C' ' 103' ' ' ILE . 31.0 m95 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.706 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.628 -0.189 . . . . 0.0 112.628 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 t70 67.06 123.63 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 110.952 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -128.94 48.35 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.35 -54.33 2.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.451 ' HA ' ' NE2' ' A' ' 8' ' ' HIS . 0.7 OUTLIER -114.1 105.46 13.23 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.723 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -153.81 112.99 3.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.718 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t 61.58 78.18 0.3 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.969 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.648 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 8.9 m-70 -107.85 -49.36 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.815 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.319 31.4 Cg_exo -71.48 146.9 51.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.501 2.134 . . . . 0.0 111.944 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -64.3 -52.72 57.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.985 0.421 . . . . 0.0 111.213 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -89.72 112.3 23.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.681 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -158.1 114.13 2.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.448 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 24.5 tttm -125.27 -70.99 0.72 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.511 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -44.88 67.17 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.274 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.02 -55.12 38.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.851 0.358 . . . . 0.0 110.939 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.87 -47.58 82.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.97 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -53.03 -40.87 64.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.57 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 24.9 mmt180 -76.8 -36.88 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.725 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.637 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 14.6 mt-30 -67.5 -32.94 74.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.799 HD21 ' HG3' ' B' ' 24' ' ' ARG . 1.4 tt -68.6 -55.84 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.558 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.13 -25.46 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 24.6 t-20 -71.76 -42.48 67.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.79 ' HG3' HD21 ' C' ' 21' ' ' LEU . 3.7 mmp_? -69.27 -45.28 70.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.814 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 HD11 ' B' ' 28' ' ' LEU . 1.9 tp -56.29 -49.09 75.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.562 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 30' ' ' THR . 33.3 t0 -64.79 -32.08 73.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 27.2 tttm -69.98 -32.89 71.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.26 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.754 HD11 HD12 ' C' ' 25' ' ' LEU . 1.7 mt -81.06 -32.37 34.04 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.69 -40.21 88.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.017 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 26' ' ' ASP . 4.3 t -76.73 -39.34 52.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.492 HH22 HG21 ' C' ' 32' ' ' VAL . 43.6 ttp85 -59.46 -41.81 90.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 28' ' ' LEU . 27.2 m -78.29 -23.6 13.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.204 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.479 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 18.6 t70 -67.63 -51.54 48.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' NZ ' ' HA3' ' A' ' 91' ' ' GLY . 32.7 pttt -76.38 -40.28 51.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.93 98.75 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -67.09 -33.9 76.47 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.882 0.372 . . . . 0.0 111.156 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.17 99.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.457 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.753 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 94.4 p -76.29 -37.31 57.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.637 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 33.0 t -63.73 -55.01 26.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.98 -32.1 69.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.51 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -64.88 -46.47 81.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.955 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -66.22 -30.39 70.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.3 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.584 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 9.7 m-20 -81.36 -15.71 54.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.46 -15.04 62.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.112 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.737 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.9 mm? -71.39 164.52 25.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.911 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' B' ' 84' ' ' LYS . 25.0 p90 -152.55 -32.02 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.148 0.499 . . . . 0.0 111.701 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HG3' ' HB3' ' A' ' 55' ' ' ASN . 15.3 tt0 73.53 106.71 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.96 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.8 Cg_endo -93.07 136.34 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.628 2.219 . . . . 0.0 112.552 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 10.6 m-85 65.52 151.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 76' ' ' ARG . . . 178.62 78.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.235 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.31 -23.28 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.206 0.603 . . . . 0.0 112.411 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 157.5 49.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.278 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 52' ' ' GLY . 0.5 OUTLIER -146.65 -176.73 5.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.605 0.24 . . . . 0.0 110.563 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.22 150.57 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.568 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.529 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 2.2 t30 -132.91 124.37 27.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.66 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 71' ' ' ILE . 24.1 t80 -87.18 128.17 35.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.319 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.737 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 38.2 p -114.71 123.08 48.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.047 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.29 136.78 18.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.451 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.05 44.35 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.582 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.424 HG12 HD13 ' A' ' 69' ' ' LEU . 16.4 m -126.9 166.98 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.801 0.334 . . . . 0.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -141.35 172.32 23.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.44 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.47 152.36 23.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.547 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.3 t80 -142.44 128.68 19.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.686 0.279 . . . . 0.0 110.737 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.36 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 p -140.35 10.07 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.479 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 9.8 t -109.6 167.6 10.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.67 -179.09 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 38' ' ' SER . . . -167.19 156.46 10.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.526 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.424 HD13 HG12 ' A' ' 60' ' ' VAL . 7.6 tp -114.58 130.97 56.83 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -129.62 141.43 50.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.682 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.666 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 7.9 tp -138.14 150.38 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.092 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.437 ' N ' HG13 ' A' ' 71' ' ' ILE . . . -169.28 177.41 42.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.395 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.6 146.4 18.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.25 158.41 27.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.528 ' HE1' ' HB ' ' A' ' 77' ' ' VAL . 30.9 t80 -126.3 125.02 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.154 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.504 ' NH2' ' HB2' ' C' ' 48' ' ' PRO . 0.0 OUTLIER -113.1 102.71 10.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.607 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 9.0 p -104.41 138.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 59.88 -167.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -126.59 66.08 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.451 ' HA ' ' HG3' ' A' ' 104' ' ' GLU . 19.9 p -165.4 -46.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.986 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.24 139.86 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.49 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.46 45.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.293 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.16 138.91 33.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.638 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' C' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.124 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.34 169.75 17.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.103 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.413 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 172.04 157.62 14.33 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.507 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.05 144.89 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 111.079 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -112.57 142.43 45.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.99 122.89 39.63 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.31 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -137.34 147.3 45.47 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.6 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.457 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 57.03 -94.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.276 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 t -159.4 -33.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 111.357 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.77 13.83 12.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 32.6 m-20 -101.85 72.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.969 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 t -116.08 127.05 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.987 0.423 . . . . 0.0 110.759 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 39' ' ' SER . 1.3 ptp -131.85 140.2 49.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.681 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -121.55 126.69 49.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.485 HD22 ' HA3' ' C' ' 61' ' ' GLY . 17.0 m120 -128.42 141.51 51.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.83 117.21 8.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.781 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.49 162.13 27.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.452 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.06 133.52 50.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.103 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.542 ' HB3' ' HD3' ' C' ' 48' ' ' PRO . 28.7 m-80 -108.38 127.86 54.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.458 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.485 HD12 ' HE1' ' A' ' 105' ' ' TRP . 0.7 OUTLIER -131.74 138.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.77 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 80' ' ' SER . 4.6 pt-20 -112.59 146.98 37.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.485 ' HE1' HD12 ' A' ' 103' ' ' ILE . 40.3 m95 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.666 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.67 -0.172 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 15.3 t70 66.92 123.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -128.85 48.39 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.37 -54.27 2.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.45 ' HA ' ' NE2' ' B' ' 8' ' ' HIS . 0.7 OUTLIER -114.15 105.44 13.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.795 -179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -153.74 112.93 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.758 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t 61.67 78.1 0.3 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.041 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.641 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 9.1 m-70 -107.87 -49.42 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.769 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.32 31.5 Cg_exo -71.47 146.96 51.19 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.458 2.105 . . . . 0.0 111.906 179.314 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -64.36 -52.81 56.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.975 0.417 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -89.65 112.21 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.735 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -157.99 114.1 2.8 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.499 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' B' ' 17' ' ' LYS . 24.5 tttm -125.24 -70.94 0.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.558 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.89 -44.94 65.92 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.241 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.88 -55.14 38.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 0.0 110.942 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.96 -47.46 82.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.99 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -53.08 -40.88 64.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.566 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.45 -29.86 70.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.259 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' B' ' 23' ' ' ASN . 24.9 mmt180 -76.74 -36.89 56.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.633 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 14.6 mt-30 -67.46 -32.96 74.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.786 HD21 ' HG3' ' C' ' 24' ' ' ARG . 1.4 tt -68.61 -55.77 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.15 -25.44 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 24.6 t-20 -71.79 -42.54 66.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.799 ' HG3' HD21 ' A' ' 21' ' ' LEU . 3.7 mmp_? -69.3 -45.25 70.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.782 HD12 HD11 ' C' ' 28' ' ' LEU . 1.9 tp -56.36 -49.06 75.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.582 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.618 ' O ' HG22 ' B' ' 30' ' ' THR . 33.3 t0 -64.73 -32.08 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.814 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.615 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 27.2 tttm -70.02 -32.9 71.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.237 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.777 HD11 HD12 ' A' ' 25' ' ' LEU . 1.7 mt -81.05 -32.34 34.08 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.7 -40.29 88.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.936 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.618 HG22 ' O ' ' B' ' 26' ' ' ASP . 4.3 t -76.68 -39.38 52.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.814 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.493 HH22 HG21 ' A' ' 32' ' ' VAL . 43.4 ttp85 -59.31 -41.91 90.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.336 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.523 HG22 ' O ' ' B' ' 28' ' ' LEU . 27.2 m -78.28 -23.63 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.157 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' B' ' 66' ' ' SER . 18.6 t70 -67.6 -51.59 48.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.986 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.46 ' NZ ' ' HA3' ' B' ' 91' ' ' GLY . 32.7 pttt -76.28 -40.41 51.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.792 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.21 -43.92 98.77 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' B' ' 32' ' ' VAL . 0.5 OUTLIER -67.14 -33.87 76.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.13 99.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.47 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.75 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 94.5 p -76.33 -37.33 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.758 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.628 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 32.7 t -63.76 -54.97 27.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.0 69.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.517 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -64.83 -46.59 81.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.612 HD13 ' O ' ' B' ' 42' ' ' LEU . 0.6 OUTLIER -66.05 -30.49 71.02 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . 9.7 m-20 -81.39 -15.64 54.59 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -15.11 62.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.073 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.744 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.9 mm? -71.4 164.59 25.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.837 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' C' ' 84' ' ' LYS . 24.9 p90 -152.58 -32.08 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.15 0.5 . . . . 0.0 111.625 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.536 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 15.4 tt0 73.49 106.61 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.0 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -93.02 136.32 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.668 2.245 . . . . 0.0 112.52 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 10.6 m-85 65.56 151.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' B' ' 76' ' ' ARG . . . 178.57 78.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.264 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.22 -23.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 123.108 0.563 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 157.54 49.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.299 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' B' ' 52' ' ' GLY . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.31 150.59 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.543 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.536 ' HB3' ' HG3' ' B' ' 47' ' ' GLN . 2.2 t30 -132.94 124.34 27.62 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.981 0.42 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.68 ' CZ ' HD11 ' B' ' 71' ' ' ILE . 24.4 t80 -87.21 128.23 35.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.224 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.744 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 37.7 p -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.965 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.3 136.76 18.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.366 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.23 177.07 44.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.572 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.427 HG12 HD13 ' B' ' 69' ' ' LEU . 16.4 m -126.89 166.96 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.377 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -141.32 172.34 23.87 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.451 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.51 152.42 23.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.3 t80 -142.53 128.6 19.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 0.0 110.716 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 63.47 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.083 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 34.8 p -140.37 10.17 2.29 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.224 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.482 ' HB3' ' OD2' ' B' ' 33' ' ' ASP . 9.8 t -109.63 167.63 10.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.72 -179.13 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' B' ' 38' ' ' SER . . . -167.13 156.59 10.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.532 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.427 HD13 HG12 ' B' ' 60' ' ' VAL . 7.6 tp -114.66 130.95 56.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.777 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.568 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -129.66 141.45 50.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.68 HD11 ' CZ ' ' B' ' 56' ' ' PHE . 7.9 tp -138.16 150.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.77 0.319 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.439 ' N ' HG13 ' B' ' 71' ' ' ILE . . . -169.14 177.43 42.86 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.2 p -158.55 146.51 18.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.31 158.37 27.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.254 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.528 ' HE1' ' HB ' ' B' ' 77' ' ' VAL . 30.8 t80 -126.3 125.01 41.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.491 ' NH2' ' HB2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.09 102.68 10.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.663 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.602 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 9.1 p -104.36 138.3 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.95 -167.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -126.58 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.447 ' HA ' ' HG3' ' B' ' 104' ' ' GLU . 20.1 p -165.47 -46.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.955 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.2 139.88 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.557 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.15 155.48 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.273 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.21 138.86 33.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -145.45 132.59 20.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.36 169.78 17.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.082 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 171.99 157.58 14.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.587 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.08 144.85 32.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -112.55 142.46 45.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.323 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.05 122.9 39.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -137.35 147.23 45.38 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.585 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.46 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 57.16 -94.64 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.252 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 47.1 t -159.37 -33.83 0.06 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.735 0.303 . . . . 0.0 111.312 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -119.75 13.87 12.47 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 32.6 m-20 -101.86 72.2 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -116.02 127.11 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.029 0.442 . . . . 0.0 110.712 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' B' ' 39' ' ' SER . 1.3 ptp -131.98 140.16 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -121.51 126.6 49.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.406 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.474 HD22 ' HA3' ' A' ' 61' ' ' GLY . 16.9 m120 -128.35 141.46 51.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.487 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.71 117.27 8.61 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.58 162.11 28.03 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.446 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -127.03 133.52 50.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.951 0.405 . . . . 0.0 111.079 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 28.7 m-80 -108.41 127.78 54.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.365 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.489 HD12 ' HE1' ' B' ' 105' ' ' TRP . 0.7 OUTLIER -131.65 138.13 53.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.795 0.331 . . . . 0.0 110.827 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.447 ' HG3' ' HA ' ' B' ' 80' ' ' SER . 4.6 pt-20 -112.69 147.0 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 0.489 ' HE1' HD12 ' B' ' 103' ' ' ILE . 40.3 m95 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.634 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.624 -0.19 . . . . 0.0 112.624 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 t70 66.96 123.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -128.9 48.34 2.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.886 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.24 -54.38 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.995 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . 0.462 ' HA ' ' NE2' ' C' ' 8' ' ' HIS . 0.6 OUTLIER -114.14 105.45 13.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.695 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -153.81 113.0 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.714 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t 61.6 78.16 0.3 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.005 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.642 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 9.0 m-70 -107.84 -49.4 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.808 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.317 31.5 Cg_exo -71.41 146.97 51.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.497 2.131 . . . . 0.0 111.9 179.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -64.43 -52.69 56.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.163 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -89.74 112.28 23.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.661 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -158.05 114.05 2.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.488 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' C' ' 17' ' ' LYS . 24.5 tttm -125.22 -70.98 0.72 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.556 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -44.9 67.05 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.311 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.01 -55.1 39.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 110.938 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.93 -47.45 82.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.999 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -53.16 -40.82 64.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.524 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.42 -29.92 70.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.279 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' C' ' 23' ' ' ASN . 24.8 mmt180 -76.73 -36.96 56.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.63 ' O ' ' HG2' ' C' ' 24' ' ' ARG . 14.6 mt-30 -67.48 -32.91 74.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.16 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.79 HD21 ' HG3' ' A' ' 24' ' ' ARG . 1.4 tt -68.54 -55.86 10.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -66.15 -25.5 66.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 24.5 t-20 -71.72 -42.51 67.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.786 ' HG3' HD21 ' B' ' 21' ' ' LEU . 3.7 mmp_? -69.26 -45.29 70.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 28' ' ' LEU . 1.9 tp -56.32 -49.09 75.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.581 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . 0.6 ' O ' HG22 ' C' ' 30' ' ' THR . 33.3 t0 -64.77 -32.06 73.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.787 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.564 ' HZ2' HD11 ' B' ' 25' ' ' LEU . 27.2 tttm -69.97 -32.96 71.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.253 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.782 HD11 HD12 ' B' ' 25' ' ' LEU . 1.7 mt -81.0 -32.4 34.24 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -66.76 -40.19 88.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.94 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.6 HG22 ' O ' ' C' ' 26' ' ' ASP . 4.4 t -76.66 -39.29 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.899 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.495 HH22 HG21 ' B' ' 32' ' ' VAL . 43.5 ttp85 -59.51 -41.83 90.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.289 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.513 HG22 ' O ' ' C' ' 28' ' ' LEU . 27.3 m -78.36 -23.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' C' ' 66' ' ' SER . 18.6 t70 -67.51 -51.53 49.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.062 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' C' ' 30' ' ' THR . 32.6 pttt -76.46 -40.3 50.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.755 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.91 98.78 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.43 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 0.5 OUTLIER -67.1 -34.01 76.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.24 99.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.475 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.765 ' HB3' ' HB1' ' C' ' 68' ' ' ALA . 95.1 p -76.27 -37.38 57.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.641 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 33.1 t -63.72 -54.88 28.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.15 -32.03 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . 0.504 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -64.86 -46.59 81.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.628 ' O ' HD13 ' C' ' 42' ' ' LEU . 0.6 OUTLIER -66.12 -30.37 70.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.072 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 43' ' ' ASN . 9.6 m-20 -81.39 -15.73 54.35 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -14.95 62.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.159 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.751 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.9 mm? -71.52 164.56 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.89 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 84' ' ' LYS . 24.8 p90 -152.55 -32.03 0.14 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.129 0.49 . . . . 0.0 111.705 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.531 ' HG3' ' HB3' ' C' ' 55' ' ' ASN . 15.4 tt0 73.49 106.64 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.974 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -92.93 136.31 1.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.647 2.231 . . . . 0.0 112.546 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 10.7 m-85 65.61 151.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' C' ' 76' ' ' ARG . . . 178.62 78.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.266 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.212 0.605 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 157.55 49.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.321 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' C' ' 52' ' ' GLY . 0.5 OUTLIER -146.58 -176.66 5.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.604 0.24 . . . . 0.0 110.579 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.27 150.62 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.613 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.531 ' HB3' ' HG3' ' C' ' 47' ' ' GLN . 2.2 t30 -132.99 124.28 27.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 111.686 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.68 ' CZ ' HD11 ' C' ' 71' ' ' ILE . 24.3 t80 -87.15 128.26 35.13 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.223 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.751 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 38.1 p -114.82 123.17 48.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.97 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.31 136.66 18.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.474 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.21 176.99 44.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.554 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.414 HG12 HD13 ' C' ' 69' ' ' LEU . 16.4 m -126.87 166.91 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.315 . . . . 0.0 111.418 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -141.25 172.41 23.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.518 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.6 152.33 23.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.587 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.3 t80 -142.46 128.62 19.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.751 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 63.41 -86.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.6 p -140.38 10.1 2.29 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . 0.471 ' HB3' ' OD2' ' C' ' 33' ' ' ASP . 9.7 t -109.57 167.67 9.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.76 -179.08 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 111.104 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . 0.765 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -167.23 156.51 10.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.541 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.414 HD13 HG12 ' C' ' 60' ' ' VAL . 7.6 tp -114.62 130.87 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.762 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.553 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -129.55 141.49 50.96 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.721 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.68 HD11 ' CZ ' ' C' ' 56' ' ' PHE . 7.9 tp -138.15 150.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.816 0.341 . . . . 0.0 111.065 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.456 ' N ' HG13 ' C' ' 71' ' ' ILE . . . -169.27 177.42 42.94 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.476 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -158.61 146.47 18.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 110.976 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.26 158.38 27.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.255 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.535 ' HE1' ' HB ' ' C' ' 77' ' ' VAL . 30.7 t80 -126.27 125.03 41.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.501 ' NH2' ' HB2' ' B' ' 48' ' ' PRO . 0.0 OUTLIER -113.12 102.77 10.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 9.0 p -104.48 138.3 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.9 -167.39 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -126.62 66.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.518 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' C' ' 104' ' ' GLU . 20.1 p -165.43 -46.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.009 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.2 139.77 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.575 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.48 45.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.302 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 tp -141.25 138.81 33.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.558 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -145.43 132.57 20.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.15 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.31 169.77 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 172.08 157.58 14.27 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.564 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.12 144.85 32.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 111.098 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -112.46 142.44 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.334 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.08 122.95 39.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -137.3 147.36 45.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.64 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 56.92 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.331 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 47.3 t -159.37 -33.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.714 0.292 . . . . 0.0 111.338 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 78.2 p -119.78 13.85 12.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.162 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 32.5 m-20 -101.91 72.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.03 127.15 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.629 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.641 ' SD ' ' HB2' ' C' ' 39' ' ' SER . 1.3 ptp -131.91 140.13 48.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.684 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -121.45 126.7 49.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.402 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.476 HD22 ' HA3' ' B' ' 61' ' ' GLY . 17.0 m120 -128.4 141.52 51.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.38 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.82 117.24 8.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -128.53 162.19 27.82 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.474 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.12 133.53 50.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.0 111.084 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.533 ' OD1' HG22 ' B' ' 57' ' ' THR . 28.5 m-80 -108.4 127.84 54.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.345 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.489 HD12 ' HE1' ' C' ' 105' ' ' TRP . 0.7 OUTLIER -131.67 138.0 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.821 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' C' ' 80' ' ' SER . 4.7 pt-20 -112.56 147.02 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 0.489 ' HE1' HD12 ' C' ' 103' ' ' ILE . 40.0 m95 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 t70 65.14 124.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -125.71 52.41 1.65 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.907 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.38 -49.89 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.032 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -129.19 113.83 15.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.722 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -156.69 103.83 2.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.773 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 t 68.44 71.39 0.3 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.067 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.751 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 8.6 m-70 -110.35 -53.97 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.704 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.751 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.313 31.4 Cg_exo -71.31 138.46 33.07 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.468 2.112 . . . . 0.0 111.973 179.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.07 -35.07 75.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.937 0.398 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.28 109.21 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.67 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -164.32 115.72 1.29 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.403 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.639 ' HE3' ' HE3' ' B' ' 13' ' ' LYS . 4.3 tttm -133.15 -59.49 0.88 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.505 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.56 -39.56 86.68 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.296 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.567 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -74.51 -52.37 12.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.859 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.64 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 0.7 OUTLIER -56.02 -47.36 77.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.057 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.491 ' HZ2' ' HA ' ' C' ' 18' ' ' PHE . 0.0 OUTLIER -61.94 -42.4 99.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.514 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -62.6 -41.13 98.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.245 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 34.5 mmt180 -73.7 -30.43 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 16' ' ' HIS . 19.2 mt-30 -71.66 -34.47 69.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.9 HD12 HD12 ' C' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.61 63.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.633 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.85 -25.51 64.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.041 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 6.2 t-20 -66.43 -37.26 84.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.551 ' HD3' ' HB2' ' C' ' 25' ' ' LEU . 6.3 mmp_? -71.02 -44.8 65.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.655 ' HA ' HD11 ' B' ' 28' ' ' LEU . 0.3 OUTLIER -61.11 -32.66 72.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.608 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 30' ' ' THR . 56.6 t0 -81.78 -28.3 33.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -73.16 -43.28 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.67 0.272 . . . . 0.0 111.217 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.642 HD11 ' HA ' ' C' ' 25' ' ' LEU . 11.4 mt -72.05 -29.01 63.73 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.78 -47.41 72.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.961 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 26' ' ' ASP . 2.5 t -71.0 -33.81 70.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.869 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.503 ' NH2' HG21 ' C' ' 32' ' ' VAL . 45.2 ttp85 -67.71 -40.11 84.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 28' ' ' LEU . 33.8 m -76.09 -29.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.669 ' HA ' ' CD2' ' A' ' 63' ' ' TYR . 7.2 t70 -62.42 -57.25 11.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.053 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 30' ' ' THR . 26.8 pttt -70.26 -44.58 68.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.756 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.3 82.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.439 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.468 HD12 HD11 ' C' ' 36' ' ' LEU . 0.4 OUTLIER -71.1 -26.32 62.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.819 0.342 . . . . 0.0 111.097 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.69 -37.68 85.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.402 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 52.3 p -82.96 -38.75 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.688 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.471 ' HB2' HD21 ' C' ' 36' ' ' LEU . 31.0 t -57.39 -57.2 13.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -32.54 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.578 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -62.31 -45.31 93.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.689 HD23 ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -66.14 -32.8 74.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.043 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' C' ' 43' ' ' ASN . 1.1 m-20 -82.83 -15.82 50.09 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.64 -17.75 64.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.135 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.769 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 2.4 mm? -75.41 162.66 28.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.812 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.534 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 45.1 p90 -143.83 -30.46 0.48 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 111.706 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.452 ' CG ' ' HB3' ' A' ' 55' ' ' ASN . 15.8 tt0 72.03 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.983 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 9.7 Cg_endo -89.13 140.6 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.693 2.262 . . . . 0.0 112.52 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 18.2 m-85 67.01 150.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.474 ' HA3' ' HG3' ' A' ' 76' ' ' ARG . . . -173.94 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.329 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.02 -19.41 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.154 0.582 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 148.44 48.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.294 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.09 4.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.674 0.273 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.35 137.94 40.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.582 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' B' ' 104' ' ' GLU . 6.5 t30 -125.95 119.7 28.42 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.02 0.438 . . . . 0.0 111.686 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.732 ' CZ ' HD11 ' A' ' 71' ' ' ILE . 17.9 t80 -80.3 128.35 33.44 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.269 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.769 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 16.7 p -114.29 119.86 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB2' HD12 ' A' ' 71' ' ' ILE . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.498 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 100' ' ' SER . . . -176.96 166.77 37.69 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.573 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.46 HG12 HD13 ' A' ' 69' ' ' LEU . 29.5 m -110.28 165.12 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.843 0.354 . . . . 0.0 111.316 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -139.15 176.09 21.2 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.396 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.31 27.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.568 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.669 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 1.3 t80 -142.72 123.33 14.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.592 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 33.3 mtt-85 65.75 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 p -137.59 12.91 2.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.7 t -109.34 173.15 6.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.35 177.21 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.111 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.72 161.19 23.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 60' ' ' VAL . 7.7 tp -119.6 136.24 54.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.713 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.689 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -136.43 137.94 40.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.638 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 8.3 tp -138.09 145.77 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 111.135 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -172.55 -175.34 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.452 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.11 158.36 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.776 0.322 . . . . 0.0 111.046 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.48 28.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.294 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -129.31 119.02 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 111.135 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.603 ' HD3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -105.82 104.0 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.739 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.731 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 10.8 p -101.9 126.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 63.86 -171.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -118.25 58.34 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.557 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.051 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.719 ' HA ' HG22 ' A' ' 103' ' ' ILE . 6.3 p -112.33 143.45 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.513 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . . . -146.64 151.78 37.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.36 132.61 35.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.578 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.17 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.64 171.33 18.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.097 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . 167.5 157.31 10.66 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.56 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 111.141 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.28 151.9 30.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.315 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.33 126.89 38.27 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.276 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 94' ' ' ASP . . . -140.89 145.57 36.32 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.614 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' NZ ' ' A' ' 34' ' ' LYS . . . 55.18 -98.54 0.05 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.275 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 -25.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 111.311 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.96 12.92 7.28 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 33.8 m-20 -98.91 69.26 1.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.09 127.04 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.716 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.642 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 5.3 ptp -133.04 147.1 52.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.702 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -126.19 130.88 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.447 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -128.08 137.85 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 111.383 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.24 109.5 7.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.773 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.448 ' HA ' ' HA3' ' C' ' 59' ' ' GLY . 91.5 p -125.24 163.47 22.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.472 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.05 140.27 50.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.963 0.411 . . . . 0.0 111.111 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.678 ' OD1' HG22 ' C' ' 57' ' ' THR . 45.2 m-80 -111.76 125.59 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.719 HG22 ' HA ' ' A' ' 81' ' ' VAL . 3.3 pt -136.67 134.43 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' C' ' 55' ' ' ASN . 6.6 pt-20 -111.66 159.45 18.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.481 ' HE1' HD12 ' A' ' 103' ' ' ILE . 50.4 m95 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.446 -0.788 . . . . 0.0 110.701 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.648 -0.181 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 t70 65.15 124.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.893 0.377 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -125.68 52.52 1.64 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.37 -49.85 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.08 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -129.23 113.84 15.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.707 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 32.3 t-105 -156.67 103.85 2.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.757 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t 68.42 71.44 0.3 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.996 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.761 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 8.8 m-70 -110.31 -54.02 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.775 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.761 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.313 31.4 Cg_exo -71.22 138.44 33.28 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.495 2.13 . . . . 0.0 111.958 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.08 -35.1 76.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.903 0.382 . . . . 0.0 111.147 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -98.29 109.21 22.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.646 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -164.29 115.71 1.29 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.445 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.639 ' HE3' ' HE3' ' A' ' 13' ' ' LYS . 4.3 tttm -133.16 -59.46 0.88 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.484 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.58 -39.64 86.54 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.231 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' B' ' 19' ' ' ARG . . . -74.41 -52.37 12.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.802 0.334 . . . . 0.0 110.94 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.636 ' O ' ' HG3' ' B' ' 20' ' ' GLN . 0.7 OUTLIER -56.1 -47.43 78.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.959 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.498 ' HZ3' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -61.93 -42.37 99.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.533 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -62.57 -41.09 98.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.304 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 34.5 mmt180 -73.75 -30.39 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' B' ' 16' ' ' HIS . 19.0 mt-30 -71.66 -34.5 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -63.99 -51.59 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.604 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.81 -25.57 64.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 19' ' ' ARG . 6.2 t-20 -66.29 -37.41 85.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.537 ' HD3' ' HB2' ' A' ' 25' ' ' LEU . 6.3 mmp_? -71.05 -44.61 65.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.65 ' HA ' HD11 ' C' ' 28' ' ' LEU . 0.3 OUTLIER -61.33 -32.52 72.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.565 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.616 ' O ' HG22 ' B' ' 30' ' ' THR . 56.6 t0 -81.82 -28.35 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.79 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.21 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 25' ' ' LEU . 11.5 mt -72.1 -28.95 63.63 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.83 -47.42 72.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.909 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.616 HG22 ' O ' ' B' ' 26' ' ' ASP . 2.5 t -71.01 -33.79 70.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.81 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.506 ' NH2' HG21 ' A' ' 32' ' ' VAL . 45.3 ttp85 -67.74 -40.1 84.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.585 HG13 ' O ' ' B' ' 28' ' ' LEU . 33.8 m -76.15 -29.44 19.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.256 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.681 ' HA ' ' CD2' ' B' ' 63' ' ' TYR . 7.2 t70 -62.62 -57.28 11.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' B' ' 30' ' ' THR . 26.8 pttt -70.13 -44.68 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -45.33 81.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.46 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -71.07 -26.36 63.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 111.075 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.53 -37.8 85.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.418 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' B' ' 90' ' ' ALA . 52.3 p -82.92 -38.76 22.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.453 ' HB2' ' SD ' ' B' ' 96' ' ' MET . 30.8 t -57.27 -57.33 13.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.56 68.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.573 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -62.18 -45.46 93.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.919 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.679 HD23 ' HB1' ' B' ' 70' ' ' ALA . 0.3 OUTLIER -66.07 -32.79 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.077 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' C' ' 43' ' ' ASN . 1.1 m-20 -82.88 -15.72 50.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.76 -17.72 64.42 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.144 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.767 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 2.4 mm? -75.39 162.71 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.857 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.94 -30.38 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.464 ' HG3' ' HB3' ' B' ' 55' ' ' ASN . 15.7 tt0 72.04 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.0 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' B' ' 49' ' ' TYR . 9.7 Cg_endo -89.15 140.66 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.626 2.217 . . . . 0.0 112.514 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.487 ' HB2' ' O ' ' B' ' 48' ' ' PRO . 18.2 m-85 67.05 150.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . -173.97 68.84 0.1 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.308 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -92.01 -19.45 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.159 0.584 . . . . 0.0 112.473 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 148.45 48.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.3 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.43 -175.07 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.552 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.41 137.95 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' C' ' 104' ' ' GLU . 6.5 t30 -125.84 119.71 28.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 111.706 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.743 ' CZ ' HD11 ' B' ' 71' ' ' ILE . 17.7 t80 -80.3 128.4 33.5 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.201 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.767 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 16.7 p -114.32 119.79 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.99 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' B' ' 71' ' ' ILE . . . -148.29 141.53 25.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.456 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' C' ' 100' ' ' SER . . . -176.91 166.76 37.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.532 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.457 HG12 HD13 ' B' ' 69' ' ' LEU . 29.6 m -110.38 165.1 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 0.0 111.307 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.573 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -139.05 176.09 21.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.403 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.0 156.28 27.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.549 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.681 ' CD2' ' HA ' ' B' ' 33' ' ' ASP . 1.3 t80 -142.66 123.25 14.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . 0.599 ' HD2' ' OD2' ' B' ' 33' ' ' ASP . 33.5 mtt-85 65.78 -88.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.063 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 64.8 p -137.56 12.89 2.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.22 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -109.33 173.14 6.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.25 177.22 7.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.123 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.71 161.14 23.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.607 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.457 HD13 HG12 ' B' ' 60' ' ' VAL . 7.8 tp -119.5 136.21 54.43 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.679 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -136.48 137.82 40.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' B' ' 56' ' ' PHE . 8.3 tp -137.99 145.79 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.085 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -172.58 -175.37 40.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.463 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.6 p -164.07 158.37 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.17 159.58 28.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.3 118.98 23.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.605 ' HD3' ' HB2' ' B' ' 82' ' ' ALA . 0.0 OUTLIER -105.84 104.03 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.712 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 10.8 p -101.91 126.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.293 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.76 -171.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -118.21 58.32 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 83.2 p -156.96 -53.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.97 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.721 ' HA ' HG22 ' B' ' 103' ' ' ILE . 6.3 p -112.37 143.43 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.605 ' HB2' ' HD3' ' B' ' 76' ' ' ARG . . . -146.7 151.72 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 111.231 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 44.9 tp -136.36 132.57 35.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.623 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.25 143.21 47.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.56 171.34 18.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.444 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . 167.45 157.33 10.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.509 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.167 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.91 30.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.339 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.39 126.81 37.97 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.311 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' B' ' 94' ' ' ASP . . . -140.85 145.61 36.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.581 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' NZ ' ' B' ' 34' ' ' LYS . . . 55.17 -98.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.27 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.37 -25.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.725 0.298 . . . . 0.0 111.287 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 92.3 p -126.95 12.88 7.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' B' ' 90' ' ' ALA . 33.8 m-20 -98.93 69.27 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.09 127.01 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.059 0.457 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.644 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 5.3 ptp -133.02 147.14 52.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.744 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -126.24 130.85 51.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.388 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -128.02 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.699 0.285 . . . . 0.0 111.449 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.11 109.46 7.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.811 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.45 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . 91.5 p -125.18 163.56 22.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.435 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -131.09 140.2 49.98 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.085 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.685 ' OD1' HG22 ' A' ' 57' ' ' THR . 45.1 m-80 -111.72 125.54 54.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.378 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.721 HG22 ' HA ' ' B' ' 81' ' ' VAL . 3.3 pt -136.66 134.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.824 0.345 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 55' ' ' ASN . 6.6 pt-20 -111.64 159.49 18.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 0.474 ' HE1' HD12 ' B' ' 103' ' ' ILE . 50.5 m95 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.623 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 t70 65.12 124.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.906 0.384 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -125.7 52.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.854 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.37 -49.99 1.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -129.2 113.83 15.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.672 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -156.69 103.88 2.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.694 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t 68.49 71.37 0.3 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.993 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.746 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 8.9 m-70 -110.3 -54.0 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.807 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.746 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.313 31.5 Cg_exo -71.28 138.48 33.19 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.433 2.089 . . . . 0.0 111.921 179.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.09 -35.08 76.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.931 0.396 . . . . 0.0 111.15 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.34 109.27 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.633 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -164.3 115.67 1.29 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.472 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.637 ' HE3' ' HE3' ' B' ' 13' ' ' LYS . 4.3 tttm -133.1 -59.58 0.88 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.482 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.46 -39.62 87.04 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.296 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . 0.556 ' O ' ' HG2' ' C' ' 19' ' ' ARG . . . -74.43 -52.38 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 110.916 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . 0.647 ' O ' ' HG3' ' C' ' 20' ' ' GLN . 0.7 OUTLIER -56.05 -47.43 77.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.992 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.521 ' HZ3' HD13 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.89 -42.32 98.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . 0.491 ' HA ' ' HZ2' ' A' ' 17' ' ' LYS . 73.8 t80 -62.63 -41.12 98.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' C' ' 15' ' ' ALA . 34.6 mmt180 -73.76 -30.29 62.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.813 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.647 ' HG3' ' O ' ' C' ' 16' ' ' HIS . 19.0 mt-30 -71.74 -34.47 69.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . 0.9 HD12 HD12 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -63.97 -51.67 63.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.57 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.77 -25.59 64.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' C' ' 19' ' ' ARG . 6.1 t-20 -66.29 -37.4 85.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' B' ' 25' ' ' LEU . 6.3 mmp_? -70.96 -44.8 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.642 ' HA ' HD11 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -61.24 -32.48 72.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . 0.607 ' O ' HG22 ' C' ' 30' ' ' THR . 56.6 t0 -81.9 -28.3 32.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -73.14 -43.26 61.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.27 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' B' ' 25' ' ' LEU . 11.4 mt -72.08 -29.03 63.71 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.68 -47.39 72.58 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.978 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.607 HG22 ' O ' ' C' ' 26' ' ' ASP . 2.5 t -71.15 -33.7 70.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.792 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.499 ' NH2' HG21 ' B' ' 32' ' ' VAL . 45.4 ttp85 -67.8 -40.09 83.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.361 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.598 HG13 ' O ' ' C' ' 28' ' ' LEU . 33.7 m -76.11 -29.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.233 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . 0.666 ' HA ' ' CD2' ' C' ' 63' ' ' TYR . 7.2 t70 -62.47 -57.38 11.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.017 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' C' ' 30' ' ' THR . 26.8 pttt -70.11 -44.65 68.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.797 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.93 -45.33 81.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 39' ' ' SER . 0.4 OUTLIER -71.15 -26.3 62.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.762 0.315 . . . . 0.0 111.067 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.55 -37.8 85.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.441 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' C' ' 90' ' ' ALA . 52.3 p -82.91 -38.77 22.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.689 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . 0.461 ' HB2' HD21 ' B' ' 36' ' ' LEU . 30.8 t -57.22 -57.35 12.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 111.089 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.52 68.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . 0.565 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -62.31 -45.29 93.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.956 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.696 HD23 ' HB1' ' C' ' 70' ' ' ALA . 0.3 OUTLIER -66.18 -32.77 74.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.061 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.58 ' HB3' ' HB2' ' B' ' 43' ' ' ASN . 1.1 m-20 -82.85 -15.8 50.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -64.74 -17.74 64.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.073 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.755 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 2.4 mm? -75.36 162.74 28.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.857 177.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 45.3 p90 -143.96 -30.38 0.48 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.092 0.472 . . . . 0.0 111.712 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.458 ' CG ' ' HB3' ' C' ' 55' ' ' ASN . 15.7 tt0 72.11 104.32 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.996 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' C' ' 49' ' ' TYR . 9.8 Cg_endo -89.16 140.59 3.94 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.67 2.247 . . . . 0.0 112.53 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' C' ' 48' ' ' PRO . 18.2 m-85 67.08 150.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . -173.87 68.82 0.1 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.278 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 p -92.05 -19.36 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.158 0.583 . . . . 0.0 112.494 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 148.38 48.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.338 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 -175.11 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.667 0.27 . . . . 0.0 110.563 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.3 137.97 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.593 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 6.5 t30 -125.9 119.76 28.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 111.67 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . 0.75 ' CZ ' HD11 ' C' ' 71' ' ' ILE . 17.8 t80 -80.32 128.38 33.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.755 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 16.8 p -114.3 119.93 38.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.983 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . 0.473 ' HB2' HD12 ' C' ' 71' ' ' ILE . . . -148.32 141.5 25.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.523 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 100' ' ' SER . . . -176.92 166.66 37.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.566 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.461 HG12 HD13 ' C' ' 69' ' ' LEU . 29.5 m -110.29 165.09 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.358 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -139.05 176.12 21.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.472 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.01 156.26 27.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.654 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' C' ' 33' ' ' ASP . 1.3 t80 -142.69 123.19 14.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.595 ' HD2' ' OD2' ' C' ' 33' ' ' ASP . 33.5 mtt-85 65.82 -88.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.032 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 64.1 p -137.53 12.93 2.98 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.172 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 32.8 t -109.35 173.15 6.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.28 177.22 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.065 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.72 161.2 23.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.546 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.461 HD13 HG12 ' C' ' 60' ' ' VAL . 7.7 tp -119.62 136.13 54.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.762 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.696 ' HB1' HD23 ' C' ' 42' ' ' LEU . . . -136.39 137.91 41.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.671 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . 0.75 HD11 ' CZ ' ' C' ' 56' ' ' PHE . 8.3 tp -138.08 145.81 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.058 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -172.57 -175.46 40.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 74.1 p -164.0 158.41 19.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.827 0.346 . . . . 0.0 111.043 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.2 159.53 28.06 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.207 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -129.29 118.99 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.377 . . . . 0.0 111.153 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.605 ' HD3' ' HB2' ' C' ' 82' ' ' ALA . 0.0 OUTLIER -105.8 104.04 13.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.721 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.734 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 10.7 p -101.95 126.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.279 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 63.87 -171.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.922 0.391 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -118.23 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.59 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -157.01 -53.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.718 ' HA ' HG22 ' C' ' 103' ' ' ILE . 6.4 p -112.41 143.49 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.509 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.605 ' HB2' ' HD3' ' C' ' 76' ' ' ARG . . . -146.72 151.72 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.202 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.4 132.62 35.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 143.21 47.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 171.32 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.454 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . 167.45 157.33 10.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.584 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -122.07 146.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.839 0.352 . . . . 0.0 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.26 151.97 30.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.336 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 126.86 38.08 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.232 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' C' ' 94' ' ' ASP . . . -140.89 145.56 36.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.615 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.427 ' HA3' ' NZ ' ' C' ' 34' ' ' LYS . . . 55.23 -98.51 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.201 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 40.6 t -155.38 -25.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 0.0 111.25 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -126.98 12.91 7.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' C' ' 90' ' ' ALA . 33.9 m-20 -98.96 69.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.07 127.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.706 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.629 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 5.3 ptp -133.03 147.15 52.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.716 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -126.25 130.86 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.422 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -128.03 137.74 52.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.15 109.54 7.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.459 ' HA ' ' HA3' ' B' ' 59' ' ' GLY . 91.6 p -125.19 163.53 22.27 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.423 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -131.11 140.23 49.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.695 ' OD1' HG22 ' B' ' 57' ' ' THR . 45.1 m-80 -111.77 125.53 54.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.402 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' C' ' 81' ' ' VAL . 3.3 pt -136.69 134.45 48.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.831 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' B' ' 55' ' ' ASN . 6.5 pt-20 -111.6 159.45 18.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 0.481 ' HE1' HD12 ' C' ' 103' ' ' ILE . 50.4 m95 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.666 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.666 -0.173 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 35.7 t70 67.9 127.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.0 110.938 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.72 49.19 2.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.29 -49.88 1.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.028 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.45 104.71 13.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.792 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.525 ' HZ2' ' HG2' ' A' ' 20' ' ' GLN . 57.6 t-105 -165.3 115.56 1.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.699 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t 64.77 83.34 0.17 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.007 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.646 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 6.0 m-70 -112.92 -47.39 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.833 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.646 ' HD3' ' HB2' ' A' ' 8' ' ' HIS 0.285 31.5 Cg_exo -70.19 149.52 64.29 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.511 2.141 . . . . 0.0 111.879 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -72.02 -45.14 62.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.87 0.367 . . . . 0.0 111.088 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -94.84 110.53 22.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.69 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 7.5 pt-20 -158.53 111.79 2.37 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.432 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -125.82 -70.85 0.72 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.476 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.42 -37.54 69.82 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.251 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.99 -54.26 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.884 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.649 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 1.8 t60 -53.79 -52.32 60.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.012 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -40.42 86.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.582 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -58.47 -35.35 72.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 111.258 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.78 -41.93 35.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.525 ' HG2' ' HZ2' ' A' ' 6' ' ' TRP . 28.8 mt-30 -59.4 -35.03 73.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -59.54 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.538 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -65.57 -21.2 66.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.8 -40.99 75.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.691 ' HD3' HD13 ' C' ' 25' ' ' LEU . 4.5 mmp_? -71.73 -43.75 65.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.815 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.67 HD13 ' HD3' ' B' ' 24' ' ' ARG . 1.2 tp -59.75 -40.97 89.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.646 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.22 -32.74 64.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.775 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HZ2' HD11 ' C' ' 25' ' ' LEU . 14.5 tttm -71.43 -29.68 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.668 0.27 . . . . 0.0 111.237 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.709 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.3 mt -85.16 -31.1 23.44 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' O ' HG22 ' A' ' 32' ' ' VAL . 25.4 t70 -66.34 -41.21 89.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.976 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.638 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 7.0 t -73.23 -44.54 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.797 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.792 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 24.3 ttp85 -60.46 -37.03 79.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.304 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 28' ' ' LEU . 33.9 m -75.71 -31.82 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.117 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.33 -50.7 64.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.032 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.792 ' HE3' ' HA ' ' A' ' 31' ' ' ARG . 23.2 pttt -71.48 -42.17 68.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.718 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -52.95 47.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.474 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.14 -38.3 87.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.087 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.06 77.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.446 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.666 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 70.3 p -75.38 -37.17 60.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.2 t -58.12 -66.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -31.47 35.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.425 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . . . -58.81 -53.37 59.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.617 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.8 tm? -69.36 -32.82 72.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.104 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -75.99 -5.67 47.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -13.81 59.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.135 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.805 ' HG ' ' HB ' ' A' ' 57' ' ' THR . 3.7 mm? -75.64 172.53 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' C' ' 46' ' ' PHE . 47.2 p90 -153.55 -26.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.66 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.93 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' B' ' 102' ' ' ASN . 9.9 Cg_endo -92.04 144.56 2.86 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.591 2.194 . . . . 0.0 112.57 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 48' ' ' PRO . 11.0 m-85 53.5 154.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.25 79.15 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.279 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.97 -26.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.142 0.577 . . . . 0.0 112.424 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 77' ' ' VAL . . . 162.2 49.35 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.34 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -146.15 -178.11 5.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.545 0.212 . . . . 0.0 110.642 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.77 144.26 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.498 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.645 ' OD1' ' HB3' ' B' ' 104' ' ' GLU . 1.7 t30 -128.75 125.3 37.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.987 0.422 . . . . 0.0 111.662 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.37 128.15 37.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.805 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 10.5 p -113.12 131.8 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.99 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.63 133.17 13.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.424 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' B' ' 100' ' ' SER . . . -166.64 179.46 40.52 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.588 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.49 177.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.763 0.316 . . . . 0.0 111.4 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.562 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . -154.04 172.93 32.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.408 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.68 156.79 28.38 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' B' ' 96' ' ' MET . 1.1 t80 -146.71 125.89 12.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.751 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 66.04 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.137 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.225 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.64 166.16 13.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -124.1 174.41 7.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 111.093 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.02 157.47 37.66 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 70' ' ' ALA . 6.8 tp -111.8 134.16 53.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.48 ' H ' HD12 ' A' ' 69' ' ' LEU . . . -131.39 136.73 48.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.68 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.84 145.79 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.147 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' THR . . . -175.96 -179.3 46.37 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -160.53 157.93 28.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.22 153.98 25.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.268 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.51 128.77 47.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.442 ' NH2' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -110.76 105.53 14.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.698 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.434 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 11.4 p -100.86 130.84 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.372 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 56.57 -167.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.056 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' HA ' ' NH2' ' A' ' 76' ' ' ARG . 58.0 mt-10 -122.59 61.71 0.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.76 -51.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.006 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.69 135.63 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.476 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.16 164.75 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.295 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.44 HD12 ' HB3' ' A' ' 101' ' ' PHE . 7.0 tp -142.58 148.27 37.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.624 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.436 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -152.74 136.05 15.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.15 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.08 18.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.412 ' HA3' HD11 ' A' ' 42' ' ' LEU . . . -179.22 154.63 14.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.571 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.58 42.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.926 0.393 . . . . 0.0 111.027 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -114.36 147.69 38.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.323 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.36 126.02 44.36 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.253 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -138.65 152.02 47.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.706 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.48 -97.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.281 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.22 -39.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -115.72 16.42 16.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.158 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.63 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 14.4 m-20 -101.12 65.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.19 119.3 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 110.704 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.476 ' HB3' ' CD1' ' C' ' 63' ' ' TYR . 0.3 OUTLIER -117.82 145.31 44.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -124.87 132.66 53.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.686 0.279 . . . . 0.0 111.451 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.05 108.55 4.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.739 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.579 ' CB ' ' HA3' ' C' ' 59' ' ' GLY . 85.0 p -128.73 160.87 31.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB3' HD12 ' A' ' 83' ' ' LEU . 18.3 p90 -125.94 138.35 53.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.908 0.385 . . . . 0.0 111.09 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.677 ' OD1' HG22 ' C' ' 57' ' ' THR . 22.9 m-80 -104.73 129.86 52.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.411 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.436 HD12 ' HE1' ' A' ' 105' ' ' TRP . 2.6 pt -131.94 132.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.824 0.345 . . . . 0.0 110.778 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.636 ' HB3' ' OD1' ' C' ' 55' ' ' ASN . 8.3 pt-20 -110.97 143.25 41.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.436 ' HE1' HD12 ' A' ' 103' ' ' ILE . 14.6 m95 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.671 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' B' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' B' ' 1' ' ' GLY . 35.8 t70 67.92 127.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 110.95 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -133.7 49.13 2.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.827 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.3 -49.97 1.91 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.969 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.39 104.77 13.92 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.813 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.525 ' HZ2' ' HG2' ' B' ' 20' ' ' GLN . 57.6 t-105 -165.33 115.54 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.744 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t 64.72 83.37 0.17 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.972 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.635 ' HB2' ' HD3' ' B' ' 9' ' ' PRO . 6.0 m-70 -112.96 -47.34 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.749 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' B' ' 8' ' ' HIS 0.284 31.5 Cg_exo -70.19 149.54 64.3 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.525 2.15 . . . . 0.0 111.856 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -72.07 -45.1 62.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -94.76 110.48 22.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.683 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.656 ' HB2' ' HB2' ' B' ' 16' ' ' HIS . 7.5 pt-20 -158.56 111.71 2.36 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.476 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -125.79 -70.84 0.72 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.506 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.46 69.32 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.274 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.05 -54.24 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 0.0 110.908 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.656 ' HB2' ' HB2' ' B' ' 12' ' ' GLU . 1.8 t60 -53.67 -52.34 60.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.071 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -40.34 86.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.558 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . 0.426 ' HA ' ' HZ2' ' C' ' 17' ' ' LYS . 81.8 t80 -58.53 -35.32 72.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.216 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -77.74 -42.0 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.525 ' HG2' ' HZ2' ' B' ' 6' ' ' TRP . 28.8 mt-30 -59.43 -34.97 73.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -59.51 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.563 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.53 -21.27 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -69.72 -40.93 75.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.67 ' HD3' HD13 ' A' ' 25' ' ' LEU . 4.5 mmp_? -71.82 -43.66 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.671 HD13 ' HD3' ' C' ' 24' ' ' ARG . 1.2 tp -59.91 -40.89 90.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.18 -32.82 65.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.529 ' HZ2' HD11 ' A' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.63 65.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.193 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.712 ' O ' HG13 ' B' ' 32' ' ' VAL . 4.2 mt -85.15 -31.0 23.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.432 ' O ' HG22 ' B' ' 32' ' ' VAL . 25.3 t70 -66.41 -41.2 89.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.941 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.63 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 7.0 t -73.22 -44.53 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.78 ' HA ' ' HE3' ' B' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.1 79.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.313 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.712 HG13 ' O ' ' B' ' 28' ' ' LEU . 33.8 m -75.63 -31.82 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.233 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.45 -50.57 64.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.78 ' HE3' ' HA ' ' B' ' 31' ' ' ARG . 23.1 pttt -71.5 -42.09 68.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.787 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.9 -52.89 48.29 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.412 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.04 -38.41 88.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.14 77.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.479 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.668 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . 70.5 p -75.33 -37.17 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.806 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 46.0 t -58.17 -65.9 0.57 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.157 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -31.4 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' HA3' ' B' ' 61' ' ' GLY . . . -58.83 -53.37 59.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.913 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.626 HD13 ' O ' ' B' ' 42' ' ' LEU . 1.8 tm? -69.35 -32.87 72.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' C' ' 43' ' ' ASN . 61.9 m-20 -76.01 -5.7 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -13.7 59.82 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.213 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.821 ' HG ' ' HB ' ' B' ' 57' ' ' THR . 3.7 mm? -75.66 172.44 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.866 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 47.0 p90 -153.48 -26.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.53 107.71 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.992 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' C' ' 102' ' ' ASN . 9.8 Cg_endo -92.07 144.57 2.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.622 2.214 . . . . 0.0 112.56 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.529 ' O ' ' O ' ' B' ' 48' ' ' PRO . 11.0 m-85 53.39 154.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' B' ' 76' ' ' ARG . . . 178.26 78.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.236 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.87 -26.5 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.11 0.564 . . . . 0.0 112.506 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' B' ' 77' ' ' VAL . . . 162.18 49.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.299 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' B' ' 52' ' ' GLY . 0.4 OUTLIER -146.21 -178.16 5.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.564 0.221 . . . . 0.0 110.62 179.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.65 144.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.55 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.644 ' OD1' ' HB3' ' C' ' 104' ' ' GLU . 1.7 t30 -128.76 125.16 37.26 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.29 128.15 37.01 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.257 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.821 ' HB ' ' HG ' ' B' ' 45' ' ' LEU . 10.4 p -113.15 131.77 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.042 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.59 133.13 13.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' CB ' ' C' ' 100' ' ' SER . . . -166.5 179.54 40.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.67 177.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 0.0 111.35 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' B' ' 41' ' ' ALA . . . -153.97 172.88 32.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.538 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.6 156.84 28.43 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.531 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' TYR . . . . . 0.481 ' CD1' ' HB3' ' C' ' 96' ' ' MET . 1.1 t80 -146.78 125.79 12.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.764 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.96 -89.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 26.5 p -137.95 16.75 2.84 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.214 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.74 166.17 13.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' B' ' 61' ' ' GLY . 0.8 OUTLIER -124.06 174.4 7.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.04 157.52 37.72 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.535 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.485 HD12 ' H ' ' B' ' 70' ' ' ALA . 6.7 tp -111.83 134.23 53.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.795 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.485 ' H ' HD12 ' B' ' 69' ' ' LEU . . . -131.49 136.71 48.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.677 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.89 145.72 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.319 . . . . 0.0 111.166 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 57' ' ' THR . . . -175.88 -179.28 46.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.406 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 74.9 p -160.57 157.92 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.918 0.39 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.18 153.99 25.51 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.215 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -126.56 128.83 47.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . 0.442 ' NH2' ' HA ' ' B' ' 79' ' ' GLU . 0.0 OUTLIER -110.72 105.52 14.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.791 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.424 ' HA ' ' HA2' ' B' ' 52' ' ' GLY . 11.4 p -100.89 130.79 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.284 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 56.62 -167.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.945 0.402 . . . . 0.0 111.102 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.442 ' HA ' ' NH2' ' B' ' 76' ' ' ARG . 57.4 mt-10 -122.59 61.79 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.77 -51.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.03 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.57 135.66 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.539 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.2 164.79 29.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' B' ' 84' ' ' LYS . 7.0 tp -142.62 148.3 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.433 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 0.0 OUTLIER -152.81 136.02 15.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.151 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.17 169.05 18.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.407 ' HA3' HD11 ' B' ' 42' ' ' LEU . . . -179.17 154.65 14.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.571 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.66 142.56 42.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.88 0.372 . . . . 0.0 111.096 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' B' ' 38' ' ' SER . . . -114.28 147.68 38.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.348 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.35 125.99 44.32 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.305 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.737 ' HB1' ' HB2' ' B' ' 34' ' ' LYS . . . -138.62 152.03 47.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.604 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.46 -97.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.272 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 41.9 t -151.19 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.64 16.44 16.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.193 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.634 ' HB3' ' HB3' ' B' ' 90' ' ' ALA . 13.9 m-20 -101.15 65.65 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.17 119.38 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -117.89 145.33 44.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.721 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.87 132.6 53.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.19 142.43 49.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.08 108.48 4.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' SER . . . . . 0.575 ' CB ' ' HA3' ' A' ' 59' ' ' GLY . 85.1 p -128.71 160.89 31.07 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.431 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . 0.433 ' HB3' HD12 ' B' ' 83' ' ' LEU . 18.2 p90 -125.93 138.35 53.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 0.0 111.038 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.679 ' OD1' HG22 ' A' ' 57' ' ' THR . 22.9 m-80 -104.72 129.87 52.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.38 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.445 HD12 ' HE1' ' B' ' 105' ' ' TRP . 2.6 pt -131.94 132.73 61.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.843 0.354 . . . . 0.0 110.801 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.645 ' HB3' ' OD1' ' A' ' 55' ' ' ASN . 8.3 pt-20 -111.02 143.2 42.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . 0.445 ' HE1' HD12 ' B' ' 103' ' ' ILE . 14.8 m95 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.705 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' C' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' C' ' 1' ' ' GLY . 35.8 t70 67.79 127.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.912 0.387 . . . . 0.0 110.972 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.75 49.19 2.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.811 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.36 -49.9 1.9 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.5 104.84 13.96 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.753 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' TRP . . . . . 0.518 ' HZ2' ' HG2' ' C' ' 20' ' ' GLN . 57.4 t-105 -165.33 115.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.779 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t 64.9 83.27 0.17 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.977 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.651 ' HB2' ' HD3' ' C' ' 9' ' ' PRO . 6.0 m-70 -112.93 -47.37 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.755 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' PRO . . . . . 0.651 ' HD3' ' HB2' ' C' ' 8' ' ' HIS 0.282 31.4 Cg_exo -70.12 149.58 64.81 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.477 2.118 . . . . 0.0 111.881 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -72.07 -45.16 61.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.957 0.408 . . . . 0.0 111.092 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -94.84 110.52 22.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.707 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 16' ' ' HIS . 7.5 pt-20 -158.46 111.66 2.38 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.441 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -125.79 -70.77 0.72 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.524 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.44 -37.5 69.62 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.256 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.14 -54.22 19.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' HIS . . . . . 0.634 ' HB2' ' HB2' ' C' ' 12' ' ' GLU . 1.8 t60 -53.69 -52.35 60.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.016 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.426 ' HZ2' ' HA ' ' B' ' 18' ' ' PHE . 0.0 OUTLIER -59.41 -40.33 86.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.504 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -58.52 -35.29 72.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 111.241 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.77 -41.94 35.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.518 ' HG2' ' HZ2' ' C' ' 6' ' ' TRP . 28.9 mt-30 -59.44 -34.99 73.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.141 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -59.5 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.591 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.64 -21.18 66.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.981 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -69.75 -40.99 75.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.671 ' HD3' HD13 ' B' ' 25' ' ' LEU . 4.4 mmp_? -71.83 -43.68 65.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.771 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.691 HD13 ' HD3' ' A' ' 24' ' ' ARG . 1.3 tp -59.82 -40.96 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -73.18 -32.8 65.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.508 ' HZ2' HD11 ' B' ' 25' ' ' LEU . 14.5 tttm -71.47 -29.69 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.168 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.717 ' O ' HG13 ' C' ' 32' ' ' VAL . 4.2 mt -85.07 -31.08 23.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . 0.43 ' O ' HG22 ' C' ' 32' ' ' VAL . 25.5 t70 -66.32 -41.27 89.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.01 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.647 ' O ' ' HG2' ' C' ' 34' ' ' LYS . 7.0 t -73.24 -44.45 59.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.783 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 24.3 ttp85 -60.45 -37.12 79.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.28 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.717 HG13 ' O ' ' C' ' 28' ' ' LEU . 33.8 m -75.55 -31.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.4 -50.65 64.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.031 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.783 ' HE3' ' HA ' ' C' ' 31' ' ' ARG . 23.1 pttt -71.53 -42.13 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.737 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.73 -53.04 46.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.422 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.04 -38.37 88.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 111.052 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.79 -44.03 77.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.416 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.677 ' HB2' ' HB1' ' C' ' 88' ' ' ALA . 70.7 p -75.37 -37.22 60.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' SER . . . . . . . . . . . . . 46.1 t -58.13 -65.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.123 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -31.36 35.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.456 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' HA3' ' C' ' 61' ' ' GLY . . . -58.8 -53.39 58.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.62 ' O ' HD13 ' C' ' 42' ' ' LEU . 1.8 tm? -69.44 -32.82 72.0 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 62.0 m-20 -75.98 -5.63 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -13.75 59.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.098 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.832 ' HG ' ' HB ' ' C' ' 57' ' ' THR . 3.7 mm? -75.66 172.52 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.878 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 47.0 p90 -153.57 -26.26 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.664 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 70.59 107.69 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.993 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -92.02 144.54 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.675 2.25 . . . . 0.0 112.568 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.525 ' O ' ' O ' ' C' ' 48' ' ' PRO . 11.0 m-85 53.43 154.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.941 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' C' ' 76' ' ' ARG . . . 178.23 79.13 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.266 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.9 -26.61 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.153 0.581 . . . . 0.0 112.434 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' C' ' 77' ' ' VAL . . . 162.24 49.42 0.02 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.299 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' C' ' 52' ' ' GLY . 0.4 OUTLIER -146.15 -178.05 5.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.587 0.232 . . . . 0.0 110.628 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.74 144.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.558 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' A' ' 104' ' ' GLU . 1.7 t30 -128.74 125.32 37.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -91.35 128.11 37.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.276 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.832 ' HB ' ' HG ' ' C' ' 45' ' ' LEU . 10.2 p -113.17 131.79 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.984 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.56 133.14 13.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.446 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.579 ' HA3' ' CB ' ' A' ' 100' ' ' SER . . . -166.62 179.43 40.53 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.54 177.09 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.349 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' C' ' 41' ' ' ALA . . . -153.96 172.99 32.64 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.424 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.69 156.77 28.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.563 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' TYR . . . . . 0.476 ' CD1' ' HB3' ' A' ' 96' ' ' MET . 1.1 t80 -146.72 125.82 12.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 65.99 -90.03 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 p -137.9 16.76 2.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.182 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -118.7 166.26 12.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' C' ' 61' ' ' GLY . 0.8 OUTLIER -124.18 174.4 7.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.347 . . . . 0.0 111.129 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' C' ' 38' ' ' SER . . . -154.98 157.44 37.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.553 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.492 HD12 ' H ' ' C' ' 70' ' ' ALA . 6.6 tp -111.82 134.21 53.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.769 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.492 ' H ' HD12 ' C' ' 69' ' ' LEU . . . -131.51 136.78 48.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tp -141.91 145.71 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 111.145 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' C' ' 57' ' ' THR . . . -175.93 -179.23 46.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.426 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -160.59 157.88 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.964 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.13 153.9 25.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.251 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.47 128.78 47.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.195 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' C' ' 79' ' ' GLU . 0.0 OUTLIER -110.66 105.59 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' C' ' 52' ' ' GLY . 11.5 p -101.02 130.81 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.964 0.412 . . . . 0.0 111.256 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 56.62 -167.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.089 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' GLU . . . . . 0.443 ' HA ' ' NH2' ' C' ' 76' ' ' ARG . 57.4 mt-10 -122.53 61.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.587 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 -51.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.012 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.66 135.6 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.11 164.81 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.226 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' C' ' 101' ' ' PHE . 7.0 tp -142.65 148.27 37.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . 0.417 ' N ' ' HG ' ' C' ' 83' ' ' LEU . 0.0 OUTLIER -152.75 136.04 15.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.212 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.23 169.05 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' C' ' 42' ' ' LEU . . . -179.18 154.64 14.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.592 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.56 142.54 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.829 0.347 . . . . 0.0 111.093 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.677 ' HB1' ' HB2' ' C' ' 38' ' ' SER . . . -114.3 147.71 38.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -125.39 126.0 44.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.306 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.725 ' HB1' ' HB2' ' C' ' 34' ' ' LYS . . . -138.68 152.01 47.68 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.621 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.35 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 42.0 t -151.23 -39.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.333 . . . . 0.0 111.32 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' SER . . . . . . . . . . . . . 23.9 p -115.63 16.4 16.48 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.161 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.629 ' HB3' ' HB3' ' C' ' 90' ' ' ALA . 14.1 m-20 -101.16 65.7 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.26 119.37 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.673 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.481 ' HB3' ' CD1' ' B' ' 63' ' ' TYR . 0.3 OUTLIER -117.85 145.25 44.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.693 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -124.89 132.65 53.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.443 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -132.26 142.39 49.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.688 0.28 . . . . 0.0 111.483 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.97 108.49 4.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.738 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . 0.576 ' CB ' ' HA3' ' B' ' 59' ' ' GLY . 84.6 p -128.67 160.85 31.18 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.435 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.439 ' HB3' HD12 ' C' ' 83' ' ' LEU . 18.3 p90 -125.94 138.38 53.77 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.896 0.379 . . . . 0.0 111.108 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' ASN . . . . . 0.668 ' OD1' HG22 ' B' ' 57' ' ' THR . 23.1 m-80 -104.73 129.89 52.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.448 HD12 ' HE1' ' C' ' 105' ' ' TRP . 2.6 pt -132.0 132.67 61.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . 0.644 ' HB3' ' OD1' ' B' ' 55' ' ' ASN . 8.3 pt-20 -110.95 143.23 41.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' TRP . . . . . 0.448 ' HE1' HD12 ' C' ' 103' ' ' ILE . 14.6 m95 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.683 179.683 . . . . . . . . 1 1 . 1 stop_ save_